注册 |登录

陈立新专利报告分享 http://blog.sciencenet.cn/u/feixiangfeixian 中美欧日韩五局及PCT专利数据统计分析报告 陈立新 Tel13592308169 QQ86065045

博文

2021年医用或梳妆用的配制品（A61K）类各专利局的PCT申请数量分布——中国占11%，美国占41%，欧洲占17%

已有 11204 次阅读 2022-11-23 21:23 |系统分类:博客资讯

陈立新 张琳 黄颖：中美欧日韩五局专利报告3110.doc

█武汉大学科教管理与评价研究中心 陈立新 张琳 黄颖

微信号：chenlixinip5

附录2  2021年PCT国际专利申请统计分析报告

附录2.6 主要技术类别下各专利局的PCT申请状况与竞争态势

附录2.6.3 医用或梳妆用的配制品（A61K）类各专利局的PCT申请数量分布

医用或梳妆用的配制品（A61K）小类主要涉及医药配制品，包括牙科制剂、化妆品或类似的梳妆用配制品、医药配制品、基因治疗、传统草药等，不包括麻醉剂、抗肿瘤药、抗生素等特定治疗药物，也不包括毛发、皮肤、口腔等护理制剂（如牙膏、胭脂、眼线、睫毛膏、洗发水、沐浴露等）。2021年，在医用或梳妆用的配制品（A61K）小类上PCT专利申请总计11483项，占总授权量的4.4%，是申请数量第3多的小类。

2021年，中国局在医用或梳妆用的配制品（A61K）小类上申请PCT专利1227项，占该小类专利申请总量的11%。美国局在该小类上申请PCT专利4713项，占该小类专利申请总量的41%。欧洲局在该小类上申请PCT专利1938项，占该小类专利申请总量的17%。可见，医用或梳妆用的配制品（A61K）小类的PCT专利申请主要来自美国局、欧洲局和中国局。

 

附表2.6.3-1  2021年医用或梳妆用的配制品（A61K）类各专利局的PCT申请数量


国家

申请数量

占本局比例

占小类比例

1

中国

1227

1.82%

10.69%

2

美国

4713

8.44%

41.04%

3

日本

754

1.59%

6.57%

4

欧洲

1938

5.24%

16.88%

5

韩国

742

3.95%

6.46%

6

国际

805

6.42%

7.01%

7

英国

227

6.60%

1.98%

8

法国

73

2.91%

0.64%

9

加拿大

113

6.09%

0.98%

10

澳大利亚

118

7.67%

1.03%

11

土耳其

131

9.17%

1.14%

12

德国

10

0.70%

0.09%

13

以色列

142

10.20%

1.24%

14

瑞典

21

1.67%

0.18%

15

俄罗斯

59

5.17%

0.51%

16

印度

89

8.77%

0.78%

17

芬兰

22

2.44%

0.19%

18

西班牙

24

2.77%

0.21%

19

荷兰

41

5.13%

0.36%

20

其他

234

--

2.04%


小计

11483

--

100%

注：本表数据按IPC主分类号统计。

 


image.png

附图2.6.3-1  2021年医用或梳妆用的配制品（A61K）类各专利局的PCT申请数量对比

 

2021年，在医用或梳妆用的配制品（A61K）小类上获得欧洲专利授权最多的公司是欧莱雅，其次是加州大学和联合利华公司。

 

附表2.6.3-2  2021年医用或梳妆用的配制品（A61K）类PCT专利申请数量前10机构


机构名称

国家

机构英文名称

专利

1

欧莱雅

法国

L'OREAL

166

2

加州大学

美国

THE REGENTS OF THE UNIVERSITY OF   CALIFORNIA

122

3

联合利华知识产权控股私人有限公司

荷兰

UNILEVER IP HOLDINGS B.V.

74

4

汉高股份有限及两合公司

德国

HENKEL AG & CO., KGAA

71

5

法国国家健康与医学研究院

法国

INSERM (INSTITUT NATIONAL DE LA   SANTé ET DE LA RECHERCHE MéDICALE)

62

6

宝洁公司

美国

THE PROCTER & GAMBLE COMPANY

56

7

拜尔斯道夫公司

德国

BEIERSDORF AG

53

8

斯坦福大学

美国

THE BOARD OF TRUSTEES OF THE   LELAND STANFORD JUNIOR UNIVERSITY

47

9

得克萨斯大学

美国

BOARD OF REGENTS, THE UNIVERSITY   OF TEXAS SYSTEM

45

10

诺华公司

瑞士

NOVARTIS AG

43

注：本表数据按照第一申请人进行统计。

 


image.png

附图2.6.3-2  2021年医用或梳妆用的配制品（A61K）类PCT专利申请数量前10机构

 

 

 

 

致谢

感谢大连理工大学刘则渊教授、河南师范大学梁立明教授、科技部中国科学技术发展战略研究院武夷山研究员、大连理工大学丁堃教授、大连理工大学杨中楷教授对本报告的大力支持与帮助。同时，向以不同形式对本报告提出意见和建议的专家学者们表示诚挚的感谢。

如需要中美欧日韩五局及PCT专利数据、专利报告，以及咨询相关专利问题请添加微信号。

微信号：chenlixinip5

 

 

附表  2021年该小类PCT国际专利申请

  

IDTitleApplicant
WO/2021/087536DENTAL FLOSSLENZING PLASTICS GMBH & CO KG
WO/2021/159155COMPOSITIONBENTSEN, Paal
WO/2021/222964IMMUNOGENIC COMPLEXES AND METHODS OF PRODUCING AND USING THE  SAMEESS HOLDING GMBH
WO/2021/222965MANNOSE-BINDING LECTIN FOR TREATMENT OR PROPHYLAXIS OF  INFECTIOUS DISEASESESS HOLDING GMBH
WO/2021/000004METHODS OF TREATING MYOCARDITIS AND/OR CARDIOMYOPATHY AND  REAGENTS THEREFORCELLMID LIMITED
WO/2021/051149BIODEGRADABLE DRUG-POLYMER CONJUGATEPOLYACTIVA PTY LTD
WO/2021/051151ORAL HEALTH IMPROVING PRODUCTSYNDK PTY. LTD.
WO/2021/051153PROTEIN PARTICLES COMPRISING A DIPHTHERIA TOXIN CROSS REACTING  MATERIAL (CRM) AMINO ACID SEQUENCE AND USES THEREOFGRIFFITH UNIVERSITY
WO/2021/056048THERAPEUTIC FORMULATIONS AND USES THEREOFBIONOMICS LIMITED
WO/2021/016652METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND  PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLSTHE UNIVERSITY OF MELBOURNE
WO/2021/127722PHARMACEUTICAL COMPOSITIONSPROTA THERAPEUTICS PTY LTD
WO/2021/174284COMBINATION TREATMENT FOR MICROORGANISMSTHE UNIVERSITY OF ADELAIDE
WO/2021/000013COMPOSITIONS AND METHODS OF USETHE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
WO/2021/000024METHODS AND AAV VECTORS FOR <i>IN VIVO</i>  TRANSDUCTIONCHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/007610INJECTABLE NUTRITIONAL SUPPLEMENTCHEMVET AUSTRALIA PTY LTD
WO/2021/003531PEPTIDES AND USES THEREOFLATERAL IP PTY LTD
WO/2021/003535METHOD FOR GUT MUCOSA PREPARATION TO ENHANCE MICROBIAL  ENGRAFTMENTMILIS, Antony
WO/2021/007618IMMUNO-ONCOLOGY THERAPY USING ISOFLAVONE COMPOUNDSNOXOPHARM LIMITED
WO/2021/007623COMPOSITIONS FOR MAINTAINING OR MODULATING MIXTURES OF ETHER  LIPID MOLECULES IN A TISSUE OF A HUMAN SUBJECTBAKER HEART AND DIABETES INSTITUTE
WO/2021/016668IMMUNOCONJUGATEDENDROCYTE BIOTECH PTY LTD
WO/2021/022336COMPOSITIONS OF PROBIOTICS AND BIOMASS AND METHODS FOR  PROMOTING HEALTH IN A SUBJECTCOMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
WO/2021/022340USES OF LONG-CHAIN POLYUNSATURATED FATTY ACIDSSWINBURNE UNIVERSITY OF TECHNOLOGY
WO/2021/030867METHOD OF MODULATING ADIPOSITYBAKER HEART AND DIABETES INSTITUTE
WO/2021/035310TARGETED DENDRIMER CONJUGATESSTARPHARMA PTY LTD
WO/2021/042171CANCER IMMUNOTHERAPYENA THERAPEUTICS PTY LTD
WO/2021/042174CANCER TREATMENTENA THERAPEUTICS PTY LTD
WO/2021/042178TREATMENT OF OPIOID WITHDRAWALKINOXIS THERAPEUTICS PTY LTD
WO/2021/056051METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASEDIMERIX BIOSCIENCE PTY LTD
WO/2021/051172LIPID PRODRUGS OF CELECOXIB AND USES THEREOFMONASH UNIVERSITY
WO/2021/056053SILICONE DROPLETSFORMULAE 8 PTY LTD
WO/2021/056056PHARMACEUTICAL COMPOUNDS AND METHODS OF USEDERMCARE-VET PTY LTD
WO/2021/056071TREATMENT OF DEMENTIAMACQUARIE UNIVERSITY
WO/2021/056072TREATMENT OF EXCITOTOXICITY-RELATED CONDITIONSMACQUARIE UNIVERSITY
WO/2021/056077THERAPEUTIC DENDRIMERSTARPHARMA PTY LTD
WO/2021/062472MEDICINAL COGNITIVE TREATMENTSACTINOGEN MEDICAL LIMITED
WO/2021/077162MODULATION OF CELLULAR VIABILITYMACQUARIE UNIVERSITY
WO/2021/077166CONTRAST AGENTSMONASH UNIVERSITY
WO/2021/077174METHODS OF TREATING CANCER USING ANDROGEN RECEPTOR ANTAGONISTSGARVAN INSTITUTE OF MEDICAL RESEARCH
WO/2021/081580TREATMENT OF RENAL CYSTIC DISEASEMONASH UNIVERSITY
WO/2021/081581ANTIBODIES FOR BINDING PLASMINOGENMONASH UNIVERSITY
WO/2021/097537MAGNETIC TRACER COMPOSITIONSFERRONOVA PTY LTD
WO/2021/097538BONE FORMATIONTHE UNIVERSITY OF SYDNEY
WO/2021/097540IMMUNOSTIMULATORY COMPOSITIONS COMPRISING SOLUBLE PARASITE  EXTRACTS AND USES THEREOFGRIFFITH UNIVERSITY
WO/2021/102508METHODS OF TREATING HIV-1 INFECTIONBIOTRON LIMITED
WO/2021/102510METHODS AND PRODUCTS FOR REDUCING SIDE EFFECTS ASSOCIATED WITH  USE OF IMMUNE AGONIST ANTIBODIESSOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE LIMITED
WO/2021/102513LEGIONELLA TREATMENT USING CANNABINOIDSBOTANIX PHARMACEUTICALS LIMITED
WO/2021/102514MORAXELLA TREATMENT USING CANNABINOIDSBOTANIX PHARMACEUTICALS LIMITED
WO/2021/102515ANTIBACTERIAL TREATMENT USING A CANNABINOID AND AN ACTIVE  AGENTBOTANIX PHARMACEUTICALS LIMITED
WO/2021/102516NEISSERIA TREATMENT USING CANNABINOIDSBOTANIX PHARMACEUTICALS LIMITED
WO/2021/108853POLYMER NANOPARTICLESTHE UNIVERSITY OF QUEENSLAND
WO/2021/108855NEUROLOGICALLY ACTIVE FLAVONOID COMPOSITIONS AND METHODS OF  USE THEREOFGRETALS AUSTRALIA PTY LTD
WO/2021/108861TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND  AMYLOID-BETA ANTIBODIESTHE UNIVERSITY OF QUEENSLAND
WO/2021/108867METHODS OF ACTIVATING CYTOTOXIC LEUKOCYTES USING PTP1B AND  PTPN2 INHIBITORSMONASH UNIVERSITY
WO/2021/108868ANTIGEN LOADINGDENDROCYTE BIOTECH PTY LTD
WO/2021/113912THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTIONAMBETEX PTY LTD
WO/2021/113914THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTIONAMBETEX PTY LTD
WO/2021/113917THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTIONAMBETEX PTY LTD
WO/2021/113926BOTULINUM TOXIN FORMULATIONS AND METHODS FOR INTRANASAL  DELIVERY THEREOF FOR THE TREATMENT OF ALLERGIC RHINITISBARBAGALLO, Francesco
WO/2021/119749TREATMENT OF GASTROINTESTINAL DISEASETHE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/127736ALLERGY TREATMENTPROTA THERAPEUTICS PTY LTD
WO/2021/127749COMPOSITIONS COMPRISING TERPENES AND THEIR USE IN THE  TREATMENT OR ALLEVIATION OF PAIN OR ANXIETYCANNADOL PHARMACEUTICALS LTD
WO/2021/127752CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-LIKE PROTEIN  (LANCL) AND USES THEREOFLATERAL IP PTY LTD
WO/2021/222967TREATMENT OF PROLIFERATIVE DISEASES OF THE CNSAUCENTRA THERAPEUTICS PTY LTD
WO/2021/138721SELF-ASSEMBLING, SELF-ADJUVANTING SYSTEM FOR DELIVERY OF  VACCINESTHE UNIVERSITY OF QUEENSLAND
WO/2021/142513COMPOSITIONS AND METHODMONASH UNIVERSITY
WO/2021/142514COMPOSITIONS AND METHODSMONASH UNIVERSITY
WO/2021/142516ORAL PEPTIDE ADMINISTRATIONTHE UNIVERSITY OF SYDNEY
WO/2021/151156DRUG DELIVERY DEVICESIDERIS, Anders William James
WO/2021/151168METHOD OF CANNABINOID THERAPYAUSCANN GROUP HOLDINGS LTD
WO/2021/151169CANNABINOID COMPOSITION AND MANUFACTURING METHODAUSCANN GROUP HOLDINGS LTD
WO/2021/155443PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING  OR PREVENTING CORONAVIRUS INFECTIONCENTRE FOR DIGESTIVE DISEASES PTY LIMITED
WO/2021/159187METHOD OF TREATMENT USING META-ARSENITEKOMIPHARM INTERNATIONAL AUSTRALIA PTY LTD
WO/2021/168516METHODS OF TREATMENT AND RELATED COMPOSITIONSASCEND BIOPHARMACEUTICALS LTD
WO/2021/168518S1P RECEPTOR MODULATORSAKAAL PHARMA PTY LTD
WO/2021/179047TREATMENT FOR CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE  TOXICITYCULLIS-HILL, Sydney David
WO/2021/179050VIRAL INHIBITIONMONASH UNIVERSITY
WO/2021/184059TREATMENT METHODSNEWSOUTH INNOVATIONS PTY LIMITED
WO/2021/195691METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN  INFLAMMATORY CONDITIONINCANNEX HEALTHCARE LIMITED
WO/2021/184062COMPOSITIONS FOR TREATING RESPIRATORY TRACT INFECTION AND USES  THEREOFLATERAL IP PTY LTD
WO/2021/184070ANTIVIRAL COMPOSITION FOR ORAL CAREADVANCE NANOTEK LTD.
WO/2021/189109QUERCETIN ENHANCEMENT FORMULATIONSMARTDNA PTY LTD
WO/2021/195694ATTENUATED POXVIRUS VECTOR BASED VACCINE FOR PROTECTION  AGAINST COVID-19SEMENTIS LIMITED
WO/2021/195698METHODS FOR THE TREATMENT OF INFLAMMATION ASSOCIATED WITH  INFECTIONNOXOPHARM LIMITED
WO/2021/195703COMBINATION THERAPY FOR INFLAMMATORY BOWEL DISEASESERVATUS LTD
WO/2021/195706NEW DYNAMIN INHIBITORS AND USESCHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/243396THERAPEUTIC METHODS OF USING CD 14 ANTAGONISTIC ANTIBODIES IN  TREATING CONDITIONS ASSOCIATED WITH A CORONAVIRUS INFECTION INCLUDING  SARS-COV-2 (COVID-19)IMPLICIT BIOSCIENCE LIMITED
WO/2021/195723METHODS FOR TREATMENT OF CORONAVIRUS INFECTIONSTHE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/203168TREATMENT FOR SEPSIS-INDUCED ORGAN DYSFUNCTIONTHE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH
WO/2021/203174TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) WITH  POLYSULFATED POLYSACCHARIDESPARADIGM BIOPHARMACEUTICALS LTD
WO/2021/207790METHOD OF PROPHYLAXIS OF CORONAVIRUS AND/OR RESPIRATORY  SYNCYTIAL VIRUS INFECTIONSTARPHARMA PTY LTD
WO/2021/207801IMMUNE CELLS WITH ENHANCED FUNCTIONTHE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/212168METHODS AND COMPOSITIONSMONASH UNIVERSITY
WO/2021/212181METHODS AND COMPOSITIONS FOR TREATING FUNGAL INFECTIONSNEOCULI PTY LTD
WO/2021/212183PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING  OR PREVENTING MICROBIAL INFECTIONSCENTRE FOR DIGESTIVE DISEASES PTY LIMITED
WO/2021/217221PREVENTING AND TREATING VIRAL INFECTIONSMUCPHARM PTY LTD
WO/2021/222971TREATMENT FOR VIRUS INDUCED ACUTE RESPIRATORY DISTRESS  SYNDROMEDIMERIX BIOSCIENCE LTD
WO/2021/222972TREATMENT FOR ACUTE RESPIRATORY DISTRESS SYNDROMEDIMERIX BIOSCIENCE LTD
WO/2021/222987COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF  FIBROTIC AND INFLAMMATORY CONDITIONSGRETALS AUSTRALIA PTY LTD
WO/2021/222988CELL ENTRY-MODULATING AGENTS AND USES THEREFORGRIFFITH UNIVERSITY
WO/2021/226662USE OF AMINOACETONITRILE COMPOUNDS FOR THE TREATMENT OF  INFECTION AND DISEASEPITNEY PHARMACEUTICALS PTY LIMITED
WO/2021/226664A HEPATITIS C NUCLEIC ACID VACCINE COMPRISING A VARIABLE  DOMAIN DELETED E2 POLYPEPTIDEMACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC  HEALTH LIMITED
WO/2021/226672METHODS AND COMPOSITIONS FOR ATI DIGESTIONGLUTAGEN PTY LTD
WO/2021/226677TREATMENT OF THROMBOSIS AND ASSOCIATED DISORDERS WITH AN  ANTI-PLATELET AGENT.THE HEART RESEARCH INSTITUTE LTD
WO/2021/237273METHODS OF TREATING PULMONARY FIBROSISAMPLIA THERAPEUTICS PTY LTD
WO/2021/232094HEDGEHOG SIGNALING -DEPENDENT CANCER TREATMENTHUDSON INSTITUTE OF MEDICAL RESEARCH
WO/2021/237291TREATMENT OF CORONAVIRUSAXELIA ONCOLOGY PTY LTD
WO/2021/237295CELL HARVEST METHODTHE UNIVERSITY OF MELBOURNE
WO/2021/237297ANTI-VIRAL EXTRACELLULAR VESICLES, THEIR METHODS OF  PREPARATION AND USESEXOPHARM LIMITED
WO/2021/237299METHODS OF ANTIPATHOGENIC TREATMENTCROFT INFRASTRUCTURE DESIGNS PTY LTD
WO/2021/243399METHODS FOR TREATING MAJOR DEPRESSIVE DISORDER AND  TREATMENT-RESISTANT DEPRESSIONIX BIOPHARMA LIMITED
WO/2021/243410ANTI-MICROBIAL AND ANTI-INFLAMMATORY COMPOSITION COMPRISING  ARTHROSPIRA EXTRACTS AND AN ORGANIC ACIDBIOVITE AUSTRALIA PTY LTD
WO/2021/243415THERAPEUTIC CONJUGATESSTARPHARMA PTY LTD
WO/2021/243417IMMUNOGENIC FORMULATIONSCENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY
WO/2021/243424METHOD OF TREATING OR PREVENTING ACUTE RESPIRATORY DISTRESS  SYNDROMECSL INNOVATION PTY LTD
WO/2021/248189COMPOUND FOR PREVENTION OR TREATMENT OF A SKIN CANCER OR SKIN  PRECANCERUNIQUEST PTY LTD
WO/2021/248196IMPROVED VIRUCIDAL FORMULATIONSFIREBRICK PHARMA LIMITED
WO/2021/248207COMPOSITION AND METHOD FOR TREATING CHRONIC PAINZELIRA THERAPEUTICS OPERATIONS PTY LTD
WO/2021/248210TREATMENT METHODS AND FORMULATIONSCURTIN UNIVERSITY
WO/2021/253087NOVEL ANTIBACTERIAL HYDROGELSNEWSOUTH INNOVATIONS PTY LIMITED
WO/2021/258140CD83 BINDING PROTEIN CONJUGATES FOR TREATING LYMPHOMAKIRA BIOTECH PTY LIMITED
WO/2021/258150METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONINGLACHESIS BIOSCIENCES LIMITED
WO/2021/258163LIQUID DISPERSIBLE CURCUMINOID COMPOSITIONS AND METHODS OF  IMPROVING COGNITIVE FUNCTIONPHARMAKO BIOTECHNOLOGIES PTY LTD
WO/2021/168522METHOD FOR OBTAINING OF AN ANTITUMOR COMPOSITION, AN ANTITUMOR  COMPOSITION AND ITS USEHADJIEVA, Nasya Spartakova
WO/2021/007626ORAL MEDICATION FOR TREATING LIPOEDEMABENITTI, Daniel Augusto
WO/2021/016679ANHYDROUS SUNSCREEN COMPOSITION COMPRISING SILICA AEROGELL'OREAL
WO/2021/016680ANHYDROUS SUNSCREEN COMPOSITION COMPRISING SILICA AEROGELL'OREAL
WO/2021/016683ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITION, PROCESS  FOR ITS PRODUCTION AND USE THEREOFL'OREAL
WO/2021/016684COSMETIC COMPOSITION, PROCESS FOR MANUFACTURING THE COSMETIC  COMPOSITION AND ITS USEL'OREAL
WO/2021/022344COSMETIC COMPLEX FOR MOISTURIZING SKIN, USE OF THE COSMETIC  COMPLEX, COSMETIC COMPOSITION AND SKIN MOISTURIZING METHODNATURA COSMéTICOS S.A.
WO/2021/022345TOPICAL COSMETIC COMPOSITION, USE OF THE COMPOSITION AND TONIC  FOR FACIAL APPLICATIONNATURA COSMéTICOS S.A.
WO/2021/022346TOPICAL COSMETIC COMPOSITION, USE OF THE COMPOSITION AND SERUM  FOR FACIAL APPLICATIONNATURA COSMéTICOS S.A.
WO/2021/022347TOPICAL COSMETIC COMPOSITION, USE OF THE COSMETIC COMPOSITION  AND MASK FOR FACIAL APPLICATIONNATURA COSMéTICOS S.A.
WO/2021/046622NATURAL SILICONE REPLACEMENT COMPOSITION, PRODUCTION METHOD  AND USE THEREOFMAIAN INDUSTRIA DE PRODUTOS QUIMICOS LTDA
WO/2021/119770COSMETIC COMPOSITION FOR A KERATIN SUBSTANCE, PROCESS FOR  MANUFACTURING A COSMETIC COMPOSITION AND USE OF THE COSMETIC COMPOSITIONL'OREAL
WO/2021/119771COSMETIC COMPOSITION, PROCESS OF MANUFACTURING THE COSMETIC  COMPOSITION AND USE OF THE COSMETIC COMPOSITIONL'OREAL
WO/2021/134118COSMETIC COMPOSITION COMPRISING A FATTY AMINE, A FATTY  ALCOHOL, A VEGETABLE FAT, A CATIONIC SURFACTANT AND A SILICONE CROSS-POLYMER  FOR USE IN HAIR CAREL'OREAL
WO/2021/151174ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND  INORGANIC COMPONENTS FOR COMPLETE MAINTENANCE OF ORAL HEALTH, METHOD FOR  OBTAINING SAME AND USESVILHENA, Fabiano Vieira
WO/2021/151177COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION, PROCESS  FOR THE PREPARATION OF A COSMETIC COMPOSITION AND METHOD FOR STYLING THE HAIRL'OREAL
WO/2021/203180HAIR COSMETIC COMPOSITION AND PROCESS FOR SHAPING OR ALTERING  THE SHAPE OF THE HAIRL'OREAL
WO/2021/217225HAIR CARE COSMETIC COMPOSITION, METHOD FOR TREATING AND/OR  SHAPING HAIR, AND PROCESS FOR MANUFACTURING A HAIR CARE COSMETIC COMPOSITIONL'OREAL
WO/2021/072514COMPOSITION, USE OF A COMBINATION OF SILVER NANOPARTICLES AND  OF A NITRIC OXIDE DONOR, PHARMACEUTICAL KIT FOR TREATING CANCER, AND METHOD  FOR TREATING CANCERFUNDAÇÃO UNIVERSIDADE FEDERAL DO ABC -UFABC
WO/2021/237317ANTIPERSPIRANT COMPOSITION, PROCESS FOR ITS PRODUCTION AND USE  THEREOFL'OREAL
WO/2021/237318COSMETIC COMPOSITION COMPRISING UNSATURATED DIOIC ACID AND  USES THEREOFL'OREAL
WO/2021/000037METHOD FOR OBTAINING BIOACTIVE INGREDIENTS, USE OF  SUBCRITICAL-WATER EXTRACTION PROCESS, BIOACTIVE INGREDIENT, USE OF BIOACTIVE  INGREDIENT AND COSMETIC COMPOSITIONNATURA COSMéTICOS S.A.
WO/2021/003543IMMUNOMODULATORY COMPOUNDS AND/OR THE PHARMACEUTICALLY  ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITION INCLUDING  IMMUNOMODULATORY COMPOUNDS AND USE OF IMMUNOMODULATORY COMPOUNDS IN THE  PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL  DISEASESUNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/007635PROCESS FOR OBTAINING A FREEZE-DRIED COMPOSITION OF  CHITOSAN-BASED NANOPARTICLES CONTAINING BROMELAIN, FREEZE-DRIED COMPOSITION  OF CHITOSAN-BASED NANOPARTICLES CONTAINING BROMELAIN AND USE IN THE TREATMENT  OF WOUNDSUNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/012028HAIR TREATMENT COMPOSITION, METHOD FOR OBTAINING SAME, USE OF  THE COMPOSITION AND HAIR TREATMENT METHODCHEMYUNION LTDA
WO/2021/207806LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH CONTROLLED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF ENDOMETRIOSISLUIZ PERACCHI, Edson
WO/2021/237321LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF CHRONIC ADRENAL INSUFFICIENCY OR HYPOCORTISOLISMLUIZ PERACCHI, Edson
WO/2021/237322LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIALUIZ PERACCHI, Edson
WO/2021/042193METHOD AND USE OF PNPP-19 FOR PREVENTING AND TREATING EYE  DISEASESBIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACêUTICOS
WO/2021/042194COMPOUND DERIVED FROM QUINOLINE, USE OF A COMPOUND,  COMPOSITION AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A CONDITION CAUSED  BY A BLOOD PARASITEFUNDAÇÃO OSWALDO CRUZ
WO/2021/151178WATER-BASED PROPYLENE GLYCOL-FREE MICROEMULSION FOR DELIVERY  OF MINOXIDIL IN THE TREATMENT OF HAIR LOSS AND METHOD FOR OBTAINING SAMEGERALDI, Katia Solange Cardoso Rodrigues Dos Santos
WO/2021/077191METHOD FOR OBTAINING CB-AG-NMS AND CB-AG-<sb>  </sb><sb>  </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICES, CB-AG-NMS AND CB-AG-<sb>  </sb><sb> </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICES, AND USE OF CB-AG-NMS AND  CB-AG-<sb> </sb><sb>  </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICESUNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/108884PROCESS FOR PRODUCING A PROPHYLACTIC AND THERAPEUTIC DNA  IMMUNOLOGICAL COMPOSITION FOR HPV AND CANCERS ASSOCIATED WITH THE VIRUS,  HYBRID PROTEIN, EXPRESSION VECTOR, IMMUNOLOGICAL COMPOSITION AND USES THEREOFINSTITUTO BUTANTAN
WO/2021/113938VITAMIN AND MINERAL FOOD SUPPLEMENTCELLAVIT REPRESENTAÇÃO DE PRODUTOS NATURAIS LTDA
WO/2021/163776SUBCUTANEOUS IMPLANTS FOR SLOW CONTROLLED RELEASE OF ACTIVE  AGENTSBITTENCOURT, Marco Antonio
WO/2021/119791OLEAGINOUS COMPLEX OBTAINED FROM ACHIOTE SEEDS AND RELATED  USESUNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/127768ANTI-PERSPIRANT COMPOSITION, COSMETIC USE AND METHOD FOR  APPLYING SAMEHART'S ALIMENTOS NATURAIS LTDA
WO/2021/127769COMPOSITION FOR TREATING CONJUNCTIVITISNARDINI, Antonio Roberto
WO/2021/151185HERBAL MEDICINE, HERBAL MEDICINAL PRODUCT AND USE THEREOFEVOLUÇÕES CIENTíFICAS E TECNOLóGICAS LTDA
WO/2021/184094ADDITIVE FOR DETOXIFICATIONSILVA, Wellington Nascimbeni
WO/2021/184095BIOACTIVE SUPPLEMENTSILVA, Wellington
WO/2021/163777COSMETIC COMPOSITION FOR KERATIN FIBERS AND APPLICATION  METHODS FOR SAID COMPOSITIONGLOSS EXPRESS DO BRASIL COMERCIO DE PRODUTOS DE BELEZA LTDA -  EPP
WO/2021/159198METHOD FOR PRODUCING DECELLULARIZED BIOMATERIAL,  DECELLULARIZED BIOMATERIAL AND USE THEREOFKHEIROS PATER INOVAÇÃO S.A
WO/2021/189121PARAMAGNETIC NANOPARTICLES, MANUFACTURING METHOD AND USE  THEREOF WITH MAGNETIC RESONANCE IMAGING CONTRASTUNIVERSIDADE DE SÃO PAULO - USP
WO/2021/195730ANTIBACTERIAL COMBINATION COMPOSITION FOR REDUCING THE  RESISTANCE OF BACTERIA TO THE MEDICINAL DRUGS IN USE AND METHOD FOR OBTAINING  SAMEWEGHER, Ermete Antonio
WO/2021/232123TASTE-MASKING SYSTEMOUROFINO SAUDE ANIMAL LTDA
WO/2021/222997COMPOSITION FOR REGULATING THE NEURO-IMMUNE-ENDOCRINE SYSTEMABOU NEHMI FILHO, Victor
WO/2021/258180PROCESS FOR OBTAINING ANTIGEN-PRESENTING VESICLES (APV) THAT  ENABLES THE COUPLING OF ONE OR MORE ANTIGENSINSTITUTO BUTANTAN
WO/2021/046628STABLE MEDICINAL CANNABIDIOL COMPOSITIONSCARDIOL THERAPEUTICS INC.
WO/2021/081619HEMP PEPTIDE COMPOSITIONS FOR NUTRACEUTICAL AND PERSONAL CARE  PRODUCTSEC LABS INC.
WO/2021/243432PHARMACEUTICAL COMPOSITIONS FOR STAINING MEMBRANES AND OTHER  BIOLOGICAL STRUCTURESTANG, Connie
WO/2021/003553COMPOUNDS FOR TREATMENT OF DIARRHEA, INFLAMMATORY BOWEL  DISEASE AND METHODS THEREOFALGERNON PHARMACEUTICALS INC.
WO/2021/081624USE OF GLUTAMATE 2B RECEPTOR ANTAGONISTS AND SIGMA RECEPTOR  AGONSISTS AS ANTITUSSIVESALGERNON PHARMACEUTICALS INC.
WO/2021/000046QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND  RELATED METHODSMICROSINTESIS INC.
WO/2021/012046CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID  MONOGLYCERIDES, METHODS AND USES THEREOFSCF PHARMA INC.
WO/2021/016710CONTROLLED RELEASE FORMULATIONS OF MULTIPLE ACTIVE  PHARMACEUTICAL AGENTS, AND PSILOCYBE-DERIVED AGENTS IN COMBINATION WITH  CANNABIS-DERIVED AGENTS AND METHODS FOR THEIR USETASSILI LIFE SCIENCES, CORP.
WO/2021/022377PERIVASCULAR LYSATES AND USES THEREOFTISSUE REGENERATION THERAPEUTICS INC.
WO/2021/022378ORAL FORMULATIONS OF CANNABIS EXTRACTS AND METHODS OF MAKING  SAMENEPTUNE WELLNESS SOLUTIONS INC.
WO/2021/026653CHOLINERGIC POTENTIATION OF BINOCULAR VISIONTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL  UNIVERSITY
WO/2021/035335COMPOSITION AND METHOD FOR FORMING A COMPOSITION FOR  INCREASING DERMAL NITRIC OXIDESPINAL RELIEF CENTRES OF CANADA INC.
WO/2021/030913CANNABINOID COMPOSITIONS, METHODS OF MAKING SAME AND USES  THEREOFHEXO OPERATIONS INC.
WO/2021/035344METHODS FOR REDUCING THC CONTENT IN COMPLEX CANNABINOID  MIXTURES IN WHICH THC IS A MINOR COMPONENTCANOPY GROWTH CORPORATION
WO/2021/046634METHODS OF TREATING CANCER BY THE USE OF PD-1 AXIS INHIBITORS  AND ANTI-PERIOSTIN ANTIBODIESBOEHRINGER INGELHEIM IO CANADA, INC.
WO/2021/046646AVOCATIN B FOR THE TREATMENT OF DISEASES AND CONDITIONSSP NUTRACEUTICALS INC.
WO/2021/046652INHIBITING ZD17-JNK INTERACTION AS A THERAPY FOR ACUTE  MYOCARDIAL INFARCTIONTHE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/051192COMPOSITION OF RADIOACTIVE AND NON-RADIOACTIVE MICROPARTICLESABK BIOMEDICAL INCORPORATED
WO/2021/056098NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLSKORANEX CAPITAL
WO/2021/056105COMPOSITIONS AND METHODS BASED ON HIV GP120 MUTANTSCENTRE HOSPITALIER DE L'UNIVERSITé DE MONTRéAL
WO/2021/056106LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTSDDS RESEARCH INC.
WO/2021/056109GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE  DELIVERY SYSTEMMEDISCA PHARMACEUTIQUE INC.
WO/2021/062546USE OF IBALIZUMAB FOR THE TREATMENT OF HIV-2 INFECTIONTAIMED BIOLOGICS INC.
WO/2021/062554ORAL CARE COMPOSITION COMPRISING CUTTLEFISH BONE POWDERVISIONATUROLAB INC.
WO/2021/062555TOPICAL FORMULATIONS AND INSTILLATES, KITS, AND METHODS FOR  TREATING INTEGUMENTARY WOUNDS, AND USES THEREOFVINSAN THERAPEUTICS INC.
WO/2021/072530CONTROLLED RELEASE FORMULATIONS OF PSILOCYBE-DERIVED AGENTS  AND METHOD FOR THEIR USE, AND METHODS AND COMPOSITIONS FOR THREATING MILD  TRAUMATIC BRAIN INJURY WITH POST TRAUMATIC STRESS DISORDER.TASSILI LIFE SCIENCES, CORP.
WO/2021/072535OIL-IN-WATER EMULSION FORMULATIONS FOR DELIVERY OF ACTIVE OR  THERAPEUTIC AGENTSIMMUNOVACCINE TECHNOLOGIES INC.
WO/2021/072538SKIN CARE FORMULATION WITH LIPOPHILIC PEPTIDESDECIEM BEAUTY GROUP INC.
WO/2021/072555COMPOSITIONS AND METHODS FOR THE TREATMENT AND/OR PROPHYLAXIS  OF DIABETES AND OTHER CONDITIONSLIFELOCK SOLUTIONS INC.
WO/2021/077211CANNABIDIOL COMPOSITIONS FOR USE IN TREATING HEART CONDITIONSCARDIOL THERAPEUTICS INC.
WO/2021/081634FORMULATION TO REDUCE OR PREVENT OXIDATIVE STRESS DAMAGEMURPHY, Kieran
WO/2021/081640FLOWABLE CANNABINOID COMPOSITIONS HAVING HIGH EFFECTIVE  CONCENTRATIONSCANOPY GROWTH CORPORATION
WO/2021/081642BIOPHOTONIC COMPOSITIONS, USES AND METHODS FOR MODULATING  MITOCHONDRIAL DYNAMICS AND FUNCTIONALITY IN SKIN AND SOFT TISSUE CONDITIONSZAGO, Michela
WO/2021/081652METHODS AND RELATED SYSTEMS FOR MAKING A RECONSTITUTED  CANNABIS MATERIAL1769474 ALBERTA LTD.
WO/2021/081654SELF-EMULSIFYING DRUG DELIVERY SYSTEM AND USES THEREOFSP NUTRACEUTICALS INC.
WO/2021/092684CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDSLONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/097562TOP LIQUID FILL METHOD AND APPARATUS FOR HARD CAPSULESCAO, Karl Wei
WO/2021/108911USE OF PSILOCIN, PSILOCYBIN OR ANALOGS THEREOF IN WEIGHT LOSS,  TREATMENT OF OBESITY AND COMPULSIVE EATING DISORDERNEONMIND BIOSCIENCES INC.
WO/2021/108918TREATMENT FOR ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC  SYNDROMEUNIVERSITY HEALTH NETWORK
WO/2021/108923COMBINED USE OF SODIUM  TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] AND ETOMOXIR FOR TREATING  CANCERSBOLD THERAPEUTICS INC.
WO/2021/108929SORTILIN BINDING CONJUGATE COMPOUNDS, COMPOSITIONS AND USES  THEREOF FOR TREATING CANCERTHERATECHNOLOGIES INC.
WO/2021/113982MINERAL SUPPLEMENTS FOR RUMINANT NUTRITIONALBERTA VETERINARY LABORATORIES LTD.
WO/2021/113983CHOLINE BOLUS COMPOSITIONS FOR RUMINANTSALBERTA VETERINARY LABORATORIES LTD.
WO/2021/113986COMPLEXES COMPRISING A CARBOHYDRATE POLYMER AND AN ACTIVE  INGREDIENT AND PROCESSES FOR THEIR PREPARATIONFOLIUM LABS INC.
WO/2021/119810ORAL DELIVERY SYSTEMS BASED ON IN SITU FORMING  PROTEIN/POLYSACCHARIDE COACERVATES9286-3620 QUéBEC INC.
WO/2021/119817HASHISH PRODUCT HAVING ENHANCED USER EXPERIENCE AND  MANUFACTURING PROCEDURE FOR OBTAINING SAMEHEXO OPERATIONS INC.
WO/2021/119822EMULSIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS INCLUDING OILSNATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/119826EXTRACTS ENRICHED WITH POLYPHENOLIC COMPOUNDS AND RELATED  METHODSROTHSTEIN, Steven
WO/2021/119827USE OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) FOR  THE TREATMENT OF ENTERIC NEUROPATHIESTRANSFERT PLUS, SOCIéTé EN COMMANDITE
WO/2021/119834MODULATORS OF CULLIN 3 ADAPTOR KBTBD4 AS ANTI-CANCER COMPOUNDSUNIVERSITE DE MONTREAL
WO/2021/119844EMULSIFYING FORMULATIONS OF CANNABINOIDS AND/OR CANNABINOID  EXTRACTSORGANIGRAM INC.
WO/2021/127786CANNABICHROMENE COMPOSITIONS AND METHODS OF SYNTHESIZING  CANNABICHROMENECANOPY GROWTH CORPORATION
WO/2021/127787CANNABICITRAN COMPOSITIONS AND METHODS OF SYNTHESIZING  CANNABICITRANCANOPY GROWTH CORPORATION
WO/2021/127788METHODS OF SYNTHESIZING HIGH-PURITY CANNABICYCLOL AND  ARTIFICIAL RESINS COMPRISING CANNABICYCLOLCANOPY GROWTH CORPORATION
WO/2021/138742COMPOSITION THAT PROMOTE PRO-RESOLVING MEDIATORSACASTI PHARMA INC.
WO/2021/146812USE OF ANTI-AGING GLYCOPEPTIDES FOR INHIBITION OF IMMUNE  REJECTION OF A GRAFTPROTOKINETIX INC.
WO/2021/151212SYSTEM AND METHOD FOR QUANTIFYING, FORMULATING AND ENHANCING  USER EXPERIENCE PROFILE OF CANNABISHEXO OPERATIONS INC.
WO/2021/159213METHOD FOR PRODUCING AN EXTRACT OF MUSHROOM AND MUSHROOM  EXTRACT MADE THEREFROMNEONMIND BIOSCIENCES INC.
WO/2021/163796METHODS AND COMPOSITIONS FOR THE INHIBITION OF HEPATITIS B AND  HEPATITIS D VIRUS INFECTIONSREPLICOR INC.
WO/2021/163802USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY  AND TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORSTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL  UNIVERSITY
WO/2021/163811POLYMERIC BINDER AND HIGH MOLECULAR WEIGHT POLYMER ANTIFOULING  COMPOSITIONSTHE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/207822DETECTION, TREATMENT, AND MONITORING OF MICROBIOME-DEPENDANT  PROTEIN FERMENTATION METABOLITESMCPHARMA BIOTECH INC.
WO/2021/168561PROCESSES FOR THE PREPARATION OF MULTICOMPONENT CRYSTALLINE  FORMS OF ACTIVE PHARMACEUTICAL INGREDIENTS USING SOLVENT VAPOURAPOTEX INC
WO/2021/168572STABLE LIQUID DISPERSINB COMPOSITIONSKANE BIOTECH INC.
WO/2021/168573NANOSTRUCTURE LIPID CARRIER DELIVERY SYSTEM, COMPOSITION, AND  METHODSCAPCIUM INC.
WO/2021/168577GENE DELIVERY SYSTEMSYMVIVO CORPORATION
WO/2021/174351COACTIVE COMBINATIONS OF ANTIMICROBIALS WITH DISPERSINBKANE BIOTECH INC.
WO/2021/179072METHODS AND APPARATUSES TO REDUCE SETTLING RATE OF A  MICRO-PARTICLE SUSPENSIONSKINLIFE TECHNOLOGIES INC.
WO/2021/179081USE OF ANTI-AGING GLYCOPEPTIDES FOR TREATMENT OF DRY EYE  DISEASE, RETINAL DEGENERATIVE DISEASES, OR OCCULAR INFLAMMATIONPROTOKINETIX INC.
WO/2021/179087TERPENE-ENHANCED COMPOSITIONS AND USES THEREOFHEXO OPERATIONS INC.
WO/2021/179088TERPENE-ENHANCED COMPOSITIONS AND USES THEREOFHEXO OPERATIONS INC.
WO/2021/179094COMPOSITION AND USE OF A CAFFEIC ACID PHENETHYL ESTER (CAPE)  COMPOUND TO TREAT CANCERUNIVERSITY OF NEW BRUNSWICK
WO/2021/184115USE OF BUCILLAMINE IN THE TREATMENT OF INFECTIOUS DISEASESREVIVE THERAPEUTICS LTD.
WO/2021/184116METHOD FOR PRODUCING ENHANCED ANTI-INFLAMMATORY/  ANTI-CATABOLIC AGENTS FROM AUTOLOGOUS PHYSIOLOGICAL FLUIDANTNOR LIMITED
WO/2021/207824USE OF PSILOCYBIN IN THE TREATMENT OF NEUROLOGICAL BRAIN  INJURY AND MIGRAINESREVIVE THERAPEUTICS LTD.
WO/2021/184123COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS  INFECTION AND RESPIRATORY COMPROMISESZEWCZUK, Myron R.
WO/2021/184125DISCOVERY OF FIFTEEN NEW ANTI-AGING PLANT EXTRACTS AND  IDENTIFICATION OF CELLULAR PROCESSES THEY AFFECT AS NEW CALORIC RESTRICTION  MIMETICSIDUNN TECHNOLOGIES
WO/2021/184128METHODS OF TREATING A CORONAVIRUS INFECTION USING COLCHICINEINSTITUT DE CARDIOLOGIE DE MONTREAL
WO/2021/189151ANTIMICROBIAL COMPOSITIONCOVALON TECHNOLOGIES INC.
WO/2021/189153USE OF FENRETINIDE FOR THE TREATMENT OF SARS-CORONA VIRUS  INFECTIONLAURENT PHARMACEUTICALS INC.
WO/2021/195750METHODS FOR TREATING ALZHEIMER'S DISEASEJEFFERIES, Wilfred
WO/2021/195763ANTIVIRAL RUTHENATE(III) THERAPEUTICSBOLD THERAPEUTICS INC.
WO/2021/195765DAPSONE FORMULATIONS AND METHODS OF USING SAMEPULMONEM INC.
WO/2021/212209CANNABICHROMENE FORMULATION FOR PAIN MANAGEMENTZYUS LIFE SCIENCES INC.
WO/2021/195777FUROSEMIDE COMPOSITIONS AND USES THEREOF FOR SUPPORTIVE  THERAPY IN CORONAVIRUS INFECTIONUNIVERSITY HEALTH NETWORK
WO/2021/195782METHODS OF USING MYT1 INHIBITORSREPARE THERAPEUTICS INC.
WO/2021/195785FERRITIN FOR CELLULAR TRACKING UTILIZING T1-WEIGHTED MRITHE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
WO/2021/203190COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4UNIVERSITY HEALTH NETWORK
WO/2021/203198COMPOSITIONS AND METHODS FOR TREATMENT OF CORONAVIRIDAE  INFECTIONSPICCHIO INTERNATIONAL INC.
WO/2021/203205PROBIOTIC COMPOSITIONS AND METHODS OF USECHANDLER BIOPHARMACEUTICAL CORPORATION
WO/2021/203206COMBINATION OF CANNABIDIOL AND A PPAR AGONISTLAVIOLETTE, Steven Robert
WO/2021/207828METHODS FOR TREATING CYTOKINE RELEASE SYNDROMEUNIVERSITY HEALTH NETWORK
WO/2021/207833METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL  SPECIES USING SUGAR GLASSESMCMASTER UNIVERSITY
WO/2021/207850WATER SOLUBLE FORMULATIONS CONTAINING CANNABINOIDSNATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/212215COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND  DIAGNOSING MYCOBACTERIAL INFECTIONSUNIVERSITY OF SASKATCHEWAN
WO/2021/212222COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE RESPIRATORY  DISTRESS SYNDROMEEDESA BIOTECH RESEARCH INC.
WO/2021/212239USES OF SUPER-OXYGENATED WATER AND GELGIS GAS INFUSION SYSTEMS INC.
WO/2021/217259BIOMEDICAL IMAGING OF BACTERIA AND BACTERIOPHAGEMULTI-MAGNETICS INCORPORATED
WO/2021/217275IMMUNOMODULATORY AND ANTIVIRAL ACTION OF BOSWELLIA GUM RESIN  EXTRACTS, DERIVED FORMULATIONS, AND BOSWELLIC ACIDS AGAINST RESPIRATORY  VIRUSES AND USES THEREOFKONDOR PHARMA INC.
WO/2021/226725HASHISH HAVING SUBSTANTIALLY UNIFORM CHARACTERISTICS AND  METHOD FOR PRODUCING SAME AT AN INDUSTRIAL SCALEHEXO OPERATIONS INC.
WO/2021/232156CANNABINOID PHARMACEUTICAL COMPOSITIONAMACATHERA INC.
WO/2021/232169SYNERGISTIC ANTI-VIRAL PHARMACEUTICAL COMPOSITION CONTAINING  TARGETING NANOPARTICLESNUECOLOGY BIOMEDICAL INC.
WO/2021/237366TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASEPEMI31 THERAPEUTICS INC.
WO/2021/243460METHOD FOR WEIGHT LOSS WITH THERAPYNEONMIND BIOSCIENCES INC.
WO/2021/243461USE OF LSD, ESA, OR DMT FOR WEIGHT LOSS.NEONMIND BIOSCIENCES INC.
WO/2021/243467CANNABINOID-HYALURONIC ACID BIOCONJUGATESLONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/248251USE OF PHYTOCANNABINOIDS FOR TREATING MULTIPLE MYELOMAENTOURAGE BIOSCIENCES INC.
WO/2021/253116COMPOSITIONS COMPRISING PSYCHOACTIVE COMPOUNDS FROM  PSYCHOACTIVE ORGANISMSPSILO SCIENTIFIC LTD
WO/2021/253123EXTRACTION OF PSYCHOACTIVE COMPOUNDS FROM PSYCHEDELIC FUNGUSPSILO SCIENTIFIC LTD
WO/2021/253124METHANOL-BASED EXTRACTION OF PSYCHOACTIVE COMPOUNDS FROM  FUNGUSPSILO SCIENTIFIC LTD
WO/2021/258206WATER-SOLUBLE ARTESUNATE-BASED THERAPY FOR CORONAVIRUS  INFECTIONSOLSTAR PHARMA
WO/2021/258209COMPOSITE COATING FOR AN ACTIVE AGENT13400719 CANADA INC.
WO/2021/258218USE OF SOLUBLE NRP1 POLYPEPTIDES FOR THE TREATMENT OF  CORONAVIRUS INFECTIONSSEMATHERA INC.
WO/2021/207860COMPOSITION OF HERBS AND SPICES FOR USE IN MEDICINEMUESSLI, Daniel
WO/2021/000057FORMULATION THAT ALLOWS THE PROTECTION OF POLYPHENOLS,  PARTICULARLY THOSE OBTAINED FROM BEE POLLEN EXTRACTPONTIFICIA UNIVERSIDAD CATóLICA DE CHILE
WO/2021/022386WATER-SOLUBLE FILM WITH BIOACTIVE AGENTS OR NATURAL EXTRACTS  FOR COSMETIC USEUNIVERSIDAD DE CHILE
WO/2021/077236ONION SKIN EXTRACT WITH PROPERTIES THAT PROTECT THE  GASTROINTESTINAL MUCOSA AGAINST DAMAGE INDUCED BY NON-STEROIDAL  ANTI-INFLAMMATORY DRUGS OR BY ALCHOL, PHARMACEUTICAL COMPOSITION OR FOOD  COMPRISING IT, METHOD OF OBTAINMENT, AND USE TO PREVENT, TREAT AND/OR  MITIGATE THE ADVERSE EFFECTS OF NSAIDS OR ALCOHOLUNIVERSIDAD DE CHILE
WO/2021/097584AGAROPHYTON CHILENSIS EXTRACT, RICH IN FREE FATTY ACIDS, AS A  NUTRACEUTICAL OR NUTRITIONAL SUPPLEMENT, SUITABLE FOR MODULATING PPARϒ  ACTIVITYUNIVERSIDAD ANDRES BELLO
WO/2021/119858METHOD FOR GENERATING ALLERGEN-SPECIFIC TOLEROGENIC CELLS,  TOLEROGENIC CELLS OBTAINED, AND METHODS FOR INDUCING ALLERGEN TOLERANCE BY  MEANS OF AUTOLOGOUS IMMUNOTHERAPYPONTIFICIA UNIVERSIDAD CATóLICA DE CHILE
WO/2021/127793ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF <i>DURVILLAEA  ANTARCTICA</i>, USEFUL FOR TREATING LESIONS CAUSED BY  ALPHAHERPESVIRINAE VIRUSESPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/127794ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF  <i>MACROCYSTIS PYRIFERA</i>, USEFUL FOR TREATING LESIONS CAUSED  BY ALPHAHERPESVIRINAE VIRUSESPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/119864MULTI-POLYMER HYDROGEL AS A DEVICE FOR ADMINISTERING  PHARMACEUTICAL AND CELLULAR THERAPEUTIC COMPONENTSUNIVERSIDAD DE CONCEPCIóN
WO/2021/119866USE OF STRAINS OF <i>LACTOBACILLUS KUNKEEI</i> AND  <i>BIFIDOBACTERIUM ASTEROIDES</i> AS A PROBIOTIC BIOSTIMULANT FOR  BEESUNIVERSIDAD DE CONCEPCIóN
WO/2021/119868PROBIOTIC STRAINS OF <i>LACTOBACILLUS SP.</i> AND  OF <i>PEDIOCOCCUS SP</i>. AND USE THEREOF IN THE PREPARATION OF A  PROBIOTIC FORMULATION FOR THE PREVENTION OF DIARRHEA CAUSED BY BACTERIAL  PATHOGENS THAT AFFECT DOGS AND CATSUNIVERSIDAD DE CONCEPCIóN
WO/2021/127797NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A  RESPIRATORY SYNCITIAL VIRUS PROTEIN AGAINST HMPVPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/195797NOVEL USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A HUMAN  RESPIRATORY SYNCYTIAL VIRUS PROTEIN AGAINST HMPV IN CATTLEPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/000062USE OF COMBINATION OF COMPOUND OF SCLEROTIORIN AND RIFAMPICIN  IN PREPARATION OF ANTI-TUBERCULOSIS DRUGSUN YAT-SEN UNIVERSITY
WO/2021/000067CELL-BINDING MOLECULE-TUBULYSIN DERIVATIVE CONJUGATE AND  PREPARATION METHOD THEREFORHANGZHOU DAC BIOTECH CO., LTD.
WO/2021/003687COMPOSITIONS AND METHODS OF USING A HUMANIZED ANTI-DKK2  ANTIBODYYALE UNIVERSITY
WO/2021/007741AQUEOUS-BASED NON-AEROSOL DRY SHAMPOO COMPOSITIONHENKEL AG & CO. KGAA
WO/2021/007800ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOFINSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/012065APPLICATION OF BEZOAR SEDATIVE PILL IN PREPARING DRUG FOR  TREATING DEPRESSIONBEIJING TONG REN TANG CHINESE MEDICINE CO., LTD.
WO/2021/012138USE OF DIAMINOGUANIDINE DERIVATIVE AND FEED COMPOSITION  THEREOF IN PREPARATION OF VETERINARY DRUGGUANGZHOU INSIGHTER BIOTECHNOLOGY CO.,LTD
WO/2021/012269ANTI-INFLAMMATORY AND ANTI-SWELLING PHARMACEUTICAL  COMPOSITION, AND USE THEREOFHU, Ping
WO/2021/016729COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUP FROM KERATIN  MATERIALSL'OREAL
WO/2021/016924CATIONIC POLYMER AND PARTICLES USABLE TO TREAT PSORIASISSUN YAT-SEN UNIVERSITY
WO/2021/016941UTILIZING STRUCTURE AND MECHANOGATING MECHANISM OF PIEZO  CHANNELS FOR PREPARATION OF MEDICAMENTS AND TECHNOLOGIESTSINGHUA UNIVERSITY
WO/2021/022466MEDICAMENT FOR TREATING STROKE CAUSED BY DEEP FUNGAL  INFECTIONSXIAO, Mingchun
WO/2021/022562PURE NATURAL COMPOUND ESSENTIAL OIL HAVING BROAD-SPECTRUM  BACTERICIDAL ACTIVITY AND PREPARATION AND APPLICATION THEREOFINSTITUTE OF MEDICINAL PLANT DEVELOPMENT, CHINESE ACADEMY OF  MEDICAL SCIENCE
WO/2021/007899INJECTABLE HYDROGEL MATERIAL AND PREPARATION METHOD THEREFOR  AND USE THEREOFZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/030932PHARMACEUTICAL COMPOSITIONS COMPRISING ONCOLYTIC HERPES  SIMPLEX VIRUS FOR SYSTEMIC ADMINISTRATIONIMMVIRA CO., LTD
WO/2021/030978USE OF NICLOSAMIDE ETHANOLAMINE SALT IN PREPARATION OF DRUGS  FOR TREATING CHEMOTHERAPY-REALATED MUSCLE INJURYSHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL
WO/2021/031102CRYSTAL FORM OF DAPRODUSTAT, PREPARATION METHOD THEREFOR AND  USE THEREOFSHENZHEN RENTAI PHARMATECH LTD.
WO/2021/026949PHASE-INVERTED EMULSION AND PREPARATION METHODZHONGSHANSHI BOSHEN CHEMICAL CO., LTD.
WO/2021/031200CD8+T CELL AND/OR B CELL REGULATIONTONGJI HOSPITAL, TONGJI MEDICAL COLLEGE OF HUAZHONG UNIVERSITY  OF SCIENCE AND TECHNOLOGY
WO/2021/035378METHOD TO INCORPORATE OLEANOLIC ACID INTO ORAL CARE  COMPOSITIONS AND ORAL CARE COMPOSITIONS BASED THEREOFCOLGATE-PALMOLIVE COMPANY
WO/2021/035386SUNSCREEN COMPOSITION WITHOUT CYCLOMETHICONESBEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/035390MEDICINE FOR TREATING PULMONARY MYCOSISXIAO, Mingchun
WO/2021/035498ANTI-TUMOR PLATINUM-BASED DRUG MINERALIZED PROTEIN  NANOPARTICLE, PREPARATION METHOD THEREFOR AND USE THEREOFSOOCHOW UNIVERSITY
WO/2021/035655MEDICINE FOR INJECTION AND PREPARATION METHOD THEREFORSICHUAN CREDIT PHARMACEUTICAL CO., LTD
WO/2021/000417USE OF PALMITOLEIC ACID FOR PREPARING COMPOSITION FOR  PREVENTING OR TREATING INFLAMMATORY DISEASESREVAISSANT (SHENZHEN) BIOSCIENCES CO., LTD.
WO/2021/042274TRADITIONAL CHINESE AND WESTERN MEDICINE COMPOSITION FOR  TREATING OSTEOARTHRITISLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/042275TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  OSTEOARTHRITISLUNAN PHARMACEUTICALGROUP CORPORATION
WO/2021/042276COMBINATION DRUG FOR TREATING OSTEOARTHRITISLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/042278MULTI-UNIT SUSTAINED-RELEASE ACIPIMOX PELLET TABLET AND  PREPARATION METHOD THEREFORLUNAN BETTER PHARMACEUTICAL CO., LTD.
WO/2021/007933APPLICATION OF MAGGOTS IN TREATMENT OF DIABETESHUA, Xiangrong
WO/2021/007934APPLICATION OF LIQUOR PRODUCT WITH SOAKED LUCILIA SERICATA FOR  TREATING DIABETESHUA, Xiangrong
WO/2021/042325COMPOSITION OF TEMPORARY DENTAL MATERIALTAIPEI UNIVERSITY OF TECHNOLOGY
WO/2021/042369NANOPARTICLE HAVING CGAS-STING PATHWAY ACTIVATION FUNCTION,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFNATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/046706A SUNSCREEN FORMULATIONSUN, Yimin
WO/2021/046765AN ANTICANCER COMBINATION OF CHIDAMIDE AND CELECOXIBGNT BIOTECH & MEDICALS CORPORATION
WO/2021/017115APPARATUS AND METHOD FOR PRODUCING FREEZE-DRIED FACIAL MASKBEIJING BENZHENGONGFANG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/051260TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  TRAUMATIC INJURY AND USE THEREOFLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051261NOVEL USE OF CHINESE MEDICINE COMPOSITIONLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051262TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREPARING DRUGS  FOR TREATING EDEMALUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051271USE OF PICEATANNOL IN PREPARING A DRUG FOR PREVENTING AND  TREATING NEURODEGENERATIVE DISEASESSHENZHEN UNIVERSITY
WO/2021/051272USE OF BISMUTH POTASSIUM CITRATE IN PREPARING DRUG FOR  PREVENTING OR TREATING NEURODEGENERATIVE DISEASESSHENZHEN UNIVERSITY
WO/2021/031270BACTERIAL MEMBRANE VESICLES, AND SEPARATION AND PREPARATION  SYSTEM AND METHOD THEREFORSICHUAN UNIVERSITY
WO/2021/051352ISOLATED ANTIGEN-BINDING PROTEIN AND USE THEREOFSPH BIOTHERAPEUTICS (HK) LIMITED
WO/2021/056231KIT FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/056248TECHNOLOGY FOR FACIAL FAT DEGRADATION AND FIRMING AND  APPLICATION OF TECHNOLOGYSHANGHAI TONGBAI BIOTECHNOLOGY CO., LTD
WO/2021/056412TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/056431NON-DRUG HELICOBACTER PYLORI BACTERICIDAL COMPOSITIONECO-GEO BIO-TECHNOLOGY COMPANY LIMITED
WO/2021/007957MESOPOROUS SPONGE SPICULE AND PREPARATION METHOD AND USE  THEREFORXIAMEN UNIVERSITY
WO/2021/062607ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO  ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/062611DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT AND  NEUTRAL AMINO ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/062621ORAL CARE COMPOSITIONS COMPRISING STANNOUS ION SOURCE, NEUTRAL  AMINO ACID, AND POLYPHOSPHATETHE PROCTER & GAMBLE COMPANY
WO/2021/062623DENTIFRICE COMPOSITIONS FOR TREATMENT OF DENTAL BIOFILMTHE PROCTER & GAMBLE COMPANY
WO/2021/062631DENTIFRICE COMPOSITIONS FOR TREATMENT OF DENTAL BIOFILMTHE PROCTER & GAMBLE COMPANY
WO/2021/003864USE OF GLYCINE IN PREPARATION OF DRUG DELIVERY REINFORCER AND  CELL TRANSPLANTATION REAGENTTIANJIN MEDICAL UNIVERSITY
WO/2021/056609SEQUENCE OF STRUCTURALLY SENSITIVE POLYPEPTIDE ANTIGEN OF VON  WILLEBRAND FACTORSOOCHOW UNIVERSITY
WO/2021/068188WS-635 USES THEREOF IN MEDICINEWATERSTONE PHARMACEUTICALS(WUHAN) CO., LTD.
WO/2021/068196METHODS OF USING IL-33 PROTEIN IN TREATING CANCERSGENERAL REGENERATIVES (SHANGHAI) LIMITED
WO/2021/068203USE OF CHLOROQUINE OR DERIVATIVE HYDROXYCHLOROQUINETHE FIRST AFFILIATED HOSPITAL OF SUN YAT-SEN UNIVERSITY
WO/2021/068239VAGINAL SLOW-RELEASE ADMINISTRATION SYSTEM FOR LUTEAL SUPPORT,  PREPARATION METHOD THEREFOR AND USE THEREOFNATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING
WO/2021/068242AN AGENT THAT ENABLES SIRT7 GENE EXPRESSION AND THE USE  THEREOFSHENZHEN UNIVERSITY
WO/2021/072595MEDICAL USE OF MESENCHYMAL STEM CELLS IN TREATMENT OF HEARING  IMPAIRMENTMARIA VON MED-BIOTECHNOLOGY CO., LTD.
WO/2021/072642USE OF PHENYLQUINOLINONES AND FLAVONOID DERIVATIVES FOR  TREATING NEUROPATHIC PAINHANGZHOU BIO-SINCERITY PHARMA-TECH CO., LTD.
WO/2021/072661ELECTROACTIVE AND DEGRADABLE SUPRAMOLECULAR MICROGEL AND  DRUG-LOADED SUPRAMOLECULAR MICROGEL, AND PREPARATION METHOD AND USE THEREOFNANJING FORESTRY UNIVERSITY
WO/2021/072683TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/031320NANO-PARTICLE BASED ON DNA PHOTOTHERMAL MELTING, PREPARATION  METHOD THEREFOR, AND APPLICATION THEREOFQINGDAO UNIVERSITY
WO/2021/031321MULTI-COLOR UP-CONVERSION NANOPROBE, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFQINGDAO UNIVERSITY
WO/2021/042451DUAL DRUG DELIVERY SYSTEM BASED ON TARGETING NUCLEOLIN,  PREPARATION METHOD THEREFOR AND USE THEREOFQINGDAO UNIVERSITY
WO/2021/072747COMPOSITION AND METHOD FOR TREATMENT OF DIABETESSHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/072773ORLISTAT CAPSULE AND PREPARATION METHOD THEREFORSHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/072780METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW  HEMATOPOIETIC FUNCTIONSSUN YAT-SEN UNIVERSITY
WO/2021/022678ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOFMABPLEX INTERNATIONAL CO., LTD.
WO/2021/077320COMPOSITION FOR CARING FOR THE SKINL'OREAL
WO/2021/046976APPLICATION OF CAS13A IN ANTAGONIZING VIRUSESINSTITUTE OF PATHOGEN BIOLOGY, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/017222SUPERMOLECULAR FORMULATIONS OF RETINOL AND DERIVATIVES THEREOF  AND PREPARATION METHODS THEREFORPROYA COSMETICS CO., LTD.
WO/2021/081782SUN CARE COMPOSITIONS WITH HOLLOW MESOPOROUS SILICA  NANOSPHERESDOW GLOBAL TECHNOLOGIES LLC
WO/2021/081859SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP  KERATIN MATERIALSL'OREAL
WO/2021/081876SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP  KERATIN MATERIALSL'OREAL
WO/2021/012460MEDICINE FOR PREVENTING AND TREATING BACTERIAL ENTERITIS OF  EELS, AND PREPARATION METHOD THEREFORJIMEI UNIVERSITY
WO/2021/031371APPLICATION OF TYROSINE KINASE INHIBITOR AS THERAPEUTIC DRUG  FOR ACUTE KIDNEY INJURYSHANDONG UNIVERSITY
WO/2021/087838TUMOR-SPECIFIC POLYPEPTIDE SEQUENCE AND USE THEREOFSHENZHEN GINO BIOTECHNOLOGY CO., LTD.
WO/2021/017255PROTEIN PEPTIDE MOISTURIZING LIQUID DISSOLVED IN WEAK ALKALINE  WATER AND PREPARATION METHOD THEREFORSUZHOU LVZHONGYUAN TEXTILE TECHNOLOGY CO. LTD
WO/2021/092802A HAIR STYLING PREPARATIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/092892APPLICATION OF QUINOLINE OR QUINAZOLINE COMPOUND IN  PREPARATION OF ANTITUMOR DRUGSPEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/092893USE OF DIARYL ETHER COMPOUND IN PREPARATION OF ANTI-TUMOR DRUGPEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/097651PHARMACEUTICAL COMPOSITION COMPRISING ORLISTAT AND  PLANT-DERIVED LIPASE INHIBITORZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097652ORLISTAT NANOSPHERES AND USE THEREOF IN PREPARATION OF  MEDICINES FOR TREATMENT OF OBESITYZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097684NEW ANTI-SOLUBLE CD14 SUBTYPE ANTIBODY AND USE THEREOFSHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
WO/2021/097691POROUS DISSOLVABLE SOLID STRUCTURETHE PROCTER & GAMBLE COMPANY
WO/2021/022718APPLICATION OF PYRAZOLOPYRIMIDINE COMPOUND IN PREPARATION OF  DRUGS FOR PREVENTING/TREATING TUMORSWEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/102624COVALENT PROTEIN DRUGS DEVELOPED VIA PROXIMITY-ENABLED  REACTIVE THERAPEUTICS (PERX)HANGZHOU BRANCH OF TECHNICAL INSTITUTE OF PHYSICS AND  CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/027181USE OF IRON-CONTAINING MATERIAL IN PREPARATION OF PRODUCT FOR  INHIBITING TRANSMISSION OF DENGUE VIRUSTSINGHUA UNIVERSITY
WO/2021/017335PREPARATION METHOD FOR XANTHAN GUM COPOLYMER NANOMICELLES AND  APPLICATION THEREOFJIANGNAN UNIVERSITY
WO/2021/102674APPLICATION OF COMBINATION OF AMPK-TARGETING INHIBITOR/SIRNA  AND PROTEASOME INHIBITOR IN ANTICANCERSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/017339APPLICATION OF HYDROXYSAFFLOR YELLOW A IN PREPARATION OF  MEDICATION FOR TREATMENT OR ADJUVANT TREATMENT OF OBESITY DISEASEBEIJING SHIJITAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY
WO/2021/102714A CONDITIONING COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102715A CONDITIONING COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/056805WILD JUJUBE SEED FLAVONE AND PHOSPHOLIPID COMPOSITE AS WELL AS  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFTAIZHOU GUOKEHUAWU BIOMEDICAL TECHNOLOGIES CO., LTD
WO/2021/036058TERIPARATIDE SUSTAINED RELEASE GEL INJECTION SOLUTION AND  PREPARATION METHOD THEREFORHYBIO PHARMACEUTICAL CO., LTD.
WO/2021/003961SKIN CARE COMPOSITION CONTAINING PLANT EXTRACT, AND  PREPARATION METHOD THEREFORZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/003962SKINCARE COMPOSITION FOR REPAIRING SKIN, AND PREPARATION  METHOD THEREFORZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/003963SKINCARE COMPOSITION FOR TIGHTENING SKIN, AND PREPARATION  METHOD THEREFORZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/102873AN OIL-IN-WATER SUNSCREEN COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102874AN OIL-IN-WATER SUNSCREEN COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102886COMPOSITION FOR CARING FOR/MAKING UP KERATAIN FIBERSL'OREAL
WO/2021/102897TWO-PHASE COMPOSITION FOR TOPICAL APPLICATIONL'OREAL
WO/2021/102935FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES HAVING  LARGE PORES AND METHOD OF MAKING SAMETHE PROCTER & GAMBLE COMPANY
WO/2021/103018METHOD FOR PREPARING RED POMEGRANATE EXTRACT AND SKINCARE  CREAM COMPRISING SAMECHEN, Bohao
WO/2021/103019METHOD FOR PREPARING COMPOSITION COMPRISING RICE WASHING WATER  AND SHAMPOO COMPRISING COMPOSITION COMPRISING RICE WASHING WATERCHEN, Bohao
WO/2021/056815CHEMOTHERAPEUTIC IMMUNE DRUG COMPOSITION AND PREPARATION  METHOD THEREOFSUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/109132COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFBIOMODI BIOTECH (SUZHOU) CO., LTD
WO/2021/103119APPLICATIONS OF MACELIGNAN IN PREPARING MEDICAMENT FOR  PREVENTING AND TREATING NEURODEGENERATIVE DISEASESSHENZHEN UNIVERSITY
WO/2021/114020PHARMACEUTICAL COMPOSITION OF ALKYNYL-CONTAINING COMPOUND,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/114024COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALSL'OREAL
WO/2021/077566APPLICATION OF DIVALENT MANGANESE IN PREPARING IMMUNITY  ENHANCING DRUG OR ANTITUMOR DRUGPEKING UNIVERSITY
WO/2021/114089METHODS OF USING CROCETIN IN TREATING SOLID TUMORSHANGZHOU MENGLANRUISI BIOTECHNOLOGY CO., LTD.
WO/2021/017365CRA4S1 GENE, ENCODED CRA4S1 PROTEIN, AND APPLICATIONZHENJIANG YANGTZE GREEN BIOTECHNOLOGY CO. LTD
WO/2021/114125USE OF LEVISTOLIDE A IN PREPARATION OF DRUGS FOR TREATING OR  PREVENTING RENAL DISEASESLIAONING SHUANGSHILI PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/068401TWO-DOSAGE-FORM ESSENCE AND PREPARATION METHOD THEREFORGUANGZHOU BIOHOPE CO., LTD.
WO/2021/114218MYCOSPORINE-LIKE AMINO ACIDS PORPHYRA-334 AND SHINORINE AND  METHOD FOR EXTRACTING PORPHYRA-334 AND SHINORINE FROM SEAWEEDSLE, Zhanxian
WO/2021/114256DRUG FOR TREATING PULMONARY FIBROSISTHE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY
WO/2021/114315USE OF HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE  PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASESSHANGHAI EAST HOSPITAL
WO/2021/119902USE OF NAPHTHYLUREA COMPOUNDSUZHOU RAYMON PHARMACEUTICALS COMPANY, LTD.
WO/2021/119966DRUG FOR TREATING DIGESTIVE SYSTEM MYCOSISXIAO, Mingchun
WO/2021/012589PREPARATION METHOD AND APPLICATION OF STANDARD LILY BULB AND  REHMANNIA DECOCTION HAVING ANTIDEPRESSANT EFFECTSHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
WO/2021/051685COMPOUND FORMULATION FOR REMOVING HPVJIANGXI SHANXING BIOTECHNOLOGY CO., LTD.
WO/2021/109251ESSENTIAL OIL COMPOSITION, PREPARATION METHOD THEREFOR AND USE  THEREOFGAIN SURE LIMITED
WO/2021/120084SOLID COMPOSITION IN THE FORM OF WATER-IN-OIL EMULSIONL'OREAL
WO/2021/093087TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING EFFECT OF  IMPROVING COGNITION, PREPARATION METHOD THEREFOR, AND TRADITIONAL CHINESE  MEDICINE PREPARATIONCHENLAND NUTRITIONALS, INC.
WO/2021/088219APPLICATION OF TRPC1 PEPTIDE MOLECULE IN PREPARATION OF DRUG  FOR TREATING INFLAMMATION CAUSED BY VIRAL INFECTIONJIANGNAN UNIVERSITY
WO/2021/047099METHOD FOR SYNTHESIZING NOVEL FERRIHYDRITE  NANO-PHOTOSENSITIZER AND USE THEREOF IN COUNTERACTING CANCER AND BACTERIANORTHWESTERN POLYTECHNICAL UNIVERSITY
WO/2021/093090TRADITIONAL CHINESE MEDICINE EXTRACT COMPOSITION HAVING  FUNCTION OF REGULATING DEPRESSION, PREPARATION METHOD THEREFOR, AND CHINESE  MEDICINE PREPARATIONCHENLAND NUTRITIONALS, INC.
WO/2021/120213DEEP BEAUTY-TREATMENT MASSAGE CREAM AND PREPARATION METHOD AND  APPLICATION METHODTANGSHAN HARBIN SHIP TECHNOLOGY CO., LTD.
WO/2021/109276COMPLEX, TISSUE REPAIR MATERIAL, PREPARATION METHOD THEREFOR  AND USE THEREOFSHAANXI BIO REGENERATIVE MEDICINE CO., LTD
WO/2021/127814PHOTO-NANOVACCINE FOR CANCER TREATMENT, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSHENZHEN PEOPLE'S HOSPITAL
WO/2021/103232PREPARATION METHOD FOR CORE-SHELL NANOPARTICLES BASED ON LIPID  MEMBRANE AND METAL ORGANIC FRAMEWORKSHANGHAI NATIONAL ENGINEERING RESEARCH CENTER FOR  NANOTECHNOLOGY LTD.
WO/2021/128027TACI-FC FUSION PROTEIN AND USE THEREOFREMEGEN CO., LTD.
WO/2021/008084ADRENALINE INJECTION AND PREPARATION METHOD THEREFORHYBIO PHARMACEUTICAL CO., LTD.
WO/2021/103238TRADITIONAL CHINESE MEDICINE COMPOUND PREPARATION FOR  PREVENTING AND TREATING PORCINE DIARRHEA AND PREPARATION METHOD THEREFORGUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/103239COLISTIN SULPHATE PREMIX AND PREPARATION METHOD THEREFORGUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/103240SOLUBLE GRANULE FOR IMPROVING PIG IMMUNITY AND METHOD FOR  PREPARATION THEREOFGUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/128045COMPOSITION FOR CONDITIONING KERATAIN FIBERSL'OREAL
WO/2021/128054COMPOSITION FOR CONDITIONING KERATAIN FIBRESL'OREAL
WO/2021/128055COMPOSITION FOR CONDITIONING KERATAIN FIBERSL'OREAL
WO/2021/128119KIT FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/120268MUPIROCINE OINTMENT AND PREPARATION METHOD THEREFORFRONT PHARMACEUTICAL PLC.
WO/2021/128232OPHIOPOGONIS RADIX DEGRADATION EXTRACT AND USE THEREOF IN  PREPARATION OF HYPOGLYCEMIC DRUGSGUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
WO/2021/128292COMPOSITION AND METHOD FOR TREATMENT OF MULTIPLE SCLEROSISWUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/128307FLAVOR COMPOSITION AND ELECTRONIC CIGARETTE LIQUID CONTAINING  FLAVOR COMPOSITIONSHENZHEN RELX TECHNOLOGY CO., LTD.
WO/2021/098011METHOD FOR COMPREHENSIVELY EXTRACTING AUTOLOGOUS LEUKOCYTES  AND PLATELET PLASMASICHUAN I LOVE WOLAI AUTOMOBILE CLUB CO., LTD
WO/2021/134171COMPOSITION FOR BRIGHTENING OR WHITENING KERATIN MATERIALSL'OREAL
WO/2021/134194ANHYDROUS COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/134394COMPOSITION COMPRISING PHENOLIC COMPOUNDS AND HYDROTROPESL'OREAL
WO/2021/134420COMPOSITION FOR CARING FOR KERATIN MATERIALS AND USE THEREOFL'OREAL
WO/2021/134454COMPOSITION FOR COSMETIC PRODUCTSL'OREAL
WO/2021/134458COMPOSITION FOR CONDITIONING KERATIN MATERIALSL'OREAL
WO/2021/134460COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/134463COMPOSITION FOR CONDITIONING KERATIN MATERIALSL'OREAL
WO/2021/134469COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/134482DIRECT COMPRESSED ACTIVATED CARBON TABLET FORMULATIONFRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
WO/2021/062960APPLICATION OF PEG INTERFERON AND PROTO-ONCOGENE PRODUCT  TARGETING INHIBITOR IN SYNERGISTIC TREATMENT OF RENAL CARCINOMASHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
WO/2021/062961APPLICATION OF PEG-INTERFERON AND PROTOONCOGENE PRODUCT  TARGETING INHIBITOR IN SYNERGISTIC INHIBITION OF TUMORSSHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
WO/2021/134623TERTIARY AMINE PHARMACEUTICAL COMPOSITION AND INDUSTRIAL BATCH  PREPARATION METHOD THEREFORAC PHARMACEUTICALS CO., LTD
WO/2021/134647SUSTAINED RELEASE COMPOSITION AND PREPARATION METHOD THEREFORDIQI PHARMACEUTICALS CO., LTD.
WO/2021/000558ACTIVATING AGENT FOR SIMULTANEOUSLY ACTIVATING OXIDATIVE  PHOSPHORYLATION PATHWAY AND INHIBITING GLYCOLYTIC PATHWAY AND APPLICATION  THEREOFLANZHOU UNIVERSITY
WO/2021/008100SYNERGISTIC EFFECT OF COBRA NEUROTOXIN POLYPEPTIDE ON  INHIBITING OPIOID HYPERALGESIA AND TOLERANCE AND ALLEVIATING PAIN ASSOCIATED  THEREWITHQI, Zhankai
WO/2021/042645APPLICATION OF COBRA NEUROTOXIN PEPTIDE MOLECULE IN TREATING  NEPHRITIS PROTEINURIAQI, Zhankai
WO/2021/051720CLASS OF ANTI-HUMAN EGFR ANTIBODY DRUG CONJUGATE AND  PREPARATION METHOD AND APPLICATION THEREOFINSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/068432APPLICATION OF ELAPIDAE SNAKE POSTSYNAPTIC NEUROTOXIN MONOMER  MOLECULE IN TREATMENT OF ALZHEIMER'S DISEASEQI, Zhankai
WO/2021/093134USE OF GROUP OF SNAKE NERVE GROWTH FACTORS AND SNAKE NERVE  GROWTH FACTOR PRECURSORS IN TREATMENT OF SENILE DEMENTIAQI, Zhankai
WO/2021/103288CELL CAPABLE OF BEING TRACED IN ORGANISM, PREPARATION METHOD  THEREFOR, AND USE THEREOF IN CELL PHARMACOKINETICS RESEARCHSHANGHAI HEXAELL BIOTECH CO., LTD.
WO/2021/138759PREPARATION METHOD FOR AND USE OF COMBINATION OF ANTIBODY  TARGETING TUMOR ANTIGEN AND INKT CELLSSHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD.
WO/2021/138824A COSMETIC CLEANSING COMPOSITIONBEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/031519ASCIDIAN EXTRACT RICH IN VARIOUS PLASMALOGENS AND PREPARATION  AND ANALYSIS METHODS THEREFORTIAN, Bing
WO/2021/109319BATH MOISTURIZER HAVING HIGH MOISTURE RETENTION EFFECT AND  PREPARATION METHOD THEREFORJOMOO KITCHEN&BATH CO., LTD
WO/2021/142577ARYLAMIDE COMPOUND BASED ON BENZENE RING SUPRAMOLECULAR  INTERACTION, SELF-ASSEMBLY MORPHOLOGY, AND USEYI, Tianqi
WO/2021/047137MEDICINE FOR TREATING PERIODONTAL DISEASE CAUSED BY  PERIODONTAL PATHOGEN INFECTIONHOSPITAL OF STOMATOLOGY, SUNYAT-SEN UNIVERSITY
WO/2021/017434APPLICATION OF ACANTHOPANAX TRIFOLIATUS POLYSACCHARIDE ATP1-1  IN PREPARATION OF MEDICINES FOR TREATING DIABETESGUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/142733COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS,  AND INSULIN AND/OR INSULIN ANALOGSSHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/142736DOSING REGIMEN OF GLP-1SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/142737COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC  STEATOHEPATITIS (NASH)SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/134842USE OF ZC3H12B GENE OR PROTEIN AND ESTABLISHMENT METHOD FOR  LIVER DISEASE ANIMAL MODELSHANGHAI OCEAN UNIVERSITY
WO/2021/142815BERBERINE AND COPTISINE, OR ACTIVE METABOLITES THEREOF, AND  APPLICATION OF SALTS THEREOF IN MEDICATION FOR PREVENTING AND/OR TREATING  URIC ACID NEPHROPATHYINSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/017448EXTERNAL COMPOSITION FOR SKIN HAVING ITCHING RELIEVING EFFECTYANGSHENGTANG (ANJI) COSMETICS CO., LTD.
WO/2021/068439SYNERGISTIC ANTI-SKIN-AGING PREPARATION COMPRISING EXOSOME AND  SPONGE SPICULE OR ANALOGUE THEREOFSHENZHEN PEOPLE'S HOSPITAL
WO/2021/056946APPLICATION OF ANTI-LCN2 ANTIBODY IN PREPARATION OF DRUG FOR  TREATING LUPUS NEPHRITISNANJING DRUM TOWER HOSPITAL
WO/2021/151251TREATING TREATMENT-RESISTANT DIABETES WITH GLUCOKINASE  ACTIVATORHUA MEDICINE (SHANGHAI) LTD.
WO/2021/151259USE OF 3-(4-HYDROXYPHENYL)PROPIONIC ACID IN PREPARATION OF  DRUGS FOR PREVENTING AND TREATING RESPIRATORY TRACT INFECTIONSUN YAT-SEN UNIVERSITY
WO/2021/082298COMPOSITION CAPABLE OF RELIEVING ECZEMA SKIN CONDITION, AND  PREPARATION METHOD THEREFORSHENZHEN YUANGUANGZHOUTECHNOLOGY CO., LTD.
WO/2021/120376COMPOSITE PROBIOTIC COMPOSITION HAVING ANTI-AGING EFFECT AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFYANG, Bo
WO/2021/159547POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING OVARIAN CANCER  AND USE THEREOFZHUHAI TENGBAI PHARMACEUTICAL CO., LTD.
WO/2021/031536USE OF NADH AND/OR NMN IN PREPARING MEDICAMENTS AND HEALTH  CARE PRODUCTS FOR BRAIN FUNCTION RECOVERYHOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/163874RECOMBINANT VIRAL VECTOR, IMMUNOGENIC COMPOSITION COMPRISING  SAME, AND USESVACDIAGN BIOTECHNOLOGY CO., LTD.
WO/2021/163897PHARMACEUTICAL COMPOSITION CONTAINING METHYLENE BLUE DYE,  NUTRIENT OR/AND CONVENTIONAL ANTITUMOR DRUG, AND APPLICATION THEREOFCHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD.
WO/2021/163915MILD CLEANSING COMPOSITION CONTAINING NEARLY SATURATED,  SATURATED OR SUPERSATURATED ACTIVE INGREDIENTS AND PREPARATION METHOD  THEREFORHUANG, Yaokun
WO/2021/163965FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES CONTAINING  CATIONIC SURFACTANTTHE PROCTER & GAMBLE COMPANY
WO/2021/163980SUBSTANCE TARGETING MASP-2 AND N PROTEIN OR BINDING THEREOF  FOR PREVENTING AND/OR TREATING CORONAVIRUS INFECTIONACADEMY OF MILITARY MEDICAL SCIENCE, ACADEMY OF MILITARY  SCIENCE, PLA.
WO/2021/164037MEDICATION FOR TREATING INFLUENZA OR INFECTIOUS DISEASEXIAO, Mingchun
WO/2021/142884USE OF ASPIRIN IN PREPARATION OF PLATELET-TARGETED DRUG  DELIVERY SYSTEMSOUTHEAST UNIVERSITY
WO/2021/138979PROBIOTIC MINERAL MATERIAL COMPOSITE PREPARATION AND  APPLICATION OF MINERAL MATERIALS IN PREPARATION OF DRUGS FOR INHIBITING  MALIGNANT TUMOR GROWTHNANJING UNIVERSITY
WO/2021/168684ORAL CARE COMPOSITIONS FOR GUM HEALTHTHE PROCTER & GAMBLE COMPANY
WO/2021/168696ORAL CARE COMPOSITIONS FOR GUM HEALTHTHE PROCTER & GAMBLE COMPANY
WO/2021/068452DNA VACCINE CAPABLE OF EFFECTIVELY TREATING AND/OR PREVENTING  TYPE 1 DIABETES AND USE THEREOFTHE FIFTH MEDICAL CENTER OF CHINESE PLA GENERAL HOSPITAL
WO/2021/174406MEDICAL USE OF ANEMOSIDE B4 IN TREATING ORAL ULCERLIU, Qi
WO/2021/174416DETECTION METHOD FOR CIRCULATING TUMOR CELLSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/168876ANTI-CORONAVIRUS APPLICATION OF ASCORBYL PALMITATESUN YAT-SEN UNIVERSITY
WO/2021/164054APPLICATION OF CANNABIDIOL IN PREPARATION OF SKINCARE PRODUCTS  HAVING SOOTHING AND ANTI-IRRITATION EFFECTSDOCTOR PLANT GUANGDONG BIOTECHNOLOGY CO., LTD.
WO/2021/051750TRADITIONAL CHINESE MEDICINE FOR TREATING DISEASES OF BODY  CAUSED BY BODY DAMPNESS, AND PREPARATION METHOD THEREFORYEUNG, Tak Wai Waisees
WO/2021/159570APPLICATION OF BAICALEIN IN PREPARING DRUG FOR PREVENTING  AND/OR TREATING NOVEL CORONOVIRUS INFECTIOUS DISEASEINSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES & PEKING UNION MEDICAL COLLEGE
WO/2021/179106APPLICATION OF GP73 INHIBITOR IN PREPARATION OF DRUG FOR  TREATING DIABETESBEIJING SUNGEN BIOMEDICAL TECHNOLOGY CO. LTD.
WO/2021/134913APPLICATION OF HUMAN CRYPTOCHROME PROTEIN I (HCRY1) IN  PREPARATION OF ANTI-ULTRAVIOLET RADIATION PREPARATIONGUANGZHOU DOUBLLE BIOPRODUCT CO., LTD
WO/2021/103342POLYETHYLENE GLYCOL CONJUGATED DRUG, AND PREPARATION METHOD  THEREFOR AND USE THEREOFCHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/109351POLYETHYLENE GLYCOL CONJUGATE DRUG, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFCHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/017475OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE,  PREPARATION METHOD AND USE THEREOFSHENYANG XINGQI PHARMACEUTICAL CO., LTD.
WO/2021/179214Methods for enhancing anti-apoptotic pathway to prevent DOX  toxicitySHENZHEN UNIVERSITY
WO/2021/012686NALOXONE HYDROCHLORIDE INJECTION AND PREPARATION METHOD  THEREFORGUANGDONG QIFANG MEDICINES CO., LTD.
WO/2021/147151USE OF FUCOSAN SULFATE IN PROMOTING FOAM CELL AUTOPHAGY TO  DECOMPOSE OX-LDLSHANDONG UNIVERSITY
WO/2021/179319COMPOSITION CONTAINING HYDROLYZED CHONDROITIN SULFATE FOR  PREVENTING AND TREATING OSTEOARTHROPATHYNANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/174581NEW USE OF INDAZOLE COMPOUNDTARAPEUTICS SCIENCE INC.
WO/2021/008149APPLICATION OF AKKERMANSIA MUCINIPHILA IN PREPARATION OF  ANTIDEPRESSANT DRUG OR HEALTH CARE PRODUCTJIANGSU PROVINCE HOSPITAL OF CHINESE MEDICINE
WO/2021/168930TABLET OF REMDESIVIR AND PREPARATION METHOD THEREFORGU, Shihai
WO/2021/036230RANOLAZINE SUSTAINED-RELEASE COMPOSITION AND PREPARATION  METHOD THEREFORHYBIO PHARMACEUTICAL CO.,LTD.
WO/2021/168931SUBMICRO EMULSION CONTAINING ACER TRUNCATUM SEED OIL AND  PREPARATION METHOD THEREFORSHENZHEN JINFENG BIOMEDICAL TECHNOLOGY CO., LTD
WO/2021/142920TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING LUNG  CANCER, AND PREPARATION AND USE THEREOFDONGGUAN HEC CORDYCEPS R&D CO., LTD.
WO/2021/147162USE OF LACTOBACILLUS REUTERI FROM BREAST MILK IN REGULATING  MATERNAL AND INFANT IMMUNE FUNCTIONFINE (HUNAN) BIOTECHNOLOGY CO., LTD.
WO/2021/012694ETHYL METHYL HYDROXYPYRIDINE MALATE OR PHARMACEUTICAL  COMPOSITION THEREOF, AND A USE IN PREVENTING AND/OR TREATING TYPE-II DIABETESKENO PHARMA LIMITED
WO/2021/073041APPLICATION OF MULTI-LINEAGE DIFFERENTIATING STRESS ENDURING  CELLS, MEDICAMENT FOR TREATING PERIPHERAL NERVE INJURY AND PREPARATION METHOD  THEREFORNANTONG UNIVERSITY
WO/2021/068459SUSPENSION CONTAINING LOW METHOXYLATION PECTIN AND  MONTMORILLONITE FOR TREATING ACUTE DIARRHEAAFFILIATED HOSPITAL OF NANTONG UNIVERSITY
WO/2021/073042USE OF MULTILINEAGE DIFFERENTIATION STRESS-ENDURING CELL, DRUG  FOR TREATING DIABETES AND PREPARATION METHOD THEREFORNANTONG UNIVERSITY
WO/2021/008161DRUG FOR ALLEVIATING PSEUDOMONAS KERATITISSHANDONG EYE INSTITUTE
WO/2021/142934APPLICATION OF JAK-1 SIGNALING PATHWAY INHIBITOR IN  PREPARATION OF MEDICAMENT FOR TREATING BRAIN INJURYSOOCHOW UNIVERSITY
WO/2021/189256USE OF MENTHOL FOR PREPARING EXTERNAL COMPOSITION FOR TREATING  NEURODEGENERATIVE DISEASE AND STROKECHINA MEDICAL UNIVERSITY
WO/2021/155631ERYTHROCYTE GEL DELIVERY SYSTEM, AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSOOCHOW UNIVERSITY
WO/2021/179351IMMUNE COMBINATION FOR INDUCING BROAD-SPECTRUM NEUTRALIZING  ANTIBODY AGAINST HIV-1SHANGHAI PUBLIC HEALTH CLINICAL CENTER
WO/2021/189279METHOD FOR REDUCING BEHAVIORAL ABNORMALITIESBENED BIOMEDICAL CO., LTD.
WO/2021/184404COMPOSITION OF NOVEL IMMUNE AGONIST COMPOUND AND USE THEREOF  IN MEDICINE CAPABLE OF RESISTING MULTIPLE DISEASESHANGZHOU XINGAO BIOTECHNOLOGY CO., LTD.
WO/2021/134935USE OF CANNABIDIOL IN PREPARATION OF DRUGS FOR PROMPTING  HEALING OF ORAL MUCOSASICHUAN UNIVERSITY
WO/2021/151264USE OF ACYLATED SPIRAMYCIN IN PREPARATION OF MEDICAMENT FOR  TREATING CORONAVIRUS INFECTIOUS DISEASESHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/184405LIPOSOME COMPRISING GULURONIC ACID OLIGOSACCHARIDE,  PREPARATION METHOD, AND USE THEREOF FOR PROMOTING IMMUNE ACTIVITYSHENZHEN UNIVERSITY
WO/2021/189355AMINO ACID MEDIATED GENE DELIVERY AND ITS USESCHINESE INSTITUTE FOR BRAIN RESEARCH, BEIJING
WO/2021/031565Treatment of Neuronal DiseasesCENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/189390MEDICAMENT FOR PREVENTING/TREATING TYPE 2 DIABETES AND USESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/189444USE OF RIFAMYCIN ANTIBIOTICS IN PREPARATION OF DRUGS AGAINST  YELLOW FEVER VIRUS INFECTIONSTHE NAVAL MEDICAL UNIVERSITY OF PLA
WO/2021/195820TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/155633USE OF ALKYL RESORCINOL COMPOUND IN PREPARATION OF DRUG FOR  PREVENTING OR TREATING ALZHEIMER'S DISEASEBEIJING TECHNOLOGY AND BUSINESS UNIVERSITY
WO/2021/195877FORMULATIONS OF HUMAN PARATHYROID HORMONE (PTH) AND METHODS  FOR PRODUCING SAMESICHUAN LUZHOU BUCHANG BIO-PHARMACEUTICAL CO., LTD.
WO/2021/195904USE OF COMPOSITION CONTAINING ASTRAGALI RADIX, PUERARIAE  LOBATAE RADIX AND ERIGERONTIS HERBACHONGQING TAIJI INDUSTRIAL (GROUP) CO., LTD
WO/2021/195905COSMETIC COMPOSITION FOR SKIN CAREL'OREAL
WO/2021/195931COSMETIC COMPOSITION IN THE FORM OF A GELL'OREAL
WO/2021/077681HYALURONIC ACID GEL COMPOSITION FOR WATER OPTOINJECTION, AND  PREPARATION METHOD THEREFORBIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.
WO/2021/077683HYALURONIC ACID GEL FOR HYALURONIC ACID INJECTION AND USE  METHOD FOR HYALURONIC ACID GELBIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD
WO/2021/196079ENERGY-ACTIVATING, ANTI-WRINKLE, ANTI-INFLAMMATORY, AND  WHITENING ORCHID EMBRYO TISSUE EXTRACTLIANG, Chiahua
WO/2021/196086METHOD FOR INHIBITING CELL ACTIVITY BY MEANS OF INTRACELLULAR  POLYMERIZATION AND PRO-DRUG IMPLEMENTING METHODSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/189517USE OF MTHFD1 INHIBITOR IN INHIBITING AND KILLING VIRUSESTSINGHUA UNIVERSITY
WO/2021/057007RAPAMYCIN NANOSCALE SUSTAINED-RELEASE AGENT AND PREPARATION  METHOD THEREOFYAN, Pengke
WO/2021/196105ANTI-TUMOR EFFECTIVE COMPONENT OF HEDYOTIS DIFFUSA,  PREPARATION METHOD THEREFOR AND USE THEREOFGUANGDONG NEW EAR LIFE TECHNOLOGY CO., LTD.
WO/2021/164107NOVEL APPLICATION OF IL-6 RECEPTOR ANTIBODIESUNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA
WO/2021/203236BAT-DERIVED CORONAVIRUS VACCINE FOR PREVENTION OF COVID-19SICHUAN CHENGYU BIOLOGICAL PRODUCTS INC.
WO/2021/168996CATALASE NANOCAPSULES AND METHODS FOR USEVIVIBABA, INC.
WO/2021/184449PREPARATION METHOD FOR AND APPLICATION OF GENETICALLY  ENGINEERED ANTITUMOR MICROPARTICLEWUHAN SHENGRUN BIOTECHNOLOGY CO., LTD
WO/2021/031579ANTI-ACETYLCHOLINESTERASE ACTIVE COMPOSITION IN CAULIS  MAHONIAE AND SCREENING METHOD THEREFOR AND APPLICATION THEREOFSHENZHEN INSTITUTE FOR DRUG CONTROL (SHENZHEN TESTING CENTER  OF MEDICAL DEVICES)
WO/2021/203377BENDAMUSTINE COMPOSITION AND USE THEREOFBIKA BIOTECH (GUANGZHOU) CO., LTD
WO/2021/203419TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  DERMATITIS OR ECZEMALUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/203434NANO MATERIAL FOR OSTEOCLAST ACIDIC CLOSED REGION AND  PREPARATION METHOD THEREFORSIR RUN RUN SHAW HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/196275APPLICATION OF EMETINE IN PREPARATION OF DRUG FOR TREATING OR  PREVENTING NOVEL CORONAVIRUSES SARS-COV-2HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF  SCIENCES
WO/2021/179396NEW APPLICATION OF HUWE1 INHIBITOR BI8622KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/208060GAS SUPPLY DEVICE, USE THEREOF FOR LIGHTENING HAIR COLOR AND  METHODTO2M CORPORATION
WO/2021/208080USE OF OVATODIOLIDE AGAINST NOVEL CORONAVIRUSCNS BIOTEK CORP.
WO/2021/212253IBRUTINIB GLUCONOLACTONE CO-CRYSTAL AND PREPARATION METHOD  THEREFORTIANJIN CREATRON BIOTECHNOLOGY CO., LTD.
WO/2021/212267COMPOSITION FOR CARING FOR THE SKINL'OREAL
WO/2021/212269APPLICATION OF ELLAGIC ACID IN PREVENTING AND TREATING NOVEL  CORONAVIRUS INFECTIONYUNNAN AGRICULTURAL UNIVERSITY
WO/2021/212270APPLICATION OF AMARONOL A IN PREVENTION AND TREATMENT OF NOVEL  CORONAVIRUS INFECTIONYUNNAN AGRICULTURAL UNIVERSITY
WO/2021/114540PEONY FACE MASK FOR CLEANSING PORES AND PREPARATION METHOD  THEREFORSHANXI LU'AN MINING (GROUP) CO., LTD
WO/2021/068478POLYPEPTIDE AND POLYPEPTIDE COMPOSITION FOR INHIBITING  HELICOBACTER PYLORI FROM FORMING BIOLOGICAL MEMBRANE AND ELIMINATING  BIOLOGICAL MEMBRANE FORMED BY HELICOBACTER PYLORIANHUI SCIENCE AND TECHNOLOGY UNIVERSITY
WO/2021/036294VAGINAL ACID-BASE BUFFER GEL AND PREPARATION METHODNANJING TIANLANG PHARMACEUTICAL CO., LTD.
WO/2021/051807PREPARATION CONTAINING HUMAN ALBUMIN AND PREPARATION METHOD  THEREFORTONGHUA ANRATE BIOPHARMACEUTICAL CO., LTD
WO/2021/212360TREATING UNTREATED OR TREATMENT-RESISTANT DIABETES WITH  GLUCOKINASE ACTIVATOR AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORHUA MEDICINE (SHANGHAI) LTD.
WO/2021/098141AEROSOL ALCOHOL-FREE NO-WASH ANTIBACTERIAL HAND SANITIZER AND  PREPARATION METHOD THEREFORZHEJIANG LUDAO TECHNOLOGY CO., LTD.
WO/2021/212404TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAMEHENKEL AG & CO. KGAA
WO/2021/088327TOOTH MINERALIZATION SOLUTION AND MINERALIZATION METHOD  THEREOFZHEJIANG UNIVERSITY
WO/2021/057022PEARL PREPARATION AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFOSM BIOLOGY CO., LTD.
WO/2021/208138TOAD SKIN STERENE TOTAL LACTONE EXTRACT, AND PREPARATION  METHOD THEREFOR AND USE THEREOFHEFEI HUAFANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/174656CHINESE PATENT MEDICINE FOR TREATING SUB-HEALTH CHRONIC  DISEASESWU, Guanlin
WO/2021/217388MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE AND  PREPARATION METHOD THEREFORJIANGSU TASLYDIYI PHARMACEUTICAL CO., LTD.
WO/2021/120486LITHIUM ION COMPOSITION AND APPLICATION THEREOFQINGDAO DEBAO SHANGJIA HOUSEHOLD PRODUCTS CO. , LTD
WO/2021/169026TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING  EPIDEMICS, AND PREPARATION METHOD THEREFOR AND USE THEREOFJIANGSU PROVINCE HOSPITAL OF TCM
WO/2021/196334APPLICATION OF PYR3 IN PREPARATION OF DRUG FOR PROTECTING  AGAINST LIVER DAMAGETHE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/196335USE OF PYR3THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/217560KIT FOR CARING FOR THE SKINL'OREAL
WO/2021/217568ASSEMBLED JADE-ACTIVATING MATERIAL FOR MAINTAINING BEAUTY AND  KEEPING YOUNG, AND ASSEMBLING AND SYNTHESIZING METHOD THEREFOR AND USE  THEREOFSICHUAN SANTAI PHARMACEUTICAL TECHNOLOGY CO. LTD
WO/2021/169034APPLICATIONS OF TRANSFERRIN OR OVEREXPRESSED TRANSFERRIN IN  PREPARING MEDICAMENT FOR TREATING AND/OR PREVENTING ULCERATIVE COLITISKUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/223143O/W EMULSION AND W/O EMULSION INVERTED THEREFROM, AND PERSONAL  CARE COMPOSITION CONTAINING SAMEMOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/217693USE OF SYMBIOTIC FERMENTATION PRODUCT OF HYDROLYZED CANDIDA  AND JAPANESE SAKE YEASTHANGZHOU QIANMEI COSMETIC CO., LTD
WO/2021/004145USE OF MIR-132 AND 212 IN PREPARATION OF DRUG FOR TREATING  ADDICTIONSHENZHEN KANGNING HOSPITAL (SHENZHEN MENTAL HEALTH INSTITUTE,  SHENZHEN MENTAL HEALTH CENTER)
WO/2021/226736TREATMENT OF ADVERSE EFFECTS CAUSED BY ATYPICAL ANTIPSYCHOTICSSHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/226738MOLECULAR-LEVEL PHARMACEUTICAL COMPOSITION COMPRISING  LENVATINIB AND PREPARATION METHOD THEREFOR AND USE THEREOFBEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RESEARCH CO. LTD.
WO/2021/217702MEDICINE AND FOOD FOR PREVENTING OR TREATING COVID-19, AND  APPLICATION THEREOFGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/226762TUMOR MICROENVIRONMENT RESPONSE-TYPE NANO-COMPOSITE DRUG  LOADING SYSTEM, AND PREPARATION METHOD THEREFOR AND USE THEREOFWANG, Shubin
WO/2021/203515PREPARATION METHOD FOR MICRORNA MICRO/NANOSPHERES AND  APPLICATION THEREOF IN HEALING SPINAL CORD INJURYYAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD.
WO/2021/082391COLLAGEN NANO INSTANT FACIAL MASK OF YEAST RECOMBINANT  COLLAGEN AND PREPARATION METHOD THEREFORNOX BELLCOW COSMETICS CO., LTD.
WO/2021/226849IMMUNOLOGICALLY ACTIVE PEPTIDE-BILIVERDIN CONJUGATE,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFINSTITUTE OF PROCESS ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/098164METHOD FOR EXTRACTING KELP POLYPHENOLSQINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/226883COMPOSITIONS AND METHODS FOR TREATING CANCER SUBMISSION OF  SEQUENCE LISTING ON ASCII TEXT FILEADAGENE AG
WO/2021/103434RECOMBINANT VARICELLA-ZOSTER VIRUS VACCINEBEIJING LUZHU BIOTECHNOLOGY CO., LTD.
WO/2021/008215POLYMER COMPOSITE MICROSPHERE, PREPARATION METHOD THEREFOR AND  USE THEREOFGUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS
WO/2021/217740COMPOSITIONS AND METHODS FOR INHIBITING VIRUS INFECTIONSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227077AMINO ACID COMPOSITION AND METHOD FOR CATALYTIC SYNTHESIS OF  AMINO ACID BY MEANS OF ENERGY RADIATIONBEIJING GUANGHE ORIGINAL TECHNOLOGY CO., LTD.
WO/2021/057042DRUG COMPOSITION CONTAINING ABIRATERONE ACETATE, AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFHUNAN HUIZE BIO-PHARMACEUTICAL CO., LTD
WO/2021/232334TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING ANTI-ACNE  EFFECT, PREPARATION METHOD THEREFOR, AND USE THEREOFJOHNSON BIOTECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/237456ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND USE THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/237609NOVEL USE OF ORIDONIN OR ORIDONIN DERIVATIVETSINGHUA UNIVERSITY
WO/2021/047210IMMUNIZATION-PURPOSE SUSPENDING AGENT, VACCINE SUSPENSION  PREPARATION METHOD AND SPRAY-DROP IMMUNIZATION METHODFOSHAN STANDARD BIO-TECH CO., LTD.
WO/2021/159636USE OF COMPOUND ZZ-8 IN PREPARING DRUG FOR TREATMENT OF  OBESITYKEY LABORATORY OF SOUTH SUBTROPICAL PLANT DIVERSITY, FAIRY  LAKE BOTANICAL GARDEN, SHENZHEN & CHINESE ACADEMY OF SCIENCES
WO/2021/012789PHARMACEUTICAL COMPOSITION CONTAINING LYSOZYME AND USE THEREOFGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/237691DEFORMABLE SOLID COMPOSITION FOR CLEANSING THE SKINL'OREAL
WO/2021/237697COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALSL'OREAL
WO/2021/042777MULTI-COMPONENT GEL SUSTAINED-RELEASE PHARMACEUTICAL  COMPOSITION FOR TREATMENT OF TUMORSSUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/042778TEMPERATURE-SENSITIVE GEL PHARMACEUTICAL COMPOSITION FOR  TREATMENT OF TUMORSSUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/155651USE OF 4-AMINOQUINOLINE COMPOUND IN TREATMENT OF CORONAVIRUS  INFECTIONACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/212617SEAWEED MASK, PREPARATION METHOD THEREFOR AND APPLICATION  THEREOFSHANDONG UNIVERSITY
WO/2021/008265ANTI-AGING SOFT CAPSULE FOR MENOPAUSAL WOMEN AND PREPARATION  METHOD THEREFORZAOZHUANG UNIVERSITY
WO/2021/068533DRUG FOR ANTAGONIZING REPLICATION OF PORCINE REPRODUCTIVE AND  RESPIRATORY SYNDROME VIRUS AND APPLICATION THEREOFNANJING AGRICULTURAL UNIVERSITY
WO/2021/135071USE OF PIPERAZINE FERULATE TABLETSSHENZHAN TRADITIONAL CHINESE MEDICINE HOSPITAL
WO/2021/227156COMPOSITIONS AND METHODS FOR TREATING CANCERADAGENE AG
WO/2021/243645GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH RENAL  IMPAIRMENTHUA MEDICINE (SHANGHAI) LTD.
WO/2021/243646GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC  IMPAIRMENTHUA MEDICINE (SHANGHAI) LTD.
WO/2021/243658TREATMENT OR PREVENTION OF CORONAVIRIDAE INFECTIONWATERSTONE PHARMACEUTICALS (WUHAN) CO., LTD.
WO/2021/243669USE OF A COMPOUND CONTAINING TWO OR MORE ALCOHOLIC HYDROXYL  GROUPS OR PHENOLIC HYDROXYL GROUPS AS A MICROBIOME REGULATOR ON SCALPHENKEL AG & CO. KGAA
WO/2021/093315COMPOSITION FOR PROTECTING LIVER, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/063016COMPOSITION WITH HYPOLIPIDEMIC FUNCTION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/057089COMPOSITION WITH CHLOASMA REMOVAL FUNCTION, PREPARATION METHOD  THEREFOR AND USE THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/022891COMPOSITION HAVING IMMUNITY-ENHANCING FUNCTION AND PREPARATION  METHOD THEREFORJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109509COMPOSITION HAVING IMMUNITY-ENHANCING FUNCTION AND PREPARATION  METHOD THEREFORJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109510COMPOSITION HAVING DIGESTION PROMOTING FUNCTION, PREPARATION  METHOD AND APPLICATION THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109511ANTI-FATIGUE COMPOSITION AND PREPARATION METHOD THEREFORJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/114586IMMUNE RESPONSE-IMPROVING COMPOSITION, PREPARATION METHOD AND  APPLICATION THEREOFJIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/196402PHARMACEUTICAL COMPOSITION AND USE THEREOFDONGGUAN HEC CORDYCEPS R&D CO., LTD.
WO/2021/217788METHOD FOR PREPARING COMPOUND-TYPE TABLETS FOR PROTECTING  LIVER AND DISPELLING EFFECTS OF ALCOHOLJIANG SU ZHONGXING PHARM.CO., LTD
WO/2021/227166APPLICATION OF SUCCINYLATION MODIFICATION OF PROTEIN IN  PREPARATION OF TUMOR CELL METABOLISM REGULATORTANG, Bo
WO/2021/174714MELANIN-BASED SUNSCREEN COMPOSITION AND PREPARATION METHOD  THEREFORJIANGNAN UNIVERSITY
WO/2021/174715PERSONAL CARE SUNSCREEN COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOFJIANGNAN UNIVERSITY
WO/2021/073131MEDICAMENT FOR EFFICIENTLY KILLING DRUG-RESISTANT DISEASE  BACTERIA AND APPLICATION THEREOF IN INHIBITING DRUG-RESISTANT DISEASE  BACTERIAOCEAN UNIVERSITY OF CHINA
WO/2021/073132APPLICATION OF HIGH PURITY NERVONIC ACID IN WHITENING AND  PREPARATION METHOD FOR HIGH PURITY NERVONIC ACIDNANJING KANGQI BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/004229NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN  PREVENTING RECURRENCE OF PSORIASISRUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/253147METHOD FOR PREPARING CELL-MEDIATED SARS-COV-2 VACCINESYIN, Xiushan
WO/2021/114596PHENYLETHANOID GLYCOSIDE EXTRACT FROM ACANTHUS ILICIFOLIUS,  AND PREPARATION METHOD THEREOF AND APPLICATION AS DRUG FOR RESISTING LIVER  DAMAGEOCEAN UNIVERSITY OF CHINA
WO/2021/143042PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE BURNS AND SKIN  GANGRENE AND APPLICATION THEREOFBEIJING GUANGJIE-YOUNG HEALTH SCIENCE AND TECHNOLOGY CO. LTD
WO/2021/189678WHOLE-CELL CONSTITUENT TRANSPORT SYSTEM AND APPLICATION  THEREOFSOOCHOW UNIVERSITY
WO/2021/217816COMPOSITION FOR PREVENTING AND TREATING PNEUMONIA, AND  PREPARATION METHOD THEREFOR AND USE THEREOF IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING PNEUMONIAINSTITUTE OF SCIENCE AND TECHNOLOGY, GUANGDONG UNIVERSITY OF  CHINESE MEDICINE
WO/2021/077770MINI COMBINED ADJUVANT NANOPARTICLE, PREPARATION METHOD  THEREFOR AND APPLICATION THEREFORINSTITUTE OF BIOMEDICAL ENGINEERING, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/248532VORICONAZOLE PREPARATION FOR EXTERNAL USE AND PREPARATION  METHOD THEREFORZHEJIANG POLY PHARM CO., LTD
WO/2021/217823DIHYDROMYRICETIN HAVING FUNCTION OF DISPELLING EFFECTS OF  ALCOHOLSONG, Kunyuan
WO/2021/243756PHARMACEUTICAL USE OF MYRICETIN IN INHIBITION OF NOVEL  CORONAVIRUSSHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/243757PHARMACEUTICAL APPLICATION OF GALLIC ACIDSHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/217826PHARMACEUTICAL APPLICATION OF DIMYRICETIN-YL-DISELENIDESHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/253338USE OF ROMIDEPSIN IN PREVENTING AND TREATING  CORONAVIRUS-RELATED DISEASESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/120562TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  EGFR-TKIS-RELATED SKIN RASH, AND USE THEREOFLIN, Lizhu
WO/2021/068550ACTIVE POLYPEPTIDE COMPOUNDSHAANXI MICOT TECHNOLOGY CO., LTD.
WO/2021/253380ORAL FORMULATIONS AND USES THEREOFINVENTISBIO CO., LTD.
WO/2021/212635APPLICATION OF BRUCEA JAVANICA FRUIT FAT-SOLUBLE EXTRACT IN  PREPARATION OF DRUG FOR PROMOTING PERIPHERAL NERVE REGENERATIONNANTONG UNIVERSITY
WO/2021/212638CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN  ANALOGSHANGZHOU DAC BIOTECH CO., LTD.
WO/2021/227200ORAL CAVITY CLEANING COMPOSITION AND APPLICATION THEREOFGUANGZHOU ZHONGYU BIOTECHNOLOGY CO., LTD.
WO/2021/147235APPLICATION OF FAVIPIRAVIR IN TREATING CORONAVIRUS INFECTIONACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/147236USE OF SUBSTITUTED AMINOPROPIONATE COMPOUND IN TREATMENT OF  SARS-COV-2 INFECTIONSACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/114605LIVER-TARGETED THERAPEUTIC DRUG BASED ON SUGAR-BASED METAL  FRAMEWORK MATERIAL AND PREPARATION METHOD THEREOFJIANGNAN UNIVERSITY
WO/2021/208237APPLICATION OF HEPTOSE CHAIN-CONTAINING OLIGOSACCHARIDE  COMPOUND IN PREPARATION OF HELICOBACTER PYLORI VACCINEJIANGNAN UNIVERSITY
WO/2021/109549JOINT APPLICATION OF QUERCETIN AND ANTIBACTERIAL MEDICAMENTCHINA AGRICULTURAL UNIVERSITY
WO/2021/000770HETEROCYCLIC COMPOUND CAPABLE OF ENHANCING IMMUNE ACTIVITY,  PREPARATION METHOD THEREFOR AND APPLICATION IN MEDICINECAMPHOR PHARMACEUTICALS LIMITED
WO/2021/169100APPLICATION OF TRISACCHARIDE REPEATING UNIT OLIGOSACCHARIDE  CHAIN IN PREPARATION OF STAPHYLOCOCCUS AUREUS VACCINESJIANGNAN UNIVERSITY
WO/2021/258326APPLICATION OF MIDAZOLAM NANOCRYSTALS IN PREPARING DRUG FOR  IMPROVING BLOOD-BRAIN BARRIER PERMEABILITYMILITARY MEDICAL INSTITUTE, ACADEMY OF MILITARY SCIENCES, PLA
WO/2021/258337HUMAN MONOCLONAL ANTIBODIES AGAINST TIGIT FOR IMMUNE RELATED  DISEASESHUAHUI HEALTH LTD.
WO/2021/258341BARNYARD GRASS EXTRACT, AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFLEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/258342TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DRUG WITHDRAWAL,  AND APPLICATION THEREOFLEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/042830RECOMBINANT HUMAN PAPILLOMA VIRUS VACCINE COMPOSITION AND USE  THEREOFIMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
WO/2021/063047USE OF EXTRACT OF OVERGROUND PART OF SCUTELLARIAE RADIX IN  AQUACULTURETHE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/012886ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOFGUANGZHOU CAS LAMVAC BIOTECH CO., LTD
WO/2021/179482TRADITIONAL CHINESE MEDICINE COMPOUND COMPOSITION HAVING  EFFECT OF PROMOTING BONE HEALTH AS WELL AS PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFCHENLAND NUTRITIONALS, INC.
WO/2021/227214STERILIZATION AND DISINFECTION COMPOSITIONNANJING GREEN INTERFACE NEW MATERIALS RESEARCH INSTITUTE CO.,  LTD
WO/2021/143060MAGNOLIA OFFICINALIS PLANT PRESERVATIVE AND BACTERIOSTATIC  COMPOSITION, PREPARATION PROCESS THEREFOR, AND APPLICATION THEREOFYUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO., LTD.
WO/2021/057152KIT FOR CARING FOR KERATIN MATERIALSL'OREAL
WO/2021/027425ANTI-INFLAMMATORY TARGETED DELIVERY SYSTEM AND PREPARATION  METHOD THEREFORSOOCHOW UNIVERSITY
WO/2021/179494DRUG FOR PREVENTING AND/OR TREATING BRAIN TUMOR AND  APPLICATION THEREOFGUANGZHOU CAS LAMVAC BIOTECH CO., LTD
WO/2021/000899A PHARMACEUTICAL COMBINATION CONTAINING mTOR INHIBITOR AND USE  THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/000926USE OF GINSENOSIDE M1 FOR TREATING CANCERLEE, Sheau-Long
WO/2021/000950PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE AND PREPARATION  METHOD THEREFORSHENZHEN RADAK BIO CORPORATION
WO/2021/000953SUBSTANCE AND METHOD FOR TREATING TUMORJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/237879USE OF AITCTHE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/004422MICROMOLECULE PI4KIIIα INHIBITOR COMPOSITION, PREPARATION  METHOD THEREFOR AND USE THEREOFNUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/114647APPLICATION OF SODIUM P-HYDROXYBENZOATE IN PREPARATION OF  DRUGS FOR TREATMENT OR PREVENTION OF INFLAMMATORY BOWEL DISEASEGUILIN MEDICAL UNIVERSITY
WO/2021/082512USE OF BLUE-LIGHT ACTIVATED BLEBBISTATIN ANALOGUES IN KILLING  DRUG-RESISTANT BACTERIASHENZHEN THIRD PEOPLE'S HOSPITAL
WO/2021/243797USE OF DROSOPHILA MELANOGASTER HSP22 PROTEIN IN PREPARATION OF  ANTI-TUMOR DRUGAFFILIATED HOSPITAL OF GUILIN MEDICAL UNIVERSITY
WO/2021/174738BIONIC NANOPARTICLE COATED WITH MESENCHYMAL STEM CELL MEMBRANE  HAVING SURFACE OVEREXPRESSING PD-L1 MOLECULE, AND PREPARATION THEREFOR AND  APPLICATION THEREOFSOOCHOW UNIVERSITY
WO/2021/248601USE OF LYCHEE PEEL EXTRACT MAINLY CONTAINING MULTIMERIC  POLYPHENOL IN PREPARATION OF α-AMYLASE INHIBITORGUANGXI ZHUANG AUTONOMOUS REGION AND CHINESE ACADEMY OF  SCIENCE, GUANGXI INSTITUTE OF BOTANY
WO/2021/042865ORAL DRUG DOSAGE FORMS HAVING A DESIRED PK PROFILE AND METHODS  OF DESIGNING AND PRODUCING THEREOFTRIASTEK, INC.
WO/2021/004477MITOCHONDRIA-BASED DRUG DELIVERY SYSTEM AND USE THEREOFTANG, Lingfeng
WO/2021/243804TRADITIONAL CHINESE MEDICINE EPIDEMIC-PREVENTION BAGBEIJING GUORUN JIUHE HEALTH TECHNOLOGY CO., LTD
WO/2021/036537USE OF KOUMINE IN PREPARATION OF DRUGS FOR TREATING  INFLAMMATORY BOWEL DISEASEFUJIAN MEDICAL UNIVERSITY
WO/2021/004524PEGYLATED SYNTHETIC KL4 PEPTIDE, COMPOSITIONS AND METHODS  THEREOFTHE UNIVERSITY OF HONG KONG
WO/2021/088399MOISTURIZING AND HYDRATING FACIAL MASK COMPOSITION, FACIAL  MASK, AND PREPARATION METHOD FOR FACIAL MASK COMPOSITIONHUBEI CHUANGJIE BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/184610GALANTAMINE PAMOATE SUSTAINED-RELEASE MICROPARTICLES FOR  INJECTION, AND PREPARATION METHOD THEREFORSHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/196443LIQUID PREPARATION OF RECOMBINANT HUMANIZED ANTI-PD-1  MONOCLONAL ANTIBODYLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/184611TABLET OF STEROID CYP17 INHIBITOR SOLID DISPERSION AND  PREPARATION METHOD THEREFORSHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/217889USE OF COMBINATION OF SMALL MOLECULE COMPOUND MLN4924 AND IFNα  IN RESISTING HBVZHEJIANG UNIVERSITY
WO/2021/174741APPLICATION OF DIMETHYL BERBAMINE COMPOUND IN INHIBITION OF  SARS-COV-2ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/253545CHITOSAN OLIGOSACCHARIDE COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFGUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/008501ENGINEERED VACCINIA VIRUSSHENZHEN HUA YAO KANG MING BIOPHARMACEUTICAL CO., LTD.
WO/2021/169149CATALASE NANOPARTICLES AND METHODS FOR USEVIVIBABA, INC.
WO/2021/098240USE OF RECOMBINANT SECRETED DDRGK1SHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY  SCHOOL OF MEDICINE
WO/2021/008520STABLE AST-3424 INJECTION PREPARATION AND PREPARATION METHODASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/179505FORSYTHIA SUSPENSA AND ASTRAGALUS MEMBRANACEUS COMPOUND  PREPARATION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOFYAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD.
WO/2021/073178AVIAN EGG DROP SYNDROME VIRUS TFIBER PROTEIN FRAGMENT, VACCINE  COMPOSITION PREPARED THEREFROM, PREPARATION METHOD, AND APPLICATIONPULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/022984AZO CALIXARENE PHARMACEUTICAL ADJUVANT AND USE THEREOFTANGSHAN TIANQUAN TECHNOLOGY CO. LTD.
WO/2021/147272USE OF BENZOATE COMPOUND IN TREATMENT OF SARS-COV-2 INFECTIONSACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/208280APPLICATION OF DRIED FLY LARVA IN PREPARATION OF DRUGS FOR  PREVENTING AND TREATING BREAST HYPERPLASIAHANGZHOU YIKETANG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/155654APPLICATION OF RITONAVIR IN TREATING SARS-COV-2 INFECTIONACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/147273APPLICATION OF NITAZOXANIDE AND ACTIVE FORM THEREOF,  TIZOXANIDE, IN TREATMENT OF SARS-COV-2 INFECTIONACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/017833ANTI-AGING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017834SKIN COMPOSITION FOR EXTERNAL USE HAVING ANTI-INFLAMMATORY  EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017835ENHANCED WHITENING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/008565USE OF ACETYLCHOLINE PATHWAY MODULATORS IN TREATMENT OF CANCERTSINGHUA UNIVERSITY
WO/2021/031750MIXED BIRCH SAP AND APPLICATION THEREOF IN SKIN CARE COSMETIC  COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017838TOPICAL SKIN COMPOSITION WITH ANTI-ECZEMA EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017839EXTERNAL SKIN COMPOSITION HAVING ANTI-ACNE EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/013028PHARMACEUTICAL COMBINATION AND USE THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/017844EXTERNAL COMPOSITION FOR SKIN HAVING ENHANCED ANTI-ECZEMA  EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017845ANTI-HAIR LOSS HAIR GROWTH COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017846ENHANCED ANTI-AGING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017877WHITENING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017878COMPOSITION WITH ACNE REMOVAL EFFECT FOR EXTERNAL APPLICATION  TO SKINZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/103581SKIN TOPICAL COMPOSITION HAVING EFFICACY OF PROMOTING WOUND  HEALING AND/OR SCAR REPAIRZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/063076APPLICATION OF ALBIZIAE CORTEX LIGNAN COMPOUND IN IMPROVING  STEATOSISJIANGNAN UNIVERSITY
WO/2021/063078LIGNAN GLYCOSIDE COMPOUND FROM BARK OF ALBIZIA JULIBRISSIN FOR  PROMOTING ENDOTHELIAL CELL PROLIFERATION AND USE THEREOFJIANGNAN UNIVERSITY
WO/2021/008600CATIONIC POLYMER NANOPARTICLE/HIL-22BP GENE COMPOUND FOR  PREVENTING AND TREATING CANCER AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOFSICHUAN UNIVERSITY
WO/2021/036572COMPOSITION FOR PREVENTING OR TREATING URIC ACID-RELATED  DISEASEGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/017910EXTERNAL SKIN TREATMENT COMPOSITION WITH ENHANCED  ANTI-INFLAMMATORY EFFECTZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017911ENHANCED HAIR LOSS PREVENTION AND HAIR GROWTH PROMOTION  COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/008622APPLICATION OF CARBON-BASED NANOMATERIAL IN PREPARATION OF  DRUG FOR RELIEVING OR TREATING HDSOOCHOW UNIVERSITY
WO/2021/017912MOISTURIZING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017913ENHANCED MOISTURE-RETAINING COSMETIC COMPOSITIONZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017925APPLICATION OF RADIX PSEUDOSTELLARIAE CYCLIC PEPTIDE B IN  IMPROVING MEMORY AND/OR PREVENTING AND TREATING ALZHEIMER’S DISEASEGUANGDONG OCEAN UNIVERSITY
WO/2021/027509PROTON-TRIGGERING-BASED NANODRUG SYSTEM HAVING  HYDROPHILIC-HYDROPHOBIC-SIZE DOUBLE CONVERSION CHARACTERISTICS AND  PREPARATION METHOD THEREFOR AND USE THEREOFCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/212678ORAL MSCS LIQUID-FILLED CAPSULE FOR TREATING INFLAMMATORY  BOWEL DISEASES AND OTHER INTESTINAL DISEASESNANJING DRUM TOWER HOSPITAL
WO/2021/208284METHOD FOR PREPARING ORAL MICROSPHERE LOADED WITH MSCS-DERIVED  EXOSOMES AND APPLICATION THEREOFNANJING DRUM TOWER HOSPITAL
WO/2021/013204METHOD FOR TREATING DISEASES BASED ON INTERFERONXIAMEN AMOYTOP BIOTECH CO., LTD.
WO/2021/013207MULTIVARIABLE DOSING METHOD FOR USE IN TREATING HIGH-EGFR  EXPRESSION CANCERSINOCELLTECH LTD
WO/2021/013214USE OF NEUTROPHILIC GRANULOCYTES IN PREPARATION OF DRUGS FOR  TREATING AND/OR PREVENTING AUTOIMMUNE HEPATITISSICHUAN UNIVERSITY
WO/2021/031791DEXIBUPROFEN FAT EMULSION INJECTION AND PREPARATION METHOD  THEREFORSOOCHOW UNIVERSITY
WO/2021/013232AIE-ACTIVE PHOTOSENSITIZER FOR SELECTIVE BACTERIAL ELIMINATION  AND CANCER CELL ABLATIONTHE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/018026LIQUID PREPARATION AND APPLICATION THEREOFZHANG, Jinyu
WO/2021/018032PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND USE THEREOF  FOR PREVENTING AND/OR TREATING DISEASEASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/018046SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOFMEDSHINE DISCOVERY INC.
WO/2021/013262NANO-MICELLE PREPARATION OF ICARITIN AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFBEIJING SHNOGEN PHARMA GROUP LTD
WO/2021/013270PHARMACEUTICAL COMPOSITION FOR TREATING POLYPNANJING SANTONG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/143096WHITENING, ACNE-REMOVING, BLACKHEAD-REMOVING AND ANTI-AGING  COMPOSITION, AND USE AND PREPARATION THEREOFGUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/031810APPLICATION OF PTBP1 INHIBITOR IN PREVENTING AND/OR TREATING  NERVOUS SYSTEM DISEASE RELATED TO FUNCTIONAL NEURONAL DEATHCENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/023069APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASESHANGHAI RIXIN BIOTECHNOLOGY CO., LTD.
WO/2021/036654GRAPHENE ALKALI TARGETING DNA MAJOR GROOVE AND INHIBITING  TOPOISOMERASE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOFSHANGHAI UNIVERSITY
WO/2021/036656ODOR-MASKING COMPOSITION, PREPARATION METHOD THEREFOR, AND USE  THEREOFLUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/208290USE OF GPHB5 GLYCOPROTEIN HORMONE IN LOWERING LIPID AND  IMPROVING INSULIN SENSITIVITYGUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/093376USE OF PHOSPHODIESTERASE 5 INHIBITOR IN PREPARATION OF  MEDICAMENT FOR RESISTING FIBROTIC DISEASESGUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/184636SHOUHUI TONGBIAN MICROCAPSULE PREPARATION AND PREPARATION  METHOD THEREFORLUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/027576COMBINATION PRODUCT COMPRISING LIMONOIDS AND SGLT-2 INHIBITORSZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/027577COMBINATION PRODUCT CONTAINING LIMONOID AND α-GLUCOSIDASE  INHIBITORZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/189743APPLICATION OF CHINESE THOROWAX ROOT-HONEYSUCKLE FLOWER  FORMULATION IN PREPARING ANTI-CORONAVIRUS DRUG AND PREPARATION METHOD FOR  CHINESE THOROWAX ROOT-HONEYSUCKLE FLOWER FORMULATIONLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/196469USE OF PREPARATION FOR REMOVING FOOD RETENTION AND RELIEVING  COUGH IN CHILDREN IN PREPARATION OF DRUG FOR TREATING FEVER SYNDROMES AND  PREPARATION METHOD THEREFORLUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/027581COMBINATION PRODUCT COMPRISING LIMONOID AND DPP-4 INHIBITORSZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/027582COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND  THIAZOLIDINEDIONEZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/184639MICROCAPSULE PREPARATION FOR ELIMINATING FOOD STAGNATION AND  RELIEVING COUGHS IN CHILDREN AND PREPARATION METHOD THEREFORSHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/027583COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND  SULFONYLUREA DRUGZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/018237DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE  TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASESJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/018240COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A  CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF  DISEASESASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/212686METHOD FOR RHO-ADRP BASED ON GENE EDITING, AND COMPOSITIONCHIGENOVO CO., LTD.
WO/2021/004549USE FOR DUAL TARGET VASCULAR INHIBITOR IN PREPARING DRUGS FOR  PREVENTING OR TREATING FIBROSISBINZHOU MEDICAL UNIVERSITY
WO/2021/068614APPLICATION OF HONOKIOL AND MAGNOLOL IN PREPARING MCR-1 ENZYME  INHIBITORUNIV JILIN
WO/2021/023099BRUCINE GEL FORMULATION AND PREPARATION METHOD THEREFORBEIJING INCREASEPHARM CORPORATION LIMITED
WO/2021/103632SAFE AND ENVIRONMENTALLY FRIENDLY IRIDESCENT NAIL POLISHJINHUA KVS CHEMICAL CO., LTD.
WO/2021/208294APPLICATION OF PDE4 INHIBITOR IN PREPARATION OF DRUG FOR  INHIBITING PROLIFERATION IN GLIOMAGUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/208295USE OF PDE4 INHIBITOR IN PREPARATION OF DRUG FOR TREATING  LEUKEMIAGUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/023108ANTI-PD-1 ANTIBODY AND MEDICAL USE THEREOFCTTQ-AKESO (SHANGHAI) BIOMED. TECH. CO., LTD.
WO/2021/023118USE OF 5-METHYLTETRAHYDROFOLIC ACID AND COMPOSITION OF  5-METHYLTETRAHYDROFOLIC ACIDLIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/139147BIVALENT ADENOVIRUS VACCINEGUANGZHOU N BIOMED LTD.
WO/2021/018310AMINOPYRIDINE DERIVATIVES FOR TREATMENT OF NON-SMALL CELL LUNG  CANCERCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/031839TARGETED POLYPEPTIDE-MODIFIED DRUG-LOADED LIPOPROTEIN  NANO-DRUG DELIVERY SYSTEM, AND PREPARATION AND APPLICATION THEREOFSHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/023178USE OF PYRROLO-FUSED SIX-MEMBERED HETEROCYCLIC COMPOUND IN  PREPARATION OF MEDICAMENT FOR TREATING FGFR2 GENE MUTATION TUMORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164210APPLICATION OF GALLIC ACID DERIVATIVE IN PREVENTION AND  TREATMENT OF ATHEROSCLEROSIS DISEASEQILU UNIVERSITY OF TECHNOLOGY
WO/2021/023231PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE  ORAL SOLID TABLET, PREPARATION METHOD THEREFOR AND USE THEREOFJIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/023237METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING  INTESTINAL MICROORGANISMSSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023238METHOD FOR TREATING ALZHEIMER’S DISEASE BY INHIBITING UPTAKE  OF AMINO ACIDS BY T CELLSSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023239USE OF MANNURONIC ACID OLIGOSACCHARIDES OR COMPOSITION  COMPRISING SAME IN TREATMENT OF TH1-DOMINANCE RELATED DISEASESSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023240METHOD FOR IDENTIFYING CARBOHYDRATE DRUG-SENSITIVE PATIENT IN  PATIENTS HAVING ALZHEIMER'S DISEASESHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023241METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING AMINO  ACID LEVELSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023263PHARMACEUTICAL COMPOSITION PRODUCING SAFE AMOUNT OF NITRIC  OXIDE IN BODY AND USE THEREOFLIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/023264PHARMACEUTICAL COMPOSITION FOR TREATING AFRICAN SWINE FEVER  AND USE THEREOFLIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/189753PHARMACEUTICAL COMPOSITION FOR STRENGTHENING BODY AND TREATING  LUNG DISEASES AND APPLICATION THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/023267PREPARATION COMPRISING ANTI-PD-1/HER2 BISPECIFIC ANTIBODY, AND  PREPARATION METHOD THEREFOR AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/023290APPLICATION OF ZINC PYRITHIONE IN TREATMENT OF LUNG CANCERXIAMEN UNIVERSITY
WO/2021/023291USE OF PROFLAVINE IN TREATMENT OF LUNG CANCERSXIAMEN UNIVERSITY
WO/2021/027704APPLICATION OF POLYPEPTIDE OR DERIVATIVE THEREOFCHENGDU HUITAI BIOMEDICINE CO., LTD.
WO/2021/036752HYPOXIC-TUMOR-TARGETING SHORT-CHAIN POLYPEPTIDE MICROMOLECULE  SELF-ASSEMBLY NANOMETER MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOFNATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/077856SIRNA AND NANO DELIVERY SYSTEM CAPABLE OF SILENCING PCSK9  PROTEIN, AND APPLICATION OF NANO DELIVERY SYSTEMGUANGZHOU MEDICAL UNIVERSITY
WO/2021/031893PROSTATITIS TREATMENTNATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/248674ANTIBACTERIAL NANOZYME AND PREPARATION METHOD THEREFORQINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/088446METHOD FOR STAGGERED POWERING-ON OF SERVER HARD DISKS, DEVICE,  AND MEDIUMCHENGDU QINGZHIXIN BIOTECHNOLOGY CO., LTD
WO/2021/212700PHARMACEUTICAL COMPOSITION FOR IMPROVING MOTION SICKNESS OF  PETS, PREPARATION METHOD THEREFOR AND USE METHOD THEREOFJIANGSU NANJING AGRICULTURAL UNIVERSITY ANIMAL PHARMACEUTICAL  CO., LTD
WO/2021/036793PYROPTOSIS-INDUCED IMMUNOTHERAPYNATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/036803USE OF LONG-ACTING PROTEIN PREPARATION FOR IMPROVING SEXUAL  DYSFUNCTIONXINTRUM PHARMACEUTICALS, LTD.
WO/2021/027912CHIDAMIDE-CONTAINING ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND  USE THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/031991COMPOSITION AND METHOD FOR TREATING HORMONE-DEPENDENT DISEASES  AND REDUCING DRUG TOLERANCE OF PATIENTS WITH HORMONE-DEPENDENT DISEASESCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/169194APPLICATION OF TETRAHYDROPALMATINE IN PREPARATION OF DRUGS  AGAINST OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITYZHEJIANG UNIVERSITY
WO/2021/027971FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD  THEREFOR AND USE THEREOFSHANGHAI SEME CELL TECHNOLOGY CO., LTD
WO/2021/203605COMPOUND AMINO ACID INJECTION FOR LIVESTOCK AND PREPARATION  METHOD THEREFORHEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/032073IN-SITU GEL CONTAINING CYCLOSPORINE MICELLES AS SUSTAINED  OPHTHALMIC DRUG DELIVERY SYSTEMIVIEW THERAPEUTICS (ZHUHAI) CO., LTD.
WO/2021/032078NOVEL ANTI-SIRPA ANTIBODIESELPISCIENCE (SUZHOU) BIOPHARMA, LTD.
WO/2021/203606PREPARATION METHOD FOR COMPOUND AMINO ACID INJECTION FOR  LIVESTOCKHEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/203607METHOD FOR PREPARING COMPOUND AMINO ACID INJECTION FOR  LIVESTOCKHEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/248688APPLICATION OF ITPP IN PREPARATION OF DRUGS FOR PREVENTING  AND/OR TREATING HYPOXIC-ISCHEMIC INJURY AND LUNG INJURYSYMEPILIN PHARMACEUTICALS CO., LTD.
WO/2021/036884APPLICATION OF HERNANDEZINE OR PHARMACEUTICALLY ACCEPTABLE  SALT THEREOF IN DRUGS FOR DIABETES OR DIABETIC COMPLICATIONSEAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/032128APPLICATION OF FLUORO-SUBSTITUTED 2-AMINOTHIAZOLE-5-AROMATIC  CARBOXAMIDEHUNAN WARRANT PHARMACEUTICAL CO., LTD
WO/2021/073249USE OF β-NMN IN PREPARATION OF DRUG FOR TREATING AND  PREVENTING SEPSIS-INDUCED ORGAN DAMAGESOOCHOW UNIVERSITY
WO/2021/036896PLANT EXTRACTION METHODBEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD
WO/2021/196505USES OF CYCLOCARYA PALIURUS LEAF FLAVONE EXTRACT IN  PREPARATION OF ANTIBACTERIAL MEDICAMENTS AND/OR ANTIBACTERIAL AGENTSWEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/032179APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING  INFECTION ASSOCIATED WITH BURN OR SCALD INJURYSICHUAN UNIVERSITY
WO/2021/036922COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALKBEIJING TIDE PHARMACEUTICAL CO., LTD.
WO/2021/036923SILVER-/GOLD-COMPOUNDS AND METHODS THEREOFTHE UNIVERSITY OF HONG KONG
WO/2021/103679LIPODISSOLVESHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSTIY  SCHOOL OF MEDICINE
WO/2021/036937APPLICATION OF PDE3 INHIBITOR AND CYTOKINE IN TREATMENT OF  TUMORSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/036975PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFORSICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/032212ANTI-AGING MEDICINE D/A TARGETING AGING CELLS IN TISSUE  MICROENVIRONMENT AND USE THEREOFSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/032213ANTI-AGING MEDICINE D/S TARGETING AGING CELLS IN TISSUE  MICROENVIRONMENT AND USE THEREOFSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/077889PARACETAMOL SUSTAINED-RELEASE PREPARATION AND 3D PRINTING  PREPARATION METHOD THEREFORACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/037013NOVEL APPLICATION OF PHENOTHIAZINES OR COMPOUND HAVING SIMILAR  STRUCTURE IN PHARMACEUTICSGUANGZHOU VIROTECH PHARMACEUTICAL CO., LTD.
WO/2021/037077PATENTIFLORIN A ANALOGS AS ANTIVIRAL AGENTSHONG KONG BAPTIST UNIVERSITY
WO/2021/037091CHIDAMIDE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/082683USE OF TRAMETINIB IN PREPARATION OF MEDICINE FOR PREVENTING  AND/OR TREATING NON-ALCOHOLIC HEPATITIS AND/OR NON-ALCOHOLIC FATTY LIVER  DISEASEBEIJING GIGACEUTICALS TECH. CO., LTD
WO/2021/037122STABLE GEL COMPOSITION HAVING HIGH OIL CONTENT, AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOFSIRIO PHARMA CO., LTD.
WO/2021/037128CHIDAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION AND USE  THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/223346APPLICATION OF YAM PROTEIN EXTRACT IN PREPARATION OF  MEDICATION FOR TREATING ERECTILE DYSFUNCTIONZHAO, Daqing
WO/2021/037188PHARMACEUTICAL USE OF PYRIMIDO[5,4-B]PYRROLIZINE COMPOUNDSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/057380COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKIN  CARE PRODUCTS FOR REGULATING SKIN BIORHYTHMHUNAN YUJIA COSMETICS MANUFACTURING CO., LTD
WO/2021/037199TRANSDERMAL AMIDE LOCAL ANESTHETIC-CONTAINING PHARMACEUTICAL  COMPOSITION AND PREPARATION METHOD THEREFORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/217982FOOT-AND-MOUTH DISEASE VIRUS-LIKE PARTICLE ANTIGEN AND VACCINE  COMPOSITION THEREOF, AND PREPARATION METHOD AND APPLICATION OF VACCINE  COMPOSITIONPULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/037212COMPOSITION USED FOR COMBATING METABOLIC DISEASES AND USES OF  COMPOSITIONINSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/037230USE OF ANNEXIN A5SUZHOU YABAO PHARMACEUTICAL R&D CO., LTD.
WO/2021/128919APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER  IMMUNE DYSREGULATION DISEASESCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/037244PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/052153APPLICATION OF CYCLIC ADENOSINE MONOPHOSPHATE, DERIVATIVES  THEREOF OR PRODRUGS THEREOF IN PREPARATION OF DRUGS FOR PREVENTING AND/OR  TREATING DEPRESSIVE DISORDERCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/203614PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CORONAVIRUS  DISEASES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFTIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
WO/2021/057391COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKINCARE  PRODUCTS FOR NIGHT OWLSHUNAN YUJIA COSMETICS MANUFACTURING CO., LTD.
WO/2021/037265SIRNA CAPABLE OF INHIBITING EXPRESSION OF MCM7 GENE,  COMPOSITION, AND APPLICATION THEREOFENZHI (GUANGZHOU) PHARMACEUTICALS, LTD.
WO/2021/253643APPLICATION OF SULPHATED POLYSACCHARIDES AGAINST NOVEL  CORONAVIRUSDALIAN POLYTECHNIC UNIVERSITY
WO/2021/043120COMPOUND AMINO ACID DIPEPTIDE INJECTION AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFZHONGSHAN HOSPITAL, FUDAN UNIVERSITY
WO/2021/232614CHITOOLIGOSACCHARIDE ORAL LIQUID AND APPLICATION THEREFOR IN  PREPARATION OF WEIGHT LOSS DRUGSGUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/043145CATIONIC NANODRUG, PREPARATION METHOD THEREFOR, AND  DRUG-LOADED IMPLANTABLE MEDICAL DEVICESHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
WO/2021/093425ROOT OF MEMBRANOUS MILKVETCH-PAECILOMYCES CICADAE FERMENTATIVE  BACTERIUM FERMENTATION SUBSTANCE AND APPLICATION THEREOFBINZHOU MEDICAL UNIVERSITY
WO/2021/047437PHARMACEUTICAL COMPOSITION FOR TREATING VIRAL INFLUENZA AND  PREPARATION THEREOFGUANGDONG RAYNOVENT BIOTECH CO., LTD.
WO/2021/043196USE OF 5-METHYLTETRAHYDROFOLATELIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/212721TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DISPELLING  DAMPNESS AND CLEARING LUNG AND APPLICATION THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208334QI-TONIFYING, DAMPNESS-ELIMINATING AND SORE-THROAT-RELIEVING  DIETARY THERAPY FORMULA, AND PREDATION METHOD THEREFOR AND APPLICATION  THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208335TRADITIONAL CHINESE MEDICINE COMPOSITION CAPABLE OF REMOVING  TOXINS, DISPELLING DAMPNESS, AND DISINHIBITING THROAT, AND APPLICATION  THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208336TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOFGUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/043227COATED GRANULE, SOLID DISPERSION, AND PREPARATION CONTAINING  VORTIOXETINE HYDROBROMIDE FOR ORAL TASTE MASKINGSEASONS BIOTECHNOLOGY (TAIZHOU) CO., LTD.
WO/2021/043231DUAL-TARGETING MATERIAL AND USE THEREOF IN DRUG DELIVERYSHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/043234USE OF BERBAMINE OR ITS ANALOGUE FOR PREVENTING OR TREATING  RNA VIRUS INFECTIONCITY UNIVERSITY OF HONG KONG
WO/2021/253647USE OF SMALL MOLECULE INHIBITOR IN TREATMENT OF RESPIRATORY  VIRAL PNEUMONIAINSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/047451DNA NANOVACCINE, PREPARATION METHOD THEREFOR AND USE THEREOFNATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/047464USE OF 4-[9-(6-AMINOPURINYL)]-2(S)-HYDROXYMETHYL BUTYRATE FOR  PREPARING OPHTHALMIC PREPARATIONSSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/184699MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION AND  PREPARATION METHOD THEREFORSHIJIAZHUANG NO. 4 PHARMACEUTICAL CO., LTD
WO/2021/139193SUSTAINED-RELEASE LONG-LASTING ANTIBACTERIAL HAND SANITIZER  AND PREPARATION METHOD THEREFORZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/139194NANO-SCALE PLANT ANTIBACTERIAL AGENT FOR HAND SANITIZER AND  PREPARATION METHOD THEREFORZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/047573USE OF MEK INHIBITOR IN COMBINATION WITH CDK4/6 INHIBITOR IN  PREPARATION OF DRUGS FOR TREATING TUMORSJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/15970417β-ESTRADIOL AND VITAMIN C MOLECULAR COMPLEX, PREPARATION  METHOD THEREFOR AND APPLICATION THEREOFZHEJIANG MEDICINE CO., LTD.XINCHANG PHARMACEUTICAL FACTORY
WO/2021/047607APPLICATION OF NON-IGF1R-BINDING SUBSTANCE IN PREVENTION  AND/OR TREATMENT OF INFLAMMATORY DISEASESSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/047623TREATMENT OF CANCER USING A COMBINATION COMPRISING  MULTI-TYROSINE KINASE INHIBITOR AND IMMUNE CHECKPOINT INHIBITORBEIGENE, LTD.
WO/2021/047629COMPOSITION FOR LIGHTENING SPOTS, MICRONEEDLE PATCH COMPRISING  COMPOSITION, AND PREPARATION METHOD THEREFORBEIJING CAS MICRONEEDLE TECHNOLOGY LTD.
WO/2021/052269WATER-SOLUBLE COMPOSITION, PREPARATION METHOD AND APPLICATION  THEREOFGUANGDONG HEJI BIOTECH CO., LTD
WO/2021/052274CEFUROXIME AXETIL PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFORSINOPHARM ZHIJUN (SHENZHEN) PHARMACEUTICAL CO., LTD
WO/2021/052305USE OF EIGHT-TREASURE PILL IN PREPARATION OF MEDICINE FOR  PREVENTING OR TREATING DISEASES RELATED TO IL-6 INFLAMMATORY CYTOKINE STORMXIAMEN TRADITIONAL CHINESE MEDICINE CO., LTD.
WO/2021/052386COMBINATION OF SMALL MOLECULE INHIBITOR OF THE PD-1/PD-L1  INTERACTION AND ANTI-PD-1 ANTIBODY FOR TREATING CANCERGUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/052398GEL COMPOSITION WITH HIGH OIL CONTENT, THE PREPARATION METHOD  AND THE USE OF THE SAMEBASF SE
WO/2021/227326COMPOSITIONS AND METHODS FOR TREATING CANCERADAGENE AG
WO/2021/057599APPLICATION OF PIRFENIDONE IN PREPARING MEDICAMENT FOR  PREVENTING AND TREATING RHEUMATOID ARTHRITISSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/052440USE OF CHIGLITAZAR AND DERIVATIVES THEREOF IN TREATING TYPE 2  DIABETES ACCOMPANIED BY ABNORMAL LIPIDS METABOLISMSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/052441USES OF COMPLEX OF ANGIOTENSIN II RECEPTOR ANTAGONIST  METABOLITE AND NEP INHIBITOR IN TREATING HEART FAILURESHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/218004APPLICATION OF PRUSSIAN BLUE NANOPARTICLES IN PREPARATION OF  DRUG FOR PREVENTING, DELAYING OR TREATING NERVOUS SYSTEM DEGENERATIVE DISEASETIANJIN UNIVERSITY
WO/2021/043319TRANSDERMAL PENETRATION ENHANCING COMPOSITION AND APPLICATION  THEREOF IN TIMOLOL PREPARATIONWUHAN CONFORM PHARMACEUTICAL CO., LTD.
WO/2021/052450REVERSED PHASE CHROMATOGRAPHY ISOLATION OF ACTIVE COMPONENT IN  AMNIOTIC FLUID OF NON-HUMAN ANIMALZHEJIANG HYGEIANCELLS BIOMEDICAL CO. LTD
WO/2021/258565APPLICATION OF CARNOSIC ACID IN PREPARATION OF ANTI-PHOTOAGING  PRODUCTSCENTRAL SOUTH UNIVERSITY
WO/2021/103777SPRAYING AGENT FOR PREVENTING AND TREATING ALLERGIC ASTHMA  COMBINED WITH ALLERGIC RHINITIS IN CHILDREN AND TEENAGERSLEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/052496IMMUNE EFFECTOR CELL IN WHICH EXPRESSION IS REGULATED BY  CYTOKINESCARSGEN THERAPEUTICS CO., LTD.
WO/2021/057661PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD SUGARSHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/057680APPLICATION OF 2,4-DIHYDROXYBENZOIC ACID OR ISOMER THEREOF IN  RELATED DISEASES OR CONDITIONS CAUSED BY IRON OVERLOADZHANG, Jianguo
WO/2021/057694LOW-CONTENT FLURBIPROFEN AXETIL PHARMACEUTICAL COMPOSITION,  AND APPLICATION THEREOFBEIJING PODCONLEY MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.
WO/2021/128995WHITENING AND MOISTURIZING HAND MASK AND PREPARATION METHOD  THEREFORGUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/128996NATURAL PLANT BACTERIOSTATIC OINTMENT CONTAINING ARTEMISIA  ARGYI EXTRACT AND PREPARATION METHOD THEREFORGUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/128997NATURAL PLANT EYE SPRAY AND PREPARATION METHOD THEREFORGUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/179567CHINESE MUGWORT LEAF COMPOSITE ESSENTIAL OIL FOR RELIEVING  SORE THROAT AND PREPARATION METHOD THEREFORGUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/057721SPECIFIC ANTIDOTAL DRUG FOR TREATING PARAQUAT ACUTE POISONINGENVIRONMENT AND PLANT PROTECTION INSTITUTE, CHINESE ACADEMY OF  TROPICAL AGRICULTURAL SCIENCES
WO/2021/018318PHARMACEUTICAL COMPOSITION CONTAINING CHIDAMIDE AND SURFACTANTSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/057764USE OF PD-1 ANTIBODY IN COMBINATION WITH TAXOID COMPOUND IN  PREPARATION OF DRUGS FOR TREATING TRIPLE-NEGATIVE BREAST CANCERJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/057881OSELTAMIVIR PREPARATIONSUNSHINE LAKE PHARMA CO., LTD.
WO/2021/169273USE OF ALBIFLORIN IN TREATMENT OF CORONAVIRUS PNEUMONIAZHANG, Zuoguang
WO/2021/057906IMMUNE EFFECTOR CELL EXPRESSING IL-15CARSGEN THERAPEUTICS CO., LTD.
WO/2021/057942GENE-ENGINEERED MESENCHYMAL STEM CELLS AND APPLICATIONS  THEREOFCHINA MEDICAL UNIVERSITY
WO/2021/057955METHOD FOR TREATING MOOD DISORDERSJIANGSU NUO-BETA PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/077990USE OF VITAMIN E COMPOUNDHUIYU HEALTH (HANGZHOU) PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/058005PHARMACEUTICAL COMPOSITION CONTAINING HUMANIZED ANTI-HUMAN  IL-17A MONOCLONAL ANTIBODYHUABO BIOPHARM (SHANGHAI) CO., LTD.
WO/2021/058014ORNIDAZOLE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD  AND USE THEREOFYANGTZE RIVER PHARMACEUTICAL GROUP NANJING HAILING  PHARMACEUTICAL CO., LTD.
WO/2021/063331USE OF COMBINATION OF EZH2 INHIBITOR AND TGF-β  RECEPTOR-CONTAINING FUSION PROTEIN IN PREPARATION OF DRUGS FOR TREATING  TUMORSJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/063332USE OF EZH2 INHIBITOR COMBINED WITH CDK4/6 INHIBITOR IN  PREPARATION OF DRUG FOR TREATING TUMORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/058021DRUG COMBINATION CONTAINING TLR7 AGONISTCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/063340USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT  INHIBITOR AND TYROSINE KINASE INHIBITOR IN PREPARATION OF MEDICATION FOR  TREATING TUMORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/253681FAVIPIRAVIR COMPOSITION AND PREPARATION METHOD THEREOFZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
WO/2021/068802APPLICATION OF NADH AND SALT AND/OR NMN THEREOF IN PREPARATION  OF DRUG OR HEALTH CARE PRODUCT FOR ENHANCING MUSCLE OR INHIBITING MUSCLE  VOLUME REDUCTIONHOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/073426APPLICATION OF NADH AND SALT THEREOF IN PREPARATION OF SKIN  PIGMENT INHIBITORHOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/078000APPLICATION OF NADH AND SALT THEREOF IN PREPARATION OF DRUGS  OR HEALTH FOOD FOR PREVENTING AND TREATING PHARYNGITISHOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/109704CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOFLO, Hsu En
WO/2021/063366DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143208METHOD FOR PREPARING HAND WASH HAVING ULTRA-STRONG  DECONTAMINATION EFFECTZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/143209METHOD FOR PREPARING HAND SANITIZER SUITABLE FOR INFANT SKINZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/063376UV LIGHT-RESPONSIVE HYPERBRANCHED POLY-β-AMINO ESTER HAVING  HIGH-EFFICIENCY GENE DELIVERY ABILITY AND PREPARATION METHOD AND APPLICATION  THEREOFSOOCHOW UNIVERSITY
WO/2021/063384DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT AND  NEUTRAL AMINO ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/103816USE OF UTERINE CAVITY FLUID-DERIVED EXOSOME IN PREPARATION OF  THERAPEUTIC DRUGS AND ADJUVANT THERAPEUTIC AGENTS FOR TREATING  INFERTILITY-RELATED DISEASESPHARCHOICE THERAPEUTICS INC
WO/2021/063387USE OF COMPOSITION OF IMATINIB AND DERIVATIVE THEREOF IN  PREPARATION OF DRUG FOR PREVENTING, TREATING AND CONTROLLING ADDICTION  RELAPSEWUHAN UNIVERSITY
WO/2021/063391CORNU GORAIS KERATIN, PREPARATION METHOD THEREFOR,  PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOFINSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/063408PREPARATION OF DRUG FOR TREATING ALZHEIMER'S DISEASEPLANTARX LIMITED
WO/2021/063414USE OF VALERIC ACID DERIVATIVE IN TREATMENT OF DOWN'S SYNDROMEXIAMEN UNIVERSITY
WO/2021/068868COMBINATION THERAPY FOR CANCERS WITH KRAS MUTATIONCOTHERA BIOSCIENCE, INC.
WO/2021/218039BIOMIMETIC AND CAMELLIA EXTRACT-CONTAINING SKIN BARRIER REPAIR  COMPOSITION AND APPLICATION THEREOFSHANGHAI FOREST CABIN BIOLOGICAL-TECH CO., LTD.
WO/2021/088585PARATHYROID HORMONE 1-34 NASAL SPRAY, PREPARATION METHOD AND  APPLICATION THEREOFACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/068879ANTIBODY COMPLEX MODIFIED BY TARGETED FUNCTIONAL MOLECULE,  COMPOSITION AND USE THEREOFFUDAN UNIVERSITY
WO/2021/027977USE FOR ULVA POLYSACCHARIDE IN SUPPRESSING β-AMYLOID PROTEIN  AGGREGATIONTIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/068890LYSOSOME-TARGETING ANTIBODY-DRUG CONJUGATE AND APPLICATION  THEREOFSUN YAT-SEN UNIVERSITY
WO/2021/082882METHOD FOR ANCHORING AND MODIFYING NANO-DRUG ON SURFACE OF  LIVING CELLCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068909AMERICAN COCKROACH EXTRACT, PREPARATION THEREOF, PREPARATION  METHODS THEREFOR AND APPLICATIONS THEREOFLIANGSHAN JIANENGDA BIOMATERIALS BREEDING CO., LTD.
WO/2021/203648TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING  GINGIVAL ATROPHY AND/OR TREATING GINGIVITISSICHUAN GREEN HERB TECHNOLOGY DEVELOPMENT CO., LTD
WO/2021/068951MEDICAL USE OF BENZENESULFONAMIDE COMPOUND AND PHARMACEUTICAL  COMPOSITION THEREOFCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068957TREATMENT AND PREVENTION OF NEPHROTOXIN-INDUCED KIDNEY  INJURIESFARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/082889ENVIRONMENTALLY-FRIENDLY METHOD OF PREPARING COMPOSITION  CONTAINING ANTI-INFLAMMATORY ACTIVE INGREDIENT AND APPLICATION THEREOFSHANGHAI JAKA BIOTECH CO., LTD.
WO/2021/068961INHALATION SOLUTION PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFORSICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/068971ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY  FOR TREATMENT OF CD20 POSITIVE DISEASESBIO-THERA SOLUTIONS, LTD.
WO/2021/073518USE OF INHIBITOR OF PLASMIN INHIBITORY FACTOR FOR PREVENTING  OR TREATING PRE-ECLAMPSIA OR ECLAMPSIAINSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/073535METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH  ADMINISTRATION OF VEGFR AND/OR VEGF INHIBITORONQUALITY PHARMACEUTICALS CHINA LTD.
WO/2021/073547APPLICATION OF BORTEZOMIB IN PREPARATION OF DRUGS FOR  TREATMENT OF OSTEOSARCOMAXI'AN JIAOTONG UNIVERSITY
WO/2021/073548PHARMACEUTICAL COMPOSITIONSUNSHINE LAKE PHARMA CO., LTD.
WO/2021/073563COMPOSITION AND METHOD FOR TREATMENT OF DIABETESSHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/103833MOLECULARLY IMPRINTED POLYMERS FOR SEQUESTERING ACETATE AND  OTHER MOLECULESCLAVES LIFE SCIENCES LIMITED
WO/2021/073586DECOQUINATE LIPOSOME, PREPARATION METHOD THEREFOR AND USE  THEREOFBLUELIGHT PHARMATECH CO ., LTD
WO/2021/073610METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW  HEMATOPOIETIC FUNCTIONSSUN YAT-SEN UNIVERSITY
WO/2021/073620USE OF ACELLULAR ADIPOSE TISSUE EXTRACT IN PROMOTING HAIR  GROWTH AND RETENTIONSHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/232667STARCH-BASED COLON-TARGETING CONTROLLED-RELEASE CRYSTAL  INCLUSION COMPLEX AND PREPARATION METHOD THEREFORSOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/078087TRADITIONAL CHINESE MEDICINE PILL REALIZING TARGETED RELEASE,  AND PREPARATION METHOD THEREFORRONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD.
WO/2021/073643DRUG FOR TREATING NON-ALCOHOLIC STEATOHEPATITISCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135520SUNFLOWER SEED COMPOSITION RICH IN PLEASANT HORMONE PRECURSOR  AND ANTIDEPRESSANT USE THEREOFCHACHA FOOD CO., LTD.
WO/2021/078110DRUG COMBINATION FOR PREVENTING OR TREATING IRRITABLE BOWEL  SYNDROMEGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/078126METHOD FOR TREATING CANCERSACURA NANOMEDICINE CORPORATION
WO/2021/174868CHLORIN NANOMETER PHOTOSENSITIZER, AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSOOCHOW UNIVERSITY
WO/2021/143243USE OF IGF1 IN COMBINATION WITH IGF1EC24 IN PREPARATION OF  MEDICINE FOR PROMOTING TISSUE REPAIR AND REGENERATIONCHONGQING UNIVERSITY
WO/2021/088645CRYSTAL FORM OF APROCITENTAN, PREPARATION METHOD THEREFOR AND  USE THEREOFCRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/243925APPLICATION OF ZIF-8 NANO MATERIAL IN DEGRADATION OF  BROAD-SPECTRUM MUTANT P53 PROTEINSOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/179616NOVEL USE OF XIAOCHAIHU GRANULES IN COMBINATION WITH  CHLOROQUINE PHOSPHATEGUANGZHOU BAIYUNSHAN GUANGHUA PHARMACEUTICAL CO., LTD
WO/2021/078246PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS,  KIT, USE THEREOF AND TREATMENT METHOD THEREOFSHENZHEN MYTANG BIOTECHNOLOGY CO., LTD.
WO/2021/093553NOVEL THERAPEUTIC DRUG FOR ISCHEMIC BRAIN DAMAGECENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/078252USE OF LIRIODENDRON CHINENSE (HEMSL.) SARG OR EXTRACT THEREOF  IN PREPARATION OF MEDICINE FOR REDUCING SERUM URIC ACID LEVEL AND PREVENTING  AND TREATING URIC ACID NEPHROPATHYSICHUAN CREATION PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/078288ACTIVATED INSULIN, COMPOUND MOMORDICA CHARANTIA PEPTIDE ORAL  MEDICINE FOR TREATMENT OF DIABETES, AND PREPARATION METHODLI, Yubao
WO/2021/078295BOTANICAL MEDICINE FOR TREATING HYPERLIPIDEMIA AND CORONARY  HEART DISEASE AND METHOD FOR PREPARATION THEREOFGUOZHONGXINGHE BIOMEDICINE TECHNOLOGY CO., LTD.
WO/2021/058038USE OF CD200 PROTEIN AND CD200 FUSION PROTEIN IN PREPARING A  DRUG FOR TREATING PSORIASISCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/088672COMPOSITION CONTAINING LEGOAMODIPINE BESYLATE HYDRATE AND  PREPARATION METHOD THEREFORSHIHUIDA PHARMACEUTICALS GROUP (JILIN) LTD.
WO/2021/078301PROTEIN DEGRADING AGENT AND USE THEREOF IN TREATMENT OF  DISEASESSHANGHAITECH UNIVERSITY
WO/2021/083089PHARMACEUTICAL COMPOSITION CONTAINING ALGINATE OLIGOSACCHARIDE  DIACIDSHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/258590APPLICATION OF β-GLUCAN AS ADHESIVE IN PREPARATION OF TABLET  OR GRANULEYICHUN WANSHEN PHARMACEUTICAL MACHINERY CO. LTD
WO/2021/114909PHOTODYNAMIC THERAPY SYSTEM, PREPARATION METHOD THEREFOR, AND  USE THEREOF IN PHOTODYNAMIC THERAPYSHENZHEN HANGUANG TECHNOLOGY CO., LTD.
WO/2021/169345METHOD AND APPLICATION FOR IMPROVING MITOCHONDRIAL FUNCTION OF  PERIPHERAL BLOOD MONONUCLEAR CELLSINSTITUTE OF ENVIRONMENTAL AND OPERATIONAL MEDICINE, ACADEMY  OF MILITARY MEDICAL SCIENCE, ACADEMY OF MILITARY SCIENCE
WO/2021/184762GOLD CLUSTERS (AuCs), COMPOSITION AND METHOD FOR TREATMENT OF  LIVER CIRRHOSISWUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/243932USE OF PHOSPHATIDYLSERINE IN PREPARATION OF DRUG FOR TREATING  INFLAMMATORY BOWEL DISEASEJIANGSU TARGET BIOMEDICAL RESEARCH INSTITUTE CO. , LTD.
WO/2021/083290RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN INHIBITOR  COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF RSV DISEASES  USING THE SAMESHANGHAI ARK BIOPHARMACEUTICAL CO. LTD.
WO/2021/083306GLP-1/GCG DUAL-ACCEPTOR AGONIST POLYPEPTIDEDONGGUAN HEC BIOPHARMACEUTICAL R&D CO., LTD.
WO/2021/083315ORALLY ADMINISTERED SOLID DOSAGE FORM DRUGASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/083336USE OF BILE ACIDS AND DERIVATIVES THEREOF IN PREPARATION OF  GPR39 AGONISTPEKING UNIVERSITY
WO/2021/083346PHARMACEUTICAL COMPOSITION COMPRISING QUINAZOLINE DERIVATIVE  OR SALT THEREOFCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/088739METHOD AND DEVICE FOR DETERMINING INTESTINAL PROBIOTIC  SUPPLEMENT FORMULA, STORAGE MEDIUM, AND PROCESSORSHENZHEN DIGITAL LIFE INSTITUTE
WO/2021/083370PREPARATION AND USE OF NANOMATERIAL SPECIFICALLY ACTIVATING  IMMUNE SYSTEMSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/083372SOLID COMPOSITION CONTAINING ANGIOTENSIN II, PREPARATION  METHOD AND USE METHOD THEREFOR AND USE THEREOFNANJING HAIWEI PHARMACEUTICAL TECHNOLOGIES CO., LTD.
WO/2021/109771METHOD FOR PREPARING MICROPOWDER MIXTURE OF ACTIVE  PHARMACEUTICAL INGREDIENTS OF GLYCOPYRRONIUM BROMIDE AND INDACATEROLCF PHARMTECH, INC.
WO/2021/129160NANOCONJUGATE OF PEGYLATED ICD INDUCER-IDO INHIBITOR,  PREPARATION METHOD THEREFOR, AND APPLICATION THEREOFSHANDONG UNIVERSITY
WO/2021/208410SKIN WHITENING, FIRMING AND MOISTURIZING FACE CREAM AND  PREPARATION METHOD THEREFORYUHUAN ZITI COSMETICS CO., LTD.
WO/2021/208411WHITENING MOISTURIZING FACE MASK IN FORM OF PASTE, AND  PREPARATION METHOD THEREFORYUHUAN ZITI COSMETICS CO., LTD.
WO/2021/093632ACTIVE ESSENCE COMPOUNDED WITH POSTBIOTICS AND PREPARATION  METHODBIO-RACE BIOTECH HANGZHOU CO., LTD.
WO/2021/129166APPLICATION OF MONASCINOL IN PREPARATION OF FAT-REDUCING  PRODUCTTIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/088846FGFR4/PD-1 COMBINATION TREATMENTSCSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/088853DRUG COMBINATION OF QUINOLINE DERIVATIVE AND PD-1 MONOCLONAL  ANTIBODYCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/174894NANOBOWL-SUPPORTED DRUG-LOADED LIPOSOME, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFSHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/088927ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2LANOVA MEDICINES LIMITED COMPANY
WO/2021/088957AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOFGUANGZHOU HENOVCOM BIOSCIENCE CO. LTD
WO/2021/109796ANTI-TUMOR DRUG SENSITIZER EMPLOYING  5-CARBOXY-8-HYDROXYQUINOLINE, AND APPLICATION THEREOFZHEJIANG UNIVERSITY
WO/2021/088975USE OF COMPOUND IN PREVENTING OR TREATING GRAFT VERSUS HOST  DISEASESHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/0889837,8-DIHYDROXYFLAVONE COMPOSITE NANO-BIOMATERIAL WITH HIGH  BIOAVAILABILITY, PREPARATION METHOD, AND APPLICATION THEREOFHANGZHOU U-MATE TECHNOLOGY CO., LTD.
WO/2021/089005USE OF FGFR INHIBITORCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/089038USE OF MULTI-TARGET PROTEIN KINASE INHIBITORCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/143313ACTIVE GENE MODIFIED PORCINE SKIN FOR COVERING AND REPAIRING  HUMAN SKIN WOUNDS AND USE THEREOFGENEO MEDICINE CO., LTD.
WO/2021/089053NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION,  AND PREPARATION AND USE THEREOFSHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/227405ETAMSYLATE INJECTION AND PREPARATION METHOD THEREFORSHANDONG FANGMING PHARMACEUTICAL GROUP CO., LTD
WO/2021/135654USE OF DISULFIRAM IN PREPARATION OF MEDICAMENT FOR PREVENTION  AND TREATMENT OF DISEASES RELATED TO NLRP3 INFLAMMASOMEGUANGZHOU MEDICAL UNIVERSITY
WO/2021/098557TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  PSORIASIS, PREPARATION METHOD THEREFOR AND USE THEREOFTASLY PHARMACEUTICAL GROUP CO., LTD.
WO/2021/258614VAGINAL GEL PREPARATION AND PREPARATION METHOD THEREFORZHUHAI SHU TONG MEDICAL TECHNOLOGY CO., LTD.
WO/2021/093764PHARMACEUTICAL COMBINATION AND USE THEREOFCSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/109823CANNABINOID NANOMICELLE PREPARATION AND METHOD FOR PREPARING  SAMEHANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/135665APPLICATION OF TETRAHYDROCANNABIVARIN IN PREVENTION AND/OR  TREATMENT OF PULMONARY ARTERIAL HYPERTENSIONHANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/104034USE OF 4-HYDROXYBENZALDEHYDE IN TREATING INFLAMMATORY BOWEL  DISEASEMEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT  CENTER
WO/2021/120937APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING  DROPTONGYAN (SHANGHAI) MEDICAL DEVICE CO., LTD.
WO/2021/196628NATURAL EDIBLE SHAMPOO AND PREPARATION METHOD THEREFORNINGBO YUFANGTANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD.
WO/2021/098606LIPID NANO DRUG DELIVERY SYSTEM TARGETING BRAIN LESION AND  PREPARATION METHOD AND APPLICATION THEREOFSHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/135682MICROBUBBLE DISPERSION SYSTEM USED FOR EFFICIENTLY SUPPLYING  OXYGEN TO VEINS AND STABILIZED BY POLYDOPAMINE NANOPARTICLES AND PREPARATION  METHOD FOR MICROBUBBLE DISPERSION SYSTEMZHEJIANG UNIVERSITY
WO/2021/223397TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL  CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOFBEIJING HANDIAN PHARMACEUTICAL CO., LTD.
WO/2021/093864USE OF HETEROLOGOUS TISSUE CELL COMPOSITION FOR TREATING  CANCERSCHINA MEDICAL UNIVERSITY
WO/2021/098621IMMUNOADJUVANT-ENCAPSULATED NANOPARTICLE AND USE THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/093881COMPOSITION FOR REGULATING IMMUNE RESPONSE IN ACIDIC  ENVIRONMENT, AND PREPARATION METHOD THEREFOR AND USE THEREOFSHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD.
WO/2021/104086METHOD FOR OVERCOMING TUMOR DRUG RESISTANCESHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/104088NANOPARTICLE DRUG DELIVERY SYSTEM, PREPARATION METHOD THEREFOR  AND USE THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/203701APPLICATION OF SOFOSBUVIR IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING CORONAVIRUSSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203702USE OF PYROGLUTAMIC ACID IN PREPARATION OF DRUGS FOR  PREVENTING AND TREATING NOVEL CORONAVIRUS OF NOVEL CORONAVIRUS PNEUMONIASHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203703USE OF CARGLUMIC ACID IN PREPARATION OF DRUGS FOR PREVENTING  AND TREATING CORONAVIRUSESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203704USE OF BACITRACIN A IN PREPARATION OF DRUGS FOR PREVENTING AND  TREATING CORONAVIRUSESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203706USE OF FOSCARNET SODIUM IN PREPARATION OF MEDICINES FOR  PREVENTING AND TREATING CORONAVIRUSESSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/098679USE OF FAK INHIBITOR IN PREPARATION OF DRUG FOR TREATING  TUMORS HAVING NRAS MUTATIONINXMED (NANJING) CO., LTD.
WO/2021/164344TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF IN  PREVENTION AND TREATMENT OF VIRAL PNEUMONIAGUANGZHOU EIGHTH PEOPLE'S HOSPITAL
WO/2021/227417METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHYTALENGEN INTERNATIONAL LIMITED
WO/2021/098686PREPARATION METHOD FOR THERAPEUTIC DRUG DELIVERY SYSTEM  CAPABLE OF CROSSING BLOOD-BRAIN BARRIER AND SPECIFICALLY TARGETING GLIOMASHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/098688LIVING ORGANISM OXYGEN SELF-PRODUCING PHOTOSENSITIZER AND USE  THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/104112NOVEL METHOD FOR IMPROVING TUMOR HYPOXIASHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/115070INDOCYANINE GREEN LIPOSOME FOR NEAR-INFRARED REGION II  FLUORESCENCE DETECTION, PREPARATION METHOD THEREFOR AND USE THEREOFSHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/098692APPLICATION OF CHERRY PLUM PRODUCT IN INHIBITING THROMBOSISZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/104120POLYETHYLENE GLYCOL CONJUGATE MEDICAMENT, PREPARATION METHOD  THERFOR AND USE THEREOFCHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/120966SHEEP HORN KERATIN, PREPARATION METHOD THEREFOR,  PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOFINSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/098755NEW APPLICATION OF BIFIDOBACTERIUM LACTIS BL-99 IN INHIBITING  INTESTINAL INFLAMMATIONINNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.
WO/2021/196654USE OF GLYCOSYL POLYETHER COMPOUND IN PREPARATION OF ANTI-RNA  VIRUS DRUGSWUHAN UNIVERSITY
WO/2021/184807COPPER CLUSTERS, COMPOSITION, AND METHOD FOR TREATMENT OF  LIVER CIRRHOSISWUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/098769TREATMENT OF CANCER WITH ANTI-OX40 ANTIBODIES AND MULTI-KINASE  INHIBITORSBEIGENE, LTD.
WO/2021/098771TREATMENT METHOD WITH IAP INHIBITORASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/120972TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  DEFICIENCY OF BOTH QI AND BLOOD, PREPARATION METHOD THEREFOR AND USE THEREOFSICHUAN NEO-GREEN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO.,  LTD
WO/2021/098791TRANSDERMAL PATCH CONTAINING MEMANTINECHENGDU KANGHONG PHARMACEUTICAL CO.LTD.
WO/2021/232717CONJUGATE CONTAINING MONO-PHOSPHORYLATED LIPID A AND  GLYCOANTIGEN, AND PREPARATION METHOD THEREFOR AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/232718CONJUGATE AND PREPARATION METHOD THEREFOR AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/232719CONJUGATE CONTAINING α-GALACTOSYL CERAMIDE ANALOGUE AND  CARBOHYDRATE ANTIGEN AND PREPARATION METHOD THEREFOR AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE(GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/104155HYDROGEL TABLET FOR DISPELLING EFFECT OF ALCOHOL AND  PROTECTING LIVER, AND PREPARATION METHOD THEREFOR AND USE THEREOFGUANGDONG OCEAN UNIVERSITY
WO/2021/109879COMPOSITION HAVING WHOLESOME PERSONALIZED INTESTINAL FLORA  DIVERSITY FUNCTION AND APPLICATIONNII, Keni
WO/2021/196659GLYCOSYL POLYETHER COMPOUND LIPOSOME, PREPARATION METHOD  THEREFOR AND MEDICINE THEREOFWUHAN UNIVERSITY
WO/2021/109880PHARMACEUTICAL COMPOSITION, COMPLEMENTARY KIT AND APPLICATION  THEREOFSHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
WO/2021/098826USE OF ALBIFLORIN OR PAEONIFLORIN IN THE PREVENTION AND/OR  TREATMENT OF RENAL ANEMIAZHANG, Zuoguang
WO/2021/115100NOVEL USE OF SULFORAPHANE AND PHARMACEUTICAL COMPOSITION  COMPRISING SAMEZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/098874HAIR CARE COMPOSITION AND PREPARATION METHOD THEREFORBIORIGHT WORLDWIDE COMPANY LIMITED.
WO/2021/196666USE OF HOMOHARRINGTONINE IN PREPARATION OF HUMAN BODY  BETA-CORONAVIRUS REPLICATION INHIBITORSUN YAT-SEN UNIVERSITY
WO/2021/104213APPLICATION OF FU TEA EXTRACT IN PREPARING ANTIFUNGAL DRUGPHARCHOICE THERAPEUTICS INC
WO/2021/104214USE OF EXOSOME DERIVED FROM CARCASS IN SKIN REGULATION PRODUCTPHARCHOICE THERAPEUTICS INC
WO/2021/218129COPPER @ RHUBARB ANTHRAQUINONE METAL ORGANIC FRAMEWORK  COMPOSITE AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF CHINESE MEDICINE)
WO/2021/104253IBUPROFEN PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOFSHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/104276USES OF FU TEA EXTRACT IN PREPARING SKIN-CONDITIONING PRODUCTPHARCHOICE THERAPEUTICS INC
WO/2021/104319COMBINED PHARMACEUTICAL COMPOSITION OF QUINAZOLINE DERIVATIVE  OR SALT THEREOF AND USE THEREOFCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104340SUBSTITUTED CROTONAMIDE PHARMACEUTICAL COMPOSITION AND  PREPARATION METHOD THEREFORJIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104341APPLICATION OF SUBSTITUTED CROTONAMIDEJIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104363COMPOSITION CONTAINING AROMATIC HETEROCYCLIC COMPOUND IN  AMORPHOUS FORM, AND PREPARATION METHOD THEREFOR AND USE THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/104371ANTIBODIES TO CD3 AND BCMA, AND BISPECIFIC BINDING PROTEINS  MADE THEREFROMSHANGHAI EPIMAB BIOTHERAPEUTICS CO., LTD.
WO/2021/109924USE OF MYRICETIN IN THE PREPARATION OF SALMONELLA TYPE Ⅲ  SECRETION SYSTEM INHIBITORJILIN UNIVERSITY
WO/2021/104442METHOD AND COMPOSITIONS FOR PREDICTING ANTI-CANCER EFFICACY OF  COMPOUNDS TARGETING APOPTOSIS PATHWAYASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/104454USE OF BI853520 IN CANCER TREATMENTINXMED (NANJING) CO., LTD.
WO/2021/104460PREPARATION METHOD FOR PALIPERIDONE PALMITATE SUSPENSIONNHWA PHARMA. CORPORATION
WO/2021/258642USE OF GCS INHIBITOR IN PREPARING DRUG FOR TREATING COCAINE  ADDICTIONWEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/104487COMPOSITION INCLUDING RILPIVIRINE AND USE THEREOF FOR TREATING  TUMORS OR CANCERAPTORUM THERAPEUTICS LIMITED
WO/2021/109945WEAKLY ACIDIC DERIVATIVE OF POORLY SOLUBLE DRUG, AND LIPOSOME  PREPARATION THEREOFSHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/104511APPLICATION OF CAR T-CELLS IN PREPARING DRUG FOR TREATING  CANCERSUZHOU NOVA THERAPEUTICS CO. LTD
WO/2021/109970XANTHINE DERIVATIVE PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFORCHENGDU EASTON BIOPHARMACEUTICALS CO., LTD
WO/2021/258643SOAP/AMINO ACID-TYPE FACIAL CLEANSING PRODUCT AND PREPARATION  METHOD THEREFORHUNAN YUJIA COSMETICS MANUFACTURING CO., LTD.
WO/2021/110049APPLICATION OF MANGANESE-TYPE HIGH-STABILITY SUPEROXIDE  DISMUTASE IN PREVENTION OR TREATMENT OF STROKECARRY HEALTH BIOPHARMACEUTICALS (HANGZHOU) CO., LTD.
WO/2021/121038EXOSOME FORMULATION FOR TREATING DRUG-RESISTANT BACTERIAL  INFECTIONSNANJING UNIVERSITY
WO/2021/110064NEW MULTI-FUNCTIONAL OLIGOPEPTIDESJIANGYIN USUN BIOCHEMICAL TECHNOLOGY CO., LTD.
WO/2021/110071METHODS FOR INDUCING INTERMITTENT FASTING AND MODULATING  AUTOPHAGYTHE HONG KONG POLYTECHNIC UNIVERSITY
WO/2021/110073PHARMACEUTICAL COMPOSITION CONTAINING ELEMENE, PREPARATION  METHOD THEREFOR, AND USE THEREOFCHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135798APPLICATION OF MULBERROSIDE A AND DERIVATIVES THEREOF IN  PREPARATION OF DRUGS FOR PROTECTING INTESTINAL BARRIERNANJING UNIVERSITY
WO/2021/110097N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2  INHIBITORSASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/129340TANDOSPIRONE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOFSICHUAN CREDIT PHARMACEUTICAL CO., LTD
WO/2021/110105USE OF NEUREGULIN-1 IN PREPARATION OF PRODUCT FOR ENHANCING  TRPC6 CHANNEL ACTIVITYGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU RESEARCH  INSTITUTE OF CHINESE MEDICINE)
WO/2021/253742APPLICATION OF WUBI CHINESE YAM PILLS IN PREPARATION OF DRUG  FOR TREATMENT OF PREMATURE OVARIAN INSUFFICIENCYHANGZHOU HUQINGYUTANG PHARMACEUTICAL CO., LTD.
WO/2021/110120ANTI-TUMOR VACCINE MOLECULE, PREPARATION METHOD THEREFOR AND  USE THEREOFCENTRAL CHINA NORMAL UNIVERSITY
WO/2021/110121HDAC6 SELECTIVE INHIBITOR AND COMBINATION THERAPY THEREOFCSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/110127METHOD OF TREATING INFLAMMATORY BOWEL DISEASECHEER GLOBAL LIMITED
WO/2021/110134THREE-LAYER HAIR CARE COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFGUANGZHOU UNIASIA COSMETIC TECHNOLOGY CO., LTD.
WO/2021/110136PHARMACEUTICAL COMBINATION AND USE THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/218154DRUG, FOOD AND APPLICATION OF ANTI-CORONAVIRUS INFECTIONGUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/110148SIRNA CONJUGATE, DOUBLE-STRANDED SIRNA CONJUGATE, SALT THEREOF  AND APPLICATION THEREOFMEDSHINE DISCOVERY INC.
WO/2021/212858APPLICATION OF HETEROCYCLIC COMPOUND CONTAINING AT LEAST TWO  SULFUR ATOMS IN PREPARING NANO-VACCINE AND PREPARED NANO-VACCINEFUZHOU UNIVERSITY
WO/2021/110164LIQUID PREPARATION CONTAINING ANTI-IL-17 ANTIBODYLIVZON MABPHARM INC.
WO/2021/143392DRUG FOR REGULATING IMMUNE FUNCTION OR TREATING IMMUNE-RELATED  DISEASESSHENZHEN YUANJIAN LIFE TECHNOLOGY CO., LTD.
WO/2021/129362USE OF AMHR2 RECOMBINANT PROTEIN OR FUSION PROTEIN IN  PREPARATION OF DRUGS FOR TREATING AMH SIGNAL AXIS ABNORMAL ACTIVATION RELATED  DISEASESPHARCHOICE THERAPEUTICS INC
WO/2021/258654SILVER ION ANTIBACTERIAL HAND SANITIZER, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFGUANGZHOU HWASUEN HEALTH INDUSTRY CO., LTD
WO/2021/110173LIPOSOME FORMULATION OF FLUTICASONE PROPIONATEANOVENT PHARMACEUTICALS CO., LTD
WO/2021/253746USE OF DALBAVANCIN IN PREPARATION OF MEDICAMENT FOR INHIBITING  BINDING OF SARS-COV-2 TO ACE2KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/115272CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION  THEREOFBEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD.
WO/2021/121082SCAVENGER RECEPTOR-A TARGETED DRUG CARRIER, AND PREPARATION  METHOD AND APPLICATION THEREOFSICHUAN UNIVERSITY
WO/2021/115321PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATIONREMEGEN CO., LTD.
WO/2021/212865COMPOUND ALLICIN SOFT CAPSULE AND METHOD FOR PREPARING AND  PACKAGING SAMEGUANGZHOU HONGKANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/115389FULVESTRANT PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFSHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/169484NANOVACCINE AND PREPARATION METHOD THEREFORZHEJIANG UNIVERSITY
WO/2021/115408PHARMACEUTICAL COMPOSITION AND USE THEREOFJIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115409PHARMACEUTICAL COMPOSITION AND USE THEREOFJIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115410IMMUNOSTIMULATORY COMPOSITION AND USE THEREOFJIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115412USE OF NITRIC OXIDE SYNTHASE PATHWAY INHIBITOR IN PREPARATION  OF MEDICINEZHUJIANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY
WO/2021/115415METHODS FOR TREATING BACTERIAL INFECTIONSMICROBIOTA I - CENTER (MAGIC) LIMITED
WO/2021/115425PHARMACEUTICAL COMPOSITION CONTAINING BPI-7711 AND PREPARATION  METHOD THEREOFBETA PHARMA (SUZHOU) , LTD.
WO/2021/115426ANTI-CLAUDIN ANTIBODY-DRUG CONJUGATE AND PHARMACEUTICAL USE  THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/073659VACCINE VECTOR PREPARED ON BASIS OF ANIONIC POLYMERS AND  DERIVATIVES THEREOFSICHUAN UNIVERSITY
WO/2021/073660LYOPHILIZED PREPARATION OF VACCINE CONTAINING ALUMINUM  ADJUVANT AND PREPARATION METHOD AND USE THEREFORSICHUAN UNIVERSITY
WO/2021/258668METHOD FOR PREPARING P/H MICROSPHERES WITH HYDROPHOBIC SOLID  POWDER WRAPPED THEREINZHEJIANG UNIVERSITY
WO/2021/196734CONTROLLED-RELEASE BRIVARACETAM PREPARATION AND PREPARATION  METHOD THEREFORJIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/244004ZEOLITE ENERGY MASK AND PREPARATION METHOD THEREFORJIANGSU FULE BIOLOGICAL ENVIRONMENTAL PROTECTION TECHNOLOGY  CO., LTD
WO/2021/164399APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONJIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/227493USE OF FGF21 IN PREPARATION OF MEDICINE FOR TREATING  COLORECTAL CANCERJIANGNAN UNIVERSITY
WO/2021/121277A METHOD AND COMPOSITION FOR TREATMENT OF A CANCERTUAN, Mei-Nan
WO/2021/164401USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION  OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONJIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/135980SOLVENT SYSTEM CAPABLE OF EFFECTIVELY DISSOLVING ORNIDAZOLE OR  LEVORNIDAZOLE, AND APPLICATION THEREOFCHONGQING DIANSUO MEDICAL TECHNOLOGY CO., LTD
WO/2021/121366LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTSALAR PHARMACEUTICALS INC.
WO/2021/258683APPLICATION OF BERBERINE-ORYZANOL TABLET IN TREATMENT OF  DIABETESYICHUN WANSHEN PHARMACEUTICAL MACHINERY CO., LTD
WO/2021/121387APPLICATION OF COMPOUND IN DRUG PREPARATIONMEDSHINE DISCOVERY INC.
WO/2021/121388TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  EGFR-TKIS RELATED SKIN RASH AND USE THEREOFYANGTZE RIVER PHARMACEUTICAL GROUP GUANGZHOU HAIRUI  PHARMACEUTICAL CO., LTD.
WO/2021/232777AEROSOLYUNNAN HEMPSON BIO-TECH CO., LTD.
WO/2021/129600JAK KINASE INHIBITOR PHARMACEUTICAL COMPOSITIONJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/129616PHARMACEUTICAL COMBINATION OF ANTI-PD-1 ANTIBODY AND HISTONE  DEACEYLASE INHIBITOR, USE THEREOF, AND USAGE METHOD THEREFORINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/129635SUSTAINED-RELEASE DRUG DELIVERY SYSTEMNANJING DELOVA BIOTECH CO. LTD.
WO/2021/129649USE OF α-KETOGLUTARATE IN PREPARATION OF DRUGTONGJI UNIVERSITY
WO/2021/129658APPLICATION OF FUSION PROTEIN IN TREATING AGE-RELATED MACULAR  DEGENERATIONINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/129673ANTI-CSF1R MOLECULES AND USE THEREOFADAGENE (SUZHOU) LIMITED
WO/2021/129678CONJUGATE WITH RADIATION-RESPONSIVE GROUP AND USE THEREOFPEKING UNIVERSITY
WO/2021/129735SOLID PREPARATION, AND PREPARATION METHOD THEREFOR AND USE  THEREOFSINOTHERAPEUTICS INC.
WO/2021/129744COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND  CANCERS BY TARGETING IGSF8SHANGHAI XBH BIOTECHNOLOGY CO., LTD.
WO/2021/129775ANTI-CTLA-4 MONOCLONAL ANTIBODY, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOFBIO-THERA SOLUTIONS, LTD.
WO/2021/129796EASILY CLEANSING MAKEUP BASE COSMETIC FOR SKINSHISEIDO COMPANY, LTD.
WO/2021/143485CURCUMIN COMPLEX, PREPARATION METHOD THEREFOR AND DETECTION  METHOD THEREFORCHENLAND NUTRITIONALS INC.
WO/2021/136089ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND METHOD FOR  INCREASING SOLUBILITY OF COMPOUNDBEIJING KONRUNS PHARMACEUTICAL CO., LTD.
WO/2021/212892BROAD-SPECTRUM ANTIVIRAL DRUG AND USE THEREOFMETHYCURE BIOTECH CORP.
WO/2021/136169FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND  APPLICATION IN SOFT CAPSULESIRIO PHARMA CO., LTD.
WO/2021/136226APPLICATIONS OF IMINOSTILBENE IN TERMS OF PREVENTING AND  TREATING CARDIAC CEREBRAL ISCHEMIA/REPERFUSION INJURYCHINESE ACADEMY OF MEDICAL SCIENCES INSTITUTE OF MEDICINAL  PLANT DEVELOPMENT
WO/2021/136262TWO-DIMENSIONAL NANO COMPOSITE MATERIAL, PREPARATION METHOD  THEREFOR AND USE THEREOFNINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING,  CHINESE ACADEMY OF SCIENCES
WO/2021/136274FORMULATION CONTAINING ANTI-TROP2 ANTIBODY-DRUG CONJUGATE AND  PREPARATION METHOD AND APPLICATION THEREOFBIO-THERA SOLUTIONS, LTD.
WO/2021/136275MULTI-STAGE FAT-PROTECTING SKINCARE COMPOSITION FOR PROTECTING  SKIN BARRIER OF INFANTSLUNALER HEALTH TECHNOLOGY (GUANGZHOU) CO LTD
WO/2021/136381PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE  TABLET, PREPARATION METHOD THEREFOR AND USE THEREOFJIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/184918USE OF EPHB4 AS TARGET IN SCREENING OF DRUGS OR MODELS FOR  INCREASING INSULIN SENSITIVITYINSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/136405ANTI-INFECTION USE OF CLASS OF THIAZOLE-CONTAINING COMPOUNDSINSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/136488CRYSTAL FORM OF PYRIDOPYRIMIDINE DERIVATIVE AND PREPARATION  METHOD THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/136492GASTRIC RETENTION TABLETGUANGZHOU BOSTAL DRUG DELIVERY CO., LTD.
WO/2021/136494GASTRIC RETENTION TABLETGUANGZHOU BOSTAL DRUG DELIVERY CO., LTD.
WO/2021/136507PHARMACEUTICAL COMPOSITION OF DIPEPTIDYL PEPTIDASE-4  INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOFCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/253803PREPARATION METHOD FOR FIRE-PURGING TABLETHAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.
WO/2021/136513METHOD FOR PREPARING PH-RESPONSIVE INTESTINE-TARGETED ACTIVE  FACTOR TRANSPORTATION SYSTEM BASED ON ANIONIC SODIUM ALGINATEDALIAN POLYTECHNIC UNIVERSITY
WO/2021/136520NEW METHOD FOR TARGETED EDITING OF RNAEDIGENE INC.
WO/2021/136523PHARMACEUTICAL COMBINATION FOR TREATING TUMORS AND APPLICATION  THEREOFFUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD
WO/2021/174995USE OF JQ-1 IN PREPARATION OF MEDICINE FOR TREATING PANCREATIC  CANCER AND METHOD FOR VERIFYING INHIBITION OF JQ-1 ON EXOSOME SECRETION OF  PANCREATIC CANCERAFFILIATED HOSPITAL OF NANTONG UNIVERSITY
WO/2021/196808NOVEL THERAPEUTIC VACCINE AGAINST NOVEL CORONAVIRUS,  PREPARATION METHOD THEREFOR, AND USE THEREOFHANGZHOU XINGAO BIOTECHNOLOGY CO., LTD
WO/2021/253807ANTI-NOVEL CORONAVIRUS COMPLEX AND PREPARATION METHOD THEREFORHANGZHOU XINGAO BIOTECHNOLOGY CO., LTD
WO/2021/136541APPLICATION OF A REAGENT DOWN-REGULATING CIRCULAR GENE  EXPRESSION IN PREPARATION OF A DRUG TO PREVENT AND/OR TREAT PULMONARY  FIBROSIS, AND DRUGBINZHOU MEDICAL UNIVERSITY
WO/2021/203769USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF DRUGS FOR TREATING  ACRAL LENTIGINOUS MELANOMAJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244027APPLICATION OF COBRA POSTSYNAPTIC NEUROTOXIN IN TREATMENT OF  DISEASES RELATED TO INFLAMMATORY CYTOKINE OVEREXPRESSIONSHEN, Zhejing
WO/2021/203779COMPOUND FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION, AND  APPLICATION THEREOFEAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/136549APPLICATION OF CINEPAZIDE MALEATE IN PREPARATION OF DRUGS FOR  PREVENTION AND TREATMENT OF STROKEBEIJING SIHUAN PHARMACEUTICAL CO., LTD.
WO/2021/139642PROGRAMMED CELL DEATH RECEPTOR 1 ANTIBODY FORMULATION AND USE  THEREOFSHANGHAI HENLIUS BIOTECH, INC.
WO/2021/139661APPLICATION OF GENE EXPRESSION INHIBITOR POU2F1 IN PREPARATION  OF DRUG FOR TREATING TISSUE FIBROSIS DISEASESPEKING UNIVERSITY THIRD HOSPITAL
WO/2021/139697APPLICATION OF SUPERNATANT OF TUMOR CELLS AFTER ACTION OF  CHEMOTHERAPEUTIC DRUGZHUKANG BIOTECHNOLOGY CO. , LTD.
WO/2021/159892HEMOSTATIC AGENT FOR CENTRAL HEMANGIOMA HEMORRHAGE OF JAW,  PREPARATION METHOD THEREFOR AND USE THEREOFNANTONG UNIVERSITY
WO/2021/139739CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND  MEDICAL USE THEREOFCHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/238232PRAMIPEXOLE HYDROCHLORIDE ORAL SOLUTIONCHANGZHOU NO.4 PHARMACEUTICAL FACTORY CO. LTD
WO/2021/143671PHARMACEUTICAL COMPOSITION OF ANTI-PD-1 ANTIBODY AND  QUINAZOLINE DERIVATIVE, USES OF COMPOSITION, AND METHOD FOR USING SAMEINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/147740USE OF MAPK/ERK PATHWAY INHIBITOR IN ANTAGONIZING SKIN AGING  AND RADIATION-INDUCED PREMATURE AGINGSHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/143736COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET  AGENTTHE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/143741TARGETING POLYPEPTIDE-DRUG CONJUGATE AND USE THEREOFBEIJING HOPE PHARMACEUTICAL CO. LTD.
WO/2021/143745LONG-ACTING ROPIVACAINE PHARMACEUTICAL COMPOSITION,  PREPARATION METHOD THEREFOR AND USE THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143746NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEMSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143751INJECTABLE LONG-ACTING ANALGESIC PHARMACEUTICAL COMPOSITION,  PREPARATION METHOD THEREFOR, AND APPLICATION THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143754COMBINATION FOR THE TREATMENT OF CANCER AND APPLICATION  THEREOFEVERFRONT BIOTECH INC.
WO/2021/143767PREPARATION OF BISPECIFIC ANTIBODY COMBINING PD-1 AND PD-L1  AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/143785PHARMACEUTICAL COMPOSITION OF AEROSOL INHALANT CONTAINING  INDACATEROL AND PREPARATION METHOD THEREOFSICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/143791PHARMACEUTICAL USE OF ESRRA GENE ENCODING FOR ESTROGEN-RELATED  RECEPTOR αCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/143799USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH FRUQUINTINIB IN  PREPARATION OF MEDICAMENTS FOR TREATING CANCERGENOR BIOPHARMA CO. LTD
WO/2021/143806APPLICATION OF WIDE-SPECTRUM FLAVIVIRUS-AGAINST ACTIVITY OF  HSP70 INHIBITORACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/143826RECOMBINANT ANTI-PROGRAMMED CELL DEATH PROTEIN 1 AND  ANTI-CLUSTER OF DIFFERENTIATION ANTIGEN 137 BISPECIFIC ANTIBODY PREPARATION  AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/143861COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC  STEATOHEPATITIS (NASH)SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/143879COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS,  AND INSULIN AND/OR INSULIN ANALOGSSHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/143906METHOD FOR TREATMENT OF NERVE INJURY AND RELATED DISEASETALENGEN INTERNATIONAL LIMITED
WO/2021/143912THERAPEUTIC ACTION OF CELL-FREE FAT EXTRACT ON FATTY LIVER AND  COMPLICATIONS THEREOFSHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/151366HEALTH FOOD OR TRADITIONAL CHINESE MEDICINE MEDICINAL FORMULA  FOR IMPROVING MALE SEXUAL FUNCTION, AND ULTRASONIC WAVE PREPARATION METHODJIANGSU UNIVERSITY
WO/2021/143919PHARMACEUTICAL COMPOSITION AND USE THEREOFHENAN TAIFENG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/147854RECOMBINANT FULLY HUMAN ANTI-TIGIT MONOCLONAL ANTIBODY  PREPARATIONS, PREPARATION METHOD THEREFOR AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/143928QUINOLINE DERIVATIVE FOR TREATING RHEUMATOID ARTHRITISCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208551APPLICATION OF THYROID HORMONE AND ANALOGUE THEREOF IN  PREPARATION OF DRUG FOR TREATING SICKLE-CELL DISEASERUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/208552USE OF THYROID HORMONE AND ANALOGUE THEREOF IN PREPARATION OF  DRUGS FOR TREATING ALPHA-THALASSEMIARUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/232836CANNABINOID COMPOUNDS AND APPLICATION THEREOF IN TREATMENT OF  PARKINSON'S DISEASEHANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/238242USE OF FULL-SPECTRUM HEMP OIL IN TREATMENT OF EPILEPSYHANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/169682TRADITIONAL CHINESE MEDICINE COMPOSITION, AND PREPARATION  METHOD THEREFOR AND APPLICATION THEREOFBEIJING REGEN-PHARMATECH CO., LTD.
WO/2021/147922EXTRACELLULAR VESICLE AND USE THEREOF IN SKIN PRODUCTSEV CELL BIOTECH (GUANGZHOU) CO., LTD.
WO/2021/148003DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF IN MEDICINESHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/203798USE OF SPLICING FACTOR PRPF31 INHIBITOR IN PREPARING DRUGCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/244044EYE DROP SUITABLE FOR LIMBAL STEM CELL DEFICIENCY AND  PREPARATIONQINGDAO HAIER BIOTECH CO.LTD
WO/2021/218249SPINOSYN DERIVATIVE AS ARGININOSUCCINATE SYNTHETASE ACTIVATOR  AND APPLICATION THEREOFCENTRAL SOUTH UNIVERSITY
WO/2021/155748INHIBITORS OF MALARIAL AND PLASMODIUM FALCIPARUM HEXOSE  TRANSPORTER AND USES THEREOFTSINGHUA UNIVERSITY
WO/2021/179817PROGESTERONE EMULSION INJECTION AND PREPARATION METHOD  THEREFORJIANGSU JIAERKE PHARMACEUTICAL GROUP CO., LTD.
WO/2021/155751TRADITIONAL CHINESE MEDICINE COMPOUND WITH FUNCTIONS OF  CLEARING LUNGS AND DETOXIFICATION, AND APPLICATION THEREOFINSTITUTE OF BASIC RESEARCH IN CLINICAL MEDICINE,CHINA ACADEMY  OF CHINESE MEDICAL SCIENCES
WO/2021/179828USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUG FOR  TREATING ACUTE LUNG INJURYSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/151387PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUNDSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/169724SUSTAINED-RELEASE DOSAGE FORM OF TOFACITINIB, PREPARATION  METHOD THEREFOR AND APPLICATION THEREOFSHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/164523AKKERMANSIA MUCINIPHILA COMPOSITIONSHANGHAI INSTITUTE OF ENDOCRINE AND METABOLIC DISEASES
WO/2021/155764COMBINATION OF BI853520 WITH CHEMOTHERAPEUTIC DRUGSINXMED (NANJING) CO., LTD.
WO/2021/129890MEDICATION FOR BLOCKING MICROBIAL INFECTION, REDUCING  CHOLESTEROL, AND PREVENTING AND TREATING ASSOCIATED TUMORS, AND USE THEREOFCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/151391APPLICATION OF ISOVALERYLSPIRAMYCIN COMPOUND AND COMPOSITION  THEREOF IN PREPARATION OF ANTIVIRAL DRUGSHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/179843ANTI-TUMOR NANO ADJUVANT BASED ON VESICLE FORMED BY  CROSS-LINKED BIODEGRADABLE POLYMER, PREPARATION METHOD THEREFOR AND USE  THEREOFSOOCHOW UNIVERSITY
WO/2021/155777USE OF PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING  NOVEL CORONAVIRUS PNEUMONIASHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/184987AD7 VECTOR VACCINE FOR PREVENTING SARS-COV-2 INFECTIONGUANGZHOU N BIOMED LTD.
WO/2021/184988AD35 VECTOR VACCINE FOR PREVENTING SARS-COV-2 INFECTIONGUANGZHOU N BIOMED LTD.
WO/2021/155795PHARMACEUTICAL COMPOSITION AND USE THEREOFQIN, Caidong
WO/2021/155798USE OF IMMUNE POLYPEPTIDE IN ANTIVIRAL DRUGCHENG, Yun
WO/2021/184990SENSITIZER DRUG, DRUG COMBINATION AND USESUN YAT-SEN MEMORIAL HOSPITAL, SUN YAT-SEN UNIVERSITY
WO/2021/227572USE OF MICRO-NANO MGH<sb>2</sb> COMPOUND PARTICLES  IN INHIBITION OF LEISHMANIA INFECTION AND TREATMENT OF LEISHMANIASISSHANGHAI JIAO TONG UNIVERSITY
WO/2021/196884USE OF CATECHOL AND DERIVATIVES IN PREPARATION OF DRUGS FOR  TREATING SLEEP DISTURBANCESXI'AN LIBANG ZHAOXIN BIOTECHNOLOGY CO., LTD.
WO/2021/155825USE OF PAX6 GENE OR EXPRESSION PRODUCT THEREOF IN PREPARATION  OF DRUG FOR INHIBITING FIBROSISPEKING UNIVERSITY THIRD HOSPITAL
WO/2021/155840USE OF ANTI-PD-1 ANTIBODY IN TREATMENT OF MALIGNANT TUMORSSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/155846PREPARATION METHOD FOR NOVEL CORONAVIRUS PNEUMONIA BIVALENT  VACCINEWENG, Binghuan
WO/2021/160049BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND  USE THEREOFSHENZHEN EULIKAN BIOTECHNOLOGY CO., LTD
WO/2021/203828USE OF INHIBITOR IN PREPARATION OF DRUGS FOR TREATING  SARS-COV-2 PNEUMONIA AND COMPLICATIONS THEREOFACADEMY OF MILITARY MEDICAL SCIENCES, PLA
WO/2021/223480CONTROLLED-RELEASE TICAGRELOR TABLET AND PREPARATION METHOD  THEREFORJIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/164600USE OF COMPOSITION IN TREATING ATHEROSCLEROSISINNOLIFE CO., LTD.
WO/2021/155867METHOD AND DRUG FOR PREVENTING AND TREATING MULTIPLE SCLEROSISTALENGEN INTERNATIONAL LIMITED
WO/2021/185006LENVATINIB PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOFSHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/160092METHOD AND DRUG FOR TREATING VIRAL PNEUMONIATALENGEN INTERNATIONAL LIMITED
WO/2021/160104FOLIUM APOCYNI VENETI EXTRACT, AND PREPARATION METHOD THEREFOR  AND USE THEREOFXIAMEN UNIVERSITY
WO/2021/1798783CLPRO-TARGETING PHILLYRIN, DERIVATIVE THEREOF, AND USE  THEREOF AGAINST NOVEL CORONAVIRUSDALIAN FUSHENG NATURAL MEDICINE DEVELOPMENT CO., LTD.
WO/2021/160115USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR TREATING BREAST  CANCERCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/160120OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTORBEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
WO/2021/160124OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTORBEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
WO/2021/160131FIBROTIC DISEASE MECHANISM AND THERAPEUTIC DRUG THEREFORGUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER
WO/2021/179881APPLICATION OF HERBAL MEDICINE COMPOSITION IN PREPARATION OF  MEDICINE FOR PREVENTING AND TREATING CORONAVIRUS COMPLICATED WITH LUNG INJURYGUANGDONG LEIYUNSHANG PHARMACEUTICAL CO., LTD.
WO/2021/169812USE OF PAX4 INHIBITOR IN PREPARATION OF DRUG FOR INHIBITING  FIBROSISPEKING UNIVERSITY THIRD HOSPITAL
WO/2021/1601399,10-DIHYDROPHENANTHRENE COMPOUNDS AND USE THEREOF IN  TREATMENT OF LIVER INJURYSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/164672ANTI-RNA VIRUS DRUG AND APPLICATION THEREOFEAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/160144METHOD FOR PREVENTING OR TREATING THROMBOEMBOLISMS BY MEANS OF  APIXABAN INJECTIONJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/160151USE OF ANTI-PD-1 ANTIBODY IN TREATMENT OF TUMORSSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/160152USE OF ANTI-PD-1 ANTIBODY IN TREATING NEUROENDOCRINE TUMORSSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/232864TREATING TUMOR USING IMMUNE EFFECTOR CELLCAFA THERAPEUTICS LIMITED
WO/2021/160163METHODS FOR PREVENTION OR TREATMENT OF VIRUS-INDUCED ORGAN  INJURY OR FAILURE WITH IL-22 DIMEREVIVE BIOTECHNOLOGY (SHANGHAI) LTD
WO/2021/164685GROUP OF PEPTIDE COMPOUNDS OMICSYNIN HAVING ANTIVIRAL ACTIVITY  AND APPLICATION THEREOFINSTITUTE OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/160170METHODS OF USE OF SOLUBLE CD24 FOR TREATING SARS-COV-2  INFECTIONONCOIMMUNE, INC.
WO/2021/160173METHODS OF USE OF SOLUBLE CD24 FOR TREATING VIRAL PNEUMONIAONCOIMMUNE, INC.
WO/2021/164689APPLICATION OF NELFINAVIR IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIASHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/160183ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITHRANIR, LLC
WO/2021/164706PHARMACEUTICAL COMPOSITION CONTAINING METHYLENE BLUE DYE AND  APPLICATION THEREOFCHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD.
WO/2021/169845METHOD FOR PREVENTING, TREATING OR DELAYING HEART FAILURE BY  USING NEUREGULIN, AND COMPOSITIONZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.
WO/2021/164717ANTI-TNF-α ANTIBODY PREPARATION, PREPARATION METHOD THEREFOR  AND USE THEREOFBIO-THERA SOLUTIONS, LTD.
WO/2021/164723GINSENOSIDE M1 AS A MODULATOR OF ANGIOTENSIN REGULATING  ENZYMES AND ITS USE FOR TREATING DISEASES OR CONDITIONS INCLUDING SYMPTOMS  CAUSED BY CORONAVIRUSLEE, Sheau-Long
WO/2021/164728PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-4R ANTIBODY AND  USE THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164740USE OF INTERFERON IN PREPARING DRUG FOR PREVENTING CORONAVIRUS  INFECTION OR PREVENTING DISEASE CAUSED BY CORONAVIRUS INFECTIONSHANGHAI GANYI MEDICAL BIOTECHNOLOGY INC.
WO/2021/164744METHODS FOR TREATING GRAFT VERSUS HOST DISEASEEVIVE BIOTECHNOLOGY (SHANGHAI) LTD
WO/2021/164755OLAPARIB PHARMACEUTICAL COMPOSITION, PREPARATION THEREOF,  PREPARATION METHOD THEREFOR AND USE THEREOFSINOTHERAPEUTICS INC.
WO/2021/169861USE OF NUCLEOSIDE COMPOUND IN TREATMENT OF CORONAVIRUS  INFECTIOUS DISEASESGENUINE BIOTECH CO., LTD.
WO/2021/169884USE OF RAPAMYCIN AND DERIVATIVES THEREOF IN PREPARATION OF  DRUGS FOR PREVENTING AND TREATING ADE CAUSED BY VIRUSESZHENG, Yunfeng
WO/2021/179902USE OF CORYDALIS SAXICOLA AND PREPARATION THEREOF IN  PREPARATION OF DRUG FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASESNANJING ZHONGSHAN PHARMACEUTICAL CO., LTD.
WO/2021/169957APPLICATION OF N-SUBSTITUTED PYRIDYL BENZISOSELENAZOLONE  COMPOUNDSHANGHAITECH UNIVERSITY
WO/2021/212995ANTI-AGEING COMPOSITION, DRUG AND HEALTHCARE PRODUCT  COMPRISING SAME, AND APPLICATION THEREFORBIORIGHT WORLDWIDE COMPANY LIMITED.
WO/2021/169974COMBINED PHARMACEUTICAL COMPOSITION FOR RESISTING DOUBLE-HIT  LYMPHOMAS, AND USE THEREOFTHE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY
WO/2021/169978USE OF RECOMBINANT CYTOKINE GENE DERIVED PROTEIN OR FRAGMENT  THEREOFGENOVA INC.
WO/2021/169984ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE  INHIBITORFUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD
WO/2021/227597USE FOR CORDYCEPS SINENSIS EXTRACT IN PREPARING DRUG FOR  PROMOTING ANGIOGENESIS AND/OR TREATING ISCHEMIC CARDIOVASCULAR AND  CEREBROVASCULAR DISEASESINSTITUTE OF ZOOLOGY, GUANGDONG ACADEMY OF SCIENCES
WO/2021/170045METHODS OF TREATING DLBCL USING BTK INHIBITORS AND  COMBINATIONS THEREOFBEIGENE SWITZERLAND GMBH
WO/2021/170060PURIFICATION OF BISPECIIFC ANTIBODIESWUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/170064ORAL CARE COMPOSITIONS FOR GUM HEALTHTHE PROCTER & GAMBLE COMPANY
WO/2021/170065ORAL CARE COMPOSITIONS FOR GUM HEALTHTHE PROCTER & GAMBLE COMPANY
WO/2021/170073USE OF SMALL MOLECULE COMPOUNDS IN TREATING DISEASES MEDIATED  BY LUNG EPITHELIAL CELL INJURY AND/OR VASCULAR ENDOTHELIAL CELL INJURYGUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD.
WO/2021/170078USE OF CSF-1R KINASE INHIBITORSHANGHAI RUNSHI MEDICAL TECHNOLOGY CO., LTD
WO/2021/170093APPLICATION OF DISULFIRAM IN CORONAVIRUS RESISTANCESHANGHAITECH UNIVERSITY
WO/2021/170099METHOD AND DRUG FOR PREVENTING AND TREATING ABNORMAL BLOOD  PRESSURE CONDITIONTALENGEN INTERNATIONAL LIMITED
WO/2021/175175PHARMACEUTICAL FORMULATION COMPRISING BEVACIZUMABSHANGHAI HENLIUS BIOTECH, INC.
WO/2021/170137ANTI-TUMOR COMPOSITIONSPH SINE PHARMACEUTICAL LABORATORIES CO., LTD
WO/2021/170138ANTI-TUMOR COMPOSITIONSPH SINE PHARMACEUTICAL LABORATORIES CO., LTD
WO/2021/175186USE OF SMALL MOLECULE SHORT PEPTIDE IN PREPARATION OF PRODUCT  FOR TREATING ACNEJINAN UNIVERSITY
WO/2021/175192TREATMENT METHODS AND BIOMARKERS FOR MDM2 INHIBITORSASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/175200FERROPTOSIS INHIBITORS–DIARYLAMINE PARA-ACETAMIDESSIRONAX LTD
WO/2021/179947USE OF PHARMACEUTICAL COMPOSITION IN PREPARING ANTIBACTERIAL  DRUGSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/179950USE OF PHARMACEUTICAL COMPOSITION IN PREPARING ANTI-VIRAL DRUGSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/179952APPLICATION OF GW8510 IN PREPARATION OF DRUGS FOR PROLONGING  LIVES, IMPROVING COGNITIVE ABILITY, AND THE LIKE OF MAMMALS IN NATURAL AGINGPEKING UNIVERSITY
WO/2021/185071COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND METHODS OF USE THEREOFTHE UNIVERSITY OF HONG KONG
WO/2021/179959PHARMACEUTICAL COMPOSITION COMPRISING JAK3/JAK1/TBK1 INHIBITOR  AND METHOTREXATE AND USE THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/175240APPLICATION OF FULLERENE AND DERIVATIVE THEREOF IN REGULATING  INTESTINAL FLORAXIAMEN FUNANO NEW MATERIAL TECHNOLOGY CO., LTD.
WO/2021/179967APPLICATION OF IFN-γ IN PREPARING ANTI-TUMOR ADJUVANT DRUGWEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/175250COMPOUNDS AND METHODS FOR TREATING DISEASES AND/OR CONDITIONS  CAUSED BY CORONAVIRUSAPTORUM THERAPEUTICS LIMITED
WO/2021/175274OLAPARIB DISSOLUTION ENHANCING COMPOSITIONSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/175275HYDROPHOBICALLY MODIFIED ALBUMIN, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOFKUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/175279APPLICATION OF PHYSICAL TRANSDERMAL TECHNOLOGY IN  SUPPLEMENTARY NUTRITION SUPPLEMENTINGSUZHOU NASHENG MICROELECTRONICS CO., LTD
WO/2021/175295APPLICATION OF MYRICETIN COMPOUND IN PREPARATION OF DRUGS FOR  PREVENTION AND TREATMENT OF NOVEL CORONAVIRUS PNEUMONIASHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227614PHARMACEUTICAL COMPOSITION FOR CLEARING LUNG AND PULMONARY  FIBROSIS AND USE THEREOFZHANG, Yingwen
WO/2021/175311PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE AND  CANNABINOID COMPOUNDS AND USE THEREOF IN MEDICINECHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/175326COMBINED USE OF CTB006 AND PONATINIBBEIJING SINOTAU BIO-PHARMACEUTICALS TECHNOLOGY CO., LTD.
WO/2021/196982ANTI-ARRHYTHMIC PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFORJIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/180027PHARMACEUTICAL COMBINATION OF ANTI-PD-1 ANTIBODY AND  MULTI-RECEPTOR TYROSINE KINASE INHIBITOR AND METHOD FOR USING SAMEHUTCHISON MEDIPHARMA LIMITED
WO/2021/180032Novel Therapeutic MethodsGUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/175333SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING  OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIANANJING SHIJIANG MEDICINE TECHNOLOGY CO., LTD
WO/2021/180055USE OF BRD4 INHIBITORCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/180068METHOD AND DRUG FOR TREATING DISEASES CAUSED BY 2019 NOVEL  CORONAVIRUSTALENGEN INTERNATIONAL LIMITED
WO/2021/180087MEDICAL USE OF ANYHDROICARITINLUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/180110USE OF ANTI-BASIGIN HUMANIZED ANTIBODY FOR PREPARING  MEDICAMENT FOR TREATING NOVEL CORONAVIRUS PNEUMONIATHE FOURTH MILITARY MEDICAL UNIVERSITY
WO/2021/218422APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONJIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/213058APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING INFECTION WITH CORONAVIRUSESJIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/213059USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION  OF DRUG FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONJIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/180184USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOMESCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/185154PHARMACEUTICAL COMPOSITION COMPRISING TIZOXANIDE AND  PHARMACEUTICAL USE THEREOFBEIJING JUNKE HUAYUAN MED TECH CO., LTD.
WO/2021/180196COMPOSITION OF PIPERAZINE-BASED DRUGSDONGGUAN HEC GENERIC DRUG R&D CO., LTD.
WO/2021/180205PVRIG BINDING PROTEIN AND ITS MEDICAL USESJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/223514HOUSING-LIKE DENTAL INSTRUMENT HAVING ANTICARIES FUNCTION AND  MANUFACTURING METHOD THEREFORWUXI EA BIOTECHNOLOGY LIMITED
WO/2021/180219ANTI-CORONAVIRUS EFFECT AND APPLICATION OF PI4K INHIBITORNUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO. LTD
WO/2021/180225NEW APPLICATION OF C60 AND METHOD FOR MEASURING ACTIVITY OF  PRODUCTS THEREOFQINGDAO AGRICULTURAL UNIVERSITY
WO/2021/203914PERAMIVIR DRY POWDER INHALANT AND PREPARATION METHOD THEREFORGUANGZHOU NUCIEN PHARMACEUTICAL CO., LTD
WO/2021/143951COLCHICINE SOLUBLE MICRONEEDLE PATCH AND PREPARATION METHOD  THEREFORNANJING UNIVERSITY
WO/2021/180237ATOMIZED INHALATION FORMULATION CONTAINING HUMAN CELL-DERIVED  EXTRACELLULAR VESICLES, PREPARATION METHOD AND USE THEREOFCELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
WO/2021/185234COMBINED PHARMACEUTICAL COMPOSITION OF COMPOUND AS C-MET  KINASE INHIBITOR AND USE THEREOFCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/213086DEXTRAN-DOCOSAHEXAENOIC ACID COUPLING POLYMER, SYNTHESIS  METHOD THEREFOR AND APPLICATION THEREOFSHANDONG UNIVERSITY
WO/2021/185265ORAL PHARMACEUTICAL COMPOSITIONSICHUAN HAISCO PHARMACEUTICAL CO LTD
WO/2021/213089A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE  NANOCARRIERS, METHODS OF MAKING AND USING THEREOFTHE UNIVERSITY OF HONG KONG
WO/2021/203933TRADITIONAL CHINESE MEDICINE FOR DISPERSING LUNG QI AND  DETOXICATIONSHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
WO/2021/185292USE OF ASTRAGALUS MEDICINAL COMPOSITION FOR PREPARING DRUG FOR  ENHANCING CANCER THERAPYPHYTOHEALTH CORPORATION
WO/2021/185340USE OF MITOCHONDRIA FOR PROMOTING WOUND REPAIR AND/OR WOUND  HEALINGTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185341USE OF MITOCHONDRIAL EXTRACT FOR TREATMENT OR/AND PREVENTION  OF KIDNEY INJURY-RELATED DISEASESTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185342USE OF MITOCHONDRIA FOR TREATMENT AND/OR PREVENTION OF TENDON  DAMAGE OR RELATED DISEASESTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185343GLYBURIDE LIPOSOME COMPOSITION AND PREPARATION METHOD THEREFORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/185344METHOD FOR TREATING CHOLESTEROL-RELATED DISEASESJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/185356USE OF BUTYLPHTHALIDE AND DERIVATIVE THEREOFCSPC NBP PHARMACEUTICAL CO., LTD
WO/2021/185359Modified red blood cells and uses thereof for delivering  agentsWESTLAKE THERAPEUTICS (HANGZHOU) CO. LIMITED
WO/2021/185364CELL CULTURE COMPOSITION AND USE THEREOFTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185373MICROPARTICLE FOR DRUG LOADING, DRUG LOADING MICROPARTICLE,  PARTICLE CONTAINING TUBE, AND IMPLANTATION SYSTEM FOR MICROPARTICLESUZHOU YIBEN LIFE TECHNOLOGY CO., LTD
WO/2021/185376COMPOSITION CONTAINING MITOCHONDRIA AND USE THEREOF FOR  REPAIRING CARTILAGE DAMAGE OR AMELIORATING DEGENERATIVE ARTHRITISTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185377COMPOSITION FOR PROMOTING HAIR REGENERATION THAT CONTAINS  PLASMA RICH IN MITOCHONDRIA, AND MANUFACTURING METHOD THEREFOR AND USE  THEREOFTAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185382METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL  COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL  COMPOSITION OBTAINED THEREFROMYU, Chongxi
WO/2021/238367APPLICATION OF MITOXANTRONE PREPARATION IN PREPARATION OF DRUG  FOR DIAGNOSING AND TREATING DISEASE RELATED TO THYROIDECTOMYSHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL  CO., LTD
WO/2021/203959HEPARIN NANO DRUG CARRIER SYSTEM FOR LOADING AMINO ANTI-TUMOR  DRUG, AND PREPARATION METHOD THEREFORNANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO., LTD.
WO/2021/190495PEGYLATED HEPARIN NANO-MICELLE LOADED WITH CARBOXYLIC ACID  ANTI-TUMOR DRUG AND PREPARATION METHOD THEREFORKINDOS PHARMACEUTICALS CO., LTD.
WO/2021/190546PHARMACEUTICAL COMPOSITION COMPRISING PROTEIN KINASE INHIBITOR  AND CHEMOTHERAPEUTIC DRUG AND USE THEREOFSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/190553ANTI-IL-1β ANTIBODY, AND PHARMACEUTICAL COMPOSITION CONTAINING  SAME, AND USE THEREOFAKESO BIOPHARMA, INC
WO/2021/190558METHOD AND DRUG FOR TREATING ALZHEIMER DISEASETALENGEN INTERNATIONAL LIMITED
WO/2021/190561METHOD AND DRUG FOR TREATING PARKINSON'S DISEASETALENGEN INTERNATIONAL LIMITED
WO/2021/190562METHOD AND DRUG FOR PROMOTING DEGRADATION OF MISFOLDED PROTEIN  AND AGGREGATE THEREOFTALENGEN INTERNATIONAL LIMITED
WO/2021/190563METHOD AND MEDICINE FOR TREATING HUNTINGTON'S DISEASETALENGEN INTERNATIONAL LIMITED
WO/2021/190573MAGNETIC NANOCOMPOSITE MATERIAL AND PREPARATION METHOD  THEREFOR AND USE THEREOFNINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING,  CHINESE ACADEMY OF SCIENCES
WO/2021/190581PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY DRUG CONJUGATE  AND USE THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/190582ANTI-OX40 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/218506APPLICATION OF PROGESTIN IN PREPARATION OF DRUG INHIBITING  CYTOKINE STORMSHENZHEN EVERGREEN THERAPEUTICS CO., LTD.
WO/2021/190588HERBA LYCOPI EXTRACT AND PREPARATION METHOD THEREFOR AND USE  THEREOFXIAMEN UNIVERSITY
WO/2021/190611TRADITIONAL CHINESE MEDICINE COMPOSITION FOR RECOVERY PHASE OF  EXOGENOUS FEVER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOFBEIJING UNIVERSITY OF CHINESE MEDICINE THIRD AFFILIATED  HOSPITAL
WO/2021/190616METHODS FOR INHIBITING CASEIN KINASESGRITSCIENCE BIOPHARMACEUTICALS CO., LTD.
WO/2021/190624PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF  USING THEREOFGANNEX PHARMA CO., LTD.
WO/2021/190631METHOD FOR DISPLAYING BISPECIFIC ANTIBODY ON SURFACE OF  MAMMALIAN CELL AND VECTORDDBIO.CO, LTD., (SHANG HAI)
WO/2021/190641METHODS FOR TREATING CYTOKINE STORM SYNDROME AND RELATED  DISEASESFU, Xin-Yuan
WO/2021/190647USE OF BERBERINE ANALOG AND JAK INHIBITOR IN TREATMENT OF  INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACTENNOVABIO (ZHEJIANG) PHARMACEUTICALS CO., LTD.
WO/2021/197254USE OF MICROORGANISMS IN REGULATION OF BODYWEIGHT AND  CHOLESTEROL LEVELMICROBIOTA I - CENTER (MAGIC) LIMITED
WO/2021/208711APPLICATION OF TYLOPHORA ALKALOID OR SALT THEREOF IN RESISTING  CORONAVIRUSNANKAI UNIVERSITY
WO/2021/197285SEMI-DRY NASAL AND ORAL CAVITY NURSING TOWEL, NURSING MASK AND  PREPARATION METHODYANG LING ANDIYUAN BIOTECHNOLOGY CO., LTD.
WO/2021/197290NOVEL APPLICATION OF ACETYLCHOLINESTERASE ACTIVITY INHIBITORTHE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/197297PHARMACEUTICAL COMPOSITION CONTAINING GINSENOSIDES RH3, PPD,  AND RH2SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/197333PHARMACEUTICAL COMBINATION AND USE THEREOFNATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/197334PHARMACEUTICAL COMBINATION AND USE THEREOFNATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/197335ANTIBODIES BINDING CD40 AND USES THEREOFBIOSION INC.
WO/2021/197346VACCINE ADJUVANT CONTAINING TRPV2 AGONIST AND USE THEREOFTSINGHUA UNIVERSITY
WO/2021/197372ANTI-TUMOR COMPOSITION CONTAINING RARE GINSENOSIDES RK2, CK,  AND PPTSHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/197376A FEBUXOSTAT TABLETJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244120SARS-COV-2 VACCINECANSINO BIOLOGICS INC.
WO/2021/208749MEDICAL USE OF RIBOSOMAL PROTEIN SA ANTIBODIES IN  IMMUNOREGULATIONJILIN UNIVERSITY
WO/2021/197430COMPOSITIONS AND METHODS FOR REDUCING GRAFT REJECTION IN  ALLOGENEIC CELL THERAPYNANJING LEGEND BIOTECH CO., LTD.
WO/2021/204060COMBINATIONS OF BCL-2/BCL-XL INHIBITORS AND RELATED USESASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/197451MULTIPLE FORMULATION OF TICAGRELORJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/227700ANTI-DRY AND ANTI-SENSITIVITY COMPOSITION AND PREPARATION  METHOD THEREFORGUANGZHOU KENENG COSMETICS RESEARCH CO. LTD
WO/2021/197492BREAST MILK OLIGOSACCHARIDES FOR IMPROVING RESISTANCE OF  ORGANISM AGAINST STAPHYLOCOCCUS AUREUS INFECTIONINNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.
WO/2021/204179NUCLEIC ACID VACCINES FOR CORONAVIRUSSUZHOU ABOGEN BIOSCIENCES CO., LTD.
WO/2021/204188UTIDELONE SEMI-HYDRATED SINGLE CRYSTAL AND PREPARATION METHOD  THEREFOR AND USE THEREOFBEIJING BIOSTAR PHARMACEUTICALS CO., LTD.
WO/2021/204192USE OF COMPOUND AS SIRT1 RECEPTOR AGONISTCATCH BIO-SCIENCE & TECHNOLOGY CO., LTD.
WO/2021/204223PHARMACEUTICAL COMPOSITION INCLUDING NICOTINAMIDEYANGTZE RIVER PHARMACEUTICAL GROUP NANJING HAILING  PHARMACEUTICAL CO., LTD.
WO/2021/218594REAGENT AND METHOD FOR REGULATING INTEGRIN β SUBUNITCENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/204279PROBIOTIC COMPOSITION FOR TREATING RAPID EYE MOVEMENT SLEEP  BEHAVIOR DISORDER, FORMULATION AND USEBEIJING FRIENDSHIP HOSPITAL AFFILIATED TO CAPITAL MEDICAL  UNIVERSITY
WO/2021/208842USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOMECSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/160192USE OF KAURANE COMPOUNDS IN PREPARATION OF DRUG FOR PREVENTION  AND TREATMENT OF SEPSIS AND MULTIPLE ORGAN DAMAGEKEY-PHARMA BIOMEDICAL INC.
WO/2021/208860MICROEMULSION-BASED VACCINE DELIVERY SYSTEM, PREPARATION  METHOD THEREFOR AND USE THEREOFSICHUAN UNIVERSITY
WO/2021/208910POLYMER PREPARATION FOR TREATING VIRUS INFECTION, AND  PREPARATION METHOD THEREFOR AND USE THEREOFSHANDONG HUBBLE KISEN BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/249009RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOFSICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/208947COFFEE SILVERSKIN EXTRACT, PREPARATION METHOD THEREFOR AND USE  THEREOFINGREDI BIOTECH CO., LTD.
WO/2021/208976SOLID PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR  AND USE THEREOFSHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/218638DRUG COMBINATION FOR TREATING DIABETES MELLITUS AND  COMPLICATIONS THEREOF AND PHARMACEUTICAL COMPOSITION OF DRUG COMBINATIONSHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/213230APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUG FOR TREATING OR PREVENTING FATTY LIVER DISEASENG, Tit
WO/2021/213232APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARING DRUG FOR TREATING OR PREVENTING HYPERLIPIDEMIANG, Tit
WO/2021/208984APPLICATION OF ABELMOSCHI COROLLA EXTRACT AS TRPC ION CHANNEL  INHIBITORJIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208985USE OF QUERCETIN-3'-O-β-D-GLUCOSIDE AS CALCIUM CHANNEL  INHIBITORJIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/209003PREVENTION AND TREATMENT OF ORGAN INJURIESFARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/209007ANTIBODY-DRUG CONJUGATESHENZHEN ENDURING BIOTECH, LTD.
WO/2021/209010METHOD AND DRUG FOR TREATING HURLER SYNDROMEEDIGENE INC.
WO/2021/209017PREPARATION SPECIFICALLY BOUND WITH CD137 AND USE THEREOFDINGFU BIOTARGET, CO., LTD.
WO/2021/175339ROLE OF HUMAN SYMBIOTIC FLORA IN IMPROVING TUMOR IMMUNOTHERAPY  RESPONSESHENZHEN XBIOME BIOTECH CO., LTD.
WO/2021/209025PHARMACEUTICAL COMPOSITIONSSHENZHEN PHARMACIN CO., LTD
WO/2021/209028METHODS OF TREATING VIRAL INFECTIONS USING ARGINASEBIO-CANCER TREATMENT INTERNATIONAL LIMITED
WO/2021/213287USE OF IRAK4 INHIBITOR IN TREATMENT OF ACUTE LUNG INJURY  ALI/ARDSSHANGHAI LEADINGTAC PHARMACEUTICAL CO., LTD.
WO/2021/213327COMPOSITION CONTAINING 7-ETHYL-10-HYDROXYCAMPTOTHECIN,  PREPARATION METHOD THEREFOR AND USE THEREOFKUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/209070GINSENOSIDE COMPOSITION HAVING ALCOHOLIC FATTY  LIVER-PREVENTING AND -TREATING FUNCTIONSHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/218687STEM CELL DRUG FOR TREATING DIABETESSOOCHOW UNIVERSITY
WO/2021/213455DRUG COMBINATION AND USE THEREOFNATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/218763PERIPLOSIDE COMPOSITION, PREPARATION METHOD THEREFOR AND USE  THEREOF IN PREPARATION OF DRUG FOR TREATMENT OF AUTOIMMUNE DISEASESSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/180250PREPARATION FOR INHIBITING CANDIDA ALBICANSNORTHWEST UNIVERSITY
WO/2021/213483APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITESZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213484APPLICATION OF RADIX GENTIANAE MACROPHYLLAE AND MONOMER  COMPOUND THEREOF IN KILLING MITESZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213485USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING  MITESZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213492DRUG-CARRYING MACROMOLECULE AND PREPARATION METHOD THEREFORSHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/238529TECHNETIUM CARBON MICROSPHERE INJECTION, PREPARATION METHOD  THEREFOR AND USE THEREOFCHENGDU NEW RADIOMEDICINE TECHNOLOGY CO., LTD.
WO/2021/218802ISOLATED RECOMBINANT ONCOLYTIC POXVIRUS CAPABLE OF BEING  REGULATED AND CONTROLLED BY MICRORNA AND USE THEREOFHANGZHOU CONVERD CO., LTD.
WO/2021/213502SLEEP-IMPROVING PHARMACEUTICAL COMPOSITION CONTAINING RARE  GINSENOSIDES RG6 AND F4SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/213504USE OF VEGF INHIBITOR IN PREPARATION OF MEDICAMENT FOR  TREATING HYPOXIA-RELATED DISEASESQILU HOSPITAL OF SHANDONG UNIVERSITY
WO/2021/213512A FORMULATION FOR TREATING OPHTHALMIC CONDITIONSGUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECHNOLOGY CO.,  LTD.
WO/2021/213520ANTI-SARS CORONAVIRUS-2 SPIKE PROTEIN ANTIBODIESSINGLE CELL TECHNOLOGY, INC.
WO/2021/213523USES OF COMBINATION OF ANTI-PD-1 ANTIBODY AND ANTI-CTLA-4  ANTIBODY IN PREVENTING OR TREATING CANCERINNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/218884USE OF ARYL GUANIDINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE  SALT THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227868PHARMACEUTICAL COMPOSITION PREPARATIONWANG, Zhaolin
WO/2021/218945ANTIBACTERIAL ANTIVIRAL PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOFYUNNAN BAIYAO GROUP CO., LTD
WO/2021/218964EXTRACT FROM CORIOLUS VERSICOLOR FOR TREATING VAGINAL OR  CERVICAL DISORDERS CAUSED BY INFECTIOUS AGENTSPROCARE HEALTH IBERIA, S.L.
WO/2021/218965APPLICATION OF RUBIACEAE TYPE CYCLIC PEPTIDE COMPOUNDS IN  PREPARATION OF DRUGS AS CGAS-STING SIGNAL PATHWAY ACTIVATORSCHINA PHARMACEUTICAL UNIVERSITY
WO/2021/218974USES OF ANTRODIA CINNAMOMEA EXTRACT IN MANUFACTURING PRODUCTS  FOR REDUCING EXPRESSION AND TREATING ASSOCIATED DISEASES OF ANGIOTENSIN  CONVERTING ENZYME 2ALPS BIOTECH CO., LTD.
WO/2021/219001COMPOSITION FOR IMPROVING IMMUNITYTHE CHINESE UNIVERSITY OF HONG KONG
WO/2021/219009DIAGNOSIS AND TREATMENT OF CANCERS SHOWING HIGH EXPRESSION OF  PIWI AND/OR NMD COMPLEX PROTEINSHANGHAITECH UNIVERSITY
WO/2021/219029SARS-COV-2 VIRAL PROTEINS AND USE THEREOFVERSITECH LIMITED
WO/2021/219031TRADITIONAL CHINESE MEDICINE COMPOSITION, AND APPLICATION OF  PREPARATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARING MEDICINE  FOR PREVENTING AND/OR TREATING ‎CORONAVIRUS DISEASE 2019TASLY PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219040HISTONE DEACETYLASE INHIBITORS FOR IMMUNOMODULATION IN TUMOR  MICROENVIRONMENTGNT BIOTECH & MEDICALS CORPORATION
WO/2021/219047METHOD FOR IMPROVING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGENSINOCELLTECH LIMITED
WO/2021/227887COMPOUND FOR TREATING AND/OR PREVENTING DISEASES CAUSED BY  CORONAVIRUS AND USE THEREOFSHANGHAITECH UNIVERSITY
WO/2021/223652COSMETIC PRODUCT AND MAKING-UP METHODMOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/219077PROTEOLYSIS TARGETING COMPOUND HAVING TISSUE TARGETING  CAPABILITY AND USE THEREOFTAI BI DI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO. LTD
WO/2021/258851PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND  PREPARATION METHOD THEREFORGUANGZHOU LIXIN PHARMACEUTICAL CO., LTD
WO/2021/223659EXTRACELLULAR VESICLES TARGETING CANCER CELLS AND USES THEREOFNANJING IASO BIOTHERAPEUTICS CO., LTD.
WO/2021/223664METHODS FOR TREATING CORONAVIRUS INFECTIONSASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/219112ISOVALERYL SPIRAMYCIN COMPOUND OR APPLICATION OF ISOVALERYL  SPIRAMYCIN COMPOSITION IN PREPARATION OF DRUG FOR TREATING SEPSIS DISEASESHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/219113USE OF ISOVALERYL SPIRAMYCIN COMPOUND OR COMPOSITION THEREOF  IN PREPARATION OF MEDICAMENT FOR TREATING IMMUNE DISORDERSSHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/219137AMINOPYRIDINE DERIVATIVE FOR TREATING DISEASES CAUSED BY MET  GENETIC ABNORMALITIESCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219138COMBINATION DRUG FOR TREATING KIDNEY CANCERCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/223713APPLICATION OF SMS2 INHIBITOR IN PREPARATION OF DRUG FOR  TREATMENT OF HIGHLY INVASIVE BREAST CANCERSHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/227937METHOD FOR ENHANCING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN  BY MEANS OF FORMING FUSION PROTEIN WITH MODIFIED FC FRAGMENTSINOCELLTECH LIMITED
WO/2021/223732BLOOD PURIFICATION CONCENTRATEXIA, Yongbiao
WO/2021/180251CROSS-LINKED MEDICATION FOR TREATMENT OF CORONAVIRAL INFECTION  AND METHOD OF TREATMENT1GLOBE BIOMEDICAL CO., LTD.
WO/2021/228037COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTI-VIRAL THERAPYVERSITECH LIMITED
WO/2021/228044DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES  THEREOFHUNILIFE BIOTECHNOLOGY, INC.
WO/2021/228069USE OF COMBINATION OF ANTI-VEGF ANTIBODY AND ANTI-PD-1  ANTIBODY FOR PREVENTING OR TREATING DISEASEINNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/244235APPLICATION OF POLYINOSINIC ACID AND SARS-COV-2 SPIKE PROTEIN  IN CONSTRUCTION OF MOUSE ARDS MODELCHINA-US (HENAN) HORMEL CANCER INSTITUTE
WO/2021/228086METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHYTALENGEN INTERNATIONAL LIMITED
WO/2021/228106ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT  INHIBITOR FOR TREATING TUMORSJOINT BIOSCIENCES (SH) LTD.
WO/2021/180252NOVEL APPLICATION AND MANUFACTURING METHOD FOR HYALURONIC ACID  FRAGMENTQINGDAO AGRICULTURAL UNIVERSITY
WO/2021/228113PREPARATION COMPRISING ANTI-IL-23P19 ANTIBODY, PREPARATION  METHOD THEREFOR AND USE THEREOFINNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/228141ANTIBODY DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE  THEREOFSICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/228146USE OF LSD1 INHIBITORCSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/228178COMPOSITIONS AND METHODS FOR TREATING CANCERADAGENE AG
WO/2021/254054VACCINE FOR PREVENTING DISEASE CAUSED BY CORONAVIRUSACADEMAY OF MILITARY MEDICAL SCIENCES, AMS, PLA
WO/2021/228213COMBINATION COMPRISING TRICYCLE COMPOUND AND USE THEREOF IN  PREPARATION OF MEDICAMENT FOR TREATING HBVFUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/228222COMBINATION FOR TREATING HEPATITIS BFUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/238689CHINESE MEDICINE COMPOSITION FOR SOOTHING NERVES AND AIDING  SLEEP, AND CHINESE MEDICINE SACHET AND APPLICATIONCHENG, Yawei
WO/2021/238690TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL  CHINESE MEDICINE SACHET USED FOR PREVENTING COLDS AND APPLICATION THEREOFCHENG, Yawei
WO/2021/233237TUMOR VACCINE, PREPARATION METHOD THEREFOR AND USE THEREOFNATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/233239APPLICATION OF ACTIVE INGREDIENT OF ROOT OF LIGULILOBE SAGE OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PREPARING ANTIVIRAL DRUGSOUTHERN MEDICAL UNIVERSITY
WO/2021/238695TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING AND  TREATING COLD IN SPRING AND GRANULES AND APPLICATION THEREOFCHENG, Yawei
WO/2021/238698TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL  CHINESE MEDICINE SACHET HELPING TO BOOST MOOD AND APPLICATION THEREOFCHENG, Yawei
WO/2021/228260PHARMACEUTICAL USE OF IRIDOID GLYCOSIDE COMPOUNDSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/233346TARGETEDLY MODIFIED EXOSOME LOADED WITH DRUG, AND PREPARATION  METHOD AND USE THEREFORBEIJING TIANTAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY
WO/2021/238752PROBIOTIC PREPARATION BASED ON  W<sb>1</sb>/O/W<sb>2</sb> TYPE DUAL EMULSION  STRUCTURE, AND PREPARATION METHOD THEREFOR AND USE THEREOFHUAZHONG AGRICULTURAL UNIVERSITY
WO/2021/238761THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS  INFECTIONBEIJING BJUT SCIENCE AND TECHNOLOGY PARK CO., LTD
WO/2021/233402BREXPIPRAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION AND  PREPARATION METHOD THEREFORJIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/197507RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD,  RECOMBINANT PLASMID, AND USE THEREFORJIANGSU KANIONREAL BIOMEDICAL TECHNOLOGY CO., LTD
WO/2021/233432BLOOD-PURIFICATION MOLECULAR CONCENTRATE, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOFXIA, Yongbiao
WO/2021/238836CANTHARIDIN ANTIVIRAL AND ANTIBACTERIAL PREPARATION,  PREPARATION METHOD THEREFOR, AND USE THEREOF FOR PREVENTING AND TREATING  NOVEL CORONAVIRUS INFECTIONGANSU YUANMEI PHARMACEUTICAL CO., LTD.
WO/2021/238957USE OF FAMITINIB IN PREPARATION OF MEDICATION FOR TREATING  TUMOR HAVING C-KIT OR PDGFRA MUTATIONJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/238978PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE PRODRUG, AND  PREPARATION METHOD AND APPLICATION THEREFORJIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/238982PHARMACEUTICAL COMPOSITION COMPRISING POLYNUCLEOTIDES AND USE  THEREOF FOR PREVENTION OR TREATMENT OF COVID-19LIAONING YISHENG BIOPHARMA CO., LTD.
WO/2021/254118APPLICATIONS OF HPK1 KINASE INHIBITOR IN PREVENTING AND/OR  TREATING ANIMAL PATHOGEN INFECTIONZHUHAI YUFAN BIOTECHNOLOGIES CO., LTD
WO/2021/244421ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES  THEREOFSTAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
WO/2021/239106APPLICATION OF ATP POTASSIUM CHANNEL MODIFIER IN PREPARATION  OF ANTI-DIABETIC NEPHROPATHY DRUGHANGZHOU QIAN BIOTECHNOLOGY LTD
WO/2021/239130PHARMACEUTICAL PREPARATION AND PREPARATION METHOD THEREFORSICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/239134LIPOSOME CONTAINING ETHYLENEDIAMINE TETRAACETIC ACID OR SALT  THEREOF AND ERIBULIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOFJIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244460BIOMARKER RELATED TO ORAL SQUAMOUS CELL CARCINOMA AND  DIAGNOSIS AND TREATMENT METHODSQINGDAO MEDINTELL BIOMEDICAL CO., LTD
WO/2021/254132ANTI-SIGLEC15 ANTIBODY AND USE THEREOFSHENGHE (CHINA) BIOPHARMACEUTICAL CO., LTD.
WO/2021/249228CAMPTOTHECIN DRUG HAVING HIGH-STABILITY HYDROPHILIC CONNECTING  UNIT AND CONJUGATE THEREOFSICHUAN BAILI PHARM CO., LTD
WO/2021/244481COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTIONTHE UNIVERSITY OF HONG KONG
WO/2021/239147β-CORONAVIRUS ANTIGEN, β-CORONAVIRUS BIVALENT VACCINE,  PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOFINSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/249236USE OF 12,15-DIOXO-α-SELENENE IN PHARMACEUTICALSKUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES
WO/2021/249240USE OF PALOVAROTENE IN TREATMENT AGAINST HBV VIRUSYANG SHENG TANG COMPANY, LTD.
WO/2021/244515PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY SYSTEM  DAMAGE AND A USE IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR IMPROVING  RESPIRATORY SYSTEM DAMAGEBUFFALO BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/244547APPLICATION OF NATURAL COMPOUND AND DERIVATIVE THEREOF IN  TREATING ARTERIAL LESIONSSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/244551COMBINED PHARMACEUTICAL COMPOSITION OF C-MET KINASE INHIBITOR  AND ANTI-PD-L1 ANTIBODYCHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/249250NOVEL IMMUNOLOGIC ADJUVANT, COMPOUND AND APPLICATION THEREOFWANG, Zhulin
WO/2021/244597METHOD FOR PREPARING FATTY ACID-BASED VC LIPOSOMEJIANGNAN UNIVERSITY
WO/2021/244606GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC  IMPAIRMENTHUA MEDICINE (SHANGHAI) LTD.
WO/2021/249286NEW DRUG FORMULA FOR IMMUNOTHERAPY AND TABLET STRUCTURE  THEREOFXU, Xinpeng
WO/2021/249288VORICONAZOLE EXTERNAL PREPARATION AND PREPARATION METHOD  THEREFORHAINAN POLY PHARM CO., LTD.
WO/2021/249289APPLICATION OF NORHARMANE IN IMPROVEMENT OF ANTIBIOTIC  ANTIBACTERIAL ACTIVITYZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/244627ISOLATED ANTIGEN BINDING PROTEIN AND USE THEREOFLONGBIO PHARMA (SUZHOU) CO., LTD.
WO/2021/244628PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND  APPLICATION THEREOFSHANGHAI BAO PHARMACEUTICALS CO., LTD.
WO/2021/249352CONJUGATE OF DOUBLE-STRANDED SIRNA ANALOGUECHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/249373STABLE HIGH-CONCENTRATION ANTI-HUMAN IL-5 MONOCLONAL ANTIBODY  LIQUID PREPARATIONSUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/249376USE OF TLR4 PATHWAY INHIBITOR AND/OR ANTAGONIST IN PREPARATION  OF DRUGZHUJIANG HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY
WO/2021/249402EFFECTS OF CELL-FREE FAT LIQUID EXTRACT ON MACROPHAGE  POLARIZATION MODULATION AND DISEASE TREATMENTSHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/254221STABLE LIQUID PREPARATION OF ANTI-IL-4Rα MONOCLONAL ANTIBODIESSUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/249420USE OF KADSURA HETEROCLITA (ROXB.) CRAIB AGENT IN PREPARATION  OF MEDICAMENT FOR RESISTING RHEUMATOID ARTHRITISHUNAN UNIVERSITY OF CHINESE MEDICINE
WO/2021/249445PHARMACEUTICAL COMPOSITION OF ANTI-IL-17A ANTIBODIES AND USE  THEREOFSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/249452RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOFSICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/249484CONJUGATE GROUP AND CONJUGATEMEDSHINE DISCOVERY INC.
WO/2021/249492METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOFMEDSHINE DISCOVERY INC.
WO/2021/249501ANTIVIRAL PREPARATIONSUNTRAP LIFE TECHNOLOGIES LTD.
WO/2021/254265USE OF COMPOUND IN PREVENTION AND/OR TREATMENT OF PATHOGEN  INFECTION IN ANIMALSGARGAMEL (ZHUHAI) BIOTECH LTD.
WO/2021/249548PHARMACEUTICAL COMPOSITION OF NOVEL CORONAVIRUS ANTIBODY AND  USE THEREOFSHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/254277MICROSUSPENSION OF AN MDM2 INHIBITOR AND THERAPEUTIC  APPLICATIONS THEREOFASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/249551LIQUID PREPARATION OF ANTI-PD-1 MONOCLONAL ANTIBODIESSUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/254287NOVEL CORONAVIRUS TANDEM EPITOPE POLYPEPTIDE VACCINE AND USE  THEREOFSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/249561THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY  DISEASESSHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/254296BIOACTIVE SUBSTANCE COMPOSITION, SERUM-FREE CULTURE MEDIUM  COMPRISING THE COMPOSITION, AND USES THEREOFZHEJIANG UNIVERSITY
WO/2021/254299USE OF BACTERIA IN CHILDREN DEVELOPMENT ASSESSMENT AND  TREATMENTTHE CHINESE UNIVERSITY OF HONG KONG
WO/2021/254327ENVELOPE REPLACEMENT-TYPE VIRAL VECTOR VACCINE AND  CONSTRUCTION METHOD THEREFORFANTASIA BIOPHARMA (ZHEJIANG) CO. LTD
WO/2021/254337NEW USE OF ACTIVE INGREDIENT WGX50 IN ZANTHOXYLUM BUNGEANUM  MAXIM. EXTRACTSHANGHAI JIAO TONG UNIVERSITY
WO/2021/254360CARBOHYDRATE MOLECULAR CLUSTER AND PREPARATION METHOD THEREFOR  AND MEDICAL USE THEREOFTUOJIE BIOTECH (SHANGHAI) CO., LTD.
WO/2021/254447STABLE FORMULATION FOR RECOMBINANT ANTI-PD-1 MONOCLONAL  ANTIBODYSINOCELLTECH LIMITED
WO/2021/259143PHARMACEUTICAL USE OF (E)-3-ARYLHETEROCYCLYL PROP-2-ENOIC ACID  DERIVATIVESMEDCURIUS INC.
WO/2021/254471ORAL FORMULATIONS AND USES THEREOFINVENTISBIO CO., LTD.
WO/2021/259195COMBINED DRUG FOR TREATING CORONAVIRUS DISEASE 2019SICHUAN UNIVERSITY WEST CHINA HOSPITAL
WO/2021/259211ANTISEPTIC COMPOSITIONSRHT LIMITED
WO/2021/259215ANTISEPTIC COMPOSITIONSRHT LIMITED
WO/2021/259288AGONIST OF DEACETYLASE AND USE THEREOFGUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU RESEARCH  INSTITUTE OF CHINESE MEDICINE)
WO/2021/259334SELF-REGULATING CHIMERIC ANTIGEN RECEPTOR AND APPLICATION  THEREOF IN TUMOR IMMUNITYNANJING BOWANG PHARMACEUTICAL TECHNOLOGY CO., LTD
WO/2021/244676NOVEL COMPOSITION FOR ENAMEL REMINERALIZATIONIBRITE SUZHOU TECHNOLOGY CO., LTD.
WO/2021/254537USE OF CYCLOVIROBUXINESOUTHWEST UNIVERSITY
WO/2021/249578MEDICATION FOR THE PREVENTION AND TREATMENT OF ASTHMA, CHRONIC  OBSTRUCTIVE PULMONARY DISEASE, OR ALLERGIC DISEASESLIU, Li
WO/2021/249579MEDICATION FOR THE PREVENTION AND TREATMENT OF COLD OR VIRAL  DISEASESLIU, Li
WO/2021/043345HUMAN RECOMBINANT HYPOSIALYLATED ERYTHROPOIETIN, METHODS OF  PURIFICATION AND THERAPEUTIC USES THEREOFCENTRO DE INMUNOLOGIA MOLECULAR
WO/2021/129897PROTEIN-BASED PHARMACEUTICAL COMPOSITION WITH NEUROPROTECTIVE,  IMMUNOMODULATING, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITYCENTRO NACIONAL DE BIOPREPARADOS
WO/2021/155871ORAL SUSPENSION WITH ANTI-ULCEROUS AND CHEMOPROTECTIVE EFFECT  ON COLON CANCER AND PREPARATION METHOD THEREOFCENTRO NACIONAL DE INVESTIGACIONES CIENTIFICAS
WO/2021/209080PEPTIDE FOR THE TREATMENT OF CYTOKINE STORM SYNDROMECENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/233484PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY  DISEASES OF VIRAL ORIGINCENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/239165PEPTIDE FOR TREATING CORONAVIRUS INFECTIONSCENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/098892DEVICE FOR THE PREPARATION OF FUNCTIONALISED SUBSTANCESGRADE MEDICAL S.R.O.
WO/2021/047699GLYCOPOLYMER, METHOD OF PREPARATION THEREOF, USE THEREOF AS  MEDICAMENTUSTAV MAKROMOLEKULARNI CHEMIE AV CR, V. V.I.
WO/2021/073667METHOD FOR THE PREPARATION OF POLYMERIC CARRIERS FOR PH-  CONTROLLED DRUG RELEASE AND THEIR CONJUGATES WITH DRUGSUSTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I.
WO/2021/115502N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF  CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONSUNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/121446COPOLYMER WITH HYDROLYTIC RELEASE OF CANCEROSTATIC AGENT  CYTARABINE, METHOD OF ITS PREPARATION AND USE THEREOFUSTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I.
WO/2021/249581METHOD OF PREPARATION OF THE TRANSFER FACTOR MEDICINE,  TRANSFER FACTOR MEDICINE, METHOD OF TESTING ITS BIOLOGICAL ACTIVITY,  PHARMACEUTICAL FORM AND ITS USEAUMED, A.S.
WO/2021/148065A METHOD OF TRANSFORMATION OF GENES INTO BACTERIAL CELLSUNIVERZITA KARLOVA, LEKARSKA FAKULTA V PLZNI
WO/2021/148066DENTAL PREPARATION COMPRISING FIBERS BASED ON HYALURONIC ACID  WITH REGULATED BIODEGRADABILITYCONTIPRO A.S.
WO/2021/013283ORAL HYGIENE AGENTS CONTAINING CAFFEINE AND L-LYSIN AS BITTER  BLOCKING AGENTSDR. KASCHNY HEALTHCARE GMBH
WO/2021/027984PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLESKORTH, Ruth-Maria
WO/2021/093912NEW FORMULATION OF LACTOBACILLUS STRAINS FOR THE TREATMENT AND  PREVENTION OF <i>HELICOBACTER PYLORI</i> COLONISATION IN THE  UPPER AIRWAYS AND THE DIGESTIVE SYSTEMBELANO MEDICAL AG
WO/2021/008652NANOSTRUCTURED IBUOPROFEN COMPOSITIONS, METHODS FOR THEIR  PREPARATION, AND PHARMACEUTICAL COMPOSITION CONTAINING THEMMYBIOTECH GMBH
WO/2021/032252ADHESIVE PLASTER CONTAINING A SPECIALLY DESIGNED RESERVOIR FOR  A PHARMACEUTICAL PREPARATIONABU-GHAZALEH, Adrian
WO/2021/143962PROVISION OF BACTERIOPHAGES IN VARIOUS DOSAGE FORMS AND  BACTERIOPHAGE APPLICATION DEVICEJUNGHANS, Simon Frank
WO/2021/209093TREATMENT OF NON-TRANSMISSIBLE INFLAMMATORY DISEASES WITH A  SUBSTANCE THAT INHIBITS TRANSCRIPTION OF THE CEBPB GENE OR THE FUNCTION OF  THE CEBPB PROTEINDERMAGNOSTIX R&D GMBH
WO/2021/213587COMBINATION WHICH CAN BE USED FOR THE TREATMENT AND  PROPHYLAXIS OF CORONAVIRUS-INDUCED PULMONARY DYSFUNCTION AND DAMAGEKIESEWETTER, Holger
WO/2021/259423USE OF COENZYME ANTAGONISTS IN ORDER TO SLOW DOWN A METABOLIC  PROCESSTAVARGENIX GMBH
WO/2021/259425BISPHOSPHONATE-MODIFIED LIPOSOMES CONTAINING NANOPARTICLESPHARMA DEVELOPMENT HOLDING GMBH
WO/2021/069036COMPRESSED NICOTINE LOZENGEFERTIN PHARMA A/S
WO/2021/001006A SKIN CARE COMPOSITIONCOLOPLAST A/S
WO/2021/023351TOPICAL FORMULATIONS COMPRISING CANNABIDIOL, METHOD OF  PREPARING THE COMPOSITION AND USE THEREOFCS GROUP APS
WO/2021/069044AN ION-EXCHANGE COMPOSITION WITH WATER-SOLUBLE MUCOADHESIVE  POLYMERSFERTIN PHARMA A/S
WO/2021/069046A VAGINAL CONTRACEPTIVE COMPOSITION FOR REINFORCEMENT OF MUCUS  BARRIER PROPERTIESCIRQLE BIOMEDICAL CONTRACEPTION ApS
WO/2021/083467ADMINISTRATION OF CD22, CD33 AND/OR TIM-3 ANTIBODIES USING  OMMAYA RESERVOIRS FOR THE TREATMENT OF CNS CANCER OR NEURODEGENERATIVE  DISEASESY-MABS THERAPEUTICS, INC.
WO/2021/151442METHOTREXATE DOSAGE FORMROS THERAPEUTICS APS
WO/2021/164832STARCH PROPIONATE USED AS A FOOD ADDITIVE AND/OR DIETARY  SUPPLEMENT FOR PREVENTION OF OVERWEIGHT AND OBESITYABILDGAARD, Ole
WO/2021/170193COMPOSITION COMPRISING EGG YOLK AND BURNT CERAL POWDER FOR  WOUND HEALINGSAHEBI, Sükrüye
WO/2021/213601B7H3 ANTIBODIES WITH CHELATORSY-MABS THERAPEUTICS, INC.
WO/2021/223824FLOWPACK FOR ORAL DELIVERY OF ACTIVE INGREDIENTSFERTIN PHARMA A/S
WO/2021/223825ORAL POWDER MIXTURE WITH SMALL SIZED PARTICLESFERTIN PHARMA A/S
WO/2021/223826MOUTHWASH FOR ORAL CARE BENEFITSFERTIN PHARMA A/S
WO/2021/259434METHOD FOR MANUFACTURING A MULTI-LAYERED FILM STRUCTURE AND  METHOD FOR MANUFACTURING MULTI-LAYERED MICROSTRUCURESMLMC THERAPEUTICS APS
WO/2021/078349PHARMACEUTICAL COMPOSITION BASED ON PLANT EXTRACTS FOR THE  TREATMENT OF FIBROMYALGIA, RHEUMATOID ARTHRITIS, LUPUS AND OTHER AUTOIMMUNE  DISEASESPORTILLO ROSADO, Rosa Maria
WO/2021/180293A COMPOSITION FOR NORMALIZING BLOOD LIPID LEVELDIKOVSKIY, Aleksander Vladimirovich
WO/2021/028005A MEDICAMENT COMPRISING ANABASINE FOR TREATMENT OF ASTHMA,  CHEST ALLERGY AND ATOPIC DERMATITSELKAZAZ, Mohamed, Fadly, Abd el Ghany
WO/2021/254582EFFICACY OF (SOFOSBUVIR PLUS LEDIPASVIR) IN EGYPTIAN PATIENTS  WITH COVID-19COMPARED TO STANDARD OF CARE TREATMENT.ALMAZA MILITARY FEVER HOSPITAL
WO/2021/013315OINTMENT FOR DIABETIC FOOT ULCER TREATMENTMOSTAFA, Mariam Mohamed Kamel
WO/2021/259441A NEW AND SAFE PHARMACEUTICAL PREPARATION FOR PROPHYLAXIS AND  TREATMENT OF RESPIRATORY VIRAL INFECTIONS, ESPECIALLY CORONA VIRUSESKHALIL, Ibrahim Taha Ibrahim
WO/2021/063468STABLE PARENTERAL PHARMACEUTICAL COMPOSITION CONTAINING  TIGECYCLINE AND PROCESS FOR THE PREPARATION THEREOFANFARM HELLAS S.A.
WO/2021/008668PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION CONTAINING CYCLOSPORINEPHARMATHEN S.A.
WO/2021/001023RNA FORMULATIONS SUITABLE FOR THERAPYBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/001029BLEND OF BEESWAX AND A LACTYLATE ESTERSYMRISE AG
WO/2021/008669PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF OPA1 FOR  USE IN THE TREATMENT OF CANCERUNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/008678USE OF N-ACYLHYDROXY AMINO ACID ESTER FOR INDUCING THE  EXPRESSION OF SUPEROXIDE-DISMUTASE AND/OR HEM OXYGENASESYMRISE AG
WO/2021/018377COSMETIC COMPOSITION WITH COMBINED FILLER AND SKIN  REGENERATIVE EFFECTGIULIANI S.P.A.
WO/2021/028024IMPROVED DOSAGE OF BALOXAVIR MARBOXIL FOR PEDIATRIC PATIENTSF. HOFFMANN-LA ROCHE AG
WO/2021/032271INDUCTION OF FUNCTIONAL ASTROCYTES FROM PLURIPOTENT STEM CELLSLU LICENSE AB
WO/2021/037383COSMETIC USE OF β-L-ASPARTYL-L-ARGININESYMRISE AG
WO/2021/043389GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENT FOR  TREATMENT OR PREVENTION OF AN IMPAIRED COGNITIONBOTALYS SA
WO/2021/043392ANTIPERSPIRANT EMULSIONBEIERSDORF AG
WO/2021/043394ANTIPERSPIRANT ACTIVE EMULSIONBEIERSDORF AG
WO/2021/047783VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCERTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/052597SKIN-CARE PRODUCT CONTAINING HYALURONIC ACID (OR A SALT  THEREOF) AND A PLANT STEM CELL EXTRACTPM-INTERNATIONAL AG
WO/2021/058091TREATMENT INVOLVING THERAPEUTIC ANTIBODY AND INTERLEUKIN-2  (IL2)BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/073742AGONIST OF TACR2UNIVERSITY OF COPENHAGEN
WO/2021/078359USE OF INHIBITORS OF CUBILIN FOR THE TREATMENT OF CHRONIC  KIDNEY DISEASESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/073761COMPOSITIONS WITH ANTIMICROBIAL PROPERTIESSYMRISE AG
WO/2021/073762COMBINATION DRUG FOR MEDICAL USE FOR THE TREATMENT OF A  DISORDER CAUSED BY DAMAGE TO RENAL TUBULAR   FUNCTIONPROSALIX AG
WO/2021/104639USE OF 2-PHENYL-6-(1H-IMIDAZOL-1-YL) QUINAZOLINE FOR THE  PREVENTION OF ABUSE AND OF SIDE EFFECTS OF AT LEAST ONE OPIOIDROTTAPHARM BIOTECH S.R.L.
WO/2021/110239STAINLES STEEL CAN FOR PRESSURISED METERED DOSE INHALERSCHIESI FARMACEUTICI S.P.A.
WO/2021/013372LIQUID ANTIBODY FORMULATIONICHNOS SCIENCES SA
WO/2021/115601BIODEGRADABLE MICROCAPSULE SYSTEMSPAPIERFABRIK AUGUST KOEHLER SE
WO/2021/115610METHOD FOR PREPARING A COMPOSITION AND USE OF THE COMPOSITION  FOR TREATMENT OR PROPHYLAXIS OF DISEASEQUANTUM PHARMACEUTICALS SA
WO/2021/121566UTILIZATION OF A COMPOSITION COMPRISING ORGANIC SILICA FOR THE  IMPROVEMENT OF THE QUALITY OF CARTILAGENOUS TISSUESAA HEALTHCARE SàRL
WO/2021/063526NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063527NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063528NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063530NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063531NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/063532NOVEL SKIN CARE COMPOSITIONS-BIOMEDIC
WO/2021/121627IMPROVED PERTUSSIS VACCINE COMPOSITIONUNIVERSITé D'AIX-MARSEILLE
WO/2021/151452OIL-IN-WATER-TYPE EMULSION COSMETICL V M H RECHERCHE
WO/2021/129927TREATMENT WITH IMMUNE EFFECTOR CELLS ENGINEERED TO EXPRESS AN  ANTIGEN RECEPTORBIONTECH CELL & GENE THERAPIES GMBH
WO/2021/129945<i>IN VITRO</i> AND <i>IN VIVO</i>  GENE DELIVERY TO IMMUNE EFFECTOR CELLS USING NANOPARTICLES FUNCTIONALIZED  WITH DESIGNED ANKYRIN REPEAT PROTEINS (DARPINS)BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/121645A TOPICAL ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION  COMPRISING ZILEUTONQURIENT CO., LTD.
WO/2021/013384SKINCARE COMPOSITIONSTHE BOOTS COMPANY PLC
WO/2021/018414PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATEZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/037396DENTAL COMPOSITIONDENTSPLY SIRONA INC.
WO/2021/078412FRACTAL FORMULATIONSMESSADEK, Jallal
WO/2021/139872SOLUBLE MELATONIN TRIPARTATE ADDUCT FOR THE PREVENTION AND  TREATMENT OF RARE AND SEVERE EYE SIGHT-THREATENING CONDITIONS AND  NEURO-OPHTHALMIC DISORDERSWORPHMED SRL
WO/2021/139874COGNITIVE DISORDER PREVENTION AND THERAPYANIMA
WO/2021/144020ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAMEIMMATICS BIOTECHNOLOGIES GMBH
WO/2021/073775ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKINSYMRISE AG
WO/2021/013385PROCESSES FOR OBTAINING A HIGHLY CONCENTRATED ANTIBODY  SOLUTIONICHNOS SCIENCES SA
WO/2021/148124COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM  BODY SURFACE LESIONSDEBX MEDICAL BV
WO/2021/155916TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS  BINDING TO PD-L1 AND CD137BIONTECH SE
WO/2021/164848NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING  NUCLEOSIDES AS MEDICAMENTSKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/170218STABLE, LIQUID EMULSIFIERS ON THE BASIS OF CITRATE ESTERS AND  THEIR USESYMRISE AG
WO/2021/170223ANTIPERSPIRANT ACTIVE EMULSIONBEIERSDORF AG
WO/2021/175405COMPOSITE RNA PARTICLESBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/175432METHOD FOR ADMINISTRATION OF AN ANTI CANCER AGENTBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/175450COMPOSITION OR OAT EXTRACT COMPRISING AVENANTHRAMIDE AND  ß-GLUCANSYMRISE AG
WO/2021/175451COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE LSYMRISE AG
WO/2021/175452COMPOSITION COMPRISING AN AVENANTHRAMIDE OR AN ANALOGUE  THEREOF WITH IMPROVED SKIN PENETRATIONSYMRISE AG
WO/2021/175453COMPOSITION COMPRISING AN AVENTHRAMIDE OR AN ANALOGUE THEREOF  WITH IMPROVED STABILITYSYMRISE AG
WO/2021/175454AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY  COMPRISING 4-HYDROXYPHENONESYMRISE AG
WO/2021/037400METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION  FRACTION WITH DAPAGLIFLOZINASTRAZENECA AB
WO/2021/139901PEPTIDE-CONTAINING COMPOSITION FOR USE FOR TREATING NEOPLASTIC  LESIONSCYTOVATION AS
WO/2021/047798VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCERTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/083555ALK INHIBITORS FOR TREATMENT OF ALK-NEGATIVE CANCER AND PLASMA  CELL-MEDIATED DISEASESUNIVERSITETET I OSLO
WO/2021/190735COSMETIC COMPOSITION FOR MAKING UP OR CARING FOR KERATIN  MATERIALS COMPRISING A FLUORESCENT COMPOUND FROM THE FAMILY OF  4-BORA-3A,4A-DIAZA-S-INDACENES, AND/OR FROM THE FAMILY OF DIFLUOROBORANE  BETA-DIKETONATESCRIME SCIENCE TECHNOLOGY
WO/2021/197589TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN  VACCINATIONBIONTECH SE
WO/2021/148143TREATMENT OF CARDIAC REMODELLINGUNIVERSITETET I OSLO
WO/2021/197639COMPOSITIONS COMPRISING 15-HEPE FOR TREATING OR PREVENTING  HEMATOLOGIC DISORDERS, AND/OR RELATED DISEASESAFIMMUNE LIMITED
WO/2021/073778COMPOSITIONS AND METHODS FOR VACCINATING PIGLETS AGAINST  <i>STREPTOCOCCUS</i>CEVA SANTE ANIMALE
WO/2021/209134ANTIMICROBIAL SILVER COORDINATION COMPLEXESPENTA SCIENCE INDUSTRIES HOLDING B.V.
WO/2021/136602ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTSLABOSERVE PHARMACEUTICAL COMPANY S.A.
WO/2021/180338COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF DNA METHYLTRANSFERASE POST STEM CELL TRANSPLANTAPREA THERAPEUTICS AB
WO/2021/219202VISUALIZATION OF HER2 EXPRESSION IN HUMAN PATIENTSHOBER BIOTECH AB
WO/2021/004673SOLID HAIR CONDITIONING COMPOSITIONSHENKEL AG & CO. KGAA
WO/2021/004674SOLID HAIR CONDITIONING COMPOSITIONSHENKEL AG & CO. KGAA
WO/2021/228358A SOLID MUCOADHESIVE COMPOSITIONSYMRISE AG
WO/2021/228363PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE  SYSTEMVAKZINE PROJEKT MANAGEMENT GMBH
WO/2021/228365USES AND FORMULATIONS OF CANNABINOIDSADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228366USES AND FORMULATIONS OF CANNABINOIDSADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228414METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN  FORMULATIONSPHARMA MAR, S.A.
WO/2021/098991COMPOSITIONS COMPRISING BACTERIAL STRAINS4D PHARMA RESEARCH LIMITED
WO/2021/233534USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOFPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/233549CLEAVABLE POLYMER DRUG CONJUGATES FOR VIRAL DISEASESRS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM  SIRKETI
WO/2021/233551OLIGONUCLEOTIDES FOR SPLICE MODULATION OF CARD9F.HOFFMANN-LA ROCHE AG
WO/2021/098992METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN  FORMULATIONSPHARMA MAR, S.A.
WO/2021/001104LIPID MIXTURE CONSISTING OF LIQUID OILS, HYDROGENATED  VEGETABLE OILS, AND SHEA BUTTERBEIERSDORF AG
WO/2021/244733HYPOXIA-RESISTANT NATURAL KILLER CELLSONK THERAPEUTICS LIMITED
WO/2021/004711FATTY ACID POLYGLYCERYL ESTER-CONTAINING CLEANSING PREPARATIONBEIERSDORF AG
WO/2021/004712CLEANSING EMULSION CONTAINING FATTY ACID POLYGLYCERYL ESTERSBEIERSDORF AG
WO/2021/013419INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN  MATERIALHENKEL AG & CO. KGAA
WO/2021/018444METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENTHENKEL AG & CO. KGAA
WO/2021/018446METHOD FOR TREATING KERATIN MATERIAL, COMPRISING THE  APPLICATION OF AN ORGANIC C1-C6-ALKOXY-SILANE AND AN AMINO ACID AND/OR AMINO  ACID DERIVATIVEHENKEL AG & CO. KGAA
WO/2021/013420INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN  MATERIALHENKEL AG & CO. KGAA
WO/2021/028093METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENTHENKEL AG & CO. KGAA
WO/2021/018447METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENTHENKEL AG & CO. KGAA
WO/2021/023415COMESTIC NANOEMULSIONBEIERSDORF AG
WO/2021/249641PHARMACEUTICAL COMPOSITIONS CONTAINING ENTEROKINE-RELEASING  SUBSTANCES IN MULTIPLE DOSAGE FORMS IN COMBINATION WITH GELLING AGENTSAPHAIA PHARMA IP AG
WO/2021/254588SOLID CLEANSING COMPOSITIONBEIERSDORF AG
WO/2021/004736REDUCING THE VIRAL ACTIVITY OF ELAFIBRANOR WITH RIBOFLAVIN OR  DHADSM IP ASSETS B.V.
WO/2021/254628FRAGRANCE MIXTURES CONTAINING 1-(4,4-DIMETHYLCYCLOHEXEN-1-YL)  ETHANONSYMRISE AG
WO/2021/254637ASSOCIATION OF NATURAL ACTIVES INGREDIENTS TO FIGHT SKIN AGINGTOMCAT INTERNATIONAL LIMITED
WO/2021/004770HAIR CARE COMPOSITION COMPRISING ANTIDANDRUFF AGENTUNILEVER N.V.
WO/2021/018479PROCESS AND APPARATUS FOR PRODUCTION OF A GRANULAR CANNABINOID  MATERIAL ESSENTIALLY SOLUBLE IN AQUEOUS MEDIUMADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/259454TINTED SUNSCREENBEIERSDORF AG
WO/2021/013452TSG6 POLYPEPTIDE FRAGMENT FOR DRY EYE DISEASETHE UNIVERSITY OF MANCHESTER
WO/2021/008822TOPICAL COMPOSITIONS AND METHODS OF USING SAME AGAINST  MITOCHONDRIAL FRAGMENTATIONUNILEVER PLC
WO/2021/008823STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONSUNILEVER PLC
WO/2021/008824BIOENERGETIC COMBINATIONS AND METHODS OF USING SAMEUNILEVER PLC
WO/2021/259471DERMAL FILLER WITH HIF-1α ACTIVITY MODULATORSTHOR, Dominik
WO/2021/259472MICELLAR DOCETAXEL FOR USE IN THE TREATMENT OF CANCEROASMIA PHARMACEUTICAL AB
WO/2021/001281METHOD OF DEPOSITING A SUBSTANCE ON A SUBSTRATEDBV TECHNOLOGIES
WO/2021/001286A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1  POSITIVE ALLOSTERIC MODULATORUCB BIOPHARMA SRL
WO/2021/001288A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1  POSITIVE ALLOSTERIC MODULATORUCB BIOPHARMA SRL
WO/2021/001290COMPOSITION COMPRISING STABILIZED PHYCOCYANIN AND ITS USESCALICEA
WO/2021/001306METHYLTHIONINIUM AS ENHANCERS OF THE COGNITIVE FUNCTIONWISTA LABORATORIES LTD.
WO/2021/013476HAIR CARE COMPOSITIONUNILEVER N.V.
WO/2021/001326METHYLTHIONINIUM FOR USE IN THE TREATMENT OF SYNAPTOPATHIESWISTA LABORATORIES LTD.
WO/2021/001332METHOD FOR OBTAINING A BOTANICAL THERMAL INFUSIONLABORATOIRES LéA
WO/2021/013479MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER  DYSFUNCTIONUNIVERSITEIT ANTWERPEN
WO/2021/001349INHALABLE COMPOSITION COMPRISING CYCLODEXTRIN FOR USE IN THE  TREATMENT OF NASAL INFLAMMATIONSAQUILON PHARMACEUTICALS
WO/2021/001356CD5 SPECIFIC T CELL RECEPTOR CELL OR GENE THERAPYMAX-DELBRüCK-CENTRUM FüR MOLEKULARE MEDIZIN IN DER  HELMHOLTZ-GEMEINSCHAFT
WO/2021/001360PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES  THEREOFADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/121677RETINOL-BASED SERUML'OREAL
WO/2021/001362PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES  THEREOFADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/001365PROPHYLAXIS AND TREATMENT OF A HUMAN PAPILLOMAVIRUS (HPV)  INFECTION OF THE CERVIXEBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTÄT
WO/2021/001366METHOD FOR STABILIZING THE PH OF AN AQUEOUS COMPOSITION  COMPRISING A DRUGOCULIS SA
WO/2021/001374PHARMACEUTICAL COMPOSITIONS FOR GLUCAGON AND GLP-1 CO-AGONIST  PEPTIDESMEDIMMUNE LIMITED
WO/2021/001380THERAPEUTIC INTERACTIONS OF LEUCOMETHYLTHIONINIUMWISTA LABORATORIES LTD.
WO/2021/001393COSMETIC COMPOSITION COMPRISING SILICONES BEARING A CARBOXYLIC  GROUP AND ANIONIC DIRECT DYES, AND COSMETIC TREATMENT PROCESSL'OREAL
WO/2021/001405COMPOUND AND COMPOSITIONS FOR MULTITARGET TREATMENT OF TAU  PROTEIN-RELATED DISORDERSFONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
WO/2021/001417RNA FORMULATIONS SUITABLE FOR THERAPYBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/001427METHODS FOR THE PROPHYLACTIC TREATMENT OF CANCER IN PATIENTS  SUFFERING FROM PANCREATITISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/001431USE OF PI3KA-SELECTIVE INHIBITORS FOR TREATING METASTATIC  DISEASE IN PATIENTS SUFFERING FROM PANCREATIC CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/001461ORAL THIN FILMLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/001462CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSISINTERVET INTERNATIONAL B.V.
WO/2021/001464COMBINATION THERAPY METHODS, COMPOSITIONS AND KITSBIONURE FARMA, S.L.
WO/2021/001508METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINEJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/004910COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY  MYCOPLASMA GENITALIUMGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/001518PXR LIGANDS FOR THE PREVENTION OR TREATMENT OF METABOLIC  DISORDERSMEDIZINISCHE UNIVERSITÄT GRAZ
WO/2021/004913COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN  FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLESOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004915COMPOSITIONS AND METHODS USING TRIGONELLINE AND MINERALS FOR  PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLESOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004919COMPOSITIONS AND METHODS USING TRIGONELLINE AND VITAMINS FOR  PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLESOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004922COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE  INTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) FOR TREATING OR  PREVENTING PHYSIOLOGICAL DISORDERS OR STATESSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/001540DETOXIFICATION OF PROTEINSPROXI BIOTECH APS
WO/2021/004942DRY COSMETIC AND/OR SKIN CARE COMPOSITIONOMYA INTERNATIONAL AG
WO/2021/004945COMPOSITION COMPRISING A NATURAL DYE, AN ANTHRAQUINONE  CATIONIC DIRECT DYE AND AN AROMATIC COMPOUNDL'OREAL
WO/2021/004948COMPOSITION COMPRISING A NATURAL DYE, A HYDRAZONO AND/OR AZO  CATIONIC SYNTHETIC DIRECT DYE AND AN AROMATIC COMPOUNDL'OREAL
WO/2021/004950COMPOSITION COMPRISING A NATURAL DYE, A TRIARYLMETHANE DIRECT  DYE AND AN AROMATIC COMPOUNDL'OREAL
WO/2021/004958COMPOSITIONS COMPRISING BACTERIAL STRAINS4D PHARMA RESEARCH LIMITED
WO/2021/001567MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPYCANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/001568METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINEJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/013510COATED EFFECT PIGMENTS AND PRODUCTION THEREOFHENKEL AG & CO. KGAA
WO/2021/013511METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING  POLYMER IVHENKEL AG & CO. KGAA
WO/2021/013512METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A SEALING REAGENT IIIHENKEL AG & CO. KGAA
WO/2021/013513COLOURING EFFECT PIGMENTS AND PRODUCTION THEREOFHENKEL AG & CO. KGAA
WO/2021/013516METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COATED EFFECT PIGMENT AND A FILM-FORMING POLYMER  IIHENKEL AG & CO. KGAA
WO/2021/052648METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COATED EFFECT PIGMENT AND A SEALING REAGENT IHENKEL AG & CO. KGAA
WO/2021/013517METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A SEALING REAGENT IHENKEL AG & CO. KGAA
WO/2021/005011TABLETING OF SPECIFIC POLYMER STABILIZERSBASF SE
WO/2021/005059MODIFIED ESCHERICHIA COLI STRAIN NISSLE AND TREATMENT OF  GASTROINTESTINAL DISORDERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/005064A COMPOSITION, A KIT AND USE THEREOFTHERAVET SA
WO/2021/005069A METHOD FOR THE PREPARATION OF A GEL-FORMING COMPOSITIONTHERAVET SA
WO/2021/005071A COMPOSITION, A KIT AND USE THEREOFTHERAVET SA
WO/2021/098996OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTIONUNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
WO/2021/005077PHARMACEUTICAL PREPARATIONMERCK PATENT GMBH
WO/2021/013546A WATER-IN-OIL EMULSION COMPOSITION FOR ENHANCED DELIVERY OF  WATER SOLUBLE SKIN BENEFIT AGENTSUNILEVER N.V.
WO/2021/005101PHARMACEUTICAL COMPOSITION COMPRISING A  TETRAHYDROPYRAZOLOPYRIMIDINONE COMPOUNDIDORSIA PHARMACEUTICALS LTD
WO/2021/005104COSMETIC COMPOSITION OF LIQUID CRYSTAL LIPID PARTICLES FOR  HAIR CARE COMPOSITIONBASF SE
WO/2021/005117TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE  AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN  CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVELTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/005118TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE  AGENT-CONTAINING LAYER COMPRISING AN ACRYLIC POLYMER AND A SKIN CONTACT LAYER  COMPRISING A SILICONE GEL ADHESIVELTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/005129COMBINATION OF IBUPROFEN AND TRAMADOL FOR RELIEVING PAINFARMALíDER, S.A.
WO/2021/259506COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND  A SAPONIN OR A LIGAND-SAPONIN CONJUGATESAPREME TECHNOLOGIES B.V.
WO/2021/259507CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN  EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME,  THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITIONSAPREME TECHNOLOGIES B.V.
WO/2021/259508CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY,  PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOFSAPREME TECHNOLOGIES B.V.
WO/2021/005147COMBINATIONGENESIS PHARMA SA
WO/2021/005153SELF-ASSEMBLING PEPTIDES IN THE PREVENTION AND TREATMENT OF  CAVITATED CARIOUS LESIONSCREDENTIS AG
WO/2021/005169TREATMENT OF PATIENTS UNDER ANTIPLATELET MEDICATION  EXPERIENCING BLEEDINGFÄLKER, Knut
WO/2021/005176TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD)GENETHON
WO/2021/005183INHIBITOR OF MAP KINASE INTERACTING SERINE/THREONINE KINASE 1  (MNK1) AND MAP KINASE INTERACTING SERINE/THREONINE KINASE 2 (MNK2), CANCER  THERAPY AND THERAPEUTIC COMBINATIONSFUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE  RECERCA
WO/2021/005189NOVEL PFAR-INHIBITING COMPOUNDSUNIVERSITE DE BRETAGNE OCCIDENTALE (UBO)
WO/2021/047804IN VITRO METHOD FOR TRANSDUCTION OF T CELLS IN THE PRESENCE OF  MALIGNANT CELLSMILTENYI BIOTEC B.V. & CO. KG
WO/2021/009020EXCIPIENT FOR BIOTHERAPEUTICSLUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/009027HIGH CONCENTRATION INSULIN FORMULATIONNOVO NORDISK A/S
WO/2021/009029TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE  IN THE TREATMENT AND/OR PREVENTION OF CANCERUNIVERSIDAD DE MURCIA
WO/2021/009040PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH A VOLATILE  ORGANIC ACTIVEBASF SE
WO/2021/009050REDUCING MALARIA TRANSMISSIONGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/009083PROCESS FOR TREATING KERATIN FIBERS, COMBINING A COMPOSITION  COMPRISING A WATER-SOLUBLE SILICATE AND A COMPOSITION COMPRISING AN AMINO  ACID AND/OR AN OLIGOPEPTIDEL'OREAL
WO/2021/009091METHODS FOR PREDICTING AND TREATING CARDIAC DYSFUNCTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/058157KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUNDHENKEL AG & CO. KGAA
WO/2021/009110COSMETIC PREPARATIONS COMPRISING NATURAL ACTIVATORSETH ZURICH
WO/2021/009126SIRNA SEQUENCES TARGETING THE EXPRESSION OF HUMAN GENES JAK1  OR JAK3 FOR A THERAPEUTIC USECOMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES
WO/2021/009142COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING  THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULARLABORATOIRES EXPANSCIENCE
WO/2021/018565SKIN CARE OIL IN WATER EMULSIONBEIERSDORF AG
WO/2021/073788NATURAL NON-PATHOGENIC MICROORGANISMS CAPABLE OF ASSOCIATING  GLYCOLIPIDS OR LIPOPEPTIDES AND USE THEREOFACARYON GMBH
WO/2021/009197DOSE DUMPING RESISTANT PHARMACEUTICAL COMPOSITIONS COMRISING  VERINURADASTRAZENECA AB
WO/2021/009219A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE  PHARMACOKINETIC PROFILEFLUOGUIDE A/S
WO/2021/009237A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDERIGSHOSPITALET
WO/2021/018596LIQUID ORAL CARE COMPOSITIONMEDA PHARMA S.P.A.
WO/2021/009266PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS ADMINISTRATIONZEALAND PHARMA A/S
WO/2021/009267ANTI-PD-L1 ANTIBODIESCAPELLA BIOSCIENCE LTD
WO/2021/013693ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORSBAYER PHARMA AKTIENGESELLSCHAFT
WO/2021/009288COMBINATION COMPRISING ALPHA-1 ANTITRYPSIN FOR USE IN TREATING  ISCHAEMIA IN A SUBJECTFUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE  RECERCA
WO/2021/018619STABILIZING THERAPEUTIC PROTEINS WITH PIPERAZIN- OR  MORPHOLINE-CONTAINING ZWITTERIONIC BUFFERING SUBSTANCESLUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/009331IMPROVED TREATMENT USING EYP001ENYO PHARMA
WO/2021/009332METHOD FOR DECREASING ADVERSE-EFFECTS OF INTERFERONENYO PHARMA
WO/2021/009333SYNERGISTIC EFFECT OF EYP001 AND IFN FOR THE TREATMENT OF HBV  INFECTIONENYO PHARMA
WO/2021/009336METHODS FOR INDUCING FULL ABLATION OF HEMATOPOIESISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013712POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT  OF MUSCLE DISEASESANAGENESIS BIOTECHNOLOGIES S.A.S.
WO/2021/013713MESNA COMPOSITION, KIT COMPRISING MESNA AND METHOD FOR  VISUALIZATION OF A MESNA COMPOSITION APPLIED TO TISSUESAUXIN SURGERY SA
WO/2021/013714COMPOSITION AND INSTRUMENT COMPRISING MESNA FOR USE IN A  METHOD OF ROBOT-ASSISTED SURGERYAUXIN SURGERY SA
WO/2021/009355SOLID FORMULATION OF A 1,2,4-OXADIAZOLE DERIVATIVEABAXYS THERAPEUTICS
WO/2021/009367GLYCOPEPTIDES INCREASING LIPID SYNTHESISTFCHEM
WO/2021/013764P21 EXPRESSING MONOCYTES FOR CANCER CELL THERAPYINSTITUT GUSTAVE ROUSSY
WO/2021/013771FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF  TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT)VIFOR (INTERNATIONAL) AG
WO/2021/013772FERROPORTIN-INHIBITORS FOR THE USE IN THE PREVENTION AND  TREATMENT OF KIDNEY INJURIESVIFOR (INTERNATIONAL) AG
WO/2021/013798THERAPEUTIC VIRAL VACCINEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/013815METHODS OF TREATING MULTIPLE SCLEROSISACTELION PHARMACEUTICALS LTD
WO/2021/013825SOFT CHEWABLE VETERINARY DOSAGE FORMINTERVET INTERNATIONAL B.V.
WO/2021/018682HYBRID MINERAL-ORGANIC COMPLEX, AND USE THEREOF FOR  MAINTAINING THE MICROBIOLOGICAL BALANCE OF THE SKIN AND/OR OF A COSMETIC  AND/OR DERMOPHARMACEUTICAL COMPOSITIONBIONUCLEI
WO/2021/023512BIFUNCTIONAL COMPOUND AND ITS USE IN IMMUNOTHERAPYCONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/013884INHIBITORS OF CHI3L1 AND THEIR USESHUMANITAS MIRASOLE S.P.A.
WO/2021/013903NEW USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVESUNIVERSITé DE LIèGE
WO/2021/013904ANTIBODY AGAINST THE OPRF PROTEIN OF <i>PSEUDOMONAS  AERUGINOSA</i>, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL  COMPOSITION CONTAINING SAMEUNIVERSITé GRENOBLE ALPES
WO/2021/028180AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/013911INHIBITORS OF THE STING PATHWAY FOR THE TREATMENT OF  HIDRADENITIS SUPPURATIVAINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013921THE SERPINB3 INHIBITOR PIPERIDINPROPIONIC ACID FOR TUMOR  TREATMENTUNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/013942USE OF MYELOPEROXIDASE INHIBITORS FOR THE TREATMENT OF  CARDIOVASCULAR DISEASES IN PATIENTS SUFFERING FROM MYELOPROLIFERATIVE  NEOPLASMSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013944FAECALIBACTERIUM PRAUSNITZII AND CHRISTENSENELLA BACTERIAL  STRAINS FOR THE TREATMENT AND PREVENTION OF BOWEL INFLAMMATIONINSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE,  L’ALIMENTATION ET L’ENVIRONNEMENT
WO/2021/013950IMMUNE CELLS DEFECTIVE FOR SUV39H1MNEMO THERAPEUTICS
WO/2021/013951VETERINARY COMPOSITIONS COMPRISING MELATONIN AND THEIR USES  FOR RUMINANTSCEVA SANTE ANIMALE
WO/2021/018747HAIR TREATMENT COMPOSITIONUNILEVER GLOBAL IP LIMITED
WO/2021/018750OPHTHALMIC COMPOSITIONS COMPRISING VISCOSIFYING POLYMERS AND  NUCLEIC ACIDSPROQR THERAPEUTICS II B.V.
WO/2021/018754AN ANTIDANDRUFF COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/018755AN ANTIDANDRUFF COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/013973COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES  THEREOFALUMIER EUROPE LIMITED
WO/2021/013999RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATESONTOCHEM GMBH
WO/2021/018786USE OF FFAR2 AGONISTS FOR THE TREATMENT OF BACTERIAL  SUPERINFECTIONS POST-VIRAL INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/018792OSTEOCRIN, LEBETIN OR ANP FOR DESTROYING BACTERIAL BIOFILMSUNIVERSITé DE ROUEN-NORMANDIE
WO/2021/014014TREATMENT AND/OR PREVENTION OF LESIONS IN THE CENTRAL AUDITORY  NERVOUS SYSTEMSENSORION
WO/2021/018798COMPOSITION COMPRISING STEROL DERIVATIVES FOR USE IN THE  TREATMENT OF A NEURONAL PATHOLOGY RELATED TO HYPOXIA, HYPOGLYCEMIA AND/OR  HYPERGLYCEMIADENDROGENIX
WO/2021/014019SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOWSAPREME TECHNOLOGIES B.V.
WO/2021/018806IGG-DEPLETED PORCINE SERUM AND THE USES THEREOFCEVA SANTE ANIMALE
WO/2021/018816ALGINATE-BASED FACIAL MASKBEIERSDORF AG
WO/2021/018824USE OF  (R)-9-(2,5-DIFLUOROPHENETHYL)-4-ETHYL-2-METHYL-1-OXA-4,9-DIAZASPIRO[5.5]UNDECAN-3-ONE  FOR THE TREATMENT OF NOCICEPTIVE PAIN, NEUROPATHIC PAIN, OSTEOARTHRITIS PAIN  AND CANCER PAIN, WHILE HAVING REDUCED SIDE EFFECTS COMPARED TO OPIOIDSESTEVE PHARMACEUTICALS, S.A.
WO/2021/037455ACRYLATE AND SILICON-FREE COSMETIC O/W EMULSIONBEIERSDORF AG
WO/2021/037456ACRYLATE AND SILICON-FREE COSMETIC O/W EMULSIONBEIERSDORF AG
WO/2021/023547PREPARATION AND FULLY COMPOUNDED STOCK FOR USE IN MEDICAL OR  DENTAL APPLICATIONS, MEDICAL OR DENTAL PRODUCT AND USE AND PREPARATION  THEREOFGEBR. BRASSELER GMBH & CO. KG
WO/2021/014026BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETYSAPREME TECHNOLOGIES B.V.
WO/2021/014027PHOSPHOLIPASE-A2 INHIBITORS FOR THE PREVENTION OF CANCER  METASTASISCOEGIN PHARMA AS
WO/2021/018862SS-31 FOR THE PREVENTION AND/OR TREATMENT OF ANEURYSMFUNDACIó INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I  SANT PAU
WO/2021/018866MEK INHIBITOR FOR TREATMENT OF STROKEEDVINCE AB
WO/2021/018879PEPTIDES FOR USE AS SENOTHERAPEUTIC AGENTSFUNDACIóN PROFESOR NOVOA SANTOS
WO/2021/018898METHODS FOR TREATING TUMORSNH THERAGUIX
WO/2021/018899USE OF GDF15 AS A MARKER FOR EXERCISE MANAGEMENTINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/018917PROCESS FOR PREPARING ADHESIVE COMPOUNDS FOR USE IN A  TRANSDERMAL THERAPEUTIC SYSTEMLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/018923PEPTIDES AS INHIBITORS OF FIBROTIC MATRIX ACCUMULATIONMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/018928NEW PHARMACEUTICAL FORMULATIONF. HOFFMANN-LA ROCHE AG
WO/2021/018931COMPOSITIONS FOR THE TREATMENT OF ATOPIC DERMATITISDERMOPHISIOLOGIQUE S.R.L. SOCIETà BENEFIT
WO/2021/018934TREATMENT OF SEBACEOUS GLAND DISORDERSECHO PHARMACEUTICALS B.V.
WO/2021/018935TREATMENT OF AGING OR UV-DAMAGED SKINECHO PHARMACEUTICALS B.V.
WO/2021/018936TREATMENT OF INFLAMMATORY SKIN CONDITIONSECHO PHARMACEUTICALS B.V.
WO/2021/018950COSMETIC COMPOSITION WITH COMBINED FILLER AND SKIN  REGENERATIVE EFFECTGIULIANI S.P.A.
WO/2021/018965ACTIVATORS OF SIRTUINS AND USES THEREOFEPI-C S.R.L.
WO/2021/018967SEROTONERGIC AGENT AND 5-HT1A-RECEPTOR ANTAGONISTATLAS PHARMACEUTICALS BV
WO/2021/023600COMBINATION PRODUCT FOR HELPING MAINTAIN THE NATURAL DEFENSES  OF THE ORGANISM AND AIDING WITH RECOVERYURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/018990PREVENTION AND REDUCTION OF CORNIFICATION DISORDERS AND  RELATED COSMETIC AGENTSMERCK PATENT GMBH
WO/2021/023609COMBINATION OF A TYPE I PROTEIN ARGININE METHYLTRANSFERASE  (TYPE I PRMT) INHIBITOR AND A METHIONINE ADENOSYLTRANSFERASE II ALPHA (MAT2A)  INHIBITORGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/023616ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE  IN EPILEPSY OR SEIZURESH. LUNDBECK A/S
WO/2021/019023COMPOUNDS FOR USE IN A METHOD OF TREATING OR PREVENTING  NEUROLOGICAL AND/OR PSYCHIATRIC DISORDERSTHE BECKLEY FOUNDATION
WO/2021/019033DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR  PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY  CROVALIMABF. HOFFMANN-LA ROCHE AG
WO/2021/019036DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR  PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY  CROVALIMABF. HOFFMANN-LA ROCHE AG
WO/2021/023644NEUTRALIZING GRANZYME B FOR PROVIDING CARDIOPROTECTION IN A  SUBJECT WHO EXPERIENCED A MYOCARDIAL INFARCTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/023646MELANOCYTE-REGULATING PEPTIDESIDP DISCOVERY PHARMA, S.L.
WO/2021/019067VETERINARY COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF  CRYPTOSPORIDIOSISCEVA SANTE ANIMALE
WO/2021/019078LIPOSOMES AND USES THEREOFUNIVERSITà DEGLI STUDI DI MILANO - BICOCCA
WO/2021/019081C3/C5 CONVERTASE ASSAYSUNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF
WO/2021/019092TOPICAL COMPOSITIONSBAUSCH HEALTH IRELAND LIMITED
WO/2021/023673PROCESS FOR PREVENTING AND/OR TREATING TRANSPIRATION AND  ASSOCIATED COMPOSITIONL'OREAL
WO/2021/023675LACOSAMIDE FOR THE TREATMENT OF ADD/ADHDSANCHEZ, Hector Mario
WO/2021/019097MEMBRANE FILTRATION OF PLANT EXTRACTS BY MEANS OF CYCLODEXTRINBIONORICA SE
WO/2021/023691IMMUNOGENIC COMPOSITIONGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/023692PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D  POLYPEPTIDEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/023695COMBINATIONS OF OLIGOSACCHARIDES AND XYLITOL FOR  DERMATOLOGICAL TREATMENTMEDA PHARMA S.P.A.
WO/2021/023698ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE  TREATMENT OF CANCERLANTHIOPEP B.V
WO/2021/019102A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A  POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A  POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS  COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMESACM BIOLABS PTE LTD
WO/2021/023733TARGETED NANOPARTICLES OF WELL-DEFINED AND REPRODUCIBLE SIZESSTAMS DIAGNOSTICS GMBH
WO/2021/023796COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A  CELL COMPRISING HETEROCYCLIC COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND  THEIR APPLICATIONSPOLYPLUS TRANSFECTION
WO/2021/023798COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A  CELL COMPRISING TRIAZOLE COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR  APPLICATIONSPOLYPLUS TRANSFECTION
WO/2021/037511SUNSCREEN COMPOSITION WITHOUT CYCLOMETHICONESBEIERSDORF AG
WO/2021/028299VIRAL PARTICLES FOR USE IN TREATING SYNUCLEINOPATHIES SUCH AS  PARKINSON'S DISEASES BY GENE THERAPYFUNDACION PARA LA INVESTIGACION MEDICA APLICADA
WO/2021/023805COMPOUND FOR COMBINATION TREATMENTINITIATOR PHARMA A/S
WO/2021/023809ETIFOXINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO  ACTIVATED MAST CELLSMC SCIENCES UG
WO/2021/023811SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2  INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/023817SOLID COMPOSITION COMPRISING A PYY COMPOUND AND A SALT OF  N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/023820EXTRACT OF SILYBUM MARIANUM (L.) GAERTN. AKENES FOR PROMOTING  HAIR GROWTHPIERRE FABRE DERMO-COSMETIQUE
WO/2021/023837INHIBITION OF METASTASIS DEVELOPMENT BY NANGPTL-4DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/028328TOPICAL COMPOSITION COMPRISING A PROSTAGLANDIN ANALOGUENOVALIQ GMBH
WO/2021/023848METHOD OF PREPARING A SOLID DOSAGE FORM AND A LUBRICANTEVONIK OPERATIONS GMBH
WO/2021/023849DOWN STREAMING PROCESS FOR THE PRODUCTION OF POLYUNSATURATED  FATTY ACID SALTSEVONIK OPERATIONS GMBH
WO/2021/023850METHOD OF PREPARING A SOLID DOSAGE FORM AND A BINDEREVONIK OPERATIONS GMBH
WO/2021/023855SOLID COMPOSITIONS COMPRISING AN EGF(A) DERIVATIVE AND A SALT  OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/023857SOLUBILITY ENHANCEMENT OF POORLY SOLUBLE ACTIVESEVONIK OPERATIONS GMBH
WO/2021/028337PEPTIDE ANTIGENS AND USES THEREOFHUMANITAS MIRASOLE S.P.A.
WO/2021/028347HLA-DR/CII PEPTIDE COMPLEXES FOR TREATING ARTHRITISFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/028350PRODUCTION OF MHC II/CII COMPLEXESFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/023876GNRH ANTAGONISTS FOR THE TREATMENT OF ESTROGEN-DEPENDENT  DISORDERSOBSEVA S.A.
WO/2021/023877COMPOSITIONS AND METHODS FOR THE TREATMENT OF  ESTROGEN-DEPENDENT DISORDERSOBSEVA S.A.
WO/2021/023885LIQUID DRESSING COMPOSITIONS AND THEIR USESCAMBRIDGE ENTERPRISE LIMITED
WO/2021/023886LIQUID DRESSING COMPOSITIONS AND THEIR VETERINARY USESCAMBRIDGE ENTERPRISE LIMITED
WO/2021/037532METHOD FOR TRAINING PATIENTS WITH THERAPEUTIC GAS MIXTURESEGOROV, Egor
WO/2021/028402IMMUNOGENIC COMPOSITIONGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/028406CHIKUNGUNYA VACCINE FORMULATIONSVALNEVA SE
WO/2021/028407SINGLE SHOT CHIKUNGUNYA VIRUS VACCINEVALNEVA SE
WO/2021/028415PERSONAL HYGIENE PRODUCTCRODA INTERNATIONAL PLC
WO/2021/028438TARGETING WNK1 IN BLOOD CANCERSKØBENHAVNS UNIVERSITET
WO/2021/028456HOLLOW THREE-DIMENSIONAL UNIT MADE FROM RETINAL TISSUE AND USE  THEREOF IN THE TREATMENT OF RETINOPATHIESTREEFROG THERAPEUTICS
WO/2021/028469COMPOSITIONS AND METHODS FOR TREATING CYTOKINE RELEASE  SYNDROME AND NEUROTOXICITYSITOKINE LIMITED
WO/2021/028479COMPOSITIONS COMPRISING TIGOLANER FOR CONTROLLING PARASITESVETOQUINOL S.A.
WO/2021/028502IMPLANTABLE CAPSULEMAXIVAX SA
WO/2021/028529NON-OXIDATIVE HAIR DYE COMPOSITION AND METHODKAO CORPORATION
WO/2021/028530DYEING COMPOSITION, METHOD, USE, AND KIT-OF-PARTS THEREOFKAO CORPORATION
WO/2021/028532KIT-OF-PARTS AND COMPOSITION FOR DYEING OF KERATIN FIBERS,  METHOD, AND USE THEREOFKAO CORPORATION
WO/2021/028538MIRABEGRON COMPOSITION AND USES THEREOFBIOHORM S.L.
WO/2021/063581AN ORAL CARE SPRAY COMPOSITION COMPRISING HEXAMETAPHOSPHATEUNILEVER GLOBAL IP LIMITED
WO/2021/028559METHOD FOR OBTAINING EFFICIENT COMPOSITIONS COMPRISING VIRAL  VECTORS FOR VACCINATION OR GENE THERAPYLEUKOCARE AG
WO/2021/028578FILM FORMULATION COMPRISING CARRIERSKLARIA PHARMA HOLDING AB
WO/2021/032646STABILIZING BUFFER FOR FACTOR VIII AND VWFOCTAPHARMA AG
WO/2021/028585BACTERIUM COMPRISING MYO-INOSITOL TO PROPIONATE PATHWAYWAGENINGEN UNIVERSITEIT
WO/2021/032648COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASETHE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER  MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIV. TRINITY OF QUEEN
WO/2021/032650PEPTIDES FOR TREATING MUSCLE ATROPHYNURITAS LIMITED
WO/2021/028598REDUCTION OF BONE RESORPTION, ESPECIALLY IN CHRONIC JOINT  DISEASESTECHNISCHE UNIVERSITÄT DARMSTADT
WO/2021/032700COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCANBEIERSDORF AG
WO/2021/032777OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF USEMINA THERAPEUTICS LIMITED
WO/2021/037629COMPOSITION, PROCESS AND KIT FOR SEMI-PERMANENT STRAIGHTENING  AND CURLING OF KERATIN FIBERSKAO CORPORATION
WO/2021/032784PLATINUM ISOTOPE COMBINED WITH BONE-TARGETING AGENTS FOR USE  IN ANTICANCER DRUGSNUCLEAR RESEARCH AND CONSULTANCY GROUP
WO/2021/032807COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND  ALPHA-LACTOGLUBULIN-OLEIC ACID COMPLEX FOR CANCER THERAPYHAMLET PHARMA AB
WO/2021/037656SOLUBILIZED FOLIC ACIDAQUANOVA AG
WO/2021/037676HAIR TREATMENT COMPOSITION IN FOAM FORMATUNILEVER GLOBAL IP LIMITED
WO/2021/037679USE OF HAIR TREATMENT COMPOSITION IN FOAM FORMATUNILEVER GLOBAL IP LIMITED
WO/2021/058206KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUNDHENKEL AG & CO. KGAA
WO/2021/032861COMBINATION OF AN UROLITHIN WITH AN IMMUNOTHERAPY TREATMENTAMAZENTIS SA
WO/2021/037702PHARMACEUTICAL COMBINATION OF A SPECIFIC THIENOPYRIDONE  DERIVATIVE WITH AN FXR AGONIST FOR THE TREATMENT OF LIVER DISEASESPOXEL
WO/2021/032873COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA  (I), AT LEAST ONE ALKOXYSILANE OF FORMULA (II), AT LEAST ONE NONAMINO  SILICONE, AND OPTIONALLY PIGMENTS AND/OR DIRECT DYESL'OREAL
WO/2021/037713OIL SUBSTITUTE FOR COSMETIC PREPARATIONSBEIERSDORF AG
WO/2021/037714PARTICULARLY NATURAL OIL SUBSTITUTE FOR COSMETIC PREPARATIONSBEIERSDORF AG
WO/2021/037716PARTICULARLY NATURAL OIL SUBSTITUTE FOR COSMETIC PREPARATIONSBEIERSDORF AG
WO/2021/037717ETHYL-CELLULOSE-CONTAINING SUNSCREEN SPRAYBEIERSDORF AG
WO/2021/037719HYDROXYPROPYLCELLULOSE-CONTAINING SUNSCREEN SPRAYBEIERSDORF AG
WO/2021/037733TROPOELASTIN FOR USE IN TREATMENT OF ACNE SCARRINGALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/037750NOVEL COMPOUNDS FOR SKIN LIGHTENINGUNILEVER GLOBAL IP LIMITED
WO/2021/032883COMBINATION THERAPY OF A PATIENT SUBGROUPBERGENBIO ASA
WO/2021/032891BINDING MOLECULES TO ARGINASE II (ARG2)CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/032894NANOPARTICLE COMPOSITION COMPRISING CHITOSAN AND CLATHRINBIOCYTO LIMITED
WO/2021/052720METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A FILM-FORMING POLYMERHENKEL AG & CO. KGAA
WO/2021/052721METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/052722METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND AN  ACIDIFIERHENKEL AG & CO. KGAA
WO/2021/047900ORAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/037871SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B6DSM IP ASSETS B.V.
WO/2021/037873SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B1DSM IP ASSETS B.V.
WO/2021/037874SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B12DSM IP ASSETS B.V.
WO/2021/037933COMBINATION OF AZD2811 NANOPARTICLES, 5-AZACITIDINE AND  VENETOCLAX FOR USE IN THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/043656COMPOSITIONS CONTAINING DI-SUBSTITUTED TEREPHTHALATES AND  LIGHT PROTECTION FILTER SUBSTANCES, DEODORANTS AND/OR ANTIPERSPIRANTSEVONIK OPERATIONS GMBH
WO/2021/037956COMBINATIONS OF MEK INHIBITORS WITH CAP-DEPENDENT ENDONUCLEASE  INHIBITORSATRIVA THERAPEUTICS GMBH
WO/2021/037960PHARMACEUTICAL FORMULATIONKLARIA PHARMA HOLDING AB
WO/2021/038014CONTROLLED RELEASE TOFACITINIB COMPOSITIONSSYNTHON B.V.
WO/2021/043673P-GP INDUCERS AS PROTECTORS AGAINST CHEMOTHERAPY-INDUCED SIDE  EFFECTS, SUCH AS PERIPHERAL NEUROPATHY (CIPN) AND HAIR LOSSSYDDANSK UNIVERSITET
WO/2021/038022NEW USE OF CYCLIC DINUCLEOTIDESHELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/038029LOADED GRANULES, THEIR PROCESS OF PRODUCTION AND THEIR USESSAKSO
WO/2021/038035SCYLLO-INOSITOL AND B-CELL MEDIATED DISORDERSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/038036B CELL TARGETED PARALLEL CAR (pCAR) THERAPEUTIC AGENTSKING'S COLLEGE LONDON
WO/2021/038043TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND  HEPATOCELLULAR CARCINOMA (HCC) WITH COMPOUNDS BINDING THE ECTODOMAIN OF  PLATELET GLYCOPROTEIN IB (GPIB) ALPHADEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN  RECHTS
WO/2021/038062T CELL EPITOPES OF HCMV AND USES OF THEREOFEBERHARD KARLS UNIVERSITÄT TüBINGEN, MEDIZINISCHE FAKULTÄT
WO/2021/038076USE OF BETA-L-ASPARTYL-L-ARGININE ON SENESCENT SKINSYMRISE AG
WO/2021/038080TREATMENTPNEUMAGEN LTD
WO/2021/038084BIOADHESIVE PARTICLES COMPRISING ACTIVE AGENTS, AND USES  THEREOFSKINOSIVE
WO/2021/038097METHOD FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME USING AN  INHIBITORY OR CYTOTOXIC AGENT AGAINST PLASMA CELLSVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/043718ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING  6-AMINONICOTINAMIDEUNIVERSITE DE PICARDIE JULES VERNE
WO/2021/043719ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING  THIONICOTINAMIDEUNIVERSITE DE PICARDIE JULES VERNE
WO/2021/043721USE OF COSMETIC PREPARATIONS FOR IMPROVING THE VISIBILITY OF  SUBEPIDERMAL PIGMENTSBEIERSDORF AG
WO/2021/043723METHODS AND COMPOSITIONS FOR TREATING PAX6- DEFICIENCY RELATED  DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/043724USE OF PYRVINIUM FOR THE TREATMENT OF A RAS PATHWAY MUTATED  ACUTE MYELOID LEUKEMIAINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/043726OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO  IMPLANTATION AND PREVENTING MISCARRIAGEOBSEVA S.A.
WO/2021/063609BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM  BLUE LIGHTBEIERSDORF AG
WO/2021/063610NOVEL SUN PROTECTIVE AGENT CONTAINING BISMUTH OXYCHLORIDE FOR  PROTECTION AGAINST BLUE LIGHTBEIERSDORF AG
WO/2021/043757FACTOR VIII PROTEIN WITH INCREASED HALF-LIFEBIOTEST AG
WO/2021/058240PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ESTER OILHENKEL AG & CO. KGAA
WO/2021/058241KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUNDHENKEL AG & CO. KGAA
WO/2021/043771FORMULATIONS AND TREATMENT METHODSCAMURUS AB
WO/2021/052753RECOMBINANT ONCOLYTIC NEWCASTLE DISEASE VIRUSES WITH INCREASED  ACTIVITYTHALLER, Arno
WO/2021/047971METHOD FOR REMINERALIZING AND/OR REDUCING SENSITIVITY OF TEETHUNILEVER IP HOLDINGS B.V.
WO/2021/043799COSMETIC COMPOSITION FOR COATING KERATINIC FIBERS COMPRISING A  L-BETA LAMMELLAR PHASE, A CYCLIC CARBONATE AND AN ACID DYEL'OREAL
WO/2021/043803PROCESS FOR PRODUCING A TABLET COMPRISING GLP-1 PEPTIDESNOVO NORDISK A/S
WO/2021/043804IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDESINSTITUT CURIE
WO/2021/043835REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CELIAC  DISEASESQUARE POWER LTD
WO/2021/043840REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CANCERSQUARE POWER LTD
WO/2021/043846REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S  DISEASESQUARE POWER LTD
WO/2021/043869INFLUENZA VIRUS VACCINES AND USES THEREOFJANSSEN VACCINES & PREVENTION B.V.
WO/2021/249661ECOBIOLOGICAL LIPO-ALCOHOLIC COMPOSITIONNAOS INSTITUTE OF LIFE SCIENCE
WO/2021/043905VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERSORYZON GENOMICS, S.A.
WO/2021/047997ORAL CARE WATER-IN-OIL EMULSIONSUNILEVER IP HOLDINGS B.V.
WO/2021/043926MANGANESE CHELATE ISOMERSGE HEALTHCARE LIMITED
WO/2021/043927GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENTBOTALYS SA
WO/2021/043949LURBINECTEDIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMAPHARMA MAR S.A.
WO/2021/043951DRUG ANTIBODY CONJUGATESPHARMA MAR, S.A.
WO/2021/048003CHIMERIC FILOVIRUS VACCINESKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/043955COMPOSITIONS AND METHODS FOR TREATING EXTENSIVE STAGE SMALL  CELL LUNG CANCER (ES-SCLC)ASTRAZENECA AB
WO/2021/043961DOSING REGIMEN FOR THE TREATMENT OF CANCER WITH AN ANTI ICOS  AGONISTIC ANTIBODY AND CHEMOTHERAPYGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/052779ELECTROSTATICALLY SPRAYABLE COSMETIC FORMULATIONIONIQ SKINCARE GMBH & CO. KG
WO/2021/044013USE OF A COMPOSITION CONTAINING AN EXTRACT OF TULIPA  GESNERIANAFRANCE COSMEPHYL-LAB
WO/2021/044045OPHTHALMIC COMPOSITION FOR THE TREATMENT OF UVEITISNOVALIQ GMBH
WO/2021/048034GLUCOCEREBROSIDASE MUTANTSF. HOFFMANN-LA ROCHE AG
WO/2021/048041ORAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/044058FAST CONSOLIDATING COMPOUNDSUNIVERSITÄT INNSBRUCK
WO/2021/044061TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC  ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENTKLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITÄT MüNCHEN
WO/2021/048081IMMUNOTHERAPEUTIC COMPOSITIONSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/052811NEW ONCOLYTIC NEWCASTLE DISEASE VIRUSES AND RECOMBINANT NDV  STRAINSTHALLER, Arno
WO/2021/048129USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND  CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/048135PHARMACEUTICAL COMBINATIONS COMPRISING A  FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR USE IN THE TREATMENT OF  NEOPLASTIC DISEASESBASILEA PHARMACEUTICA INTERNATIONAL AG
WO/2021/048162COMPOUND FOR INHIBITING CELL DEATHCHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL
WO/2021/048171METHOD TO IMPROVE PHAGOCYTOSISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/048172DELIVERY VEHICLE FOR IN SITU DELIVERING OF PHARMACEUTICAL  AGENTSRIVER STONE BIOTECH APS
WO/2021/048235TREATMENT OF HR DEFICIENT CANCERTHE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/048266TREATMENT OF TYPE 2 DIABETES MELLITUSSANOFI
WO/2021/048268USE OF HDL IN THE PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASEETABLISSEMENT FRANÇAIS DU SANG
WO/2021/052855STABLE PERFUMING COMPOSITIONS HAVING GOOD SPRAY PROPERTIESSOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/052856STABILIZER CONCENTRATES FOR WAX DISPERSIONSBASF SE
WO/2021/048283METHOD FOR PROMOTING WEIGHT LOSS BY ADMINISTERING A DIET RICH  IN ARABINOXYLAN OLIGOSACCHARIDESUNIVERSITY OF COPENHAGEN
WO/2021/048313DENTAL COMPOSITIONDENTSPLY SIRONA INC.
WO/2021/048314REBAMIPIDE FOR USE IN PREVENTION AND/OR TREATMENT OF ARTERIAL  STIFFNESSSQUARE POWER LTD
WO/2021/048315USE OF DUOX1 INHIBITORS FOR TREATING CANCERINSTITUT GUSTAVE ROUSSY
WO/2021/048322GOLF BALL-LIKE MICROPARTICLES FOR USE IN THE TREATMENT AND  PREVENTION OF PULMONARY DISEASESAQUILON PHARMACEUTICALS
WO/2021/223894PEPTIDE FOR PREVENTION OR TREATMENT OF COVID-19APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH
WO/2021/052877PREMIX AND COMPOSITION AND METHODS OF PREPARING THE SAMEUNILEVER IP HOLDINGS B.V.
WO/2021/048338COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATIONINTERVET INTERNATIONAL B.V.
WO/2021/048339VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCERTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/048359METHODS OF TREATING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)  USING IL-17RA ANTIBODYBAUSCH HEALTH IRELAND LIMITED
WO/2021/048402LASSAVIRUS VACCINESKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/048412COMBINATION THERAPIES COMPRISING PANOBINOSTAT FOR THE  TREATMENT OF CHOLANGIOCARCINOMASEALD AS
WO/2021/048417COMBINATION THERAPIES COMPRISING DASATINIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMASEALD AS
WO/2021/048418COMBINATION THERAPIES COMPRISING BORTEZOMIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMASEALD AS
WO/2021/048419COMBINATION THERAPIES COMPRISING TRAMETINIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMASEALD AS
WO/2021/048430COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASESAMABIOTICS
WO/2021/048431COMPOUNDS FOR TREATING ATAXIAAMABIOTICS
WO/2021/104700METHOD FOR IMPROVING COLOUR RETENTION OF DYED KERATINOUS  MATERIAL, ESPECIALLY HUMAN HAIRHENKEL AG & CO. KGAA
WO/2021/104701IMPROVING THE PERFORMANCE OF PIGMENT-BASED DYES BY USING A  PRETREAMENT AGENTHENKEL AG & CO. KGAA
WO/2021/104702METHOD FOR IMPROVING THE TACTILE SENSATION OF DYED KERATINOUS  MATERIAL, ESPECIALLY HUMAN HAIRHENKEL AG & CO. KGAA
WO/2021/104703AGENT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND PHOSPHOROUS-CONTAINING SURFACTANTHENKEL AG & CO. KGAA
WO/2021/048436POLYETHYLENE GLYCOL FOR USE IN THE TREATMENT AND PREVENTION OF  ABDOMINAL INFLAMMATORY DISEASES AND/OR ASSOCIATED DISEASESCONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/104704PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, PIGMENT, POLYSACCHARIDE AND A FATTY CONSTITUENTHENKEL AG & CO. KGAA
WO/2021/048438INHIBITOR OF METADHERIN EXPRESSIONSECARNA PHARMACEUTICALS GMBH & CO. KG
WO/2021/048441METHOD AND APPARATUS FOR CELL ISOLATION AND ISOLATED CELLS FOR  WOUND HEALINGVERITACELL
WO/2021/052923ACTIVE SUBSTANCE DELIVERY SYSTEM WITH DELAYED DELIVERYCAPNOMED GMBH
WO/2021/052926AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMIC  DISORDERSCHIESI FARMACEUTICI S.P.A.
WO/2021/052952METHODS OF TREATMENT AND/OR PREVENTION OF DISORDERS AND  SYMPTOMS RELATED TO BKCA AND/OR SK CHANNELOPHATHIESUNIVERSITE DE BORDEAUX
WO/2021/052960STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITIONADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/052962TREATMENT OF SPINAL CORD INJURYINSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/053001CAMPHORSULFONIC ACID AND COMBINATIONS THEREOF WITH CATIONIC  EXCIPIENTS AS VISCOSITY REDUCING AGENTS IN HIGH CONCENTRATED PROTEIN  FORMULATIONSMERCK PATENT GMBH
WO/2021/053018TARGETING MISSPLICED TRANSCRIPTS IN GENETIC DISORDERSUNIQURE IP B.V.
WO/2021/063686AN ORAL CARE COMPOSITION COMPRISING HEXAMETAPHOSPHATE AND A  PIGMENTUNILEVER IP HOLDINGS B.V.
WO/2021/053040METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITSADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/053047BIOACTIVE IMPLANTS FOR DRUG DELIVERYTHE QUEEN'S UNIVERSITY OF BELFAST
WO/2021/053058ALVELESTAT FOR USE IN THE TREATMENT OF GRAFT REJECTION,  BRONCHIOLITIS OBLITERANS SYNDROME AND GRAFT VERSUS HOST DISEASEMEREO BIOPHARMA 4 LIMITED
WO/2021/115648DOSAGE FORM COMPRISING AN ALKALINE AGENT AND AN ENTERIC  COATING LAYEREVONIK OPERATIONS GMBH
WO/2021/115649DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASEEVONIK OPERATIONS GMBH
WO/2021/115650DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASEEVONIK OPERATIONS GMBH
WO/2021/053076COMBINATION THERAPY WITH VILDAGLIPTIN AND METFORMINNOVARTIS AG
WO/2021/053078NICOTINE POUCHENORAMA PHARMA AB
WO/2021/053093ANTIPERSPIRANT COMPOSITIONSUNILEVER IP HOLDINGS B.V.
WO/2021/053126METHOD OF TREATING HBV INFECTION USING A CORE PROTEIN  ALLOSTERIC MODULATORF. HOFFMANN-LA ROCHE AG
WO/2021/053155COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF AN ANTIAPOPTOTIC BCL-2 FAMILY PROTEINAPREA THERAPEUTICS AB
WO/2021/053163IMMUNE STIMULATING MICELLE COMPOSITIONDANMARKS TEKNISKE UNIVERSITET
WO/2021/053167EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASEAMW GMBH
WO/2021/053171EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASEAMW GMBH
WO/2021/053173METHODS FOR TRIGGERING M1 MACROPHAGE POLARIZATIONNH THERAGUIX
WO/2021/053178PREPARATION FOR REMOVAL AND/OR PREVENTION OF AN INFECTION  ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIDISRLS GLOBAL AB
WO/2021/053185MELFLUFEN FORMULATIONS AND THEIR USE IN THE TREATMENT OR  PROPHYLAXIS OF OSTEOSARCOMAONCOPEPTIDES AB
WO/2021/053194KV1.3 BLOCKERSZEALAND PHARMA A/S
WO/2021/053198POLYMER OR POLYCONDENSATE BASED ON PEPTIDE, LINKER AND  OPTIONALLY OTHER MONOMERS AND METHOD FOR PREPARING THE SAMEECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/058423COMPOSITION WITH DRUG MICRO-NANO PARTICLES OF AN ANTI-CANCER  AGENTCAPNOMED GMBH
WO/2021/058428COMPOSITIONS FOR USE IN REDUCING INFLAMMATIONEVONIK OPERATIONS GMBH
WO/2021/053234COMPOUNDS AND COMPOSITIONS FOR TREATING KIDNEY DISEASEJOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/053240A NOVEL HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USEUNIVERSITEIT ANTWERPEN
WO/2021/063727A POUCH PRODUCT SUITABLE FOR APPLICATION IN AN ORAL CAVITYSCHJÖLIN, Evaggelos
WO/2021/053246ORAL DELIVERY SYSTEMUNIVERSITY COLLEGE DUBLIN
WO/2021/063734CDK4/6 INHIBITORS FOR THE TREATMENT OF PSORIASISEBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/063737AGENT FOR THE TREATMENT OF PSORIASISEBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/058454NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR  INHALATIONCHIESI FARMACEUTICI S.P.A.
WO/2021/058463A LIPOSOME SYSTEM COMPRISING A LIPID, AN ACTIVE COMPOUND AND A  VECTOR PEPTIDEWESTFÄLISCHE WILHELMS-UNIVERSITÄT MüNSTER
WO/2021/058472TREATMENT INVOLVING THERAPEUTIC ANTIBODY AND INTERLEUKIN-2  (IL2)BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/058492NANOPARTICLE COMPOSITIONS FOR GENE THERAPYUNIVERSITY COLLEGE DUBLIN
WO/2021/104709METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED BY APPLYING A PIGMENTHENKEL AG & CO. KGAA
WO/2021/104710METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN AMINO SILICONE AND A PIGMENTHENKEL AG & CO. KGAA
WO/2021/058514COMPOSITIONS AND METHODS USING ADENOSYLCOBALAMINSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/058521A TOPICAL PLANT EXTRACT FORMULATION COMPRISING URTICA DIOICA  AND VITAMIN ATHE CEUTICS COMPANY GESMBH
WO/2021/058549RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTICADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/058604HYPOCHLORITE COMPOSITION AND SYSTEM AND METHOD FOR PREPARING A  HYPOCHLORITE COMPOSITION AND USE OF THE SAMEKONINKLIJKE PHILIPS N.V.
WO/2021/058611KIT, SYSTEM AND METHOD FOR PREPARING AND USE OF A  PEROXIDE-CONTAINING COMPOSITIONKONINKLIJKE PHILIPS N.V.
WO/2021/058628SCYLLO-INOSITOL AND ITS USE AS INSULIN SENSITIZERSOCIéTé DES PRODUITS NESTLé SA
WO/2021/058636ANTI-NRP1A ANTIBODIES AND THEIR USES FOR TREATING EYE OR  OCULAR DISEASESBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/058651HYDROGEL COMPOSITIONS FOR THE CONTROLLED AND CONSTANT RELEASE  OF ACTIVE AGENTSTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/058656RIFAXIMIN LIQUID FORMULATIONSBAUSCH HEALTH IRELAND LIMITED
WO/2021/058670PHARMACEUTICAL DELIVERY DEVICE AND METHOD OF MANUFACTUREUNIVERSITY OF ULSTER
WO/2021/058679POWDER AND PROCESS FOR CLEANING TEETH BY USE OF SUCH POWDERFERTON HOLDING S.A.
WO/2021/058684MODIFIED VESICULAR STOMATITIS VIRUS GLYCOPROTEIN AND USES  THEREOF FOR THE TREATMENT OF BRAIN TUMORSUNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/058715HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERSBMG PHARMA S.P.A.
WO/2021/063813PROCESS FOR PREPARING NANOPARTICLES IN THE FORM OF A POWDER  COMPRISING A BIO-RESORBABLE POLYESTEREVONIK OPERATIONS GMBH
WO/2021/058744USE OF MüLLERIAN INHIBITING SUBSTANCE INHIBITORS FOR TREATING  CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/058758CELL COMPOSITION COMPRISING RADIOLABLED MESENCHYMAL STEM  CELLS, USE THEREOF AND METHOD FOR PREPARING RADIOLABELED MESENCHYMAL STEM  CELLSGLOBAL STEM CELL TECHNOLOGY NV
WO/2021/058794DOSING REGIMENS FOR TREATMENT OF PATIENTS WITH LOCALLY  ADVANCED SQUAMOUS CELL CARCINOMADEBIOPHARM INTERNATIONAL S.A.
WO/2021/058798USE OF FGFR INHIBITORS IN FGFR-GENETICALLY ALTERED CANCERS TO  ENHANCE PATIENT RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN SEQUENTIAL  TREATMENT SETTINGSJANSSEN PHARMACEUTICA NV
WO/2021/058810PEDIATRIC TRAZODONE COMPOSITIONS AND METHOD OF TREATMENT  THEREOFANGELINI S.P.A.
WO/2021/058811SHORT-CHAIN FATTY ACID PENTANOATE AS ENHANCER FOR CELLULAR  THERAPY AND ANTI-TUMOR THERAPYPHILIPPS-UNIVERSITÄT MARBURG
WO/2021/058818NOVEL MEDICAL USES OF THIOL-FUNCTIONALIZED POLYGLYCEROL  DERIVATIVESFREIE UNIVERSITÄT BERLIN
WO/2021/083593LAG TIME REDUCTION/ICE SPRAYLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/058831THERAPEUTIC EFFICACY BY PULMONARY DELIVERY OF LIVE ATTENUATED  MYCOBACTERIAUNIVERSIDAD DE ZARAGOZA
WO/2021/058835CONTROL OF TUMOUR GROWTH AND GUT BLEEDING BY BIOSURFACTANTSUNIVERSITY OF ULSTER
WO/2021/063917VACCINE AGAINST CHLAMYDIA IN SWINEUNIVERSITEIT GENT
WO/2021/069256SILICA FOR ORAL CARE COMPOSITIONSRHODIA OPERATIONS
WO/2021/063945COMBINED THERAPY COMPRISING AN INHIBITOR OF INTERLEUKIN-17  ACTIVITY AND A VITAMIN D RECEPTOR AGONISTSERVEI DE SALUT DE LES ILLES BALEARS – IBSALUT
WO/2021/064009PROTEIN BINDERS TO IRHOM2 EPITOPESSCIRHOM GMBH
WO/2021/064034A PUNICA GRANATUM EXTRACT AND ITS COSMETIC USESL'OREAL
WO/2021/064050IMMUNOGENIC COMPOSITIONSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/064072USE OF RETINOIC ACID RECEPTOR (RAR) AGONISTS FOR REVERSING,  PREVENTING, OR DELAYING CALCIFICATION OF AORTIC VALVEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064076LIPOSOMES COMPRISING ANTI-LOX ANTIBODYISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI  TUMORI (I.R.S.T.) S.R.L.
WO/2021/064088BETA-GLUCANS HAVING SUPERIOR IMMUNO-STIMULATING PROPERTIESUNIVERSITEIT GENT
WO/2021/064105EXTRACT OF ORGANIC HUMIFIED MATERIALSFELLNER, Stefan Johannes
WO/2021/064116COMPOSITIONS WITH POLYMERIC OR OLIGOMERIC HYDROXY PHENYL  TRIAZINE UV FILTERBASF SE
WO/2021/064123PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDESYNTHON B.V.
WO/2021/064132TREATMENT OF MENOPAUSAL SYNDROME AND/OR SYMPTOMS ASSOCIATED  WITH MENOPAUSEBESINS HEALTHCARE IRELAND LIMITED
WO/2021/064151COMBINATION OF THE ETHYL ESTERS OF DOCOSAHEXAENOIC AND  EICOSAPENTAENOIC ACID PLUS VITAMIN D3 FOR PREVENTION OF AGE-RELATED DISEASESUNIVERSITÄT ZüRICH
WO/2021/064167COMBINATION PRODUCT FOR RELIEVING THE BRONCHIURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/064169COMBINATION PRODUCT FOR RELIEVING THE BRONCHI AND FACILITATING  FALLING ASLEEPURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/064173USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTI-GLYCATION  ANTI-AGEING SKIN TREATMENTSEDERMA
WO/2021/064180METHODS AND COMPOSITIONS FOR MODULATING MACROPHAGES  POLARIZATIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064184METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF  OVARIAN CANCER, BREAST CANCER OR PANCREATIC CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064197ISOLATED POLYPEPTIDE AND POLYPEPTIDE COMPLEXES FOR PREVENTION,  ALLEVIATION AND/OR TREATMENT OF HCV INFECTIONSKØBENHAVNS UNIVERSITET
WO/2021/064217METHOD FOR TREATING AND/OR PREVENTING A PARASITIC INFECTION IN  A TELEOSTPREVIWO AS
WO/2021/064227SINGLE DOMAIN ANTIBODIES SPECIFICALLY BINDING GLOBO - SERIES  GLYCANSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/069344PROCESS FOR THE PREPARATION OF A NANOPARTICULATE ACTIVE  INGREDIENTBAYER AKTIENGESELLSCHAFT
WO/2021/069345PROCESS FOR PRODUCING NANOPARTICULATE RIVAROXABANBAYER AKTIENGESELLSCHAFT
WO/2021/069349PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING  CRYSTALLINE AND AMORPHOUS FRACTIONS OF AN ACTIVE SUBSTANCEBAYER AKTIENGESELLSCHAFT
WO/2021/069350PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING  ACTIVE SUBSTANCE, POLYMER AND SURFACTANTBAYER AKTIENGESELLSCHAFT
WO/2021/083616HAIR CARE COMPOSITIONGIVAUDAN SA
WO/2021/069426PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN  AND ITS APPENDAGESSEDERMA
WO/2021/073961SOLUTION OF CELLULOSE IN A QUATERNARY AMMONIUM COMPOUND AND A  CO-SOLVENTBASF SE
WO/2021/104728BIODEGRADABLE BEADSBASF SE
WO/2021/104729BIODEGRADABLE BEADS WITH DYES AND PIGMENTSBASF SE
WO/2021/069486MEK INHIBITORS FOR THE TREATMENT OF HANTAVIRUS INFECTIONSATRIVA THERAPEUTICS GMBH
WO/2021/069496AN ANHYDROUS PHARMACEUTICAL COMPOSITION FOR MAINTENANCE  TREATMENT OF PSORIASISLEO PHARMA A/S
WO/2021/069497SYSTEMIC ADMINISTRATION OF PEPTIDES FOR THE TREATMENT OF  SPINAL CORD INJURY AND/OR FOR REMYELINATIONAXOLTIS PHARMA
WO/2021/069523CALRETICULIN FOR TREATING OR PREVENTING AN ANGIOGENIC EYE  DISEASEUAB BALTYMAS
WO/2021/069527NON-DEGRADABLE EMBOLISATION MICROSPHEREGUERBET
WO/2021/069528NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHEREGUERBET
WO/2021/069533HAIR TREATMENT COMPOSITIONSUNILEVER IP HOLDINGS B.V.
WO/2021/073988ANTIPERSPIRANT EMULSIONUNILEVER IP HOLDINGS B.V.
WO/2021/073989AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/069542ZAFIRLUKAST DERIVATIVES FOR USE AS CONTRACEPTIVE AGENTSRIGSHOSPITALET
WO/2021/069553USE OF LIVER PROGENITOR OR STEM CELLS, LYSATES THEREOF, AND/OR  CONDITIONED MEDIUM IN DISORDERS CHARACTERIZED BY VASCULAR HYPERPERMEABILITYPROMETHERA BIOSCIENCES S.A./N.V.
WO/2021/069558COMPOSITIONS OF THE OLEA EUROPAEA V. SYLVESTRIS WITH  ANTIMICROBIAL EFFICACYTAPROGGE GMBH
WO/2021/069576A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOIDBLACKHAWK PARTNERS LTD
WO/2021/069578RIBOFLAVIN FOR USE IN CONTROLLING BLOOD PRESSURE DURING  PREGNANCYDSM IP ASSETS B.V.
WO/2021/069590GELATIN CAPSULES WITH GROUND CALCIUM CARBONATECAPSUGEL FRANCE SAS
WO/2021/069615IMPROVED ANTI-HANGOVER COMPOSITION, ITS PREPARATION AND USESZOBRIUS PHARMA AS
WO/2021/074012HAIR TREATMENT METHODUNILEVER IP HOLDINGS B.V.
WO/2021/074025USE OF ESCULENTIN AND ITS DERIVATIVES FOR USE IN THE TREATMENT  OF CYSTIC FIBROSISUNIVERSITà DEGLI STUDI DI ROMA “LA SAPIENZA”
WO/2021/069685FLUORESCENT VANCOMYCIN ANALOGUEUNIVERSITE DE STRASBOURG
WO/2021/069686NOVEL THERAPEUTIC COMBINATIONS COMPRISING DERIVATIVES OF  OXAZAPHOSPHORINES FOR THE TREATMENT OF CANCERINSTITUT GUSTAVE ROUSSY
WO/2021/069698HEALING AND CONDUCTIVE COMPOSITION COMPRISING COLLAGENMONDERNA HEALTH & WELLNESS
WO/2021/204409OLEYL PHOSPHOCHOLINE CONTAINING GRANULATESOBLITA THERAPEUTICS BVBA
WO/2021/069705ISOINDOLINONE COMPOUNDSMONTE ROSA THERAPEUTICS
WO/2021/069709ANTI-CHEMOKIN LIKE RECEPTOR 1 HUMANIZED ANTIBODIES AND THEIR  THERAPEUTIC APPLICATIONSOSE IMMUNOTHERAPEUTICS
WO/2021/078553NOVEL PEDIATRIC COMBINATIONCESSATECH A/S
WO/2021/069740METHOD FOR PREVENTING HUMAN GLANDS FROM RADIATION DAMAGEKCM CONSULTING GMBH
WO/2021/083657COSMETIC PREPARATION COMPRISING ALKALINE EARTH METAL SALTS,  CARBOXYLIC ACIDS AND EMULSIFIERS HAVING BRANCHED HYDROPHOBIC CHAINSBEIERSDORF AG
WO/2021/089278MICROMETRIC SIZE COMPOSITION AND ITS USE AS A PLANT ALKALOID  COADJUVANT AGENTBEIJING ENBIWO BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/074118LIQUID OMEGA-3 FATTY ACID COMPOSITIONS FOR DIRECT ORAL  ADMINISTRATIONHERMES ARZNEIMITTEL GMBH
WO/2021/110306MULTI-TONE HAIR DYEING METHOD IN THREE STEPSHENKEL AG & CO. KGAA
WO/2021/115664HAIR STYLING COMPOSITION I CONTAINING SUGARHENKEL AG & CO. KGAA
WO/2021/074158ORAL CARE COMPOSITIONLACER, S.A.
WO/2021/074159MEMBRANE-BASED TWO COMPONENT THERAPEUTIC GAS RELEASE SYSTEM  FOR ORAL ADMINISTRATIONJULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/074164ORAL CARE COMPOSITIONLACER, S.A.
WO/2021/074198NOVEL TETRAZOLESBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/074261B-LYMPHOCYTE SPECIFIC AMATOXIN ANTIBODY CONJUGATESHEIDELBERG PHARMA RESEARCH GMBH
WO/2021/074284USE OF NICOTINAMIDE MONONUCLEOTIDE (NMN) FOR THE PREVENTION  AND/OR TREATMENT OF RHEUMATOID ARTHRITIS, AND CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/074314AQUEOUS FORMULATIONS COMPRISING BUFFERED TIOTROPIUM BROMIDE  FOR TOPICAL TREATMENT OF HYPERHIDROSISNOTOXINS IP B.V.
WO/2021/074352NOVEL VACCINE COMPOSITIONSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/074357THIOPHENE DERIVATIVES FOR USE IN TREATING PORTAL INFLAMMATION  AND FIBROSISENYO PHARMA
WO/2021/121715METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND,  A  HYDROXYCARBOXYLIC ACID ESTER, A COLOURING COMPOUND AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/121716METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, SHELLAC,  A  DYEING COMPOUND AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/121717METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  DYEING COMPOUND AND A OLIGOMERESTERHENKEL AG & CO. KGAA
WO/2021/121718METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND  TANNIC ACIDHENKEL AG & CO. KGAA
WO/2021/0893004-[5-[(RAC)-1-[5-(3-CHLOROPHENYL)-3-ISOXAZOLYL]ETHOXY]-4-METHYL-4<i>H</i>-1,2,4-TRIAZOL-3-YL]PYRIDINE  FOR USE IN PREVENTION AND/OR TREATMENT OF SURMENAGE IN A MAMMALTHULIN, Claes
WO/2021/121721METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A DYEING COMPOUND AND A PRE-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/074368IRON(III) COMPLEXES HAVING NEW CONTRAST AGENT PROPERTIES, FOR  MAGNETIC RESONANCE IMAGINGCHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/121722METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A HYDROXYCARBOXYLIC ACID ESTER,  C<sb>1</sb>-C<sb>10</sb> ALCOHOL AND A DYEING  COMPOUNDHENKEL AG & CO. KGAA
WO/2021/121723METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN HYDROXYCARBOXYLIC ACID ESTER, A DIOL AND A  DYEING COMPOUNDHENKEL AG & CO. KGAA
WO/2021/121724METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE, A  DYEING COMPOUND AND SHELLACHENKEL AG & CO. KGAA
WO/2021/121725METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  COPOLYMER OF (METH)ACRYLIC ACID AND MALEIC ACID (ANHYDRIDE)HENKEL AG & CO. KGAA
WO/2021/121726METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE, A  DYEING COMPOUND AND  GALACTOMANNANHENKEL AG & CO. KGAA
WO/2021/121727METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  COPOLYMER OF STYRENE AND MALEIC ACID (ANHYDRIDE)HENKEL AG & CO. KGAA
WO/2021/074398A PROCESS FOR PRODUCING MICROPARTICLES FOR USE AS MICROBEADS  AND MICROPARTICLES PRODUCED ACCORDING TO THE PROCESSSEAGREEN BIO LIMITED
WO/2021/074399CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC  PHYSIOLOGICALLY ACTIVE SUBSTANCESADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/074403CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC  PHYSIOLOGICALLY ACTIVE SUBSTANCESADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/074409COMPOSITION FOR THE TREATMENT OF (PRE)OBESITY AND/OR  ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/074423VACCINE PRODUCTJANSSEN VACCINES & PREVENTION B.V.
WO/2021/074431MICROBIAL COMPOSITIONS, STRAINS AND METHODSUNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
WO/2021/110313METHOD FOR COLOURING KERATIN MATERIAL, COMPRISING THE USE OF  AN ORGANIC C1-C6 ALKOXY SILANE AND TWO STRUCTURALLY DIFFERENT CELLULOSE TYPESHENKEL AG & CO. KGAA
WO/2021/089306ANTI-INFLAMMATORY COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/110314METHOD FOR COLOURING KERATIN MATERIAL, COMPRISING THE USE OF  AN ORGANIC C1-C6 ALKOXYSILANE AND FIBRESHENKEL AG & CO. KGAA
WO/2021/078685METHOD OF REDUCING DENTAL HYPERSENSITIVITYUNILEVER IP HOLDINGS B.V.
WO/2021/074452COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYL  PHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID  DERIVATIVES WITH CLINDAMYCIN AND ARTESUNATEDMG DEUTSCHE MALARIA GMBH
WO/2021/078726PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTSBRACCO IMAGING SPA
WO/2021/197646AQUEOUS OCTENIDINE-CONTAINING COMPOSITION FOR TREATING AND/OR  PREVENTING AN EXACERBATION OF DISEASES CAUSED BY A CORONAVIRUS INFECTIONSCHüLKE & MAYR GMBH
WO/2021/078761TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL  ADMINISTRATION OF FINGOLIMODLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/121734MODIFIED GRPR ANTAGONIST PEPTIDES FOR IMAGING AND THERAPY OF  CANCERTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/083766TREATMENT OF PRURITUS IN HORSESEVAX AG
WO/2021/078810SCHIZOPHRENIC DISORDER TREATMENT USING COMBINATION THERAPYCAMBRIDGE COGNITION LTD.
WO/2021/078814USE OF CYCLODEXTRINS AS A RADIOSTABILIZERGE HEALTHCARE LIMITED
WO/2021/078835PHARMACEUTICAL COMPOSITION COMPRISING SELEXIPAGACTELION PHARMACEUTICALS LTD
WO/2021/078864COMPOSITIONS FOR THE TREATMENT OF EPITHELIAL LESIONSGIELLEPI S.P.A.
WO/2021/078889METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE WITH  A FERROPORTIN INHIBITOR (VIT-2763)VIFOR (INTERNATIONAL) AG
WO/2021/078910IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDESINSTITUT CURIE
WO/2021/078912TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASENURITAS LIMITED
WO/2021/078920COMPOSITIONS COMPRISING 2'-FUCOSYLLACTOSE TO PREVENT ASTHMAFRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/078925METHODS OF TREATING CANCERASTRAZENECA AB
WO/2021/078939RNA OLIGONUCLEOTIDES FOR PREVENTING AGGREGATION OF PROTEINSUNIVERSITÄT WIEN
WO/2021/078952ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL  COMPOSITION COMPRISING SAMESORBONNE UNIVERSITE
WO/2021/078958COMPOUNDS FOR USE (IN PARTICULAR RIPA-56) IN THE PREVENTION  AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASESORBONNE UNIVERSITE
WO/2021/078964ORAL GLIPTIN COMPOSITIONS AND METHOD FOR PREPARATION THEREOFAUTHENDA PHARMACEUTICALS AG
WO/2021/078982PRODUCT FOR COSMETIC SKIN CARES.I.P.R.E.S. S.R.L.
WO/2021/078987COMBINATION TREATMENTS FOR CANCERCELEX ONCOLOGY INNOVATIONS LIMITED
WO/2021/078988RECOMBINANT L-ASPARAGINASEJAZZ PHARMACEUTICALS IRELAND LTD.
WO/2021/078991TREATMENT OF CONDITIONS OF THE NERVOUS SYSTEMKWOK, Jessica
WO/2021/104770ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL UND GLYCERYL  STEARATE CITRATE AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID  ACTIVE SUBSTANCE COMBINATIONSBEIERSDORF AG
WO/2021/104777ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND ONE OR MORE  EMULSIFIERS FROM THE GROUP OF PHOSPHATES AND SULFATES, AND COSMETIC OR  DERMATOLOGICAL PREPARATIONS CONTAINING SUCH ACTIVE SUBSTANCE COMBINATIONSBEIERSDORF AG
WO/2021/079010ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS  THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER  NEURODEGENERATIVE CONDITIONSINSTITUT PASTEUR DE MONTEVIDEO
WO/2021/099072HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/099073HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/104780ANTIMICROBIAL COMPOSITIONS COMPRISING MODIFIED CLAY AND  COPOLYMERSUNILEVER IP HOLDINGS B.V.
WO/2021/083867PHARMACEUTICAL COMPOSITION INCLUDING A SYNERGISTIC COMBINATION  OF IBUPROFEN AND N-ACETYLCYSTEINEE-PHARMA TRENTO S.P.A.
WO/2021/083899PROCESS FOR PREPARING A DYE COMPOSITION COMPRISING THE MIXING  OF SOLID PARTICLES WITH AN AQUEOUS COMPOSITION CONTAINING ARGININE, AND THE  USE THEREOFL'OREAL
WO/2021/083901PROCESS FOR PREPARING A DYE COMPOSITION, COMPRISING THE MIXING  OF AT LEAST TWO TYPES OF SOLID PARTICLES WITH AN AQUEOUS COMPOSITION, AND USE  THEREOFL'OREAL
WO/2021/083902ALKALINE COMPOSITION COMPRISING AT LEAST THREE DIFFERENT  ALKALINE AGENTS FOR THE TREATMENT OF KERATIN FIBRES, METHODS AND USESL'OREAL
WO/2021/083903COATED COLOURING SOLID PARTICLES COMPRISING AT LEAST ONE  DIRECT DYE AND/OR ONE OXIDATION DYE PRECURSORL'OREAL
WO/2021/083904PROCESS FOR PREPARING A DYE COMPOSITION BY MIXING SOLID  PARTICLES AND AN OXIDIZING COMPOSITION AND AN ALKALINE COMPOSITIONL'OREAL
WO/2021/083910DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINEASTRAZENECA AB
WO/2021/083912COMBINATION THERAPY HAVING ANTIOXYDANT PROPERTIESGENFIT
WO/2021/083919COMPOSITION CONTAINING PREBIOTIC BACTERIA AND LICOCHALCONE ABEIERSDORF AG
WO/2021/083920COMPOSITION CONTAINING PREBIOTIC BACTERIA AND PROTECTOR  STRAINSBEIERSDORF AG
WO/2021/104782USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL  PREPARATIONS FOR THE CARE OF TATTOOED HUMAN SKIN AND IN PARTICULAR FOR  INCREASING BRILLIANCY  OF TATTOOS ON  DARK HUMAN SKINBEIERSDORF AG
WO/2021/104786A CONDITIONING COMPOSITIONBEIERSDORF AG
WO/2021/083958NOVEL PEPTIDES INDUCING SATIETYSPECIALITES PET FOOD
WO/2021/083959METHODS AND COMPOSITIONS FOR TREATING UVEAL MELANOMAINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/083964NEW MEANS AND METHODS FOR THERAPY AND DIAGNOSIS OF DNA VIRUS  INFECTIONSTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/083970MEDICAL COMPOSITIONS AND THEIR USE IN TREATING INFLAMMATORY  BOWEL DISEASEBIOMILLENIA SAS
WO/2021/083989PROCESS FOR PREPARING NANO- OR MICROPARTICLES COMPRISING A  CARRIER-POLYMER AND ONE OR MORE BIOLOGICALLY ACTIVE INGREDIENTSEVONIK OPERATIONS GMBH
WO/2021/083992DENTAL COMPOSITE MATERIALKULZER GMBH
WO/2021/084007FOAM PRECURSOR LIQUID AND FOAM CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/084013NEW TREATMENT REGIMEN FOR THE TREATMENT OF NEUROLOGICAL  DISEASES OR CONDITIONSBIONURE FARMA, S.L.
WO/2021/099088HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/084030ORAL PHARMACEUTICAL COMPOSITION COMPRISING A MELT-AGGLOMERATED  ACTIVE INGREDIENT COREHERMES ARZNEIMITTEL GMBH
WO/2021/084055BLEACHING POWDER COMPOSITIONKAO GERMANY GMBH
WO/2021/084058COMPOSITION FOR THE PREVENTION AND TREATMENT OF DISEASES OF  THE RESPIRATORY SYSTEMNEILOS S.R.L.
WO/2021/084062ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE  TREATMENT OF LEUKEMIA OR LYMPHOMAMORPHOSYS AG
WO/2021/089419THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO  TREAT B-CELL MALIGNANCIESASTRAZENECA AB
WO/2021/084064SEQUENTIAL ANTI-CD19 THERAPYMORPHOSYS AG
WO/2021/099089SUNSCREEN COMPOSITION CONTAINING SILICA FOR PROTECTION FROM  BLUE LIGHTBEIERSDORF AG
WO/2021/084068COMBINATION OF A CXCR7 ANTAGONIST WITH AN S1P1 RECEPTOR  MODULATORIDORSIA PHARMACEUTICALS LTD
WO/2021/099090NOVEL SUNSCREEN COMPOSITION CONTAINING SILICA FOR PROTECTION  AGAINST BLUE LIGHTBEIERSDORF AG
WO/2021/084082COSMETIC COMPOSITION FOR IMPROVED BLEACHING OR DYEING OF  KERATIN FIBERSKAO CORPORATION
WO/2021/084083AQUEOUS OXIDATIVE COMPOSITION COMPRISING XANTHINE DERIVATIVESKAO CORPORATION
WO/2021/084084AQUEOUS OXIDIZING COMPOSITION COMPRISING AMINO ACIDSKAO CORPORATION
WO/2021/084085TWO-PART OXIDATIVE DYEING COMPOSITIONKAO CORPORATION
WO/2021/084087BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE  AGENTSCIS PHARMA AG
WO/2021/089433SOLID DISPERSIONS OF URSOLIC ACID POTASSIUM SALTINDENA S.P.A.
WO/2021/084120LIQUID ORAL FORMULATION OF BUMETANIDENEUROCHLORE
WO/2021/089445ORAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/084124COMBINED INHIBITION OF PD-1, TGFβ AND ATM TOGETHER WITH  RADIOTHERAPY FOR THE TREATMENT OF CANCERARES TRADING S.A.
WO/2021/084136COSMETIC COMPOSITION CONTAINING AN EXTRACT FROM OPUNTIA FICUS  INDICAWELEDA AG
WO/2021/089500SUNSCREEN COMPOSITION WITH LOW STICKINESSDSM IP ASSETS B.V.
WO/2021/089501NOVEL METHODDSM IP ASSETS B.V.
WO/2021/089554INTRANASAL ADMINISTRATION OF MEROTOCIN FOR IMPROVING LACTATIONFERRING B.V.
WO/2021/089580ORAL FORMULATION OF X842CINCLUS PHARMA AG
WO/2021/089581TOOTH WHITENING COMPOSITIONUNIVERSITAT AUTONOMA DE BARCELONA
WO/2021/110341WATER-RESISTANT COSMETIC SUNSCREENBEIERSDORF AG
WO/2021/104813SIMULTANEOUS IMAGE REPRESENTATION OF TWO DIFFERENT FUNCTIONAL  AREASSIEMENS HEALTHCARE GMBH
WO/2021/099117A COSMETIC COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/089649ANDROGEN RECEPTOR INHIBITORS FOR THE TREATMENT OF  NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN SUBJECTS WITH SEVERE  HEPATIC IMPAIRMENTJANSSEN PHARMACEUTICA NV
WO/2021/089651DIAGNOSTIC METHODAMAZENTIS SA
WO/2021/089678GLP-1 RECEPTOR AGONISTS IN DEMENTIANOVO NORDISK A/S
WO/2021/089692INHIBITOR OF BINDING BETWEEN PODOCIN AND KERATIN 8 FOR USE IN  THE TREATMENT OF NEPHROTIC SYNDROMETHE UNIVERSITY OF BRISTOL
WO/2021/094192SOLID PARTICLES CONTAINING SOLID PRIMARY PARTICLES THAT  CONSIST ESSENTIALLY OF NATIVE CELLULOSEEVONIK OPERATIONS GMBH
WO/2021/089704COMBINED INHIBITION OF PD-1, TGFB AND TIGIT FOR THE TREATMENT  OF CANCERMERCK PATENT GMBH
WO/2021/089715USE OF COLCHICINE IN THE TREATMENT AND PREVENTION OF LUNG  CANCERMURRAY AND POOLE ENTERPRISES, LTD.
WO/2021/089721TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL INFECTION.HERCULES PHARMACEUTICALS B.V.
WO/2021/089736COMBINED THERAPY FOR MUSCULAR DISEASESASSOCIATION INSTITUT DE MYOLOGIE
WO/2021/089752SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2  INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/089761SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF  N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACIDNOVO NORDISK A/S
WO/2021/089768TREATMENT AND PREVENTION OF A NEURODEGENERATIVE DISORDERINFLAZOME LIMITED
WO/2021/089769TREATMENT AND PREVENTION OF NEUROINFLAMMATION OR AN  INFLAMMATORY BRAIN DISORDERINFLAZOME LIMITED
WO/2021/089770PROTEIN PURIFICATIONJANSSEN VACCINES & PREVENTION B.V.
WO/2021/089776TREATMENT AND PREVENTION OF A TRAUMATIC BRAIN DISORDERINFLAZOME LIMITED
WO/2021/089781TREATMENT OR PREVENTION OF PSYCHIATRIC BRAIN DISORDERS USING  THE NLRP3 INHIBITOR N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-1  -ISOPROPYL-1 H-PYRAZOLE-3-SULFONAMIDEINFLAZOME LIMITED
WO/2021/089782TREATMENT OF AUTOINFLAMMATORY DISORDERSINFLAZOME LIMITED
WO/2021/089783TREATMENT OF ARTHRITISINFLAZOME LIMITED
WO/2021/089790MITROCHONDRIA-TARGETING ANTIOXIDANTSGIVAUDAN SA
WO/2021/089791METHODS FOR THE TREATMENT OF CANCERS THAT HAVE ACQUIRED  RESISTANCE TO KINASE INHIBITORSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/089794METHODS OF TREATING CANCER WITH A COMBINATION OF A  PLATINUM-BASED AGENT AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATEGENMAB A/S
WO/2021/089807ANTIVIRAL PREPARATION FROM CHESTNUT SHELLS OF  <i>CASTANEA SATIVA</i> MILLMICRONATURE S.R.L.
WO/2021/104834COMBINATION THERAPYADC THERAPEUTICS SA
WO/2021/089840FERMENTATION METHOD FOR THE PRODUCTION OF PHYTOESTROGENSMRM HEALTH N.V.
WO/2021/089845CD93 INHIBITORS FOR USE IN THE TREATMENT OF CANCERUNIVERSITÄT BERN
WO/2021/089848USE OF SODIUM OCTENYL-SUCCINATE STARCHES AS A BINDER IN  CONTINUOUS WET GRANULATIONROQUETTE FRERES
WO/2021/094259NPY2 RECEPTOR AGONISTSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/104844CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/094296USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE  WITH PRESERVED EJECTION FRACTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/094331INOSITOL PHOSPHATE COMPOUNDS FOR USE IN TREATING, INHIBITING  THE PROGRESSION, OR PREVENTING CARDIOVASCULAR CALCIFICATIONSANIFIT THERAPEUTICS, S.A.
WO/2021/094334CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/094344POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIIICSL BEHRING LENGNAU AG
WO/2021/094378TYPE I INTERFERON INHIBITION IN SYSTEMIC LUPUS ERYTHEMATOSUSASTRAZENECA AB
WO/2021/094379EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS  FOR THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/094390(S)-2-(1-(5-(CYCLOHEXYLCARBAMOYL)-6-(PROPYLTHIO)PYRIDIN-2-YL)PIPERIDIN-3-YL)  ACETIC ACID FOR USE IN TREATING WOUNDSUNIVERSITY OF LEEDS
WO/2021/094396COMPOSITION FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYCMS DENTAL A/S
WO/2021/094424AN INHIBITOR OF AN IRON-CONTAINING HYDROGENASE OF A  METHANOGENIC ARCHAEON FOR USE IN THE TREATMENT OR PREVENTION OF A  PARKINSONIAN CONDITIONUNIVERSITé DU LUXEMBOURG
WO/2021/094429DEODORANT COMPOSITIONSUNILEVER IP HOLDINGS B.V.
WO/2021/094561RINSABLE OILY SOLUTION FOR CONTROLLING LICEDERMOWAVE
WO/2021/094562ANTIGENIC PEPTIDES FOR PREVENTION AND TREATMENT OF B-CELL  MALIGNANCYENTEROME S.A.
WO/2021/094563TREATMENT AND PREVENTION OF DENGUE DISEASEJANSSEN PHARMACEUTICALS, INC
WO/2021/129977PLANT EXTRACTS FOR TREATMENT OF INCREASED FACIAL VASCULARITYORIFLAME COSMETICS AG
WO/2021/099241COMPOSITIONS AND METHODS FOR GLUTATHIONE ENHANCEMENT FOR USE  IN BRAIN HEALTHSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/115730HAIR STYLING COMPOSITION CONTAINING DISACCHARIDESHENKEL AG & CO. KGAA
WO/2021/115731MICROPLASTIC-FREE COMPOSITIONHENKEL AG & CO. KGAA
WO/2021/094610CHITOSAN FOR USE IN A METHOD OF PREVENTING OR TREATING A  CARDIOVASCULAR DISEASEBIOMEDICA PHARMA GMBH
WO/2021/094626MEDICAL COMPOSITION FOR TREATING CARDIAC WASTING AND CACHEXIARELAXERA PHARMAZEUTISCHE GMBH & CO. KG
WO/2021/121823TINTING CONDITIONER HAVING IMPROVED DYEING PERFORMANCEHENKEL AG & CO. KGAA
WO/2021/099292AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/099346PHARMACEUTICAL DELIVERY DEVICEFERRING B.V.
WO/2021/099402PHARMACEUTICAL COMPOSITIONS COMPRISING AN INHIBITOR OF A  HISTON-DEACETYLASE (HDACI) AND AN AGONIST OF TOLL-LIKE-RECEPTOR 7 AND/OR 8  (TLR7 AND/OR TLR8) AND THEIR USE IN THE TREATMENT OF CANCERSTRUMBERG, Dirk
WO/2021/121843COMPOSITION COMPRISING THROMBIN DERIVED PEPTIDES AND USE  THEREOFIN2CURE AB
WO/2021/099444A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUISINTERVET INTERNATIONAL B.V.
WO/2021/099446A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUISINTERVET INTERNATIONAL B.V.
WO/2021/099450INHIBITORS OF HSP70 PROTEININSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/099453AQUEOUS LIQUID EXTRACT OF SPIRULINA FOR PREVENTING AND/OR  TREATING PERIPHERAL CHEMOTHERAPY-INDUCED NEUROPATHIES AND THE SYMPTOMS  THEREOF, AND CORRESPONDING COMPOSITION AND USEALGOSOURCE
WO/2021/099458A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUISINTERVET INTERNATIONAL B.V.
WO/2021/099460CURABLE COMPOSITION FOR DENTAL IMPRESSIONDENTSPLY SIRONA INC.
WO/2021/099462CURABLE COMPOSITION FOR DENTAL IMPRESSIONDENTSPLY SIRONA INC.
WO/2021/099481SOLID COMPOSITION CONTAINING RUFINAMIDEMEDICHEM, S.A.
WO/2021/099515PROCESS FOR TREATING KERATIN FIBERS, COMPRISING A  (POLY)CARBODIIMIDE COMPOUND, AN AQUEOUS DISPERSION OF PARTICLES OF  POLYMER(S)AND A COLORING AGENTL'OREAL
WO/2021/099517COMPOSITION COMPRISING A (POLY)CARBODIIMIDE COMPOUND AND A  COLORING AGENTL'OREAL
WO/2021/099531ZONISAMIDE ORODISPERSIBLE TABLETSBIOHORM, S.L.
WO/2021/121859HAIR TREATMENT PROCESSL'OREAL
WO/2021/121860COSMETIC COMPOSITION COMPRISING A SILICONE RESIN AND A  PARTICULAR AMINO SILICONEL'OREAL
WO/2021/099555COSMETIC PREPARATION CONTAINING ANISIC ACID AND LEVULINIC  ACID, HAVING SELECTIVE ANTIMICRIOBIAL EFFECTBEIERSDORF AG
WO/2021/099572MEDICAL USES OF 4-1BBL ADJUVANTED RECOMBINANT MODIFIED  VACCINIA VIRUS ANKARA (MVA)BAVARIAN NORDIC A/S
WO/2021/099575MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES LOADED  WITH AT LEAST ONE PHOTOSENSITIZER AND USES THEREOF FOR THE TREATMENT OF  PERITONEAL CARCINOMATOSISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/099586RECOMBINANT MVA VIRUSES FOR INTRATUMORAL AND/OR INTRAVENOUS  ADMINISTRATION FOR TREATING CANCERBAVARIAN NORDIC A/S
WO/2021/099608METHODS FOR MANUFACTURING TISSUE INTERFACING COMPONENTSMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/099611INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF  BETA-LACTOGLOBULINARLA FOODS AMBA
WO/2021/099616MASITINIB FOR THE TREATMENT OF SICKLE CELL DISEASEAB SCIENCE
WO/2021/099624COMPOSITIONS COMPRISING A BACTERIAL STRAIN OF THE GENUS  FUSICATENIBACTER4D PHARMA RESEARCH LIMITED
WO/2021/105040MULTIPLE UNIT PELLET SYSTEM TABLET COMPRISING RIBOFLAVINDSM IP ASSETS B.V.
WO/2021/105041MUPS TABLET COMPRISING RIBOFLAVINDSM IP ASSETS B.V.
WO/2021/105051COMPOSITION FOR THE 3D PRINTING OF SEMISOLID DRUGSFUNDACION IDONIAL
WO/2021/099635NEW SOLID STATE FORM OF LURBINECTEDINPHARMA MAR, S.A.
WO/2021/105059UK 114 SALMON PROTEINS FOR USE IN THE TREATMENT, DIAGNOSIS AND  PREVENTION OF MALIGNANT TUMOURSBARTORELLI CUSANI, Alberto
WO/2021/099638COMPOSITION AND FOOD SUPPLEMENT, IN PARTICULAR FOR ORAL AND  DENTAL CARESMILLEAN
WO/2021/105061WHOLE CELL VACCINES AND METHODS OF PRODUCTION THEREOFGOTOVAX AB
WO/2021/105073BENZOCOUMARIN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS  AND USES THEREOFSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105074DIRECT AMPK ACTIVATOR COMPOUNDS COMBINED WITH INDIRECT AMPK  ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOFSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105075DIBENZOPYRAN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS  AND USES THEREOFSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105076Z-STILBENE AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND  USES THEREOFSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105093FREEZE-DRIED POWDER CONTAINING  2-[(3-AMINOPROPYL)AMINO]ETHANETHIOL AND ITS USE FOR PREPARING A THERMOGELCLEVEXEL PHARMA
WO/2021/121882HAIR DYEING PROCESS USING AT LEAST ONE SILICONE COMPRISING AT  LEAST ONE CARBOXYLIC ACID ANHYDRIDE GROUP, AT LEAST ONE AMINO SILICONE AND AT  LEAST ONE PIGMENT AND/OR DIRECT DYEL'OREAL
WO/2021/105137TREM-1 INHIBITORS FOR THE TREATMENT OF VASO-OCCLUSIONS AND  TISSUE INJURIES IN PATIENTS SUFFERING FROM SICKLE CELL DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105164PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY  VASCULAR DISEASE AND/OR CARDIAC DYSFUNCTION IN FONTAN-PALLIATED PATIENTSACTELION PHARMACEUTICALS LTD
WO/2021/105167TRIPLE VACCINE AGAINST AVIBACTERIUM PARAGALLINARUM AND AVIAN  ENCEPHALOMYELITIS VIRUS AND FOWL POX VIRUSBOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/105217USE OF RHAMNOSE AND ARABINOSE FOR DENTAL POWDER JET CLEANINGFERTON HOLDING S.A.
WO/2021/105219PARTHANATOS CELL DEATH INHIBITORS FOR USE IN THE TREATMENT OF  PSORIASISUNIVERSIDAD DE MURCIA
WO/2021/105224KDM SUBFAMILY 6 PROTEIN INHIBITOR FOR USE IN THE TREATMENT OF  CANCERFUNDACIó INSTITUT DE RECERCA CONTRA LA LEUCèMIA JOSEP CARRERAS
WO/2021/110544METHOD FOR MANUFACTURING A SOLID ADMINISTRATION FORM AND SOLID  ADMINISTRATION FORMMERCK PATENT GMBH
WO/2021/110545DEPOSITION OF NANOSUSPENSIONS OF ACTIVE PHARMACEUTICAL  INGREDIENTS ON CARRIERSMERCK PATENT GMBH
WO/2021/105331METHODS OF TREATING PULMONARY ARTERIAL HYPERTENSIONACTELION PHARMACEUTICALS LTD
WO/2021/105340NON-RINSED VETERINARY COMPOSITIONSCEVA SANTE ANIMALE
WO/2021/115800TREATMENT OF HEMORRHOIDS WITH ANTICOAGULANT DRUGSDE KEULENAER, Hendrik
WO/2021/105353COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A NUTRIENT  AND/OR MINERAL FOR THE PREVENTION OR TREATMENT OF MASTITISSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105361COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A N-3 FATTY ACID  FOR THE PREVENTION OR TREATMENT OF MASTITISSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105371METHODS FOR STRATIFYING DIABETES PATIENTSIMCYSE SA
WO/2021/105384TARGETING THE NLS REGION OF NUPR1 PROTEIN TO TREAT CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105391COMBINATION COMPRISING NUPR1 INHIBITORS TO TREAT CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105392SUSPENSION COMPRISING A PROTEIN PARTICLE SUSPENDED IN A  NON-AQUEOUS VEHICLENOVALIQ GMBH
WO/2021/105393PROCESSES FOR OBTAINING STABLE GLP-1 COMPOSITIONSNOVO NORDISK A/S
WO/2021/105407miRNA-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FOR  THE PREVENTION AND THE TREATMENT OF TISSUE DISORDERSNOVADIP BIOSCIENCES
WO/2021/105414USE OF 2-PHENYL-6-(1H-IMIDAZOL-1-YL) QUINAZOLINE FOR THE  PREVENTION OF ABUSE AND OF SIDE EFFECTS OF AT LEAST ONE OPIOIDROTTAPHARM BIOTECH S.R.L.
WO/2021/105419(R)-4-(1-(6-(4-(TRIFLUOROMETHYL)BENZYL)-6-AZASPIRO[2.5]OCTANE-5-CARBOXAMIDO)-CYCLOPROPYL)  BENZOIC ACID OR ITS SALT ALSO IN POLYMORPHIC FORM A FOR USE IN THE PREVENTION  OF HETEROTOPIC OSSIFICATIONROTTAPHARM BIOTECH S.R.L.
WO/2021/110561INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS FOR USE IN  TREATING HEPATITIS B INFECTIONEVOTEC INTERNATIONAL GMBH
WO/2021/105435PROOXIDATIVE CHAIN-TRANSFER AGENTS FOR USE IN THE TREATMENT OF  MALIGNANT TUMOUR OR INFECTIOUS DISEASESUNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/110562INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS AND USES  THEREOFEVOTEC INTERNATIONAL GMBH
WO/2021/105461USE OF COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF  ANKYLOSING SPONDYLITIS, AND CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/105474NEW COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4  EXPRESSIONFACIO INTELLECTUAL PROPERTY B.V.
WO/2021/105481NOVEL COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4  EXPRESSIONFACIO INTELLECTUAL PROPERTY B.V.
WO/2021/105509CHIMERIC OPSIN GPCR PROTEINSUNIVERSITÄT BERN
WO/2021/110608PEPTIDES AND COMPOSITIONS FOR USE IN COSMETICS AND MEDICINELIPOTRUE, S.L.
WO/2021/110625HAIR TREATMENT PROCESS COMPRISING THE APPLICATION OF A  COMPOSITION COMPRISING CATIONIC POLYMERS AND ORGANOSILANES, FOLLOWED BY A  WASHING STEPL'OREAL
WO/2021/110697SOLID PHARMACEUTICAL FORMULATIONS OF  6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(-4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINEASTRAZENECA AB
WO/2021/110732METHOD FOR PRODUCING SPRAY-FREEZE-DRIED PARTICLES, AND  PARTICLES PRODUCED ACCORDINGLYRHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/110737USE OF MASITINIB FOR THE TREATMENT OF EOSINOPHILIC ASTHMAAB SCIENCE
WO/2021/110748A DAY-AND-NIGHT AND INSIDE-OUTSIDE COLLAGEN-CONTAINING  TREATMENTLABORATORIO GENOVE, S.A.
WO/2021/122005DIALIPHATIC KETONE MIXTURES, COMPOSITIONS COMPRISING SAME AND  USE THEREOFSOLVAY SA
WO/2021/110768COSMETIC CLEANING COMPOSITIONS IN POWDER FORMYODI SAS
WO/2021/115886A HEMOSTATIC AGENT AND USES THEREOFROYAL COLLEGE OF SURGEONS IN IRELAND
WO/2021/115887DOT PRINTING METHOD AND DEVICE FOR ADDITIVE MANUFACTURING OF  DOSAGE FORMS WHICH CONTAIN ACTIVE SUBSTANCESDIHESYS DIGITAL HEALTH SYSTEMS GMBH
WO/2021/110782THE CHOLESTEROL-SYNTHESIS INTERMEDIATES FOR TREATMENT  DEMYELINATING DISORDERSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/130002FOOD SUPPLEMENT FOR ALZHEIMERFOLIUM BIOSCIENCES EUROPE B.V.
WO/2021/110796INHIBITORS OF SHP2BAYER AKTIENGESELLSCHAFT
WO/2021/110805COMBINATION OF AN AZETIDINE LPA1 RECEPTOR ANTAGONIST WITH  PIRFENIDONE AND/OR NINTEDANIB FOR USE IN THE TREATMENT OF FIBROTIC DISEASESIDORSIA PHARMACEUTICALS LTD
WO/2021/110817POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS  TARGETING TNFA AND OX40LABLYNX NV
WO/2021/110860REACTIVE CONJUGATESDEBIOPHARM RESEARCH & MANUFACTURING S.A.
WO/2021/110885BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORSALBIREO AB
WO/2021/110915METHOD FOR TRANSFORMING AN ESSENTIAL OILPRANARÔM INTERNATIONAL S.A.
WO/2021/110919TREATMENT OF DISEASES RELATED TO HEPATITIS B VIRUSISA PHARMACEUTICALS
WO/2021/110923PERSONAL DENTAL CARE PRODUCT FOR PREVENTING DEMINERALISATIONCREDENTIS AG
WO/2021/110942PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG  BIS(MONOETHANOLAMINE)SYNTHON B.V.
WO/2021/110959PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG  BIS(MONOETHANOLAMINE)SYNTHON B.V.
WO/2021/110968MACROCYCLES COMPRISING A 4-AMIDO-2,4-PENTADIENOATE MOIETY FOR  THE TREATMENT OF HYPOXIC CANCERSAARHUS UNIVERSITET
WO/2021/110976PEPTIDE COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIESAXOLTIS PHARMA
WO/2021/110978DEEP-LAYER REMINERALIZATION OF HYDROXYLAPATITEDR. KURT WOLFF GMBH & CO. KG
WO/2021/110979LIPID VESICLES AS OXIDATIVE STRESS SENSORSMEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/110983CO-AMORPHOUS FORMS OF BETA-LACTOGLOBULIN AND A DRUG SUBSTANCEZERION APS
WO/2021/110989VACCINE CONJUGATESULTIMOVACS AB
WO/2021/110991CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR  STRUCTURES IN THE KIDNEYUNIVERSITÄT ZüRICH
WO/2021/115977LIQUID PHARMACEUTICAL COMPOSITION COMPRISING CYTISINEADAMED PHARMA S.A.
WO/2021/116000INVERSE LATEX FOR A COSMETIC COMPOSITION COMPRISING A SPECIFIC  CHELATING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID FUNCTION AND A  NEUTRAL FUNCTIONSOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/111007STABLE COMPOSITIONS OF FC MULTIMERSCSL BEHRING LENGNAU AG
WO/2021/116114AEROSOL HAIR DYEING DEVICE BASED ON A CROTONIC ACID COPOLYMER  AND A FATTY AMINEL'OREAL
WO/2021/116188COMBINATION PRODUCT CONTRIBUTING TO THE WELL-BEING OF PREGNANT  WOMEN, COMPRISING EPA, DHA, VITAMINS AND MINERALSURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/122239INHIBITION OF TMEM16A BY BENZBROMARONE OR NICLOSAMIDE FOR  TREATING POLYCYSTIC KIDNEY DISEASE AND/OR POLYCYSTIC LIVER DISEASEUNIVERSITÄT REGENSBURG
WO/2021/130022VIRUS-MIMETIC NANOPARTICLESUNIVERSITÄT REGENSBURG
WO/2021/116244MODULATION OF DRUG RELEASE AND BIOAVAILABILITY OF COMPOSITIONS  CONTAINING DOLUTEGRAVIR SODIUM AND OTHER ANTI HIV DRUGSSANDOZ AG
WO/2021/144080METHOD FOR INCORPORATING ACTIVE SUBSTANCES INTO THE SKINBEIERSDORF AG
WO/2021/122278NON-STICK ANTIBIOTIC GELSAO TECHNOLOGY AG
WO/2021/116275DENTAL RESIN MODIFIED GLASS-IONOMER COMPOSITION AND KIT  COMPRISING SAID COMPOSITIONDENTSPLY SIRONA INC.
WO/2021/116331STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES  COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERYCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/116367CELLULOSE NANOCRYSTAL EFFECT PIGMENTS FOR COSMETIC  APPLICATIONSBASF COLORS & EFFECTS GMBH
WO/2021/116370THICKENING SILICA AS FLUORIDE CARRIER FOR TAILORED DELIVERY  AND SLOW RELEASEGABA INTERNATIONAL HOLDING GMBH
WO/2021/116372INHIBITORS OF KDM5A FOR USE IN TREATMENT OF IDIOPATHIC  INFLAMMATORY MYOPATHIESUNIVERSITEIT ANTWERPEN
WO/2021/116389EPAC1 INHIBITORS FOR THE TREATMENT OF IDIOPATHIC PULMONARY  FIBROSISINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/116420USE OF TLR7 AND/OR TLR8 AGONISTS FOR THE TREATMENT OF  LEPTOSPIROSISINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/122382AQUEOUS COMPOSITION COMPRISING A CATIONIC POLYMER, AN ANIONIC  POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A  FATTY PHASE AND A PIGMENTL'OREAL
WO/2021/116432BIODEGRADABLE MICROCAPSULE SYSTEMSPAPIERFABRIK AUGUST KOEHLER SE
WO/2021/116443COMPOSITION COMPRISING PROPOLIS PARTICLESPOLLENERGIE
WO/2021/116475AMPHOTERICIN B CONJUGATED STABILIZED GOLD NANOPARTICLES AND  USES THEREOFMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/116476AGONISTS OF RNA ADENOSINE N-6 METHYLATION FOR USE IN  SUPPRESSING HIV-1 LATENT PROVIRUS ACTIVATION AND REPLICATIONCHEMESTMED LTD.
WO/2021/116477METHOD OF SUPPRESSING CANCER BY RNA m6A METHYLTRANSFERASE  METTL16 INHIBITORSCHEMESTMED LTD.
WO/2021/228422OXYBUTYNIN FOR INTRAVESICAL USEFARCO-PHARMA GMBH
WO/2021/122412AQUEOUS COMPOSITION FOR TREATING KERATIN FIBRES, COMPRISING A  PLANT OIL, A HYDROCARBON-BASED OIL, A GLYCEROLATED NONIONIC SURFACTANT, A  POLYSACCHARIDE AND A SOLVENTL'OREAL
WO/2021/116487COMPOUNDS FOR USE IN THE TREATMENT OF NIEMANN-PICK C DISEASESOM INNOVATION BIOTECH, S.A.
WO/2021/122434COMBINATION OF AN AHR-INHIBITOR AND AN PD1-INHIBITOR ANTIBODY  AND ITS USE IN THE TREATMENT OF CANCERBAYER AKTIENGESELLSCHAFT
WO/2021/122481COMPOSITION COMPRISING A NATURAL DYE AND A FATTY AMINEL'OREAL
WO/2021/122482COSMETIC OR DERMATOLOGICAL COMPOSITION ACTING IN PARTICULAR ON  THE EFFECTS OF BLUE LIGHT ON SKIN AND ITS APPENDAGES, AND ASSOCIATED USESSEDERMA
WO/2021/116498ESKETAMINE FORMULATIONS AND METHODS FOR PREPARATION AND  STORAGEJANSSEN PHARMACEUTICA NV
WO/2021/197655SYRINGE AND KIT FOR INTRAVESICAL USEFARCO-PHARMA GMBH
WO/2021/122507INACTIVATED PISCINE ORTHOREOVIRUS VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/122515PARASITE CONTROL IN RUMINANTSINTERVET INTERNATIONAL B.V.
WO/2021/122545USE OF THE GDF-5 MUTANT FOR THE TREATMENT OF PAIN AND  CARTILAGE DESTRUCTIONMERCK PATENT GMBH
WO/2021/122608LOW-MOLECULAR GELLING AGENT AS FRAGRANT SUBSTANCE DISPENSING  SYSTEMHENKEL AG & CO. KGAA
WO/2021/122638DEVICE FOR SPRAYING A TWO-PHASE COMPOSITION COMPRISING AN  AQUEOUS PHASE COMPRISING ONE OR MORE POLYOLS AND AN OILY PHASE COMPRISING  NON-SILICONE OILSL'OREAL
WO/2021/122639TWO-PHASE COMPOSITION COMPRISING AN AQUEOUS PHASE COMPRISING  ONE OR MORE POLYOLS AT A CONTENT RANGING FROM 5% TO 30% BY WEIGHT AND AN OILY  PHASE COMPRISING NON-SILICONE OILSL'OREAL
WO/2021/122647HIGH VISCOSITY ELASTIC GELS AND USES THEREFORWARWICK INTERNATIONAL GROUP LTD.
WO/2021/122717NEW HENNA-BASED EXTRACT FOR USE IN DYEING KERATIN FIBERS, ITS  PREPARATION METHOD AND COMPOSITIONS CONTAINING ITL'OREAL
WO/2021/122741PREBIOTIC AND PROBIOTIC TREATMENT TO REDUCE ORAL DYSBIOSIS AND  PROMOTE EUBIOSISFUNDACIóN PARA EL FOMENTO DE LA INVESTIGACIóN SANITARIA Y  BIOMéDICA DE LA COMUNITAT VALENCIANA
WO/2021/122758COMPOSITIONS COMPRISING CYANIDIN-3-GALACTOSIDE FOR USE AS  VASORELAXANTEVONIK OPERATIONS GMBH
WO/2021/122809COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION  AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR  MICROBIOME-PROTECTIONEUROPEAN MOLECULAR BIOLOGY LABORATORY
WO/2021/122813ANGIOGENESIS PROMOTING AGENTS FOR PREVENTION OF METASTATIC  CANCERUNIVERSITÄT BASEL
WO/2021/122838NON-ELICITED DEDIFFERENTIATED <i>LAVANDULA  ANGUSTIFOLIA</i> PLANT CELLS, EXTRACTS THEREOF AND COSMETIC USES  THEREOFL'OREAL
WO/2021/122840COSMETIC COMPOSITION COMPRISING A CATIONIC ASSOCIATIVE  POLYMER, A CARBOXYLIC ANIONIC SURFACTANT, OPTIONALLY A NONIONIC SURFACTANT  AND AN AMPHOTERIC OR ZWITTERIONIC SURFACTANTL'OREAL
WO/2021/130088COSMETIC COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST  ONE CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND AT LEAST ONE  SURFACTANTL'OREAL
WO/2021/249664ANTI-BLYS ANTIBODY FOR TREATING PROTEINURIC KIDNEY DISEASEGLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED
WO/2021/122873PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING A HETEROCYCLIC  ORGANIC ANIONL'OREAL
WO/2021/122874PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING AN AROMATIC  ORGANIC ANIONL'OREAL
WO/2021/122876PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING AN AROMATIC  ORGANIC ANIONL'OREAL
WO/2021/122896CRYPTOSPORIDIOSIS VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/122923STABILIZATION OF SELENITE IN A NUTRITIONAL SOLUTION BY  DISSOLVED OXYGENBAXTER INTERNATIONAL INC.
WO/2021/122925PARENTERAL NUTRITION SOLUTION COMPRISING A SELENIUM SOURCEBAXTER INTERNATIONAL INC.
WO/2021/122928ORAL RESPIRATORY VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/122935METHOD FOR THE COSMETIC TREATMENT OF KERATIN FIBRES COMPRISING  A STAGE OF APPLICATION OF A RARE EARTH METAL COMPOSITION AND A STAGE OF  APPLICATION OF A COMPOSITION COMPRISING SURFACTANTSL'OREAL
WO/2021/122946METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS  EMPLOYING A RARE EARTH METAL COMPOSITION AND AN ALKALINE COMPOSITIONL'OREAL
WO/2021/122957DENTAL ROOT CANAL FILLING COMPOSITIONDENTSPLY DETREY GMBH
WO/2021/122996A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203QURIENT CO., LTD.
WO/2021/123003PROCESS FOR THE COSMETIC TREATMENT OF KERATIN FIBRES USING A  DETERGENT COMPOSITION AND A RARE EARTH METAL COMPOSITIONL'OREAL
WO/2021/123011ASSOCIATION OF FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM I-4573  WITH PENTASA<sp>®</sp> FOR THE TREATMENT AND PREVENTION OF  GASTROINTESTINAL INFLAMMATIONEXELIOM BIOSCIENCES
WO/2021/123013SMART DRUG DELIVERY SYSTEM AND PHARMACEUTICAL KIT FOR DUAL  NUCLEAR MEDICAL CYTOTOXIC THERANOSTICSJOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/123061PROCESS FOR PREPARING A COMPOSITION FOR DYEING THE HAIR  STARTING FROM A COMPOSITION IN POWDER FORM AND AN AQUEOUS COMPOSITIONL'OREAL
WO/2021/123088A PHARMACEUTICAL COMPOSITION OF A PYRAZOLE COMPOUND DISPERSED  IN A POLYMER MATRIXINTERVET INTERNATIONAL B.V.
WO/2021/123104MULTIVALENT HVT VECTOR VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/123108A PYRAZOLE PHARMACEUTICAL COMPOSITIONINTERVET INTERNATIONAL B.V.
WO/2021/123110SEMI-SOLID NATURAL PERFUMEEXPRESSIONS PARFUMEES
WO/2021/123117METHOD FOR PRODUCING OIL-IN-WATER EMULSIONSFRESENIUS KABI AUSTRIA GMBH
WO/2021/123119TREATMENT OF ACUTE HEART FAILURELUND, Lars H.
WO/2021/123121LIPID-BASED COMPOSITIONS COMPRISING LIPOPHILIC SALTS AND  ACIDIC PH MODIFIERSCAPSUGEL BELGIUM NV
WO/2021/123131COMPOSITION FOR THE TREATMENT OF HYPERTENSION AND/OR  ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/123142COMPOUNDS FOR TREATMENT OF EYE DISEASES ASSOCIATED WITH  EXCESSIVE VASCULARISATIONACTIVE BIOTECH AB
WO/2021/123144PRO-PERFUME COMPOSITIONSFIRMENICH SA
WO/2021/123164OILY SOLID COSMETICL V M H RECHERCHE
WO/2021/123165DOSAGE FORM COMPRISING AMORPHOUS SOLID SOLUTION OF  EMPAGLIFLOZIN WITH POLYMERKRKA, D.D., NOVO MESTO
WO/2021/123174SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOFUNIVERSITE DE STRASBOURG
WO/2021/123192EDOXABAN TABLETSBIOHORM, S.L.
WO/2021/123198LEUKEMIA TREATMENTDEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/123202FORMULATIONS OF ANTI-PD1 ANTIBODIESFORMYCON AG
WO/2021/123228PHARMACEUTICAL COMPOSITION COMPRISING GLP-1 ANALOGUEKRKA, D.D., NOVO MESTO
WO/2021/130126LIQUID COMPOSITION COMPRISING IBUPROFEN AND PHENYLEPHRINENUTRA ESSENTIAL OTC, S.L.
WO/2021/123229SYNTHESIS OF LACTONE DERIVATIVES AND THEIR USE IN THE  MODIFICATION OF PROTEINSGENIE BIOTECH UK LTD.
WO/2021/123232NUCLEIC ACID VACCINATION USING NEO-EPITOPE ENCODING CONSTRUCTSEVAXION BIOTECH APS
WO/2021/123233RETINOL-BASED COMPOSITIONL'OREAL
WO/2021/123243METHODS AND VACCINE COMPOSITIONS TO TREAT CANCERSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/123245NAD-PRECURSORS AND DIETARY RESTRICTION FOR TREATING  AGE-RELATED MEDICAL CONDITIONSLEIBNIZ-INSTITUT FüR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT  E.V. (FLI)
WO/2021/123280DIETARY SUPPLEMENT FOR LIPEDEMA PATIENTSPANTEA GMBH
WO/2021/123289SOLUBLE REAR LAYER FOR OTFLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/123300TREATMENT OF HEPATIC AND CARDIOVASCULAR DISORDERSLIFESEARCH
WO/2021/123302COMPOSITION COMPRISING A ROSEWOOD EXTRACTL'OREAL
WO/2021/123306COMPOSITION COMPRISING A CATIONIC CELLULOSE-BASED POLYMER, A  SULFONIC ANIONIC POLYMER AND A FIXING POLYMERL'OREAL
WO/2021/123309COMPOSITION COMPRISING A DISPERSION OF POLYMER PARTICLES IN A  NON-AQUEOUS MEDIUM, A CATIONIC POLYMER AND AN ANIONIC POLYMERL'OREAL
WO/2021/123311COMPOSITION COMPRISING A SOLUBILIZED SOLID FATTY ALCOHOL AND A  MONOALCOHOLL'OREAL
WO/2021/123323LON PROTEASE, ALPHA-HEMOLYSIN, CK1-ALPHA-1; C-MYB INHIBITOR OR  A CEBP-DELTA INHIBITOR AS THERAPEUTICSLINNANE PHARMA AB
WO/2021/123325COMPOSITION COMPRISING A NATURAL DYE, A DISPERSANT, AN OIL AND  A FATTY-PHASE THICKENERL'OREAL
WO/2021/123329HAIR DYEING COMPOSITION COMPRISING A DIRECT DYE, A  SCLEROGLUCAN GUM AND A NON-IONIC ASSOCIATIVE POLYMERL'OREAL
WO/2021/123341COMPOSITION COMPRISING DIOSMINKRKA, D.D., NOVO MESTO
WO/2021/123345PROCESS FOR COLOURING KERATIN MATERIALS USING A PARTICULAR  OILY DISPERSION AND AT LEAST TWO AMINE COMPOUNDS THAT ARE DIFFERENT FROM EACH  OTHERL'OREAL
WO/2021/123347PROCESS FOR THE COSMETIC TREATMENT OF KERATIN FIBRES USING A  RARE-EARTH METAL AND A PARTICULAR POLYMERL'OREAL
WO/2021/123352RETINOL-BASED SERUML'OREAL
WO/2021/123355PROBIOTICS FOR REGULATING BLOOD GLUCOSEGENBIOMA APLICACIONES, S.L.
WO/2021/123377COMPOSITION FOR THE TREATMENT OF INFLAMMATION AND/OR  ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/123378COMPOSITIONS COMPRISING BACTERIAL STRAINS4D PHARMA RESEARCH LIMITED
WO/2021/123399MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR  VESICLES FOR TARGETED CARGO DELIVERYMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/123419COMPOSITION FOR THE TREATMENT OF AMYLOID-BETA ASSOCIATED  DISEASESBASF SE
WO/2021/130168A PHARMACEUTICAL FORMULATIONWARSZAWSKIE ZAKLADY FARMACEUTYCZNE POLFA SA
WO/2021/123430POLYMERIC NANOPARTICLES AS VACCINE ADJUVANTSTHE PROVOST, FELLOWS, SCHOLARS AND OTHER MEMBERS OF BOARD OF  TRINITY COLLEGE DUBLIN
WO/2021/123432IGG:TGFBETARII FUSION PROTEIN COMPOSITIONARES TRADING S.A.
WO/2021/130170PROCESS FOR THE PREPARATION OF DISPERSIONS COMPRISING  INHALABLE IMMUNOSUPPRESSIVE ACTIVE INGREDIENTSZAMBON S.P.A.
WO/2021/130180TOPICAL COMPOSITIONS COMPRISING PEA PROTEINS AND POLYPHENOLSDEVINTEC SAGL
WO/2021/130181NOVEL FAECAL COMPOSITIONLAURIDSEN, Hengameh, Chloe
WO/2021/130182CAPSULE COMPRISING A FAECAL COMPOSITIONLAURIDSEN, Hengameh, Chloe
WO/2021/130192COMPOSITION COMPRISING ASCORBIC ACIDL'OREAL
WO/2021/130195METHOD OF TREATING VIRUS INFECTION USING A TLR7 AGONISTF. HOFFMANN-LA ROCHE AG
WO/2021/130210PROCESS FOR DESIGNING A RECOMBINANT POXVIRUS FOR A THERAPEUTIC  VACCINETRANSGENE
WO/2021/130215GOLDEN LIPID NANOPARTICLES FOR GENE THERAPYUNIVERSIDAD DEL PAíS VASCO/EUSKAL HERRIKO UNIBERTSITATEA
WO/2021/130219USES OF LIPOTEICHOIC ACID FROM BIFIDOBACTERIABIOPOLIS, S.L.
WO/2021/130223TREATMENT INVOLVING IMMUNE EFFECTOR CELLS GENETICALLY MODIFIED  TO EXPRESS ANTIGEN RECEPTORSBIONTECH CELL & GENE THERAPIES GMBH
WO/2021/130225IN VITRO AND IN VIVO GENE DELIVERY TO IMMUNE EFFECTOR CELLS  USING NANOPARTICLES FUNCTIONALIZED WITH DESIGNED ANKYRIN REPEAT PROTEINS  (DARPINS)BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/130226COMPOSITION FOR THE PREPARATION OF PERINDOPRIL ARGININE  GRANULES, A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION  COMPRISING THE GRANULESKRKA, D.D., NOVO MESTO
WO/2021/130232BILE ACID DERIVATIVES IN THE MEDICAL INTERVENTION OF ANXIETIES  AND/OR STRESS SYMPTOMSMEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/130237uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL  THERAPYRIGSHOSPITALET
WO/2021/130264TRANSPARENT COMPOSITION FOR USE IN SKINCARE AND/OR HAIRCARES.P.C.M. SA
WO/2021/130269COMBINATION OF AN ALPHA-PLL WITH A BETA-LACTAM FOR TREATING  ANTIBIOTIC BACTERIAL RESISTANCEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/130270PHARMACEUTICAL COMBINATION OF ANTIVIRAL AGENTS TARGETING HBV  AND/OR AN IMMUNE MODULATOR FOR TREATMENT OF HBVF. HOFFMANN-LA ROCHE AG
WO/2021/170283BIO-FERMENTED SURFACTANTS FOR REDUCING ABRASION OF DENTAL  ENAMELHENKEL AG & CO. KGAA
WO/2021/130305COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC  REACTIONAPOSCIENCE AG
WO/2021/130329RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT  OF CXCR4 EXPRESSING TUMORSISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE
WO/2021/130335EMULSIFIED LIP GELL'OREAL
WO/2021/130349COSMETIC COMPOSITIONS COMPRISING MELANOIDINSKAFFE BUENO APS
WO/2021/130377POLYMERIC NANOPARTICLES FOR ENHANCED CANCER TREATMENTTHE QUEEN'S UNIVERSITY OF BELFAST
WO/2021/130381COMBINATION OF A HDAC INHIBITOR AND VX MOLECULES, AND ITS USE  FOR THE TREATMENT OF CYSTIC FIBROSISCENTRE D'ETUDE DES CELLULES SOUCHES (CECS)
WO/2021/130382COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND  ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN  CONFORMATIONAL DISORDERCENTRE D'ETUDE DES CELLULES SOUCHES (CECS)
WO/2021/148229COMPOSITION FOR WEIGHT MANAGEMENT OF A SUBJECTMRS-BIOTECH
WO/2021/136763ISOQUINOLINE DERIVATIVES FOR USE IN TREATING GLUT1 DEFICIENCY  SYNDROMEGLIAPHARM SA
WO/2021/136784A COMPOSITION FOR THE TREATMENT OF MALE INFERTILITYLABORATORIO REIG JOFRé, S.A.
WO/2021/136786PREPARATION COMPRISING ELEMENTAL SILVER FOR TREATMENT AND  PREVENTION OF PERIODONTITISGUGGENBICHLER, Joseph Peter
WO/2021/136788PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE  APPLICATION OF A COMPOSITION COMPRISING A PARTICULAR COMPOUND COMPRISING AT  LEAST TWO TETRAZOLES GROUPSL'OREAL
WO/2021/136812BACTERIAL DELIVERY VEHICLES FOR IN VIVO DELIVERY OF A DNA  PAYLOADELIGO BIOSCIENCE
WO/2021/136827COMPOUND FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS  SYSTEM DISORDERSABAXYS THERAPEUTICS
WO/2021/136835COMPOSITIONS AND METHODS FOR THE PREVENTION OF S.  <i>AUREUS </i>INFECTIONANTAGONIS
WO/2021/136841PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF  POST-SURGICAL PAINPEPTINOV
WO/2021/151619USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE  INHALATORY TREATMENT OF INFLAMMATORY PULMONARY DISEASESMETRIOPHARM AG
WO/2021/151620USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE  TREATMENT OF RARE CHRONIC INFLAMMATORY PULMONARY DISEASESMETRIOPHARM AG
WO/2021/170290INHIBITORS OF HUMAN DEUBIQUITINASES FOR THE TREATMENT OF  CORONAVIRAL INFECTIONSIMMUNOLOGIK GMBH
WO/2021/1907835-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF  ACUTE LUNG INJURYMETRIOPHARM AG
WO/2021/2192446'-METHOXYCINCHONAN-9-OLS FOR THE TREATMENT OF CORONAVIRAL  INFECTIONSIMMUNOLOGIK GMBH
WO/2021/233571TREATMENT AGENT FOR ANTIVIRAL THERAPY, APPLICATOR, AND METHOD  FOR PRODUCING A TREATMENT AGENTNINODERM UG (HAFTUNGSBESCHRÄNKT)
WO/2021/244771METHOD FOR SOLUBILIZING NATURAL, ENDOGENOUS AND SYNTHETIC  CANNABINOIDSATHENION AG
WO/2021/249667COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONSMETRIOPHARM AG
WO/2021/148241COSMETIC FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING  NOVEL PEPTIDES THAT IMPROVE APPEARANCE AND REGENERATION OF SKINASC REGENITY LTD
WO/2021/160346NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUSINSTITUT PASTEUR
WO/2021/204423USE OF 15-MEMBERED AZALIDES AS ACTIVE AGENTS IN THE TREATMENT  OF VIRAL INFECTIONSUNIVERSITY OF ZAGREB SCHOOL OF MEDICINE
WO/2021/209173NOVEL THERAPEUTIC USE OF PLEUROMUTILINSNABRIVA THERAPEUTICS GMBH
WO/2021/209174THERAPEUTIC USE OF PLEUROMUTILINSNABRIVA THERAPEUTICS GMBH
WO/2021/223914PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION COMPRISING BRIMONIDINEPHARMATHEN S.A.
WO/2021/228434PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION CONTAINING CYCLOSPORINEPHARMATHEN S.A.
WO/2021/254662CROSSLINKED STARCH DERIVATIVE-BASED MATRIXROQUETTE FRERES
WO/2021/175497METHOD FOR COLORING KERATIN MATERIAL, COMPRISING THE USE OF  TWO STRUCTURALLY DIFFERENT SILANES AND TWO STRUCTURALLY DIFFERENT POLYMERSHENKEL AG & CO. KGAA
WO/2021/197673AGENTS FOR IMPROVED OXIDATIVE LIGHTENING OF KERATIN FIBRESHENKEL AG & CO. KGAA
WO/2021/180369METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, ALGINIC ACID (SALT),   A DYEING COMPOUND AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/180370METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, A GLYCEROL ESTER, A COLORING COMPOUND AND A  POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/180372PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/140101PREPARATION AND USE OF CANNABIS NANO-FORMULATIONCANNAXAN GMBH
WO/2021/140103COGNITIVE DISORDER PREVENTION AND THERAPYANIMA
WO/2021/140111HAIR CONDITIONER ALLOWING THE USE OF SOAP AS SHAMPOOLYNELINE SàRL
WO/2021/140113CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINESBOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/175499PERSONAL CARE COMPOSITION AND METHODSUNILEVER IP HOLDINGS B.V.
WO/2021/140123VACCINES TARGETING NEISSERIA GONORRHOEAEEVAXION BIOTECH APS
WO/2021/148249NEW COMPOSITION AS SHAVING PREPARATIONBEIERSDORF AG
WO/2021/140141COSMETIC TREATMENT METHODL'OREAL
WO/2021/140174GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF CHRONIC  KIDNEY DISEASE AND DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETESMEDIMMUNE LIMITED
WO/2021/140183ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING  GASTROINTESTINAL DISORDERSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/140194COMPOUNDS FOR PROMOTING FOLLICLE MATURATIONAARHUS UNIVERSITET
WO/2021/136848COMPOSITION FOR USE IN THE TREATMENT OF COGNITIVE DISORDERSBIOSEARCH, S.A.
WO/2021/140228COSMETIC COMPOSITIONCREASEARCH BV
WO/2021/140229COSMETIC COMPOSITIONCREASEARCH BV
WO/2021/144211EDIBLE TOOTHPASTE COMPOSITION TO BE SUCKED OR CHEWED, METHOD  FOR PREPARING SAID TOOTHPASTE COMPOSITIONDANA, Jean Dominique
WO/2021/144231HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/084139NANO-DRY MELTINGBAYER AKTIENGESELLSCHAFT
WO/2021/144245NATIVE AND POROUS STARCH AS WHITE PIGMENT IN TOOTHPASTEROQUETTE FRERES
WO/2021/144249HYPOPARATHYROIDISM TREATMENTASCENDIS PHARMA BONE DISEASES A/S
WO/2021/144254SALMONELLA-BASED DNA VACCINES IN COMBINATION WITH AN  ANTIBIOTICVAXIMM AG
WO/2021/144267HAIR TREATMENT COMPOSITIONS AND METHODSUNILEVER IP HOLDINGS B.V.
WO/2021/144272HAIR TREATMENT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/144274USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF JOINT PAIN  INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/144302BIOMARKERS FOR DETERMINING SUSCEPTIBILITY TO OXOPIPERAZINE  DERIVATIVES AND METHODS OF USING SAMEINTHERA BIOSCIENCE AG
WO/2021/180378METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, HYALURONIC ACID (SALT),  A DYEING COMPOUND AND A POST-TREATMENT  AGENTHENKEL AG & CO. KGAA
WO/2021/180379METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, TWO DYEING COMPOUNDS AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/144313VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIESSYNAFFIX B.V.
WO/2021/144314VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIESSYNAFFIX B.V.
WO/2021/144315CONJUGATES OF ANTIBODIES AN IMMUNE CELL ENGAGERSSYNAFFIX B.V.
WO/2021/144326TOPICAL COMPOSITION COMPRISING HYDROXAMIC ACID AND  ATRACTYLENOLIDEUNILEVER IP HOLDINGS B.V.
WO/2021/144330USE OF FXR AGONISTS FOR TREATING AN INFECTION BY HEPATITIS D  VIRUSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/144333PROBIOTIC COMPOSITION FOR USE AS AN ANTIOXIDANTBIOPOLIS, S.L.
WO/2021/144338METHOD OF TREATMENT OF CANCER OR TUMOURADAPTIMMUNE LIMITED
WO/2021/160366POLYACRYLATE-FREE COSMETIC PREPARATIONBEIERSDORF AG
WO/2021/144360SMALL MOLECULE CSF-1R INHIBITORS IN THERAPEUTIC AND COSMETIC  USESF. HOFFMANN-LA ROCHE AG
WO/2021/144364PARTICLES OF A MIXTURE OF IRON(III)-OXYHYDROXIDE, SUCROSE AND  ONE OR MORE STARCHES, PREFERABLY OF SUCROFERRIC OXYHYDROXIDEVIFOR (INTERNATIONAL) AG
WO/2021/144365PRODUCT AND MANUFACTURING PROCESS FOR A GUMMCNEIL AB
WO/2021/144367LOZENGEMCNEIL AB
WO/2021/144369FIMH MUTANT, COMPOSITIONS THEREWITH AND USE THEREOFJANSSEN PHARMACEUTICALS, INC.
WO/2021/144381COMPOSITIONS FOR ALLEVIATING THE SYMPTOMS OF LOW ANTERIOR  RESECTION SYNDROME BY TOPICAL ADMINISTRATION TO THE NEORECTUMREPOCEUTICALS A/S
WO/2021/164959METHOD FOR PROVIDING PERSONALIZED CELLS WITH CHIMERIC ANTIGEN  RECEPTORS (CAR) AGAINST TUMOR MICROENVIRONMENT CELLSMILTENYI BIOTEC B.V. & CO. KG
WO/2021/144403DOSAGE FORM WITH SUSTAINED RELEASE MELATONIN PELLETSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/148314ACCELERATED ELIMINATION OF  (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOLIDORSIA PHARMACEUTICALS LTD
WO/2021/144415IMMUNOGLOBULIN SINGLE DOMAIN ANTIBODIES FOR DELIVERY OF  MUCOSAL VACCINESUNIVERSITEIT GENT
WO/2021/144450A COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING  PEPTIDE CONJUGATEFLUOGUIDE A/S
WO/2021/144457FORMULATIONS OF CD38 ANTIBODIES AND USES THEREOFGENMAB A/S
WO/2021/144460CONTROLLED RELEASE FORMULATIONSUNIVERSIDAD DE ZARAGOZA
WO/2021/156043TESTOSTERONE CONTAINING PHARMACEUTICAL COMPOSITIONDIURNAL LIMITED
WO/2021/148347BILAYER TABLET COMPRISING TELMISARTAN AND AMLODIPINEZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/219255NATURAL MATERIAL PADORGANOID TECHNOLOGIES GMBH
WO/2021/148362DIRECTLY COMPRESSIBLE POLYMER COMBINATIONS FOR MATRIX TABLETS  WITH EXTENDED DRUG RELEASEMERCK PATENT GMBH
WO/2021/148366PLANT-BASED COMPOSITION IN A FORM SUITABLE FOR TOPICAL  ADMINISTRATION AND ASSOCIATED PRODUCTION METHODMENELIK
WO/2021/148396EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS  FOR THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/148405INHIBITORS OF INTRACELLULAR BACTERIAL GROWTH AND PERSISTENCE  AS ANTIBIOTICSCONSEJO SUPERIOR DE INVESTIGACIONES (CSIC)
WO/2021/148428ISOTROPIC CONCENTRATE AND WASH COMPOSITIONSUNILEVER IP HOLDINGS B.V.
WO/2021/148436SUBSTANCE COMBINATION WITH ISOQUINOLINE ALKALOIDS AND A  COCCIDIOSTAT OR COCCIDIOSIS INOCULANTPHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH
WO/2021/148439METHODS FOR STIMULATING CEREBROVASCULAR FUNCTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/151756BASE EDITOR LACKING HNH AND USE THEREOFETH ZURICH
WO/2021/164974SHAVING AID CONTAINING HYDROXYALKYL CELLULOSESBEIERSDORF AG
WO/2021/148496USE OF TETRAPEPTIDES AND FUNCTIONALISED MICROCAPSULES AS SKIN  PENETRATION CARRIERSINFINITEC ACTIVOS, S.L.
WO/2021/148500COMPOUNDS AND CONJUGATES THEREOFMEDIMMUNE LIMITED
WO/2021/148501COMPOUNDS AND CONJUGATES THEREOFMEDIMMUNE LIMITED
WO/2021/148511LIPID NANOPARTICLESETHERNA IMMUNOTHERAPIES NV
WO/2021/148572COMPOSITION COMPRISING HYALURONIC ACID AND A POLYOL AND/OR  CARBOXYMETHYL CELLULOSELABORATOIRES GENEVRIER SAS
WO/2021/148619TOPICAL COMPOSITIONS COMPRISING A MACROLIDE IMMUNOSUPPRESSANTBAUSCH HEALTH IRELAND LIMITED
WO/2021/148633COMPLEX OF 7-DEACETYFORSKOLINE AND PVPSCIPHARM S.à R.L.
WO/2021/148634TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT  ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVELUYE PHARMA SWITZERLAND AG
WO/2021/148646MICRIBIOTA-DERIVED PROTEINS INDUCING IL-10 RELEASE FROM HUMAN  CELLS AND USES THEREOFENTEROME S.A.
WO/2021/148667AESTHETIC DENTAL FILLING MATERIAL HAVING HIGH CURING DEPTHIVOCLAR VIVADENT AG
WO/2021/151828THE USE OF A POLYLYSINE FOR INCREASING THE GLOSS OF HAIRBASF SE
WO/2021/151857PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED  PHARMACEUTICAL FORMULATIONCHIESI FARMACEUTICI S.P.A.
WO/2021/151865MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAYEVOTEC INTERNATIONAL GMBH
WO/2021/151872ALLERGEN PROTECTION AGAINST URUSHIOLSBEIERSDORF AG
WO/2021/151877TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES FOR  PROTECTING SKIN FROM ALLERGENSBEIERSDORF AG
WO/2021/156104METHOD FOR OBTAINING AN AQUEOUS EXTRACT OF LAVENDER,  COMPOSITIONS COMPRISING SUCH AN EXTRACT AND THEIR COSMETIC USESISP INVESTMENTS LLC.
WO/2021/151879PROTECTING SKIN FROM ALLERGENSBEIERSDORF AG
WO/2021/151905TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR THE TREATMENT OF  RENAL DISEASETRANSITION THERAPEUTICS (IRELAND 2) LIMITED
WO/2021/165001HUMECTANT-FREE TOOTHPASTE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/151946COMPOSITIONS COMPRISING BACTERIAL STRAINS4D PHARMA RESEARCH LIMITED
WO/2021/151956COMPOSITION FOR TREATING INTESTINAL OR PULMONARY DISEASESINSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE,  L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/151963PHARMACEUTICAL COMPOSITION FOR CONTROLLING PARASITES ON  NON-HUMAN ORGANISMSBAYER ANIMAL HEALTH GMBH
WO/2021/151964USE OF AZOLE COMPOUNDS TO STIMULATE THE IMMUNE SYSTEM AND AS  INHIBITORS FOR S-PLA2GIBDIACCURATE
WO/2021/151974INTERFERING WITH MRNA SPLICING TO ENHANCE RESPONSE TO  CHECKPOINT IMMUNOTHERAPIES.STICHTING HET NEDERLANDS KANKER INSTITUUT - ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/151984TREATMENT OF CANCERINNATE PHARMA
WO/2021/152009GRANULAR PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION FROM A  PRE-FILLED STRAW AND METHOD OF MANUFACTURING SUCH PHARMACEUTICAL PRODUCTALTERNO LABS D.O.O.
WO/2021/152060CONTROLLED RELEASE SELEXIPAG COMPOSITIONACTELION PHARMACEUTICALS LTD
WO/2021/152065APREPITANT FOR USE IN THE TOPICAL TREATMENT OF FACIAL  NEURALGIAASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/156145ADONIRUBIN AND DHA FOR HEART HEALTHDSM IP ASSETS B.V.
WO/2021/152115BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLESMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/152119HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT  OF INFLAMMATORY PULMONARY DISEASESADVITA LIFESCIENCE GMBH
WO/2021/152129AMORPHOUS SOLID DISPERSION OF  8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINEABIVAX
WO/2021/152136PASTE COMPRISING MAGNETIC ALKOXYSILANE-COATED METAL CONTAINING  NANOPARTICLESMAGFORCE AG
WO/2021/190810IMPROVING THE FASTNESS TO WASHING OF PIGMENT-CONTAINING DYES  BY USING AN OXIDATIVE PRETREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/156172PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB AND A  STABILIZING AGENTBAYER AKTIENGESELLSCHAFT
WO/2021/152172HYPERBRANCHED POLYESTER POLYOL DERIVATIVE AS DRUG SOLUBILIZERFREIE UNIVERSITÄT BERLIN
WO/2021/152175PULMONARY DELIVERY OF ANTIBODIESSANOFI
WO/2021/156213LIPID NANOPARTICLES FOR DELAYED DELIVERY OF FRAGRANCE WITH  ENHANCED WATER SOLUBILITY, THEIR PREPARATION AND USECLARIANT INTERNATIONAL LTD
WO/2021/152184COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST  AND A GLP-1 RECEPTOR AGONISTADOCIA
WO/2021/156223NANOFORMULATIONS OF METHYL  {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}CARBAMATEADVERIO PHARMA GMBH
WO/2021/156227METHODS OF TREATING AND ASSESSING PULMONARY ARTERIAL  HYPERTENSION WITH SELEXIPAGACTELION PHARMACEUTICALS LTD
WO/2021/156242FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCEFIRMENICH SA
WO/2021/156258TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS  BINDING TO PD-L1 AND CD137BIONTECH SE
WO/2021/156267CORONAVIRUS VACCINECUREVAC AG
WO/2021/156275COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND OCULAR  HYPERTENSIONNICOX S.A.
WO/2021/156277IMMUNE CELL EXPRESSING ADAPTER CHIMERIC ANTIGEN RECEPTOR FOR  SENSING SOLUBLE ANTIGENSMILTENYI BIOTEC B.V. & CO. KG
WO/2021/156289COMBINATION CONTAINING A DUOCARMYCIN DERIVATIVE-COMPRISING  ANTIBODY-DRUG CONJUGATE AND THIOSULFATEBYONDIS B.V.
WO/2021/156291CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS  SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOFI+MED S. COOP.
WO/2021/156310TAFA4 POLYPEPTIDE OR POLYNUCLEOTIDE FOR TREATING INFLAMMATORY  DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156326ANTIBODIES FOR USE IN THERAPYGENMAB A/S
WO/2021/156330ORAL CARE COMPOSITION FOR ANIMALSDR. KURT WOLFF GMBH & CO. KG
WO/2021/156340PDAC TREATMENT REGIMENSWEDISH ORPHAN BIOVITRUM AB (PUBL)
WO/2021/156345INJECTABLE COMPOSITION FOR SKIN AND SOFT TISSUE AUGMENTATIONMERZ PHARMA GMBH & CO. KGAA
WO/2021/156369USE OF LOW DOSES OF HYDROXYCHLOROQUINE FOR THE TREATMENT OF  LIPIN-1 DEFICIENCYINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156381ACTIVE INGREDIENT OF AN ERYTHROCYTES-CONTAINING COMPOSITIONGHASHGHAEINIA, Mehrdad
WO/2021/156385LIPID COMPOSITION COMPRISING OMEGA-3 FATTY ACIDSWELLNESS HOLDING B.V.
WO/2021/160519TREATMENT OF PRIMARY BILIARY CHOLANGITIS WITH ELAFIBRANORGENFIT
WO/2021/156404TREATMENT OF HPV-RELATED DISEASESISA PHARMACEUTICALS
WO/2021/156435MUCOADHESIVE SOLID OR SEMISOLID OCULAR DELIVERY SYSTEMS BASED  ON PREACTIVATED THIOMERSBIOADHESIVE OPHTHALMICS
WO/2021/156437FENFLURAMINE FOR USE IN TREATING PATIENTS WITH LENNOX-GASTAUT  SYNDROMEZOGENIX INTERNATIONAL LIMITED
WO/2021/170374COMPOSITION FOR USE IN PREVENTION OR TREATMENT OF OESOPHAGEAL  DISEASES LINKED TO EPITHELIAL BARRIER DEFECTSTHELIAL B.V.
WO/2021/156490CORONA VIRUS BINDERSVIB VZW
WO/2021/170380IMPROVED PREPARATIONBEIERSDORF AG
WO/2021/160543METHOD FOR TREATING VASO OCCLUSIVE CRISES ASSOCIATED WITH  SICKLE CELL DISEASENICOX S.A.
WO/2021/156504TREATMENT OF PANX1 ASSOCIATES DISEASESNURITAS LIMITED
WO/2021/160608PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND  METFORMINZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/160650A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF A CANCERABILITY PHARMACEUTICALS S.L.
WO/2021/160659GAS-FILLED MICROVESICLES FOR THERAPEUTIC USEBRACCO SUISSE SA
WO/2021/170409USE OF A COMBINATION OF A SACCHARIDE AND GLYCEROL FOR  PREBIOTIC BENEFITSUNILEVER IP HOLDINGS B.V.
WO/2021/160700COMPOSITION COMPRISING RAMIPRIL AND INDAPAMIDEADAMED PHARMA S.A.
WO/2021/160708COMBINATION OF REGORAFENIB AND MSLN-TTC FOR TREATING CANCERBAYER AKTIENGESELLSCHAFT
WO/2021/160724PROCESS FOR SITE-SPECIFIC MODIFICATION OF AN ANTIBODYORANO MED
WO/2021/204441METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF A  ORGANOSILICON COMPOUND, A POLYSACCHARIDE, A COLORING COMPOUND AND A  POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/160763FGFR TYROSINE KINASE INHIBITORS AND ANTI-PD1 AGENTS FOR THE  TREATMENT OF UROTHELIAL CARCINOMAJANSSEN PHARMACEUTICA NV
WO/2021/160764FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HIGH-RISK  NON-MUSCLE INVASIVE BLADDER CANCERJANSSEN PHARMACEUTICA NV
WO/2021/160766LIPID COMPOSITION AND USE THEREOF FOR DELIVERY OF A  THERAPEUTICALLY ACTIVE AGENT TO ENDOTHELIUMPANTHERNA THERAPEUTICS GMBH
WO/2021/160768COMPOUNDS USEFUL AS ANTI-VIRAL AGENTSNATURE CRETE PHARMACEUTICALS PC
WO/2021/160769A BACTERIAL COMPOSITION FOR THE TREATMENT OF CANCERUNIVERSITÄT ZüRICH
WO/2021/160873NANOPARTICLES ENCAPSULATING SMALL MOLECULESETH ZURICH
WO/2021/165177USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT  OF CARDIAC DISEASES IN FELINESBOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/160881INTRANASAL MRNA VACCINESETHERNA IMMUNOTHERAPIES NV
WO/2021/165204TOPICALLY ADMINISTRABLE LYSATE OF DEDIFFERENTIATED CELLS OF  THE PLANT HELICHRYSUM STOECHAS FOR MOISTURIZING SKINSOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165205TOPICALLY ADMINISTRABLE LYSATE (LY) OF DEDIFFERENTIATED CELLS  OF THE PLANT HELICHRYSUM STOECHAS FOR ELIMINATING OR REDUCING INFLAMMATION OF  THE SKINSOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165206TREATMENT OF DRY AMD WITH INTEGRIN ANTAGONISTSOXURION NV
WO/2021/165207TRANSPARENT COLORED COSMETIC INGREDIENT FOR COSMETIC PRODUCTS,  POSSIBLY CAPABLE OF AUTOMATICALLY CHANGING COLOR WHEN IRRADIATED BY  ULTRAVIOLET LIGHT.INTERCOS S.P.A.
WO/2021/165226SUBCUTANEOUS ADMINISTRATION OF FACTOR VIIIBIOTEST AG
WO/2021/165227AMPHIPHILIC POLYMERS AND THEIR USE FOR IMPROVED PRODUCTION OF  NANOPARTICLES FOR THE TARGETED DELIVERY OF ANTIGENSTOPAS THERAPEUTICS GMBH
WO/2021/165240TAFOXIPARIN FOR THE TREATMENT OF PREECLAMPSIADILAFOR AB
WO/2021/175577TRANSPARENT DENTIFRICE COMPRISING ZINCUNILEVER IP HOLDINGS B.V.
WO/2021/175583LIPID NANOPARTICLES COMPRISING A FRAGRANCECLARIANT INTERNATIONAL LTD
WO/2021/144476PHARMACEUTICAL FORMULATIONSNOVO NORDISK A/S
WO/2021/144477GLP-1 COMPOSITIONS AND USES THEREOFNOVO NORDISK A/S
WO/2021/165285MONO- AND MULTI-TRIAZOLOMINIGASTRINS FOR TARGETING OF  CCK2R-POSITIVE NEOPLASMSPAUL SCHERRER INSTITUT
WO/2021/165306OPTIMIZATION OF PEPTIDE-MELANIN BINDINGASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
WO/2021/165312VACCINE ADJUVANT COMPRISING AN INVERSE MICROLATEXSOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165316PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZINZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/165348PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED  PHARMACEUTICAL FORMULATIONCHIESI FARMACEUTICI S.P.A.
WO/2021/165369TREATMENT OF CORNEAL VASCULARISATIONVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/175605OXYGEN/CARBON DIOXIDE COMPOSITIONS FOR MEDICAL USESAVIATION WORKS LIMITED
WO/2021/175606AN EFFECTIVE ANTI-ACNE PERSONAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/165402CAPSULE COMPRISING A VITAMIN E ESTER FOR PREVENTING THE ONSET  OF VAGINAL DYSBIOSIS AND RESULTING VAGINAL PATHOLOGIESHULKA S.R.L.
WO/2021/165405A PHARMACEUTICAL COMBINATION OF AN ARTEMISININ COMPOUND,  5-AMINOLEVULINIC ACID OR METHYL-5-AMINOLEVULINIC ACID AND A CHEMOTHERAPEUTIC  AGENTJLP HEALTH GMBH
WO/2021/165420METHOD FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASEMESOBLAST INTERNATIONAL SàRL
WO/2021/170489AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGEUCL BUSINESS PLC
WO/2021/165424AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE 2UCL BUSINESS PLC
WO/2021/165426ANTIMICROBIAL COMPOSITIONSFIRMENICH SA
WO/2021/165429CXCL8 (INTERLEUKIN-8) ACTIVITY INHIBITOR AND CORTICOSTEROID  COMBINATION AND PHARMACEUTICAL COMPOSITION AND USE THEREOFDOMPE' FARMACEUTICI SPA
WO/2021/165452MOLECULES TARGETING MUTANT RAS PROTEINAELIN THERAPEUTICS
WO/2021/165453MOLECULES TARGETING PROTEINSAELIN THERAPEUTICS
WO/2021/165456MOLECULES TARGETING RAS PROTEINAELIN THERAPEUTICS
WO/2021/165463METHOD OF TREATING BACTERIAL INFECTIONS AND PHARMACEUTICAL  COMPOSITION FOR TREATING BACTERIAL INFECTIONSINSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE,  L’ALIMENTATION ET L’ENVIRONNEMENT
WO/2021/165472MASITINIB FOR THE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT  SUBPOPULATIONAB SCIENCE
WO/2021/165477USE OF MICA IN PRESSED POWDERIMERTECH SAS
WO/2021/165484DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR  PRODUCTION OF BIOLOGICAL ENTITIESUNIVERSITé DE LIèGE
WO/2021/165499INHIBITORS AND USES THEREOFENTHERA S.R.L.
WO/2021/165510CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE  IN THE TREATMENT OF CANCER-RELATED FATIGUEDOMPE' FARMACEUTICI SPA
WO/2021/170516FORMULATION BASED ON NATURAL INGREDIENTS FOR USE IN TREATING  PROCTOLOGICAL DISORDERSNATHURA S.P.A.
WO/2021/165537A METHOD FOR SEPARATION OR DEPLETION OF EMPTY AAV CAPSIDS FROM  FULL AAV CAPSIDSBIA SEPARATIONS D.O.O.
WO/2021/165543PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE  TREATMENTORIGIMM BIOTECHNOLOGY GMBH
WO/2021/170548PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF  DYSMENORRHEA AND/OR PREMENSTRUAL SYNDROME (PMS)CORNELLI, Umberto
WO/2021/170566RESHAPING COMPOSITION FOR KERATIN FIBERSKAO GERMANY GMBH
WO/2021/175660PREPARATION FOR MAGNETIZING KIDNEY STONES AND KIDNEY STONE  FRAGMENTS AND KIT FOR REMOVING KIDNEY STONES AND KIDNEY STONE FRAGMENTSTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/165549TREATMENT OF MEDICAL INDICATIONVALLAURIX TRADING SARL MC
WO/2021/170614AEROSOL COMPRISING 5-METHOXY-N.N-DIMETHYLTRYPTAMINEGH RESEARCH LIMITED
WO/2021/170618COMPOSITIONS COMPRISING <i>LUFFA CYLINDRICA</i>  ROOT EXTRACTCLARIANT INTERNATIONAL LTD
WO/2021/175672COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED  ELASTICITY AND EXTENSIBILITYCOVESTRO DEUTSCHLAND AG
WO/2021/170684KRAS EPITOPES AND ANTIBODIESOBLIQUE THERAPEUTICS AB
WO/2021/170741TREATMENT OF HBVJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/170763ANTI-ADM-ANTIBODIES BINDING TO THE FREE N-TERMINUS FOR  ACCELERATED TRANSITION OF ADM-GLY TO BIO-ADM IN PATIENTS WITH ADM-GLY/  BIO-ADM RATIO ABOVE A THRESHOLD AND COMBINATION WITH VITAMIN CSPHINGOTEC GMBH
WO/2021/170772COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF CD47 MEDIATED SIGNALINGAPREA THERAPEUTICS AB
WO/2021/170784GENE THERAPY FOR MAPLE SYRUP URINE DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/170793COMBINATION COMPRISING ALPELISIB AND  6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC  ACIDSANOFI
WO/2021/170806USES AND COMPOSITIONS BASED ON POLYPHENOLS FOR IMPROVING THE  ORAL BIOAVAILABILITY OF HYDROXYTYROSOLBIOSEARCH, S.A.
WO/2021/170807DAPTOMYCIN FORMULATIONXELLIA PHARMACEUTICALS APS
WO/2021/175716COMPOSITE RNA PARTICLESBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/170811METHOD OF TREATING EYE DISEASE USING TRPV4 ANTAGONISTSGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/170816USE OF PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR  THERAPEUTIC PURPOSEPAM THERAGNOSTICS GMBH
WO/2021/170817COMPOSITION FOR DISPERSING A LIPOSOLUBLE COMPOUND IN AN  AQUEOUS PHASESENSIENT COSMETIC TECHNOLOGIES
WO/2021/170821METHOD FOR VIRUS PRODUCTIONTECHNISCHE HOCHSCHULE MITTELHESSEN
WO/2021/170828HIGH POLYOL WASH COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/170831ENZYME REPLACEMENT THERAPY FOR TREATING POMPE DISEASEELEVA GMBH
WO/2021/170834COMPOSITION FOR THE PREVENTION AND TREATMENT OF DYSBIOSISMUCOSA INNOVATIONS, S.L.
WO/2021/170841PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE  AND METHODS OF THEIR USEBIOSERGEN AS
WO/2021/170848INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES  MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASEACADEMISCH MEDISCH CENTRUM
WO/2021/175740FOLATE PREPARATIONS FOR THE TREATMENT OF OCULAR DISEASESAPROFOL AG
WO/2021/175755FORMULATION OF LISINOPRIL AND AMLODIPINEALKALOID AD SKOPJE
WO/2021/175763TOPICAL COMPOSITION COMPRISING CANNABIDIOLEMMAC LIFE SCIENCES LTD.
WO/2021/170869CORONAVIRUS VACCINESKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/175773DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL  PHOSPHORIC ACID SALTGRüNENTHAL GMBH
WO/2021/175775COSMETIC COMPOSITION WITH OPTIMIZED STARCH AND COSMETIC  APPLICATIONS THEREOFINTERCOS S.P.A.
WO/2021/170875PHARMACEUTICAL COMPOSITIONS COMPRISING  2-[(4<i>S</i>)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4<i>H</i>-QUINAZOLIN-4-YL]ACETATE  AND SODIUM IONSAIC246 GMBH & CO. KG
WO/2021/170878SODIUM  2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE  AND PHARMACEUTICAL COMPOSITIONS THEREOFAIC246 GMBH & CO. KG
WO/2021/175816COMPOUNDS FOR USE IN A METHOD OF TREATING, PREVENTING AND/OR  REDUCING THE SYMPTOMS OF PAINTHE BECKLEY FOUNDATION
WO/2021/175823PLD FOR USE IN COMBINATION IN THE TREATMENT OF CORONAVIRUSPHARMA MAR, S.A.
WO/2021/175824METHOD FOR ADMINISTRATION OF AN ANTI CANCER AGENTBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/175826COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTIONPHARMA MAR, S.A.
WO/2021/175829COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONSPHARMA MAR, S.A.
WO/2021/175831COMPOUNDS FOR USE IN VIRAL INFECTIONSPHARMA MAR, S.A.
WO/2021/175857COMPOUNDS FOR USE IN INFLAMMATORY CONDITIONSPHARMA MAR, S.A.
WO/2021/175877COMPOSITION FOR USE IN A TREATMENT OF CERVICAL CELL  ABNORMALITIES COMPRISING SELENITE COMPOUND AND ACIDSELO MEDICAL GMBH
WO/2021/175914CONDITIONING REGIMEN FOR TRANSPLANTHANSA BIOPHARMA AB
WO/2021/175924TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR  USE IN COMBINATION THERAPYACTIVE BIOTECH AB
WO/2021/175926COMPOSITION FOR POLYAMINE BIOSYNTHESISBM HEALTH GMBH
WO/2021/175960FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE  PRODUCTION TO PROTECT AGAINST CORONAVIRUSESROCKETVAX AG
WO/2021/175998COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC  SYNDROME AND INFLAMMATORY BOWEL DISEASESINSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE,  L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/176000PROCESS FOR PRODUCING A HYDROLYSATE OF SCUTELLARIA ROOT, WHICH  IS ENRICHED AND STANDARDIZED WITH FLAVONOIDS OF INTEREST, THE HYDROLYSATE  OBTAINED BY SUCH A PROCESS, AND COSMETIC AND DERMOCOSMETIC APPLICATIONS OF  SUCH A HYDROLYSATEEXSYMOL
WO/2021/176001METHOD FOR TREATING INFLAMMATORY LUNG DISEASES USING  MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLSMESOBLAST INTERNATIONAL SàRL
WO/2021/176010ANTIVIRAL TREATMENTECOSYNTH NV
WO/2021/176017TREATMENT OF VIRAL INFECTIONPNEUMAGEN LTD
WO/2021/176035BLOOD PREPARATION USEFUL FOR WOUND HEALING AND TISSUE  REGENERATIONNOVYSTEM S.P.A.
WO/2021/176038SYNERGISTIC AND TARGETING COMPOSITIONS FOR TREATMENT OF  ARTERIAL AND VENOUS THROMBOSISASTRAZENECA AB
WO/2021/176044LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC  LATERAL SCLEROSISCENTRE HOSPITALIER UNIVERSITAIRE DE NIMES
WO/2021/254667COBICISTAT FOR PREVENTION AND/OR TREATMENT OF CORONAVIRUS  INFECTIONSUNIVERSITÄT HEIDELBERG
WO/2021/176070METHODS OF SLOWING BRAIN VOLUME LOSSACTELION PHARMACEUTICALS LTD
WO/2021/176074COMPOSITION COMPRISING AN AVENANTHRAMIDE WITH IMPROVED SKIN  PENETRATIONSYMRISE AG
WO/2021/176083PHARMACEUTICAL COMPOSITIONS COMPRISING DASATINIB ANHYDROUS AND  USES THEREOFZENTIVA K.S.
WO/2021/176085STEROIDAL NITRONE F2 FOR USE IN THE PREVENTION AND/OR  TREATMENT OF PERMANENT CEREBRAL ISCHAEMIAISQUAEMIA BIOTECH, S.L.
WO/2021/176088COMPOUNDS FOR THE TREATMENT OF COVID-19DOMPE' FARMACEUTICI SPA
WO/2021/176093NICOTINAMIDE MONONUCLEOTIDE AND BIS-NICOTINAMIDE DINUCLEOTIDE  DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIANUVAMID SA
WO/2021/180603SOFT CHEWABLE FORMED BODY FOR THE ADMINISTRATION TO ANIMALSBAYER ANIMAL HEALTH GMBH
WO/2021/176096PHARMACEUTICAL COMPOSITION COMPRISING SGLT2 INHIBITORKRKA, D.D., NOVO MESTO
WO/2021/176098MODULATORS OF ARALAR FOR TREATING NEUROLOGICAL DISORDERSUNIVERSITé DE LAUSANNE
WO/2021/180612MIXTURE COMPOSITION COMPRISING GLYCOLIPIDS AND TRIETHYL  CITRATEEVONIK OPERATIONS GMBH
WO/2021/176100IONTOPHORETIC COMPOSITION FOR ADMINISTERING S-KETAMINELTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/180643HSD11B1 INHIBITORS FOR USE IN IMMUNOTHERAPY AND USES THEREOFUNIVERSITE DE GENEVE
WO/2021/180731COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES AND  CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180732COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180739COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180740COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF LUNG DISEASES AND CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180741COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF PANCREATIC DISEASES AND CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180742METHYL-CYCLODEXTRIN FOR USE IN TREATING ENVELOPED VIRUS  INFECTIONS SUCH AS COV-2GARNIER, Patrice
WO/2021/180780TREATMENT AND/OR DIAGNOSIS OF A CANCER TYPE CHARACTERIZED BY  EXPRESSING ZINC TRANSPORTER ZIP4UNIVERSITAT POMPEU FABRA
WO/2021/180787PROTEOLYSIS TARGETING CHIMERA (PROTAC) FOR DEGRADATION OF  AURORA A-KINASEJULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/180821COMPOSITIONS OF IL-6/IL-6R ANTIBODIES AND METHODS OF USE  THEREOFTIZIANA LIFE SCIENCES PLC
WO/2021/180832HYBRID CAR AND HYBRID TCR CELLS TO TREAT INFECTIOUS DISEASESUNIVERSITEIT GENT
WO/2021/180839ANTI-AGING CARE COMPOSITION COMPRISING PERFUMESBASF SE
WO/2021/180848SUNFLOWER PHOSPHOLIPID COMPOSITION CONTAINING  PHOSPHATIDYLCHOLINELIPOID GMBH
WO/2021/180850METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE IMESOBLAST INTERNATIONAL SàRL
WO/2021/180851METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE IIMESOBLAST INTERNATIONAL SàRL
WO/2021/180857COMBINATIONS OF BETA-LACTAM COMPOUNDS, PROBENECID, AND  VALPROIC ACID AND USES THEREOFITERUM THERAPEUTICS INTERNATIONAL LIMITED
WO/2021/180862PHARMACEUTICAL COMPOSITIONS COMPRISING ELAGOLIX SODIUMSYNTHON B.V.
WO/2021/180867A NANOPARTICLE FOR USE IN THE TREATMENT OF AN OCULAR DISEASEUNIVERSITÄT REGENSBURG
WO/2021/180884FETUIN A FOR TREATMENT OF RENAL DISORDERSUNIVERSITAET BERN
WO/2021/180885TREATMENT OF STEM CELL DEFICIENCYOSPEDALE SAN RAFFAELE S.R.L.
WO/2021/180896TOPICAL PREPARATIONSEPITHEAL LIMITED
WO/2021/185680A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS SEROTYPE  9, SEQUENCE TYPE 16INTERVET INTERNATIONAL B.V.
WO/2021/180908THERAPEUTIC SYSTEM FOR THE TOPIC, TRANSDERMAL AND  TRANSCUTANEOUS APPLICATION OF CARBON MONOXIDEJULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/180913NEW USE AND METHOD OF TREATMENTREDWOOD PHARMA AB
WO/2021/180915USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS  DERIVATIVES FOR PREVENTING AND/OR TREATING DORSAL PAIN, AND CORRESPONDING  COMPOSITIONSNUVAMID SA
WO/2021/180916USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS  DERIVATIVES FOR THE PREVENTION AND/OR TREATMENT OF MUSCLE, LIGAMENT OR TENDON  PAIN INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONSNUVAMID SA
WO/2021/180919METHOD FOR THE TREATMENT OF A RESPIRATORY DISEASE, DISORDER,  OR CONDITION RESULTING FROM A VIRAL INFECTIONSOFTHALE NV
WO/2021/180943COMPOSITIONS IMPROVING POXVIRUS STABILITYBAVARIAN NORDIC A/S
WO/2021/180963A PROTEASE INHIBITOR REGIMEN FOR TREATING SUBJECTS INFECTED  WITH HIVJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/180969CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING  ALPHA-V-BETA-6 INTEGRIN IN VIVOTECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/180973BIFIDOBACTERIUM LONGUMPRECISIONBIOTICS GROUP LIMITED
WO/2021/185719RGD-CONTAINING PEPTIDE AND USE THEREOF FOR CANCER TREATMENTAC BIOSCIENCE SA
WO/2021/185728BIOCOMPOSITES COMPRISING PROBIOTICS, COLLAGEN AND BACTERIAL  EXTRACELLULAR POLYSACCHARIDE AND USES THEREOFBIOSEARCH, S.A.
WO/2021/185736CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES  DEFINED BY THE MEAN TOTAL SURFACE AREAGIVAUDAN SA
WO/2021/185746COMPOUNDS FOR USE IN TREATMENT OF RESPIRATORY DISEASEAARHUS UNIVERSITET
WO/2021/180981STABILIZATION OF PHARMACEUTICAL COMPOSITIONS COMPRISING  POLYSORBATELEK PHARMACEUTICALS D.D.
WO/2021/185773GOLD-CONTAINING AGENTS FOR THE TREATMENT OF LUNG INFECTIONSPRODUKEM MOLEKULARES DESIGN GMBH
WO/2021/185775ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPESBIONTECH CELL & GENE THERAPIES GMBH
WO/2021/190979WHITENING ORAL CARE COMPOSITIONSRHODIA OPERATIONS
WO/2021/185783COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/185791TREATMENT OF EPILEPSYKATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/185798POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND  ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYNDROMESPHARIS BIOTEC GMBH
WO/2021/185802COMPOSITION FOR ENHANCING UROLITHIN PRODUCTION IN A HUMAN  SUBJECTMIGALIS APS
WO/2021/185804SCORED TABLETGRüNENTHAL GMBH
WO/2021/185807A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A  METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE  IN A MAMMALGEMOAB GMBH
WO/2021/190993COMPOSITIONS CONTAINING RHAMNOLIPIDE, ALKYL POLYGLYCOSIDE AND  ACYL LACTYLATEEVONIK OPERATIONS GMBH
WO/2021/185821LIQUID FORMULATIONS OF GLUCAGON ANALOGUESZEALAND PHARMA A/S
WO/2021/185832NEW THERAPEUTIC TREATMENTSWEDISH ORPHAN BIOVITRUM AG
WO/2021/185838NEW THERAPEUTIC USE OF ANAKINRA FOR COVID-19SWEDISH ORPHAN BIOVITRUM AB (PUBL)
WO/2021/185842USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOFPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/185844USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOFPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/185851VACCINE COMPOSITIONS FOR HIV PREVENTION AND TREATMENTINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/185874USE OF LACTOFERRINMEAD JOHNSON NUTRITION COMPANY
WO/2021/185876USE OF LACTOFERRINMEAD JOHNSON NUTRITION COMPANY
WO/2021/185887REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH FOR TREATING  INITIAL NON-RESPONDERSGRüNENTHAL GMBH
WO/2021/185890GINSENOSIDE COMPOSITIONSGIVAUDAN SA
WO/2021/185897GINSENOSIDE COMPOSITIONSGIVAUDAN SA
WO/2021/185912METHOD FOR THE TREATMENT NLRP3-ASSOCIATED DISEASESSOFTHALE NV
WO/2021/185921LIQUID FORMULATION OF GM-CSF FOR INHALATIONDRUGRECURE APS
WO/2021/185948A STABILIZED PROTEIN OF INTERESTMICREOS HUMAN HEALTH B.V.
WO/2021/185953COSMETIC COMPOSITION AND TREATMENT FOR TREATING SKIN SAGGINGSEDERMA
WO/2021/185959ESTROGEN-RELATED RECEPTOR ALPHA AGONISTS FOR THE TREATMENT AND  THE PROGNOSIS OF BONE METASTASESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/185969VARIANTS OF HLYA AND USES THEREOFNUMAFERM GMBH
WO/2021/186001DOSE TREATMENTS OF TAUOPATHIESAC IMMUNE SA
WO/2021/186024NEW ANTI-VEGFC ANTIBODIES AND USES THEREOFCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
WO/2021/186035CYCLOTIDES IN COMBINATION WITH KAPPA OPIOID RECEPTOR LIGANDS  FOR MS THERAPYMEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/186041JOSAMYCIN FOR USE IN PREVENTION AND TREATMENT OF FIBROSISUNIVERSITÄT ROSTOCK
WO/2021/186042PLASMID COMPRISING ALOPECIA ANTIGENNOVO NORDISK A/S
WO/2021/186053COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION  & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE  INFECTIONABIVAX
WO/2021/186054SORTILIN ANTAGONISTS FOR USE IN THE TREATMENT OF DIABETIC  RETINOPATHYINSUSENSE APS
WO/2021/186060RADIOLABELED GASTRIN ANALOGUE FOR USE IN A METHOD OF TREATING  AND/OR IMAGING CCKB RECEPTOR POSITIVE DISEASES, IN PARTICULAR PULMONARY AND  EXTRAPULMONARY SMALL-CELL CARCINOMADEBIOPHARM INTERNATIONAL S.A.
WO/2021/186061IDEBENONE FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS  SYNDROME (ARDS) IN PATIENTS DIAGNOSED WITH A CORONAVIRUS INFECTIONBEMIDO SA
WO/2021/204520COMPOSITION COMPRISING RESVERATROLGALENUS G.H. AG
WO/2021/186074COMPOSITIONS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERSTALICLA SA
WO/2021/191094ERBB-TARGETED THERAPIES FOR NEUROPATHIC PAINUNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/191108TREATMENT OR PREVENTION OF ACUTE ORGAN DAMAGE INDUCED BY VIRAL  INFECTION WITH A NK1 INHIBITOR AND/OR A GABAPENTINOIDPLUS VITECH, S.L.
WO/2021/191131PROTEIN DISULFIDE ISOMERASE INHIBITORS FOR USE IN THE  TREATMENT OF ALPHA 1-ANTITRYPSIN DEFICIENCYUNIVERSITE DE BORDEAUX
WO/2021/191136DMEH ENHANCERLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/186078METHOD FOR PRODUCING POLYMERSOMESHEIDELBERG UNIVERSITY
WO/2021/186079COLLOIDAL CARRIER SYSTEMS FOR TRANSFER OF AGENTS TO A DESIRED  SITE OF ACTIONHEIDELBERG UNIVERSITY
WO/2021/186080HEAT-TREATED PLATELET-DERIVED GROWTH FACTOR EXTRACT FOR USE IN  A METHOD OF PREVENTING OR TREATING A TISSUE DEFECTPANGERŠIČ, Rok
WO/2021/213749COLOR-STABLE SUNSCREENBEIERSDORF AG
WO/2021/197906CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/197908METHOD OF TREATING THE SCALPUNILEVER IP HOLDINGS B.V.
WO/2021/1911691,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME  FOR USE IN THE TREATMENT OF COVID-19ARTEMIFLOW GMBH
WO/2021/213752TRANSPARENT COSMETIC GELBEIERSDORF AG
WO/2021/213753ENVIRONMENTALLY FRIENDLY COSMETIC SUNSCREENBEIERSDORF AG
WO/2021/213760ENVIRONMENTALLY FRIENDLY SUNSCREENBEIERSDORF AG
WO/2021/191197COMBINATION THERAPY COMPRISING AN AXL INHIBITORBERGENBIO ASA
WO/2021/191236NUCLEOTIDE ANALOGUES FOR THE TREATMENT OF CORONAVIRUSESR.G.C.C. HOLDINGS AG
WO/2021/191240COMBINATION THERAPYANTABIO SAS
WO/2021/191243PIGMENT COMPRISING RAPHANUS SATIVUS EXTRACT AND  MONTMORILLONITEGIVAUDAN SA
WO/2021/191251COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF  LacNAc-LacFRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/191253METHODS FOR PRODUCING HEME PEROXIDASESTECHNISCHE UNIVERSITÄT WIEN
WO/2021/191265RNA PARTICLES COMPRISING POLYSARCOSINEBIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/191266AEROSOLIZATION OF HDL FOR THE TREATMENT OF LUNG INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/191268A MODIFIED RELEASE MULTIPLE UNIT ORAL DOSAGE FORM OF  DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE AND A PROCESS FOR ITS  PREPARATIONINIBSA GINECOLOGíA, S.A.
WO/2021/191273COMPOSITIONS FOR USE IN TREATING MEIBOMIAN GLAND DYSFUNCTIONHOVIONE SCIENTIA LIMITED
WO/2021/191274NEW STRATEGY TO TREAT AND PREVENT DISEASES CAUSED BY  ENTEROBACTERIAEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239292TREATMENT OF CANCERIMMUTEP S.A.S.
WO/2021/191297VIRUCIDAL HAND CREAM FORMULATIONUNIVERSITÄT BASEL
WO/2021/191305CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19DOMPE' FARMACEUTICI SPA
WO/2021/191312METHODS OF TREATING COVID-19 WITH RIFAXIMINBAUSCH HEALTH IRELAND LIMITED
WO/2021/191318SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF OVERT  HEPATIC ENCEPHALOPATHYBAUSCH HEALTH IRELAND LIMITED
WO/2021/191320OPHTHALMIC FORMULATION COMPRISING  N-[5-(AMINOSULFONYL)-4-METHYL-1,3-  THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)PHENYL]ACETAMIDE HEMIHYDRATEAICURIS GMBH & CO. KG
WO/2021/191336A COMBINATION OF FLAVONOIDS AND SPHINGOSINE 1 PHOSPHATE LYASE  INHIBITORS FOR THE TREATMENT OF LUNG INFLAMMATIONAC BIOSCIENCE SA
WO/2021/191342VIRUSTATIC AGENTREINMüLLER, Johannes
WO/2021/191353METHODS FOR PROVIDING A VACCINEWüRFEL, Wolfgang
WO/2021/198041A PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYCHLOROQUINE,  CHLOROQUINE, OR METABOLITE THEREOFBLACKHAWK PARTNERS LIMITED
WO/2021/198051BIO-BASED POLYURETHANE DISPERSIONS FOR DECORATIVE COSMETIC  APPLICATIONSCOVESTRO DEUTSCHLAND AG
WO/2021/191412CATHEPSIN SUBSTRATES & CATHEPSIN INHIBITORS AND USES  THEREOFECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/191416DRY POWDER FORMULATION FOR PULMONARY DELIVERY AND METHODS OF  USEASTRAZENECA AB
WO/2021/191417COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIESSOM INNOVATION BIOTECH, S.A.
WO/2021/191422NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF  BACTERIAL INFECTIONSNUVAMID SA
WO/2021/191431A CONSUMABLE PRODUCT COMPRISING MALTED CEREALS FOR PROMOTING  RECOVERY AT PHYSICAL ACTIVITYLANTMÄNNEN FUNCTIONAL FOODS AB
WO/2021/191432TARGETING QUORUM-SENSING PEPTIDES FOR DIAGNOSIS, TREATMENT  AND/OR PREVENTION OF COLORECTAL CANCER METASTASISUNIVERSITEIT GENT
WO/2021/191435USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  ADRENOLEUKODYSTROPHY OR ADRENOMYELONEUROPATHYPOXEL
WO/2021/191436METHODS FOR TREATMENT OF VIRUSAPEIRON BIOLOGICS AG
WO/2021/198099USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  DIABETIC NEPHROPATHYPOXEL
WO/2021/204568A TOPICAL COMPOSITION FOR TREATMENT OF PRURITUSUNIVERSITÄT BASEL
WO/2021/191455NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND  ANTI-INTERFERON EFFECTUNIVERSITE DE PARIS
WO/2021/191456COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITIONVECTURA LIMITED
WO/2021/198115TREATMENTUNION THERAPEUTICS A/S
WO/2021/198116FORMULATIONUNION THERAPEUTICS A/S
WO/2021/191460NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND  ANTI-INTERFERON EFFECTUNIVERSITE DE PARIS
WO/2021/191461AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR  TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENTSORBONNE UNIVERSITE
WO/2021/191462COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USESSHARED VISION TECHNOLOGY LTD.
WO/2021/204572BEADS COMPRISING A BUFFER SYSTEMCHEMISCHE FABRIK BUDENHEIM KG
WO/2021/198135METHOD OF TREATING VIRAL INFECTIONSIMMUPHARMA FRANCE SA
WO/2021/198139VIRUCIDAL COMPOSITIONS AND USE THEREOFECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/228465METHOD FOR TREATING HUMAN HAIR WITH AGENTS CONTAINING MIXTURES  OF ORGANIC C1-C6 ALKOXY SILOXANESHENKEL AG & CO. KGAA
WO/2021/191464USE OF CONJUGATES COMPRISING TUMOUR-SELECTIVE LIGANDS AND  GROUPS CAPABLE OF RELEASING CARBON MONOXIDE (CO), FOR EXERTING  IMMUNOMODULATORY EFFECTS IN CANCER TREATMENTINSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/198176POLYPEPTIDE FOR THE PROPHYLAXIS AND TREATMENT OF VIRAL  INFECTIONSPHARIS BIOTEC GMBH
WO/2021/198177BIOMATERIAL COMPRISING A POROUS RESORBABLE MATRIX AND  ASSOCIATED MANUFACTURING METHODUNIVERSITE GRENOBLE ALPES
WO/2021/198191QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A  CANCERENYO PHARMA
WO/2021/191469COMPOSITION FOR THE TREATMENT OF GASTRO-INTESTINAL DYSFUNCTION  AND/OR ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/191470COMPOSITION COMPRISING GLYCERIDES FOR THE TREATMENT OF  GASTRO-INTESTINAL DYSFUNCTION AND/OR ASSOCIATED MORBIDITIES THERETOBASF SE
WO/2021/198195AGONIST COMBINATIONZEALAND PHARMA A/S
WO/2021/198196GLP-1/GLP-2 DUAL AGONISTSZEALAND PHARMA A/S
WO/2021/198198OIL-IN-WATER EMULSION COMPRISING A SOLID LIPID MATERIALFIRMENICH SA
WO/2021/198212OPHTHALMIC FORMULATION AND ITS USEOY FINNSUSP AB
WO/2021/198216NEW METHOD TO TREAT THE HEPATOTOXICITY INDUCED BY AMANITINSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/198220TREATMENT AND PREVENTION OF SECONDARY INFLAMMATION IN PATIENTS  SUFFERING FROM A VIRAL INFECTIONALLERO THERAPEUTICS B.V.
WO/2021/198229SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY  FOR IMAGING AND THERAPY PURPOSESANTAROS MEDICAL AB
WO/2021/198253USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/198254BIOCHANIN A DERIVATIVES FOR TREATMENT OF BEST1 -RELATED  RETINOPATHIESUNIVERSITÄT REGENSBURG
WO/2021/198255AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING  FROM SEPSIS, SEPTIC SHOCK,, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR  MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)NERRE THERAPEUTICS LIMITED
WO/2021/198256COMPOSITION HAVING IMPROVED VOLUNTARY ACCEPTANCEBAYER ANIMAL HEALTH GMBH
WO/2021/198258TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN  VACCINATIONBIONTECH SE
WO/2021/198284USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  CARDIOVASCULAR DISEASESPOXEL
WO/2021/198285HOMOGENEOUS LIQUID COMPOSITION COMPRISING 1,2-OCTANEDIOL AND  USE THEREOFMINASOLVE SAS
WO/2021/198316COMPOUNDS, COMPOSITIONS AND DEVICES FOR USE IN THE PREVENTION  OR TREATMENT OF CORONA-VIRUS INFECTIONSVOSSENSTEYN
WO/2021/198327LIQUID PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED  PRODRUGS OF ADRENOMEDULLIN AND USEBAYER AKTIENGESELLSCHAFT
WO/2021/198328PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED PRODRUGS  OF ADRENOMEDULLIN AND USEBAYER AKTIENGESELLSCHAFT
WO/2021/198332CONDENSATION PRODUCT FOR USE IN A METHOD FOR THE TREATMENT OF  COVID-19BASF SE
WO/2021/198333BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAPF. HOFFMANN-LA ROCHE AG
WO/2021/198336USE OF HAEMOGLOBIN FROM ANNELIDS FOR TREATING ACUTE  RESPIRATORY DISTRESS SYNDROMEHEMARINA
WO/2021/198346EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING COVID-19DR. NESSELHUT BESITZGESELLSCHAFT MBH
WO/2021/198353A FLEXIBLE FOIL FOR THE DELIVERY OF THERAPEUTIC CARGOSDANMARKS TEKNISKE UNIVERSITET
WO/2021/198369AGENTS FOR USE IN THE THERAPEUTIC OR PROPHYLACTIC TREATMENT OF  RETINAL PIGMENT EPITHELIUM ASSOCIATED DISEASESPANDA-JONAS, Songhomitra
WO/2021/198376NOVEL SALMONELLA-BASED CORONAVIRUS VACCINEVAXIMM AG
WO/2021/204634TOPICAL PHARMACEUTICAL COMPOSITION IN THE FORM OF AN AQUEOUS  GEL COMPRISING AT LEAST AMITRIPTYLINEALGOTHERAPEUTIX
WO/2021/198395SURFACTANT PROTEIN D FOR USE IN TREATING CORONAVIRUS  INFECTIONSTRIMUNOCOR LIMITED
WO/2021/198399COMPOSITIONS AND METHODS CONTAINING N-ACETYLCYSTEIN AND  NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES  AND CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/204655MODIFIED VECTORS FOR PRODUCTION OF RETROVIRUSGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/198410AMYLOSE/CAROTENOIDS COMPLEXATION PROCESSECLYPSE INK BIOTECHNOLOGY
WO/2021/198413STABILIZED VACCINE COMPOSITIONSJANSSEN VACCINES & PREVENTION B.V.
WO/2021/198415METHODS OF TREATMENT USING NICLOSAMIDESOFTHALE NV
WO/2021/198439REDUCED CALORIC INTAKE AND IMMUNOTHERAPY FOR THE TREATMENT OF  CANCERIFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
WO/2021/198442ISOQUINOLINE DERIVATIVES FOR USE IN THERAPYVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/198449TUMOR ANTIGENS FOR LIVER CANCER IMMUNOTHERAPYISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE
WO/2021/198454METHOD FOR TREATING HYPERINFLAMMATION USING MESENCHYMAL  LINEAGE PRECURSOR OR STEM CELLSMESOBLAST INTERNATIONAL SàRL
WO/2021/198464WOUND CARE COMPOSITIONS AND METHODS OF PREPARATION THEREOFT.J.SMITH AND NEPHEW,LIMITED
WO/2021/204705CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COMPOSITIONS  FOR USE IN THE TREATMENT OR PREVENTION OF IRON DEFICIENCY ASSOCIATED WITH  LIVER DISEASESNEMYSIS LTD.
WO/2021/209274HYDRATABLE COSMETIC COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/204717AMINOQUINOLINES FOR TREATING CORONAVIRUS INFECTIONSOXANDIA LTD
WO/2021/198504ACTIVE SUBSTANCES FOR MEDICAL USEINFLAMED PHARMA GMBH
WO/2021/198506USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)POXEL
WO/2021/198511METHODS AND COMPOSITIONS FOR TREATMENT OF SARS-COV-2 INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/198516COMPOSITIONINOCELLS B.V.
WO/2021/198517COMPOSITIONINOCELLS B.V.
WO/2021/198524REGIMEN FOR REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCHGRüNENTHAL GMBH
WO/2021/204751PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASESPOXEL
WO/2021/204755PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASESPOXEL
WO/2021/204756METHODS FOR THE TREATMENT OF HEADACHE DISORDERSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/204757TREATMENT OF ARDS AND OTHER PARAMETERS RELATED TO COVID-19STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
WO/2021/204781ARTC1 LIGANDS FOR CANCER TREATMENTUNIVERSITÄT ZüRICH
WO/2021/204802LABELLED SUBSTANCE AND METHODS OF DETECTION OF INFLAMMATION  AND INFECTION USING SAID SUBSTANCEPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/20481225-HYDROXYVITAMIN D2 AND/OR D3 FOR USE IN OBESITYCARBOGEN AMCIS B.V.
WO/2021/204814NACHR, SUCH AS NICOTINE, FOR USE IN THE PREVENTION AND THE  TREATMENT OF COVID-19 DISEASEASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/204825INACTIVATED SARS-CoV-2 VIRUS VACCINEVALNEVA AUSTRIA GMBH
WO/2021/198535USE OF AN ARSENIC COMPOUND FOR TREATING A SHORT OR LONG  CYTOKINE STORM IN VARIOUS AUTOIMMUNE/INFLAMMATORY DISEASES IN HUMANS OR  ANIMALSMEDSENIC
WO/2021/204843TOPICAL USE OF ERLOTINIB FOR TREATING KERATODERMAS IN CHILDRENLABORATOIRES C.T.R.S.
WO/2021/204861COMPOSITIONS FOR USE IN THE INHIBITION OF CORONAVIRUS  REPLICATIONNORDIC PHARMA LAB APS
WO/2021/204873IMMUNOGENIC COMPOSITION COMPRISING AN ANTIGENIC MOIETY AND A  LIPOSOMAL FORMULATION, METHOD OF PRODUCING THE COMPOSITION, THE COMPOSITION  FOR USE AS A MEDICAMENT, IN PARTICULAR FOR USE AS A VACCINEINNOMEDICA HOLDING AG
WO/2021/239307NOVEL TRANSDUCTION ENHANCERS AND USES THEREOFUNIVERSITÄT ZüRICH
WO/2021/204883PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY BOWEL  DISEASESCVASTHERA
WO/2021/204889METHOD FOR PRODUCING A POROUS ACTIVE INGREDIENT CARRIER BY  MEANS OF HOT-MELT EXTRUSIONRESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
WO/2021/204923PIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS FOR USE IN THE  TREATMENT OF A CORONAVIRUS INFECTIONVIRONOVA MEDICAL AB
WO/2021/204924COMPOUNDS FOR USE IN THE TREATMENT OF HYPERCYTOKINEMIAVIRONOVA MEDICAL AB
WO/2021/204935MEMBRANES FOR MEDICAL DEVICESDEFYMED
WO/2021/204955COMPOUNDS FOR TREATING PNEUMONIA, SEPSIS, AND CORONAVIRUS  INFECTIONHEIDELBERG IMMUNOTHERAPEUTICS GMBH
WO/2021/204969PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY  AGAINST AN INFECTION BY SARS-COV-2 (COVID-19)EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/204985USE OF VIDOFLUDIMUS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/204991IMMUNOSTIMULATORY COMPOSITIONSBAYER ANIMAL HEALTH GMBH
WO/2021/204994OFATUMUMAB FOR TREATING MS WHILE MAINTAINING SERUM IGGNOVARTIS AG
WO/2021/204998NATURAL ANTIBODIES IN PROPHYLAXIS AND THERAPYHEIDELBERG IMMUNOTHERAPEUTICS GMBH
WO/2021/205010NUCLEIC ACIDS ENCODING HUMAN FUS PROTEIN AND USE IN THE  TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)INSERM - INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE
WO/2021/205017IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USEVALNEVA AUSTRIA GMBH
WO/2021/205025COMBINATORY TREATMENT FOR LYMPHOMAUNIVERSITE DE PARIS
WO/2021/205026PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ENVELOPED DNA OR  RNA VIRUS INDUCED INFECTIONS AND DISORDERSLOGICK ENERGETICS B.V.
WO/2021/205027INDIVIDUALIZED THERAPEUTIC ANTICANCER VACCINEVACCIBODY AS
WO/2021/205029USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019  (COVID-19)AB SCIENCE
WO/2021/213822COMPOSITIONS COMPRISING CYS-PEPTIDESEVONIK OPERATIONS GMBH
WO/2021/209405MULTI-PHASE COSMETIC COMPOSITION COMPRISING AT LEAST TWO  IMMISCIBLE OILY PHASESCHANEL PARFUMS BEAUTE
WO/2021/219360COMPRESSED TABLET COMPRISING L-THEANINEDSM IP ASSETS B.V.
WO/2021/209419BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF  HEPATITIS EJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209425ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS EJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209427SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF  HEPATITIS EJANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209437NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS  PREVENTION AND TREATMENT WITHOUT PRESERVATIVESFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E. V.
WO/2021/209441USE OF A POLAR EXTRACT OF <i>SKELETONEMA</i> IN  PHOTODYNAMIC THERAPYIFREMER
WO/2021/209442NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS  PREVENTION AND TREATMENTFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E. V.
WO/2021/209450RESINIFERATOXIN COMPOSITIONSMESTEX AG
WO/2021/209452DOSAGE UNITS AND REGIMEN, USES, METHODS OR FORMULATIONS OF  COMPOSITIONS COMPRISING A RECOMBINANT PROTEIN COMPRISING INTERLEUKIN-12 AND  AN ANTIBODY BINDING THE EXTRA-DOMAIN B OF FIBRONECTINPHILOGEN S.P.A.
WO/2021/209455COMPOSITION FOR IMPROVING COGNITIVE FUNCTIONACTIV'INSIDE
WO/2021/209458COMBINATION TREATMENT OF CANCERARES TRADING S.A.
WO/2021/209459METHODS OF USING SOLID DISPERSIONS OF RIFAXIMIN FOR THE  TREATMENT OF SICKLE CELL DISEASEBAUSCH HEALTH IRELAND LIMITED
WO/2021/223966ADENOMYOSIS ASSOCIATED INFERTILITY AND HDAC INHIBITORSNADEZHDA REPRODUCTIVE SCIENCE OOD
WO/2021/209465PEPTIDE FOR THE TREATMENT OF NET-ASSOCIATED DISEASESUNIVERSITEIT MAASTRICHT
WO/2021/209471ULIPRISTAL ACETATE OTFLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/209472ORAL THIN FILM WITH SMOOTH FUSED FILMLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/209493MEANS AND METHODS OF PREVENTING AND TREATING INFECTIONSSOLYPLUS GMBH
WO/2021/219376PERSONAL CARE COMPOSITIONS WITH ENHANCED SOLUBILITY ACTIVESUNILEVER IP HOLDINGS B.V.
WO/2021/219378STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINEUNILEVER IP HOLDINGS B.V.
WO/2021/209510INHIBITORS OF TRPC6 FOR TREATING RESPIRATORY CONDITIONSBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/209520MOLECULES FOR USE IN THE TREATMENT OF VIRAL INFECTIONSISTITUTO EUROPEO DI ONCOLOGIA S.R.L.
WO/2021/209521VECTORS FOR THE TREATMENT OF ACID CERAMIDASE DEFICIENCYGENETHON
WO/2021/209541TAXIFOLIN FORMULATION COMPRISING THIAMINEEVANIUM HEALTHCARE GMBH
WO/2021/209545COMPOSITION COMPRISING TRABECTEDIN AND AN AMINO ACIDEVER VALINJECT GMBH
WO/2021/209548COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED  CONDITIONSHENLEZ APS
WO/2021/209562LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF  PATHOGENIC INFECTIONSTATENS SERUM INSTITUT
WO/2021/209563COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS BY  RESPIRATORY SYNDROME-RELATED CORONAVIRUSSOM INNOVATION BIOTECH, S.A.
WO/2021/213891USE OF A MULTIFUNCTIONAL LIGAND FOR TREATING DRY EYES,  MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONSH4 ORPHAN PHARMA
WO/2021/209566O/W EMULSION CONTAINING ETHANOLDR. KURT WOLFF GMBH & CO. KG
WO/2021/213898A CHIMERIC ENDOLYSIN POLYPEPTIDE.MICREOS HUMAN HEALTH B.V.
WO/2021/209589PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL  AND BACTERIAL PNEUMONIA AND SEPSISANDREAS HETTICH GMBH & CO. KG
WO/2021/209590IMPROVED PROBIOTIC STRAINS AND USES THEREOFAMUCIN OY LTD
WO/2021/233614COMPOSITIONS AND METHODS FOR PROVIDING SCALP CARE BENEFITSUNILEVER IP HOLDINGS B.V.
WO/2021/209591CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTSESTETRA SRL
WO/2021/209593ACTIVE PRINCIPLE COMPRISING A PEEL EXTRACT OF IMMATURE PUNICA  GRANATUM FRUIT AND USES FOR PREVENTING AND/OR COMBATTING ACNESOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
WO/2021/209594BROMODOMAIN INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF  CORONAVIRUS INFECTIONS AND DISEASES CAUSED THEREBYEBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/209596THERAPEUTIC USE OF PLEUROMUTILINSNABRIVA THERAPEUTICS GMBH
WO/2021/209607SCD83 FOR WOUND HEALING, HAIR GROWTH, AND SKIN AND HAIR CAREFRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NüRNBERG
WO/2021/209608MEDICAL METHODS AND MEDICAL USESJOSEPH, Bertrand Marie René
WO/2021/213923MEDICAL USE OF DARIDOREXANTIDORSIA PHARMACEUTICALS LTD
WO/2021/213924CORONAVIRUS VACCINEBIONTECH SE
WO/2021/213931NOVEL NON-PROTEINIC FURIN INHIBITOREPHYLA
WO/2021/209620CYSTEINE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR  TREATMENT OF CORONAVIRUSALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/209623COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID  AND METHOD FOR MANUFACTURING SAMEELEONOR SPRL
WO/2021/209625HIGH POTENCY NATURAL KILLER CELLSONK THERAPEUTICS LIMITED
WO/2021/228492PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASEUNILEVER IP HOLDINGS B.V.
WO/2021/209627MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPYCANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/209631FMT PERFORMANCE PREDICTION TEST TO GUIDE AND OPTIMIZE  THERAPEUTIC MANAGEMENT OF GVHD PATIENTSMAAT PHARMA
WO/2021/209633METHODS AND FORMULATIONS FOR ADMINISTRATION OF THIOCARBAMATE  DERIVATIVES A2A INHIBITORSITEOS BELGIUM SA
WO/2021/213946PROPHYLAXIS AND TREATMENT OF CORONAVIRUS INFECTIONENGLMEIER, Ludwig
WO/2021/213948A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAEINTERVET INTERNATIONAL B.V.
WO/2021/213949A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIGINTERVET INTERNATIONAL B.V.
WO/2021/209644USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED  ACUTE RESPIRATORY DISTRESSPHARMING INTELLECTUAL PROPERTY B.V.
WO/2021/209645COMPOSITION FOR TREATING KERATIN TISSUEPVAC MEDICAL TECHNOLOGIES LTD
WO/2021/213992METHOD OF GENERATING A DRIED DRUG FORMULATIONHOFFMANN-LA ROCHE INC.
WO/2021/228502PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASEUNILEVER IP HOLDINGS B.V.
WO/2021/228503PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASEUNILEVER IP HOLDINGS B.V.
WO/2021/214023COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE  TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASESBAYER AKTIENGESELLSCHAFT
WO/2021/219428METHOD FOR DELIPIDATING PLANT EXTRACTSMAX ZELLER SOEHNE AG
WO/2021/214033VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL  DISEASESIMMUNIC AG
WO/2021/214043IMMUNIZATION SCHEME FOR VARIANT SURFACE GLYCOPROTEIN CARRIERSDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN  RECHTS
WO/2021/214045HPMC CAPSULE WITH REDUCED POWDER RETENTIONCAPSUGEL FRANCE SAS
WO/2021/214053PROCESS FOR DENSIFYING KERATIN FIBERS, BASED ON SILICONE, AN  ALKOXYSILANE AND A COLORING AGENTL'OREAL
WO/2021/214055COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA  (I), AT LEAST ONE NON AMINO SILICONE OF FORMULA (II) AND AT LEAST ONE  COLORING AGENTL'OREAL
WO/2021/214056PROCESS FOR THE TREATMENT OF KERATIN FIBERS EMPLOYING A  COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA (I), AT LEAST ONE  NON AMINO SILICONE OF FORMULA (II) HAVING A WEIGHT-AVERAGE MOLECULAR WEIGHT  OF LESS THAN OR EQUAL TO 1500 G/MOL AND AT LEAST ONE COLORING AGENTL'OREAL
WO/2021/214081SARS-COV-2 VACCINESNEC ONCOIMMUNITY AS
WO/2021/228519PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASEUNILEVER IP HOLDINGS B.V.
WO/2021/214119THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCERIFOM - FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
WO/2021/214126DRUG ANTIBODY CONJUGATESPHARMA MAR, S.A.
WO/2021/214129ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF  CANCERUNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/219458GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE AS  EXCIPIENTOMYA INTERNATIONAL AG
WO/2021/214139COMPOSITION FOR USE IN THE TREATMENT OF GROUP-B STREPTOCOCCUS  (GBS) INFECTIONSGIELLEPI S.P.A.
WO/2021/214158CO-CRYSTAL OF GABAPENTIN, KETOPROFEN AND LYSINE,  PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USEDOMPE' FARMACEUTICI SPA
WO/2021/214163SYNERGISTIC ADMIXTURES OF GABAPENTIN AND KETOPROFEN,  PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USEDOMPE' FARMACEUTICI SPA
WO/2021/214170ORALLY ADMINISTERED HYDROGEL COMPOSITION, KIT AND USEKIFIK
WO/2021/214175ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR  THE TREATMENT OF SPLEEN DISORDERSUNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/214179SYNTHETIC <i>STREPTOCOCCUS PNEUMONIAE</i>  SACCHARIDE CONJUGATES TO CONSERVED MEMBRANE PROTEINMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/214200ROCK INHIBITORS FOR USE IN TREATING OR PREVENTING PULMONARY  EDEMAATRIVA THERAPEUTICS GMBH
WO/2021/214205PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCTFIRMENICH SA
WO/2021/214209PRODUCT AND PROCESS FOR THE DECONTAMINATION OF NANOPARTICLES  FROM THE SKINLEIBNIZ-INSTITUT FüR POLYMERFORSCHUNG DRESDEN E.V.
WO/2021/214220GLUCAGON ANALOGUES AS LONG-ACTING GLP-1/GLUCAGON RECEPTOR  AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITISBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/214221ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND FOLFIRISANOFI
WO/2021/214222ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES, TRIFLURIDINE AND TIPIRACILSANOFI
WO/2021/214223ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND FOLFOXSANOFI
WO/2021/214227ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND CETUXIMABSANOFI
WO/2021/214233TREATMENT OF HYPOTHALAMIC OBESITYSANIONA A/S
WO/2021/214234SYNERGISTIC PRESERVATIVE/PERSONAL CARE COMPOSITION CONTAINING  AN ALKYLENE GLYCOL ESTERARCH UK BIOCIDES LTD
WO/2021/214245NOVEL PHARMACOLOGICAL CHAPERONE COMPOUNDS OF HUMAN ACID  ALPHA-GLUCOSIDASE AND THE THERAPEUTIC USE THEREOFUNIVERSITé GRENOBLE ALPES
WO/2021/214253DOSAGE REGIMEN FOR THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/214254PHARMACEUTICAL FORMULATIONSASTRAZENECA AB
WO/2021/219495METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR  INHIBITING VIRAL REPLICATIONDALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH
WO/2021/214270COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC  ANTIGEN RECEPTORSASTRAZENECA AB
WO/2021/214279REPLICATION-COMPETENT CONTROLLED HERPESVIRUSES EXPRESSING A  SARS COV-2 ANTIGENHSF PHARMACEUTICALS
WO/2021/214282METHODS FOR PREVENTING INDUCTION OF IMMUNE RESPONSES TO THE  TRANSDUCED CELLS EXPRESSING A TRANSGENE PRODUCT AFTER OCULAR GENE THERAPYINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/214292COMPOSITION COMPRISING FIBRE AND MULBERRYSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/214293COMPOSITION COMPRISING A DNA-DEGRADING ENZYME FOR USE IN A  METHOD FOR THE TREATMENT OF IMMUNOSUPPRESSION AFTER ACUTE TISSUE INJURYKLINIKUM DER UNIVERSITÄT MüNCHEN (KUM)
WO/2021/214296TREATMENT OF CORONA VIRUS INFECTIONSJOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/239346METHODS OF TREATMENT OF VIRAL DISEASESSOFTHALE NV
WO/2021/214297IMMUNIZATION AGAINST SARS-COV-RELATED DISEASESISA PHARMACEUTICALS B.V.
WO/2021/214300COMPOSITION COMPRISING A FIBROUS MATERIALWEIDMANN HOLDING AG
WO/2021/214320PLASMINOGEN FOR USE IN TREATING AND PREVENTING LUNG  DYSFUNCTIONPREVIPHARMA CONSULTING GMBH
WO/2021/214321NOVEL COMBINATION FOR THE TREATMENT OF AIDS21C BIO
WO/2021/214326USE OF MULBERRY EXTRACT FOR CONTROLLING POSTPRANDIAL GLUCOSE  RESPONSESOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/214328PH-DEPENDENT RELEASE NANOPARTICLES FOR INCORPORATION OF ACTIVE  SUBSTANCES, PREPARATION METHOD AND THERAPEUTIC USES OF SAMECENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/116503THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY  DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDSSMALL PHARMA LTD
WO/2021/214337SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR COELIAC  DISEASEDR. FALK PHARMA GMBH
WO/2021/214338SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR TG2-RELATED  DISEASESDR. FALK PHARMA GMBH
WO/2021/214339VACCINE AGAINST HUMAN-PATHOGENIC CORONAVIRUSESACM BIOLABS PTE LTD
WO/2021/214341SRC KINASE ACTIVATORS AND/OR ENG FUNCTION INHIBITORS AS  ENHANCERS OF SKIN HOMEOSTASIS/REGENERATION AND HAIR GROWTHDERMA INNOVATE S.L.
WO/2021/219543SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITISNOVO NORDISK A/S
WO/2021/219545COMPOSITION FOR TREATING AND/OR PREVENTING VESTIBULODYNIAPEPTONIC MEDICAL AB
WO/2021/219547ANHYDROUS COSMETIC COMPOSITION COMPRISING POLYOLS,  MONOALCOHOLS, FATTY AMINES AND AT LEAST 0.1% OF CARBOXYLIC ACIDSL'OREAL
WO/2021/219576MULTIPARTICULATE DOSAGE FORM CONTAINING EVA COPOLYMER AND  ADDITIONAL EXCIPIENTGRüNENTHAL GMBH
WO/2021/219577DOSAGE FORM COMPRISING HOT-MELT EXTRUDED PELLETS CONTAINING  EVA COPOLYMER AND GLIDING AGENTGRüNENTHAL GMBH
WO/2021/219581SYSTEM AND METHOD FOR PROVIDING FERTILITY ENHANCING DIETARY  RECOMMENDATIONS IN INDIVIDUALS WITH PROSTATE CONDITIONSSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/239360PEG-FREE SOAP GEL PREPARATIONBEIERSDORF AG
WO/2021/224058COMPOSITION COMPRISING ALBUMIN FOR USE IN THE TREATMENT OF  AMYOTROPHIC LATERAL SCLEROSIS (ALS) BY PLASMA EXCHANGEGRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/219619METHODS TO GENERATE VACCINE COMPOSITIONS THAT PRIME HUMAN  LEUKOCYTE ANTIGEN CLASS I RESTRICTED CD8 T-CELL RESPONSES AGAINST VIRAL  NON-VIRION-INTEGRAL DERIVED EPITOPESGENOVIE AB
WO/2021/219622HAND SANITISER COMPOSITIONDSM IP ASSETS B.V.
WO/2021/219624A NICOTINE ORAL DELIVERY PRODUCTJT INTERNATIONAL SA
WO/2021/219639PHARMACEUTICAL COMPOSITION AND METHOD FOR INDUCING AN IMMUNE  RESPONSER.G.C.C. HOLDINGS AG
WO/2021/224068PEPTIDES CONTAINING A PCNA INTERACTING MOTIF FOR USE IN THE  TREATMENT OF SOLID CANCERTHERAPIM PTY LTD
WO/2021/219671TREATMENT OF PULMONARY COMPLICATIONS OF CORONAVIRUS INFECTIONSNOORIK BIOPHARMACEUTICALS AG
WO/2021/219691DAPAGLIFLOZIN AND AMBRISENTAN FOR THE PREVENTION AND TREATMENT  OF COVID-19ASTRAZENECA AB
WO/2021/219710SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINENOVO NORDISK A/S
WO/2021/219719METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITSADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/219720METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITSADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/219722AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING AT LEAST  ONE SILICONE ACRYLIC COPOLYMER AND AT LEAST ONE PROPELLANTL'OREAL
WO/2021/219750ANTI-CANCER VACCINES AND RELATED THERAPYTHE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/219762USE OF A SYNTHETIC AAV CAPSID FOR GENE THERAPY OF MUSCLE AND  CENTRAL NERVOUS SYSTEM DISORDERSGENETHON
WO/2021/219763IONIC LIQUID AS AN ANTIPERSPIRANTNOVIGO GMBH & CO. KG
WO/2021/228570USE OF SULCONAZOLE COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/219808SOLID AND LIQUISOLID FORMULATIONS OF CORALLOPYRONIN ARHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/219817LIQUISOLID PHARMACEUTICAL FORMULATION AND PROCESS FOR  MANUFACTURINGRHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/224118PERSONAL CARE COMPOSITIONS COMPRISING A METAL PIROCTONE  COMPLEXUNILEVER IP HOLDINGS B.V.
WO/2021/219846STIMULATION OF THE GROWTH OF GUT BIFIDOBACTERIAADARE PHARMACEUTICALS SAS
WO/2021/239384MINERAL-OIL-FREE W/O EMULSION WITH A VARIABLE CONSISTENCYBEIERSDORF AG
WO/2021/239385SUNSCREEN WITH A COMBINATION OF CARNAUBA WAX AND HYDROGENATED  RAPESEED OILBEIERSDORF AG
WO/2021/224133AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/219857HELP APHERESIS FOR THE TREATMENT OF SERIOUSLY ILL COVID-19  PATIENTSSEIDEL, Dietrich
WO/2021/224138METHODS OF REDUCING MORTALITY RISK IN SUBJECTS SUFFERING FROM  AN UNDERLYING DISEASE OR CONDITION BY ADMINISTRATION OF METHYLNALTREXONEBAUSCH HEALTH IRELAND LIMITED
WO/2021/219879TREATMENTS OF INFLAMMATORY BOWEL DISEASEAQILION AB
WO/2021/2198815-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-QUINOLINE-3-CARBOXAMIDE  POTASSIUM SALT FOR TREATING INFLAMMATORY BOWEL DISEASESAQILION AB
WO/2021/224144METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  COVID-19WISTA LABORATORIES LTD.
WO/2021/224145METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  COVID-19WISTA LABORATORIES LTD.
WO/2021/224146METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  HYPOXEMIAWISTA LABORATORIES LTD.
WO/2021/224153COMBINATION OF MICRONUTRIENTS TO STIMULATE THE ENDOGENOUS  PRODUCTION OF HYDROGEN SULFIDE (H<sb>2</sb>S)PARTHENOGEN SAGL
WO/2021/224167AN ANTIPERSPIRANT COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/254685SUBSTANCE FOR DYEING KERATIN FIBERS, CONTAINING SPECIFIC  NONIONIC EMULSIFIERS, PIGMENTS AND AMINOSILICONESHENKEL AG & CO. KGAA
WO/2021/224169HYDROGEL IRRADIATIONASCENDIS PHARMA A/S
WO/2021/259538PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/259539METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF A  POLYETHYLENE GLYCOL ETHER OF A PROPYLENE GLYCOL FATTY ACID ESTERHENKEL AG & CO. KGAA
WO/2021/219896TREATMENT AND/OR PREVENTION OF A DISEASE OR A SYNDROME RELATED  TO A VIRUS INFECTIONATLAS BIOTECHNOLOGY S.A.
WO/2021/224198Mifepristone oral form for its use in cervix ripening and  labour inductionDISPHAR INTERNATIONAL BV
WO/2021/224203THE USE OF HYPERBRANCHED COPOLYMERS FOR BALANCING MICROBIAL  GROWTHDSM IP ASSETS B.V.
WO/2021/224234ANTIVIRAL USE OF CILENGITIDEHELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/224235USE OF DOPAMINE D3 PARTIAL AGONISTS FOR TREATING CENTRAL  NERVOUS SYSTEM DISORDERSBIOPROJET PHARMA
WO/2021/224259METHOD FOR COSMETIC TREATMENT BY COMBINED ILLUMINATION AND  APPLICATION OF A COMPOSITION COMPRISING NIACINAMIDE, AND ASSOCIATED DEVICELIGHTINDERM
WO/2021/224260EXOSOME-ANCHORING FUSION PROTEINS AND VACCINESBIOVELOCITA S.R.L
WO/2021/224261SOLUBLE TORS AND FUSIONS TO ANTI-CD3 RECOGNISING KRAS G12D FOR  THE TREATMENT OF CANCERIMMUNOCORE LIMITED
WO/2021/224264ANTIPATHOGEN VESICLEEK BIOSCIENCES GMBH
WO/2021/224270METHOD TO TREAT VIRAL INFECTION INDUCED BY A CORONAVIRUSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/224301PEPTIDES FOR PREVENTING OR TREATING VIRAL INFECTIONSSORBONNE UNIVERSITE
WO/2021/224313NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTSDISRUPTIVE MATERIALS PHARMA AB
WO/2021/233681DRUG DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES  FUNCTIONALIZED WITH BIOACTIVE COMPOUNDS FROM EUPHORBIA EXTRACT AND THE USES  THEREOFCELLBITEC, S.L.
WO/2021/224334COMBINATION CONTAINING TWO NICOTINE-CONTAINING DRUGS FOR THE  TREATMENT OF COVID-19LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/224338TREATMENT OF HYPERURICEMIAFREDERIKSBERG HOSPITAL
WO/2021/224354PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A  INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEMQUANTUM GENOMICS
WO/2021/224356NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE4LIVING BIOTECH
WO/2021/144478COMBINATION TREATMENT FOR FUMARATE-RELATED DISEASESIMCYSE SA
WO/2021/224381COMBINATION THERAPY FOR TREATING CANCERASTRAZENECA AB
WO/2021/224382COMPOUNDS FOR THE TREATMENT OF COVID-19DOMPE' FARMACEUTICI SPA
WO/2021/254687PIGMENT SUSPENSION AND COSMETIC PRODUCT PREPARED USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/224397IMMUNOGENIC PEPTIDES WITH EXTENDED OXIDOREDUCTASE MOTIFSIMCYSE SA
WO/2021/254688METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN ALKYL(POLY)GLYCOSIDE, A DYEING COMPOUND AND A  POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/259543METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A DERIVATIVE OF ALKYLATED SILANOL, A COLORING  COMPOUND AND A POST-TREATMENT AGENTHENKEL AG & CO. KGAA
WO/2021/259544PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSIONHENKEL AG & CO. KGAA
WO/2021/224403IMMUNOGENIC PEPTIDES WITH NEW OXIDOREDUCTASE MOTIFSIMCYSE SA
WO/2021/224416METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF  THERAPEUTIC PROTEINSCELLECTIS S.A.
WO/2021/224419PHOTOOXIDATIVE INACTIVATION OF PATHOGENS INCLUDING SARS-CoV-2SCHIKORA, Detlef
WO/2021/224429EXOSOME-ANCHORING CORONAVIRUS FUSION PROTEINS AND VACCINESBIOVELOCITA S.R.L
WO/2021/224432IL-18 BINDING PROTEIN (IL-18BP) IN RESPIRATORY DISEASESAB2 BIO SA
WO/2021/224439CLICK OMVsDE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS,  MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT
WO/2021/224444PROCESS FOR PRODUCING AN ORAL THIN FILM COMPRISING  MICROPARTICLESLTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/224449STEM CELLS FOR TREATMENT OF RESPIRATORY DISORDERSXINTELA AB
WO/2021/224455COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN  HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITYLEGACY HEALTHCARE (SWITZERLAND) SA
WO/2021/224463COSMETIC COMPOSITION COMPRISING CELLODEXTRINSPFEIFER & LANGEN GMBH & CO. KG
WO/2021/224467TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE  ACETATE AND NIRAPARIBJANSSEN PHARMACEUTICA NV
WO/2021/224469TREATMENTS OF PROSTATE CANCER WITH COMBINATIONS OF ABIRATERONE  ACETATE AND NIRAPARIBJANSSEN PHARMACEUTICA NV
WO/2021/224471PHARMACEUTICAL FORMULATIONS OF ABIRATERONE ACETATE AND  NIRAPARIBJANSSEN PHARMACEUTICA NV
WO/2021/224494NEW TREATMENTS OF VIRAL INFECTIONSKANCERA AB
WO/2021/224499BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20GENMAB A/S
WO/2021/228731FELINE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VACCINEINTERVET INTERNATIONAL B.V.
WO/2021/224503PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS  INFECTIONSAICURIS GMBH & CO. KG
WO/2021/228746A NOVEL ANTIBODY BINDING SPECIFICALLY TO HUMAN CEACAM1/3/5 AND  USE THEREOFLEUKOCOM GMBH
WO/2021/228750COMPATIBLE SOLUTES FOR PREVENTING OR TREATING SARS-COV-2  INFECTIONSBITOP AG
WO/2021/228758ATR INHIBITORS FOR THE TREATMENT OF CANCERASTRAZENECA AB
WO/2021/228760FORMULATIONS OF ANTI-IL-33 ANTIBODIESMEDIMMUNE LIMITED
WO/2021/228762USE OF TMPRSS2 INHIBITORS FOR THE TREATMENT OF LUNG VIRAL  INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/228768PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE  SYSTEMVAKZINE PROJEKT MANAGEMENT GMBH
WO/2021/224505MODULATION OF MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN  SIGNALINGEBERHARD KARLS UNIVERSITÄT TüBINGEN
WO/2021/228788COMPOSITION COMPRISING METHYLFOLATEALFASIGMA S.P.A.
WO/2021/228800SLOW RELEASE PLASMINOGEN ACTIVATOR FORMULATION FOR USE IN THE  TREATMENT OF THROMBOTIC OR HAEMORRHAGIC DISEASEOP2LYSIS
WO/2021/228805METHODS AND COMPOSITIONS USING SERPIN PRODUCING BACTERIASOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/228816ADMINISTRATION OF HOMOLOGOUS ADENOVIRAL VECTORSJANSSEN VACCINES & PREVENTION B.V.
WO/2021/228817EMID2 PROTEIN AS ANTI-CANCER TREATMENTINTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY  - ICGEB
WO/2021/228824COSMETIC COMPOSITION BASED ON BIOSOURCED ISODODECANE AND  PREPARATION METHOD THEREOFGLOBAL BIOENERGIES
WO/2021/228832RED CELL EXTRACELLULAR VESICLES (RCEVS) CONTAINING CARGOES AND  METHODS OF USE AND PRODUCTION THEREOFERYTECH PHARMA
WO/2021/228846COMPOUND FOR PREVENTING OR TREATING A VIRAL INFECTIONINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/228852SOLID SOLUTION MADE FROM GUM ARABIC AND AT LEAST ONE  LIPOSOLUBLE ACTIVE SUBSTANCEMETABOLIC TUNING AG
WO/2021/233735PHARMACEUTICAL PREPARATION FOR USE IN THE TREATMENT OF  SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)CYTOPHARMA GMBH
WO/2021/228853VACCINE AGAINST SARS-COV VIRUSOSE IMMUNOTHERAPEUTICS
WO/2021/228863USES AND FORMULATIONS OF CANNABINOIDSADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228865USES AND FORMULATIONS OF CANNABINOIDSADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228866AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE  PREVENTION AND/OR TREAETMENT OF THROMBOCYTOPENIAAPLAGON OY
WO/2021/228867METHODS FOR IMAGE-GUIDED RADIOTHERAPYUNIVERSITE CLAUDE BERNARD LYON 1
WO/2021/239463CROSSLINKABLE PREPOLYMERS FOR CHEMICALLY STABLE POLYMER GELSLUMENDO AG
WO/2021/228917PREVENTION OF VISIBLE PARTICLE FORMATION IN PARENTERAL PROTEIN  SOLUTIONSF. HOFFMANN-LA ROCHE AG
WO/2021/228921INHALABLE LACTOSE CONTAINING COMPOSITIONMEGGLE GMBH & CO. KG
WO/2021/228937UROGENITAL CLEANSING COMPOSITIONPEPTONIC MEDICAL AB
WO/2021/228942PROTEASE FORMULATION FOR TREATMENT OF MICROBIAL INFECTIONSZYMIQ TECHNOLOGY AB
WO/2021/254697METAMIZOLE DERIVATIVES FOR THE PREVENTION AND TREATMENT OF  PULMONARY HYPERTENSIONCHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/228956NEW METHOD TO TREAT CUTANEOUS T-CELL LYMPHOMAS AND TFH DERIVED  LYMPHOMASINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/228983A PHARMACEUTICAL COMPOSITION COMPRISING AN ARSENIC COMPOUND,  AN INDUCTOR OF TYPE-1 IFN AND A PROTEIN KINASE INHIBITOR FOR TREATING CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239471CANCER TREATMENT STRATEGIES USING ARENAVIRUS VECTORSHOOKIPA BIOTECH GMBH
WO/2021/229002TREATMENT OF COMPLICATIONS CAUSED BY INFECTIONS OF SEVERE  ACUTE RESPIRATORY SYNDROME CORONAVIRUSJOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/229013PEPTIDIC SCAFFOLDS, PROCESSES FOR MANUFACTURING THE SAME, AND  USES THEREOF AS SOLUBLE SUPPORTSSYNHELIX
WO/2021/229014COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED  IMMUNOGENIC FRAGMENTSLIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229015COMPOSITION OF NANOPARTICLESLIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229020NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENSLIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229035UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCERFUNDACIóN PROFESOR NOVOA SANTOS
WO/2021/244831THERAPEUTIC SOLID DOSAGE FORMSSMALL PHARMA LTD
WO/2021/239478SUNSCREEN WITH A COMBINATION OF WAXES, CETYL PALMITATE AND  HYDROGENATED RAPESEED OILBEIERSDORF AG
WO/2021/229065NEW IMMUNOGENIC COMPOSITIONS AND USE THEREOF FOR PREPARING  HEPATITIS C AND HEPATITIS B VACCINESUNIVERSITE DE TOURS
WO/2021/229086COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF MARINE  MOLLUSC VIRAL INFECTIONIFREMER
WO/2021/259554BIODEGRADABLE ADHESIVE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/229100BRADYKININ B2 RECEPTOR ANTAGONIST FOR TREATMENT OF  SARS-COV2-INFECTIONHELMHOLTZ ZENTRUM MüNCHEN DEUTSCHES FORSCHUNGSZENTRUM FüR  GESUNDHEIT UND UMWELT (GMBH)
WO/2021/229101STEM CELLS FOR TREATING SKIN LESIONSRIGSHOSPITALET
WO/2021/229102MEANS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL  AGGREGATIONVIB VZW
WO/2021/229104ANTI-CD38 SINGLE-DOMAIN ANTIBODIES IN DISEASE MONITORING AND  TREATMENTUNIVERSITé DE LIèGE
WO/2021/233853THE USE OF CHELATORS FOR THE PREVENTION OF VISIBLE PARTICLE  FORMATION IN PARENTERAL PROTEIN SOLUTIONSF. HOFFMANN-LA ROCHE AG
WO/2021/233874ELAFIBRANOR FOR THE TREATMENT OF PRIMARY SCLEROSING  CHOLANGITISGENFIT
WO/2021/233885MIMOTOPE PEPTIDES OF THE SPIKE PROTEIN FROM THE SARS-COV-2  VIRUSSYNTHETIC VACCINES LTD
WO/2021/233899USE OF PSYCHOTROPIC DRUGS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233901PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASERRW B.V.
WO/2021/233902PLANT COMPOUNDS FOR TREATING ALZHEIMER'S DISEASERRW B.V.
WO/2021/259557COSMETIC PREPARATION COMPRISING ANTIPERSPIRANT INORGANIC  SALTS, CARBOXYLIC ACIDS AND 1,3-PROPANEDIOLBEIERSDORF AG
WO/2021/233923IMPROVEMENT OF INSOLUBLE FIBRE FERMENTABILITY AND SHORT CHAIN  FATTY ACID PRODUCTION BY BIFIDOBACTERIUM LONGUMSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/233924METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIESHANSA BIOPHARMA AB
WO/2021/233927ANTIBODY THAT BINDS SPECIFICALLY TO THE SARS COV 2 SPIKE  PROTEIN, AND METHODS FOR ITS MANUFACTUREIGNOVA GMBH
WO/2021/233944PARA-AMINO-BENZYL LINKERS, PROCESS FOR THEIR PREPARATION AND  THEIR USE IN CONJUGATESLES LABORATOIRES SERVIER
WO/2021/233948METHOD TO TREAT A PATHOGEN LUNG INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233950COMPOUNDS FOR USE IN THE REACTIVATION OF HIV IN LATENT  HIV-INFECTED CELLSCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/233956EZETIMIBE FOR TREATING ENVELOPED VIRUS INFECTIONSMELETIOS THERAPEUTICS
WO/2021/233960USE OF HUMAN MILK OLIGOSACCHARIDES IN NUTRITIONAL COMPOSITIONS  FOR ENHANCING BONE DEVELOPMENT AND/OR BONE STRENGTHSOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/233962METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE  SYNDROMEINSTITUT CURIE
WO/2021/233966METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233967INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOFINTERVET INTERNATIONAL B.V.
WO/2021/233973COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOFFIRMENICH SA
WO/2021/233988COMPOSITION COMBINING JONZAC THERMAL SPRING WATER AND A  CENTELLA ASIATICA EXTRACT AND THE REPAIRING/HEALING EFFECT THEREOFLABORATOIRES LéA
WO/2021/234005A PERSONAL CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/234006COMPOSITIONS AND METHODS FOR TREATING CANCER EXPRESSING CD90  AND CD326MILTENYI BIOTEC B.V. & CO. KG
WO/2021/234007PROPOFOL FOR DIAGNOSIS OF PRIMARY HEADACHETESA LABTEC GMBH
WO/2021/234008ORAL FILM FOR SAFE ADMINISTRATION OF APITESA LABTEC GMBH
WO/2021/239544OPHTHALMIC COMPOSITION BASED ON HYALURONIC ACID TO PROTECT  FROM DAMAGES CAUSED BY ENVIRONMENTAL POLLUTIONCOLOMBO, Stefano
WO/2021/234014ANTI-ACNE COMPOSITIONSL'OREAL
WO/2021/244854USE OF SAA, RSAA, OR INHIBITORS OF SAA IN THE TREATMENT OF  DYSREGULATED INFLAMMATIONLIKA ANTISEPSIS GBR
WO/2021/239546USE OF A MINERAL BLEND AS COSMETIC AGENT FOR WET COSMETIC  COMPOSITIONSOMYA INTERNATIONAL AG
WO/2021/234031A PARTICLE ENCAPSULATING HYDROPHILIC OR AMPHIPHILIC BIOLOGICAL  COMPOUNDSSPHERA ENCAPSULATION S.R.L.
WO/2021/259560CO-GROUND ACTIVE(S) COMPRISING PRODUCT COMPRISING  SURFACE-REACTED CALCIUM CARBONATEOMYA INTERNATIONAL AG
WO/2021/234055COMPOSITIONS AND METHODS FOR PROVIDING SKIN CARE BENEFITSUNILEVER IP HOLDINGS B.V.
WO/2021/234057PEPTIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF A  DISEASE CAUSED BY A VIRUS AFFECTING THE RESPIRATORY TRACTFUNDACIóN PARA EL FOMENTO DE LA INVESTIGACIóN SANITARIA Y  BIOMéDICA DE LA COMUNITAT VALENCIANA (FISABIO)
WO/2021/234074COMPOSITION COMPRISING DIFFERENT SPECIFIC COLLAGENS AND USES  ON THE SKINMONDERNA HEALTH & WELLNESS
WO/2021/234084MAXI-K POTASSIUM CHANNEL OPENERS FOR THE TREATMENT OF FRAGILE  X ASSOCIATED DISORDERSKAERUS BIOSCIENCE LIMITED
WO/2021/234094CEFTRIAXONE COMPOSITIONS WITH MAGNESIUM COMPONENTXELLIA PHARMACEUTICALS APS
WO/2021/234097MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS  INFECTIONS AND/OR COVID-19 CYTOKINE STORMATRIVA THERAPEUTICS GMBH
WO/2021/254721AGENT FOR DYEING KERATINOUS FIBRES, CONTAINING PIGMENTS AND  C<sb>2</sb>-C<sb>30</sb> ALKYL METHICONESHENKEL AG & CO. KGAA
WO/2021/239578EMULSIONS FOR CONTROLLED DRUG RELEASEAVIGNON UNIVERSITE
WO/2021/234111COMPOSITION COMPRISING SAFRANAL AND PROBIOTICSACTIV' INSIDE
WO/2021/234127NUCLEOSIDE ANALOGUE TO INHIBIT THE MAIN PROTEASE OF SARS-CoV-2  VIRUSINSTITUT DE RECHERCHE EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUEE
WO/2021/234128NUCLEOSIDE ANALOGUES TO INHIBIT THE MAIN PROTEASE OF A  CORONAVIRUSINSTITUT DE RECHERCHE EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUEE
WO/2021/254723A PERSONAL CARE COMPOSITION BASED ON TITANIUM OXIDE AND A  CROSSPOLYMER OF ADIPIC ACID AND NEOPENTYL GLYCOLUNILEVER IP HOLDINGS B.V.
WO/2021/234134BARK-FREE, STABLE DOUBLE EMULSIONCAPSUM
WO/2021/234135BARK-FREE, STABLE DISPERSIONCAPSUM
WO/2021/239622BRANCHED AMINO-ACID-BASED POLYMERS FOR HAIR STRENGTHENINGBASF SE
WO/2021/249751COSMETIC PRODUCT WITH HIGH DEGREE OF EMPTYING OF THE  PREPARATION FROM THE PACKAGINGBEIERSDORF AG
WO/2021/254729AVERMECTINS FOR USE IN TREATING CORONAVIRIDAE INFECTIONHUVEPHARMA EOOD
WO/2021/239662PI3K GAMMA INHIBITOR PEPTIDE FOR TREATMENT OF  FIBROPROLIFERATIVE VASCULAR DISEASESKITHER BIOTECH S.R.L.
WO/2021/234178TNFα IMMUNOCONJUGATE THERAPY FOR THE TREATMENT OF BRAIN TUMORSPHILOGEN S.P.A
WO/2021/239666THERAPEUTIC METHODSDIACCURATE
WO/2021/239667NEW THERAPY FOR THE TREATMENT OF TUMORSUNIVERSITà DEGLI STUDI DI TRENTO
WO/2021/239687TCDTA-DERIVED FE(III) COMPLEXES FOR USE IN MAGNET RESONANCE  IMAGING WITH LIVER AND KIDNEY EXCRETIONCHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/249760A COSMETIC COMPOSITION COMPRISING 6-METHYL-PICOLINAMIDEUNILEVER IP HOLDINGS B.V.
WO/2021/239709METHOD FOR PRODUCING A LIPOSOME DISPERSIONLEON-NANODRUGS GMBH
WO/2021/239720COSMETIC COMPOSITION COMPRISING AT LEAST 30% BY WEIGHT OF  BRANCHED ALKANE AND A COMBINATION OF PARTICULAR SILICONESL'OREAL
WO/2021/234181USE OF FAP INHIBITOR IN A METHOD OF DIAGNOSISUNIVERSITÄT HEIDELBERG
WO/2021/259580HIGHLY VISCOUS COSMETIC NANOEMULSIONBEIERSDORF AG
WO/2021/239742ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES  AND PROCESS FOR ITS PREPARATIONGIVAUDAN SA
WO/2021/239786EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG  CANCERASTRAZENECA AB
WO/2021/244910HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR  PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A  DONORGRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239790METHOD FOR THE TREATMENT OF VIRUS INFECTION WITH IVIG AND  CONVALESCENT PLASMAGRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239796METHOD FOR THE TREATMENT OF A VIRAL INFECTION WITH HUMAN  ALPHA-1 ANTITRYPSINGRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239798SOLID SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (S-SNEDDS)EVONIK OPERATIONS GMBH
WO/2021/239809TREATMENT OF COVID-19 PATIENTSASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
WO/2021/239812POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPYQUELL THERAPEUTICS LIMITED
WO/2021/239815FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL  NERVOUS SYSTEM DISORDERSUNIVERSITAT AUTòNOMA DE BARCELONA
WO/2021/239817THERAPEUTIC COMBINATIONS COMPRISING AGONISTS OF FERROPTOSIS  FOR TREATING PROLIFERATIVE DISORDERSCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS
WO/2021/254753USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGINGUNILEVER IP HOLDINGS B.V.
WO/2021/254754USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGINGUNILEVER IP HOLDINGS B.V.
WO/2021/239838SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)  POLYPEPTIDES AND USES THEREOF FOR VACCINE PURPOSESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239844SGLT-2 INHIBITORS OR IL-1R ANTAGONISTS FOR REDUCTION OF  HYPOGLYCAEMIA IN PREDIABETESUNIVERSITÄTSSPITAL BASEL
WO/2021/239850USE OF NMN TO REDUCE IMMUNODEPRESSION AND IMMUNOSENESCENCENUVAMID SA
WO/2021/239878TREATMENT OF INFECTIONSACT THERAPEUTICS LTD
WO/2021/239880NUCLEIC ACID BASED COMBINATION VACCINESCUREVAC AG
WO/2021/239890BIFIDOBACTERIA FOR PREVENTING, REDUCING OR TREATING SKIN AGINGDUPONT NUTRITION BIOSCIENCES APS
WO/2021/239892MONO- AND BIS-NITROSYLATED PROPANEDIOLS FOR THERAPEUTIC USEATTGENO AB
WO/2021/239893AMORPHOUS SOLID DISPERSION OF ACALABRUTINIBBEND RESEARCH, INC.
WO/2021/239905COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF  THROMBIINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239906MONO- AND BIS-NITROSYLATED ALKYL POLYOLS FOR THERAPEUTIC USEATTGENO AB
WO/2021/239915FOXO INHIBITORS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY  ABNORMAL PROCESSING OF TDP-43 AND/OR FUS PROTEINSADMINISTRACIóN GENERAL DE LA COMUNIDAD AUTóNOMA DE EUSKADI
WO/2021/239917COMBINATION SOLID ORAL DOSAGE FORMS OF GONADOTROPIN-RELEASING  HORMONE ANTAGONISTSMYOVANT SCIENCES GMBH
WO/2021/244964COMPOSITIONS AND METHODS FOR TREATING INFECTIONS AND NETOPATHYBLACK CAT BIO LIMITED
WO/2021/239938COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITY FOR  RETINOIC ACID PRECURSORUNILEVER IP HOLDINGS B.V.
WO/2021/239943AZELASTINE AS ANTIVIRAL TREATMENTCEBINA GMBH
WO/2021/239961A COMPOSITION COMPRISING HP-HMG FOR USE IN TREATING  INFERTILITYFERRING B.V.
WO/2021/239965CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES  THEREOFFUNDACIó PRIVADA INSTITUT D'INVESTIGACIó ONCOLòGICA DE VALL  HEBRON
WO/2021/239968CD40 BINDING PROTEINSTRIKE PHARMA AB
WO/2021/244983COOLING PERSONAL CARE COMPOSITION COMPRISING A POLYOL AND A  POLYOXYEHTYLENE-POLYOXYPROPYLENE BLOCK COPOLYMERUNILEVER IP HOLDINGS B.V.
WO/2021/239980A PEPTIDE COCKTAILHUBRO THERAPEUTICS AS
WO/2021/239987MULTISPECIFIC ANTIBODYNUMAB THERAPEUTICS AG
WO/2021/239992ANTIFUNGAL PRODRUGSCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/239996IMMUNOMODULATORY COMPLEX AND USES THEREOF FOR THERAPYCOMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/240004PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE  AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A  GLUCAGON SUPPRESSOR WITH PRANDIAL ACTIONADOCIA
WO/2021/240006PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE  AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A  GLUCAGON SUPPRESSOR WITH PRANDIAL ACTIONADOCIA
WO/2021/244996SYNTHETIC OLIGOSACCHARIDE VACCINES AGAINST STREPTOCOCCUS  PNEUMONIAE WITH MICROPARTICLE ADJUVANT FORMULATIONSMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/245001MICROEMULSION FOR THE TREATMENT OF DRY EYE SYNDROMEAZAD PHARMA AG
WO/2021/240013VACCINE FORMULATIONSIMNATE SARL
WO/2021/245018A HIGH SPF SKIN CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/245032NUTRACEUTIC COMPOSITION CONTAINING LIMONENE AND A DRY EXTRACT  OF COCOA FIBRE FOR THE TREATMENT OF OBESITYTARGETING GUT DISEASE SRL
WO/2021/245081COMPOSITION COMPRISING AT LEAST THREE TYPES OF  POLYSACCHARIDES, AT LEAST ONE PASTY COMPOUND OF PLANT ORIGIN AND WATERL'OREAL
WO/2021/245082A HIGH UV PROTECTION CLEANSING COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/245095METHOD TO IMPROVE IMMUNOTHERAPIESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245107MODULATORS OF PURINERGIC RECEPTORS AND RELATED IMMUNE  CHECKPOINT FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROMINSTITUT GUSTAVE ROUSSY
WO/2021/245111RECOMBINANT RHABDOVIRUS ENCODING FOR A CD80 EXTRACELLULAR  DOMAIN FC-FUSION PROTEINBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/245140DIAGNOSIS, PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONEMERGEX VACCINES HOLDING LIMITED
WO/2021/245159NATURALLY DERIVED SURFACTANT SYSTEM AND COMPOSITION COMPRISING  THE SAMEUNILEVER IP HOLDINGS B.V.
WO/2021/245160NATURALLY DERIVED SURFACTANT SYSTEM WITH POLYGLYCEROL ESTERS  AND COMPOSITIONS COMPRISING THE SAMEUNILEVER IP HOLDINGS B.V.
WO/2021/245172STABILIZATION OF 1,2,4-TRIOXANE COMPOUNDS BY CHLOROGENIC ACIDSARTEMIFLOW GMBH
WO/2021/245179LIQUID OPHTHALMIC COMPOSITION COMPRISING A SPIRULINA PLATENSIS  FULL EXTRACTWELIFEPHARMA SAGL
WO/2021/245199GLP1R AGONIST NMDAR ANTAGONIST CONJUGATESKØBENHAVNS UNIVERSITET
WO/2021/254790AN ANTIMICROBIAL COMPOSITION FOR TACKLING MALODOURUNILEVER IP HOLDINGS B.V.
WO/2021/245204STABLE FORMULATION OF EFINACONAZOLETHE MATERIA COMPANY LIMITED
WO/2021/245206TOPICAL SOLUTION OF EFINACONAZOLE WITH HIGH SUBUNGUAL  PENETRATIONTHE MATERIA COMPANY LIMITED
WO/2021/245207USE OF E. COLI STRAINS EXPRESSING HIGH LEVEL OF ALPHA-GAL TO  MODULATE IMMUNITY AND PROVIDE PROTECTION AGAINST INFECTIOUS DISEASES IN  ANIMALSINSTITUT NATIONAL DE RECHERCHE POUR L' AGRICULTURE, L'  ALIMENTATION ET L' ENVIRONNEMENT
WO/2021/245223HIGH DOSE AND LOW VOLUME BOTULINUM TOXIN TREATMENT OF FACIAL  WRINKLESMERZ PHARMA GMBH & CO. KGAA
WO/2021/245224METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR  DISEASESINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245233IMPROVING ANTIBODY TOLERABILTY ASSOCIATED WITH INTRAVENOUS  ADMINISTRATIONBIOINVENT INTERNATIONAL AB
WO/2021/249886AQUEOUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN  MATERIALS COMPRISING A FATTY ACID MONOESTER, A FATTY ACID SALT, A PULLULAN  AND A POLYOLL'OREAL
WO/2021/245237MODEL FOR PREDICTION OF TOLERABILITY ISSUES IN CONNECTION WITH  INTRAVENOUS ADMINISTRATION OF THERAPEUTIC ANTIBODIESBIOINVENT INTERNATIONAL AB
WO/2021/245238IMPROVING ANTIBODY TOLERABILITY ASSOCIATED WITH INTRAVENOUS  ADMINISTRATIONBIOINVENT INTERNATIONAL AB
WO/2021/245249TREATMENT OF CD30-POSITIVE CANCERTESSA THERAPEUTICS LTD.
WO/2021/245254USE OF MULTIFUNCTIONAL LIGANDS FOR TREATING THE RESPIRATORY  DISTRESS AND CYTOKINE STORM SYNDROMES ASSOCIATED WITH CORONAVIRUS VIRAL  INFECTIONSH4 ORPHAN PHARMA
WO/2021/245260THERAPEUTIC NANOCARRIER SYSTEM AND METHODS OF USEGREGORIOU, Yiota
WO/2021/245263PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER  RADIOTHERAPY AND IMAGINGRIGSHOSPITALET
WO/2021/245280USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF  TOURETTE SYNDROMENOEMA PHARMA AG
WO/2021/245281METHODS OF TREATMENT OF TUBEROUS SCLEROSIS COMPLEXNOEMA PHARMA AG
WO/2021/249921NANOPARTICLES AS BIORESORBABLE AND RADIOPAQUE  ACTIVE-INGREDIENT CARRIERS FOR THE THERAPY OF CANCERS OF THE PANCREASFRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/254804AGENT FOR DYEING KERATINOUS MATERIAL, IN PARTICULAR HUMAN  HAIR, CONTAINING AMINOSILICONES, PIGMENTS AND ALKYLPOLYGLYCOSIDESHENKEL AG & CO. KGAA
WO/2021/249951METHODS AND COMPOSITIONS FOR TREATMENT OF BRAIN VIRAL  INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245291TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT  SUFFERING FROM A CORONAVIRUS INFECTIONINOTREM
WO/2021/249960COMPOSITIONS COMPRISING NARCISSUS SPP. PLANT EXTRACT AND USE  THEREOFCLARIANT INTERNATIONAL LTD
WO/2021/249969COMBINATION PRODUCT FOR THE TREATMENT OF CANCER DISEASESMERCK PATENT GMBH
WO/2021/249974FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR  TARGETED THROMBOLYTIC THERAPYINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/249982ANTIVIRAL COMPOUNDSIBYLLA BIOTECH S.R.L.
WO/2021/249996COMPOSITIONS COMPRISING 2X-121 AND METHODS FOR TREATING  CORONAVIRUS INFECTIONONCOLOGY VENTURE APS
WO/2021/250001RETINOL-BASED COMPOSITIONL'OREAL
WO/2021/250008RETINOL-BASED COMPOSITIONL'OREAL
WO/2021/250010ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSISMV BIOTHERAPEUTICS SA
WO/2021/250019COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF URINARY TRACT  INFECTIONS AND FOR USE IN COSMETICSG. POHL-BOSKAMP GMBH & CO. KG
WO/2021/250025SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND  THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCERUNIVERSITÄT ZüRICH
WO/2021/250029SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTIONUNIVERSITÄT ZüRICH
WO/2021/250043ASSAY FOR THE DETECTION OF THE CYS-LIKE PROTEASE (MPRO) OF  SARS-COV-2CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/250081NRF2 ACTIVATOR FOR USE IN TREATING DILATED CARDIOMYOPATHIESGENETHON
WO/2021/250082TREATMENT OF DILATED CARDIOMYOPATHIESGENETHON
WO/2021/254851PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION  TRIGGERED BY COVID-19HORPHAG RESEARCH IP (PYC) LTD.
WO/2021/250110PROCESS FOR THE PREPARATION OF AN EXTRACT OF EPILOBIUM SPP.  WITH HIGH OENOTHEIN B CONTENTISTITUTO FARMOCHIMICO FITOTERAPICO EPO S.R.L. ED IN FORMA  ABBREVIATA: EPO S.R.L.
WO/2021/250130PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELLFIRMENICH SA
WO/2021/250193METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF  CHRONIC KIDNEY DISEASEINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/250196NEW USE OF RABEXIMODCYXONE AB
WO/2021/250198METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF  FGFR3-RELATED COGNITIVE DEFICITINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/250199RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITISCYXONE AB
WO/2021/250200CANCER THERAPYPROKARIUM LIMITED
WO/2021/250204ORAL FORMULATION COMPRISING A CRYSTALLINE FORM OF RABEXIMODCYXONE AB
WO/2021/259663COSMETIC COMPOSITION FOR IMPROVING APPEARANCE OF SKINUNILEVER IP HOLDINGS B.V.
WO/2021/250205IMPROVED ADHESIVE DRUG CARRIERUMC UTRECHT HOLDING B.V.
WO/2021/250207BROMELAIN PROTEASE, BROMELAIN, JACALIN-LIKE LECTIN, EXTRACT  FROM THE STEM AND/OR THE FRUIT OF A PINEAPPLE PLANT, COMBINATION PREPARATION,  BROMELAIN PROTEASE INHIBITOR, PROTEIN/PROTEASE MIX, AND GLYCATED BROMELAIN  PROTEIN FORMED BY EXOGENOUS NON-ENZYMATIC GLYCATION, FOR USE IN THE TREATMENT  OR PROPHYLAXIS OF VIRUS INFECTIONS CAUSED BY CORONAVIRUSES IN A HUMAN OR  ANIMALURSAPHARM ARZNEIMITTEL GMBH
WO/2021/250212PEPTIDES FOR TREATMENT OF SEPSIS AND CANCERNORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU)
WO/2021/250219A RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) VACCINE  AGAINST CORONAVIRUS DISEASEBAVARIAN NORDIC A/S
WO/2021/259668USE OF A BORON CLUSTER AS TRANSMEMBRANE CARRIERJACOBS UNIVERSITY BREMEN GGMBH
WO/2021/250231THIENOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF  CORONAVIRUS INFECTIONINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/259669NANOPARTICULATE COMPOSITIONALGIAX PHARMACEUTICALS GMBH
WO/2021/250236COMPOSITION COMPRISING NANOPARTICLES, METHOD FOR THE  PREPARATION OF A COMPOSITION COMPRISING NANOPARTICLES AND USES OF THE  COMPOSITION FOR DENTAL TREATMENTUNIVERSITAT INTERNACIONAL DE CATALUNYA, FUNDACIó PRIVADA
WO/2021/250239A HYDROALCOHOLIC GEL AND A METHOD OF MANUFACTURING SAID GELVIRAMAL LIMITED
WO/2021/250240DIAZA-18-CROWN-6 DERIVATIVE USEFUL FOR CHELATING RADIUM,  CONJUGATE AND RADIUM CHELATE COMPRISING THE SAME, AND USES THEREOFORANO
WO/2021/259673HYDROXYCHLOROQUINE LIQUID COMPOSITIONSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/250260MODULATORS OF TIGHT JUNCTION PERMEABILITYTHE UNIVERSITY OF BATH
WO/2021/250263LIPID NANOPARTICLESETHERNA IMMUNOTHERAPIES NV
WO/2021/254928METHYLENE BLUE AND RIBOFLAVIN FOR PROPHYLACTIC AND THERAPEUTIC  ANTI-VIRAL THERAPYCERNY, Erich, H.
WO/2021/254937FECAL MATTER FOR TREATMENT OF CACHEXIAACADEMISCH MEDISCH CENTRUM
WO/2021/250275ANTIBODY FORMULATION DILUENTICHNOS SCIENCES SA
WO/2021/254978COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONSMERCK PATENT GMBH
WO/2021/254982COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONSMERCK PATENT GMBH
WO/2021/254998BIODEGRADABLE UV ABSORBERSBASF SE
WO/2021/255003IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDSGIVAUDAN SA
WO/2021/255046HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255047HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255049HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255050HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255051HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/255129NOVEL USE OF A MODULATOR OF GLUCOSYLCERAMIDE DEGRADATION FOR  VIRAL INFECTIONSSPEDDING RESEARCH SOLUTIONS, SAS
WO/2021/259742MODIFIED EXOTOXIN A PROTEINSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/259743KLEBSIELLA PNEUMONIAE O-ANTIGEN VACCINEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/255156NOVEL DIPEPTIDE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF  AND A NOVEL THERAPEUTIC USE OF DIPEPTIDE COMPOUNDSUNIVERSITE PARIS-SACLAY
WO/2021/259748COMPOSITIONS COMPRISING ZINC AND ANTIMICROBIAL AGENTUNILEVER IP HOLDINGS B.V.
WO/2021/255159FORMULATION COMPRISING DAPRODUSTATGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/255160METHOD FOR PRODUCING PERSONALIZED COSMETICSBASF SE
WO/2021/255172MARC1 INHIBITORS FOR TREATMENT OF LIPID METABOLISM DISORDERSCLEMENT, Bernd
WO/2021/255177METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATIONBASF SE
WO/2021/255179PLASMA-TREATED HYDROGEL COMPOSITIONS AND USES THEREOFUNIVERSITAT POLITèCNICA DE CATALUNYA
WO/2021/255194COMPOSITION COMPRISING A SHORT-CHAIN FATTY ACID SALT AND AT  LEAST ONE LONG-CHAIN FATTY ACIDL'OREAL
WO/2021/255200GELLED COMPOSITION COMPRISING A SHORT-CHAIN FATTY ACID SALTL'OREAL
WO/2021/255204NEW STRATEGY FOR TREATING PANCREATIC CANCERINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/255217AMATOXIN AND AMATOXIN CONJUGATES FOR USE IN INHIBITION OF RNA  VIRUS REPLICATIONHEIDELBERG PHARMA RESEARCH GMBH
WO/2021/255218A PHARMACEUTICAL COMBINATION COMPRISING AN ANTI-VIRAL  PROTONOPHORE AND A SERINE PROTEASE INHIBITORCHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/255219SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID  CONSTRUCT HAVING A SPECIFIC ORDER OF GENESINTERVET INTERNATIONAL B.V.
WO/2021/255222SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA  REPLICON PARTICLESINTERVET INTERNATIONAL B.V.
WO/2021/259772PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE  PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY CORONAVIRIDAEEVONIK OPERATIONS GMBH
WO/2021/255226ANTIVIRAL USE OF CALIXARENESCEBINA GMBH
WO/2021/259783POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND  CARGO MOLECULESHELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/255239OXOPIPERAZINE DERIVATIVES FOR THE TREATMENT OF CANCERINTHERA BIOSCIENCE AG
WO/2021/255245GENE THERAPY EXPRESSION SYSTEM ALLOWING AN ADEQUATE EXPRESSION  IN THE MUSCLES AND IN THE HEART OF SGCGGENETHON
WO/2021/255246ACALABRUTINIB MALEATE DOSAGE FORMSACERTA PHARMA B.V.
WO/2021/255251PULMONARY FORMULATION COMPRISING CANNABINOIDSCANNOVEX BV
WO/2021/255252FORMULATION COMPRISING CANNABINOIDSCANNOVEX BV
WO/2021/255260COMPOSITION COMPRISING A POLYOL AND AT LEAST ONE POLYGLYCERYL  ESTERL'OREAL
WO/2021/255264BIODEGRADABLE COMPOSITIONS AND IMPLANTSRE-VANA THERAPEUTICS LTD
WO/2021/255270SELF-AMPLIFYING SARS-COV-2 RNA VACCINEZIPHIUS VACCINES
WO/2021/259809PROCESS FOR DYEING KERATIN FIBERS USING A DIRECT DYE AND A  SACCHARINATE SALT AND COMPOSITION COMPRISING THEML'OREAL
WO/2021/259810COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN  FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS  COMPOSITIONL'OREAL
WO/2021/255282CONJUGATED AND LABELLED APELIN, PREPARATION AND USES THEREOFUNIVERSITE D'AIX MARSEILLE
WO/2021/255295SWELLABLE GELATIN COMPOSITIONSUNIVERSITEIT GENT
WO/2021/259869OXINE-CONTAINING CELL RADIOLABELLING AGENTSKING'S COLLEGE LONDON
WO/2021/259925CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY,  PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOFSAPREME TECHNOLOGIES B.V.
WO/2021/259927ANTI-CD2 ANTIBODIESZELARION MALTA LIMITED
WO/2021/259928COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND  A SAPONIN OR A LIGAND-SAPONIN CONJUGATESAPREME TECHNOLOGIES B.V.
WO/2021/259943HAIR CARE COMPOSITIONUNILEVER IP HOLDINGS B.V.
WO/2021/259944CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN  EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME,  THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITIONSAPREME TECHNOLOGIES B.V.
WO/2021/259962COMPOSITIONS AND KITS OF PARTS COMPRISING  N,N-DIMETHYLTRYPTAMINE AND HARMINE AND THEIR USE IN THERAPYUNIVERSITY OF ZüRICH
WO/2021/259963IMMUNIZATION AGAINST WNT4 FOR TREATMENT AND PROPHYLAXIS OF  BREAST CANCERPANDORA ENDOCRINE INNOVATION B.V.
WO/2021/259972ANTICANCER COMBINATION THERAPY COMPRISING A SOS1 INHIBITOR AND  A KRAS G12C INHIBITORBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/259973COMPOSITION COMPRISING A PARTICULAR SILICONE EMULSION, A  PARTICULAR (METH)ACRYLAMIDE POLYMER, SURFACTANTS AND A CATIONIC  POLYSACCHARIDEL'OREAL
WO/2021/259974COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST ONE  CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND A CHEMICAL  OXIDIZING AGENT AND/OR AN OXIDATION DYEL'OREAL
WO/2021/260048COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE  COPOLYMER COMPRISING AT LEAST TWO DIFFERENT POLYMER UNITS BEARING A(N)  (UN)SATURATED HYDROCARBON-BASED CHAIN IN A FATTY MEDIUML'OREAL
WO/2021/260054SAPONIN DERIVATIVES FOR USE IN MEDICINESAPREME TECHNOLOGIES B.V.
WO/2021/260061SAPONIN DERIVATIVES FOR USE IN MEDICINESAPREME TECHNOLOGIES B.V.
WO/2021/260062PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE  APPLICATION OF A MAKEUP-REMOVING COMPOSITION, THE KERATIN FIBRES HAVING BEEN  DYED BEFOREHANDL'OREAL
WO/2021/260065MVA-BASED VACCINE AGAINST COVID-19 EXPRESSING SARS-COV-2  ANTIGENSCONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/260068VASOPRESSIN-2 RECEPTOR ANTAGONIST PEPTIDES AND USES THEREOFCOMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/260078COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE  COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A SURFACTANTL'OREAL
WO/2021/260079COSMETIC COMPOSITION COMPRISING A GRAFTED POLYHYDROXYALKANOATE  COPOLYMER IN A FATTY MEDIUML'OREAL
WO/2021/260093SOFT GELATIN CAPSULESITF RESEARCH PHARMA, S.L.U
WO/2021/260109A COMBINATION OF A CBP/p300 BROMODOMAIN INHIBITOR AND AN EGFR  INHIBITOR FOR USE IN TREATING EGFR-MUTANT NSCLCTOLREMO THERAPEUTICS AG
WO/2021/260110HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND  THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF FIBROTIC DISEASETOLREMO THERAPEUTICS AG
WO/2021/260111COMBINATION OF A CBP/P300 BROMODOMAIN INHIBITOR AND A KRAS  INHIBITOR FOR THE TREATMENT OF CANCERTOLREMO THERAPEUTICS AG
WO/2021/260120ARIMOCLOMOL FOR TREATING GAUCHER DISEASEORPHAZYME A/S
WO/2021/260129HUMANIZED ANTIGEN BINDING UNITS FOR TARGETING OSTEOSARCOMA  CELLSOSLO UNIVERSITETSSYKEHUS HF
WO/2021/260131VIRUS-LIKE PARTICLES OF CMV MODIFIED BY FUSIONSAIBA AG
WO/2021/260139METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS  ASSOCIATED WITH INTENSE STRESSINSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/260141COMPOSITIONINEOS SERVICES BELGIUM SA
WO/2021/260145METHOD FOR INCORPORATING ORGANIC COMPOUNDS IN SOLUTION WITHIN  A HYDROGELLABORATOIRES VIVACY
WO/2021/260152INHIBITORS OF ACID SPHINGOMYELINASE FOR PREVENTING AND  TREATING THE COVID-19 DISEASEASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/260164THROMBIN C-TERMINAL PEPTIDES TO TREAT CORONAVIRAL INFECTIONSIN2CURE AB
WO/2021/260168USE OF COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING  COMPOSITIONS THEREOFCHEMCOM S.A.
WO/2021/260176SYNTHETIC EPITOPES OF BETACORONAVIRUSESVIROMETIX AG
WO/2021/260186ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT  RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODSJUNO THERAPEUTICS GMBH
WO/2021/260197ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSIONF. HOFFMANN-LA ROCHE AG
WO/2021/260198AGARICUS BLAZEI FERMENTED GRAINS AGAINST LAWSONIA  INTRACELLULARIS INFECTIONNUTRECO IP ASSETS B.V.
WO/2021/260208SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATIONBAYER AKTIENGESELLSCHAFT
WO/2021/260209CCR8 ANTIBODIES AND USES THEREOFBAYER AKTIENGESELLSCHAFT
WO/2021/260210ANTI CCR8 ANTIBODY THERAPY: BIOMARKERS & COMBINATION  THERAPIESBAYER AKTIENGESELLSCHAFT
WO/2021/260211TARGETED RELEASE RIFAXIMIN COMPOSITIONSBAUSCH HEALTH IRELAND LIMITED
WO/2021/105524PHARMACEUTICAL COMPOSITION OF IBUPROFEN SALT WITH LYSINE IN  THE FORM OF AN ORAL SOLUTIONMMC INTERNATIONAL HEALTH HOLDING, S.L.
WO/2021/219903CANNABINOIDS FOR USE IN SUPRESSING CANCER STEM CELLSEMERALD HEALTH BIOTECHNOLOGY ESPAÑA S.L.
WO/2021/250289PROBIOTIC FOR THE TREATMENT OF INFERTILITY AND RECURRENT  PREGNANCY LOSSBIOSEARCH, S.A.
WO/2021/019116PHARMACEUTICAL COMPOSITION FOR USE IN THE PROPHYLACTIC AND/OR  THERAPEUTIC TREATMENT OF L-DOPA-INDUCED DYSKINESIAUNIVERSIDADE DE SANTIAGO DE COMPOSTELA
WO/2021/023903HYPOLEPTINEMIC COMPOSITION AND USE THEREOFUNIVERSITAT ROVIRA I VIRGILI
WO/2021/023908FOOD PRODUCT DERIVED FROM THE OLIVE PLANT, PRODUCTION METHOD  AND ASSOCIATED USESROQUE INICIATIVAS SL
WO/2021/044073RECOMBINANT NANNOCHLOROPSIS GADITANA PROTEINUNIVERSIDAD DE CáDIZ
WO/2021/099662THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND  IMAGING AGENTS TO CANCER CELLSUNIVERSITAT POLITèCNICA DE VALèNCIA
WO/2021/099665PLACENTAL DECIDUA PARIETALIS STEM CELLS FOR USE IN CHRONIC  STRESS URINARY INCONTINENCEFUNDACIóN PARA LA INVESTIGACIóN BIOMéDICA DEL HOSPITAL 12 DE  OCTUBRE
WO/2021/136862LIQUID GALENIC COMPOSITION FOR ORAL USE COMPRISING MELATONIN  AND A ZINC SALT AND CORRESPONDING METHOD AND USELABORATORIOS VIÑAS S.A.
WO/2021/152192LOW AND VERY LOW MOLECULAR WEIGHT HEPARINS FOR THE TREATMENT  OF DEEP VEIN THROMBOSISLABORATORIOS FARMACéUTICOS ROVI, S.A.
WO/2021/165558BREAKABLE GALENIC CAPSULEFINGERCLIK, S.L.
WO/2021/198545USE OF BREASTMILK EXOSOMES AS RADIOISOTOPE VEHICLE FOR THE  DIAGNOSIS AND TREATMENT OF NEOPLASMSINSTITUTO DE SALUD CARLOS III (ISCIII)
WO/2021/205049COMPOUNDS FOR THE PROPHYLAXIS AND/OR TREATMENT OF ACUTE  RESPIRATORY DISTRESS SYNDROMESERVICIO ANDALUZ DE SALUD
WO/2021/205053INJECTABLE MELATONIN COMPOSITION FOR THE TREATMENT OF VIRAL  DISEASESUNIVERSIDAD DE GRANADA
WO/2021/209667METHOD FOR OBTAINING A BOTANICAL EXTRACTEUROMED, S.A.
WO/2021/209670THERAPEUTIC TREATMENT FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS  USING A MONOCLONAL ANTIBODY AGAINST THE PRE-T CELL RECEPTORCONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS
WO/2021/214361LONG LASTING ANTISEPTIC FOR HYGIENIC FRICTION WASHING AND  PRE-SURGICAL WASHING OF HANDSUNIVERSIDAD COMPLUTENSE DE MADRID
WO/2021/214364THERAPEUTIC USE OF A MAQUI EXTRACT IN CROHN'S DISEASEUNIVERSIDAD DE SEVILLA
WO/2021/214370SELF-ADHERENT PATCHES OF POLYMER FIBRES FOR THE CONTROLLED  RELEASE OF PERFUMEBIOINICIA, S.L.
WO/2021/229119SELF-ADHESIVE PATCHES MADE OF FIBRES FOR THE CONTROLLED  RELEASE OF BIOACTIVESBIOINICIA, S.L.
WO/2021/229131IN VITRO METHOD FOR RECOVERING THE EXPRESSION OF THE F5 GENE  ENCODING COAGULATION FACTOR VUNIVERSIDAD COMPLUTENSE DE MADRID
WO/2021/245315PREVENTION AND/OR TREATMENT OF COGNITIVE IMPAIRMENT ASSOCIATED  WITH DEMENTIA SYNDROMESUNIVERSIDAD DE MáLAGA
WO/2021/255310STRAIN OF THE BACTEROIDES GENUS FOR USE IN THE TREATMENT  AND/OR PREVENTION OF EATING DISORDERSCONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/001601METHODS FOR ADMINISTERING  (R)-N-[4-(1,4,5,6-TETRAHYDRO-6-OXO-3-PYRIDAZINYL)PHENYL]ACETAMIDEORION CORPORATION
WO/2021/001603PHARMACEUTICAL COMPOSITION OF DAROLUTAMIDEORION CORPORATION
WO/2021/005268PIEZO AGONISTS FOR PREVENTING OR REVERTING ABNORMAL AMYLOID  DEPOSITIONITÄ-SUOMEN YLIOPISTO
WO/2021/019128A DENTAL MATERIALSTICK TECH OY
WO/2021/023914A METHOD AND A COMPOUND FOR PREVENTING MAMMALIAN CANCER CELL  PROLIFERATION AND FOR TREATING CANCEROY GRANULA AB LTD
WO/2021/023915METHOD OF ENHANCING THE ANTIMICROBIAL ACTION OF SYSTEMICALLY  ADMINISTERED ANTIBIOTICSKOITE HEALTH OY
WO/2021/038125CONJUGATES AND CONJUGATES FOR USE IN PREVENTING OR TREATING OF  BRAIN DAMAGE AND NEURODEGENERATIVE DISEASESMEDICORTEX FINLAND OY
WO/2021/123506STABILE CONJUGATEGLYKOS BIOMEDICAL OY
WO/2021/152214COMPOSITION COMPRISING RASPBERRY KETONEKOIVUBIOTECH OY
WO/2021/156540STABLE PHARMACEUTICAL COMPOSITIONS OF ROPINIROLEORION CORPORATION
WO/2021/160937THERAPY OF RAS-DEPENDENT CANCERSTURUN YLIOPISTO
WO/2021/160938SYSTEMIC ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION  COMPRISING CDNF OR MANF POLYPEPTIDE FOR USE IN THE TREATMENT OF REPERFUSION  INJURYHERANTIS PHARMA OYJ
WO/2021/170915METHOD AND KIT FOR TREATING SKIN INFECTIONSKOITE HEALTH OY
WO/2021/176146PHARMACEUTICAL COMPOSITIONS OF A KINASE INHIBITORORION CORPORATION
WO/2021/191496MEDICINE FOR COVID-19 AND TREATMENTTHERAPEUTICA BOREALIS OY
WO/2021/205074INHALABLE FORMULATIONAALTO UNIVERSITY FOUNDATION SR
WO/2021/205075COMBINATORY TREATMENTAALTO UNIVERSITY FOUNDATION SR
WO/2021/205077MIMETIC NANOPARTICLES FOR PREVENTING THE SPREADING AND  LOWERING THE INFECTION RATE OF NOVEL CORONAVIRUSESFINNCURE OY
WO/2021/205079NOVEL VACCINE COMPOSITIONSFINNCURE OY
WO/2021/219939SALVE COMPOSITION, METHOD OF MANUFACTURE AND USE OF THE  COMPOSITIONNORDIC BIOTECH GROUP OY
WO/2021/219940HOMING PEPTIDE-GUIDED DECORIN CONJUGATES FOR USE IN TREATING  EPIDERMOLYSIS BULLOSATAMPERE UNIVERSITY FOUNDATION SR
WO/2021/255336STABLE ANTI-CLEVER-1 ANTIBODY FORMULATIONFARON PHARMACEUTICALS OY
WO/2021/069807COSMETIC COMPOSITION, METHOD FOR PREPARATION AND USE OF SAME  AS A MASK FOR THE COSMETIC TREATMENT OF SKIN, PARTICULARLY THE FACES.A. THALGO TCH
WO/2021/084166GOLD NANOSTRUCTURE COMPRISING ENZYMES AND ANTIOXIDANTSBIO EVEN SAS
WO/2021/014057COSMETIC SKIN WHITENING COMPOSITION COMPRISING  HEXYLRESORCINOL, UNDECYLENOYL PHENYLALANINE AND TRIMETHOXYBENZYLIDENE  PENTANEDIONELABORATOIRE GARANCIA
WO/2021/064299ANTI-UV COSMETIC COMPOSITIONCOATEX
WO/2021/001637SOLID COSMETIC COMPOSITIONCHANEL PARFUMS BEAUTE
WO/2021/001638SOLID HYDRATING COSMETIC COMPOSITIONCHANEL PARFUMS BEAUTE
WO/2021/005310COMPOSITION FOR THE TREATMENT OF EMOTIONAL DISORDERSMOUSSET, Pierre-Yves
WO/2021/009445SULPHATE-FREE CONCENTRATED RHEO-FLUIDIFYING FOAMING  COMPOSITION AND USES THEREOFLABORATOIRES DE BIOLOGIE VéGéTALE YVES ROCHER
WO/2021/019151COSMETIC COMPOSITION IN THE FORM OF A COMPACT,  IMPACT-RESISTANT POWDERSOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES SEPPIC
WO/2021/014103PARTICULATE STRUCTURES MADE FROM GOLD NANOPARTICLES, METHODS  FOR PREPARING SAME AND USES THEREOF FOR TREATING SOLID TUMOURSUNIVERSITE DE FRANCHE COMTE
WO/2021/014108NASAL OR ORAL SPRAY COMPOSITION CONTAINING SULFURLABORATOIRES GRIMBERG
WO/2021/014109CONTINUOUS METHOD FOR NANO-EMULSIFICATION BY CONCENTRATION  PHASE INVERSIONUNIVERSITé D'ANGERS
WO/2021/019185COMPOSITIONS COMPRISING A MIXTURE OF VITAMINS AND MINERALS IN  THE FORM OF A COMBINATION OF A GASTRO-SOLUBLE ORAL FORM AND A  GASTRO-RESISTANT ORAL FORM, AND USE THEREOFLABORATOIRES GRIMBERG
WO/2021/023938STICK OF COSMETIC PRODUCT COMPRISING TWO COMPOSITIONS, METHOD  AND DEVICE FOR MANUFACTURING SUCH A STICK OF COSMETIC PRODUCTPARFUMS CHRISTIAN DIOR
WO/2021/028632PHARMACEUTICAL COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM  OF A DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY  PHASE AND COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCESOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES SEPPIC
WO/2021/028633ANHYDROUS COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM OF A  DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY PHASESOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES SEPPIC
WO/2021/023952NOVEL COSMETIC USE OF AN EPILOBIUM ANGUSTIFOLIUM EXTRACTBASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/028640LOW-DOSAGE ORODISPERSIBLE OPIOID TABLET AND METHOD FOR  PREPARING SAMEETHYPHARM
WO/2021/064316COMBINATION OF CICLOPIROXOLAMINE AND PIROCTONE OLAMINE FOR  COMBATING DANDRUFFPIERRE FABRE DERMO-COSMETIQUE
WO/2021/064332ANTI-CD30-DRUG CONJUGATES AND THEIR USE IN THERAPYMC SAF
WO/2021/064334COSMETIC OR NUTRACEUTICAL USE OF A <i>TERMINALIA  CATAPPA</i> EXTRACTBASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/069828COMPOSITION CONTAINING CAROTENOIDS AND USE THEREOF FOR  PROTECTING NEURONS AGAINST NEURODEGENERATIONSERIVE, Benoît
WO/2021/069836MASKING THE TASTE OF ISOSORBIDEROQUETTE FRERES
WO/2021/074542NOVEL HYDROCORTISONE HEMISUCCINATE LYOPHILISATELABORATOIRE AGUETTANT
WO/2021/084200POLYSACCHARIDE-BASED GELLED FOAMURGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/084211EMULSION USABLE IN PARTICULAR AS A TECHNOLOGICAL AUXILIARY IN  THE FIELD OF PLASTICS, OR AS AN ENCAPSULATION SYSTEM FOR ACTIVE AGENTS,  PREPARATION METHOD AND APPLICATIONS THEREOFLACTIPS
WO/2021/084213USE OF NEUROSPORENE TO PROTECT THE SKIN FROM THE HARMFUL  EFFECTS OF BLUE LIGHTDEINOVE
WO/2021/099715USE OF A GLYCINE BETAINE DERIVATIVE AS AN AGENT FOR  CONDITIONING KERATIN FIBRESSURFACTGREEN
WO/2021/094687COSMETIC USE OF AN AROMATIC RAW MATERIAL EXTRACT FOR  PROTECTING SKIN FROM BLUE LIGHTROBERTET S.A.
WO/2021/094697PROCESS FOR PRODUCING AN ORALLY ADMINISTERED PHARMACEUTICAL  COMPOSITION WITH COLONIC DELIVERYETHYPHARM
WO/2021/099742SYNTHESIS OF MELDRUM'S ACID DERIVATIVES HAVING ANTI-UVA AND  ANTI-BLUE LIGHT, ANTI-PIGMENTATION AND/OR ANTIOXIDANT ACTIVITIESINSTITUT DES SCIENCES ET INDUSTRIES DU VIVANT ET DE  L'ENVIRONNEMENT - AGROPARISTECH
WO/2021/105620BIOCOMPATIBLE OILY FERROFLUID AND PREPARATION PROCESSUNIVERSITE DE BORDEAUX
WO/2021/111065THREE-PHASE COSMETIC COMPOSITIONLABORATOIRES M&L
WO/2021/105634COMPOSITION COMPRISING ACTIVATED CARBON AND FRUCTANS FOR  PREVENTING, REGULATING AND/OR TREATING INTESTINAL FUNCTIONAL DISORDERSPOUGNAS, Jean-Luc
WO/2021/105637MICROGELS AND THE STIMULABLE PHOTONIC AND INTERFERENCE  APPLICATIONS THEREOFLVMH RECHERCHE
WO/2021/123531MEDICAL COMPOSITION OR DEVICE COMPRISING OLIGO(ETHYLENE  GLYCOL) POLYMERSLVMH RECHERCHE
WO/2021/105638USE OF HYDROPEROXY ALCOHOLS AND THE DERIVATIVES THEREOF AS  ANTIMICROBIAL AGENTSDEMETA
WO/2021/123532MEDICAL COMPOSITION OR DEVICE COMPRISING OLIGO(ETHYLENE  GLYCOL) POLYMERSLVMH RECHERCHE
WO/2021/105641N2-ARYLMETHYL-4-HALOALKYL-PYRIDAZIN-3-ONE CFTR MODULATORS FOR  THE TREATMENT OF CYSTIC FIBROSISUNIVERSITE DE REIMS CHAMPAGNE-ARDENNE
WO/2021/111096COSMETIC COMPOSITION COMPRISING EXTRACTS OF KIGELIA AND  NASTURTIUML V M H RECHERCHE
WO/2021/116573COSMETIC COMPOSITION COMPRISING EXTRACTS OF KIGELIA AND ORCHIDL V M H RECHERCHE
WO/2021/116611FORMULATION FOR METHYLENE BLUE AND METHODUNIVERSITE DE BORDEAUX
WO/2021/116616COSMETIC COMPOSITION COMPRISING EXTRACTS OF POMEGRANATE AND  PEONYL V M H RECHERCHE
WO/2021/116623COSMETIC CARE COMPOSITIONS, REINFORCEMENT AND/OR REPAIR OF  KERATIN FIBERS COMPRISING THE COMBINATION OF BABASSU OIL AND SODIUM  DILAURAMIDOGLUTAMIDE LYSINEPIERRE FABRE DERMO-COSMETIQUE
WO/2021/123600PERFUME REMOVER COMPOSITIONL V M H RECHERCHE
WO/2021/123624COSMETIC COMPOSITION COMPRISING D-CHIRO-INOSITOLL V M H RECHERCHE
WO/2021/123631COSMETIC COMPOSITION COMPRISING ASCORBIC ACID 2-GLUCOSIDE AND  ACETYLATED HYALURONIC ACID OR A SALT THEREOFL V M H RECHERCHE
WO/2021/123660CURCUMINOID-FREE EXTRACT OF CURCUMA LONGA IN INFLAMMATORY  DERMATOSESPIERRE FABRE DERMO-COSMETIQUE
WO/2021/123667COSMETIC COMPOSITION HAVING GLOSS AND LASTING PROPERTIESL V M H RECHERCHE
WO/2021/123669LIQUID COSMETIC COMPOSITION WITH GLOSS AND LASTING PROPERTIESL V M H RECHERCHE
WO/2021/130453ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF  PSORIASISCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -
WO/2021/144528COMBINATION OF DILTIAZEM AND VIRAL POLYMERASE INHIBITORSUNIVERSITE CLAUDE BERNARD LYON 1
WO/2021/152250COSMETIC, NUTRACEUTICAL OR DERMATOLOGICAL USE OF A TAMARINDUS  INDICA L. EXTRACT AND/OR A COMPOSITION COMPRISING ITBASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/156556MURRAYA KOENIGII EXTRACT AND USE THEREOF IN COSMETICSGATTEFOSSé SAS
WO/2021/152265TWO-PHASE COMPOSITION FOR MAKEUP REMOVAL AND/OR CLEANSINGLABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER
WO/2021/160968COMBINATION OF ANETHOLE TRITHIONE OR ITS DERIVATIVE,  4-OH-ANETHOLE TRITHIONE, WITH DOXYCYCLINE OR MINOCYCLINE FOR THE USE THEREOF  IN THE TREATMENT OF PARKINSON'S DISEASEPETITJEAN, Olivier
WO/2021/165623NOVEL COSMETIC AND/OR DERMATOLOGIC COMPOSITION WITH OSMOTIC  SYNERGY AND RELATED PRODUCTION METHODBIANCHIN, Claire
WO/2021/170961ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPYMC SAF
WO/2021/181044COMPOSITION COMPRISING DILTIAZEM FOR TREATING A VIRAL  INFECTION CAUSED BY SARS-COV-2 VIRUSESUNIVERSITE CLAUDE BERNARD LYON 1
WO/2021/181052COSMETIC USE OF REOTIER WATER FOR MAINTAINING THE BALANCE OF  SKIN MICROBIOTALABORATOIRES M&L
WO/2021/191525PLATELET LYSATE FOAM FOR CELL CULTURE, CELL THERAPY AND  TISSULAR REGENERATION AND METHOD FOR OBTAINING SAMEUNIVERSITE PAUL SABATIER TOULOUSE III
WO/2021/186131ESTOLIDE COMPOSITION FOR TOPICAL APPLICATIONSTOTAL MARKETING SERVICES
WO/2021/198588PHYTOECDYSONES AND DERIVATIVES THEREOF FOR USE IN TREATING  DISORDERED RESPIRATORY FUNCTION ON VIRAL INFECTIONBIOPHYTIS
WO/2021/219963METHOD FOR EXTRACTING ODOUR FROM A PLANT MATERIAL, IN  PARTICULAR FROM MUTE FLOWERS, IN SOLID FORMGENIALIS
WO/2021/219968FRAGRANT COMPOSITIONLVMH RECHERCHE
WO/2021/224575COSMETIC COMPOSITION COMPRISING AT LEAST ONE CALCAREOUS RED  ALGAESETALG
WO/2021/229170MUCOADHESIVE TABLET FOR TREATING OROPHARYNGEAL FUNGAL  INFECTIONSVECTANS PHARMA
WO/2021/234270COSMETIC NAIL CARE COMPOSITION IN THE FORM OF A VARNISHFIABILA
WO/2021/234271COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM  ENDOMETRIOSISGYNOV
WO/2021/234295COMPOSITION COMPRISING A METAL ASCORBOCAMPHORATE COMPOUND FOR  USE IN THE TREATMENT OF INFECTIONS CAUSED BY HERPES VIRUSESM.G.B. PHARMA
WO/2021/234299COMPOSITION COMPRISING A METAL ASCORBOCAMPHORATE COMPOUND FOR  USE IN THE TREATMENT OF PAPILLOMAVIRUS INFECTIONSM.G.B. PHARMA
WO/2021/234301USE OF A PROTEIN EXTRACT OF MORINGA OLEIFERA SEEDS AS AN  ANTI-POLLEN AGENTBASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/234324COMPOUND AND COMPOSITION FOR INDUCING NEUROPROTECTIONREST THERAPEUTICS
WO/2021/028644NOVEL THERAPEUTIC USEARTIOS PHARMA LIMITED
WO/2021/028646ADMINISTRATION REGIMES OF CANNABINOIDS IN COMBINATION WITH  CHEMOTHERAPEUTICS AGAINST CANCERJAY PHARMA INC.
WO/2021/111098NEW COMPOSITIONNANEXA AB
WO/2021/245365<i>IMPROVED IMMUNOMODULATOR COMPOSITIONS AND VIRAL  PATHOGEN TREATMENTS</i>REMEDY RESEARCH LIMITED
WO/2021/148763PEPTIDE INHIBITORS OF GUANINE NUCLEOTIDE EXCHANGE FACTOR-H1UCL BUSINESS LTD
WO/2021/186137V DELTA1+ T CELLS FOR THE TREATMENT OF MYELOID MALIGNANCIESGAMMADELTA THERAPEUTICS LIMITED
WO/2021/005325PHARMACEUTICAL COMPOSITION FOR NASAL DELIVERYOREXO AB
WO/2021/001646APOLIPOPROTEIN B ANTAGONISTARGONAUTE RNA LIMITED
WO/2021/001650PI3K INHIBITOR FOR USE IN THE THERAPY OF B CELL LYMPHOMAKARUS THERAPEUTICS LTD.
WO/2021/001651HDAC INHIBITORS FOR USE IN THE THERAPY OF BILIARY TRACT  CANCERSKARUS THERAPEUTICS LTD.
WO/2021/005337SONODYNAMIC THERAPYINNOVATION ULSTER LIMITED
WO/2021/005338NOVEL CANCER ANTIGENS AND METHODSTHE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/005340HYDROPHOBICALLY ASSOCIATING POLYMER COUNTER ION PAIR COMPLEXESMALVERN COSMECEUTICS LIMITED
WO/2021/001661ANTIBACTERIAL AND ANTIPARASITIC QUINOXALINE-2,3-DIAMINE  DERIVATIVESABERYSTWYTH UNIVERSITY
WO/2021/005374DIAGNOSTIC REAGENTTHE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS
WO/2021/009487SEXUAL PLEASURE ENHANCEMENT COMPOSITIONSBEAUTY DNA LTD.
WO/2021/009504NEW FORMULATIONSBALTICGRUPPEN BIO AB
WO/2021/009505NEW FORMULATIONSBALTICGRUPPEN BIO AB
WO/2021/009510METHOD FOR PRECONDITIONING A SUBJECT WHO IS ABOUT TO RECEIVE A  T-CELL THERAPYAUTOLUS LIMITED
WO/2021/014132CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS  AND METHODS OF PREPARATION THEREOFGW RESEARCH LIMITED
WO/2021/014153COSMETIC COMPOSITION COMPRISING AN ORAL CAPSULE CONTAINING  HYALURONIC ACID AND WHEAT GRAIN OIL WITH PHYTOCERAMIDESIIAA LTD
WO/2021/019214TREATMENT OF PITT-HOPKINS SYNDROMEHEALX LTD
WO/2021/014174TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOFINSTIL BIO (UK) LIMITED
WO/2021/019231USE OF CANNABIDIOL IN THE TREATMENT OF DRAVET SYNDROMEGW RESEARCH LIMITED
WO/2021/019232AFRICAN SWINE FEVER VACCINETHE PIRBRIGHT INSTITUTE
WO/2021/019234PHARMACEUTICAL DEVELOPMENTHELPERBY THERAPEUTICS LIMITED
WO/2021/019235HANTAVIRUS ANTIGENIC COMPOSITIONSECRETARY OF STATE FOR HEALTH AND SOCIAL CARE
WO/2021/019249CLOZAPINE FOR USE IN TREATING PATHOGENIC IMMUNOGLOBULIN DRIVEN  B CELL DISEASEZARODEX THERAPEUTICS LIMITED
WO/2021/023977FORMULATIONS COMPRISING CORTICOTROPIN RELEASING HORMONE (CRH)  AND ALPHA-2 MACROGLOBULINTARIAN BIOLOGICS LIMITED
WO/2021/019253ULTRASOUND-TRIGGERED LIPOSOME PAYLOAD RELEASEIMPERIAL COLLEGE INNOVATIONS LTD
WO/2021/028655SOLID COSMETIC COMPOSITION COMPRISING VEGETABLE BUTTER AND  VEGETABLE OILCOSMETIC WARRIORS LIMITED
WO/2021/028666CONJUGATE AND USES THEREOFOXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/028679PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINEVERONA PHARMA PLC
WO/2021/032955TREATMENTQUEEN MARY UNIVERSITY OF LONDON
WO/2021/028696AMOEBICIDAL COMPOSITIONS FOR CONTACT LENS SOLUTIONSUNIVERSITY OF THE WEST OF SCOTLAND
WO/2021/028697VACCINEUNIVERSITY OF SURREY
WO/2021/028698TREATMENT OF FRAGILE X SYNDROMEHEALX LTD
WO/2021/028700BACTERIAL COMPOSITIONS FOR THE TREATMENT OF DISEASEMICROBIOTICA LIMITED
WO/2021/032990PHARMACEUTICAL COMPOSITIONS COMPRISING 1,1-DIFLUOROETHANE AND  A CANNABINOIDMEXICHEM FLUOR S.A. DE C.V.
WO/2021/032993METHOD FOR MAKING MICRONEEDLES USING A HIGH VISCOSITY  COMPOSITIONINNOTURE IP LIMITED
WO/2021/032997THERAPEUTIC CONJUGATEPORTON BIOPHARMA LIMITED
WO/2021/038219USE OF CANNABINOIDS IN THE TREATMENT OF DYSKINESIA ASSOCIATED  WITH PARKINSON'S DISEASEGW RESEARCH LIMITED
WO/2021/038249ENGINEERED REGULATORY T CELLKING'S COLLEGE LONDON
WO/2021/038250PARASITIC NEMATODE VACCINETHE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/038253TREATMENT OF OBESITY AND RELATED CONDITIONSUNIVERSITY OF GREENWICH
WO/2021/044158TREATMENT OF FRAGILE X SYNDROME WITH IBUDILAST IN COMBINATION  WITH METFORMIN, CANNBIDIOL, SERTRALINE OR QUERCETINHEALX LTD
WO/2021/044175NOVEL METHODBABRAHAM INSTITUTE
WO/2021/048554COMBINATION OF ZIDOVUDINE AND FLUOROQUINOLONE ANTIBIOTICHELPERBY THERAPEUTICS LIMITED
WO/2021/053331PROINSULIN PEPTIDES FOR TYPE 1 DIABETESKING'S COLLEGE LONDON
WO/2021/058967COMBINATION OF GOLD COMPLEXES WITH OLAPARIB OR OTHER PARP1/2  INHIBITORS FOR USE IN THE TREATMENT OF CANCER RESISTANT TO SAID PARP1/2  INHIBITORSVARSITY PHARMACEUTICALS LIMITED
WO/2021/058969TRIPHENYLENE DERIVATIVES FOR USE IN IMAGING BIOLOGICAL TISSUE  OR FLUIDCHROMATWIST LIMITED
WO/2021/074584MICROSPHERE-DRUG COMBINATIONUCL BUSINESS LTD
WO/2021/058977FORMULATIONHEWLETT HEALTHCARE LIMITED
WO/2021/058979THERAPYVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/064357ORAL FILMS AND A METHODS FOR THE MANUFACTURE AND DELIVERY  THEREOFBIOFILM LIMITED
WO/2021/064369NON-TOXIC CLOSTRIDIAL NEUROTOXIN POLYPEPTIDES FOR USE IN  TREATING NEUROLOGICAL DISORDERSIPSEN BIOPHARM LIMITED
WO/2021/069875COMPOSITION FOR DELIVERING NITRIC OXIDE TO SKININSENSE LIMITED
WO/2021/069876COMPOSITION FOR DELIVERING NITRIC OXIDE TO SKININSENSE LIMITED
WO/2021/069890TREATMENT OF OSTEOPENIA AND/OR OSTEOPOROSISTHE UNIVERSITY OF BIRMINGHAM
WO/2021/069891ANTIVIRAL COMPOUNDS AND METHODSTHE UNIVERSITY OF NOTTINGHAM
WO/2021/069901LACTOSE PARTICLES AND METHOD OF PRODUCTION THEREOFUNIVERSITY OF HUDDERSFIELD
WO/2021/074598COMBINATION OF ZIDOVUDINE WITH A TETRACYCLINE ANTIBIOTICHELPERBY THERAPEUTICS LIMITED
WO/2021/074614TREATMENT OR PREVENTION OF LEUKAEMIAVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/074622BICYCLIC PEPTIDE LIGAND DRUG CONJUGATESBICYCLETX LIMITED
WO/2021/074646NEW FORMULATIONSBALTICGRUPPEN BIO AB
WO/2021/074647METHODS FOR TREATING CANCERBICYCLERD LIMITED
WO/2021/074648VECTOR FOR CANCER TREATMENTCANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/074654HAIR CARE FORMULATIONKDC/ONE SWALLOWFIELD LIMITED
WO/2021/074655CANCER VACCINEUNIVERSITY OF SOUTHAMPTON
WO/2021/079122ENGINEERED REGULATORY T CELLUCL BUSINESS LTD
WO/2021/116651TOPICAL COMPOSITION AND METHODS OF MEASURING THE COOLING  ABAILITY OF A TOPICAL COMPOSITIONFUTURA MEDICAL DEVELOPMENTS LIMITED
WO/2021/079129DOSING REGIMENCYCLACEL LIMITED
WO/2021/084229TRANSDERMAL PATCHUNIVERSITY OF SUNDERLAND
WO/2021/079135(-)-CIS TETRAHYDROCANNABINOL ((-)-CIS-THC) FOR USE AS A  MEDICAMENTGW RESEARCH LIMITED
WO/2021/079136(+)-CIS TETRAHYDROCANNABINOL ((+)-CIS-THC) FOR USE AS A  MEDICAMENTGW RESEARCH LIMITED
WO/2021/079137(+)-TRANS TETRAHYDROCANNABINOL ((+)-TRANS-THC) FOR USE AS A  MEDICAMENTGW RESEARCH LIMITED
WO/2021/079142ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONSNUSEED PTY LTD.
WO/2021/079148CANNABIDIVARIN PREPARATIONS FOR USE AS A MEDICAMENTGW RESEARCH LIMITED
WO/2021/079150USE OF CANNABIDIOL PREPARATIONS IN THE TREATMENT OF FRAGILE X  SYNDROMEGW RESEARCH LIMITED
WO/2021/079151USE OF CANNABIDIOL PREPARATIONS IN THE TREATMENT OF TEMPORAL  LOBE EPILEPSYGW RESEARCH LIMITED
WO/2021/079152USE OF CANNABIDIOL PREPARATIONS IN THE TREATMENT OF ABSENCE  EPILEPSYGW RESEARCH LIMITED
WO/2021/090003METHOD FOR SELECTIVE RECOVERY OF HYDROPHOBIC COMPOUNDSGROW BIOTECH PLC
WO/2021/090013NEW COMPOSITION COMPRISING AMORPHOUS NANOPOROUS SILICA  PARTICLESNANOLOGICA AB
WO/2021/090015NEW COMPOSITIONSVICORE PHARMA AB
WO/2021/090018NEW COMPOSITIONSVICORE PHARMA AB
WO/2021/090019NEW COMPOSITIONSVICORE PHARMA AB
WO/2021/094752PRODUCTION SYSTEMOXFORD BIOMEDICA (UK) LIMITED
WO/2021/099775CANNABIDIOL-TYPE CANNABINOID COMPOUNDGW RESEARCH LIMITED
WO/2021/099777CANNABIDIOL-TYPE CANNABINOID COMPOUNDGW RESEARCH LIMITED
WO/2021/099781CANNABIDIOL-TYPE CANNABINOID COMPOUNDGW RESEARCH LIMITED
WO/2021/099783CANNABIDIOL-TYPE CANNABINOID COMPOUNDGW RESEARCH LIMITED
WO/2021/099792GELLED OIL-IN-WATER EMULSION COMPRISING AT LEAST ONE  CANNABINOIDVITUX GROUP AS
WO/2021/099803COMPOUNDS FOR USE IN THE TREATMENT OF ACUTE INTERMITTENT  PORPHYRIAVESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/105664BONDED NEUROTOXINSTHE UNIVERSITY OF SHEFFIELD
WO/2021/105666SOLID COSMETIC COMPOSITION COMPRISING LUMINESCENT ZINC  SULPHIDECOSMETIC WARRIORS LIMITED
WO/2021/105688PHAGOCYTOSED SELF-ASSEMBLING PROTEINSCELL GUIDANCE SYSTEMS LIMITED
WO/2021/105694BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 AND USES THEREOFBICYCLETX LIMITED
WO/2021/105697TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTIONUCL BUSINESS LTD
WO/2021/105720PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS FOR THE TREATMENT  OF RETINOBLASTOMAOXULAR LIMITED
WO/2021/111128IMPROVEMENTS IN WEIGHT CONTROLJUDD HEALTH LIMITED
WO/2021/111143METHODS AND COMPOSITIONS PRODUCED THEREBYALBUMEDIX LIMITED
WO/2021/111149NEW PROCESS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONSNANEXA AB
WO/2021/116670TREATMENT OR PREVENTION OF ISCHAEMIC STROKE REPERFUSION INJURYCAMBRIDGE ENTERPRISE LIMITED
WO/2021/116679TREATMENTS OF DIABETIC MACULAR EDEMA AND IMPAIRED VISUAL  ACUITYKALVISTA PHARMACEUTICALS LIMITED
WO/2021/116701CHEMOTHERAPEUTIC DRUG IMPLANTEXTRUDED PHARMACEUTICALS LTD
WO/2021/116705COLLAGEN PRODUCTION3D BIO-TISSUES LIMITED
WO/2021/123750NEW THERAPYUCL BUSINESS LTD
WO/2021/123773ANTIMICROBIAL COMPOSITIONSOXY SOLUTIONS AS
WO/2021/123784PERSONAL LUBRICANT COMPOSITIONRECKITT BENCKISER HEALTH LIMITED
WO/2021/123799RED BLOOD CELL-DERIVED VESICLEIMPERIAL COLLEGE INNOVATIONS LIMITED
WO/2021/123800CELLAUTOLUS LIMITED
WO/2021/123804ORAL CANNABINOID FORMULATIONSGW RESEARCH LIMITED
WO/2021/123810ANTIGEN-BINDING DOMAIN BINDING TO PSMAAUTOLUS LIMITED
WO/2021/123813TREATMENT AND PROGNOSIS OF PANCREATIC CANCERCAMBRIDGE ENTERPRISE LIMITED
WO/2021/130483COMPOSITIONSJVS PRODUCTS LTD
WO/2021/130498COMBINATION THERAPYTURBINE SIMULATED CELL TECHNOLOGIES LTD
WO/2021/136933IMMUNOTHERAPEUTIC TREATMENT OF CANCERIMMODULON THERAPEUTICS LIMITED
WO/2021/160982COMPOSITIONS AND APPLICATIONS THEREOFNASALEZE PATENTS LIMITED
WO/2021/229200ANTI-VIRAL PREPARATION AND METHOD OF MANUFACTURING AN ANTI-  VIRAL PREPARATIONSKIN LOGISTICS LTD
WO/2021/140331ANTIMICROBIAL FIBRESADVANCED MEDICAL SOLUTIONS LIMITED
WO/2021/140340COMPOSITIONS AND METHODS COMPRISING SANSHOOL AS LIP  INTERACTING COMPONENTSDIET SHIELD LTD
WO/2021/140343LIGAND DRUG CONJUGATES AND MODIFIED BET INHIBITORSHOVIONE SCIENTIA LIMITED
WO/2021/148779POLYHEDRIN DELIVERY SYSTEM RELEASING GROWTH FACTORSCELL GUIDANCE SYSTEMS LIMITED
WO/2021/148788ENGINEERED IMMUNE CELLSUCL BUSINESS LTD
WO/2021/148805TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING  IMIDAZO[1,2-B]PYRIDAZINE COMPOUNDSBENEVOLENTAI BIO LIMITED
WO/2021/148807PHARMACEUTICAL COMPOSITIONS AND THEIR USESBENEVOLENTAI BIO LIMITED
WO/2021/152314IMPROVED ASSAY FOR DETERMINING NEUTRALISING ANTIBODY TITRE TO  A VIRAL VEKTORFREELINE THERAPEUTICS LIMITED
WO/2021/152328TREATMENT OF SKIN CONDITIONSIPSEN BIOPHARM LIMITED
WO/2021/156607DRUG FORMULATIONSTHE UNIVERSITY OF NOTTINGHAM
WO/2021/161023COMPOUNDS USEFUL IN INHIBITING KETOHEXOKINASE AND METHODS OF  MAKING AND USING THE SAMEINORBIT THERAPEUTICS AB
WO/2021/161034USE OF COMPOUNDS THAT ARE ABLE TO CROSS-LINK THE EXTRACELLULAR  MATRIX FOR PREVENTING OR INHIBITING THE MIGRATION OF CANCER CELLSCAMBRIDGE ENTERPRISE LIMITED
WO/2021/161043PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED  BY CORONAVIRUSIMMODULON THERAPEUTICS LIMITED
WO/2021/161047USP7 INHIBITOR FOR USE IN THE TREATMENT OF CANCERALMAC DISCOVERY LIMITED
WO/2021/1656672019-NCOV (SARS-COV-2) VACCINEVAXBIO LTD
WO/2021/170982THERAPYUCL BUSINESS LTD
WO/2021/171003<i>EX VIVO</i> GAMMA DELTA T CELL POPULATIONSGAMMADELTA THERAPEUTICS LIMITED
WO/2021/171028ANTI-INFECTIVE BICYCLIC PEPTIDE CONJUGATESBICYCLETX LIMITED
WO/2021/171034LIQUID PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE AND  GLYCOPYRROLATEVERONA PHARMA PLC
WO/2021/171035COMPOSITIONS AND USES THEREOFBENEVOLENTAI CAMBRIDGE LIMITED
WO/2021/171036TREATMENT OF LIVER FAILUREHEPYX LIMITED
WO/2021/171042COMPOSITION FOR MODULATING INTESTINAL PERMEABILITY AND/OR  TREATING AND/OR PREVENTING LEAKY GUT RELATED DISEASES, AND METHOD FOR  MODULATING INTESTINAL PERMEABILITY AND/OR TREATING AND/OR PREVENTING LEAKY  GUT RELATED DISEASESINDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
WO/2021/171045METHODS OF TREATING TUBEROUS SCLEROSIS COMPLEX WITH  CANNABIDIOL AND EVEROLIMUSGW RESEARCH LIMITED
WO/2021/176214PHARMACEUTICAL FORMULATIONS COMPRISING  6-CHLORO-7-(4-(4-CHLOROBENZYL)PIPERAZIN-1 -YL)-2-(1,3-DIMETHYL-1  HPYRAZOL-4-YL)-3H- IMIDAZO[4,5-B]PYRIDINEELLIPSES PHARMA LTD
WO/2021/176234VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTIONTHE PIRBRIGHT INSTITUTE
WO/2021/176235VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTIONTHE PIRBRIGHT INSTITUTE
WO/2021/176236VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTIONTHE PIRBRIGHT INSTITUTE
WO/2021/181096GENE THERAPY OF NIEMANN-PICK DISEASE TYPE CUCL BUSINESS LTD
WO/2021/181099SOLID CLEANSING COMPOSITION COMPRISING AN ACYL ALKYL  ISETHIONATEINNOSPEC ACTIVE CHEMICALS LLC
WO/2021/181100COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSEOXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/186151AZD1656 FOR USE IN THE TREATMENT OF PNEUMONITIS AND/OR  MYCORDITIS CAUSED BY A CORONAVIRUSEXCALIBUR MEDICINES LIMITED
WO/2021/181115COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASESILC THERAPEUTICS LIMITED
WO/2021/186160MODIFIED BOTULINUM NEUROTOXIN FOR TREATING LIMB SPASTICITYIPSEN BIOPHARM LIMITED
WO/2021/186162HYBRID INTERFERONS FOR TREATING VIRAL INFECTIONSILC THERAPEUTICS LIMITED
WO/2021/209739METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR  TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCYMEREO BIOPHARMA 4 LIMITED
WO/2021/186166GLP RECEPTOR AGONISTSHEPTARES THERAPEUTICS LIMITED
WO/2021/209740METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR  TREATING CORONAVIRUS INFECTIONMEREO BIOPHARMA 4 LIMITED
WO/2021/186167TREATMENT OF UPPER FACIAL LINESIPSEN BIOPHARM LIMITED
WO/2021/186169ORAL GLP RECEPTOR AGONISTSHEPTARES THERAPEUTICS LIMITED
WO/2021/186180IMIDAZOLYL THIOPEHENE SULFONYL CARBAMATES FOR USE IN THE  TREATMENT OF DISEASES ASSOCIATED WITH ANGIOTENSIN IIVICORE PHARMA AB
WO/2021/191592NEW USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONISTVICORE PHARMA AB
WO/2021/191630CORONAVIRUS VACCINEIMPERIAL COLLEGE INNOVATIONS LIMITED
WO/2021/198675CANCER THERAPY WITH MICROBUBBLES.INNOVATION ULSTER LIMITED
WO/2021/198684POLYPEPTIDES DERIVED FROM THE C-TERMINUS OF  ACETYLCHOLINESTERASE FOR USE IN SKIN CONDITIONSNEURO-BIO LTD
WO/2021/198686CYCLIC PEPTIDES FROM THE C-TERMINUS OF ACETYLCHOLINESTERASE  FOR TREATMENT OF SKIN DISORDERS AND FOR COSMETICAL USENEURO-BIO LTD
WO/2021/198691SODIUM BUTYRATE FOR USE IN THE PREVENTION OR TREATMENT OF  RHINOVIRUS INFECTIONEDINBURGH NAPIER UNIVERSITY
WO/2021/198694NOVEL FORMULATIONSARECOR LIMITED
WO/2021/198701INFLUENZA VACCINESDIOSYNVAX LTD
WO/2021/198705CORONAVIRUS VACCINEPEPTC VACCINES LIMITED
WO/2021/205153NEW USE OF <i>N,N-</i>BIS-2-MERCAPTOETHYL  ISOPHTHALAMIDEEMERAMED LIMITED
WO/2021/205161BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TSLPBICYCLETX LIMITED
WO/2021/205172CELLAUTOLUS LIMITED
WO/2021/205173METHODAUTOLUS LIMITED
WO/2021/205185PHARMACEUTICAL FORMULATIONSBLUE EARTH DIAGNOSTICS LTD
WO/2021/209762INJECTABLE OIL-BASED PHARMACEUTICAL COMPOSITIONNANEXA AB
WO/2021/214439METHODS AND COMPOSITIONS FOR TREATING AND COMBATTING  TUBERCULOSISTHIRTY RESPIRATORY LIMITED
WO/2021/214440NITRIC OXIDE OR NITRIC OXIDE RELEASING COMPOSITIONS FOR USE IN  TREATING SARS-COV AND SARS-COV-2THIRTY RESPIRATORY LIMITED
WO/2021/214451TREATMENT OF PULMONARY FIBROSISNOORDEEN, Mohamed Hamza
WO/2021/214462TRANSFECTION AND TRANSDUCTION SYSTEMN4 PHARMA UK LIMITED
WO/2021/214467A DIAGNOSTIC TOOL IMPROVEMENT COMPRISING A PATHOGEN BINDING  MOLECULECELLBIO
WO/2021/214475NEW USESAIVIVO LTD
WO/2021/214486NEW CAPSULE COMPOSITION FOR PERORAL ADMINISTRATIONVICORE PHARMA AB
WO/2021/214487NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATIONVICORE PHARMA AB
WO/2021/214488NEW DRY POWDER COMPOSITION FOR PERORAL ADMINISTRATIONVICORE PHARMA AB
WO/2021/214492METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION  OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATORBERGENBIO ASA
WO/2021/214494INTERLEUKIN INHIBITORSUNIVERSITY OF GREENWICH
WO/2021/214495DIAZINE AND TRIAZINE COMPOUNDS TO TREAT CYTOKINE STORM  SYNDROMEUNIVERSITY OF GREENWICH
WO/2021/219990T CELL THERAPYACHILLES THERAPEUTICS UK LIMITED
WO/2021/220011ANTI-INFECTIVE BICYCLIC PEPTIDE CONJUGATESBICYCLETX LIMITED
WO/2021/2200125-(1H-INDOL-3-YL)-OXAZOLE, -OXADIAZOLE AND -FURAN DERIVATIVES  AS ENHANCERS OF SPERM MOTILITYSPERMATECH AS
WO/2021/224618DISSOLVABLE HYDROGEN PEROXIDE TEETH WHITENING STRIP OR FILMBIOFILM LIMITED
WO/2021/224629CELLAUTOLUS LIMITED
WO/2021/224634VITAMIN A FOR USE IN THE TREATMENT OF TRAUMATIC BRAIN INJURYNOORDEEN, Mohamed Hamza
WO/2021/224641DOSAGE REGIMEN OF AMLODIPINECLOSED LOOP MEDICINE LTD
WO/2021/229212MODIFIED IPSCSADAPTIMMUNE LIMITED
WO/2021/229218METHODAUTOLUS LIMITED
WO/2021/229234METHOD OF TREATMENT OF CANCER OR TUMOURADAPTIMMUNE LIMITED
WO/2021/229237CYCLOSPORINE ANALOGUESUCL BUSINESS LTD
WO/2021/234362TOPICAL DISULFIRAM FOR TREATING VIRAL INFECTIONSUNIVERSITY OF WOLVERHAMPTON
WO/2021/234366NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERYOREXO AB
WO/2021/234386FORMULATION COMPRISING A PROTEINACEOUS MICROGELUNIVERSITY OF LEEDS
WO/2021/234391BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 AND USES  THEREOFBICYCLETX LIMITED
WO/2021/234407IBUPROFEN-CONTAINING SOFT GELATIN CAPSULESRECKITT BENCKISER HEALTH LIMITED
WO/2021/234408NOVEL FORMULATIONRECKITT BENCKISER HEALTH LIMITED
WO/2021/234409IBUPROFEN CONTAINING SOFT GELATINE CAPSULERECKITT BENCKISER HEALTH LIMITED
WO/2021/234412ANTIMICROBIAL MATERIALCOPPER CLOTHING LIMITED
WO/2021/240145ANTI-VIRAL THERAPYNOVABIOTICS LIMITED
WO/2021/240155ANTIBODY-DRUG CONJUGATESSPIREA LIMITED
WO/2021/240163COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OR  PREVENTION OF HAIR LOSSCHOPRA, Sunil
WO/2021/250402COMPOSITION FOR TREATMENT OF FRAGILE X SYNDROMEHEALX LTD
WO/2021/250421FLUID GEL COMPOSITIONSTHE UNIVERSITY OF BIRMINGHAM
WO/2021/250422FLUID GEL COMPOSITIONSTHE UNIVERSITY OF BIRMINGHAM
WO/2021/250423POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELSTHE UNIVERSITY OF BIRMINGHAM
WO/2021/255420ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE,  PIOGLITAZONE OR ROSIGLITAZONETHE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/255432JELLYFISH COLLAGEN USEJELLAGEN PTY LTD
WO/2021/255438COMBINATION OF DEXAMETHASONE AND A MINERALOCORTICOID RECEPTOR  ANTAGONIST FOR USE IN THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROMEIMAGINATIVES GROUP LIMITED
WO/2021/255440ULTRASOUND-SENSITIVE BIODEGRADEABLE MULTI-CAVITY MICRO-  PARTICLESOXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/255441BIODEGRADABLE MULTI-CAVITY MICROPARTICLES AND THEIR USE IN  TREATMENTOXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/255446USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSYGW RESEARCH LIMITED
WO/2021/255457SKINCARE FORMULATIONCREIGHTONS PLC
WO/2021/255464NUTRACEUTICAL COMPOSITIONHAHN, Norman
WO/2021/255472ANTIMICROBIAL COMBINATIONSMARVELBIOTICS LIMITED
WO/2021/255474TOOTH WHITENING AND TOOTH SENSITIVITY STRIP OR FILMBIOFILM LIMITED
WO/2021/255483COMPOSITION FOR TOPICAL DERMATOLOGICAL DELIVERYLIMEWAY PHARMA DESIGN LIMITED
WO/2021/260379THERAPEUTICS FOR THE TREATMENT OF FSHDUCL BUSINESS LTD
WO/2021/260387MMP-9 AND MMP-12 INHIBITION FOR TREATING SPINAL CORD INJURY OR  RELATED INJURY TO NEUROLOGICAL TISSUETHE UNIVERSITY OF BIRMINGHAM
WO/2021/260390THERAPEUTIC TREATMENT USING PROTEIN KINASE C (PKC) INHIBITORS  AND CYTOTOXIC AGENTSCAMBRIDGE ENTERPRISE LIMITED
WO/2021/260391NATURAL PLANT BASED DELIVERY SYSTEMUNIVERSITY OF HUDDERSFIELD
WO/2021/058987NON RINSABLE MIXTURES FOR CARING ANIMALS WITH GOLD  NANOPARTICLESPLIN - NANOTECHNOLGY S.A.
WO/2021/240183PREPARATION METHOD OF A COLLOIDAL SYSTEM OF STABILISATION AND  CONTOLLED RELEASE OF ROYAL JELLY COMPONENTS FOR VARIOUS USESAPIVITA S.A.
WO/2021/094792METHOD FOR THE DEVELOPMENT OF A DELIVERY PLATFORM TO PRODUCE  DELIVERABLE PTD-IVT-mRNA THERAPEUTICSARISTOTLE UNIVERSITY OF THESSALONIKI E.L.K.E.
WO/2021/229247FENDILINE AGAINST NEURODEGENERATIVE OR NEURODEVELOPMENTAL  DISEASES, CANCER OR COVID 19 PROLIFERATIONVAMVAKIDES, Alexandre
WO/2021/245432NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF COVID-19  PATIENTS, SEPSIS AND HYPOXEMIABIOHELLENIKA S.A.
WO/2021/214497PHARMACEUTICAL COMPOSITION COMPRISING L-TRIIODOTHYRONINE (T3)  FOR USE IN THE TREATMENT OF TISSUE HYPOXEMIA AND SEPSISUNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A.
WO/2021/009525MEDICINAL AND/OR PHARMACEUTICAL COMPOSITIONS FOR INTRAVESICAL  INSTILLATION, PREPARATION AND USE THEREOFLOVáSZ, Sándor
WO/2021/024005MONOAMINE OXIDASE B INHIBITORS FOR USE IN THE PREVENTION OR  TREATMENT OF PROSTATE CARCINOMATOXIE EUROPE INTELLIGENS KéMIAI SZENZOROKAT KUTATó, FEJLESZTŐ  KORLáTOLT FELELŐSSéGŰ TáRSASáG
WO/2021/069941APPARATUS FOR OPENING AND CLOSING OF TWO-PART MATERIAL  CONTAINERS, PREFERABLY CAPSULESHADAS, Tamás
WO/2021/130509ICAN DERIVATIVES FOR ANTIFUNGAL USEDEBRECENI EGYETEM
WO/2021/220022URINARY ALKALIZING MEDICINAL AND/OR PHARMACEUTICAL COMPOSITION  FOR THE ORAL TREATMENT OF INTERSTITIAL CYSTITIS / BLADDER PAIN SYNDROME  (IC/BPS) AND FORMULATION THEREOFLOVáSZ, Sándor
WO/2021/191643COMPOSITIONS COMPRISING DEUTERIUM DEPLETED WATER FOR THE  NORMALIZATION OF LEPTIN CONCENTRATION IN THE BODY SYSTEMHYD RáKKUTATó éS GYóGYSZERFEJLESZTŐ KFT.
WO/2021/224646METHOD FOR THE TREATMENT OF RNA VIRUS INVOLVED DISEASESTURNSOLE BIOLOGICS LLC.
WO/2021/224648METHOD OF MODIFYING THE DRUG RELEASE RATE OF A POLYMERIC  CARRIER CONTAINING AN ACTIVE SUBSTANCE AND A PHARMACEUTICAL PRODUCT  COMPRISING A POLYMERIC CARRIER CONTAINING AN ACTIVE SUBSTANCE TREATED BY SAID  METHODKOVáCS, Zsolt
WO/2021/240187BENZAMIDE DERIVATIVES AS ANTI-INFLAMMATORY COMPOUNDS AND USES  THEREOFSEMMELWEIS EGYETEM
WO/2021/048577OIL-IN- WATER EMULSION GEL COMPOSITIONL V M H RECHERCHE
WO/2021/033003HORMONE D (VITAMIN D) AND ITS DERIVATIVES FOR THE TREATMENT  AND PREVENTION OF CANCERINDUSTRIAL TECHNOLOGIES & BIOTECHNOLOGIES
WO/2021/019268METHODS FOR TREATING TUMORSNH THERAGUIX
WO/2021/069944PHARMACEUTICAL COMPOSITION COMPRISING MIRABEGRON AND PROCESS  FOR MANUFACTURING THE SAMEALVOGEN KOREA CO., LTD.
WO/2021/058990MIDAZOLAM IN FLEXIBLE BAGSINFORLIFE SA
WO/2021/044183ANTI-CANCER AGENTISHII, Hitoshi
WO/2021/014184READY-TO-ADMINISTER FENTANYL FORMULATIONSHIKMA PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/105733PHAGE-RESISTANT MICROORGANISMSMIRELES, Ivan Alejandro De La, Peña
WO/2021/123857OIL-IN-WATER EMULSIFIED COSMETICL V M H RECHERCHE
WO/2021/123859OILY SOLID COSMETICL V M H RECHERCHE
WO/2021/123860WATER-IN-OIL EMULSIFIED COSMETIC COMPOSITIONL V M H RECHERCHE
WO/2021/123861OIL-IN-WATER EMULSIFIED COSMETICL V M H RECHERCHE
WO/2021/019278ENHANCING DRUG ACTIVITY THROUGH ACCENTUATED BUCCAL/SUBLINGUAL  ADMINISTRATIONBANERJEE, Debasish
WO/2021/024028HERBAL MEDICATION FOR ERADICATION OF HELICOBACTER PYLORI  INFECTION AND TREATMENT OF FUNCTIONAL GASTROINTESTINAL DISORDERSBORDBAR, Ghasem
WO/2021/038283AUTOANTIGENIC PEPTIDES (CALVICIFIV), PRESENTED BY TOLEROGENIC  DENTRITIC CELLS, USEFUL FOR THE PERSONALIZED TREATMENT OF RHEUMATOID  ARTHRITISUNIVERSIDAD DE CHILE
WO/2021/048595A METHOD FOR PREVENTING HUMAN VIRUS ASSOCIATED DISORDERS IN  PATIENTSNOVARTIS AG
WO/2021/033020ALKALI METAL SALT OF CARBOXYALKYL ETHER OF TAMARIND GUM WITH  IMPROVED COMPOSITIONTANNA, Raj Mahendra
WO/2021/105742AN IMPROVED PROCESS FOR THE PREPARATION OF PREGABALINHIKAL LIMITED
WO/2021/111172A COLLAGEN-HYDROXYAPATITE DEVICE FOR NON-SURGICAL PERIODONTAL  TREATMENTDATUM DENTAL LTD.
WO/2021/094820METHOD OF MANUFACTURING ZINC OXIDE NANOPARTICLESPOLITECHNIKA KRAKOWSKA IM. TADEUSZA KOŚCIUSZKI
WO/2021/123874CANNABINOID COMPOSITIONS WITH HIGH SOLUBILITY AND  BIOAVAILABILTYPISAK, Mehmet Nevzat
WO/2021/053383METHOD FOR PREVENTING PROGRESSION TO METABOLIC SYNDROMEDASMAN DIABETES INSTITUTE
WO/2021/090054GUT-PROTECTIVE COMPOSITIONS COMPRISING BOSWELLIC ACIDINVENTIA HEALTHCARE LIMITED
WO/2021/198715REGIMEN FOR TREATING A NEISSERIA GONORRHOEAE INFECTION WITH  GEPOTIDACINGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/229255TOOLS AND METHOD FOR PREVENTING A A￥ NEUTRALIZATION BY  ANTIBODIESGENETHON
WO/2021/019295SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASISREMMEREIT, Jan
WO/2021/014217ARTICLES COMPRISING STEROID DIMERS AND THEIR USE IN THE  DELIVERY OF THERAPEUTIC AGENTSRIPPLE THERAPEUTICS CORPORATION
WO/2021/048610ANTIBIOTIC COMBINATION THERAPIESBIOVERSYS AG
WO/2021/048611RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONSBIOVERSYS AG
WO/2021/048612RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONSBIOVERSYS AG
WO/2021/044208ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN  ROR1, AND USE FOR THE SAMELEGOCHEM BIOSCIENCES, INC.
WO/2021/038289COMPOSITIONS FOR MONOCYTE AND MACROPHAGE POLARIZATION AND  METHODS OF USEORBSEN THERAPEUTICS LIMITED
WO/2021/048626COMPOSITIONS FOR THE TREATMENT OF SOLID TUMORSRAZIEL THERAPEUTICS LTD.
WO/2021/053389METHODS OF TREATING EPILEPTIC PATIENTS WITH FENFLURAMINEZOGENIX INTERNATIONAL LIMITED
WO/2021/053397COSMETIC OR DERMATOLOGICAL COMPOSITION FOR CLEANSING AND/OR  REMOVING MAKE-UP, COMPRISING SUCCINIC ACID FOR PREVENTING, REDUCING OR  ELIMINATING SKIN IMPERFECTIONS, TREATING SKIN DISORDERS AND PREVENTING,  TREATING AND COMBATING HYPER-SEBORRHEIC CONDITIONS OF THE SCALP.ROQUETTE FRERES
WO/2021/105761COMPOSITIONS AND THEIR USES FOR TREATING CANCERSINSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE  (INSERM)
WO/2021/053400DMSO-FREE SYNTHESIS OF OLIGOPEPTIDE-MODIFIED POLY(BETA-AMINO  ESTER)S AND THEIR USE IN NANOPARTICLE DELIVERY SYSTEMSARATINGA.BIO TNP
WO/2021/074689IMMUNOMODULATORY IL-2 AGENTS IN COMBINATION WITH IMMUNE  CHECKPOINT INHIBITORSALKERMES PHARMA IRELAND LIMITED
WO/2021/079188COMBINATION THERAPIES WITH VENETOCLAX AND TIM-3 INHIBITORSNOVARTIS AG
WO/2021/090058METERED DOSE FOR DEMODEX AND DISORDERS RELATED THERETOAZURA OPHTHALMICS LTD.
WO/2021/090061METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE  CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN  INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITORRESVERLOGIX CORP.
WO/2021/094827USE OF BISANTRENE TO TREAT MEASURABLE RESIDUAL DISEASE IN  ACUTE MYELOID LEUKEMIARACE ONCOLOGY LTD.
WO/2021/090067COMPOSITIONS AND METHODS FOR PRODUCING A VIRAL VACCINE WITH  REDUCED PARTICLE SIZESEQIRUS UK LIMITED
WO/2021/079195TIM-3 INHIBITORS AND USES THEREOFNOVARTIS AG
WO/2021/090069METHODS AND COMPOSITIONS FOR USE OF GROWTH FACTOR ANTIBODIES  IN COMBINATION WITH NON-TYROSINE TARGETING KINASE INHIBITORSIN3BIO LTD.
WO/2021/090070METERED DOSE FOR DISORDERS IN OR AROUND THE EYEAZURA OPHTHALMICS LTD.
WO/2021/111185COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATIONINTOCELL, INC.
WO/2021/130532PROCESS FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING  MICRO PARTICLESSUNSTAR INC.
WO/2021/123908CAR-T CELL THERAPY TARGETING NGCGM3LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
WO/2021/255492DRUG COMPRISING PLGA NANOPARTICLES LOADED WITH CAPE TARGETED  WITH ANGIOPEP-2 PEPTIDEYILDIZ TEKNIK üNIVERSITESI
WO/2021/136968MANUFACTURING OF SELENIUM DISULFIDE COMPOSITIONSAZURA OPHTHALMICS LTD.
WO/2021/205196COMPOSITIONS AND PREVENTION AND INTERVENTION METHODS FOR  COVID-19 WITH DIVINE AYATS' FITRA30 COVID-19 PROTOCOLMUHAMMAD, Taliah
WO/2021/130541TRANSDERMAL SIRNA DELIVERY COMPOSITION AND USE THEREFORXIAMEN UNIVERSITY
WO/2021/148845OPHTHALMIC COMPOSITION FOR THE TREATMENT OF DRY EYE DISEASEVISUFARMA S.P.A.
WO/2021/161064CORE/SHELL MICROCAPSULES AND A METHOD FOR THE FABRICATION OF  CORE/SHELL MICROCAPSULESPOLITECHNIKA WARSZAWSKA
WO/2021/001694CONSTRUCTIVE ARRANGEMENT APPLIED TO SURGICAL FIELD FOR  CESAREAN DELIVERYCLíNICA MéDICA TRINA LTDA
WO/2021/009572AEROSOL FORMULATION, CANISTER AND INHALER CONTAINING THE  FORMULATION, AND METHOD OF USEKINDEVA DRUG DELIVERY L.P.
WO/2021/176257COMPOSITION FOR USE AS A MEDICAMENT FOR THE TREATMENT OF  SUDDEN ATTACKS OF COVID-19 AND OTHER PATHOGENIC EPIDEMICS, SERA SET AND  METHOD FOR IDENTIFYING VIRAL ANTIGENS AND EFFECTIVE ANTIBODIESLAW, Peter K.
WO/2021/181132METHOD OF ACTIVATION OF A SONOSENSITIZING AGENTPOLITECNICO DI TORINO
WO/2021/181139METHODS AND COMPOSITIONS FOR TREATMENT OF LUNG CANCERINNOPHARMASCREEN, INC
WO/2021/009573AEROSOL FORMULATION, CANISTER AND INHALER CONTAINING THE  FORMULATION, AND METHOD OF USEKINDEVA DRUG DELIVERY L.P.
WO/2021/191652COMPOSITION AND METHODS FOR PREVENTION AND TREATMENT OF  VASCULAR DISORDERSJAFARI JAVID, Mihan
WO/2021/198725FOSALVUDINE AND FOZIVUDINE TIDOXIL FOR USE IN THE TREATMENT OF  COVID-19, AND USE OF THE STRUCTURALLY SIMPLIFIED DERIVATIVES THEREOFCHIRACON GMBH
WO/2021/198739NOVEL MEDICINAL COMPOUND FOR COMBATING VIRAL INFECTIONS LIKE  CORONA VIRUS INFECTION AND METHOD OF MITIGATING THE CONDITIONSRANAWEERA, Ananda Sarath
WO/2021/198740METHOD FOR OBTAINING ANTIOXIDANTS, DIET FIBER, AND OTHER  NUTRIENTS FROM PLANT BY-PRODUCTSASESORíA, INVESTIGACIóN Y PRODUCCIóN DE ALIMENTOS MAURICIO  ANDRéS POBLETE BUSTAMANTE EIRL
WO/2021/198745DRUG FOR PREVENTION OR TREATMENT OF IRRITABLE BOWEL SYNDROME  OR INFLAMMATORY BOWEL DISEASEANTONIOLI, Luca
WO/2021/059027SUSTAINED RELEASE FORMULATION CONTAINING ASPALATHUS LINEARIS  EXTRACTCAPE PENINSULA UNIVERSITY OF TECHNOLOGY
WO/2021/224659PHARMACEUTICAL COMPOSITION AND KIT-OF-PARTS FOR USE AGAINST  INFECTIONS CAUSED BY CORONAVIRUSESARISTIZABAL BERNAL, Beatriz Helena
WO/2021/224664APPLICATION OF DALARGIN FOR THE PREVENTION OF VRIS AND  PREVENTION OF THE DEVELOPMENT OF COMPLICATIONS DURING VRISPVP LABS PTE. LTD.
WO/2021/229270RECOMBINANT VACCINE AGAINST COVID-19 IN A VIRAL VECTORLABORATORIO AVI-MEX, S.A. DE C.V.
WO/2021/234429PERSIAN GULF BROWN ALGAE, SALVADORA PERSICA MICROPARTICLE AND  PURSLANE EXTRACT AS HERBAL TOOTHPASTERAZMPOUR, Farkhondeh
WO/2021/234430MODIFIED RELEASE DOSAGE FORM COMPRISING VILDAGLIPTIN AND  PROCESS FOR MANUFACTURING THE SAMELOTUS INTERNATIONAL PTE. LTD.
WO/2021/191664A METHOD AND COMPOSITION FOR TREATING COVID-19SOLANKE, Rekha Vijaysing
WO/2021/240204SPERM HEAD FOR RESOLUTION OF INFLAMMATION, TISSUE REPAIR &  REGENERATION, AND RESTORATION OF TISSUE FUNCTION: NEW APPROACH OF CELL  THERAPYPAKRAVAN, Nafiseh
WO/2021/240206ENZALUTAMIDE FORMULATIONLOTUS INTERNATIONAL PTE. LTD.
WO/2021/123925HERBAL COMPOSITIONS AND ADMINISTRATION METHODS FOR THE  TREATMENT OF INFECTIONS AND INFLAMMATION OF VULVOVAGINAL AND THE PELVIC  ORGANSBANOOYE ARMAGHAN TEB
WO/2021/229278<i>CONCENTRATED LIQUID NON-STEROIDAL ANTIANDROGEN  SOLUTION AND METHOD FOR PREPARING THE SOLUTION</i>NOVOCAP S.A
WO/2021/260409PHARMACEUTICAL COMPOSITION FOR SARS-COV-2 PREVENTION AND/OR  TREATMENTAHMED MAHMOUD METWALLY ALKHATIP, Ahmed Abdelaal
WO/2021/038318HERBAL COMPOSITION FOR REDUCING FAT, SUGAR, ARSENIC, GLUTEN  AND GLYCEMIC INDEX OF NATURAL FOODMR. N. M., Sasi Kumar
WO/2021/005436COMBINATION THERAPY OF GPR119 AGONISTS AND DPP-4 INHIBITORSMANKIND PHARMA LTD.
WO/2021/176263TOPICAL FORMULATIONS CONTAINING MTOR INHIBITORSSHANGHAI AUCTA PHARMACEUTICALS CO., LTD.
WO/2021/001728PROCESS FOR PREPARATION OF EDOXABANGLENMARK LIFE SCIENCES LIMITED
WO/2021/186231AN INSTANTLY SEMI-SOLID DERMAL PRODUCT MANUFACTURING METHOD  BASED ON A FRESH EXTRACT AND AN APPARATUS THEREOFKHORI, Vahid
WO/2021/209800TREATMENT FOR HUMAN INFECTION FROM CORONA VIRUS AND INFLUENZA  VIRUS (H1N1) (PIGS FLU.)ELHAYESH, Mohamed Khairy Abd Ellatif
WO/2021/001743TRANSLATION INHIBITORS AND USES THEREOFEFFECTOR THERAPEUTICS, INC.
WO/2021/009595CYCLOPHOSPHAMIDE INJECTABLE COMPOSITION AND METHODS FOR  PRODUCING SAMEHETERO HEALTHCARE LIMITED
WO/2021/009605DISPERSIBLE TABLETS OF ABIRATERONE ACETATESHILPA MEDICARE LIMITED
WO/2021/001789THERAPEUTIC USES OF OXIDISING HYPOTONIC ACID SOLUTIONSAPR APPLIED PHARMA RESEARCH, S.A.
WO/2021/005478COMPRESSED MACITENTAN COMPOSITIONS, METHODS AND USES THEREOFTECNIMEDE - SOCIEDADE TéCNICO-MEDICINAL, SA
WO/2021/001804ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASECADILA HEALTHCARE LIMITED
WO/2021/005483EXTRACTION OF ANIMAL-DERIVED PULMONARY SURFACTANTSMAHBOUDI, Fereidoun
WO/2021/001805STABLE DIPYRIDAMOLE FORMULATIONS AND THEIR METHODS OF  PREPARATIONOCULAR DISCOVERY LTD.
WO/2021/001806STABLE DIPYRIDAMOLE FORMULATIONS WITH REDUCED IMPURITIESOCULAR DISCOVERY LTD.
WO/2021/005493CGRP ANTAGONISTS AND BOTULINUM TOXINS FOR THE TREATMENT OF  INFLAMMATORY AND NEUROLOGIC DISORDERSALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/005494CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT  OF NEUROPSYCHIATRIC AND NEUROLOGICAL DISORDERSALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/005497CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT  OF CORTICAL SPREADING DEPRESSION ASSOCIATED DISORDERSALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/005500STABLE FORMULATIONS OF RECOMBINANT PROTEINSUNICHEM LABORATORIES LTD
WO/2021/005501NALTREXONE FORMULATIONINTAS PHARMACEUTICALS LTD.
WO/2021/005541ADMINISTRATION OF STING AGONIST AND CHECKPOINT INHIBITORSTAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/005544STABLE ORAL COMPOSITION OF CYCLOPHOSPHAMIDEINTAS PHARMACEUTICALS LTD.
WO/2021/009623LIQUID FORMULATION, IN PARTICULAR TO TREAT A CORNEAL TISSUEVISION ENGINEERING ITALY SRL
WO/2021/005549A PROCESS FOR ISOLATING S-ISOMER CRYSTALS OF INDOXACARBGHARDA CHEMICALS LIMITED
WO/2021/005562EMOLLIENT HUMECTANT FORMULATION COMPRISING SYNTHETIC WAX  ESTERS BASED ON PALM OILZUÑIGA, Rafael
WO/2021/009633SYNTHETIC CHROMATIN VACCINEMASSEY UNIVERSITY
WO/2021/009640THERAPEUTIC POTENTIAL OF CURCUMIN/CYCLODEXTRIN/CELLULOSE  NANOCRYSTALS IN THE TREATMENT OF PERIPHERAL NEUROPATHIESUNIVERSITE DE LIMOGES
WO/2021/009658COMPOSITIONS FOR TREATMENT OF ASHERMAN'S SYNDROME, METHODS FOR  PREPARING THE SAME AND APPLICATIONS THEREOFPALANIVEL, Vasanthi
WO/2021/009659COMPOSITIONS FOR TREATMENT OF ERECTILE DYSFUNCTION, METHODS  FOR PREPARING THE SAME AND APPLICATIONS THEREOFPALANIVEL, Vasanthi
WO/2021/009660COMPOSITION AND METHODS FOR IMPROVING THICKNESS AND  RECEPTIVITY OF ENDOMETRIAL LININGPALANIVEL, Vasanthi
WO/2021/009661COMPOSITIONS AND METHODS FOR MANAGING FEMALE INFERTILITYPALANIVEL, Vasanthi
WO/2021/009662COMPOSITIONS FOR TREATMENT OF INFERTILITY CAUSED BY POOR SEMEN  QUALITY, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOFPALANIVEL, Vasanthi
WO/2021/009663COMPOSITIONS FOR TREATMENT OF AZOOSPERMIA, METHODS FOR  PREPARING THE SAME AND APPLICATIONS THEREOFPALANIVEL, Vasanthi
WO/2021/009664METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION WITH LIVER X  RECEPTOR AGONISTSNOVARTIS AG
WO/2021/009684MODIFIED AAV CAPSID PROTEINS FOR TREATMENT OF ARTHRITIC  DISEASEMEIRAGTX UK II LIMITED
WO/2021/014275ORODISPERSIBLE POWDER COMPOSITION COMPRISING A TRIPTANBIOPHARMA SYNERGIES, S.L.
WO/2021/009686PHARMACEUTICAL COMPOSITION OF IMATINIBINTAS PHARMACEUTICALS LTD.
WO/2021/024057POLYLYSINE POLYMERS WITH ANTIMICROBIAL AND/OR ANTICANCER  ACTIVITYINTERNATIONAL BUSINESS MACHINES CORPORATION
WO/2021/009692TRIPARTITE SYSTEMS FOR PROTEIN DIMERIZATION AND METHODS OF USEMEDIMMUNE LIMITED
WO/2021/009694FUNCTIONAL BINDERS SYNTHESIZED AND SECRETED BY IMMUNE CELLSNATIONAL UNIVERSITY OF SINGAPORE
WO/2021/009695FORMULATIONS OF  (S)-3-AMINO-6-METHOXY-N-(3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPYL)-5-(TRIFLUOROMETHYL)PICOLINAMIDENOVARTIS AG
WO/2021/009700PHARMACEUTICAL COMPOSITION OF TEMOZOLOMIDE.INTAS PHARMACEUTICALS LTD.
WO/2021/019350COMPOSITION AND METHODS FOR THE TREATMENT OF ANAL AND RECTAL  DISORDERSCELLIX BIO PRIVATE LIMITED
WO/2021/014292COSMETIC PRODUCT, PACKAGING AND PREPARATION PROCEDUREIKA S.R.L.
WO/2021/009706CROCIN-SORAFENIB COMBINATION THERAPY FOR LIVER CANCERUNITED ARAB EMIRATES UNIVERSITY
WO/2021/028743NUTRITIONAL COMPOSITIONS FOR MANAGEMENT OF IRRITABLE BOWEL  DISEASE/SYNDROME AND IMPROVE GUT HEALTHJEYAKODI, Shankaranarayanan
WO/2021/014348PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS  FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONSNICOX OPHTHALMICS, INC.
WO/2021/014349TREATMENT COMPRISING FXR AGONISTSNOVARTIS AG
WO/2021/014350COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTSNOVARTIS AG
WO/2021/014351TREATMENT COMPRISING SGLT INHIBITORS, E.G. SGLT 1/2 INHIBITORSNOVARTIS AG
WO/2021/014356FOAM COMPOSITIONS FOR WOUND TREATMENT, SYSTEMS OF DELIVERY,  AND METHODS OF USEKCI LICENSING, INC.
WO/2021/014360ORAL MODIFIED RELEASE DOSAGE FORMSPFIZER INC.
WO/2021/014368METHOD OF PRODUCING CAR-T CELLS, NUCLEIC ACID-INTRODUCING  CARRIER AND KITKABUSHIKI KAISHA TOSHIBA
WO/2021/014370PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND  PREVENTION OF MOTION SICKNESSZANOTTI, Eros
WO/2021/014372BROMOCRIPTINE FOR USE IN TREATING EYE DISEASES ASSOCIATED WITH  ELEVATED LEVEL OF VEGF AND A PHARMACEUTICAL COMPOSITION COMPRISING  BROMOCRIPTINEOSEKA, Maciej
WO/2021/014376A WATER-IN-OIL EMULSION WITH EMOLLIENT AND METHODS OF USING  THE SAMESHISEIDO COMPANY, LTD.
WO/2021/019375KV1.3 ANTAGONISTS FOR USE IN THE TREATMENT OF CHRONIC AND  ACUTE PAINSEA4US - BIOTECNOLOGIA E RECURSOS MARINHOS, LDA.
WO/2021/014395PROCESS FOR THE SYNTHESIS OF DEUTERATED CAPSAICIN,  CAPSAICINOIDS AND SYNTHETIC CAPSAICIN ANALOGSDR. REDDY’S INSTITUTE OF LIFE SCIENCES
WO/2021/014398INTEGRATED HUMAN CYTOMEGALOVIRUS / GLIOBLASTOMA VACCINEUNIVERSITY OF RIJEKA FACULTY OF MEDICINE
WO/2021/240225IMMUNITY BOOSTER PRODUCT FOR PATIENTS OF COVID-19NATUREVIVE IINNOVATION PRIVATE LIMITED
WO/2021/014407PRESSED POWDER COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/019395FOOD SUPPLEMENT, FOR USE AS ADJUVANT, FOR PREVENTING VASCULAR  DEMENTIACRISTALFARMA S.R.L.
WO/2021/014420USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2  DIABETES MELLITUS AND MODERATE RENAL IMPAIRMENTLEXICON PHARMACEUTICALS, INC.
WO/2021/014422INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN TUNIVERSITà DEGLI STUDI DI ROMA "LA SAPIENZA"
WO/2021/014426A COMPOSITION COMPRISING SIMETHICONE AND SUCROSE ESTERS AND  USE THEREOF AS AN ANTIFOAM AGENTS.I.I.T. S.R.L. - SERVIZIO INTERNAZIONALE IMBALLAGGI  TERMOSALDANTI
WO/2021/161084N-(4-FLUOROPHENYL)-5-PHENYL-[1,2,4] TRIAZOLO [1,5-A]  PYRIDINE-2-CARBOXAMIDE DERIVATIVES AND THEIR SYNTHESIS THEREOFNINGEGOWDA, Raghu
WO/2021/019421ASCORBATE IN THE PREVENTION OF STATIN INDUCED VASCULAR  CALCIFICATIONRATH, Matthias
WO/2021/028752ANTI-TFN ANTIBODIES FOR TREATING TYPE I DIABETESJANSSEN BIOTECH, INC.
WO/2021/019434COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF  SYMPTOMS RELATED TO TIREDNESS AND FATIGUENEILOS S.R.L.
WO/2021/024101PHARMACEUTICAL COMPOSITION OF S1PR MODULATORSUNIVERSITà DEGLI STUDI DI FIRENZE
WO/2021/024105TULOBUTEROL TRANSDERMAL PATCH AND IT'S PROCESSAZISTA INDUSTRIES PVT LTD
WO/2021/019464USES OF DAN FAMILY BMP ANTAGONISTS FOR INHIBITING OCULAR  NEOVASCULARIZATION AND TREATING OCULAR CONDITIONS9636137 CANADA INC.
WO/2021/019479NEW FORMULATIONS OF AMISULPRIDELABORATORI BALDACCI S.P.A.
WO/2021/024108ORAL ANTI-HYPERGLYCEMIC FORMULATIONDOUND, Yogesh
WO/2021/019493PHARMACEUTICAL COMPOSITION COMPRISING HMG-COA REDUCTASE  INHIBITORS AND FENOFIBRATEINTAS PHARMACEUTICALS LTD.
WO/2021/019499SOLID ORAL MULTIPLE-UNIT IMMEDIATE RELEASE COMPOSITIONS,  METHODS AND USES THEREOFTECNIMEDE - SOCIEDADE TéCNICO-MEDICINAL, SA
WO/2021/044231COMPOUNDS COMPRISING CURCUMIN AND BASIC AMINO ACIDSALPARIS, S.A. DE C.V.
WO/2021/019506MULTIPARTICULATE MICROPARTICLE CONTROLLED RELEASE FORMULATION  COMPRISING COMBINATION OF AMINO ACIDS AND PHYTOCOMPOUNDVETAGRO INTERNATIONAL S.R.L.
WO/2021/024141PREVENTION OR TREATMENT OF DISEASES AND DISORDERS ASSOCIATED  WITH TISSUE DAMAGELI, Xiaoxiang
WO/2021/024150PROCESS FOR THE PREPARATION OF ANTHRAQUINONE TOPICAL  FORMULATIONNEUHEIT PHARMA TECHNOLOGIES PVT. LTD
WO/2021/028772CHOLECALCIFEROL FOR USE IN THE TREATMENT OF CELIAC DISEASEABIOGEN PHARMA SPA
WO/2021/024158TREATMENT FOR ALL CANCERSBROMLEY, Peter
WO/2021/024170INCREASING CANCER CELLS' SENSITIVITY TO TUMOR TREATING FIELDS  (TTFIELDS) BY INHIBITING IL11 ACTIVITYVOLOSHIN-SELA, Tali
WO/2021/024191COMBINATION TREATMENTS WITH BENZODIAZEPINONE COMPOUNDS AND  PHOSPHOINOSITIDE 3-KINASE PATHWAY INHIBITORS FOR TREATING CANCERBRISTOL-MYERS SQUIBB COMPANY
WO/2021/024211ANTIMICROBIAL TOPICAL COMPOSITIONS CONTAINING MANUKA OILMANUKA THERAPEUTICS LTD.
WO/2021/024216PROBIOTIC MIXTUREUNIVERSITà CATTOLICA DEL SACRO CUORE
WO/2021/024220USE OF THE ANTI-P-SELECTIN ANTIBODY CRIZANLIZUMAB FOR TREATING  SICKLE CELL NEPHROPATHY AND CHRONIC KIDNEY DISEASE ASSOCIATED WITH SICKLE  CELL DISEASENOVARTIS AG
WO/2021/024231METFORMIN COMPLEXES WITH TRANSITION METALS AND P GROUP  ELEMENTSUNIVERSIDAD SANTIAGO DE CALI
WO/2021/024237INFUSION DOSAGE FORM OF NOREPINEPHRINESUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/028832AMMONIA AS A PROCESSING AID FOR SPRAYED SOLID DISPERSIONSCAPSUGEL BELGIUM NV
WO/2021/028838INTRATHECAL ADMINISTRATION OF LEVETIRACETAMSINTETICA S.A.
WO/2021/028842A STABLE READY-TO-USE INJECTABLE COMPOSITION OF GEMCITABINE OR  ITS SALT AND METHODS FOR PRODUCING SAMEHETERO HEALTHCARE LIMITED
WO/2021/033081STABLE AEROSOL COMPOSITION FOR INHALATION COMPRISING  GLYCOPYRRONIUM, FORMOTEROL AND CORTICOSTEROIDGLENMARK PHARMACEUTICAL LIMITED
WO/2021/033143NON-STAINING CURCUMINOID COMPOSITIONINVENTIA HEALTHCARE LIMITED
WO/2021/033144ORAL SUSPENSION OF CAPECITABINEINTAS PHARMACEUTICALS LTD.
WO/2021/033145NOVEL INJECTABLE FORMULATIONS OF ARTESUNATELEIUTIS PHARMACEUTICALS PVT LTD
WO/2021/033149COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY  ANANDAMIDE DEFICIENCY AND USES THEREOFBUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/033154COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANTERIOR  BLEPHARITIS AND POSTERIOR BLEPHARITISPADMANABHAN, Vishwanath
WO/2021/038460TREATMENT OF MENSTRUAL CYCLE-INDUCED SYMPTOMSPERIOD PILL BV
WO/2021/038480COMBINATIONS FOR TREATING INFLUENZA VIRUSJANSSEN PHARMACEUTICALS, INC.
WO/2021/038486FORMULATIONS COMPRISING ARGININE AND/OR A PHARMACEUTICALLY  ACCEPTABLE SALT THEREOF AND AN ACID ACTIVE INGREDIENT WITH A PKA OF 1 -5GRAAL S.R.L.
WO/2021/038487COMPOUNDS USEFUL TO TREAT PAINKASHIV BIOSCIENCES, LLC
WO/2021/038500ESKETAMINE FOR THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE  DISORDER, INCLUDING SUICIDALITYJANSSEN PHARMACEUTICALS, INC.
WO/2021/038508JET MIXING LIPID NANOPARTICLE MANUFACTURING PROCESSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/038519METHODS OF MANUFACTURING ANAMORELIN TABLETS HAVING IMPROVED  STABILITYHELSINN HEALTHCARE SA
WO/2021/038529TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS3M INNOVATIVE PROPERTIES COMPANY
WO/2021/038532NOVEL FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY  ACTIVE ANTIBODYKASHIV BIOSCIENCES, LLC
WO/2021/044280SELENOSUGARS AND COSMETIC USES THEREOFSELENO THERAPEUTICS PTY LTD.
WO/2021/044283EYE DROPS BASED ON A STERILIZABLE LIPOSOMAL FORMULATION BASED  ON CURCUMIN AND OPHTHALMIC USE THEREOFOFFHEALTH S.P.A.
WO/2021/176264LIPOSOMAL COMPOSITIONS AND PROCESS FOR PREPARATION THEREOFDOUND, Yogesh
WO/2021/044287TREATMENT OF LIVER DISEASE OR DISORDER COMPRISING ACTRII  RECEPTOR ANTAGONISTSNOVARTIS AG
WO/2021/048688PRODUCT FOR THE TREATMENT OF ERECTILE DYSFUNCTIONPVP LABS PTE. LTD.
WO/2021/044327SOLID FORMS OF FILGOTINIB MALEATE AND PROCESSES THEREOFDR. REDDY'S LABORATORIES LIMITED
WO/2021/044328CABAZITAXEL LIQUID FORMULATIONSSHILPA MEDICARE LIMITED
WO/2021/044350SOLID FORMS OF ENCEQUIDAR MESYLATE AND PROCESSES THEREOFDR. REDDY’S LABORATORIES LIMITED
WO/2021/044351METHODS OF TREATING LIVER DISEASE USING LTA4H INHIBITORSNOVARTIS AG
WO/2021/044357PHARMACEUTICAL COMPOSITIONRENOWN PHARMA INC.
WO/2021/044360THERAPEUTIC FUSION PROTEINSNOVARTIS AG
WO/2021/044361THERAPEUTIC FUSION PROTEINSNOVARTIS AG
WO/2021/044362THERAPEUTIC FUSION PROTEINSNOVARTIS AG
WO/2021/044377UNIVERSAL DONOR CELLSCRISPR THERAPEUTICS AG
WO/2021/186233COMPOSITION, LIPID PARTICLE MANUFACTURING KIT, SUBSTANCE  DELIVERY METHOD, AND DETECTION METHODSHINSHU UNIVERSITY
WO/2021/048736TREATMENT OF HIDRADENITIS WITH JAK INHIBITORSPFIZER INC.
WO/2021/048748PHARMACEUTICAL FORMULATIONS COMPRISING DICLOFENACFTF PHARMA PRIVATE LIMITED
WO/2021/038543TREATMENT OF DIMINISHED OVARIAN RESERVE USING MENSTRUAL BLOOD  STROMAL CELLSKAZEMNEJADLEILI, Somaieh
WO/2021/053476PROCESS FOR PREPARATION OF DIROXIMEL FUMARATEGLENMARK LIFE SCIENCES LIMITED
WO/2021/048809NOVEL SUBSTITUTED SULFOXIMINE DERIVATIVESCADILA HEALTHCARE LIMITED
WO/2021/048817DRUG DELIVERY FORMULATIONSMEDINCELL S.A.
WO/2021/048821USE OF AN OREXIN 2 RECEPTOR AGONIST FOR THE TREATMENT OF  EXCESSIVE SLEEPINESSTAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/048822TAK-925 FOR USE IN TREATING NARCOLEPSYTAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/053486TRANSPARENT WOUND DRESSINGS CONTAINING THYMOL NANOPARTICLESMOHAMMADI PURFARD, Amin
WO/2021/053489USE OF AN MDM2 INHIBITOR FOR THE TREATMENT OF MYELOFIBROSISNOVARTIS AG
WO/2021/059075ANTI-CEACAM ANTIBODIES AND USES THEREOFJANSSEN BIOTECH, INC.
WO/2021/053493COMPOSITIONS FOR USE IN INHIBITING SRC KINASE AND TREATING AND  PREVENTING ASSOCIATED DISORDERSENZENE BIOSCIENCES LIMITED
WO/2021/059082GEL-CHEWABLE DOSAGE FORMJOHNSON & JOHNSON CONSUMER INC.
WO/2021/053518A METHOD OF SNAKE FISH EXTRACTIONBASILIANUS BASUKI NUGROHO, Edward
WO/2021/053523COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF  BIS-DIOXOPIPERAZINESTRYP THERAPEUTICS
WO/2021/053542PHARMACEUTICAL COMPOSITIONS FOR OBESITY MANAGEMENTDR. REDDY’S LABORATORIES LIMITED
WO/2021/053564PHARMACEUTICAL COMPOSITION COMPRISING REMOGLIFLOZIN OR SALT OR  ESTER THEREOF AND TENELIGLIPTIN OR SALT THEREOFGLENMARK PHARMACEUTICALS LIMITED
WO/2021/053581A MICRORNA DYSLIPIDEMIA INHIBITORDASMAN DIABETES INSTITUTE
WO/2021/053586WET-PACKED SOFT HYDROGEL OCULAR INSERTSALCON INC.
WO/2021/053589COMPOUNDS FOR THE INDUCTION OF ANTIGEN-SPECIFIC IMMUNE  TOLERANCEANOKION SA
WO/2021/053618TREATMENT COMPRISING FXR AGONISTSNOVARTIS AG
WO/2021/053636BACTERIAL STRAINS, THEIR COMPOSITIONS AND THEIR USE FOR THE  TREATMENT OF GASTROINTESTINAL DISORDERSSOFAR S.P.A.
WO/2021/053641COMPOSITIONS BASED ON BACTERIAL STRAINS AND BERRY EXTRACTS AND  THEIR USE AS ANTI-INFLAMMATORIESSOFAR S.P.A.
WO/2021/053642COMPOSITIONS BASED ON BACTERIAL STRAINS AND THEIR USE AS  ANTI-INFLAMMATORIESSOFAR S.P.A.
WO/2021/059133POLYMERIC MICELLE, METHODS OF PRODUCTION AND USES THEREOFASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEERING AND CELL  BASED TECHNOLOGIES & THERAPIES A4TEC - ASSOCIAÇÃO
WO/2021/059140LACTIC ACID VAGINAL FILM AND IT'S PROCESSAZISTA INDUSTRIES PVT LTD
WO/2021/059142NOVEL POLYMORPH FORM OF (  R)-2-[2-AMINO-3-(INDOL-3-YL)PROPIONYLAMINO]-2-METHYLPROPIONIC ACID AND USES  THEREOFGALIMEDIX THERAPEUTICS INC.
WO/2021/059151ORAL CARE COMPOSITION WITH AMMONIUM ALKYL SULFONATE OR  CARBONATE COMPONENTS FOR TREATING CARIES3M INNOVATIVE PROPERTIES COMPANY
WO/2021/074718CREAM FOR TREATING ACNE AND MELASMATRIPOD, Maria
WO/2021/059181NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOFPFIZER INC.
WO/2021/059215ORAL CARE COMPOSITIONCHURCH & DWIGHT CO., INC.
WO/2021/059221BENRALIZUMAB FOR USE IN METHODS OF TREATING LATE-ONSET ASTHMAASTRAZENECA AB
WO/2021/059234STABLE AQUEOUS PARENTERAL SOLUTIONS OF NONSTEROIDAL  ANTI-INFLAMMATORY DRUGS (NSAIDS)CADILA HEALTHCARE LIMITED
WO/2021/059240TREATMENT OF CELIAC DISEASEINTREXON ACTOBIOTICS NV D/B/A PRECIGEN ACTOBIO
WO/2021/059241MICROBIOME COMPOSITIONS AND METHODS OF TREATMENT OF ATOPIC  DISEASESTHE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/064550LIQUID POLYMER COMPOSITIONS AND SYSTEMS FOR EXTENDED DELIVERY  OF PEPTIDES AS ACTIVE PHARMACEUTICAL INGREDIENTSTOLMAR INTERNATIONAL LIMITED
WO/2021/064567COMBINATION TREATMENT FOR CANCERASTRAZENECA AB
WO/2021/064575TREATMENT COMPRISING THE USE OF FXR AGONISTSNOVARTIS AG
WO/2021/064580CONTROLLED RELEASE INJECTABLE ONDANSETRON FORMULATIONSSHILPA MEDICARE LIMITED
WO/2021/064589INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CYCLOBENZAPRINECADILA HEALTHCARE LIMITED
WO/2021/053651EXTRACT OF COCCULUS HIRSUTUS FOR TREATMENT OF COVID-19SUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/064608CAPSULE FOR FUNCTIONALIZING A PRODUCT, METHOD AND USES THEREOFCENTITVC - CENTRO DE NANOTECNOLOGIA E MATERIAIS TéCNICOS  FUNCIONAIS E INTELIGENTES
WO/2021/064614TOLL-LIKE RECEPTOR 7 AND/OR 8 AGONISTS AND USES THEREOFJANSSEN BIOPHARMA, INC.
WO/2021/064618METHOD FOR TREATING HIV WITH CABOTEGRAVIR AND RILPIVIRINEVIIV HEALTHCARE COMPANY
WO/2021/064636ESSENTIALLY SODIUM-FREE EFFERVESCENT SOLID PHARMACEUTICAL  COMPOSITIONSINTAS PHARMACEUTICALS LTD.
WO/2021/084345PHARMACEUTICAL COMPOSITION COMPRISING MITOTANE ADMINISTERED  ORALLY FOR TREATMENT OF ADRENOCORTICAL CARCINOMA AND CUSHING'S SYNDROMESKIBA, Mohamed
WO/2021/064678HYDROGEL-LIKE PARTICLES, METHODS ANS USES THEREOFASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEERING AND CELL  BASED TECHNOLOGIES & THERAPIES A4TEC - ASSOCIAÇÃO
WO/2021/064682PEDIATRIC SUSPENSION FORMULATIONXEOLAS PHARMACEUTICALS LTD.
WO/2021/070039DETECTING HOMOLOGOUS RECOMBINATION DEFICIENCIES (HRD) IN  CLINICAL SAMPLESIMMUNITYBIO, INC.
WO/2021/070066IMPROVED TOPICAL COMPOSITION OF COLCHICINEZENVISION PHARMA LLP
WO/2021/070093CANNABIDIOL-ENHANCED PROBIOTIC COMPOSITIONS AND USES THEREOF  FOR TREATMENT OF INFECTIONSBUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/090086GREEN SYNTHESIS OF SILVER NANOPARTICLES USING CMC POWDER AND  INVESTIGATION OF ITS ANTIBACTERIAL ACTIVITYAHARI, Hamed
WO/2021/070120TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE  IN THE TREATMENT OF SEIZURE DISORDERSPIKE THERAPEUTICS, INC., 1219014 B.C. LTD.
WO/2021/070121GASTROINTESTINAL HEALTH COMPOSITIONANATARA LIFESCIENCES LIMITED
WO/2021/070123SOLID FORMS OF OMECAMTIV MECARBIL DIHYDROCHLORIDE AND  PROCESSES THEREOFDR. REDDY’S LABORATORIES LIMITED
WO/2021/070125NOVEL AMIDE DERIVATIVES OF LINAGLIPTIN AND PROCESS FOR THE  PREPARATION THEREOFZENVISION PHARMA LLP
WO/2021/074763XANTHOPHYLL COMPOSITION COMPRISING LUTEIN AND ZEAXANTHIN WITH  ENHANCED BIOAVAILABILITYOMNIACTIVE HEALTH TECHNOLOGIES LIMITED
WO/2021/070150AN INHALABLE DRY POWDER COMPOSITION FOR PULMONARY DISEASESGLENMARK SPECIALTY S.A.
WO/2021/074769COMBINATION THERAPY FOR TREATING A HEMATOLOGICAL MALIGNANCYASTRAZENECA AB
WO/2021/074772MODULATORS OF PNPLA3 EXPRESSIONASTRAZENECA AB
WO/2021/074782COMPOSITION AND USE OF AN OPHTHALMIC SOLUTION BASED ON  HYALURONIC ACID AND ARABINOGALACTANMD ITALY SRL
WO/2021/074790TRANSDERMAL DELIVERY OF CANNABIDIOLPIKE THERAPEUTICS, INC., 1219014 B.C. LTD.
WO/2021/074808PHARMACEUTICAL COMPOSITION COMPRISING SACUBITRIL AND VALSARTAN  AND PROCESS FOR PREPARATION THEREOFAUROBINDO PHARMA LIMITED
WO/2021/214536PHARMACEUTICAL COMPOSITION OF CHLORINE FOR TREATMENT OF  RESPIRATORY VIRAL INFECTIONLIFEACTIVUS PRIVATE LIMITED
WO/2021/074833TOPICAL COMPOSITIONS COMPRISING PARTHENOLIDESKINCARE SAGL
WO/2021/084361USE OF EXFOLIATED BLACK PHOSPHORUS FOR THE TREATMENT OF  PROSTATE CANCERSMATERIAS S.R.L.
WO/2021/079254A TOPICAL ANTIBIOTIC CONTAINING PHARMACEUTICAL COMPOSITION FOR  BACTERIAL INFECTIONS AND WOUND HEALINGSULUR, Vishagan Vanangamudi
WO/2021/074912MIXTURE AND COMPOSITION COMPRISING FRUIT EXTRACTS, POLYPHENOLS  AND INULIN, AND USE THEREOF IN THE TREATMENT OF ACUTE AND CHRONIC  INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACTGHS - GEMELLI HEALTH SYSTEM S.R.L.
WO/2021/074913MIXTURE COMPRISING FRUIT EXTRACTS, POLYPHENOLS EXTRACTED FROM  <i>OLEA EUROPAEA L.</i> AND INULIN, AND USE THEREOF IN THE  TREATMENT OF INFLAMMATORY DISEASES OF THE CARDIOVASCULAR SYSTEMGHS - GEMELLI HEALTH SYSTEM S.R.L.
WO/2021/019523A PROCESS FOR THE PREPARATION OF CARIPRAZINE SALTSUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/079273COMPOSITIONS COMPRISING A DHODH INHIBITOR FOR THE TREATMENT OF  ACUTE MYELOID LEUKEMIARHIZEN PHARMACEUTICALS AG
WO/2021/079300COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE  PULMONARY DISEASES (COPD)CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/079302PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITORSLUPIN LIMITED
WO/2021/079303PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF  CYSTITIS OF VARIOUS ETIOLOGIESFIDIA FARMACEUTICI S.P.A.
WO/2021/099860PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN  AGMAT-POSITIVE CELLS IN LAYER 2/3 OF MOUSE CORTEXFRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
WO/2021/079339A STABLE PARENTERAL DOSAGE FORM OF CETRORELIX ACETATESUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/084401CONFECTIONERY PRODUCT FOR INSTANT OPTICAL TOOTH WHITENINGPERFETTI VAN MELLE S.P.A.
WO/2021/084411SUBSTANTIALLY PURE CLARITHROMYCIN 9-OXIME AND ITS PREPARATION  THEREOFHIKAL LIMITED
WO/2021/084441METHODS AND COMPOSITIONS FOR TREATMENT OF CANCERENZYCHEM LIFESCIENCES CORPORATION
WO/2021/084483METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1  AND LOW MEAN ARTERIAL PRESSUREMALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
WO/2021/084494NOVEL PEPTIDES AND USES THEREOF FOR TREATING CANCERSYMTHERA CANADA LTD.
WO/2021/105792RECTAL-USE COMPOSITION FOR THE TREATMENT OF CONSTIPATIONCAPRIKA SRL
WO/2021/084495THE USE OF A SPLICING MODULATOR FOR A TREATMENT SLOWING  PROGRESSION OF HUNTINGTON'S DISEASENOVARTIS AG
WO/2021/033174SYNTHESIS, CHARACTERIZATION, AND BIOLOGICAL EVALUATION OF  IBUPROFEN DERIVATIVE AGAINST COLON AND BREAST CANCER CELL-LINESAL-OBAIDI, Zaid Mahdi Jaber
WO/2021/123949PHARMACEUTICAL COMPOSITIONS COMPRISING  N-[1-(5-CYANO-PYRIDIN-2-YLMETHYL)-1H-PYRAZOL-3-YL]-2-[4-(1-TRIFLUOROMETHYL-CYCLOPROPYL)-PHENYL]-ACETAMIDEIDORSIA PHARMACEUTICALS LTD
WO/2021/090146COMBINATION THERAPY FOR TREATING CANCERASTRAZENECA AB
WO/2021/084522BIMATOPROST 0.01% SOLUTION COMPOSITIONS FOR THE TREATMENT OF  OCULAR HYPERTENSIONRAFARM UK LIMITED
WO/2021/090154THE INTEGRATED ACTIVE COMPOSITION FOR OSTEOARTHRITIS AND JOINT  WELLNESSOMNIACTIVE HEALTH TECHNOLOGIES LIMITED
WO/2021/090177COMPOUNDS FOR TREATMENT OF DENGUE INFECTIONSUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/044401PYRIMIDINE DERIVATIVES AS ANTI-DIABETIC AGENTSUNITED ARAB EMIRATES UNIVERSITY
WO/2021/090214BERBERINE COMPOSITIONS AND THEIR USEALESCO S.R.L.
WO/2021/090228COMPOSITIONS COMPRISING BACTERIAL STRAINS FOR USE IN  INCREASING THE BIOAVAILABILITY OF AMINO ACIDS DERIVED FROM PROTEINSSOFAR S.P.A.
WO/2021/090283SHORTENING TUBERCULOSIS THERAPY AND REDUCING RELAPSE BY  CO-ADMINISTERING CHLOROQUINE IN TB AND HIV-TB COINFECTED CONDITIONSFOUNDATION FOR NEGLECTED DISEASE RESEARCH
WO/2021/090284COMPOSITION FOR THE MAKING OF AN EMULSIFIABLE TRIPHASIC  FORMULATION, AND KIT FOR THE USE OF SUCH COMPOSITIONLEVA, Francesco
WO/2021/094893NANOPARTICLES FOR MEDICAL AND DIAGNOSTIC APPLICATIONSFONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
WO/2021/094917STABLE AQUEOUS ANTI-TFPI ANTIBODY FORMULATIONPFIZER INC.
WO/2021/094921GOLD NANOCLUSTER IN THE TREATMENT OF FRIEDREICH'S ATAXIAUNIVERSITA' DEGLI STUDI DI MILANO
WO/2021/094924LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC  SUBSTANCESCOCHLEAR LIMITED
WO/2021/094933EZETIMIBE AND CURCUMIN FOR USE IN CANCER TREATMENTUNIVERSITY OF SOUTH AFRICA
WO/2021/094948COMPOSITION FOR REDUCING CARDIOVASCULAR RISKNEILOS S.R.L.
WO/2021/0949531-(((2S,3S,4S)-3-ETHYL-4-FLUORO-5-OXOPYRROLIDIN-2-YL)METHOXY)-7-METHOXYISOQUINOLINE-6-CARBOXAMIDE  COMBINATIONS AND ORAL DOSAGE FORMSPFIZER INC.
WO/2021/094959AN INJECTABLE INSECTICIDAL FORMULATIONCOROMANDEL INTERNATIONAL LTD.
WO/2021/094983POLYPEPTIDES RELATED TO HMGB1 USEFUL FOR PROMOTING TISSUE  REGENERATION, COMPOSITIONS COMPRISING SAME, AND USES THEREOFOXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/094984DOSAGE REGIMENS FOR VACCINESAELIX THERAPEUTICS, S.L.
WO/2021/094989HOMEOPATHIC TOPICAL COMPOSITIONV P LYF
WO/2021/099901STABLE TOPICAL PHARMACEUTICAL COMPOSITIONINTAS PHARMACEUTICALS LTD.
WO/2021/094992AMORPHOUS PHARMACEUTICAL COMPOSITIONS OF ABIRATERONE ACETATESUVEN LIFE SCIENCES LIMITED
WO/2021/094993SYNTHETIC COMPOSITION FOR BALANCING THE BILE ACID PROFILE IN  THE INTESTINEGLYCOM A/S
WO/2021/099906VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USESJANSSEN BIOTECH, INC.
WO/2021/095008PHARMACEUTICAL FORMULATION OF LONAFARNIB WITH A  SULFOBUTYLETHER B-CYCLODEXTRINCYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LABORATORY LTD.
WO/2021/095009THERAPY FOR HEMATOPOIETIC CELL MALIGNANCIES USING GENETICALLY  ENGINEERED T CELLS TARGETING CD70CRISPR THERAPEUTICS AG
WO/2021/095010RENAL CELL CARCINOMA (RCC) THERAPY USING GENETICALLY  ENGINEERED T CELLS TARGETING CD70CRISPR THERAPEUTICS AG
WO/2021/095011CD70+ SOLID TUMOR THERAPY USING GENETICALLY ENGINEERED T CELLS  TARGETING CD70CRISPR THERAPEUTICS AG
WO/2021/099924METHODS OF TREATING LUPUS NEPHRITIS USING INTERLEUKIN-17  (IL-17) ANTAGONISTSNOVARTIS AG
WO/2021/099935PHARMACEUTICAL FORMULATIONS FOR MANAGING URIC ACID CONTENT IN  HUMAN BODYZYCIE TECHNOLEGAL LLP
WO/2021/099966NOVEL BENZOTHIOPHENE DERIVATIVES AND USE THEREOF FOR  STIMULATING MITOCHONDRIAL TURNOVERNIBN, THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV  LTD.
WO/2021/099973INJECTABLE COMPOSITIONS OF URSODEOXYCHOLIC ACIDSHILPA MEDICARE LIMITED
WO/2021/099974COLOURING COMPOSITION BASED ON DYE PLANTS AND USE THEREOF FOR  HAIR DYEINGGIULIANI S.P.A.
WO/2021/099977CROSSLINKED BUTYRATE OR BUTYRATE-FORMATE DERIVATIVES OF  HYALURONIC ACID AND THE CROSSLINKING PROCESS THEREOFBMG PHARMA S.P.A.
WO/2021/099982DOSAGE AND ADMINISTRATION OF A BACTERIAL SACCHARIDE  GLYCOCONJUGATE VACCINEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/099983LANTIBIOTIC SOLUTION AGAINST BACTERIAL INFECTIONSSTERIFY S.R.L.
WO/2021/123960CANNABINOID COMPOSITIONS WITH HIGH SOLUBILITY AND  BIOAVAILABILITYPISAK, Mehmet Nevzat
WO/2021/090301APREMILAST LOW-DOSE TOPICAL PHARMACEUTICAL COMPOSITIONSSARUDBHAVA FORMULATIONS PRIVATE LIMITED
WO/2021/105840PROCESS FOR PURIFICATION OF FLURALANERHIKAL LIMITED
WO/2021/100027ANTI-INFLAMMATORY COMPOUNDS FOR USE IN THE TREATMENT OF DERMAL  DISORDERSCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
WO/2021/105866NOVEL EXTRACTION PROCESS FOR THE PREPARATION OF WATER SOLUBLE  CURCUMIN OLEORESINSHRINIVASAN, Sowmmya
WO/2021/105869ORAL CARE COMPOSITION WITH CHOLIC ACID COMPONENTS FOR TREATING  CARIES3M INNOVATIVE PROPERTIES COMPANY
WO/2021/116808TOPICAL SKIN CARE COMPOSITION AND METHODS FOR TREATING ECZEMAAVICANNA INC.
WO/2021/105900SYSTEM AND METHOD FOR DELIVERY OF GAS TO A TISSUEBEYOND AIR, INC.
WO/2021/105901METHODS EMPLOYING GASEOUS NITRIC OXIDE FOR INHIBITING TUMOR  GROWTHBEYOND AIR, INC.
WO/2021/234442NOSODES FOR THE PREVENTON, ALLEVIATION OF SYMPTOMS AND  TREATMENT OF VIRAL INFECTIONSSHAH, Rajesh
WO/2021/105922PHARMACEUTICAL COMPOSITIONSDOUGLAS PHARMACEUTICALS LIMITED
WO/2021/105943MIXTURE OF HMOsGLYCOM A/S
WO/2021/105964MIXTURE OF HMOS FOR IMPROVING THE MICROBIOTA OF PREGNANT WOMENGLYCOM A/S
WO/2021/100030STABLE PARENTERAL FORMULATIONS OF DULOXETINELEIUTIS PHARMACEUTICALS PRIVATE LIMITED
WO/2021/064718TARGETING B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING  LIGAND-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLSCASE WESTERN RESERVE UNIVERSITY
WO/2021/111286PREPARATION OF MICRO-ORGANISMS FOR EXTRACTING ACTIVE PLANT  INGREDIENTS, EXTRACTS OBTAINED AND THEIR USESBIOCORIUM
WO/2021/116824ORAL PRODUCT COMPRISING A CANNABINOIDNICOVENTURES TRADING LIMITED
WO/2021/116826ORAL PRODUCT COMPRISING A CANNABINOIDNICOVENTURES TRADING LIMITED
WO/2021/111312CURCUMIN COMPOSITIONS FOR OSTEOARTHRITIS AND JOINT WELLNESSOMNIACTIVE HEALTH TECHNOLOGIES LIMITED
WO/2021/111320METHODS FOR TREATING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN  PATIENTS WITH DEMENTIASUVEN LIFE SCIENCES LIMITED
WO/2021/111330TREATING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA  PATIENTSSUVEN LIFE SCIENCES LIMITED
WO/2021/111339(S)-3-[1-METHYLPYRROLIDIN-2-YL]PYRIDINE, ANALOGUES THEREOF,  PRECURSORS THEREOF, OR ITS DERIVATIVES, FOR THE USE AS A PHARMACEUTICAL IN  FORM OF A HOMOGENEOUS, VISCOUS, SEMI-SOLID TOPICAL MEDICATION AND TOPICAL  MEDICATIONSOLIS HERRERA, Arturo
WO/2021/111340(S)-3-[1-METHYLPYRROLIDIN-2-YL]PYRIDINE, ANALOGUES THEREOF,  PRECURSORS THEREOF, OR ITS DERIVATIVES, FOR THE USE AS A PHARMACEUTICAL IN  FORM OF A SOLID SUBSTANCE AND A TABLETSOLIS HERRERA, Arturo
WO/2021/111358COMPOSITION COMPRISING BUDESONIDE FOR OPHTHALMIC USENTC S.R.L.
WO/2021/111364NANOSTRUCTURED DRUG DELIVERY SYSTEM AS A MULTIFUNCTIONAL  PLATFORM FOR THERAPYUNIVERSIDADE DE COIMBRA
WO/2021/116854ORAL PRODUCTS WITH ACTIVE INGREDIENT COMBINATIONSNICOVENTURES TRADING LIMITED
WO/2021/111372EYE TOPICAL COMPOSITION CONTAINING METABOLITES OF THE  FERMENTATION OF LACTOBACILLUSSIFI S.P.A.
WO/2021/100031DRUG FOR TREATMENT OR PREVENTION OF CEREBRAL HEMORRHAGE, AND  METHOD FOR TREATMENT OR PREVENTION OF CEREBRAL HEMORRHAGE USING SAID DRUGTMS CO., LTD.
WO/2021/111385SUSTAINED RELEASE ESTROGEN VAGINAL RING PESSARY FOR TREATMENT  OF ATROPHY, CYSTITIS AND UTEROVAGINAL PROLAPSECHOWDARY, Prathima
WO/2021/111404FORMULATIONS COMPRISING A MINERAL AND/OR A VITAMIN AND A  POLYSACCHARIDE, COMPOSITIONS THEREOF AND USE THEREOF IN SUPPLEMENTING SAID  MINERAL AND/OR VITAMINALESCO S.R.L.
WO/2021/111407SOLID FORM FORMULATION COMPRISING CHROMIUM OR COPPER OR A  VITAMIN, COMPOSITIONS AND USES THEREOFALESCO S.R.L.
WO/2021/111419MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF RIOCIGUATCADILA HEALTHCARE LIMITED
WO/2021/111422COMPOSITION COMPRISING 2'-FL AND DFL FOR USE IN A METHOD FOR  REDUCING PAINGLYCOM A/S
WO/2021/116872PHARMACEUTICAL COMPOSITIONS COMPRISING CABOTEGRAVIRVIIV HEALTHCARE COMPANY
WO/2021/111426HISTATIN-1 FORMULATION FOR THE TREATMENT, REPAIR OR  REGENERATION OF BONE TISSUE IN A SUBJECTUNIVERSIDAD DE CHILE
WO/2021/116887LIPID-CONTAINING ORAL COMPOSITIONNICOVENTURES TRADING LIMITED
WO/2021/116892ORAL COMPOSITIONS WITH REDUCED WATER ACTIVITYNICOVENTURES TRADING LIMITED
WO/2021/116897PROCESS FOR THE PREPARATION OF VILDAGLIPTINOPTIMUS DRUGS (P) LTD
WO/2021/116901FORMS OF BINIMETINIB AND PROCESS FOR PREPARATION THEREOFBIOCON LIMITED
WO/2021/116907DISSOLVABLE POLYMERIC EYE INSERTS WITH A BIODEGRADABLE POLYMERALCON INC.
WO/2021/116918ORAL COMPOSITIONS INCLUDING GELSNICOVENTURES TRADING LIMITED
WO/2021/090303FORMULATION OF SAFFRON AND A METHOD OF PREPARATION THEREOFANVAR, Amirali
WO/2021/124023GOLD- AND GRAPHENE-BASED MIXTURE AND COMPOSITIONS AND USE  THEREOFIDI INTEGRATORI DIETETICI ITALIANI S.R.L.
WO/2021/116929COMPOSITION COMPRISING THE BH3-MIMETIC ABT-199 (VENETOCLAX)  AND AT LEAST ONE INHIBITOR OF THE NADPH PRODUCTIONUNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/124028NANOPARTICLES FOR CANCER TREATMENTUNIVERSIDAD DE GUADALAJARA
WO/2021/116986HAIR CLEANSER COMPOSITION, KIT AND METHOD FOR HAIR CLEANINGKAO CORPORATION
WO/2021/124044PHARMACEUTICAL COMPOSITION OF CYCLOOXYGENASE – 2 INHIBITORSTHEMIS MEDICARE LIMITED
WO/2021/117016COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH  STEROIDS AND A MODULATORBUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/176268NANOPARTICULATE FORMULATION FOR DIAGNOSIS AND/OR TREATMENT OF  CANCERINDIAN INSTITUTE OF TECHNOLOGY KANPUR
WO/2021/171083COMBINATION OF NICLOSAMIDE AND DOXORUBICININDIAN INSTITUTE OF TECHNOLOGY KANPUR
WO/2021/124096ONCE DAILY CANCER TREATMENT REGIMEN WITH A PRMT5 INHIBITORPFIZER INC.
WO/2021/124152COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFECTION USING  CATIONIC POLYMERS AND STABILIZERSPFIZER INC.
WO/2021/124191ORALLY ADMINISTERED COMBINATIONS OF AMOXICILLIN AND AVIBACTAM  DERIVATIVES FOR TREATING MYCOBACTERIAL INFECTIONSARIXA PHARMACEUTICALS, INC.
WO/2021/124210TREATMENT WITH SITE SPECIFIC HER2 ANTIBODY-DRUG CONJUGATESPFIZER INC.
WO/2021/124244GASTRO-RESISTANT MICROPARTICLES COMPRISING INOSITOL AND/OR  GYMNEMA SYLVESTRE EXTRACT, PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS  THEREOF AND USES THEREOFIDI INTEGRATORI DIETETICI ITALIANI S.R.L.
WO/2021/124249USE OF HYALURONIC ACID DERIVATIVES IN THE REGENERATION OF BONE  AND CARTILAGE TISSUESSILDEHA SWISS S.A.
WO/2021/124253A MULTICOMPONENT COMPOSITION COMPRISING A COLLAGEN,  RESVERATROL AND ASTAXANTHIN AND THE USE THEREOF FOR THE TREATMENT OF  TENDINOPATHIESKOLINPHARMA S.P.A.
WO/2021/124264VETERINARY FORMULATIONS COMPRISING RAPAMYCIN AND METHODS OF  USING THE SAME FOR TREATING ANIMAL DISEASESTRIVIUMVET DAC
WO/2021/124266PEGYLATION OF A TRAIL LIGANDUNIVERSITà DEGLI STUDI "G. D'ANNUNZIO"  CHIETI-PESCARA
WO/2021/124301FORMULATIONS AND METHOD FOR TREATMENT OF INFLAMMATORY DISEASESVYOME THERAPEUTICS INC.
WO/2021/130647PROBIOTIC FORMULATIONS FOR LIVER AND ORAL HEALTH AND  ENHANCEMENT OF IMMUNITYS A PHARMACHEM PRIVATE LIMITED
WO/2021/124306COMPOSITION FOR THE PROTECTION OF THE GASTROINTESTINAL MUCOSA  AND FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED THEREWITHNEILOS S.R.L.
WO/2021/144639COMPOSITIONS COMPRISING AMINO ACIDS FOR USE IN THE PREVENTION  AND TREATMENT OF CHEMOTHERAPY SIDE EFFECTSPROFESSIONAL DIETETICS S.P.A.
WO/2021/144640COMPOSITIONS COMPRISING AMINO ACIDS FOR PREVENTION AND/OR  TREATMENT OF CANCERPROFESSIONAL DIETETICS S.P.A.
WO/2021/148868ELETRIPTAN HYDROBROMIDE FOR TREATMENT OF SPINAL CORD INJURY  AND IMPROVEMENT OF LOCOMOTOR FUNCTIONTECHNOPHAGE, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA,  S.A.
WO/2021/137101ANTIOXIDANT EXTRACTS AND COMPOSITIONSNEXTFERM TECHNOLOGIES LTD.
WO/2021/130675COMPOSITION AND METHODS OF MANUFACTUREPHOENIX EAGLE COMPANY PTY LTD
WO/2021/130677COMPOSITION WITH SUPERABSORBENT POLYMERSHISEIDO COMPANY, LTD.
WO/2021/130684ORALLY DISSOLVING FORMULATIONS OF PRUCALOPRIDESHILPA MEDICARE LIMITED
WO/2021/130700COMPOUND FOR THE TREATMENT OF THE HEMOLYTIC-UREMIC SYNDROMEALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA
WO/2021/130728LIQUID COMPOSITIONS COMPRISING TERPENES AND CANNABINOIDSBUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/130729THERAPEUTIC MOLECULES FOR COMBATING SEPSISCENTRE FOR CELLULAR AND MOLECULAR PLATFORMS
WO/2021/137147DOSAGE REGIME WITH ESKETAMINE FOR TREATING MAJOR DEPRESSIVE  DISORDERCLEXIO BIOSCIENCES LTD.
WO/2021/137148DOSAGE REGIME WITH ESKETAMINE FOR TREATING NEUROPSYCHIATRIC OR  NEUROLOGICAL CONDITIONSCLEXIO BIOSCIENCES LTD.
WO/2021/137152CURABLE ORAL CARE COMPOSITION CONTAINING SILVER AND FLUORIDE3M INNOVATIVE PROPERTIES COMPANY
WO/2021/137154AQUEOUS ZINC ORAL CARE COMPOSITIONS WITH FLUORIDE3M INNOVATIVE PROPERTIES COMPANY
WO/2021/137160STABLE IMMEDIATE RELEASE TABLET AND CAPSULE FORMULATIONS OF  1-((2S,5R)-5-((7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)-2-METHYLPIPERIDIN-1-YL)PROP-2-EN-1-ONEPFIZER R&D UK LIMITED
WO/2021/140417INSTRUCTIONS FOR COMPOSITION AND SENSITIVITYAZURA OPHTHALMICS LTD.
WO/2021/140418METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE  CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN  INHIBITOR AND A DIPEPTIDYL PEPTIDASE 4 INHIBITORRESVERLOGIX CORP.
WO/2021/144649ADENO ASSOCIATED VIRUS BASED GENE THERAPY FOR PHENYLKETONURIATAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/144657COMBINATION COMPRISING A TIM-3 INHIBITOR AND A HYPOMETHYLATING  AGENT FOR USE IN TREATING MYELODYSPLASTIC SYNDROME OR CHRONIC MYELOMONOCYTIC  LEUKEMIANOVARTIS AG
WO/2021/152390COMPOSITIONS FOR THE TREATMENT OF ANGIOLIPOMARAZIEL THERAPEUTICS LTD.
WO/2021/152396METHODS FOR PROMOTING WEIGHT LOSS89BIO LTD.
WO/2021/152398DOSAGES AND METHODS FOR TREATING PULMONARY ARTERIAL  HYPERTENSION WITH RODATRISTATALTAVANT SCIENCES GMBH
WO/2021/171088NANOCARRIERS FOR DELIVERY OF MOLECULES TO CLINICALLY RELEVANT  CELL TYPES<<QR.BIO>>, LIMITED LIABILITY COMPANY
WO/2021/165749PEPTIDES FOR TREATING MUCOSACARRUTHERS, Jean
WO/2021/176273ORAL SOLID PREPARATIONSTAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/176276METHOD OF TREATING A VIRAL INFECTIONBOUKARI, Morou
WO/2021/181157TREATMENT OF CORONAVIRUS INFECTIONREDHILL BIOPHARMA LTD.
WO/2021/181159COMPOSITIONS AND METHODS FOR TREATING REPERFUSION INJURY OR  HEMORRHAGE AFTER RECANALIZATION THERAPYGNT PHARMA CO., LTD.
WO/2021/186243SKIN CARE COMPOSITIONS COMPRISING 8 OR MORE RECOMBINANT HUMAN  GROWTH FACTORS AND USE THEREOF FOR REDUCING SINGS OF AGINGSKINGEN INTERNATIONAL INC.
WO/2021/186244ROTOMERIC ISOMERS OF  4-ALKYL-5-HETEROARYL-3H-1,2-DITHIOLE-3-THIONESST IP HOLDING AG
WO/2021/186245HIGH CONCENTRATION ANTI-Aß PROTOFIBRIL ANTIBODY FORMULATIONS  AND METHODS OF USE THEREOFEISAI R&D MANAGEMENT CO., LTD.
WO/2021/191676HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID FOR  TREATMENT OF CORONAVIRUSES AND SPECIFICALLY NOVEL CORONAVIRUS-19 (COVID-19)S.L.A. PHARMA AG
WO/2021/186246TEMPERATURE-RESPONSIVE VIRUS STORAGE SYSTEMTRIZELL LTD.
WO/2021/191677COMPOSITIONS AND METHODS FOR TARGETING HPV-INFECTED CELLSTHE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/191686TARGETED POLY(BETA-AMINO ESTER)SARATINGA.BIO TNP
WO/2021/186248FREE FATTY ACIDS AND METHODS OF MANUFACTURE AND USE FOR  TREATING CORONAVIRUS AND OTHER VIRAL RESPIRATORY INFECTIONSLIPID PHARMACEUTICALS EHF
WO/2021/198769VACCINE COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUSVARIATION BIOTECHNOLOGIES INC.
WO/2021/198774SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING  CORONAVIRUS INFECTIONLIFESCIENCE AS
WO/2021/220050NEW COMPOSITIONS USEFUL FOR TREATING ELEVATED BLOOD LIPID  LEVELSHEALTH AND HAPPINESS (H&H) HONG KONG LIMITED
WO/2021/198777COMPOSITIONS AND METHODS FOR TREATING CANCERTRIZELL LTD.
WO/2021/1987781-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE FOR  PREVENTION OR TREATMENT OF EMOTIONAL BLUNTINGH. LUNDBECK A/S
WO/2021/198786USE OF MITOCHONDRIA-TARGETED ANTIOXIDANTS TO TREAT SEVERE  INFLAMMATORY CONDITIONSMITOTECH S.A.
WO/2021/20522525-HYDROXYVITAMIN D FOR THE TREATMENT OF SARS-COV-2 INFECTIONEIRGEN PHARMA LTD.
WO/2021/186250METHODS OF TREATING VIRAL INFECTIONS AND HEALTH CONSEQUENCESDAVIDOFF, Allen
WO/2021/209815TRANSDERMAL MICRO-DOSING DELIVERY OF PSYCHEDELICS DERIVATIVESPIKE THERAPEUTICS, INC.
WO/2021/214544ORAL DELIVERY SYSTEM COMPRISING HYDROXYCHLOROQUINE AND/OR  CHLOROQUINEGLANIS PHARMACEUTICALS, INC.
WO/2021/214545TRANSDERMAL AND/OR TOPICAL PHARMACEUTICAL FORMULATIONS  COMPRISING CANNABIDIOL AND/OR TETRAHYDROCANNABINOL FOR THE TREATMENT OF  CHRONIC PAINPIKE THERAPEUTICS, INC.
WO/2021/214547COMPOSITIONS AND METHODS FOR TREATING UPPER RESPIRATORY  INFECTIONSSANOTIZE RESEARCH AND DEVELOPMENT CORP.
WO/2021/209823METHODS FOR TREATING ACUTE CONDITIONS USING LIPID BINDING  PROTEIN- BASED COMPLEXESABIONYX PHARMA SA
WO/2021/224679COMPOSITIONS COMPRISING ENZYMES AND PROBIOTICS, AND METHODS  FOR PREVENTING OR TREATING MACULAR DEGENERATIONGENOFOCUS, INC.
WO/2021/220059COMPOSITION FOR REDUCING HEPATIC TRIGLYCERIDES AND/OR  IMPROVING GLUCOSE METABOLISMCOMPAGNIE GERVAIS DANONE
WO/2021/229294TREATMENT FOR DEPRESSIONTAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/234452COMPOSITIONS AND METHODS FOR INHIBITING REPLICATION OF  ENVELOPED RESPIRATORY VIRUSESTSG THERAPEUTICS PTE. LTD.
WO/2021/234457AN INHALED IL-1 BLOCKADE TREATMENT FOR RESPIRATORY TRACT  IMMUNOPATHOLOGYALTAVANT SCIENCES GMBH
WO/2021/234458ADAMTS13 COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING  COMPLICATIONS OF CORONAVIRUS DISEASETAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/245458HARD CAPSULE DOSAGE FORM AND USES THEREOFEIRGEN PHARMA LTD.
WO/2021/250462HIGH MOLECULAR WEIGHT HYALURONIC ACID FOR USE IN THE TREATMENT  OF CORNEAL NERVE DAMAGE OR LOSSI. COM MEDICAL GMBH
WO/2021/255518COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIARIKEN
WO/2021/250468SYNTHETIC METHODS FOR PREPARATION OF  4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINENEUROCRINE BIOSCIENCES, INC.
WO/2021/260427HYALURONIC ACID-BASED FORMULATIONS FOR TREATMENT AND  PREVENTION OF OCULAR HYPERTENSION AND GLAUCOMAI.COM MEDICAL GMBH
WO/2021/255522TRANSDERMAL DRUG DELIVERY SYSTEM FOR KETAMINEGUANGZHOU DAZHOU BIOMEDICINE LTD.
WO/2021/255524COMPOSITIONS AND METHODS FOR TREATING FRONTOTEMPORAL DEMENTIABIOASIS TECHNOLOGIES, INC.
WO/2021/191689TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND  PHARMACEUTICAL COMPOSITIONSYUYU PHARMA, INC.
WO/2021/260430USE OF HIGH MOLECULAR WEIGHT HYALURONIC ACID AS OCULAR  TRANSPORTING VEHICLEI.COM MEDICAL GMBH
WO/2021/260437MULTI-LAYERED MEDICAMENT FOR INHALATIONMYLAN PHARMA UK LIMITED
WO/2021/260438ANTIBODY-DRUG CONJUGATES COMPRISING ANTI-B7-H3 ANTIBODIESINTOCELL, INC.
WO/2021/260441FORMULATIONS INCLUDING  5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDEMYLAN PHARMA UK LIMITED
WO/2021/260443COMBINATIONS OF 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINESBAYER AKTIENGESELLSCHAFT
WO/2021/140424FINGOLIMOD EXTENDED RELEASE INJECTABLE SUSPENSIONSHILPA MEDICARE LIMITED
WO/2021/140425A PROCESS FOR PREPARATION OF IMATINIB BY USING VILSMEIER  REAGENTSAKAR HEALTHCARE LIMITED
WO/2021/140427PRMT5 INHIBITOR FOR USE IN A METHOD OF TREATING PSORIASIS AND  OTHER AUTOIMMUNE CONDITIONSPFIZER INC.
WO/2021/140435RECOMBINANT VACCINIA VIRUSPFIZER INC.
WO/2021/140437ANIONIC ALKYL SULPHATE COMPONENT FOR TREATING CARIES3M INNOVATIVE PROPERTIES COMPANY
WO/2021/140443METHODS FOR TREATMENT OF DAMAGED BILIARY DUCTSMOR RESEARCH APPLICATIONS LTD.
WO/2021/140478COMBINATION THERAPY FOR TREATING CANCERASTRAZENECA AB
WO/2021/144720TREATMENT OF LATE-ONSET NEURODEGENERATIVE DISEASES IN  HETEROZYGOUS NPC1 GENE MUTATION CARRIERSINTRABIO LTD
WO/2021/144721GRAPE SEED EXTRACTS FOR USE IN THE PREVENTION OR REDUCTION OF  STRESSINDENA S.P.A.
WO/2021/144727COMPOSITION FOR THE PROTECTION OF GASTRIC MUCOSANEILOS S.R.L.
WO/2021/144746USE OF ICRF-193 DERIVATIVES AND PHARMACEUTICAL PREPARATIONS  CONTAINING THEREOF FOR THE PREVENTION OF CHRONIC CUMULATIVE CARDIOTOXICITY  CAUSED BY THERAPY WITH ANTHRACYCLINE ANTICANCER DRUGSUNIVERZITA KARLOVA V PRAZE
WO/2021/144759GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC  CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN CANCER THERAPYCRISPR THERAPEUTICS AG
WO/2021/148969MEDICAMENT COMPRISING A COMBINATION OF AMNIOTIC MEMBRANE AND  UMBILICAL CORD BLOOD SERUM FOR WOUND HEALINGPLACELTA (PTY) LTD
WO/2021/152430METHOD FOR ADMINISTRATION OF URSODEOXYCHOLIC ACIDSHILPA MEDICARE LIMITED
WO/2021/148973MULTIFUNCTIONAL NANOPARTICLES BASED ON METALLIC NANOALLOYS FOR  DIAGNOSTIC AND THERAPEUTIC USEUNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/148986COSMETIC COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/148990CELLULAR UPTAKEAXCESS LIMITED
WO/2021/148992PHARMACEUTICAL COMPOSITIONS OF RALTEGRAVIRLUPIN LIMITED
WO/2021/149004A SYNERGISTIC BACTERICIDE AND BACTERIOSTATIC ORGANIC  SANITIZING/DISINFECTANT/CLEANING FORMULATIONUNIVERSIDAD DE CONCEPCIóN
WO/2021/149012METHODS OF STIMULATING BONE GROWTH WITH ABALOPARTIDE AND  DENOSUMABRADIUS HEALTH, INC.
WO/2021/152441PHARMACEUTICAL COMPOSITION FOR REDUCING PROTEIN BOUND UREMIC  TOXINSFRIMLINE PRIVATE LIMITED
WO/2021/156698A SINGLE LAYER CHEWABLE TABLET COMPRISING CETIRIZINEJOHNSON & JOHNSON CONSUMER INC.
WO/2021/152462PROCESS FOR PREPARATION OF LASMIDITANGLENMARK LIFE SCIENCES LIMITED
WO/2021/152467COMBINATIONS COMPRISING BH3-MIMETIC COMPOUNDS AND INHIBITORS  OF EARLY STAGES OF AUTOPHAGY FOR USE IN THE TREATMENT OF NON-HODGKIN'S B-CELL  LYMPHOMAS AND LYMPHOID AND/OR MYELOID LEUKEMIASUNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/152488METHODS OF TREATING AN INFLAMMATORY OR OBSTRUCTIVE AIRWAY  DISEASE USING ANTI-TSLP ANTIBODYNOVARTIS AG
WO/2021/152492BUTYRIC ACID SALT-BASED COMPOSITION FOR RECTAL APPLICATION FOR  THE TREATMENT OF PROCTOLOGY DISORDERSCAPRIKA SRL
WO/2021/152495COMBINATION TREATMENTS AND USES AND METHODS THEREOFGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/152497BETA-GLUCAN FOR USE IN MODULATION OF AN IMMUNE RESPONSE IN A  REMISSIONPLEURAN, S.R.O.
WO/2021/152501COMPOUNDS FOR USE IN THE TREATMENT OF LEUKEMIAUNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA"
WO/2021/156718METHOD AND COMPOSITION FOR MICROBIOME BASED AMELIORATION OF  SKIN ASSOCIATED AUTOIMMUNE INFLAMMATORY DISEASESTATA CONSULTANCY SERVICES LIMITED
WO/2021/152555NOVEL IMMUNOTHERAPY FOR TUMOURS AND CANCERS, AND ASSOCIATED  INFLAMMATIONMEDASANI, Munisekhar
WO/2021/156735STABLE OPHTHALMIC FORMULATIONS BASED ON LOW-CONCENTRATION  POVIDONE IODIDE IN PLASTIC CONTAINERSMEDIVIS S.R.L.
WO/2021/209826USE OF BACTERIAL COMPOSITIONS IN THE TREATMENT AND PROPHYLAXIS  OF AIRWAY DISEASESDE SIMONE, Claudio
WO/2021/156769METHODS FOR TREATING NEUROLOGICAL SYMPTOMS ASSOCIATED WITH  LYSOSOMAL STORAGE DISEASESGENZYME CORPORATION
WO/2021/156774COMBINATION THERAPY FOR TREATING MPS1GAIN THERAPEUTICS SA
WO/2021/156777MICROBIAL COMBINATIONS AND USES THEREOFBUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/156792TARGETED PLASMA PROTEIN DEGRADATIONNOVARTIS AG
WO/2021/156797METHOD OF TREATING POSTPRANDIAL INFLAMMATIONDASMAN DIABETES INSTITUTE
WO/2021/156811NOVEL PROCESSES FOR PREPARATION OF TEZACAFTORLAURUS LABS LIMITED
WO/2021/156813XANTHAN-BASED OPHTHALMIC TOPICAL FORMULATIONS WITH A REDUCED  DOSAGE REGIMENSIFI S.P.A.
WO/2021/156831MIRNA-485 INHIBITOR FOR GENE UPREGULATIONBIORCHESTRA CO., LTD.
WO/2021/156832USE OF MIRNA-485 INHIBITORS FOR TREATING AMYOTROPHIC LATERAL  SCLEROSIS (ALS)BIORCHESTRA CO., LTD.
WO/2021/156833USE OF MIRNA-485 INHIBITORS FOR TREATING TAUOPATHYBIORCHESTRA CO., LTD.
WO/2021/156839COMPOSITION IN THE FORM OF POWDER CONTAINING AN EXTRACT OF  CANNABIS SATIVA FOR THE TREATMENT OF INFLAMMATIONS OR INFECTIONS OR ALLERGIES  OF THE RESPIRATORY SYSTEM AND /OR HYPERSECRETION OF THE MUCUS, AND DEVICE FOR  ITS DOSAGESOFAR S.P.A.
WO/2021/161203USE OF AN ALIPHATIC ESTER OF A POLYGLYCEROL PHOSPHATE AS AN  EMULSIFIER FOR THE PREPARATION OF COMPOSITIONS FOR TRICHOLOGICAL USEGREENGREDIENTS S.R.L.
WO/2021/161205MICROBIAL COMBINATIONS WITH MODULATORS OF THE OPIOID SYSTEM  AND USES THEREOFEYAL RESEARCH CONSULTANTS LTD
WO/2021/165795ASCORBIC ACID COMPONENT FOR USE IN A METHOD OF TREATING THE  SURFACE OF A PREPARED TOOTH3M INNOVATIVE PROPERTIES COMPANY
WO/2021/161211MASSAGE BARJOHNSON & JOHNSON CONSUMER INC.
WO/2021/161216FARNESOID X RECEPTOR MODULATING COMPOUNDS AND METHODS OF USING  THE SAMEINORBIT THERAPEUTICS AB
WO/2021/165802COMPOSITION FOR THE TREATMENT OF SKIN AND MUCOUS MEMBRANE  DISEASESNEILOS S.R.L.
WO/2021/161244NEOANTIGENS EXPRESSED IN OVARIAN CANCER AND THEIR USESJANSSEN BIOTECH, INC.
WO/2021/161245NEOANTIGENS EXPRESSED IN MULTIPLE MYELOMA AND THEIR USESJANSSEN BIOTECH, INC.
WO/2021/161251COSMETIC PRODUCTBAKEL S.R.L.
WO/2021/161262TREATMENT OF PATIENTS HAVING c-MET EXON 14 SKIPPING MUTATIONSJANSSEN BIOTECH, INC.
WO/2021/161263GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOFABBVIE INC.
WO/2021/161274MICRORNA ANGPTL3 INHIBITORDASMAN DIABETES INSTITUTE
WO/2021/161283COMPOUNDS FOR TREATING CORONAVIRUS INFECTIONNLC PHARMA LTD
WO/2021/165841COMPOUND FOR THE TREATMENT OF A GLYCOGENOSISENEA - AGENZIA NAZIONALE PER LE NUOVE TECNOLOGIE, L'ENERGIA E  LO SVILUPPO ECONOMICO SOSTENIBILE
WO/2021/165846COMPOSITION FOR THE PROTECTION OF THE GASTROINTESTINAL MUCOSA  AND FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED THEREWITHNEILOS S.R.L.
WO/2021/165849THERAPEUTIC COMBINATIONS COMPRISING A RAF INHIBITOR FOR USE IN  TREATING BRAF MUTANT NSCLCNOVARTIS AG
WO/2021/165859A COMPOSITION COMPRISING VITAMIN K2-7 IN COMBINATION WITH  VITAMIN K-1 IN PUREST FORMDOUND, Yogesh
WO/2021/165876NOVEL THERAPEUTICAL TOOLS AND METHODS USING  TEMPERATURE-SENSTIVE RECEPTORS FOR TREATING BLINDNESSFRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
WO/2021/165888COMBINATION TREATMENT OF STROKE WITH PLASMIN-CLEAVABLE PSD-95  INHIBITOR AND REPERFUSIONNONO INC.
WO/2021/165891INHIBITION OF REPERFUSION INJURY WITH A PSD-95 INHIBITORNONO INC.
WO/2021/165924AZELAIC ACID ESTERS IN THE TREATMENT OR PREVENTION OF  DYSLIPIDEMIA AND ASSOCIATED CONDITIONSNEW FRONTIER LABS, LLC
WO/2021/165926A STABLE READY TO USE PHARMACEUTICAL COMPOSITION OF  LEVOTHYROXINEINTAS PHARMACEUTICALS LTD.
WO/2021/171163COMBINATIONS OF DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS  AND ACETYL-COA CARBOXYLASE INHIBITORPFIZER INC.
WO/2021/171164COMBINATIONS FOR TREATMENT OF NAFLD/NASH AND RELATED DISEASESPFIZER INC.
WO/2021/229311RECOMBINANT VACCINE AGAINST COVID-19 BASED ON A PARAMYXOVIRUS  VIRAL VECTORLABORATORIO AVI-MEX, S.A. DE C.V.
WO/2021/171196HYBRID COSMETIC PRODUCT CONSISTING OF CREAMY COMPACT POWDERART COSMETICS S.R.L.
WO/2021/171206METHODS FOR ENHANCING TRANSDERMAL DELIVERY OF  GLYCOSAMINOGLYCANS (GAGS)B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION  UNIVERSITY
WO/2021/171215TOPICAL COMPOSITIONS DESIGNED TO MAINTAIN AND/OR RESTORE THE  INTEGRITY OF THE MUCOSA AND DAMAGED EPIDERMISRICERFARMA S.R.L.
WO/2021/171216ANTI-AGEING COSMETIC COMPOSITIONS FOR MEN AND WOMEN,  CONTAINING BIOACTIVE PROTEIN, AND THE METHOD OF ITS PRODUCTIONREELABS PVT. LTD.
WO/2021/171222DRY SHAMPOO COMPOSITIONCHURCH & DWIGHT CO., INC.
WO/2021/171237PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATIONHK INNO.N CORPORATION
WO/2021/171239PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE  COMPOUNDHK INNO.N CORPORATION
WO/2021/171261A TRIPLE PHARMACEUTICAL COMBINATION COMPRISING DABRAFENIB, AN  ERK INHIBITOR AND A SHP2 INHIBITORNOVARTIS AG
WO/2021/176327LIPOSOMAL COMPOSITIONS OF CURCUMIN AND PROCESS FOR PREPARATION  THEREOFDOUND, Yogesh
WO/2021/176330METHODS TO TREAT CANCER USING  (R)-N-(3-FLUORO-4-((3-((1-HYDROXYPROPAN-2-YL)AMINO)-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)OXY)PHENYL)-3-(4-FLUOROPHENYL)-1-ISOPROPYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXAMIDEARRAY BIOPHARMA INC.
WO/2021/176349COMBINATION OF AN ANAPLASTIC LYMPHOMA KINASE INHIBITOR AND A  CYCLIN DEPENDENT KINASE INHIBITORPFIZER INC.
WO/2021/176352CUSTOMMUNE: A WEB TOOL FOR DESIGNING PERSONALIZED AND  POPULATION-TARGETED PEPTIDE VACCINESTAREK, Mohammad
WO/2021/181205ENZYMES WITH IMPROVED THERMOSTABILITY FOR THE DEGRADATION OF  PLASTIC PRODUCTSRODRíGUEZ CHAMORRO, Daniel Eduardo
WO/2021/176369METHODS OF INHIBITING SARS-COV-2 REPLICATION AND TREATING  CORONAVIRUS DISEASE 2019PFIZER INC.
WO/2021/186278T CELLS THAT RESPOND TO PATIENT NEOEPITOPESIMMUNITYBIO, INC.
WO/2021/176387NEW USE OF PROBIOTICSLA MARCA, Antonio
WO/2021/181221SMALL MOLECULES FOR REGULATION OF LONG NON-CODING RNASCELLIDO THERAPEUTICS B.V.
WO/2021/176397EXPRESSION OF SARS-COV PROTEINS, NUCLEIC ACID CONSTRUCTS,  VIRUS LIKE PROTEINS (VLPS) AND METHODS RELEVANT THERETOPREMAS BIOTECH PVT. LTD
WO/2021/176409PRESERVATIVE COMBINATION FOR VACCINE COMPOSITIONSANOFI HEALTHCARE INDIA PRIVATE LIMITED
WO/2021/181234BACTERICIDAL DEBRIDEMENT COMPOSITIONS FOR SURGICAL SITE  INFECTIONS AND CHRONIC WOUND HEALINGDEPUY SYNTHES PRODUCTS, INC.
WO/2021/176424ANTI-CD36 ANTIBODIES AND THEIR USE TO TREAT CANCERONA THERAPEUTICS, S.L.
WO/2021/176428PHENANTHROLINE, CARBAZOLE AND FLAVYLIUM BASED CYANINES AND  COMPOSITIONS AND METHODS OF MAKING AND USING THE SAMEJAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH
WO/2021/181248COMPOSITIONS COMPRISING FUNCTIONAL FRAGRANCES AND  CANNABIS-DERIVED COMPOUNDSTHIS WORKS PRODUCTS LIMITED
WO/2021/224693CANNABINOID-COMPRISING COSMETIC COMPOSITIONSTHIS WORKS PRODUCTS LIMITED
WO/2021/181258COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF BENIGN  PROSTATIC HYPERTROPHY (BPH)IDI INTEGRATORI DIETETICI ITALIANI S.R.L.
WO/2021/181261LACTOFERRIN FOR ORAL INHALATION USE FOR THE TREATMENT OF A  DISEASE CAUSED BY A SARS-CORONA VIRUSSOFAR S.P.A.
WO/2021/181262CONTROLLED RELEASE FORMULATIONS COMPRISING DROTAVERINE OR SALT  THEREOFALMENDRO PROPERTIES AND TRADING LLP
WO/2021/181268ADAM10 ENDOCYTOSIS INHIBITOR PEPTIDES AND RELATED USES FOR THE  TREATMENT OF ALZHEIMER'S DISEASEUNIVERSITA' DEGLI STUDI DI MILANO
WO/2021/181272BACTERIAL STRAINS AND COMPOSITIONS THEREOF FOR ORAL USE IN THE  TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY SYSTEMSOFAR S.P.A.
WO/2021/181276COMPOSITION COMPRISING LACTOFERRIN AND PROBIOTIC BACTERIAL  STRAINS FOR ORAL USE WITH ANTIVIRAL ACTIONSOFAR S.P.A.
WO/2021/181279COMPOSITIONS AND METHODS FOR TREATING COVID-19 INFECTIONS  AND/OR SYMPTOMS THEREOFENZYCHEM LIFESCIENCES CORPORATION
WO/2021/186296OPHTHALMIC DEVICES CONTAINING TRANSITION METAL COMPLEXES AS  HIGH ENERGY VISIBLE LIGHT FILTERSJOHNSON & JOHNSON VISION CARE, INC.
WO/2021/181309COMPOSITIONS AND METHODS FOR AGE RELATED EYE DISEASES  COMPRISING HIGH CONCENTRATIONS OF VITAMINSBAUSCH HEALTH IRELAND LIMITED
WO/2021/181310COMPOSITIONS AND METHODS FOR EYE HEALTH COMPRISING AREDS AND  VITAMIN B COMPLEXBAUSCH HEALTH IRELAND LIMITED
WO/2021/181311COMPOSITIONS AND METHODS FOR EYE HEALTH COMPRISING VERY LONG  CHAIN FATTY ACIDSBAUSCH HEALTH IRELAND LIMITED
WO/2021/181317MONOCLONAL ANTIBODY PHARMACEUTICAL COMPOSITIONLUPIN LIMITED
WO/2021/181366MATERIALS AND METHODS FOR BINDING SIGLEC-3/CD33JANSSEN BIOTECH, INC
WO/2021/186325ALMITRINE FOR TREATING THE HYPOXEMIA OF A CORONAVIRUS  INFECTIONFORREST, Michael, David
WO/2021/181368METHODS OF TREATING RESPIRATORY DISEASE WITH DEUPIRFENIDONEPURETECH LYT 100, INC.
WO/2021/186334HYDRO-SOLVO-THERMAL GRAPHENE OXIDE SYNTHESIS METHODSAHOO, Nanda Gopal
WO/2021/186348DIHYDRO-SPIRO[INDOLINE-3:1'-ISOQUINOLIN]-2-ONES AS  ANTIMALARIAL AGENTSTHE UNIVERSITY OF BUEA
WO/2021/186354CONTROLLED-RELEASE PHARMACEUTICAL FORMULATIONS FOR TREATMENT  OF INTESTINAL INFECTIONSDPL PHARMA S.P.A.
WO/2021/186356FORMULATION COMPRISING HIF PROLYL HYDROXYLASE INHIBITORSCADILA HEALTHCARE LIMITED
WO/2021/186366OPHTHALMIC CHLOROPROCAINE GEL HAVING IMPROVED FUNCTIONALITYSINTETICA S.A.
WO/2021/186392COMPOSITIONCARROLL, Noel
WO/2021/186396TGF-BETA INHIBITION, AGENTS AND COMPOSITION THEREFORONCOTELIC INC.
WO/2021/186401METHODS OF TREATING LYMPHEDEMA WITH DEUPIRFENIDONEPURETECH LYT 100, INC.
WO/2021/186409MODIFIED RELEASE FORMULATIONS AND DOSAGE REGIMENSINVEX THERAPEUTICS LTD
WO/2021/198844INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORSORPHA BIOTECH S.R.L.
WO/2021/191788LEAVE-ON LIGHT OIL HAIR COMPOSITIONJOHNSON & JOHNSON CONSUMER INC.
WO/2021/191790LEAVE-ON PENETRATING OIL HAIR COMPOSITIONJOHNSON & JOHNSON CONSUMER INC.
WO/2021/191792LEAVE-ON SERUM HAIR COMPOSITIONJOHNSON & JOHNSON CONSUMER INC.
WO/2021/205268COMPOSITION FOR SUPPOSITORIES FOR THE TREATMENT OF THE  PROSTATIC DISEASESCAPRIKA SRL
WO/2021/191796COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING VIRAL  INFECTIONS, INCLUDING CORONAVIRUS INFECTIONS, AND METHODS OF USING THE SAMEENGENEIC MOLECULAR DELIVERY PTY LTD
WO/2021/191800ANTIMICROBIAL SOLUTIONS AND METHODS OF USING THE SAME IN THE  TREATMENT OR PREVENTION OF INFECTIONSKERECIS AG
WO/2021/191803ORAL TERPENE CYCLODEXTRIN INCLUSION COMPLEX VEHICLESCZAP RESEARCH AND DEVELOPMENT, LLC
WO/2021/191811A NOVEL WOUND GEL COMPOSITIONACUPHARM INVESTMENTS (PTY) LIMITED
WO/2021/191812TREATMENT OF TYPE 2 DIABETES OR OBESITY OR OVERWEIGHT WITH  2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL}  PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC  ACID OR A PHARMACEUTICALLY SALT THEREOFPFIZER INC.
WO/2021/191815COMPOSITIONS COMPRISING CARUM CARVI AND ROSMARINUS OFFICINALIS  EXTRACTS AND METHODS OF USING SAMEJOHNSON & JOHNSON CONSUMER INC.
WO/2021/191826MODULATING AN IMMUNE RESPONSE WITH CUPROUS COMPLEXESC LAB PHARMA INTERNATIONAL, S.A.
WO/2021/191840COMPOSITIONS COMPRISING CARUM CARVI AND ROSMARINUS OFFICINALIS  EXTRACTS AND METHODS OF USING SAMEJOHNSON & JOHNSON CONSUMER INC.
WO/2021/191855BACTERIAL STRAINS, THE COMPOSITIONS THEREOF AND USE THEREOF IN  A METHOD FOR THE TREATMENT OF VITAMIN D DEFICIENCY, AND DISORDERS ASSOCIATED  THEREWITHSOFAR S.P.A.
WO/2021/198863COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF  PATHOGENIC ESCHERICHIA COLIINTRON BIOTECHNOLOGY, INC.
WO/2021/191864FOOD SUPPLEMENTS FOR THE PREVENTION OF COVID-19DOUND, Yogesh
WO/2021/191871IN VIVO USE OF MODIFIED CELLS OF LEUKEMIC ORIGIN FOR ENHANCING  THE EFFICACY OF ADOPTIVE CELL THERAPYDCPRIME B.V.
WO/2021/191875CATHEPSIN INHIBITORS FOR PREVENTING OR TREATING VIRAL  INFECTIONSGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/198880STABILIZED IGG4 ANTIBODIES AND USES THEREOFMEDIMMUNE, LLC
WO/2021/198908OPHTHALMIC COMPOSITIONS FOR TREATING CORONAVIRUSESCORONEO, Minas Theodore
WO/2021/198909COMPOSITIONS FOR TREATMENT OF SPINAL CORD INJURY, METHODS AND  USES THEREOFUNIVERSIDADE DO MINHO
WO/2021/198921SYNERGISTIC HERBAL COMPOSITION AS A BROAD-SPECTRUM  PROPHYLACTIC MAJOR AND METHOD TO PREPARE THE SAMESINGH, Pawan Kumar
WO/2021/198927COMPOSITIONS FOR THERAPY OR TREATMENT OF PARKINSON'S DISEASE,  METHODS AND USES THEREOFUNIVERSIDADE DO MINHO
WO/2021/198929ANTI-IL6 AGENT FOR TREATING CORONAVIRUS INFECTIONJANSSEN BIOTECH, INC.
WO/2021/198938DIISOPROPYLAMINE COMPOUND AND IODINE FOR TREATING CANCER,  ENDOMETRIOSIS AND PAIN IN PATIENTS WITH CANCER OR ENDOMETRIOSISTHAI MINH PHARMACEUTICALS JSC
WO/2021/198940COMPOSITION FOR PREVENTING OR TREATING CHRONIC OR ACUTE VIRUS  INFECTION AND/OR SEPSIS IN HUMANS OR ANIMALSTHAI MINH PHARMACEUTICALS JSC
WO/2021/205289METHOD FOR TRANSFORMING INHOMOGENEOUS AQUEOUS SOLUTIONS  COMPRISING INORGANIC AND ORGANIC COMPONENTS INTO HOMOGENEOUS SOLUTIONINNOSTUDIO ZRT.
WO/2021/198949DUAL ANTAGONIST OF PGD2/DPR2 AND THROMBOXANE A2/TPR RECEPTORS  AND USE FOR TREATMENT OF MALAPTIVE IMMUNE RESPONSE OR THROMBOTIC DIATHESISGUPTA, Nisha
WO/2021/198954EXOSOME-ENRICHED EXTRACELLUALR VESICLES ISOLATION, METHOD AND  USES THEREOFUNIVERSIDADE DO MINHO
WO/2021/198962METHOD FOR TREATING VIRAL DISEASESCYTOCOM INC.
WO/2021/198965NEODEGRADER CONJUGATESORUM THERAPEUTICS, INC.
WO/2021/198966CONJUGATESORUM THERAPEUTICS, INC.
WO/2021/205296METHOD OF TREATING COVID-19PFIZER INC.
WO/2021/205297ADMINISTRATION OF mTOR INHIBITORS INTO THE CENTRAL NERVOUS  SYSTEMDOLCETTA, Diego
WO/2021/198980METHODS OF TREATING CORONAVIRUS DISEASE 2019PFIZER INC.
WO/2021/198985TETRAHYDROCANNABINOL EMULSION AND METHOD OF MAKING AND USINGBROWN, Brian
WO/2021/198995STABLE AQUEOUS PARENTERAL SOLUTIONS OF DESGLYMIDODRINECADILA HEALTHCARE LIMITED
WO/2021/205303FORMULATION COMPRISING OZONATED OIL FOR USE IN THE PREVENTION  AND/OR TREATMENT OF LEISHMANIASISPROJECT & COMMUNICATIONS LTD
WO/2021/199003OXIDIZED LIPIDS AND TREATMENT OR PREVENTION OF INFLAMMATION OR  INFECTIOUS DISEASE CAUSED BY CORONAVIRUS INFECTIONVASCULAR BIOGENICS LTD.
WO/2021/205326CURABLE COMPOSITIONS AND METHODS OF USING THE SAME3M INNOVATIVE PROPERTIES COMPANY
WO/2021/205338ALISPORIVIR FOR USE IN HUMAN VIRAL INFECTIONSDEBIOPHARM INTERNATIONAL SA
WO/2021/2053411-METHYLNICOTINAMIDE FOR THE PREVENTION/TREATMENT OF  INFLAMMATORY AIRWAY DISEASESPHARMENA S.A.
WO/2021/176434CPG-ADJUVANTED SARS-COV-2 VIRUS VACCINEVALNEVA AUSTRIA GMBH
WO/2021/205350HA-PACLITAXEL CONJUGATE FOR TREATMENT OF MESOTHELIOMAFIDIA FARMACEUTICI S.P.A.
WO/2021/205358COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERYJANSSEN BIOTECH, INC.
WO/2021/205359ANTI-PHF-TAU ANTIBODIES AND USES THEREOFJANSSEN BIOTECH, INC.
WO/2021/205363CO-TREATMENT WITH CDK4/6 AND CDK2 INHIBITORS TO SUPPRESS TUMOR  ADAPTATION TO CDK2 INHIBITORSPFIZER INC.
WO/2021/209863CORONAVIRUS-INHIBITOR MEDICAL AIDADAMAS BIOTECH S.R.L.
WO/2021/205367USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF LIVER  CANCER, MELANOMA, LYMPHOMA AND LEUKEMIAASKAT INC.
WO/2021/205376CALORIC RESTRICTION MIMETIC COMPOSITIONSSOLONGEVITY NUTRACEUTICALS S.R.L.
WO/2021/205391TARGETED PROTEASE DEGRADATION (TED) PLATFORMEUBULUS BIOTHERAPEUTICS INC.
WO/2021/205395USE OF BACTERIAL STRAINS LACTOBACILLUS BREVIS, LACTOBACILLUS  PLANTARUM AND/OR LACTOBACILLUS PENTOSUS IN THE REDUCTION OF AN INGESTED OR  ACCUMULATED AMOUNT OF PHOSPHONATES IN THE HUMAN MICROBIOTAPROBIOTICAL S.P.A.
WO/2021/205402ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDERJINA PHARMACEUTICALS, INC.
WO/2021/205403ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDERJINA PHARMACEUTICALS, INC.
WO/2021/205404ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDERJINA PHARMACEUTICALS, INC.
WO/2021/205405ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDERJINA PHARMACEUTICALS, INC.
WO/2021/205408IGY IMMUNOGLOBULINS TARGETING CORONAVIRUS, METHODS OF  PREPARING SAME, AND METHODS OF USING SAMEIGY IMMUNE TECHNOLOGIES AND LIFE SCIENCES INC.
WO/2021/205411COMPOSITIONS COMPRISING NANOPARTICLES, METHOD OF MAKING AND  USES THEREOFORGANICELL REGENERATIVE MEDICINE, INC.
WO/2021/2054122-DEOXY-D-GLUCOSE FOR PREVENTION AND TREATMENT OF A VIRAL  DISEASE, IN PARTICULAR OF COVID-19EXPLORATION INVEST PTE LTD
WO/2021/234471AN ANTIBODY FRAGMENT BASED ANTIMICROBIAL CONJUGATE SELECTIVELY  TARGETING PSEUDOMONASABGENICS LIFESCIENCES PRIVATE LIMITED
WO/2021/214588ANTI-TNF ALPHA AGENT FOR TREATING CORONAVIRUS INFECTIONSJANSSEN BIOTECH, INC.
WO/2021/209892PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE  COMPOUNDHK INNO.N CORPORATION
WO/2021/209893PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING  AMIN OP YRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR  SOLVATE THEREOFJANSSEN BIOTECH, INC.
WO/2021/209897PSMA AND STEAP1 VACCINES AND THEIR USESJANSSEN BIOTECH, INC.
WO/2021/209900INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATIONVIIV HEALTHCARE UK (NO.5) LIMITED
WO/2021/2099103-AZA-BICYCLE[3.2.1]OCTANE CARBOXYLIC ACIDS AND THEIR  DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATIONSMINERVA S.R.L.
WO/2021/209919SOLID ORAL DOSAGE FORM COMPRISING POMALIDOMIDETECNIMEDE - SOCIEDADE TéCNICO-MEDICINAL, SA
WO/2021/209925CORONAVIRUS SEROLOGY ASSAYPFIZER INC.
WO/2021/209935PROCESS FOR THE SYNTHESIS OF A CONJUGATE OF HYALURONIC ACID  AND PACLITAXELFIDIA FARMACEUTICI S.P.A.
WO/2021/209940PHARMACEUTICAL COMPOSITION CONTAINING  N-(4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE,  (2S)-HYDROXYBUTANEDIOATEMSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/209942MICROBIAL TREATMENT FOR WATER SYSTEMS AND SOIL REMEDIATIONNEW LIFE BIOSCIENCES LLC
WO/2021/209945METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCERTAVANTA THERAPEUTICS HUNGARY INCORPORATED
WO/2021/209947STABLE READY TO DILUTE FORMULATIONS OF CARFILZOMIBKASHIV BIOSCIENCES, LLC
WO/2021/220099SEMI-SOLID FORMULATION FOR VOLUNTARY ORAL ADMINISTRATION OF  BIOACTIVE COMPOUNDS TO RODENTSUNIVERSIDADE DE COIMBRA
WO/2021/209956METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS  WITH DIVALPROEX SODIUMFLAMEL IRELAND LIMITED
WO/2021/209965A SAPOGENIN POLYETHYLENE GLYCOL ESTER COMPLEX OF FORMULA-I, A  COMPOSITION, PROCESS OF PREPARATION, AND APPLICATIONS THEREOFPHYTOSOL INDIA PRIVATE LIMITED
WO/2021/209970SARS COV-2 SPIKE PROTEIN CONSTRUCTGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/209975OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT  LINEAR HYALURONIC ACIDWELIFEPHARMA SAGL
WO/2021/214623DOSING REGIMEN FOR TREATING A DISEASE MODULATED BY CSF-1RNOVARTIS AG
WO/2021/214624METHODS AND COMPOSITIONS FOR INHIBITING ENVELOPED VIRUSES  USING LOW MOLECULAR WEIGHT HYDROPHOBICALLY MODIFIED POLYMERSJOHNSON & JOHNSON CONSUMER INC.
WO/2021/214625METHODS OF INHIBITING ENVELOPED VIRUSES USING LOW MOLECULAR  WEIGHT HYDROPHOBICALLY MODIFIED POLYMERSJOHNSON & JOHNSON CONSUMER INC.
WO/2021/214626METHODS AND COMPOSITIONS FOR INHIBITING INFLUENZA VIRUSES  USING LOW MOLECULAR WEIGHT HYDROPHOBICALLY MODIFIED POLYMERS AND POLYALKYLENE  GLYCOLSJOHNSON & JOHNSON CONSUMER INC.
WO/2021/214627METHODS AND COMPOSITIONS FOR INHIBITING ENVELOPED VIRUSES  USING HIGH MOLECULAR WEIGHT HYDROPHOBICALLY MODIFIED POLYMERSJOHNSON & JOHNSON CONSUMER INC.
WO/2021/214628METHODS AND COMPOSITIONS FOR INHIBITING ENVELOPED VIRUSES  USING HIGH MOLECULAR WEIGHT HYDROPHOBICALLY MODIFIED POLYMERSJOHNSON & JOHNSON CONSUMER INC.
WO/2021/214637COMPOSITION AND METHODS FOR TREATING RESPIRATORY DISEASESST. JUDE CHILDREN'S RESEARCH HOSPITAL
WO/2021/214658PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PRODUCTS OF  HETERODIMERIC HUMAN INTERLEUKIN-15 (HETIL-15)NOVARTIS AG
WO/2021/214661ORAL COMPOSITION COMPRISING S-ADENOSYL METHIONINE AND A  PROBIOTIC AND ITS USE FOR TREATING AND/OR PREVENTING MOOD DISORDERSMONTEFARMACO OTC S.P.A.
WO/2021/234475MODIFIED RELEASE COMPOSITIONS AND METHODS OF MEMANTINE HCL  EXTENDED RELEASE, DONEPEZIL HCL IMMEDIATE RELEASE PELLETSPELLETS PHARMA LIMITED
WO/2021/214674FOAMING MAKEUP REMOVERELEGANT BEST INVESTMENT LIMITED
WO/2021/214688PHARMACEUTICAL COMPOSITIONS AND ANTI-VIRAL USES THEREOFZION MEDICAL B.V.
WO/2021/214703A VACCINE AGAINST SARS-COV-2 AND PREPARATION THEREOFCADILA HEALTHCARE LIMITED
WO/2021/214717DOSING REGIMEN FOR THE USE OF SIPONIMOD FOR THE TREATMENT OF  ACUTE RESPIRATORY DISTRESS SYNDROMENOVARTIS AG
WO/2021/220124A PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT USING  L-CARNOSINE AND GLUTATHIONE, ITS PRECURSORS OR DERIVATIVES THEREOFSINGH, Shyam Sunder
WO/2021/220133NOVEL MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF  TAMSULOSIN AND SOLIFENACINZIM LABORATORIES LIMITED
WO/2021/214738OXYSTEROL FOR THE USE IN THE TREATMENT AND THE PREVENTION OF  CORONAVIRUS DISEASESPANOXYVIR SRL
WO/2021/220136COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF  RESPIRATORY TRACT INFECTIONSTDC TECHNOLOGY DEDICATED TO CARE SRL
WO/2021/220137PANNEXIN-1 INHIBITORS FOR THE TREATMENT OF SARS-COV-2 INFECTED  COVID-19 PATIENTS WITH OR WITHOUT AN ASSOCIATED ACUTE RESPIRATORY SYNDROMESAPIR PHARMACEUTICALS INC.
WO/2021/245473TLR 9 INHIBITORSINSILICO MEDICINE IP LIMITED
WO/2021/224724ANTI-CANCER PROTEINSUNICHEM LABORATORIES LTD
WO/2021/220194OPHTHALMIC COMPOSITIONS COMPRISING A COMBINATION OF  BRINZOLAMIDE AND BRIMONIDINESENTISS PHARMA PRIVATE LIMITED
WO/2021/220199CCR7 ANTIBODY DRUG CONJUGATES FOR TREATING CANCERNOVARTIS AG
WO/2021/220211SUPERFOOD FOR PROLONGING THE LONGEVITY OF AN INDIVIDUALGIULIANI S.P.A.
WO/2021/220216METHODS FOR CLEARING VITREOUS HEMORRHAGEMOR RESEARCH APPLICATIONS LTD.
WO/2021/220236PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPYCADILA HEALTHCARE LIMITED
WO/2021/220246RECOMBINANT SARS-COV-2 POLYPEPTIDES AND USESUNIVERSITY OF CAPE TOWN
WO/2021/234483INHIBITORS OF CORONAVIRUS PROTEASESUNSHINE BIOPHARMA INC.
WO/2021/220250LERIGLITAZONE FOR TREATING LUNG INFLAMMATION AND INTERSTITIAL  LUNG DISEASEMINORYX THERAPEUTICS S.L.
WO/2021/220251AN IMPROVED PROCESS OF PURIFICATION OF PROTEINKASHIV BIOSCIENCES, LLC
WO/2021/220253AN IMPROVED PROCESS OF AFFINITY CHROMATOGRAPHYKASHIV BIOSCIENCES, LLC
WO/2021/224766METHODS FOR TREATING CORONAVIRUS DISEASESIBCELL BIOTECH AB
WO/2021/224784COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERSLANDA LABS (2012) LTD.
WO/2021/224785COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERSLANDA LABS (2012) LTD.
WO/2021/224789COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERSLANDA LABS (2012) LTD.
WO/2021/224793COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERSLANDA LABS (2012) LTD.
WO/2021/224794COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERSLANDA LABS (2012) LTD.
WO/2021/224803PEPTIDE INHIBITORS OF SARSR-COV INFECTIONNONO INC.
WO/2021/224809PROLINE HYDROXYLASE INHIBITORS FOR USE IN THE SKELETAL MUSCLE  REGENERATIONPOLICLINICO SAN DONATO S.P.A. - ISTITUTO DI RICOVERO E CURA A  CARATTERE SCIENTIFICO
WO/2021/224813DISEASE MODIFYING AGENTS, DRUG DELIVERY SYSTEM AND METHOD  THEREOF FOR THE MANAGEMENT OF OSTEOARTHRITISINDIAN INSTITUTE OF TECHNOLOGY KANPUR
WO/2021/224815STABLE AQUEOUS PARENTERAL SOLUTIONS OF NONSTEROIDAL  ANTI-INFLAMMATORY DRUG (NSAID)CADILA HEALTHCARE LIMITED
WO/2021/224823METHODS OF TREATING CROHN'S DISEASE WITH ANTI-IL23 SPECIFIC  ANTIBODYJANSSEN BIOTECH, INC.
WO/2021/224825COMPOSITIONS COMPRISING THYMOL FOR USE IN THE TREATMENT OF  INFLAMMATORY OR FUNCTIONAL BOWEL DISORDERS BY MODULATING THE ENDOCANNABINOID  SYSTEMVETAGRO INTERNATIONAL S.R.L.
WO/2021/224836A SYNERGISTIC FORMULATION FOR MANAGEMENT OF RESPIRATORY  PATHOGENS INCLUDING CORONAVIRUSESSABHARANJAK, Shefali
WO/2021/224854COMPOSITION FOR THE PREVENTION AND TREATMENT OF FOLATE AND/OR  VITAMIN B12 DEFICIENCY CONDITIONS, PARTICULARLY HYPERHOMOCYSTEINEMIAINPHA RESEARCH S.R.L.
WO/2021/224867PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND NAZARTINIBNOVARTIS AG
WO/2021/224890METHODS OF TREATING OR PREVENTING CORONAVIRUS INFECTIONAURINIA PHARMACEUTICALS INC.
WO/2021/229397COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF  PATHOGENIC ESCHERICHIA COLIINTRON BIOTECHNOLOGY, INC.
WO/2021/229419SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC  MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE  GASTROINTESTINAL TRACTMOGON PHARMACEUTICALS SAGL
WO/2021/229420SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC  MATRICES FOR CHRONOTROPIC ADMINISTRATION IN THE GASTROINTESTINAL TRACT OF  FOODS, DIET SUPPLEMENTS, NUTRACEUTICALS AND MEDICAL DEVICESGIELLEPI S.P.A.
WO/2021/229433COMPOSITIONS COMPRISING BACTERIAL STRAINS AND USE THEREOF FOR  THE TREATMENT OF OCULAR DISEASES AND LESIONSPROBIOTICAL S.P.A.
WO/2021/229439THERAPEUTIC COMBINATIONS COMPRISING A CRAF INHIBITORNOVARTIS AG
WO/2021/229442STABLE FORMULATIONS OF TEMOZOLOMIDE FOR ORAL ADMINISTRATIONSHORLA PHARMA LTD
WO/2021/229448RNA REPLICON ENCODING A STABILIZED CORONA VIRUS SPIKE PROTEINJANSSEN PHARMACEUTICALS, INC.
WO/2021/229450SARS-COV-2 VACCINESJANSSEN PHARMACEUTICALS, INC.
WO/2021/229461MYELIN NANOVESICLES AND USES THEREOFCONSIGLIO NAZIONALE DELLE RICERCHE
WO/2021/229466PHARMACEUTICAL COMPOSITION CONTAINING EDARAVONE AS AN ACTIVE  AGENTTOV «MEDYCHNYI TSENTR «M.T.K.»
WO/2021/229467COMBINED HYPEROSMOLAR SOLUTION FOR INFUSIONM.T.K. MEDICAL CENTER LIMITED LIABILITY COMPANY
WO/2021/240281ORAL LIQUID FORMULATIONS OF LENVATINIBSHILPA MEDICARE LIMITED
WO/2021/229479COMPOSITION FOR PREVENTING OR TREATING OBESITY-RELATED DISEASE  CONTAINING AMPHIREGULIN-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE STRUCTUREBIONEER CORPORATION
WO/2021/229480POLYMORPH OF RIFAXIMIN, PROCESS FOR THE PREPARATION THEREOF  AND PHARMACEUTICAL COMPOSITION CONTAINING RIFAXIMINATRA PHARMACEUTICALS LIMITED
WO/2021/229501MIXTURE AND COMPOSITION FOR THE PREVENTION AND TREATMENT OF  DISEASES OF THE CIRCULATORY SYSTEM AND OF RELATED SYMPTOMSNEILOS S.R.L.
WO/2021/229513TOOLS AND METHOD FOR PREVENTING AAV NEUTRALIZATION BY  ANTIBODIESGENETHON
WO/2021/229519STEROLS IN THE TREATMENT AND/OR PREVENTION OF SARS-COV-2  INFECTIONBAR PHARMACEUTICALS SOCIETA' A RESPONSABILITA' LIMITATA
WO/2021/250482OPHTHALMIC COMPOSITIONS COMPRISING A COMBINATION OF  FLUOROQUINOLONE ANTIBACTERIAL AGENT AND AN ANTI-INFLAMMATORY AGENTSENTISS PHARMA PRIVATE LIMITED
WO/2021/229533A FATTY ACID BASED COMPOSITION FOR TREATMENT AND/OR PREVENTION  OF ENVELOPED-VIRUS RELATED INFECTIONSPALANI LLC
WO/2021/234526NOVEL EXTENDED RELEASE COMPOSITION OF  2-(2-AMINOTHIAZOL-4-YL)-N-[4-(2-{[(2R)-2-HYDROXY2-PHENYLETHYL] AMINO} ETHYL)  PHENYL] ACETAMIDEZIM LABORATORIES LIMITED
WO/2021/234527AN ANTIBODY FRAGMENT BASED ANTIFUNGAL CONJUGATE SELECTIVELY  TARGETING CANDIDAABGENICS LIFESCIENCES PRIVATE LIMITED
WO/2021/234530NOVEL EXTENDED RELEASE COMPOSITION OF TOFACITINIB, ITS  DERIVATIVES AND SALTSZIM LABORATORIES LIMITED
WO/2021/240293COMBINATION OF ACTIVE INGREDIENTS, COMPOSITIONS CONTAINING IT  AND THEIR USE TO SUSTAIN AND STRENGTHEN THE IMMUNE SYSTEMAPHARM SRL
WO/2021/234532PHARMACEUTICAL FORMULATIONS AND THEIR PREPARATIONS FOR  TREATMENT OF CANCERCELLIX BIO PRIVATE LIMITED
WO/2021/240295PROCESS FOR PREPARATION OF FAVIPIRAVIRGLENMARK LIFE SCIENCES LIMITED
WO/2021/234536LIPOPHILIC EYE CONTOUR GEL AND METHOD FOR THE PREPARATION  THEREOFOFFHEALTH S.P.A.
WO/2021/234538PROCESS FOR PREPARING AN ACTIVE LIPOSOME, RELATED COMPOSITIONS  AND USESLABIOTRE S.R.L.
WO/2021/234548LIPID-POLYMER COMPOSITIONS AND METHODS OF USEMAX BIOLOGY CO. LTD.
WO/2021/234562SLOW-RELEASE MEDICAL PLASTERFIDIA FARMACEUTICI S.P.A.
WO/2021/234584PHARMACEUTICAL COMPOSITIONS COMPRISING ADALIMUMABSHILPA BIOLOGICALS PRIVATE LIMITED
WO/2021/234634METHOD OF TREATING INFLAMMATORY BOWEL DISEASE WITH A  COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF ALPHAJANSSEN BIOTECH, INC.
WO/2021/234642THE COMBINATION OF ACETYL LEUCINE AND 4-AMINOPYRIDINE OR  ACETAZOLAMIDE FOR TREATING ATAXIAINTRABIO LTD
WO/2021/234650METHOD OF TREATING OR PREVENTING AN INFECTIONSUPERBREWED FOOD, INC.
WO/2021/234660COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF DISEASES  OF THE RESPIRATORY TRACT AND AS A STIMULANT OF THE IMMUNE SYSTEMNEILOS S.R.L.
WO/2021/234662GENETICALLY ENGINEERED CAR T CELLS THAT SECRETE INTERLEUKIN-12  AND THERAPEUTIC USES THEREOFCRISPR THERAPEUTICS AG
WO/2021/234668SYSTEM, METHOD AND USE OF A CERTAIN MEDICATION FOR REDUCING  VIRAL REPLICATION IN THE AIRWAYS MUCOSAERIVEROS, Carlos Alberto
WO/2021/240330PHARMACEUTICAL COMPOSITION OF EXTENDED-RELEASE ORAL SUSPENSION  AND PROCESS FOR PREPARATION THEREOFLYRUS LIFE SCIENCES PVT LTD
WO/2021/234676COMPOUNDS AND METHODS FOR SUPPRESSING AN IMMUNE RESPONSE TO  SUBSTANCES CONTAINING POLYETHYLENE GLYCOLAAB THERAPEUTICS, LLC
WO/2021/240333CRYSTALLINE FORMS OF SOLVATES OF TRYPTOPHAN DERIVATIVES,  COMPOSITIONS COMPRISING THEM AND USES THEREOFGALIMEDIX THERAPEUTICS INC.
WO/2021/240340PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1  IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIESUNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA"
WO/2021/240352PHARMACEUTICAL FORMULATIONS OF PILOCARPINE R-(+)-LIPOATECELLIX BIO PRIVATE LIMITED
WO/2021/240368TREATMENT OF AUTISM SPECTRUM DISORDER WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.
WO/2021/240371METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS  INFECTION AND ASSOCIATED COAGULOPATHYUNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/240373DOSING REGIMENS FOR  <i>N</i>-((5-FLUORO-2,3-DIHYDROBENZOFURAN-4-YL)METHYL)-8-(2-METHYLPYRIDIN-3-YL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-5-AMINE,  OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR USE IN TREATING  PRC2-MEDIATED DISEASES OR DISORDERSNOVARTIS AG
WO/2021/240375METHOTREXATE FOR USE IN THE PHARMACEUTICAL OR VETERINARY  PREVENTION AND/OR TREATMENT OF VIRAL INFECTIONSBLUEPRINT PHARMA S.R.L.
WO/2021/240376OPHTHALMIC NANOEMULSION COMPOSITIONSLUPIN LIMITED
WO/2021/240382COMPOSITION COMPRISING PEPSTATIN AND ALGINIC ACID OR A SALT  THEREOF, AND USE THEREOFDRUGS MINERALS AND GENERICS ITALIA S.R.L. IN FORMA ABBREVIATA  D.M.G. ITALIA S.R.L.
WO/2021/240383TABLET COMPRISING OPICAPONEONO PHARMACEUTICAL CO., LTD.
WO/2021/245499NOVEL SMALL MOLECULES FOR TARGETED DEGRADATION OF UNTARGETABLE  KRAS IN CANCER THERAPYPILLAI UNIVERSAL LLC
WO/2021/240398COMPOSITIONS COMPRISING A DERIVATIVE OF <i>CANNABIS  SATIVA</i> AND BACTERIAL STRAINS AND THERAPEUTIC USE THEREOFSOFAR S.P.A.
WO/2021/240399COMPOSITIONS COMPRISING A DERIVATIVE OF CANNABIS SATIVA AND  BACTERIAL STRAINS AND THERAPEUTIC USE THEREOFSOFAR S.P.A.
WO/2021/245503PROCESS FOR THE PREPARATION OF EFLORNITHINE DERIVATIVES AND  THEIR PHARMACEUTICAL ACCEPTABLE SALTS THEREOFCELLIX BIO PRIVATE LIMITED
WO/2021/240454TREATMENT FOR PSORIASIS AND SKIN INFLAMMATORY DISEASESCADILA HEALTHCARE LIMITED
WO/2021/245512NEUROKININ (NK)-1 RECEPTOR ANTAGONISTS FOR USE IN THE  TREATMENT OF PULMONARY FIBROSIS CONDITIONS PROMOTED BY MECHANICAL INJURY TO  THE LUNGSNERRE THERAPEUTICS LIMITED
WO/2021/255560ANATABINE POWDER COMPOSITIONSPHILIP MORRIS PRODUCTS S.A.
WO/2021/240458AN IMPROVED PROCESS OF STORING AND PREPARING THE PROTEINKASHIV BIOSCIENCES, LLC
WO/2021/240461DIETARY SUPPLEMENTSNEOLIFE INTERNATIONAL LLC
WO/2021/245518BETA-CRYPTOXANTHIN COMPOSITION FOR EYE HEALTHOMNIACTIVE HEALTH TECHNOLOGIES LIMITED
WO/2021/245519FAST DISPERSIBLE PHARMACEUTICAL COMPOSITION COMPRISING  CAPECITABINESHILPA MEDICARE LIMITED
WO/2021/245520COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF  PATHOGENIC ESCHERICHIA COLIINTRON BIOTECHNOLOGY, INC.
WO/2021/245522LIQUID CANNABIS COMPOSITIONS AND USES THEREOFBUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/245533TREATMENT FOR THE INFLAMMATORY BOWEL DISEASECADILA HEALTHCARE LIMITED
WO/2021/245539DRUG CONJUGATE HAVING ENHANCED DRUG DELIVERY AND  INTERNALIZATION EFFICIENCYBIK THERAPEUTICS INC.
WO/2021/245541A COMPOSITION OF PEGYLATED INTERFERON ALPHA-2B FOR THE  TREATMENT OF SARS-COV-2 INFECTION AND RELATED MANIFESTATIONSCADILA HEALTHCARE LIMITED
WO/2021/245547LIPOSOMAL SYSTEM WITH KILLER TNF-APOPTOSIS INDUCED LIGAND  (KILLERTRAIL), PRO-APOPTOTIC-DIRECTINGUNIVERSITà DEGLI STUDI "G. D'ANNUNZIO"  CHIETI-PESCARA
WO/2021/245569PHARMACEUTICAL COMPOSITION COMPRISING: A BISABOLOL COMPOUND,  VALENCENE AND A|TERPINENE COMPOUNDRHEA GENETICS PTE. LTD.
WO/2021/245590AN IMPROVED PROCESS FOR THE PREPARATION OF TRIAZOLE  DERIVATIVESMETROCHEM API PRIVATE LIMITED
WO/2021/245611MODIFIED BETACORONAVIRUS SPIKE PROTEINSGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/250519COMPOSITIONS FOR TOPICAL TREATMENT OF ACQUIRED MELANOSIS OF  THE SKINPROFESSIONAL DIETETICS S.P.A.
WO/2021/250571BIOAVAILABLE SUGAR-BASED DICLOFENAC FORMULATIONSAPR APPLIED PHARMA RESEARCH, S.A.
WO/2021/250606COMPOSITION FOR TREATING CORONAVIRUS DISEASE-19 (COVID-19)JW PHARMACEUTICAL CORPORATION
WO/2021/250611CONTROLLED RELEASE OF SELF-EMBEDDING PARTICLES FOR LOCALIZED  DRUG DELIVERYJANSSEN BIOTECH, INC.
WO/2021/250620COMPOSITIONS AND METHODS FOR ENHANCING  N-ACETYLGALACTOSAMINE-6-SULFATASE ENZYME ACTIVITY AND TREATING  MUCOPOLYSACCHARIDOSIS TYPE IVAPONTIFICIA UNIVERSIDAD JAVERIANA
WO/2021/250628BACTERIAL IMMUNIZATION USING NANOPARTICLE VACCINEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/260486COMPOSITIONS FOR TREATING KERATIN FIBERSREVLON CONSUMER PRODUCTS CORPORATION
WO/2021/255621TREATMENT OF FOOD ALLERGY USING ANTI-IGE ANTIBODIESNOVARTIS AG
WO/2021/255622COMBINATION OF ALCAFTADINE AND A CORTICOSTEROIDALKEM LABORATORIES LIMITED
WO/2021/255625PROTEASE COMPOSITIONANATARA LIFESCIENCES LIMITED
WO/2021/255639SYNTHESIS OF A GUANYLATE CYCLASE AGONIST BY FRAGMENTS BASED  APPROACHANTHEM BIOSCIENCES PRIVATE LIMITED
WO/2021/255648HYPERIMMUNE GLOBULINS FOR TREATMENT OF INFLUENZA AEMERGENT BIOSOLUTIONS CANADA INC.
WO/2021/255667IFENPRODIL FOR USE IN THE TREATMENT OF CHRONIC SEIZURESINSTYTUT BIOLOGII DOŚWIADCZALNEJ IM. MARCELEGO NENCKIEGO  POLSKA AKADEMIA NAUK
WO/2021/255681A SIMPLE PROCESS FOR THE PREPARATION OF FAVIPIRAVIR AND ITS  INTERMEDIATES THEREOFHIKAL LIMITED
WO/2021/255684SHIGELLA-TETRAVALENT (SHIGELLA4V) BIOCONJUGATEGLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/255690IMMUNOGENIC COMPOSITIONS AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM)  DIFFICILE AND METHODS THEREOFPFIZER INC.
WO/2021/255691COMPOSITIONS AND METHODS FOR TREATING VIRUS INFECTIONNOVMETAPHARMA CO., LTD.
WO/2021/260511MULTIPHASIC CONTRACEPTIVE AND/OR HORMONE REPLACEMENT THERAPYMILLICENT PHARMA LIMITED
WO/2021/260516AN ORGANIC AMINE SALT OF FAVIPIRAVIR AND A PROCESS FOR THE  PURIFICATION OF FAVIPIRAVIRPI INDUSTRIES LTD.
WO/2021/260525COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS  SYSTEMS FOR THE|DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULESUNIVERSITA' DEGLI STUDI DI TORINO
WO/2021/260528DOSING REGIMEN COMPRISING  3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVESNOVARTIS AG
WO/2021/260530LONG ACTING GLP-1/GIP DUAL AGONISTSSUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/240488COMPOSITIONS AND METHODS FOR TREATING NEOVASCULARIZATION AND  ISCHEMIC RETINOPATHIES BY TARGETING ANGIOGENESIS AND CHOLESTEROL TRANSPORTBAYLOR COLLEGE OF MEDICINE
WO/2021/260546COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF VAGINAL  DISEASESNEILOS S.R.L.
WO/2021/260552METHOD FOR TREATMENT OF PANCREATITISNOVMETAHEALTH CO., LTD.
WO/2021/260558AQUEOUS MEDIUM-SOLUBLE POWDER FOR BLOOD FLOW SIMULATIONBIOMODEX, S.A.S.
WO/2021/260560COMPOSITION FOR TREATING PULMONARY FIBROSISJW PHARMACEUTICAL CORPORATION
WO/2021/260567DISPERSIBLE TABLET FORMULATIONS COMPRISING DOLUTEGRAVIRVIIV HEALTHCARE COMPANY
WO/2021/260569FORMULATIONSVIIV HEALTHCARE COMPANY
WO/2021/260577METHODS OF TREATING INFLAMMATORY BOWEL DISEASE WITH TL1A  ANTIBODIESPFIZER INC.
WO/2021/260578COMBINATION OF ANTIBODY-DRUG CONJUGATE AND CDK9 INHIBITORASTRAZENECA UK LIMITED
WO/2021/260579COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATR INHIBITORASTRAZENECA UK LIMITED
WO/2021/260580COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATM INHIBITORASTRAZENECA UK LIMITED
WO/2021/260582COMBINATION OF ANTIBODY-DRUG CONJUGATE AND AURORA B INHIBITORASTRAZENECA UK LIMITED
WO/2021/260583COMBINATION OF ANTIBODY-DRUG CONJUGATE AND DNA-PK INHIBITORASTRAZENECA UK LIMITED
WO/2021/260591METHODS OF REDUCING MORTALITY IN PATIENTS SUFFERING FROM COPDPEARL THERAPEUTICS, INC.
WO/2021/260602HYPERIMMUNE GLOBULINS FOR TREATMENT AND PREVENTION OF COVID-19EMERGENT BIOSOLUTIONS CANADA INC.
WO/2021/260622OPHTHALMIC COMPOSITION AND USE THEREOF IN THE TREATMENT OF EYE  DISEASESSIFI S.P.A.
WO/2021/260636A PHARMACEUTICAL COMPOSITION COMPRISING L-CARNOSINE AND GINKGO  BILOBA EXTRACTSINGH, Shyam Sunder
WO/2021/260641ORAL FILM OF HIV DRUGSLAURUS LABS LIMITED
WO/2021/260657ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING  GENETICALLY ENGINEERED T CELLS TARGETING CD19CRISPR THERAPEUTICS AG
WO/2021/260662NON-ALCOHOLIC ANTISEPTIC GEL CONSISTS OF BENZALKONIUM CHLORIDEFARAHMNAD, Farrokh
WO/2021/260667COMPOSITION FOR HAIR FOLLICLE MODULATION, METHODS AND USES  THEREOFUNIVERSIDADE DO MINHO
WO/2021/260671EXTRACT OF A FUNGUS OF THE BOLETUS FUNGI FAMILY FOR USE IN  PARTICULAR IN THE PREVENTION OF COVID-19 DISEASEVAN ELSLANDE, Aude
WO/2021/260675AGENTS FOR SENSITIZING SOLID TUMORS TO TREATMENTYEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/024247OIL- SUSPENSION OF EDIBLE SOLIDS AND METHODS OF PREPARING THE  SAMEOMEGA 3 GALILEE LTD.
WO/2021/009761COMBINATION THERAPY FOR THE TREATMENT OF CANCERBIOLINERX LTD.
WO/2021/009763METHODS OF TREATING PAINYEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/014447TREATMENT OF SKIN DISORDERS WITH TOPICAL TAPINAROF-EGFR  INHIBITOR COMPOSITIONSSOL-GEL TECHNOLOGIES LTD.
WO/2021/014453TOPICAL JAK INHIBITOR COMBINATION COMPOSITIONS FOR TREATMENT  OF INFLAMMATORY SKIN CONDITIONSSOL-GEL TECHNOLOGIES LTD.
WO/2021/024256ANTICANCER AGENTSYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD
WO/2021/024258COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASESCARMEL HAIFA UNIVERSITY ECONOMIC CORPORATION LTD.
WO/2021/024263COMPOSITIONS TARGETING GPM6A AND METHODS FOR DIAGNOSIS AND  TREATMENT OF CANCERTEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
WO/2021/024265METHODS OF TREATING NON-INFECTIOUS INFLAMMATORY DISORDERSRAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/028908METHODS FOR PREVENTING AN IMMUNOGLOBULIN E-RELATED DISEASEMY-OR DIAGNOSTICS LTD.
WO/2021/028916PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF OPIOID  ANTAGONISTSYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/028917PHYTOCANNABINOIDS FOR PREVENTING OR TREATING NON-ALCOHOLIC  FATTY LIVER DISEASE, DYSLIPIDEMIA, AND TYPE 2 DIABETESYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/028919METHODS AND COMPOSITIONS FOR PREVENTING SKIN TOXICITIES CAUSED  BY BIOLOGICAL TARGETED CANCER DRUGSHADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED
WO/2021/028926SKIN-CARE COMPOSITIONS AND USES THEREOFAHAVA - DEAD SEA LABORATORIES LTD.
WO/2021/033180ADHESIVE DRUG DELIVERY MICROPARTICLES AND A PRODUCT COMPRISING  THEREOFPENHASI, Adel
WO/2021/033182ADHESIVE DRUG DELIVERY FILM AND A MICROPARTICLE COMPRISING  THEREOFPENHASI, Adel
WO/2021/044405THERAPEUTIC APOPTOTIC CELLS FOR TREATMENT OF OSTEOARTHRITISENLIVEX THERAPEUTICS LTD
WO/2021/038563PROTEIN BASED CANNABIS COMPOSITIONSIZUN PHARMACEUTICALS CORP.
WO/2021/038569TREATMENT OF BACTERIAL VAGINOSISYEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/038573DRUG CONTAINING TARGETING LIPOSOMESNEXTAR CHEMPHARMA SOLUTIONS LTD.
WO/2021/038574CANNABINOID CONTAINING TARGETING LIPOSOMESNEXTAGE CANNABIS INNOVATION LTD.
WO/2021/044420LIQUID COMPOSITIONS COMPRISING A LEVODOPA AMINO ACID CONJUGATE  AND USES THEREOFNEURODERM, LTD.
WO/2021/053667COMBINATION CANCER THERAPY AND CYTOKINE CONTROL THERAPY FOR  CANCER TREATMENTENLIVEX THERAPEUTICS LTD
WO/2021/053681IL-2 CHIMERIC PROTEINS FOR IMMUNOSUPPRESSIONNATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
WO/2021/059266ANTI-AGING COMPOSITIONS AND METHODS OF USE THEREOFS.I.S. SHULOV INNOVATIVE SCIENCE LTD.
WO/2021/059267COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE,  AGE-RELATED AND TRAUMA-INDUCED DISORDERSS.I.S. SHULOV INNOVATIVE SCIENCE LTD.
WO/2021/059270TREATMENT OF GENETIC DISEASES CHARACTERIZED BY UNSTABLE mRNAsYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/059275THIAMINE THERAPY FOR FATTY LIVER ASSOCIATED DISEASESTHE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL  DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER)
WO/2021/059281TREATMENT OF SKIN DISORDERS WITH TOPICAL COMBINATION  COMPOSITIONS COMPRISING TAPINAROF AND AN ADDITIONAL AHR ACTIVATORSOL-GEL TECHNOLOGIES LTD.
WO/2021/059283TREATMENT OF CUTANEOUS ADVERSE EFFECTS CAUSED BY ONCOLOGICAL  THERAPY WITH TOPICAL TAPINAROF COMPOSITIONSSOL-GEL TECHNOLOGIES LTD.
WO/2021/064729INJECTABLE COMPOSITION FOR THE TREATMENT OF MUSCULOSKELETAL  DISORDERS AND METHODS OF USE THEREOFPATCHOR LTD.
WO/2021/064730LIPOSOMAL CANNABINOIDS AND USES THEREOFYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD
WO/2021/070183A COMPOSITION FOR BOOSTING THE IMMUNE SYSTEMMAOLAC LTD.
WO/2021/070184COMPOSITIONS AND METHODS FOR INHIBITING COLLAGEN LOSSLYCORED LTD.
WO/2021/084527SELF-EMULSIFYING CANNABIS EXTRACTISRAEL PLASTICS AND RUBBER CENTER LTD.
WO/2021/084534METHODS AND COMPOSITIONS FOR TREATING, AMELIORATING,  PREVENTION AND RECURRENCE-PREVENTION OF ANORECTAL DISORDERSGINSBERG, Ori
WO/2021/084540INHIBITORS OF MMEJ PATHWAY FOR PREVENTION AND TREATMENT OF  PRE-MYELOID AND MYELOID MALIGNANCIESYEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/084541TREATMENT OF HAIR LOSS DISORDERS WITH A TOPICAL EGFR INHIBITORSOL-GEL TECHNOLOGIES LTD.
WO/2021/084543TREATMENT OF TOOTH DECAY USING A CHEWING GUM COMPOSITION  COMPRISING CANNABINOIDSM. MUSTIX LTD
WO/2021/090309ORALLY ADMINISTRABLE FILMS COMPRISING POORLY WATER SOLUBLE  ACTIVE INGREDIENTS AND PREPARATION THEREOFMAABAROT PRODUCTS LTD.
WO/2021/090322METHOD OF TREATING PALMOPLANTAR KERATODERMASOL-GEL TECHNOLOGIES LTD.
WO/2021/095032GLUCOSE UPTAKE INHIBITORS AND USES THEREOFMETABOMED LTD
WO/2021/100041TREATING ALZHEIMER'S DISEASEYEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/100051TREATMENT OF SKIN DISORDERS WITH TOPICAL COMPOSITIONS  COMPRISING TAPINAROF AND A PDE4 INHIBITORSOL-GEL TECHNOLOGIES LTD.
WO/2021/105996CANNABINOID AND LYCOPENE ANTI-INFLAMMATORY SYNERGISTIC  COMBINATIONSLYCORED LTD.
WO/2021/124316HIGH CBD CANNABIS SATIVA LINES AND EXTRACTS WITH  ANTI-INFLAMMATORY POTENCIES FOR ORAL AND GUT HEALTHSWYSH INC.
WO/2021/111441USE OF MMP INHIBITIONBIOND BIOLOGICS LTD.
WO/2021/111446BIODEGRADABLE POLYMERIC COMPOSITIONS, METHODS OF PREPARATION  AND USES THEREOFB.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION  UNIVERSITY
WO/2021/137222METHODS OF TREATING ATOPIC DERMATITISICHILOV TECH LTD.
WO/2021/137224CANNABIDIOLIC ACID ESTERS FOR TREATING MUSCULAR DYSTROPHYEPM GROUP, INC.
WO/2021/137225FLOATING DRUG DELIVERY SYSTEMS COMPRISING CANNABINOIDSYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/137229COMPOSITIONS, KITS AND METHODS FOR ENHANCING THERAPEUTIC  COMPLIANCERIVIA RESEARCH PTE. LTD.
WO/2021/137230METHODS OF CULTURING T CELLS AND USES OF SAMEKAHR MEDICAL LTD.
WO/2021/137234A MOLDED COMPOSITION FOR TOPICAL APPLICATION AND USES THEREOFFISCHER PHARMACEUTICALS LTD
WO/2021/137237MICROBIAL CONSORTIUM AND USES THEREOFBIOMICA LTD.
WO/2021/137241DELIVERY COMPOSITIONS AND METHODSEDITY THERAPEUTICS LTD.
WO/2021/144792STRESS MANAGEMENT IN HUMAN SUBJECTS IN NEED THEREOFYEDA RESEARCH & DEVELOPMENT CO. LTD.
WO/2021/144794COMPOUNDS FOR USE IN TREATMENT AND/OR PREVENTION OF  CLOSTRIDIAL NEUROTOXINS INTOXICATIONTHE ISRAEL INSTITUTE OF BIOLOGICAL RESEARCH (IIBR)
WO/2021/144798PEPTIDE COMPOUNDS AND METHODS OF TREATING DISEASES USING SAMEIMMUNITY PHARMA LTD.
WO/2021/144799CANNABINOIDS FOR USE IN TREATMENTCAN-FITE BIOPHARMA LTD.
WO/2021/152576MAGNETIC DRUG DELIVERY CAPSULES AND SYSTEMSPILLUETTE LTD.
WO/2021/149064COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY  CONDITIONS AND DISEASES OF THE SKINLANDVER, Guy
WO/2021/152579PEPTIDES USEFUL IN PRESERVATION AND/OR RESTORATION OF  FUNCTIONAL PANCREATIC ISLETS AND IN TREATING DIABETESTHE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
WO/2021/152587TREATING ACUTE LIVER DISEASE WITH TLR-MIK INHIBITORSYEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/152589ALPHA-1-ANTITRYPSIN MUTANTS, COMPOSITIONS COMPRISING SAME, AND  USE THEREOFB. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION  UNIVERSITY
WO/2021/181372AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF ACIDOSISAMORPHICAL LTD.
WO/2021/152601NOVEL ACTIVATORS OF THE LIPIDATING TRANSPORTER ATP BINDING  CASSETTE PROTEIN TYPE 1 (ABCA1) AND THERAPEUTIC USES THEREOFRAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/156856TOPICAL OPTHALMOLOGICAL COMPOSITION CONTAINING HYALURONATE AND  TAURINE HAVING NON-NEWTONIAN RHEOLOGICAL PROPERTIESRESDEVCO RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/156857COMPOSITIONS COMPRISING AMELOGENIN AND USES THEREOFPRUDENTIX LTD.
WO/2021/156869ASPACYTARABINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOFBIOSIGHT LTD.
WO/2021/161317STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING VALGANCYCLOVIR  AND USES THEREOFCTS CHEMICAL INDUSTRIES LTD.
WO/2021/161319COMBINATION THERAPY FOR TREATING AMYOTROPHIC LATERAL USING  PRIDOPIDINE AND ANOTHER ACTIVE AGENTPRILENIA NEUROTHERAPEUTICS LTD.
WO/2021/165960IMPROVED ANTIDEPRESSANT THERAPYICHILOV TECH LTD.
WO/2021/171285USE OF EARLY APOPTOTIC CELLS FOR TREATING COVID-19ENLIVEX THERAPEUTICS LTD
WO/2021/171294BACTERIAL CULTURES FOR INCREASING VITAMIN B12 IN PLANTSHINOMAN LTD.
WO/2021/171297COMPOSITIONS COMPRISING LTB AND PATHOGENIC ANTIGENS, AND USE  THEREOFMIGAL GALILEE RESEARCH INSTITUTE LTD.
WO/2021/191886COMPOSITIONS COMPRISING TERPENES AND TERPENOIDS AND USE  THEREOF FOR PREVENTING AND TREATING VIRAL-INDUCED INFECTIONS OF THE  RESPIRATORY SYSTEMEYBNA TECHNOLOGIES LTD.
WO/2021/181390ANTIGEN SPECIFIC EPITOPE–BASED ANTI-INFECTIVE VACCINESVAXIL BIOTHERAPEUTICS LTD.
WO/2021/191888<i>CANNABIS SATIVA</i> (HEMP AND CANNABIS)  PRODUCTS FOR VIRAL DISEASE PREVENTION AND MANAGEMENTI.P. ISRAEL PATENTS LTD.
WO/2021/181394METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND  SEQUELAE THEREOFPLURISTEM LTD.
WO/2021/181398CXCR4 INHIBITOR FOR THE TREATMENT OF ACUTE RESPIRATORY  DISTRESS SYNDROME AND VIRAL INFECTIONSBIOLINERX LTD.
WO/2021/186430NANO-DELIVERY SYSTEM AND THERAPEUTIC AND DIAGNOSTIC USE  THEREOFBAR ILAN UNIVERSITY
WO/2021/186435POLYMERIC COMPOSITIONS FOR INTRANASAL ADMINISTRATIONNASUS PHARMA LTD.
WO/2021/186437TREATMENT WITH POWDERED INTRANASAL EPINEPHRINENASUS PHARMA LTD.
WO/2021/186438MOLECULES THAT TARGET PROTEINS OF CORONAVIRUSES AND USES  THEREOF AS ANTI-VIRAL "COCKTAIL"BAR-ILAN UNIVERSITY
WO/2021/186453COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING A  CORONAVIRUS INFECTIONALKALAY, Rachel
WO/2021/186454COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING  NON-MALIGNANT RESPIRATORY DISEASEALKALAY, Rachel
WO/2021/186455COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING  INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND  THYROID DISEASESALKALAY, Rachel
WO/2021/186456COMPOSITIONS AND METHODS FOR TREATING SOLID AND SOFT TUMORS  AND PROLIFERATIVE DISEASESALKALAY, Rachel
WO/2021/191891CANNABINOID COMPOSITIONS AND AEROSOLSROXX LABS LTD.
WO/2021/191895PHARMACEUTICAL COMPOSITIONS AND USE THEREOFHADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
WO/2021/191903PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES  AND METHODS OF USE THEREOFBONE SCI. BIO LTD.
WO/2021/191904METHODS FOR PREVENTING AND TREATING VIRAL INFECTIONTREE OF LIFE PHARMA LTD.
WO/2021/191907LIPOSOMAL FORMULATIONS COMPRISING AT1 RECEPTOR BLOCKERS AND  USES THEREOFYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/199028COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSISSPLISENSE LTD.
WO/2021/199029COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSISSPLISENSE LTD.
WO/2021/199032MITOCHONDRIAL AUGMENTATION THERAPYMINOVIA THERAPEUTICS LTD.
WO/2021/199035MEANS AND METHODS FOR ENHANCING CANNABINOIDS EFFICACYMOLAD, Ami
WO/2021/199040MITOCHONDRIA-ENRICHED GENETICALLY ENGINEERED CELLS AND USES  THEREOFMINOVIA THERAPEUTICS LTD.
WO/2021/199041SYSTEM AND A METHOD FOR OBTAINING AN IMPROVED PLASMA EXTRACTESTAR TECHNOLOGIES LTD
WO/2021/199046IMMUNOMODULATORY COMPOSITIONS AND USE THEREOFBIOND BIOLOGICS LTD.
WO/2021/205437PHARMACEUTICAL COMPOSITIONS FOR TREATING CORONA VIRUS DISEASEVECHT-LIFSHITZ, Susan Eve
WO/2021/205438ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF  CANCERS AND INFECTIONSYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/205446PICKERING EMULSION-BASED VACCINESTHE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL  DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER)
WO/2021/205459CANNABIDIOL-CONTAINING COMPOSITIONS AND USES THEREOFRAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/209990COMPOSITION AND METHOD FOR TREATING CANCER WITH CANNABINOIDSCANNABICS PHARMACEUTICALS INC.
WO/2021/209992COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASESRAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/209993USE OF METABOLIC REGULATORS FOR THE TREATMENT OF COVID-19YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/209995CELL-DERIVED VESICLES COMPRISING WILD-TYPE P53 PROTEIN FOR  ANTIVIRAL THERAPYEXOPROTHER MEDICAL LTD.
WO/2021/209998COMPOSITION FOR THE TREATMENT OF RESPIRATORY SYMPTOMS AND  METHODS THEREOFMOLAD, Ami
WO/2021/210002CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE  THEREOF IN THERAPYICHILOV TECH LTD.
WO/2021/214764SOLID DISPERSIONS AND PARTICLES AND METHODS FOR  CONTROLLED-RELEASE OF LIPID-SOLUBLE OR DISPESIBLE ACTIVESYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/214767NOVEL THRERAPY FOR ACUTE DAMAGE TO LUNG TISSUEREMODELESS CV LTD
WO/2021/214771GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR PREVENTION AND  TREATMENT OF VIRAL DISEASESTHE ISRAEL INSTITUTE OF BIOLOGICAL RESEARCH (IIBR)
WO/2021/214772METHODS AND REGIMENS FOR THE TREATMENT OF HEMATOLOGICAL CANCERBIOSIGHT LTD.
WO/2021/220273PHARMACEUTICAL COMPOSITIONS FOR RELIEF OF COVID-19 SYMPTOMS  AND METHODS OF PRODUCING AND USING THEMZALTZMAN, Pinchas
WO/2021/220284E PROTEIN CHANNEL BLOCKERS AND ORF3 INHIBITORS AS  ANTI-COVID-19 AGENTSYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/224912GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHINGYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/224914TREATMENT OF VIRAL INFECTION, DISEASE OR DISORDER USING A  SELECTIVE S1R AGONISTPRILENIA NEUROTHERAPEUTICS LTD.
WO/2021/224920METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET CELLSPLURISTEM LTD.
WO/2021/224924CANNABIDIOLIC ACID ESTERS FOR TREATING RESPIRATORY DISTRESS  INCLUDING ACUTE RESPIRATORY DISTRESS SYNDROME AND CORONAVIRUSEPM (IP), INC.
WO/2021/224930PRO-LYCOPENE RICH COMPOSITION AND METHODS OF USING SAMELYCORED LTD.
WO/2021/229566COMPOSITIONS OF TRYPTOPHOL DERIVATIVES AND 4-ETHYL-PHENOL  DERIVATIVES, AND METHODS OF USING SAMEB. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION  UNIVERSITY
WO/2021/229574COMPOSITIONS FOR INHALATION AND USES THEREOF FOR DISINFECTING  THE UPPER RESPIRATORY AIRWAYSCOROLABS LTD.
WO/2021/229577COLLAGEN AS A DELIVERY TOOL FOR METAL-BASED ANTI-VIRAL AGENTSCOLLPLANT LTD.
WO/2021/229578COMPOSITIONS FOR DELIVERY OF BIOACTIVE AGENTS INTO HAIR  FOLLICLESFOLLICLE PHARMA LTD
WO/2021/234687ANTIVIRAL COMPOSITIONS COMPRISING LIPOSOME-ENCAPSULATED  ASCORBYL GLUCOSIDE AND NATURAL EXTRACTSBIONEXT LABS LTD
WO/2021/229581DE-NOVO DESIGNED TRANSMEMBRANE POLYPEPTIDES AND THEIR USES IN  CELLULAR IMMUNOTHERAPYYEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/240505COMPOSITIONS FOR TREATMENT OF PSORIASIS OF THE SCALPINNOCAN PHARMA LTD.
WO/2021/234697COMPOSITIONS AND METHODS FOR THE TREATMENT AND MANAGEMENT OF  INFLAMMATION USING HYDROXYNORKETAMINESPIRIFY PHARMA INC.
WO/2021/234700PHOTOSYNTHETICALLY CONTROLLED SPIRULINA EXTRACTS FOR TREATING  THE CYTOKINE STORM SYNDROMEVAXA TECHNOLOGIES LTD.
WO/2021/234716STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES  THEREOFSOL-GEL TECHNOLOGIES LTD.
WO/2021/240510COMPOSITIONS OF CANNABINOIDS AND METHODS OF USING SAMEASANA BIO GROUP LTD.
WO/2021/240519INHIBITORS OF AMINO ACIDS TRANSPORTERS AND USE THEREOFHADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
WO/2021/245658COMPOSITIONS AND METHODS FOR TREATING HEADACHESTECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED
WO/2021/245677COMPOSITIONS AND METHODS FOR TREATING DYSPLASTIC AND  EARLY-STAGE NEOPLASTIC CONDITIONSDIGESTIX BIOSCIENCE INC.
WO/2021/245679A SARS-COV-2 VACCINETHE ISRAEL INSTITUTE OF BIOLOGICAL RESEARCH
WO/2021/245682NOVEL PEPTIDE VACCINES AND USES THEREOFBAR-ILAN UNIVERSITY
WO/2021/250661SHAN-ZHA FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERSTHE OPEN UNIVERSITY
WO/2021/255741EPHB2 ANTIBODY AND USE THEREOF IN COMBINATION THERAPY4C BIOMED SERVICES LTD.
WO/2021/260692COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASE  CAUSED BY CORONAVIRUSKAMADA LTD.
WO/2021/038577MESQUITE GUM COMPOSITIONS AS COLON TARGETED DELIVERY SYSTEMCHOUDHARI, Alap
WO/2021/181402SARVA JURA KUDINEERMALARKANNAN, S.P.
WO/2021/106004PHARMACEUTICAL COMPOSITION OF S-ADENOSYLMETHIONINEKUSUM HEALTHCARE PVT. LTD.
WO/2021/084548A METHOD OF MANUFACTURING OF NANO ZINC FOR SLOW RELEASE,  ENHANCED UTILIZATION BY THE PLANTS AND APPLICATION THEREOFNANO BIOTECHNOLOGY RESEARCH CENTER, INDIAN FARMERS FERTILISER  COOPERATIVE LIMITED (IFFCO) KALOL
WO/2021/048868A DRUG DELIVERY CARRIER COMPOSITION FOR BRAIN DISORDERSGUNDALA, Venkata Naveen Kumar
WO/2021/152605A PAIN-RELIEF FORMULATION AND THE METHOD THEREOFSOMADE, Prakash Maruti
WO/2021/014459NOVEL SOLID EMULSION FORMULATION USING SYNBIOTICS AND PROCESS  THEREOFLOVELY PROFESSIONAL UNIVERSITY
WO/2021/009768AN ORAL PHARMACEUTICAL COMPOSITION FOR ALPHA- AMYLASE  INHIBITIONLOVELY PROFESSIONAL UNIVERSITY
WO/2021/001860PHARMACEUTICAL COMPOSITIONS OF BOSWELLIA SERRATAREDASANI, Vijayendrakumar Virendrakumarji
WO/2021/005623A VACCINE FORMULATION FOR PROTECTION AGAINST ENTEROTOXIGENIC  <i>E. COLI</i> (ETEC) AND CHOLERAMSD WELLCOME TRUST HILLEMAN LABORATORIES PVT. LTD.
WO/2021/009770A PROCESS FOR THE PREPARATION OF VENETOCLAX AND ITS POLYMORPHS  THEREOFNATCO PHARMA LIMITED
WO/2021/240531TRANSMUCOSAL DOSAGE FORMS OF REMDESIVIRJUBILANT GENERICS LIMITED
WO/2021/009775ORAL FORMULATIONS OF EDARAVONE AND METHOD OF MANUFACTURING  THEREOFBDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
WO/2021/229591NOVEL USE OF NON-IONIC SURFACTANT FOR THE TREATMENT OF  COVID–19KRISHNAMACHARI, Ramu
WO/2021/019576OPTHALMIC COMPOSITION OF BEVACIZUMABGENNOVA BIOPHARMACEUTICALS LIMITED
WO/2021/199056VACCINE FOR NOVEL CORONA VIRUSSINHA, Kanishk
WO/2021/024274A PERSONAL CARE COMPOSITIONFINE ORGANIC INDUSTRIES LIMITED
WO/2021/033198AN IMPROVED PROCESS FOR PREPARATION OF VILANTEROL OR A  PHARMACEUTICALLY ACCEPTABLE SALT THEREOFMELODY HEALTHCARE PVT. LTD
WO/2021/044434COMPOSITION FOR TREATMENT OF BURN WITH SCAR REMOVALJOSE, Huxley
WO/2021/260712A LIPOSOMAL COMPOSITION OF PTEROCARPUS SANTALINUS AND THE  PROCESS THEREOFPHATAK, Rohan Sharadanand
WO/2021/028943CANNABIDIOL ORALLY DISINTEGRATING TABLETSTENSHI KAIZEN PRIVATE LIMITED
WO/2021/038596COMPOSITION FOR POSITRON EMITTING TOMOGRAPHY IMAGING IN  CUSHING'S SYNDROMEWALIA, Dr. Rama
WO/2021/100056PROLONGED RELEASE PHARMACEUTICAL COMPOSITIONS OF IVABRADINEABBOTT HEALTHCARE PVT. LTD.
WO/2021/038601LIQUID PHARMACEUTICAL COMPOSITIONS OF MELATONIN FOR ORAL AND  PARENTERAL ADMINISTRATIONREDASANI, Vijayendrakumar Virendrakumarji
WO/2021/044436IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS  FOR ITS PREPARATION THEREOFSERUM INSTITUTE OF INDIA PRIVATE LIMITED
WO/2021/048871SYNERGISTIC BIOACTIVE COMPOSITIONS FOR TREATING NEUROLOGICAL  DISORDERSCELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/070200STABLE COMPOSITIONS OF (7AS,2'S)-2-OXOCLOPIDOGREL AND ITS  PHARMACEUTICAL SALTSIPCA LABORATORIES LIMITED
WO/2021/074930NITROGEN CONTAINING BICYCLIC COMPOUNDSWOCKHARDT LIMITED
WO/2021/079380IMPROVED PROCESS FOR THE PREPARATION OF  (2S)-N-{(1S)-1-(2-CHLOROPHENYL)-2-[(3,3-DIFLUOROCYCLOBUTYL)-AMINO]-2-OXOETHYL}-1-(4-CYANOPYRIDIN-2-YL)-N-(5-FLUOROPYRIDIN-3-YL)-5-OXOPYRROLIDINE-2-CARBOXAMIDEMSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/095048ORALLY DISINTEGRATING PHARMACEUTICAL COMPOSITIONS OF APIXABANUNISON PHARMACEUTICALS PVT. LTD.
WO/2021/084559SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR TREATING  CEREBROVASCULAR DISEASESCELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/084560SYNERGISTIC NUTRITIONAL NEUROPROTECTIVE COMPOSITIONS FOR  AMELIORATING NEURAL DYSFUNCTIONCELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/100063ORAL FILM COMPOSITION COMPRISING LEVOTHYROXINEWOCKHARDT LIMITED
WO/2021/124344PYRIDAZINE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE-2  INHIBITORSAbida
WO/2021/111464A PROCESS FOR THE PREPARATION OF HIGHLY PURE VALSARTANHARMAN FINOCHEM LIMITED
WO/2021/124346NOVEL 4-(6-OXO-3-SUBSTITUTED PHENYLPYRIDAZIN-1(6  <i>H</i>)-YL)BENZALDEHYDES OF PHARMACEUTICAL INTEREST/, Abida
WO/2021/111470A PROCESS FOR PREPARATION OF PEGYLATED THERAPEUTIC PROTEINSINDIAN INSTITUTE OF TECHNOLOGY DELHI
WO/2021/117057POLYMORPH OF  N-ETHYL-1-(3-(TRIFLUOROMETHYL)PHENYL)PROPAN-2-AMINE HYDROCHLORIDE AND PROCESS  FOR PREPARATION THEREOFMAITHRI DRUGS PVT LTD
WO/2021/117062Process for the preparation of  4-[7-(6-Cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-  diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide and its polymorphsMSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/117065FORMULATIONS OF POLYBASIC DRUGS TO REDUCE MULTI-ORGAN TOXICITYCHAUDHARY, Manu
WO/2021/130779PHARMACEUTICAL COMPOSITION OF CASR MODULATORS AND METHODS AND  USES THEREOFLUPIN LIMITED
WO/2021/137257SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR ENHANCING ATP  EFFICIENCYCELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/140524VIRAL VACCINE COMPOSITIONS AND METHODS OF PREPARATIONS THEREOFBHARAT BIOTECH INTERNATIONAL LIMITED
WO/2021/1864586-OXO-3-PHENYLPYRIDAZINE BASED CYCLOOXYGENASE-2 INHIBITORS FOR  THE TREATMENT OF INFLAMMATORY DISEASESABIDA
WO/2021/152623IMPROVED PROCESSES FOR THE PREPARATION OF TAFAMIDIS AND ITS  MEGLUMINE SALTDR. REDDY’S LABORATORIES LIMITED
WO/2021/152624NOVEL DENTAL CARE AND CLEANSING COMPOSITIONGROUP PHARMACEUTICALS LIMITED
WO/2021/152635HAIR CARE COMPOSITION AND A METHOD OF PREPARING THE SAMEBAJAJ CONSUMER CARE LTD.
WO/2021/161346PROCESS FOR THE PREPARATION OF GAMMA AMINO BUTYRIC ACIDS AND  ANALOGS THEREOFCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/165998A STABLE DELIVERY COMPLEX COMPRISING A DIPEPTIDE WITH A  CONFORMATIONALLY RESTRICTED AMINO ACIDINTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
WO/2021/171318TRANSMUCOSAL PHARMACEUTICAL COMPOSITION OF LEVOCETIRIZINEALKEM LABORATORIES LTD
WO/2021/176479COMPOSITION FOR ENHANCING CHANCES OF CONCEPTION AND FEMALE SEX  RATIO IN BOVINESAGROCLEAN
WO/2021/176480BIMETALLIC FLUORESCENT NANOCOMPOSITES FOR CANCER THERANOSTICSCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/181420PROCESS FOR THE SYNTHESIS OF CANNABIDIOL AND INTERMEDIATES  THEREOFCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN  REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860)
WO/2021/186471SOLID DOSAGE FORMS FOR ORAL CO-ADMINISTRATION OF POLYPHENOLS  AND TRANSITION METAL IONSINVENTIA HEALTHCARE LIMITED
WO/2021/191926TASTE MASKED AND RAPIDLY DISINTEGRATING ULTRA THIN IRON  ORODISPERSIBLE FILM AND A PROCESS THEREOFAAVISHKAR ORAL STRIPS PRIVATE LIMITED
WO/2021/191928EFLORNITHINE COMPOSITION AND DOSAGE FORMS FOR THE TREATMENT OF  VIRAL INFECTIONNAVIN SAXENA RESEARCH & TECHNOLOGY PVT. LTD.
WO/2021/199076INJECTABLE ARIPIPRAZOLE FORMULATIONCIPLA LIMITED
WO/2021/199077RISPERIDONE MICROSPHERES, PROCESS FOR THEIR PREPARTION AND  USES THEREOFBIOLOGICAL E LIMITED
WO/2021/199078INTERACTION OF SARS-COV-2 PROTEINS WITH MOLECULAR AND CELLULAR  MECHANISMS OF HOST CELLS AND FORMULATIONS TO TREAT COVID-19.AKSEERA PHARMA CORP.
WO/2021/199082ANTIMICROBIAL COMPOUNDS AND USES THEREOFJAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH
WO/2021/205471COMPOSITION, INJECTABLE HYDROGEL AND METHODS THEREOFJAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH
WO/2021/205473STRUCTURALLY DEFINED, BETTER TOLERATED, ORALLY ADMINSTERED,  PROCESSED ARSENOLITE, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL  COMPOSITION AND USES THEREOFBENDALE, Yogesh
WO/2021/210025COMPOSITIONS AND METHODS FOR COATINGS, ANTIMICROBIAL TEXTILES,  SANITIZATION AND DISINFECTIONINDIAN INSTITUTE OF TECHNOLOGY BOMBAY
WO/2021/210026A CELL-FREE GROWTH FACTOR CONCENTRATE, METHOD OF PREPARING THE  SAME AND A KIT THEREOFPALANIVEL, Vasanthi
WO/2021/220293PRE-SHAMPOO FORMULATION AND METHOD OF PREPARING THE SAMEDAWAR, Premal
WO/2021/220297A NOVEL POLYHERBAL PHARMACEUTICAL COMPOSITION EXHIBITING  IMMUNOMODULATORY AND ANTI-VIRAL ACTIVITY AND METHOD OF PREPARATION THEREOFKARNAN, Ramakrishnan
WO/2021/234724Pharmaceutical formulation containing stable granules of  clavulanic acidTWENTY FIRST CENTURY PHARMACEUTICALS PVT. LTD.
WO/2021/224938IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDENEULAND LABORATORIES LIMITED
WO/2021/224946CORONAVIRUS VACCINE THROUGH NASAL IMMUNIZATIONBHARAT BIOTECH INTERNATIONAL LIMITED
WO/2021/229602USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONSGODAVARI BIOREFINERIES LIMITED
WO/2021/229603FORMULATION OF PURE DIMETHOXY CURCUMIN-HUMAN SERUM ALBUMIN AND  A PROCESS FOR THE PREPARATION THEREOFSREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND  TECHNOLOGY
WO/2021/229609COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF  CONDITIONS CAUSED BY SARS-COV-2 (COVID-19)BIOINCEPTION PVT LTD
WO/2021/234731SUSTAINED RELEASE COMPOSITIONSDR REDDY'S INSTITUTE OF LIFE SCIENCES
WO/2021/240540NOVEL SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR TREATING  SEIZURES AND CHRONIC INFLAMMATORY DISEASESCELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/240543TRANSMUCOSAL PHARMACEUTICAL COMPOSITIONS OF ANTIVIRAL DRUGSJUBILANT GENERICS LIMITED
WO/2021/245696HERBAL MOUTHWASH FORMULATIONBIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS), PILANI
WO/2021/245697NOVEL SYNERGISTIC MEDICINAL COMPOSITIONS FOR TREATING  DYSFUNCTIONAL D-SERINE SIGNALINGCELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/245704PHARMACEUTICAL COMPOSITIONS FOR PERIODONTAL DISEASEDR. REDDY’S LABORATORIES LTD.
WO/2021/245705AZIRINE CONTAINING COMPOUNDS AS ANTI-ANGIOGENESIS AGENTS AND A  PROCESS FOR THE PREPARATION THEREOFCOUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
WO/2021/245706SAFE AND HIGHLY EFFECTIVE BROAD SPECTRUM PRESERVATIVE  COMPOSITION GINOGUARD GPGODREJ INDUSTRIES LTD (CHEMICALS)
WO/2021/245707SYNTHESIS OF AMINOACID CONJUGATE OF  TRIS(HYDROXYMETHYL)PHOSPHINE AND NANOPARTICLE COMPOSITION THEREOFDHANVANTARI NANO AYUSHADI PVT. LTD.
WO/2021/250700PHARMACEUTICAL COMPOSITION OF PANCREATINKUSUM HEALTHCARE PVT. LTD.
WO/2021/250702IMPROVED PROCESS FOR PREPARATION OF SITAGLIPTINAARTI INDUSTRIES LIMITED
WO/2021/250705A PROCESS FOR PREPARATION OF 3,6-DICHLOROCYANO PYRAZINE,  3,6-DIOXOPIPERAZINE DERIVATIVES AND PRODUCTION OF FAVIPIRAVIR THEREOFCOUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (AN INDIAN  REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860))
WO/2021/255760HERBAL FORMULATION FOR THE TREATMENT OF MENOPAUSAL SYNDROMEINDIAN COUNCIL OF MEDICAL RESEARCH
WO/2021/260727ORAL LIQUID FORMULATIONS OF RUXOLITINIBNOVARTIS AG
WO/2021/260731WATER SOLUBLE 3-O-ACETYL-11-KETO-β-BOSWELLIC ACID AND METAL  ION COMPOSITIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOFLAILA NUTRACEUTICALS
WO/2021/260740NOVEL SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR PROMOTING  AXONAL REGENERATIONCELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/044448MOUTHWASH COMPRISING BLACK MULBERRY FRUIT EXTRACTMOHAMMADI, Fatemeh
WO/2021/100065SOLUBLE PREPARATION FOR NASAL DOUCHES, CORRESPONDING NASAL  IRRIGATION KIT AND OPERATING PROCEDURE FOR CARRYING OUT NASAL DOUCHESOTOSAN S.R.L.
WO/2021/005630RADIOPHARMACEUTICAL COMPOUND AND COMPOSITION FOR POSITRON  EMISSION TOMOGRAPHY (PET) IMAGING OF INTERLEUKIN-2 RECEPTOR POSITIVE CELLS,  PROCESS FOR THE PREPARATION THEREOF, RELATED KIT AND USES THEREOFSAPIENZA UNIVERSITA' DI ROMA
WO/2021/019588NANOTECHNOLOGY-BASED DELIVERY SYSTEM OF BERGAMOT ESSENTIAL  OIL, METHOD OF PREPARATION OF THE SYSTEM AND USES THEREOFUNIVERSITà DELLA CALABRIA
WO/2021/090345COMPOSITION AND FORMULATION FOR THE TREATMENT OF INTESTINAL  GAS AND BLOATINGBIOFARMA S.R.L.
WO/2021/181436PEROXIREDOXIN 6 OR A SYNTHETIC ANALOGUE THEREOF FOR USE AS A  HYPOGLYCAEMIC AGENTUNIVERSITà DEGLI STUDI DI ROMA "TOR VERGATA"
WO/2021/186484PEROXIREDOXIN 6 (PRDX6) FOR USE IN THE TREATMENT OF  RESPIRATORY DISORDERSUNIVERSITà DEGLI STUDI DI ROMA "TOR VERGATA"
WO/2021/210033CATECHIN CONTAINING COMPOSITIONS AND USESADAMAS BIOTECH S.R.L
WO/2021/220319POLYNUCLEOTIDES ENCODING SARS-COV-2 ANTIGENS AND USE THEREOF  IN THE MEDICAL FIELD AS VACCINESTAKIS S.R.L.
WO/2021/240568ADENOSINE FOR THE PREVENTION AND TREATMENT OF ACUTE  RESPIRATORY DISTRESS SYNDROME (ARDS)UNIVERSITà DEGLI STUDI DI ROMA "TOR VERGATA"
WO/2021/181437A METHOD OF PREPARING ALGINATE MICRO-PARTICULATESUNIVERSITY OF PETRA
WO/2021/001986ORAL CAVITY COMPOSITION FOR ANIMAL, AND PERIODONTAL  DISEASE-PREVENTING AGENT, INFECTIOUS DISEASE-PREVENTING AGENT, AND  HALITOSIS-PREVENTING AGENT WHICH ARE FOR ANIMAL AND USE SAMESOSIN CO., LTD.
WO/2021/005676COMPOSITIONS FOR PREPARING MICROEMULSION, MICROEMULSION,  METHOD FOR PRODUCING COMPOSITION AND MICROEMULSION, AND USE OF MICROEMULSIONMORESCO CORPORATION
WO/2021/014654HYDROPHILIZED ORGANIC POWDER AND COSMETIC INCLUDING  HYDROPHILIZED ORGANIC POWDERMIYOSHI KASEI, INC.
WO/2021/014655HYDROPHILIZED INORGANIC POWDER AND COSMETIC COMPOUNDED WITH  SAID HYDROPHILIZED INORGANIC POWDERMIYOSHI KASEI, INC.
WO/2021/014656HYDROPHILIZED INORGANIC POWDER AND COSMETIC PREPARATION  CONTAINING SAID HYDROPHILIZED INORGANIC POWDERMIYOSHI KASEI, INC.
WO/2021/024393CANCER COMBINATION THERAPY USING AZABICYCLIC COMPOUND AND  POLYADENOSINE-5'-DIPHOSPHATE RIBOSE POLYMERASE INHIBITORTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/024419PHARMACEUTICAL COMPOSITIONHIRATA CORPORATION
WO/2021/024485HALAL DISINFECTANT LIQUIDHONBUSANKEI CO., LTD.
WO/2021/029020ORAL PHARMACEUTICAL COMPOSITIONOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/033247CELL-CONTAINING PHARMACEUTICAL COMPOSITIONCELLAXIA INC.
WO/2021/038679INTRAORAL SURFACE PATCHLTASTE INC.
WO/2021/044608DANTROLENE AQUEOUS FORMULATION AND METHOD FOR PREPARING SAMECMIC HOLDINGS CO., LTD.
WO/2021/048961AGENT FOR SUPPRESSING/IMPROVING BAD SKIN CAUSED BY FATIGUE  AND/OR STRESS AND SCREENING METHOD FOR AGENTS FOR SUPPRESSING/IMPROVING BAD  SKIN CAUSED BY FATIGUE AND/OR STRESSSHISEIDO COMPANY, LTD.
WO/2021/044640ANTICANCER AGENTISHII, Hitoshi
WO/2021/079435BACTERIOPHAGE COMPOSITIONMEIJI SEIKA PHARMA CO., LTD.
WO/2021/084760METHOD FOR SKIN STATE EVALUATION USING ACTIVATED PAR-2 IN SKIN  AS INDEX, METHOD FOR SCREENING PAR-2 ACTIVATION PROMOTER OR INHIBITOR, AND  PAR-2 ACTIVATION INHIBITORSHISEIDO COMPANY, LTD.
WO/2021/095092ORALLY DISINTEGRATING TABLETOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/106209ADHESIVE PATCHKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/106210POULTICEKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/106212ADHESIVE PATCHKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/106214ADHESIVE PATCHKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/111636ANTI-GDF15 ANTIBODYOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/117122PROPHYLACTIC OR THERAPEUTIC AGENT FOR LYSOSOMAL ACID LIPASE  DEFICIENCY SYNDROMEREBORNA BIOSCIENCES, INC.
WO/2021/111641GUIDE RNA FOR CONDITIONAL AND POST-TRANSCRIPTIONAL CONTROL OF  CRISPR-CAS PROTEINTHE UNIVERSITY OF TOKYO
WO/2021/106231A COMPOUND HAVING INHIBITORY ACTIVITY AGAINST KRAS G12D  MUTATIONTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/0847654-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOFTAIHO PHARMACEUTICAL CO., LTD
WO/2021/124495SKIN CLEANSER COMPOSITIONKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/124496SPRAY PREPARATION FOR SKIN CLEANINGKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/124497LIQUID COMPOSITION FOR SKIN CLEANSINGKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/131021ANTI-CTLA-4 ANTIBODY AND USE THEREOFCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/131032ADHESIVE PATCHNICHIBAN CO., LTD.
WO/2021/144936COMPOSITION CONTAINING FULLERENE CLATHRATED WITH ORGANIC  COMPOUND, AND COSMETIC AND EXTERNAL-USE COMPOSITION CONTAINING SAMEYOKOTA, Junji
WO/2021/009950AGENT FOR ENHANCING EFFECT OF ANTICANCER AGENTDELTA-FLY PHARMA, INC.
WO/2021/181711ALLERGY THERAPEUTIC AGENTISHII, Hitoshi
WO/2021/186579ORALLY INGESTIBLE ADSORBENT AND METHOD FOR PRODUCING SAMEOHGI TECHNOLOGICAL CREATION CO., LTD.
WO/2021/192113METHOD FOR TREATING CANCER AND SYSTEM THEREFOROTSUKA MEDICAL DEVICES CO., LTD.
WO/2021/106240PRODUCTION METHOD FOR EDIBLE FILM, FILM PREPARATION, AND  EDIBLE FILMNISSHA CO.,LTD.
WO/2021/070407PRODUCTION METHOD AND DETECTION METHOD OF AFRICAN SWINE FEVER  VIRUSNATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION
WO/2021/192270HYDROUS PATCHNICHIBAN CO., LTD.
WO/2021/199239PACKAGED AQUEOUS COMPOSITIONKOWA COMPANY, LTD.
WO/2021/131092PHARMACEUTICAL PRODUCTSENJU PHARMACEUTICAL CO., LTD.
WO/2021/166274PHARMACEUTICAL PRODUCTSENJU PHARMACEUTICAL CO., LTD.
WO/2021/205629METHOD FOR PRODUCING POWDER SURFACE-TREATED WITH GEMINI IONIC  SURFACTANT, ULTRAVIOLET ABSORBER, AND THICKENER, WATER DISPERSION THEREOF,  AND COSMETICS INCORPORATING SAMEMIYOSHI KASEI, INC.
WO/2021/210070PHARMACEUTICAL COMPOSITION FOR ADENOVIRAL CONJUNCTIVITISOKUDA Kenji
WO/2021/214905PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING OR  TREATING CANCER WITH COMBINED USE OF ANTI-HUMAN FN14 ANTIBODY AND IMMUNE  CHECKPOINT INHIBITORASTELLAS PHARMA INC.
WO/2021/214950PHARMACEUTICAL COMPOSITION FOR TREATMENT, PREVENTION OR  MANAGEMENT OF MENTAL DISORDERNATIONAL UNIVERSITY CORPORATION SHIMANE UNIVERSITY
WO/2021/224999MICROSPHERES IN WHICH BIOACTIVE SUBSTANCE IS UNIFORMLY  DISPERSED, AND SUSTAINED-RELEASE PREPARATION CONTAINING SAMEM. TECHNIQUE CO., LTD.
WO/2021/038975BIFIDOBACTERIUM SPP. EXPRESSING AND SECRETING DIABODY-TYPE  BSABANAEROPHARMA SCIENCE, INC.
WO/2021/250741LIQUID COSMETIC PREPARATION FOR EYELINERNIPPON TELEGRAPH AND TELEPHONE CORPORATION
WO/2021/250742COSMETIC FOR EYELASHESNIPPON TELEGRAPH AND TELEPHONE CORPORATION
WO/2021/005941ALBIZIA JULIBRISSIN EXTRACT-CONTAINING COMPOSITIONTOYOBO CO., LTD.
WO/2021/260750SKINCARE COSMETIC FREE OF SODIUM HYDROXIDE AND POTASSIUM  HYDROXIDENAKAJIMA SANGYO KABUSHIKIKAISHA
WO/2021/033420PORCINE CIRCOVIRUS TYPE 2 VLP VACCINEJECTAS INNOVATORS COMPANY LIMITED
WO/2021/084791COMPOSITION TARGETED TO ADENOSINE A2A RECEPTORIMMNO, INC.
WO/2021/059645DENTAL COMPOSITION AND DENTAL RESTORATION KITGC CORPORATION
WO/2021/002352COMPOSITION FOR TREATING OR PREVENTING TARDIVE DYSKINESIA, AND  METHOD FOR SCREENING ACTIVE INGREDIENT FOR TREATING OR PREVENTING TARDIVE  DYSKINESIAKYOTO UNIVERSITY
WO/2021/002355PHARMACEUTICAL COMPOSITION FOR TREATING INFLUENZA VIRUS  INFECTIONSAILLIS INC.
WO/2021/002359NUCLEIC ACID DRUG AND USE THEREOFVERITAS IN SILICO INC.
WO/2021/006143HAIR COSMETICKAO CORPORATION
WO/2021/002411METHOD FOR MANUFACTURING ORALLY DISINTEGRATING TABLET, AND  ORALLY DISINTEGRATING TABLETSAWAI PHARMACEUTICAL CO., LTD.
WO/2021/006199TREATMENT OF HEMATOLOGIC CANCER WITH PD-1/CD3 DUAL SPECIFICITY  PROTEINONO PHARMACEUTICAL CO., LTD.
WO/2021/006202MODIFIED NEURAMINIDASETOKUSHIMA UNIVERSITY
WO/2021/002457AGENT FOR SUPPRESSING BITTERNESS IN ASENAPINE, AND METHOD FOR  SUPPRESSING BITTERNESSMEIJI SEIKA PHARMA CO., LTD.
WO/2021/006222NUCLEIC ACID CARRIER AND METHOD FOR ADMINISTERING NUCLEIC ACIDTOKYO MEDICAL UNIVERSITY
WO/2021/075095HARDENING PASTE AND ALGINATE DENTAL IMPRESSION MATERIALGC CORPORATION
WO/2021/020047IMMUNE INDUCER AND PHARMACEUTICAL COMPOSITION FOR PREVENTING  OR TREATING AGING-RELATED DISEASESNIIGATA UNIVERSITY
WO/2021/002481RENAL TARGETING-TYPE DRUG DELIVERY CARRIER HAVING EXCELLENT  BIODEGRABILITYKYOTO PHARMACEUTICAL UNIVERSITY
WO/2021/006305APTAMER FOR TGF-β1 AND USE OF SAMERIBOMIC INC.
WO/2021/006316SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING  CANCER CELLSNATIONAL CANCER CENTER
WO/2021/010303THERAPEUTIC AGENT FOR DISEASE CAUSED BY DOMINANT MUTANT GENERIKEN
WO/2021/010326ANTI-MUTATION TYPE FGFR3 ANTIBODY AND USE THEREFORCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/010346NEUTRALIZING ANTIBODY FOR TOOTH REGENERATION TREATMENT  TARGETING USAG-1 MOLECULEKYOTO UNIVERSITY
WO/2021/010348TRANSFORMING GROWTH FACTOR β1 AS PREVENTIVE OR THERAPEUTIC  AGENT FOR DEPRESSION OR SYMPTOMS OF DEPRESSIONNATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY
WO/2021/131116CARRIER FOR CELL DELIVERYKABUSIKIKAISYA ITO
WO/2021/010449RNA MOLECULE, CHIMERIC NA MOLECULE, DOUBLE-STRANDED RNA  MOLECULE, AND DOUBLE-STRANDED CHIMERIC NA MOLECULETHE UNIVERSITY OF TOKYO
WO/2021/020210GUT MICROBIOTA REGULATING AGENTKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/079579WATER SOLUBLE O-GLYCOSYL FLAVONOID COMPOSITIONS AND METHODS  FOR PREPARING SAMEALPS PHARMACEUTICAL IND. CO., LTD.
WO/2021/015218PREVENTION OR TREATMENT OF FIBROTIC DISEASE WHICH TARGETS  TRANSCRIPTION-ASSOCIATED FACTORKYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/020268BIOGRAFT MATERIALFUJIFILM CORPORATION
WO/2021/020282ANTIBODY RECOGNIZING EXTRACELLULAR REGION OF ALK2/ACVR1SAITAMA MEDICAL UNIVERSITY
WO/2021/020336PHARMACEUTICAL COMPOSITION FOR TREATING TUMOREISAI R&D MANAGEMENT CO., LTD.
WO/2021/020342TEMPERATURE-RESPONSIVE DRUG/POLYMER COMPOUND AND APPLICATION  OF COMPOUND TO DRUG DELIVERYTHE UNIVERSITY OF TOKYO
WO/2021/015294COMBINATION THERAPY FOR CANCER TREATMENTTAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/029216DENTIN REGENERATIVE CELL CULTURENATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY
WO/2021/024854SOLID COSMETIC PREPARATION AND METHOD FOR PRODUCING SAMESHISEIDO COMPANY, LTD.
WO/2021/020412NUCLEIC ACID DRUG TARGETING MURF1SHIONOGI & CO., LTD.
WO/2021/020416BISPECIFIC ANTIBODYONO PHARMACEUTICAL CO., LTD.
WO/2021/100251BASE PASTE AND ADDITION-TYPE SILICONE IMPRESSION MATERIAL FOR  USE IN DENTISTRYGC CORPORATION
WO/2021/020446COMPOSITION CONTAINING HERPES SIMPLEX VIRUSTAKARA BIO INC.
WO/2021/020462INTRACELLULAR DELIVERY PEPTIDEKYOTO UNIVERSITY
WO/2021/024897COMBINATION DRUG FOR TREATING MALIGNANT TUMOR, PHARMACEUTICAL  COMPOSITION FOR TREATING MALIGNANT TUMOR, AND PHARMACEUTICAL COMPOSITION FOR  MALIGNANT TUMOR TREATMENTNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/020505PHARMACEUTICAL COMPOSITION FOR TREATING CANCERKYOTO UNIVERSITY
WO/2021/020535PHARMACEUTICAL COMPOSITION FOR OTIC ADMINISTRATIONASTELLAS PHARMA INC.
WO/2021/015297TRANSGENIC NON-HUMAN ANIMAL CAPABLE OF CONTROLLING EXPRESSION  OF TRANSCRIPTION FACTOR RP58TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
WO/2021/024930HARD CAPSULE FORMULATION SEALED WITH BAND SEAL INCLUDING TAGQUALICAPS CO., LTD.
WO/2021/020552COMPOSITION FOR IMPROVING MEMORYBGG JAPAN CO., LTD.
WO/2021/020554METHOD FOR TREATING LIVER CANCER WITH COMBINED USE OF  REIC/DKK-3 GENE AND ANTI-TUMOR AGENTMOMOTARO-GENE INC.
WO/2021/020564GD2 BINDING MOLECULEMIE UNIVERSITY
WO/2021/029238AGENT FOR PREVENTING OR TREATING TH17 CELL-INDUCED DISEASE AND  SCREENING METHOD FOR AGENTS FOR PREVENTING OR TREATING TH17 CELL-INDUCED  DISEASETOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/024986AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENTNATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL  UNIVERSITY
WO/2021/029260α-GLUCOSIDASE INHIBITOR, INVERTASE INHIBITOR, AND SUGAR  ABSORPTION INHIBITORKINKI UNIVERSITY
WO/2021/025013WATER-IN-OIL EMULSION COMPOSITIONSHOWA DENKO K.K.
WO/2021/025018PHARMACEUTICAL COMPOSITION FOR THERAPY AND/OR PROPHYLAXIS OF  COLORECTAL CANCERKYOTO UNIVERSITY
WO/2021/025020PHARMACEUTICAL AGENT FOR TRANSMUCOSAL ADMINISTRATIONDENKA COMPANY LIMITED
WO/2021/025031BIOMARKER FOR ACCESSING EFFICACY OF IMMUNE CHECKPOINT  INHIBITORONO PHARMACEUTICAL CO., LTD.
WO/2021/059755COMPOSITION FOR SYMPATHETIC NERVE ACTIVATIONMORINAGA MILK INDUSTRY CO., LTD.
WO/2021/025065COMBINATION THERAPY FOR CANCER USING AZABICYCLIC COMPOUND AND  POLY(ADENOSINE 5'-DIPHOSPHATE-RIBOSE) POLYMERASE INHIBITORTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/025102MEDICINE FOR PREVENTING AND/OR TREATING INSULIN-DEPENDENT  DIABETES MELLITUSNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/029318IMMUNE CHECKPOINT INHIBITOR, THERAPEUTIC AGENT FOR IMMUNE  CHECKPOINT-RELATED DISEASE, IMMUNOSUPPRESSANT, ANTI-FIBRONECTIN ANTIBODY OR  DERIVATIVE THEREOF, FIBRONECTIN ANALOG, KIT FOR DETECTING FIBRONECTIN OR  PARTIAL PROTEIN THEREOF, AND METHOD FOR DETECTING FIBRONECTIN OR PARTIAL  PROTEIN THEREOFTOHOKU UNIVERSITY
WO/2021/025118COMPOSITION USED FOR FORMING COATINGKAO CORPORATION
WO/2021/029334RNA INTERFERENCE AGENT, MULTIPLE CHEMICALLY MODIFIED  OLIGONUCLEOTIDE, AND USE THEREOFNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/029346AGENT FOR TREATING OR PREVENTING CEREBROVASCULAR DEMENTIATOHOKU UNIVERSITY
WO/2021/025147SULFATED HYALURONIC ACIDTOKYO CHEMICAL INDUSTRY CO., LTD.
WO/2021/029368COMBINED USE OF ARTIFICIAL ADJUVANT VECTOR CELLS AND AN  IMMUNOSTIMULANTRIKEN
WO/2021/029424NOVEL TREATMENT AND PREVENTION OF DISEASE BASED ON  IMMUNOLOGICAL MEMORYNATIONAL INSTITUTES OF BIOMEDICAL INNOVATION, HEALTH AND  NUTRITION
WO/2021/029429ORAL PHARMACEUTICAL COMPOSITIONOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/029430ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC  COMPOUNDOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/029434THERAPEUTIC AGENT FOR DROPPED HEAD SYNDROME AND THORACOLUMBAR  DEFORMITYISHII, Ken
WO/2021/029438PARTICLES, PHARMACEUTICAL COMPOSITION, AND METHOD FOR  PRODUCING PARTICLESRICOH COMPANY, LTD.
WO/2021/039447COMPOSITION SUITABLE FOR CLEANSINGL'OREAL
WO/2021/039448COMPOSITION COMPRISING AMPS POLYMER AND POLYSACCHARIDEL'OREAL
WO/2021/033725COSMETICSHISEIDO COMPANY, LTD.
WO/2021/033727MICRORNA EXPRESSION REGULATORKEWPIE CORPORATION
WO/2021/049268POLYMERIZABLE DENTAL COMPOSITIONGC CORPORATION
WO/2021/039554CANCER CHEMOTHERAPY SUPPORTING AGENT, FOOD, AND DRUGBIOMEDICAL RESEARCH GROUP INC.
WO/2021/039574HEAVY-CHAIN ANTIBODY IN WHICH O-LINKED SUGAR CHAIN  MODIFICATION IS SUPPRESSEDKANEKA CORPORATION
WO/2021/039586MODIFIED BORON NITRIDE POWDERTOKUYAMA CORPORATION
WO/2021/039610COMPOSITION COMPRISING MICROCAPSULE AND CELL STRUCTUREFUJIFILM CORPORATION
WO/2021/039616COMBINATION THERAPY AND BIOMARKER INDICATING EFFICACY THEREOFSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/033773ABCC11 INHIBITORTHE UNIVERSITY OF TOKYO
WO/2021/039873COMPOSITE PROTEIN MONOMER HAVING NON-STRUCTURAL PROTEIN OF  VIRUS SUPPORTED THEREON, AGGREGATE OF COMPOSITE PROTEIN MONOMER, AND  COMPONENT VACCINE COMPRISING AGGREGATE AS ACTIVE INGREDIENTTOKYO INSTITUTE OF TECHNOLOGY
WO/2021/039936COMPOSITION COMPRISING POLYION COMPLEX AND TEXTURE AGENTL'OREAL
WO/2021/039945CROSS-SPECIES ANTI-LATENT TGF-BETA 1 ANTIBODIES AND METHODS OF  USECHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/039961RING-FUSED PYRAZOLE DERIVATIVESUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/039972UROTHELIAL CELL INDUCTION AGENT AND METHOD FOR INDUCING  UROTHELIAL CELLSCELLAXIA INC.
WO/2021/039975JELLY PREPARATION CONTAINING LEVOCARNITINE AT HIGH  CONCENTRATIONMARUISHI PHARMACEUTICAL CO., LTD.
WO/2021/044975WATER-IN-OIL COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/049335DENTAL POLYMERIZABLE COMPOSITIONGC CORPORATION
WO/2021/040022CELL-PENETRATING PEPTIDE AND USE THEREOFUNIVERSITY PUBLIC CORPORATION OSAKA
WO/2021/040027SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE  MATERIAL, AND METHOD FOR PRODUCING SAMESAN-EI GEN F.F.I., INC.
WO/2021/045005COMPOSITION FOR EXTERNAL APPLICATIONROHTO PHARMACEUTICAL CO., LTD.
WO/2021/045073SEASONAL INFLUENZA VACCINE CAPABLE OF INDUCING VIRUS-SPECIFIC  ANTIBODY INTO NASAL CAVITYDENKA COMPANY LIMITED
WO/2021/059908AEROSOL SPRAY HAIRSTYLING PRODUCTMANDOM CORPORATION
WO/2021/045151FILM MOLDING COMPOSITION AND FILMSHIN-ETSU CHEMICAL CO., LTD.
WO/2021/045159THERAPEUTIC OR PROPHYLACTIC METHOD FOR DIABETES USING  COMBINATION MEDICINEJAPAN TOBACCO INC.
WO/2021/045161CHRONIC KIDNEY DISEASE TREATMENT OR PREVENTION METHODJAPAN TOBACCO INC.
WO/2021/045176O/W EMULSION COMPOSITIONKOKYU ALCOHOL KOGYO CO., LTD.
WO/2021/045184THERAPEUTIC AGENT FOR POLYCYTHEMIAPERSEUS PROTEOMICS INC.
WO/2021/045190THERAPEUTIC AGENT FOR MYOCARDITISTOHOKU UNIVERSITY
WO/2021/054190W/O TYPE EMULSION COSMETIC PREPARATIONTAIKI CORP., LTD.
WO/2021/106312EXTRACELLULAR VESICLES DERIVED FROM LIVING BODY AND CONTAINING  ONCOLYTIC VIRUSNATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
WO/2021/049504GALNAC-OLIGONUCLEOTIDE CONJUGATE FOR LIVER-TARGETED DELIVERY  USE, AND METHOD FOR PRODUCING SAMEDAIICHI SANKYO COMPANY, LIMITED
WO/2021/049519METHOD FOR PREVENTING PRECIPITATION OF INJECTABLE SOLUTION  CONTAINING p-BORONOPHENYLALANINESTELLA PHARMA CORPORATION
WO/2021/049520INJECTION CONTAINING p-BORONOPHENYLALANINESTELLA PHARMA CORPORATION
WO/2021/049529FORMULATIONSEKISUI CHEMICAL CO., LTD.
WO/2021/059986COLLAGEN PRODUCTION ENHANCER, PHARMACEUTICAL, COSMETIC, AND  METHOD FOR PRODUCING COLLAGEN PRODUCTION ENHANCERMURATA MANUFACTURING CO., LTD.
WO/2021/049587COMPOSITION FOR ENHANCING EFFECT OF ANTIBODY DRUGAUREO CO., LTD.
WO/2021/049599PHARMACEUTICAL COMPOSITION CONTAINING P-BORONOPHENYLALANINE  AND METHOD FOR PRODUCING SAMESTELLA PHARMA CORPORATION
WO/2021/049612DRUG FOR IMPROVING FLUID RETENTION IN ACUTE HEART FAILURENATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA
WO/2021/225011MICROSPHERE HAVING PHYSIOLOGICALLY ACTIVE SUBSTANCE UNIFORMLY  DISPERSED THEREIN, AND SUSTAINED-RELEASE PREPARATION CONTAINING SAMEM. TECHNIQUE CO., LTD.
WO/2021/049633DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL  ALPORT SYNDROMENATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/049634NUCLEIC ACID CONSTRUCT THAT ENCODES CHIMERIC RHODOPSINRESTORE VISION CO., LTD.
WO/2021/040056GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS  OF USES THEREOFASTELLAS PHARMA INC.
WO/2021/060079COSMETICSHISEIDO COMPANY, LTD.
WO/2021/060091RUTIN COMPOSITIONSALPS PHARMACEUTICAL IND. CO., LTD.
WO/2021/054370NUCLEIC ACID COMPLEXNATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL  UNIVERSITY
WO/2021/054373COMPOSITION FOR ELONGATING TELOMERESOSATO INTERNATIONAL INC.
WO/2021/054420SUGAR CHAIN-PRESENTING PARTICLES AND PRODUCTION METHOD THEREOFNATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/054440PHARMACEUTICAL COMPOSITIONUNIVERSITY OF FUKUI
WO/2021/054442AGENT FOR IMPROVING SKIN TEXTUREKAWASAKI GAKUEN EDUCATIONAL FOUNDATION
WO/2021/065568INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT  CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD  FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20  ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING  THERETOCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/054457CURABLE COMPOSITION FOR DENTISTRYKURARAY NORITAKE DENTAL INC.
WO/2021/060343T-CELL RECEPTOR EXPRESSED BY HUMAN T-CELLS THAT RECOGNIZE  PEPTIDE DERIVED FROM URLC10 OR PEPTIDE DERIVED FROM DEPDC1ONCOTHERAPY SCIENCE, INC.
WO/2021/060351NSAID-BONDED ALGINIC ACID DERIVATIVEMOCHIDA PHARMACEUTICAL CO., LTD.
WO/2021/060395SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITIONMOCHIDA PHARMACEUTICAL CO., LTD.
WO/2021/065686NUCLEIC ACID THAT INHIBITS EXPRESSION OF MEX3B GENE, MEX3B  GENE EXPRESSION INHIBITING AGENT, METHOD FOR INHIBITING MEX3B GENE  EXPRESSION, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASE CAUSED BY MEX3B  GENE EXPRESSIONTHE UNIVERSITY OF TOKYO
WO/2021/060425PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYSTEMIC  SCLERODERMATHE UNIVERSITY OF TOKYO
WO/2021/060440LIPID NANOPARTICLE LYOPHILIZED COMPOSITIONNOF CORPORATION
WO/2021/060441DEGRADABLE MULTI-ARM POLYETHYLENE GLYCOL DERIVATIVENOF CORPORATION
WO/2021/060453CROSSLINKED OPTICALLY ACTIVE SECONDARY AMINE DERIVATIVESUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/060460METHOD FOR MANUFACTURING REPAIRING AGENT FOR BIOLOGICAL TISSUE  DAMAGE, AND REPAIRING AGENT FOR BIOLOGICAL TISSUE DAMAGETWO CELLS CO., LTD.
WO/2021/015300AGENT FOR TREATING, PREVENTING OR IMPROVING PSYCHIATRIC AND  NERVOUS SYSTEM DISORDERS OR SYMPTOMSTOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/070644SOFT CAPSULESUNSHO PHARMACEUTICAL CO., LTD.
WO/2021/065768SPACE-FORMING AGENT, SUBCUTANEOUS INJECTION PREPARATION, AND  SPACE-FORMING METHODTERUMO KABUSHIKI KAISHA
WO/2021/065788EMULSION COMPOSITION, COSMETIC COMPOSITION, AND METHOD FOR  PRODUCING EMULSION COMPOSITIONDAIO PAPER CORPORATION
WO/2021/192366PATCHNICHIBAN CO., LTD.
WO/2021/065987INTESTINAL ENVIRONMENT-IMPROVING AGENTACACIA-NO-KI CO., LTD.
WO/2021/066062INHIBITOR AGAINST EXPRESSION OF IMMUNE CHECKPOINT MOLECULERENASCIENCE INC.
WO/2021/066078MUSCLE TISSUE-REGENERATING AGENTSPIBER INC.
WO/2021/066098W/O/W EMULSION COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/066109MEDICATION AND METHOD FOR INHIBITING NONENAL-INDUCED SKIN  DAMAGESHISEIDO COMPANY, LTD.
WO/2021/066134MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT AGAINST CANINE CD20NIPPON ZENYAKU KOGYO CO., LTD.
WO/2021/066136THERAPEUTIC AGENT FOR MUSCULAR DYSTROPHYTHE UNIVERSITY OF TOKYO
WO/2021/066144PHARMACEUTICAL DRUG CONTAINING HETEROCYCLIDENE ACETAMIDE  DERIVATIVESENJU PHARMACEUTICAL CO., LTD.
WO/2021/066149PHARMACEUTICAL COMPOSITION AND KIT CHARACTERIZED BY CONTAINING  NOVEL PENAM DERIVATIVE OR SALT THEREOF AND ONE OR MORE COMPOUNDS SELECTED  FROM Β-LACTAMASE INHIBITOR COMPOUND, ANTIBACTERIAL COMPOUND AND SALTS OF  THESEFUJIFILM CORPORATION
WO/2021/066175TRANSMUCOSAL DELIVERY SYSTEM FOR MEDICINAL ACTIVE INGREDIENT  TO SUBMUCOSA OF BLADDERSEIKAGAKU CORPORATION
WO/2021/070778NANODISCKANEKA CORPORATION
WO/2021/070785METHOD FOR PRODUCING PIG INFECTIOUS VIRUSNATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION
WO/2021/085062COMPOSITION FOR SLEEP IMPROVEMENT COMPRISING ERGOTHIONEINE OR  SALT THEREOFSUNTORY HOLDINGS LIMITED
WO/2021/075328EXTERNAL PREPARATION FOR TREATING EPILEPSY OR AUTISM SPECTRUM  DISORDEROSAKA UNIVERSITY
WO/2021/070875DENTAL COMPOSITIONKURARAY NORITAKE DENTAL INC.
WO/2021/070883HUMAN NTCP-BINDING ANTIBODY CAPABLE OF INHIBITING INFECTION OF  HEPATITIS B VIRUS (HBV) TO HUMAN HEPATOCYTESRIKEN
WO/2021/070885PHARMACEUTICAL COMPOSITION WHICH CAN BE USED FOR PREVENTION  AND/OR TREATMENT OF ACQUIRED HEMOPHILIA A, AND PRODUCT COMPRISING SAID  PHARMACEUTICAL COMPOSITIONCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/070893PHARMACEUTICAL COMPOSITION INCLUDING TEMPERATURE-RESPONSIVE  IONIC LIQUIDTORAY INDUSTRIES, INC.
WO/2021/070896HALITOSIS ALLEVIATOR OR HALITOSIS PREVENTIVESBI PHARMACEUTICALS CO., LTD.
WO/2021/085069BIOLOGICAL TISSUE ATTACHING FILM AND TRANSFER SHEETTOPPAN PRINTING CO., LTD.
WO/2021/070956siRNA EXPRESSION VECTORTAKARA BIO INC.
WO/2021/075433WATER-IN-OIL EMULSION COSMETICKAO CORPORATION
WO/2021/079795LAYERED TRANSDERMAL PATCHMEDRX CO., LTD.
WO/2021/075477MOTOR NEURON DEGENERATION INHIBITORKYOTO UNIVERSITY
WO/2021/075491TRANSDERMAL ABSORPTION-TYPE PATCHKYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/124663DENTAL ADHESIVE COMPOSITIONTOKUYAMA DENTAL CORPORATION
WO/2021/075525CELL CULTURE FOR TREATING INFLAMMATORY DISEASETERUMO KABUSHIKI KAISHA
WO/2021/075535DIABETES THERAPY TARGETING ABNORMAL STEM CELLSNATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL  SCIENCE
WO/2021/075536THERAPY FOR DIABETES USING STEM CELL MIGRATION AGENTNATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL  SCIENCE
WO/2021/075544RI-LABELED HUMANIZED ANTIBODYNIHON MEDI-PHYSICS CO., LTD.
WO/2021/075545HUMANIZED ANTIBODY AND METHOD FOR USING THE SAMESUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/075559CELL GROWTH INHIBITOR OR CELL DEATH INDUCER FOR  CANCER-ASSOCIATED FIBROBLASTSJUNTENDO EDUCATIONAL FOUNDATION
WO/2021/131264COMPOSITION CONTAINING BLACK GINGER EXTRACT AND COMPOSITION  FOR ORAL ADMINISTRATIONMARUZEN PHARMACEUTICALS CO., LTD.
WO/2021/085197HIGH INTERNAL AQUEOUS PHASE EMULSIONL'OREAL
WO/2021/085211METHOD FOR SUPPRESSING PRODUCTION OF ASENAPINE-N-OXIDEHISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/079869UREMIC TOXIN REDUCING AGENTBIOFERMIN PHARMACEUTICAL CO., LTD.
WO/2021/085232COMPOSITION FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE  DISORDERSICHIMARU PHARCOS CO., LTD.
WO/2021/079887PREVENTATIVE OR THERAPEUTIC AGENT FOR TAUOPATHYKYOTO UNIVERSITY
WO/2021/085252PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR INFLAMMATORY  PULMONARY DISEASENATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
WO/2021/085291COMPOSITION FOR TGR5 ACTIVATIONSUNTORY HOLDINGS LIMITED
WO/2021/085295IMMUNE RESPONSE SUPPRESSORUNIVERSITY OF TSUKUBA
WO/2021/079958COMBINATION OF ANTI-GARP ANTIBODY AND IMMUNOREGULATORDAIICHI SANKYO COMPANY, LIMITED
WO/2021/075585THERAPEUTIC AGENT FOR RENAL DYSFUNCTIONEDUCATIONAL FOUNDATION KYORIN GAKUEN
WO/2021/079962PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF  HEARING LOSSOSAKA UNIVERSITY
WO/2021/079978THERAPEUTIC OR PROPHYLACTIC AGENT FOR CACHEXIATORAY INDUSTRIES, INC.
WO/2021/079984NOVEL SUBSTITUTED CONDENSED RING COMPOUNDSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/079986BACTERIOPHAGE COMPOSITIONMEIJI SEIKA PHARMA CO., LTD.
WO/2021/079987MUSCLE QUALITY IMPROVEMENT AGENTAJINOMOTO CO., INC.
WO/2021/079988AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND  DIFFERENTIATIONSUN MEDICAL CO., LTD.
WO/2021/131291DENTAL IMPRESSION MATERIAL AND COMBINED IMPRESSION MATERIALGC CORPORATION
WO/2021/080008METHOD FOR PRODUCING MONOVALENT CCAP PRODUCTKAGOSHIMA UNIVERSITY
WO/2021/080020NUCLEIC ACID DELIVERY ENHANCERNATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY
WO/2021/095510COMPOSITE SOIL BACTERIA PREPARATION FOR PREVENTING AND  TREATING INFECTIOUS DISEASE AND METHOD FOR PREVENTING AND TREATING INFECTIOUS  DISEASE IN ANIMALSKAWASHIMA CO., LTD
WO/2021/090739COMPOSITION AND METHOD FOR TREATING CANDIDA AURIS INFECTIONFUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/085496COMPOSITION, ANTIOXIDANT AGENT, ANTISACCHARIFICATION AGENT,  NEURITE OUTGROWTH PROMOTER, AND COGNITIVE FUNCTION IMPROVERYAMADA BEE COMPANY, INC.
WO/2021/085497DRUG FOR TREATING CANCER, COMBINATION DRUG, DRUG COMPOSITION,  IMMUNE RESPONSIVE CELL, NUCLEIC ACID DELIVERY VEHICLE, AND PRODUCTNOILE-IMMUNE BIOTECH INC.
WO/2021/085509NUCLEOSIDE DERIVATIVE AND USE THEREOFNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/085518AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING FUSION PROTEIN  OF SERUM ALBUMIN AND GROWTH HORMONEJCR PHARMACEUTICALS CO., LTD.
WO/2021/090754POLYPHASE OIL-BASED SOLID COSMETICKOSE CORPORATION
WO/2021/085528CD4 MIMIC COMPOUND WITH ANTI-HIV ACTIVITYNATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/131314STABLE FREEZE-DRIED FORMULATION CONTAINING DAPTOMYCINNIPRO CORPORATION
WO/2021/152944GLASS IONOMER CEMENT FOR DENTAL USEGC CORPORATION
WO/2021/111782DENTAL ADHESIVE COMPOSITION, DENTAL ADHESIVE MEMBER, AND  DENTAL ADHESIVE MEMBER PACKAGING BODYTOKUYAMA DENTAL CORPORATION
WO/2021/085584INSULIN RESISTANCE INHIBITOR FOR RUMINANT ANIMALSIDEMITSU KOSAN CO., LTD.
WO/2021/085592NUCLEIC ACID FOR SUPPRESSING GENE EXPRESSION OF  DISEASE-SPECIFIC COL3A1 MUTANT ALLELE AND PHARMACEUTICAL COMPOSITION FOR  TREATING VASCULAR EHLERS-DANLOS SYNDROMENANOCARRIER CO., LTD.
WO/2021/085624COMPOSITION FOR TREATMENT AND/OR PREVENTION OF TUMORFUKUSHIMA MEDICAL UNIVERSITY
WO/2021/085633METHOD FOR USING ULTRAFINE BUBBLESSHISEIDO COMPANY, LTD.
WO/2021/085639THERAPY FOR INTERSTITIAL CYSTITIS BY PLURIPOTENT STEM CELLSLIFE SCIENCE INSTITUTE, INC.
WO/2021/085640AGENT FOR INHIBITING DECREASE OF MUSCLE MASS IN PATIENT  REQUIRING FASTINGOSAKA UNIVERSITY
WO/2021/085650VACCINENEROME INSTITUTE OF BIOLOGICAL RESOURCES
WO/2021/095599PD-1 SIGNAL INHIBITOR COMBINATION THERAPYKYOTO UNIVERSITY
WO/2021/095618GLYCERIN-CONTAINING EMULSIFIED COSMETICSSEIWA KASEI COMPANY, LIMITED
WO/2021/090911METHOD FOR SELECTIVELY KILLING PROTEIN AGGREGATE-CONTAINING  CELLS, KIT THEREFOR, THERAPEUTIC DRUG FOR PROTEIN MISFOLDING DISEASES AND  DRUG PRODUCT FOR REMOVING PROTEIN AGGREGATES FROM BLOOD PRODUCTCENTRAL GLASS COMPANY, LIMITED
WO/2021/192393MALARIA TRANSMISSION-BLOCKING VACCINESPATH
WO/2021/090926AGENT FOR PREVENTING OR TREATING ARRHYTHMIA AND DEVICE FOR  PREVENTING OR TREATING ARRHYTHMIASCHOOL JURIDICAL PERSON THE KITASATO INSTITUTE
WO/2021/0856534-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOFTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/149329NOVEL USE OF HIC-5 INHIBITORSHOWA UNIVERSITY
WO/2021/090945CELL CULTURE FOR TREATING DISEASE OF LOWER EXTREMITYOSAKA UNIVERSITY
WO/2021/095703ANTI-HUMAN CRIPTO-1 ANTIBODYGSP ENTERPRISE, INC.
WO/2021/149334THICKENERNATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND  TECHNOLOGY
WO/2021/095775ANTIPLASMIN AGENTKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/095779ORALLY DISINTEGRATING TABLETOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/100600GLYCERIN DISPERSION AND COSMETICMIYOSHI KASEI, INC.
WO/2021/095805THERAPEUTIC AGENT AND PROPHYLACTIC AGENT FOR FUNCTIONAL  GASTROINTESTINAL DISORDERS AND XEROSTOMIANIPPON SHINYAKU CO., LTD.
WO/2021/095809ENHANCER POLYNUCLEOTIDE RESPONDING TO HEART FAILURE AND  EXPRESSION VECTOR INCLUDING SAID ENHANCER POLYNUCLEOTIDEOSAKA UNIVERSITY
WO/2021/095814COMPOSITION FOR IMPROVING MENTAL STATE, PRODUCTION METHOD FOR  COMPOSITION FOR IMPROVING MENTAL STATE, AND USE OF FRUIT OF EGGPLANT FOR  IMPROVING MENTAL STATESHINSHU UNIVERSITY
WO/2021/100614NEUROPSYCHOLOGICAL FUNCTION IMPROVER COMPRISING SOYBEAN  PEPTIDE AND/OR COLLAGEN PEPTIDEKYOTO UNIVERSITY
WO/2021/095838NUCLEIC ACID LIPID PARTICLE VACCINE ENCAPSULATING HPV MRNADAIICHI SANKYO COMPANY, LIMITED
WO/2021/095840METHODS OF TREATING LSD1-RELATED DISEASES and Disorders WITH  LSD1 INHIBITORSTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/095876LIPID COMPOSITIONFUJIFILM CORPORATION
WO/2021/100666COSMETIC COMPOSITIONMANDOM CORPORATION
WO/2021/100676EXTERNAL PREPARATION FOR SKINKAO CORPORATION
WO/2021/100677COMBINATION DRUGCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/100685TREATMENT OR PREVENTION OF PSYCHIATRIC DISEASE BASED ON KIF3  MOTOR, AND DRUG SCREENINGTHE UNIVERSITY OF TOKYO
WO/2021/100744CROSSLINKED PRODUCT OF AMYLOID-β PROTEIN (Aβ) ABLE TO BE  SUBSTITUTE FOR AMYLOSPHEROID (ASPD), AND ANALYSIS OF ASPDTAO HEALTH LIFE PHARMA CO., LTD.
WO/2021/100750WATER-IN-OIL COSMETIC PREPARATIONSHIN-ETSU CHEMICAL CO., LTD.
WO/2021/100794ANTIBODY-CONTAINING PREPARATIONCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/100837COMPOSITION FOR PREVENTING OR REDUCING HYPERURICEMIA, AND  METHOD FOR PRODUCING SAMEHYAKKICHI JAPAN TECHNOLOGICAL DEVELOPMENT CO., LTD.
WO/2021/124793AGGREGATION INHIBITORY AGENT AND MEDICAL COMPOSITION AND  MEDICAL DEVICE INCLUDING SAMENIPRO CORPORATION
WO/2021/106782METHOD FOR IMPROVING HOLDING POWER OF ADHESIVE AGENT LAYER IN  ROPINIROLE-CONTAINING TRANSDERMAL PATCH, AND ROPINIROLE-CONTAINING  TRANSDERMAL PATCH HAVING IMPROVED HOLDING POWERHISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/106952PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR GRAFT-VERSUS-HOST  DISEASETOKYO METROPOLITAN GOVERNMENT
WO/2021/260966COMPOSITION TARGETING ADENOSINE-PRODUCING ENZYMESAITAMA MEDICAL UNIVERSITY
WO/2021/106978PHARMACEUTICAL COMPOSITIONCYTLIMIC INC.
WO/2021/131476CURABLE COMPOSITION FOR DENTISTRYTOKUYAMA DENTAL CORPORATION
WO/2021/107005PROPHYLACTIC OR THERAPEUTIC AGENT FOR CYTOMEGALOVIRUS-RELATED  DISEASESNATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT
WO/2021/107013ADJUVANT COMPOSITIONRIKEN
WO/2021/111980PROPHYLACTIC OR AMELIORATING AGENT FOR ORTHOSTATIC  HYPOTENSION, AND COMPOSITION CONTAINING SAMELIFE QUALITY KENKYUJYO CO., LTD.
WO/2021/111981AGENT FOR PREVENTION OR REMEDIATION OF DEMENTIA AND  COMPOSITION CONTAINING SAMELIFE QUALITY KENKYUJYO CO., LTD.
WO/2021/111982AGENT FOR PREVENTION OR REMEDIATION OF STRESS DISORDERS AND  COMPOSITION CONTAINING SAMELIFE QUALITY KENKYUJYO CO., LTD.
WO/2021/111983AGENT FOR PREVENTING OR AMELIORATING FUNCTIONAL SOMATIC  SYNDROMES AND COMPOSITION INCLUDING THE SAMELIFE QUALITY KENKYUJYO CO., LTD.
WO/2021/107029PROPHYLACTIC OR THERAPEUTIC AGENT FOR NON-ALCOHOLIC  STEATOHEPATITIS IN HUMANSMITSUBISHI TANABE PHARMA CORPORATION
WO/2021/107033PHARMACEUTICAL COMPOSITIONSENJU PHARMACEUTICAL CO., LTD.
WO/2021/107034MEDICINAL COMPOSITION FOR SOFT CONTACT LENSSENJU PHARMACEUTICAL CO.,LTD.
WO/2021/107035PHARMACEUTICAL COMPOSITION FOR SOFT CONTACT LENSSENJU PHARMACEUTICAL CO., LTD.
WO/2021/140773PHYSICAL FUNCTION RECOVERY PROMOTERFOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE
WO/2021/107060MEDICINE FOR REDUCING ADVERSE EFFECTS OF PIRFENIDONESHIONOGI & CO., LTD.
WO/2021/107066PROPHYLACTIC AND THERAPEUTIC PHARMACEUTICAL AGENT FOR HIV  INFECTIOUS DISEASES CHARACTERIZED BY COMPRISING COMBINATION OF INTEGRASE  INHIBITOR AND ANTI-HIV AGENTSHIONOGI & CO., LTD.
WO/2021/107067PHARMACEUTICAL OR COSMETIC COMPOSITIONMARUHO CO., LTD.
WO/2021/107082THERAPEUTIC AGENT FOR CARCINOMATOUS PERITONITISPERSEUS PROTEOMICS INC.
WO/2021/107084INSULIN SECRETION-PROMOTING AGENT AND BLOOD SUGAR LEVEL  IMPROVER USING SAME, DIABETES IMPROVER, AND FOODREFINE HOLDINGS CO. LTD.
WO/2021/131490DENTAL FILLING AND REPAIRING MATERIAL KITTOKUYAMA DENTAL CORPORATION
WO/2021/107101VASODILATOR AND USE THEREOFBIORADICAL RESEARCH INSTITUTE CORP.
WO/2021/107122HYPOXIA RESPONSE CONTROL BY SPECIFIC AMINO ACID OR AMINO  ACID-LIKE SUBSTANCEKEIO UNIVERSITY
WO/2021/225013MICROSPHERES CONTAINING UNIFORMLY DISPERSED PRIMARY AGENT AND  SUSTAINED-RELEASE PREPARATION CONTAINING MICROSPHERES CONTAINING UNIFORMLY  DISPERSED PRIMARY AGENTM. TECHNIQUE CO., LTD.
WO/2021/107152DENTAL COMPOSITIONKURARAY NORITAKE DENTAL INC.
WO/2021/112056METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT VECTOR  CELLS (aAVC)ASTELLAS PHARMA INC.
WO/2021/112140AGENT FOR PREVENTING OR AMELIORATING PERIODONTAL DISEASEKAO CORPORATION
WO/2021/131568COMPOSITION FOR SUPPRESSING OR IMPROVING REDUCTION IN AMOUNT  OF PHYSICAL ACTIVITYSUNTORY HOLDINGS LIMITED
WO/2021/131569COMPOSITION FOR IMPROVING SLEEP AND COMPOSITION FOR IMPROVING  CIRCADIAN RHYTHMSUNTORY HOLDINGS LIMITED
WO/2021/131570COMPOSITION FOR AMELIORATING OR SUPPRESSING DECLINE OF  COGNITIVE FUNCTIONSSUNTORY HOLDINGS LIMITED
WO/2021/112174OPTICAL ANTIMICROBIAL THERAPEUTIC METHODNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/112176COMPOSITION FOR IMPROVING QUALITY OF SLEEPKUREI OKINAWA CO., LTD.
WO/2021/112185ANTI-GDF15 ANTIBODYOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/112196COMPOSITION FOR SUPPRESSING LOSS OF MUSCLE TISSUETOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES
WO/2021/112207DRUG FOR TREATING SYMPTOM OF CEREBRAL INFARCTION IN ACUTE  STAGE CEREBRAL INFARCTION PATIENTNATIONAL CEREBRAL AND CARDIOVASCULAR CENTER
WO/2021/112208OIL-IN-WATER EMULSION SUNSCREEN COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/112220THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE WITH ABNORMAL  PROTEIN ACCUMULATIONUNIVERSITY OF MIYAZAKI
WO/2021/112235MEDICINE AND MEDICINAL COMPOSITION FOR TREATING OR PREVENTING  C3 NEPHROPATHY, AND COMPLEMENT C3B DEGRADATION ACCELERATORUNIVERSITY OF MIYAZAKI
WO/2021/112240RHINENCHYSIS COMPOSITION CONTAINING OLOPATADINETOKO YAKUHIN KOGYO CO., LTD.
WO/2021/112242PHARMACEUTICAL COMPOSITION COMPRISING STEROID COMPOUND AND  OLOPATADINETOKO YAKUHIN KOGYO CO., LTD.
WO/2021/117697SOLID PHARMACEUTICAL PREPARATIONFUJI YAKUHIN CO., LTD.
WO/2021/117735METHOD FOR PREVENTING CLOUDINESS OF PREFILLED SYRINGE OR  CARTRIDGE PREPARATION CONTAINING TERIPARATIDE OR SALT THEREOF BY SHAKINGASAHI KASEI PHARMA CORPORATION
WO/2021/117754AGENT FOR REPAIRING OR SUPPRESSING DNA DAMAGENATIONAL CEREBRAL AND CARDIOVASCULAR CENTER
WO/2021/117769PHARMACEUTICAL COMPOSITION AND TREATMENT AGENTFUJIFILM CORPORATION
WO/2021/117770PHARMACEUTICAL COMPOSITION AND TREATMENT AGENTFUJIFILM CORPORATION
WO/2021/117771METHOD FOR PREPARING PEPTIDE EMULSION FORMULATIONSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/117792MELATONIN-CONTAINING GRANULESNOBELPHARMA CO., LTD.
WO/2021/149390COLORING HAIR DYE AND AEROSOL TYPE COLORING HAIR DYEPINOLE CO., LTD.
WO/2021/131750EXTERNAL COMPOSITION FOR REDUCING DULLNESS AROUND EYES,  COSMETIC AND QUASI-PHARMACEUTICAL PRODUCTHORUS CO., LTD.
WO/2021/117824INCRETIN PRODUCTION ACCELERATOR AND SUGAR UPTAKE ACCELERATORINADA Akari
WO/2021/117839DENTAL COMPOSITIONKURARAY NORITAKE DENTAL INC.
WO/2021/117840INDUCTION OF PROLIFEROUS PANCREATIC ISLET PRECURSOR CELL-LIKE  CELLS BY TRANSIENT EXPRESSION OF Mycl AND INDUCTION OF DIFFERENTIATION INTO  INSULIN-POSITIVE CELLSTHE UNIVERSITY OF TOKYO
WO/2021/125066COSMETIC PROCESS USING HYALURONIC ACID DROPLETSL'OREAL
WO/2021/125068COMPOSITION INCLUDING CATIONIC POLYSACCHARIDE AND ANIONIC  ANTIOXIDANTL'OREAL
WO/2021/125069COMPOSITION COMPRISING HYALURONIC ACID-BASED POLYION COMPLEX  PARTICLEL'OREAL
WO/2021/117842POWDER COSMETIC COMPOSITIONL'OREAL
WO/2021/125071BI-PHASE SUN CARE COMPOSITIONL'OREAL
WO/2021/117857COMPOSITION FOR LOWERING HEART RATEMEIJI CO., LTD.
WO/2021/117861SMALL-SIZED TABLET HAVING EXCELLENT PRODUCIBILITY AND ELUTION  PROPERTIESSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/125093EYELASH EXTENSION ADHESIVESHIMADA, Katsura
WO/2021/117886FREEZE-DRIED PREPARATION CONTAINING MEGAKARYOCYTES AND  PLATELETSNATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY
WO/2021/112263ADIPONECTIN PRODUCTION PROMOTERKOHAKU BIO TECHNOLOGY CO.,LTD.
WO/2021/125118STABLE COMPOSITION COMPRISING COMBINATION OF SPECIFIC  INGREDIENTSL'OREAL
WO/2021/131849METHOD FOR PRODUCING POWDERED SOLID COMPOSITION, AND POWDERED  SOLID COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/125139METHOD FOR IMPROVING OLFACTORY SENSITIVITYKAO CORPORATION
WO/2021/131872ORAL COMPOSITIONKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/125174OIL-IN-WATER TYPE EMULSION COSMETIC FOR SKIN CARE USING  ELECTROPHORESISSHISEIDO COMPANY, LTD.
WO/2021/131915FIBER TREATMENT AGENT COMPOSITIONKAO CORPORATION
WO/2021/131939HAIR COSMETIC COMPOSITIONKAO CORPORATION
WO/2021/125211SUNSCREEN COSMETICSHISEIDO COMPANY, LTD.
WO/2021/125212SUNSCREEN COSMETICSHISEIDO COMPANY, LTD.
WO/2021/131948OIL-BASED COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/125219OIL-IN-WATER EMULSION COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/145128MUTANT KLF PROTEIN, AND METHOD FOR PRODUCING INDUCED  PLURIPOTENT STEM CELLSRIKEN
WO/2021/125246FLUORESCENT CURABLE DENTAL COMPOSITION AND CURED PRODUCT  THEREOFKURARAY NORITAKE DENTAL INC.
WO/2021/125261THERAPEUTIC FOR HIGH-RISK MYELODYSPLASTIC SYNDROMEMETROPOLITAN RESEARCH CENTER FOR BLOOD DISORDERS
WO/2021/125263USE OF ANTIBODY-DRUG CONJUGATES AND ANTIBODIES FOR DRUG  DELIVERYNATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
WO/2021/125291GLUTATHIONE-CONTAINING COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/125303EGG ALLERGY PREVENTING AGENT OR THE LIKE, AND FOOD COMPOSITION  CONTAINING SAMENATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT
WO/2021/132044COSMETIC COMPOSITION IN THE FORM OF W/O EMULSION COMPRISING  SPHERICAL HYDROPHOBIC SILICA AEROGEL AND ESTER OILL'OREAL
WO/2021/125304SUN CARE COMPOSITIONL'OREAL
WO/2021/132045ANHYDROUS COMPOSITION FOR TOPICAL DELIVERY OF ACTIVE  INGREDIENTSL'OREAL
WO/2021/125311ANTISENSE NUCLEIC ACID ENABLING EXON SKIPPINGNIPPON SHINYAKU CO., LTD.
WO/2021/125313THERAPEUTIC AGENT CONTAINING FUSED PYRIMIDINE COMPOUND AS  ACTIVE INGREDIENTTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/132067COMPOSITION FOR ORAL CAVITYLION CORPORATION
WO/2021/125315ANTI-INFLAMMATORY LIQUID COMPOSITION FOR COVERING ORAL MUCOSA,  AND MEDICINAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF STOMATITIS USING  SAMEHANIC WHITE LABO CO., LTD.
WO/2021/132072FILM-COATED TABLETS HAVING SMOOTH SURFACEDAIICHI SANKYO COMPANY, LIMITED
WO/2021/125342COMPOSITION FOR SUPPRESSING OBESITYDAICEL CORPORATION
WO/2021/125345VASODILATOR AND USE THEREOFBIORADICAL RESEARCH INSTITUTE CORP.
WO/2021/132100MICRONEEDLE DEVICE AND METHOD FOR PRODUCING SAMEHISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/132117METHOD FOR MEASURING HUMAN HEPATOCYTE REPLACEMENT RATE IN  HUMAN HEPATOCYTE CHIMERIC ANIMALSEKISUI MEDICAL CO., LTD.
WO/2021/132157BRAIN DISEASE THERAPEUTIC AGENT AND USE THEREFORPUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
WO/2021/132166METHOD FOR PRODUCING ERIBULIN-BASED ANTIBODY-DRUG CONJUGATEEISAI R&D MANAGEMENT CO., LTD.
WO/2021/132169ORAL LIQUID COMPOSITIONLION CORPORATION
WO/2021/132201PROPHYLACTIC OR THERAPEUTIC AGENT FOR DEMYELINATING DISEASEOSAKA UNIVERSITY
WO/2021/149442FLAVONOID COMPOSITIONHOGAPLANTS CO., LTD.
WO/2021/132302DRUG FOR PREVENTING DIALYSIS SHIFT OR RENAL DEATHTORAY INDUSTRIES, INC.
WO/2021/132309PHARMACEUTICAL COMPOSITIONNATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL  UNIVERSITY
WO/2021/132329BODY FAT REDUCING AGENT AND METHOD FOR SCREENING SUBSTANCE  HAVING BODY FAT REDUCING EFFECTOSAKA UNIVERSITY
WO/2021/132348DRUG CONTAINING EFINACONAZOLEKAKEN PHARMACEUTICAL CO., LTD.
WO/2021/132438ORALLY DISINTEGRATING TABLET INCLUDING PYRROLE CARBOXAMIDEDAIICHI SANKYO COMPANY, LIMITED
WO/2021/132444WATER-IN-OIL-TYPE EMULSIFIED SUNSCREEN COSMETICKAO CORPORATION
WO/2021/132453CAPILLARY BLOOD VESSEL DISORDER INHIBITING AGENT, CAPILLARY  BLOOD VESSEL DISORDER AMELIORATING AGENT, AND CAPILLARY ANGIOGENESIS  ACCELERATING AGENTNATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY
WO/2021/132462PHARMACEUTICAL COMPOSITION CONTAINING DOUBLE-STRANDED  RIBONUCLEIC ACID INHIBITING EXPRESSION OF COMPLEMENT C5EISAI R&D MANAGEMENT CO., LTD.
WO/2021/132463DENTAL RESTORATION MATERIAL COMPOSITIONKURARAY NORITAKE DENTAL INC.
WO/2021/132472PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR CHRONIC  PROSTATITIS/CHRONIC PELVIC PAIN SYNDROMENIPPON SHINYAKU CO., LTD.
WO/2021/132473ANTITUMOR DRUG FOR USE IN COMBINATION WITH IMMUNE CHECKPOINT  INHIBITORNIPPON SHINYAKU CO., LTD.
WO/2021/132501TAPE PREPARATIONNICHIBAN CO., LTD.
WO/2021/140945SHEET-PROVIDING METHOD AND SHEET-PROVIDING SYSTEMKAO CORPORATION
WO/2021/132529WATER-CONTAINING TRANSDERMALLY ABSORPTIVE COMPOSITIONKYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/132530COMPOSITE COMPRISING POLYVINYL ALCOHOL AND WATER-SOLUBLE  THICKENERL'OREAL
WO/2021/132531COMPOSITE COMPRISING POLYVINYL ALCOHOL AND HYDROPHILIC AND  WATER-DISPERSIBLE FILLERL'OREAL
WO/2021/132532COSMETIC COMPOSITION COMPRISING SPHERICAL HYDROPHOBIC SILICA  AEROGEL AND COMPOSITE SILICA PARTICLES AND/OR HOLLOW SILICA PARTICLESL'OREAL
WO/2021/132541METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL  SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE  LIKE CONTAINING SAMECHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/132543MATERIAL FOR TREATING FISTULAEA PHARMA CO., LTD.
WO/2021/192471PEMETREXED FORMULATIONNAGASE MEDICALS CO., LTD.
WO/2021/192472PEMETREXED FORMULATIONNAGASE MEDICALS CO., LTD.
WO/2021/132550POST-OPERATION ADJUVANT THERAPY AGENTTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/132565AQUEOUS SUSPENSION COMPOSITION CONTAINING SIROLIMUS OR SALT  THEREOFSANTEN PHARMACEUTICAL CO., LTD.
WO/2021/132589POLYNUCLEOTIDE AND MEDICINAL COMPOSITIONNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/132592METHOD FOR PREDICTING SENSITIVITY OF CANCER CELL TO GPX4  INHIBITORCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/132598AQUEOUS COMPOSITIONROHTO PHARMACEUTICAL CO., LTD.
WO/2021/132609AQUEOUS COMPOSITIONROHTO PHARMACEUTICAL CO., LTD.
WO/2021/132626THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CLASSICAL SWINE FEVERNATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/132636CANCER TREATMENT METHOD AND MEDICINENONPROFIT ORGANIZATION NORTH EAST JAPAN STUDY GROUP
WO/2021/132659DISPERSION LIQUID FOR COMPLEX BETWEEN PROTEIN AND CERIUM OXIDE  NANOPARTICLE, METHOD FOR ELIMINATING ACTIVE SPECIES, AND METHOD FOR PRODUCING  DISPERSION LIQUID FOR COMPLEX BETWEEN PROTEIN AND CERIUM OXIDE NANOPARTICLETORAY INDUSTRIES, INC.
WO/2021/132668MATERIAL FOR PROMOTING PENETRATIONNISSAN CHEMICAL CORPORATION
WO/2021/132673AGENT FOR PREVENTING OR TREATING ACUTE-PHASE NEUROMYELITIS  OPTICAOSAKA UNIVERSITY
WO/2021/132691D-SERINE TRANSPORT MODIFIER AND SCREENING METHOD THEREOF, AND  SCREENING METHOD OF D-SERINE TRANSPORTER PROTEINKAGAMI INC.
WO/2021/132697NOVEL USE OF STEVIOLSUNTORY HOLDINGS LIMITED
WO/2021/132698NEW USES FOR STEVIOLSUNTORY HOLDINGS LIMITED
WO/2021/132703PHARMACEUTICAL COMPOSITION FOR TREATING LIPID STORAGE DISORDERNATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/132707PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR  PRODUCING THE SAMEKURARAY NORITAKE DENTAL INC.
WO/2021/132734COMPOSITION COMPRISING SPHERICAL HYDROPHOBIC SILICA AEROGEL  AND SILICONE POLYMERL'OREAL
WO/2021/141020NUCLEIC ACID INTRODUCTION USING TWO TYPES OF TBK1/IKKe  INHIBITORSOSAKA UNIVERSITY
WO/2021/141038OIL-IN-WATER EMULSION COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/141041THERAPEUTIC AGENT FOR TAUOPATHIESSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/141066PLATELET AGGREGATORKAMUI PHARMA, INC.
WO/2021/186855METHOD FOR DETECTING INDICATOR OF T-CELL LYMPHOMA AND  UTILIZATION THEREOFMANDOM CORPORATION
WO/2021/145296HARD CAPSULE CONTAINING CELLULOSE DERIVATIVE AS BASE MATERIAL  AND HAVING IMPROVED MECHANICAL STRENGTH AND OXYGEN PERMEABILITYCAPSUGEL JAPAN INC.
WO/2021/145355PHARMACEUTICAL COMPOSITION FOR TREATING MYOPIA, PREVENTING  MYOPIA, AND/OR SUPPRESSING PROGRESSION OF MYOPIASANTEN PHARMACEUTICAL CO., LTD.
WO/2021/145356DRUG COMPOSITION FOR TREATING NEARSIGHTEDNESS, PREVENTING  NEARSIGHTEDNESS, AND/OR MINIMIZING PROGRESSION OF NEARSIGHTEDNESSSANTEN PHARMACEUTICAL CO., LTD.
WO/2021/145364HEMATOPOIETIC-CELL STORAGE SOLUTION CONTAINING TREHALOSEOTSUKA PHARMACEUTICAL FACTORY,INC.
WO/2021/145372TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSYNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/145373DRUG SUBSTANCE OF LEMBOREXANT AND MEDICINAL COMPOSITION  COMPRISING SAMEEISAI R&D MANAGEMENT CO., LTD.
WO/2021/145385BIOCOMPATIBLE MATERIAL, AND METHOD FOR PRODUCING BIOCOMPATIBLE  MATERIALFUJIFILM CORPORATION
WO/2021/145394ANTI-INFLAMMATORY AGENT AND METHOD FOR PRODUCING EXTRACELLULAR  VESICLES HAVING ANTI-INFLAMMATORY ACTIONFUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/145395ANTIFIBROTIC AGENT, AND METHOD FOR PRODUCING EXTRACELLULAR  VESICLES HAVING ANTIFIBROTIC ACTIONFUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/145425KIDNEY REGENERATION ACCELERATOR AND PRODUCTION METHOD FOR SAMEKEIO UNIVERSITY
WO/2021/145432AGENT FOR PREVENTION OR TREATMENT OF DIABETIC AUTONOMIC  NEUROPATHYOSAKA UNIVERSITY
WO/2021/145435PROPHYLACTIC OR THERAPEUTIC AGENT FOR DEMENTIAOSAKA UNIVERSITY
WO/2021/145450UV RAY-BLOCKING PARTICULATE COMPOSITIONNISSAN CHEMICAL CORPORATION
WO/2021/153365METHOD FOR PRODUCING PANCREATIC ISLET-CONTAINING CAPSULEOTSUKA PHARMACEUTICAL FACTORY, INC.
WO/2021/149714AGENT FOR TREATING BONE TUMOR, AND METHOD FOR EVALUATING ION  CHANNEL AGONIST FOR TREATMENT OF BONE TUMOR, ETC.CHANNELOSEARCH TECHNOLOGY
WO/2021/149767HETEROCYCLIC DERIVATIVESUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/149786METHODS OF TREATING CANCER USING DIHYDROPYRIMIDIN-2-ONE  COMPOUNDSJAPAN TOBACCO INC.
WO/2021/149809OIL-IN-WATER-TYPE EMULSIFIED COSMETIC MATERIALSHISEIDO COMPANY, LTD.
WO/2021/149813FRAGRANCE COMPOSITION, SCENT DISPENSER AND METHOD FOR REDUCING  MALODORKAO CORPORATION
WO/2021/149817Enhancement of anti-tumor activity of SHP2 inhibitor  pyrimidinone in combination with novel cancer medicines in cancersTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/149818COMBINATION AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCERNATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF  AGRICULTURE AND TECHNOLOGY
WO/2021/149827EXTERNAL PREPARATION CONTAINING RAPAMYCINNOBELPHARMA CO., LTD.
WO/2021/153485COMPOSITION CONTAINING CURCUMIN COMPOUND, AND METHOD FOR  PRODUCING SAMETHERABIOPHARMA INC.
WO/2021/153525ESOMEPRAZOLE ORAL PREPARATION AND METHOD FOR PRODUCING SAMETOWA PHARMACEUTICAL CO., LTD.
WO/2021/153570PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)  INHIBITOR AND PHARMACEUTICAL USE THEREFORTHE KITASATO INSTITUTE
WO/2021/153624COMPOSITION OR KIT FOR HAIR BLEACHING OR FOR HAIR DYEINGSHISEIDO COMPANY, LTD.
WO/2021/153634COMPOSITION FOR PREVENTING FADING OF DYED HAIR AND KIT FOR  DYED HAIRSHISEIDO COMPANY, LTD.
WO/2021/153635HIGHLY SAFE NON-LAMELLAR LIQUID CRYSTAL FORMING COMPOSITIONFARNEX INCORPORATED
WO/2021/157457BLONANSERIN-CONTAINING PATCH AND METHOD FOR MANUFACTURING SAMEKANEKA CORPORATION
WO/2021/260986TESTICULAR FUNCTION IMPROVING AGENT AND TESTICULAR FUNCTION  IMPROVING METHODDEXON PHARMACEUTICALS INC.
WO/2021/153651SUNSCREEN COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/153660SOLID POWDER COSMETICKOSE CORPORATION
WO/2021/153665NOVEL ALKYNE DERIVATIVECARNA BIOSCIENCES, INC.
WO/2021/153673DRUG FOR PREVENTING AND/OR TREATING IMMUNE-RELATED SIDE  EFFECT, GENETICALLY MODIFIED NON-HUMAN ANIMAL, AND NON-HUMAN MODEL ANIMAL FOR  IMMUNE-RELATED SIDE EFFECTUNIVERSITY OF TSUKUBA
WO/2021/153703TREATMENT FOR CHONDRODYSTROPHIAKYOTO UNIVERSITY
WO/2021/153708CHOLESTEROL ANALOG HAVING ANTI-HELICOBACTER PYLORI ACTIVITYSHINSHU UNIVERSITY
WO/2021/153716CONTROLLED RELEASE COMPOSITIONNIPPON SHINYAKU CO., LTD.
WO/2021/153718FIBROBLAST GROWTH FACTOR 21 INDUCER, AND COMPOSITION FOR  SUPPRESSING ALCOHOL PREFERENCE OR SIMPLE SUGAR PREFERENCEKYOTO UNIVERSITY
WO/2021/153719MEDICINAL COMPOSITION COMPRISING DENTAL PULP-DERIVED CELLSJCR PHARMACEUTICALS CO., LTD.
WO/2021/205719METHOD FOR PRODUCING CARBON DIOXIDE-CONTAINING HYDROGEL  ARTICLEKAO CORPORATION
WO/2021/161811VASODILATOR COMPOSITION, VASODILATOR COMPOSITION KIT,  PHARMACEUTICAL COMPOSITION FOR DISEASES CAUSED BY BLOOD VESSEL CONSTRICTION  OR OBSTRUCTIVE IMPAIRMENT, AND PHARMACEUTICAL COMPOSITION KIT FOR DISEASES  CAUSED BY BLOOD VESSEL CONSTRICTION OR OBSTRUCTIVE IMPAIRMENTAICHI MEDICAL UNIVERSITY
WO/2021/255978NON-RINSING-OFF-TYPE STERILIZATION CLEANER COMPOSITIONLION CORPORATION
WO/2021/153771HYALURONIC ACID PRODUCTION PROMOTERSHISEIDO COMPANY, LTD.
WO/2021/153773PHOTOAGING INHIBITORSHISEIDO COMPANY, LTD.
WO/2021/153776ANGIOGENESIS INHIBITORSHISEIDO COMPANY, LTD.
WO/2021/153780ANTIOXIDANT OR SKIN STRESS INHIBITORSHISEIDO COMPANY, LTD.
WO/2021/255979ANTI-OBESITY COMPOSITION AND COMPOSITION FOR ORAL  ADMINISTRATIONTOYO SHINYAKU CO., LTD.
WO/2021/153781COLLAGEN SACCHARIFICATION INHIBITORSHISEIDO COMPANY, LTD.
WO/2021/153785AGENT FOR MAINTAINING OR ENHANCING COLLAGEN PRODUCTION ABILITYSHISEIDO COMPANY, LTD.
WO/2021/153788SKIN BARRIER FUNCTION ENHANCERSHISEIDO COMPANY, LTD.
WO/2021/171908COMPOSITION COMPRISING POLYION COMPLEX AND FATTY ALCOHOLL'OREAL
WO/2021/171909COMPOSITION COMPRISING POSITIVELY CHARGED POLYION COMPLEXL'OREAL
WO/2021/153798METHOD FOR ASSESSING POSSIBILITY OF ONSET OR PROGRESSION OF  CHRONIC KIDNEY GRAFT REJECTION AND CHRONIC KIDNEY DISEASE, TEST KIT, AND  PHARMACEUTICAL COMPOSITIONNATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/157569USE OF POLYETHER COMPOUNDSENJU PHARMACEUTICAL CO., LTD.
WO/2021/157601ANTI-MEFLIN ANTIBODY FOR USE IN TREATING CANCER IN SUBJECT  HAVING CANCER, AND PHARMACEUTICAL COMPOSITION INCLUDING SAID ANTIBODYNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/157619AGENT FOR TREATING OR PREVENTING PANCREATIC FISTULANOF CORPORATION
WO/2021/161876BENDAMUSTINE LIQUID PREPARATIONFUJIFILM CORPORATION
WO/2021/157627ORAL COMPOSITIONTOYO SHINYAKU CO., LTD.
WO/2021/157634DETERMINATION AGENT AND DETERMINATION METHOD FOR TAUOPATHY AND  DEMENTIA-RELATED DISEASESSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/157650ANTICANCER AGENT COMPOSITIONCARNA BIOSCIENCES, INC.
WO/2021/157677HYALURONIC ACID DERIVATIVE COMPOSITION, PHARMACEUTICAL  COMPOSITION AND HYALURONIC ACID DERIVATIVE-DRUG CONJUGATE COMPOSITIONASAHI KASEI KABUSHIKI KAISHA
WO/2021/157681THERAPEUTIC AGENT FOR SUBRETINAL HYPERREFLECTIVE MATERIAL OR  RETINAL DISORDERS ACCOMPANYING SUBRETINAL HYPERREFLECTIVE MATERIALRIBOMIC INC.
WO/2021/157682THERAPEUTIC AGENT FOR MYALGIC ENCEPHALOMYELITIS/CHRONIC  FATIGUE SYNDROMEMITSUBISHI TANABE PHARMA CORPORATION
WO/2021/157688SKIN COMPOSITION FOR EXTERNAL USEKAO CORPORATION
WO/2021/171972SOLID PREPARATIONSCREEN HOLDINGS CO., LTD.
WO/2021/157730NUCLEIC ACID DRUG AND USE THEREOFVERITAS IN SILICO INC.
WO/2021/161981NOVEL MEDICAMENT FOR TREATING HEPATIC ENCEPHALOPATHYOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/161982NOVEL MODIFYING REAGENTS FOR THE PRESENCE RATIO OF INTESTINAL  MICROFLORAOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/161983NOVEL MEDICAMENT FOR TREATING INFLAMMATORY DISEASEOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/161984DICLOFENAC SODIUM-CONTAINING PATCHHISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/161985DICLOFENAC SODIUM-CONTAINING PATCHHISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/161987BISPHOSPHONATE-CONTAINING CARBON PARTICLE COMPOSITE AND METHOD  FOR PRODUCING SAMENATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND  TECHNOLOGY
WO/2021/162004DICLOFENAC SODIUM-CONTAINING ADHESIVE PATCHHISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/162020ANTI-CD137 ANTIGEN-BINDING MOLECULE FOR USE IN CANCER  TREATMENTCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/162054TYPE 2 RYANODINE RECEPTOR ACTIVITY INHIBITORJUNTENDO EDUCATIONAL FOUNDATION
WO/2021/162074AQUEOUS COSMETIC PREPARATIONKOSE CORPORATION
WO/2021/210257COMPOSITE PARTICLE AND METHOD FOR PRODUCING SAMESHIN-ETSU CHEMICAL CO., LTD.
WO/2021/162126INHIBITOR OF ASPARTIC ACID SYNTHESIS IN TUMOR CELLS, INHIBITOR  OF SPHEROID FORMATION OF TUMOR CELLS, INHIBITOR OF TUMOR CELL METASTASIS,  ACTIVITY ENHANCER OF GLYCOLYTIC INHIBITOR, AND PHARMACEUTICAL COMPOSITION FOR  SUPPRESSING AND/OR PREVENTING TUMOR METASTASISCCI HOLDINGS INC.
WO/2021/192726CHOLINE UPTAKE INHIBITOR, APOPTOSIS INDUCER, ANTICANCER DRUG,  AND USE THEREOFTOKYO MEDICAL UNIVERSITY
WO/2021/166899GASTRIC PROTEASE INHIBITOR-CONTAINING DRUG FOR COMBINATION USE  WITH INCRETIN MIMETICUBE INDUSTRIES, LTD.
WO/2021/166981CROSS-LINKED NUCLEOSIDE AND NUCLEOTIDE USING SAMEOSAKA UNIVERSITY
WO/2021/166986PATCH PREPARATIONNITTO DENKO CORPORATION
WO/2021/166987TRANSDERMAL ABSORPTION PREPARATIONSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/172157EXTERNAL PREPARATION CONTAINING TETRACAINEKANEKA CORPORATION
WO/2021/172162DISINFECTING COMPOSITIONNOF CORPORATION
WO/2021/167006ANTITUMOR EFFECT ENHANCING AGENT CONTAINING URACIL DERIVATIVE  COMPOUNDTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/167017AEROSOL COMPOSITION AND AEROSOL PREPARATIONHISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/167032DRUG AND FOOD FOR TREATING AND/OR PREVENTING ENTERITIS AND/OR  HEPATITISKEIO UNIVERSITY
WO/2021/167056MEDICINE CONTAINING USAG-1-TARGETING RNA MOLECULE FOR TOOTH  REGENERATION THERAPYKYOTO UNIVERSITY
WO/2021/172188BIOCOMPATIBLE MATERIALFUJIFILM CORPORATION
WO/2021/172210BIOCOMPATIBLE MATERIALFUJIFILM CORPORATION
WO/2021/172211BIOCOMPATIBLE MATERIALFUJIFILM CORPORATION
WO/2021/172213BIOCOMPATIBLE MATERIALFUJIFILM CORPORATION
WO/2021/167088COMPOSITION FOR ALLEVIATING PULMONARY HYPERTENSION, METHOD FOR  PREDICTING PROGNOSIS OF PULMONARY HYPERTENSION, METHOD FOR ASSISTING IN  DETERMINING SEVERITY OF PULMONARY HYPERTENSION, AND METHOD FOR ASSISTING IN  DIAGNOSING PULMONARY HYPERTENSIONNAKAOKA Yoshikazu
WO/2021/199792FORMULATION FOR PREVENTING OR TREATING PNEUMONIAOSAKA UNIVERSITY
WO/2021/172304COMPOSITION FOR ENHANCING ESTROGEN SECRETIONMOTHER & CHILD CO., LTD.
WO/2021/172359CDK9 INHIBITOR PRODRUG AND LIPOSOME INCLUDING THE SAMESUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/172395COATED BULK DRUG PARTICLESTOWA PHARMACEUTICAL CO., LTD.
WO/2021/172418METHOD FOR PRODUCING INACTIVATED INFLUENZA VACCINE AND VACCINE  COMPOSITION THEREOFDENKA COMPANY LIMITED
WO/2021/172430OIL-IN-WATER EMULSION COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/182121BIOFILM TRANSPARENTIZING REAGENT, AND BIOFILM OBSERVATION  METHOD USING SAID TRANSPARENTIZING REAGENTTHE JIKEI UNIVERSITY
WO/2021/172462DRUG COMPOSITION AND METHOD FOR PROMOTING RECOVERY OF  GASTROINTESTINAL TRACT POST-SURGERYSHIONOGI & CO., LTD.
WO/2021/172463COSMETIC CONTAINING SILOXANE LINKAGE-CONTAINING POLYMER  COMPOUND HAVING HOST GROUP AND/OR GUEST GROUPSHISEIDO COMPANY, LTD.
WO/2021/172490COMBINATION DRUG, AND DRUG FOR PREVENTING OR SUPPRESSING  DEVELOPMENT OF PYRIMIDINE ANTIMETABOLITE RESISTANCEFUJIFILM CORPORATION
WO/2021/172498ANTISENSE NUCLEIC ACID INDUCING SKIPPING OF EXON 51NIPPON SHINYAKU CO., LTD.
WO/2021/172515DIAGNOSTIC IMAGING AGENT FOR OLIGOMERIC AMYLOIDNATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL  SCIENCE
WO/2021/199813AQUEOUS SUSPENSION CONTAINING REBAMIPIDE OR SALT THEREOF AND  POLYMERSANTEN PHARMACEUTICAL CO., LTD.
WO/2021/199814SILVER-SALT-CONTAINING OPHTHALMIC AQUEOUS COMPOSITION WITH  WHICH RESIN CONTAINER IS FILLEDSANTEN PHARMACEUTICAL CO., LTD.
WO/2021/172519PANCREATIC CANCER DIAGNOSIS ASSISTANCE METHOD AND  PHARMACEUTICAL COMPOUND FOR TREATING PANCREATIC CANCERTOKYO METROPOLITAN GERIATRIC HOSPITAL AND INSTITUTE OF  GERONTOLOGY
WO/2021/172546DIGESTIVE ENZYME AGENTAMANO ENZYME INC.
WO/2021/172582METHOD FOR SCREENING ANTICANCER AGENT AND COMBINATION DRUG OF  KINASE INHIBITORS FOR TREATMENT OF PANCREATIC CANCERNATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/177256DRUG CONTAINING SOFPIRONIUM BROMIDEKAKEN PHARMACEUTICAL CO., LTD.
WO/2021/177257METHOD FOR TREATING PRIMARY AXILLARY HYPERHIDROSIS AND  PHARMACEUTICAL PRODUCT THEREFORKAKEN PHARMACEUTICAL CO., LTD.
WO/2021/177267PREVENTION OR TREATMENT OF ANEURYSMS USING MIR-33B INHIBITORMITSUBISHI TANABE PHARMA CORPORATION
WO/2021/199850OXIDATIVE STRESS INHIBITOR AND ANTIOXIDANT AGENTBOSQUET SILICON CORP.
WO/2021/177332NLRP3 INFLAMMASOME INHIBITOR AND PHARMACEUTICAL COMPOSITION  FOR PREVENTING OR TREATING INFLAMMATORY DISEASETOHOKU UNIVERSITY
WO/2021/177335BRAIN FUNCTION IMPROVING COMPOSITIONSAN-EI GEN F.F.I., INC.
WO/2021/177352COMPOSITION AND FUNCTIONAL FOOD PRODUCT COMPRISING GREEN TEA  EXTRACTTOYOTA JIDOSHA KABUSHIKI KAISHA
WO/2021/177397L-ERGOTHIONEINE-CONTAINING COMPOSITIONNAGASE & CO., LTD.
WO/2021/182283COMPOSITION FOR SUPPRESSING DECREASE IN OR IMPROVING SKIN  BARRIER FUNCTION, COMPOSITION FOR SUPPRESSING DECREASE IN OR IMPROVING  EXPRESSION OF TYPE 4 COLLAGEN, AND METHOD FOR SCREENING SUBSTANCES HAVING  ACTION TO SUPPRESS DECREASE IN OR IMPROVE SKIN BARRIER FUNCTIONSUNTORY HOLDINGS LIMITED
WO/2021/177438ANTIBODY-DRUG CONJUGATE INCLUDING NOVEL CYCLIC DINUCLEOTIDE  DERIVATIVEDAIICHI SANKYO COMPANY, LIMITED
WO/2021/235044AGENT FOR REVERSING TRIGLYCERIDE DEPOSIT-TYPE ATHEROSCLEROSISOSAKA UNIVERSITY
WO/2021/182330CANCER THERAPY AID FOR ENHANCING ANTICANCER DRUG EFFECTKEIO UNIVERSITY
WO/2021/182367CLEANSING AGENTSHISEIDO COMPANY, LTD.
WO/2021/182377CLOSTRIDIODES DIFFICILE GROWTH INHIBITORNUTRI CO., LTD.
WO/2021/182430DETERGENTSHISEIDO COMPANY, LTD.
WO/2021/182457NOVEL 3,5-DIAMINOBENZOIC ACID COMPOUND, AND PIN1 INHIBITOR AND  THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES USING SAMEHIROSHIMA UNIVERSITY
WO/2021/182467GRANULES AND PREPARATION USING SAMESAWAI PHARMACEUTICAL CO., LTD.
WO/2021/182469GRANULES AND PREPARATION USING SAMESAWAI PHARMACEUTICAL CO., LTD.
WO/2021/182498POLYSACCHARIDE COMPOSITE PARTICLESNISSAN CHEMICAL CORPORATION
WO/2021/182517SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR INDUCING -1 FRAME  SHIFT AND COMPOSITIONYANO, Takamitsu
WO/2021/182538AGENT/COMPOSITION CONTAINING CARYOPHYLLENE, AND VARIOUS USES  THEREOFKINKI UNIVERSITY
WO/2021/187289METHOD FOR PRODUCING PARTICLESRICOH COMPANY, LTD.
WO/2021/187306COSMETIC COMPOSITIONSHIN-ETSU CHEMICAL CO., LTD.
WO/2021/182570MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCERTORAY INDUSTRIES, INC.
WO/2021/182571MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCERTORAY INDUSTRIES, INC.
WO/2021/182572MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCERTORAY INDUSTRIES, INC.
WO/2021/182573MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCERTORAY INDUSTRIES, INC.
WO/2021/182574MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCERTORAY INDUSTRIES, INC.
WO/2021/187314MITOCHONDRIAL DYSFUNCTION IMPROVING AGENTFUKUOKA UNIVERSITY
WO/2021/182596AMELIORATING AGENT FOR DEEPENING OF UPPER EYELID SULCUSKOWA COMPANY, LTD.
WO/2021/182597VIRAL INFECTION THERAPEUTICTHE UNIVERSITY OF TOKYO
WO/2021/182607DIARRHEA INHIBITORTORAY INDUSTRIES, INC.
WO/2021/187380ARRHYTHMOGENIC-CARDIOMYOPATHY-PATIENT-DERIVED PLURIPOTENT STEM  CELLS, USE THEREOF, AND DRUG FOR TREATING ARRHYTHMOGENIC CARDIOMYOPATHYOSAKA UNIVERSITY
WO/2021/193224PHARMACEUTICAL COMPOSITION FOR TREATING DYSCHROMATOSIS  SYMMETRICA HEREDITARIA, DYSCHROMATOSIS SYMMETRICA HEREDITARIA MODEL MOUSE,  AND SCREENING METHOD FOR COMPOUND FOR TREATING DYSCHROMATOSIS SYMMETRICA  HEREDITARIANATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/187478COMPOSITION CONTAINING SELF-ASSEMBLING PEPTIDEKANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/187546ANTI-PSYCHIATRIC DISEASE AGENTUNIVERSITY OF TSUKUBA
WO/2021/187548TREATMENT OR PREVENTION METHOD FOR CHRONIC HEART FAILUREJAPAN TOBACCO INC.
WO/2021/187592PHARMACEUTICAL COMPOSITION CONTAINING BETAMETHASONE VALERATESHIONOGI HEALTHCARE CO., LTD.
WO/2021/187593COMPOSITION CONTAINING BETAMETHASONE VALERATESHIONOGI HEALTHCARE CO., LTD.
WO/2021/187608NOVEL GRANULES AND PRODUCTION METHOD THEREFORNOBELPHARMA CO., LTD.
WO/2021/193393A METHOD OF ADMINISTERING A NANOPARTICLEKAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION
WO/2021/210343ANTITUMOR AGENTNATIONAL UNIVERSITY CORPORATION NARA INSTITUTE OF SCIENCE AND  TECHNOLOGY
WO/2021/200299CELLULAR AGING INHIBITOR, BIOLOGICAL TISSUE REPAIR PROMOTER,  GENE EXPRESSION REGULATOR, AND MANUFACTURING METHODFUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/205852BIOLOGICAL FUNCTION REGULATING AGENT, EPIDERMAL METABOLISM  PROMOTING AGENT, FAT ACCUMULATION INHIBITING AGENT, FAT DECOMPOSITION  PROMOTING AGENT, ADIPONECTIN PRODUCTION PROMOTING AGENT, FUNCTIONAL FOOD,  COSMETIC, AND METHOD FOR PRODUCING BIOLOGICAL FUNCTION REGULATING AGENTNITTA GELATIN INC.
WO/2021/200313PACKAGED AQUEOUS COMPOSITIONKOWA COMPANY, LTD.
WO/2021/193503COSMETIC COMPOSITIONMANDOM CORPORATION
WO/2021/193659COMPOSITION WHICH IS FOR TREATING OR PREVENTING RENAL CELL  CANCER AND CONTAINS D-ALLOSE AS ACTIVE INGREDIENT, AND METHOD FOR TREATING OR  PREVENTING CANCER USING SAMENATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
WO/2021/193703CENTRAL NERVOUS SYSTEM POTENTIATING COMPOSITIONSHIBAURA INSTITUTE OF TECHNOLOGY
WO/2021/200447COSMETIC GEL SHEET INCLUDING WAFER PAPER AS SUPPORT AND  PRODUCTION METHOD THEREFORCOSMED PHARMACEUTICAL CO., LTD.
WO/2021/193744METHOD FOR TREATING CANCER AND SYSTEM FOR SAMEOTSUKA MEDICAL DEVICES CO., LTD.
WO/2021/205886BINDERJAPAN VAM & POVAL CO., LTD.
WO/2021/205887SUSTAINED RELEASE BASEJAPAN VAM & POVAL CO., LTD.
WO/2021/193790AROMATIC HETEROCYCLIC DERIVATIVE HAVING SEROTONIN RECEPTOR  BINDING ACTIVITYSHIONOGI & CO., LTD.
WO/2021/193835ANTI-INFLAMMATORY IMMUNOENHANCERSCENT SCIENCE INTERNATIONAL INC.
WO/2021/200574SKIN TREATMENT METHODKAO CORPORATION
WO/2021/193856RENAL FUNCTION PROTECTANTTOHOKU UNIVERSITY
WO/2021/193874TRANSDERMAL PATCHNICHIBAN CO., LTD.
WO/2021/193900IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND  PHARMACEUTICAL COMPOSITION CONTAINING SAMETHE UNIVERSITY OF KITAKYUSHU
WO/2021/205902LAMELLAR GEL-CONTAINING COMPOSITION, EMULSIFIED COMPOSITION,  AND COMPOSITION FOR AGENT FOR EXTERNAL USE ON SKINSHISEIDO COMPANY, LTD.
WO/2021/200651CORONAVIRUS INFECTION TREATMENT DRUGFUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/193928PHARMACEUTICAL DRUG FOR DESTROYING TUMOR CELLSPHOTOQ3 INC.
WO/2021/200705AGENT FOR INHIBITING REDUCTION OF DECOMPOSITION OF MODIFIED  ELASTIN, AGENT FOR MAINTAINING NORMAL ELASTIC FIBERS, AGENT FOR INHIBITING  FORMATION OF ELASTIN-ELAFIN COMPLEX, AND COMPOSITION CONTAINING SAID AGENTSSUNTORY HOLDINGS LIMITED
WO/2021/200767TABLET, MEDICINE, AND METHOD AND KIT FOR MANUFACTURING SAID  TABLET AND MEDICINEEISAI R&D MANAGEMENT CO., LTD.
WO/2021/200800VACCINE FOR PREVENTING OR TREATING CORONAVIRUS INFECTION OR  SYMPTOMS ASSOCIATED WITH CORONAVIRUS INFECTIONOSAKA UNIVERSITY
WO/2021/200823ERIBULIN-CONTAINING PARENTERAL PHARMACEUTICAL SOLUTIONNIPRO CORPORATION
WO/2021/200857BISPECIFIC ANTIBODYMIE UNIVERSITY
WO/2021/200922FUSION PROTEIN SUITABLE FOR DISSOLVING FIBRIN CLOT, AND  PHARMACEUTICAL COMPOSITION CONTAINING SAID FUSION PROTEINNATIONAL CANCER CENTER
WO/2021/200975PHARMACEUTICAL COMPOSITIONMITSUBISHI TANABE PHARMA CORPORATION
WO/2021/201059COMPOSITION CONTAINING MENTHOLSUNSHO PHARMACEUTICAL CO., LTD.
WO/2021/201100THERAPEUTIC AGENT USING GENOME-EDITED PLURIPOTENT STEM CELLKEIO UNIVERSITY
WO/2021/201152ADHESIVE PATCHNICHIBAN CO., LTD.
WO/2021/201170METHOD FOR SCREENING FOR, METHOD FOR PRODUCING, AND METHOD FOR  DESIGNING DRUG ACTIVE INGREDIENTSSKY PHARMA CO., LTD.
WO/2021/201171SUPPRESSION OF NEUROINFLAMMATION AND COMPOSITION AND METHOD  THEREFORKYOTO UNIVERSITY
WO/2021/220712OPHTHALMIC COMPOSITIONROHTO PHARMACEUTICAL CO., LTD.
WO/2021/201201PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEW CORONAVIRUS  INFECTION (COVID-19) AND PHARMACEUTICAL COMPOSITIONINTERPROTEIN CORPORATION
WO/2021/201224MITOCHONDRION PROTECTING AGENT, MITOCHONDRIAL DYSFUNCTION  IMPROVING AGENT, OR MITOCHONDRIAL FUNCTION IMPROVING AGENTSTAGEN CO., LTD.
WO/2021/201238METHODS OF ADMINISTERING AN ARIPIPRAZOLE INJECTABLE  PREPARATIONOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/201239METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTSOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/201258COMPOSITION CONTAINING NUCLEIC ACID, METHOD FOR PRODUCING  COMPOSITION CONTAINING NUCLEIC ACID, AND METHOD FOR INTRODUCING NUCLEIC ACIDSTATEART INC.
WO/2021/193982NERVE CELL DEGENERATION INHIBITORKYOTO UNIVERSITY
WO/2021/201260PEPTIDE HAVING MESENCHYMAL STEM CELL MOBILIZING ACTIVITYSTEMRIM INC.
WO/2021/201261PAIN TREATMENT DRUGSHIONOGI & CO., LTD.
WO/2021/201262MEDICINE FOR TREATING SLEEP APNEA SYNDROMESHIONOGI & CO., LTD.
WO/2021/201263COMPOSITION FOR IMPROVING INTESTINAL ENVIRONMENT OR ORAL  ENVIRONMENTKIRIN HOLDINGS KABUSHIKI KAISHA
WO/2021/201264PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION FOR  TREATING, PREVENTING OR ALLEVIATING OSTEOARTHRITISTHERABIOPHARMA INC.
WO/2021/201267ANTITUMOR AGENTFUJIFILM CORPORATION
WO/2021/206020PROPHYLACTIC OR THERAPEUTIC AGENT FOR ATTENTION-DEFICIT  HYPERACTIVITY DISORDEROSAKA UNIVERSITY
WO/2021/241000COMPOSITIONTAIYO KAGAKU CO., LTD.
WO/2021/241004AEROSOL-TYPE HAIR CLEANING AGENTKAO CORPORATION
WO/2021/206078MEDICINE FOR KILLING TUMOR CELLSPHOTOQ3 INC.
WO/2021/206103VACCINE FOR SUBCUTANEOUS ADMINISTRATIONAPPLIED MEDICAL ENZYME RESEARCH INSTITUTE CORPORATION
WO/2021/206105EXTRACELLULAR VESICLE SECRETION INHIBITOR FOR INHIBITING  EXTRACELLULAR VESICLE SECRETION, AND USE OF THE SAMETHEORIA SCIENCE INC.
WO/2021/210490ADHESIVE SHEET FOR SKINCOSMED PHARMACEUTICAL CO., LTD.
WO/2021/206158METHOD OF CANCER THERAPYONO PHARMACEUTICAL CO., LTD.
WO/2021/206159SOLID PREPARATION AND MANUFACTURING METHOD THEREOFNIPPON SHINYAKU CO., LTD.
WO/2021/206160ANTIBODY-DRUG COMPLEXONO PHARMACEUTICAL CO., LTD.
WO/2021/206167CANCER THERAPY USING 3,5-DISUBSTITUTED BENZENE ALKYNYL  COMPOUND AND MEK INHIBITORTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/215274SKIN EXTERNAL AGENT COMPOSITION AND DEODORANTSHISEIDO COMPANY, LTD.
WO/2021/210515AGENT FOR INCREASING CD25-POSITIVE REGULATORY T CELLS IN  KIDNEYNATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/210538METHOD FOR ADMINISTERING PHARMACEUTICAL PREPARATIONMATSUKAWA YOUETSU
WO/2021/220792ANTIBACTERIAL AGENTKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/229979PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CEREBRAL  SMALL VESSEL DISEASENIIGATA UNIVERSITY
WO/2021/210609BLASTOCYST FORMATION PROMOTING AGENTWASEDA UNIVERSITY
WO/2021/210636BREAST CANCER THERAPEUTIC AGENTEISAI R&D MANAGEMENT CO., LTD.
WO/2021/210646AQUEOUS COMPOSITION CONTAINING EPINASTINE OR SALT THEREOFSANTEN PHARMACEUTICAL CO., LTD.
WO/2021/210648MEDICINE CONTAINING TREHALOSE OR TREHALOSE DERIVATIVE AND  NASAL SPRAYNEXT21 KABUSHIKI KAISHA
WO/2021/210673AGENT FOR IMPROVING SYMPTOMS OF MENOPAUSEKAO CORPORATION
WO/2021/210681CEREBRAL INFARCTION TREATMENT COMPOSITIONKYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/215364AGENT FOR PREVENTING OR TREATING INTRAUTERINE INFECTIONOSAKA UNIVERSITY
WO/2021/210683HEAT-RESISTANT CAPSULE AND FOOD/BEVERAGE INCLUDING SAMESUNSHO PHARMACEUTICAL CO., LTD.
WO/2021/210684THERAPEUTIC AGENT FOR HYPERKINESIAKYOWA KIRIN CO., LTD.
WO/2021/215375FORMULATION CONTAINING HMGB1 PARTIAL PEPTIDESHIONOGI & CO., LTD.
WO/2021/215405IMMUNOSTIMULANT AND COMPOSITION FOR TREATMENT OR PREVENTIONOSAKA UNIVERSITY
WO/2021/220869METHOD FOR MANUFACTURING SOLID COSMETIC AND PRESS HEADSHISEIDO COMPANY, LTD.
WO/2021/215420CLEANSING AGENTSHISEIDO COMPANY, LTD.
WO/2021/215462IMPROVED PEPTIDE VACCINEBRIGHTPATH BIOTHERAPEUTICS CO., LTD.
WO/2021/256077COGNITIVE FUNCTION IMPROVING AGENT, COGNITIVE FUNCTION  MAINTAINING AGENT, HIPPOCAMPUS FUNCTION IMPROVING AGENT, AND HIPPOCAMPUS  FUNCTION MAINTAINING AGENTMORINAGA MILK INDUSTRY CO., LTD.
WO/2021/215469PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING OR  TREATING CANCER WITH COMBINED USE OF ANTI-HUMAN Fn14 ANTIBODY AND IMMUNE  CHECKPOINT INHIBITORASTELLAS PHARMA INC.
WO/2021/215473AGENT FOR PREVENTING OR TREATING FRAILTYOSAKA UNIVERSITY
WO/2021/215478PHARMACEUTICAL COMPOSITION FOR TREATMENT, PREVENTION, OR  MANAGEMENT OF PSYCHIATRIC DISORDERNATIONAL UNIVERSITY CORPORATION SHIMANE UNIVERSITY
WO/2021/241091COSMETIC OR EXTERNAL SKIN PREPARATION IN WHICH AQUEOUS POLYMER  EMULSION IS BLENDEDNIKKO CHEMICALS CO., LTD.
WO/2021/215517THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE  2019 (COVID-19)NEOPHARMA JAPAN CO., LTD.
WO/2021/230064BLONANSERIN-CONTAINING PATCH AND PRODUCTION METHOD THEREFORKANEKA CORPORATION
WO/2021/221043CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH  COMBINATION OF PYRAZINE DERIVATIVE AND ANOTHER CORONAVIRUS INFECTION  THERAPEUTIC DRUGFUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/221066IMMUNE FUNCTION ENHANCING COMPOSITIONINSTITUTE OF RHEOLOGICAL FUNCTION OF FOOD CO., LTD.
WO/2021/221074LIQUID PREPARATION CONTAINING BRIMONIDINESENJU PHARMACEUTICAL CO., LTD.
WO/2021/251023DENTAL CURABLE COMPOSITIONTOKUYAMA DENTAL CORPORATION
WO/2021/221101LIQUID FORMULATION AND PHARMACEUTICAL PRODUCT CONTAINING  CILASTATINDENKA COMPANY LIMITED
WO/2021/221111PROPHYLACTIC OR THERAPEUTIC AGENT FOR RNA VIRUS-RELATED  DISEASESKYOTO UNIVERSITY
WO/2021/221116PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF  CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER,  COLORECTAL CANCER, BILIARY TRACT CANCER AND LIVER CANCER, PROPHYLACTIC OR  THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN  COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND  METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCERTHE UNIVERSITY OF TOKYO
WO/2021/221135ORAL SOFT COMPOSITIONALIMENT INDUSTRY CO., LTD.
WO/2021/221137MEDICINE AND TEST KIT EACH USING ANTI-SARS-COV-2 ANTIBODYKAO CORPORATION
WO/2021/221149OIL-IN-WATER EMULSION COMPOSITIONSHISEIDO COMPANY, LTD.
WO/2021/225113METHOD FOR CONCENTRATING IONIC CHEMICAL SPECIESNATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY
WO/2021/221159STORAGE CONTAINER FOR ANTIBODY DRUG MEDICINE SOLUTIONNISSAN CHEMICAL CORPORATION
WO/2021/221167CANCER THERAPEUTIC AGENT AND CANCER THERAPEUTIC METHODNAGASAKI UNIVERSITY
WO/2021/225135THERAPEUTIC AGENT FOR NAKAJO-NISHIMURA SYNDROMEKYOTO UNIVERSITY
WO/2021/230131THERAPEUTIC AGENT FOR MILD COGNITIVE IMPAIRMENTSHIMADZU CORPORATION
WO/2021/225149NOVEL THERAPEUTIC AGENT FOR VASCULAR DISORDERNATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/230145NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) CONCENTRATION  INCREASING AGENTSUNTORY HOLDINGS LIMITED
WO/2021/230146COMPOSITION CONTAINING SESAMIN OR LIKE AND NR AND/OR NMNSUNTORY HOLDINGS LIMITED
WO/2021/225161ANTIDEPRESSANT/ANXIOLYTIC DRUG IN WHICH PAC1 RECEPTOR  ANTAGONIST IS USEDKAGOSHIMA UNIVERSITY
WO/2021/215545ANTICANCER COMBINATION THERAPY WITH  N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE  INHIBITOR OF KRAS-G12CTAIHO PHARMACEUTICAL CO., LTD.
WO/2021/230179MEDICINE FOR TREATING RELAPSED OR REFRACTORY MULTIPLE MYELOMADAIICHI SANKYO COMPANY, LIMITED
WO/2021/230233THERAPEUTIC OR PROPHYLACTIC AGENT FOR INFECTIOUS DISEASENIPPON MEDICAL SCHOOL FOUNDATION
WO/2021/230247PHARMACEUTICAL COMPOSITION FOR TREATING CANCERSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/230252COMPOSITION AND METHOD FOR ACTIVATING IMMUNITY OF FISH AND  SHELLFISHMITSUBISHI CORPORATION LIFE SCIENCES LIMITED
WO/2021/230256REBAUDIOSIDE D-RICH STEVIA PLANTSUNTORY HOLDINGS LIMITED
WO/2021/230264AGENT FOR DIAGNOSIS-ASSISTING, PREVENTING OR TREATING DISEASES  IN BILIARY SYSTEMSCOHIA PHARMA, INC.
WO/2021/230286COMPOUND, METHOD AND PHARMACEUTICAL COMPOSITION FOR REGULATING  EXPRESSION OF ATAXIN 3MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/235293CUG REPEAT SEQUENCE BINDING AGENTOSAKA UNIVERSITY
WO/2021/230308IMPURITY PRODUCTION-INHIBITED DRUG COMPOSITIONSHIONOGI & CO., LTD.
WO/2021/230317PHARMACEUTICAL COMPOSITION USED TO TREAT SUBJECT IN HYPOXIC  STATE DUE TO RESPIRATORY FAILURE, ETC.NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL  UNIVERSITY
WO/2021/230340NOVEL INHALANTKOWA COMPANY, LTD.
WO/2021/230358ANTIVIRAL AGENTJNC CORPORATION
WO/2021/230359ANTIVIRAL AGENTJNC CORPORATION
WO/2021/230369GOLD NANOPARTICLE-CONTAINING MEDICINEOSAKA UNIVERSITY
WO/2021/230374SHEET PRODUCTKAO CORPORATION
WO/2021/235390ANTI-SARS-COV-2 DRUGKAGOSHIMA UNIVERSITY
WO/2021/235392ANTI-SARS-COV-2 DURGONCOLYS BIOPHARMA, INC.
WO/2021/235425PARTICLE CONTAINING LIPID NANOPARTICLES, AND METHOD FOR  PRODUCING SAMERICOH COMPANY, LTD.
WO/2021/235436APOMORPHINE-CONTAINING PERCUTANEOUS ABSORPTION TYPE  PREPARATIONMEDRX CO., LTD.
WO/2021/246172OPHTHALMIC COMPOSITION, PHOTOSTABILIZATION METHOD AND METHOD  FOR SUPPRESSING DISCOLORATIONLION CORPORATION
WO/2021/235486COMPOSITION FOR PROMOTING INTESTINAL TRACT DEVELOPMENT,  COMPOSITION FOR IMPROVING PULMONARY FUNCTION AND COMPOSITION FOR ENHANCING  IMMUNE FUNCTIONMORINAGA MILK INDUSTRY CO., LTD.
WO/2021/235494MEDICAL AGENT CONTAINING ACTIVE SULFUR COMPOUND AS MAIN  INGREDIENTAKAIKE, Takaaki
WO/2021/235506EPITHELIAL CANCER THERAPEUTIC AGENTOSAKA UNIVERSITY
WO/2021/235508PHARMACEUTICAL FOR TREATING FATTY LIVER DISEASESSHIONOGI & CO., LTD.
WO/2021/235517NOVEL T-CELL ACTIVATORRIKEN
WO/2021/235527LIQUID PREPARATION CONTAINING BRIMONIDINEEYE THERAPIES, LLC
WO/2021/235532DRUG FOR ENHANCING FIBRINOLYTIC SYSTEM, AND USE THEREFORRENASCIENCE INC.
WO/2021/246200MUSCLE ATROPHY SUPPRESSING AGENTICHIMARU PHARCOS CO., LTD.
WO/2021/241444DISPERSIONDNP FINE CHEMICALS CO., LTD.
WO/2021/241504AGENT FOR PROTECTING AND/OR REGENERATING NEUROMUSCULAR  JUNCTIONSONO PHARMACEUTICAL CO., LTD.
WO/2021/241523PD-1 AGONIST-CONTAINING PHARMACEUTICAL COMPOSITION FOR  TREATING OR PREVENTING Th2-MEDIATED DISEASEFOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE
WO/2021/241582SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING  PRESBYOPIASANTEN PHARMACEUTICAL CO., LTD.
WO/2021/241613THERAPEUTIC AGENT FOR RNA VIRAL INFECTION OBTAINED BY  COMBINING PYRAZINE DERIVATIVE AND THIOPURINE DERIVATIVEFUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/256200CATHEPSIN K INHIBITOROCHANOMIZU UNIVERSITY
WO/2021/241666ANTIVIRAL AGENTKYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION
WO/2021/246272COSMETIC COMPOSITIONKAO CORPORATION
WO/2021/246275COSMETIC COMPOSITIONKAO CORPORATION
WO/2021/246301BEAUTY MICRONEEDLE ARRAYCOSMED PHARMACEUTICAL CO., LTD.
WO/2021/241719IMPROVED GRANZYME B VARIANTCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/241720ANTIBODY-CONTAINING FORMULATIONCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/246332COMPOSITION FOR TREATING, IMPROVING, AND/OR PREVENTING  PROGRESSION OF BOVINE PAPILLOMATOSIS CAUSED BY BOVINE PAPILLOMAVIRUSKINOPHARMA, INC.
WO/2021/246352EXTERNAL DERMATOLOGICAL COMPOSITION FOR GERMICIDAL AND  VIRUCIDAL USEKAO CORPORATION
WO/2021/246385ULTRAVIOLET LIGHT SENSITIVITY REDUCING AGENTKAO CORPORATION
WO/2021/246399THERAPEUTIC DRUG FOR DISEASE CAUSED BY INTESTINAL IMMUNE  DISORDERKEIO UNIVERSITY
WO/2021/246453ANTIMICROBIAL AGENT FOR NONHUMAN ANIMALISHIHARA SANGYO KAISHA, LTD.
WO/2021/246455ANTIFUNGAL AGENT FOR USE IN HUMANSISHIHARA SANGYO KAISHA, LTD.
WO/2021/251268COSMETIC COMPOSITIONKAO CORPORATION
WO/2021/246496METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED  DYSFUNCTIONTHE UNIVERSITY OF TOKYO
WO/2021/251340AGENT FOR REVERSING RESISTANCE TO ANTICANCER DRUGSY'S AC CO., LTD.
WO/2021/251428COMPOSITION FOR SUPPRESSING OR IMPROVING DEPRESSIONKIRIN HOLDINGS KABUSHIKI KAISHA
WO/2021/251450PROPHYLACTIC OR THERAPEUTIC AGENT FOR PORPHYRIAMITSUBISHI TANABE PHARMA CORPORATION
WO/2021/251452PREVENTIVE OR THERAPEUTIC AGENT FOR ACTINIC SKIN DISEASEMITSUBISHI TANABE PHARMA CORPORATION
WO/2021/251453NUCLEIC ACID LIPID PARTICLE VACCINEDAIICHI SANKYO COMPANY, LIMITED
WO/2021/251458SCRUBBING AGENT, SCRUBBING AGENT-CONTAINING COMPOSITION, AND  SCRUBBING AGENT PRODUCTION METHODDAICEL CORPORATION
WO/2021/251460COMPOSITION FOR TREATING CANCER HAVING CAFSNATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY
WO/2021/251485CLEANSING COMPOSITIONMERRY PLUS CORPORATION
WO/2021/256427SENSITISER FOR CANCER TREATMENTKORTUC INC
WO/2021/251505MITOCHONDRIAL FUNCTION-IMPROVING COMPOSITIONMORINAGA MILK INDUSTRY CO., LTD.
WO/2021/256451ENCAPSULATED ISLETOTSUKA PHARMACEUTICAL FACTORY, INC.
WO/2021/256470BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING,  AND FOR ADJUVANT USESOPHY INC.
WO/2021/261330THERAPEUTIC AGENT FOR FIBROSISNIITSU Yoshiro
WO/2021/256473ANTI-CORONAVIRUS AGENTKYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION
WO/2021/261341COMPOSITION FOR INHIBITING PHOSPHODIESTERASE 5 ACTIVITY AND  IMPROVING ERECTILE FUNCTIONKOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/256495INHIBITION OF VIRUS THROUGH INHIBITION OF IMPORTINOSAKA UNIVERSITY
WO/2021/256547COMPOSITION FOR TREATING, PREVENTING, OR ALLEVIATING  SARS-COV-2 INFECTIOUS DISEASETHERABIOPHARMA INC.
WO/2021/256555ANTI-T CELL ANTIGEN-BINDING MOLECULE FOR USE IN COMBINATION  WITH ANGIOGENESIS INHIBITORCHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/261423COMPOSITION FOR PROMOTING PRODUCTION OF INTERLEUKIN-10MEIJI CO., LTD.
WO/2021/261444ADJUVANT WITH TLR4 AGONIST ACTIVITYSUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/261471THERAPEUTIC AGENT FOR OBSESSIVE-COMPULSIVE DISORDERKYOTO UNIVERSITY
WO/2021/261571BLOOD-CEREBROSPINAL FLUID BARRIER PROTECTING AGENTNATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/261576LIPID SECRETION PROMOTING AGENTSANTEN PHARMACEUTICAL CO., LTD.
WO/2021/261592REPEAT BINDING AGENTKYOTO UNIVERSITY
WO/2021/261598THERAPEUTIC AGENT FOR DRUG-INDUCED BRADYCARDIA AND  BRADYARRHYTHMIAOSAKA UNIVERSITY
WO/2021/261599PROPHYLACTIC/THERAPEUTIC AGENT FOR NOVEL CORONA VIRUS  INFECTIOUS DISEASEARAKI Seiichi
WO/2021/261601METHOD FOR SELECTING CANCER PATIENT FOR WHICH COMBINATION  THERAPY OF RETINOID AND CANCER TREATMENT AGENT WILL BE EFFECTIVE, AND  COMBINED DRUG OF RETINOID AND CANCER TREATMENT AGENTRAQUALIA PHARMA INC.
WO/2021/029443LOCAL HEMOSTATIC COMPOSITIONRIM, Chun Mok
WO/2021/015342COMPOSITION FOR PREVENTING OR TREATING SPINAL CORD INJURY,  COMPRISING TRPV4 ANTAGONISTSUNGKWANG MEDICAL FOUNDATION
WO/2021/020612METHOD FOR TREATING STROKE BY USING TRICYCLIC DERIVATIVEJEIL PHARMACEUTICAL CO.,LTD
WO/2021/020618PHARMACEUTICAL COMPOSITION COMPRISING TRIMETHOBENZAMIDE OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTING  OR TREATING NEUROPATHIC PAINFRONTBIO INC.
WO/2021/006413DUAL MODELING FACIAL PACKCHO, Sung Min
WO/2021/029467A SOLID DOSAGE FORM FOR ORALLY ADMINISTRATIONSAM CHUN DANG PHARM. CO., LTD.
WO/2021/040064PHARMACEUTICAL COMPOSITION COMPRISING VACCINIA VIRUS AND  HYDROXYUREA AS ACTIVE INGREDIENT FOR TREATMENT OF CANCERBIONOXX INC.
WO/2021/040065PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING  ANTICANCER VIRUS, IMMUNE CHECKPOINT INHIBITOR AND HYDROXYUREA AS ACTIVE  INGREDIENTSBIONOXX INC.
WO/2021/006418PHARMACEUTICAL COMPOSITION COMPRISING PROTEIN OF TENTONIN AS  ACTIVE INGREDIENT FOR TREATMENT OF DIABETES MELLITUSKOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/040085COMPOSITION FOR ALLEVIATING AND TREATING NARCOLEPSY,  CONTAINING FERMENTED RICE BRAN POWDER AS ACTIVE INGREDIENT, AND PREPARATION  METHOD THEREFORRAPHAGEN
WO/2021/045242COMPOSITION FOR AMELIORATING PREMENSTRUAL SYNDROME SYMPTOMS,  INCLUDING CHRYSANTHEMUM SIBIRICUM EXTRACTGENENCELL INC.
WO/2021/054493METHOD FOR PRODUCTION OF FUNCTIONAL POLYSACCHARIDE AND  COSMETIC COMPOSITIONCABOEXPERT INC.
WO/2021/015357COSMETICS MANUFACTURING APPARATUSMOMSEE LIFE & HEALTH CARE CO., LTD.
WO/2021/054510COMPOSITION FOR PREVENTING AND TREATING BREAST CANCER  INCLUDING SELENOPSAMMAPLIN A AS ACTIVE INGREDIENTSEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
WO/2021/006426BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH AND USE THEREOFINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/070999COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING  METABOLIC SYNDROMES INCLUDING OBESITY, DIABETES, HYPERLIPIDEMIA, AND FATTY  LIVERNUTRACORE CO., LTD.
WO/2021/080037COMPOSITION COMPRISING PATIENT'S JOINT FLUID-DERIVED  MESENCHYMAL STEM CELL FOR TREATMENT OF RHEUMATOID ARTHRITISGYEONGSANG NATIONAL UNIVERSITY HOSPITAL
WO/2021/085696SMALL LIPID NANOPARTICLES, AND CANCER VACCINE INCLUDING SAMEKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/095910COSMETIC COMPOSITION CONTAINING HORSE OIL AND SKIN CARE METHOD  USING SAMEJEJUUDA CO.,LTD.
WO/2021/095921AGRIMONIA EUPATORIA EXTRACT PREPARATION METHOD, AND  COMPOSITION FOR IMPROVING LIVER FUNCTIONS OR TREATING LIVER DISEASES,  CONTAINING EXTRACTBIONIC TRADING CORPORATION
WO/2021/095945USE OF SILDENAFIL AND ROCK INHIBITORS FOR TREATING STROKE OR  SEQUELAE FOLLOWING STROKESOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION  FOUNDATION
WO/2021/095946COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES,  INCLUDING CCR2 AS ACTIVE INGREDIENTTHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/015369ORAL MUCOADHESIVE FILM COMPOSITION COMPRISING LOW-MOLECULAR  WEIGHT COLLAGEN PEPTIDE AND NATURAL EXTRACT COMPLEX, AND ORAL MUCOADHESIVE  FILM MANUFACTURED USING SAMEKOREA PRIME PHARM CO., LTD.
WO/2021/100884COMPOSITION, COMPRISING VINEGAR PICKLED EGG AS ACTIVE  INGREDIENT, FOR PREVENTION, ALLEVIATION, OR TREATMENT OF DIABETIC FOOT ULCERKANG, U Pong
WO/2021/100889COMPOSITION FOR TREATING SPINAL CORD INJURY, COMPRISING STEM  CELLS TREATED WITH NOVEL COMPOUNDUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/100897PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING BIGUANIDE-BASED COMPOUND AND FERROCENE OR FERROCENE DERIVATIVE AS  ACTIVE INGREDIENTSFRONTBIO INC.
WO/2021/054523LIQUID TREATMENT COMPOSITION, AND METHOD FOR PRODUCING SAMEMACKLIN COSMETIC
WO/2021/066248COMPOSITION COMPRISING EXOSOME DERIVED FROM NEST OF  FORK-TAILED STORM-PETREL AS ACTIVE INGREDIENT FOR IMPROVING SKIN CONDITIONSD BIOTECHNOLOGIES CO., LTD
WO/2021/095966SKIN-WHITENING COSMETICS COMPOSITION CONTAINING CHLORELLA  EXTRACT AS ACTIVE INGREDIENTGENECELLPHARM CO., LTD.
WO/2021/100940PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MACULAR  DEGENERATION, CONTAINING PRUNELLA VULGARIS EXTRACT AS ACTIVE INGREDIENTCHONG KUN DANG HEALTHCARE CORP.
WO/2021/054526NANOPARTICLES WITH SPECIAL COATING AND USE THEREOFSUNGKWANG MEDICAL FOUNDATION
WO/2021/107233HEALTH FUNCTIONAL COMPOSITION COMPRISING NATURAL COMPOSITE  MATERIALS, AND PREPARATION METHOD THEREFORFRIEND OF GREENBELT
WO/2021/085734METHOD FOR PREPARING COMPOSITION FOR CONTROLLING BLOOD SUGAR,  CONTAINING COMPLEX-CULTURED MUSHROOM MYCELIUMGIUNCHAN CO., LTD.
WO/2021/060624COMPOSITION FOR PREVENTING OR TREATING KELOID OR HYPERTROPHIC  SCARTEGO SCIENCE INC.
WO/2021/054531STABILIZED EFINACONAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION  COMPRISING ANTIOXIDANTBIOBELIEF CO., LTD
WO/2021/054532EFINACONAZOLE-CONTAINING STABILIZED PHARMACEUTICAL COMPOSITION  COMPRISING CHELATING AGENTBIOBELIEF CO., LTD
WO/2021/054533STABILIZED EFICONAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION  COMPRISING SORBIC ACID AS ACIDBIOBELIEF CO., LTD
WO/2021/054534STABILIZED EFINACONAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION  COMPRISING COMBINATION OF CHELATING AGENT AND ANTIOXIDANTBIOBELIEF CO., LTD
WO/2021/054535STABILIZED EFINACONAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION  COMPRISING COMBINATION OF CHELATING AGENT, ANTIOXIDANT, AND ACIDBIOBELIEF CO., LTD
WO/2021/054536STABILIZED PHARMACEUTICAL COMPOSITION COMPRISING EPINACONAZOLEBIOBELIEF CO., LTD
WO/2021/112297COSMETIC COMPOSITION COMPRISING COMPOSITE FERMENTED PRODUCT OF  GALACTOMYCES AND LICHEN-DERIVED MINERALSNATURE IN LAB. INC
WO/2021/112298METHOD FOR PRODUCING COMPLEX FERMENTATION PRODUCT OF  LICHEN-DERIVED MINERALS AND GALACTOMYCESNATURE IN LAB. INC
WO/2021/112299TIME-LAG FERMENTATION METHOD OF GALACTOMYCES CONTAINING  LICHEN-DERIVED MINERAL AND COSMETIC COMPOSITION USING SAMENATURE IN LAB. INC
WO/2021/020663COMPOSITION COMPRISING LACTOBACILLUS REUTERI ATG-F4 FOR  PREVENTION OR TREATMENT OF MUSCULAR DISORDERATOGEN CO.,LTD
WO/2021/071028CORE-SHELL PCM MICROCAPSULE HAVING AUTOMATIC TEMPERATURE  CONTROL FUNCTION AND COOLING COSMETIC COMPOSITION COMPRISING SAME FOR  EXTERNAL APPLICATION TO SKINBIOGENICS, INC.
WO/2021/112325CLEANSER COMPOSITION, FOR HUMAN BODY, FOR MOISTURIZING OR  SOOTHING SKIN, COMPRISING SEAWEED-DERIVED POLYSACCHARIDE AS ACTIVE INGREDIENTATHENA CO., LTD.
WO/2021/132783FOAMABLE COSMETICYOSHIMOTO R&D INC.
WO/2021/137305PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  BACTERIAL INFECTIONGYEONGSANG NATIONAL UNIVERSITY HOSPITAL
WO/2021/095989DAPSONE TO TREAT BRAIN INFLAMMATION FOR HUMAN WELL-BEINGLEE, Jon-hon
WO/2021/149853COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTHLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/153823METHOD FOR PREPARING CHITOSAN HYDROGEL-CHELATOR FOR CANCER  THERAPYKAI BIOTECH CO., LTD
WO/2021/157753COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR  REGROWTHLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/149860COMPOSITION FOR ALLEVIATING ATOPIC DERMATITIS AND REDUCING  SKIN WRINKLES, USING LACTOBACILLUS-FERMENTED THYME EXTRACT AS EFFECTIVE  COMPONENTSD BIOTECHNOLOGIES CO., LTD
WO/2021/162145COMPOSITION FOR IMPROVING SKIN CONDITIONCJ CHEILJEDANG CORPORATION
WO/2021/167120ANTI-ALLERGY COMPOSITION FOR ATOPIC DERMATITIS ALLEVIATION OR  SKIN REGENERATION, CONTAINING GUAIYL ACETATE AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/167121COMPOSITION FOR ALLERGY PREVENTION, ATOPIC DERMATITIS  ALLEVIATION, OR SKIN REGENERATION, COMPRISING NONANE AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/167123COMPOSITION COMPRISING STRAIGHT CHAIN ALKANE HAVING 14 TO 17  CARBON ATOMS AS ACTIVE INGREDIENT, FOR MUSCLE STRENGTHENING, MUSCLE  ENHANCEMENT, MUSCLE DIFFERENTIATION, MUSCLE REGENERATION, OR SARCOPENIA  SUPPRESSIONINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/167146COMPOSITION FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT  CONTAINING LAURUS NOBILIS EXTRACT AS ACTIVE INGREDIENT, AND FUNCTIONAL HEALTH  FOODKOSABIO INC.
WO/2021/060632METHOD FOR EFFECTIVELY ENHANCING SKIN PENETRATION AND BEAUTY  CARE EFFECT USING EXTRACELLULAR MATRIX PROTEIN SOLUTION, ENCAPSULATED IN  UNILAMELLAR LIPOSOME, FOR PREVENTING SKIN AGING OR REDUCING WRINKLESSOGANG UNIVERSITY RESEARCH BUSINESS DEVELOPMENT FOUNDATION
WO/2021/172624MULTI-USE HEMOSTATIC COMPOSITION AND METHOD FOR PRODUCING SAMETHERACION BIOMEDICAL CO. LTD.
WO/2021/075645PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FAMILIAL  ADENOMATOUS POLYPOSIS, COMPRISING NICLOSAMIDE AND METFORMINBAOBAB AIBIO CO., LTD.
WO/2021/177494TOOTHPASTE COMPOSITIONLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/182654METHOD FOR PREPARING POLYDOPAMINE NANOMOTOR USING UREASE, AND  USE OF SAMEPHI BIOMED INC.
WO/2021/002561MICRONEEDLE CONTAINING SYMPLOCARPUS FOETIDUS EXTRACTLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/025254POLYMER COATING AGENT HAVING CONCURRENTLY EXCELLENT WATER AND  OIL REPELLENT PROPERTIES AND COSMETIC COMPOSITION COMPRISING SAME SHOWING  EXCELLENT MAKE-UP PERSISTENCYLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/182661COMPOSITION FOR IMPROVING ANTIBACTERIAL, ANTI-INFLAMMATORY,  ANTIVIRAL, AND IMMUNE FUNCTIONS, COMPRISING EXTRACT OF LIGULARIA STENOCEPHALA  AS ACTIVE INGREDIENTNATURESENSE CO.,LTD.
WO/2021/182662ANTIMICROBIAL, ANTI-INFLAMMATORY, ANTIVIRAL, AND IMMUNOLOGICAL  FUNCTION-ENHANCING COMPOSITION COMPRISING EXTRACTS OF BRASSICA OLERACEA VAR.  BOTRYTIS OR ITALIANA L. AND CIRSIUM JAPONICUM VAR. MAACKII (MAXIM)FAMENITY CO.,LTD.
WO/2021/182663VITAMIN B6-COUPLED POLYOL-BASED POLYDIXYLITOL GENE TRANSPORTER  COMPRISING PEPTIDE BINDING SPECIFICALLY TO CANCER STEM CELL AND CANCER STEM  CELL-TARGETED THERAPY TECHNIQUEELBIO INCORPORATED
WO/2021/187635PRODUCTION OF MIXTURE FOR PREVENTING AND TREATING RESPIRATORY  INFECTIOUS DISEASES AND VIRAL PNEUMONIASEUNG, Kyungsun
WO/2021/201303FUNCTIONS OF DAPSONE AND DERIVATIVES OF REGULATING NLRP3  INFLAMMASOME ACTIVATION IMPLICATED IN VARIOUS HUMAN DISEASES, SUCH AS  ALZHEIMER'S DISEASE, PRION DISEASES, TYPE 2 DIABETES, AND INFECTIOUS DISEASESLEE, Jong-hoon
WO/2021/201310ETHOSOME COMPOSITION HAVING VITAMIN AND DEXPANTHENOL  ENCAPSULATED THEREIN, AND PREPARATION METHOD THEREFORHYUNDAIBIOSCIENCE CO.,LTD.
WO/2021/206187COMPOSITION COMPRISING GOLD NANOPARTICLE AS ACTIVE INGREDIENT  FOR PREVENTION OR TREATMENT OF CORONA VIRUS-19CHIN, Chur
WO/2021/193999ELASTIC MAKEUP POWDER DERIVED FROM NATURAL INORGANIC  PARTICULATES AND METHOD OF PREPARING SAMESUNJIN BEAUTY SCIENCE CO., LTD.
WO/2021/045343STRUCTURE FOR PROMOTING TRANSDERMAL ABSORPTION, PREPARATION  METHOD THEREFOR, AND COSMETIC COMPOSITION COMPRISING SAMEHNB9 CO.,LTD
WO/2021/201333COSMETIC COMPOSITION FOR ALLEVIATING OR PREVENTING ACNE,  CONTAINING NATURAL EXTRACTS AS ACTIVE INGREDIENTSKPT LTD
WO/2021/145512SOLID PERSONAL CARE PRODUCT AND PRODUCTION METHOD THEREOFBLISSPACK CO., LTD.
WO/2021/221196COMPOSITION FOR IMPROVING DAMAGED HAIRBEAUTEE COLLAGEN CO., LTD.
WO/2021/085769COMPOSITION COMPRISING BOTULINIUM TOXIN OR SALT THEREOF FOR  INCREASING ENDOMETRIAL BLOOD FLOW RATECHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/033871SOFT CAPSULE CONTAINING TYNDALIZED BACTERIA IN FILMPHIL INTERNATIONAL CO., LTD.
WO/2021/020700COMPOSITION FOR PREVENTING, IMPROVING, OR TREATING ISCHEMIC  BRAIN DISEASES, COMPRISING LACTOBACILLUS GASSERI SWPM102SUNGWUN PHARMACOPIA CORPORATION
WO/2021/230388IMPROVED ANTICANCER DRUG COMBINING CARBOPLATIN AS PLATINUM  ANTICANCER DRUG WITH POLYSUCCINIMIDECHAE, Chang Hoon
WO/2021/002588PHARMACEUTICAL COMPOSITION CONTAINING TAMSULOSIN OR  HYDROCHLORIDE THEREOF AND PREPARATION METHOD THEREFORHANMI PHARM. CO., LTD
WO/2021/045345ORAL PHARMACEUTICAL COMPOSITION COMPRISING TERIPARATIDE AND  METHOD FOR PREPARING SAMEICURE BNP CO., LTD.
WO/2021/029517PHARMACEUTICAL COMPOSITION FOR IMPROVING OR TREATING  POST-SURGICAL HYPOPARATHYROIDISM AND TREATMENT METHOD USING THE SAMEDONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/010586COSMETIC COMPOSITION FOR SKIN LIFTING FOR ANTI-AGING AND SKIN  CARE METHOD USING SAMESIMFLE-STICK CO.LTD
WO/2021/201335STAMINA-IMPROVING COMPOSITION AND STAMINA-IMPROVING NATURAL  TEA COMPRISING SAMENAM, Jong Hyun
WO/2021/167168COMPOSITION, CONTAINING AGASTACHE RUGOSA AND LICORICE EXTRACT  AS ACTIVE INGREDIENT, FOR PREVENTING OR TREATING RESPIRATORY DISEASES CAUSED  BY FINE DUSTCOSMAX NBT, INC.
WO/2021/215574DISPERSANT OR DISPERSION MEDIA COMPOSITION COMPRISING  2,3-BUTANEDIOL, AND COSMETIC COMPOSITION COMPRISING SAMEGS CALTEX CORPORATION
WO/2021/241780COMPOSITION FOR INHIBITING HAIR GRAYING, AND USE THEREOFLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/241786TRILAYER LIPOSOME COMPOSITION COMPRISING CATIONIC POLYMER  CONJUGATE AND LIPOSOME, AND COSMETIC COMPOSITION COMPRISING SAMEH&A PHARMACHEM CO., LTD
WO/2021/241788COMPOSITION FOR PREVENTING OR TREATING DIABETESLEE, Sam Goo
WO/2021/187670COMPOSITION FOR ALLEVIATING CORONAVIRUS INFECTION USING  RALOXIFENEGYEONGGIDO BUSINESS AND SCIENCE ACCELERATOR
WO/2021/246557URATE OXIDASE-ALBUMIN CONJUGATE HAVING CERTAIN NUMBER OF  CONJUGATED ALBUMINS, AND METHOD FOR PRODUCING SAMEPROABTECH CO., LTD.
WO/2021/251508METHOD FOR EXTRACTING EXTRACT OF LIQUOR PRODUCTION BY-PRODUCT  AND COMPOSITION FOR WHITENING, WRINKLE IMPROVEMENT AND ANTI-AGING COMPRISING  THE EXTRACT ACCORDING TO THE METHODKIM, Sang Wook
WO/2021/010596COSMETIC COMPOSITION COMPRISING GRAPHENE OXIDE AS ACTIVE  INGREDIENTCOSMAX, INC.
WO/2021/006490COSMETIC COMPOSITION CONTAINING GRAPHENE QUANTUM DOTS AS  ACTIVE INGREDIENTCOSMAX, INC.
WO/2021/194010COMPOSITION FOR TREATMENT AND PREVENTION OF INFLAMMATORY  DISEASES CONTAINING COMPLEX EXTRACT OF BEET, RED ONION, AND PURPLE-FLESHED  SWEET POTATO AS ACTIVE INGREDIENTGUSTAR CO., LTD.
WO/2021/075663COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING  NON-ALCOHOLIC FATTY LIVER DISEASE COMPRISING LACTOBACILLUS HELVETICA AND  BIFIDOBACTERIUM STRAINSCKD BIO CORPORATION
WO/2021/033898SODIUM DEOXYCHOLATE-CONTAINING AQUEOUS COMPOSITION STABLE  AGAINST PRECIPITATIONAH, Youngchang
WO/2021/256579COMPOSITION FOR TREATMENT OF GLUTARIC ACIDURIA AND  ADMINISTRATION METHOD THEREFORNOVEL PHARMA INC.
WO/2021/071051METHOD FOR PREPARING ENTERIC-COATED PANCREATIN PELLETSNENSYS CO., LTD.
WO/2021/221228WATER-DISPERSIBLE COSMETIC COMPOSITION FOR BLOCKING  ULTRAVIOLET RADIATION COMPRISING DIFFERENT KINDS OF ORGANIC THICKENERSKOLMAR KOREA CO., LTD.
WO/2021/033899COMPOSITION FOR WOUND HEALING OR ACCELERATING WOUND HEALING,  CONTAINING, AS ACTIVE INGREDIENT, COMBINATION OF HYALURONIC ACID AND  LYOPHILIZED EXOSOMES DERIVED FROM STEM CELLSEXOCOBIO INC.
WO/2021/157785PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  DIABETES COMPRISING HENEICOSANE, AND FOOD COMPOSITION COMPRISING SAMEREPUBLIC OF KOREA(RURAL DEVELOPMENT ADMINISTRATION)
WO/2021/010604COSMETIC COMPOSITION COMPRISING MICROSPHERES CONTAINING HIGH  CONCENTRATION OF OXYGEN AND METHOD FOR PREPARING SAMECOIZ. CO., LTD.
WO/2021/167175PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING MTOR-SIGNALING INHIBITOR AS ACTIVE INGREDIENTKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/241796COSMETIC COMPOSITION AND METHOD FOR PRODUCING SAMEMACBIOTECH CO., LTD.
WO/2021/015426AQUEOUS ANTISEPTIC COMPOSITION HAVING IMPROVED ANTIBACTERIAL  PERSISTENCE COMPRISING CHLORHEXIDINE OR DERIVATIVE THEREOF AND FABRIC TYPE  ANTISEPTIC COMPRISING SAMEHUONS CO., LTD.
WO/2021/149880COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH,  COMPRISING, AS ACTIVE INGREDIENT, MIXED EXTRACT OF CUCUMBER, EGGPLANT AND  SNAILLEE, Dong wan
WO/2021/225214COMPOSITION HAVING ANTI-INFLAMMATORY AND ANTIVIRAL EFFECT,  COMPRISING PLACENTAL EXTRACELLULAR VESICLESTS CELL BIO CO., LTD.
WO/2021/002637TOOTHPASTE FOR PREVENTING COLD TEETH AND PERIODONTAL DISEASES  AND MANUFACTURING METHOD THEREFORKIM, Cheon-Gyun
WO/2021/006507METHOD FOR PREPARING COMPOSITION POWDER FOR FEMININE WASH  CONTAINING PROPOLIS AND NATURAL EXTRACTINVENTAGE LAB INC.
WO/2021/261635NOVEL IMMUNOSTIMULANT AND VACCINE COMPOSITION COMPRISING SAMEREPUBLIC OF KOREA(ANIMAL AND PLANT QUARANTINE AGENCY)
WO/2021/002642COMPOSITION FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS,  COMPRISING SNAKE VENOMDNBIO PHARM, INC.
WO/2021/194013RECOMBINANT PROTEIN FOR ELIMINATING BOAR TAINT AND VACCINE  COMPOSITION COMPRISING SAMEBIOAPPLICATIONS INC.
WO/2021/002645COMPOSITION FOR EXCRETION OF SUGAR COMPRISING HYDROGEL AND  EGFR LIGAND AS ACTIVE INGREDIENTSINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/015437COMPOSITION FOR PREVENTING, TREATING, OR AMELIORATING VIRAL  INFECTION DISEASE, CONTAINING ACTIVE OXYGEN PRODUCTION INHIBITOR AND ACTIVE  OXYGEN SCAVENGER COMPLEX AS ACTIVE INGREDIENTSKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/002664COMPOSITION FOR PREVENTING, RELIEVING OR TREATING CANCERINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/002697USE OF RECOMBINANT ANTIBACTERIAL PROTEIN ABLYSIN FOR  EFFECTIVELY KILLING MULTIDRUG-RESISTANT PATHOGENIC BACTERIAKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/006549METHOD FOR PREPARING DERMOBIOTICS BLOCK COMPOSITION HAVING  SKIN MOISTURIZING AND SKIN REGENERATION FUNCTIONSHYUNDAI BIOLAND CO., LTD.
WO/2021/002735CELL SURFACE ANTIGEN OF T CELL AND VARIOUS USES THEREOFGOOD T CELLS, INC.
WO/2021/025302MAGNETICALLY ACTUATED MICROROBOT USING BIO-BASED ORGANISMDAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/141192COMPOSITION FOR PREVENTING OR TREATING DRY EYE SYNDROME,  CONTAINING SPARASSIS CRISPA EXTRACTLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/006603NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING ALLERGIC  DISEASESPROGEN CO., LTD.
WO/2021/006607COMPOSITION, FOR PREVENTING, TREATING, OR ALLEVIATING  DIABETES, COMPRISING LGI3-DERIVED PEPTIDE AS EFFECTIVE COMPONENTCHUNG-ANG UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/125477PHARMACEUTICAL COMPOSITION CONTAINING PRION PROTEIN-SPECIFIC  ANTIBODYSTEM BIO CO., LTD
WO/2021/029541ELASTIC LIPOSOME COMPOSITION COMPRISING SUCROSE-BASED  SURFACTANT AND COSMETIC COMPOSITION CONTAINING SAMEKOLMAR KOREA CO., LTD.
WO/2021/006615CAPSULE FOR COSMETICSLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/049742COSMETIC COMPOSITION HAVING EXCELLENT PERCUTANEOUS ABSORPTIONKOLMAR KOREA CO., LTD.
WO/2021/006637COSMETIC COMPOSITION COMPRISING 5-BENZYLAMINOSALICYLIC ACID  DERIVATIVE AND LOCAL ADMINISTRATION METHOD THEREOFGNT PHARMA CO., LTD.
WO/2021/006663COMPOSITION COMPRISING O-CYCLIC PHYTOSPHINGOSINE-1-PHOSPHATE  FOR PREVENTING OR TREATING PARKINSON′S DISEASEAXCESO BIOPHARMA CO.,LTD.
WO/2021/006684METHOD FOR PREPARATION OF ULTRASONICATED YEAST EXTRACT HAVING  EXCELLENT INHIBITORY ACTIVITY AGAINST SKIN CANCER AND SKIN CANCER-INHIBITING  COMPOSITION COMPRISING ULTRASONICATED YEAST EXTRACT PREPARED BY SAME METHODKOREA FOOD RESEARCH INSTITUTE
WO/2021/006707USE OF SGK1 INHIBITOR AS THERAPEUTIC AGENT FOR INFLAMMATORY  NEUROLOGICAL DISEASESINDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
WO/2021/010698CANCER CELL-TARGETED DRUG DELIVERY CARRIER AND COMPOSITION FOR  PROMOTING PHOTO-THERMAL TREATMENT EFFECTS, BOTH OF WHICH CONTAIN M1  MACROPHAGES AS ACTIVE INGREDIENTKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/010702COMPOSITION FOR REGENERATING GROWTH PLATEAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/010704COMPOSITION FOR REGENERATING NUCLEUS PULPOSUSAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/010715PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE  DISEASESINDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/010719LONG-LASTING FORMULATION CONTAINING RIVASTIGMINE, AND METHOD  FOR PREPARING SAMEG2GBIO, INC.
WO/2021/010728PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE  DISEASESINDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/020771STABLE PHARMACEUTICAL COMPOSITION COMPRISING ESOMEPRAZOLE AND  SODIUM BICARBONATECHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/010762PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  METABOLIC BONE DISEASES, CONTAINING BENTONITE AS ACTIVE INGREDIENTKOREA INSTITUTE OF GEOSCIENCE AND MINERAL RESOURCES
WO/2021/187679COMPOSITION, COMPRISING SEA CUCUMBER-DERIVED SAPONIN COMPOUND,  FOR PREVENTING, ALLEVIATING, OR TREATING NEUROPATHYKOREA INSTITUTE OF OCEAN SCIENCE ＆ TECHNOLOGY
WO/2021/010790ANTICANCER COMPOSITION COMPRISING SALVIA MILTIORRHIZA  BIOCONVERSION EXTRACT AND RED GINSENG BIOCONVERSION EXTRACTRE BIO, INC.
WO/2021/010791COMPOSITION FOR ALLEVIATING, PREVENTING, OR TREATING  CARDIOVASCULAR DISORDERS, CONTAINING BIOCONVERTED SALVIA MILTIORRHIZA EXTRACT  AND BIOCONVERTED RED GINSENG EXTRACTRE BIO, INC.
WO/2021/010798IMMUNOGENIC COMPOSITION COMPRISING MULTIVALENT STREPTOCOCCUS  PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATESCELLTRION, INC.
WO/2021/040233COSMETIC COMPOSITION COMPRISING CALAMINE DISPERSED IN  BIOPOLYMER, AND SHEET MASK USING SAMECOSMAX, INC.
WO/2021/080129COMPOSITION FOR STRENGTHENING SKIN BARRIER AND ALLEVIATING  ATOPIC DERMATITIS, HAVING HYDRANGENOL OR PHYLLODULCIN AS ACTIVE INGREDIENTCOSMAX BIO CO., LTD.
WO/2021/060688PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING INHIBITOR OF MYO1D EXPRESSION AS EFFECTIVE COMPONENTINDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/020820PHARMACEUTICAL COMPOSITION COMPRISING UDENAFILCOREPHARM BIO CO., LTD.
WO/2021/020841COMPOSITION FOR PREVENTING OR TREATING METABOLIC LIVER DISEASESTANDIGM INC.
WO/2021/020857USE OF COMPOSITION FOR PREVENTION, ALLEVIATION OR TREATMENT OF  BONE LOSS DISORDERS, CONTAINING EXTRACTS OF REYNOUTRIA JAPONICA AND CASSIAE  CORTEX INTERIORNOVMETAPHARMA CO., LTD.
WO/2021/020860PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  ARTERIOSCLEROSIS CONTAINING CYCLODEXTRIN POLYMER AS ACTIVE INGREDIENTKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/020885PHARMACEUTICAL COMPOSITION FOR TREATING LEVODOPA-INDUCED  DYSKINESIA OR FOR SUPPRESSING PROGRESSION THEREOFPEPTRON, INC.
WO/2021/118004COMPLEX FORMULATION COMPRISING DONEPEZIL AND MEMANTINECHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/045392PHARMACEUTICAL COMPOSITION COMPRISING HDAC INHIBITOR AND  ANTI-PD1 ANTIBODY OR ANTI PD-L1 ANTIBODYCRYSTALGENOMICS, INC.
WO/2021/020902NOVEL ANTICANCER COMPOUND AND PHARMACEUTICAL COMPOSITION  COMPRISING SAME AS ACTIVE INGREDIENTHAIM BIO CO., LTD.
WO/2021/020912USE OF COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING  COGNITIVE DYSFUNCTION COMPRISING EXTRACT OF POLYGONUM CUSPIDATUM ROOT AND  CINNAMOMUM CASSIANOVMETAPHARMA CO., LTD.
WO/2021/020923COMPOSITION AND METHOD FOR PREVENTING, ALLEVIATING, OR  TREATING LIVER INJURYKOBIOLABS, INC.
WO/2021/020945ANTICANCER AGENT AND METHOD FOR PREPARATION OF POROUS SILICA  PARTICLELEMONEX INC.
WO/2021/125488LIPOLYSIS COMPOSITION USING SURFACE-MODIFIED GAS-GENERATING  NANOPARTICLESSUPERNOVA BIO CO., LTD.
WO/2021/020950COMPOSITION COMPRISING HYALURONIC ACID AND PLURONIC FOR  PREVENTING OR TREATING ARTICULAR AND CARTILAGE INJURYHA, Yoo Jin
WO/2021/025415PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  METABOLIC DISEASES, CONTAINING DEHYDRO-6-GINGERDIONEUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/040257PHARMACEUTICAL FORMULATIONS COMPRISING SODIUM  PALMITOYL-L-PROLYL-L-PROLYL-GLYCYL-L-TYROSINATE AND METHODS FOR PREPARING THE  SAMEBRIDGE BIOTHERAPEUTICS, INC.
WO/2021/182685USE OF L-NUCLEOSIDE FOR TREATING CORONAVIRUSBUKWANG PHARMACEUTICAL CO., LTD.
WO/2021/206227COSMETIC COMPOSITION COMPRISING QUERCUS ACUTA THUNB FRUIT  EXTRACT FOR PREVENTING AND ALLEVIATING ULTRAVIOLET LIGHT-CAUSED SKIN AGINGJEONNAM BIOINDUSTRY FOUNDATION
WO/2021/029619COSMETIC COMPOSITION COMPRISING BENTONITE AS ACTIVE INGREDIENTKOREA INSTITUTE OF GEOSCIENCE AND MINERAL RESOURCES
WO/2021/033973COMPOSITION FOR INHIBITING MYELOID-DERIVED SUPPRESSOR CELL  COMPRISING MITF INHIBITOR AS ACTIVE INGREDIENTSOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/025529SKIN WHITENING COMPOSITION CONTAINING  DIHYDRO-5-METHYLFURAN-2(3H)-ONE DERIVATIVESTEMORE CO., LTD.
WO/2021/025532ANTICANCER COMPOSITION USING SLC1A5 TRANSCRIPT VARIANT,  ANTICANCER DRUG SCREENING METHOD, AND CANCER DIAGNOSIS METHODUIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY
WO/2021/025533COMPOSITION COMPRISING SKELETAL MUSCLE STEM CELL-DERIVED  EXOSOME AS ACTIVE INGREDIENT FOR IMPROVING SKIN CONDITIONKONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP
WO/2021/029631INTRAORAL FAST-DISINTEGRATING FORMULATION CONTAINING HEMP OIL  EXTRACT OR HEMP POWDER EXTRACT AS RAW MATERIAL OF FORMULATIONCTC SCIENCE INC.
WO/2021/049768CHITOSAN-COATED NANOCAPSULE CONTAINING RETINOL OR RETINOL  DERIVATIVE, AND USE THEREOFSKINMED CO., LTD.
WO/2021/040275DISPERSION OF CERIUM OXIDE FOR ENHANCING SKIN BARRIER, SKIN  MOISTURIZING, AND/OR BLOCKING FINE DUST, AND COSMETIC COMPOSITION COMPRISING  SAMEKOLMAR KOREA CO., LTD.
WO/2021/033990COMPOSITION COMPRISING EXOSOMES DERIVED FROM INDUCED  PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELL PRECURSOR FOR PREVENTION  OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITISBREXOGEN INC.
WO/2021/101019COMPOSITION FOR INDUCING DIFFERENTIATION OF CANINE  ADIPOSE-DERIVED STEM CELLS INTO BROWN ADIPOCYTES USING BOMBYX MORI EXTRACT,  METHOD FOR INDUCING DIFFERENTIATION, AND PET FEED ADDITIVE FOR REDUCING BODY  FAT AND PREVENTING OBESITY CONTAINING SAMEGACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/029656PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  NONALCOHOLIC STEATOHEPATITIS, CONTAINING HYDROQUINONE DERIVATIVE AND  OBETICHOLIC ACIDBIOTOXTECH CO., LTD.
WO/2021/029659COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES OR  ATOPIC DERMATITIS COMPRISING ETHYL VANILLIN, SUBERIC ACID, THIAZOLE OR SALT  THEREOF AS EFFECTIVE COMPONENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/033994COMPOSITION COMPRISING SALVIA MILTIORRHIZA OR PAEONIA  LACTIFLORA EXTRACT AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF LIPID  METABOLISM DISORDERUSCAREPHARM CO.,LTD
WO/2021/033995COMPOSITION COMPRISING AMOMUM TSAOKO EXTRACT FOR PREVENTION,  ALLEVIATION, OR TREATMENT OF SARCOPENIA-RELATED DISEASEKOREAN DRUG CO., LTD.
WO/2021/029673COMPOSITION FOR INHIBITING TOXICITY OF NANOPARTICLES AND  ENVIRONMENTALLY-DERIVED FINE PARTICLESAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/029679COSMETIC COMBINATION COMPRISING PEPTIDE COMPLEX MICRONEEDLE  FOR EFFECTIVE REDUCTION OF DEEP WRINKLE AND APPLICATION METHOD THEREOFSR BIOTEK INC.
WO/2021/029684PEPTIDE-COMPLEXED MICRONEEDLE AND COSMETIC COMPOSITION  COMPRISING SAMESR BIOTEK INC.
WO/2021/177518PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD CHOLESTEROL,  PREVENTING OR TREATING CARDIOVASCULAR DISEASES AND REDUCING INFLAMMATIONSEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/034080COMPOSITION FOR PREVENTION OR TREATMENT OF ALLERGIC DISEASE OR  ATOPIC DERMATITIS COMPRISING CARVONE OR SALT THEREOF AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/034082COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES OR  ATOPIC DERMATITIS, COMPRISING OCIMENE, CAMPHOR, OR SALT THEREOF AS ACTIVE  INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/034094COMPOSITION COMPRISING KAEMPFERIDE AS ACTIVE INGREDIENT FOR  PREVENTION OR TREATMENT OF PROTEIN CONFORMATIONAL DISORDERINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/034095COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASE  COMPRISING KAEMPFERIDE AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/034098USE OF IMMUNOCYTOKINE COMPRISING INTERFERON-BETA OR VARIANT  THEREOF FOR TREATING HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE CANCERGENOPHARM INC.
WO/2021/034121ULTRAVIOLET BLOCKING COSMETIC COMPOSITION IN CHROMATIC  EMULSION STATELG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/177519PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER  CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND  FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE  DERIVATIVE, OR FLAVANONE DERIVATIVEFRONTBIO INC.
WO/2021/040337NICLOSAMIDE DELAYED-RELEASE COMPOSITION AND ANTIVIRAL USE  THEREOFDAEWOONG THERAPEUTICS INC.
WO/2021/034150COSMETIC COMPOSITION COMPRISING EUTECTIC MIXTURELG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/060714COSMETIC COMPOSITION FOR PREVENTING SKIN AGING AND REDUCING  SKIN WRINKLES, COMPRISING SELAGINELLA ROSSII WARB. EXTRACTKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/049775ADDITIVE COMPOSITION FOR PREVENTING VITAMIN C PRECIPITATIONAMOREPACIFIC CORPORATION
WO/2021/034162PHARMACEUTICAL COMPOSITION COMPRISING LATE-PASSAGE HUMAN  MESENCHYMAL STEM CELLS INDUCED TO DIFFERENTIATE TO GLIA-LIKE CELLS AS ACTIVE  INGREDIENT FOR TREATMENT OF STROKESEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/034164PHARMACEUTICAL COMPOSITION FOR ALZHEIMER'S TREATMENT  CONTAINING AS ACTIVE INGREDIENT LATE-STAGE HUMAN MESENCHYMAL STEM CELLS  INDUCED TO DIFFERENTIATE INTO GLIA-LIKE CELLSSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/040371ANTI-INFLAMMATORY COMPOSITIONOSTEONEUROGEN INC.
WO/2021/040389PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SOLID  CANCER, CONTAINING EPIDITHIODIOXOPIPERAZINE DERIVATIVE OR PHARMACEUTICALLY  ACCEPTABLE SALTS THEREOFEWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
WO/2021/167192ANTIBACTERIAL, ANTI-INFLAMMATORY COMPOSITION FOR IMPROVING  BLOOD CIRCULATION, DISSOLVING WASTE, ACTIVATING AND REGENERATING CELLS, AND  STRENGTHENING IMMUNE FUNCTION AND ORGAN FUNCTION, AND INCLUDING ESSENTIAL  AROMA OIL AS ACTIVE INGREDIENTSINK CUP CO., LTD.
WO/2021/040416PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING BONE  LOSS INDUCED BY METABOLIC BONE DISEASES, COMPRISING ARTEMISIA SCOPARIA  EXTRACT AS ACTIVE INGREDIENTINDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/054637COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING  DEGENERATIVE BRAIN DISEASE, COMPRISING PERIOSTRACUM CICADAE EXTRACTKOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/107341TRANSDERMAL ABSORPTION PREPARATION CONTAINING RASAGILINE OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOFWOOSHIN LABOTTACH CO., LTD.
WO/2021/040439INFLUENZA VACCINE COMPOSITION BASED ON NOVEL NUCLEIC ACIDNA VACCINE INSTITUTE
WO/2021/040440PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING  NONALCOHOLIC STEATOHEPATITIS (NASH)CELLTRION INC.
WO/2021/040449COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING  ANGELICA GIGAS, ACONITUM CARMICHAELI DEBEAUX, AND ZINGIBER OFFICINALE ROSCOE  MIXED EXTRACT AS ACTIVE INGREDIENTUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/040470COMPOSITION CONTAINING EXTRACT OF LILIUM HANSONII LEICHTLIN EX  BAKERLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/040496PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING  VACCINIA VIRUS AND GRANULOPOIESIS INHIBITOR AS ACTIVE INGREDIENTSBIONOXX INC.
WO/2021/045485IMMUNE MICROBUBBLE COMPLEX, AND USE THEREOFIMGT CO, LTD.
WO/2021/045501COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING IL-2  SURFACE EXPRESSION-EXTRACELLULAR VESICLES AS ACTIVE INGREDIENTKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/045504COSMETIC MATERIAL COMPOSITION COMPRISING SOLID PHASE POLYMER  HAVING IMPROVED SOLUBILITYLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/045520COSMETIC COMPOSITION COMPRISING FIBROBLAST GROWTH FACTOR 17SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/045538COMPOSITION FOR DIAGNOSING OR TREATING CONDITIONS ASSOCIATED  WITH INCREASED ELF4E ACTIVITY COMPRISING ELF4E INHIBITORSOVARGEN CO., LTD.
WO/2021/045554PHARMACEUTICAL COMPOSITION COMPRISING PROCESSED FISH PRODUCT  AND/OR PROCESSED SOYBEAN PRODUCT AS ACTIVE INGREDIENTJANG, Young Jin
WO/2021/045567COMPOSITION FOR PREVENTING OR TREATING SALIVARY GLAND DISESAES  USING CELL-DERIVED VESICLEMDIMUNE INC.
WO/2021/045569COMPOSITION COMPRISING BILBERRY EXTRACT AS ACTIVE INGREDIENT  FOR PREVENTING OR TREATING SENSORINEURAL HEARING IMPAIRMENTIMDPHARM INC.
WO/2021/071102LIQUID CRYSTALLINE STRUCTURE-FORMING OMEGA-3-FATTY ACID  COMPOSITIONIMDPHARM INC.
WO/2021/049825NANOEMULSION OPHTHALMIC COMPOSITION COMPRISING CYCLOSPORINE  AND MENTHOL, AND PREPARATION METHOD THEREOFTAEJOON PHARMACEUTICAL CO., LTD.
WO/2021/045595PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY  OR NON-ALCOHOLIC FATTY LIVER, CONTAINING DENTAL TISSUE-DERIVED MULTIPOTENT  STEM CELLSINDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL  UNIVERSITY
WO/2021/049850ANTICANCER THERANOSTIC AGENT ACTIVATED BY ANTI-ANGIOGENESIS  AND HYPOXIC ENVIRONMENTKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/221239PHARMACEUTICAL BOTULINUM TOXIN COMPOSITION CONTAINING TANNIC  ACIDKOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/049852LACTOBACILLUS PARACASEI SUBSP. TOLERANS SW1 STRAIN HAVING SKIN  WRINKLE IMPROVEMENT ABILITY AND PRODUCING HIGHLY FUNCTIONAL NATURAL  METABOLITES, AND USE THEREOFUNIVERSITY OF SEOUL INDUSTRY COOPERATION FOUNDATION
WO/2021/049864COMPOSITION FOR AMELIORATING DRY EYE SYNDROME CONTAINING  ARALIA ELATA EXTRACTMEDVILL
WO/2021/049920SURFACE-MODIFIED EXTRACELLULAR VESICLE AND COMPOSITION  COMPRISING SAMETHERABEST CO.,LTD
WO/2021/085849PHARMACEUTICAL COMPOSITION COMPRISING ISOLIQUIRITIGENIN  DERIVATIVE FOR PREVENTION OR TREATMENT OF BONE DISEASECATHOLIC KWANDONG UNIVERSITY INDUSTRY FOUNDATION
WO/2021/172678COMPOSITION FOR AMELIORATING HYPERURICEMIA COMPRISING  DENDROPANAX MORBIFERA LEV. EXTRACTHURIMHWANGCHILCORP.
WO/2021/080184SMALL-SIZED, SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION  COMPRISING CHOLINE ALFOSCERATEKOREA UNITED PHARM. INC.
WO/2021/080185SUSTAINED-RELEASE, SMALL-SIZED ORALLY ADMINISTERED PREPARATION  CONTAINING CHOLINE ALFOSCERATEKOREA UNITED PHARM. INC.
WO/2021/080188COMPOSITION FOR PREVENTION OR TREATMENT OF DEPRESSION  COMPRISING PROTEIN EXPRESSION INHIBITOR AND USE THEREOFSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/080189COMPOSITION FOR SKIN WHITENING, AND USE THEREOFSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/085853COMPOSITION FOR ENHANCING IMMUNE ACTIVITY AND METHOD THEREFORSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/060773COSMETIC COMPOSITION FOR AMELIORATING ACNE COMPRISING  QUERCETIN, TERPENE, AND VITAMIN K AS ACTIVE INGREDIENTSINCODONBIOCOSMETIC CO.,LTD.
WO/2021/071126COMPOSITION, FOR PREVENTION OR TREATMENT OF CANCER DISEASE,  COMPRISING CYTOTOXIC T CELLS ACTIVATED BY T HELPER CELL-DERIVED EXTRACELLULAR  VESICLES AS ACTIVE INGREDIENTKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/054767CARBON-COATED GADOLINIUM OXIDE, AND METHOD FOR PREPARING SAMEKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/071127COMPOSITION COMPRISING INHIBITOR AGAINST EXPRESSION OF  EXOSOMAL PD-L1 AS ACTIVE INGREDIENT FOR ENHANCING ANTICANCER EFFECTKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/054773COSMETIC COMPOSITION WITH MULTIPLE EMULSION FORMULATION FOR  ACTIVE INGREDIENT STABILIZATION AND SKIN ABSORPTION ACCELERATIONCOSMAX, INC.
WO/2021/091080COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS, OR PROMOTING  HAIR GROWTH OR HAIR THICKENING, COMPRISING COMPLEX EXTRACT OF BEET, RED ONION  AND PURPLE-FLESHED SWEET POTATO AS ACTIVE INGREDIENTGUSTAR CO., LTD.
WO/2021/060792IMMUNOSUPPRESSIVE COMPOSITION COMPRISING CHITOSAN AND USE  THEREOFPOSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
WO/2021/060797MULTILAYERED CATIONIC LIPOSOME FOR ENHANCING SKIN ABSORPTION  AND PREPARATION METHOD THEREFORCOSMAX, INC.
WO/2021/235609ANTIBACTERIAL AND BIOFILM FORMATION-INHIBITING COMPOSITION  CONTAINING MYRISTOLEIC ACID AS ACTIVE INGREDIENTRESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY
WO/2021/066381RETINAL-CONTAINING MULTILAMELLAR VESICLE AND COSMETIC  COMPOSITION COMPRISING SAMEDAREUN COSMETICS CO., LTD.
WO/2021/060824VACCINE COMPOSITION AGAINST SEVERE FEVER WITH THROMBOCYTOPENIA  SYNDROME VIRUSSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/060841NOVEL MULTILAYER SUPPOSITORY AGENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/060862PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MALARIA,  CONTAINING FUCOIDAN AS ACTIVE INGREDIENTKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG  CAMPUS
WO/2021/060868CERIUM OXIDE INORGANIC FILLER-REINFORCED POLYMER AND  TWO-COMPONENT COSMETIC COMPOSITION USING SAMELG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/060869MICROPARTICLE-STRUCTURED THICKENER HAVING IMPROVED SENSATION  OF USELG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/060870COSMETIC COMPOSITION CONTAINING FERMENTATION PRODUCT OF SPROUT  GINSENG, AND PREPARATION METHOD THEREFORDAEBONG LS CO., LTD.
WO/2021/107370CORE TABLET PREPARATION COMPRISING PROTON PUMP INHIBITOR AND  MOSAPRIDEKOREA UNITED PHARM. INC.
WO/2021/060880PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  SARCOPENIA, CONTAINING UNNATURAL AMINO ACIDMYO-TEC-SCI
WO/2021/118026CORE TABLET FORMULATION CONTAINING PROTON PUMP INHIBITOR AND  MOSAPRIDEKOREA UNITED PHARM. INC.
WO/2021/060884PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  SARCOPENIA CONTAINING NON-NATURAL AMINO ACID DERIVATIVEMYO-TEC-SCI
WO/2021/060922COMPOSITION FOR PREVENTING OR TREATING NEUROPATHIC PAIN,  CONTAINING SYRINGARESINOLUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/215598COMPOSITION FOR PREVENTION OR TREATMENT OF EPILEPSY AND  PREPARATION METHOD THEREFORKWON, Hyeok Bun
WO/2021/060927COMPOSITION FOR ALLEVIATING, PREVENTING OR TREATING  SARCOPENIA, CONTAINING WHEY PROTEIN HYDROLYSATE AS ACTIVE INGREDIENTMAEIL DAIRIES CO., LTD.
WO/2021/060933COMPOSITION FOR PREVENTING OR TREATING INFECTIOUS DISEASES  CAUSED BY MYCOBACTERIUM TUBERCULOSIS, NONTUBERCULOUS MYCOBACTERIA OR  GRAM-POSITIVE BACTERIA, CONTAINING MMAGNU2 COMPOUND AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL  UNIVERSITY
WO/2021/066425GINGER-DERIVED EXTRACELLULAR VESICLES AND USE THEREOFKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/066429DIOSCOREA JAPONICA THUNB-DERIVED EXTRACELLULAR VESICLES AND  USE THEREOFKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/066431POMEGRANATE-DERIVED EXTRACELLULAR VESICLES AND USE THEREOFKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/060944PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER  COMPRISING YAP-TEAD INTERACTION INHIBITOR AND HYPOGLYCEMIC AGENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/060949CO-CRYSTALLINE EFINACONAZOLE, AND METHOD FOR PRODUCING SAMEDAEBONG LS, LTD
WO/2021/060950AMORPHOUS EFINACONAZOLE SOLID DISPERSIONDAEBONG LS, LTD
WO/2021/080206COMPOSITION CONTAINING SWEET POTATO STEM OR LEAF EXTRACT AS  ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF EAR DISEASEVIVOIN CO. LTD
WO/2021/066443PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE MYELOID LEUKEMIA  CONTAINING FLT3 INHIBITOR AND MDM2 INHIBITORHANMI PHARM. CO., LTD.
WO/2021/071159ANTIDIABETIC, HYPOTENSIVE, OR ANTIOXIDANT COMPOSITION  COMPRISING YEAST FERMENTATE OF RHYNCHOSIA NULUBILIS AND METHOD FOR PREPARING  SAME COMPOSITIONCOENBIO CO., LTD.
WO/2021/066510COSMETIC COMPOSITION FOR HAIR AND SCALP CARE TREATMENT, AND  METHOD FOR PRODUCING SAMESIN, Hong Chul
WO/2021/162196PHARMACEUTICAL COMPOSITION CONTAINING MACROLIDE COMPOUND,  PRODUCTION METHOD THEREFOR, AND METHOD USING SAMESEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/085876COMPOSITION INCLUDING TREMELLA FUCIFORMIS CULTURE MEDIUM  EXTRACTDAEBONG LS, LTD
WO/2021/066600GLUCAGON, COMPOSITION COMPRISING GLP-1 RECEPTOR AND GIP  RECEPTOR DUAL AGONIST AND THERAPEUTIC USE THEREOFHANMI PHARM. CO., LTD.
WO/2021/107381COMPOSITION COMPRISING FERULIC ACID AND ANALOGS THEREOF FOR  PREVENTING AND TREATING SKIN DISEASES CAUSED BY GENETIC MUTATIONUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/071269COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL  DISEASE COMPRISING EXTRACTS OF COMPLEX HERBAL MEDICINESHELIXMITH CO., LTD
WO/2021/256619COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING COGNITIVE  DYSFUNCTION, COMPRISING PEPTIDE CAPABLE OF CONTROLLING SYNAPTIC PLASTICITYINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/071308COMPOSITION FOR DEODORIZING THIOL COMPOUNDSNVIA CO., LTD.
WO/2021/071317PHARMACEUTICAL COMPOSITION COMPRISING COMPLEX CRUDE DRUG  EXTRACT AND CELECOXIBPMG PHARM CO., LTD
WO/2021/071321COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE  DISEASES CONTAINING MIXED HERBAL EXTRACT OF GENKWAE FLOS, CLEMATIDIS RADIX,  AND GASTRODIAE RHIZOMAMTHERA PHARMA CO., LTD.
WO/2021/071326STABLE LIQUID COMPOSITION, METHOD FOR PREPARING SAME, AND  FORMULATION COMPRISING SAMESAMSUNG BIOEPIS CO., LTD.
WO/2021/071334PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING TYPE 2  DIABETES, CONTAINING QUERCETIN-3-O-XYLOSIDETHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/085890PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING TYPE 2  DIABETES, INCLUDING QUERCETIN-3-O-RHAMNOSIDETHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/075818ANTARCTIC LICHEN UMBILICARIA ANTARCTICA EXTRACT HAVING  ANTI-INFLAMMATORY ACTIVITY, AND COMPOSITION CONTAINING SAMEKOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
WO/2021/091107COMPOSITION FOR ENHANCING RADIATION SENSITIVITY CONTAINING  AGELOXIME D AS ACTIVE INGREDIENTKOREA INSTITUTE OF OCEAN SCIENCE ＆ TECHNOLOGY
WO/2021/075853COMPOSITION COMPRISING EMP3 INHIBITOR FOR INHIBITING GROWTH OF  CANCER STEM CELL AND USE THEREOFKOREA ATOMIC ENERGY RESEARCH INSTITUTE
WO/2021/075864METHOD FOR PRODUCING HIGH-CONCENTRATION CYTOKINE-CONTAINING  ANTI-AGING ESSENCE THROUGH MATURING AND CYTOKINE PRODUCTION SYSTEM MODULE  THEREFORSENIOR SCIENCE & LIFE CO. LTD.
WO/2021/075870COMPOSITION, COMPRISING RIP KINASE INHIBITOR, FOR PREVENTING  HAIR LOSS OR PROMOTING HAIR REGROWTHSTEMORE CO., LTD.
WO/2021/080256ANTIFUNGAL COMPOSITION CONTAINING CARBAZOLE COMPOUND AS ACTIVE  INGREDIENTKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/080257COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL  DISEASE, COMPRISING SULGLYCOTIDE AS ACTIVE INGREDIENTSAMIL PHARMACEUTICAL CO., LTD.
WO/2021/075911MICELLE HAVING DRUG RESISTANCE AND CONTAINING SURFACE-MODIFIED  METAL NANOPARTICLES THEREIN, USE THEREOF, AND PREPARATION METHOD THEREFORFUSION BIOTECHNOLOGY CO., LTD.
WO/2021/075923DIPROPYLENE GLYCOL COMPOSITION AND PREPARATION METHOD THEREFORSK PICGLOBAL CO., LTD.
WO/2021/075926PHARMACEUTICAL COMPOSITION COMPRISING PROTON PUMP INHIBITOR  AND ANTACIDHANMI PHARM. CO., LTD.
WO/2021/075928COMPOSITION FOR ENHANCING OR IMPROVING IMMUNE SYSTEM  COMPRISING BIFIDOBACTERIUM BIFIDUMGENOME AND COMPANY
WO/2021/075929COMPOSITION, COMPRISING AN ARTEMISIA PRINCEPS LEAF EXTRACT,  FOR ALLEVIATION OF SKIN DAMAGEDONG-A PHARMACEUTICAL CO., LTD.
WO/2021/075931COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFECTIOUS  DISEASE CAUSED BY TUBERCULOSIS AND NON-TUBERCULOUS MYCOBACTERIAL INFECTIONINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/112398COMPOSITION COMPRISING VITAMIN CE•CIS COSMETIC CO., LTD.
WO/2021/235616PREVENTIVE OR THERAPEUTIC COMPOSITION FOR SEVERE ACUTE  RESPIRATORY SYNDROME CORONAVIRUS TYPE 2 INFECTIOUS DISEASESYNTEKABIO, INC.
WO/2021/080297COMPOSITION CONTAINING EVENING PRIMROSE FLOWER EXTRACT AS  ACTIVE INGREDIENT FOR PREVENTING OR TREATING OBESITY OR METABOLIC SYNDROMES  INDUCED THEREBYDOCTOR TJ CO., LTD
WO/2021/080298COMPOSITION CONTAINING ENTEROCCOCUS FAECALIS AS ACTIVE  INGREDIENT FOR PREVENTING OR TREATING OBESITY OR METABOLIC SYNDROMES INDUCED  THEREBYDOCTOR TJ CO., LTD
WO/2021/080312USE OF IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUNDS FOR  PREVENTION, ALLEVIATION, OR TREATMENT OF COGNITIVE DISORDERS, OR FOR  IMPROVING COGNITIVE FUNCTIONSK BIOPHARMACEUTICALS CO., LTD.
WO/2021/080313USE OF IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUND FOR  PREVENTION, ALLEVIATION, OR TREATMENT OF DEVELOPMENTAL DISABILITYSK BIOPHARMACEUTICALS CO., LTD.
WO/2021/096089NOVEL COMPOSITION COMPRISING STEM CELL-DERIVED EXOSOMES AND  POLYDEOXYRIBONUCLEOTIDE AS ACTIVE INGREDIENTSEXOCOBIO INC.
WO/2021/118044COSMETIC COMPOSITION FOR STABILIZING POORLY SOLUBLE MATERIALCOSMAX, INC.
WO/2021/080331COMPOSITION FOR ENHANCING THERAPEUTIC EFFECT OF STEM CELL,  COMPRISING IMMUNOSUPPRESSANT, AND METHOD FOR ENHANCING THERAPEUTIC EFFECT OF  STEM CELL USING SAMESAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/080345INJECTABLE INTRAOCULAR MICROGEL AS DRUG DELIVERY SYSTEM, AND  HYDROGEL COMPRISING SAMESEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/096093COMPOSITION FOR HAIR TREATMENT, CONTAINING OLEFIN-BASED  UNSATURATED HYDROCARBON-CONTAINING OILLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/080363COMPOSITION FOR PREVENTING OR TREATING CANCERINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/080373RV2299C-ESAT6-HSPX-RIPA FUSION PROTEIN COMPOSITION FOR  BOOSTING BCG VACCINETHE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL  UNIVERSITY (IAC)
WO/2021/080375A PHARMACEUTICAL PREPARATION COMPRISING AN AMIDE DERIVATIVE  INHIBITING THE GROWTH OF CANCER CELL AND A PHARMACEUTICAL PRODUCT CONTAINING  THE SAMEHANMI PHARM. CO., LTD.
WO/2021/172692INGESTIBLE TABLET OR POWDERED ORAL CLEANING COMPOSITIONBAREUN CO., LTD.
WO/2021/080388COMPOSITION FOR PREVENTING OR TREATING PORCINE EPIDEMIC  DIARRHEA VIRUS INFECTION, COMPRISING COMPLEX CONTAINING CURCUMINOID-BASED  COMPOUND AND LICORICE EXTRACT OR FRACTION THEREOFKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/080396COMPOSITION FOR PREVENTING OR TREATING VALVULAR HEART DISEASE  COMPRISING RSPO3 INHIBITORTHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/172694DRUG DELIVERY COMPOSITION USING CROSSLINKED HYALURONIC ACID  AND MANUFACTURING METHOD THEREFORJP CARES
WO/2021/086042COSMETIC COMPOSITION COMPRISING RED GINSENG MARC-DERIVED  OLIGOSACCHARIDE, AND METHOD FOR PRODUCING SAMEDAEBONG LS CO., LTD.
WO/2021/091164PHAMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY  OR ALLERGY COMPRISING ROSE EXTRACT AS ACTIVE INGREDIENTCHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/086076COMPOSITION FOR PREVENTING OR INHIBITING AXONAL DEGENERATIONCHECKMATE THERAPEUTICS INC.
WO/2021/086097POWDER-TYPE HEMOSTATIC COMPOSITION AND PREPARATION METHOD  THEREFORSAMYANG BIOPHARMACEUTICALS CORPORATION
WO/2021/086120COMPOSITION, COMPRISING SALVIA MILTIORRHIZA BUNGE EXTRACT AS  ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF BENIGN PROSTATIC  HYPERPLASIA OR ALOPECIACUROME BIOSCIENCES CO., LTD.
WO/2021/107427COSMETIC COMPOSITION FOR SKIN BARRIER ENHANCEMENT OR SKIN  BIOACTIVE SUBSTANCE ABSORPTION PROMOTIONCOSMAX, INC.
WO/2021/251565PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE  COMPOUNDHK INNO.N CORPORATION
WO/2021/096134MOISTURIZING OR ANTI-ATOPIC COMPOSITION CONTAINING FATTY ACIDS  OR FATTY ACID DERIVATIVESDAEBONG LS, LTD
WO/2021/091188SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION FOR ORAL  ADMINISTRATION, CONTAINING REBAMIPIDE OR PHARMACEUTICALLY ACCEPTABLE SALT  THEREOFAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/101128FINE BUBBLE-CONTAINING COSMETIC FOR IMPROVING DERMAL  PENETRATION, MANUFACTURING SYSTEM OF FINE BUBBLE-CONTAINING COSMETIC FOR  IMPROVING DERMAL PENETRATION, AND MANUFACTURING METHOD OF FINE  BUBBLE-CONTAINING COSMETIC FOR IMPROVING DERMAL PENETRATIONLEE, Sung-Joo
WO/2021/091209COMPOSITION FOR HOST-DIRECTED THERAPYINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/091210COMPOSITION FOR HOST-DIRECTED THERAPYINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/125551COSMETIC MANUFACTURING DEVICE, AND DISCHARGE INFORMATION  DETERMINATION METHOD FOR COSMETIC MANUFACTURING DEVICELG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/091246SUSTAINED-RELEASE MICROSPHERES CAPABLE OF CONTROLLING INITIAL  RELEASE, AND PREPARATION METHOD THEREFORNEXTBIOMEDICAL CO., LTD.
WO/2021/091272POLYMER NANOPARTICLE COMPOSITION FOR INDUCING IMMUNITY AND  PREPARATION METHOD THEREFORSAMYANG BIOPHARMACEUTICALS CORPORATION
WO/2021/091284COSMETIC COMPOSITION FOR PREVENTING SKIN AGING AND REDUCING  SKIN WRINKLES, COMPRISING VIBURNUM STELLATO-TOMENTOSUM EXTRACTKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/157818GRAPHENE-BASED COMPOSITION FOR TREATING KIDNEY DISEASEBIOGRAPHENE INC.
WO/2021/145543CONJUGATE CONSISTING OF EXTRACELLULAR MATRIX AND ANTICANCER  DRUG, AND MEDICAL USE THEREOFDAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/091316COMPOSITION, COMPRISING TMEM176B OR AN EXPRESSION OR ACTIVITY  REGULATOR THEREOF AS AN ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF  DEGENERATIVE BRAIN DISEASEAMYLOID SOLUTION INC.
WO/2021/091319GLYPICAN-3-SPECIFIC MODIFIED APTAMER AND USE THEREOFAPTAMER SCIENCES INC.
WO/2021/091333MICROSPHERE FOR CONTINUOUS RELEASE AND METHOD FOR  MANUFACTURING SAMEWHAN IN PHARMACEUTICAL CO., LTD.
WO/2021/251566WATER-DISPERSIBLE COSMETIC COMPOSITION FOR ULTRAVIOLET  BLOCKING CONTAINING INORGANIC THICKENER AND ORGANIC THICKENERKOLMAR KOREA CO., LTD.
WO/2021/091356COMPOSITION FOR PREVENTING OR TREATING STRESS-RELATED DISEASES  INCLUDING METHYL BENZOATE AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/096186COSMETIC COMPOSITION FOR SKIN IMPROVEMENT COMPRISING TARAXACUM  OFFICINALE LEAF EXTRACTRADIANT.CO.LTD
WO/2021/125558COMPOSITION FOR HAIR BLACKENING, PREVENTING HAIR WHITENING, OR  HAIR DYEING, COMPRISING EXOSOME DERIVED FROM STEM CELL AS ACTIVE INGREDIENTEXOCOBIO INC.
WO/2021/096199PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF  IMMUNE-RELATED DISEASES COMPRISING PYRIMETHAMINE AS ACTIVE INGREDIENTSK CHEMICALS CO., LTD.
WO/2021/132879COMPOSITION FOR PREVENTION AND TREATMENT OF ATOPIC DERMATITIS  COMPRISING, AS ACTIVE INGREDIENT, NOVEL BIFIDOBACTERIUM ANIMALIS SUBSP.  LACTIS LM1017 DERIVED FROM KOREAN INFANTSLACTOMASON CO., LTD.
WO/2021/096217PHARMACEUTICAL COMPOSITION, COMPRISING RECOMBINANT STABILIZED  GALECTIN 9 PROTEIN, FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS AND  BONE DISEASEGBIOLOGICS INC.
WO/2021/096220COMPOSITION FOR PREVENTING OR TREATING RENAL DISEASES,  COMPRISING EXOSOMES DERIVED FROM PRECURSOR CELLS OF INDUCED PLURIPOTENT STEM  CELL-DERIVED MESENCHYMAL STEM CELLSBREXOGEN INC.
WO/2021/112437TRANSDERMAL DELIVERY COMPOSITE USING COVALENT ORGANIC  FRAMEWORK AND POLYMERH&A PHARMACHEM CO., LTD
WO/2021/096270PHARMACEUTICAL COMPOSITION FOR TREATING MULTIPLE SCLEROSIS ON  BASIS OF AMPK INHIBITORY FUNCTION AND ZINC HOMEOSTASIS CONTROL FUNCTIONZINCURE CORP.
WO/2021/096278LIQUID PHASE COMPOSITION FOR ANTIBODY DRUGSAMSUNG BIOEPIS CO., LTD.
WO/2021/194038METHOD FOR PRODUCING SERUM COMPOSITION FOR PREVENTING OR  TREATING MUCOSA-RELATED INFECTIOUS DISEASE IN YOUNG MAMMALS, SERUM  COMPOSITION PRODUCED THEREBY, AND USE THEREOFAHN, Byung Chul
WO/2021/118080PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCLE  DISEASES COMPRISING GINSENOSIDES RG2, RG4, RG6, RH1, AND RH4 AS ACTIVE  INGREDIENTSAREZ CO., LTD.
WO/2021/112441COMPOSITION FOR PREVENTING OR TREATING PIGMENTATION,  CONTAINING IRE 1α BLOCKER AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/096303CONTRAST AGENT COMPOSITION FOR OPTICAL IMAGE, FOR EARLY  DIAGNOSIS OF RHEUMATOID ARTHRITISINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/125570DEVICE, METHOD, AND SYSTEM FOR MANUFACTURING COSMETICSLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/101187NOVEL VACCINE IMMUNE ADJUVANT COMPOSITION CONTAINING BAVACHINKOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/149902COMPOSITION COMPRISING SALVIA MILTIORRHIZA EXTRACT AS ACTIVE  INGREDIENT FOR PREVENTION AND TREATMENT OF DEPRESSION IN MENOPAUSAL WOMENUNDBIO.CO.,LTD
WO/2021/101244COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING  ANTI-CD300C MONOCLONAL ANTIBODIESCENTRICS BIO
WO/2021/101257COMPOSITION FOR DIAGNOSING, PREVENTING, OR TREATING COGNITIVE  DYSFUNCTION COMPRISING COTL1 AS ACTIVE INGREDIENTAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/101259COMPOSITION, COMPRISING COTL1 AS ACTIVE INGREDIENT, FOR  DIAGNOSIS OF BONE DISEASE OR OBESITYAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/101265KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERYSAMYANG BIOPHARMACEUTICALS CORPORATION
WO/2021/101268BENZAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND  PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR  PREVENTION OR TREATMENT OF CANCERKOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/101295ORAL PHARMACEUTICAL COMPOSITION COMPRISING CARBAMATE COMPOUND  AND PREPARATION METHOD THEREFORSK BIOPHARMACEUTICALS CO., LTD.
WO/2021/162211STABILIZER FOR ADENO-ASSOCIATED VIRUSES AND METHOD FOR  STABILIZING ADENO-ASSOCIATED VIRUSES BY USING SAMEINNOTHERAPY INC.
WO/2021/101340ANTICANCER THERAPY-AIDING COMPOSITION INCLUDING LIPOSOME  COMPOSITION AND DRUG DELIVERY METHOD USING SAMECHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/145552THERAPEUTIC USE OF LONG-ACTING CONJUGATE OF TRIPLE AGONIST  HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON AND GLP-1 AND GIP RECEPTORS  AGAINST LUNG DISEASEHANMI PHARM. CO., LTD.
WO/2021/101344EYE DROP COMPOSITION FOR PREVENTING OR TREATING EYE DISEASESAMJIN PHARMACEUTICAL CO., LTD.
WO/2021/132897COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF  CANCER CACHEXIA COMPRISING PIPERINEUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/107547COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF  RESPIRATORY DISEASEDANDI BIOSCIENCE INC.
WO/2021/107576COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING SKIN  PHOTOAGING, OR FOR WHITENING, COMPRISING RACEMIC DHPV OR ENANTIOMERS THEREOFSUNGKWANG MEDICAL FOUNDATION
WO/2021/137439PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, FOR  TREATMENT OF LIVER CANCERMIRAEBIOPHARM
WO/2021/107644USE OF COMPOSITION FOR ENHANCING ANTICANCER EFFECT, COMPRISING  ERRγ INHIBITOR AS ACTIVE INGREDIENTNOVMETAHEALTH CO., LTD.
WO/2021/125611ECO-FRIENDLY SMART PHOTOSENSITIZER AND PHOTO-STEM CELL THERAPY  PRODUCT COMPRISING SAMEKIM, Jin Wang
WO/2021/107689PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING  IMMUNE CHECKPOINT INHIBITOR AND FUSION PROTEIN INCLUDING IL-2 PROTEIN AND  CD80 PROTEINGI INNOVATION, INC.
WO/2021/107690COMBINATION THERAPY OF CYCLOSERINE AND LITHIUM FOR THE  TREATMENT OF DEPRESSIONNEURORIVE INC
WO/2021/107692PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  OPTIC NERVE DISEASESUNGKWANG MEDICAL FOUNDATION
WO/2021/107706NOVEL USE OF MILK EXOSOMESKOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/107719COMPOSITION FOR PREVENTING OR TREATING HYPERTENSIONHELIXMITH CO., LTD
WO/2021/107747RNA INTERFERENCE-INDUCING NUCLEIC ACID COMPRISING  8-OXOGUANINE, MODIFIED NUCLEIC ACID BINDING TO MICRORNA COMPRISING  8-OXOGUANINE, AND USES THEREOFKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/112541PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF  SECONDARY CANCER, COMPRISING ALDEHYDE INHIBITOR AND BIGUANIDE-BASED COMPOUNDHAIM BIO CO., LTD.
WO/2021/112548PHARMACEUTICAL COMPOSITIONJIN YANG PHARM. CO., LTD.
WO/2021/177553TEA COMPOSITION HAVING EFFICACY FOR PREVENTING OR IMPROVING  RESPIRATORY DISEASES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAMENAM, Jong Hyun
WO/2021/235637COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF  RESPIRATORY DISEASENAM, Jong Hyun
WO/2021/125632EXTERNAL USE COMPOSITION COMPRISING PAEONOL AND PANTHENOL OR  PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS ACTIVE INGREDIENTSGENTRIBIO INC.
WO/2021/112563COMPOSITION FOR PREVENTING OR TREATING CRANIAL NERVE SYSTEM  DISEASES COMPRISING RITA OR DERIVATIVE THEREOFDAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/112587PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING NDPK ACTIVATOR AND SGLT-2 INHIBITORHAIM NATURE CO., LTD.
WO/2021/118162ADDITIVE COMPOSITION FOR FORMULATION, CAPABLE OF STABILIZING  PORES OF SOLID PREPARATION PARTICLES, AND PREPARATION METHOD THEREFORNATUREPUREKOREA CO., LTD.
WO/2021/132926PROBIOTIC PASTE FOR ANIMALS, AND MANUFACTURING METHOD THEREFORYEO, Jang Wook
WO/2021/125641METHOD FOR CONTROLLING ACTIVE DISCHARGE OF SELF-HEALING  PEPTIDE MOTIF ACCORDING TO BIOLOGICAL ENVIRONMENT AND EXTERNAL STIMULIAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/112597COMPOSITION FOR TREATING DIABETIC RETINOPATHY, COMPRISING RAAV  CONTAINING SOLUBLE VEGFR-1 VARIANT CDNACDMOGEN CO., LTD
WO/2021/112614PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BEHCET'S  DISEASE AND RHEUMATOID ARTHRITIS, CONTAINING PEPTIDE OR MIXTURE THEREOF AS  ACTIVE INGREDIENTAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/112615COMPOSITION CONTAINING PEPTIDE OR PEPTIDE COMPOUND AS ACTIVE  INGREDIENT, AND MEDICAL USE THEREFORAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/112654METHODS OF TREATING CHEMOTHERAPY OR RADIOTHERAPY INDUCED  NEUTROPENIAHANMI PHARM. CO., LTD.
WO/2021/118199COMPOSITION COMPRISING P53-ACTIVATING PEPTIDEKNU-INDUSTRY COOPERATION FOUNDATION
WO/2021/118212PHARMACEUTICAL COMPOSITION COMPRISING PEPTIDE THAT INHIBITS  INTERACTION OF P53 AND FOXO4KNU-INDUSTRY COOPERATION FOUNDATION
WO/2021/235638METHOD FOR PREPARING BAMBOO MULTI-COMPLEX HAVING ANTIBACTERIAL  AND COSMETIC FUNCTIONS, AND COSMETIC COMPOSITION CONTAINING SAMEDAMYANG JUKSOON FARMING ASSOCIATION CORPORATION
WO/2021/132949COMPOSITION FOR PREVENTING OR TREATING ADVANCED GLYCATION END  PRODUCT-ASSOCIATED DISEASE, COMPRISING AUCUBININDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY
WO/2021/132950PHARMACEUTICAL COMPOSITION CONTAINING AUCUBIN FOR PREVENTING  OR TREATING MACULAR DEGENERATIONINDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY
WO/2021/118286COMPOSITION FOR STIMULATING AND INDUCING CHANGES IN  ENVIRONMENT AROUND AGING SKIN CELLSAMOREPACIFIC CORPORATION
WO/2021/182725USE OF CONDITIONED MEDIUM FOR ALLEVIATING AND PREVENTING HAIR  LOSS CONTAINING HIGH CONCENTRATION OF EXTRACELLULAR VESICLE WITH ENHANCED  FUNCTIONBIOSOLUTION CO., LTD
WO/2021/118292COMPOSITION FOR WOUND HEALING, CONTAINING METAL-ORGANIC  FRAMEWORKSEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/118298PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING  FIBROSIS, COMPRISING PHEOPHORBIDE COMPOUND AS ACTIVE INGREDIENTPAEAN BIOTECHNOLOGY INC.
WO/2021/118321STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL PREPARATIONSAMSUNG BIOEPIS CO., LTD.
WO/2021/118323TANDEM INSULIN-LIKE GROWTH FACTOR-1 AND COMPOSITION COMPRISING  SAME AS ACTIVE INGREDIENT FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTHNEXGEN BIOTECHNOLOGIES, INC.
WO/2021/118324PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCERSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/132970COMPOSITION FOR SKIN ELASTICITY ENHANCEMENT AND WRINKLE  IMPROVEMENT COMPRISING MILK EXOSOMESUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/118328ANTICANCER THERANOSTIC COMPOUNDS HAVING HEPATOCELLULAR  CARCINOMA SPECIFICITYKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/125733PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HAIR  LOSSCELROS BIOTECH
WO/2021/125762COMPOSITION FOR PREVENTING OR TREATING DEMENTIA, CONTAINING  PEPTIDE NUCLEIC ACID COMPLEX WITH BLOOD-BRAIN BARRIER PENETRATION ABILITY AS  ACTIVE INGREDIENTSEASUN THERAPEUTICS
WO/2021/125783HAIR PERM FORMING METHOD USING ELECTROLYZED WATERKUNKUK UNIVERSITY INDUSTRIAL COOPERATION CORP
WO/2021/125788SOLID PREPARATION FOR ORAL ADMINISTRATION, COMPRISING  SUNITINIB HYDROCHLORIDE, AND METHOD FOR PREPARING SAMESAMYANG HOLDINGS CORPORATION
WO/2021/125797COMPOSITION HAVING IMPROVED SOLUBILITY AND BIOAVAILABILITY OF  OLAPARIBSAMYANG HOLDINGS CORPORATION
WO/2021/125800COMPOUND FOR INHIBITING ANGIOGENESIS FACTOR, AND USE THEREOFUNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
WO/2021/125805KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY,  COMPRISING POLYLACTIC ACID SALTSAMYANG HOLDINGS CORPORATION
WO/2021/125810COMPOSITION FOR TREATING SYNUCLEINOPATHIESSTANDIGM INC.
WO/2021/125811COMPOSITION FOR TREATING SYNUCLEINOPATHIESSTANDIGM INC.
WO/2021/125824PHARMACEUTICAL FORMULATION COMPRISING CIBENZOLINE OR SALT  THEREOFCELLTRION INC.
WO/2021/125841PHARMACEUTICAL COMPOSITION FOR ARTERIAL ADMINISTRATION,  COMPRISING ADULT STEM CELL LINE CONTAINING BASIC HELIX-LOOP-HELIX (BHLH)  NEUROGENIC TRANSCRIPTION FACTOR GENESCELL&BRAIN CO., LTD.
WO/2021/125847METHOD FOR SCREENING FOR MATERIAL FOR REGULATING PEXOPHAGY BY  USING N-TERMINAL ARGINYLATION OF N-DEGRON PATHWAY, AND FOR PREVENTING,  ALLEVIATING OR TREATING PBD, METHOD FOR DIAGNOSING PBD, AND COMPOSITION FOR  REGULATING PEXOPHAGY OR PREVENTING, ALLEVIATING OR TREATING PBDPROTECH CO., LTD.
WO/2021/125852NOVEL INJECTABLE FORMULATIONPROGEN CO., LTD.
WO/2021/125868COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING  POLYP AS ACTIVE INGREDIENTKIM, Hong Yeoul
WO/2021/125874LIQUID PHARMACEUTICAL COMPOSITION OF  1-(5-(2,4-DIFLUOROPHENYL)-1-((3-FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROLE-3-YL)-N-METHYLMETHANEAMINEDAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/133000ANTI-INFLAMMATORY OR ANTIANGIOGENIC PHARMACEUTICAL COMPOSITIONLG CHEM, LTD.
WO/2021/125894PATCH ATTACHABLE TO TEETHLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/125906LIPOLYTIC SUBSTANCE AND PREPARATION METHOD THEREFORAMMEDICS CO., LTD.
WO/2021/137491ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING  PROBIOTICS AND ANTIBIOTICS, AND METHOD USING SAMESHIM, Min Bo
WO/2021/125910PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING NDPK ACTIVATOR AND H-PRUNE INHIBITORHAIM NATURE CO., LTD.
WO/2021/137494COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPRISING  BUTYRICIMONAS SP. STRAIN AS ACTIVE INGREDIENTSAHMYOOK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/137495PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  NON-ALCOHOLIC FATTY LIVER DISEASE COMPRISING BUTYRICIMONAS SP. STRAIN AS  ACTIVE INGREDIENTSAHMYOOK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/133014COMPOSITION CONTAINING DMT-TIC PEPTIDE DERIVATIVE FOR  PREVENTING OR TREATING HAIR LOSSSTEMORE CO., LTD.
WO/2021/133017COLONIC PURGATIVE COMPOSITIONVIVOZON,INC.
WO/2021/133023COMPLEX FORMULATION COMPRISING SITAGLIPTIN AND DAPAGLIFLOZIN,  AND PREPARATION METHOD THEREFORHANMI PHARM. CO., LTD.
WO/2021/137504PHARMACEUTICAL FORMULATION HAVING IMPROVED STABILITY AND  MANUFACTURING METHOD THEREFORDAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/137506COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS,  CONTAINING WDR34 INHIBITOR, AND USE THEREOFKOREA ATOMIC ENERGY RESEARCH INSTITUTE
WO/2021/149925PHARMACEUTICAL COMPOSITION FOR TREATING TRPV1  ACTIVITY-MEDIATED DISEASESRUDACURE CORPOARATION
WO/2021/133046METFORMIN SUSTAINED RELEASE FORMULATION AND METHOD FOR  PREPARATION THEREOFDAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/133051MICROSPHERES COMPRISING ROPINIROLE, AND INJECTION COMPOSITION  COMPRISING SAMEWHAN IN PHARMACEUTICAL CO., LTD.
WO/2021/215616COMPOSITION FOR TREATING CORONAVIRUS INFECTION OR INFECTIOUS  DISEASE, COMPRISING POLYPHOSPHATESINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/215617COMPOSITION FOR DISINFECTING, OR PREVENTING INFECTION BY OR  INFECTIOUS DISEASES CAUSED BY CORONAVIRUS, COMPRISING POLYPHOSPHATEINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/133087PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  METABOLIC BONE DISEASES, COMPRISING GLP-2 OR CONJUGATE THEREOFHANMI PHARM. CO., LTD.
WO/2021/133091PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  NONALCOHOLIC STEATOHEPATITIS, CONTAINING ASTER KORAIENSIS NAKAI EXTRACTMAYJUNE LIFE & HEALTH, CO., INC.
WO/2021/145586GAS-GENERATING MICELLE FOR REDUCING LOCALIZED FATSUPERNOVA BIO CO., LTD.
WO/2021/137561PHARMACEUTICAL COMPOSITION COMPRISING 4-HEXYLRESORCINOL AS  ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF BONE DISEASEKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/145589COSMETIC NYLON FIBER AND MANUFACTURING METHOD THEREFORKOREA DYEING & FINISHING TECHNOLOGY INSTITUTE
WO/2021/137606PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING SGLT-2 INHIBITOR AND GOSSYPOLHAIM BIO CO., LTD.
WO/2021/137610METHOD FOR PRODUCING NANOPARTICLES COMPRISING  LOW-MOLECULAR-WEIGHT AMPHIPHILIC BLOCK COPOLYMERSAMYANG HOLDINGS CORPORATION
WO/2021/137611IMMUNE CELLS HAVING NANOSTRUCTURE ATTACHED THERETOTHERABEST CO.,LTD
WO/2021/141319NANOPARTICLES FOR DRUG DELIVERY SURFACE-MODIFIED WITH PEPTIDE  FOR TARGETING BRAIN CANCER CELLS, METHOD FOR PREPARING SAME, AND USE THEREOFUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/137647UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED  FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUNDATHENA CO., LTD.
WO/2021/137656NOVEL FORMULATION FOR LOCAL INJECTIONINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/145595LIPID NANOPARTICLES FOR IN-VIVO DRUG DELIVERY, AND USES  THEREOFENHANCEDBIO INC.
WO/2021/002739PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  INFLAMMATORY SKIN DISEASES, CONTAINING INTERLEUKIN-32 PROTEIN AS ACTIVE  INGREDIENTCHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/020957SKIN-WHITENING COMPOSITION COMPRISING ROYAL AZALEA ROOT  EXTRACT AS EFFECTIVE COMPONENTKOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/096330COMPOSITION FOR PREVENTION OR TREATMENT OF EAR DISEASE  COMPRISING CASTANOPSIS CUSPIDATA PLANT EXTRACT OR FRACTION AS ACTIVE  INGREDIENTINVIVOTEC CO., LTD.
WO/2021/125920METHOD FOR ALLEVIATING CANCER-INDUCED PAIN THROUGH CONTROL OF  PAIN SIGNALS IN CENTRAL NERVOUS SYSTEMINDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
WO/2021/137667COMPOSITION FOR TREATING PARKINSON’S DISEASE CONTAINING  BOTULINUM NEUROTOXIN, AND METHOD FOR TREATING PARKINSON’S DISEASE USING SAMEATGC CO.LTD
WO/2021/137668ORAL DISINFECTANT WITH IMPROVEMENT IN STAINING SIDE EFFECTOSSTEMIMPLANT CO., LTD.
WO/2021/137677COMPOSITION CONTAINING PLANT EXTRACTLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/137678COMPOSITION CONTAINING PAPER MULBERRY EXTRACTSLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/141355COMPOSITION COMPRISING VGF-DERIVED PEPTIDE FOR PREVENTION OR  TREATMENT OF BONE DISEASETHE ASAN FOUNDATION
WO/2021/141368COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION,  CONTAINING CELL PERMEABLE NUCLEIC ACID COMPLEX AS ACTIVE INGREDIENTSEASUN THERAPEUTICS
WO/2021/149945FUSION PROTEIN COMPRISING PD-L1 PROTEIN AND USE THEREOFGENEXINE, INC.
WO/2021/141425PHARMACEUTICAL COMPOSITION, FOR PREVENTING AND TREATING  HEMATOLOGICAL CANCER, COMPRISING BIGUANIDE-BASED COMPOUND AS ACTIVE  INGREDIENTHAIM BIO CO., LTD.
WO/2021/141426COMPOSITION FOR TREATING FRAGILE X SYNDROME OR RELATED  DEVELOPMENTAL DISORDERS, COMPRISING LISURIDE COMPOUND AS ACTIVE INGREDIENTKONKUK UNIVERSITY GLOCAL INDUSTRYACADEMIC COLLABORATION  FOUNDATION
WO/2021/141439COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE  CONTAINING COFFEE SILVER SKIN EXTRACT, FRACTION THEREOF, OR COMPOUND ISOLATED  THEREFROMGANGNEUNG-WONJU NATIONAL UNIVERSITY INDUSTRY ACADEMY  COOPERATION GROUP
WO/2021/141446COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDERS  COMPRISING MESENCHYMAL STEM CELLSCORESTEM CO.,LTD.
WO/2021/141465COMPOSITION FOR PREVENTING OR TREATING ANTICANCER  AGENT-INDUCED ALLODYNIA AND THERAPEUTIC METHOD USING SAMEUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/145618PHARMACEUTICAL COMPOSITION INCLUDING R-THIOCTIC ACID OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OIL, AND DISPERSION AIDKOREA UNITED PHARM. INC.
WO/2021/145622PHARMACEUTICAL COMPOSITION INCLUDING R-THIOCTIC ACID OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND EMULSIFIERKOREA UNITED PHARM. INC.
WO/2021/145625PHARMACEUTICAL COMPOSITION COMPRISING R-THIOCTIC ACID OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ENTERIC COATING BASE MATERIALKOREA UNITED PHARM. INC.
WO/2021/141473NOVEL LACTOBACILLUS PLANTARUM STRAIN, POLYSACCHARIDES DERIVED  FROM STRAIN, AND USE THEREOFIMMUNOBIOME INC.
WO/2021/157883HARD CAPSULE AGENT COMPRISING ENTERIC PROTON PUMP INHIBITOR  AND MOSAPRIDE SUSTAINED-RELEASE FORMULATIONKOREA UNITED PHARM. INC.
WO/2021/210762ANTICANCER ADJUVANT AND PHARMACEUTICAL COMPOSITION FOR  TREATING ANTICANCER-AGENT-RESISTANT CANCER, AND KIT COMPRISING SAMEDONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY  COOPERATION
WO/2021/145672ARGININE ASPARTATE-CONTAINING COMPOSITION FOR SUPPRESSING OLD  PERSON SMELLHUMEDIX CO., LTD.
WO/2021/145676TABLET COMPRISING ATORVASTATIN AND EZETIMIBEILDONG PHARMACEUTICAL CO., LTD.
WO/2021/145699COMPOSITION FOR TREATING SKIN DISEASES, COMPRISING COLCHICINEKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/145703PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  ALZHEIMER'S AND USE THEREOFTOOLGEN INCORPORATED
WO/2021/149974MICRO-SPICULE COMPOSITION TO CONTROL ITS SHAPE AND METHOD FOR  PRODUCING THE SAMEPAEAN AESTHETICS INC.
WO/2021/145720ANTIGEN COMPOSITION FOR PREVENTING OR TREATING VIRAL  INFECTIOUS DISEASESKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG  CAMPUS
WO/2021/172755PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  INFLUENZA VIRUS INFECTION, COMPRISING GREEN PLUM EXTRACT AS ACTIVE INGREDIENTINDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/145742COMPOSITION FOR IMPROVING ATHLETIC FUNCTION, COMPRISING  PHLOROTANNIN AS ACTIVE INGREDIENTMANNAS INC.
WO/2021/201395STABILIZING AGENT FOR RADIOPHARMACEUTICAL, AND  RADIOPHARMACEUTICAL COMPOSITION COMPRISING SAMETHE ASAN FOUNDATION
WO/2021/150003COMPOSITION COMPRISING ROSA LAEVIGATA FRUIT EXTRACT FOR  ALLEVIATION OF RESPIRATORY DISEASEUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/1500272-PART SKINCARE FORMULATIONSHIN, Seungyun
WO/2021/157916UNSATURATED FATTY ACID-CONJUGATED CP2C-TARGETING PEPTIDE-BASED  ANTICANCER AGENTINDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
WO/2021/251581SOLID COSMETIC COMPOSITION FOR BLOCKING ULTRAVIOLET RADIATION  HAVING WATER RESISTANCE AND CLEANSING PROPERTIESLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/150050PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING PROTON PUMP  INHIBITOR AND ANTACIDHANMI PHARM. CO., LTD.
WO/2021/150066PHARMACEUTICAL COMPOSITION COMPRISING SMALL OCTOPUS-DERIVED  PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASENATIONAL MARINE BIODIVERSITY INSTITUTE OF KOREA
WO/2021/150076PHARMACEUTICAL COMPOSITION OR HEALTH FUNCTIONAL FOOD FOR  PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASESFNG RESEARCH CO.,LTD.
WO/2021/150077PHARMACEUTICAL COMPOSITION OR HEALTH FUNCTIONAL FOOD FOR  PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASEFNG RESEARCH CO.,LTD.
WO/2021/187745PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING  CHARCOT-MARIE-TOOTH DISORDER, COMPRISING MESENCHYMAL STEM CELLS OR INSULIN  SECRETED BY MESENCHYMAL STEM CELLSSAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/150088PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION FOR  ANIMAL, AND FOOD COMPOSITION, EACH COMPRISING NATURAL SUBSTANCE EXTRACT, AND  PREPARATION METHOD THEREFORLK. INC.
WO/2021/162282COMPOSITION USING NOVEL LACTOBACILLUS PLANTARUM KC3 STRAIN FOR  PREVENTION OR TREATMENT OF IMMUNE IMPAIRMENT, RESPIRATORY INFLAMMATORY  DISEASE, ALLERGY, AND ASTHMA AND USE THEREOFKT&G CORPORATION
WO/2021/153980PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING WEISSELLA CIBARIA WIKIM28 AS ACTIVE INGREDIENTLISCURE BIOSCIENCES CO., LTD.
WO/2021/177600PHARMACEUTICAL COMPOSITION COMPRISING GENUS LEUCONOSTOC STRAIN  AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCERLISCURE BIOSCIENCES CO., LTD.
WO/2021/157939COMPOSITION FOR PREVENTING OR TREATING BRAIN DISEASES,  CONTAINING SAHA AS ACTIVE INGREDIENTRESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/153981ANTIBODY-DRUG CONJUGATE COMPRISING IMMUNE CHECKPOINT INHIBITOR  AND EXOSOME SECRETION INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING  SAMERESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/154012PULSE-TYPE COMPOSITION FOR MAINTAINING WEAKLY ACIDIC  ENVIRONMENT IN VAGINAD-NATURE CO., LTD.
WO/2021/154016PHARMACEUTICAL ADJUVANT COMPOSITION COMPRISING  2S-2`METHOXY-KURARINONE AS ACTIVE INGREDIENT FOR TREATMENT OF CARDIOVASCULAR  DISEASESEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/154017COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES  OF DIGESTIVE SYSTEM OR COLITIS, COMPRISING REOVIRUS AS ACTIVE INGREDIENTVIROCURE, INC.
WO/2021/154027STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL PREPARATIONSAMSUNG BIOEPIS CO., LTD.
WO/2021/154038EXTENDED-RELEASE TYPE METAL-ORGANIC FRAMEWORK USING  CYCLODEXTRIN AND MANUFACTURING METHOD THEREFORSOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/157968CONTROLLED-RELEASE FORMULATION FOR HEARING LOSS AND  PREPARATION METHOD THEREFORMICROBIO CO., LTD.
WO/2021/215627COMPOSITION FOR PREVENTING OR TREATING LIPID-RELATED METABOLIC  DISEASES, COMPRISING LACTOBACILLUS PLANTARUM ATG-K2 OR ATG-K6ATOGEN CO., LTD.
WO/2021/215629FOAM TYPE SEMI-PERMANENT HAIR DYEING COMPOSITIONKOLMAR KOREA CO., LTD.
WO/2021/246610COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES,  COMPRISING LACTOBACILLUS SAKEI CVL-001 STRAININDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/167269WHITENING COMPOSITION COMPRISING PLUM SEED EXTRACT AS ACTIVE  INGREDIENTINDUSTRY ACADEMIC COOPERATION FOUNDATION KEIMYUNG UNIVERSITY
WO/2021/158008COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS, COMPRISING  3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE DERIVATIVESTEMORE CO.,LTD.
WO/2021/158013HYDROGEL AND METHOD FOR PREPARING THE SAMEKOREA ATOMIC ENERGY RESEARCH INSTITUTE
WO/2021/158045COMPOSITION FOR INTRAPERICARDIAL INJECTION COMPRISING STEM  CELLS AND USE THEREOFHIERABIO INC.
WO/2021/158053PULMONARY SURFACTANT PARTICLE LOADED WITH NUCLEIC ACID OR  PROTEIN FOR INHALED DELIVERY, AND METHOD FOR PRODUCING SAMEKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/177608COMPOSITION HAVING ANTIOXIDATIVE EFFECT, COMPRISING SUBSTANCE  PBIOSOLUTION CO.,LTD
WO/2021/158059COMPOSITION COMPRISING RILMENIDINE COMPOUND AS ACTIVE  INGREDIENT FOR TREATMENT OF FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL  DISABILITYKONKUK UNIVERSITY GLOCAL INDUSTRYACADEMIC COLLABORATION  FOUNDATION
WO/2021/158071PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  CANCERS ASSOCIATED WITH KRAS MUTATIONWELLMARKER BIO CO., LTD.
WO/2021/158084HYBRID COMPOUND AND PREPARATION METHOD THEREFORBORYUNG PHARMACEUTICAL CO., LTD
WO/2021/162375EXOSOME COMPRISING PHOTOCLEAVABLE PROTEIN, AND USE THEREOFRESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/158091COMPOSITION COMPRISING CHEMOKINE INHIBITOR, COLONY STIMULATING  FACTOR INHIBITOR, AND CANCER IMMUNOTHERAPY AGENT FOR PREVENTION OR TREATMENT  OF CANCER AND COMBINATION THERAPYAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/162408WATER-DISPERSIBLE, OIL-FREE, AND UV-BLOCKING COSMETIC  COMPOSITION AND PREPARATION METHOD THEREFORKOLMAR KOREA CO., LTD.
WO/2021/162415COSMETIC COMPOSITION FOR SKIN IMPROVEMENT COMPRISING, AS  ACTIVE INGREDIENTS, POLYSACCHARIDES, YEAST EXTRACT, AND STRAIN FERMENTATION  PRODUCT WITH CHARACTERISTICS OF PROBIOTICSLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/162417COMPOSITION FOR PREVENTING OR TREATING CANCER BY USING  MATURATION INDUCTION OF IMMATURE DENDRITIC CELLSLISCURE BIOSCIENCES CO., LTD.
WO/2021/162419CANCER PREVENTION OR TREATMENT COMPOSITION USING MATURATION  INDUCTION OF IMMATURE DENDRITIC CELLSLISCURE BIOSCIENCES CO., LTD.
WO/2021/162421COMPOSITION FOR CANCER PREVENTION OR TREATMENT, USING  MATURATION INDUCTION OF IMMATURE DENDRITIC CELLSLISCURE BIOSCIENCES CO., LTD.
WO/2021/162426METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FOR PREVENTION OR  TREATMENT OF BRAIN NEURONAL DISEASES, COMPRISING GHRELIN TREATMENT, AND USE  THEREOFSAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/162448WATER-SOLUBLE CATECHIN COMPLEX, AND COMPOSITION FOR PREVENTING  OR TREATING ATOPIC DERMATITIS COMPRISING SAMEKOLON INDUSTRIES, INC.
WO/2021/162451PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  CONTAINING BILE ACIDS OR DERIVATIVES THEREOF, BIGUANIDE-BASED COMPOUNDS, AND  TWO OR MORE KINDS OF ANTIVIRAL AGENTS AS ACTIVE INGREDIENTSFRONTBIO INC.
WO/2021/162457ANTICANCER THERAPY USING FAECALIBACTERIUM SP. MICROORGANISMCHUNLAB, INC.
WO/2021/162460NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING NON-ALCOHOLIC  LIVER DISEASEGENEXINE, INC.
WO/2021/162463COMPOSITION FOR PREVENTING, TREATING, AND ALLEVIATING ATOPIC  DERMATITIS COMPRISING FLAVONE-RESVERATROL CONJUGATE COMPOUNDAGERA BIOTECH, INC.
WO/2021/162478PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING GENIPIN AND ELESCLOMOLSAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/162525PHARMACEUTICAL COMPOSITION FOR INHIBITING INFLAMMATORY  RESPONSE COMPRISING HYDROXYUREABIONOXX INC.
WO/2021/167308NOVEL USE OF ANTICANCER AGENT PRODRUG CONJUGATEUNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
WO/2021/162532PHARMACEUTICAL COMPOSITION COMPRISING SUSTAINED-RELEASE  MICROSPHERES INCLUDING GLP-1 ANALOGUE OR PHARMACEUTICALLY ACCEPTABLE SALT  THEREOFG2GBIO, INC.
WO/2021/167346COMPOSITION FOR PREVENTING OR TREATING DIABETESSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/167350COMPOSITION FOR TREATING CLIMACTERIC DISORDER COMPRISING  LACTOBACILLUS GASSERI BNR17ACEBIOME INC.
WO/2021/167364PHARMACEUTICAL COMPOSITION COMPRISING ESOMEPRAZOLE AND SODIUM  BICARBONATE HAVING EXCELLENT RELEASE PROPERTIESCHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/167389PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  CONTAINING MTOR-SIGNALING INHIBITOR AS ACTIVE INGREDIENTKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/167418NOVEL TUMOR-ASSOCIATED ANTIGEN PROTEIN OLFM4 AND USES THEREOFSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/225260COMPOSITION FOR HEALING WOUNDS COMPRISING REGULATORY T  CELL-CONDITIONED MEDIAIMMUNISBIO CO., LTD.
WO/2021/167429TARGETED CRYSTALLIZATION OF MIXED-CHARGE NANOPARTICLES IN  LYSOSOMES FOR INDUCING SELECTIVE DEATH OF CANCER CELLSINSTITUTE FOR BASIC SCIENCE
WO/2021/172897PHARMACEUTICAL COMPOSITION COMPRISING DEOXYCHOLIC ACIDLG CHEM, LTD.
WO/2021/177660WEIGHT LOSS COMPOSITION COMPRISING OENOTHEIN B ANALOGUES AS  ACTIVE INGREDIENTMETAIMMUNETECH INC.
WO/2021/172908COMPOSITION HAVING IMPROVED USABILITYAMOREPACIFIC CORPORATION
WO/2021/177679LIVE-PATHOGEN-MIMETIC NANOPARTICLES BASED ON PATHOGEN CELL  WALL SKELETON, AND PRODUCTION METHOD THEREOFRESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/172960SUSTAINED-RELEASE PREPARATION FOR TREATING HEART FAILURE,  COMPRISING SACUBITRIL AND VALSARTAN, AND MULTIPLE-RELEASE COMPLEX PREPARATION  COMPRISING SAME AND PREPARATION METHOD THEREFORELYSON PHARM CO., LTD.
WO/2021/194110COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES,  CONTAINING JUJUBOSIDE A AS ACTIVE INGREDIENTUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/177693NANOPARTICLE STRUCTURE AND FORMATION METHOD THEREFORSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/194112METHOD FOR PRODUCING LARGE-DIAMETER SIO2 POWDER, AND COSMETIC  COMPOSITION CONTAINING SAMESUKGYUNG AT CO., LTD.
WO/2021/221287NANOPARTICLES HAVING APOPTOSIS-INDUCING GAS PRECURSOR  IMPREGNATED THEREIN, AND PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION OR  TREATMENT, COMPRISING SAME AS ACTIVE INGREDIENTRESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/221288COMBINATION DRUG COMPRISING MOSAPRIDE AND PROTON PUMP  INHIBITORKOREA UNITED PHARM. INC.
WO/2021/177721PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  CANCER IN WHICH KRAS MUTATION AND ACTIVATED RON ARE PRESENTWELLMARKER BIO CO., LTD.
WO/2021/177728USE OF 2,3,5-SUBSTITUTED THIOPHENE COMPOUND FOR PREVENTING,  AMELIORATING, OR TREATING OVARIAN CANCERPHAROS IBIO CO., LTD
WO/2021/177779COMPOSITION FOR PREVENTING OR TREATING SJÖGREN'S SYNDROME,  CONTAINING SPHINGOSYLPHOSPHORYLCHOLINE AS ACTIVE INGREDIENTRESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/235659COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF  ATOPIC DERMATITIS DISEASENAM, Jong Hyun
WO/2021/187787METHOD FOR SCREENING PLK-1 INHIBITOR, INHIBITOR SCREENED  THEREBY, AND USE THEREOFINNOPHARMASCREEN INC.
WO/2021/201451PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING  LIPID-PHOTOTHERMAL NANOPARTICLE HAVING ANTIBODY BOUND TO SURFACESEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
WO/2021/235661ENTEROENDOCRINE CELL TARGET POLYMER CONJUGATED WITH  PHOTOSENSITIZER, AND MEDICAL USE THEREOF FOR AMELIORATING METABOLIC DISEASETHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/182864A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS  COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF SKIN ULCER  AND THE USE THEREOF.MEDIHELPLINE CO., LTD
WO/2021/182865A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS  COMPRISING LONGANAE ARILLUS FOR TLSP INHIBITION AND THE TREATMENT OR  ALLEVIATION OF SKIN INFLAMMATORY DISEASE AND THE USE THEREOF.MEDIHELPLINE CO., LTD.
WO/2021/182866COMPOSITION FOR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH  COMPRISING GROWTH FACTORMEDICOSBIOTECH INC.
WO/2021/182873A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS  COMPRISING LONGANAE ARILLUS FOR THE SKIN REGENERATION AND THE TREATMENT OR  ALLEVIATION OF SKIN WOUND AND THE USE THEREOF.MEDIHELPLINE CO., LTD.
WO/2021/182874LIQUID PHARMACEUTICAL COMPOSITION HAVING IMPROVED STABILITYSAMSUNG BIOEPIS CO., LTD.
WO/2021/182876PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  NONALCOHOLIC STEATOHEPATITISDONG-A ST CO., LTD.
WO/2021/182877PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  DIABETES AND METABOLIC DISEASES ASSOCIATED THEREWITHDONG-A ST CO., LTD.
WO/2021/187804PHOTO-CURABLE COMPOSITION FOR TOOTH RESTORATIONGRAPHY INC.
WO/2021/182894COMPOSITION FOR PREVENTING OR TREATING CARDIOMETABOLIC  DISEASES, CONTAINING ELAEOCARPUS PETIOLATUSSEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/182895COSMETIC COMPOSITION FOR INCREASING BENEFICIAL BACTERIA OF  SKINLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/182897PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  NK/T-CELL LYMPHOMA OR NK-CELL LEUKEMIA, COMPRISING PHOSPHODIESTERASE TYPE 5  INHIBITORSAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/182900METHOD FOR PREVENTING OR TREATING MTOR-ASSOCIATED DISEASES  THROUGH REGULATION OF VEGFR-3 EXPRESSIONINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/182901COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES,  COMPRISING TAT PEPTIDE VARIANT AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/182903COMPOSITION COMPRISING PI3 KINASE INHIBITOR AND BTK INHIBITORBORYUNG PHARMACEUTICAL CO., LTD
WO/2021/256665COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL OR MENTAL  DISORDERS COMPRISING VESICLES DERIVED FROM LACTOBACILLUS PARACASEIMD HEALTHCARE INC.
WO/2021/201461ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND  METFORMINHANMI PHARM. CO., LTD.
WO/2021/187809TRANQUILIZING COMPOSITIONNATURAL ENDOTECH CO., LTD.
WO/2021/187813DEFORMABLE HYDROGEL PARTICLES AND PHARMACEUTICAL COMPOSITION  FOR CANCER TREATMENT COMPRISING SAMESCHOLAR FOXTROT CO., LTD.
WO/2021/182913COMPOSITION, COMPRISING PLACENTA EXTRACT, FOR PREVENTING OR  TREATING LIVER DISEASE AND IMPROVING LIVER FUNCTIONGREEN CROSS WELLBEING CORPORATION
WO/2021/194142RECOMBINANT PROTEIN FOR NEUTERING OR SPAYING ANIMAL, AND  VACCINE COMPOSITION COMPRISING SAMEBIOAPPLICATIONS INC.
WO/2021/182917COMPOSITION FOR INDUCING APOPTOSIS OF CELLS HAVING GENOMIC  SEQUENCE VARIATION AND METHOD FOR INDUCING APOPTOSIS OF CELLS BY USING  COMPOSITIONINSTITUTE FOR BASIC SCIENCE
WO/2021/182927PHARMACEUTICAL COMPOSITION FOR TREATING NOVEL METABOLIC  SYNDROME AND DISEASES ASSOCIATED THEREWITHSL METAGEN
WO/2021/187842PHARMACEUTICAL PREPARATION FOR TREATING SARS-CORONAVIRUS  INFECTIONS, AND MEDICAL USE THEREOFINSTITUT PASTEUR KOREA
WO/2021/187851PARTICLES ENCAPSULATING TARGETED APTAMER CONJUGATES, AND USE  THEREOFKIM, Sung Chun
WO/2021/187880NOVEL USE OF CROSS-FLOW FILTRATION DEVICE FOR PREPARING  FUNCTIONAL EXOSOMEEXOSTEMTECH CO., LTD.
WO/2021/194152COMPOSITE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FIBROSIS  DISEASEKOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
WO/2021/194153DEVELOPMENT OF COMBINED THERAPEUTIC AGENT FOR FIBROTIC  DISEASESKOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
WO/2021/241862PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION OR TREATMENT,  COMPRISING INOSITOL POLYPHOSPHATE MULTIKINASE INHIBITOR AS ACTIVE INGREDIENTKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/187896PHARMACEUTICAL COMPOSITION COMPRISING DIABETES THERAPEUTIC  AGENT AND HYPERLIPIDEMIA THERAPEUTIC AGENTDAEWOONG THERAPEUTICS INC.
WO/2021/187897FUSION PROTEIN PREPARATION COMPRISING IL-2 AND CD80 PROTEINSGI INNOVATION, INC.
WO/2021/187902NUCLEIC ACID-BASED ANTICANCER AGENTKIM, Sung Chun
WO/2021/187905PHARMACEUTICAL COMPOSITION FOR CANCER AND RESISTANT CANCER  COMPRISING TRICHOSANTHES KIRILOWII MAXIM, DICTAMNUS DASYCARPUS TURCZ AND  MORUS ALBA L.SONGHEON R&D
WO/2021/187922PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING  FUSION PROTEIN INCLUDING IL-2 PROTEIN AND CD80 PROTEIN AND ANTICANCER DRUGGI INNOVATION, INC.
WO/2021/187932VACCINE COMPOSITION FOR PREVENTING HAND, FOOT, AND MOUTH  DISEASE, COMPRISING GLA-SEKNU-INDUSTRY COOPERATION FOUNDATION
WO/2021/187942USE OF CYCLO-HISPRO (CHP) FOR LOWERING BLOOD PRESSURENOVMETAPHARMA CO., LTD.
WO/2021/187944THERAPEUTIC USE OF COENZYME Q10 SOLUBILIZING COMPOSITIONTHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/206309PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  DISEASES CAUSED BY SARS-COV-2DONG WHA PHARM. CO., LTD.
WO/2021/230487COMPOSITION COMPRISING AMNION EPITHELIAL CELL-DERIVED EXOSOME  AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF OCULAR DISEASEKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/210798PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN  DISEASE, INCLUDING GLYCINE TRANSPORTER AS ACTIVE INGREDIENTAMYLOID SOLUTION INC.
WO/2021/261712HEMOGLOBIN DERIVATIVE CO-CONJUGATED WITH FATTY ACID-LINKED PEG  AND ALKOXY PEG AS A BLOOD SUBSTITUTESUNBIO, INC.
WO/2021/206316AGENT FOR TREATING CONTRAST-INDUCED ACUTE KIDNEY INJURYAPTABIO CO., LTD.
WO/2021/210799PULMONARY FIBROSIS MEDICINE CONTAINING PYRAZOLE DERIVATIVEAPTABIO CO., LTD.
WO/2021/215677COMPOSITION FOR ALLEVIATING SKIN DAMAGE BY USING RED  ALGAE-DERIVED CELLULOSE NANOMATERIAL, AND PREPARATION METHOD THEREFORKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/194228PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  CANCERL-BASE CO., LTD.
WO/2021/201488THROMBUS IMAGING RADIOPHARMACEUTICAL AND COMPOSITIONTHE ASAN FOUNDATION
WO/2021/194253ORAL TABLET COMPOSITION OF POMALIDOMIDE AND METHOD FOR  PREPARING SAMESAMYANG HOLDINGS CORPORATION
WO/2021/194256PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  RETINITIS PIGMENTOSA, COMPRISING MESENCHYMAL STEM CELLS DERIVED FROM HUMAN  EMBRYONIC STEM CELLSSEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/206328NOVEL RECOMBINANT EXOSOME AND USE THEREOFKOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/194276PHARMACEUTICAL COMPOSITION, FOR PREVENTION OR TREATMENT OF  CANCER, COMPRISING 13-HYDROXYOCTADECADIENOIC ACID AS ACTIVE INGREDIENTKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/194280NOVEL PHARMACEUTICAL FORMULATION WITH IMPROVED STABILITY  CONTAINING TAXANE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR HYDRATE  THEREOFBORYUNG PHARMACEUTICAL CO., LTD
WO/2021/194281TARS DERIVED FROM AKKERMANSIA MUCINIPHILA OR FRAGMENT THEREOF,  AND USE THEREOFKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/246627PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  PARKINSON'S DISEASE, COMPRISING  2-(4-(1-HYDROXYPROPANE-2-YL)PHENYL)ISOINDOLINE-1-ONE COMPOUNDYEP BIO CO. LTD.
WO/2021/201502AN ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF  COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION  OF INFLAMMATORY DISEASE AND THE USE THEREOF.MEDIHELPLINE CO., LTD.
WO/2021/201503AN ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF  COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION  OF ARTHRITIS DISEASE AND THE USE THEREOF.MEDIHELPLINE CO., LTD.
WO/2021/194287NOVEL CERIUM OXIDE NANOCOMPOSITE AND USE THEREOFCENYX BIOTECH INC.
WO/2021/194290PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING EPIDEMIC  RNA VIRAL INFECTIOUS DISEASESHIN POONG PHARMACEUTICAL CO., LTD.
WO/2021/210804METHOD FOR PREPARING RED ALGAL MICROFIBRILLATED CELLULOSE, AND  USE THEREOFKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/206335PEPTIDE FOR PREVENTING OR TREATING HAIR LOSS, AND USE THEREOFDAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/201532COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING FEMALE  MENOPAUSAL SYNDROME, CONTAINING ROSA RUGOSA EXTRACT AS ACTIVE INGREDIENTKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/241873COMPOSITION FOR PREVENTING OR TREATING SARS CORONAVIRUS 2  DISEASEKYUNGSUNG UNIVERSITY INDUSTRY COOPERATION FOUNDATION
WO/2021/206355ANTI-POLLUTION COMPOSITE POWDER HAVING UV AND FINE DUST  BLOCKING FUNCTION AND COSMETIC COMPOSITION COMPRISING SAMECQV CO., LTD.
WO/2021/246628COSMETIC COMPOSITION FOR LIPSKOLMAR KOREA CO., LTD.
WO/2021/201588HEPARIN-BILE ACID OLIGOMER CONJUGATES FOR ANTICANCER THERAPYST PHARM CO., LTD.
WO/2021/206360BOTULINUM TOXIN PRE-FILLED INJECTABLE FORMULATION THAT  FACILITATES DISCHARGE RATE CONTROL AND IS STABLEMEDYTOX INC.
WO/2021/201612NOVEL VACCINE COMPOSITION FOR PREVENTION AND TREATMENT OF  CORONAVIRUSSL VAXIGEN, INC.
WO/2021/251602COMPOSITION FOR PREVENTING OR TREATING DISEASE CAUSED BY  MUSCLE LOSS, COMPRISING AGENT INHIBITING PHF20MITOS THERAPEUTICS INC.
WO/2021/221330SONOSENSITIVE LIPOSOME AND METHOD FOR PREPARING SAMEIMGT CO, LTD.
WO/2021/201647HAND SANITIZER COMPOSITION HAVING CAPSULES CONTAINING ACTIVE  SUBSTANCE AND METHOD FOR PREPARING SAMEACTIVON CO., LTD.
WO/2021/206379COMPOSITION FOR CANCER PREVENTION OR TREATMENT, CONTAINING, AS  ACTIVE INGREDIENT, SALVIANOLIC ACID B OR TANSHINONE IPUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION  FOUNDATION
WO/2021/201654PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  MUCOSITIS INDUCED BY RADIOTHERAPY, CHEMOTHERAPY, OR COMBINATION THEREOF,  COMPRISING GLP-2 DERIVATIVES OR LONG-ACTING CONJUGATE OF SAMEHANMI PHARM. CO., LTD.
WO/2021/201657COMPOSITION FOR CANCER DIAGNOSIS, PREVENTION OR TREATMENT,  CONTAINING EPHA10 INHIBITOR, AND USE THEREOFINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/201660CELL CAPSULATING LAYER, CAPSULATED CELLS, CELL CAPSULATING  COMPOSITION AND PREPARATION METHOD THEREFORSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/206397NOVEL ANTIBACTERIAL PEPTIDE OR PEPTIDE ANALOG AND USE THEREOFCAMP THERAPEUTICS INC.
WO/2021/251603ADIPOCYTE DIFFERENTIATION INHIBITOR AND COMPOSITION COMPRISING  SAMEHNB9 CO., LTD
WO/2021/215700COMPOSITION FOR PREVENTING OR TREATING ISCHEMIA REPERFUSION  INJURY COMPRISING NADPH OXIDASE 1 INHIBITOR AS ACTIVE INGREDIENTKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/235685PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCERVIROCURE, INC.
WO/2021/206455FRACTION EXTRACT OF MELISSA OFFICINALIS LEAVES AND NOVEL  PHARMACEUTICAL COMPOSITION INCLUDING SAMEANGIOLAB, INC.
WO/2021/215709WHITENING COSMETIC COMPOSITION COMPRISING SODIUM PYRUVATE AS  ACTIVE INGREDIENTLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/206459STEM CELL-DERIVED EXOSOMES CONTAINING PAIN REGULATORS, AND  USES THEREOFEXOSTEMTECH CO., LTD.
WO/2021/206470COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF  URINATION-RELATED DISEASES COMPRISING CEPHALOTOCINKOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/206480COMPOSITION AND METHOD FOR AN ANTIBIOTIC-INDUCING IMBALANCE IN  MICROBIOTAPSOMAGEN, INC.
WO/2021/235695PREVENTIVE OR THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR  CORONAVIRUS INFECTION COMPRISING TETRAARSENIC HEXOXIDECHEMAS CO., LTD.
WO/2021/210851ANTIVIRAL COMPOSITION COMPRISING PLACENTA EXTRACTGREEN CROSS WELLBEING CORPORATION
WO/2021/210852ANTI-VIRAL COMPOSITION COMPRISING PLACENTA-DERIVED MATERIALGREEN CROSS WELLBEING CORPORATION
WO/2021/210853ANTIVIRAL COMPOSITION COMPRISING PLACENTA-EXTRACT-DERIVED  MICRORNAGREEN CROSS WELLBEING CORPORATION
WO/2021/206498FLAVONOID GLYCOSIDE HAVING ANTI-CORONAVIRUS ACTIVITYKWON, Dur Han
WO/2021/210872COMPOSITION FOR PREVENTING OR TREATING DIABETIC SKIN DISEASE,  COMPRISING EXOSOME DERIVED FROM THROMBIN-TREATED STEM CELLSAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/210897METHOD AND COMPOSITION FOR EVALUATING RESPONSE TO  NEURODEGENERATIVE DISEASE TREATMENT AGENTGENUV INC.
WO/2021/230506HERBAL MEDICINE COMPOSITION FOR TREATING COVID-19 AND OTHER  VIRAL DISEASESKANG, Seong Cheon
WO/2021/261726COMPOSITION FOR TREATING HAIR OR FIBERS, COMPRISING ALKYL  KETENE COMPOUNDLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/210929NOVEL PHARMACEUTICAL FORMULATION HAVING IMPROVED STABILITY  COMPRISING AMORPHOUS EMPAGLIFLOZINBORYUNG PHARMACEUTICAL CO., LTD
WO/2021/210962CONTRAST AGENT COMPOSITION FOR DETECTING LESIONAL MARGINS OF  ASTROCYTOSIS-RELATED DISEASES COMPRISING QUINOLINE DERIVATIVE AS ACTIVE  INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/210963CONTRAST AGENT COMPOSITION FOR DETECTING LESION MARGINS OF  DEMENTIA CAUSED BY DEGENERATIVE BRAIN DISEASE, COMPRISING QUINOLINE  DERIVATIVE AS ACTIVE INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/210964CONTRAST MEDIUM COMPOSITION, COMPRISING C11-ACETATE AS ACTIVE  INGREDIENT, FOR DETECTING MARGINS OF LESION OF ASTROCYTOSIS-RELATED DISEASEINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/210965CONTRAST COMPOSITION FOR DETECTING LESION MARGINS OF DEMENTIA  CAUSED BY DEGENERATIVE BRAIN DISEASE, CONTAINING C11-ACETATE AS ACTIVE  INGREDIENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/215798PHARMACEUTICAL COMPOSITION FOR TREATING SARS-CORONAVIRUS  INFECTION, AND MEDICAL USE THEREOFINSTITUT PASTEUR KOREA
WO/2021/215801PREVENTIVE OR THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR  HYPERLIPIDEMIA COMPRISING TRIPLE AGONIST ACTING ON ALL OF GLUCAGON, GLP-1 AND  GIP RECEPTORS, OR CONJUGATE THEREOF, AND PREVENTIVE OR THERAPEUTIC METHODHANMI PHARM. CO., LTD.
WO/2021/221377COMPOSITION FOR INHIBITING ANTICANCER-AGENT-INDUCED  OVOTOXICITY, CONTAINING MIXED EXTRACT OF MEDICINAL HERBS AS ACTIVE INGREDIENTKOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/215836PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING EYE  DISEASES COMPRISING VERBENONE DERIVATIVESHIN POONG PHARMACEUTICAL CO., LTD.
WO/2021/221384SKIN WHITENING COMPOSITION CONTAINING ITACONIC ACID DERIVATIVESTEMORE C0., LTD.
WO/2021/251616COMPOSITION COMPRISING EXOSOMES DERIVED FROM FELINE  MESENCHYMAL STEM CELLS AND METHOD OF TREATING INFLAMMATORY DISEASES BY USING  SAMEDAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/251617CRUDE DRUG COMPOSITION FOR ALLEVIATING OR TREATING RHINITIS,  PHARMACOPUNCTURE SOLUTION OF ORIENTAL MEDICINE COMPRISING SAME, INJECTION  COMPRISING SAME, AND PHARMACOPUNCTURING METHOD USING SAMEOSUNG NATURAL BIO CO., LTD.
WO/2021/215852PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC  CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITIONCELLTRION INC.
WO/2021/241892NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING DRY EYE SYNDROMENOVACELL TECHNOLOGY INC.
WO/2021/215856ENTERIC-COATED PREPARATION COMPRISING PIRFENIDONE HAVING  IMPROVED SAFETY AND STABILITY, AND METHOD FOR PREPARING SAMEYUNGJIN PHARM. CO., LTD.
WO/2021/215882COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH  COMPRISING CAMELLIA PERICARP EXTRACT AS ACTIVE INGREDIENTBIOSPECTURM, INC.
WO/2021/215887COMPOSITION COMPRISING CRICKET OR EXTRACT THEREOF FOR  IMPROVING BOWEL MOVEMENT FUNCTIONCJ CHEILJEDANG CORPORATION
WO/2021/215891HEPATIC REGENERATION PROMOTING COMPOSITION COMPRISING  6-O-TRANS-FERULOYL CATALPOL AS ACTIVE INGREDIENTEWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
WO/2021/221405FUNCTIONAL COSMETIC COMPOSITION COMPRISING PLANT EXTRACT AS  ACTIVE INGREDIENT AND PREPARATION METHOD THEREFORTHE GARDEN OF NATURALSOLUTION CO., LTD.
WO/2021/215896METHOD FOR TREATING CERVICAL CANCERGENEXINE, INC.
WO/2021/221435PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  CORONAVIRUS DISEASE-19KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/241898VETERINARY ORALLY-DISINTEGRATING-FILM FORMULATION FOR TREATING  OR PREVENTING PARASITIC INFECTIOUS DISEASES IN ANIMALSKYONGBO PHARM.CO.,LTD.
WO/2021/221447USE OF ACTIVE ANDROGEN RECEPTOR ANTAGONIST FOR CANCER  TREATMENTLEE, Kyung Il
WO/2021/221472MICELLE PARTICLES COMPRISING AMPHIPATHIC GINSENOSIDE,  COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREOFMODNBIO, INC. CO., LTD.
WO/2021/221482NOVEL PROTEIN CONJUGATE, AND USE THEREOF FOR PREVENTING OR  TREATING NONALCOHOLIC STEATOHEPATITIS, OBESITY AND DIABETESONEGENE BIOTECHNOLOGY INC.
WO/2021/225343COMPOSITION FOR PREVENTING OR TREATING COGNITIVE DISORDER,  COMPRISING IRIS LACTEA EXTRACTKOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/225349COMPOSITION FOR PREVENTING OR TREATING HEAD TRAUMATHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/225363ANTI-INFLAMMATORY OR ANTIDIABETIC COMPOSITION COMPRISING  METABOLITE OF MARINE-DRIVED FUNGUS PENICILLIUM GLABRUM SF-7123KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
WO/2021/225397CYCLOSERINE AND PENTOXIFYLLINE COMBINATION THERAPY FOR  TREATMENT OF DEPRESSIONNEURORIVE INC
WO/2021/246666ANTICANCER DRUG COMPOSITION COMPRISING AS ACTIVE INGREDIENT  TLR5 AGONIST DERIVED FROM FLAGELLINTHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/225410PHARMACEUTICAL COMPOSITION FOR BRAIN CANCER TREATMENTINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/230600ANTICANCER COMPOSITION COMPRISING METABOLIC ANTICANCER DRUGNOAHM INC.
WO/2021/241914ANTIBACTERIAL SUBSTANCE HAVING LYTIC ACTIVITY AGAINST  ACTINOBACILLUS PLEUROPNEUMONIAE AND METHOD FOR PRODUCING SAMEINTRON BIOTECHNOLOGY, INC.
WO/2021/230647PERCUTANEOUS ABSORPTION PREPARATION COMPRISING DONEPEZIL WITH  IMPROVED STABILITYDONG-A ST CO., LTD.
WO/2021/230664PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEART  FAILURE AND ISCHEMIC HEART DISEASE, COMPRISING SACUBITRIL, VALSARTAN, AND  NEBIVOLOL, AND PHARMACEUTICAL COMPLEX FORMULATION COMPRISING SAMEELYSON PHARM CO., LTD.
WO/2021/230667CORONAVIRUS THERAPEUTIC AGENT COMPRISING ZANTHOXYLUM PIPERITUM  LEAF EXTRACT AS ACTIVE INGREDIENTMECOX CUREMED CO., LTD.
WO/2021/230677NOVEL POLYPHENOL COMPOUND AND ANTIFUNGAL COMPOSITION  CONTAINING SAME AS ACTIVE INGREDIENTRESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/235773PHARMACEUTICAL LIQUID COMPOSITION COMPRISING BOTULINUM TOXINOSSTEMIMPLANT CO., LTD.
WO/2021/230704COMPOSITION FOR ENHANCING IMMUNE RESPONSE BY USING ACTIVATION  FUNCTION OF DENDRITIC CELLS OF STROMAL VASCULAR FRACTIONS ISOLATED FROM  ADIPOSE TISSUESSEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/235807ORAL HEALTH CARE COMPOSITION COMPRISING AS ACTIVE INGREDIENT  NIPA PALM-DERIVED COMPOSITE NATURAL MATERIAL CONTAINING PHYTO-SALT,  PREPARATION METHOD THEREFOR, AND ORAL HEALTH CARE PRODUCT MANUFACTURED USING  COMPOSITIONHIM CO., LTD.
WO/2021/235811PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  SMALL-CELL LUNG CANCER ASSOCIATED WITH RON MUTANTS AND METHOD USING SAMEWELLMARKER BIO CO., LTD.
WO/2021/235812PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  NON-SMALL CELL LUNG CANCER ASSOCIATED WITH RON MUTATION, AND METHOD USING  SAMEWELLMARKER BIO CO., LTD.
WO/2021/235813PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  PANCREATIC CANCER ASSOCIATED WITH RON MUTATION AND METHOD USING SAMEWELLMARKER BIO CO., LTD.
WO/2021/246684COMPOSITION FOR ANTI-INFLAMMATION, WOUND HEALING OR WOUND  HEALING PROMOTION, COMPRISING ROSE STEM CELL-DERIVED EXOSOMES AS ACTIVE  INGREDIENTEXOCOBIO INC.
WO/2021/251644COMPLEX PHARMACEUTICAL PREPARATION, FOR PREVENTING OR TREATING  CARDIOVASCULAR DISEASE, COMPRISING AMLODIPINE, LOSARTAN AND CHLORTHALIDONE IN  SINGLE-LAYER TABLETHANMI PHARM. CO., LTD.
WO/2021/241941LIMAPROST-CONTAINING SUSTAINED RELEASE FORMULATIONYONSUNG FINE CHEMICAL CO., LTD.
WO/2021/241943PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  CANCERINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/241953FERMENTED NANO-EMULSIFIER COMPOSITION AND PREPARATION METHOD  THEREFORUNITED ACTIVE INC.
WO/2021/235907LIQUID FORMULATION OF LONG-ACTING CONJUGATE OF GLUCAGON  DERIVATIVEHANMI PHARM. CO., LTD.
WO/2021/241966PRUSSIAN BLUE/PLURONIC NANOPARTICLE COMPLEX FOR REMOVAL OF  REACTIVE OXYGEN AND USE THEREOFKOREA INSTITUTE OF CERAMIC ENGINEERING AND TECHNOLOGY
WO/2021/235913LIQUID FORMULATION OF LONG-ACTING CONJUGATE OF GLP-2HANMI PHARM. CO., LTD.
WO/2021/246704UV-BLOCKING COSMETIC COMPOSITION HAVING INCREASED UV-BLOCKING  EFFICIENCY DUE TO HEAT AND UV LIGHTLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/235915LIQUID FORMULATIONHANMI PHARM. CO., LTD.
WO/2021/235916LIQUID PREPARATION OF LONG-ACTING CONJUGATE OF  GLUCAGON/GLP-1/GIP TRIGONAL AGONISTHANMI PHARM. CO., LTD.
WO/2021/241981COMPOSITION FOR PREVENTING OR TREATING CANCERINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/242002LSP1-DEFICIENT T CELLTHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/242021CONTROLLED RELEASE MICROSPHERES CONTAINING GLUCAGON-LIKE  PEPTIDE 1 AGONIST, AND METHOD FOR PRODUCING SAMEAULBIO CO.,LTD.
WO/2021/242040SUSTAINED-RELEASE METFORMIN COATED TABLET HAVING CONTROLLED  RELEASE BY OSMOTIC PRESSUREKOREA UNITED PHARM. INC.
WO/2021/242043COMPOSITION FOR PREVENTING, TREATING OR AMELIORATING METABOLIC  SYNDROME COMPRISING LACTOBACILLUS FERMENTED PRODUCT OF PEONY EXTRACT OR  β-GENTIOBIOSYL PAEONIFLORIN AS ACTIVE INGREDIENTKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/242044COMPOSITION COMPRISING HIBISCUS, ROSEMARY, AND GRAPE SEED  EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DEGENERATIVE BRAIN  DISEASEPOSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
WO/2021/242056BIFIDOBACTERIUM SP. STRAIN AND EXTRACELLULAR VESICLE DERIVED  THEREFROM, AND ANTI-INFLAMMATORY AND ANTI-BACTERIAL USES THEREOFBIOBANKHEALING INC.
WO/2021/256730PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  CONTAINING, AS ACTIVE INGREDIENT, ISOSAKURANETIN OR PHARMACEUTICALLY  ACCEPTABLE SALT THEREOFAJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/242070PHOTOREACTIVE COSMETIC COMPOSITION FOR ENHANCING SKIN  ELASTICITY AND REDUCING SKIN WRINKLES, AND PREPARATION METHOD THEREFORD.R. NANO CO., LTD
WO/2021/246744COMPOSITION COMPRISING OSTEOPONTIN INHIBITOR AS ACTIVE  INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF NEURODEGENERATIVE  DISEASETHE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/246755COMPOSITION, FOR PREVENTING, ALLEVIATING OR TREATING METABOLIC  DISEASE, COMPRISING PHOSPHOLIPASE D2 INHIBITORRESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/246757PHARMACEUTICAL COMPOSITION FOR ENHANCING RADIOTHERAPY  COMPRISING FUSION PROTEIN CONTAINING IL-2 PROTEIN AND CD80 PROTEINGI INNOVATION, INC.
WO/2021/251673PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  PERIODONTAL DISEASE OR LUXATED TEETHHYSENSBIO
WO/2021/246797PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER  CONTAINING ANTIVIRAL AGENT AND ANTIDEPRESSANT AS ACTIVE INGREDIENTSFRONTBIO INC.
WO/2021/256751COMPOSITION COMPRISING FIBROBLAST-DERIVED EXTRACELLULAR  VESICLE AS ACTIVE INGREDIENT FOR TREATING SKIN AND MUCOSAL WOUNDKYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/246833COMPOSITION, FOR PREVENTING OR TREATING INFLAMMATORY DISEASE,  COMPRISING HYDROLYSIS EXTRACT OF PULSATILLA KOREANA AND ANEMONE RADDEANA AS  ACTIVE INGREDIENTBACK, Ju Youn
WO/2021/251710ANTIVIRAL COMPOSITION OBTAINED THROUGH DRUG REPOSITIONINGKOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/251723CONDITIONING SHAMPOO COMPOSITION HAVING LAMELLAR STRUCTURECOSMAX, INC.
WO/2021/251730COMPOSITION COMPRISING REGENTIDE-034 AND REGENTIDE-041 FOR  SKIN CARE OR WRINKLE REDUCTIONNINEBIOPHARM CO.,LTD.
WO/2021/251756N-ACYLHYDRAZONE-DERIVATIVE-MARKER CONJUGATE AND PHARMACEUTICAL  COMPOSITION CONTAINING SAMEKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/256773COSMETIC COMPOSITION COMPRISING FERMENTED CHESTNUT HUSK  EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENTKOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/251788COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING ALLERGIC  DISEASES OR PRURITUS, CONTAINING PENTAPEPTIDE AS ACTIVE INGREDIENTCAREGEN CO., LTD.
WO/2021/251789COMPOSITION COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENTCAREGEN CO., LTD.
WO/2021/251790DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY  ACTIVITY AND USE THEREOFCAREGEN CO., LTD.
WO/2021/251792PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COVID-19  RESPIRATORY SYNDROMECHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/256793COMPOSITION COMPRISING LACTOBACILLUS BACTERIUM-DERIVED VESICLE  FOR PREVENTING OR TREATING METABOLIC DISEASE OR MUSCULAR DISEASEMD HEALTHCARE INC.
WO/2021/261824CATIONIC COSMETIC COMPOSITION FOR REINFORCING ADHESION OF  MAKEUP AND PREVENTING RUBBING-OFF THEREOFCOSMAX, INC.
WO/2021/256844PHARMACEUTICAL COMPOSITIONWHAN IN PHARMACEUTICAL CO., LTD.
WO/2021/256854COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF  SEPSIS OR SEPTIC SHOCKINDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY
WO/2021/256855COMPOSITION FOR TREATING METASTATIC SOLID CANCER, COMPRISING  TSG6 INHIBITORINDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY  ERICA CAMPUS
WO/2021/256858COMPOSITION FOR IMPROVING, PREVENTING OR TREATING  NON-ALCOHOLIC FATTY LIVER DISEASE AND PREPARATION METHOD THEREFORWELLNESSBIO INC.
WO/2021/256865PHARMACEUTICAL COMPOSITION CONTAINING SAURURUS CHINENSIS  FRACTION, AND PREPARATION METHOD THEREFORDADANGANDBIO CO., LTD.
WO/2021/261837ORAL PHARMACEUTICAL COMPOSITION COMPRISING NAFAMOSTAT MESYLATE  AS ACTIVE INGREDIENTNEWGLAB PHARMA CO.,LTD
WO/2021/261844ANTI-OBESITY, ANTI-DYSLIPIDEMIA, ANTIOXIDANT OR  ANTI-INFLAMMATORY COMPOSITION CONTAINING ANGELICA DAHURICA EXTRACTKOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/256901COMPOSITION FOR BONE REGENERATION COMPRISING METTL7A  OVEREXPRESSING STEM CELLS, METHOD FOR PREPARING SAME, AND CELL THERAPY  PRODUCT COMPRISING SAMEDONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/256904COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING  COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY  CONTROL FUNCTIONUIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY
WO/2021/261855ZINC TRANSPORTER ACTIVATOR COMPOSITIONMETACEN THERAPEUTICS
WO/2021/261870COMPOSITION COMPRISING 6'-HYDROXY JUSTCIDIN-B, FOR PREVENTING,  AMELIORATING OR TREATING ALLERGIC DISEASESDONG WHA PHARM. CO., LTD.
WO/2021/261871COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING  RESPIRATORY DISEASES COMPRISING 6'-HYDROXY JUSTICIDIN BDONG WHA PHARM. CO., LTD.
WO/2021/261891METHOD AND COMPOSITION FOR ENHANCING CANCER TREATMENT EFFICACY  OF BACTERIA EXTRACELLULAR VESICLESROSETTA EXOSOME CO., LTD.
WO/2021/261895SOLID CLEANSER COMPOSITIONSHIM, Yeonjeong
WO/2021/261903COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION FOR  AMELIORATING, PREVENTING, OR TREATING SKIN DISEASES COMPRISING  NATURAL-KILLER-CELL CULTURE-DERIVED EXOSOMESGREEN CROSS WELLBEING CORPORATION
WO/2021/261909COMPOSITION FOR PREVENTING OR TREATING FIBROSISINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/261916ALCOHOL-BASED DISINFECTANT COMPOSITION HAVING MOISTURIZING  EFFECT, AND PREPARATION METHOD THEREFORJINWOO BIO CO., LTD.
WO/2021/261926LONG-ACTING INJECTION FOR DEMENTIA TREATMENTAULBIO CO.,LTD.
WO/2021/261927EYEDROP COMPOSITION COMPRISING DIQUAFOSOLTAEJOON PHARMACEUTICAL CO., LTD.
WO/2021/261930OPHTHALMIC COMPOSITION COMPRISING DIQUAFOSOLTAEJOON PHARMACEUTICAL CO., LTD.
WO/2021/261931OPHTHALMIC COMPOSITION COMPRISING DIQUAFOSOLTAEJOON PHARMACEUTICAL CO., LTD.
WO/2021/261936COMPOSITION FOR PREVENTING OR TREATING ENCEPHALITIS AND  DEGENERATIVE BRAIN DISEASESINDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/261941PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS,  COMPRISING FUNCTIONALIZED TRANSITION METAL DICHALCOGENIDESINDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY  ERICA CAMPUS
WO/2021/261965PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  RETINAL NEURODEGENERATIVE DISEASES, COMPRISING PROX1 INHIBITOR AS ACTIVE  INGREDIENTKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/261966CYCLODEXTRIN-BASED COMPOSITE COMPOSITION FOR ORAL  ADMINISTRATION AND METHOD FOR PRODUCING SAMESOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/261968COSMETIC MATERIAL FOR ALLEVIATING DEHYDRATED SKIN, COSMETIC  PRODUCT RECOMMENDATION METHOD BASED ON SELF-DIAGNOSIS OF DEHYDRATED SKIN,  METHOD FOR EVALUATING DEHYDRATED SKIN, AND COSMETIC PRODUCT RECOMMENDATION  METHOD BASED ON MEASUREMENT OF DEHYDRATED SKINLG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/261971COMPOSITION FOR ACNE TREATMENT OR SKIN IMPROVEMENTPARK, Si Hun
WO/2021/060962THERAPEUTIC AND PROPHYLACTIC COMPOSITION FOR USE IN DENTISTRYIBRAGIMOV, Zainulla Faritovich
WO/2021/145755METHOD FOR SYNERGISTICALLY REDUCING ADVERSE EFFECTS OF AIR  TRAVEL ON HUMAN HEALTHLURYE, Arman Zhenisovich
WO/2021/187968PHARMACEUTICAL KIT AND METHOD OF TREATING INFLAMMATORY  PROCESSESKAMIL LTD
WO/2021/235923METHOD OF OBTAINING OF THE INACTIVATED VACCINE FOR COVID-19  PROPHYLAXISRSE ON ECR "RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY  PROBLEMS" OF CS MES RK
WO/2021/071350BASIC COMPOSITION FOR MOUTH OR BODY HYGIENE OR FOR HEALTH,  COMPRISING A GROUND SUBSTANCE OR A POWDER OR AN EXTRACT FROM A PLANT OF THE  GENUS WHITE HOREHOUND OR COMMON HOREHOUNDUNINVERSITé INTERNATIONALE D'AGADIR - UNIVERSIAPOLIS
WO/2021/080409RADIOLABELLED (LYS<sp>3</sp>)BN-IPSMA FOR THE DUAL  RECOGNITION OF THE PSMA AND GRPR PROTEINS <i>IN VIVO</i>INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES
WO/2021/125931SUPPLEMENT COMPRISING A MIXTURE OF CAPSAICIN AND SULFORAPHANE  AS AN ANTI-INFLAMMATORY, ANTI-FIBROTIC AND ANALGESIC COADJUVANT FOR  INFLAMMATION OF THE GASTRIC MUCOSA, GASTRITIS CAUSED BY DIFFERENT AGENTSCENTRO DE RETINA MéDICA Y QUIRúRGICA, S.C.
WO/2021/010812SYNERGISTIC COMBINATION OF S-KETOROLAC AND PREGABALIN IN A  PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROPATHIC PAINAMEZCUA AMEZCUA, Federico
WO/2021/010814COMPOSITIONS OF FILM COATINGS FOR TABLETS WITH INCREASED  GLOSS, METHOD FOR PRODUCTION THEREOF AND APPLICATION OF SAMEDVA FARMA MEXICANA S.A. DE C.V.
WO/2021/025550NANOEMULSION OF 18β-GLYCYRRHETINIC ACIDATSO CORPORATE AFFAIRS, S.A. DE C.V.
WO/2021/045606OPHTHALMIC PHARMACEUTICAL COMPOSITION, PREPARATION METHODS AND  USES OF SAMESOPHIA HOLDINGS, S.A. DE C.V.
WO/2021/020961EXTRACT OF <i>PERSICARIA MINOR</i> AND USE FOR  TREATING OR ALLEVIATING SYMPTOMS AND/OR CONDITIONS ASSOCIATED WITH  HYPERURICEMIABIOTROPICS MALAYSIA BERHAD
WO/2021/025551COMPOSITION FOR IMMUNOTHERAPY AND PREPARATION METHOD THEREOFBADEN R&D LABORATORIES GMBH
WO/2021/235924METHOD AND COMPOSITIONS FOR IMPROVING SCALP HEALTHWIPRO MANUFACTURING SERVICES SDN. BHD.
WO/2021/101367USE OF A COMPOSITION COMPRISING VITAMIN E TOCOTRIENOLS FOR  MANAGING CEREBRAL AUTOSOMAL-DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS  AND LEUKOENCEPHALOPATHY (CADASIL)HOVID BERHAD
WO/2021/045607A SUSTAINED RELEASE HYDROGEL COMPOSITIONMALAYSIAN PALM OIL BOARD
WO/2021/101369A SYNBIOTIC ORAL CARE COMPOSITIONINTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA
WO/2021/101370COMPOSITION(S) COMPRISING AQUEOUS OIL PALM FRUIT EXTRACT FOR  INCREASING TYROSINE HYDROXYLASE LEVELS AND IMPROVING BRAIN HEALTHMALAYSIAN PALM OIL BOARD
WO/2021/225431NOVEL PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR REPAIRING  DAMAGED RETINA AND TREATING VISUAL LESIONLOH, Hui Ling
WO/2021/225432NOVEL PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR REPAIRING  DAMAGED LIVER, TREATING DISEASE ASSOCIATED WITH DAMAGED LIVER AND IMPROVING  FUNCTIONS OF LIVERLOH, Hui Ling
WO/2021/246861COMPOSITION FOR NORMALISATION OF FATTY LIVER AND METHOD FOR  PRODUCING THE SAMEHOVID BERHAD
WO/2021/246862POLYOL ESTERS FROM BIOBASED FEEDSTOCKS FOR USE AS EMOLLIENT IN  PERSONAL CARE APPLICATIONSPETROLIAM NASIONAL BERHAD (PETRONAS)
WO/2021/086172COMPOSITION COMPRISING EPA, MA AND LEUCINE FOR IMPROVING  MUSCLE FUNCTIONN.V. NUTRICIA
WO/2021/010824ORAL DISODIUM PYROPHOSPHATE FOR USE IN REDUCING CALCIFICATIONSTICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/025554COMBINATION COMPRISING AN ACTIVATOR OF THE GLUCOCORTICOID  RECEPTOR AND AN INHIBITOR OF IFG-1 SIGNALING FOR CARCINOMA TREATMENTSTICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/034192PHARMACEUTICAL EUTECTIC SALT FORMULATIONSERANOVO HOLDING B.V.
WO/2021/040526Q-ER PEPTIDEBIOTEMPT B.V.
WO/2021/066649METHODS OF TREATMENT FOR MODIFYING HEMODYNAMICSEBI ANTI SEPSIS B.V.
WO/2021/080421NOVEL DRUG COMBINATIONS FOR TREATMENT OF A CARCINOMASTICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/080427CHIMERIC POLYPEPTIDE FOR REGULATING IMMUNE CELLSSTICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/086180HYPER-LOADED METAL-COMPLEXED POLYMERSSTICHTING VUMC
WO/2021/086188DOSAGE FORM FOR EXTENDED RELEASE OF AN ANTIBODY OR LARGE  PROTEININNOCORE TECHNOLOGIES B.V.
WO/2021/086190COMPOSITION COMPRISING EPA, MA AND LEUCINE FOR IMPROVING  MUSCLE FUNCTIONN.V. NUTRICIA
WO/2021/091381PHARMACEUTICAL LIQUID COMPOSITION, KIT OF PARTS COMPRISING THE  PHARMACEUTICAL LIQUID COMPOSITION, AND METHOD FOR PREPARING THE  PHARMACEUTICAL LIQUID COMPOSITIONMPERIUM B.V.
WO/2021/091382PHARMACEUTICAL LIQUID COMPOSITION, KIT OF PARTS COMPRISING THE  PHARMACEUTICAL LIQUID COMPOSITION, AND METHOD FOR PREPARING THE  PHARMACEUTICAL LIQUID COMPOSITIONMPERIUM B.V.
WO/2021/107775TEIPP PEPTIDE VARIANT AND USES THEREOFACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC)
WO/2021/107779METHOD FOR OBTAINING CAR-NK CELLSGLYCOSTEM THERAPEUTICS B.V.
WO/2021/118359COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASESULFATEQ B.V.
WO/2021/125951PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING OR STOPPING  METASTASESLOGICK ENERGETICS B.V.
WO/2021/141494PROCESS FOR PREPARING CANNABINOID-CONTAINING PARTICLESSTABICAN B.V.
WO/2021/150109ABT-751 AND IONIZING RADIATIONSTICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/158115ANTIMICROBIAL PEPTIDE FOR TREATMENT AND CONTROLLING SKIN  DISORDERS RELATING TO MICROBIAL INFECTIONCBMR SCIENTIFIC NANOSCIENCE B.V.
WO/2021/167458USE OF A SOLUBLE GUANYLATE CYCLASE (SGC) STIMULATOR OR OF A  COMBINATION OF A SGC STIMULATOR AND AN SGC ACTIVATOR FOR CONDITIONS WHEREIN  THE HEME GROUP OF SGC IS OXIDIZED OR WHEREIN SGC IS DEFICIENT IN HEMEUNIVERSITEIT MAASTRICHT
WO/2021/172982THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA  AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIAUNIVERSITEIT MAASTRICHT
WO/2021/172987TOPICAL DICLOFENAC COMPOSITIONS AND METHODSFERRING B.V.
WO/2021/177822MODULATING ANTI-TUMOR IMMUNITYSTICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/182951SOLID DEEP EUTECTIC SOLVENT FORMULATION PLATFORMSERANOVO HOLDING B.V.
WO/2021/182958COMPOSITIONS FOR DISRUPTING BIOFILM FORMATION AND FOR TREATING  BIOFILM-RELATED DISORDERSAHV INTERNATIONAL
WO/2021/201677COMPOSITIONS AND METHODS TARGETING INFLUENZAKIADIS PHARMA INTELLECTUAL PROPERTY B.V.
WO/2021/201679COMPOSITIONS AND METHODS TARGETING CORONAVIRUSESKIADIS PHARMA INTELLECTUAL PROPERTY B.V.
WO/2021/201680TREATMENT OF HYPERINFLAMMATORY SYNDROMEHASAN, Djohan
WO/2021/201685COMPOSITION AND METHOD FOR PRODUCING A COMPOSITIONBIOPRONEO B.V.
WO/2021/206547METHODS AND MEANS FOR MODIFYING HEMODYNAMICS IN INFECTIONSBIOTEMPT B.V.
WO/2021/206548ANTIMICROBIAL PEPTIDE FOR TREATMENT AND CONTROLLING VIRUS  INFECTIONSCBMR SCIENTIFIC NANOSCIENCE B.V.
WO/2021/206549USE OF PHENOL IN TREATMENT OF MICROBIALLY INDUCED DYSPNOEALIN, Wen Zhi
WO/2021/206560USE OF VITAMIN K IN PREVENTING OR COUNTERACTING COVID-19  DISEASE AND DIAGNOSTIC TEST TO ESTIMATE THE RISK OF DEVELOPING SEVERE DISEASE  OR MORTALITY BY COVID-19EMPHYSEMA SOLUTIONS BV
WO/2021/210984CORONAVIRUS VACCINEERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM
WO/2021/246868CHROMANOL, QUINONE OR HYDROQUINONE COMPOUNDS FOR TREATMENT OF  SEPSISSULFATEQ B.V.
WO/2021/261992CONJUGATE OF GALNAC AND SAPONIN, THERAPEUTIC COMPOSITION  COMPRISING SAID CONJUGATE AND A GALNAC-OLIGONUCLEOTIDE CONJUGATESAPREME TECHNOLOGIES B.V.
WO/2021/261993PHARMACEUTICAL COMPOSITION FOR TREATMENT OF COVID-19 AND  RELATED PATHOLOGIESUNTHREADT B.V.
WO/2021/261995COMBINATION OF AN ANTIBODY-DRUG CONJUGATE AND AN  ANTIBODY-SAPONIN CONJUGATESAPREME TECHNOLOGIES B.V.
WO/2021/261996HYDRAZONE-BASED SAPONIN DERIVATIVESSAPREME TECHNOLOGIES B.V.
WO/2021/261998THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE  AND SAPONIN, AND USES THEREOFSAPREME TECHNOLOGIES B.V.
WO/2021/080438TREATMENT OF PANCREATIC CANCEREXACT THERAPEUTICS AS
WO/2021/002763USE OF A COMPOSITION COMPRISING 3,6,7-TRIMETHYLLUMAZINE FOR  PREVENTING, AMELIORATING OR TREATING MMP-9 ASSOCIATED CONDITIONS AND  INFLAMMATIONCOMVITA LIMITED
WO/2021/010843TRANSDERMAL SOLVENT SYSTEM AND METHODS OF USEDONAGHYS LIMITED
WO/2021/045632CANCER VACCINEVICTORIA LINK LTD
WO/2021/071365NANOFIBRE MATRIX MADE OF NATURAL POLYMERS WITH NATURAL  FUNCTIONAL INGREDIENTS FOR COSMETIC PRODUCTSREVOLUTION FIBRES LIMITED
WO/2021/154102METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEMANGIOMADAVIS, Paul Frank
WO/2021/201699ANTIVIRAL TREATMENT COMPRISING BLIS CONTAINING PROBIOTIC  PRODUCTSBLIS TECHNOLOGIES LIMITED
WO/2021/206566VIRAL TREATMENTS INVOLVING MANUKA HONEY AND COMPONENTS THEREOFMANUKAMED LIMITED PARTNERSHIP
WO/2021/215938ANTI-VIRAL METHODS AND COMPOSITIONSOHA HONEY LIMITED PARTNERSHP
WO/2021/242123MEDICAMENT BASED ON EXTRACTS OF EIGHT (8) MEDICINAL PLANTS FOR  COVID-19 TREATMENTKLEDA, Samuel
WO/2021/242124MEDICAMENT BASED ON A MIXTURE OF ESSENTIAL OILS OF SEVEN (7)  MEDICINAL PLANTS FOR COVID-19 TREATMENT, USED ALONE OR IN COMBINATION WITH  THE MIXTURE OF EXTRACTS OF EIGHT (8) OTHER MEDICINAL PLANTSKLEDA, Mgr Samuel
WO/2021/071371A HERBAL MEDICINE COMPOSITIONS FOR TREATMENT OF DENGUE AND  THEIR PRODUCTIONDE LA SALLE MEDICAL AND HEALTH SCIENCES INSTITUTE
WO/2021/060998PHARMACOLOGICAL COMPOSITION FOR TREATMENT OF NERVOUS TISSUE  DYSFUNCTION, IN PARTICULAR VIRAL LATENCY, AND THE USE OF J05 ATC GROUP  SUBSTANCES IN TREATMENT OF NERVOUS TISSUE DYSFUNCTION, IN PARTICULAR VIRAL  LATENCYCHUPTYŚ CONTISSI, Janusz
WO/2021/118374INTRATHECAL ADMINISTRATION OF T REGULATORY CELLS IN THE  TREATMENT OF MULTIPLE SCLEROSISGDAŃSKI UNIWERSYTET MEDYCZNY
WO/2021/006753A BASE AND A PHARMACEUTICAL COMPOSITION CONTAINING ITBIOTTS S.A.
WO/2021/020978POWDERED PLANT PREPARATION, THE MANNER IN WHICH IT IS  OBTAINED, MICROGRANULES AND TABLETS OBTAINED FROM THAT PREPARATION AND THE  WAYS OF PRODUCING THEMBIOFITON SP. Z O.O.
WO/2021/235954COMPOSITION FOR TREATMENT OF AMERICAN FOULBROOD IN BEES AND  EXTRACT FROM POLYPOROID FUNGUS, IN PARTICULAR <i>TYROMYCES  FISSILIS</i>, FOR USE IN TREATMENT AND/OR PROPHYLAXIS OF AMERICAN  FOULBROOD IN BEESINSTYTUT INNOWACJI I TECHNOLOGII POLITECHNIKI BIAŁOSTOCKIEJ  SP. Z O.O.
WO/2021/049963PHARMACEUTICAL COMPOSITION OF BIMATOPROST AND TIMOLOLWARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA SA
WO/2021/075988RECOMBINANT POLYPEPTIDE FOR USE AS A MEDICINE, ANTISEPTIC  AGENT, ANTIBACTERIAL AGENT, ANTI-INFLAMMATORY AGENT, COMPOSITIONS COMPRISING  IT AND USES THEREOFMIĘDZYNARODOWY INSTYTUT BIOLOGII MOLEKULARNEJ I KOMóRKOWEJ W  WARSZAWIE
WO/2021/107794METHOD OF MAKING A SYSTEM CONTAINING GOLD NANOPARTICLES AND  USE OF THE SYSTEM IN ANTITUMOR THERAPYINSTYTUT FIZYKI JĄDROWEJ IM. HENRYKA NIEWODNICZAŃSKIEGO PAN
WO/2021/162562STABLE RAMIPRIL COMPOSITION AND FIXED DOSE COMPOSITION  COMPRISING THEREOFADAMED PHARMA S.A.
WO/2021/201705USE OF SULFONATED POLYSTYRENE DERIVATIVES IN THE TREATMENT  AND/OR PROPHYLAXIS OF INFECTION CAUSED BY ZIKA VIRUSUNIWERSYTET JAGIELLONSKI
WO/2021/215942COSMETIC COMPOSITION COMPRISING HEMP OILJANKOWIAK, Janusz Ryszard
WO/2021/221521A SOLID CO-AMORPHOUS DISPERSION OF VALSARTAN, A METHOD FOR  SYNTHETIZING THE SAME AND A MEDICAL USE OF THE DISPERSIONUNIWERSYTET HUMANISTYCZNO-PRZYRODNICZY IM JANA DLUGOSZA W  CZESTOCHOWIE
WO/2021/162563LIPOPOLYSACCHARIDES FOR TREATING FOOD ALLERGIESUNIWERSYTET WARSZAWSKI
WO/2021/173020FORMULATION OF A TURMERIC EXTRACT COMPRISING CURCUMINOIDS,  METHOD OF PRODUCTION THEREOF, THE USE OF THE FORMULATION AND PRODUCTS  COMPRISING THEREOFNOMI BIOTECH CORPORATION SP. Z O.O.
WO/2021/246884COMPOSITION CONTAINING CANNABINOIDSHEALTHCANNSP.ZO.O.
WO/2021/246886COMPOUNDS FOR THE TREATMENT OR DIAGNOSIS OF COVID-19POLITECHNIKA WROCŁAWSKA
WO/2021/262019SYNERGISTIC COMPOSITION OF PHAGES AND ITS FORMATION METHODPROTEON PHARMACEUTICALS S.A.
WO/2021/1674784-PYRROLIDIN-1-YL-5-P-TOLYL-THIENO[2,3-D] PYRIMIDINE FOR USE  IN THE TREATMENT OF AGING-ASSOCIATED AND PREMATURE AGING DISEASES THROUGH  RESTORED CHROMOSOMAL STABILITY AND INHIBITION OF CELLULAR SENESCENCEIBMC - INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR
WO/2021/182981MICRONISED OPICAPONEBIAL - PORTELA & Ca, S.A.
WO/2021/201710THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, AND  ASSOCIATED BIOMARKERS BASED ON TRK-BINSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/246890DIETARY SUPPLEMENT FOR IMPROVED IMMUNE HEALTH AND METHOD OF  TREATMENT FOR CORONAVIRUS USING SAMEQATAR FOUNDATION FOR EDUCATION, SCIENCE AND COMMUNITY  DEVELOPMENT
WO/2021/251842TARGETING OF LACTATE DEHYDROGENASE C, METHODS OF PREPARING  SAME, AND METHODS OF USING SAME IN COMBINATION WITH ANTI-CANCER TREATMENTSQATAR FOUNDATION FOR EDUCATION, SCIENCE AND COMMUNITY  DEVELOPMENT
WO/2021/107799MEDICAL DEVICE FOR TEMPORIZATIONARAMA, Stefan Sorin
WO/2021/066672USE OF ALHAGI PSEUDALHAGI PLANT EXTRACT (VARIANTS)MUSAKHANOVA, Oygul Mirzayusufovna
WO/2021/025584FULLERENE-CONTAINING ORAL CARE PRODUCTSOBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "SPLAT  GLOBAL"
WO/2021/025585USE OF DENDRIMERS IN AGENTS FOR CARE OF THE TEETH AND ORAL  CAVITYOBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'YU "SPLAT  GLOBAL"
WO/2021/133191COMPOSITION FOR REMINERALIZING TOOTH ENAMELMATELO, Svetlana Konstantinovna
WO/2021/040563EXFOLIATING POWDEREGOROVSKAIA, Irina Sergeevna
WO/2021/167481MICELLIZED SOLUTION OF FULLERENES, AND METHOD FOR THE  PRODUCTION AND USE THEREOFJOINT STOCK COMPANY AQUANOVA RUS
WO/2021/002771CONJUGATE OF FLUORESCENT DYE FOR THE VISUALIZATION OF PSMA  EXPRESSING CELLSOBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU IZVARINO FARMA
WO/2021/020992METHOD FOR PURGING THE INTESTINE AND KIT FOR IMPLEMENTING SAMEOBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTIYU  "GELESPON"
WO/2021/206581GENETIC CONSTRUCT-BASED VACCINE AGAINST CORONAVIRUS INFECTIONDUKHOVLINOV, Ilya Vladimirovich
WO/2021/225463ANTI-RNA VIRAL PHARMACEUTICAL COMPOSITION AVIFAVIR EFFECTIVE,  INTER ALIA, AGAINST SARS-COV-2LIMITED LIABILITY COMPANY "CHROMIS" (LLC  "CHROMIS")
WO/2021/096388COMPOSITION WITH A PROLONGED ANTIBACTERIAL EFFECTOBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "SPLAT  GLOBAL"
WO/2021/061006COMPOSITION FOR CORRECTING THE BEHAVIOUR OF CATS AND DOGSOBSHESTVO S OGRANICHENNOY OTVETSTVENNOST'YU  "NAUCHNO-PROIZVODSTVENNAYA KOMPANIYA "SKIFF"
WO/2021/242134METHOD FOR TREATING RNA VIRAL INFECTIONS, INTER ALIA COVID-19  (SARS-COV-2)LIMITED LIABILITY COMPANY "CROMIS" (LLC  "CROMIS")
WO/2021/020997TREATMENT FOR HOT FLUSHES, AND RE-ESTABLISHING A MENSTRUAL  CYCLE DURING THE PERIMENOPAUSEOBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTJU  "PARAPHARM"
WO/2021/221532SARS-COV-2 ANTIVIRAL DRUG ANTIPROVIRIVASHCHENKO, Andrey Alexandrovich
WO/2021/002776IMMUNOBIOLOGICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST  SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2FEDERAL STATE BUDGETARY INSTITUTION "NATIONAL RESEARCH  CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAMED AFTER THE HONORARY ACADEMICIAN  N.F. GAMALEYA" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION
WO/2021/211006INHALED HEXAPEPTIDE FOR TREATING INTERLEUKIN-6 RELATED  RESPIRATORY DISEASESFEDERAL STATE BUDGETARY INSTITUTION CENTER OF BIOMEDICAL  TECHNOLOGIES OF FEDERAL MEDICAL AND BIOLOGICAL AGENCY
WO/2021/061009PANCREATIN MICROCAPSULESAVVA RUS, JOINT STOCK COMPANY
WO/2021/118400PHARMACOLOGICAL COMPOSITION FOR TREATING PROCTOLOGICAL  DISEASES (VARIANTS)BARANNIKOV, Aleksandr Evgen'evich
WO/2021/080464METHOD FOR RESTORING REPRODUCTIVE FUNCTION IN WOMENKISELEV, Vsevolod Ivanovich
WO/2021/076009EXPRESSION VECTOR AGAINST SEVERE ACUTE RESPIRATORY SYNDROME  VIRUS SARS-COV-2FEDERAL STATE BUDGETARY INSTITUTION "NATIONAL RESEARCH  CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAMED AFTER THE HONORARY ACADEMICIAN  N.F. GAMALEYA" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION
WO/2021/076010PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST  SARS-COV-2FEDERAL STATE BUDGETARY INSTITUTION "NATIONAL RESEARCH  CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAMED AFTER THE HONORARY ACADEMICIAN  N.F. GAMALEYA" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION
WO/2021/137722PHARMACEUTICAL COMPOSITION CONTAINING COMPLEXES OF ALLOFERON  AND ZINCBEKKER, German Petrovich
WO/2021/101409METHOD FOR PREVENTING AND TREATING MOTION SICKNESSPASTUSHENKOV, Vladimir Leonidovich
WO/2021/118403SYSTEM FOR DELIVERING 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE  SUCCINATE FOR PERORAL ADMINISTRATIONOBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTIYU  "NAUCHNO-PROIZVODSTVENNAYA KOMPANIYA "PHARMASOFT"
WO/2021/015647EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACTSKORSAKOVA, Nadezhda Vitalevna
WO/2021/133221MEANS FOR IMPROVING REPRODUCTIVE FUNCTIONFLOROVA, Marina Aleksandrovna
WO/2021/021005USE OF N,N'-SUBSTITUTED 3,7-DIAZABICYCLO[3.3.1]NONANE  DERIVATIVES FOR TREATING DEPRESSIONOBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU "KIU EM  FARMA"
WO/2021/049978HEMOSTATIC COMPOSITION WITH REPARATIVE PROPERTIES (VARIANTS)LIMITED LIABILITY COMPANY "KHIMIKO-FARMATSEVTICHESKIE  TEKHNOLOGII"
WO/2021/040570MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASESEPSHTEIN, Oleg Iliich
WO/2021/034228AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI-PD1 ANTIBODY  PROLGOLIMAB AND USE THEREOFJOINT STOCK COMPANY "BIOCAD"
WO/2021/049980NOVEL COMPOSITIONS FOR TREATMENT AND PROPHYLAXIS OF VIRAL  DISEASESLTD "VALENTA-INTELLEKT"
WO/2021/054863STIMULATOR OF TESTICULAR TISSUE REPARATIVE REGENERATION  PROCESSESROZIEV, Rakhimdzhan Akhmetdzhanovich
WO/2021/054864USE OF A COMPLEX OF  9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH B-CYCLODEXTRIN TO  CORRECT DISORDERS OF SPERMATOGENESISROZIEV, Rakhimdzhan Akhmetdzhanovich
WO/2021/054865USE OF A COMPLEX OF  9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH B-CYCLODEXTRIN TO  TREAT PATHOZOOSPERMIAROZIEV, Rakhimdzhan Akhmetdzhanovich
WO/2021/054866USE OF A PHARMACEUTICAL COMPOSITION OF B-CYCLODEXTRIN WITH  9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE TO INCREASE/RESTORE  LIBIDOROZIEV, Rakhimdzhan Akhmetdzhanovich
WO/2021/054867IMMUNOCYTOKINE COMPRISING HETERODIMERIC PROTEIN COMPLEX BASED  ON IL-15/IL-15RαJOINT STOCK COMPANY "BIOCAD"
WO/2021/118407METHOD FOR A COSMETIC EFFECT ON FACIAL KERATIN MATERIALREM, Anastasia Valerievna
WO/2021/211013PHARMACEUTICAL COMPOSITION COMPRISING MACOZINONE FOR TREATING  TUBERCULOSISOBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "NIARMEDIK  PLYUS"
WO/2021/076020PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PROPHYLAXIS  OF INFECTIOUS INFLAMMATORY DISEASESGAPONOV, Andrey Mikhaylovich
WO/2021/194375DRUG FOR TREATING CORONAVIRAL AND RETROVIRAL INFECTIONS AND  HEPATITIS CLASKAVYI, Vladislav Nikolaevich
WO/2021/112724MIRTAZAPINE AND TIZANIDINE COMBINATION FOR USE IN PAIN  DISORDERSLTD "VALENTA-INTELLEKT"
WO/2021/137738COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES OF THE THROATSHAMTSYAN, Mark Markovich
WO/2021/221537SARS-COV-2 ANTIVIRAL DRUG ANTIPROVIRIVASHCHENKO, Andrey Alexandrovich
WO/2021/242136DRUG FOR A COMBINATION THERAPY FOR DISEASES CAUSED BY  BETACORONAVIRUSESOBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTIYU  "NAUCHNO-PROIZVODSTVENNAYA KOMPANIYA "PHARMASOFT"
WO/2021/173036PHARMACEUTICAL COMPOSITION BASED ON DIPEPTIDYL PEPTIDASE-4  INHIBITOROBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTJU  "NEOBIOTEK"
WO/2021/225467SARS-COV-2 ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE  THEREOFLIMITED LIABILITY COMPANY "CROMIS" (LLC  "CROMIS")
WO/2021/225468SARS-COV-2 ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE  THEREOFLIMITED LIABILITY COMPANY "CROMIS" (LLC  "CROMIS")
WO/2021/188012DRUG IN THE FORM OF A COMPLEX OF 3,3’-DIINDOLYLMETHANE WITH  β-CYCLODEXTRINKISELEV, Vsevolod Ivanovich
WO/2021/188013METHOD FOR TREATING ENDOMETRIOSIS AND CONCOMITANT FORMATION OF  ADHESIONSKISELEV, Vsevolod Ivanovich
WO/2021/145795BIOADHESIVE ANTIBACTERIAL AGENT AND METHOD FOR MANUFACTURING  SAME (VARIANTS)AKCIONERNOE OBSHCHESTVO "PROIZVODSTVENNAYA  FARMACEVTICHESKAYA KOMPANIYA OBNOVLENIE"
WO/2021/225469BIOLOGICALLY ACTIVE COMPLEX, AND TOOTHPASTE AND MOUTHWASH  BASED THEREONOBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "SPLAT  GLOBAL"
WO/2021/206587SARS-COV-2 DNA VACCINE BASED ON GENE THERAPY DNA VECTOR  GDTT1.8NAS12GENETIC DIAGNOSTICS AND THERAPY 21 LTD
WO/2021/242142STABLE AQUEOUS PHARMACEUTICAL COMPOSITION FOR INHALATION  CONTAINING A HEXAPEPTIDEFEDERAL STATE BUDGETARY INSTITUTION SCIENTIFIC CENTER OF  BIOMEDICAL TECHNOLOGIES OF FEDERAL MEDICAL AND BIOLOGICAL AGENCY
WO/2021/256961SINGLE USE PERFUME AND COSMETIC DRY PRODUCTSHKOLNY, Vladimir Nikolaevich
WO/2021/206589COMPOSITION FOR THE PREVENTION OR TREATMENT OF ENDOTHELIAL  DYSFUNCTIONSOLOVYEV, Nikolay Vladimirovich
WO/2021/235977METHOD FOR TREATING ENDOMETRIOSIS WITH ASSOCIATED PAIN  SYNDROMEKISELEV, Vsevolod Ivanovich
WO/2021/235983DRUG WITH PROLONGED ANALGESIC ACTIONFEDERALNOJE GOSUDARSTVENNOJE BUDZHETNOJE UCHREZHDENIE NAUKI  TIKHOOKEANSKY INSTITUT BIOORGANICHESKOI KHIMII IM. G.B.ELYAKOVA  DALNEVOSTOCHNOGO OTDELENIYA ROSSYSKOI AKADEMII NAUK (TIBOKH DVO RAN)
WO/2021/262040USE OF A GLUTARIMIDE DERIVATIVE FOR TREATING DISEASES  ASSOCIATED WITH ABERRANT INTERLEUKIN-6 ACTIVITYLTD “VALENTA-INTELLEKT”
WO/2021/107825X-RAY SENSITIVE STAIN FOR TEETH FRACTURE DETECTIONALJARBOU, Fahd
WO/2021/010888NOVEL BSSL ANTIBODIESLIPUM AB
WO/2021/029813PREVENTING AND TREATING HYPOGLYCEMIADIAMYD MEDICAL AB
WO/2021/040600DESLORATADINE AND/OR LORATADINE FOR TREATMENT AND/OR  PROPHYLACTIC TREATMENT OF MELANOMAHAKMED AB
WO/2021/071413YEAST FOR THE TREATMENT OF ALLERGYMILMED UNICO AB
WO/2021/071419VIBRIO CHOLERAE PROTEIN FOR USE AGAINST CANCERWAI, Sun Nyunt
WO/2021/076033DESLORATADINE FOR THE TREATMENT AND/OR PROPHYLAXIS OF CANCERSHAKMED AB
WO/2021/076043USE OF TERM AMNIOTIC FLUID CELLS FOR THE TREATMENT OF ACUTE  AND CHRONIC RESPIRATORY DISEASESAMNIOTICS AB
WO/2021/080500TREATMENT OF INFLAMMATORY CONDITION IN MUCOUS MEMBRANE OR SKINMUCOCORT AB
WO/2021/086252STABILIZED AMORPHOUS CALCIUM MAGNESIUM PHOSPHATE PARTICLE  COMPOSITIONSPSILOX AB
WO/2021/107835ORAL ADMINISTRATION OF IRON SUCCINATE FOR USE IN TREATING IRON  DEFICIENCY IN PATIENTS HAVING HEART FAILUREDOUBLE BOND PHARMACEUTICALS AB
WO/2021/101433CARBAZATE-ACTIVATED POLYVINYL ALCOHOL (PVAC) AS A  POLYMER-BASED ANTITUMORAL AGENTBERGLUND, David
WO/2021/145807PEG-LIPIDICOAT MEDICAL AB
WO/2021/173069NANOPARTICLES FOR USE IN THE TREATMENT AND DIAGNOSIS OF CNS  DISORDERSUPPSALA THERAPEUTICS AB
WO/2021/201765NEW COMPOSITIONS FOR ORAL OR NASAL USELIW INNOVATION AB
WO/2021/206623SOLUBLE ACE2 FOR TREATMENT OF COVID-19MARKO-VARGA, György
WO/2021/211043TREATMENT OF CORONAVIRUS INFECTIONSTX MEDIC AB
WO/2021/211044TREATMENT OF SEPSIS AND HYPERCYTOKINEMIATX MEDIC AB
WO/2021/215987COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF  RESPIRATORY INFECTIONSBONOSS MEDICAL AKTIEBOLAG
WO/2021/225509NEW COMPOSITIONS FOR ORAL OR NASAL USELIW INNOVATION AB
WO/2021/225510A SUNSCREEN COMPOSITION COMPRISING HIGHLY POROUS AMORPHOUS  MESOPOROUS MAGNESIUM CARBONATE AND A CHEMICAL UV FILTERDISRUPTIVE MATERIALS OPERATIONS AB
WO/2021/230804FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITYTRANSMED GOTHENBURG AB
WO/2021/040610RECOMBINANT POLYPEPTIDES AND METHODS OF USE THEREOFIMUNAMI LABORATORIES PTE. LTD.
WO/2021/021014PHARMACEUTICAL PREPARATION WITH CURCUMINOIDS NANOPARTICLES AND  A METHOD FOR PRODUCING THE SAMEAASTAR PTE LTD
WO/2021/262081RECOMBINANT POLYPEPTIDES AND COMBINATIONS FOR USE IN THE  TREATMENT OF CANCERIMUNAMI LABORATORIES PTE. LTD.
WO/2021/066740METHOD OF PREPARATION WHITE EMULSIFIED SCENTED CROCODILE OILLIANG CHIEH, Wee
WO/2021/034267FORMULATIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF  PERIPHERAL NEUROPATHY AND ITS ASSOCIATED DISEASES.LOH, Yin Sze
WO/2021/010898TREATMENT/PREVENTION OF DISEASE BY LINC COMPLEX INHIBITIONAGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/021021TREATMENT OF DILATED CARDIOMYOPATHY AND/OR CARDIAC FIBROSISNATIONAL UNIVERSITY OF SINGAPORE
WO/2021/025618USE OF AN OSMOLYTE IN MANUFACTURE OF A MEDICAMENT FOR  TREATMENT OF OCULAR DISORDERSSINGAPORE HEALTH SERVICES PTE LTD
WO/2021/025625COMPOUNDS FOR HEPATITIS B TREATMENTAGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/034272TREATMENT OF IDIOPATHIC HYPOHIDROSISNATIONAL SKIN CENTRE (SINGAPORE) PTE LTD
WO/2021/040627A METHOD OF PROMOTING SURVIVAL AND/OR FUNCTION OF A MOTOR  NEURON AND RELATED AGENTS, USES AND METHODSAGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/045686HETEROCYCLIC COMPOUNDS AS MODULATORS OF BETA-CATENIN / TCF4  INTERACTIONAGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/066747SELF-ADMINISTRABLE AND IMPLANTABLE POLYMERIC MICRO-LANCE  SHAPED DEVICE FOR CONTROLLED AND TARGETED DELIVERYNANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/071431GENETICALLY MODIFIED T CELLS AND USES THEREOFNATIONAL UNIVERSITY OF SINGAPORE
WO/2021/086266DNMT1 -SPECIFIC APTAMERS AND PRODUCTION AND USES THEREOFNATIONAL UNIVERSITY OF SINGAPORE
WO/2021/112772INFLAMMATION-RESPONSIVE ANTI-INFLAMMATORY HYDROGELSNANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/118465A PHARMACEUTICAL FORMULATION FOR INHIBITING BODY MALODOURNATIONAL SKIN CENTRE (SINGAPORE) PTE LTD
WO/2021/118469USE OF VALPROIC ACID FOR REDUCING POST-OPERATIVE SCARRING  FOLLOWING A GLAUCOMA SURGERYSANTEN PHARMACEUTICAL CO., LTD.
WO/2021/126087METHOD FOR TREATING ANGELMAN SYNDROME AND RELATED DISORDERSNATIONAL UNIVERSITY OF SINGAPORE
WO/2021/141538COMBINATION THERAPYAGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/145821NUCLEIC ACID LOADED RED BLOOD CELL EXTRACELLULAR VESICLESCARMINE THERAPEUTICS PTE. LTD.
WO/2021/183059METHODS OF TREATING, PREVENTING OR AMELIORATING DEPRESSION OR  ANXIETY WITH CAROTENOIDSAGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/188052USE OF A COMPOUND OR COMPOSITION COMPRISING AN INHIBITOR OF  NLRP1 INFLAMMASOME ACTIVATION FOR THE TREATMENT OF HUMAN AIRWAY INFLAMMATIONNANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/188055MODULATION OF CXCR3 CHEMOKINE SIGNALLING FOR OSTEOPOROSIS  THERAPYNATIONAL UNIVERSITY OF SINGAPORE
WO/2021/194428RINSE-FREE SANITIZERCHAMPS INNOVATIONS PTE. LTD.
WO/2021/206633METHODS AND COMPOSITIONS FOR TREATING LIVER CANCERENGINE BIOSCIENCES PTE. LTD.
WO/2021/236016COMPOSITIONS AND METHODS FOR THE DELIVERY OF AGENTS TO  BIOLOGICAL TARGETSFORMULYTICA PTY LTD.
WO/2021/246966COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREOFNATIONAL UNIVERSITY OF SINGAPORE
WO/2021/188059COLLOID SILVER FOR USE AND METHOD FOR ITS PREPARATIONMARKOVIĆ, Danijela
WO/2021/006822PHARMACEUTICAL COMPOSITIONS HAVING SYNERGISTIC EFFECTS OF  NATURAL EXTRACTS FOR CANCER TREATMENT UNDERGOING CHEMOTHERAPYCHIANGMAI UNIVERSITY
WO/2021/021032A COMPOSITION CONTAINING CASHEW LEAF EXTRACT AND PRODUCTION  METHOD THEREOFMARK ONE INNOVATION CENTER COMPANY LIMITED
WO/2021/034276YEAST HAVING IMPROVEMENT OF LACTIC ACID TOLERANCE AND USE  THEREOFPTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED
WO/2021/080519SNAIL MUCUS COLLECTION PROCESS AND ITS USEPUTTARATHUVANUN, Kitpong
WO/2021/242180A COMPOSITION AND A METHOD OF REJUVENATING DNA AND PREVENTING  DNA DAMAGECHULALONGKORN UNIVERSITY
WO/2021/066754COMPOSITION OF DURIAN AND MANGOSTEEN EXTRACTS AND METHOD OF  PREPARATION THEREOFTIPSURAT CO., LTD.
WO/2021/236023FERMENTED - CONCENTRATED EXTRACTION METHOD OF HOUTTUYNIA  CORDATA FOR MEDICAL USINGRINCOME, Udom
WO/2021/257006A PHYTOMEDICINE AND ITS DERIVATIVES EFFECTIVE AGAINST HAND,  FOOT AND MOUTH DISEASE (HFMD) BASED UPON <i>OROXYLUM INDICUM </i>MAHIDOL UNIVERSITY
WO/2021/257007AN ANTIVIRAL PHARMACEUTICAL COMPOSITION WITH THERAPEUTIC AGENT  ORIGINATED FROM<i> ASTRAEUS ASIATICUS</i>MAHIDOL UNIVERSITY
WO/2021/242184A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING  REPLICATION OF CORONAVIRUSMAHIDOL UNIVERSITY
WO/2021/101458LOTION FOR HAIR AND HAIR SKINÇETİN, Aydın
WO/2021/034281A METHOD FOR PRODUCING A BIOACTIVE COMPONENT-CONTAINING  NANO-COMPOSITE, AND A MONTMORILLONITE-BASED, BIOACTIVE COMPONENT-CONTAINING  NANO-COMPOSITEBEZMIALEM VAKIF UNIVERSITESI
WO/2021/071444A UNIQUE GRANULATION PROCESS FOR RIVAROXABAN CONTAINING  GRANULESSANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/076066ORAL FORMULATIONS COMPRISING SITAGLIPTIN HCI MONOHYDRATE WITH  IMPROVED PHARMACEUTICAL CHARACTERISTICSSANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/080527TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING DIFLUOCORTOLONE  AND ISOCONAZOLEPHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/080529SOLID PHARMACEUTICAL FORMULATIONS COMPRISING TICAGRELORSANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/091498PHARMACEUTICAL COMPOSITIONS COMPRISING TENOFOVIR AND  EMTRICITABINEPHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/096444PHARMACEUTICAL COMPOSITIONS COMPRISING TICAGRELORSANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/096446ASC SPECKS IN CANCER IMMUNOTHERAPYBOGAZICI UNIVERSITESI
WO/2021/101461ORAL SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING LANTHANUM  CARBONATE OCTAHYDRATESANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/101466A METHOD FOR PRODUCING MULTIVIRUS SPECIFIC T CELLSACIBADEM LABMED SAĞLIK HİZMETLERİ A.Ş.
WO/2021/1260962-[2-({12,12-DIMETHYL-4-OXO-6-PHENYL-3,11-DIOXATRICYCLO[8.4.0.0,2,7]TETRADECA-1,5,7,9-TETRAEN-8-YL}OXY)ACETAMIDO]BENZAMIDE  AND DERIVATIVES AS INHIBITOR OF CLOCK:BMAL1 INTERACTION FOR THE TREATMENT OF  CIRCADIAN RHYTHM DISEASES AND DISORDERSKOC UNIVERSITESI
WO/2021/101467A METHOD FOR REDESIGN AND EXPANSION OF NK92 CELLS FOR USE IN  IMMUNOTHERAPYACIBADEM MEHMET ALİ AYDINLAR üNİVERSİTESİ
WO/2021/126098GASTRO-RESISTANT PELLET COMPRISING DULOXETINESANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/126099AN ENTERIC COATED PELLET COMPRISING DULOXETINE HYDROCHLORIDE  WITH OPTIMIZED DEGREES OF NEUTRALIZATIONSANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/025643COMPOUNDS EXHIBITING ANTI-TUBERCULOSIS ACTIVITYANADOLU üNİVERSİTESİ
WO/2021/096449SKIN-PRICK TEST MATERIAL AND PRODUCTION METHOD TO BE USED IN  THE DIAGNOSIS OF ALLERGY FROM CLADOSPORIUM HERBARUM, CLADOSPORIUM  CLADOSPORIOIDES AND ALTERNARIA ALTERNATA MOLDSCUKUROVA UNIVERSITESI REKTORLUGU
WO/2021/118485A PRODUCTION METHOD OF BIOACTIVE SUBSTANCE THYMOKINONE BY  USING AY-YLDIZ CATALYST WHITH USE POTENTIAL IN CANCER TREATMENTCUKUROVA UNIVERSITESI REKTORLUGU
WO/2021/133279A SOLID ORAL PHARMACEUTICAL GEMIFLOXACIN MESYLATE COMPOSITION  WITH IMPROVED RELEASE PATTERN AND DISINTEGRATION MECHANISMSANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/101469A DRUG FOR ANTICANCER AND ANTIVIRAL TREATMENT AND SYNTHESIS  METHOD THEREOFGAZIANTEP UNIVERSITESI REKTORLUGU
WO/2021/13777111-(4-CHLOROPHENYL)-4-(2,3-DIHYDRO-1H-INDOLE-1-CARBONYL)-3,11-DIMETHYL-5,10,DIOXATRICYCLO[7.4.0.0,2,6,]TRIDECA-1,3,6,8-TETRAEN-13-ONE  AND DERIVATIVES AS DESTABILIZER OF CRY1 FOR THE TREATMENT OF CIRCADIAN RHYTHM  ASSOCIATED DISEASES AND DISORDERSKOC UNIVERSITESI
WO/2021/145830PHARMACEUTICAL COMPOSITIONS COMPRISING MESALAMINE AND RELEVANT  EXCIPIENTS IN THE TREATMENT OF ULCERATIVE COLITISPHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/145831PHARMACEUTICAL COMPOSITIONS COMPRISING TADALAFIL AND RELEVANT  EXCIPIENTSPHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/150178PHARMACEUTICAL COMPOSITIONS COMPRISING IBUPROFEN,  PSEUDOEPHEDRINE AND ASCORBIC ACIDPHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/137780PREPARATION OF FILM TABLET COMPOSITION COMPRISING HEME IRON  FOR IRON DEFICIENCYİLKO İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/133284A COMPOSITION OF HYALURONIC ACID AND HYDROLYZED COLLAGEN WITH  VITAMINS AND ITS PRODUCTION METHODMELİKOĞLU, Ahmet
WO/2021/133285A HERBAL PERFORMANCE ENHANCEMENT MIX AND ITS PRODUCTION  PROCESSMELİKOĞLU, Ahmet
WO/2021/162647A NOVEL PROCESS FOR PREPARATION OF PAZOPANIB HYDROCHLORIDEDEVA HOLDING
WO/2021/167554USE OF SYNTHESIZED COMPOUNDS AS AN INHIBITOR OF EF2-KINASE  ENZYMECANAKKALE ONSEKIZ MART UNIVERSITESI REKTORLUGU
WO/2021/025644COMPOUNDS EXHIBITING ANTI-TUBERCULOSIS ACTIVITYANADOLU üNİVERSİTESİ
WO/2021/194436THE NATURAL ANTIVIRAL AND ANTI-INFLAMMATORY COMPOUND CONSIST  OF BIOFLAVONOIDS WHICH EXTRACTED FROM PAPAVER RHOEAS RED PETALSNANOBIOMED SAĞLIK VE YAŞAM BILIMLERI A. Ş.
WO/2021/188066A PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION HAVING  ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL, ANTIPARASITIC AND ANTICANCER  CHARACTERISTICSBASLIK, Hakan
WO/2021/054909A METHOD OF OBTAINING STROMAL VASCULAR FRACTIONT-BİYOTEKNOLOJİ LABORATUVAR ESTETİK MEDİKAL KOZMETİK SAN TİC  LTD ŞTİ
WO/2021/216012A SYSTEM THAT PREVENTS COVID19 VIRUSES FROM GETTING INTO THE  BODY AND REMOVES IT FROM THE BODYÇALIŞ, Bilal
WO/2021/225533A STAR BLOCK COPOLYMER USED AS DRUG CARRIER FOR TREATMENT OF  CANCERİLMOR KİMYA VE TEKSTİL SANAYİ VE TİCARET LİMİTED ŞİRKETİ
WO/2021/101475SYNTHESIS AND IMPROVEMENT OF A NUCLEOSIDE ANALOGUE AS AN  ANTI-CANCER AND ANTI-VIRAL DRUGGAZIANTEP UNIVERSITESI REKTORLUGU
WO/2021/201791PROPOLIS EXTRACT CONTAINING LACTIC ACIDAPİPARK ARICILIK üRETİM DANIŞMANLIK EĞİTİM ISLAH VE ARGE  İTHALAT İHRACAT SANAYİ TİCARET A.Ş.
WO/2021/076076CYSTITIS SOLUTION COMPRISING HYALURONIC ACID AND POLYETHYLENE  GLYCOL AND PRODUCTION METHOD THEREOFBETATECH MEDIKAL CIHAZLAR SANAYI MUMESSILLIK IC VE DIS TICARET  LIMITED SIRKETI
WO/2021/262103FORMATION OF A CREAM AND LOTION THAT ENSURES PROTECTION OF  SKIN HEALTHCANPOLAT, Cevdet
WO/2021/006839METHOD FOR OBTAINING SOLID PLASMA AS A FILLING MATERIALGAZİ ENDüSTRİ ANONİM ŞİRKETİ
WO/2021/002821A METHOD FOR OBTAINING SAPONIN MOLECULES AND UTILIZING ACTIVE  MOLECULES AS IMMUNOMODULATORİZMİR YüKSEK TEKNOLOJİ ENSTİTüSü
WO/2021/010920A STABLE COMPOSITION COMPRISING TETRACYCLIN AND TRETINOIN FOR  TOPICAL ACNE TREATMENTASSOS İLAÇ KİMYA GIDA üRüNLERİ üRETİM VE TİCARET ANONİM  ŞİRKETİ
WO/2021/006845SMART TEMPERATURE-SENSITIVE HYDROGELS WITH ANTIFUNGAL PROPERTY  THAT PERFORM CONTROLLED DRUG RELEASEAKDENIZ UNIVERSITESI
WO/2021/006850CURCUMINOID ORAL COMPOSITIONS COMPRISING SILICAPISAK, Mehmet Nevzat
WO/2021/010924AN EFFERVESCENT TABLET COMPOSITION OF SITAGLIPTINSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/025647A SACHET FORMULATION COMPRISING POLYETHYLENE GLYCOLSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/034289USE OF CANNABINOID 1 RECEPTOR AGONIST ARACHIDONOYL  CYCLOPROPYLAMIDE (ACPA) IN NON SMALL CELL LUNG CANCERHACETTEPE üNİVERSİTESİ
WO/2021/015703NANOPROPOLIS SYNTHESIS METHOD WITH HEALING EFFECT AGAINST SIDE  EFFECTS OF CANCER DRUG CISPLATINFIRAT UNIVERSITESI REKTORLUGU
WO/2021/021049A DEXTRAN COATED SILICA AEROGEL USED AS A DRUG CARRIER SYSTEM  AND A DEXTRAN COATED SILICA AEROGEL PRODUCTION METHODYILDIZ TEKNIK UNIVERSITESI
WO/2021/021050CAROB TREE (CERATONIA SILIQUA L.) LEAVES IN THE TREATMENT OF  AIRWAY INFLAMMATION OCCURRING IN ALLERGIC ASTHMAT.C. ERCİYES üNİVERSİTESİ
WO/2021/021051PLATELET RICH-FIBRIN DERIVED MESENCHYMAL STEM CELLST.C. ERCİYES üNİVERSİTESİ
WO/2021/021054MOVABLE SPACE MAINTAINERS WHICH REALIZE CONTROLLED ION RELEASET.C. ERCIYES UNIVERSITESI
WO/2021/021055COMBINATION OF OXOLAMINE AND TERBUTALINEEĞİLMEZ, Mehmet Vedat
WO/2021/021062ANTIBODY-POLYMER-CONJUGATESBOGAZICI UNIVERSITESI
WO/2021/021063PLANT EXOSOMES USED FOR TREATMENT OF DISEASES ORIGINATING FROM  PROTEIN AGGREGATES FORMED IN CELLSYEDITEPE UNIVERSITESI
WO/2021/025652AN EXTRACT FROM CANNABIS AND PEGANUMT.C. ERCİYES üNİVERSİTESİ
WO/2021/045706A COMBINATION COMPRISING VILDAGLIPTIN AND METFORMINSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/054912EFFERVESCENT TABLET FORMULATIONS COMPRISING DAPAGLIFLOZIN AND  METFORMINSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/061065SOLID ORAL PHARMACEUTICAL FORMULATIONS COMPRISING SAPROPTERIN  DIHYDROCHLORIDE AND AT LEAST ONE PHARMACEUTICAL EXCIPIENTSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/061066EFFERVESCENT FORMULATIONS OF SAPROPTERIN DIHYDROCHLORIDESANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/061067PHARMACEUTICAL FORMULATIONS COMPRISING SAPROPTERIN  DIHYDROCHLORIDE AND AT LEAST ONE ANTIOXIDANTSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/091502A METHOD FOR PRODUCING A PRODUCT SUITABLE FOR USE IN THE  TREATMENT OF HAIR LOSS AND SCAROVALI, Ercüment
WO/2021/040645AN ANTI-AGING COSMETIC PRODUCTT.C. ERCIYES UNIVERSITESI
WO/2021/040646SELF MICROEMULSIFYING DRUG DELIVERY SYSTEMS (SMEDDS)  COMPRISING OLMESARTAN MEDOXOMILKOMESLİ, Yelda
WO/2021/045712USE OF PLANT EXOSOMES FOR ENHANCING VIABILITY AND HAIR GROWTH  CAPACITY OF SKIN CELLSYEDITEPE UNIVERSITESI
WO/2021/201796TARGETED RELEASE OF NICLOSAMIDE COMPOSITIONS WITH HIGH  SOLUBILITY AND BIOAVAILABILITYIMUNEKS FARMA ILAC SAN. VE TIC.A.S
WO/2021/066772CELL CULTURE MEDIUM FOR REDUCING FUCOSYLATION AND BASIC  VARIANTS IN THE PRODUCTION OF ANTIBODIESARVEN ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/045717A PHARMACEUTICAL COMPOSITION CONTAINING EPIBRASSINOLIDE (EBR)T.C. ISTANBUL KULTUR UNIVERSITESI
WO/2021/045718A PHARMACEUTICAL COMPOSITION CONTAINING EPIBRASSINOLIDE (EBR)  AND ROSCOVITINE (ROSC)T.C. ISTANBUL KULTUR UNIVERSITESI
WO/2021/080531A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR  INHALATIONARVEN ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/054921METHOD OF PRODUCING CRYOGELS WITH NATURAL BIOMATERIALS AND USE  OF SUCH CRYOGELS AS SOFT TISSUE SCAFFOLDS OR DRUG DELIVERY SYSTEMSYEDITEPE UNIVERSITESI
WO/2021/076081BOSENTAN MONOHYDRATE LOADED LIQUID SELF NANOEMULSIFYING DRUG  CARRIER SYSTEM AND TABLET FORMULATIONTEKSİN, Zeynep Şafak
WO/2021/126112A METHOD FOR PRODUCING GARLIC EXTRACTGüVEN, Şefik
WO/2021/080541PRODUCTION OF MONOCLONAL ANTIBODY SPECIFIC TO CELL RECEPTOR  CD24ANKARA üNIVERSITESI REKTÖRLüĞü
WO/2021/080542PRODUCTION OF MONOCLONAL ANTIBODY SPECIFIC TO STEM CELL  SURFACE MARKER CD133ANKARA üNIVERSITESI REKTÖRLüĞü
WO/2021/080544MICROORGANISM-BASED NATURAL FOOD SUPPLEMENT DEVELOPED TO  PREVENT CONSTIPATION PROBLEMS IN HUMANSANKARA üNİVERSİTESİ REKTÖRLüĞü
WO/2021/086292BILAYER TABLET FORMULATIONS COMPRISING DAPAGLIFLOZIN AND  METFORMINSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/091510A CAPSULE COMPRISING ELTROMBOPAG OLAMINESANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/101481A PELLET COMPOSITION COMPRISING PROPIVERINE OR A  PHARMACEUTICALLY ACCEPTABLE SALT THEREOFSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/101482A SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS  DAPAGLIFLOZIN ISOLATED FROM A POLAR SOLVENTSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/133299ORALLY DISINTEGRATING TABLETS COMPRISING FLURBIPROFEN AND  ELETRIPTANSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/101483A PHARMACEUTICAL FORM COMPRISING ACIDIC SUBSTANCESANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/091511CONJUGATION OF PROTEIN DRUGS WITH BIOPOLYMERS BY AN ENZYMATIC  METHODHACETTEPE üNİVERSİTESİ
WO/2021/096464A NOVEL NANOTECHNOLOGIC APPROACH TO GLIOBLASTOMA TREATMENT  WITH SOLID LIPID CARRIERSEGE üNİVERSİTESİ
WO/2021/257018ANTI-SCAR AND ANTI-AGING TOPICAL COMPOSITIONSMONTERO GIDA SANAYI VE TICARET ANONIM SIRKETI
WO/2021/112795ORAL DOSAGE FORMS CONTAINING INDOMETHACINATATüRK üNİVERSİTESİ BİLİMSEL ARAŞTIRMA PROJELERİ BİRİMİ
WO/2021/201797A COSMETIC AND TOPICAL COMPOSITION WHICH INCREASES CELL  VIABILITYYILDIZ TEKNIK UNIVERSITESI
WO/2021/126116SPOT LIGHTENING HERBAL COSMETIC FORMULATIONGAZI UNIVERSITESI REKTORLUGU
WO/2021/133307COSMETIC FORMULATION CONTAINING THE SMOKE TREE EXTRACTGAZI UNIVERSITESI REKTORLUGU
WO/2021/133308GROWTH AND OSTEOGENIC DIFFERENTIATION MEDIUM FOR THE DENTAL  PULP MESENCHYMAL STEM CELLSGAZI UNIVERSITESI REKTORLUGU
WO/2021/133309RED CALIFORNIAN WORM EXTRACT AND THE USE THEREOFGAZI UNIVERSITESI
WO/2021/126118SYNTHESIS OF 2-(SUBSTITUTEDPHENYL)-5-(SUBSTITUTEDHETEROARYL)-  1H-BENZIMIDAZOLE DERIVATIVES AND INVESTIGATION OF THEIR BIOLOGICAL EFFECTSANADOLU üNİVERSİTESİ
WO/2021/118501HAEMOSTATIC GEL FORMULATION PRODUCTION FROM FOMES FOMENTARIUS  EXTRACTTRAKYA UNIVERSITESI REKTORLUGU
WO/2021/242197NOVEL USE CHANGING MITOCHONDRIAL MEMBRANE POTENTIAL IN OLIVE  OILANKARA üNIVESITESI REKTÖRLüĞü
WO/2021/137809PHARMACEUTICAL SOLUTION THAT FACILITATES DENTAL  REMINERALISATION AND ELIMINATES LESION PAINAKDENIZ UNIVERSITESI
WO/2021/251918USE OF PROPOLIS OBTAINED BY SPECIAL EXTRACTION METHOD IN  SPREADABLE MIXTURESSBS BİLİMSEL BİO ÇÖZüMLER SANAYİ VE TİCARET A.Ş.
WO/2021/137835PENICILLIN DERIVATIVES AND METHOD FOR THEIR SYNTHESIST.C. ERCİYES üNİVERSİTESİ
WO/2021/137837A NOVEL VISCOELASTIC FORMULATION FOR OSTEOARTHRITIS TREATMENT  AND A PRODUCTION METHOD THEREOFVSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI
WO/2021/251920USE OF PROPOLIS OBTAINED BY SPECIAL EXTRACTION METHOD IN  LIQUID MIXTURESSBS BİLİMSEL BİO ÇÖZüMLER SANAYİ VE TİCARET A.Ş.
WO/2021/137840METHOD OF INDUCING AND STIMULATING PANCREATIC CANCER STEM  CELLS AND CANCER CELLS TO APOPTOSISDİCLE üNİVERSİTESİ REKTÖRLüK ÖZEL KALEM
WO/2021/150187CAPSULE-IN-CAPSULE COMPRISING DABIGATRAN ETEXILATESANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/150188CRYSTALLINE FORM C OF VORTIOXETINE HYDROBROMIDESANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/194446A SACHET FORMULATION COMPRISING METFORMIN AND DAPAGLIFLOZINSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/162659NUTRITIONAL COMPOSITIONS FOR PROMOTING GERIATRIC HEALTH  MAINTENANCEMONTERO GIDA SANAYI VE TICARET ANONIM SIRKETI
WO/2021/154188PHARMACEUTICAL COMPOSITION SUITABLE FOR VAGINAL DELIVERYEXELTIS ILAC SANAYII VE TICARET ANONIM SIRKETI
WO/2021/162662USE OF BMP INHIBITORS IN THE TREATMENT OF MOLAR PREGNANCYBOGAZICI UNIVERSITESI
WO/2021/167571DRG-MDM2-2 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2)  INHIBITORBAHCESEHIR UNIVERSITESI
WO/2021/167573DRG-MDM2-4 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2)  INHIBITORBAHCESEHIR UNIVERSITESI
WO/2021/167574DRG-MDM2-5 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2)  INHIBITORBAHCESEHIR UNIVERSITESI
WO/2021/173103A NOVEL SELECTIVE MAO-B INHIBITOR DRG-MAOB-2 FOR USE IN  TREATMENT OF NEURODEGENERATIVE DISEASESBAHCESEHIR UNIVERSITESI
WO/2021/206652TARGETING TIM-3 AND LAG-3 RECEPTORS INDUCED BY CD44+ CD90+  CANCER STEM CELLS IN SMALL CELL LUNG CANCERHACETTEPE üNİVERSİTESİ
WO/2021/201800FLURBIPROFEN NANOSUSPENSION BASED GEL FORMULATIONGAZI UNIVERSITESI REKTORLUGU
WO/2021/194455FERULA ELEAOCHYTRIS ROOT EXTRACT SOLUTION FOR USE IN ERECTILE  DISFUNCTION TREATMENTKAHRAMANMARAŞ SüTÇü İMAM üNİVERSİTESİ
WO/2021/201803DEVELOPMENT OF MICROEMULSION FORMULATION FROM  <i>ROSMARINUS</i> <i>OFFICINALIS</i> ESSENTIAL OIL  AND THE ANTIFUNGAL EFFECT OF THESE FORMULATIONSISTANBUL MEDIPOL UNIVERSITESI
WO/2021/201805NICLOSAMIDE COMPOSITIONS WITH HIGH SOLUBILITY AND  BIOAVAILABILITYIMUNEKS FARMA ILAC SAN. VE TIC. A.S.
WO/2021/216022GEL FORMULATION COMPRISING ETODOLAC NANOSUSPENSIONGAZI UNIVERSITESI REKTORLUGU
WO/2021/251924HERBAL SUPPLEMENT CREAM SUPPORTING WOUND HEALING AND REDUCTION  OF INFLAMMATIONAKMAN, Enes Emre
WO/2021/251925HERBAL SUPPLEMENT CREAM USED IN CANCER PATIENTSAKMAN, Enes Emre
WO/2021/221587MULTI-PROBIOTIC OIL COMBINATION CONTAINING CALENDULA OIL AND  PRODUCTION METHOD THEREOFHLY AROMATERAPİ HİZMETLERİ KOZMETİK SANAYİ TİCARET ANONİM  ŞİRKETİ
WO/2021/225551USE OF EXTRACELLULAR VESICLES AS IMMUNOPROPHILACTICS AND  IMMUNOTHERAPEUTICS FOR LEISHMANIASISYEDITEPE UNIVERSITESI
WO/2021/246985THE PROCESS FOR THE PREPARATION OF A FILM COATED TABLET  COMPRISING LINAGLIPTIN AND METFORMINSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/262114AN ORALLY DISINTEGRATING TABLET FORMULATION COMPRISING  SITAGLIPTINSANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/262115A STABLE COMBINATION OF VILDAGLIPTIN AND METFORMIN HCISANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/262116A FILM COATED TABLET COMPRISING VILDAGLIPTIN AND METFORMIN HCISANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/242204GEL FORMULATIONS OBTAINED FROM <i>PHLOMIS</i>  PLANT EXTRACT AND THEIR USE IN WOUND TREATMENTİSTANBUL MEDİPOL üNİVERSİTESİ
WO/2021/242205GEL FORMULATIONS OBTAINED FROM <i>CISTUS  CRETICUS</i> EXTRACT AND THE USE OF THESE AS HEMOSTATIC AGENTSİSTANBUL MEDİPOL üNİVERSİTESİ
WO/2021/257027AN EFFECTIVE COMPOSITION IN HEALING WOUNDST.C. ISTANBUL AYDIN UNIVERISTESI
WO/2021/251934METHOD OF OBTAINING SEA BUCKTHORN (HIPPOPHAE RHAMNOIDES)  EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULASYEDITEPE UNIVERSITESI
WO/2021/257029A URACIL COMPOUNDS WITH ANTICANCER ACTIVITYBURSA TEKNİK üNİVERSİTESİ REKTÖRLüĞü
WO/2021/257033GENETIC MOLECULE ENCAPSULATION IN MESOPOROUS  SILICA/POLYETHYLENE GLYCOL HYBRID STRUCTUREGAZIANTEP UNIVERSITESI REKTORLUGU
WO/2021/230849PHARMACEUTICAL COMPOSITIONS PREPARED BY DRY MILLING METHOD AND  CONTAINING CELECOXIB WITH INCREASED DISSOLUTION RATEHACETTEPE üNİVERSİTESİ
WO/2021/006856MEDICINE IN THE FORM OF EYE DROPSALMAKAIEVA, Liudmyla Hryhorivna
WO/2021/177930PHARMACEUTICAL COMPOSITION WITH INCREASED SOLUBILITY OF  GESPERIDINE AND METHOD OF ITS PREPARATIONVYSHNEVSKYY, Ihor Anatoliyovych
WO/2021/167580WATER-SOLUBLE SOLID DISPERSION OF QUERCETIN, FORMS THEREOF, A  METHOD OF OBTAINING THEREOF, USE OF ALKALINE AGENT, AND A KITSCIENTIFIC INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL  PHARMACEUTICAL PLANT" PUBLIC JOINT STOCK COMPANY
WO/2021/201813THE METHOD OF INHIBITING OF THE FIBRIN POLYMERIZATIONPALLADIN INSTYTUTE OF BIOCHEMISTRY OF THE NATIONAL ACADEMY OF  SCIENCES OF UKRAINE
WO/2021/211085METHOD OF PREVENTING AND TREATING DISEASES CAUSED BY ENVELOPED  VIRUSES, INCLUDING CORONAVIRUSES (VARIANTS), AND A SET OF PHARMACEUTICAL  PREPARATIONS FOR IMPLEMENTING SAID METHODGUNJAN, Kumar
WO/2021/010937METHODS AND COMPOSITIONS FOR THE TREATMENT OF SICKLE CELL  DISEASES AND THALASSEMIAEMMAUS MEDICAL, INC.
WO/2021/034298COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF  CHRONIC HYPOXEMIA AND DYSPNEAMARTIN, Alain
WO/2021/040673METHODS FOR THE TREATMENT OF CHRONIC HYPOXEMIA AND INHIBITING  LUNG FIBROSIS IN PATIENTS WITH PULMONARY FIBROSIS WITH AND WITHOUT COPDMARTIN, Alain
WO/2021/002855MAMMARY TUMOR VIRUS VACCINEVIRAGO VAX INC.
WO/2021/006877TOPICAL SCALP CARE COMPOSITIONSTHE PROCTER & GAMBLE COMPANY
WO/2021/010951MODIFIED NATURAL KILLER CELLS AND METHODS OF USING THE SAMECHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/010953TOPICAL SKINCARE COMPOSITIONS COMPRISING CENTELLA ASIATICATHE PROCTER & GAMBLE COMPANY
WO/2021/011002COMPOSITIONS AND METHODS FOR INDUCING DEFECATIONDIGNIFY THERAPEUTICS, LLC
WO/2021/029861METHODS AND SYSTEMS FOR TREATING ACNE AND OTHER INFLAMMATORY  SKIN CONDITIONSDATTNER, Alan M.
WO/2021/029893WETTING COMPOSITION INCLUDING SILICONE POLYMER SOFTENING AGENT  AND WET WIPES INCLUDING THE SAMEKIMBERLY-CLARK WORLDWIDE, INC.
WO/2021/029896SPLICE MODULATING OLIGONUCLEOTIDES TARGETING RECEPTOR FOR  ADVANCED GLYCATION END PRODUCTS AND METHODS OF USELIFESPLICE PHARMA LLC
WO/2021/040735XENOGEN-FREE MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF  USETHE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/040736TANDEM CD19 CAR-BASED COMPOSITIONS AND METHODS FOR  IMMUNOTHERAPYOBSIDIAN THERAPEUTICS, INC.
WO/2021/040744PATHOGENIC CONTROL COMPOSITIONS AND METHODSBRACEWELL, JR., John Kenneth
WO/2021/034334TOPICAL DOXYCYCLINE HYDROGEL WITH IMPROVED LONG-TERM STABILITYNANOPHARMACEUTICS, INC.
WO/2021/034335METHODS OF ADMINISTERING TESETAXEL WITH GLUCOCORTICOIDS THAT  ARE CYP3A4 INDUCERSODONATE THERAPEUTICS, INC.
WO/2021/050064ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS FOR  MITIGATING DISEASE-INDUCED TISSUE DAMAGEICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/050089GENETIC TEST FOR IDENTIFYING CATS AT A HIGH RISK FOR  DEVELOPING TUBULOINTERSTITIAL FIBROSISWASHINGTON STATE UNIVERSITY
WO/2021/054971PROCESS FOR PREPARING POTENT PLANT BASED COSMETIC ACTIVES AND  APPLICATION TO AN ANTIPERSPIRANT ACTIVEMENETRIER, David Benoît Camille
WO/2021/054978CARDIAC CARDENOLIDES TO REDUCE FIBROSIS AND ENHANCE EPITHELIAL  DIFFERENTIATIONPOLLARD, Bette, Silver
WO/2021/034336COMPOSITIONS AND METHODS FOR IN VIVO GENE EDITINGSALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/061128DISPERSIBLE ADHESIVELY BONDED TISSUE LAMINATEKIMBERLY-CLARK WORLDWIDE, INC.
WO/2021/061154DIASTEREOMERIC LINKING REAGENTS FOR NUCLEOTIDE PROBESBRENTANO BIOTECHNOLOGY ASSOCIATES
WO/2021/066840ANTI-CD25 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE  THEREOFR.P. SCHERER TECHNOLOGIES, LLC
WO/2021/071468NEOEPITOPE VACCINE AND IMMUNE STIMULANT COMBINATIONS AND  METHODSNANTCELL, INC.
WO/2021/071499RUBIDIUM AND/OR ZINC COMPOUNDS FOR TREATING PARKINSON'S AND  OTHER NEURODEGENERATIVE DISEASESVECTOR VITALE IP LLC
WO/2021/076124USE OF JAK1 INHIBITORS FOR THE TREATMENT OF CUTANEOUS LUPUS  ERYTHEMATOSUS AND LICHEN PLANUS (LP)INCYTE CORPORATION
WO/2021/080608BRANCHED MOIETY FOR USE IN CONJUGATESMEDIMMUNE, LLC
WO/2021/086312REDUCED ADAPTIVE MICROBIAL RESISTANCE TREATMENT FOR FLESH  EATING DISEASESALAZAR, Jennie
WO/2021/086403STABLE LOW pH PERSONAL CARE COMPOSITIONS AND METHODS FOR THE  SAMECOLGATE-PALMOLIVE COMPANY
WO/2021/050093A METHOD OF REDUCING VIABILITY OF CANCER CELLS BY APPLYING  ALTERNATING ELECTRIC FIELDS AND ADMINISTERING CHECKPOINT INHIBITORS TO THE  CANCER CELLSNOVOCURE GMBH
WO/2021/091532METHODS OF TREATING MYELOPROLIFERATIVE DISORDERSCONSTELLATION PHARMACEUTICALS, INC.
WO/2021/091535TREATING MYELOPROLIFERATIVE DISORDERS WITH CPI-0610 AND A JAK  INHIBITORCONSTELLATION PHARMACEUTICALS, INC.
WO/2021/091541IDENTIFYING CANCER NEOANTIGENS FOR PERSONALIZED CANCER  IMMUNOTHERAPYKRI TECHNOLOGIES INCORPORATED
WO/2021/091560ONCOLYTIC VIROTHERAPY AND IMMUNOTHERAPYBAYLOR COLLEGE OF MEDICINE
WO/2021/096479TREATMENT FOR INFLAMMATORY BOWEL DISEASE AND RADIATION-INDUCED  INTESTINAL INJURYTRIM-EDICINE, INC.
WO/2021/096518PERSONAL CARE COMPOSITIONS FOR TREATING ODOR CAUSING BACTERIA  AND METHODS FOR THE SAMECOLGATE-PALMOLIVE COMPANY
WO/2021/050094METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2  VARIANTS ENCODING AFLIBERCEPTADVERUM BIOTECHNOLOGIES, INC.
WO/2021/101521COMPOSITION AND METHOD FOR TREATING HEMATOLOGIC CANCERSPROVECETUS PHARMATECH, INC.
WO/2021/101569METHOD OF PREVENTING THE DEVELOPMENT OF MELANOMAVECTOR VITALE IP LLC
WO/2021/107926A FILL FORMULATION METHOD FOR HARD, SOFT, AND LIQUID CAPSULES  COMPRISING THE MIXTURE OF A POLYMER AND A FILL COMPONENT THAT WILL MIGRATE  INTO OR THROUGH A CAPSULE SHELL WITH SERVICEABLE FUNCTIONSLEACH, Connor
WO/2021/107946ORAL COMPOSITIONSARNOLD, Michael
WO/2021/025719METHODS OF BULK DROPLET VITRIFICATIONTHE GENERAL HOSPITAL CORPORATION
WO/2021/071534MUTANT VACCINIA VIRUSES AND USE THEREOFICELL KEALEX THERAPEUTICS
WO/2021/126140ESTERIFICATION OF ACETIC ACID RECOVERED FROM WOOD ACETYLATION  WITH ETHER-ALCOHOLSEASTMAN CHEMICAL COMPANY
WO/2021/126142ESTERIFICATION OF ACETIC ACID RECOVERED FROM WOOD ACETYLATION  WITH ALCOHOLSEASTMAN CHEMICAL COMPANY
WO/2021/126227COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF  OBESITYVECTOR VITALE IP LLC
WO/2021/126228COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF  TYPE 2 DIABETESVECTOR VITALE IP LLC
WO/2021/126230A METHOD OF TREATING NONALCOHOLIC STEATOHEPATITISVECTOR VITALE IP LLC
WO/2021/126231COMPOSITION AND METHOD FOR THE TREATMENT OF TYPE I DIABETESVECTOR VITALE IP LLC
WO/2021/025723SMALL MOLECULE DRUGS AND RELATED METHODS FOR TREATMENT OF  DISEASES RELATED TO TDP-43, ALPHA-SYNUCLEIN, HUNTINGTIN'S PROTEIN AND TAU  PROTEIN OLIGOMER FORMATIONACELOT, INC.
WO/2021/066869ANTIBODY COMPOSITIONS COMPRISING FC MUTATIONS AND  SITE-SPECIFIC CONJUGATION PROPERTIESTAE LIFE SCIENCES
WO/2021/091582NEUROSOME/ASTROSOME COMPOSITIONS AND METHODS OF USETHE METHODIST HOSPITAL
WO/2021/126281FORMULATED AND/OR CO-FORMULATED LIPOSOME COMPOSITIONS  CONTAINING TOLL-LIKE RECEPTOR ("TLR") AGONIST PRODRUGS USEFUL IN  THE TREATMENT OF CANCER AND METHODS THEREOFNAMMI THERAPEUTICS, INC.
WO/2021/002887GUT-TARGETED NLRP3 ANTAGONISTS AND THEIR USE IN THERAPYNOVARTIS INFLAMMASOME RESEARCH, INC.
WO/2021/141595PREPARATION AND PRESERVATION OF COLLAGEN MICROBUBBLESADVANCED MICROBUBBLES LABORATORIES LLC
WO/2021/034345NOVEL USES OF CRENOLANIBAROG PHARMACEUTICALS, INC.
WO/2021/054999THERAPEUTIC PROTEIN COMPOSITIONS AND METHODSPLASMA TECHNOLOGIES, LLC
WO/2021/141602TONGKAT ALI EXTRACT PRODUCTION PROCESSES AND USES THEREOFINNOVUS PHARMACEUTICALS, INC.
WO/2021/141603POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONSTYNDALL FORMULATION SERVICES, LLC
WO/2021/141605FORMULATIONS OF PACLITAXEL WITH POLY(AMINO ACID) BLOCK  POLYMERSTYNDALL FORMULATION SERVICES, LLC
WO/2021/145871A METHOD OF TREATMENT IN PREDISPOSED SUBJECTS FOR LMNA-RELATED  DILATED CARDIOMYOPATHYTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/015818HIV PRE-EXPOSURE PROPHYLAXISTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/080635FREE-FLOWING POWDER FROM CANNABINOID OILSNIICHEL, Robert
WO/2021/154205EXOSOME-MEDIATED TRANSFECTION FOR DELIVERY OF NUCLEIC ACIDS3P BIOTECHNOLOGIES, INC.
WO/2021/154216FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT  DYSREGULATION USING THE SAMEALEXION PHARMACEUTICALS, INC.
WO/2021/154220PHOSPHOLIPID COMPOUNDS AND FORMULATIONSAPPLAUD MEDICAL, INC.
WO/2021/107967PHARMACEUTICAL COMPOSITIONS OF LURASIDONESLAYBACK PHARMA LLC
WO/2021/158219COMPOUNDS AND COMPOSITIONS FOR RETINAL INJURY DETECTION AND  METHODS OF USING SAMEMOLECULAR TARGETING TECHNOLOGIES, INC.
WO/2021/150253EPHEDRINE COMPOSITIONS AND METHODSNEVAKAR INC.
WO/2021/076176LIQUID EMULSION THERAPY FOR TREATING ACUTE CANNABINOID  INTOXICATIONDONALDSON, Jack
WO/2021/167608BIOACTIVE MEDICAL CERAMIC CEMENTNUSMILE, LTD.
WO/2021/167609METHOD FOR TREATING AND PREVENTING CORONAVIRUS (COVID-19)  INFECTION BY DIRECT PULMONARY ADMINISTRATION OF A SELECTED MICROORGANISMXIA, Xin, Rui
WO/2021/086426D-AMPHETAMINE COMPOUNDS, COMPOSITIONS, AND PROCESSES FOR  MAKING AND USING THE SAMEKEMPHARM, INC.
WO/2021/086427D-AMPHETAMINE COMPOUNDS, COMPOSITIONS, AND PROCESSES FOR  MAKING AND USING THE SAMEKEMPHARM, INC.
WO/2021/015820ENHANCED ANTIBIOTIC AND DRUG DELIVERY FOR AQUEOUS TOPICAL  APPLICATIONS FOR HUMAN AND VETERINARY USESOTIKO, Christopher, Ayo
WO/2021/173130NOVEL CANNABINOID GLYCOSIDES AND USES THEREOFVITALITY BIOPHARMA, INC.
WO/2021/173160HAIR GROWTH AND SCALP PREPARATIONSZAVERI, Chanda
WO/2021/177936CANNABINOID AND ANESTHETIC COMPOSITIONS AND METHODSGHALILI, Babak
WO/2021/177937CANNABINOID AND MENTHOL COMPOSITIONS AND METHODSGHALILI, Babak
WO/2021/177938VETERINARY CANNABINOID AND MENTHOL COMPOSITIONS AND METHODSGHALILI, Babak
WO/2021/177939VETERINARY CANNABINOID, MENTHOL AND ANESTHETIC COMPOSITIONS  AND METHODSGHALILI, Babak
WO/2021/177940CANNABINOID AND MENTHOL GEL COMPOSITIONS, PATCHES AND METHODSGHALILI, Babak
WO/2021/177941CANNABINOID, MENTHOL AND CAFFEINE DISSOLVABLE FILM  COMPOSITIONS, DEVICES AND METHODSGHALILI, Babak
WO/2021/177942CANNABINOID AND MENTHOL GUM AND LOZENGE COMPOSITIONS AND  METHODSGHALILI, Babak
WO/2021/034349METHODS FOR PREVENTING DENGUE AND HEPATITIS ATAKEDA VACCINES, INC.
WO/2021/050102METHODS OF RESTORING LYSOSOMAL FUNCTION OF RETINAL PIGMENT  EPITHELIAL CELLS BY ACTIVATION OF TFEBUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/177979BACTERIAL VECTOR VACCINE AGAINST PARASITIC WORMS AND METHOD OF  VACCINATIONTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL  UNIVERSITY
WO/2021/091585CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USENOCION THERAPEUTICS, INC.
WO/2021/091586CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USENOCION THERAPEUTICS, INC.
WO/2021/183131DOSAGE FORMS FOR IMPROVING ORGAN TRANSPLANTATION, GRAFT VERSUS  HOST DISEASE AND STEM CELLS TRANSPLANTSAPHIOS CORPORATION
WO/2021/150256FULLERENE PHOSPHONATES, METHOD, AND MEDICAMENTBUTZLOFF, Peter, Robert
WO/2021/188096METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONSDST PHARMA, INC.
WO/2021/061192NOVEL TRIMETHYLGLYCYLGLYCERIN COMPOSITIONS AND THEIR USE IN  DEVELOPING ANTI-CANCER DRUGS AND RNA VACCINESWJWU & LYNN INSTITUTE FOR STEM CELL RESEARCH
WO/2021/194481DOSING FOR TREATMENT WITH ANTI-TIGIT AND ANTI-PD-L1 ANTAGONIST  ANTIBODIESGENENTECH, INC.
WO/2021/002910ORAL CARE COMPOSITIONS AND METHODSCOLGATE-PALMOLIVE COMPANY
WO/2021/206688AROMATHERAPY COMPOSITIONSMONQ, LLC
WO/2021/173166COMPOSITIONS AND METHODS FOR TREATING URINARY CONDITIONSINNOVUS PHARMACEUTICALS, INC.
WO/2021/118629NOVEL CHROMAN DERIVATIVES HAVING ESTROGEN RECEPTOR DEGRADATION  ACTIVITY AND USES THEREOFACCUTAR BIOTECHNOLOGY INC.
WO/2021/211098PREVENTION AND TREATMENT OF VIRAL INFECTION-INDUCED ORGAN  FAILURETRIM-EDICINE, INC.
WO/2021/133430PROGESTERONE FORMULATION TO TRIGGER OVULATION AND PROVIDE  LUTEAL PHASE SUPPORTAUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/211100METHODS AND COMPOSITIONS FOR INDUCING AUTOPHAGYSELECTA BIOSCIENCES, INC.
WO/2021/211104PROCESS FOR GENERATING GENETICALLY ENGINEERED AUTOLOGOUS T  CELLSAMGEN INC.
WO/2021/211123ADJUVANT-ANTIBIOTIC COMBINATION AGAINST GRAM-NEGATIVE BACTERIAUNIVERSITY OF NOTRE DAME DU LAC
WO/2021/158248METHOD FOR TREATING CORONAVIRUS INFECTIONSOYAGEN, INC.
WO/2021/045804METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF  PHOSPHODIESTERASE-4 INHIBITORSARCUTIS, INC.
WO/2021/021259FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT  INHIBITS MCL1 PROTEINAMGEN INC.
WO/2021/080646BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT  HOPKINS SYNDROMENEUREN PHARMACEUTICALS LIMITED
WO/2021/002920METHOD AND APPARATUS FOR ACCUMULATING CROSS-ALIGNED FIBER IN  AN ELECTROSPINNING DEVICEUNIVERSITY OF CENTRAL OKLAHOMA
WO/2021/006941TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN  DOGSBOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/006942TELMISARTAN FOR THE TREATMENT OF HYPERTENSION IN DOGSBOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/221656COMPOSITIONS AND METHODS OF USE THEREOFSYNEDGEN, INC.
WO/2021/221668ANTI-SARS-COV-2 MONOCLONAL ANTIBODY COMPOSITIONSIREPERTOIRE, INC.
WO/2021/183162ENHANCING GERMICIDAL ACTIVITIES OF ALCOHOL BY COMPOUNDS  DERIVED FROM PLANTSAUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/091593ROCK KINASE INHIBITORSCERVELLO THERAPEUTICS, LLC
WO/2021/112914FINISHED PHARMACEUTICAL DOSAGE FORM OF A METHENAMINE SALT SUCH  AS METHENAMINE MANDELATEEDENBRIDGE PHARMACEUTICALS, LLC
WO/2021/055022ASSOCIATION BETWEEN 4 COPIES OF EXON 3 OF fAIM AND PROGRESSIVE  CHRONIC KIDNEY DISEASE IN CATSWASHINGTON STATE UNIVERSITY
WO/2021/225606COMPOSITIONS AND METHODS FOR PROMOTING PROLIFERATION IN  CARDIOMYOCYTESTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/061203METHODS OF IMPROVING EXERCISE PERFORMANCE, SINGLE VENTRICULAR  PERFORMANCE, AND MYOCARDIAL PERFORMANCE INDEX (MPI) IN SINGLE VENTRICLE HEART  DISEASE, USING UDENAFIL COMPOSITIONSMEZZION PHARMA CO., LTD.
WO/2021/230886A METHOD FOR TREATING CANCER WITH AN ORAL DOSAGE FORM OF AN  FGFR4 INHIBITOREISAI R&D MANAGEMENT CO., LTD.
WO/2021/236080METHODS OF TREATING CANCERSFOGHORN THERAPEUTICS INC.
WO/2021/080648SILICON-BASED CANNABIDIOL DERIVATIVES AND COMPOSITIONS THEREOFGELEST TECHNOLOGIES, INC.
WO/2021/015841BORON-CONTAINING PHARMACOPHOREMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/021276MULTI-TARGETED, TUNABLE, SUSTAINED DELIVERY OF PAYLOADS TO  CHARGED AVASCULAR TISSUESMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/242235PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PSYCHIATRIC  SYMPTOMS OF PATIENTS WITH ALZHEIMER'S DISEASE AND FOR PSYCHIATRIC DISORDERSLA PHARMATECH INC.
WO/2021/021277STABILIZED FORMULATIONS OF 4-AMINO-3-SUBSTITUTED BUTANOIC ACID  DERIVATIVESSAOL INTERNATIONAL LIMITED
WO/2021/236116ANTIVIRAL MEDICINAL TEMPLATEDELAHOUSSAYE, Kevin
WO/2021/242258TREATMENT OF HOMOCYSTINURIA AND HYPERHOMOCYSTEINEMIA USING  CYSTATHIONINE-GAMMA-LYASEAEGLEA BIOTHERAPEUTICS, INC.
WO/2021/247000METHODS OF TREATMENT USING ICAM-MODULATING AGENTSAVM BIOTECHNOLOGY, LLC
WO/2021/158251NOVEL CANNABINOID CARRIER COMPOSITIONS HAVING ENHANCE  PHARMACOKINETIC PROPERTIES AND METHODS OF USE THEREOFDESERT HARVEST, INC.
WO/2021/247009COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING  COMPLEX AND HORMONE THERAPY AGENTGALERA LABS, LLC
WO/2021/002994A METHOD OF PREPARING A RADIOACTIVE YTTRIUM PHOSPHATE PARTICLE  SUSPENSIONKORENKO, Michael
WO/2021/247020METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION  DISORDERS ASSOCIATED WITH MSH3 ACTIVITYTRIPLET THERAPEUTICS, INC.
WO/2021/076196METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE  LARGE B-CELL LYMPHOMAGENENTECH, INC.
WO/2021/236128METHODS AND COMPOSITIONS FOR REDUCING ADIPOCYTE NUMBERSSU, Shih-Horng
WO/2021/251987METHOD OF DISPERSING HYDROPHOBIC SUBSTANCES IN AQUEOUS  CLEANSING SYSTEMRENMATIX, INC.
WO/2021/003015COMPOSITIONS AND METHODS FOR TREATING EYE DISEASESCLOUDBREAK THERAPEUTICS LLC
WO/2021/015894COMPOSITION FOR AND METHOD OF IMPROVING TISSUE PERFORMANCETRIM-EDICINE, INC.
WO/2021/007007COMPOSITIONS AND METHODS FOR DIAGNOSING URINARY TRACT  INFECTIONSZOMEDICA PHARMACEUTICALS CORP.
WO/2021/257073METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FROM NEONATAL STEM  CELLSKONG, Joy
WO/2021/257089METHODS AND COMPOSITIONS FOR TREATING CHEMOTHERAPY-INDUCED  DIARRHEANAPO PHARMACEUTICALS, INC.
WO/2021/257092NEW COMPOUNDS AND THEIR USE AS THERAPEUTICALLY ACTIVE  SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF DISEASES INVOLVING THE  RETINAL PIGMENT EPITHELIUMENDOGENA THERAPEUTICS, INC.
WO/2021/034403CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOFEPM GROUP, INC.
WO/2021/007020ORAL CARE GUMMIESBASF SE
WO/2021/262141PERSONAL LUBRICANTS COMPRISING LAMBDA-CARRAGEENANTREMBLAY, Mario Elmen
WO/2021/034405PLATINUM COMPLEX ANTI-NEOPLASTIC AGENTS COMPRISING A  CANNABINOID LIGANDDIVERSE BIOTECH, INC.
WO/2021/076197CONJUGATE MOLECULESDIVERSE BIOTECH, INC.
WO/2021/007035AEROSOL TEXTURIZING HAIR FILLER AND COLORANT WITH FIBERSAMERICAN SPRAYTECH, L.L.C.
WO/2021/034406HEMOSTATIC DEVICE AND METHODJU, Chien-Ping
WO/2021/040873THIXOTROPIC DELIVERY SYSTEMSUNIVERSITY OF MONTANA
WO/2021/021349METHODS OF TREATING PAIN CONDITIONS AND COMPOSITIONS RELATED  THERETONXGEN MEDICINE, INC.
WO/2021/045836ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND  ANTIGEN-BINDING FRAGMENTSREGENERON PHARMACEUTICALS, INC.
WO/2021/262186HP-HMG FOR USE IN THE TREATMENT OF INFERTILITY IN A PATIENT  WITH POLYCYSTIC OVARY SYNDROMEFERRING B.V.
WO/2021/262196COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND  PARKINSON'S DISEASELA PHARMATECH INC.
WO/2021/003074ANTI-CD38 ANTIBODY AND METHODS OF USE THEREOFCRYSTAL BIOSCIENCE INC.
WO/2021/003075ANTI-B7-H3 ANTIBODY AND METHODS OF USE THEREOFCRYSTAL BIOSCIENCE INC.
WO/2021/003084P2X7R ANTAGONISTSQIAN, Ligang
WO/2021/003086TASIMELTEON USE IN TREATING SLEEP ABERRATIONSVANDA PHARMACEUTICALS INC.
WO/2021/007062PROCESS FOR REMOVING COBALT, LEAD, CADMIUM AND CHROMIUM IONS  FROM BODILY FLUIDS USING METALLATE ION EXCHANGE COMPOSITIONSUOP LLC
WO/2021/040881IMMUNE TOLERANT ELASTIN-LIKE RECOMBINANT PEPTIDES AND METHODS  OF USEUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/003132ENGINEERED SUCROSE PHOSPHORYLASE VARIANT ENZYMESCODEXIS, INC.
WO/2021/141628KRAS G12C INHIBITORSMIRATI THERAPEUTICS, INC.
WO/2021/003138METHODS AND COMPOSITIONS FOR TREATMENT OF PANCREATIC CANCERMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/007070CHIMERIC ANTIGENS FOR TREATING VIRAL INFECTIONAKSHAYA BIO INC.
WO/2021/003163TREATING CANCER WITH A BROMODOMAIN AND EXTRA-TERMINAL (BET)  FAMILY INHIBITORFORMA THERAPEUTICS, INC.
WO/2021/003189HETERODIMERIC ANTIBODIES THAT BIND TO CD38 AND CD3SORRENTO THERAPEUTICS, INC.
WO/2021/003194EIF4E INHIBITORS FOR USE AS IMMUNE CHECKPOINT MODULATORS AND  RELATED METHODSEFFECTOR THERAPEUTICS, INC.
WO/2021/003195RECOMBINANT AAV VECTORS WITH ALTERED IMMUNOGENCITY AND METHODS  OF MAKING THE SAMEWRIGHT, John, Fraser
WO/2021/003197GENOMIC AND EPIGENOMIC COMPARATIVE, INTEGRATIVE PATHWAY  DISCOVERYRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/003223HYDROPHILIC LINKERS FOR MULTIVALENT PEPTIDE CONJUGATESVALITOR, INC.
WO/2021/003246PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPYACCURE HEALTH INC.
WO/2021/003254CRYOPRESERVATION MEDIUM COMPRISING A TISSUE EXTRACTAUXOCELL LABORATORIES, INC.
WO/2021/003277EXENATIDE COMPOSITIONS FOR PULMONARY ADMINISTRATION AND USE  THEREOFAERAMI THERAPEUTICS, INC.
WO/2021/003279SYSTEM FOR ENHANCING THERAPEUTIC COMPLIANCE OF THE ANTI-CANCER  COMPOUND E7766EISAI R&D MANAGEMENT CO., LTD..
WO/2021/003314HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORSNUVATION BIO INC.
WO/2021/003315TRANSDERMAL PATCH PROVIDING IMPROVED PERMEABILITYROWLEY, Clifford, T.
WO/2021/003330INHIBITING THE RNA METHYLTRANSFERASE METTL3 OR ITS INTERACTION  WITH EIF3H TO SUPPRESS ONCOGENE TRANSLATION AND TUMORIGENESISCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/007091PREBIOTIC COSMETIC COMPOSITIONS AND METHODS FOR THE  PREPARATION THEREOFCOSMEVIA LLC
WO/2021/003340COMPOSITIONS AND METHODS FOR TREATING MYOCARDIUM WITH  MESENCHYMAL STEM CELL SCAFFOLDUNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/003341HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN  ANIMALSELLEVET SCIENCES
WO/2021/007094ENDOSTATIN PEPTIDES FOR THE TREATMENT OF TUMORS, FIBROSIS AND  ACUTE LUNG INJURYMUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/003348HIV ANTIGENS AND MHC COMPLEXESGRITSTONE ONCOLOGY, INC.
WO/2021/003352METHODS OF FUNCTIONAL VASCULARIZATION OF PANCREATIC ISLETS AND  BETA-CELL ORGANOIDSCORNELL UNIVERSITY
WO/2021/003357ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1)  ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOFREGENERON PHARMACEUTICALS, INC.
WO/2021/034414MODULATION OF DENDRITIC CELL FUNCTION BY THE PHOSPHOLIPID  MESSENGER LPACORNELL UNIVERSITY
WO/2021/003393METHOD, COMPOSITION, AND APPARATUS FOR TREATING HEADACHEEQUINOX OPHTHALMIC, INC.
WO/2021/007107ANTIMICROBIAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR  USE AGAINST GRAM-NEGATIVE AND ACID-FAST BACTERIACONTRAFECT CORPORATION
WO/2021/007108METHOD FOR PREVENTING HAIR LOSSICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/003403NEURODEGENERATIVE DISEASE THERAPIES UTILIZING THE SKIN-BRAIN  AXISOHIO STATE INNOVATION FOUNDATION
WO/2021/007109DESIGN AND EFFICIENT SYNTHESIS OF LIPID-FLUORESCEIN CONJUGATES  FOR CAR-T CELL THERAPYPURDUE RESEARCH FOUNDATION
WO/2021/007111VIRAL VECTOR THERAPYAPELLIS PHARMACEUTICALS, INC.
WO/2021/007113POLYMER PARTICLES FOR NEUTROPHIL INJURYTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/003433SUSTAINED RELEASE COMPOSITIONS OF ENDOXIFENATOSSA THERAPEUTICS, INC.
WO/2021/003467METERED DOSING COMPOSITIONS AND METHODS OF USE OF PSYCHEDELIC  COMPOUNDSSW HOLDINGS, INC.
WO/2021/007146REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTSOLEMA PHARMACEUTICALS, INC.
WO/2021/007147WOUND DEBRIDEMENT SYSTEMSREGENICS AS
WO/2021/007151NANO-DISPERSION METHODS FOR CANNABIS EXTRACTUNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE
WO/2021/007155PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF  2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE  HEMISUCCINATE, AND PREPARATION OF  2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE  ACETATEELI LILLY AND COMPANY
WO/2021/007160TRANS-CYCLOOCTENE BIOORTHOGONAL AGENTS AND USES IN CANCER AND  IMMUNOTHERAPYTAMBO, INC.
WO/2021/007165METHODS FOR TREATING AND FOR INHIBITING PROGRESSION OF  SEIZURESALLERGAN, INC.
WO/2021/007172FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USEBELITE BIO, LLC
WO/2021/007189CRYSTALLINE FORMS OF PLASMA KALLIKREIN INHIBITORSREZOLUTE, INC.
WO/2021/007192USE OF IMMUNE MODULATORS TO IMPROVE NERVE REGENERATIONTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/007196METHODS AND COMPOSITIONS TO INCREASE THE HARDNESS AND  RESISTANCE OF ENAMELTHE PROCTER & GAMBLE COMPANY
WO/2021/007208CXCR6 INHIBITORS AND METHODS OF USESANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/007245NOVEL METHODSINTRA-CELLULAR THERAPIES, INC.
WO/2021/007277COMPOUNDS AND METHODS FOR THE TREATMENT AND PREVENTION OF  FIBROTIC DISEASE STATES AND CANCERPURDUE RESEARCH FOUNDATION
WO/2021/007278IMPROVED MRNA-LOADED LIPID NANOPARTICLES AND PROCESSES OF  MAKING THE SAMETRANSLATE BIO, INC.
WO/2021/007286COMPOSITIONS AND METHODS FOR CANCER THERAPYBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/007303NANOPARTICLE FORMULATION OF BCL-2 INHIBITORRECURIUM IP HOLDINGS, LLC
WO/2021/236134COMPOSITIONS AND METHODS FOR INHIBITION OF SARS-COV-2 VIRAL  INFECTIONSTHE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/007318COMPOSITION AND METHOD FOR TREATING GASTROINTESTINAL DISORDERARJIL BIOTECH HOLDING COMPANY LIMITED
WO/2021/007322METHODS OF USING MODIFIED CYTOTOXINS TO TREAT CANCERNORTHWESTERN UNIVERSITY
WO/2021/007329TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1  SIALIDASEUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/007330CERDULATINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL  COMPOSITIONS AND USES THEREOFDERMAVANT SCIENCES GMBH
WO/2021/007341LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODSBIOPLX, INC.
WO/2021/007378COMPOUNDS FOR USE IN TREATING HUNTINGTON'S DISEASEPTC THERAPEUTICS, INC.
WO/2021/150266AGENTS THAT INTERFERE WITH IL-1BETA RECEPTOR SIGNALLINGTAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED
WO/2021/007382COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S  DISEASEVOYAGER THERAPEUTICS, INC.
WO/2021/007383MODIFIED CELLS AND RELATED METHODSCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/007386INDANES AS PD-L1 INHIBITORSCHEMOCENTRYX, INC.
WO/2021/011283INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE  FRAGMENTSNORTHWESTERN UNIVERSITY
WO/2021/007396ENGINEERED REGULATORY T CELLSTHE CHILDREN'S MERCY HOSPITAL
WO/2021/007402PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS  THERAPEUTICSCYBREXA 3, INC.
WO/2021/007409MEDICAL DEVICE SOLUTIONS FOR TREATING DENTAL DISEASE AND  METHODS FOR THE TREATMENT OF DENTAL DISEASEKYTODENT, LLC
WO/2021/011299MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXMEDETOMIDINEPACIRA PHARMACEUTICALS, INC.
WO/2021/011309BIOLOGICAL TRANSPORT SYSTEMS AND METHODSCUMBO, Thomas, A.
WO/2021/007470METHOD AND COMPOSITION FOR TREATING PAINSHIH, Ming-Che
WO/2021/011327COMPOUND FOR TREATING CYSTIC FIBROSISORPHOMED, INC.
WO/2021/007487FORMULATIONS OF T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS  OF USE THEREOFPRAXIS PRECISION MEDICINES, INC.
WO/2021/007488SUBSTITUTED HETEROCYCLES AS ANTIVIRAL AGENTSENANTA PHARMACEUTICALS, INC.
WO/2021/055081ENDOTHELIAL AND SMOOTH MUSCLE LIKE TISSUE PRODUCED FROM URINE  CELLS AND USES RELATED THERETOEMORY UNIVERSITY
WO/2021/007489POLYURETHANE GELSNANOMETICS LLC (D.B.A. PHD BIOSCIENCES)
WO/2021/007491TARGETING PTPN22 IN CANCER THERAPYTHE JOHNS HOPKINS UNIVERSITY
WO/2021/007504METHODS AND COMPOSITIONS COMPRISING REDUCED LEVEL OF HOST CELL  PROTEINSREGENERON PHARMACEUTICALS, INC.
WO/2021/007506COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONSNANJING ZHENGXIANG PHARMACEUTICALS CO., LTD.
WO/2021/011368TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY  NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNASE)  ACTIVITYGENKIN, Dmitry Dmitrievich
WO/2021/011369METHODS OF TREATMENT USING ENCAPSULATED CELLSPRIMEGEN BIOTECH, LLC
WO/2021/011377METHODS OF ENHANCING IMMUNOGENICITY OF CANCERSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/007521METHOD AND COMPOUNDS FOR TREATING OR PREVENTING AUTOIMMUNE  DISORDERS OR IMMUNE RESPONSES MODULATED BY THE EXPRESSION OF IDO1THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/007525METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCERCASE WESTERN RESERVE UNIVERSITY
WO/2021/007527COMPOSITIONS AND METHODS FOR TREATING PEROXISOMAL BIOGENESIS  DISORDERSUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/007533AGENTS THAT INTERFERE WITH THYMIC STROMAL LYMPHOPOIETIN  (TSLP)-RECEPTOR SIGNALINGTAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED
WO/2021/011398FUNCTIONALIZED NANOPARTICLES AND THEIR USE IN TREATING  BACTERIAL INFECTIONSBEKALE, Laurent
WO/2021/011404THERAPEUTIC PROTEIN FORMULATIONS COMPRISING ANTIBODIES AND  USES THEREOFCONTRAFECT CORPORATION
WO/2021/007563NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMSARBOR BIOTECHNOLOGIES, INC.
WO/2021/011421COMPOSITIONS AND METHODS FOR TREATING ALZHEIMERS DISEASEUNIVERSITY OF SOUTH FLORIDA
WO/2021/011431RECOMBINANT SPIDER SILK EXTRUDATE FORMULATIONSBOLT THREADS, INC.
WO/2021/011432COMPOSITIONS AND METHODS FOR TREATING DEMENTIA WITH LEWY  BODIESEIP PHARMA, INC.
WO/2021/011437PEPTIDES AND METHODS FOR TREATING DISEASESOP-T LLC
WO/2021/007572METHODS FOR GROWING AFRICAN SWINE FEVER VIRUS IN FETAL PORCINE  LUNG ALVEOLAR MACROPHAGE CELLSAPTIMMUNE BIOLOGICS, INC.
WO/2021/007573ENGINEERING NOTCH LIGANDS TO ENHANCE THE ANTI-TUMOR ACTIVITY  OF ADOPTIVELY TRANSFERRED T CELLSH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/011456EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONSRESEARCH DEVELOPMENT FOUNDATION
WO/2021/011462METHODS FOR THE NON-TOXIC TREATMENT FOR OPIOID DRUG WITHDRAWAL  COMBINING NORIBOGAINE AND CANNABINOIDSDEMERX, INC.
WO/2021/011465METHOD FOR VACCINATING AVIANS AGAINST REOVIRUSBIOMUNE COMPANY
WO/2021/011466USE OF NANOPARTICLES FOR TREATING RESPIRATORY INFECTIONS  ASSOCIATED WITH CYSTIC FIBROSISATTOSTAT, INC.
WO/2021/011471TREATMENT OF HEART DEFECTS AND CONDITIONS IN PEDIATRIC  PATIENTSUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/011480COMPOSITIONS AND METHODS TO BLOCK AND BIND CXCR4 TO MODULATE  CELLULAR FUNCTIONTHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/011488COMPOSITIONS COMPRISING ALDOXORUBICIN HYDROCHLORIDE AND  IFOSFAMIDE AND THEIR USE FOR THE TREATMENT OF SOFT TISSUE SARCOMANANTKWEST, INC.
WO/2021/011496IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USEOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/011500USE OF A BENZOATE CONTAINING COMPOSITION TO TREAT  NEURODEGENERATIVE DISORDERSRUSH UNIVERSITY MEDICAL CENTER
WO/2021/011501THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF MITOTIC KINASE  INHIBITOR AND IMMUNE CHECKPOINT INHIBITOROREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/011503MOSQUITO EGG CRYOPRESERVATIONSANARIA INC.
WO/2021/011504NANOPARTICLE SYSTEMS FOR TARGETED DELIVERY OF CRISPR/CAS13 AND  METHODS OF USING SAMEDUKE UNIVERSITY
WO/2021/015986CANCER VACCINE COMPOSITIONS AND METHODS FOR USING SAME TO  PREVENT AND/OR TREAT CANCERDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/015987ANTIGENIC GLYCOPROTEIN E POLYPEPTIDES, COMPOSITIONS, AND  METHODS OF USE THEREOFMERCK SHARP & DOHME CORP.
WO/2021/011529OPIOID GROWTH FACTOR RECEPTOR (OGFR) ANTAGONISTS, IN  PARTICULAR NALOXONE AND/OR NALTREXONE FOR TREATING CANCERROVAXA
WO/2021/011538CAPSULE DOSAGE FORMS, METHODS OF PREPARATION AND METHODS OF  USE THEREOFR.P. SCHERER TECHNOLOGIES, LLC
WO/2021/011544HIV VACCINES AND METHODS OF MAKING AND USINGGILEAD SCIENCES, INC.
WO/2021/015997METHODS AND COMPOSITIONS FOR GENE DELIVERYPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/011548SKIN CARE COMPOSITIONS COMPRISING SYNERGISTIC BLEND OF SACRED  LOTUS AND TEA PLANT OR SACRED LOTUS AND GERMAN CHAMOMILE AND COSMETIC  APPLICATIONS THEREOFISP INVESTMENTS LLC
WO/2021/011550METHODS AND COMPOSITIONS FOR TREATING PULMONARY ARTERIAL  HYPERTENSIONYALE UNIVERSITY
WO/2021/011572ENHANCING THE ANTIVIRAL EFFICACY OF RNA VIRUS INHIBITION BY  COMBINATION WITH MODULATORS OF PYRIMIDINE METABOLISMTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/201903METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTIONPHOENIX BIOTECHNOLOGY, INC.
WO/2021/011579EVOLVED BOTULINUM NEUROTOXINS AND USES THEREOFPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/011592COMPOUNDS AS NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS  AND USES THEREOFVIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/011597PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR  THERAPEUTIC TREATMENTOVID THERAPEUTICS INC.
WO/2021/011609METHODS OF TREATING OVARIAN, FALLOPIAN TUBE AND PERITONEAL  CANCERTESARO, INC.
WO/2021/011614METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN  IL-4R ANTAGONISTSANOFI BIOTECHNOLOGY
WO/2021/016012PRETOMANID COMPOSITIONSTHE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/011619SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS  THEREFROMSOUTH DAKOTA BOARD OF REGENTS
WO/2021/011622SECNIDAZOLE SOFT GELATIN CAPSULE AND METHODS AND USES THEREOFLUPIN INC.
WO/2021/011634PROTEIN DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/011645EQUINE ESOMEPRAZOLE FORMULATIONS AND METHODS OF USEKINDRED BIOSCIENCES, INC.
WO/2021/011660METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF LUNG  CANCERONCOCYTE CORPORATION
WO/2021/011662COMPOSITIONS AND METHODS FOR BROILER HEALTH AND PERFORMANCENATIVE MICRO BIALS, INC.
WO/2021/011664COMPOSITION AND METHODS FOR THE TREATMENT OF SKIN CONDITIONSBIODERM, INC.
WO/2021/011669COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSIONCUTISPHARMA, INC.
WO/2021/011674METHODS USEFUL IN TREATING CANCERS HARBORING A KRAS OR HRAS  MUTATION OR AMPLIFICATIONMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/066922ANTIVIRAL HETEROCYCLIC COMPOUNDSENANTA PHARMACEUTICALS, INC.
WO/2021/011778SMALL MOLECULE INHIBITORS OF KU70/80 AND USES THEREOFARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/011779MESENCHYMAL STEM CELL COMPOSITIONSAKAN BIOSCIENCES LLC
WO/2021/011781UNIVERSAL CHIMERIC ANTIGEN RECEPTORS AND METHODS FOR MAKING  AND USING THEMTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016043IMPROVED HOMOLOGY DEPENDENT REPAIR GENOME EDITINGINARI AGRICULTURE, INC.
WO/2021/011799INFLAMMATORY BOWEL DISEASES THERAPY INVOLVING DISRUPTING  CCR9:DRD5 HETEROMER ASSEMBLYFUNDACIóN CIENCIA PARA LA VIDA (FCV)
WO/2021/011800METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC  INHIBITORCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/011802METHODS AND COMPOSITIONS FOR UNSILENCING IMPRINTED GENESTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/011806IMMUNE TOLERIZATION AGENTS AND POTENTIATORSANTOLRX, INC.
WO/2021/011808CARDIAC SARCOMERE INHIBITOR ORAL FORMULATIONSCYTOKINETICS, INC.
WO/2021/016049ACETYLCHOLINE MODULATION OF IMMUNE FUNCTIONBCELL SOLUTIONS, INC.
WO/2021/011826PROCESS OF MAKING MEMBRANE LIPID COATED NANOPARTICLESCOASTAR THERAPEUTICS INC.
WO/2021/011842SYNTHETIC PRODUCTION OF SINGLE-STRANDED ADENO ASSOCIATED VIRAL  DNA VECTORSGENERATION BIO CO.
WO/2021/016054SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING  CANCERTHE GENERAL HOSPITAL CORPORATION
WO/2021/011844COMBINATION CANCER THERAPY AGENTS AND METHODSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016061INHIBITORS OF MICRORNA 451A FOR TREATMENT OF ENDOMETRIOSISYALE UNIVERSITY
WO/2021/011857USE OF PLATELETS IN TREATING INFECTIONSCELLPHIRE, INC.
WO/2021/055090DEGRADABLE PHASE CHANGING POLYMERS FOR DENTAL/MEDICAL  APPLICATIONSRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/011871MERTK DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/011873BORON-CONTAINING RHO KINASE INHIBITORSPERCIPIAD, INC.
WO/2021/011874GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSISUNIVERSITY OF MIAMI
WO/2021/016081METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL  DISORDERSFINCH THERAPEUTICS HOLDINGS LLC.
WO/2021/011875COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016082COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISORDERSTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/016083METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL  DISORDERSFINCH THERAPEUTICS HOLDINGS LLC
WO/2021/011878METHOD OF TREATING PARKINSON'S DISEASEVENTURIS THERAPEUTICS, INC.
WO/2021/016090COMPOSITIONS AND METHODS FOR INDIVIDUALIZED CHARACTERIZATION  OF NON-IGE MEDIATED FOOD ALLERGIESTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/016091CHIMERIC ANTIGEN RECEPTORS FOR DIRECT AND INDIRECT TARGETING  OF FIBRONECTIN-POSITIVE TUMORSST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/011887CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING  OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASEUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/011891LONG-ACTING FORMULATIONS OF TENOFOVIR ALAFENAMIDEGILEAD SCIENCES, INC.
WO/2021/016102INHIBITORS OF TYROSINE KINASEBRIDGENE BIOSCIENCES, INC.
WO/2021/011896LONG-ACTING FORMULATIONS AND VEHICLESDURECT CORPORATION
WO/2021/016106MULTILAMELLAR RNA NANOPARTICLESUNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED
WO/2021/016112NON-SEDATING DEXMEDETOMIDINE TREATMENT REGIMENSBIOXCEL THERAPEUTICS, INC.
WO/2021/011903FACTOR H POTENTIATING ANTIBODIES AND USES THEREOFGEMINI THERAPEUTICS INC.
WO/2021/011907ORDERED PROCESSING OF BLOOD PRODUCTS TO PRODUCE  THERAPEUTICALLY ACTIVE CELLSGPB SCIENTIFIC, INC.
WO/2021/016118COMPOSITIONS FOR THE TREATMENT OF CONDITIONS BY DERMAL FILLERSDERMATA THERAPEUTICS, LLC
WO/2021/011912COMBINATION OF INTEGRIN-TARGETING KNOTTIN-FC FUSION AND  ANTI-CD47 ANTIBODY FOR THE TREATMENT OF CANCERTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/016126AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY IN HUMANSUNIVERSITY OF FLORIDA RESEARCHFOUNDATION, INCORPORATED
WO/2021/011925TREATMENT OF UROTHELIAL AND KIDNEY CANCERS BY USE OF  ENDOTHELIN B RECEPTOR ANTAGONISTSENB THERAPEUTICS, INC.
WO/2021/016134PREPARATION OF LIPOPHILIC ACTIVE INGREDIENTSSPI PHARMA, INC.
WO/2021/011929USE OF FRATAXIN FOR TREATING LEIGH SYNDROME, FRENCH CANADIAN  TYPECHONDRIAL THERAPEUTICS, INC.
WO/2021/011930SLIRP FUSION PROTEINS AND USE THEREOF FOR TREATING LEIGH  SYNDROMECHONDRIAL THERAPEUTICS, INC.
WO/2021/016141ANTI-COCCIDIAL PHYTOGENIC FORMULATIONSACADEMIA SINICA
WO/2021/016174FUSION POLYPEPTIDE FOR IMMUNOTHERAPYMEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/011935PREPARATIONS COMPRISING MESENCHYMAL STEM CELLS AND  CANNABINOIDS AND METHODS OF THEIR USEDIRECT BIOLOGICS, LLC
WO/2021/016190COMPOSITIONS AND METHODS FOR MODULATING DRUG-USE DISORDERSBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/173180LIQUID BIOPSY YIELD ENHANCEMENTSINGHAL, Seema
WO/2021/016194SECOND GENERATION SENECA VALLEY VIRUS ONCOLYTIC THERAPY:  COMPOSITIONS AND METHODS THEREOFRACANIELLO, Vincent, R.
WO/2021/016203PDLIM2 AS A BIOMARKER FOR CANCER AND AS AN ANTI-CANCER  TREATMENT TARGETUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/016204ANTIBODY-STING AGONIST CONJUGATES AND THEIR USE IN  IMMUNOTHERAPYIMMUNESENSOR THERAPEUTICS, INC.
WO/2021/016208METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIASPRUCE BIOSCIENCES, INC.
WO/2021/016211POROUS SELF-HEALING POLYMER MATRIX FOR ENCAPSULATION OF ACTIVE  MACROMOLECULES AND METHODSTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/016227SYNTHETIC GENETIC ELEMENTS FOR BIOMANUFACTUREJANSSEN BIOTECH, INC.
WO/2021/016236METHOD OF REMOTELY CONTROLLING PAINNOVILLA PHARMACEUTICALS, INC.
WO/2021/016249TARGET PEPTIDES FOR CANCER THERAPY AND DIAGNOSTICSUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/016261CELL TREATMENTS AND THERAPEUTIC REINFUSION METHODSALAMIN, Todd
WO/2021/021499THERMALLY-MODULATED ULTRASOUND CONTRAST AGENTSPURDUE RESEARCH FOUNDATION
WO/2021/021503USE OF ALVEOLAR OR AIRWAY ORGANOIDS FOR THE TREATMENT OF LUNG  DISEASES AND DISORDERSTHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/016293IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USINGUNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/016305SOFTSHELL CAPSULE FORMULATIONS, AND METHODS OF PREPARATION AND  USE THEREOFR.P. SCHERER TECHNOLOGIES, LLC
WO/2021/016314ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL  DISORDERSANAVEX LIFE SCIENCES CORP.
WO/2021/016330POLYPEPTIDES HAVING ANTI-SENESCENT EFFECTS AND USES THEREOFONESKIN, INC.
WO/2021/016333ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORSUNIVERSITY OF HAWAII
WO/2021/016338METHODS OF TREATING SLEEP DISORDERS ASSOCIATED WITH PAINASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
WO/2021/016347COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND  OTHER DISEASESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016353COMPOSITION AND METHOD FOR ADOPTIVE IMMUNOTHERAPYYANG, Wen
WO/2021/021520NRF2 ACTIVATION FOR TREATMENT OF NEPHROGENIC DIABETES  INSIPIDUSUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/016361METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE  NUCLEIC ACID-BASED AGENTSTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/021523DNA-AFFIBODY-DRUG NANOPARTICLES FOR INHIBITING THE METASTASIS  OF CANCER CELLS OVEREXPRESSING HER2ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/016368TOPICAL EXOSOME COMPOSITIONS AND ASSOCIATED METHODSERIVAN BIO, LLC
WO/2021/016369PIMAVANSERIN FOR TRATING SCHIZOPHRENIA OR FOR TREATING  PSYCHOSIS SECONDARY TO NEURODEGENERATIVE DISORDERS OR DEPRESSIVE DISORDERACADIA PHARMACEUTICALS INC.
WO/2021/021528METHODS OF PREVENTING OR TREATING FATTY DEGENERATION OF  SKELETAL MUSCLEBOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/016388INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/016392MULTIVALENT FIBROBLAST-TARGETED AGENTS AND METHODS OF USEPURDUE RESEARCH FOUNDATION
WO/2021/016401NOVEL ANTICANCER DRUG FL118 FORMULATION IN COMBINATION WITH  IMMUNOTHERAPY FOR TREATMENT OF HUMAN CANCERCANGET BIOTEKPHARMA
WO/2021/016409EZH2 INHIBITION IN COMBINATION THERAPIES FOR THE TREATMENT OF  CANCERSCONSTELLATION PHARMACEUTICALS, INC.
WO/2021/021535GLUCOSE-RESPONSIVE INSULIN CONJUGATESMERCK SHARP & DOHME CORP.
WO/2021/021543COMPOSITIONS AND METHODS FOR ATTENUATING SIDE EFFECTS OF  IMMUNE CHECKPOINT INHIBITOR THERAPYCORBUS PHARMACEUTICALS, INC.
WO/2021/016422METHODS AND COMPOSITIONS FOR TREATING ANDROGEN RECEPTOR  DEFICIENT, ANDROGEN RECEPTOR LOW, AND CASTRATION-RESISTANT PROSTATE CANCERSFRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/016423COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDSCAAMTECH LLC
WO/2021/021548SELF-FOAMING CLEANSING COMPOSITIONL'OREAL
WO/2021/016430STABLE COMPOSITIONS OF MRNA-LOADED LIPID NANOPARTICLES AND  PROCESSES OF MAKINGTRANSLATE BIO, INC.
WO/2021/016435TWO-STEP LONG-WEAR COSMETIC SYSTEML'OREAL
WO/2021/021559A MODULAR, INTEGRATED PROCESS AND APPARATUS FOR EXTRACTING,  REFINING AND REMEDIATING ACTIVE SUBSTANCES FROM PLANT MATERIALBIOMASS OIL SEPARATION SOLUTIONS, LLC
WO/2021/016451CD63 AGONIST-RELATED METHODS AND COMPOSITIONSAGONOX, INC.
WO/2021/021563FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC  ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASEESPERVITA THERAPEUTICS, INC.
WO/2021/016457METHODS OF CREATING A SUBSTANCE WITH DIFFERENT FREEZING POINTS  BY ENCAPSULATIONTHE GENERAL HOSPITAL CORPORATION
WO/2021/016462THE PEPTIDOMIMETIC COMPOUND  (R)-2-AMINO-N-((S)-L-(((S)-5-AMINO-L-(3-BENZYL-1,2,4-OXADIAZOL-5-YL)PENTYL)AMINO)-3-(4-HYDROXY-2,6-DIMETHYLPHENYL)-I-OXOPROPAN-2-YL)-5-GUANIDINOPENTANAMIDE  IN THE TREATMENT OF NEURODEGENERATIVE DISEASESSTEALTH BIOTHERAPEUTICS CORP
WO/2021/021567METHODS AND ASSEMBLIES FOR PREPARING AND DISPENSING LYOSPHERES  OF PHARMACEUTICAL COMPOSITIONSMERCK SHARP & DOHME CORP.
WO/2021/016464METHODS AND COMPOSITIONS FOR TREATING CANCERCITY OF HOPE
WO/2021/021572ANTIOXIDANT AND ANTIVIRAL COMPOSITIONS AND METHODSMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/016520LIPOSOMAL NUTRACEUTICAL COMPOSITIONS AND METHODS OF MAKING THE  SAMEVASAYO, LLC
WO/2021/016521PHOTO INDUCED CONTROL OF PROTEIN DESTRUCTIONBETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/021603ENGINEERED HCV E2 IMMUNOGENS AND RELATED VACCINE COMPOSITIONSTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/021607YAP INHIBITION FOR WOUND HEALINGTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/016529METHODS AND COMPOSITIONS FOR HEPATITIS C VIRUS (HCV)THE JOHNS HOPKINS UNIVERSITY
WO/2021/021613A DERMAL PATCH FOR TRANSDERMAL ADMINISTRATION OF GHRELIN  PATHWAY BLOCKERHAMRAH, Pedram
WO/2021/016537CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOFNORTH CAROLINA STATE UNIVERSITY
WO/2021/021615RECOMBINANT HEME OXYGENASE-1 (HO-1) FOR THE TREATMENT OF  SICKLE CELL DISEASESHIRE HUMAN GENETIC THERAPIES, INC.
WO/2021/016543ANTIVIRAL COMBINATIONS OF THIAZOLIDE COMPOUNDSROMARK LABORATORIES L.C.
WO/2021/016548POLYIODIDE BINDING COMPOUNDS AND METHODS OF USE THEREOFNORTH CAROLINA STATE UNIVERSITY
WO/2021/016552N-CADHERIN BINDING MOLECULES AND USES THEREOFZOMEDICA PHARMACEUTICALS CORP.
WO/2021/016554CUPTSM FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERSALS THERAPY DEVELOPMENT INSTITUTE
WO/2021/021631IMMUNE CELLS WITH ENHANCED CYTOTOXICITY AND METHODS OF USE  THEREOFLUDWIG INSTITUTE FOR CANCER RESEARCH LTD
WO/2021/021644COMPOSITIONS AND METHODS FOR TREATMENT OF PRESBYOPIAALLERGAN SALES, LLC
WO/2021/016576TOPICAL COMPOSITIONSSKIN MEDICINALS LLC
WO/2021/021647DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST  DISEASE (GVHD) WITH IL-22 FC FUSION PROTEINSGENENTECH, INC.
WO/2021/021649METHODS FOR DETERMINING RISK OF DEVELOPING INSULIN RESISTANCETHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/021668PEPTIDES FOR TREATING NON-EXUDATIVE MACULAR DEGENERATION AND  OTHER DISORDERS OF THE EYEALLEGRO PHARMACEUTICALS, LLC
WO/2021/016609CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND CHIMERIC  STIMULATING RECEPTORS AND USES THEREOFEUREKA THERAPEUTICS, INC.
WO/2021/016612MEDICATION COATED WITH HEMP OR OTHER CANNABINOIDHEMPVANA, LLC
WO/2021/021705ANTIBODY PRE-LOADED CD16+NK-92 CELLS AS AN EFFECTIVE  THERAPEUTIC PRODUCT FOR TUMOR LYSISNANTKWEST, INC.
WO/2021/021708COMPOSITIONS FOR TREATING SEXUAL DYSFUNCTIONCHEMISTYRX
WO/2021/021713COMPOSITIONS AND METHODS OF USING C/EBP ALPHA SARNAMINA THERAPEUTICS LIMITED
WO/2021/021716COMPOSITIONS AND METHODS FOR INHIBITING NEOINTIMAL FORMATIONUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/021717ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING  THE SAMEBRII BIOSCIENCES, INC.
WO/2021/021729MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE  COMPOSITIONS AND METHODS OF USING THE SAMESANOFI PASTEUR INC.
WO/2021/016621POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CD38 CHIMERIC  ANTIGEN RECEPTORCELULARITY INC.
WO/2021/021741TREATMENT OF P53-DEFICIENT CANCERSHEALTH RESEARCH, INC.
WO/2021/021753A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINENDSU RESEARCH FOUNDATION
WO/2021/021759DETECTION OF MEDIATORS OF DOPAMINE TRANSMISSIONUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/021765NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINSEVOLVE BIOSYSTEMS, INC.
WO/2021/021774COMPOSITION AND METHOD FOR PROMOTING WOUND HEALINGTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/021778A COMPOSITION FOR MUCOSAL ADMINISTRATION TO AVIANSPHIBRO ANIMAL HEALTH CORPORATION
WO/2021/025899PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER PHARMACEUTICAL  COMPOSITIONSSAREPTA THERAPEUTICS, INC.
WO/2021/021811MYOSIN DERIVED PEPTIDES AND RELATED COMPOUNDS WITH  ANTICOAGULANT ACTIVITIESTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/021816CALPAIN INHIBITORS AND USES THEREOF FOR TREATING NEUROLOGICAL  DISORDERSBLADE THERAPEUTICS, INC.
WO/2021/091605COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS  AND ANTI-PD-1 ANTIBODIESCOMPUGEN LTD.
WO/2021/021837ANTI-PVRIG ANTIBODIES FORMULATIONS AND USES THEREOFCOMPUGEN LTD.
WO/2021/021846ANTIBODIES FOR THE DIAGNOSIS AND TREATMENT OF B-CELL ACUTE  LYMPHOBLASTIC LEUKEMIATHE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/021877GIPR-AGONIST COMPOUNDSELI LILLY AND COMPANY
WO/2021/021885METHODS OF TREATING ADVANCED PROSTATE CANCERTHE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/021893COMPOUNDS FOR USE IN TREATING NEUROLOGICAL DISORDERSCONSTELLATION PHARMACEUTICALS, INC.
WO/2021/021904PHARMACOLOGICAL INHIBITORS OF THE ENL YEATS DOMAINTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/021907METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND  CYTOTOXICITY OF NATURAL KILLER CELLSNKARTA, INC.
WO/2021/021909DOSING REGIMENS FOR ORAL COMPLEMENT FACTOR D INHIBITORSBIOCRYST PHARMACEUTICALS, INC.
WO/2021/021922COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIESMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/021927COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG  INFLAMMATIONREGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/021937ANTIGEN-SPECIFIC T CELL BANKS AND METHODS OF MAKING AND USING  THE SAME THERAPEUTICALLYBAYLOR COLLEGE OF MEDICINE
WO/2021/021939PLANT-BASED CHEMICALS FOR VARROA MITE CONTROLBOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/021944SYSTEMS AND METHODS FOR ASSESSING A TARGET MOLECULEAXBIO INC.
WO/2021/021951WDR5-MYC INHIBITORSVANDERBILT UNIVERSITY
WO/2021/021959SUBCUTANEOUS DELIVERY OF MULTIMERIC OLIGONUCLEOTIDES WITH  ENHANCED BIOACTIVITYMPEG LA, L.L.C.
WO/2021/021978COMPOSITIONS CONTAINING COPOLYMER OF VINYLPYRROLIDONE AND  ACRYLIC ACID AND FILM FORMING AGENTL'OREAL
WO/2021/021988TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED MRNA  ENCODING CFTRTRANSLATE BIO, INC.
WO/2021/021989CELLS FOR IMPROVED IMMUNOTHERAPY AND USES THEREOFMEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/150268METHODS OF TREATMENT OF ASTHMA AND COPDBRIDGE PHARMA, INC.
WO/2021/025935DNA-FISH METHOD FOR MEASUREMENT OF TELOMERE LENGTHGEORGETOWN UNIVERSITY
WO/2021/021994USE OF HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS FOR  TREATING SICKLE CELL DISEASEGLYCOMIMETICS, INC.
WO/2021/021996METHODS OF TREATING DISORDERS ASSOCIATED WITH ELEVATED LEVELS  OF ANTIBODIES THAT INTERACT WITH THE NMDA RECEPTORAPTINYX INC.
WO/2021/021999COMPOSITIONS AND METHODS FOR UPREGULATION OF HUMAN FETAL  HEMOGLOBINTHE UAB RESEARCH FOUNDATION
WO/2021/022001VACCINE COMPOSITIONS AND METHODS OF SELECTING ANTIGENSTRUSTEES OF TUFTS COLLEGE
WO/2021/022005FOCAL TREATMENT OF PROSTATE CANCERNYMOX CORPORATION
WO/2021/022012METHODS AND COMPOSITION FOR TREATING RESPIRATORY OBSTRUCTIVE  DISEASESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/022037IL-38-SPECIFIC ANTIOBODIESIMMUNOME, INC.
WO/2021/022044DEPLETION REGIMES FOR ENGINEERED T-CELL OR NK-CELL THERAPYFORTY SEVEN, INC.
WO/2021/022056COMPOSITIONS AND METHODS AND USES THEREOFFOAMIX PHARMACEUTICALS LTD.
WO/2021/022058ANTIARRHYTHMIC FORMULATIONINCARDA THERAPEUTICS, INC.
WO/2021/022061ARYL HYDROCARBON RECEPTOR ACTIVATORSOREGON STATE UNIVERSITY
WO/2021/022065WATER-SOLUBLE CANNABIS COMPOSITIONETAIN IP, LLC
WO/2021/022066COMPOSITIONS AND METHODS FOR INHIBITING BACTERIAL VIRULENCE  AND FLIM-BASED DEVICE AND METHOD FOR ANTIBIOTIC SUSCEPTIBILITY TESTINGTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/022070PREBIOTIC-INDUCED ANTI-TUMOR IMMUNITYSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/025959TARGETING THE GASTROINTESTINAL BARRIER TO TREAT AGE-RELATED  DISORDERSTHE GENERAL HOSPITAL CORPORATION
WO/2021/022076MOLECULES AND METHODS RELATED TO TREATMENT OF UNCONTROLLED  CELLULAR PROLIFERATIONST. JUDE CHILDREN'S RESEARCH HOSPITAL
WO/2021/022078DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPYXRAD THERAPEUTICS, INC.
WO/2021/022081METHOD FOR TREATING SOLID TUMORSBREAKBIO CORP.
WO/2021/022088INTRACRANIAL DELIVERY OF MEDICINAL SOLUTIONINCUBE LABS, LLC
WO/2021/022103COCRYSTALS OF POSACONAZOLE, METHODS OF MAKING AND USING SAMETHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/003488COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASESTRUETIVA, INC.
WO/2021/022105COMPOSITIONS AND METHODS FOR TREATING CANCER WITH  NUCLEOSIDE-METABOLISM MODULATORSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/022107MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOFTHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/022110INDUCING IMMUNE EFFECTS USING BACTERIA OF THE GENUS  <i>BIFIDOBACTERIUM</i>EVELO BIOSCIENCES, INC.
WO/2021/025976SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS,  ANALOGUES THEREOF, AND METHODS USING SAMEARBUTUS BIOPHARMA, INC.
WO/2021/022113MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOFTHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/022116INSULIN ANALOGUES WITH GLUCOSE REGULATED CONFORMATIONAL SWITCHTHERMALIN INC.
WO/2021/022117A PEPTOID-PEPTIDE HYBRID, NMEG-ACGRP, AND ITS USE IN  CARDIOVASCULAR DISEASESUNIVERSITY OF SOUTH CAROLINA
WO/2021/022121NITRILOTRIACETIC ACID-CONTAINING LIPIDOID NANOPARTICLESTRUSTEES OF TUFTS COLLEGE
WO/2021/025984RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONSTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/022132USE OF E-SELECTIN ANTAGONISTS TO ENHANCE THE SURVIVAL OF  RECONSTITUTED, BONE MARROW-DEPLETED HOSTSMAGNANI, John L.
WO/2021/022134BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOFTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/025985METHODS OF TREATING SUBSTANCE ABUSE DISORDER, DYSPNEA,  TINNITUS, AND CHILD AND ADOLESCENT DEPRESSIONPRAXIS PRECISION MEDICINES, INC.
WO/2021/025988DOSING PROTOCOLS AND REGIMENS FOR AMINOSTEROL TREATMENTENTERIN, INC.
WO/2021/025997MATERIALS AND METHODS FOR MULTIDIRECTIONAL BIOTRANSPORTATIONJANSSEN BIOTECH, INC.
WO/2021/025999METHODS AND COMPOSITIONS TO PROMOTE TARGETED GENOME  MODIFICATIONS USING HUH ENDONUCLEASESMONSANTO TECHNOLOGY LLC
WO/2021/026000MATERIALS AND METHODS FOR POLYMERIC ANTIBODY RECEPTOR  TARGETINGJANSSEN BIOTECH, INC.
WO/2021/066931MOLECULAR GUIDE SYSTEM PEPTIDES AND USES THEREOFBROWN, Kathlynn C.
WO/2021/022166ANTIBODY SPECIFIC FOR GPC3 AND METHODS OF USE THEREOFR.P. SCHERER TECHNOLOGIES, LLC
WO/2021/022172A DOSING REGIMEN FOR AN IDO INHIBITORINCYTE CORPORATION
WO/2021/022173COMPOSITIONS AND METHODS FOR DELIVERY OF RNA INTERFERENCE  AGENTS TO IMMUNE CELLSMODERNATX, INC.
WO/2021/022185POLY(BETA-THIOESTER) POLYMERS AND POLYMERIC NANOPARTICLESMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/022186DEUTERATED MK2 PATHWAY INHIBITORS AND METHODS OF USING THE  SAMEACLARIS THERAPEUTICS, INC.
WO/2021/022189COMPOSITIONS AND METHODS FOR TREATING ALPHA THALASSEMIATHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026021METHODS OF ADMINISTERING ANTI-SIGLEC-8 ANTIBODIES AND  CORTICOSTEROIDSALLAKOS INC.
WO/2021/026024COMPOSITIONS AND METHODS FOR TARGETING AND KILLING ALPHA-V  BETA-3 -POSITIVE CANCER STEM CELLS (CSCS) AND TREATING DRUG RESISTANT AND  METASTATIC CANCERSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/022208TARGETED GENE THERAPY TO TREAT NEUROLOGICAL DISEASESKAPLITT, Michael G.
WO/2021/022213INTRAVENOUS VITAMIN C THERAPY PROTOCOL FOR THE TREATMENT OF  CANCERRIORDAN CLINIC
WO/2021/026028METHODS FOR TREATING OR PREVENTING CANCERS INVOLVING THE  ADMINISTRATION OF ANTI-CCR5 RECEPTOR AGENTSCYTODYN INC.
WO/2021/022220ANTICANCER AGENTSTHE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/022223DUX4 EXPRESSING CELLS AND USES THEREOFSANA BIOTECHNOLOGY, INC.
WO/2021/022224COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF THEIR  USE IN THE INHIBITION OF INTERACTION BETWEEN IL18 AND IL18RBETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/026046TREATMENT OF CANINE CANCERSONEHEALTHCOMPANY, INC.
WO/2021/022249FCRN ANTIBODIES AND METHODS OF USE THEREOFMOMENTA PHARMACEUTICALS, INC.
WO/2021/026066COMPOSITIONS OF TROFINETIDENEUREN PHARMACEUTICALS LIMITED
WO/2021/026071METHOD FOR TREATING SEXUAL DYSFUNCTIONCATALYST PHARMACEUTICALS, INC.
WO/2021/026074BISPECIFIC ANTIBODY TARGETING OF T REGULATORY CELLS FOR  TREATMENT OF INFLAMMATORY CONDITIONSUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/026084COMPOSITIONS FOR THE TREATMENT OF HAIR LOSSANEIRA PHARMA, INC.
WO/2021/022258TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF HEMATOLOGICAL  CANCERSTETRAPHASE PHARMACEUTICALS, INC.
WO/2021/026091PREMIXED ULTRA-STABLE SINGLE-CHAIN INSULIN ANALOGUE  FORMULATIONSCASE WESTERN RESERVE UNIVERSITY
WO/2021/026124GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUSMARINUS PHARMACEUTICALS, INC.
WO/2021/026153ESTROGEN RECEPTOR MODULATORS FOR TREATING MUTANTSRECURIUM IP HOLDINGS, LLC
WO/2021/026169ANTI-ISCHEMIC COMPOSITIONSSERAPHIM THERAPEUTICS, INC.
WO/2021/026185INDOLE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES  THEREOFNEW YORK UNIVERSITY
WO/2021/026195AUTOLOGOUS THYMIC TISSUE TRANSPLANTATIONUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/026203METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC  IMMUNOTHERAPY BY ADMINISTERING AN IL-4R ANTAGONISTREGENERON PHARMACEUTICALS, INC.
WO/2021/026232KETAMINE FOR THE TREATMENT OF POSTPARTUM SYMPTOMS AND  DISORDERSTHE KETAMINE RESEARCH FOUNDATION
WO/2021/026247USE OF SEPIAPTERIN AND METABOLITES THEREOF TO TREAT RADIATION  EXPOSUREPTC THERAPEUTICS MP, INC.
WO/2021/026248NON-WOVEN WATER-SOLUBLE WIPEL'OREAL
WO/2021/026273SCALEABLE PREPARATION OF POLYKETIDESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026275GENETICALLY MODIFIED ENTEROVIRUS VECTORSVIROGIN BIOTECH CANADA LTD
WO/2021/026285FORMULATIONS INCLUDING DIHYDROHONOKIOLKIRKLAND, Justin
WO/2021/026287DISSOLVED C60 AND METHOD OF PRODUCING DISSOLVED C60INNOVATION FOR SUCCESS, LLC
WO/2021/026289Microsphere-Based Injectible Celecoxib FormulationAVIDENCE THERAPEUTICS, INC.
WO/2021/026290T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITYTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/026310PROCESSES OF PREPARING POLYGLUTAMATED ANTIFOLATES AND USES OF  THEIR COMPOSITIONSL.E.A.F. HOLDINGS GROUP LLC
WO/2021/026312USE OF TGF-ALPHA POLYPEPTIDE OR ANTI-TGF-ALPHA ANTIBODIES FOR  THE TREATMENT OF DISEASES AND DISORDERSTODARO, George, J.
WO/2021/030136ANTIBODY CHEMICALLY INDUCED DIMERIZERS (AbCID) AS MOLECULAR  SWITCHES AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026337METHOD OF TREATING KELOIDSICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/040996SIDE-DELIVERABLE TRANSCATHETER PROSTHETIC VALVES AND METHODS  FOR DELIVERING AND ANCHORING THE SAMEVDYNE, INC.
WO/2021/026353THERAPEUTIC EXTRACELLULAR VESICLESOHIO STATE INNOVATION FOUNDATION
WO/2021/030145SYSTEMS AND METHODS FOR MECHANOGENETIC FUNCTIONAL ULTRASOUND  IMAGINGTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/026358COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF AGENTSMODERNA TX, INC.
WO/2021/026375FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF PAINALKERMES, INC.
WO/2021/026377LACTAM-CONTAINING COMPOUNDS FOR THE TREATMENT OF PAINALKERMES, INC.
WO/2021/026378INDOLE COMPOUNDS FOR THE TREATMENT OF PAINALKERMES, INC.
WO/2021/026380PHENYLTRIAZOLE COMPOUNDS FOR THE TREATMENT OF PAINALKERMES, INC.
WO/2021/030155COMPOSITION OF PHARMACEUTICAL CARRIER SOLUTION FOR MESENCHYMAL  STEM CELLS AND USE OF THE SAMEBAYLX, INC.
WO/2021/030156COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF  BLADDER CANCERTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026391CELL PENETRATING PEPTIDE FUNCTIONALIZED PERFLUOROCARBON  NANOEMULSION COMPOSITIONS AND METHODS FOR IMAGING CELL POPULATIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026393CETUXIMAB-IR700 CONJUGATE COMPOSITIONSRAKUTEN MEDICAL, INC.
WO/2021/026395COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF THEIR  USE IN REVERSING CANCER CHEMORESISTANCETHE GENERAL HOSPITAL CORPORATION
WO/2021/030165TRPSWITCH − A STEP FUNCTION CHEMO-OPTOGENETIC LIGANDUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/030166ANTI-HOG TCN1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION  AND USE THEREOFSIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/026413PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF  NEUROLOGICAL DISEASESACLIPSE ONE INC.
WO/2021/026421PHARMACEUTICAL COMPOSITIONS OF  (6AS)-6-METHYL-5,6,6A,7-TETRAHYDRO-4H-DIBENZO[DE,G]QUINOLINE-10,11-DIOLACLIPSE ONE INC.
WO/2021/040999METHODS AND COMPOSITIONS FOR STIMULATING EXOSOME SECRETIONUNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/026429BUTYRYLCHOLINESTERASE COMPOUNDS AND USE IN DISEASES OF THE  NERVOUS SYSTEMTREVENTIS CORPORATION
WO/2021/030182BIFUNCTIONAL SINGLE VARIABLE DOMAIN T CELL RECEPTORS AND USES  THEREOFA2 BIOTHERAPEUTICS, INC.
WO/2021/030183COMBINATION TREATMENT OF SYSTEMIC FUNGAL INFECTIONSTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/026447METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A  MUTATION IN THE GLA GENEAMICUS THERAPEUTICS, INC.
WO/2021/026450HYBRID AMPHOTERICIN B DERIVATIVES WITH REDUCED TOXICITYTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/026451COMPOUNDS AND METHOD FOR TREATING CYTOKINE RELEASE SYNDROMERIGEL PHARMACEUTICALS, INC.
WO/2021/030190CBD FORMULATIONS AND USES THEREOFJUPITER WELLNESS, INC.
WO/2021/026454METHOD OF TREATING CANCERLAEKNA LIMITED
WO/2021/026455ANTIBIOTIC PEPTIDES, COMPOSITIONS AND USES THEREOFTHE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/026456WATER-SOLUBLE CANNABINOIDSOROCHEM TECHNOLOGIES, INC.
WO/2021/030196ELP FUSION PROTEINS COMPRISING PARATHYROID HORMONE FOR  CONTROLLED AND SUSTAINED RELEASEPHASEBIO PHARMACEUTICALS, INC.
WO/2021/026465JAK INHIBITORSVIMALAN BIOSCIENCES, INC.
WO/2021/030198COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMSVEDANTA BIOSCIENCES, INC.
WO/2021/026480COMPOSITIONS AND METHODS FOR DECREASING INTRAOCULAR PRESSUREDUKE UNIVERSITY
WO/2021/026483ADDITIONAL MASS TAG POLYMERS FOR MASS CYTOMETRYFLUIDIGM CANADA INC.
WO/2021/026484IMPLANTABLE CONSTRUCTS AND USES THEREOFWILLIAM MARSH RICE UNIVERSITY
WO/2021/030212METHOD OF ENHANCING THE EFFICACY AND STABILITY OF INGREDIENTS  IN SUSPENSIONSNANOPHASE TECHNOLOGIES CORPORATION
WO/2021/026491FUSION PROTEINS AGAINST SIALOSYLATED GLYCOSPHINGOLIPIDS AND  SIALATED GLYCOPROTEINS AND USES THEREOFON. TARGET MOLECULES BIOTECH INC.
WO/2021/026492KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTSHUMANWELL PHARMACEUTICAL US
WO/2021/026507METHODS OF IMPROVING ORGAN FUNCTIONCEDARS-SINAI MEDICAL CENTER
WO/2021/030218LIPIDATED CATIONIC PEPTIDE-PEG COMPOSITIONS FOR NUCLEIC ACID  DELIVERYNUTCRACKER THERAPEUTICS, INC.
WO/2021/030232OLFACTORY DELIVERY OF THERAPEUTIC COMPOUNDS TO THE CENTRAL  NERVOUS SYSTEMLOCUS IP COMPANY, LLC
WO/2021/026520HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN BTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/026522METHOD OF GENERATING ACTIVATED T CELLS FOR CANCER THERAPYCEDARS-SINAI MEDICAL CENTER
WO/2021/030248TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES  COMPRISING AN ATP COMPETITIVE AKT INHIBITOR, A CDK4/6 INHIBITOR, AND  FULVESTRANTGENENTECH, INC.
WO/2021/030250METHODS FOR INCREASING THE BIOAVAILABILITY OF OTC AND  PHARMACEUTICAL DRUGSLOCUS IP COMPANY, LLC
WO/2021/045870MIRTAZAPINE AS A PRE-SHIPPING INHIBITOR OF BOVINE RESPIRATORY  DISEASEIOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/026529INHIBITION OF INTERACTION BETWEEN OCT4 AND MAPKAPK2 OR  DNA-PKCS TO REGULATE C-MYC IN CANCERTEXAS TECH UNIVERSITY SYSTEM
WO/2021/030260PROLIPOSOMAL TESTOSTERONE UNDECANOATE FORMULATIONSTESORX PHARMA, LLC
WO/2021/030292COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED  METHODSAXOLOTL BIOLOGIX, INC.
WO/2021/030306DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTSMERCK SHARP & DOHME CORP.
WO/2021/030326BRUSH POLYMERS FOR THERAPEUTIC APPLICATIONSNORTHWESTERN UNIVERSITY
WO/2021/030335A STEREOISOMERICALLY PURE NK-3 RECEPTOR ANTAGONIST AND  CRYSTALLINE FORMS THEREOFMILLENDO THERAPEUTICS, INC.
WO/2021/0303431,4 DIHYDROPYRIDINE COMPOSITIONS, METHODS OF MAKING AND USEAMERICAN REGENT, INC.
WO/2021/030359PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL  NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCERPEPTINOVO BIOPHARMA, LLC
WO/2021/034548MITOCHONDRIAL MODULATION TO IMPROVE METABOLIC SYNDROME DURING  AGINGTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/030404METHODS AND COMPOSITIONS FOR TREATING VASCULAR MALFORMATIONSDECIPHERA PHARMACEUTICALS, LLC
WO/2021/030405RIPRETINIB FOR TREATING GASTROINTESTINAL STROMAL TUMORSDECIPHERA PHARMACEUTICALS, LLC
WO/2021/030407DIAGNOSTIC TEST FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUSUNIVERSITY OF MASSACHUSETTS
WO/2021/030411HYDROPHOBIC PEPTIDE SALTS FOR EXTENDED RELEASE COMPOSITIONSBIOMARIN PHARMACEUTICAL INC.
WO/2021/030433GENETICALLY ENGINEERED HUMAN FETAL LIVER NICHE AS PLATFORM FOR  BIOMANUFACTURING OF HEMATOPOIETIC STEM CELLSARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/030451GLYCEROL AS A PERMEATION ENHANCER AND COMPOSITIONS CONTAINING  THE SAMEDECIBEL THERAPEUTICS, INC
WO/2021/030469THERAPEUTIC MITOCHONDRIAL PEPTIDESCOHBAR, INC.
WO/2021/030472NANOPARTICLE COMPOSITIONSJANUARY THERAPEUTICS, INC.
WO/2021/030474ARTICLES AND METHODS FOR ADMINISTRATION OF THERAPEUTIC AGENTSMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/030511PROCESS FOR PREPARING  1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLATES AND 4-AMINOQUINOLINE COMPOUNDS  THEREFROMLOHOCLA RESEARCH CORPORATION
WO/2021/034582LARGE SCALE PRODUCTION OF EXOSOME MIMETICS AND USES THEREOFCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/030526METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROMERIGEL PHARMACEUTICALS, INC.
WO/2021/030528COMPOSITION AND METHOD FOR TREATMENT OF HIPPOCAMPAL SYNAPSE  DYSFUNCTION AND COGNITIVE DEFICITS IN ALZHEIMER'S DISEASEBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/030538HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT  A COSMETIC CONDITIONSTANDARD OF CARE CORPORATION
WO/2021/030542URACIL DERMAL PHARMACEUTICAL FORMULATIONNANOMETICS LLC (D.B.A PHD BIOSCIENCES)
WO/2021/030550NON-ACTIVATED, AMORPHOUS, pH NEUTRAL, TWO-PART BEDSIDE-READY  CLAY DELIVERY SYSTEM THAT TREATS PATHOGEN INFECTIONS IN HUMANS AND ANIMALSMCCORD, Darlene E.
WO/2021/030553METHODS OF TREATING <i>CRYPTOCOCCUS</i> INFECTIONSMATINAS BIOPHARMA NANOTECHNOLOGIES, INC.
WO/2021/030559DISAGGREGATION OF NANODIAMOND PARTICLESTHE CURATORS OF THE UNIVERSITY OF MISSOURI
WO/2021/030571METHODS OF TREATING PSYCHOLOGICAL AND BRAIN DISORDERSUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/041046BIO-BASED AND BIODEGRADABLE ELASTOMER FOR COSMETIC AND  PERSONAL CAREGRANT INDUSTRIES, INC.
WO/2021/030582THERAPEUTIC AGENT EFFECTIVENESS AND ITS ROUTE OF  ADMINISTRATIONALTIMMUNE, INC.
WO/2021/030586DUAL BISPECIFIC ANTIBODY COMPOUNDS AND USES THEREOFCITY OF HOPE
WO/2021/030588ORTHOPOXVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I  LIKE PROTEIN (OMCP) FOR TREATMENT OF AUTOIMMUNE DISEASECOURIER THERAPEUTICS, INC.
WO/2021/034616METHODS OF TREATING A SUBJECT WITH A CDC42-SPECIFIC INHIBITORCHILDREN' S HOSPITAL MEDICAL CENTER
WO/2021/030607PIMAVANSERIN FOR TREATING NEURODEGENERATIVE DISEASESACADIA PHARMACEUTICALS INC.
WO/2021/030619METHODS OF TREATING CANCERF. HOFFMANN-LA ROCHE AG
WO/2021/034627SMALL MOLECULE STIMULATORS OF THE CORE PARTICLE OF THE  PROTEASOMEPURDUE RESEARCH FOUNDATION
WO/2021/034629LARAZOTIDE FORMULATIONS9 METERS BIOPHARMA, INC.
WO/2021/034631METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING  4,6-BIS(BENZYLTHIO)HEXANOIC ACID FOR TREATING CANCERRAFAEL PHARMACEUTICALS, INC.
WO/2021/034634COMPOSITIONS AND METHODS UTILIZING A NOVEL HUMAN FOXO3 ISOFORMNEW YORK SOCIETY FOR THE RUPTURED AND CRIPPLED MAINTAINING THE  HOSPITAL FOR SPECIAL SURGERY
WO/2021/034635THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER USING  6,8-BIS-BENZYLTHIO-OCTANOIC ACID AND A GLUTAMINASE INHIBITORRAFAEL PHARMACEUTICALS, INC.
WO/2021/030665FORMULATIONS OF BENZAZEPINE CONJUGATES AND USES THEREOFSILVERBACK THERAPEUTICS, INC.
WO/2021/030671TETRACYCLIC COMPOUNDS AND THEIR SALTS, COMPOSITIONS, AND  METHODS FOR THEIR USESENHWA BIOSCIENCES, INC.
WO/2021/030679COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF  METABOLIC DISEASES AND DISORDERSUNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/034653COMBINATION THERAPY WITH GOLD CONTROLLED TRANSGENESCHIMERA BIOENGINEERING, INC.
WO/2021/030686CRYSTALLINE FORMS OF QUINOLINE ANALOGS AND SALTS THEREOF,  COMPOSITIONS, AND THEIR METHODS FOR USESENHWA BIOSCIENCES, INC.
WO/2021/030687THERAPEUTIC PEPTIDESCOHBAR, INC.
WO/2021/030689ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND  ADMINISTRATIONCYTOLYF THERAPEUTICS LLC
WO/2021/030698SENSITIZATION CREAM COMPRISING L-ARGININE AND L-CITRULLINE AND  THERAPEUTIC USES THEREOFINNOVUS PHARMACEUTICALS, INC.
WO/2021/030701IMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDSACUITAS THERAPEUTICS, INC.
WO/2021/030702DRINKABLE SUPPLEMENT COMPOSITION FOR IMPROVED HEALTH AND  HYDRATIONLOCUS IP COMPANY, LLC
WO/2021/030706IMMUNO ONCOLOGY COMBINATION THERAPIES WITH IL-2 CONJUGATESSYNTHORX, INC.
WO/2021/030717HERBAL PREPARATION FOR STIMULATION OF HAIR GROWTH, CONTROL OF  HAIR FALL, DANDRUFF AND INFECTIONS THEREOF USING AGERATUM SPP.GE NUTRIENTS, INC.
WO/2021/034689ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY  CELLSH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/030730METHODS FOR TREATING DISEASE ASSOCIATED WITH SENESCENCESTEADMAN PHILIPPON RESEARCH INSTITUTE
WO/2021/034697COMBINED CANCER THERAPY INVOLVING CHEMICAL ACTIVATION OF  INTEGRINS AND TARGETED CELL IMMUNOTHERAPYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030745COMBINED TRANSGENE AND INTRON-DERIVED MIRNA THERAPY FOR  TREATMENT OF SCA1THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/030749THERAPEUTIC PEPTIDESCOHBAR, INC.
WO/2021/030752THERAPEUTIC PEPTIDESCOHBAR, INC.
WO/2021/034716THROMBOSOMES AS AN ANTICOAGULANT REVERSAL AGENTCELLPHIRE, INC.
WO/2021/034718WATER-BASED EXTRACTION AND PURIFICATION PROCESSES FOR  CANNABINOID ACIDSMEDPHARM IOWA LLC
WO/2021/030763MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOFIONIS PHARMACEUTICALS, INC.
WO/2021/030766COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHYBIOGEN MA INC.
WO/2021/034728COMPOSITIONS AND PARTICLES FOR PAYLOAD DELIVERYAPPLIED MOLECULAR TRANSPORT INC.
WO/2021/030777EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOFCODIAK BIOSCIENCES, INC.
WO/2021/034729N-ARYL SULFONAMIDE DERIVATIVES AS VACCINE ADJUVANTTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030783COMPOSITIONS AND METHODS FOR THE TREATMENT CANCER AND CNS  DISORDERSDUKE UNIVERSITY
WO/2021/030785METHOD FOR THE PREPARATION OF LOW MOLECULAR WEIGHT PORCINE  LYMPHO-RETICULAR POLYPEPTIDES AND FORMULATIONS THEREOFDE URBINA GAVIRIA, Santiago
WO/2021/030787MODIFIED FACTOR VII POLYPEPTIDES FOR SUBCUTANEOUS  ADMINISTRATION AND ON-DEMAND TREATMENTCATALYST BIOSCIENCES, INC.
WO/2021/076217EDIBLE UNCLONABLE FUNCTIONSPURDUE RESEARCH FOUNDATION
WO/2021/030789NANOENCAPSULATED CANNABIDIOLCASTOR, Trevor, P.
WO/2021/030792THERAPEUTIC PEPTIDESCOHBAR, INC.
WO/2021/030794THERAPEUTIC PEPTIDESCOHBAR, INC.
WO/2021/030799THERAPEUTIC PEPTIDESCOHBAR, INC.
WO/2021/034774FUCOSYLATION AND IMMUNE MODULATION IN CANCERH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/030808PHOSPHATIDYLSERINE BINDING MOLECULES BLOCK IMMUNE SUPPRESSION  OF TUMOR ASSOCIATED EXOSOMESTHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/055124DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE  BUPROPIONAXSOME THERAPEUTICS, INC.
WO/2021/034804PHARMACEUTICAL FORMULATIONS OF TENOFOVIR ALAFENAMIDEGILEAD SCIENCES, INC.
WO/2021/034834COMPOSITIONS FOR SUNSCREEN COMPOUNDS AND METHODS THEREOFPMIDG, LLC
WO/2021/034850IN-SITU GEL FORMING OPHTHALMIC FORMULATIONS CONTAINING  DIFLUPREDNATEIVIEW THERAPEUTICS, INC.
WO/2021/034863CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND  COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN  PRODRUGSCHORDA PHARMA, INC.
WO/2021/101606COMPOSITIONS FOR SUNSCREEN COMPOUNDS AND METHODS THEREOFPMIDG, LLC
WO/2021/050219PHARMACEUTICAL COMPOSITION FOR TREATING INSOMNIAEISAI R&D MANAGEMENT CO., LTD.
WO/2021/034879PROBIOTIC DELIVERY OF GUIDED ANTIMICROBIAL PEPTIDESBAYLOR UNIVERSITY
WO/2021/034883TOPICAL NEUROSTEROID FORMULATIONSARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/034924TRANS-CYCLOOCTENE LABELED ANTISENSE OLIGONUCLEOTIDES, RADIO  LABELED TETRAZINE AND METHODSBIOGEN MA INC.
WO/2021/034943IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12WAYNE STATE UNIVERSITY
WO/2021/034952ANTI-CD19 ANTIBODIES AND USES THEREOFELPIS BIOPHARMACEUTICALS
WO/2021/034953COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2  MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLSNAVIDEA BIOPHARMACEUTICALS, INC.
WO/2021/034958MATERIALS FOR DELIVERY OF TETHERABLE PROTEINS IN BONE IMPLANTSTHERADAPTIVE, INC.
WO/2021/034962POLYMORPHIC FORMS OF DEOXYCYTIDINE, COMPOSITIONS COMPRISING  THE SAME AND USESMODIS THERAPEUTICS, INC.
WO/2021/034963IMMUNOLOGICALLY ACTIVE FRAGMENTS OF TOXOPLASMA GONDIIWASHINGTON UNIVERSITY
WO/2021/034982IMMUNE CELLS FOR ADOPTIVE CELL THERAPIESBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/034984SKELETAL MYOBLAST PROGENITOR CELL LINEAGE SPECIFICATION BY  CRISPR/CAS9-BASED TRANSCRIPTIONAL ACTIVATORSDUKE UNIVERSITY
WO/2021/034986CROTON LECHLERI COMPOSITIONS FOR USE IN TREATING BLEEDING,  WOUNDS AND INFECTIONSALPHYN BIOLOGICS
WO/2021/034992METHOD OF TREATING KRAS-ASSOCIATED CANCERSTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/034996TREATMENT OF CARDIOVASCULAR DISEASESSTEMCYTE INC.
WO/2021/035010CORROLE-BASED FRAMEWORKS AND METHODS OF USE THEREOFMA, Shengqian
WO/2021/035031INHIBITORS OF PHOSPHOLIPID SYNTHESIS AND METHODS OF USETHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/035037METHOD TO INCREASE SYSTEMIC BLOOD PRESSURE IN SHOCKGEORGETOWN UNIVERSITY
WO/2021/035048USE OF INHIBITORS OF YAP AND SOX2 FOR THE TREATMENT OF CANCERGEORGETOWN UNIVERSITY
WO/2021/035049IMPROVED RECOMBINANT PMHC MOLECULESUTI LIMITED PARTNERSHIP
WO/2021/066958INHIBITOR OF BTK AND MUTANTS THEREOFNEWAVE PHARMACEUTICAL INC.
WO/2021/035054LYMPHODEPLETION DOSING REGIMENS FOR CELLULAR IMMUNOTHERAPIESPRECISION BIOSCIENCES, INC.
WO/2021/035068INHIBITORS OF ZIKA VIRUS INFECTIONNEW YORK BLOOD CENTER, INC.
WO/2021/035078TYPE III NKT CELLS AND RELATED COMPOSITIONS AND METHODSAKESO THERAPEUTICS, INC.
WO/2021/035086SOLVENT DELIVERY SYSTEM FOR TOPICAL DELIVERY OF ACTIVE AGENTSTIMBER PHARMACEUTICALS, INC.
WO/2021/035093CHIMERIC INHIBITORY RECEPTORSENTI BIOSCIENCES, INC.
WO/2021/035101MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC  LATERAL SCLEROSIS AND RELATED DISORDERSBIOHAVEN THERAPEUTICS LTD.
WO/2021/035102PROCESS AND COMPOSITION MATTER OF NANOPARTICLE FORMULATION FOR  SYSTEMIC TREATMENT OF SEPSISPURDUE RESEARCH FOUNDATION
WO/2021/041171INTERCELLULAR ADHESION MOLECULE 1 (ICAM1) ANTIBODY DRUG  CONJUGATE AND USES THEREOFCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/041173BACTERIAL STRAIN USEFUL FOR TREATMENT OF AGE-RELATED  CONDITIONSWAKE FOREST UNIVERSITY HEALTH SCIENCES
WO/2021/035114PRODRUGS AND FORMULATIONS THEREOFBOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
WO/2021/035126MEDICAL APPARATUS WITH <i>CANNABIS SATIVA</i> L.PURE GREEN PHARMACEUTICALS, INC.
WO/2021/035128COMPOSITIONS AND METHODS FOR TREATING CHRONIC MYELOMONOCYTIC  LEUKEMIAH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/141637COMPOSITIONS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL  SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASESTHE SALLIE ASTOR BURDINE BREAST FOUNDATION
WO/2021/041206IL-15 CONJUGATES AND USES THEREOFSYNTHORX, INC.
WO/2021/041208METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS TO  PATIENTS WITH SEVERE RENAL IMPAIRMENTNEUROCRINE BIOSCIENCES, INC.
WO/2021/035142JUST SUNSCREENPOUCH PAC INNOVATIONS, LLC
WO/2021/035144OPTICAL BASED METHODS FOR DETERMINING ANTIMICROBIAL DOSING  REGIMENSUNIVERSITY OF HOUSTON SYSTEM
WO/2021/041222MULTI-ARMED POLYOXAZOLINES AND COMPOSITIONS, SYSTEMS AND  METHODS PERTAINING TO THE SAMEBOSTON SCIENTIFIC SCIMED, INC.
WO/2021/041230RADIOPAQUE MULTI-ARMED POLYMERS AND COMPOSITIONS, SYSTEMS AND  METHODS PERTAINING TO THE SAMEBOSTON SCIENTIFIC SCIMED, INC.
WO/2021/112931COMPOSITIONS COMPRISING MEROTERPENES AND LINOLEIC ACID  DERIVATIVES AND THEIR USE FOR REGULATING THE ENDOCANNABINOID SYSTEMSYTHEON LIMITED
WO/2021/035168METHODS FOR REPROGRAMMING CANCER CELLSTHOMAS JEFFERSON UNIVERSITY
WO/2021/035172DIAGNOSTICS AND METHODS FOR PROGNOSING RESPONSE TO  IMMUNOTHERAPY BASED ON THE METHYLATION STATUS OF IMMUNE SYNAPSE GENE  SIGNATUREH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/041246POZIOTINIB COMBINATION WITH VEGFR2 INHIBITORS AND METHODS OF  USE THEREOFSPECTRUM PHARMACEUTICALS, INC.
WO/2021/035177VARIANT FC DOMAINS AND USES THEREOFCIDARA THERAPEUTICS, INC.
WO/2021/035178MONOUNSATURATED FATTY ACID COMPOSITION AND USE FOR TREATING  FATTY LIVER DISEASEBURKE & BOYER, INC.
WO/2021/041247O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDESUNIVERSITY OF MASSACHUSETTS
WO/2021/041250IGM GLYCOVARIANTSIGM BIOSCIENCES, INC.
WO/2021/035181UBE3A FOR THE TREATMENT OF ANGELMAN SYNDROMETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/041264USE OF A NEUTROPHIL ELASTASE INHIBITOR IN LUNG DISEASEPH PHARMA CO., LTD.
WO/2021/035194COMBINATION THERAPY OF A T CELL THERAPY AND AN ENHANCER OF  ZESTE HOMOLOG 2 (EZH2) INHIBITOR AND RELATED METHODSJUNO THERAPEUTICS, INC.
WO/2021/035196COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASESOXALURX, INC.
WO/2021/035198COMPOSITIONS AND METHODS USING NON-STEROIDAL ANTI-INFLAMMATORY  DRUGSAPPLIED BIOLOGICAL LABORATORIES, INC.
WO/2021/035200INTEGRATED IMAGE LAYER CONSTRUCTIONSMABBOTT, Robert, J.
WO/2021/035205METHOD OF PREPARING A DE-FIBRINATED PLATELET LYSATE, AND USES  OF SAID METHODAWIDI, Abdalla S.
WO/2021/041299METHOD AND KIT FOR DETERMINING BENEFIT OF CHEMOTHERAPYST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/041301MODIFICATION OF PLANT MESSENGER PACKS WITH CHARGED LIPIDSFLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/035214NUCLEOSIDE PRODRUGS AND USES RELATED THERETOEMORY UNIVERSITY
WO/2021/041312SILICONE-FREE, LOW-FRICTION CLEANSER WITH HIGH-FOAMING  PROPERTIESL'OREAL
WO/2021/041316CD24 EXPRESSING CELLS AND USES THEREOFSANA BIOTECHNOLOGY, INC.
WO/2021/041317DDX17 AND NLRC4 TARGETING FOR INFLAMMATORY DISEASESUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/041326SUPER ABSORBENT POLYMER RECYCLING TO PRESSURE SENSITIVE  ADHESIVESTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/041335BIO-REMEDIAL NON-IMMUNOGENIC CANNABINOID DELIVERYSORSE TECHNOLOGY CORPORATION
WO/2021/041347METHODS OF TREATMENT USING BCN057 AND BCN512BCN BIOSCIENCES L.L.C.
WO/2021/041348METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE  DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERSARVINAS OPERATIONS, INC.
WO/2021/041350MUCOADHESIVE COMPOSITIONS AND METHOD OF USE THEREOFISP INVESTMENTS LLC
WO/2021/041355DIFFERENTIALLY-METHYLATED REGIONS OF THE GENOME USEFUL AS  MARKERS OF EMBRYO-ADULT TRANSITIONSAGEX THERAPEUTICS, INC.
WO/2021/041357FEED ADDITIVE FORMULATION FOR FISH AND METHODS OF MAKING AND  USING THE SAMEBIORESOURCE INTERNATIONAL, INC.
WO/2021/041374LIPOSOME FORMULATION OF FLUTICASONE FUROATE AND METHOD OF  PREPARATIONHUANG, Cai Gu
WO/2021/041392SUBSTITUTED (7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO COMPOUNDS  USEFUL AS JAK1 INHIBITORSCHEMWERTH, INC.
WO/2021/041430A SYSTEM AND METHOD USING PHOTOCHEMICAL OXYGEN STORAGE AND  RELEASEPORTLAND STATE UNIVERSITY
WO/2021/041443ORGANOID MESODERM LINEAGE DIVERSIFICATIONCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/041495METHOD TO MAINTAIN OR ENHANCE TISSUETHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/041496ZINC PHOSPHATE CONTAINING COMPOSITIONSCOLGATE-PALMOLIVE COMPANY
WO/2021/041506RATIONALLY DESIGNED LAWSONE DERIVATIVES AS ANTIMICROBIALS  AGAINST MULTIDRUG-RESISTANT <i>STAPHYLOCOCCUS AUREUS</i>KENT STATE UNIVERSITY
WO/2021/041515ORAL CARE COMPOSITIONS HAVING INCREASED FOAM PRODUCTION AND  METHODS FOR THE SAMECOLGATE-PALMOLIVE COMPANY
WO/2021/041518METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENSTURNSTONE BIOLOGICS CORP.
WO/2021/041559PLANT ACTIVES AND THEIR ANTI-POLLUTION EFFECTS THEREOFMAJEED, Muhammed
WO/2021/041561TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY  STEATOHEPATITIS WITH SLC25A1 INHIBITORSAVANTAGGIATI, Mauria Laura
WO/2021/041572COMPOSITIONS COMPRISING DECARBOXYLATED CANNABINOIDSNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/041583COMPOUNDS TO IDENTIFY BETA-LACTAMASES, AND METHODS OF USE  THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/041608SYSTEM AND METHOD OF MULTI-DRUG DELIVERYABBVIE INC.
WO/2021/041616ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS  AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONSARIXA PHARMACEUTICALS, INC.
WO/2021/041637COMPOSITIONS COMPRISING CANNABINOID IONS DISSOLVING IN  GLYCEROLNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/177999METHODS OF ADMINISTERING ELAGOLIXABBVIE INC.
WO/2021/041662PERIPHERAL NERVE AGONISTS SUPPRESS INFLAMMATIONUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/041671KRAS G12D INHIBITORSMIRATI THERAPEUTICS, INC.
WO/2021/041672METHODS OF TREATING CANCER USING TNFRSF25 ANTIBODIESPELICAN THERAPEUTICS, INC.
WO/2021/041673VAPOR PHASE COATING TECHNOLOGY FOR PHARMACEUTICAL ABUSE  DETERRENT FORMULATIONSAPPLIED MATERIALS, INC.
WO/2021/041675VAPOR PHASE COATINGS FOR PHARMACEUTICAL SOLUBILITY CONTROLAPPLIED MATERIALS, INC.
WO/2021/041711HEPARIN AND HEPARAN SULFATE FROM MODIFIED MST CELLS AND  METHODS OF MAKING AND USINGTEGA THERAPEUTICS, INC.
WO/2021/076238CLEAR NAIL TOP COAT COMPOSITIONS AND METHODS OF MAKINGILNP COSMETICS INC.
WO/2021/041721ANTIMICROBIAL VACCINE COMPOSITIONSONEBIOPHARMA, INC.
WO/2021/041725SYNTHETIC CARS TO TREAT IL13Rα2 POSITIVE HUMAN AND CANINE  TUMORSTHE TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA
WO/2021/041730COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDSDELPOR, INC.
WO/2021/041740COMPOSITIONS OF OPIOID ANTAGONISTS, IMPLANT DEVICES, AND  TREATMENT METHODS FOR OPIOID USE DISORDERDELPOR, INC.
WO/2021/041744ARYL BENZOYL IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF LUNG  CANCERUNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/041749Brown Adipose Tissue Myosin II Activators for Metabolic  TherapyTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/041760COSMETIC COMPOSITION HAVING A LAMELLAR NETWORKL'OREAL
WO/2021/041773METHODS FOR THE TREATMENT OF THYROID EYE DISEASEHZNP LIMITED
WO/2021/041776LIPOSOMAL TROPONOID COMPOUND FORMULATIONSUNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/041784HEMOGLOBIN-BASED NANOPARTICLES FOR OXYGEN DELIVERYOHIO STATE INNOVATION FOUNDATION
WO/2021/041791METHODS AND USES FOR APELIN RECEPTOR AGONISTSRTI INTERNATIONAL, INC.
WO/2021/041800TRANSDERMAL DEVICE COMPRISING PAIN MOLECULESREMEDY DIAGNOSTICS LLC
WO/2021/041824DRUG-POLYMER AMORPHOUS SOLID DISPERSIONS USING LINEAR POLY  (ACRYLIC ACID) POLYMERSLUBRIZOL ADVANCED MATERIALS, INC.
WO/2021/041834DEVELOPING AN EFFICIENT HYBRIDOMA PLATFORM FOR THERAPEUTIC  ANTIBODY DISCOVERYGENENTECH, INC.
WO/2021/041855LACTOCOCCAL EXPRESSION OF IL-35 FOR TREATMENT OF DISEASEMONTANA STATE UNIVERSITY
WO/2021/041858DIFFERENTIATED TENDON CELLS DERIVED FROM PLURIPOTENT  PROGENITOR CELLS AND METHODS OF USE THEREOFICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/041860METHODS FOR PRODUCING HOLLOW CERAMIC SPHERESPLASSEIN TECHNOLOGIES LTD. LLC
WO/2021/041866SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/041891USE OF DEOXYCHOLIC ACID, DERIVATIVES, OR SALTS THEREOF IN  MANAGING BACTERIAL INFECTIONS AND COMPOSITIONS RELATED THERETOEMORY UNIVERSITY
WO/2021/041895STAPLED BETA-CATENIN LIGANDSOHIO STATE INNOVATION FOUNDATION
WO/2021/041896NOVEL THERANOSTIC AGENTS FOR PSMA POSITIVE CANCERSMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/041906PEPTIDES FOR THE TREATMENT OF RENAL DISORDERSTHE GEORGE WASHINGTON UNIVERSITY
WO/2021/041912REACTIVATING P53 MUTANTS FOR CANCER TREATMENT BY TARGETING  PROLIDASE (PEPD)HEALTH RESEARCH, INC.
WO/2021/041923TRANSMISSION PREVENTION OF VIRUSES WITH APPLICATION OF  ANTISEPTIC COMPOSITION3M INNOVATIVE PROPERTIES COMPANY
WO/2021/041936CD25 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOFMONTEFIORE MEDICAL CENTER
WO/2021/126320TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED  DISORDERSAMYLYX PHARMACEUTICALS INC.
WO/2021/041942COLLAGEN P4H1 INHIBITOR AND ITS USEUNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/041956NON-FLAMMABLE, DRY PERSONAL CARE PRODUCT CONTAINING  trans-1233zd AND ETHANOLHONEYWELL INTERNATIONAL INC.
WO/2021/041964CONJUGATED INHIBITORS OF DNA DAMAGE RESPONSEPROLYNX LLC
WO/2021/041972ANTI-IL31 ANTIBODIES FOR VETERINARY USEKINDRED BIOSCIENCES, INC.
WO/2021/041981COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETOASSEMBLY BIOSCIENCES, INC.
WO/2021/041982NEUROTOXIN COMPOSITIONS FOR USE IN TREATING NEUROLOGIC AND  PSYCHIATRIC DISORDERSAEON BIOPHARMA, INC.
WO/2021/041986IMPROVED PRODUCTION OF RECOMBINANT AAV USING EMBRYONATED AVIAN  EGGSUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/041989COMPOSITIONS AND METHODS FOR TREATMENT OF INFLUENZA A  INFECTIONVIR BIOTECHNOLOGY, INC.
WO/2021/041991HYDROPHILIC BIOPOLYMER MEDICAMENT DELIVERY MECHANISMDIOMICS CORPORATION
WO/2021/041997CO-POTENTIATORS FOR THERAPY OF CYSTIC FIBROSIS CAUSED BY  MINIMAL FUNCTION CFTR MUTANTSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/042001COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDESNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/042015BIODEGRADABLE SOFT ELASTOMERS FOR REGENERATIVE ENGINEERINGNORTHWESTERN UNIVERSITY
WO/2021/042019ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOFAGENUS INC.
WO/2021/042024STING MODULATORS, COMPOSITIONS, AND METHODS OF USEUNIVERSITY OF SOUTH FLORIDA
WO/2021/042027METHODS OF GENERATING AND ISOLATING MIDBRAIN DOPAMINE NEURONSMEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/042029OXYTOCIN COMPOSITIONS FOR TREATMENT OF TINNITUSNEW YORK UNIVERSITY
WO/2021/042038TREATMENT OF PAIN BY TARGETING NR4A1UNIVERSITY OF CINCINNATI
WO/2021/042039SYNTHETIC ANTIMICROBIAL PEPTIDESAJK PHARMACEUTICAL LLC
WO/2021/042045METHODS FOR SCALABLE GENE INSERTIONSTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/042046MEMBRANE-ACTIVE ANTI-BACTERIAL COMPOUNDS AND USES THEREOFTRUSTEES OF DARTMOUTH COLLEGE
WO/2021/042048COPPER-ATSM FOR TREATING NEURODEGENERATIVE DISORDERS  ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTIONRESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/042050RNA-REGULATED FUSION PROTEINS AND METHODS OF THEIR USECORNELL UNIVERSITY
WO/2021/042055PEGLOTICASE FOR TREATMENT OF GOUT IN RENAL TRANSPLANT  RECIPIENTSHORIZON PHARMA RHEUMATOLOGY LLC
WO/2021/173184FORMULATION INCLUDING A COMBINATION OF β-ENDORPHIN AND  ADRENOCORTICOTROPIC HORMONEADAMIS PHARMACEUTICALS CORPORATION
WO/2021/042060COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO  CELLSYALE UNIVERSITY
WO/2021/042064PEPTIDE INHIBITORS OF FOCAL ADHESION KINASE ACTIVITY AND USES  THEREOFARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/042071RECOVERY OF HEPATIC FUNCTION OF CULTURED HEPATOCYTESLI, Albert
WO/2021/042080N-ARYL ARYLSULFONAMIDES THAT FUNCTION AS MITOCHONDRIAL  UNCOUPLERS FOR THE TREATMENT OF METABOLIC DISEASE AND CANCERUNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/046033BIOMIMETIC NANOEMULSIONS FOR OXYGEN DELIVERYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046034SMALL MOLECULE LIVER X RECEPTOR MODULATORS AND USES THEREOFUNIVERSITY OF HOUSTON SYSTEM
WO/2021/050320PHARMACEUTICAL COMPOSITIONS COMPRISING HEPARINOIDS AND METHODS  FOR PREPARING THEREOFHARROW IP, LLC
WO/2021/046047ENHANCED TOOTHPASTE AND KITSBEAUTYPASTE LLC
WO/2021/046048METHODS AND COMPOSITIONS FOR IMPROVING ONCOLYTIC VIRUS  INFECTION FOR NONPERMISSIVE CANCERSARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/046078COMB POLYMER AND BLOCK COPOLYMER STABILIZED NANOPARTICLES  ENCAPSULATING NUCLEIC ACIDS AND OTHER SOLUBLE HYDROPHILIC COMPOUNDSTHE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/046081METHODS AND COMPOSITIONS FOR TREATMENT OF DEMYELINATING  DISORDERSRUSH UNIVERSITY MEDICAL CENTER
WO/2021/046092A NOVEL POLYMORPH AND USES THEREOFPROCYPRA THERAPEUTICS, LLC
WO/2021/046100METHODS FOR TREATMENT USING PHTHALOCYANINE DYE-TARGETING  MOLECULE CONJUGATESRAKUTEN MEDICAL, INC.
WO/2021/046112AMINOQUINOLINE COMPOUNDS, IMMUNOCONJUGATES, AND USES THEREOFBOLT BIOTHERAPEUTICS, INC.
WO/2021/046125A NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA  VIRUSARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/046130COMPOSITIONS OF FULVIC ACID AND CANNABINOID AND USES THEREOFOMNI BIOCEUTICAL INNOVATIONS, INC.
WO/2021/046133IL-22 ORAL, INTRA-RECTAL, OR OTHER GUT-RELATED COMPOSITIONS  AND METHODS OF USE THEREOFAMGEN INC.
WO/2021/046139DOUBLE-DIGESTION ASSAY FOR ANALYZING LIGAND-DRUG CONJUGATESSEAGEN INC.
WO/2021/046169METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALSUNIVERSITY OF CINCINNATI
WO/2021/046178COMPOUNDS AND METHODS FOR TREATING CANCERDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/046179NOVEL COMPOUNDSINTRA-CELLULAR THERAPIES, INC.
WO/2021/046183METHODS OF TREATING EPILEPSY USING THE SAMETREVENA, INC.
WO/2021/046186VACCINE FOR TREATMENT OF CANCER AND METHOD OF MAKING BY STRESS  REPROGRAMMINGVCELL THERAPEUTICS, INC.
WO/2021/046190CYSTATHIONINE BETA-SYNTHASE ENZYME THERAPY FOR TREATMENT OF  ELEVATED HOMOCYSTEINE LEVELSORPHAN TECHNOLOGIES LTD.
WO/2021/050348PEROXIDASE ACTIVITY TOWARDS 10-ACETYL-3,7-DIHYDROXYPHENOXAZINECODEXIS, INC.
WO/2021/046196MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND  TERPENESQUICKSILVER SCIENTIFIC, INC.
WO/2021/046200STABLE LONG-TERM INFUSABLE FORMULATIONS AND METHODSCYLERUS, INC.
WO/2021/046205ADOPTIVE CELL THERAPY AND METHODS OF DOSING THEREOFTMUNITY THERAPEUTICS INC.
WO/2021/046216METHODS FOR IDENTIFYING BIOMARKERS TO PREDICT TREATMENT  RESPONSEARCH ONCOLOGY, INC.
WO/2021/046220COMPOUNDS AND METHODS FOR TREATING CANCERDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/046233CHELATE-CONTAINING PSMA INHIBITORSCANCER TARGETED TECHNOLOGY LLC
WO/2021/046250METHODS OF TREATMENTINTRA-CELLULAR THERAPIES, INC.
WO/2021/046254LIPOSOMAL SPHERICAL NUCLEIC ACID (SNA) CONSTRUCTS FOR SPLICE  MODULATIONEXICURE, INC.
WO/2021/046260ASIALOGLYCOPROTEIN RECEPTOR MEDIATED DELIVERY OF  THERAPEUTICALLY ACTIVE CONJUGATESARCTURUS THERAPEUTICS, INC.
WO/2021/046265LIPID NANOPARTICLE COMPOSITIONS COMPRISING CLOSED-ENDED DNA  AND CLEAVABLE LIPIDS AND METHODS OF USE THEREOFGENERATION BIO CO.
WO/2021/046296PALATABLE SOFT-CHEWBAYER HEALTHCARE LLC
WO/2021/046303CANNABIGEROL PROLINE COCRYSTALSEBERS TECH INC.
WO/2021/046305PALATABLE GRANULAR VETERINARY COMPOSITIONSBAYER HEALTHCARE LLC
WO/2021/046307HYBRIDIZED POLY(AMIDOAMINE)-AMINO ACID DENDRIMERSNORTH CAROLINA STATE UNIVERSITY
WO/2021/046315INHIBITORS OF ENCEPHALITIC ALPHAVIRUSESWISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/046322A SMALL MOLECULE THERAPEUTIC FOR PARKINSON'S DISEASE PAIRED  WITH A BIOMARKER OF THERAPEUTIC ACTIVITYWANG, Xinnan
WO/2021/046325INHIBITORS OF SGLT AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/046347IMMUNOCONJUGATE SYNTHESIS METHODBOLT BIOTHERAPEUTICS, INC.
WO/2021/046350RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC  DERMATITISINCYTE CORPORATION
WO/2021/046363GENE EDITING FOR VIRAL INFECTIONSTHEMBA INC.
WO/2021/046368METHODS AND COMPOUNDS MODIFYING MITOCHONDRIAL FUNCTIONWANG, Xinnan
WO/2021/046371TREATMENT AND PREVENTION OF PULMONARY INJURYTHE UAB RESEARCH FOUNDATION
WO/2021/046374MICROEMULSION DELIVERY SYSTEMS FOR ALCOHOL-SOLUBLE SPECIES  INCLUDING NONDERIVATIZED HORMONESQUICKSILVER SCIENTIFIC, INC.
WO/2021/046388COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF  POLLINATORS AGAINST PESTICIDESARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/046398COMBINATION ANTIVIRAL THERAPY FOR MEASLESTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/046404METHOD FOR INCREASING LYMPHOCYTE COUNT BY USING IL-7 FUSION  PROTEIN IN TUMORSGENEXINE, INC.
WO/2021/046405PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND  GLUCOSE CONTENTBAXTER INTERNATIONAL INC.
WO/2021/046408DIETARY SUPPLEMENT TO PROMOTE GUT HEALTHTERRAGENICS NUTRITION, INC.
WO/2021/046417COMPOSITIONS AND METHODS FOR DETECTING ALLERGEN REACTIVE TH2  CELLSBENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
WO/2021/046426CYCLIC DINUCLEOTIDE STING AGONISTS TETHERED TO A PD-1 OR  CTLA-4 ANTIBODIESSPEROVIE BIOSCIENCES, INC.
WO/2021/046432CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND  COMPOSITIONS FOR THE TREATMENT OF CANCERTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046443METHOD FOR CAPTURING AND PURIFICATION OF BIOLOGICSAMICUS THERAPEUTICS, INC.
WO/2021/046444TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID FOR THE  TREATMENT OF PSORIASIS IN PEDIATRIC PATIENTSENCORE DERMATOLOGY, INC.
WO/2021/046445DIMERIC ANTIGEN RECEPTORS (DAR) THAT BIND BCMASORRENTO THERAPEUTICS, INC.
WO/2021/046446COMPOSITIONS AND METHODS OF USE FOR ENHANCING FERTILITYYOURCHOICE THERAPEUTICS, INC.
WO/2021/046448VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID  HYDROXYLATED DERIVATIVES, AND METHODS OF USEBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/046450NUTRITIONAL SUPPLEMENTS AND METHODS OF SUPPLEMENTATION  AFFECTING THE ENDOCANNABINOID SYSTEMAMARE GLOBAL
WO/2021/046451COMPOSITIONS AND METHODS FOR DHFR TUNABLE PROTEIN REGULATIONOBSIDIAN THERAPEUTICS, INC.
WO/2021/046456NITRITE FORMULATIONS AND USES THEREOF FOR THE TREATMENT OF  LUNG INJURYUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/046480NUCLEIC ACID-MEDIATED DELIVERY OF THERAPEUTICSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046497ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOFSHEN, Haifa
WO/2021/046500TRANSDUCTION EFFICIENCY ASSAYBLUEBIRD BIO, INC.
WO/2021/046532ADMINISTRATION OF THERAPEUTIC AGENTS TO BRAIN AND OTHER CELLS  AND TISSUETHE JOHNS HOPKINS UNIVERSITY
WO/2021/050429TOPICAL COMPOSITION FOR TREATMENT OF PAINPUREFORM GLOBAL, INC.
WO/2021/050430DEVELOPMENT OF EMBRYONIC-LIKE TISSUE FROM STEM CELLSTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/046549COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONSCIDARA THERAPEUTICS, INC.
WO/2021/046550EXTRACELLULAR VESICLE-FENRETINIDE COMPOSITIONS, EXTRACELLULAR  VESICLE-C-KIT INHIBITOR COMPOSITIONS, METHODS OF MAKING AND USES THEREOFMANTRA BIO, INC.
WO/2021/050449COMPOSITIONS AND METHODS OF SUPPRESSING AVERSIVENESS OF  PHARMACEUTICALS AND INGESTIBLE MATERIALSMONELL CHEMICAL SENSES CENTER
WO/2021/050469HIGH SPF SUNSCREEN COMPOSITIONSVI-JON, LLC
WO/2021/050470SUSTAINED RELEASE THERMOSETTING GELS COMPRISING SODIUM CHANNEL  BLOCKERS AND THE METHODS OF MAKING THE SAMEFLEXION THERAPEUTICS, INC.
WO/2021/050490METHODS OF ENHANCING RADIOTHERAPY USING FERROPTOSIS INDUCERS  AS RADIOSENSITIZERSTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/050510ENGINEERED PEPTIDE AND PEPTIDE MIMETIC COMPOSITIONS AND  METHODSTHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/050521COMPOSITIONS, METHODS AND USES FOR FREE FATTY ACID SCREENING  OF CELLS AT SCALETHE BROAD INSTITUTE, INC.
WO/2021/050527COMPOSITIONS AND METHODS FOR MAKING AND USING MULTISPECIFIC  ANTIBODIESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/050532COMPOSITIONS FOR TREATING FUNGAL INFECTIONSAFYX THERAPEUTICS A/S
WO/2021/050534NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMSARBOR BIOTECHNOLOGIES, INC.
WO/2021/050538METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED  AMPK PROTEINUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/050547MITOCHONDRIAL COMPLEX I INHIBITORS AND METHODS OF USESANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/050554IL-2 CONJUGATES AND METHODS OF USE TO TREAT AUTOIMMUNE  DISEASESSYNTHORX, INC.
WO/2021/050558NEUROTOXIN COMPOSITIONS FOR USE IN TREATING GASTROPARESISAEON BIOPHARMA, INC.
WO/2021/050568NANOPARTICLES FOR SELECTIVE TISSUE OR CELLULAR UPTAKEYALE UNIVERSITY
WO/2021/050571NOVEL NUCLEOBASE EDITORS AND METHODS OF USING SAMEBEAM THERAPEUTICS INC.
WO/2021/050580CRYSTALLINE FORM OF A MULTI-TYROSINE KINASE INHIBITOR, METHOD  OF PREPARATION, AND USE THEREOFMIRATI THERAPEUTICS, INC.
WO/2021/050591BISPECIFIC ANTIBODY CAR CELL IMMUNOTHERAPYCYTOIMMUNE THERAPEUTICS, INC.
WO/2021/050606COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED  WITH CLEC16A DYSFUNCTION OR LOSSTHE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/050629POLYMER DRUGS FOR CANCER THERAPIESVIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/050645COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITISGENENTECH, INC.
WO/2021/050648METHODS OF TREATING CANCERRGENIX, INC.
WO/2021/050649METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2  VARIANTS ENCODING AFLIBERCEPTADVERUM BIOTECHNOLOGIES, INC.
WO/2021/050653PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE  INHIBITORSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/050666AAV-ZYME AND USE FOR INFUSION REPLACEMENT THERAPYAAV GENE THERAPEUTICS, INC.
WO/2021/050687STABLE AQUEOUS FORMULATIONS OF AFLIBERCEPTCOHERUS BIOSCIENCES, INC.
WO/2021/050696COMPOSITIONS AND METHODS FOR IMPROVING TUMOR PENETRATION OF  TUMOR SPECIFIC ANTIBODIESTHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/050700CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOFTHE BROAD INSTITUTE, INC.
WO/2021/050702KDM INHIBITORS AND USES THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/050718METHODS OF TREATMENT RELATED TO COMPLEXES OF VON WILLEBRAND  FACTOR AND COMPLEMENT C1QBAXALTA INCORPORATED
WO/2021/050721QUINOLINE DERIVATIVES AND USES IN MANAGING CANCEREMORY UNIVERSITY
WO/2021/050722AN IMMUNOTHERAPEUTIC FOR PROSTATE CANCER TREATMENTHEXAMER THERAPEUTICS, INC.
WO/2021/050727ANTI-VIRAL COMPOSITIONS AND METHODS OF MAKING AND USINGUNIVERSITY OF LOUISVILLE RESEARCH FOUNDATIONS,INC.
WO/2021/050732METHODS OF TREATING KRAS MUTANT CANCERSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/050743COMPOSITIONS AND METHODS FOR TREATING SLOW-FLOW VASCULAR  MALFORMATIONSYALE UNIVERSITY
WO/2021/050752CHIMERIC ORTHOGONAL RECEPTOR PROTEINS AND METHODS OF USEGARCIA, Kenan Christopher
WO/2021/050754INHALED DELIVERY OF PEPTIDE MIMICS OF CXCL10 FOR TARGETED  ANTI-FIBROTIC THERAPYUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/050778LIPOPOLYSACCHARIDE MOLECULES FOR ENHANCING IMMUNE RESPONSESTHE PENN STATE RESEARCH FOUNDATION
WO/2021/050779ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLESUNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/050786CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND  THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOFCALIFORNIA AMBER INC.
WO/2021/050799COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING  ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULESPURDUE RESEARCH FOUNDATION
WO/2021/050800METHODS AND COMPOSITIONS FOR THE TREATMENT OF HPV-RELATED  CANCERBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/050812METABOLIC REPROGRAMMING OF IMMUNE CELLS FOR THE TREATMENT OR  PREVENTION OF DISEASES AND DISORDERSARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/050824CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALSPRELUDE THERAPEUTICS INCORPORATED
WO/2021/050848ENGINEERED CELLS AND USES THEREOFOHIO STATE INNOVATION FOUNDATION
WO/2021/050862ANTIGEN RECOGNIZING RECEPTORS TARGETING CD371 AND USES THEREOFMEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/050864HUMAN CYTOMEGALOVIRUS VACCINEMODERNATX, INC.
WO/2021/050877COMPOSITIONS INCLUDING MOLECULES OF MODIFIED MRNA AND METHODS  OF USING THE SAMEICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/050890PEPTIDE-BASED COMPOSITIONS AND METHODS FOR TREATING  ALZHEIMER'S DISEASEBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/050913INHIBITORS OF SARM1DISARM THERAPEUTICS, INC.
WO/2021/050917PHOSPHOLIPID ETHER CONJUGATES AS CANCER-TARGETING DRUG  VEHICLESCELLECTAR BIOSCIENCES, INC.
WO/2021/050936METHODS OF TREATMENT WITH CD8 T CELL-MEDIATED IMMUNE THERAPYPROVIDENCE HEALTH & SERVICES - OREGON
WO/2021/050937METHODS FOR THE TREATMENT OF ARID1A-DEFICIENT CANCERSTHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/050940TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS  DELIVERED BY LIPID NANOPARTICLESREGENERON PHARMACEUTICALS, INC.
WO/2021/050945THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDSTERNS, INC.
WO/2021/050948COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION  PROTEINSTCR2 THERAPEUTICS INC.
WO/2021/050953COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC  BIOLOGICS FOR TREATMENT OF DISEASEELEKTROFI, INC.
WO/2021/050954COMPOSITIONS AND METHODS RELATED TO HUMAN NEUTRALIZING  ANTIBODIES TO HEPATITIS BTHE ROCKEFELLER UNIVERSITY
WO/2021/050956ANTIVIRAL PRODRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOFTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/050961ANTIVIRAL PRODRUGS AND FORMULATIONS THEREOFTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/050964HPK1 ANTAGONISTS AND USES THEREOFNIMBUS SATURN, INC.
WO/2021/050965COMPOSITIONS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDERCRESTOVO HOLDINGS LLC
WO/2021/050974ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDSTHE BROAD INSTITUTE, INC.
WO/2021/050975USE OF GHOST NANOVESICLES AS THERAPEUTICSLOTVALL, Jan
WO/2021/050978TREATMENT OF SKIN BLISTERING DISEASES USING ANTIBODIESUNIVERSITY OF CINCINNATI
WO/2021/050980DRUGGABLE TARGET TO TREAT RETINAL DEGENERATIONTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH & HUMAN SERVICES
WO/2021/050986LNP-FORMULATED MRNA THERAPEUTICS AND USE THEREOF FOR TREATING  HUMAN SUBJECTSMODERNATX, INC.
WO/2021/050991COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIALACERTA THERAPEUTICS, INC
WO/2021/050994HETEROBICYCLIC CARBOXAMIDES AND USES THEREOFAERIE PHARMACEUTICALS, INC.
WO/2021/051003OPHTHALMIC FORMULATIONS OF METHOTREXATEALDEYRA THERAPEUTICS, INC.
WO/2021/051015COMPOSITIONS AND METHODS FOR RESCUING RETINAL AND CHOROIDAL  STRUCTURE AND FUNCTIONAUCKLAND UNISERVICES LIMITED
WO/2021/051016SYSTEMS AND ASSAYS FOR IDENTIFYING PU.1 INHIBITORSMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/051033POLYGENIC SCORE FOR CARDIAC HEART FAILUREHENRY FORD HEALTH SYSTEM
WO/2021/051042UNIVERSAL DONOR SELECTION METHOD TO IDENTIFY NK-CELL-DONORSTHE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/051043HYDROGEN GAS ELIMINATORSDAVIES, Benjamin Rhys
WO/2021/055273ANIONIC POLAR PHOSPHOLIPID COMPOSITION AND RELATED METHODS FOR  TREATMENT OF MUCOSAL CONDITIONSESSENTIAL LIPID TECHNOLOGIES, LLC
WO/2021/051065TERT, WT-1, PMSA IMMUNOGENIC COMPOSITIONS AND METHODS OF  TREATMENT USING THE SAMEINOVIO PHARMACEUTICALS, INC.
WO/2021/051079METHODS AND COMPOSITIONS FOR ASSESSING AND PREDICTING  THERAPEUTIC RESPONSELANKENAU INSTITUTE FOR MEDICAL RESEARCH
WO/2021/051080OPIOID INDEPENDENT SURGICAL ANESTHETICUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/055288NANOPARTICLE PHARMACEUTICAL DELIVERY SYSTEMADEIRA PHARMA, LLC
WO/2021/051088NK CELL IMMUNOTHERAPY COMPOSITIONS, METHODS OF MAKING AND  METHODS OF USING SAMEOHIO STATE INNOVATION FOUNDATION
WO/2021/247064COMBINATION OF RUXOLITINIB WITH INCB057643 FOR TREATMENT OF  MYELOPROLIFERATIVE NEOPLASMSINCYTE CORPORATION
WO/2021/061437CO-DELIVERY OF TGF-β SIRNA AND PDL1 SIRNA TO TREAT CANCERSIRNAOMICS, INC.
WO/2021/055329ANTI-CD39 ANTIBODY COMPOSITIONS AND METHODSSURFACE ONCOLOGY, INC.
WO/2021/055352METHODS AND COMPOSITIONS FOR PRESERVING BACTERIAVEDANTA BIOSCIENCES, INC.
WO/2021/096589SMALL MOLECULES POLYMERASE INHIBITORSGEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/055383METHODS OF BLOCKING ASFV INFECTION THROUGH INTERRUPTION OF  CELLULAR RECEPTORSCHEN, Dalu
WO/2021/055385DIAGNOSTIC ASSAY FOR CANCERSTITCH BIO, LLC
WO/2021/055409ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOF IN  RENAL DISEASEOPSIDIO, LLC
WO/2021/055419COMPOSITIONS FOR IMPROVING EYE HEALTH AND METHODS OF MAKING  AND USING THEREOFOASIS MEDICAL, INC.
WO/2021/055437CD70 TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AND USES  THEREOFTHE GENERAL HOSPITAL CORPORATION
WO/2021/055448TREATMENT OF DISC DEGENERATIVE DISEASE AND STIMULATION OF  PROTEOGLYCAN SYNTHESIS BY FIBROBLAST CONDITIONED MEDIA AND FORMULATIONS  THEREOFFIGENE, LLC
WO/2021/055459HIGHLY EFFICIENT DNA BASE EDITORS MEDIATED BY RNA-APTAMER  RECRUITMENT FOR TARGETED GENOME MODIFICATION AND USES THEREOFRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/055467ORALLY ADMINISTRABLE NANO-MEDICINE FOR VIRAL DISEASESUNIVERSITY OF MIAMI
WO/2021/055489COMPOSITIONS AND METHODS FOR THE TREATMENT OF SWI-SNF MUTANT  TUMORSGROHAR, Patrick, J.
WO/2021/055492SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF  ENDOTOXEMIAMICROBIOME LABS, LLC
WO/2021/055493TREATMENT OF SYNGAP1 ENCEPHALOPATHYZYNERBA PHARMACEUTICALS, INC.
WO/2021/055497CNP VARIANTS AND CONJUGATES THEREOFBIOMARIN PHARMACEUTICAL INC.
WO/2021/055499TREATMENT OF BEHAVIORAL IMPAIRMENT IN DEVELOPMENTAL AND  EPILEPTIC ENCEPHALOPATHYZYNERBA PHARMACEUTICALS, INC.
WO/2021/055505SUBCUTANEOUSLY INJECTABLE INSULIN FORMULATIONS AND METHODS OF  ADMINISTRATIONCASS PHARMACEUTICALS, INC.
WO/2021/055506ANTIMICROBIAL AGENTS AND COMPOSITIONS AND USES THEREOFCHEMIC LABORATORIES, INC.
WO/2021/055518BENZIMIDAZOLES AND METHODS OF USING SAMEUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/055530PROTEIN TAG TO INDUCE LIGAND DEPENDENT DEGRADATION OF  PROTEIN/PROTEIN-FUSIONSDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/055553SPRAYABLE LIQUID LIDOCAINE SOLUTIONCELISTA PHARMACEUTICALS LLC
WO/2021/055554METHODS TO IMPROVE PATIENT RESPONSE TO IMMUNE CHECKPOINT  INHIBITORS AND FUNCTIONAL TESTS TO PREDICT RESPONSEBIOMARKER STRATEGIES, LLC
WO/2021/055575CONTROLLED NUTRIENT DELIVERY TO PANCREATIC ISLETS USING A  NOVEL MESOPOROUS SILICA-BASED NANOPARTICLE PLATFORMTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/055576COMBINATION OF MODAFINIL AND AN AMPAKINE FOR IMPROVING  COGNITIONPURDUE PHARMA L.P.
WO/2021/055580AN ANAPLASTIC LYMPHOMA KINASE (ALK) CANCER VACCINE AND METHODS  OF USECHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/055583HUMAN ANTI-PD-L1 PEPTIDE VACCINES AND METHODS OF THEIR USEOHIO STATE INNOVATION FOUNDATION
WO/2021/055625BEE VACCINES AND METHODS OF USEDALAN ANIMAL HEALTH, INC.
WO/2021/055636THERAPEUTIC USES AND METHODS OF DELIVERY OF VISCOUS  COMPOSITIONS DURING PRE AND POST SURGICAL PERIODS, FOR TREATMENT OF  RESPONSIVE DISEASES OF THE EAR, NOSE, AND THROATTOPICAL SINUS THERAPEUTICS, INC.
WO/2021/055638RADIOLABELING OF ANTI-CD45 IMMUNOGLOBULIN AND METHODS OF USE  THEREOFACTINIUM PHARMACEUTICALS, INC.
WO/2021/055641FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND  THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASESPURDUE RESEARCH FOUNDATION
WO/2021/055651EXTENDED RELEASE DOSAGE FORMS FOR TYK2 INHIBITORSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/055652DOSAGE FORMS FOR TYK2 INHIBITORSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/055658IMPLANIMPLANTABLE SCAFFOLDS AND USES THEREOF FOR IMMUNOTHERAPY  OTHER USESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055660PROTEIN PRODUCING NANOLIPOSOMES AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055668INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9XFORMA THERAPEUTICS, INC.
WO/2021/055672COMPOSITIONS OF CANNABINOIDS FOR DELIVERY BY INHALATIONBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/055697IMMUNOACTIVE MICROPARTICLES AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055703TOUGH GEL-BASED DRUG DELIVERY COMPOSITIONS AND METHODS THEREOFPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/055713INTEGRIN RECEPTOR ALPHA V BETA 3 AND ITS LIGAND INVOLVED IN  CHRONIC ITCHNORTH CAROLINA STATE UNIVERSITY
WO/2021/061515SHP2 INHIBITORS AND USES THEREOFSYNBLIA THERAPEUTICS, INC.
WO/2021/055725USE OF A PPAR-DELTA AGONIST IN THE TREATMENT OF KIDNEY DISEASERENEO PHARMACEUTICALS, INC.
WO/2021/055731IL-36 CYTOKINE EXPRESSING ONCOLYTIC VIRUSES FOR TREATING  CANCERUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/055747THERAPEUTIC CONJUGATESTOTUS MEDICINES INC.
WO/2021/055749THERAPEUTIC CONJUGATESTOTUS MEDICINES INC.
WO/2021/055753METHODS AND COMPOSITIONS FOR INHIBITION OF CMP-SUGAR  SYNTHETASESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055760SYNTHETIC DNA VECTORS AND METHODS OF USEINTERGALACTIC THERAPEUTICS, INC.
WO/2021/055777METHODS FOR REDUCTION OF BITTERNESS IN CANNABINOIDS USING  MYCELIAL MATERIALSMYCOTECHNOLOGY, INC.
WO/2021/086513METHODS FOR THE PRODUCTION OF PSILOCYBIN AND INTERMEDIATES OR  SIDE PRODUCTSMIAMI UNIVERSITY
WO/2021/055785ENDOCANNABINOID MIMETIC AND ANTI-INFLAMMATORY COMPOUND  CONTAINING COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOFPHARMA COSMETIX RESEARCH, LLC
WO/2021/055788HIGH DENSITY LIPOPROTEIN-LIKE NANOPARTICLES AS INDUCERS OF  FERROPTOSIS IN CANCERNORTHWESTERN UNIVERSITY
WO/2021/055789USE OF DKK-1 INHIBITORS FOR TREATING CANCERLEAP THERAPEUTICS, INC.
WO/2021/055807ACTIVATING PYRUVATE KINASE RFORMA THERAPEUTICS, INC.
WO/2021/055808ANTIBODIES DIRECTED AGAINST TENOFOVIR AND DERIVATIVES THEREOFABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
WO/2021/055809METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF  METABOLIC DISEASES AND DISORDERSRESEARCH DEVELOPMENT FOUNDATION
WO/2021/055814POSITRON EMISSION TOMOGRAPHY GUIDED DELIVERY OF MITOCHONDRAL  COMPLEX I INHIBITORSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055817STABILIZED C-FMS INTRACELLULAR FRAGMENTS (FICD) PROMOTE  OSTEOCLAST DIFFERENTIATION AND ARTHRITIC BONE EROSIONNEW YORK SOCIETY FOR THE RUPTURED AND CRIPPLED MAINTAINING THE  HOSPITAL FOR SPECIAL SURGERY
WO/2021/0558203'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC  ACID AND ITS SALTS FORMULATIONNOVARTIS AG
WO/2021/154339NUTRACEUTICAL EXTRACTS OF <i>HIPPOPHAE  RHAMNOIDES</i> AND <i>TERMINALIA CHEBULA</i> AND USES  THEREOFBIOMICS, LLC
WO/2021/055860EFFECTIVE DOSAGES OF AN ADENOVIRAL-BASED BIOLOGICAL DELIVERY  AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS IN HUMANS,  AND COMPOSITIONS COMPRISING THE SAMEFLEXION THERAPEUTICS, INC.
WO/2021/055863PYRUVATE KINASE R (PKR) ACTIVATING COMPOSITIONSFORMA THERAPEUTICS, INC.
WO/2021/055865SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF  BIOLOGICALLY ACTIVE COMPOUNDSSEAGEN INC.
WO/2021/055875COMPOSITIONS AND METHODS FOR MICROBIOME MODULATIONANCILIA, INC.
WO/2021/055876COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN  BINDING DOMAIN CONSTRUCTS TARGETED TO CD38MOMENTA PHARMACEUTICALS, INC.
WO/2021/055890CONTROLLED RELEASE FORMULATIONS OF RILUZOLE AND THEIR USESICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/055895ANTI-PTCRA ANTIBODY-DRUG CONJUGATES AND USES THEREOFREGENERON PHARMACEUTICALS, INC.
WO/2021/055907TREATMENT OF CANCERABBVIE INC.
WO/2021/061554IBUDILAST ORAL FORMULATIONS AND METHODS OF USING SAMEMEDICINOVA, INC.
WO/2021/055933NOVEL MIMETICS OF HEPARIN OLIGOSACCHARIDESBOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/055936SMALL-MOLECULE INHIBITORS FOR THE  <i>Β</i>-CATENIN/B-CELL LYMPHOMA 9 PROTEIN−PROTEIN INTERACTIONH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/055939NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMSOHIO STATE INNOVATION FOUNDATION
WO/2021/055956METHODS OF TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) AND  NF1-MEDIATED CONDITIONS AND COMPOSITIONS FOR USE IN SUCH METHODSTHE UAB RESEARCH FOUNDATION
WO/2021/055985IPSC-DERIVED, HYPOIMMUNOGENIC, MYELOID PROGENITOR CELLSCELLERANT THERAPEUTICS, INC.
WO/2021/061586MICROENCAPSULATED PROBIOTIC AND COMPOSITIONS CONTAINING THE  SAMEGPCP IP HOLDINGS LLC
WO/2021/061642NOVEL UREAS HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND  USES THEREOFACCUTAR BIOTECHNOLOGY INC.
WO/2021/061643METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONPMV PHARMACEUTICALS, INC.
WO/2021/061644NOVEL SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES WITH  ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOFACCUTAR BIOTECHNOLOGY INC.
WO/2021/061648METHODS AND COMPOSITIONS FOR STIMULATION OF ENDOGENOUS T CELL  RESPONSESMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/061676MULTI-ANTIGENIC PEPTIDE MIMICS OF GONOCOCCAL  LIPO-OLIGOSACCHARIDE (LOS) EPITOPESUNIVERSITY OF MASSACHUSETTS
WO/2021/061687COMPOSITIONS AND METHODS FOR RESTORING OR INCREASING TISSUE  PERFUSIONVIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/035226METHODS FOR SOLUBILIZATION OF ARSENIC SULFIDE MINERALS AND  THEIR USE AS THERAPEUTICSSAVARINO, Andrea
WO/2021/067076METHODS FOR TREATING OR PREVENTING OBESITY AND BODY WEIGHT  MANAGEMENTBRILLIAN PHARMA INC.
WO/2021/061695TREATMENT OF EGFR MUTANT-RELATED CANCERS USING A COMBINATION  OF EGFR AND CDK4/6 INHIBITORSBETA PHARMA, INC.
WO/2021/061708MONOCLONAL ANTIBODY AGAINST CANINE FIBROBLAST ACTIVATION  PROTEIN THAT CROSS-REACTS WITH MOUSE AND HUMAN FIBROBLAST ACTIVATION PROTEIN  (FAP)THE TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA
WO/2021/076281SYSTEM AND PROCESS FOR FORMING CURVED GLASS LAMINATE ARTICLE  USING SEPARATION MATERIALCORNING INCORPORATED
WO/2021/061719METHODS FOR TREATING METASTATIC TRIPLE NEGATIVE BREAST CANCER  WITH ANTI-PD-1 ANTIBODIESMERCK SHARP & DOHME CORP.
WO/2021/067089COMPOSITIONS THAT PREFERENTIALLY POTENTIATE SUBTYPES OF GABAA  RECEPTORS AND METHODS OF USE THEREOFATHENEN THERAPEUTICS, INC.
WO/2021/061749COMBINATION THERAPIESMIRATI THERAPEUTICS, INC.
WO/2021/061763ALDOKETO REDUCTASE INHIBITORS AND USES THEREOFCASE WESTERN RESERVE UNIVERSITY
WO/2021/061770COSMETIC COMPOSITIONSL'OREAL
WO/2021/061775IMMUNE ASSAY FOR MONITORING RESPONSE TO ONCOLYTIC VACCINIA  VIRUS AND USES THEREOFSILLAJEN, INC.
WO/2021/067100COMPOSITIONS AND METHODS FOR EXTENDING LIFESPANMARVELBIOME, INC.
WO/2021/061803PHOSPHODIESTERASE INHIBITORS AND USENANJING ZHENGXIANG PHARMACEUTICALS CO., LTD.
WO/2021/061807BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF  HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETIONASCENDO BIOTECHNOLOGY, INC.
WO/2021/061818METHOD FOR INDUCING TUMOR REGRESSIONVEROSCIENCE LLC
WO/2021/061837BIOMATERIAL-BASED ANTIGEN FREE VACCINE AND THE USE THEREOFPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/061847METHODS OF TREATMENTS TO PROLONG GESTATION AND COMPLICATIONS  OF MENSTRUATION OR GESTATIONTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/061853CBL INHIBITORS AND COMPOSITIONS FOR USE IN ADOPTIVE CELL  THERAPYNURIX THERAPEUTICS, INC.
WO/2021/061867ANTI-CD47 ANTIBODIES, ACTIVATABLE ANTI-CD47 ANTIBODIES, AND  METHODS OF USE THEREOFCYTOMX THERAPEUTICS, INC.
WO/2021/061870CBL INHIBITORS AND COMPOSITIONS FOR EXPANSION OF IMMUNE CELLSNURIX THERAPEUTICS, INC.
WO/2021/061873METHODS, COMPOSITIONS, AND KITS FOR TREATING POLYCYSTIC KIDNEY  DISEASEELOXX PHARMACEUTICALS, INC.
WO/2021/061874METHODS AND COMPOSITIONS FOR TREATING ACUTE MYELOID LEUKEMIAPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/061888HAIR COSMETIC COMPOSITIONS CONTAINING GUMS FATTY ALCOHOL, AND  ESTERSL'OREAL
WO/2021/061894ERK5 DEGRADERS AS THERAPEUTICS IN CANCER AND INFLAMMATORY  DISEASESDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/061913DICLOFENAC SODIUM TOPICAL SOLUTIONENCUBE ETHICALS, PVT. LTD.
WO/2021/061929BICYCLIC CARBOXYLATES AS MODULATORS OF TRANSPORTERS AND USES  THEREOFNIROGY THERAPEUTICS, INC.
WO/2021/108022INCLUSION COMPLEXES OF PHARMACEUTICALS AND CYCLIC OLIGOMERSDISPERSOL TECHNOLOGIES, LLC
WO/2021/061940BIOARTIFICIAL PANCREASISLA TECHNOLOGIES, INC.
WO/2021/061944CREATINE FOR IMMUNOTHERAPYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061991COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY AND  IMMUNE DISEASESPROLACTA BIOSCIENCE, INC.
WO/2021/062003PHARMACEUTICAL COMPOSITION COMPRISING THROMBOLYTIC  PEPTIDE-TETRAHYDROISOQUINOLINE CONJUGATELUMOSA THERAPEUTICS CO., LTD
WO/2021/062007TREATMENT OF MITOCHONDRIAL DEFICITS AND AGE-RELATED DISEASES  USING BLOOD PRODUCTSCYTEGEN CORP.
WO/2021/062012USE OF KLK10 AND ENGINEERED DERIVATIZATIONS THEREOFEMORY UNIVERSITY
WO/2021/062022METABOLIC RESCUE OF RETINAL DEGENERATIONTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/062030DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)K-GEN, INC.
WO/2021/062036JAK INHIBITORSVIMALAN BIOSCIENCES, INC.
WO/2021/062037PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER  IMMUNE RESPONSE AGAINST CD47AUBURN UNIVERSITY
WO/2021/062039T-CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAMECHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/062048METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR  RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIESARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/062049BENEFICIAL BACTERIA AND SECRETORY IMMUNOGLOBULIN ATHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/062056ORAL ADMINISTRATION OF GENETICALLY ENGINEERED BACTERIANOVOME BIOTECHNOLOGIES, INC.
WO/2021/062057EXOGENOUS LOADING OF EXOSOMES VIA LYOPHILIZATIONCODIAK BIOSCIENCES, INC.
WO/2021/062060STING AGONIST COMPRISING EXOSOMES COMBINED WITH IL-12  DISPLAYING EXOSOMES FOR TREATING A TUMOURCODIAK BIOSCIENCES, INC.
WO/2021/062061ORAL PHARMACEUTICAL IMMEDIATE RELEASE COMPOSITION AND METHOD  OF TREATMENT FOR WEIGHT LOSSAARDVARK THERAPEUTICS INC.
WO/2021/062084NOVEL COMPOSITIONS AND METHODS FOR BONE GRAFTS AND FUSIONSTHE JOHNS HOPKINS UNIVERSITY
WO/2021/062089XANTHINE CB1 INHIBITORSGOLDFINCH BIO, INC.
WO/2021/062122COMBINATION ANTI-CD30 ADC, ANTI-PD-1 AND CHEMOTHERAPEUTIC FOR  TREATMENT OF HEMATOPOIETIC CANCERSSEAGEN INC.
WO/2021/062128METHODS AND COMPOSITIONS FOR TREATING A DISEASE OR DISORDERYALE UNIVERSITY
WO/2021/062157COMPOSITIONS AND METHODS FOR TREATING METASTATIC  GASTROINTESTINAL CANCERTHE ROCKEFELLER UNIVERSITY
WO/2021/062163METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONSDISC MEDICINE, INC.
WO/2021/062169METHODS AND COMPOSITIONS FOR THE EXPRESSION OF CONSTITUTIVELY  ACTIVE RAP1A FROM A VMD2 PROMOTERUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/062171METHODS FOR TREATING ANEMIA OF CHRONIC DISEASEDISC MEDICINE, INC.
WO/2021/062181CONJUGATED CHIMERIC PROTEINSORIONIS BIOSCIENCES, INC.
WO/2021/062189ISOXAZOLE-3-CARBOXAMIDE DERIVATIVES AND THEIR USE FOR  TREATMENT OF DISEASES CAUSED BY VIRUS INFECTIONCOLLABORATIONS PHARMACEUTICALS, INC.
WO/2021/108025CELL-BASED CANCER VACCINES AND CANCER THERAPIESMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/062196MINIMAL ARRESTIN DOMAIN CONTAINING PROTEIN 1 (ARRDC1)  CONSTRUCTSPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/062200ENHANCING CANCER THERAPY TREATMENT WITH BH3 MIMETICSTHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/062201COMPOSITIONS AND METHODS FOR NUCLEOPROTEIN TARGETING AND  EXPRESSIONSPOTLIGHT THERAPEUTICS
WO/2021/062202METHODS FOR DEPLETION OF DELETERIOUS MITOCHONDRIAL GENOMESUNIVERSITY OF MASSACHUSETTS
WO/2021/062208BIPHASE CHEMICAL PEELL'OREAL
WO/2021/062212VACCINES AND IMMUNOGLOBULINS TARGETING AFRICAN SWINE FEVER  VIRUS, METHODS OF PREPARING SAME, AND METHODS OF USING SAMEIGY IMMUNE TECHNOLOGIES AND LIFE SCIENCES INC.
WO/2021/062217ANTI-INFLAMMATORY THERAPY IN ARRHYTHMOGENIC CARDIOMYOPATHY  (ACM)BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/062227COMPOSITIONS AND METHODS FOR TREATMENT OF LIQUID CANCERSBEAM THERAPEUTICS INC.
WO/2021/062232METHODS FOR REDUCING REWARDING EFFECTS OF MORPHINE WITHOUT  AFFECTING ITS ANALGESIC EFFECTSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/062238METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE AND  THALASSEMIATHE UNIVERSITY OF CHICAGO
WO/2021/062246CRF RECEPTOR ANTAGONISTS AND METHODS OF USENEUROCRINE BIOSCIENCES, INC.
WO/2021/062263METHODS OF EVALUATING POLYPEPTIDE-MODIFIED POLYMERS IN  COMPOSITIONSSIGILON THERAPEUTICS, INC.
WO/2021/062264METHODS FOR TREATING HYPERPHENYLALANINEMIAPTC THERAPEUTICS MP, INC.
WO/2021/062268THERAPEUTIC NEUTRALIZATION ANTIBODIES FOR THE TREATMENT OF  PEANUT ALLERGYTHE GENERAL HOSPITAL CORPORATION
WO/2021/062273METHODS OF EVALUATING SMALL MOLECULE-MODIFIED POLYMERS IN  COMPOSITIONSSIGILON THERAPEUTICS, INC.
WO/2021/062282COMBINATION THERAPY WITH CGRP ANTAGONISTSALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/062298BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL  ONTOLOGY OF GLYCOCALYX DISRUPTIONARTEREZ, INC.
WO/2021/062307NOVEL METHODSINTRA-CELLULAR THERAPIES, INC.
WO/2021/062313IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE  TREATMENT OF CANCERBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/062316AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF  MYCOBACTERIAL INFECTIONSTHE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/062317EXTRACELLULAR VESICLE COMPOSITIONSCODIAK BIOSCIENCES, INC.
WO/2021/062318THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE  TREATMENT OF MYCOBACTERIAL INFECTIONSTHE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/062319INDOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT  OF MYCOBACTERIAL INFECTIONSTHE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/067158COSMETIC COMPOSITION COMPRISING BIODEGRADABLE POLYMERSL'OREAL
WO/2021/067164HAIR COSMETIC COMPOSITIONS CONTAINING CATIONIC COMPOUNDS,  PANTHENOL, AND OILSL'OREAL
WO/2021/067167CLOSTRODIOIDES DIFFICILE TREATMENTTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/062347COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF  PANCREATITISDUKE UNIVERSITY
WO/2021/067173HAIR COSMETIC COMPOSITIONS CONTAINING CATIONIC POLYMERS,  ACRYLATE-BASED POLYMERS, GUMS, AND POLYOLSL'OREAL
WO/2021/062355METHODS AND COMPOSITIONS FOR TREATING DIABETIC RETINOPATHYMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/067181HBV VACCINES AND METHODS TREATING HBVGILEAD SCIENCES, INC.
WO/2021/062374TABLETIZATION OF PEPTIDE SELF-ASSEMBLIES AND METHODS OF MAKING  AND USING THE SAMEDUKE UNIVERSITY
WO/2021/062412LUNG FIBROSIS MODEL AND METHODS OF USING THE SAMEDUKE UNIVERSITY
WO/2021/067216HAIR TREATMENT COMPOSITIONL'OREAL
WO/2021/067248ANHYDROUS MAGNETIC EYELINER COMPOSITIONL'OREAL
WO/2021/067261KNOTTIN-IMMUNOSTIMULANT CONJUGATES AND RELATED COMPOSITIONS  AND METHODSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/067297TREATMENT OF ALCOHOLIC HEPATITISDURECT CORPORATION
WO/2021/067299CHARCOAL ADHESIVE COMPOSITION FOR LASHES OR LASH EXTENSIONSLASHIFY, INC.
WO/2021/067310COMBINATION GMCI AND ATRI CANCER TREATMENTCANDEL THERAPEUTICS, INC.
WO/2021/067313EUKARYOTIC SEMI-SYNTHETIC ORGANISMSTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/067324METHODS OF TREATING POMPE DISEASEACADEMIA SINICA
WO/2021/067335BENZOXAZINONE COMPOUNDS AS KLK5/7 DUAL INHIBITORSMOLECULAR SKIN THERAPEUTICS, INC.
WO/2021/067336METHOD OF TREATMENT USING SYNERGISTIC DIETARY SUPPLEMENTS TO  RELIEVE PHYSICAL DISCOMFORT AND PAIN, OR MENTAL DISCOMFORT LINKED TO  MENSTRUATIONSEMAINE HEALTH CO.
WO/2021/046562ANTIVIRAL PEPTOID COMPOSITIONSMAXWELL BIOSCIENCES, INC.
WO/2021/067388POLY-DIOXANONE MULTI-BLOCK COPOLYMER FOR OCULAR PROTEIN  DELIVERYALLERGAN SALES, LLC
WO/2021/067393SMALL MOLECULE INHIBITORS OF Id PROTEINSMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/067403BIOMARKERS FOR ANTIBODY-DRUG CONJUGATE MONOTHERAPY OR  COMBINATION THERAPYIMMUNOMEDICS, INC.
WO/2021/067417POLYGENIC RISK SCORE FOR IN VITRO FERTILIZATIONMYOME, INC.
WO/2021/067421PREPARING THERAPEUTICALLY ENHANCED HUMAN MESENCHYMAL STEM  CELLS AND USES THEREOFUNIVERSITY OF MIAMI
WO/2021/067439RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOFTHE JOHNS HOPKINS UNIVERSITY
WO/2021/067458PROTEIN-MACROMOLECULE CONJUGATES AND METHODS OF USE THEREOFBEIJING XUANYI PHARMASCIENCES CO., LTD.
WO/2021/067465TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH  UPADACITINIBABBVIE INC.
WO/2021/067479COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET  LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDSNAVIDEA BIOPHARMACEUTICALS, INC.
WO/2021/067480COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS  INFECTIONUNIVERSITY OF WASHINGTON
WO/2021/067491LONG ACYL-CHAIN PHOSPHOLIPID OXYGEN MICROBUBBLES FOR TREATING  TUMOR HYPOXIATHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/067506METHODS OF TREATING CONDITIONS RELATED TO THE  S1P<sb>1</sb> RECEPTORARENA PHARMACEUTICALS, INC.
WO/2021/067526COMPLEMENT INHIBITORS FOR TREATING DRUG-INDUCED  COMPLEMENT-MEDIATED RESPONSEALEXION PHARMACEUTICALS, INC.
WO/2021/067528COMPOUNDS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUSTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/071728DOSING REGIMEN FOR INJECTABLE CETIRIZINEJDP THERAPEUTICS LLC
WO/2021/067545NON-TOXIC LISTERIOLYSIN O POLYPEPTIDES AND USES THEREOFOHIO STATE INNOVATION FOUNDATION
WO/2021/067546IMMUNOMODULATORY IMIDE DRUGS AS ZETA-CHAIN-ASSOCIATED PROTEIN  KINASE 70 (ZAP70) AGONISTS AND USES THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/126341METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONSBLAZE BIOSCIENCE, INC.
WO/2021/06754918-MC FOR TREATMENT OF SUBSTANCE USE DISORDERSMIND MEDICINE, INC.
WO/2021/067569SUBSTITUTED 1, 6-NAPHTHYRIDINE INHIBITORS OF CDK5GOLDFINCH BIO, INC.
WO/2021/067571TARGETED PULMONARY DELIVERY COMPOSITIONS AND METHODS USING  SAMERUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/067577HEAVY ATOM-FUNCTIONALIZED UPCONVERTERS FOR INCREASING  UPCONVERSION THRESHOLDS FOR 3D PRINTINGPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/067585METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS AND REDUCING  CANDIDIASISADARE PHARMACEUTICALS US, L.P.
WO/2021/067630DUAL-CHANNEL HEATING AND COOLING APPARATUS AND METHODGENTHERM MEDICAL, LLC
WO/2021/067644COMBINATION THERAPY WITH IMMUNE STIMULATORY CONJUGATESSILVERBACK THERAPEUTICS, INC.
WO/2021/067655USE OF GDF15 FOR TREATING CARDIOMETABOLIC SYNDROME AND OTHER  CONDITIONSAMGEN INC.
WO/2021/067668ADAMTS13 TREATMENT TO ENHANCE GRAFT SURVIVALTHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/067682TRICYCLIC KINASE INHIBITORS AND USES THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/067683CARBOMER BASED TOOTH PASTE COMPOSITION COMPRISING CROSSLINKED  POLYVINYLPYRROLIDONE FOR BUILDING VISCOSITYISP INVESTMENTS LLC
WO/2021/126344COMPOSITIONS AND METHODS COMPRISING ENGINEERED BACTERIOPHAGEPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/067696ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4VANDERBILT UNIVERSITY
WO/2021/067697METHODS AND MATERIALS FOR TREATING NEUROTOXICITYCAVION, INC.
WO/2021/071751BONDED POWDERS FOR THE TREATMENT OF BODILY LESIONSCOOK MEDICAL TECHNOLOGIES LLC
WO/2021/067702COMBINATIONS OF GABA-A RECEPTOR POSITIVE ALLOSTERIC MODULATORS  AND NMDA ANTAGONISTS, NMDA NEGATIVE ALLOSTERIC MODULATORS OR NMDA PARTIAL  AGONISTSPRAXIS PRECISION MEDICINES, INC.
WO/2021/067738DEVELOPMENT OF IMAGING AND THERAPEUTIC GLUCOSE ANALOGUES FOR  SODIUM DEPENDENT GLUCOSE TRANSPORTERSUNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/067741GLYCOPEPTIDES FOR INDUCING AN IMMUNE RESPONSE AND METHODS OF  USEAVCI, Fikri
WO/2021/067746PRESERVATIVE-FREE FORMULATIONS OF TETRACAINE HCLALTAIRE PHARMACEUTICALS, INC.
WO/2021/067752TARGETING CAP-DEPENDENT TRANSLATION TO REDUCE SEIZURES IN MTOR  DISORDERSYALE UNIVERSITY
WO/2021/067761COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIESATYR PHARMA, INC.
WO/2021/067775ANTO-CONNEXIN ANTIBODY FORMULATIONSALAMAB THERAPEUTICS, INC.
WO/2021/067792A METHOD FOR DIFFERENTIATING INNATE LYMPHOID CELLS FOR  IMMUNOTHERAPYTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/067799METHODS AND MATERIALS FOR MODULATING NRF2 PATHWAYTHE GENERAL HOSPITAL CORPORATION
WO/2021/067806TRANSDERMAL DELIVERY OF DRONABINOLSTARTON THERAPEUTICS, INC.
WO/2021/067807LYOPHILIZED COMPOSITION COMPRISING (S)-ISOPROPYL  2-((S)-2-ACETAMIDO-3-(1H-INDOL-3-YL)PROPANAMIDO)-6-DIAZO-5-OXOHEXANOATE FOR  INTRAVENOUS ADMINISTRATION AND THE USE THEREOFDYKSTRA, Steven
WO/2021/067818METHODS AND APPARATUS FOR FABRIC INTERFACE POLLINGGIGAIO NETWORKS, INC.
WO/2021/067820FORMULATION OF ANTIBODY-DRUG CONJUGATESEAGEN INC.
WO/2021/067834CANNABINOIDS AND USES THEREOFCORBUS PHARMACEUTICALS, INC.
WO/2021/067850METHODS OF DETECTING circRNAWASHINGTON UNIVERSITY
WO/2021/067852EVALUATING AND SCREENING BIOLOGICAL SAMPLESPREDICTIVE TECHNOLOGY GROUP, INC.
WO/2021/0678595-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOFTENAYA THERAPEUTICS, INC.
WO/2021/067861CAMPTOTHECIN PEPTIDE CONJUGATESSEAGEN INC.
WO/2021/067863TARGETED IL-12 HETERODIMERIC FC-FUSION PROTEINSXENCOR, INC.
WO/2021/067864ZINC FINGER PROTEIN TRANSCRIPTION FACTORS FOR TREATMENT OF  PRION DISEASESANGAMO THERAPEUTICS, INC.
WO/2021/067872ORAL CAVITY CLEANING COMPOSITION, METHOD, AND APPARATUSNOVAFLUX, INC.
WO/2021/211159METHODS AND COMPOSITION FOR IMPROVED ANTISEPSISVELOCE BIOPHARMA LLC
WO/2021/211160METHODS AND COMPOSITIONS FOR IMPROVED TREATMENT OF SINUS  DISEASEVELOCE BIOPHARMA LLC
WO/2021/067897STORAGE STABLE SOMATOSTATIN-DOPAMINE CHIMERIC COMPOUNDS AND  SALT FORMS THEREOFTIBURIO THERAPEUTICS INC.
WO/2021/067914COMBINATION THERAPY FOR ACUTE MYELOID LEUKEMIA,  MYELODYSPLASTIC SYNDROMES AND OTHER BLOOD DISEASES AND DISORDERSTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/067917TREATMENT OF EOSINOPHILIC DISORDERS WITH AVAPRITINIBBLUEPRINT MEDICINES CORPORATION
WO/2021/067930TUMOR-TARGETING POLYPEPTIDE NANOPARTICLE DELIVERY SYSTEM FOR  NUCLEIC ACID THERAPEUTICSSIRNAOMICS, INC.
WO/2021/067938HYDROPHOBICALLY-MODIFIED BIOPOLYMER MATERIALSMEDCURA, INC.
WO/2021/067943PIEZO1 AGONISTS FOR THE PROMOTION OF BONE FORMATIONBIOVENTURES, LLC
WO/2021/067945COSMETIC COMPOSITIONS COMPRISING CHITOSAN AND HYDROXYPROPYL  METHYLCELLULOSE AND THEIR USE FOR IMPROVING HAIR STRENGTH AND RELATED  PROPERTIESLIVING PROOF, INC.
WO/2021/067946BIOMARKER-BASED TREATMENT OF FOCAL SEGMENTAL  GLOMERULOSCLEROSIS AND DIABETIC KIDNEY DISEASEGOLDFINCH BIO, INC.
WO/2021/067947NUTRITIONAL COMPOSITIONS FOR THE MANAGEMENT OF HYPONATREMIANEPHCENTRIC, LLC
WO/2021/067967PREPARATION OF PYRAZOLO[3,4-B]PYRIDINES AS ANTIMALARIALSUNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/067971MICROBIOME INTERVENTIONSMARS, INCORPORATED
WO/2021/071800COMBINATIONS AND METHODS FOR TREATING CANCERUNIVERSITY OF SOUTH FLORIDA
WO/2021/071806ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER  CHANNEL BLOCKERSD. E. SHAW RESEARCH, LLC
WO/2021/071812ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER  CHANNEL BLOCKERSD.E SHAW RESEARCH, LLC
WO/2021/071821ARYLMETHYLENE AROMATIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER  CHANNEL BLOCKERSD.E. SHAW RESEARCH, LLC
WO/2021/071823COMPOSITIONS AND METHODS FOR PULMONARY SURFACTANT-BIOMIMETIC  NANOPARTICLESTHE GENERAL HOSPITAL CORPORATION
WO/2021/071830MODULATING LYMPHATIC VESSELS IN NEUROLOGICAL DISEASEUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/071835ADENO-ASSOCIATED VIRUS VECTOR PHARMACEUTICAL COMPOSITION AND  METHODSREGENXBIO INC.
WO/2021/071857FACILITATING CONTROLLED MOLECULAR ASSEMBLY OF NANOSCALE  STRUCTURES VIA DYNAMIC CONFINEMENT OF SOLVENTTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/071864THERAPEUTIC PHARMACEUTICAL COMPOSITIONSSIOLTA THERAPEUTICS, INC.
WO/2021/071867ORAL CARE COMPOSITION COMPRISING A CANNABINOIDCOLGATE-PALMOLIVE COMPANY
WO/2021/071875CHONDROGENIC HUMAN MESENCHYMAL STEM CELL (MSC) SHEETSUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/071876PHOTOLYTIC COMPOUNDS AND TRIPLET-TRIPLET ANNIHILATION MEDIATED  PHOTOLYSISUNIVERSITY OF MASSACHUSETTS
WO/2021/071902MICRONIZED DRUG RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND  METHODS OF PREPARATION THEREOFBRILLIAN PHARMA INC.
WO/2021/071922A PYRAZOLOPYRIMIDINE DERIVATIVE AS A HCK INHIBITOR FOR USE IN  THERAPY, IN PARTICULAR MYD88 MUTATED DISEASESDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/071931THREE-DIMENTIONAL SURFACE FOR PROTEIN AND SMALL MOLECULE  MICROARRAYSTHE JOHNS HOPKINS UNIVERSITY
WO/2021/071932ANTIMICROBIAL AND ANTIVIRAL EFFECTS OF C2-C7<sb>  </sb>ALKYL BORONIC ACIDSCORNELL UNIVERSITY
WO/2021/071934POLYMERIC METHYLPREDNISOLONE CONJUGATES AND USES THEREOFUNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/071965ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF  PHOSPHOMANNOMUTASE 2 DEFICIENCYAPPLIED THERAPEUTICS INC.
WO/2021/071967COMPOSITIONS FOR PULMONARY DELIVERY OF CANNABINOIDS AND  ASSOCIATED METHODS AND SYSTEMSISLAND BREEZE SYSTEMS CA, LLC
WO/2021/071974ORALLY IMPLANTABLE DRUG DELIVERY DEVICEOAK CREST INSTITUTE OF SCIENCE
WO/2021/071977IN VITRO METHODS AND COMPOSITIONS FOR ENHANCING THE ACTIVATION  OF DENDRITIC CELLS AND T CELLS, AND FOR INDUCING A TH-1 IMMUNE RESPONSENORTHWEST BIOTHERAPEUTICS, INC.
WO/2021/071979COMPOSITIONS AND METHODS FOR INCREASING EPITHELIAL BARRIER  FUNCTIONBOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/242294PEPTIDES FOR COVID-19 PREVENTION AND TREATMENTSOTIRA COVID, LLC
WO/2021/086565WEAKLY BASIC DRUG AND IONIC POLYMER PHARMACEUTICAL  FORMULATIONS AND METHODS OF FORMATION AND ADMINISTRATION THEREOFDISPERSOL TECHNOLOGIES, LLC
WO/2021/072017METHOD OF INDUCTION OF TUMOR ASSOCIATED ANTIGENS WITH  BRYOSTATINBRYOLOGYX INC.
WO/2021/072028ACTIVATORS OF HEME REGULATED INHIBITOR KINASE (HRI)THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/072034METHODS AND COMPOSITIONS FOR TREATING ATAXIA TELANGIECTASIACHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/072044METHODS OF TREATMENT USING A GENETICALLY MODIFIED AUTOLOGOUS  T-CELL IMMUNOTHERAPYPACT PHARMA, INC.
WO/2021/086567COMPOUNDS AND METHODS FOR POTENTIATING COLISTIN ACTIVITYUNIVERSITY OF NOTRE DAME DU LAC
WO/2021/072045THERAPEUTIC CANNABIS EXTRACTSJENNY'S ROSE, LLC
WO/2021/072050EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONSREFORM BIOLOGICS, LLC
WO/2021/072055COMPOSITIONS AND METHODS FOR PREVENTING, REDUCING AND  REVERSING OPIOID-INDUCED RESPIRATORY DEPRESSIONBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/072075MULTI-DOMAIN PROTEIN VACCINEFRITSCH, Edward
WO/2021/072076DAUGHTERLESS MALE MAMMALS FOR NON-HUMAN POPULATION SUPPRESSIONMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/072083Na/K-ATPase LIGANDS AND USE THEREOF FOR TREATMENT OF CANCERMARSHALL UNIVERSITY RESEARCH CORPORATION
WO/2021/072095METHODS OF TREATING PEMPHIGUS BY ADMINISTERING  (R)-2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILEPRINCIPIA BIOPHARMA INC.
WO/2021/072098BIOMARKERS FOR GRAFT-VERSUS-HOST DISEASEINCYTE CORPORATION
WO/2021/072103METHODS FOR DETECTING A FOOD SPECIFIC IMMUNE RESPONSEUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/072113COMPOSITIONS FOR THE DELIVERY OF PROTEINSAFYX THERAPEUTICS A/S
WO/2021/072115CRISPR-MEDIATED HUMAN GENOME EDITING WITH VECTORSREGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/072116BIOMARKERS FOR GRAFT-VERSUS-HOST DISEASEINCYTE CORPORATION
WO/2021/072129PROTEINS CONTAINING MULTIPLE, DIFFERENT UNNATURAL AMINO ACIDS  AND METHODS OF MAKING AND USING SUCH PROTEINSTRUSTEES OF BOSTON COLLEGE
WO/2021/072136LASER ETCHED CAPSULES AND METHODS OF MAKING THEMBAYER HEALTHCARE LLC
WO/2021/072139FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDESMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/072159ANODIC OXIDATION OF 5-AMINOURACILMEDIBEACON INC.
WO/2021/072167COMPOSITIONS AND METHODS FOR <i>IN VIVO</i>  SYNTHESIS OF UNNATURAL POLYPEPTIDESTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/072184METHODS OF FORMING CURED COMPOSITE MATERIALS WITH OPTIMIZED PH  AND RELATED COMPOSITIONS AND SYSTEMSSOLIDIA TECHNOLOGIES, INC.
WO/2021/072194STABILIZED HEMOGLOBIN COMPOSITIONS AND PHARMACEUTICAL  FORMULATIONS THEREOFMEDICAL TECHNOLOGY ASSOCIATES II, INC.
WO/2021/072198ORAL COMPLEMENT FACTOR D INHIBITORSBIOCRYST PHARMACEUTICALS, INC.
WO/2021/072201RAAV-MEDIATED IN VIVO DELIVERY OF SUPPRESSOR TRNASUNIVERSITY OF MASSACHUSETTS
WO/2021/072203TGFBETAR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOFSILVERBACK THERAPEUTICS, INC.
WO/2021/072218METHOD OF TREATING IMMUNOTHERAPY NON-RESPONDERS WITH AN  AUTOLOGOUS CELL THERAPYPACT PHARMA, INC.
WO/2021/072225MODULATING INTERLEUKIN-10 SIGNALING TO BOOST HEALING IN  DIABETIC WOUNDSRUSH UNIVERSITY MEDICAL CENTER
WO/2021/072235FRACTIONATED DOSING OF A PHOSPHOLIPID ETHER ANALOG FOR THE  TREATMENT OF CANCERCELLECTAR BIOSCIENCES, INC.
WO/2021/072238FEEDER-BASED AND FEEDER-FREE STEM CELL CULTURE SYSTEMS FOR  STRATIFIED EPITHELIAL STEM CELLS, AND USES RELATED THERETOUNIVERSITY OF HOUSTON SYSTEM
WO/2021/072246ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR  RECEPTORSYALE UNIVERSITY
WO/2021/072250RECOMBINANT POLYPEPTIDES FOR REGULATABLE CELLULAR LOCALIZATIONTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/072255LIGHT ACTIVATED NANOPARTICLE COMPOSITIONS AND USES THEREOFMOLECULAR EXPRESS, INC.
WO/2021/072260A TERPENE-REDUCED CANNABINOID ADJUNCTJAMAICAN BREW HOUSE
WO/2021/072264ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL  ENGAGERSARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/072265METHODS OF TREATING AN EYE DISORDERKODIAK SCIENCES INC.
WO/2021/072269TARGETED BIFUNCTIONAL DEGRADERSYALE UNIVERSITY
WO/2021/072272EPICARDIAL DELIVERY OF GENE THERAPYXYLOCOR THERAPEUTICS, INC.
WO/2021/072273ONCOLYTIC VIRUS COMPRISING IMMUNOMODULATORY TRANSGENES AND  USES THEREOFARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/072276COMPOSITIONS AND METHODS FOR UPREGULATING ISOFORMS OF  DYSTROPHIN AS THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY (DMD)YALE UNIVERSITY
WO/2021/072281MODIFIED ENDONUCLEASES AND RELATED METHODSUNIVERSITY OF WASHINGTON
WO/2021/072286CANCER COMBINATION TREATMENTS USING ANTI-STAT3 NUCLEIC ACID  CONJUGATESCITY OF HOPE
WO/2021/072289METHODS AND SYSTEMS USING PEPTIDES FOR TARGETING AND MAPPING  HUMAN NERVES IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERYALUME BIOSCIENCES, INC.
WO/2021/072298PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH  IMPROVED PROPERTIESGENENTECH, INC.
WO/2021/072302MODIFIED STEM CELLS AND METHODS OF USE THEREOFNEW YORK STEM CELL FOUNDATION, INC.
WO/2021/072306METHODS AND SYSTEMS FOR MICROFLUIDIC SCREENING1859, INC.
WO/2021/072311COMPOSITIONS WITH PURIFIED <i>BOMBYX MORI</i>  COCOON SILK PEPTIDE FIBER AND REFINED <i>BUGLOSSOIDES</i>  <i>ARVENSIS</i> SEED OIL, AND RELATED METHODSBRAINI LLC
WO/2021/072312COMPOSITIONS AND METHODS FOR TARGETING CD13 AND TIM-3 WITH CAR  T CELLS TO TREAT ACUTE MYELOID LEUKEMIATHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/072319TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST  GROWTH FACTOR RECEPTOR SIGNALINGG1 THERAPEUTICS, INC.
WO/2021/072325COMPOSITIONS OF AJULEMIC ACID AND USES THEREOFCORBUS PHARMACEUTICALS, INC.
WO/2021/072330GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER  DISEASESSILVERBACK THERAPEUTICS, INC.
WO/2021/072332METHODS FOR COSMETIC SKIN REMODELINGELC MANAGEMENT LLC
WO/2021/072349SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR  TREATING CANCERTOBEBIO NOVEL DRUG CO., LTD.
WO/2021/072350SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR  TREATING CANCERTOBEBIO NOVEL DRUG CO., LTD.
WO/2021/072351DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS USING  ALTERED RATIOS OF METABOLITE CONCENTRATIONSSTEMINA BIOMARKER DISCOVERY, INC.
WO/2021/072353CHIMERIC ANTIGEN RECEPTORS AGAINST HUMAN CYTOMEGALOVIRUSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/076444METHODS FOR TREATING BREAST CANCEROLATEC THERAPEUTICS LLC
WO/2021/072359MANUFACTURE METHOD FOR AQUEOUS FORMULATION OF  MANGANESE-CONTAINING COORDINATION COMPLEX, FORMULATION AND METHOD OF  TREATMENTGALERA LABS, LLC
WO/2021/072369LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF  MAKING AND USING THE SAMEDUKE UNIVERSITY
WO/2021/076448SOMATOSTATIN MODULATORS FOR TREATING PITUITARY ADENOMASCRINETICS PHARMACEUTICALS, INC.
WO/2021/072372VARIANT IGF2 CONSTRUCTSAMICUS THERAPEUTICS, INC.
WO/2021/072385COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLSUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/072390USE OF ENTPD3 FOR IDENTIFICATION, ISOLATION, AND ENHANCING  MATURE STEM CELL DERIVED INSULIN-PRODUCING CELLSTHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/072395MODIFIED OLIGONUCLEOTIDESALNYLAM PHARMACEUTICALS, INC.
WO/2021/076465CANNABIDIOL ADJUVANT THERAPY FOR TREATMENT OF DISC  DEGENERATIVE DISEASEFIGENE, LLC
WO/2021/076474WATER-RESISTANT AND/OR PHOTOPROTECTIVE COMPOSITIONS COMPRISING  NON-SOLUBILIZED MICRONIZED WAXESLUBRIZOL ADVANCED MATERIALS, INC
WO/2021/080814FILM COMPOSITIONSCOLGATE-PALMOLIVE COMPANY
WO/2021/072399ENGINEERING BACILLUS SUBTILIS AS A VERSATILE AND STABLE  PLATFORM FOR PRODUCTION OF NANOBODIESNORTHEASTERN UNIVERSITY
WO/2021/076485METHODS AND COMPOSITIONS FOR TREATING IRON DISORDERSBEYONDSPRING PHARMACEUTICALS, INC.
WO/2021/076506A STABLE EFFERVESCENT CO-PROCESSED EXCIPIENT COMPOSITION AND A  PROCESS FOR PREPARING THE SAMEISP INVESTMENTS LLC
WO/2021/076514METHODS FOR TREATING IMMUNE THROMBOCYTOPENIA BY ADMINISTERING  (R)-2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILEPRINCIPIA BIOPHARMA INC.
WO/2021/072407DELIVERY SYSTEM COMPLEXES COMPRISING A PRECIPITATE OF AN  ACTIVE AGENT AND METHODS OF USETHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/076525TREATMENT OF AUTOIMMUNITY AND TRANSPLANT REJECTION THROUGH  ESTABLISHMENT AND/OR PROMOTION OF TOLEROGENIC PROCESSES BY  FIBROBLAST-MEDIATED REPROGRAMMING OF ANTIGEN PRESENTING CELLSFIGENE, LLC
WO/2021/076543EPCAM BINDING FIBRONECTIN TYPE III DOMAINSARO BIOTHERAPEUTICS COMPANY
WO/2021/076562PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTIONPEREZ, Pedro, P.
WO/2021/076565METHOD OF NORMALIZING THE NEUTROPHIL TO LYMPHOCYTE RATIO IN  CANCER PATIENTS WITH A SELECTIVE GLUCOCORTICOID RECEPTOR ANTAGONISTCORCEPT THERAPEUTICS INCORPORATED
WO/2021/076566COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASEUNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/076572ERGOLINE-LIKE COMPOUNDS FOR PROMOTING NEURAL PLASTICITYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/080827SEQUENTIAL MULTI-STEP FLASH NANOPRECIPITATION FOR THE  FORMATION OF NANOPARTICLES WITH HIGH CORE LOADINGSTHE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/086610COMPOSITIONS AND METHODS OF USEVERA BIOTECHNOLOGY, INC.
WO/2021/076600COMPOSITIONS COMPRISING NOVEL PROKARYOTIC SODIUM CHANNELS AND  ASSOCIATED METHODSDUKE UNIVERSITY
WO/2021/076610SHIGELLA MULTI-EPITOPE FUSION ANTIGEN PROTEINS AND METHODS OF  USETHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/076616COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER  DISEASES (NAFLD)COHERUS BIOSCIENCES, INC.
WO/2021/076618TREATMENT OF UTERINE FIBROIDS USING PURIFIED COLLAGENASETHE JOHNS HOPKINS UNIVERSITY
WO/2021/076630NANO-ENABLED IMMUNOTHERAPY IN CANCERTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/076655COMBINATION THERAPY OF KRAS INHIBITOR AND SHP2 INHIBITOR FOR  TREATMENT OF CANCERSAMGEN INC.
WO/2021/076666METHODS OF TREATING CANCER WITH A STING AGONISTIMMUNESENSOR THERAPEUTICS, INC.
WO/2021/076674FIBROBLAST-BASED IMMUNOTHERAPY OF GRAVES DISEASEFIGENE, LLC
WO/2021/076687COMPOSITIONS, SYSTEMS AND METHODS FOR CONFERRING DURABLE  SHAPING OF KERATINOUS FIBERSL'OREAL
WO/2021/076688HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASESCHEMOCENTRYX, INC.
WO/2021/076691HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASESCHEMOCENTRYX, INC.
WO/2021/076703COMPOUNDS AND METHODS FOR MODULATING IMMUNE-RELATED PROTEINSVIVIDION THERAPEUTICS, INC.
WO/2021/076709DOSAGES AND USES OF ORNITHINE PHENYLACETATE FOR TREATING  HYPERAMMONEMIAOCERA THERAPEUTICS, INC.
WO/2021/076710N-ACYLATED HISTIDINE DIPEPTIDES AS ANTICANCER AGENTSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/076712EARLY MANAGEMENT AND PREVENTION OF SEPSIS AND SEPSIS-LIKE  SYNDROMESOPHIREX, INC.
WO/2021/076714METHODS TO TREAT HEPATITIS DELTA VIRAL INFECTIONSEIGER BIOPHARMACEUTICALS, INC.
WO/2021/076718OIL-IN-WATER EMULSIONS AND METHODS OF USECAPSUGEL BELGIUM NV
WO/2021/076722COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGINGCUROLOGY, INC.
WO/2021/076723ALKYLESTERS OF ALPHA-METHYL-DL-TYROSINE FOR USE IN TREATING  CANCERTYME, INC.
WO/2021/080846NOVEL CONJUGATION CHEMISTRY FOR CATALYTIC ANTIBODY 38C2THE SCRIPPS RESEARCH INSTITUTE
WO/2021/076755AN ACTIVITY-GUIDED MAP OF ELECTROPHILE-CYSTEINE INTERACTIONS  IN PRIMARY HUMAN IMMUNE CELLSTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/080847SYSTEMS AND METHODS FOR CELL CULTURINGFLASKWORKS, LLC
WO/2021/076766CURCUMINOID COMPOSITION FOR THERAPEUTIC MANAGEMENT OF  METABOLIC SYNDROMEMAJEED, Muhammed
WO/2021/076778A BIODISSOLVABLE FILM FOR LOCALIZED AND EFFICIENT TREATMENT OF  VULVODYNIATHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/076780METHODS AND COMPOSITIONS FOR CANCER TREATMENT USING  NANOPARTICLES CONJUGATED WITH MULTIPLE LIGANDS FOR BINDING RECEPTORS ON NK  CELLSTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/076792COMPOSITIONS COMPRISING HYALURONIDASE AND/OR COLLAGENASE  AND/OR 4-METHYLUMBELLIFERONE (4-MU) AND METHODS OF TREATMENT USING SAMESTANDARD OF CARE CORPORATION
WO/2021/076808METHODS FOR DETECTING AND INHIBITING BRAIN METASTASISCORNELL UNIVERSITY
WO/2021/076811MRNAS ENCODING GRANULOCYTE-MACROPHAGE COLONY STIMULATING  FACTOR FOR TREATING PARKINSON'S DISEASEMODERNA TX, INC.
WO/2021/076817METHODS AND COMPOSITIONS RELATED TO TREATMENT AND PREVENTION  OF CANCER BY INHIBITION OF DGAT1 AND DGAT2OHIO STATE INNOVATION FOUNDATION
WO/2021/076852SMALL EXTRACELLULAR VESICLE-ASSOCIATED VEGF AS A PREDICTOR FOR  THERAPEUTIC RESPONSESBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/076856MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING  MYOTONIC DYSTROPHYDYNE THERAPEUTICS, INC.
WO/2021/076860SULFATE-FREE SURFACTANT SYSTEMETHOX CHEMICALS, LLC
WO/2021/076865POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND  USING THEREOFUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/076866GENERATION OF INDUCED PLURIPOTENT STEM CELLS WITH  POLYCISTRONIC SOX2, KLF4, AND OPTIONALLY C-MYCTHE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST  ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE
WO/2021/086635PHARMACEUTICAL UNIT DOSE SYSTEMS FOR ORAL DRY SOLUTION AND  SUSPENSIONBRILLIAN PHARMA INC.
WO/2021/076883MUSCLE REGENERATION AND GROWTHBROWN UNIVERSITY
WO/2021/076890INHIBITING HUMAN INTEGRIN  α<sb>4</sb>β<sb>7</sb>MORPHIC THERAPEUTIC, INC.
WO/2021/076906TLR7/8 AGONISTS TO ENHANCE IMMUNE RESPONSES IN OPIOID USING  INDIVIDUALSCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/076908COMBINATION THERAPIES FOR TREATING MYELODYSPLASTIC SYNDROMES  AND ACUTE MYELOID LEUKEMIAFORTY SEVEN, INC.
WO/2021/076920METHOD AND COMPOSITION FOR INCREASING MUSCLE PROTEIN SYNTHESISCAPSUGEL BELGIUM NV
WO/2021/076926METHOD AND COMPOSITION FOR INCREASING MUSCLE PROTEIN SYNTHESISCAPSUGEL BELGIUM NV
WO/2021/076930PLXDC ACTIVATORS AND THEIR USE IN THE TREATMENT OF BLOOD  VESSEL DISORDERSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/076936COMPOSITIONS COMPRISING CANNABINOID MOLECULES THAT ARE  DISSOLVED IN WATER-MISCIBLE SOLVENTSNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/076939HLA-RESTRICTED VCX/Y PEPTIDES AND T CELL RECEPTORS AND USE  THEREOFBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/076942USE OF SUCCINATE AS BIOMARKER IN DIAGNOSIS AND TREATMENT OF  CANCERSNATIONAL HEALTH RESEARCH INSTITUTES
WO/2021/076945TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON  REGULATION IN ANIMALSAMBYS MEDICINES, INC.
WO/2021/076960LIVE VIRUS VACCINE INJURY RISKANAND, Rene
WO/2021/076961COMPOSITIONS AND METHODS OF TREATMENT FOR INHIBITING CAPILLARY  TUBE REGRESSIONUNIVERSITY OF SOUTH FLORIDA
WO/2021/076964STATHMIN 2 (STMN2) AS A THERAPEUTIC TARGET FOR PARKINSON'S  DISEASEICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/076965NUCLEIC ACIDS ENCODING HIV NEUTRALIZING ANTIBODIES AND USES  THEREOFMINICIRCLE, INC.
WO/2021/076966PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE  TREATMENT OF CANCERIKENA ONCOLOGY, INC.
WO/2021/076973EXTRACELLULAR VESICLE-BASED AGENTS AND METHODS FOR THE  TREATMENT OF NEUROPATHIC DISORDERSTHE JOHNS HOPKINS UNIVERSITY
WO/2021/076985CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR  LEUKEMIASUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/076991COMPOSITIONS AND METHODS FOR TREATING BLOOD DISORDERSANNEXON, INC.
WO/2021/076998PRODUCER VIRUSES FOR GENERATION OF RETROVIRUSES IN SITUKALIVIR IMMUNOTHERAPEUTICS LLC
WO/2021/076999FECAL-DERIVED STERILE POSTBIOTIC COMPOSITION AND METHOD  THEREFORHUBBLE BIOSCIENCE INC.
WO/2021/077018COMPOSITIONS AND METHODS FOR MODULATING INNATE IMMUNE  SIGNALING PATHWAYSDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/077031COMPOUNDS AND METHODS TARGETING QSOX1SAPPHIRE BIOTECH, INC.
WO/2021/0770342,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR  SUPPRESSING AND TREATING HEMOGLOBINOPATHY, THALASSEMIA, SICKLE CELL DISEASE  AND OTHER DISORDERSPTC THERAPEUTICS, INC.
WO/2021/077055BOTULINUM TOXIN FOR USE IN TREATMENTPENLAND FOUNDATION
WO/2021/077058EXTENDED HALF-LIFE G-CSF AND GM-CSF VITAMIN D CONJUGATESRAMEA LLC
WO/2021/077061SELF-MICROEMULSIFYING MULTI-DELIVERABLE SYSTEMSQUICKSILVER SCIENTIFIC, INC.
WO/2021/077066LIPID AND LIPID NANOPARTICLE FORMULATION FOR DRUG DELIVERYTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/077067LIPID NANOPARTICLES AND FORMULATIONS THEREOF FOR CAR MRNA  DELIVERYTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/077070COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING  ANTIBODIESYALE UNIVERSITY
WO/2021/077105HUMAN PERIVENTRICULAR ENDOTHELIAL CELL THERAPY FOR  NEUROPSYCHIATRIC DISORDERSTHE MCLEAN HOSPITAL CORPORATION
WO/2021/077108METHOD OF TREATING AUTISMTHE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/077113METHODS OF TREATMENT OF BLADDER CANCER BY USING MODIFIED  BACILLUS CALMETTE-GUéRINTEXAS BIOMEDICAL RESEARCH INSTITUTE
WO/2021/077114COMPOSITIONS AND METHODS FOR DELIVERING EXOSOMES USING  MICRONEEDLE DEVICES TO THE SKINAQUAVIT PHARMACEUTICALS, INC.
WO/2021/077115GENE THERAPY TARGETING COCHLEAR CELLSRESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/077119ANTIMICROBIAL ORGANOSILANESTOPIKOS PHARMACEUTICALS, INC.
WO/2021/080929N-(HETEROARYL) QUINAZOLIN-2-AMINE DERIVATIVES AS LRRK2  INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME CORP.
WO/2021/080935METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES USING  2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZ  YL)AMINO)ISOINDOLINE-1,3-DIONECELGENE CORPORATION
WO/2021/080936METHODS OF TREATING CHRONIC LYMPHOCYTIC LEUKEMIA USING  2-(2,6-DIOXOPIPERIDIN-3YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1.  3-DIONECELGENE CORPORATION
WO/2021/080937PHARMACEUTICAL COMPOSITIONS COMPRISING  (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE  AND METHODS OF USING THE SAMECELGENE CORPORATION
WO/2021/086679MODIFIED ZEOLITE CATALYST COMPOSITIONS AND METHODS OF USEW.R. GRACE & CO.-CONN.
WO/2021/101646PROPHYLACTIC SKIN TREATMENT FOR RADIATION THERAPYTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/126359VITAMIN A AND VITAMIN C COMBINATIONS WITH ENHANCED STABILITYBARNET PRODUCTS, LLC
WO/2021/080955SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND  ACTIVE AGENTS FOR COMBINED USECELGENE CORPORATION
WO/2021/101647RECOMBINANT MICELLE AND METHOD OF IN VIVO ASSEMBLYMOZZA
WO/2021/080972ORALLY INGESTIBLE DELIVERY SYSTEMSOANE PHARMA LLC
WO/2021/080983METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB  IN COMBINATION WITH CAPECITABINE AND TRASTUZUMABSEAGEN INC.
WO/2021/0866894-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOFPRIME REACH TRADING LIMITED
WO/2021/081011METHODS OF ADMINISTERING CANNABINOID TO PEOPLE DIAGNOSED WITH  HIVTILRAY INC.
WO/2021/081022TETRABENAZINE TRANSDERMAL DELIVERY DEVICESHINKEI THERAPEUTICS LLC
WO/2021/081043MUCUS PENETRATING PARTICLE COMPOSITIONS AND METHODS OF USE  THEREOF ENHANCING IMMUNE RESPONSETHE JOHNS HOPKINS UNIVERSITY
WO/2021/081058COMPOSITIONS, METHODS AND USES OF MESSENGER RNATRANSLATE BIO, INC.
WO/2021/081062METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASES AND  DISORDERSSELECTA BIOSCIENCES, INC.
WO/2021/086698METHODS FOR REDUCING THE TEMPERATURE OF SOL-GEL TRANSITIONSROCHAL INDUSTRIES, LLC
WO/2021/081069COMPOSITIONS AND METHODS FOR ENHANCING RETINAL GANGLION CELL  DEVELOPMENT AND PLURIPOTENT STEM CELL-DERIVED THREE-DIMENSIONAL TISSUETHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/081081METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING CANCER  USING PYRVINIUM COMPOSITIONSTHOMAS JEFFERSON UNIVERSITY
WO/2021/081108METHODS OF TREATING PROSTATE CANCERARVINAS OPERATIONS, INC.
WO/2021/081110PEPTIDES AND USE THEREOFANEXIGEN, INC.
WO/2021/081115COMPOSITIONS AND METHODS FOR IN VITRO ACTIVATION AND EXPANSION  OF SERIAL KILLER T CELL POPULATIONS AND PASSIVE IMMUNIZATION OF A CANCER  PATIENT WITH TUMOR CELL KILLING CELLSALLOPLEX BIOTHERAPEUTICS
WO/2021/081120RECOMBINANT NEURAMINIDASE AND USES THEREOFICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/081130USE OF PINE RESIN FOR TREATING AND PREVENTING MUSCLE SORENESS  AND FOOT & JOINT PAINSPRAINGO, LLC
WO/2021/081133ENGINEERED NATURAL KILLER CELLS AND METHODS FOR USING THE SAME  IN IMMUNOTHERAPY AND AUTOPHAGY INHIBITION TECHNIQUESPURDUE RESEARCH FOUNDATION
WO/2021/081138COMPOSITIONS COMPRISING SUPERFINE COMPOUNDS AND PRODUCTION  THEREOFESOLATE LTD
WO/2021/081140SUPERFINE COMPOUNDS AND PRODUCTION THEREOFESOLATE LTD
WO/2021/081149TREATMENT AND CONTROL OF BACTERIAL AND FUNGAL DISEASE IN  HONEYBEESTALLGRASS BIOLOGICS L.L.C.
WO/2021/081167PROTEIN KINASE INHIBITORS AND USE THEREOF FOR TREATMENT OF  NEIMODEGENERATIVE DISEASESXAVIER UNIVERSITY OF LOUISIANA
WO/2021/081193METHODS OF ADMINISTRATION OF IL-2 RECEPTOR AGONISTSNEOLEUKIN THERAPEUTICS, INC.
WO/2021/081203ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF  AGE-RELATED MACULAR DEGENERATION AND OTHER OCULAR DISEASES AND DISORDERSAPPLIED GENETIC TECHNOLOGIES CORPORATION
WO/2021/081204DISRUPTION OF VASCULAR SMOOTH MUSCLE RELAXATION BY CARFILZOMIB  MAY BE THE PRIMARY REASON FOR CFZ-INDUCED VASCULAR DYSFUNCTIONAMGEN INC.
WO/2021/081225ORNITHINE TRANSCARBAMYLASE (OTC) CONSTRUCTS AND METHODS OF  USING THE SAMEGENEVANT SCIENCES GMBH
WO/2021/081229CORTICAL NEURAL PROGENITOR CELLS FROM IPSCSCEDARS-SINAI MEDICAL CENTER
WO/2021/081231USE OF MBV FOR TREATING AUTOIMMUNE DISEAEUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/081251LIPID COATED IRON OXIDE NANOPARTICLES FOR OTITIS MEDIAOTOMAGNETICS, INC.
WO/2021/086726IMPROVED METHODS, KITS, COMPOSITIONS AND DOSING REGIMENS FOR  THE USE OF HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2ASAN BIOSCIENCES, LLC
WO/2021/081258TGF-β POLYPEPTIDESCUE BIOPHARMA, INC.
WO/2021/081276STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING ESTRADIOL AND  PROGESTERONE FOR ORAL ADMINISTRATIONSLAYBACK PHARMA LLC
WO/2021/081292METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH α1A-AR  PARTIAL AGONISTSCURASEN THERAPEUTICS, INC.
WO/2021/081293COMPOSITIONS FOR TREATMENT OF ANNULAR SPINAL DISC INJURYWARSAW ORTHOPEDIC, INC
WO/2021/081296NOVEL ANTIBODIES FOR DETECTING EPSTEIN BARR VIRUS-POSITIVE  GASTRIC CANCERLABAER, Joshua
WO/2021/081301COMPUTATIONAL DESIGN OF ALPHA(V) BETA (6) INTEGRIN BINDING  PROTEINSROY, Anindya
WO/2021/081313METHODS FOR IDENTIFYING STRUCTURAL FEATURES OF LIPIDSTHE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/081315COMPOUNDS AND METHODS FOR THE TREATMENT OF CRYPTOSPORIDIOSISTHE BROAD INSTITUTE, INC.
WO/2021/081326COMPOSITIONS AND METHODS FOR MINIMIZING PROTEIN LOSS AT LOW  PROTEIN CONCENTRATIONSAMGEN INC.
WO/2021/081337METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASECASE WESTERN RESERVE UNIVERSITY
WO/2021/081338COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE  DISORDERSAUDENTES THERAPEUTICS, INC.
WO/2021/086751COSMETIC COMPOSITIONS COMPRISING VINYLPYRROLIDONE COPOLYMERSL'OREAL
WO/2021/081357TREATMENT OF EPILEPTIC CONDITIONS WITH  GABA<sb>A</sb> RECEPTOR MODULATORSNEUROCYCLE THERAPEUTICS, INC.
WO/2021/108050COMPOSITIONS AND METHODS COMPRISING VIRAL VECTOR SYSTEMS FOR  MULTIPLEXED ACTIVATION OF ENDOGENOUS GENES AS IMMUNOTHERAPY AND VIRAL-BASED  IMMUNE-GENE THERAPYYALE UNIVERSITY
WO/2021/086753AMORPHOUS SOLID SUCCINYLATED 3-(FATTY ACID  AMIDO)-2-HYDROXY-1-(PROTECTED HYDROXY)-PROPANE SALTS AND METHODS OF MAKING  THE SAMEGERON CORPORATION
WO/2021/081365HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES  THEREOFPROMETHEUS BIOSCIENCES, INC.
WO/2021/081366PIMOBENDAN FORMULATION AND METHOD OF USE THEREOFPIEDMONT ANIMAL HEALTH INC.
WO/2021/086754CRYSTALLINE SOLIDS OF 3-PALMITOYL-AMIDO-1,2-PROPANEDIOL AND  3-PALMITOYL-AMIDO-2-HYDROXY-1-DIMETHOXYTRIPHENYLMETHYLETHER-PROPANE AND  METHODS OF MAKING AND USING THE SAMEGERON CORPORATION
WO/2021/081375INHIBITORS OF RAF KINASESKINNATE BIOPHARMA INC.
WO/2021/081376METHODS OF TREATING THE SYMPTOMS OF AUTISM SPECTRUM DISORDERMAPLIGHT THERAPEUTICS, INC.
WO/2021/081378GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF  SAME IN IMMUNOTHERAPYIOVANCE BIOTHERAPEUTICS, INC.
WO/2021/081384SYNTHETIC NUCLEASESGREENVENUS, LLC
WO/2021/081395METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH  RECOMBINANT CFH PROTEINSGEMINI THERAPEUTICS INC.
WO/2021/081401METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH  CFH-ENCODING VECTORSGEMINI THERAPEUTICS INC.
WO/2021/081402MACROMOLECULE-SUPPORTED THIENOAZEPINE COMPOUNDS, AND USES  THEREOFBOLT BIOTHERAPEUTICS, INC.
WO/2021/081405METHODS FOR DETECTION OF MACRO-HETEROPLASMY AND  MICRO-HETEROPLASMY IN MITOCHONDRIAL DNAIMEL BIOTHERAPEUTICS, LTD.
WO/2021/081407THIENOAZEPINE IMMUNOCONJUGATES, AND USES THEREOFBOLT BIOTHERAPEUTICS, INC.
WO/2021/081430FIBRIN-BINDING COMPOUNDS FOR IMAGING AND TREATMENTCOLLAGEN MEDICAL, LLC
WO/2021/081448SYNERGISTIC INHIBITORS OF CREB-MEDIATED GENE TRANSCRIPTIONOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/081466POLYNUCLEOTIDE-LINKED BIOCONJUGATES AND METHODS OF MAKING AND  USINGPHITONEX, INC.
WO/2021/086773AQUEOUS CONDITIONER FORMULATION FOR THERMALLY STYLED HAIRDOW GLOBAL TECHNOLOGIES LLC
WO/2021/081481LOW DOSE ADJUVANT EPIGENETIC CANCER THERAPYTHE JOHNS HOPKINS UNIVERSITY
WO/2021/133460COMPOSITIONS AND METHODS FOR TREATING CANCER AND IMPROVING  EPITHELIAL HOMEOSTASISTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/081495POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERYTHE JOHNS HOPKINS UNIVERSITY
WO/2021/081499CHIKUNGUNYA VIRUS-LIKE PARTICLE VACCINE AND METHODS OF USING  THE SAMEEMERGENT TRAVEL HEALTH INC.
WO/2021/081500MITOCHONDRIA-TARGETED ATOVAQUONE: A MORE POTENT AND MORE  EFFECTIVE ANTITUMOR, ANTIMICROBIAL, AND ANTIMALARIAL DRUGTHE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/108051ATROPINE-SCOPOLAMINE WITH ENHANCED STABILITYCMC PHARMACEUTICALS, INC.
WO/2021/081515COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN  IMMUNODEFICIENCY VIRUSCIDARA THERAPEUTICS, INC.
WO/2021/091718ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR  DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMDIVERIC BIO, INC.
WO/2021/081540PREPARATION AND USE OF THERAPEUTIC HYDROGELSBRIOPRYME BIOLOGICS, INC.
WO/2021/086806CANNABINOID PRODUCTS WITH HIGH BIOAVAILABILITYTHE CHEMIST'S CABINET, LLC
WO/2021/086829METHODS FOR TREATING LEUKEMIA AND USE OF A LEUKEMIC STEM CELL  SIGNATURE TO PREDICT CLINICAL SENSITIVITY TO THERAPIESCELGENE CORPORATION
WO/2021/086830USE OF BIOMARKERS TO PREDICT CLINICAL SENSITIVITY TO  2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-  OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDECELGENE CORPORATION
WO/2021/086879COMPOUNDS AND METHODS OF USETANGO THERAPEUTICS, INC.
WO/2021/086889METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND  INFECTIOUS DISEASESCHINOOK THERAPEUTICS, INC.
WO/2021/086892METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROMEACADIA PHARMACEUTICALS INC.
WO/2021/086904SMALL MOLECULE ACTIVATORS OF TIE-2AERPIO PHARMACEUTICALS, INC.
WO/2021/086909COMBINATION OF A PD-1 ANTAGONIST, A VEGFR/FGFR/RET TYROSINE  KINASE INHIBITOR AND A CBP/BETA-CATENIN INHIBITOR FOR TREATING CANCEREISAI R&D MANAGMENT CO., LTD.
WO/2021/086914DIMERIC NAPHTHALIMIDE FORMULATIONSALUCENT BIOMEDICAL, INC.
WO/2021/086917PSMA-TARGETING IMAGING AGENTSTHE CLEVELAND CLINIC FOUNDATION
WO/2021/086938DRIP-FREE CLEANSING MASK WITH ENHANCED ACTIVE DEPOSITIONL'OREAL
WO/2021/086946PHARMACEUTICAL COMPOSITIONS OF ALBUMIN AND RAPAMYCINABRAXIS BIOSCIENCE, LLC
WO/2021/086958IMMUNE CELL RECEPTOR ANTIBODIES CONJUGATED TO HIGH AFFINITY  SIGLEC-LIGANDSTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/086962SODIUM-DEPENDENT GLUCOSE TRANSPORTER 2 AS A DIAGNOSTIC AND  THERAPEUTIC TARGET FOR PRE-MALIGNANT LESIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/086964METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE  APPLICATIONSPRECISION BIOLOGICS
WO/2021/086967TREATMENT OF DIABETIC NEPHROPATHY WITH AN SGC STIMULATORCYCLERION THERAPEUTICS, INC.
WO/2021/086973FORMULATION FOR DELIVERY OF LUBRICIN GENEUNIVERSITY OF IOWA RESEARCH FOUNDATION
WO/2021/086981COMPOSITIONS AND METHODS FOR TREATING CANCER USING ANTI-HER2  ANTIBODY DRUG CONJUGATECSPC DOPHEN CORPORATION
WO/2021/086997TREATING TISSUE FIBROSIS AND/OR INJURY AND-OR ORGAN FAILURE  WITH INTERLEUKIN 24 OR INTERLEUKIN 20 ANTAGONISTLBL BIOTECHNOLOGY INC.
WO/2021/087007GENE THERAPY VECTORSUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/087015ENGINEERED ANTIBODIES TO HIV ENVINTERNATIONAL AIDS VACCINE INITIATIVE
WO/2021/087019ONCOLYTIC VIROTHERAPY WITH INDUCED ANTI-TUMOR IMMUNITYUNIVERSITY OF HOUSTON SYSTEM
WO/2021/091751SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC  ACETYLCHOLINE RECEPTORSMERCK SHARP & DOHME CORP.
WO/2021/087021PEPTIDE-NANOPARTICLE CONJUGATESWISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/087031PEPTIDE MIMETICS OF DKK3B AND METHODS OF USEACWORTH PHARMACEUTICALS, INC.
WO/2021/087037LUNG-SPECIFIC TARGETING-PEPTIDE (LTP), COMPOSITIONS, AND USES  THEREOFUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/087050CRIZANLIZUMAB CONTAINING ANTIBODY FORMULATIONNOVARTIS AG
WO/2021/087051TOPICAL COMPOSITIONS AND METHODS OF USE THEREOFPS THERAPY LTD.
WO/2021/087058SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS,  DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED  EFFICACYTRANEXAMIC TECHNOLOGIES, LLC
WO/2021/087071METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLSSTITCH BIO, LLC
WO/2021/087072COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING  RESPIRATORY SYNCYTIAL VIRUS INFECTIONMOHAPATRA, Shyam S.
WO/2021/087074THERAPEUTIC FORMULATIONS AND USES THEREOFPIEDMONT ANIMAL HEALTH INC.
WO/2021/087082PRODRUGS OF ITACONATE AND METHYL ITACONATETHE JOHNS HOPKINS UNIVERSITY
WO/2021/087083USE OF ITACONATE AND ITS DERIVATIVES/ANALOGUES TO INDUCE HAIR  GROWTHTHE JOHNS HOPKINS UNIVERSITY
WO/2021/087096P53 MODULATORS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/096692ARTIFICIAL MELANIN NANOPARTICLES AND PRECURSOR MOLECULES AS  HAIR DYESNORTHWESTERN UNIVERSITY
WO/2021/087105IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN  IMMUNOTOXINDUKE UNIVERSITY
WO/2021/087113LOCAL ANESTHETICS WITH SELECTIVE-SENSORY NERVE BLOCKADECHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/087114ANTI-ANGIOPOIETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF  USEUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/087127CANNABINOIDS AND USES THEREOFCORBUS PHARMACEUTICALS, INC.
WO/2021/087138METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS  WITH INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)SYROS PHARMACEUTICALS, INC.
WO/2021/087144THERAPEUTIC METHODS USING VADADUSTATAKEBIA THERAPEUTICS, INC.
WO/2021/087145HUMAN CELLULAR MODEL FOR INVESTIGATING  CORTICO-STRIATAL-MIDBRAIN NEURAL PATHWAYSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/087186DENTAL VARNISHDENTSPLY SIRONA INC.
WO/2021/087195COMPOSITIONS AND USES THEREOF FOR TREATING IRRADIATION-INDUCED  INTESTINAL DAMAGEUNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/087200SYSTEM AND METHOD FOR SEPARATION OF BLOOD COMPONENTSOWL MANOR MEDICAL, LLC
WO/2021/087205CHIMERIC RECEPTOR SENSORSSENTI BIOSCIENCES, INC.
WO/2021/087207SYNTHESIS OF HOLLOW SILICA PARTICLES AND USE IN SUN CARE  COMPOSITIONSDOW GLOBAL TECHNOLOGIES LLC
WO/2021/087234LINEAGE REPROGRAMMING AS A CANCER IMMUNOTHERAPYTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/087239METHOD FOR TREATING SKINKAO CORPORATION
WO/2021/087248ANTI-CD37 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE  THEREOFR.P. SCHERER TECHNOLOGIES, LLC
WO/2021/091788MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES  THEREOFCRINETICS PHARMACEUTICALS, INC.
WO/2021/087258COMPOSITIONS AND METHODS FOR TREATING ALCOHOL USE DISORDER OR  A RELATED CONDITION THEREOFTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/112987METHODS OF TREATING COGNITIVE IMPAIRMENT ASSOCIATED WITH  NEURODEGENERATIVE DISEASEAPTINYX INC.
WO/2021/091791INHIBITION OF THE VE-PTP PHOSPHATASE PROTECTS THE KIDNEY FROM  ISCHEMIA-REPERFUSION INJURYNORTHWESTERN UNIVERSITY
WO/2021/087291COMPOSITIONS AND METHODS RELATED TO ORGANIC OXIDESNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/087314FIBROUS PRODUCT FOR MEDICINAL, COSMETIC OR DERMATOLOGIC USESWM LUXEMBOURG SARL
WO/2021/087359PRODRUG COMPOSITIONS AND METHODS OF TREATMENTAQUESTIVE THERAPEUTICS, INC.
WO/2021/087360COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A  SUBJECT FOR TREATMENT OF CONDITIONS OF THE EYECOLORADO STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/087361ZINC FINGER NUCLEASE VARIANTS FOR TREATING OR PREVENTING  LYSOSOMAL STORAGE DISEASESSANGAMO THERAPEUTICS, INC.
WO/2021/087366COMPOSITIONS AND METHODS FOR GENOME ENGINEERINGSANGAMO THERAPEUTICS, INC.
WO/2021/087372LHRH-PACLITAXEL CONJUGATES AND METHODS OF USEWORCESTER POLYTECHNIC INSTITUTE
WO/2021/087381HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPYMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/087382SYSTEMS AND METHODS FOR INCREASING NITROGEN MONOXIDE  CONCENTRATION AND REMOVING NITROGEN DIOXIDE FROM A GAS STREAMTHIRD POLE, INC.
WO/2021/087392IMPROVING RENAL FUNCTION AFTER KIDNEY TRANSPLANTATIONANGION BIOMEDICA CORP.
WO/2021/087401METHODS AND COMPOSITIONS FOR TREATING A PREMATURE TERMINATION  CODON-MEDIATED DISORDERTEVARD BIO, INC.
WO/2021/087406DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND  PROGENTOR CELLSMAGENTA THERAPEUTICS, INC.
WO/2021/087408OTIC FORMULATIONS FOR DRUG-INDUCED OTOTOXICITYOTONOMY, INC.
WO/2021/087415METHOD OF TREATING INFECTIONS BY BACTERIOLYTIC ENZYMES AND  MANUFACTURE THEREOFUNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/087419NANOPARTICLE COMPOSITION AND METHOD OF USE AND MANUFACTUREVERTELOVA, Regina
WO/2021/091801COMPOSITIONS OF CLOFAZIMINE, COMBINATIONS COMPRISING THEM,  PROCESSES FOR THEIR PREPARATION, USES AND METHODS OF TREATMENT COMPRISING  THEMMANNKIND CORPORATION
WO/2021/091806CHANGING GUT MICROBIOTA TO REDUCE ALCOHOL CRAVINGVIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/087432METHODS OF TREATMENT USING AN MTORC1 MODULATORNAVITOR PHARMACEUTICALS, INC.
WO/2021/087436FIBROBLAST-DERIVED UNIVERSAL IMMUNOLOGICAL COMPOSITIONFIGENE, LLC
WO/2021/087439INTRATUMORAL ADMINISTRATION OF IMMUNE CELLULAR THERAPEUTICSFIGENE, LLC
WO/2021/087441COMPOSITION AND METHODS FOR PREVENTING AND TREATING AFRICAN  SWINE FEVER IN WILD AND DOMESTIC SWINEANUBIS BIO CORPORATION
WO/2021/091815ANTI-CD30 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE  TREATMENT OF HIV INFECTIONSEAGEN INC.
WO/2021/091823SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORSALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/087458TARGETING NONSENSE-MEDIATED DECAY TO ACTIVATE P53 PATHWAY FOR  THE TREATMENT OF CANCERBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/087466GENERATION OF CD38 KNOCK-OUT PRIMARY AND EXPANDED HUMAN NK  CELLSRESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/087492SUBSTANTIALLY ANHYDROUS, CONCENTRATED SURFACTANT COMPOSITIONSRITA CORPORATION
WO/2021/091846TREATMENT OF MAST CELL DISEASES AND EOSINOPHILIC DISORDERSBLUEPRINT MEDICINES CORPORATION
WO/2021/091855BLOOD PLASMA FRACTIONS FOR USE IN MUSCLE REGENERATIONALKAHEST, INC.
WO/2021/091862CAROTENOID COMPOSITIONS AND USES THEREOFL.E.A.F. HOLDINGS GROUP LLC
WO/2021/091869AZAPODOPHYLLOTOXIN DERIVATIVES AND METHODS OF TREATING  LYMPHOMA AND KIDNEY CANCERTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/091871HIGH AFFINITY AND DUAL-SPECIFICITY PEPTIDE ANTAGONISTS OF MDM2  AND MDMX FOR P53 ACTIVATIONUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/091881HIGH CONCENTRATION CELL PENETRATING CASPASE INHIBITOR  CONJUGATES COMPOSITIONS AND METHODS THEREOFTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/091896METHOD FOR TREATING CANCERTHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/091899BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1 (BAI1) ANTIBODIES AND  USES THEREOFGENISPHERE, LLC
WO/2021/091902COMBINATION PHARMACOLOGICAL INTERVENTIONS FOR MULTIPLE  MECHANISMS OF OBSTRUCTIVE SLEEP APNEAAPNIMED, INC. (DELAWARE)
WO/2021/091904USE OF A JANUS KINASE INHIBITOR AND A TELOMERASE INHIBITOR FOR  THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMSGERON CORPORATION
WO/2021/091905LIPOSOMAL FORMULATIONS FOR DELIVERY OF CANNABINOIDS AND  METHODS OF MAKING THEREOFVELLA BIOSCIENCE, INC.
WO/2021/091906METHODS FOR TREATING LEUKEMIAAMGEN INC.
WO/2021/091916SELF-EMULSIFYING CANNABINOID FORMULATION AND METHODLANDRACE BIOSCIENCE INC.
WO/2021/091924PH RESPONSIVE BLOCK COPOLYMER COMPOSITIONS, MICELLES, AND  METHODS OF USEONCONANO MEDICINE, INC.
WO/2021/137932USE OF IODIDE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF  CHEMOTHERAPY-ASSOCIATED CACHEXIA AND CARDIOTOXICITYFARADAY PHARMACEUTICALS, INC.
WO/2021/091935ALLOGENEIC T-CELLS AND METHODS FOR PRODUCTION THEREOFLONZA WALKERSVILLE, INC.
WO/2021/091937HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONSALEXION PHARMACEUTICALS, INC.
WO/2021/091938COCHLEAR OUTER HAIR CELL PROMOTERS AND USES THEREOFDECIBEL THERAPEUTICS, INC.
WO/2021/091946COMBINATION THERAPY WITH  2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)  METHYL)-2,2-DIFLUOROACETAMIDECELGENE CORPORATION
WO/2021/091950VESTIBULAR SUPPORTING CELL PROMOTERS AND USES THEREOFDECIBEL THERAPEUTICS, INC.
WO/2021/091953N-TERMINAL SCFV MULTISPECIFIC BINDING MOLECULESREGENERON PHARMACEUTICALS, INC.
WO/2021/091958RIG-I INNATE IMMUNE RECEPTOR ANTAGONISTS AND METHODS OF USING  SAMEYALE UNIVERSITY
WO/2021/108096CAR T CELLS WITH ENHANCED METABOLIC FITNESSH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/091978USES OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTORSCELGENE CORPORATION
WO/2021/091981COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE CHECKPOINT  INHIBITOR THERAPYVEDANTA BIOSCIENCES, INC.
WO/2021/091986INTERLEUKIN 10 CONJUGATES AND USES THEREOFSYNTHORX, INC.
WO/2021/091997VARICELLA ZOSTERADJUVANCE TECHNOLOGIES, INC.
WO/2021/092007METHODS OF MAKING CELLULAR THERAPIESVERASTEM, INC.
WO/2021/092020METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSISUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/092030DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND  MPN-RELATED DISORDERS WITH NAVITOCLAXABBVIE INC.
WO/2021/137935NOVEL SUPEREBASTINE AGAINST THERAPY RESISTANT PROSTATE CANCERUNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/092059CYTOTOXIC LIPID PARTICLES FOR TREATING GLIOBLASTOMANORTHWESTERN UNIVERSITY
WO/2021/092060METHODS OF TREATMENTENGMAB SARL
WO/2021/092062ADHESIVE COMPOSITIONS COMPRISING THERAPEUTICSREVBIO, INC.
WO/2021/092065ULTRASMALL NANOPARTICLES AND METHODS OF MAKING, USING AND  ANALYZING SAMECORNELL UNIVERSITY
WO/2021/092079TREATMENTS FOR SYSTEMIC SCLEROSISACCELERON PHARMA INC.
WO/2021/092080EXTRACELLULAR VESICLES AND USES THEREOF FOR ANTIBODY DELIVERYARUNA BIO, INC.
WO/2021/092090METHODS FOR PALMAR OR PLANTAR ADMINISTRATION OF PHARMACEUTICAL  COMPOSITIONSDERMIRA, INC.
WO/2021/092094ANTIGEN-BINDING PROTEINS TARGETING SHARED NEOANTIGENSGRITSTONE ONCOLOGY, INC.
WO/2021/092095NEOANTIGEN VACCINE THERAPYGRITSTONE ONCOLOGY, INC.
WO/2021/092096INDIVIDUALIZED DOSING OF RADIOACTIVE TRACERS FOR IMAGINGLIKEMINDS, INC.
WO/2021/092110MICROBIAL DETECTION PLATFORMNUCLEASE PROBE TECHNOLOGIES, INC.
WO/2021/092120METHODS AND COMPOSITIONS FOR ENHANCING OVERALL HEALTH AND  LONGEVITY IN MAMMALSMYOS RENS TECHNOLOGY INC.
WO/2021/092130COMPOSITIONS AND METHODS FOR RNA-ENCODED DNA-REPLACEMENT OF  ALLELESPAIRWISE PLANTS SERVICES, INC.
WO/2021/092134DOSING REGIMEN FOR ANTI-DLL3 AGENTSAMGEN INC.
WO/2021/092140METHODS OF REDUCING LACTATE IN LIVER DISEASE PATIENTS USING  VARIANTS AND FUSIONS OF FGF19/FGF21 POLYPEPTIDESNGM BIOPHARMACEUTICALS, INC.
WO/2021/092143MICRORNA BLOCKADE FOR THE TREATMENT OF DISEASEYALE UNIVERSITY
WO/2021/092151SELECTIVE HDAC6 DEGRADERS AND METHODS OF USE THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/092153SELECTIVE DUAL HISTONE DEACETYLASE 6/8 (HDAC6/8) DEGRADERS AND  METHODS OF USE THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/092159PAPD5 INHIBITION AS A TREATMENT FOR DYSKERATOSIS CONGENITA,  APLASTIC ANEMIA AND MYELODYSPLASTIC SYNDROME CAUSED BY REDUCED TELOMERASE RNA  LEVELSTHE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE
WO/2021/096753CD200 RECEPTOR ANTAGONIST BINDING MOLECULESELI LILLY AND COMPANY
WO/2021/092172FUNCTIONALLY MODIFIED MAYTANSINOIDS AND COMPOSITIONS AND  METHODS OF USE THEREOFUNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/092174SELECTIVE HISTONE DEACETYLASE (HDAC) DEGRADERS AND METHODS OF  USE THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/092187DETECTION AND TREATMENT OF CONDITIONS RELATED TO LUTEINIZING  HORMONE/FOLLICLE-STIMULATING HORMONE (LH/FSH) LEVELSUNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH
WO/2021/092190COMBINATION THERAPY FOR CANCERHEALTH RESEARCH, INC.
WO/2021/092199ISOLATION, PRESERVATION, AND EXPANSION OF CANINE UMBILICAL  CORD MESENCHYMAL STROMAL CELLSKANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/092200BIOSYNTHESIS OF CHEMICALLY DIVERSIFIED NON-NATURAL TERPENE  PRODUCTSBOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/092204METHODS AND COMPOSITIONS FOR NUCLEIC ACID-GUIDED NUCLEASE CELL  TARGETING SCREENSPOTLIGHT THERAPEUTICS
WO/2021/092206MYCOBACTERIAL COMPOSITIONS AND BIOMARKERS FOR USE IN TREATMENT  AND MONITORING OF THERAPEUTIC RESPONSIVENESSBETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/092209BOVINE MILK-ISOLATED POWDERED EXOSOMES, NUTRITIONAL  COMPOSITIONS AND METHODSABBOTT LABORATORIES
WO/2021/092214HYGIENE PRODUCT POD AND METHODS OF USING SAMENOHBO, LLC
WO/2021/092223HLA RESTRICTED HORMAD1 T CELL RECEPTORS AND USES THEREOFBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/092225NANOPARTICLES COMPRISING PRODRUGS STABILIZED BY ALBUMIN FOR  TREATMENT OF CANCER AND OTHER DISEASESLUMINUS BIOSCIENCES, INC.
WO/2021/092227DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS ELANE  GENE USING GUIDES 21-30 NUCLEOTIDES IN LENGTHEMENDOBIO INC.
WO/2021/092238TOPICAL FORMULATIONS OF CYCLOOXYGENASE INHIBITORS AND THEIR  USESMARTECH TOPICAL, INC.
WO/2021/092239TOPICAL COMPOSITIONS COMPRISING IRAK4 INHIBITORS FOR USE IN  TREATING DERMATOLOGICAL CONDITIONS CHARACTERISED BY INFLAMMATIONDERMIRA, INC.
WO/2021/092240MRGPRX2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY  DISORDERSDERMIRA, INC.
WO/2021/092242ROR GAMMA T INHIBITORS AND TOPICAL USES THEREOFDERMIRA, INC.
WO/2021/092246TYK2 PSEUDOKINASE LIGANDSVENTYX BIOSCIENCES, INC.
WO/2021/092252GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM  STEM CELLS AND THERAPEUTIC USES THEREOFFORMAN, Stephen J.
WO/2021/092254PHAGE COMPOSITIONS COMPRISING CRISPR-CAS SYSTEMS AND METHODS  OF USE THEREOFLOCUS BIOSCIENCES, INC.
WO/2021/092262MRGPRX2 ANTAGONISTS AND USES THEREOFDERMIRA, INC.
WO/2021/092266GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHOD OF MAKING  AND USING THEREOFSYSTIMMUNE, INC.
WO/2021/092286AMORPHOUS FORM OF A COMPLEMENT COMPONENT C5A RECEPTORCHEMOCENTRYX, INC.
WO/2021/092287CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOFNORTH CAROLINA STATE UNIVERSITY
WO/2021/092290CHIMERIC ANTIGEN RECEPTOR T CELL THERAPYKITE PHARMA, INC.
WO/2021/092292FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a  RECEPTORCHEMOCENTRYX, INC.
WO/2021/092295SALT FORMS OF A COMPLEMENT COMPONENT C5A RECEPTORCHEMOCENTRYX, INC.
WO/2021/092307COMPOSITIONS CONTAINING FENCHOLS AND METHODS OF USEBEDOUKIAN RESEARCH, INC.
WO/2021/092315ANTIPERSPIRANT FORMULATIONS COMPRISING HEMISQUALANEAMYRIS, INC.
WO/2021/096773A PRECISION MEDICINE METHOD FOR IMMUNOTHERAPYEDIFICE HEALTH, INC.
WO/2021/092340COMPOSITIONS AND METHODS FOR DELIVERING CANNABINOIDS TO SKINAMYRIS, INC.
WO/2021/092341SODIUM-GLUCOSE LINKED TRANSPORTER INHIBITORS FOR THE  MANAGEMENT OF CHRONIC KIDNEY DISEASE, HYPERTENSION, AND HEART FAILURE IN  COMPANION ANIMALSINCREVET, INC.
WO/2021/092347METHODS AND COMPOSITIONS FOR TYPE 2 DIABETES THERAPYSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/092349LIPID-BASED FORMULATIONS OF SCY-078 SALTSSCYNEXIS, INC.
WO/2021/173193USE OF BRAIN-SPECIFIC ANTIGENS TO HOME, BLOCK AND DELIVER  CELL-BASED TREATMENTS TO THE BRAINTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/092354FORMULATIONS AND DOSES OF PEGYLATED URICASESELECTA BIOSCIENCES, INC.
WO/2021/092392USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT  AGAINST ENVELOPED VIRUSESCORNELL UNIVERSITY
WO/2021/092406TRAMADOL HYDROCHLORIDE SOLUTIONATHENA BIOSCIENCE, LLC
WO/2021/092407INHIBITORS OF INFLUENZA VIRAL ENTRYTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/092417VACCINES AND RELATED METHODS FOR TREATMENT OF PSEUDOMONAS  BACTERIAL INFECTIONSMARSHALL UNIVERSITY RESEARCH CORPORATION
WO/2021/092421ENDOTHELIAL LIPASE ANTIBODIES FOR THE TREATMENT OF  CARDIOVASCULAR DISEASESMEDIMMUNE, LLC
WO/2021/092427REPLICATION-ENHANCED ONCOLYTIC ADENOVIRUSESMEMGEN, INC.
WO/2021/092428HEMP EXTRACT AND METHODS OF USE THEREOFELLEVET SCIENCES
WO/2021/092439METHODS OF TREATING DEPRESSIVE DISORDERSXENON PHARMACEUTICALS INC.
WO/2021/092440SYNTHETIC MODIFIED RNA AND USES THEREOFICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/092446FENTANYL HAPTEN, FENTANYL HAPTEN-CONJUGATES, AND METHODS FOR  MAKING AND USINGREGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/092452THERAPEUTIC PROTEIN-BASED NANOPARTICLES AND METHODS FOR MAKING  THE SAMETHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/092459COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSIONIONIS PHARMACEUTICALS, INC.
WO/2021/096783USE OF MOG FOR PRIMING A TREATMENT FOR GLIOBLASTOMATHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/092470COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERSRETINA FOUNDATION OF THE SOUTHWEST
WO/2021/092471METABOLIC REPROGRAMMING OF IMMUNE CELLS TO ENHANCE THE  EFFICACY OF PROPHYLACTIC AND THERAPEUTIC VACCINESSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/092472METHODS OF TREATING HYPEROXALURIAALLENA PHARMACEUTICALS, INC.
WO/2021/092474TREATING LIVER DISORDERSTERNS, INC.
WO/2021/092483GASTRIC RESIDENCE SYSTEMS HAVING A FILAMENT FOR IMPROVED  GASTRIC RESIDENCELYNDRA, INC.
WO/2021/092484GASTRIC RESIDENCE SYSTEMS HAVING ARMS WITH CONTROLLED  STIFFNESS FOR IMPROVED GASTRIC RESIDENCELYNDRA, INC.
WO/2021/092486FORMULATIONS FOR RELEASE-RATE MODULATING FILMS FOR GASTRIC  RESIDENCE SYSTEMSLYNDRA, INC.
WO/2021/092487POLYMERIC LINKERS FOR A GASTRIC RESIDENCE SYSTEMLYNDRA, INC.
WO/2021/092491GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF ACTIVE AGENTSLYNDRA, INC.
WO/2021/092496THIAZOLIDINEDIONE ANALOGS FOR THE TREATMENT OF NAFLD AND  METABOLIC DISEASESCIRIUS THERAPEUTICS, INC.
WO/2021/092498COMBINATION OF A T CELL THERAPY AND (S)-3-[4-(4-MORPHOLIN-4  YLMETHYL-BENZYLOXY)-L-OXO-L,3-DIHYDRO-ISOINDOL-2-YL]- PIPERIDINE-2,6-DIONEJUNO THERAPEUTICS, INC.
WO/2021/092499TREATMENTS OF MENIERE'S DISEASESPIRAL THERAPEAUTICS, INC.
WO/2021/092513CRISPR AND AAV STRATEGIES FOR X-LINKED JUVENILE RETINOSCHISIS  THERAPYREGENERON PHARMACEUTICALS, INC.
WO/2021/092515REMOTE-CONTROLLED IMAGE-GUIDED DRUG DELIVERY VIA  ULTRASOUND-MODULATED MOLECULAR DIFFUSIONCALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/092522TOPICAL DELIVERY OF TOFACITINIB USING IONIC LIQUIDCAGE BIO, INC.
WO/2021/101739HUMAN ANTIBODIES THAT NEUTRALIZE ZIKA VIRUS AND METHODS OF USE  THEREFORVANDERBILT UNIVERSITY
WO/2021/092535METABOLITE-BASED POLYMERS AND MICROPARTICLES FOR DELIVERY OF  THERAPEUTIC AGENTS AND TISSUE REGENERATIONARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/096794METHOD OF TREATING AN INDIVIDUAL WITH A HEALTH CONDITION WITH  FECAL MICROBIOTA TRANSPLANTHAZAN, Sabine
WO/2021/092554PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HBV  DISORDERSASSEMBLY BIOSCIENCES, INC.
WO/2021/133476COMBINATION THERAPY USING AN IL-2 RECEPTOR AGONIST AND AN  IMMUNE CHECKPOINT INHIBITORNEOLEUKIN THERAPEUTICS, INC.
WO/2021/092560EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORSHUMANIGEN, INC.
WO/2021/092562EXON SKIPPING OF FC-EPSILON-RI-BETA AND MS4A6A IN COMBINATION  FOR THE TREATMENT OF ALLERGIC DISEASESNORTH CAROLINA STATE UNIVERSITY
WO/2021/092564CULTIVATED AUTOLOGOUS LIMBAL EPITHELIAL CELL (CALEC)  TRANSPLANTATIONMASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/092577METHODS AND MATERIALS FOR USING ENGINEERED MESENCHYMAL STEM  CELLS TO TREAT INFLAMMATORY CONDITIONS AND DEGENERATIVE DISEASESMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/096813EXTRACT, CONSUMABLE PRODUCT AND METHOD FOR ENRICHING BIOACTIVE  METABOLITE IN AN EXTRACTBRIGHTSEED, INC
WO/2021/092589METHODS FOR ENGINEERING THERAPEUTICS AND USES THEREOFTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/092593USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORSTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/113027METHOD AND COMPOSITIONS FOR TREATING GLIOBLASTOMAPHOENIX BIOTECHNOLOGY, INC.
WO/2021/242297NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MENOPAUSE  RELATED ANXIETY AND DEPRESSIONLA PHARMA TECH INC.
WO/2021/096871TYPE V PHOSPHODIESTERASE INHIBITOR COMPOSITIONS, METHODS OF  MAKING THEM AND METHODS OF USING THEMAMERICAN REGENT, INC.
WO/2021/096882COMPOSITIONS, METHODS AND KITS FOR ALTERING ADIPOCYTESNUSIRT SCIENCES, INC.
WO/2021/096886METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY  CRYSTALLIZATIONNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/092598METHODS OF TREATMENT WITH MYOSIN MODULATORMYOKARDIA, INC.
WO/2021/096912CRISPR/CAS9 SYSTEM AS AN AGENT FOR INHIBITION OF POLYOMA JC  INFECTIONTEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/096921LOW CONTAMINANT ANTIMICROBIAL VACCINESONEBIOPHARMA, INC.
WO/2021/096926CONTRACEPTIVE MEDICAL DEVICESPOLY-MED, INC.
WO/2021/096948ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/096951LIPOSOME COMPOSITIONS AND METHODS OF TREATMENT TARGETED TO  TUMOR ENDOTHELIUMWASHINGTON UNIVERSITY
WO/2021/096970NATURAL KILLER CELL THERAPIESIMMUNITYBIO, INC.
WO/2021/096971COMPOSITION AND METHOD FOR IN VIVO ASSAY OF OPIOID RECEPTORSTHE TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/096972POLYMERIC NANOPARTICLES THAT TARGET LIVER SINUSOIDAL  ENDOTHELIAL CELLS TO INDUCE ANTIGEN-SPECIFIC IMMUNE TOLERANCETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/096997BIOMARKERS FOR NANOPARTICLE COMPOSITIONSABRAXIS BIOSCIENCE, LLC
WO/2021/097002USE OF PYRIDYLOXYPYRIMIDINES FOR TREATING INFECTIOUS DISEASESBP ASSET V, INC.
WO/2021/097003METHODS FOR TREATING DISEASESCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/101777SELF-SOLIDIFYING TOPICAL FORMULATIONS WITH LOCAL ANESTHETICZHANG, Jie
WO/2021/097008USE OF PYRIDYLOXYPYRIDINES FOR TREATING INFECTIOUS DISEASESBP ASSET V, INC.
WO/2021/097009SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS  DISEASESBP ASSET V, INC.
WO/2021/097021TREATMENT AND PROTECTION AGAINST  <i>ASPERGILLUS</i> INFECTION AND ASPERGILLOSIS DISEASEUNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/097024HUMAN HENDRA VIRUS AND NIPAH VIRUS ANTIBODIES AND METHODS OF  USE THEREFORVANDERBILT UNIVERSITY
WO/2021/097027SELADELPAR FOR USE IN THE TREATMENT OF ALCOHOLIC LIVER DISEASECYMABAY THERAPEUTICS, INC.
WO/2021/097034SELADELPAR FOR USE IN THE TREATMENT OF INTESTINAL BARRIER  DYSFUNCTION AND ASSOCIATED DISEASESCYMABAY THERAPEUTICS, INC.
WO/2021/097035AN APPARATUS AND METHODS TO RAPIDLY DETECT, SEPARATE, PURIFY,  AND QUANTIFY VARIOUS VIRUSES FROM CELLS, CULTURED MEDIUM AND OTHER FLUIDSFLUID-SCREEN, INC.
WO/2021/097038NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODSTREMEAU PHARMACEUTICALS, INC.
WO/2021/097060PRO IMMUNE MODULATING MOLECULE COMPRISING A CLUSTERING MOIETYHARPOON THERAPEUTICS, INC.
WO/2021/097069OLEIC ACID DERIVATIVES AS TREATMENTS FOR FRIEDREICH ATAXIA AND  INHIBITORS OF FERROPTOSISTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/097075SUBSTITUTED ISOINDOLONYL 2,2'-BIPYRIMIDINYL COMPOUNDS,  ANALOGUES THEREOF, AND METHODS USING SAMEARBUTUS BIOPHARMA, INC.
WO/2021/097077SHORT CONJUGATED OLIGOELECTROLYTES AND ANTIBIOTICSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097084METHODS FOR TREATING IMMUNOSUPPRESSION AND DISEASES ASSOCIATED  WITH IMMUNOSUPPRESSIONTHE UAB RESEARCH FOUNDATION
WO/2021/097109LENTIVIRAL VECTORS IN HEMATOPOIETIC STEM CELLS TO TREAT  X-LINKED CHRONIC GRANULOMATOUS DISEASETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097122SREBP INHIBITOR COMPRISING A THIOPHENE CENTRAL RINGCAPULUS THERAPEUTICS, LLC
WO/2021/097123THIOPHENE COMPOUNDS WITH CYCLIC AMIDES, AND USES THEREOFCAPULUS THERAPEUTICS, LLC
WO/2021/097125LENTIVIRAL VECTORS IN HEMATOPOIETIC STEM CELLS TO TREAT  RECOMBINATION-ACTIVATING GENE 1 (RAG1) SEVERE COMBINED IMMUNODEFICIENCY  (SCID)THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097131COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S  DISEASEORCHARD THERAPEUTICS (EUROPE) LIMITED
WO/2021/097146METHODS AND COMPOSITIONS FOR TREATING CANCERABCENTRA, LLC
WO/2021/097159METHOD FOR PREPARING HETEROLEPTIC TRIARYLBISMUTHANES AND  COMPOUNDS PRODUCED BY THE SAMEUNIVERSITY OF HAWAII
WO/2021/097160PEDIATRIC FORMULATIONS FOR TREATMENT OF CANCERCELGENE CORPORATION
WO/2021/097163PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABINOID ANIONSNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/097174NANOEMULSION COMPOSITIONS FOR TREATING AEROALLERGEN ASSOCIATED  ALLERGY AND INFLAMMATIONTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/097191METHODS OF TREATING OXIDATIVE STRESS TO MODULATE REDOX  BALANCE, PREVENTING OXIDATIVE STRESS INDUCED CELL DAMAGE AND DEATHREDOX BALANCE, LLC
WO/2021/101802PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USEBIOVENTUS, LLC .
WO/2021/097213COMBINATION OF A BTK INHIBITOR AND AN MDM2 INHIBITOR FOR  CANCER TREATMENTQUOGUE IP HOLDINGS LLC
WO/2021/097220METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB  IN COMBINATION WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATESEAGEN INC.
WO/2021/097227IL-15 FUSION PROTEIN ENHANCED ADOPTIVE CELL THERAPEUTICSALTOR BIOSCIENCE, LLC
WO/2021/097240COMPOUNDS AND USES THEREOFYUMANITY THERAPEUTICS, INC.
WO/2021/097243COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES  THEREOFAPRINOIA THERAPEUTICS INC.
WO/2021/097246METHODS AND PRODUCTS FOR TREATING RENAL DISEASECHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/097247MULTIMODAL COMPOSITIONS AND METHODS OF TREATMENTAQUESTIVE THERAPEUTICS, INC.
WO/2021/097254HIV IMMUNOGENS, VACCINES, AND METHODS RELATED THERETOEMORY UNIVERSITY
WO/2021/097271COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETOASSEMBLY BIOSCIENCES, INC.
WO/2021/097278COMPOSITIONS AND METHODS FOR IMMUNOTHERAPYLUDWIG INSTITUTE FOR CANCER RESEARCH LTD
WO/2021/097286DRUG FORMULATIONS AND METHODS OF TREATMENT FOR METABOLIC  DISORDERSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097288COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE  DISEASESFINCH THERAPEUTICS HOLDINGS LLC
WO/2021/097289PEGYLATED RECOMBINANT IMMUNOTOXINSTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/097294COMPOSITIONS AND METHODS FOR IMMUNOTHERAPYSURFACE ONCOLOGY, INC.
WO/2021/097299METHODS AND COMPOSITIONS FOR SMOKING CESSATIONBEHAVIORAL DIAGNOSTICS, LLC
WO/2021/097305SUPRAMOLECULAR NANOSUBSTRATE-MEDIATED DELIVERY SYSTEM ENABLES  CRISPR/CAS9 KNOCKIN OF HEMOGLOBIN BETA GENE-A POTENTIAL THERAPEUTIC SOLUTION  FOR HEMOGLOBINOPATHIESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097306DUAL SUPRAMOLECULAR NANOPARTICLE VECTORS ENABLE  CRISPR/CAS9-MEDIATED KNOCKIN OF RETINOSCHISIN 1 GENE-A POTENTIAL NON-VIRAL  THERAPEUTIC SOLUTIONS FOR X-LINKED JUVENILE RETINOSCHISISTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/101813HYBRID VIRUS-LIKE PARTICLES AND USES THEREOF AS A THERAPEUTIC  HEPATITIS B VACCINEVLP BIOTECH, INC.
WO/2021/101814INTRANASAL LEPTIN PREVENTS OPIOID-INDUCED RESPIRATORY  DEPRESSION IN OBESITYTHE GEORGE WASHINGTON UNIVERSITY
WO/2021/097327TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONSUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/097329IMMORTALIZED CARDIAC STEM CELLS FOR CARDIAC REPAIRNEOPROGEN, INC.
WO/2021/097345HEPARAN SULFATE (HS) OLIGOSACCHARIDES EFFECT IN LIVER ISCHEMIA  REPERFUSION INJURYTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/097351FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR  THE TREATMENT OF RADIATION DERMATITIS AND OTHER SKIN DISORDERSKANNALIFE SCIENCES, INC.
WO/2021/108151TRANSDERMAL DELIVERY SYSTEMBAI, Xuefei
WO/2021/097387SILICA SHELL ENCAPSULATED POLYAROMATIC-CORE MICROPARTICLESARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/113062PDIA4 INHIBITORS AND USE THEREOF FOR INHIBITING ß-CELL  PATHOGENESIS AND TREATING DIABETESACADEMIA SINICA
WO/2021/097390CELLULAR MOLECULAR THERANOSTICS NANOPROBE SYSTEMS AND METHODSDUKE UNIVERSITY
WO/2021/097401COMBINATION THERAPY WITH PROTEIN KINASE B ACTIVATION INHIBITOR  TO TREAT CANCERH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/097411ANTI-FUNGAL COMPOSITIONS AND METHODS FOR USING SAMETHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/101836ANTIMALARIAL AGENTSMERCK SHARP & DOHME CORP.
WO/2021/097423FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF  STROKEFIGENE, LLC
WO/2021/216118ANTIVIRAL & VIRUCIDAL NASAL SPRAY COMPOSITIONS AND RELATED  TREATMENT METHODSFERRER MEDICAL INNOVATIONS, LLC
WO/2021/097427XANOMELINE DERIVATIVES AND METHODS FOR TREATING NEUROLOGICAL  DISORDERSKARUNA THERAPEUTICS, INC.
WO/2021/097434FIBROBLAST THERAPY FOR INFLAMMATORY BOWEL DISEASEFIGENE, LLC
WO/2021/141672STABLE FORMULATIONS OF SILK-DERIVED PROTEINSILK TECHNOLOGIES, LTD.
WO/2021/101854COMPOUNDS AND METHODS OF PREPARING COMPOUNDS S1P1 MODULATORSTREVENA, INC.
WO/2021/101902COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING  ISCHEMIA-REPERFUSION INJURY AND/OR LUNG INJURYYALE UNIVERSITY
WO/2021/101903DUAL ANDROGEN RECEPTOR/AKR1C3 INHIBITORSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/101905PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF  IMAGING A TUMORONCONANO MEDICINE, INC.
WO/2021/101910METHODS OF ADMINISTERING VOXELOTORGLOBAL BLOOD THERAPEUTICS, INC.
WO/2021/101926TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTHSTAMETS, Paul, Edward
WO/2021/101929INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE  TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLSTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/101943PERSONAL CARE COMPOSITION COMPRISING A MULTISTAGE POLYMERDOW GLOBAL TECHNOLOGIES LLC
WO/2021/101966TREATMENT OF FIBROSIS WITH COMBINED BLOCKADE OF IL-6 AND  IMMUNE CHECKPOINTTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/101983TOUGH TISSUE SEALANTS AND THE USE THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/101989AQUEOUS MIXTURES COMPRISING CELLULOSE NANOCRYSTALS AND  SULFONATED POLYESTERNORTH CAROLINA STATE UNIVERSITY
WO/2021/101998INTRAVAGINAL RING DEVICESDARé BIOSCIENCE, INC.
WO/2021/102004DOSING REGIMENS FOR A PROTEIN KINASE C INHIBITORIDEAYA BIOSCIENCES, INC.
WO/2021/102021PRESERVATION OF NEURON HEALTH AND REGENERATIVE CAPACITY  FOLLOWING NERVOUS SYSTEM INJURYTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/102032BLOOD PLASMA FRACTIONS FOR USE IN LIVER REGENERATIONALKAHEST, INC.
WO/2021/102038AKT INHIBITORS FOR ENHANCING CHIMERIC T CELL PERSISTENCEH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/102052DIRECTED CONJUGATION TECHNOLOGIESKLEO PHARMACEUTICALS, INC.
WO/2021/102053VITAMIN B12 COMPOUND SUPPLEMENTATION METHODS AND COMPOSITIONSLUPIN, INC.
WO/2021/102057HYPERACTIVE DENDRITIC CELLS ENABLE DURABLE ADOPTIVE CELL  TRANSFER-BASED ANTI-TUMOR IMMUNITYCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/102058STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER  IMMUNOTHERAPYCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/102063CYTOKINE FUSION PROTEINS, AND THEIR PHARMACEUTICAL  COMPOSITIONS AND THERAPEUTIC APPLICATIONSANWITA BIOSCIENCES, INC.
WO/2021/102068USER-FRIENDLY INGREDIENT LABELTHE PROCTER & GAMBLE COMPANY
WO/2021/108195BDELLOVIBRIO TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSISBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/102072COMPOSITION AND METHOD FOR SKIN TREATMENTRYTHERA THERAPEUTICS, INC.
WO/2021/102084IONIC LIQUIDS FOR DRUG DELIVERYPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/102085HIGH-THROUGHPUT MONODISPERSE AEROSOLS OF MICRO-SHELL PARTICLESTHE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/145952USE OF KETAMINE IN THE TREATMENT OF CACHEXIAASTROMEDICAL BIOTECHNOLOGY, LTD.
WO/2021/102090NUTRITIONAL COMPOSITIONS FOR TREATING A CLOSTRIDIUM DIFFICILE  INFECTIONABBOTT LABORATORIES
WO/2021/102092CANCER TREATMENT USING CAMPTOTHECIN DERIVATIVESVIVACITAS ONCOLOGY, INC.
WO/2021/108202MODIFIED VIRAL THERAPEUTICS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102113SUNSCREEN COMPOSITIONS WITH MULTIPLE PHOTOPROTECTING UV  FILTERSCOTY INC.
WO/2021/102114SUBSTITUTED HETEROCYCLICS WITH THERAPEUTIC ACTIVITY IN HIVNEW YORK BLOOD CENTER, INC.
WO/2021/102115PROCESSES FOR THE PREPARATION OF ALPHA-HYDROXY ESTERS VIA  GRIGNARD COUPLING AND THIOLATION REACTIONSKEMIN INDUSTRIES, INC.
WO/2021/113083TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND  METHODS OF MAKING AND USING THE SAMEJLABS BEAUTY LLC
WO/2021/102124METHODS OF INDUCING OR ENHANCING FARNESOID X RECEPTOR  (FXR)-MEDIATED TRANSCRIPTIONAL RESPONSEYALE UNIVERSITY
WO/2021/102142OKN-007 AS A THERAPEUTIC AGENTOKLAHOMA MEDICAL RESEARCH FOUNDATION
WO/2021/102161METHODS FOR TREATING INFLAMMATORY BOWEL DISEASEANGION BIOMEDICA CORP.
WO/2021/102170CANNABIS PLANT EXTRACTS WITH BUTANEJENNY'S ROSE, LLC
WO/2021/102182SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT  OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERSSPARK THERAPEUTICS, INC.
WO/2021/102204HETEROARYL COMPOUNDSVIVACE THERAPEUTICS, INC.
WO/2021/102234ADENO-ASSOCIATED VIRAL VECTOR VARIANTSTHE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/102235USE OF GELSOLIN TO TREAT OR PREVENT LUNG INJURY AND DISEASETHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/102251USE OF SGLT2 INHIBITORS TO TREAT PRIMARY BILLIARY CHOLANGITISAVOLYNT
WO/2021/102258COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2  INHIBITORINCYTE CORPORATION
WO/2021/102267GENERATION OF KIDNEY GLOMERULAR SPECIFIC ENDOTHELIAL CELLS AND  METHODS OF USECORNELL UNIVERSITY
WO/2021/108255LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATIONTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102279ANTI-CANCER COMPOSITIONS AND METHODSUNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/102299CASPASE 6 INHIBITORS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102302COMPOSITIONS AND METHODS FOR TREATING CCR9-MEDIATED DISEASES  USING CCR9 INHIBITOR AND ANTI-TNF-ALPHA BLOCKING ANTIBODIESCHEMOCENTRYX, INC.
WO/2021/102305METHODS AND COMPOSITIONS FOR GENERATING FUNCTIONALLY MATURE  BETA CELLS AND USES THEREOFWASHINGTON UNIVERSITY
WO/2021/102307VACCINIA VIRUSES AND METHODS FOR USING VACCINIA VIRUSESUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/102313COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETOASSEMBLY BIOSCIENCES, INC.
WO/2021/102320METHODS FOR PROVIDING CONTINUOUS THERAPY AGAINST PNAG  COMPRISING MICROBESONEBIOPHARMA, INC.
WO/2021/102322CELL-PERMEABLE CYCLIC PEPTIDES AND USES THEREOFUNNATURAL PRODUCTS INC.
WO/2021/102323PHARMACEUTICAL PACKAGING UNITS AND METHODS FOR CONCOMITANT  ADMINISTRATION OF RADIOTRACERSLIKEMINDS, INC.
WO/2021/102326TREATMENT FOR REDUCING ADVERSE EVENTS INCLUDING CHEMOTHERAPY  DISCOMFORT AND OTHER CONDITIONSSIAMON, Al
WO/2021/102328PROPHYLAXIS AND REVERSAL OF STIMULANT AND OPIOID/OPIATE  OVERDOSE AND/OR TOXIC EXPOSURETORRALVA MEDICAL THERAPEUTICS LLC
WO/2021/102330COMPOSITIONS AND METHODS FOR TREATMENT OF PAINSYNVENTA LLC
WO/2021/102332TGFBETAR2 INHIBITOR-LRRC15 ANTIBODY CONJUGATES AND USES  THEREOFSILVERBACK THERAPEUTICS, INC.
WO/2021/102337COMPOSITIONS AND METHODS FOR TREATING CANCER WITH DUOCARSLENTIGEN TECHNOLOGY, INC.
WO/2021/102343SOLID DOSE PHARMACEUTICAL COMPOSITIONSUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
WO/2021/102352TUMOR ORGANOID CULTURE COMPOSITIONS, SYSTEMS, AND METHODSTEMPUS LABS, INC.
WO/2021/102353COMBINATION CANNABINOID-NAD+ PRECURSOR FORMULATION FOR  TREATMENT OF INFLAMMATION AND METHODS RELATED THERETOCANOLE LLC
WO/2021/102356COMBINATION THERAPY OF A COENZYME Q10 COMPOUND AND RADIATION  THERAPY FOR TREATMENT OF GLIOMABERG LLC
WO/2021/102357METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTORARENA PHARMACEUTICALS, INC.
WO/2021/102358COMBINATION CANNABINOID-PHENYLETHANOID FORMULATION FOR  TREATMENT OF INFLAMMATION AND METHODS RELATED THERETOCANOLE LLC
WO/2021/102361CASPASE 6 INHIBITORS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102369MICRONEEDLE PATCH FOR IMMUNOSTIMULATORY DRUG DELIVERYVERADERMICS INCORPORATED
WO/2021/102370METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITYUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/102372MONOCLONAL ANTIBODIES THAT TARGET HUMAN OX40ABVISION, INC.
WO/2021/102376MONOCLONAL ANTIBODIES THAT TARGET HUMAN CD47 PROTEINABVISION, INC.
WO/2021/102379METHODS OF REDUCING NEUROLOGICAL DAMAGE IN WILSON DISEASE  PATIENTSALEXION PHARMACEUTICALS, INC.
WO/2021/102389TETANUS TOXOID AND CRM-BASED PEPTIDES AND METHODS OF USEUNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/236154RAPID VIRAL ASSAYBARNHIZER, Bret, T.
WO/2021/118796BIOMARKERS FOR THE DIAGNOSIS OF ATRIAL FIBRILLATION CAUSE OF  STROKEISCHEMIA CARE LLC
WO/2021/102403METHODS OF TREATING CANCER USING DKK-1-INHIBITORSLEAP THERAPEUTICS, INC.
WO/2021/108302CELA-1 INHIBITION FOR TREATMENT OF LUNG DISEASECHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/108303PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PULMONARY  HYPERTENSIONPHPRECISIONMED, LLC
WO/2021/113105SKIN CARE PRODUCT AND METHOD FOR ITS PRODUCTIONSKB LLC
WO/2021/108308SYSTEMS AND DEVICES FOR DELIVERING CARGO MATERIAL AND METHODS  OF DELIVERING CARGO MATERIALSGEORGIA TECH RESEARCH CORPORATION
WO/2021/102423COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING  AGE-ASSOCIATED INFLAMMATION AND DISORDERSBROWN UNIVERSITY
WO/2021/102428CANNABIDIOL AND/OR COBICISTAT COMBINATION DRUG THERAPYSHINKEI THERAPEUTICS, INC.
WO/2021/102433COMPOSITIONS AND METHODS FOR USE IN TYPE 1 DIABETESTHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/108331COMBINATION THERAPY FOR HEAD AND NECK CANCERTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/108338A COMBINATION OF A BTK INHIBITOR AND ABATACEPT FOR THE  TREATMENT OF RHEUMATOID ARTHRITISBRISTOL-MYERS SQUIBB COMPANY
WO/2021/108343FORMULATIONS COMPRISING LIPID-LOWERING AND BLOOD  PRESSURE-LOWERING DRUGSFORDOZ PHARMA C0RP.
WO/2021/108350COMBINATION THERAPY USING FABP5 INHIBITORS WITH TAXANES FOR  TREATMENT OF CANCERTHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/108353TREATMENT OF CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT  BIND TO 191P4D12 PROTEINSAGENSYS, INC.
WO/2021/108360METHODS OF USING SOLUBLE SOLID DISPERSIONS FOR RIFAXIMINUNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/108389METHOD OF PRODUCING NATURAL KILLER CELLS AND COMPOSITIONS  THEREOFNKMAX CO., LTD.
WO/2021/102445USES OF CD20-BINDING MOLECULES AND ADDITIONAL THERAPEUTIC  AGENTSMOLECULAR TEMPLATES, INC.
WO/2021/108427EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONSREFORM BIOLOGICS, LLC
WO/2021/108442MODULATORS OF CAS9 POLYPEPTIDE ACTIVITY AND METHODS OF USE  THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/108447METHODS FOR TREATING AND/OR PREVENTING IDIOPATHIC PNEUMONIA  SYNDROME (IPS) AND/OR CAPILLARY LEAK SYNDROME (CLS) AND/OR ENGRAFTMENT  SYNDROME (ES) AND/OR FLUID OVERLOAD (FO) ASSOCIATED WITH HEMATOPOIETIC STEM  CELL TRANSPLANTOMEROS CORPORATION
WO/2021/108462IMMUNE CELL DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE  CELLS AND THE TUMOR MICROENVIRONMENTANSUN BIOPHARMA, INC.
WO/2021/108469AHR INHIBITORS AND USES THEREOFIKENA ONCOLOGY, INC.
WO/2021/108472NOVEL ORGANOLEPTIC COMPOUNDSINTERNATIONAL FLAVORS & FRAGRANCES INC.
WO/2021/108474METHOD FOR EXTRACTION AND PURIFICATION OF AI18F-LABELED HBED  CONJUGATESBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108482PENTAPEPTIDE AND METHODS OF USE THEREOFTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/113136METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF  TYPE 1 DIABETESDR. MARY MORRIS & ASSOCIATES, LLC
WO/2021/108508HAIR TREATMENT COMPOSITIONS, KITS, AND METHODS OF USEL'OREAL
WO/2021/108513ION CHANNEL MODULATORSPRAXIS PRECISION MEDICINES, INC.
WO/2021/108538PLATELETS LOADED WITH mRNACELLPHIRE, INC.
WO/2021/108539PLATELET DIAGNOSTIC IMAGING AGENTSCELLPHIRE, INC.
WO/2021/108544CAPSID INHIBITORS FOR THE PREVENTION OF HIVGILEAD SCIENCES, INC.
WO/2021/108548SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS EMULSIONSREGENERON PHARMACEUTICALS, INC.
WO/2021/108549NOVEL THYROMIMETICSAUTOBAHN THERAPEUTICS, INC.
WO/2021/108561METHODS AND COMPOSITIONS FOR MODULATING HETEROCHROMATIN  DYSFUNCTION, GENOMIC INSTABILITY, AND ASSOCIATED CONDITIONSLA JOLLA INSTITUTE FOR IMMUNOLOGY
WO/2021/108565CHEMOTHERAPY FOR GLIOMA THROUGH NEURONAL CONVERSIONTHE PENN STATE RESEARCH FOUNDATION
WO/2021/108581POTENT AND SELECTIVE AZAINDOLE INHIBITORS OF CDK8 AND CDK19DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/108601FORMULATIONS OF TERAMEPROCOL AND TEMOZOLOMIDE AND THEIR USE IN  STIMULATION OF HUMORAL IMMUNITY IN TUMORSTHE JOHNS HOPKINS UNIVERSITY
WO/2021/108605COMPOSITION AND METHOD FOR CONVERTING HUMAN GLIAL CELLS INTO  NEURONSTHE PENN STATE RESEARCH FOUNDATION
WO/2021/108613CD19 AND CD22 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOFNOVARTIS AG
WO/2021/108616SOLID DISPERSION OF PAN-RAF KINASE INHIBITORDOT THERAPEUTICS-1, INC.
WO/2021/108623COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF  BABESIOSISTUFTS MEDICAL CENTER, INC.
WO/2021/108625FORMULATIONS OF ION CHANNEL MODULATORS AND METHODS OF  PREPARATION AND USE OF ION CHANNEL MODULATORSPRAXIS PRECISION MEDICINES, INC.
WO/2021/108643COMPOSITIONS FOR IMPROVING ATHLETIC PERFORMANCE AND METHODS OF  USE THEREOFFITBIOMICS INC.
WO/2021/108649TLR7 AGONISTSPRIMMUNE THERAPEUTICS, INC.
WO/2021/108650LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING  OF B CELLSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108661CHIMERIC ANTIGEN RECEPTORS BINDING BCMA AND CD19 AND USES  THEREOFNOVARTIS AG
WO/2021/108662COMPOUND COMPRISING A NUCLEIC ACID AND A HALF-LIFE EXTENSION  MOTIFDTX PHARMA, INC.
WO/2021/108665LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING  OF MSC CELLSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108670COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR  CELLSUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/108671LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING  OF NK CELLSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108682COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDSTURNING POINT THERAPEUTICS, INC.
WO/2021/108689METHODS FOR USE OF AN ANGIOCRINE FACTOR IN TREATING A PATIENT  EXPOSED TO MYELOABLATIVE INSULTHACKENSACK MERIDIAN HEALTH CENTER FOR DISCOVERY AND INNOVATION
WO/2021/108693COMBINATION THERAPIES FOR TREATING CANCERALX ONCOLOGY INC.
WO/2021/108705NUCLEAR FACTOR KAPPA B PATHWAY INHIBITION TO ARREST CALCIFIC  AORTIC STENOSISCORNELL UNIVERSITY
WO/2021/108720LOBINALINE N-OXIDES AS POSITIVE ALLOSTERIC MODULATORS OF THE  DOPAMINE TRANSPORTER WITH POTENTIAL VALUE IN THE TREATMENT OF SUBSTANCE ABUSE  DISORDERSUNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/108722SUSTAINED RELEASE DRUG DELIVERY DEVICEOAK CREST INSTITUTE OF SCIENCE
WO/2021/108731APOSOME COMPOSITIONS AND METHODS OF USETHE METHODIST HOSPITAL
WO/2021/108737MAGNETIC COMPOSITION COMPRISING A POLYMER BLEND AND HIGH  LOADING OF MAGNETIC MATERIALL'OREAL
WO/2021/108748ACELLULAR PLACENTAL THERAPIES FOR NECROTIZING ENTEROCOLITISPLAKOUS THERAPEUTICS, INC.
WO/2021/108751HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT  CELLULITESTANDARD OF CARE CORPORATION
WO/2021/108761BROADLY NEUTRALIZING AND POTENT ANTIBODIES AGAINST HIVUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/108764DENTAL MATERIAL COMPOSITION FOR FORMING MINERAL APATITE BONDS  AND CARIES PREVENTIONINTER-MED, INC.
WO/2021/108769COMPOSITIONS AND METHODS FOR CULTURING HEMATOPOIETIC STEM AND  PROGENITOR CELLSDEVERRA THERAPEUTICS INC.
WO/2021/113163USE OF REBOXETINE TO TREAT NERVOUS SYSTEM DISORDERSAXSOME THERAPEUTICS, INC.
WO/2021/108790PURIFICATION OF REPTILIAN HYALURONIC ACID AND ITS USE FOR SOFT  AND HARD TISSUE REPAIR AND REGENERATIONLACERTA LIFE SCIENCES, LLC
WO/2021/108792METHOD OF PURIFYING POLYSACCHARIDESLONZA LTD
WO/2021/113206ATTENUATED AVIAN REOVIRUS STRAINS 94826 C140 AND 96139 C140UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/113209HAIR CONDITIONER COMPOSITIONS CONTAINING BEHENAMIDOPROPYL  DIMETHYLAMINETHE PROCTER & GAMBLE COMPANY
WO/2021/113211HAIR CONDITIONER COMPOSITIONS WITH A PRESERVATION SYSTEM  CONTAINING SODIUM BENZOATE AND GLYCOLS AND/OR GLYCERYL ESTERSTHE PROCTER & GAMBLE COMPANY
WO/2021/113212THERAPY FOR THE TREATMENT OF CANCERCELGENE CORPORATION
WO/2021/118826DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND  ACYLSULFONAMIDESDHANOA, Daljit
WO/2021/113219COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCERGENENTECH, INC.
WO/2021/113261COMPOSITIONS COMPRISING NOVEL CANNABINOID AND TERPENE PROFILESNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/113266TREATING COGNITIVE DISORDERS USING TRAPIDILSINOPIA BIOSCIENCES, INC.
WO/2021/113286STABLE LIQUID FORMULATIONS COMPRISING A GLUCAGON-LIKE PEPTIDE  1 AND USES THEREOFROSE PHARMA LLC
WO/2021/113311TREATMENT OF CANCER USING ACETYLCHOLINE MODULATION AND  IMMUNOTHERAPYBCELL SOLUTIONS, INC.
WO/2021/113328TUMOR CELL VACCINESNEUVOGEN, INC.
WO/2021/113347TARGETING MB2 OF THE MYC ONCOGENE AND ITS INTERACTION WITH  TRRAP IN CANCERTHE TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/113357SALTS AND POLYMORPHS OF CETHROMYCIN FOR THE TREATMENT OF  DISEASE SALTS AND POLYMORPHS OF CETHROMYCINALIQUANTUMRX, INC.
WO/2021/113364SELECTIVE INHIBITION OF T FOLLICULAR HELPER CELLS FOR  TREATMENT OF AUTOIMMUNE DISORDERSNEW YORK UNIVERSITY
WO/2021/113376COMPOSITIONS AND METHODS FOR EPITOPE SCANNINGTHE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/113377ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEREOFOHIO STATE INNOVATION FOUNDATION
WO/2021/113381PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM  CHANNEL OPENER EZOGABINEXENON PHARMACEUTICALS INC.
WO/2021/113382COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL  NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERYCORNELL UNIVERSITY
WO/2021/113401HISTONE DEACYTLASE 6 MODULATION OF TITIN PROTEIN MEDIATED  CARDIAC TISSUE STIFFNESS AND METHOD FOR SAMETHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/113403POLYPHOSPHAZENE DRUG CARRIERSONSELEX PHARMACEUTICALS, INC.
WO/2021/113409TRANSDERMAL PENETRATION BY MODULATING EPITHELIAL JUNCTIONSAMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/113410TRANSDERMAL PENETRANT FORMULATIONS FOR VITAMINS, MINERALS AND  SUPPLEMENTSAMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/113411TRANSDERMAL PENETRANT FORMULATIONS FOR VITAMINS, MINERALS AND  SUPPLEMENTSAMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/113412Lipid-DNA Labeling of Lipid Bilayer Particles for  Amplification QuantitationTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/113433<i>MYCOPLASMA</i> VACCINE COMPOSITION AND METHODSUNIVERSITY OF CONNECTICUT
WO/2021/113436INHIBITORS OF HIF-2ALPHAARCUS BIOSCIENCES, INC.
WO/2021/113440OLIGOPEPTIDE, TESTING KIT THEREOF, MEDICAL COMPOSITION THEREOF  AND USE OF MEDICAL COMPOSITIONCHINA MEDICAL UNIVERSITY
WO/2021/113450METHODS OF IMAGING USING MULTIPLE IMAGING AGENTSIMAGINAB, INC.
WO/2021/113473COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASISTHE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/113497DOSING OF A BRUTON'S TYROSINE KINASE INHIBITORLOXO ONCOLOGY, INC.
WO/2021/113498CYCLOOXYGENASE-2 INHIBITION FOR THE TREATMENT OF SAA-HIGH  ASTHMATHE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH  AND HUMAN SERVICES
WO/2021/113500COMBINATION THERAPIES FOR THE TREATMENT OF CANCERBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/113515INJECTABLE HYDROGELS FOR CELL DELIVERY TO THE VITREOUSTHE SCHEPENS EYE RESEARCH INSTITUTE, INC.
WO/2021/113519NANOPARTICLE COMPOSITIONS AND METHODS OF USETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/113524GLP2 RECEPTOR AGONISTS AND METHODS OF USETHE SCRIPPS RESEARCH INSTITUTE
WO/2021/113528MODULATORS OF PROGRAMMED DEATH-LIGAND-1 AND/OR PROGRAMMED  DEATH-LIGAND-2SOUTHERN RESEARCH INSTITUTE
WO/2021/113535PEPTIDE CONJUGATES AND METHODS OF USETHE SCRIPPS RESEARCH INSTITUTE
WO/2021/113536SYSTEMS AND METHODS FOR LIPID NANOPARTICLE DELIVERY OF GENE  EDITING MACHINERYDUKE UNIVERSITY
WO/2021/113541ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASESSTOKE THERAPEUTICS, INC.
WO/2021/113543METHODS FOR CANCER IMMUNOTHERAPY, USING LYMPHODEPLETION  REGIMENS AND CD19, CD20 OR BCMA ALLOGENEIC CAR T CELLSPRECISION BIOSCIENCES, INC.
WO/2021/113544COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSIONACCELERON PHARMA INC.
WO/2021/113551THERAPEUTIC COMPOUNDS FOR METHODS OF USE IN INSULIN RESISTANCEBAYLOR COLLEGE OF MEDICINE
WO/2021/113557BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN  PROTEOSOME PATHWAYNURIX THERAPEUTICS, INC.
WO/2021/077125COMPOSITIONS COMPRISING PEDF-DERIVED SHORT PEPTIDES (PDSP) AND  USES THEREOFBRIM BIOTECHNOLOGY, INC.
WO/2021/113566PROCESSES FOR PREPARING  2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDECELGENE CORPORATION
WO/2021/113574A T CELL-BASED IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM VIRAL  INFECTIONS AND TUMORSYALE UNIVERSITY
WO/2021/113580OPHTHALMIC PHARMACEUTICAL COMPOSITIONSVANDA PHARMACEUTICALS INC.
WO/2021/113585METHOD OF TREATING CANCER BY ADMINISTRATION OF AN ANTI-PD-1 OR  ANTI-PD-L1 THERAPEUTIC AGENT VIA A LYMPHATIC DELIVERY DEVICESORRENTO THERAPEUTICS, INC.
WO/2021/113591VEGF MINI-TRAPS AND METHODS OF USE THEREOFREGENERON PHARMACEUTICALS, INC.
WO/2021/113595PHOSPHORUS DERIVATIVES AS KRAS INHIBITORSBETA PHARMA, INC.
WO/2021/113596COMPOSITIONS AND METHODS COMPRISING AN ANTI-CD47 ANTIBODY IN  COMBINATION WITH A TUMOR TARGETING ANTIBODYSORRENTO THERAPEUTICS, INC.
WO/2021/113605METHODS, COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF  CANCER BY INHIBITING NOTCH-1 MATURATIONUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/118873METHOD FOR PREPARING CD7-NEGATIVE, CD3-POSITIVE T CELLSST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/113611SPLIT DEAMINASE BASE EDITORSTHE GENERAL HOSPITAL CORPORATION
WO/2021/113620ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE  TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASEFLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/113628ADOPTIVE CELL THERAPY WITH ZBTB20 SUPPRESSIONTHE TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/113634TRANSGENE CASSETTES DESIGNED TO EXPRESS A HUMAN MECP2 GENETHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS
WO/2021/113635ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE  TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASEFLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/113637OPHTHALMIC FORMULATIONS FOR THE TREATMENT OF PRESBYOPIARESTORE VISION, LLC.
WO/2021/113638PROTEIN-LOADED PLGA NANOSPHERESWEST VIRGINIA UNIVERSITY
WO/2021/113642METHODS FOR TREATING OSTEOARTHRITISPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/113648AFFINITY MOLECULES THAT DIRECT THE METABOLISM AND POLARIZATION  OF MACROPHAGES AND SYNERGIZE THE IMMUNE CHECKPOINT BLOCKADE THERAPYTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/113651DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERYASHVATTHA THERAPEUTICS, INC.
WO/2021/113656CANNABINOIDS AND USES THEREOFCORBUS PHARMACEUTICALS, INC.
WO/2021/113657TRIANTENNARY N-ACETYLGALACTOSAMINE MODIFIED HYDROXYL  POLYAMIDOAMINE DENDRIMERS AND METHODS OF USE THEREOFASHVATTHA THERAPEUTICS, INC.
WO/2021/113658METHODS AND COMPOSITIONS OF PREVENTING AND TREATING DENTAL  CARIESFORSYTH DENTAL INFIRMARY FOR CHILDREN
WO/2021/113662DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY TO THE  EYEASHVATTHA THERAPEUTICS, INC.
WO/2021/113665RAPAMYCIN ANALOGS AND USES THEREOFNAVITOR PHARMACEUTICALS, INC.
WO/2021/188169OPHTHALMIC COMPOSITION AND METHOD OF USEAWH, Carl C.
WO/2021/113669CANNABINOIDS AND USES THEREOFCORBUS PHARMACEUTICALS, INC.
WO/2021/118885PRE-TARGETING IMAGING AGENTSELI LILLY AND COMPANY
WO/2021/113685REGULATORY T CELL (TREG) COMPOSITIONS AND METHODS FOR TREATING  NEURODEGENERATIVE DISEASETHE METHODIST HOSPITAL
WO/2021/113686MASP-2 INHIBITORS AND METHODS OF USEOMEROS CORPORATION
WO/2021/113688COMBINATION THERAPIES FOR TREATMENT OF MYELODYSPLASTIC  SYNDROMESUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
WO/2021/113689SPAK/OSR INHIBITORS AND METHODS OF USING SAMEYALE UNIVERSITY
WO/2021/113694HDAC INHIBITOR SOLID STATE FORMSVIRACTA THERAPEUTICS, INC.
WO/2021/113697ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATESSEAGEN INC.
WO/2021/113702METHODS OF TREATMENT USING ILT7 BINDING PROTEINSVIELA BIO, INC.
WO/2021/113709ORAL CARE PRODUCTS AND METHODSCOLGATE-PALMOLIVE COMPANY
WO/2021/113734METHODS FOR ENHANCING IMMUNITY AND TUMOR TREATMENTRAKUTEN MEDICAL, INC.
WO/2021/113740COMPOSITIONS AND METHODS FOR REDUCING OFF-TARGET TOXICITY OF  ANTIBODY DRUG CONJUGATESTHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/113743SMALL MOLECULE RPN13 INHIBITORS WITH ANTITUMOR PROPERTIESTHE JOHNS HOPKINS UNIVERSITY
WO/2021/113747METHODS OF DECELLULARIZATION AND RECELLULARIZATION OF ORGANS  AND PORTIONS OF ORGANSMIROMATRIX MEDICAL INC.
WO/2021/113748COMPOSITION OF TRIAXIAL ANTIBODIES AND METHOD OF MAKING AND  USING THEREOFARBELE CORP.
WO/2021/113757USE OF A KV7 POTASSIUM CHANNEL OPENER FOR TREATING PAINXENON PHARMACEUTICALS INC.
WO/2021/113759PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOFCELULARITY INC.
WO/2021/113761EXOSOMES-BASED THERAPY FOR LIVER FIBROSIS AND OTHER DISEASES  ASSOCIATED WITH FIBROSISBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/113764RNAI-BASED TARGETING COMPOUNDS AND USES THEREOF TO PREVENT  ACQUIRED HEARING LOSSMUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/113775METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL  DIURETICSRESQ PHARMACEUTICALS LLC
WO/2021/113777CIRCULAR RNA COMPOSITIONS AND METHODSORNA THERAPEUTICS, INC.
WO/2021/113786A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND  METHODS OF USE THEREOFSAGE THERAPEUTICS, INC.
WO/2021/113788RECRUITMENT METHODS AND COMPOUNDS, COMPOSITIONS AND SYSTEMS  FOR RECRUITMENTPAIRWISE PLANTS SERVICES, INC.
WO/2021/113795COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSISFLATLEY DISCOVERY LAB, LLC
WO/2021/113800COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTIONTHE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/113802METHOD OF TREATMENT WITH KCNQ CHANNEL OPENERSICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/118918RADIOMICS-BASED TREATMENT DECISION SUPPORT FOR LUNG CANCERH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/113812INJECTABLE MICRO-ANNEALED POROUS SCAFFOLD FOR ARTICULAR  CARTILAGE REGENERATIONUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/118927METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF NUCLEIC ACID  THERAPEUTICSINSIDEOUTBIO, INC.
WO/2021/113820CONJUGATES AND METHODS FOR TREATING LIVER FIBROSISGENEVANT SCIENCES GMBH
WO/2021/113824STABILIZATION OF RETROMER FOR THE TREATMENT OF ALZHEIMER'S  DISEASE AND OTHER NEURODEGENERATIVE DISORDERSTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/113826ROTARY SEPARATION APPARATUS AND PROCESS OF USETHE ORIGINAL RESINATOR, LLC
WO/2021/113829COMPOSITIONS AND METHODS FOR TUNABLE MAGNETIC NANOPARTICLESTHE GENERAL HOSPITAL CORPORATION
WO/2021/113831ANTI-PVRIG AND ANTI-TIGIT ANTIBODIES FOR ENHANCED NK-CELL  BASED TUMOR KILLINGCOMPUGEN LTD.
WO/2021/113834GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEXMARINUS PHARMACEUTICALS, INC.
WO/2021/118955METHODS AND SYSTEMS FOR TREATING OR PREVENTING  PREGNANCY-RELATED HYPERTENSIVE DISORDERSAGGAMIN LLC
WO/2021/118957METHODS AND SYSTEMS FOR TREATING OR PREVENTING  PREGNANCY-RELATED HYPERTENSIVE DISORDERSAGGAMIN LLC
WO/2021/118976M. TUBERCULOSIS AG85 PROTEINS AND METHODS OF USEUNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/118988COMPOSITIONS AND METHODS FOR PREVENTING RECURRENCE OF CANCERYALE UNIVERSITY
WO/2021/118997BCG CAR CONSTRUCTS AND METHODS OF THEIR MANUFACTURE AND USEVERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC.
WO/2021/119008METHODS OF PREPARING CANCER TREATMENTS AND METHODS OF TREATING  CANCERNANT HOLDINGS IP, LLC
WO/2021/119018A METHOD TO IMPROVE SLEEP QUALITY IN THE ELDERLY BY  CONTROLLING EXCITABILITY OF HYPOCRETIN NEURONSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/119019OLIGONUCLEOTIDES FOR TREATMENT OF ANGIOPOIETIN LIKE 4  (ANGPTL4) RELATED DISEASESEMPIRICO INC.
WO/2021/119020COMPOSITIONS AND METHODS OF PRODUCING DE-FLAVORED PEPPERCORNBRIGHTSEED, INC.
WO/2021/119023MULTIPLE MYELOMA COMBINATION THERAPIES BASED ON PROTEIN  TRANSLATION INHIBITORS AND IMMUNOMODULATORSTHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/119030ENHANCED CARDIOMYOCYTE REGENERATIONANIMATUS BIOSCIENCES, LLC
WO/2021/119033COMPOSITIONS AND METHODS OF TREATMENTGB004, INC.
WO/2021/119053ADENO ASSOCIATED VIRUS VECTORS FOR THE TREATMENT OF HUNTER  DISEASESHIRE HUMAN GENETIC THERAPIES, INC.
WO/2021/119061METHODS FOR GENERATING HEMATOPOIETIC STEM CELLSTHE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/119081HEPATITIS B CAPSID ASSEMBLY MODULATORSVENATORX PHARMACEUTICALS, INC.
WO/2021/119096PHARMACEUTICAL COMPOSITIONS AND METHODSTYME, INC.
WO/2021/119105COMBINATION THERAPY WITH LIV1-ADC AND PD-1 ANTAGONISTSEAGEN INC.
WO/2021/119108USE OF FGFR INHIBITORS FOR TREATMENT OF IDIOPATHIC SHORT  STATURECEDARS-SINAI MEDICAL CENTER
WO/2021/119135STABILIZED FORMULATIONS CONTAINING ANTI-CD20 X ANTI-CD3  BISPECIFIC ANTIBODIESREGENERON PHARMACEUTICALS, INC.
WO/2021/119146BIOMOLECULE FOR TREATMENT OF CORNEAL PATHOLOGIESBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/119159IRAK DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/119166CARIPRAZINE RELEASE FORMULATIONSHALO SCIENCE LLC
WO/2021/119172COMPOSITIONS AND METHODS FOR TARGETING GLYPICAN-2 IN THE  TREATMENT OF CANCERSHEPHERD THERAPEUTICS, INC.
WO/2021/126637METHODS OF TREATING PANCYTOPENIANANTCELL, INC.
WO/2021/119199ALPHA-5 BETA-1 INHIBITORSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119206TARGETED PHAGE THERAPYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119218ALKALINE PHOSPHATASE POLYPEPTIDES AND METHODS OF USE THEREOFALEXION PHARMACEUTICALS, INC.
WO/2021/119221METHODS OF PREPARING VIRAL VECTORSREPLIGEN CORPORATION
WO/2021/119234GLYCOSYLATED ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I  RECEPTOR AND USES THEREOFHORIZON PHARMA IRELAND LTD.
WO/2021/119257ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS OF USE THEREOFHOMOLOGY MEDICINES, INC.
WO/2021/119276COMPOSITIONS AND METHODS FOR CONTROLLING CERUMEN PRODUCTIONFREE STATE PHARMA INC
WO/2021/119291MICROBIAL COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION  OF DISEASENORTHEASTERN UNIVERSITY
WO/2021/119293T-CELL EPITOPES OF HUMAN PARAINFLUENZA VIRUS 3 FOR ADOPTIVE  T-CELL IMMUNOTHERAPYCHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/119298COMBINATION THERAPIES FOR THE TREATMENT OF CANCERH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/247076METHOD FOR IMPROVING SUBSTITUTION RATE AND/OR SUBSTITUTION  EFFICIENCY OF HYALURONAN-DRUG CONJUGATEAIHOL CORPORATION
WO/2021/119316METHODS OF TREATING CANCERRGENIX, INC.
WO/2021/119327TRANSPORE DELIVERY OF CANNABINOID AND USES THEREOFSTUDIN, Joel
WO/2021/119330POLYMER MATRIXES FOR DIFFERENT COMPOSITIONS OF MITOCHONDRIALLY  TARGETED ANTIOXIDANTSSKULACHEV, Maxim
WO/2021/119332MICRONEEDLE DELIVERY DEVICE WITH DETACHABLE HYBRID MICRONEEDLE  DEPOTS FOR LOCALIZED DELIVERY OF CELLSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119334ORGANIC COMPOUNDINTRA-CELLULAR THERAPIES, INC.
WO/2021/126667SURFACTANTS FOR USE IN PERSONAL CARE AND COSMETIC PRODUCTSADVANSIX RESINS & CHEMICALS LLC
WO/2021/119343COMPOSITIONS AND METHODS FOR SUBSTITUTED  7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRASTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/119347TRANSDERMAL COLD ATMOSPHERIC PLASMA-MEDIATED IMMUNE CHECKPOINT  BLOCKADE THERAPYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119350TISSUE CATALYZED GROWTH OF POLYMER AS EPITHELIAL LININGS FOR  THERAPYMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/119354SYNTHETIC TISSUE BARRIERS AND USES THEREOFMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/119358DEBARYOMYCES SPECIES AS AN INDICATOR OF NON-HEALING ULCERS IN  CROHN'S DISEASEWASHINGTON UNIVERSITY
WO/2021/119376PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER  IMMUNOTHERAPYNE1 INC.
WO/2021/126672COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC  ANTIGEN RECEPTORS TARGETING GLYPICAN 3MEDIMMUNE, LLC
WO/2021/119423NEAR INFRARED FLUORESCENT DYES, FORMULATIONS AND RELATED  METHODSWASHINGTON UNIVERSITY
WO/2021/119424EPITOPIC VACCINE FOR AFRICAN SWINE FEVER VIRUSEPIVAX, INC.
WO/2021/119429NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOFCUGENE INC.
WO/2021/119432METHODS OF TREATING ANTIPSYCHOTIC-INDUCED WEIGHT GAIN WITH  MIRICORILANTCORCEPT THERAPEUTICS INCORPORATED
WO/2021/119439COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF BCL-2 AND  BCL-XL ANTAGONISTSTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/119456LIQUID TASIMELTEON FORMULATIONS AND METHODS OF USE THEREOFVANDA PHARMACEUTICALS INC.
WO/2021/119464COMPOSITIONS AND MODULAR NANO- AND MICROPARTICLES FOR THE  DELIVERY OF VARIOUS AGENTS AND USE THEREOFVERI NANO INC.
WO/2021/119475CYSTINE DIAMIDE ANALOGS FOR CYSTINURIARUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/119497MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USETHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/119500VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATIONIMMUNOLUX INTERNATIONAL CORP.
WO/2021/119503CONTROLLED-DELIVERY CROMAKALIM PRODRUGSQLARIS BIO, INC.
WO/2021/119505ANTI-LY6G6D ANTIBODIES AND METHODS OF USEGENENTECH, INC.
WO/2021/119516CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES  THEREOFCUGENE INC.
WO/2021/119522COMPOUNDS, POLYMERS, DEVICES, AND USES THEREOFSIGILON THERAPEUTICS, INC.
WO/2021/119523USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORSREPARE THERAPEUTICS INC.
WO/2021/119525SHP1 AND SHP2 INHIBITORS AND THEIR METHODS OF USETIAKI THERAPEUTICS INC.
WO/2021/119534IL-2 ORTHOLOGS AND METHODS OF USESYNTHEKINE, INC.
WO/2021/119536CANNABINOID ENRICHED COMPOSITION AND METHOD OF USINGCANNABIS GLOBAL, INC.
WO/2021/119538THERAPEUTIC CELL COMPOSITIONS AND METHODS FOR MANUFACTURE AND  USES THEREOFMYELOID THERAPEUTICS, INC.
WO/2021/119539METHOD AND COMPOSITIONS FOR REGULATED ARMORING OF CELLSSENTI BIOSCIENCES, INC.
WO/2021/126716SURFACTANTS FOR USE IN HEALTHCARE PRODUCTSADVANSIX RESINS & CHEMICALS LLC
WO/2021/119545DURABLE VACCINATIONGRITSTONE BIO, INC.
WO/2021/119555COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE RESPONSEKUMQUAT BIOSCIENCES INC.
WO/2021/119561INHIBITORS OF CANCER BIOMARKERS AND USES THEREOFUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/119563NOVEL ENZYMESINSCRIPTA, INC.
WO/2021/126725NOVEL SUBSTITUTED 1,3,8-TRIAZASPIRO[4,5]DECANE-2,4-DIONE  COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) AND/OR TRYPTOPHAN  2,3-DIOXYGENASE (TDO) INHIBITORSMERCK SHARP & DOHME CORP.
WO/2021/126728PRMT5 INHIBITORSMERCK SHARP & DOHME CORP.
WO/2021/126729PRMT5 INHIBITORSMERCK SHARP & DOHME CORP.
WO/2021/126732PRMT5 INHIBITORSMERCK SHARP & DOHME CORP.
WO/2021/133579COMPOSITIONS AND METHODS FOR SINGLE-STEP MULTIPURPOSE SURFACE  FUNCTIONALIZATIONRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/138031PPAR AGONIST COMPLEX AND METHODS OF USERODAN & FIELDS, LLC
WO/2021/119583LANTHANIDE COMPOUNDS FOR LUMINESCENCE "TURN-ON"  DETECTIONUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/119585COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLESDNALITE THERAPEUTICS, INC.
WO/2021/081543COMPOSITIONS AND PROCESSES FOR REMEDIATING  H<sb>2</sb>S, SULFUR-CONTAINING COMPOSITIONS, AND CONTAMINANTS IN  CONTAMINATED FLUIDSGAPS TECHNOLOGY, LLC
WO/2021/119607STABLE MONOMERIC INSULIN FORMULATIONS ENABLED BY  SUPRAMOLECULAR PEGYLATION OF INSULIN ANALOGUESTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/119615METHODS FOR TREATING PARKINSON'S DISEASEMEIRAGTX UK II LIMITED
WO/2021/119623METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSENORTHWESTERN UNIVERSITY
WO/2021/119639COMPOSITIONS, SYSTEMS, AND METHODS FOR MEASURING PROTEIN  SECRETION AT A SINGLE-CELL LEVELOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/141733METHOD OF MODULATING A FIBROTIC CONDITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/126799MACROCYCLIC PEPTIDES AS POTENT INHIBITORS OF K-RAS G12D MUTANTMERCK SHARP & DOHME CORP.
WO/2021/126804INDAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE  TREATMENT OF HERPES VIRUSESMERCK SHARP & DOHME CORP.
WO/2021/126816DOSING REGIMEN OF A KRAS G12C INHIBITORAMGEN INC.
WO/2021/126822THROMBOMODULIN FUNCTIONAL DOMAINS FOR USE IN PROMOTING  OSTEOBLAST FUNCTIONS AND BONE HEALINGBLUE BLOOD BIOTECH CORP.
WO/2021/126829CONTINUOUS PROCESSES FOR MANUFACTURING IMPREGNATED POROUS  CARRIERS AND FOR MANUFACTURING PHARMACEUTICALS CONTAINING IMPREGNATED POROUS  CARRIERSRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/126855METHODS FOR TREATING PROGRESSIVE HYPERBILIRUBINEMIAMALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
WO/2021/126870COMPOSITIONS OF BILE ACIDS AND PHENYLBUTYRATE COMPOUNDSAMYLYX PHARMACEUTICALS INC.
WO/2021/126872MULTI-SPECIFIC T CELL RECEPTORSOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/126874OPHTHALMIC COMPOSITIONS COMPRISING D2OSYDNEXIS, INC.
WO/2021/126884LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART  FAILURE WITH PRESERVED EJECTION FRACTION (PH-HF-pEF)TENAX THERAPEUTICS, INC.
WO/2021/146016SUSTAINED RELEASE COMPOSITIONS COMPRISING LIOTHYRONINEKASHIV SPECIALTY PHARMACEUTICALS, LLC
WO/2021/126902AMIDO-SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE  THEREOF FOR THE TREATMENT OF HERPES VIRUSESMERCK SHARP & DOHME CORP.
WO/2021/126905MAGNETIC MINIATURE DEVICE AND SYSTEM FOR REMOTELY MANEUVERING  ITBIONAUT LABS LTD.
WO/2021/126906METHODS FOR TREATING CANCER USING A COMBINATION OF A PD-1  ANTAGONIST, AN ILT4 ANTAGONIST, AND CHEMOTHERAPEUTIC AGENTSMERCK SHARP & DOHME CORP.
WO/2021/126929MODIFIED INTERFERON-ALPHA-2 HAVING REDUCED IMMUNOGENICITYEPIVAX, INC.
WO/2021/126942INHIBITORS OF MHC-I NEF DOWNMODULATION FOR TREATING HIVTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/126944GEL COMPOSITIONS FOR MITIGATION OF BURN INJURIES, KITS  CONTAINING THE GEL COMPOSITIONS, AND ASSOCIATED METHODSYUSUF, Zaki
WO/2021/126973COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATIONORIONIS BIOSCIENCES, INC.
WO/2021/126974BIFUNCTIONAL AGENTS FOR PROTEIN RECRUITMENT AND/OR DEGRADATIONORIONIS BIOSCIENCES, INC.
WO/2021/126989TWO-WAY MAGNETIC RESONANCE TUNING NANOPROBE ENHANCED  SUBTRACTION IMAGINGTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/126990OXYTOCIN DERIVATIVES WITH IMPROVED PROPERTIESTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/127000MYELOID CELL-TARGETED NANOPARTICLES AND RELATED COMPOSITIONS  AND METHODSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/127007ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USEBLUEBIRD BIO, INC.
WO/2021/127008COMPOSITIONS AND METHODS FOR TREATING NEUROMUSCULAR DISORDERSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/127013HIGHLY EFFICIENT MYELOPEROXIDASE ACTIVATABLE IMAGING AGENTSTHE GENERAL HOSPITAL CORPORATION
WO/2021/127017COMBINATIONS OF FLAVIVIRUS PROTEINS, PEPTIDE SEQUENCES,  EPITOPES, AND METHODS AND USES THEREOFLA JOLLA INSTITUTE FOR IMMUNOLOGY
WO/2021/127024CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND  METHODS OF MAKING AND USING SAMEWASHINGTON UNIVERSITY
WO/2021/127036COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127039COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127041COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127042COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127043COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127044COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127045COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127046COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127047COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/127048METHODS OF PRODUCTION OF ARGININE-SILICATE COMPLEXESNUTRITION 21, LLC
WO/2021/127052DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN  APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR,  A TUMOR NECROSIS FACTOR-α (TNF-α) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL  PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC  PROTEASE INHIBITORCELLA THERAPEUTICS, LLC
WO/2021/127057METHODS AND COMPOSITIONS FOR CORRECTION OF DMD MUTATIONSPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/127070INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CGRP INHIBITORSBIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
WO/2021/127071BICYCLIC HETEROCYCLE COMPOUNDS METHODS OF USE THEREOF FOR THE  TREATMENT OF HERPES VIRUSESMERCK SHARP & DOHME CORP.
WO/2021/127088MATERIALS AND METHODS FOR IN VIVO BIOLOGICAL TARGETINGJANSSEN BIOTECH, INC.
WO/2021/127107TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATING ONYCHOMYCOSISGLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
WO/2021/127124DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE  LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A  NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR  A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSIONCELLA THERAPEUTICS, LLC
WO/2021/127133N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4-NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE  AND ITS USE FOR TREATING HIV INFECTIONTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/127135METHODS AND COMPOSITIONS FOR DIAGNOSIS OF TUBERCULOSISPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/127166INHIBITORS OF ENL/AF9 YEATSKHAN, Tanweer A.
WO/2021/127176UNNATURAL AMINO ACIDS AND USES THEREOFTEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/127185NOVEL DDR1 ANTIBODIES AND USES THEREOFTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/127189POTENTIATION OF HELMINTH TREATMENTELANCO TIERGESUNDHEIT AG
WO/2021/127190IRAK DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/127210METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERSCURASEN THERAPEUTICS, INC.
WO/2021/127217COMBINATION ANTI-CANCER THERAPIES WITH INDUCERS OF  IRON-DEPENDENT CELLULAR DISASSEMBLYFLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/127235COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS,  ENHANCING DRUG POTENCY AND TREATING CANCER, AND METHODS FOR MAKING AND USING  SAMEPERSEPHONE BIOSCIENCES, INC.
WO/2021/127261ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOFTHE GENERAL HOSPITAL CORPORATION
WO/2021/127271LIVE ATTENUATED LEISHMANIA PARASITE VACCINES WITH ENHANCED  SAFETY CHARACTERISTICSTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/127275GSK-3 MODULATOR OTIC FORMULATIONSOTONONY, INC.
WO/2021/127278IRAK DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/127294PEPTOID-CONTAINING PERSONAL LUBRICANTMAXWELL BIOSCIENCES, INC.
WO/2021/127305METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM  CELLSVIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/133643STAPLED OLEFIN CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORSMERCK SHARP & DOHME CORP.
WO/2021/133644STAPLED TRIAZOLE CO-AGONISTS OF THE GLUCAGON AND GLP-1  RECEPTORSMERCK SHARP & DOHME CORP.
WO/2021/141751ARGINASE INHIBITORS AND METHODS OF USEMERCK SHARP & DOHME CORP.
WO/2021/138079COMBINATION CANCER TREATMENT USING A PD-1 ANTAGONIST, AN ILT4  ANTAGONIST, AND LENVATINIB OR SALTS THEREOF.MERCK SHARP & DOHME CORP.
WO/2021/127308GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROMEOVID THERAPEUTICS INC.
WO/2021/127309NONINVASIVE QUANTITATION OF FULL VERSUS EMPTY CAPSIDS USING  WATER PROTON NMRUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/262229AZOXYSTROBIN EFFICACY IN PERSONAL CARE FORMULATIONSTHE PROCTER & GAMBLE COMPANY
WO/2021/262230AZOXYSTROBIN IN A SULFATE FREE PERSONAL CARE COMPOSITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/127318TRANSPARENT COMPOSITION WITH SOLUBLE SCALP HEALTH ACTIVETHE PROCTER & GAMBLE COMPANY
WO/2021/127337TRPML MODULATORSCASMA THERAPEUTICS, INC.
WO/2021/133653THERAPY FOR THE TREATMENT OF CANCERMACROGENICS, INC.
WO/2021/127353SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS AND USES  THEREOFARO BIOTHERAPEUTICS COMPANY
WO/2021/127359USE OF LEMBOREXANT FOR TREATING INSOMNIAEISAI R&D MANAGEMENT CO., LTD.
WO/2021/127376TREATMENT OF, AND DIFFERENTIAL DIAGNOSIS BETWEEN,  ACTH-DEPENDENT CUSHING'S SYNDROME AND ACTH-INDEPENDENT CUSHING'S SYNDROMECORCEPT THERAPEUTICS INCORPORATED
WO/2021/127391MOLECULAR TARGETS FOR ADDICTIONTHE JACKSON LABORATORY
WO/2021/127398CAFFEINE CITRATE FORMULATIONSOYE THERAPEUTICS, INC
WO/2021/133667T CELL PERFORMANCE ASSAY AS A PROGNOSTIC FACTOR FOR CLINICAL  OUTCOMEBAYLOR COLLEGE OF MEDICINE
WO/2021/127407CAI NANOEMULSIONSFORWARDVUE PHARMA, INC.
WO/2021/127413FILTER AIDS FOR NON AQUEOUS LIQUIDSIMERYS USA, INC.
WO/2021/127414USE OF FUCOSYLATION INHIBITOR FOR PRODUCING AFUCOSYLATED  ANTIBODYBRISTOL-MYERS SQUIBB COMPANY
WO/2021/127428CHIMERIC ANTIGEN RECEPTORS TARGETING B7-H3 (CD276) AND  ASSOCIATED METHODSALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/127429SOS1 INHIBITORSMIRATI THERAPEUTICS, INC.
WO/2021/127434AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED  BY NANOTECHNOLOGY AND PROTEOMICSWISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/127452COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND  POTENTIATION OF ANTIBIOTICSGEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/127456METHODS OF INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR  PROTEINSRAIN THERAPEUTICS INC.
WO/2021/127459GPR139 RECEPTOR MODULATORSBLACKTHORN THERAPEUTICS, INC.
WO/2021/127460PCSK9 ANTAGONIST COMPOUNDSMERCK SHARP & DOHME CORP.
WO/2021/127463NOVEL PRIME-BOOST INFLUENZA VACCINEVIVALDI BIOSCIENCES INC.
WO/2021/127466COMBINATION TREATMENT OF LIVER DISEASES USING INTEGRIN  INHIBITORSNOVARTIS AG
WO/2021/141758UNIVERSAL VACCINES AGAINST IMMUNOGENS OF PATHOGENIC ORGANISMS  THAT PROVIDE ORGANISM-SPECIFIC AND CROSS-GROUP PROTECTIONXU, Jian, Qing
WO/2021/127473COMPOSITIONS AND METHODS FOR MANAGING INFECTIONS OF A URINARY  TRACTMETAGENICS, INC.
WO/2021/127483COMBINATION TREATMENT OF LIVER DISEASES USING INTEGRIN  INHIBITORSNOVARTIS AG
WO/2021/127486SMALL-MOLECULE COVALENT INHIBITION OF RAL GTPASESTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/127496COMBINATION TREATMENTS FOR WALDENSTROM'S MACROGLOBULINEMIAX4 PHARMACEUTICALS, INC.
WO/2021/127500ANTIBODIES AGAINST INTEGRIN ALPHA 11 BETA 1MOMENTA PHARMACEUTICALS, INC.
WO/2021/127517NOVEL USESINTRA-CELLULAR THERAPIES, INC.
WO/2021/127525PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR FACTOR  XI/XIA ANTIBODIESANTHOS THERAPEUTICS, INC.
WO/2021/127541METHODS OF TREATING BRAIN DISORDERSNEURONASAL, INC.
WO/2021/127546ORAL TABLETS COMPRISING ROLLER-COMPACTED GRANULES OF NAPROXEN  SODIUM, METHODS OF PREPARING THEREOF, AND METHODS OF USING THEREOFBAYER HEALTHCARE LLC
WO/2021/133689LIPOXYGENASE INHIBITORSSRI INTERNATIONAL
WO/2021/127554COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/127556METHODS FOR TREATING CANCER COMPRISING LOW DOSE RADIATIONBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/127559COMPOSITIONS COMPRISING CANNABINOID ANIONS AND ANTI-NUCLEATING  AGENTSNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/127561ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF  EGFRC4 THERAPEUTICS, INC.
WO/2021/127572METHODS OF SCHIZOPHRENIA TREATMENTINTRA-CELLULAR THERAPIES, INC.
WO/2021/127580POWASSAN VIRAL ANTIGENS AND RELATED COMPOSITIONS, AND USES  THEREOF TO VACCINATE AND TREAT PATIENTSMASLOW, Joel
WO/2021/127583SELECTIVE HIGH AFFINITY LIGAND DIAGNOSTICS AND THERAPEUTICSSHAL TECHNOLOGIES, INC.
WO/2021/127594ENGINEERED CELLS FOR THERAPYEDITAS MEDICINE, INC.
WO/2021/127617VACCINES AGAINST AFRICAN SWINE FEVER VIRUS, AND METHODS OF  USING SAMETHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/127623CROSSLINKED PLA-BASED COPOLYMERSPENDANT BIOSCIENCES, INC.
WO/2021/138116OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO  NERVE IMAGINGOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/127639STEM CELL DELIVERYUNIVERSITY OF MIAMI
WO/2021/127641IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLESTRANSLATE BIO, INC.
WO/2021/127643FLUOROALKYL-OXADIAZOLES AND USES THEREOFTENAYA THERAPEUTICS, INC.
WO/2021/127650COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDSENTRADA THERAPEUTICS, INC.
WO/2021/127651MODEL ORGANISMS HUMANIZED FOR DRUG DISCOVERY AND SCREENINGNEMAMETRIX, INC
WO/2021/127653COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST  STAPHYLOCOCCUS AUREUSWASHINGTON UNIVERSITY
WO/2021/133742STABILIZATION OF MHC COMPLEXESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133777MONOAMINE OXIDASE INHIBITORS AS MODIFIERS OF BETA CELL  VULNERABILITY IN TYPE 1 DIABETESJOSLIN DIABETES CENTER
WO/2021/133778GAMMA-HYDROXYBUTYRATE (GHB) DOSINGJAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/133784NATURE-BASED COMPOSITIONS, DISPENSING SYSTEMS AND METHODS FOR  PROVIDING SENSORIAL AND AESTHETIC BENEFITS TO ACNE PRONE SKINL'OREAL
WO/2021/133790PREVENTION AND TREATMENT OF KIDNEY FAILURE BY ADMINISTRATION  OF FIBROBLASTS AND PRODUCTS THEREOFFIGENE, LLC
WO/2021/133793SUPPRESSION OF INTERLEUKIN-17 PRODUCTION AND INHIBITION OF  TH17 CELL GENERATION BY FIBROBLASTS AND PRODUCTS THEREOFFIGENE, LLC
WO/2021/133798INHIBITION OF TNF-ALPHA BY FIBROBLASTS AND FIBROBLAST EXOSOMESFIGENE, LLC
WO/2021/133800THERAPEUTIC AMOEBA AND USES THEREOFAMEBAGONE, LLC
WO/2021/133811SOLID STATE FORMS OF CENICRIVIROC AND PROCESS FOR PREPARATION  THEREOFTEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/133812COMPOSITIONS COMPRISING MICROBES AND METHODS OF USE AND MAKING  THEREOFPENDULUM THERAPEUTICS, INC.
WO/2021/138156BIOFILM PREVENTION AND TREATMENTARMS PHARMACEUTICAL LLC
WO/2021/133821MANAGING MICROBIAL DYSBIOSIS WITH TEMOCILLINENTASIS THERAPEUTICS, INC.
WO/2021/133822REGENERATIVE POLYPEPTIDES AND USES THEREOFJUVENA THERAPEUTICS,INC.
WO/2021/133844TREATMENT OF MILD TRAUMATIC BRAIN INJURYOXEIA BIOPHARMACEUTICALS, INC.
WO/2021/133854METHODS AND COMPOSITIONS FOR PRODUCING A HETEROLOGOUS  ANTIVIRAL COMPOUND IN A HOST CELLTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133858HEPARIN-ASSOCIATED POLYPEPTIDES AND USES THEREOFJUVENA THERAPEUTICS, INC.
WO/2021/133862TARGETING THE INTRINSIC APOPTOTIC MACHINERY IN GLIOBLASTOMATHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133866COMPOUNDS FOR THE TREATMENT OF MYELOFIBROSISACTUATE THERAPEUTICS, INC.
WO/2021/133867COMPOSITIONS AND METHODS FOR STYLING HAIRPAREKH, Aakash Jagat
WO/2021/133877CONTROL OF HISTAMINE TO PROMOTE HEALTH AND CONTROL  ENTEROCOLITIS USING PROBIOTIC COMPOSITIONS AND/OR HISTAMINE DEGRADING ENZYMESIOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/138183MACHINE LEARNING SYSTEM FOR INTERPRETING HOST PHAGE RESPONSEADAPTIVE PHAGE THERAPEUTICS, INC.
WO/2021/133896TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION  FACTOR INHIBITORS AND USES THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/133904SOLID DOSAGE FORMS CONTAINING BACTERIA AND MICROBIAL  EXTRACELLULAR VESICLESEVELO BIOSCIENCES, INC.
WO/2021/133908PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF  MULTIPLE INFLAMMATORY DISORDERSAARDVARK THERAPEUTICS INC.
WO/2021/133914COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING SKIN  DAMAGETHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/162790COLLOIDAL PARTICLE FORMULATIONS WITH ADVANCED FUNCTIONALITYBENANOVA INC.
WO/2021/133940COMPOSITIONS AND METHODS INVOLVING AMINO ACIDS FOR THE  TREATMENT OF FAT INFILTRATIONS IN MUSCLEAXCELLA HEALTH INC.
WO/2021/138205FTNIR SPECTROSCOPY FOR REACTION MONITORING OF ACRYLAMIDE  SYNTHESISKEMIRA OYJ
WO/2021/133948COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES  AND DISORDERSAXCELLA HEALTH INC.
WO/2021/133950POLYPHENOL COMPOSITIONS AND USES THEREOFMETAGENICS, INC.
WO/2021/133957BENZIMIDAZOLE COMPOUNDS AS HDAC6 INHIBITORSONKURE, INC.
WO/2021/133962CONFECTIONS FOR SKIN PROTECTION: COMPOSITIONS, METHODS FOR  MAKING, AND APPLICATIONS THEREOFGROVE COLLABORATIVE, INC.
WO/2021/138209METHODS FOR CULTURING CANCER CELLS AND FOR INHIBITING INVASION  OF CANCERTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133977PROGRAMMABLE DNA NUCLEASE-ASSOCIATED LIGASE AND METHODS OF USE  THEREOFTHE BROAD INSTITUTE, INC.
WO/2021/133989PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDSBAYMEDICA, INC.
WO/2021/133993METHODS AND SYSTEMS FOR MOLECULAR DISEASE ASSESSMENT VIA  ANALYSIS OF CIRCULATING TUMOR DNALEXENT BIO, INC.
WO/2021/134010METHODS OF NORMALIZING ABERRANT GLYCOLYTIC METABOLISM IN  CANCER CELLSPATEL, Chirag Bihesh
WO/2021/134023COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERYAJK PHARMACEUTICAL LLC
WO/2021/134026COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERYAJK PHARMACEUTICAL LLC
WO/2021/134029TOPICAL NICOTINE FOR SMOKING CESSATIONAMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/134042METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE  DEHYDROGENASEOHIO STATE INNOVATION FOUNDATION
WO/2021/134045METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE  DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENTOHIO STATE INNOVATION FOUNDATION
WO/2021/138257COMPOSITIONS FOR IMPARTING COLOR AND TONE TO THE HAIRSHI, Minli
WO/2021/138258COMPOSITIONS FOR TREATING HAIRSHI, Minli
WO/2021/134081AUGMENTATION OF FIBROBLAST MEDIATED REGENERATION OF  INTRAVERTEBRAL DISCSFIGENE, LLC
WO/2021/134082CROSSLINKED HA-COLLAGEN HYDROGELS AS DERMAL FILLERSALLERGAN, INC.
WO/2021/138279SYSTEM AND METHOD FOR SALT HOLDING INTEGRATABLE PILLOWWIESINGER, Paulette K.
WO/2021/138280INDIVIDUALIZED VACCINES FOR CANCER TREATMENT AND PREVENTIONMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/138286SELF-COMPLEMENTARY AAV DELIVERY SYSTEM FOR CRISPR/CAS9THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/138298MALT1 MODULATORS AND USES THEREOFRHEOS MEDICINES, INC.
WO/2021/138302INTRAPANCREATIC M2 POLARIZATION OF MACROPHAGES TO TREAT TYPE 1  DIABETESUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/138314COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERSBLUE OAK PHARMACEUTICALS, INC.
WO/2021/138315COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERSBLUE OAK PHARMACEUTICALS, INC.
WO/2021/138332NOVEL ANUCLEATED CELLS FOR DRUG DELIVERY AND METHODS OF USE  THEREOFPLATELET BIOGENESIS, INC.
WO/2021/138335DEODORANT AND PERSONAL CARE COMPOSITIONSREM BRANDS, INC.
WO/2021/138350MAMMALIAN CELLS SECRETING GDNF AND THEIR THERAPEUTIC USEGLORIANA THERAPEUTICS
WO/2021/138364KINASES AS BIOMARKERS FOR NEURODEGENERATIVE CONDITIONSCHASE THERAPEUTICS CORPORATION
WO/2021/138378ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOFOBI PHARMA, INC.
WO/2021/138386PROPELLANT-FREE FORMULATION FOR INHALATIONHUANG, Cai Gu
WO/2021/162796COMPOSITIONS COMPRISING DESOXIMETASONE AND TAZAROTENETARO PHARMACEUTICAL INDUSTRIES LTD.
WO/2021/138390MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS,  DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPYMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/138391INDAZOLE COMPOUNDSTYRA BIOSCIENCES, INC.
WO/2021/138446COMPOSITIONS CONTAINING EXOSOME CARRYING NF-kB INHIBITORS AND  METHODS OF USING THEREOFILIAS BIOLOGICS INC.
WO/2021/138448TEMPERATURE-BASED TRANSIENT DELIVERY OF ZSCAN4 NUCLEIC ACIDS  AND PROTEINS TO CELLS AND TISSUESELIXIRGEN THERAPEUTICS, INC.
WO/2021/138450NOVEL SMALL MOLECULE SHC BLOCKERS FOR TREATING LIVER DISEASE  AND METABOLIC DISEASEBUTO CORPORATION
WO/2021/138454METHODS OF MAKING AND USING REGULATORY T CELLS AND EFFECTOR T  CELLS HAVING CHIMERIC ANTIGEN RECEPTORS TARGETED TO CD6, CD19, AND/OR AN  IL-13R FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERSCITY OF HOPE
WO/2021/138456COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR  FLAVONOIDS AND USES THEREOFCALIBRATED THERAPEUTICS, LLC
WO/2021/138467ANTI-CD73 ANTIBODIES AND USES THEREOFINCYTE CORPORATION
WO/2021/138483AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE  THEREOFDECIPHERA PHARMACEUTICALS, LLC
WO/2021/138485COMPOSITIONS OF  1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHENYL)-3-PHENYLUREADECIPHERA PHARMACEUTICALS, LLC
WO/2021/138525TOPICAL COMPOSITION COMPRISING TOFACITINIB AND FINGOLIMODVYNE PHARMACEUTICALS LTD.
WO/2021/138561NOVEL TETRAHYDROCURCUMIN COMPOSITIONS, METHODS OF MAKING, AND  METHODS OF USING THE SAMERENIBUS THERAPEUTICS, INC.
WO/2021/138562COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETOASSEMBLY BIOSCIENCES, INC.
WO/2021/141828COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETOASSEMBLY BIOSCIENCES, INC.
WO/2021/138564ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING  THE SAMECURE PHARMACEUTICAL HOLDING CORP.
WO/2021/158317METHODS FOR PREVENTING AND REVERSING OPIOID ANALGESIC  TOLERANCE IN SUBJECTS WITH CHRONIC PAINTHE REASEARCH FOUNDATION FOR SUNY
WO/2021/138571COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETOASSEMBLY BIOSCIENCES, INC.
WO/2021/178036STABLE PICKERING-TYPE EMULSIONSCIELLA JAMES, LLC
WO/2021/138581TNAP LOCALLY ADMINISTERED FOR PROMOTING PERIODONTAL HEALTHTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/138582FUSION PROTEINS AND METHODS OF USE THEREOFTHE JOHNS HOPKINS UNIVERSITY
WO/2021/138588COMPOSITIONS OF HYDROGELS AND METHODS OF USE THEREOFREPERTOIRE IMMUNE MEDICINES, INC.
WO/2021/138597WATER-SOLUBLE CANNABINOID FORMULATIONS AND METHODS OF THEIR  MAKINGSOLUSCIENCE, LLC
WO/2021/138599COSMETIC COMPOSITIONSFORTE SUBSIDIARY, INC.
WO/2021/003492FIBROUS STRUCTURES CONTAINING CATIONIC SURFACTANTS AND SOLUBLE  ACIDSTHE PROCTER & GAMBLE COMPANY
WO/2021/007587PERSONAL CARE CLEANING COMPOSITIONSTHE PROCTER & GAMBLE COMPANY
WO/2021/007593COMPOUNDS USEFUL FOR INHIBITING BFL1 AND THEIR USE IN THERAPYCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/007594IRE1 ACTIVATING COMPOUNDS FOR USE IN THERAPYTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/007596HAIR CONDITIONING COMPOSITION COMPRISING BRANCHED FATTY  ALCOHOL AND TRIESTERTHE PROCTER & GAMBLE COMPANY
WO/2021/016637COMPOSITIONS FOR TREATMENT OF SUBSTANCE USE DISORDERUNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER
WO/2021/016640COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED  THERAPEUTIC AGENTSTHE UNIVERSITY OF CHICAGO
WO/2021/022306WATER-SOLUBLE PERSONAL CLEANSING PRODUCTS COMPRISING FIBROUS  ELEMENTS COMPRISING NATURAL OR MODIFIED STARCH, USES, METHODS AND KITTHE PROCTER & GAMBLE COMPANY
WO/2021/026565DISSOLVABLE VITAMIN C AND RETINOL FILMMARY KAY INC.
WO/2021/026572PERSONAL CARE COMPOSITIONSCOLGATE-PALMOLIVE COMPANY
WO/2021/042127A PACKAGED HAIR CARE COMPOSITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/051130COMBINATION THERAPY FOR THE TREATMENT OF MIGRAINESTHE UNIVERSITY OF CHICAGO
WO/2021/051133PERSONAL CARE COMPOSITIONS COMPRISING ANTI-DANDRUFF AGENTSTHE PROCTER & GAMBLE COMPANY
WO/2021/051135PIKFYVE INHIBITORS FOR CANCER THERAPYAI THERAPEUTICS, INC.
WO/2021/056029METHODS AND COMPOSITIONS FOR TREATING PAIN AND OTHER EPH  RECEPTOR-ASSOCIATED CONDITIONSTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/127668METHOD AND SYSTEM FOR MANUFACTURING OF PHARMACEUTICAL FORMULAS  IN FORM OF ORALLY DISINTEGRATING FILMS (ODF)VUONG, Dieu, Cam
WO/2021/072419PERSONAL CARE COMPOSITIONS AND METHODSCOLGATE-PALMOLIVE COMPANY
WO/2021/072422ORAL CARE COMPOSITIONS AND METHODS OF USECOLGATE-PALMOLIVE COMPANY
WO/2021/072423ORAL CARE COMPOSITIONS AND METHODS OF USECOLGATE-PALMOLIVE COMPANY
WO/2021/081554METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIACHEMISTRYRX
WO/2021/092613METHODS OF MODIFYING BIOFILMCOLGATE-PALMOLIVE COMPANY
WO/2021/087520BROADLY PROTECTIVE BOVINE PARAINFLUENZA 3 VIRUS AND BOVINE  VIRAL DIARRHEA VIRUS VACCINEKANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/127672MULTI-BENEFIT PERSONAL CARE COMPOSITIONS AND METHODS FOR THE  SAMECOLGATE-PALMOLIVE COMPANY
WO/2021/097483ORAL CARE COMPOSITIONSCOLGATE-PALMOLIVE COMPANY
WO/2021/097484ORAL CARE COMPOSITIONSCOLGATE-PALMOLIVE COMPANY
WO/2021/119650VISCOSITY STABLE SLS FREE TOOTHPASTES CONTAINING ZINC  COMPOUNDS AND ARGININECOLGATE-PALMOLIVE COMPANY
WO/2021/127674ORAL CARE COMPOSITIONS CONTAINING INULINCOLGATE-PALMOLIVE COMPANY
WO/2021/127675PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAMECOLGATE-PALMOLIVE COMPANY
WO/2021/127676PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAMECOLGATE-PALMOLIVE COMPANY
WO/2021/127677PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAMECOLGATE-PALMOLIVE COMPANY
WO/2021/127681PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAMECOLGATE-PALMOLIVE COMPANY
WO/2021/113871ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE THEREOFCOLGATE-PALMOLIVE COMPANY
WO/2021/119664HERBAL COSMETIC COMPOSITION FOR TREATING SKINMARY KAY INC.
WO/2021/119669METHODS AND COMPOSITIONS FOR TREATMENT OF ACUTE MYELOID  LEUKEMIALOMA LINDA UNIVERSITY PATHOLOGY MEDICAL GROUP, INC.
WO/2021/134096ORAL CARE COMPOSITIONSCOLGATE-PALMOLIVE COMPANY
WO/2021/134097METHODS FOR IMPROVING BARRIER INTEGRITY OF GINGIVAL TISSUECOLGATE-PALMOLIVE COMPANY
WO/2021/127699ORAL CARE COMPOSITIONS AND METHODS OF USECOLGATE-PALMOLIVE COMPANY
WO/2021/167703FORMULATED AND/OR CO-FORMULATED LIPOSOME COMPOSITIONS  CONTAINING TGFB ANTAGONIST PRODRUGS USEFUL IN THE TREATMENT OF CANCER AND  METHODS THEREOFNAMMI THERAPEUTICS, INC.
WO/2021/154455LIGAND-MEDIATED DELIVERY OF THERAPEUTIC PROTEINS AND THE USES  THEREOFPURDUE RESEARCH FOUNDATION
WO/2021/138646SYSTEMS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT BY  DIRECT INJECTION OF A TARGETED POPULATION OF CELLSPRIVO TECHNOLOGIES, INC.
WO/2021/138674A NOVEL METHOD TO MANUFACTURE SYNTHETIC MEATFYBRAWORKS FOODS, INC.
WO/2021/141862METHODS OF MODULATING STING PATHWAY ACTIVATIONTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/138678RNA SPLICING MODULATIONTHE GENERAL HOSPITAL CORPORATION
WO/2021/138681BIOACTIVE PLASTICS WITH PROGRAMMABLE DEGRADATION AND  MICROPLASTIC ELIMINATIONTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/141890TWO-STEP GENE SWAPPIONEER HI-BRED INTERNATIONAL, INC.
WO/2021/141892METHODS OF TREATING CLEAR CELL RENAL CARCINOMA (CCRCC) USING  AXL DECOY RECEPTORSARAVIVE INC.
WO/2021/141902HIGHLY SIALYLATED MULTIMERIC BINDING MOLECULESIGM BIOSCIENCES, INC.
WO/2021/141917ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF NEUROLOGICAL  DISORDERSAUM LIFETECH, INC.
WO/2021/141919TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND  ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR  2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILEPRINCIPIA BIOPHARMA INC.
WO/2021/194604THERAPEUTIC COMPOSITIONS COMPRISING GRAFT MATERIALS AND  BETA-TCP BINDING PEPTIDES AND USES THEREOFTHERADAPTIVE, INC.
WO/2021/141944FORMULATIONS FOR DELIVERY OF OLIGONUCLEOTIDES TO LUNG CELLSTRANSLATE BIO MA, INC.
WO/2021/141955COMPOSITIONS AND METHODS FOR INCREASING CELLULAR VITALITY AND  LONGEVITY AND DECREASING MOLECULAR AGEINGJUVN3 HOLDINGS, LLC
WO/2021/141956TREATMENT OF PAIN ASSOCIATED WITH CESAREAN SECTION SURGERY  WITH SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONSPACIRA PHARMACEUTICALS, INC,
WO/2021/141959TREATMENT OF PAIN BY ADMINISTRATION OF SUSTAINED-RELEASE  LIPOSOMAL ANESTHETIC COMPOSITIONSPACIRA PHARMACEUTICALS, INC.
WO/2021/141960CYANO-PYRIMIDINE INHIBITORS OF EGFR/HER2DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/141963TREATMENT OF PAIN BY SUBARACHNOID ADMINISTRATION OF  SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONSPACIRA PHARMACEUTICALS, INC.
WO/2021/146082BIHETEROCYCLIC INHIBITORS OF ISPF FOR TREATMENT OF MICROBIAL  INFECTIONSPOINT LOMA NAZARENE UNIVERSITY
WO/2021/141970RECRUITMENT OF DNA POLYMERASE FOR TEMPLATED EDITINGPAIRWISE PLANTS SERVICES, INC.
WO/2021/141974COMBINATION CANCER THERAPY USING CHK INHIBITORWU, Fan
WO/2021/141980COMBINATION CANCER THERAPY USING CHK INHIBITORWU, Fan
WO/2021/141985NOVEL DOMINANT NEGATIVE FAS POLYPEPTIDES, CELLS COMPRISING  THEREOF AND USES THEREOFMEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/141986CHIMERIC GMCSF-IL18 RECEPTORST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/142002ANTI-CCR8 ANTIBODIES AND USES THEREOFVACCINEX, INC.
WO/2021/142020FORMULATIONS OF SN-38 WITH POLY(AMINO ACID) BLOCK POLYMERSTYNDALL FORMULATION SERVICES, LLC
WO/2021/142026SHP2 INHIBITOR DOSING AND METHODS OF TREATING CANCERREVOLUTION MEDICINES, INC.
WO/2021/142030METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTORARENA PHARMACEUTICALS, INC.
WO/2021/142043ANTI-SLC34A2 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS  OF USE THEREOFCYTOMX THERAPEUTICS, INC.
WO/2021/142056COMBINATIONS OF TIE-2 ACTIVATORS AND PROSTAGLANDINS AND USES  THEREOFAERPIO PHARMACEUTICALS, INC.
WO/2021/142074METHOD FOR CHEMICAL SEPARATION OF CANNABINOIDSPRECISION EXTRACTION CORPORATION
WO/2021/142075MICROWAVE ASSISTED DECARBOXYLATION OF CANNABIS RESINSPRECISION EXTRACTION CORPORATION
WO/2021/142083A METHOD FOR ENHANCING THE PHARMACOKINETICS OR INCREASING THE  PLASMA CONCENTRATION OF METHYL  3-((METHYLSULFONYL)AMINO)-2-(((4-PHENYLCYCLOHEXYL)OXY)METHYL)PIPERIDINE-1-CARBOXYLATE  OR A SALT THEREOF WITH AN INHIBITOR OF CYTOCHROME P450TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/142088SOURCE SPECIFIC EXOSOMES FOR DETERMINING AVOIDANCE OF CANCER  TREATMENT AND AVOIDANCE OF CHECKPOINT INHIBITOR THERAPIESTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/142115SANGLIFEHRIN ANALOGS AND USES THEREOFPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/142124TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING  2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4,4-DIMETHYLPENT-2-ENENITRILEPRINCIPIA BIOPHARMA INC.
WO/2021/142127A METHOD OF ENGINEERING NATURAL KILLER CELLS TO TARGET  CD70-POSITIVE TUMORSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/142128BIOMARKER AND DRUGGABLE TARGET OF NEURODEGENERATIONUNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER
WO/2021/142132COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASE BY  MANIPULATION OF SERINE METABOLISMTHE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/142143FGF-21 CONJUGATE FORMULATIONSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/142145TARGETED STEROID COMPOUNDSGARDEEN, Spencer S.
WO/2021/142148SOLID STATE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR  PRODUCING AND USING SAMEARMIS BIOPHARMA, INC.
WO/2021/142171TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIAAPELLIS PHARMACEUTICALS, INC.
WO/2021/142180AHR INHIBITORS AND USES THEREOFIKENA ONCOLOGY, INC.
WO/2021/142183METHODS OF TREATING CORTICAL DEMENTIA ASSOCIATED WANDERINGWOOLSEY PHARMACEUTICALS, INC
WO/2021/162808METHODS OF TREATING PSEUDOBULBAR AFFECT AND OTHER EMOTIONAL  DISTURBANCESWOOLSEY PHARMACEUTICALS, INC
WO/2021/194607METHODS OF USING RHO KINASE INHIBITORS TO TREAT FRONTOTEMPORAL  DEMENTIAWOOLSEY PHARMACEUTICALS, INC
WO/2021/142186PHARMACEUTICAL COMPOSITION AND USE THEREOFALPHALA CO., LTD.
WO/2021/194608METHODS OF TREATING PROTEINOPATHY- ASSOCIATED WANDERINGWOOLSEY PHARMACEUTICALS, INC
WO/2021/216139METHODS OF USING RHO KINASE INHIBITORS TO TREAT ALZHEIMER'S  DISEASEWOOLSEY PHARMACEUTICALS, INC
WO/2021/257122METHODS OF USING RHO KINASE INHIBITORS TO TREAT VASCULAR  DEMENTIAWOOLSEY PHARMACEUTICALS, INC
WO/2021/262250METHODS OF TREATING NEURODEVELOPMENTAL DISORDERSWOOLSEY PHARMACEUTICALS, INC
WO/2021/142192MICROPARTICLE-BASED ENZYME SYSTEMS FOR SELECTIVE REMOVAL OF  TARGET MOLECULESSYNLIFE, INC.
WO/2021/142199SITE SPECIFIC ANTIBODY-DRUG CONJUGATES WITH PEPTIDE-CONTAINING  LINKERSMERSANA THERAPEUTICS, INC.
WO/2021/142202COMPOSITIONS OF IXABEPILONER-PHARM US OPERATING LLC
WO/2021/142212ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED  TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAMEVIRION THERAPEUTICS, LLC
WO/2021/142217MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF  MILCK1DYNE THEREAPEUTICS, INC.
WO/2021/142227MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF  GENES ASSOCIATED WITH MUSCLE HEALTHDYNE THERAPEUTICS, INC.
WO/2021/142230METHODS TO ALTER LATENCY IN EBV+ MALIGNANCIESCORNELL UNIVERSITY
WO/2021/142231SUSTAINED IMMUNOTHERAPYFUSION PHARMACEUTICALS INC.
WO/2021/154476ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOFDYNE THERAPEUTICS, INC.
WO/2021/142237METHODS FOR ADMINISTERING LUCITANIB AND COMBINATIONS THEREOFCLOVIS ONCOLOGY, INC.
WO/2021/142240COMPOSITIONS COMPRISING NICLOSAMIDE FOR USE IN TREATING  CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSEFIRST WAVE BIO, INC.
WO/2021/142244SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL  DELIVERY OF ACTIVE AGENTSTOPIX PHARMACEUTICALS, INC.
WO/2021/142256BROADLY REACTIVE VIRAL ANTIGENS AS IMMUNOGENS, COMPOSITIONS  AND METHODS OF USE THEREOFUNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/142257METHODS OF TREATING SPLENOMEGALYTELIOS PHARMA, INC.
WO/2021/142258MACROCYCLIC CHELATES AND USES THEREOFFUSION PHARMACEUTICALS INC.
WO/2021/142260MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF  ACVR1DYNE THERAPEUTICS, INC.
WO/2021/142279COMPOSITIONS AND METHODS OF TREATMENT USING VEILLONELLA  PARVULAEVELO BIOSCIENCES, INC.
WO/2021/142280METHODS OF MAKING TOLEROGENIC DENDRITIC CELLSMODERNATX, INC.
WO/2021/142282COMPOSITIONS AND METHODS FOR AMELIORATING PAIN AND REDUCING  FEVERTHE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/142287HIGH TRIPLET YIELD PHENOTHIAZINE DONOR-ACCEPTOR COMPLEXES FOR  PHOTOREDOX CATALYSISTHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/142288METHODS OF ADMINISTERING NALBUPHINETREVI THERAPEUTICS, INC.
WO/2021/142291STIMULATION OF HAIR GROWTHTHE GENERAL HOSPITAL CORPORATION
WO/2021/142300METHODS AND COMPOSITIONS FOR DELIVERY OF IMMUNOTHERAPY AGENTS  ACROSS THE BLOOD-BRAIN BARRIER TO TREAT BRAIN CANCERTHE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/142302COMPOSITIONS AND METHODS FOR AUTOIMMUNITY REGULATIONTCR2 THERAPEUTICS INC.
WO/2021/150383COSMECEUTICAL COMPOSITIONTRIM-EDICINE, INC.
WO/2021/142305METHODS OF TREATING TUMORSCOIMMUNE, INC.
WO/2021/142315METHODS AND COMPOUNDS FOR THE TREATMENT OF FRAGILE XDESIGN THERAPEUTICS, INC.
WO/2021/142317TOPICAL COMPOSITIONS CONTAINING ROFECOXIB AND METHODS OF  MAKING AND USING THE SAMEBRIORI BIOTECH, LLC
WO/2021/142320METHODS OF USING ANDROGRAPHOLIDE, ORIDONIN AND  ISOLIQUIRITIGENIN AND DERIVATIVES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/142322METHODS FOR OBTAINING COMPOUNDS FROM A PLANT OR FUNGUS  MATERIAL, RESPECTIVE COMPOSITIONS, AND USES THEREOFREAL ISOLATES, LLC
WO/2021/142329METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED  PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT  INHIBITORSDISC MEDICINE, INC.
WO/2021/142347COMPOSITIONS AND METHODS FOR NON-ALCOHOLIC STEATOHEPATITIS  (NASH)FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/142353COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B (HBV) AND  HEPATITIS D (HDV)FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/142355NANOPARTICLES FOR EXPRESSION OF GENES OF INTEREST AND/OR  REGULATION OF SIGNALING PATHWAYSAPRIKYAN, Andranik Andrew
WO/2021/142358COMPOSITIONS AND METHODS FOR TREATING HEPATIC ENCEPHALOPATHY  (HE)FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/142359STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATIONAMGEN INC.
WO/2021/142360STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATIONAMGEN INC.
WO/2021/142373METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES WITH α4β7  INTEGRIN ANTAGONISTSPROTAGONIST THERAPEUTICS, INC.
WO/2021/142395THERAPEUTIC COMBINATIONS OF DRUGS AND METHODS OF USING THEMCONSYNANCE THERAPEUTICS, INC.
WO/2021/142410NEURAL REGENERATION WITH SYNTHETIC PROTEIN ADMINISTRATIONRETINAL SOLUTIONS, LLC
WO/2021/142413HUMAN ANTIBODIES TO CRIMEAN CONGO HEMORRHAGIC FEVER VIRUSVANDERBILT UNIVERSITY
WO/2021/146127USE OF N2-QUINCLINE OR ISOQUINOLINE SUBSTITUTED PURINE  DERIVATIVES IN CANCER TREATMENTWU, Zhanggui
WO/2021/142420PYRAZOLO[1,5-<i>a</i>]PYRIMIDIN-7(4<i>H</i>)-ONE  INHIBITORS OF DYNEINKAPOOR, Tarun M.
WO/2021/142425TREATMENT OF NEUROLOGICAL DISORDERS WITH AVERMECTINSEQUILIBRE NEUROSCIENCE LTD.
WO/2021/142435COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHYSOLID BIOSCIENCES INC.
WO/2021/142447VIRAL VECTOR FOR COMBINATION THERAPYSOLID BIOSCIENCES INC.
WO/2021/146147BCMA-DIRECTED CELLULAR IMMUNOTHERAPY COMPOSITIONS AND METHODSNKARTA, INC.
WO/2021/142450SUPPRESSION OF INFLAMMASOME ACTIVATIONSAH, Rajan
WO/2021/142454TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDESONCOLMMUNIN, INC.
WO/2021/142460METHOD FOR DETERMINING SENSITIVITY TO 2,2'-DITHIO-BIS-ETHANE  SULFONATELANTERN PHARMA INC.
WO/2021/142467METHOD AND DEVICE FOR EVALUATING HAIR GROWTH TREATMENTSLASERCAP COMPANY - TRANSDERMAL CAP, INC.
WO/2021/146153SEMI-RIGID DISPLAY BOARDTHE GILMAN BROTHERS COMPANY
WO/2021/201950METHOD FOR REDUCING THE OCCURRENCE OF THROMBOSIS OR  THROMBOEMBOLISMTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/146163PYRIDAZINE AND 1,2,4-TRIAZINE DERIVATIVES AS FGFR KINASE  INHIBITORSBETA PHARMA, INC.
WO/2021/146176MEDICINAL COMPOSITIONS FOR CARBON DIOXIDE BASED METERED DOSE  INHALERSKINDEVA DRUG DELIVERY L.P.
WO/2021/146187EMULSION BASED DRUG SCREENINGFLUENT BIOSCIENCES INC.
WO/2021/146199PREDICTION OF PANCREATIC DUCTAL ADENOCARCINOMA USING COMPUTED  TOMOGRAPHY IMAGES OF PANCREASCEDARS-SINAI MEDICAL CENTER
WO/2021/146213METHODS FOR TREATING CANCERS USING GM-CSF ENCODING  POLYNUCLEOTIDE AND ADDITIONAL AGENTSGRADALIS, INC.
WO/2021/146215SUSTAINED RELEASE DRUG DELIVERY SYSTEMS WITH REDUCED  IMPURITIES AND RELATED METHODSDURECT CORPORATION
WO/2021/146257CONCENTRATED SODIUM VALPROATE FOR RAPID DELIVERYTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/146258COMBINATION THERAPY FOR CANCERTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146265CELL DELIVERY ARTICLES AND METHODS OF ADMINISTRATIONINCUBE LABS, LLC
WO/2021/146272METHODS FOR TREATING VIRAL INFECTIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146291SELF-ASSEMBLING PEPTIDE GEL FORMULATION AND METHODS OF USEARCH BIOSURGERY, INC.
WO/2021/146292TARGETING PAR1 AND PAR2 TO REGULATE LIPID AND CHOLESTEROL  ABUNDANCEMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/146296SWALLOWABLE DEVICES FOR DRUG DELIVERY IN AN INTESTINAL TRACTRANI THERAPEUTICS, LLC
WO/2021/146309TREATMENT OF VOMITING AND NAUSEA WITH MINIMUM DOSE OF  OLANZAPINESTARTON THERAPEUTICS, INC.
WO/2021/146318REPEATED ADMINISTRATION OF DIHYDROERGOTAMINE FOR TREATMENT OF  FREQUENT MIGRAINE HEADACHESIMPEL NEUROPHARMA, INC.
WO/2021/146328FORMULATIONS FOR PROTEIN THERAPEUTICSAPTEVO RESEARCH AND DEVELOPMENT LLC
WO/2021/146331POLYOXAZOLINE MODIFICATIONS MITIGATE STRUCTURAL DEGENERATION  OF BIOPROSTHETIC HEART VALVESTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/146334FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINETHE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF  MILITARY MEDICINE, INC.
WO/2021/146336METHODS AND COMPOSITIONS FOR PREVENTING ADSORPTION OF  THERAPEUTIC PROTEINS TO DRUG DELIVERY SYSTEM COMPONENTSAPTEVO RESEARCH AND DEVELOPMENT LLC
WO/2021/146344COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING  PATHWAYSLIFEVANTAGE CORPORATION
WO/2021/146373RADIONUCLIDE-LHRH CONJUGATES FOR DIAGNOSIS OF REPRODUCTIVE  CANCERSEASTERN KENTUCKY UNIVERSITY
WO/2021/146378COMPOSITIONS OF SUBSTITUTED PYRAZOLOPYRIMIDINES AND USES  THEREOFKSQ THERAPEUTICS, INC.
WO/2021/146390COMPOSITIONS AND METHODS FOR TARGETED PROTEIN STABILIZATION BY  REDIRECTING ENDOGENOUS DEUBIQUITINASESTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/146393HIGH THROUGHPUT GENETIC BARCODING AND ANALYSIS METHODSWILLIAM MARSH RICE UNIVERSITY
WO/2021/146397BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS  DETRIMENTALSYNLOGIC OPERATING COMPANY, INC.
WO/2021/146399COMPOSITIONS COMPRISING A NOVEL MAMMALIAN ORTHOREOVIRUS AND  METHODS FOR MAKING AND USINGPHIBRO ANIMAL HEALTH CORPORATION
WO/2021/146400METHODS AND COMPOSITIONS RELATING TO PROLONGED INFLAMMATORY  INHIBITION AND/OR PROLONGED TREATMENT OF SPINAL PAIN BY CHIMERA DECOYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/150420TOPICAL FORMULATION FOR BINDING TO DERMATOLOGICAL CANNABINOID  RECEPTORSKADO, Jessica
WO/2021/146408CARBONIC ANHYDRASE II COMPOSITIONS AND METHODS OF USE THEREOFUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/146425METHODS OF TREATING ACUTE MUSCLE SPASMSNEURANA PHARMACEUTICALS, INC.
WO/2021/146428NITRO-FATTY ACID-CONTAINING MICROBUBBLES AND USED THEREFORUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/146436BIASED IL2 MUTEINS METHODS AND COMPOSITIONSSYNTHEKINE, INC.
WO/2021/146464PERICYTE-SPARING THERAPYTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/146471TRANSPLANTED CELL PROTECTION VIA INHIBITION OF  POLYMORPHONUCLEAR CELLSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146481IL2 MUTEINSSYNTHEKINE, INC.
WO/2021/146483UTROPHIN UPREGULATION COMPOUNDS FOR DUCHENNE MUSCULAR  DYSTROPHY THERAPYTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/146506TYROSINE DERIVATIVES FOR MODULATING CANCERTYME, INC.
WO/2021/146523SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILESEVELO BIOSCIENCES, INC.
WO/2021/146539CROSSLINKED DEXTRAN-BASED HYDROGELS AND USES THEREOFTHE JOHNS HOPKINS UNIVERSITY
WO/2021/146553MACROMOLECULAR PRODRUGS FOR LIGHT-EMITTING DIODES AND USES  THEREOFCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/146566ENGINEERED FIBROBLASTS AS CELL THERAPY TO TREAT CANCER VIA  TUMOR STROMA STABILIZATIONTHE JOHNS HOPKINS UNIVERSITY
WO/2021/146571TUMOR CELL-DERIVED EXOSOMES AND METHOD OF TREATING COLORECTAL  CANCERREGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/146582COMPOSITIONS AND METHODS FOR CONTROLLING UNDESIRABLE MICROBES  AND IMPROVING ANIMAL HEALTHAGBIOME, INC.
WO/2021/146598METHODS AND COMPOSITIONS FOR TREATING ATOPIC DERMATITISSECOND GENOME, INC.
WO/2021/146604COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS TARGETING  B-CELL MATURATION ANTIGEN AND GAMMA SECRETASE INHIBITORSALLOGENE THERAPEUTICS, INC.
WO/2021/146625GENE THERAPY FOR TREATMENT OF <i>CRX-</i>AUTOSOMAL  DOMINANT RETINOPATHIESTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/146629HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTSNUVATION BIO INC.
WO/2021/146631HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTSNUVATION BIO INC.
WO/2021/146644METHODS AND COMPOSITIONS FOR TREATING ULCERATIVE COLITISSECOND GENOME, INC.
WO/2021/146647METHODS AND COMPOSITIONS FOR TREATING CANCERSECOND GENOME, INC.
WO/2021/146648COMPOSITIONS FOR MANAGING CHRONIC OBSTRUCTIVE PULMONARY  DISEASEMAJEED, Muhammed
WO/2021/146651PROCESS AND COMPOSITIONS FOR ENHANCING ENERGY EXPENDITUREMAJEED, Muhammed
WO/2021/146668CHANGING EYE COLOR BY GENE TRANSDUCTIONHILL, James W.
WO/2021/146678METHODS FOR PRODUCING CANNABINOID-CONTAINING CRYSTALS USING  SUPERCRITICAL FLUIDCALDERA GROUP LLC
WO/2021/146681MULTIVALENT STREPTOCOCCUS VACCINESINVENTPRISE, LLC
WO/2021/188191TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORSPURDUE RESEARCH FOUNDATION
WO/2021/146687A CANNABOSIDE COMPOSITION AND METHOD TO PRODUCECANNABIS GLOBAL, INC.
WO/2021/150471LIPOSOME FORMULATION OF VILANTEROL TRIFENATATEHUANG, Cai, Gu
WO/2021/162827COMPOSITIONS OF FREE FLOWING HYDROPHOBIC CARBOHYDRATE  DERIVATIVES AND METHODS FOR USECORN PRODUCTS DEVELOPMENT, INC.
WO/2021/150476THERAPEUTIC TYROSINE KINASE INHIBITORS FOR RELAPSING MULTIPLE  SCLEROSIS (RMS)GENZYME CORPORATION
WO/2021/150489INHALABLE FORMULATION OF A SOLUTION CONTAINING GLYCOPYRROLATE  AND OLODATEROL HYDROCHLORIDEHUANG, Cai, Gu
WO/2021/221741NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR  TREATING OR PREVENTING AN INFECTION IN A MAMMALLONZA CONSUMER HEALTH INC.
WO/2021/150501EXPANDED FOAM FOR DELIVERY OF FUNCTIONAL INGREDIENTSBOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
WO/2021/146704THE KINASE NEK10 AND ITS USE IN TREATING AND DIAGNOSING  BRONCHIECTASIS AND OTHER RESPIRATORY DISORDERSTHE GENERAL HOSPITAL CORPORATION
WO/2021/146713METHODS OF TREATING FRAGILE X SYNDROME WITH REELINUNIVERSITY OF SOUTH FLORIDA
WO/2021/146715NEUTROPHIL ELASTASE BINDING PEPTIDES AND COMPOSITIONS THEREOFCASE WESTERN RESERVE UNIVERSITY
WO/2021/146719<i>T-CELL DEATH ASSOCIATED GENE 8</i>  (<i>TDAG8</i>) MODULATION TO ENHANCE CELLULAR CANCER THERAPIESBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/146735CBD ORAL FORMULATIONCLEAR LAKE RESEARCH, LLC
WO/2021/150543NOVEL AND POTENT JAK/STAT INHIBITORTEXAS TECH UNIVERSITY SYSTEM
WO/2021/150559DOSING REGIMENS AND METHODS FOR TREATING CANCERPANBELA THERAPEUTICS, INC.
WO/2021/188194ENGINEERED INCOHERENT FEED FORWARD LOOP AND USES THEREOFMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/150570TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN  GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)REGENXBIO INC.
WO/2021/150595NOVEL FORMULATIONS COMPRISING CANNABISNUTRAMAX LABORATORIES, INC.
WO/2021/150598AFFINITY PEPTIDE CONJUGATED WITH ANTIOXIDANT FOR PROTECTION OF  PROTEINS FROM OXIDATIONARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/150621SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/150635DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE  TUMOR MICROENVIRONMENTANSUN BIOPHARMA, INC.
WO/2021/150645NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOFCRESCENTA BIOSCIENCES
WO/2021/206783VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINEXIE, Qiyi
WO/2021/150662TREATMENT OF PERIODONTITIS VIA INDUCTION OF M2 MACROPHAGESUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/150694HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS  RETROVIRUSES (HERVS)THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/150713HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS  RETROVIRUSES (HERVS)THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/150744CONTINUOUS PRODUCTION OF KERATIN FIBERSNUTECH VENTURES
WO/2021/150747PHENYLEPHRINE HYDROCHLORIDE COMPOSITIONS AND CONTAINERSNEVAKAR INC.
WO/2021/150756INHIBITORS OF GLUTATHIONE S-TRANSFERASES (GSTS) AND  NAD(P)H:QUINONE OXIDOREDUCTASE 1 (NQO1), PHARMACEUTICAL COMPOSITIONS, AND  USES IN MANAGING CANCEREMORY UNIVERSITY
WO/2021/150760COMPOSITIONS AND METHODS FOR INHIBITING OR SCREENING FOR CD8  AND METHODS AND ASSAYS FOR DETECTING CD8 IN CELLSWASHINGTON UNIVERSITY
WO/2021/150767HEPATOPANCREATIC NECROSIS DISEASE SIGNATURES AND USES THEREOFARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/150770ONCOGENIC TRIM37 IS A TARGETABLE EPIGENETIC DRIVER OF  METASTASIS AND LINKS CHEMORESISTANCE AND METASTATIC FATE IN TRIPLE-NEGATIVE  BREAST CANCERUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/150774SYSTEMS AND COMPOSITIONS FOR DELIVERING ACTIVE PLANT  COMPONENTSKINSTATE, INC.
WO/2021/150775DISCRIMINATING PARKINSON'S DISEASE FROM MULTIPLE SYSTEM  ATROPHY USING ALPHA-SYNUCLEIN PMCABOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/150785SYSTEMS AND METHODS FOR PROCESSING AND STABILIZING PLANT  MATERIALSE.&J. GALLO WINERY
WO/2021/150794LOW MOLECULAR WEIGHT PROTEIN COMPOSITIONSADVANCE INTERNATIONAL INC.
WO/2021/150806HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTSENANTA PHARMACEUTICALS, INC.
WO/2021/150807SKIN CARE COMPOSITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/150829STABLE ANTIBODY FORMULATIONREGENERON PHARMACEUTICALS, INC.
WO/2021/154591THERAPEUTIC USES OF DULAGLUTIDEELI LILLY AND COMPANY
WO/2021/150835HETEROCYCLIC LSF INHIBITORS AND THEIR USESTRUSTEES OF BOSTON UNIVERSITY
WO/2021/154593THERAPEUTIC USES OF TIRZEPATIDEELI LILLY AND COMPANY
WO/2021/150840ANTAGONISM AS A THERAPY FOR TDP-43 PROTEINOPATHIESUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/150867DESIGNING ANTISENSE OLIGONUCLEOTIDE DELIVERY PEPTIDES BY  INTERPRETABLE MACHINE LEARNINGSAREPTA THERAPEUTICS, INC.
WO/2021/150871COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE  DISORDERS WITH RIPK1/RIPK3 INHIBITORSARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/150874RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NAWISCONSIN ALUMNI RESEARCH FOUNDATION (WARF)
WO/2021/150884CHIMERIC ANTIGEN RECEPTOR T-CELL IMMUNOTHERAPY IN THE  TREATMENT OF CANCERB CELL SOLUTIONS, INC.
WO/2021/150912THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOFTVARDI THERAPEUTICS, INC.
WO/2021/150943ARSENIC TRIOXIDE MICROCRYSTAL-LOADED MICROSPHERESMUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/150945METHODS OF DIAGNOSING AND TREATING CANCERICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/150962SUSTAINED-RELEASE MATRICES FOR ADVENTITIAL OR PERIADVENTITIAL  NEURAL ABLATION AND USES THEREOFW. L. GORE & ASSOCIATES, INC.
WO/2021/150979OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGINGOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/150981AMORPHOUS SOLID DISPERSIONS OF DASATINIB AND USES THEREOFNANOCOPOEIA, LLC
WO/2021/150983METHODS FOR TREATING PARKINSON'S DISEASE WITH SEPIAPTERINPTC THERAPEUTICS MP, INC.
WO/2021/150985REDUCING SIDE EFFECTS OF NMDA ANTAGONISTSSEELOS THERAPEUTICS, INC.
WO/2021/150987NOVEL ERYTHROID SPECIFIC ENHANCERS AND USES THEREOFALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES
WO/2021/150997LOCALIZED EXPRESSION OF THERAPEUTIC NUCLEIC ACIDS IN LUNG  EPITHELIAL CELLSENGENE, INC.
WO/2021/150998COMPOSITIONS FOR INHIBITION OF HERPESVIRUSESBOGER, Ravit
WO/2021/151003COMPOSITIONS OF OXYHYDROGEN AND THE THERAPEUTIC USE THEREOF  FOR OCULAR CONDITIONSKHJ BIOLOGICAL LLC
WO/2021/151004COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING  TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING  IMMUNOGLOBULINSSPARK THERAPEUTICS, INC.
WO/2021/151005INHALED DAS181 TO TREAT CANCER IN THE LUNGANSUN BIOPHARMA, INC.
WO/2021/151008METHODS FOR DOSING AND TREATMENT OF FOLLICULAR LYMPHOMA AND  MARGINAL ZONE LYMPHOMA IN ADOPTIVE CELL THERAPYJUNO THERAPUETICS, INC.
WO/2021/151011TREATMENT OF NEURODEGENERATIVE PROTEINOPATHIES USING FAS  APOPTOSIS INHIBITORY MOLECULE (FAIM) OR A FRAGMENT AND/OR A MIMETIC THEREOFKAKU, Hiroaki
WO/2021/151013GROWTH FACTOR FORMULATION FOR CONDITION ASSOCIATED WITH OTIC  EVENTOTONOMY, INC.
WO/2021/151014PGDH INHIBITORS AND METHODS OF MAKING AND USINGMYOFORTE THERAPEUTICS, INC.
WO/2021/151018METHODS AND COMPOSITIONS FOR GENERATING TYPE I VESTIBULAR HAIR  CELLSDECIBEL THERAPEUTICS, INC.
WO/2021/151019NOVEL METHOD OF ENHANCED DRUG DELIVERY TO THE NERVOUS SYSTEMTHE GENERAL HOSPITAL CORPORATION
WO/2021/151029THERAPEUTIC EXOSOMES AND METHOD OF PRODUCING THEMAGEX THERAPEUTICS, INC.
WO/2021/151031PROTEIN-ANTIVIRAL COMPOUND CONJUGATESREGENERON PHARMACEUTICALS, INC.
WO/2021/151038QUANTITATIVE CONTROL OF ACTIVITY OF ENGINEERED CELLS  EXPRESSING UNIVERSAL IMMUNE RECEPTORSTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/151043METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL  INFECTIONHAN, Jang Hyun
WO/2021/151044PRODRUG FOR THE TREATMENT OF DISEASE AND INJURY OF OXIDATIVE  STRESSNACUITY PHARMACEUTICALS, INC.
WO/2021/151062HETEROCYCLIC COMPOUNDS AND USES THEREOFTHE TRUSTEES OF PRINCETON UNIVERISTY
WO/2021/154647USE OF STATINS TO TREAT OR PREVENT DRUG-INDUCED HEARING LOSSTHE UNITED STATE OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/151079MODULATING LYMPHATIC VESSELS IN NEUROLOGICAL DISEASEUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/151099THERAPEUTIC DOUBLE STRANDED RNA AND METHODS FOR PRODUCING THE  SAMEAIM IMMUNOTECH INC.
WO/2021/154682TISSUE DOSING FOR INTRALUMINAL LOCAL DRUG DELIVERYCONVERGASCENT LLC
WO/2021/154687METHODS FOR TREATING SARS COV-2 INFECTIONSGILEAD SCIENCES, INC.
WO/2021/154703COMPOSITIONS INCLUDING ANTIMICROBIAL POLYMER-PEPTIDE  CONJUGATES AND USES THEREOFUNIVERSITY OF PUERTO RICO
WO/2021/154709CLATHRIN-CHIMERIC ANTIBODY RECEPTOR CONSTRUCTS FOR IMMUNE CELL  ACTIVATION THERAPY IN VIVONANOTOMER, INC.
WO/2021/151104SALICYLAMIDE DERIVATIVES AND RELATED METHODS OF MAKINGTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/154735SREBP INHIBITORS COMPRISING A THIOPHENE CENTRAL RINGCAPULUS THERAPEUTICS, LLC
WO/2021/154745GONORRHEA SUBUNIT VACCINEOREGON STATE UNIVERSITY
WO/2021/154750TREATMENT OF ADRENOCORTICAL CARCINOMA WITH SELECTIVE  GLUCOCORTICOID RECEPTOR MODULATORS (SGRMs) AND ANTIBODY CHECKPOINT INHIBITORSCORCEPT THERAPEUTICS INCORPORATED
WO/2021/154752COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HEPATITIS  B AND DSVENSKA VACCINFABRIKEN PRODUKTION AB
WO/2021/154761METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST  ANTIBODYGENENTECH, INC.
WO/2021/154763CORONAVIRUS RNA VACCINESMODERNATX, INC.
WO/2021/154767METHOD FOR TREATMENT OF ACQUIRED COGNITIVE DEFICITSCORNELL UNIVERSITY
WO/2021/154773METHOD OF IMPROVING RESILIENCE AND RECOVERY IN HEALTHY MAMMALSLONZA CONSUMER HEALTH INC.
WO/2021/154774JOINT HEALTH COMPOSITION AND USE THEREOF IN HEALTHY MAMMALSLONZA CONSUMER HEALTH INC.
WO/2021/154812CORONAVIRUS VACCINE FORMULATIONSNOVAVAX, INC.
WO/2021/154828DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES THEREOFCODAGENIX INC.
WO/2021/154833IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED  NITRIC OXIDE (iNO) TREATMENTBELLEROPHON THERAPEUTICS
WO/2021/154839BISPECIFIC TRANSDUCTION ENHANCERUMOJA BIOPHARMA, INC.
WO/2021/154845BIOLOGIC FILLER FOR RESTORING AND REGENERATING TISSUEGENIPHYS, LLC
WO/2021/154872COMPOSITIONS INCLUDING PROBIOTIC BACTERIA FOR THE EXPRESSION  AND SECRETION OF ENTEROCINS TO CONTROL CLOSTRIDIA PERFRINGENS-INDUCED  NECROTIC ENTERITIS IN LIVESTOCK AND RELATED METHODSGENERAL PROBIOTICS, INC.
WO/2021/154882HDAC6-INHIBITED HUMAN REGULATORY T CELLSH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/154886NATURAL KILLER CELLS FOR TREATMENT OF CORONAVIRUS INFECTIONSORRENTO THERAPEUTICS, INC.
WO/2021/154893LUNG BIOMARKERS AND METHODS OF USE THEREOFPROGNOMIQ INC
WO/2021/154917METHODS OF USING MOMELOTINIB TO TREAT JOINT INFLAMMATIONSIERRA ONCOLOGY, INC.
WO/2021/154921STRUCTURAL OPTIMIZATION METHOD TO IMPROVE THE THERANOSTIC  PERFORMANCE OF PEPTIDE RECEPTOR-TARGETED RADIONUCLIDE THERAPY FOR CANCERSUNIVERSITY OF IOWA RESEARCH FOUNDATION
WO/2021/154929COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTHVERASTEM, INC.
WO/2021/154938BACTERIAL ADMIXTURESTHE JACKSON LABORATORY
WO/2021/154940LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS,  LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOFCONTRAFECT CORPORATION
WO/2021/154948PRODRUGS USEFUL IN ADOPTIVE CELL THERAPYMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/154954COMPOSITIONS AND METHODS FOR TREATING BIOFILMS, INFECTIONS AND  PERIODONTITISETHEIM BIOTICS, LLC
WO/2021/154958METHODS FOR MATURING AN ARTERIOVENOUS FISTULAALUCENT BIOMEDICAL, INC.
WO/2021/154963TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN  IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLSREGENXBIO INC.
WO/2021/154966COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERSKAMARI PHARMA LTD.
WO/2021/154969HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT  FIBROSISSTANDARD OF CARE CORPORATION
WO/2021/154974SCREENING FOR INHIBITORS OF PROSTAGLANDIN E SYNTHASE 3 USEFUL  FOR TREATMENT OF PROSTATE CANCERTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/154976METHODS OF TREATING BRAIN CANCER WITH PANOBINOSTATSECURA BIO, INC.
WO/2021/154979STABILIZED MENTHOL AND OTHER VOLATILE COMPOUND COMPOSITIONS  AND METHODSGHALILI, Babak
WO/2021/154992PROCESS AND SYSTEM FOR ACELLULAR THERAPYORGENESIS INC.
WO/2021/155002COMPOSITIONS AND METHODS FOR HAIRFEREBEE, Rachel
WO/2021/155007COMPOSITIONS COMPRISING A COMPOUND COMPRISING A PHOSPHATE  GROUP, AND METHODS FOR PROTECTING HAIRFEREBEE, Rachel
WO/2021/155016ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND  METHODS OF USETHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/155025METHOD OF PREVENTING OR TREATING PANCREATIC DYSFUNCTION OR  DIABETES BY UPREGULATING HUMAN CATHELICIDIN LL-37 TO INHIBIT ISLET AMYLOID  POLYPEPTIDE (IAPP) SELF-ASSEMBLYTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/155034COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING MUC16  SPECIFIC FUSION PROTEINSTCR2 THERAPEUTICS INC.
WO/2021/155042IL15/IL15R ALPHA HETERODIMERIC FC-FUSION PROTEINS FOR THE  TREATMENT OF CANCERGENENTECH, INC.
WO/2021/155050KINASE MODULATORS, PHARMACEUTICAL COMPOSITIONS, AND  THERAPEUTIC APPLICATIONSBIOTHERYX, INC.
WO/2021/155087METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCYVERTEX PHARMACEUTICALS INCORPORATED
WO/2021/155097CD40-L BLOCKADE TO ENHANCE SYNTHETIC ANTIBODY THERAPYTHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/155100COMPOUNDS AND USES THEREOFFOGHORN THERAPEUTICS INC.
WO/2021/155118COMPOSITIONS AND METHODS FOR MICROBIAL TREATMENT OF SKIN  DISORDERSDUPONT US HOLDING, LLC
WO/2021/155119THERAPEUTICS FOR COVID-19THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/155128TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITIONTEXAS CHILDREN'S HOSPITAL
WO/2021/155129ANTI-CD30 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE  TREATMENT OF NON-HODGKIN LYMPHOMASEAGEN INC.
WO/2021/155149METHODS OF INDUCING NEOEPITOPE-SPECIFIC T CELLS WITH A PD-1  AXIS BINDING ANTAGONIST AND AN RNA VACCINEGENENTECH, INC.
WO/2021/155171DELIVERY OF COMPOSITIONS COMPRISING CIRCULAR  POLYRIBONUCLEOTIDESFLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/155173TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND  PLASMA HALF-LIFEARCUTIS BIOTHERAPEUTICS, INC.
WO/2021/155175COMPOSITIONS FOR TRANSLATION AND METHODS OF USE THEREOFFLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/155177COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN  MODULATION AND USES THEREOFFLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/155178EYE TREATMENTS EMPLOYING SERUM FROM WHOLE BLOODMULLER, David
WO/2021/158440IMMUNOGENIC COMPOSITIONS TO TREAT AND PREVENT MICROBIAL  INFECTIONSLONGHORN VACCINES AND DIAGNOSTICS, LLC
WO/2021/155195COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE,  NEURODEVELOPMENTAL, MYODEGENERATIVE, AND LYSOSOMAL STORAGE DISORDERSGEORGETOWN UNIVERSITY
WO/2021/155198NANOMATERIALS FOR TARGETED TREATMENT AND IMAGING OF ANEURYSMAL  MICROENVIRONMENTTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/155212NOVEL ANTAGONISTS FOR TREATMENT OF GI TRACT CONDITIONSAIM BIOLOGICS, INC.
WO/2021/155225COMPOUNDS AND USES THEREOFFOGHORN THERAPEUTICS INC.
WO/2021/155229GUT BACTERIUM-BASED TREATMENT TO INCREASE POULTRY GUT HEALTH  AND FOOD SAFETYIOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/155243RESPIRATORY VIRUS IMMUNIZING COMPOSITIONSMODERNATX, INC.
WO/2021/167770IMMUNE CELL MODULATORSOCTAGON THERAPEUTICS, INC.
WO/2021/155253ANAT INHIBITORS AND METHODS OF USE THEREOFATOMWISE INC.
WO/2021/155259METHODS OF TREATING PSMA-POSITIVE CANCER USING RADIONUCLIDE  THERAPYCANCER TARGETED TECHNOLOGY LLC
WO/2021/155262COMPOUNDS AND USES THEREOFFOGHORN THERAPEUTICS INC.
WO/2021/155264COMPOUNDS AND USES THEREOFFOGHORN THERAPEUTICS INC.
WO/2021/155265COMPOSITIONS AND METHODS FOR STEM CELL CHONDROGENESISWASHINGTON UNIVERSITY
WO/2021/155267MRNAS ENCODING METABOLIC REPROGRAMMING POLYPEPTIDES AND USES  THEREOFMODERNATX, INC.
WO/2021/155274METHODS OF PREPARING LIPID NANOPARTICLESMODERNATX, INC.
WO/2021/155277MODULATION OF IMMUNE CELLSOCTAGON THERAPEUTICS, INC.
WO/2021/155279COMPOSITIONS AND METHODS FOR REGULATING FATTY ACIDSWASHINGTON UNIVERSITY
WO/2021/155281COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASEAPPLIED MOLECULAR TRANSPORT INC.
WO/2021/155288FIBROBLAST ACTIVATION PROTEIN (FAP) - TARGETED ANTIFIBROTIC  THERAPYLOW, Philip, Stewart
WO/2021/155292FIBROBLAST ACTIVATION PROTEIN (FAP) - TARGETED ANTIFIBROTIC  THERAPYLOW, Philip, Stewart
WO/2021/155297METHODS FOR LABELING AND TARGETING CELLSPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/155312PLACENTAL DERIVED NATURAL KILLER CELLS FOR TREATMENT OF  CORONAVIRUS INFECTIONSCELULARITY INC.
WO/2021/155316COMPOUNDS AND USES THEREOFFOGHORN THERAPEUTICS INC.
WO/2021/155320COMPOUNDS AND USES THEREOFFOGHORN THERAPEUTICS INC.
WO/2021/162879METHODS AND COMPOSITIONS FOR ANTIMICROBIAL USE OF SYNTHETIC  LYSINE ANALOGS, DERIVATIVES, MIMETICS, AND PRODRUGSTRANEXAMIC TECHNOLOGIES, LLC
WO/2021/162880COMPOSITIONS OF VITAMIN A PALMITATE, PROCESSES FOR THEIR  PREPARATION, USES AND METHODS COMPRISING THEMADVENT THERAPEUTICS INC.
WO/2021/206787NOVEL N-ARYL OXAMIC ACIDSPURDUE RESEARCH FOUNDATION
WO/2021/155337COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSISTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/158463DIAMINE-LINKED RECEPTOR-SPECIFIC CYCLIC PEPTIDESPALATIN TECHNOLOGIES, INC.
WO/2021/158464REVERSE AMIDE-LINKED MELANOCORTIN RECEPTOR-SPECIFIC CYCLIC  PEPTIDESPALATIN TECHNOLOGIES, INC.
WO/2021/158466SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF  TREATING REFRACTIVE OCULAR DISORDERSVTV THERAPEUTICS LLC
WO/2021/158476MICRORNA-7 COMPOSITIONS FOR PROMOTING FUNCTIONAL RECOVERY  FOLLOWING SPINAL CORD INJURY AND METHODS OF USE THEREOFRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/155355NANOMATERIALS FOR TARGETED TREATMENT OF PULMONARY TISSUETHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/155383METHODS AND COMPOSITIONS FOR TARGETED DELIVERY, RELEASE,  AND/OR ACTIVITYPROTZ, Jonathan M.
WO/2021/158496DRUG FORMULATIONS FOR RESERVOIR-BASED DELIVERYMEDTRONIC, INC.
WO/2021/158516IRE1α MODULATORS AND USES THEREOFNIMBUS IASO, INC.
WO/2021/158517COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF  MASTITISCUREMAST, INC.
WO/2021/158534METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN  RECEPTOR T CELLS WITH HAPTEN LABELLED CELLSSEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH  INSTITUTE)
WO/2021/158560TOPICAL MONTELUKAST FORMULATIONSTARO PHARMACEUTICAL INDUSTRIES LTD.
WO/2021/158561METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASESTRANEXAMIC TECHNOLOGIES, LLC
WO/2021/158565POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA  AND USES THEREOFCITY OF HOPE
WO/2021/158573METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS  TO MOLECULESNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/158574COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTSNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/158575COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM  ANIONS TO MOLECULESNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/158601METHODS AND COMPOSITIONS RELATED TO THE USE OF ERGOTHIONEINEBLUE CALIFORNIA
WO/2021/158611PARTICLES FUNCTIONALIZED WITH IMAGEABLE RADIOISOTOPES AND  METHODS OF MAKING AND USE THEREOFUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/158622ANTI-FIBRINOLYTIC LOADED PLATELETSCELLPHIRE, INC.
WO/2021/158625METHODS OF TREATING ACQUIRED HEMOPHILIA WITH ANTI-FIBRINOLYTIC  LOADED PLATELETSCELLPHIRE, INC
WO/2021/158626ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES  THEREOFETERNITY BIOSCIENCE INC.
WO/2021/158632FORMULATIONS OF DOCETAXELZHUHAI BEIHAI BIOTECH CO., LTD.
WO/2021/158634IRAK DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/158635ANTI-VIRAL COMPOSITIONS AND METHODS OF USEAL THERAPEUTICS, INC.
WO/2021/158645METHODS OF TREATING CONGENITAL HEMOPHILIA WITH  ANTI-FIBRINOLYTIC LOADED PLATELETSCELLPHIRE, INC.
WO/2021/158646TREATMENT OF VON WILLEBRAND DISEASECELLPHIRE, INC.
WO/2021/158648RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS IN PLANTSVECPROBIO, INC.
WO/2021/158701METHOD FOR TREATING CORONAVIRUS INFECTIONSOYAGEN, INC.
WO/2021/158713FOAM COMPOSITIONS FOR THE TREATMENT OF CANCERTDL INNOVATIONS LLC
WO/2021/158714COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONSNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/158739DRUG-LOADED AMINO ACID-BASED POLY(ESTER UREA) FILMS FOR  CONTROLLED LOCAL RELEASE OF NON-OPIOID ANALGESIC COMPOUNDSBECKER, Matthew
WO/2021/162928WATER DISPERSIBLE COMPOSITE PARTICLES, METHODS OF MAKING, AND  COATINGSUNIVERSITY OF FLORIDA RESEARCH FOUNDATION
WO/2021/158755LEPTOSPIRAL PROTEINS AND USES THEREOFYALE UNIVERSITY
WO/2021/158777TREATMENT OF MENORRHAGIA IN PATIENTS WITH SEVERE VON  WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWFBAXALTA INCORPORATED
WO/2021/158783METHOD OF TREATING A SOLID TUMOR WITH A COMBINATION OF AN IL-7  PROTEIN AND CAR-BEARING IMMUNE CELLSWASHINGTON UNIVERSITY
WO/2021/158789CHAOTROPIC AGENTS FOR REDUCING FORMATION OF DOUBLE-STRANDED  RNAULTRAGENYX PHARMACEUTICAL INC.
WO/2021/158792METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY DISEASES OR  DISORDERSAGIOS PHARMACEUTICALS, INC.
WO/2021/158799PROPHYLACTIC USES OF ANNEXIN A2THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/158814GENE THERAPY SYSTEMS AND RELATED METHODS FOR TREATMENT OF  HEARING LOSSRESCUE HEARING INC.
WO/2021/158815ZIKA VIRUS IMMUNOGENIC COMPOSITIONSNEW YORK BLOOD CENTER, INC.
WO/2021/158820NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND  SYSTEMIC ADMINISTRATIONOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/158825COMPOSITIONS AND METHODS FOR NUTRITIONAL SUPPLEMENTSDAILYCOLORS HEALTH INC.
WO/2021/211191NOVEL LYMPHOID-SPECIFIC TYROSINE PHOSPHATASE (LYP) INHIBITORSPURDUE RESEARCH FOUNDATION
WO/2021/158838DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATORARGENTUM PHARMACEUTICALS LLC
WO/2021/158839TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATORARGENTUM PHARMACEUTICALS LLC
WO/2021/158841TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATORARGENTUM PHARMACEUTICALS LLC
WO/2021/158843TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATORARGENTUM PHARMACEUTICALS LLC
WO/2021/158844TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATORARGENTUM PHARMACEUTICALS LLC
WO/2021/158845TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATORARGENTUM PHARMACEUTICALS LLC
WO/2021/158847TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATORARGENTUM PHARMACEUTICALS LLC
WO/2021/158848DOSAGE REGIMEN OF AN S1P RECEPTOR AGONISTARGENTUM PHARMACEUTICALS LLC
WO/2021/158850CHIMERIC ANTIGEN RECEPTORS WITH CD28 MUTATIONS AND USE THEREOFMEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/158851PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIRHUANG, Cai Gu
WO/2021/158857ASSAYS FOR DETECTING PEANUT ALLERGIESALLERGENIS LLC
WO/2021/158884TREATMENT REGIMEN FOR CANCER USING IMMUNOMODULATIONBIOXCEL THERAPEUTICS, INC.
WO/2021/158888PSYCHEDELIC TREATMENT FOR HEADACHE DISORDERSYALE UNIVERSITY
WO/2021/158899ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/158907COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONSAETIO BIOTHERAPY, INC.
WO/2021/158936PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS  FOR AMELIORATING HEARING LOSSGNEDEVA, Ksenia
WO/2021/158937BORTEZOMIB-LOADED NANOPARTICLESTHE JOHNS HOPKINS UNIVERSITY
WO/2021/158947COMBINATION THERAPIES AND BIOMARKERS FOR TREATING CANCERLI, Xiang
WO/2021/158949COMBINATION THERAPIES AND BIOMARKERS FOR TREATING B-CELL  LYMPHOMASLI, Xiang
WO/2021/158957DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOFSUMMIT BIOSCIENCES INC.
WO/2021/158960ANTIBODIES PROTECTIVE AGAINST INFLUENZA BELLEBEDY, Ali
WO/2021/158962T CELL RECEPTORS TARGETING DEFECTIVE DNA REPAIR PROTEINSUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/158968COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASESOCULAR THERAPEUTIX, INC.
WO/2021/158969POLYPEPTIDE AFFINITY LIGANDS AND METHODS OF USINGAVANTOR PERFORMANCE MATERIALS, LLC
WO/2021/158990THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM  DUSTARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/158991METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/158992IMPROVED METHODS AND COMPOSITIONS FOR CROMAKALIM PRODRUG  THERAPYQLARIS BIO, INC.
WO/2021/158996RNA-LOADED NANOPARTICLES AND USE THEREOF FOR THE TREATMENT OF  CANCERUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/158999GENE EDITING METHODS FOR TREATING SPINAL MUSCULAR ATROPHYTHE BROAD INSTITUTE, INC.
WO/2021/159011METHOD FOR TREATING NERVOUS SYSTEM INJURIES USING BOLDINE AND  ANALOGS THEREOFUNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/159016ARTIFICIAL SYNAPSESDIADEM BIOTHERAPEUTICS INC.
WO/2021/159021LIPID PRODRUGS OF NEUROSTEROIDSPURETECH LYT, INC.
WO/2021/159027TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDAEIGER BIOPHARMACEUTICALS, INC.
WO/2021/225657PROTECTION FROM IONIZING RADIATIONAVISA MYKO, INC.
WO/2021/159035ONCOLYTIC VIRUS COMPOSITIONS AND METHODS FOR THE TREATMENT OF  CANCERCITY OF HOPE
WO/2021/159038METHODS TO REFINE CANNABINOIDSNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/159040SARS-COV-2 MRNA DOMAIN VACCINESMODERNATX, INC.
WO/2021/159042COMPOSITIONS COMPRISING EXTRACTS OF APLINIA AND OTHER PLANTS  FOR IMPROVING JOINT HEALTH AND TREATING ARTHRITISUNIGEN, INC.
WO/2021/159044N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED  THERETOEMORY UNIVERSITY
WO/2021/159050COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONSHI, Yuenian
WO/2021/167805TWO-STEP REACTIVE LIP SYSTEML'OREAL
WO/2021/159058NOVEL CANNABINOIDS FORMULATIONS AND THEIR USE FOR THE  TREATMENT OF ACUTE FLACCID MYELITISDIVERSE BIOTECH, INC.
WO/2021/159059COMPOSITION AND METHOD FOR THE TREATMENT AND PREVENTION OF  CARDIAC, PULMONARY, DERMAL, AND RENAL FIBROSISEMERALD HEALTH PHARMACEUTICALS INC.
WO/2021/159062COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC  DISEASEBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/159068COMPOSITION AND METHOD OF USING GERMINATIVE COMPOUNDS IN  PROBIOTICS FOR INFLAMMATION REDUCTION IN HUMANSNCH CORPORTION
WO/2021/159075ATTENUATED <i>SALMONELLA</i> SYNTHESIZING ANTIGENS  FOR VACCINATING AGAINST <i>HELICOBACTER PYLORI</i>CURTISS, Roy
WO/2021/159076USES OF GLYCYRRHETINIC ACID, GLYCYRRHIZIC ACID FOR TREATMENT  OF PNEUMONITIS/PNEUMONIA/PULMONARY FIBROSISZHANG, Lurong
WO/2021/159077COMPOSITIONS AND METHODS FOR ATTENUATING OPIOID INDUCED CARDIO  AND/OR RESPIRATORY DEPRESSIONCASE WESTERN RESERVE UNIVERSITY
WO/2021/167810COMPOSITIONS FOR SKINCARE AND USE THEREOFANJON BIOLOGICS, INC.
WO/2021/159088GAS PHASE METHODS TO EXTRACT NATURAL PRODUCTSNATURAL EXTRACTION SYSTEMS, LLC
WO/2021/159093INHIBITION OF BETA-ARRESTIN OLIGOMERIZATION IN TAUOPATHYUNIVERSITY OF SOUTH FLORIDA
WO/2021/159118COMPOSITION AND METHOD OF MRNA VACCINES AGAINST NOVEL  CORONAVIRUS INFECTIONRNALMMUNE, INC.
WO/2021/163002HPV VACCINEMERCK SHARP & DOHME CORP.
WO/2021/163007THERAPEUTIC COMPOSITION AND METHODSVISCERA LABS, INC.
WO/2021/163023STABLE FORMULATIONS OF DRONABINOLTRYAGX LABS INC.
WO/2021/163024COMPOSITIONS INCLUDING DICHOTOMOUS COMPOSITE PARTICLES,  ARTICLE INCLUDING THE COMPOSITION, AND STRUCTURES HAVING SUPERHYDROPHOBIC,  SUPEROLEOPHOBIC, OR OMNIPHOBIC SURFACESUNIVERSITY OF FLORIDA RESEARCH FOUNDATION
WO/2021/163037METHODS OF TREATING AND PREVENTING ENGRAFTMENT ARRHYTHMIASUNIVERSITY OF WASHINGTON
WO/2021/163058METHODS OF STIMULATING AN ANTI-TUMOR RESPONSE USING A  SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORCORCEPT THERAPEUTICS INCORPORATED
WO/2021/206799COMPOUNDS FOR THE TREATMENT OF SARSPURDUE RESEARCH FOUNDATION
WO/2021/163069CANCER IMMUNOTHERAPY USING TRANSFUSIONS OF ALLOGENEIC,  TUMOR-SPECIFIC CD4+ T CELLSTHE JOHNS HOPKINS UNIVERSITY
WO/2021/163131DEVICE, KIT, AND METHOD FOR ISLET TRANSPLANTATIONYOUHEALTH BIOTECH, LIMITED
WO/2021/163172OMECAMTIV MECARBIL TABLETAMGEN INC.
WO/2021/163183METHODS OF TREATING FABRY DISEASEAMICUS THERAPEUTICS, INC.
WO/2021/163186DEUTERATED POLYUNSATURATED FATTY ACIDS OR ESTERS THEREOF FOR  COSMETIC APPLICATIONSRETROTOPE, INC.
WO/2021/163190HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR  DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASESUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/163192MYC INHIBITORS AND USES THEREOFSTEMSYNERGY THERAPEUTICS, INC.
WO/2021/163199TREATMENT OF INFECTIOUS DISEASESDURECT CORPORATION
WO/2021/163238CANNABINOID AND MENTHOL TRANSDERMAL DELIVERY SYSTEMS AND  METHODSGHALILI, Babak
WO/2021/163242METHODS FOR IMPROVED DELIVERY OF THERAPEUTIC AGENTSWILLIAM MARSH RICE UNIVERSITY
WO/2021/163246IMPROVED AQUACULTURE FEED ADDITIVEHP INGREDIENTS CORP.
WO/2021/163252TOPICAL NALOXONE COMPOSITIONS AND METHODS FOR USING THE SAMETEIKOKU PHARMA USA, INC.
WO/2021/163253PROGESTERONE COMBINATIONSGLIA, LLC
WO/2021/163272PLATELET FACTORS AND COGNITIVE IMPROVEMENTTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/163274METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSISTHE GENERAL HOSPITAL CORPORATION
WO/2021/163281ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATING PENDRED  SYNDROMEACCUTAR BIOTECHNOLOGY INC.
WO/2021/163302COMPOUNDS, COMPOSITIONS, AND METHODS FOR PROTEIN DEGRADATIONDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/163304ACTIVATION OF NEUROPEPTIDE RECEPTORS ON PLASMACYTOID DENDRITIC  CELLS TO TREAT OR PREVENT OCULAR DISEASES ASSOCIATED WITH NEOVASCULARIZATION  AND INFLAMMATIONTUFTS MEDICAL CENTER, INC.
WO/2021/173364TREATMENT FOR CHEMOBRAINYALE UNIVERSITY
WO/2021/163327COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR  DISORDERSUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/163329ANTI-BCMA THERAPY IN AUTOIMMUNE DISORDERSCELGENE CORPORATION
WO/2021/188234METHOD OF TREATING AN INDIVIDUAL WITH A HEALTH CONDITION WITH  FECAL MICROBIOTA TRANSPLANTHAZAN, Sabine
WO/2021/163338XPO1 INHIBITORS FOR USE IN TREATING CANCERKARYOPHARM THERAPEUTICS INC.
WO/2021/163339CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF  THERAPEUTICS TO HEPATIC STELLATE CELLSGENEVANT SCIENCES GMBH
WO/2021/173366SHORT AND LONG-TERM SURFACE DISINFECTANTS UTILIZING ALCOHOL  AND ZINC PYRITHIONE COMPOSITIONSCAO GROUP, INC
WO/2021/163357GENE THERAPY VECTORS FOR TREATING HEART DISEASETENAYA THERAPEUTICS, INC.
WO/2021/163364TRISPECIFIC BINDING MOLECULESABBVIE BIOTECHNOLOGY LTD.
WO/2021/163365SARS-COV-2 VACCINETHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/163367EXOGENOUS NITRIC OXIDE FOR IMPROVED SUSCEPTIBILITY AND LOWERED  ANTIBIOTIC RESISTANCE IN RESISTANT RESPIRATORY BACTERIATHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/163375MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY  AND TREATMENTUNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/163386DEVICES AND METHODS FOR DETERMINING PHOSPHATE LEVELS IN  NATURAL WATERMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/163389BCMA-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS  AND METHODS AND USES THEREOFJUNO THERAPEUTICS, INC.
WO/2021/163391CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS  AND METHODS AND USES THEREOFJUNO THERAPEUTICS, INC.
WO/2021/163398T CELL EPITOPE CLUSTERS AND RELATED COMPOSITIONS USEFUL IN THE  PREVENTION, DIAGNOSIS, AND TREATMENT OF COVID-19EPIVAX, INC.
WO/2021/163400COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONSCYTOAGENTS, INC.
WO/2021/173367POWDER COMPOSITIONS HAVING REDUCED FRAGILITYL'OREAL
WO/2021/163416METHODS OF MEASURING AND PURIFYING EXTRACELLULAR VESICLESPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/163425MARGARIC ACID DECREASES PIEZ02-MEDIATED PAINTHE UNITED STATES OF AMERICA, as represented by THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/163427REGULATORY T CELL EPITOPES AND DETOLERIZED SARS-COV-2 ANTIGENSEPIVAX, INC.
WO/2021/163429CONDITIONED MEDIUM FROM CELLS CULTURED UNDER HYPOXIC  CONDITIONS AND USES THEREOFALLERGAN SALES, LLC
WO/2021/163432CO-ADMINISTRATION OF PREDNISOLONE/METHYL PREDNISOLONE AND  ZOLEDRONIC ACID TO TREAT AND PREVENT OSTEOARTHRITISLEVOLTA PHARMACEUTICALS, INC.
WO/2021/163438POLYPEPTIDES, COMPOSITIONS, AND THEIR USE TO TREAT OR LIMIT  DEVELOPMENT OF AN INFECTIONUNIVERSITY OF WASHINGTON
WO/2021/163448VACCINE AND METHODS FOR DETECTING AND PREVENTING FILARIASISTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/163452SMARTCORE COMPOSITIONS AND METHODSNPI, LLC
WO/2021/211198INDUCING PRODUCTION OF ANTI-OLIGOMANNOSE ANTIBODIESSRI INTERNATIONAL
WO/2021/163455SCALABLE AND FACILE CELL-MEMBRANE-COATING TECHNOLOGY FOR BOTH  POSITIVELY AND NEGATIVELY CHARGED PARTICLESTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/163456T CELL EPITOPES AND RELATED COMPOSITIONS USEFUL IN THE  PREVENTION, DIAGNOSIS, AND TREATMENT OF COVID-19EPIVAX, INC.
WO/2021/163467LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF,  AND USE THEREOFTEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/163472MONITORING VIABILITY OF ORGANS FOR TRANSPLANTATIONTHE GENERAL HOSPITAL CORPORATION
WO/2021/163484METHODS OF GENERATING AND USING SENESCENT-INDUCED CELLS FOR  TREATMENT OF CANCER AND COMPOSITIONS RELATING THERETOTHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/163490TARGETED DEPLETION OF BACTERIA FROM MIXED POPULATIONS THROUGH  PROGRAMMABLE CELL-CELL ADHESIONUNIVERSITY OF WASHINGTON
WO/2021/163499TAZ GENE OR ENZYME REPLACEMENT THERAPYCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/163501GAS AND LIQUID FLOW REGULATION SYSTEM FOR CELL CULTUREXCELL BIOSCIENCES, INC.
WO/2021/163504FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF  TREATING INFLAMMATORY DISEASEAMGEN INC.
WO/2021/163513HEAT SHOCK PROTEIN MODULATORS AND ANTI-HUNTINGTON DISEASE  THERAPEUTIC AGENTSUNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/163520POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND  THEIR MEDICAL USESRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/163528COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PRURITUSLENUS THERAPEUTICS, LLC
WO/2021/163529BUPRENORPHINE TREATMENTSBIODELIVERY SCIENCES INTERNATIONAL, INC.
WO/2021/163530THERAPEUTIC COMBINATIONS COMPRISING  UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS AND POLY  (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORSKSQ THERAPEUTICS, INC.
WO/2021/167845ORAL CARE COMPOSITIONSUNSTAR AMERICAS, INC.
WO/2021/163550HAPLOTYPE-BASED TREATMENT OF RP1 ASSOCIATED RETINAL  DEGENERATIONSMASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/163580METHODS FOR TREATING TAUOPATHYRETROTOPE, INC.
WO/2021/163585TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITIONTEXAS CHILDREN'S HOSPITAL
WO/2021/163594TREATMENT OF CEREBRAL PALSY USING FIBROBLASTSFIGENE, LLC
WO/2021/163602RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCERTHE JOHNS HOPKINS UNIVERSITY
WO/2021/163610TREATMENT OF OTIC DISEASES AND CONDITIONSSPIRAL THERAPEUTICS INC.
WO/2021/163620PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOFTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
WO/2021/163622VACCINES AND USES THEREOF TO INDUCE AN IMMUNE RESPONSE TO  SARS-COV2GEOVAX, INC.
WO/2021/163627MACROCYCLIC ULK1/2 INHIBITORSSALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/163629INHIBITORS OF ULK1/2 AND METHODS OF USING SAMESALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/163631CALPAIN-2 INHIBITOR COMPOUNDS AND METHODS OF TREATMENTWESTERN UNIVERSITY OF HEALTH SCIENCES
WO/2021/163633MONO AND COMBINATION THERAPIES WITH ULK1/2 INHIBITORSSALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/211201NOVEL FLAME RETARDANT RESINPURDUE RESEARCH FOUNDATION
WO/2021/173373INJECTABLE CONTROLLED-RELEASE FORMULATIONS OF PROGESTOGEN  DRUGSFORDOZ PHARMA CORP.
WO/2021/183259FAMOTIDINE AND FAMOTIDINE ANALOGS FOR CORONA VIRUS TREATMENTNANOPHARMACEUTICS, INC.
WO/2021/167860GEMFIBROZIL FORMULATIONPOLARYX THERAPEUTICS, INC.
WO/2021/163666SMALL MOLECULE REGULATORS OF NOTCH1 AND USES THEREOFSHARMA, Arun K.
WO/2021/163672TRANSFERABLE MICROBIOTA FOR THE TREATMENT OF ULCERATIVE  COLITISCORNELL UNIVERSITY
WO/2021/167879TELOMERE LENGTH MODULATION USING FIBROBLASTSSPINALCYTE, LLC
WO/2021/167883METHOD FOR TREATING ASTHMA OR ALLERGIC DISEASETHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/167885CD137 BINDING MOLECULES AND USES THEREOFMACROGENICS, INC.
WO/2021/163683INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE, COMPOSITIONS  AND USES THEREOFPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/167894COMPOSITIONS AND METHODS FOR TREATING MALARIARUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/167920DEVICES, SYSTEMS AND METHODS FOR SENSING AND DISCERNING  BETWEEN FAT AND MUSCLE TISSUE DURING MEDICAL PROCEDURESAPYX MEDICAL CORPORATION
WO/2021/167942TRANSMUCOSAL DRUG DELIVERY SYSTEMNORTH ATLANTIC HOLDINGS LLC
WO/2021/167964PILRA ANTIBODIES AND METHODS OF USE THEREOFALECTOR LLC
WO/2021/167974<i>N</i>-ACETYLCYSTEINE COMPOSITIONS AND METHODSNEVAKAR INC.
WO/2021/173399COSMETIC COMPOSITIONS CONTAINING A SUGAR ALCOHOL, A SACCHARIDE  COMPOUND AND PECTIN AND METHODS OF USEL'OREAL
WO/2021/167996GROUP A STREP IMMUNOGENIC COMPOSITIONS WITH  POLYSACCHARIDE-PROTEIN CONJUGATESVAXCYTE, INC.
WO/2021/168008A  5-(4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZIN-7-YL)-2-CYANO-3,4-DIHYDROXYTETRAHYDROFURANE  DERIVATIVE AS ANTIVIRAL AGENTGILEAD SCIENCES, INC.
WO/2021/168015METHODS OF BARCODING NUCLEIC ACID FOR DETECTION AND SEQUENCINGUNIVERSAL SEQUENCING TECHNOLOGY CORPORATION
WO/2021/168042CELL-CULTURE BIOREACTORORGENESIS INC.
WO/2021/168043THERAPEUTIC AGENT NANOPARTICLES AND METHODS OF PREPARATIONNANO PHARMASOLUTIONS, INC.
WO/2021/168044COMPOSITION AND METHOD TO ENHANCE COGNITIVE SUPPORT AND BRAIN  HEALTHNUTRISCIENCE INNOVATIONS LLC
WO/2021/168082SPECIFIC TRYPTAMINES FOR USE IN THE TREATMENT OF MOOD  DISORDERSGILGAMESH PHARMACEUTICALS, INC.
WO/2021/168100FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF  USING THE SAMEAMGEN INC.
WO/2021/168106DEUTERATED NEUROSTEROIDPRAXIS PRECISION MEDICINES, INC.
WO/2021/173419COMPOSITIONS AND METHODS OF TREATING CANCERTILLEAD THERAPEUTICS, INC.
WO/2021/168110THERAPIES FOR THE TREATMENT OF DISEASES AND DISORDERS  ASSOCIATED WITH ABNORMAL EXPRESSION OF A NEURAL-ASSOCIATED GENETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/168122SINGLE CHAIN TRIMER MHC CLASS II NUCLEIC ACIDS AND PROTEINS  AND METHODS OF USEINSTITUTE FOR SYSTEMS BIOLOGY
WO/2021/168133ISOPROTERENOL COMPOSITIONS AND METHODSNEVAKAR INC.
WO/2021/168135COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE IN  TRANSPLANTATION RECIPIENTSTHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/168140ADENO-ASSOCIATED VIRAL (AAV)-MEDIATED SGPL1 GENE THERAPY FOR  TREATMENT OF SPHINGOSINE-1-PHOSPHATE LYASE INSUFFICIENCY SYNDROME (SPLIS)CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND
WO/2021/168147BACTERIOPHAGE COMPOSITIONS FOR TREATING  <i>STAPHYLOCOCCUS</i> INFECTIONARMATA PHARMACEUTICALS, INC.
WO/2021/168161USE OF CYCLOSPORINE ANALOGUES FOR TREATING FIBROSISHEPION PHARMACEUTICALS, INC.
WO/2021/168169ANTI-BAFF RECEPTOR ANTIBODIES AND USES THEREOFYINNUOLAI BIOTECH LTD.
WO/2021/168173METHODS AND COMPOSITIONS FOR TREATING VIRAL RESPIRATORY  INFECTIONSSYNKINE THERAPEUTICS, INC.
WO/2021/168186RECOMBINANT MYXOMA VIRUSES AND USES THEREOFBARTEE, Eric
WO/2021/168194ENGINEERED ANTI-HER2 BISPECIFIC PROTEINSDENALI THERAPEUTICS INC.
WO/2021/168202EGFR INHIBITION TRIGGERS AN ADAPTIVE RESPONSE BY CO-OPTING  ANTIVIRAL SIGNALING PATHWAYS IN LUNG CANCERUNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/168206L-SEPIAPTERIN AND METHODS OF USE FOR TREATING DISEASES AND  DISORDERSMUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/168218COMPOSITIONS COMPRISING AXITINIB AND METHODS OF TREATING  OCULAR DISORDERSCLEARSIDE BIOMEDICAL, INC.
WO/2021/168235COMPOSITIONS OF SOLUBLE BETA GLUCAN AND RELATED METHODSKEMIN INDUSTRIES, INC.
WO/2021/168239SUPRACHOROIDAL DELIVERY OF DRUG PARTICLES TO REDUCE TOXICITYTHE JOHNS HOPKINS UNIVERSITY
WO/2021/173442IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION  OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/168266ERADICATION OF MERKEL CELL POLYOMAVIRUSTEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/168271DROPLET FORMATION AND PARTICLE MORPHOLOGYELEKTROFI, INC.
WO/2021/168274NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOFSILVERBACK THERAPEUTICS, INC.
WO/2021/168283THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER USING  BRAF AND/OR MEK INHIBITOR COMBINATION THERAPYVANDERBILT UNIVERSITY
WO/2021/168290MULTILAMELLAR RNA NANOPARTICLES AND METHODS OF SENSITIZING  TUMORS TO TREATMENT WITH IMMUNE CHECKPOINT INHIBITORSUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/168295USE OF NICOLSAMIDE FORMULATIONS FOR ANTIVIRAL THERAPYYOURCHOICE THERAPEUTICS, INC.
WO/2021/168303FLT3 BINDING PROTEINS AND METHODS OF USEHARPOON THERAPEUTICS, INC.
WO/2021/168312AFFINITY MOLECULES AND ASSAYS FOR SARS-COV-2 NUCLEOCAPSID  ANTIGENSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/168318VACCINE COMPOSITIONS FOR PREVENTING CORONAVIRUS DISEASEINTERNATIONAL AIDS VACCINE INITIATIVE INC.
WO/2021/168321COMPOSITION AND METHODS FOR TREATING INFECTIOUS AGENTS USING  PATHOGEN-SPECIFIC ANTIBODIESANUBIS BIO CORPORATION
WO/2021/168328NICLOSAMIDE FORMULATIONS FOR USE AS CONTRACEPTIVEYOURCHOICE THERAPEUTICS, INC.
WO/2021/173449ORTHOGONAL SAFETY SWITCHES TO ELIMINATE GENETICALLY ENGINEERED  CELLSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/168349PHARMACEUTICAL COMPOSITIONS OF ALPHA-2-ADRENERGIC RECEPTOR  AGONISTS AND THEIR USE FOR IMPROVING VISIONALLERGAN, INC.
WO/2021/168350ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR REDUCING REDNESS AND  INCREASING WHITENESS IN EYES AND OTHER OPHTHALMIC PURPOSESALLERGAN, INC.
WO/2021/168363SYSTEMS AND METHODS RELATED TO CANCERPREDICTIVE TECHNOLOGY GROUP, INC.
WO/2021/168375CHIMERIC ANTIGEN RECEPTOR T CELL THERAPYKITE PHARMA, INC.
WO/2021/168376CHIMERIC ANTIGEN RECEPTOR T CELL THERAPYKITE PHARMA, INC.
WO/2021/168379BISPECIFIC GD2 AND B7H2 BINDING MOLECULES AND METHODS OF USEWIN THERAPEUTICS, INC.
WO/2021/168386GLP-1R AND GCGR AGONISTS, FORMULATIONS, AND METHODS OF USESPITFIRE PHARMA LLC
WO/2021/168388YEAST DISPLAY LIBRARIES, ASSOCIATED COMPOSITIONS, AND  ASSOCIATED METHODS OF USE3T BIOSCIENCES, INC.
WO/2021/173459PLATELET ACTIVATION USING SPECIFIC FREQUENCIESCELL CODE, LLC
WO/2021/173468USE OF RADIATION TO PREDISPOSE PLATELET ACTIVATIONCELL CODE, LLC
WO/2021/173474CYCLOSPORINE COMPOSITIONS AND METHODS OF USEBACAINN BIOTHERAPEUTICS, LTD.
WO/2021/173476COMPOUNDS, PHARMACEUTICAL FORMULATIONS, AND METHODS FOR  TREATMENT OF CANCERTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/173482IMPROVED ALKYL BENZOATE SOLUBILIZED ORGANIC SUNSCREEN FILTERSETHOX CHEMICALS, LLC
WO/2021/168403METHODS OF TREATING IDIOPATHIC HYPERSOMNIAJAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/168405COMPOSITIONS AND METHODS FOR ORGAN-PROTECTIVE EXPRESSION AND  MODULATION OF CODING RIBONUCLEIC ACIDSCOMBINED THERAPEUTICS, INC.
WO/2021/168410ELECTROSPUN STRUCTURES HAVING A PHARMACEUTICAL AND METHODS OF  MAKING AND USING THE SAMENANOFIBER SOLUTIONS, LLC
WO/2021/168413BASIC DOMAIN-DELETED DNASE1-LIKE 3 AND USES THEREOFNEUTROLIS, INC.
WO/2021/168421METHOD OF ENHANCING IMMUNOTHERAPY USING ER STRESS PATHWAY  INHIBITORSH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/168430COMPOSITIONS AND METHODS FOR TREATING RENAL INJURYCASE WESTERN RESERVE UNIVERSITY
WO/2021/168434IGG VARIANTS FOR INDUCTION OF IMMUNE RESPONSE WITHOUT ADJUVANTARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/202013ANTI-GIPR ANTIBODY AND METHODS OF USE THEREOFCRYSTAL BIOSCIENCE INC.
WO/2021/194672COMPOSITIONS AND METHODS FOR DELIVERY OF RNAHDT BIO CORP.
WO/2021/168447NANO-PENETRATIVE CANNABINOID OIL BLENDS AND COMPOSITIONS AND  METHODS OF FORMULATION THEREOFTHERAGUN, INC.
WO/2021/173523HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2  INHIBITORNEWAVE PHARMACEUTICAL INC.
WO/2021/173524SOS1 INHIBITORSMIRATI THERAPEUTICS, INC.
WO/2021/173526THERAPEUTIC DELIVERY OF LOCKED NUCLEIC ACID CONJUGATED  ANTISENSE MIR-1THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/202014ANTI-ANDROGEN OR AN ANDROGEN RECEPTOR ANTAGONIST FOR TREATMENT  OF A VIRAL RESPIRATORY INFECTIONAPPLIED BIOLOGY, INC.
WO/2021/173533COMPOSITIONS COMPRISING METHYLPHENIDATE-PRODRUGS, PROCESSES OF  MAKING AND USING THE SAMEKEMPHARM, INC.
WO/2021/173537FORMULATIONS OF ANTI-ENDOTHELIAL LIPASE ANTIBODIESMEDIMMUNE, LLC
WO/2021/173550APOAEQUORIN AND CURCUMIN CONTAINING COMPOSITIONS AND METHODSQUINCY BIOSCIENCE, LLC
WO/2021/173586NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR  RECEPTORS AND USE FOR TREATING CANCERTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/173592SYNTHETIC ROCAGLATES WITH BROAD-SPECTRUM ANTIVIRAL ACTIVITIES  AND USES THEREOFMEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/173598COMBINATION DECITABINE AND CEDAZURIDINE SOLID ORAL DOSAGE  FORMSOTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/173614SYSTEMS, COMPOSITIONS, AND METHODS FOR TREATING KERATINOUS  SUBSTRATESL'OREAL
WO/2021/173624EUTECTIC BASED ANESTHETIC COMPOSITIONS AND APPLICATIONS  THEREOFTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/173632METHODS FOR MONITORING THE PROGRESS OF POLYSACCHARIDE  SIZE-REDUCTIONMERCK SHARP & DOHME CORP.
WO/2021/173641IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANTVANDA PHARMACEUTICALS INC.
WO/2021/173650PLACENTAL TISSUE COMPOSITIONS AND METHODSAZIYO BIOLOGICS INC.
WO/2021/173658NAPHTHOQUINONE-BASED CHALCONE DERIVATIVES AND USES THEREOFHOFMANN, Robert F.
WO/2021/173677POTENT AND SELECTIVE DEGRADERS OF ALKDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/173702COMPOSITIONS AND METHODS FOR TREATING CANCER AND TUMOROBLATO, INC.
WO/2021/173707COMPOSITIONS AND METHODS FOR TREATMENT OF CYTOKINE STORM AND  CYTOKINE RELEASE SYNDROMEYINUOKE MEDICINE SCIENCE TECHNOLOGY COMPANY LTD.
WO/2021/173713HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19ATEA PHARMACEUTICALS, INC.
WO/2021/173721SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND  METHODS OF USE THEREOFUNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/173723USE OF CYCLOSPORINE ANALOGUES FOR TREATING CANCERHEPION PHARMACEUTICALS, INC.
WO/2021/173724SYSTEMS AND METHODS FOR PROTECTING NUCLEIC-ACID MOLECULESTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/173731SELECTIVE ANDROGEN RECEPTOR COVALENT ANTAGONISTS (SARCAS) AND  METHODS OF USE THEREOFUNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/173740METHODS OF TREATING PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS  USING AN INHIBITOR OF BRUTON'S TYROSINE KINASEGENENTECH, INC.
WO/2021/173741COMFREYNS, ARYLNAPHTHALENE LIGNANS THAT INHIBIT  PRO-INFLAMMATORY GENE EXPRESSION, AND PHARMACEUTIC COMPOSITION COMPRISING  THEMTHE PROCTER & GAMBLE COMPANY
WO/2021/173744METHODS OF TREATMENT OF INFLAMMATORY CYTOKINE-RELATED  ARTHRITIC DISORDERSBRIDGE PHARMA, INC.
WO/2021/173770POLYMERIC STABILIZING AGENTS FOR IMPLANTABLE DRUG DELIVERY  DEVICESNANO PRECISION MEDICAL, INC.
WO/2021/173773CAMPTOTHECIN DERIVATIVES AND CONJUGATES THEREOFMEDIBOSTON, INC.
WO/2021/173783ANTIBODIES CONJUGATED WITH FATTY ACID MOLECULES AND USES  THEREOFPHANES THERAPEUTICS, INC.
WO/2021/173797ENZYMES FOR SIALYLATION OF GLYCANSMOMENTA PHARMACEUTICALS, INC.
WO/2021/173802CHEMICALLY-STABILIZED ALLOSTERIC MODULATORS OF LEUCINE-RICH  REPEAT KINASE 2 (LRRK2)UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/173806METHOD OF TREATING DISEASESERGO HEALTH LLC
WO/2021/173808RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED  WITH URIC ACID AND METHODS OF USE THEREOFSYNLOGIC OPERATING COMPANY, INC.
WO/2021/178209APTAMERS AND USE THEREOFAPTITUDE MEDICAL SYSTEMS, INC.
WO/2021/173832CANCER TREATMENT METHODSBOLT BIOTHERAPEUTICS, INC.
WO/2021/173838METHODS, KITS AND COMPOSITIONS FOR NOVEL AGAROSE-BASED DERMAL  FILLER WITH ENHANCED RHEOLOGICAL PROPERTIES PROVIDING SAFETY FEATURESADVANCED AESTHETIC TECHNOLOGIES, INC.
WO/2021/173840IMPROVED PROCESSES OF PREPARING MRNA-LOADED LIPID  NANOPARTICLESTRANSLATE BIO, INC.
WO/2021/173847COBRA1/NELF-B AS A BOOSTER FOR EFFICACY OF CD8+ T CELL-BASED  THERAPYTHE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED  NOT-FOR-PROFIT CORPORATION
WO/2021/178218NAIL LACQUER WITHOUT NITROSAMINECOTY INC.
WO/2021/173870COMPOSITION AND METHOD TO PREPARE LONG-ACTING INJECTABLE  SUSPENSION CONTAINING MULTIPLE CANCER DRUGSUNIVERSITY OF WASHINGTON
WO/2021/173879IDENTIFICATION OF BIOMIMETIC VIRAL PEPTIDES AND USES THEREOFLIGANDAL, INC.
WO/2021/173889USES OF ANTI-CD3 ANTIBODY FOLATE BIOCONJUGATESAMBRX, INC.
WO/2021/173892ANIMAL MODELS OF LIPID METABOLISM AND METHODS OF TREATING  HYPERLIPIDEMIA OR HYPERLIPIDEMIA-RELATED DISEASESACADEMIA SINICA
WO/2021/173896MATERIALS AND METHODS FOR MODULATING AN IMMUNE RESPONSEJANSSEN BIOTECH, INC.
WO/2021/173907HIGH DOSE INFLUENZA VACCINE FOR PEDIATRIC SUBJECTSSANOFI PASTEUR, INC.
WO/2021/173920METHODS FOR DETECTING FOOD ALLERGIESTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/173922CATALASE NANOCAPSULES AND METHODS FOR USEVIVIBABA, INC.
WO/2021/173923PYRROLIDINE-FUSED HETEROCYCLESERASCA, INC.
WO/2021/173925NONVIRAL GENERATION OF GENOME EDITED CHIMERIC ANTIGEN RECEPTOR  T CELLSWISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/173929COMPOSITIONS AND METHODS FOR TREATING MISFOLDED PROTEIN OCULAR  DISORDERSCASE WESTERN RESERVE UNIVERSITY
WO/2021/173930KCNT1 INHIBITORS AND METHODS OF USEPRAXIS PRECISION MEDICINES, INC.
WO/2021/173936ORAL FAST-DISPERSING DOSAGE FORM OF RIMEGEPANTBIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
WO/2021/178232INHALABLE FORMULATION OF A SOLUTION CONTAINING GLYCOPYRRONIUM  BROMIDEHUANG, Cai Gu
WO/2021/173948METHODS FOR ENRICHING MARROW INFILTRATING LYMPHOCYTES  ("MILS"), COMPOSITIONS CONTAINING ENRICHED MILS, AND METHODS OF  USING ENRICHED MILSWINDMIL THERAPEUTICS, INC.
WO/2021/173954COMPOSITIONS COMPRISING HYDROLYSED PROTEINSCRODA, INC.
WO/2021/173960TREATMENT OF CARM1-OVEREXPRESSING AND/OR ARID1A MUTANT CANCERS  WITH IRE-1/XBP-1 INHIBITORSTHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/173962METHODS AND MATERIALS FOR DIAGNOSIS AND TREATMENT OF NEURONAL  DISORDERGENEMO, INC.
WO/2021/173964METHODS FOR ACTIVATION AND EXPANSION OF TUMOR INFILTRATING  LYMPHOCYTESKSQ THERAPEUTICS, INC.
WO/2021/173965IDENTIFICATION OF VARIABLE INFLUENZA RESIDUES AND USES THEREOFMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/173972PENTAGALLOYL GLUCOSE DERIVED FROM SCHINUS PLANTS AND METHODS  OF USEEMORY UNIVERSITY
WO/2021/178239SYSTEMS AND METHODS FOR CARBON DIOXIDE ENHANCED DELIVERY OF  TOPICAL SUBSTANCESCRYOCONCEPTS LP
WO/2021/173985METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLSNOVARTIS AG
WO/2021/173987CELL-TARGETED NANOPARTICLES TO INHIBIT RNA CARGOTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/183303COMPOSITIONS AND METHODS FOR NALOXONE DELIVERYPURDUE PHARMA L. P.
WO/2021/173999METHOD OF ENHANCING AQUEOUS HUMOR OUTFLOW AND REDUCING  INTRAOCULAR PRESSURENORTHWESTERN UNIVERSITY
WO/2021/174000STABILIZED COATED BUTYRATE FOR COLON RELEASEBIOKIER, INC.
WO/2021/174003COMPOSITIONS AND METHODS FOR REDUCING RESISTANCE TO OR  ENHANCING IMMUNOTHERAPYWASHINGTON UNIVERSITY
WO/2021/174013METHODS AND COMPOSITIONS USING SYNTHETIC NANOCARRIERS  COMPRISING IMMUNOSUPPRESSANTSELECTA BIOSCIENCES, INC.
WO/2021/174019COMPOUNDS AND METHODS FOR MODULATING SMN2IONIS PHARMACEUTICALS, INC.
WO/2021/174021TUNABLE EXTENDED RELEASE HYDROGELSFRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/174024METHODS OF TREATING IATROGENIC AUTOIMMUNE COLITISFIRST WAVE BIO, INC.
WO/2021/174026RADIATION CURABLE PHASE CHANGE MATERIAL SOLUTIONS AND SHAPE  STABLE THERMOSET PHASE CHANGE MATERIAL GELS FORMED THEREFROMMICROTEK LABORATORIES, INC.
WO/2021/174034MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATIONGENZYME CORPORATION
WO/2021/174039DELIVERY OF LOW VISCOSITY FORMULATIONSJAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/174041COMPOSITIONS AND METHODS FOR REDUCING CYTOKINE EXPRESSIONEVELO BIOSCIENCES, INC.
WO/2021/174045RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND  THERANOSTIC USES THEREOFBRISTOL-MYERS SQUIBB COMPANY
WO/2021/174052MITIGATION OF STATISTICAL BIAS IN GENETIC SAMPLINGFOUNDATION MEDICINE, INC.
WO/2021/174055TUMOR-INFILTRATING LYMPHOCYTES WITH ENHANCED TUMOR REACTIVITYH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/174059METHOD FOR REMOVING HOST CELL DNA FROM VIRUS PREPARATIONTAKEDA VACCINES, INC.
WO/2021/174069DIROFILARIA VOLATILE ORGANIC COMPOUND SIGNATURES AND USES  THEREOFAUBURN UNIVERSITY
WO/2021/178246GENE VECTOR CONTROL BY CARDIOMYOCYTE-EXPRESSED MICRORNASTENAYA THERAPEUTICS, INC.
WO/2021/174109DISSEMINATED NEOPLASIA CELLS AND METHODS OF THEIR USE TO  CONTROL INVASIVE OR PEST SPECIESBIOMILAB, LLC
WO/2021/174116METHODS FOR OPIATE AND OPIOID OVERDOSE PREVENTION AND REVERSALTORRALVA MEDICAL THERAPEUTICS LLC
WO/2021/174128COMPOSITIONS AND METHODS FOR MUCOSAL VACCINATION AGAINST  SARS-COV-2UNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/174132COMPOSITIONS COMPRISING SELF-ASSEMBLING VACCINES AND METHODS  OF USING THE SAMETHE WISTAR INSTITUTE OF ANATOMY & BIOLOGY
WO/2021/174134FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE SKIN GRAFT HEALINGMICROCURES, INC.
WO/2021/174135COMPOUNDS THAT MODULATE ANTI-TUMOR IMMUNITY AND METHODS OF  DOING THE SAMEUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/174142RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-COV-2 VIRUSTONIX PHARMACEUTICALS HOLDING CORP.
WO/2021/174149FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALINGMICROCURES, INC.
WO/2021/178253ANTI-CD19 ANTIBODIES AND METHODS OF USING AND MAKING THEREOFSYSTIMMUNE, INC.
WO/2021/174168METHODS FOR TREATING GAIN-OF-FUNCTION DISORDERS COMBINING GENE  EDITING AND GENE THERAPYBLUEALLELE, LLC
WO/2021/178257VIRUS-LIKE PARTICLE VACCINES FOR OPIOID DRUGSUNM RAINFOREST INNOVATIONS
WO/2021/178260DELIVERY OF COSMETIC AGENTS, COMPOSITIONS AND USE THEREOFELC MANAGEMENT LLC
WO/2021/178261METHODS FOR REPAIRING SKIN USING NANOFIBERSELC MANAGEMENT LLC
WO/2021/174183ENCAPSULATED CLEANSING COMPOSITIONHENKEL IP & HOLDING GMBH
WO/2021/174188A PERSONAL CARE PRODUCT AND A METHOD FOR MAKING A PERSONAL  CARE PRODUCT BY AN ADDITIVE PROCESSHENKEL IP & HOLDING GMBH
WO/2021/174192CONDITIONING COMPOSITIONHENKEL IP & HOLDING GMBH
WO/2021/174193METHOD OF MANUFACTURING PEPTIDE NANOPARTICLESDUPAGE MEDICAL TECHNOLOGY, INC.
WO/2021/178306CORONAVIRUS VACCINES COMPRISING A TLR9 AGONISTDYNAVAX TECHNOLOGIES CORPORATION
WO/2021/174195USE OF THYROMIMETICS FOR THE TREATMENT OF CANCERTHE UNIVERSITY OF VERMON
WO/2021/174198SELECTIVE MODULATION OF TRANSFORMING GROWTH FACTOR BETA  SUPERFAMILY SIGNALING VIA MULTI-SPECIFIC ANTIBODIESTHE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/174205PRODRUGS OF NEUROACTIVE STEROIDSBRII BIOSCIENCES, INC.
WO/2021/178318CORONAVIRUS VACCINES COMPRISING A TLR9 AGONISTDYNAVAX TECHNOLOGIES CORPORATION
WO/2021/178321CORONAVIRUS VACCINES COMPRISING A TLR9 AGONISTDYNAVAX TECHNOLOGIES CORPORATION
WO/2021/174217COMPOSITIONS, METHODS, DEVICES, AND KITS FOR DETECTING THE  NUMBER AND GENOMIC LOCATIONS OF POLYMORPHIC LINE-1 ELEMENTS IN AN INDIVIDUALADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
WO/2021/178346METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS BY  ADMINISTRATION OF TAFENOQUINE60 DEGREES PHARMACEUTICALS LLC
WO/2021/178351TRICYCLIC DITERPENE ISOLATED FROM PINE ROSIN FOR THE TREATMENT  OF PAIN AND INFLAMMATIONUNIVERSITY OF SOUTH FLORIDA
WO/2021/178355NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTIONPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/178371A PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT USING  SERRATIOPEPTIDASE, MANNOSE OR ITS DERIVATIVE, AND OPTIONALLY ANTINFECTION  AGENTSPATEL, Nimesh
WO/2021/178395FIBROBLAST AND TLR ACTIVATED FIBROBLAST TREATMENT OF VIRAL  INDUCED ACUTE RESPIRATORY DISTRESS SYNDROMEFIGENE, LLC
WO/2021/178396IMIDAZOLE-BASED SYNTHETIC LIPIDOIDS FOR IN VIVO MRNA DELIVERY  INTO IMMUNE CELLSTRUSTEES OF TUFTS COLLEGE
WO/2021/202031PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY  FOR CORONAVIRUSFIGENE, LLC
WO/2021/202032FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE  REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)FIGENE, LLC
WO/2021/178406USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONSAMPLYX PHARMACEUTICALS, INC.
WO/2021/178416IMMUNE-MEDIATED CORONAVIRUS TREATMENTSHEAT BIOLOGICS, INC.
WO/2021/178417COMPOSITIONS CONTAINING RAPID-ACTING INSULIN ANALOGUESTHERMALIN INC.
WO/2021/178437GLUCOSE TRIPTOLIDE CONJUGATES AND USES THEREOFTHE JOHNS HOPKINS UNIVERSITY
WO/2021/178449COMPOSITIONS AND METHODS FOR THE TREATMENT OF PANCREATIC  CANCERWASHINGTON UNIVERSITY
WO/2021/178465BUCCAL AND ENTERIC DELIVERY OF FATTY ACIDS WITH ORAL HYGIENE  PRACTICESCLEAR LAKE RESEARCH, LLC
WO/2021/178471USE OF QX314 TO PREVENT SYMPATHOEXCITATION ASSOCIATED WITH  ADMINISTRATION OF TRPV1 MODULATORSNEUCURES, INC.
WO/2021/178481PROTEIN NANOPARTICLE DESIGN AND APPLICATIONDUKE UNIVERSITY
WO/2021/178485PYRIMIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USESSHIH, Chuan
WO/2021/178510COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE  TRANSCARBAMYLASE DEFICIENCYARCTURUS THERAPEUTICS, INC.
WO/2021/178514CARDIOSPHERE-DERIVED CELLS, EXOSOMES DERIVED THEREFROM, AND  METHODS OF USING SAME TO TREAT VOLUMETRIC MUSCLE LOSSCEDARS-SINAI MEDICAL CENTER
WO/2021/178525COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CANCER  USING DEUBIQUITINASE INHIBITORSTHE UNIVERSITY OF CHICAGO
WO/2021/178531THE RAD51 INHIBITOR COMPOUND 67A (2301085-06-1) AT A SPECIFIC  DOSAGE FOR TREATING CANCERCYTEIR THERAPEUTICS, INC.
WO/2021/178541DRUG COMBINATIONS FOR INHIBITING INFLAMMATION AND SRC KINASE  ACTIVATION FOLLOWING INVASIVE SURGICAL PROCEDURESSINTETICA S.A.
WO/2021/188296METHODS OF TREATING XANTHINE OXIDASE-RELATED DISEASES WITH  NIFLUMIC ACID AND DERIVATIVES THEREOFBAYLOR COLLEGE OF MEDICINE
WO/2021/178555METHOD OF TREATMENT OR ALLEVIATING SYMPTOMS OF A DISORDER WITH  CURCUMINANOTHER CHANCE NUTRA, LLC
WO/2021/178561USE OF DOWNSTREAM FACTORS IN THE KLOTHO PATHWAY TO ASSESS  KLOTHO ACTIVITYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/178565METHODS OF TREATING HYPERGLYCEMIA AND SUPPRESSING ONSET OF  TYPE 1 DIABETESADITXT, INC.
WO/2021/178569ANTI-DR5 POLYPEPTIDES AND METHODS OF USE THEREOFREGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/178571ON DEMAND EXPRESSION OF EXOGENOUS FACTORS IN LYMPHOCYTES TO  TREAT HIVAMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
WO/2021/178579CANNABIS TREATMENT OF INSOMNIA, PAIN, AND SKIN CONDITIONSALTE VERDE LLC
WO/2021/178582SYSTEMS AND METHODS FOR TREATING PATIENTS INFECTED WITH  SARS-COV-2HDL THERAPEUTICS, INC.
WO/2021/178612COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTIONJANSSEN PHARMACEUTICALS, INC.
WO/2021/178621ENGINEERED INFLUENZA NEURAMINIDASE ANTIGENSUNIVERSITY OF WASHINGTON
WO/2021/178623IMMUNOGENIC COMPOSITIONS AGAINST SEVERE ACUTE RESPIRATORY  SYNDROME CORONAVIRUS 2NEW YORK BLOOD CENTER, INC.
WO/2021/178637IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/178639COMPOSITIONS DERIVED FROM SALVIA HISPANICA SEEDSSIGNUM BIOSCIENCES, INC.
WO/2021/178650LOW-TEMPERATURE SYNTHESIS OF THYMOQUINONE AND HARMALINE  COMPOUNDSANKH LIFE SCIENCES LIMITED
WO/2021/178657METHODS FOR TREATING CANCER USING A COMBINATION OF A PD-1  ANTAGONIST, A CTLA4 ANTAGONIST, AND LENVATINIB OR A PHARMACEUTICALLY  ACCEPTABLE SALT THEREOFMERCK SHARP & DOHME CORP.
WO/2021/178661COMPOSITIONS CONTAINING A PATHOGENIC ANTIGEN AND AN IMMUNE  STIMULATORONCOSEC MEDICAL INCORPORATED
WO/2021/178663COMPOSITIONS AND METHODS FOR TREATMENT OF PLATINUM-BASED  CHEMOTHERAPEUTIC RESISTANT TUMORSTHE GEORGE WASHINGTON UNIVERSITY
WO/2021/178684CAR AND NRF2 DUAL ACTIVATOR AGENTS FOR CYCLOPHOSPHAMIDE-BASED  AND DOXORUBICIN-BASED TREATMENTS OF CANCERUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/178691IBOGAINE ANALOGS AS THERAPEUTICS FOR NEUROLOGICAL AND  PSYCHIATRIC DISORDERSTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/178700METHODS AND COMPOSITIONS FOR TREATING CANNABIS USE DISORDER  AND MITIGATING CANNABINOID WITHDRAWALPLEOPHARMA, L.L.C.
WO/2021/178701METHODS AND COMPOSITIONS FOR THE DELIVERY OF MODIFIED  LYMPHOCYTE AGGREGATESEXUMA BIOTECH CORP.
WO/2021/178705ANTI-CANCER AND ANTI-PROLIFERATIVE COMPOSITIONS, AND METHODS  FOR THEIR USE IN TREATING CANCERNATREON, INC.
WO/2021/178707COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC LIVER  DISORDERSPOSEIDA THERAPEUTICS, INC.
WO/2021/178714ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES  THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/178725COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERYVERVE THERAPEUTICS, INC.
WO/2021/178734METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH  MYELOPEROXIDASE INHIBITORBIOHAVEN THERAPEUTICS LTD.
WO/2021/178737METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A  MUTATION IN THE GLA GENEAMICUS THERAPEUTICS, INC.
WO/2021/178740INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF  THE SAMETHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/178741INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF  THE SAMETHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/183370COMPOUNDS WITH IMMUNOMODULATORY ACTIVITY AND THERAPEUTIC USES  THEREOFPURDUE RESEARCH FOUNDATION
WO/2021/183371NANO-COMPOSITE MICROPARTICLES OF POLYMYXINPURDUE RESEARCH FOUNDATION
WO/2021/206831ETHANOLAMINE FORMULATION FOR TREATING EPITHELIAL OVARIAN  CARCINOMAMETANOI THERAPEUTICS, INC.
WO/2021/178752SERINE PROTEASE INHIBITORS FOR SUPPRESSING OR PREVENTING  ANAPHYLACTIC REACTIONTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/178768METHODS OF TREATING APOL-1 DEPENDENT FOCAL SEGMENTAL  GLOMERULOSCLEROSISVERTEX PHARMACEUTICALS INCORPORATED
WO/2021/178779COMBINATION THERAPY COMPRISING AXL/MER AND PD-1/PD-L1  INHIBITORSINCYTE CORPORATION
WO/2021/178789METHODS OF USING REBASTINIB IN THE TREATMENT OF DIFFERENT  CANCEROUS DISORDERSDECIPHERA PHARMACEUTICALS, LLC
WO/2021/216205VACCINES FORMED BY VIRUS AND ANTIGEN CONJUGATIONKENTUCKY BIOPROCESSING, INC.
WO/2021/178807COMBINATION OF AN LSD-1 INHIBITOR AND NIVOLUMAB FOR USE IN  TREATING SCLC OR SQNSCLCCELGENE QUANTICEL RESEARCH, INC.
WO/2021/178818THERAPEUTIC AGENTS AND CONJUGATES THEREOFBEIJING XUANYI PHARMASCIENCES CO., LTD.
WO/2021/178834TOPICAL PHARMACEUTICAL FORMULATIONS OF A CYCLIC DEPSIPEPTIDELIFEMAX LABORATORIES, INC.
WO/2021/178841HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONSJANPIX, LTD.
WO/2021/178843ULINASTATIN POLYPEPTIDESDIAMEDICA USA INC.
WO/2021/178846METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASESOLEMA PHARMACEUTICALS, INC.
WO/2021/178850METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL  AND RELATED SERRULATANE-TYPE DITERPENESBOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/178857ALPHA SUBSTITUTED STAT INHIBITORS AND COMPOSITIONS THEREOFJANPIX, LTD.
WO/2021/178860AMINO ACID COMPOSITIONS AND METHODS FOR MUSCLE AND MYOTUBE  MODULATIONAXCELLA HEALTH INC.
WO/2021/178863METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS  NEPHROPATHYMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/178864TREATMENTS FOR IMPROVING OR LESSENING IMPAIRMENT OF  MITOCHONDRIAL FUNCTIONALLEGRO PHARMACEUTICALS, LLC
WO/2021/178866IRF MODULATOR-EXPRESSING ONCOLYTIC VIRUSES FOR TREATING CANCERUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/178871CANNABIDIOL NANODRUG FORMULATIONS AND METHODS FOR USE THE SAMEUNIVERSITY OF MIAMI
WO/2021/178877PRODUCTION OF VACCINES COMPRISING INACTIVATED SARS-COV-2 VIRAL  PARTICLESTHE COLORADO STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/178878METHODS AND COMPOSITIONS FOR TREATING MUSCLE ATROPHYNELLONE THERAPEUTICS, INC.
WO/2021/1788792019-NCOV SUBUNIT VACCINE AND MICRONEEDLE ARRAY DELIVERY  SYSTEMUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/206833METHODS AND COMPOSITIONS FOR TREATING TISSUE DAMAGE RESULTING  FROM VIRAL INFECTIONSNELLONE THERAPEUTICS, INC.
WO/2021/178886CORONAVIRUS DISEASE (COVID-19) VACCINETHOMAS JEFFERSON UNIVERSITY
WO/2021/178887METHODS, COMPOUNDS, AND COMPOSITIONS FOR MODIFYING CAR-T CELL  ACTIVITYPURDUE RESEARCH FOUNDATION
WO/2021/178890INNATE IMMUNITY KILLER CELLS TARGETING PSMA POSITIVE TUMOR  CELLSSORRENTO THERAPEUTICS, INC.
WO/2021/178891LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN  ANTIGENS AND METHODS OF USE THEREOFUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/178899USE OF CANNABANOIDS IN THE TREATMENT OF PROLIFERATIVE DIABETIC  RETINOPATHYPANIGRAHI, Dipak
WO/2021/178903TREATMENT OF PAIN AND VASOCONSTRICTIONAISA PHARMA, INC.
WO/2021/178907STAT INHIBITORY COMPOUNDS AND COMPOSITIONSJANPIX, LTD.
WO/2021/178920COMPOUNDS FOR TARGETED DEGRADATION OF BRD9C4 THERAPEUTICS, INC.
WO/2021/178930POLYMER IMPLANTSFOUNDRY THERAPEUTICS, INC.
WO/2021/183407NORRIN REGULATION OF PLASMALEMMA VESICLE-ASSOCIATED PROTEIN  AND USE TO TREAT MACULAR DEGENERATIONRETINAL SOLUTIONS, LLC
WO/2021/178949ANTIBODY FRAGMENTS CONJUGATED TO PEG-PLGA NANOPARTICLES  IMPROVE IMMUNOTHERAPY AGAINST CANCER CELLSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/178951TUMOR TARGETED FLUORESCENCE GUIDANCE FOR INTRAOPERATIVE MARGIN  ASSESSMENTH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/183431FEM1B PROTEIN BINDING AGENTS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183433GENE REPLACEMENT THERAPY FOR FOXG1 SYNDROMEUNIVERSITY OF MASSACHUSETTS
WO/2021/178964SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN  SUBJECTS USING MICROCHANNEL DELIVERY DEVICESAQUAVIT PHARMACEUTICALS, INC.
WO/2021/178968COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR  BACTERIAL INFECTIONSENDOLYTIX TECHNOLOGY, INC.
WO/2021/178969COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR  BACTERIAL INFECTIONSENDOLYTIX TECHNOLOGY, INC.
WO/2021/178971VACCINES AGAINST SARS-COV-2 AND OTHER CORONAVIRUSESTHE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF  MILITARY MEDICINE, INC.
WO/2021/178973COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR  (CAR)-MODIFIED CELL MODULATIONALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/178974COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR  BACTERIAL INFECTIONSENDOLYTIX TECHNOLOGY, INC.
WO/2021/178975A METHOD TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS  (CAR-T CELLS) FROM PATHOGEN-SPECIFIC CYTOTOXIC LYMPHOCYTES TO ENABLE THE  SUBSEQUENT IN VIVO MODULATION OF THEIR FUNCTIONAL ACTIVITYALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/178977COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERSUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/183463COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUSPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/194735MODULATION OF MAMMALIAN CELL LINEAGE BY SYNTHETIC IMMODULATOR  PEPTIDESMASCARENHAS, Desmond
WO/2021/183467PROCESS FOR MAKING A WATER SOLUBLE, FULL SPECTRUM HEMP OILNORTHEAST KIND ASSETS, LLC
WO/2021/183469CEREBROSPINAL FLUID ASSAY CONTROL SOLUTIONAMPRION, INC.
WO/2021/183474INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD  STEM CELLS, AND USES RELATED THERETOUNIVERSITY OF HOUSTON SYSTEM
WO/2021/183485HETEROMULTIVALENT SPHERICAL NUCLEIC ACIDS AND USES IN  THERAPEUTIC AND DIAGNOSTIC APPLICATIONSEMORY UNIVERSITY
WO/2021/183505PERSONAL CARE COMPOSITION COMPRISING MANNOSE OLIGOSACCHARIDESCARGILL, INCORPORATED
WO/2021/183533ACTIVE BOOSTER IMMUNIZATION AGAINST TETANUS, DIPHTHERIA AND  PERTUSSISDYNAVAX TECHNOLOGIES CORPORATION
WO/2021/206837A PHARMACEUTICAL COMPOSITION AND ITS USE TO INHIBIT MEMBRANE  ACE2 EXPRESSIONRATH, Matthias, W.
WO/2021/183540SHINGLES VACCINES COMPRISING A TLR9 AGONISTDYNAVAX TECHNOLOGIES CORPORATION
WO/2021/183554MANIPULATING GLYCOGEN IN ALZHEIMER'S DISEASE, EPILEPSY,  TRAUMATIC BRAIN INJURY, AND ALS AS A TREATMENTUNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/183556IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS OF PRODUCTION FOR  CORONAVIRUSADMA BIOLOGICS, INC.
WO/2021/183562SURFACTANTS FOR PERSONAL CARE AND COSMETIC PRODUCTSADVANSIX RESINS & CHEMICALS LLC
WO/2021/183563CORONAVIRUS VACCINE COMPOSITIONS AND METHODSARCTURUS THERAPEUTICS, INC.
WO/2021/183564COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSESARCTURUS THERAPEUTICS, INC.
WO/2021/183582SURFACTANTS FOR HEALTHCARE PRODUCTSADVANSIX RESINS & CHEMICALS LLC
WO/2021/183588LIPOSOME COMPOSITION AND PREPARATION METHOD THEREOFCHUNG YUAN CHRISTIAN UNIVERSITY
WO/2021/183590ANTISEPTIC-ANTIBIOTIC GUMBOS EFFECTIVE AGAINST GRAM-NEGATIVE  PATHOGENSBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/188326SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF  CORONAVIRUS INFECTIONENZO BIOCHEM, INC.
WO/2021/183595ENHANCED EFFICACY OF COMBINATION OF GEMCITABINE AND  PHOSPHATIDYLSERINE-TARGETED NANOVESICLES AGAINST PANCREATIC CANCERUNIVERSITY OF CINCINNATI
WO/2021/183596MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASEUNIVERSITY OF CINCINNATI
WO/2021/183624DELIVERY OF GENE EXPRESSION MODULATING AGENTS FOR THERAPY  AGAINST CANCER AND VIRAL INFECTIONUNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/188334USE OF ST266 TO TREAT SEVERE SYSTEMIC INFLAMMATION AND  POST-ACUTE COVID-19 SYNDROMENOVEOME BIOTHERAPEUTICS, INC.
WO/2021/183628NOVEL MODIFIED TETRACYCLINES FOR TREATMENT OF ALCOHOL USE  DISORDER, PAINT AND OTHER DISORDERS INVOLVING POTENTIAL INFLAMMATORY  PROCESSESTEXAS TECH UNIVERSITY SYSTEM
WO/2021/183640METHODS OF TREATING CANCER USING CHECKPOINT INHIBITORS IN  COMBINATION WITH PURINE CLEAVING ENZYMESEMORY UNIVERSITY
WO/2021/183650METHODS FOR TREATING NEUTROPENIAX4 PHARMACEUTICALS, INC.
WO/2021/183675METHODS FOR GENERATING ENGINEERED MEMORY-LIKE NK CELLS AND  COMPOSITIONS THEREOFMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/183685FUSION MOLECULES OF PSGL-1 OR TSGL ANIONIC DOMAINS TO  CHECKPOINT-MODULATING ANTIBODIES AND OTHER ANTIBODIESSHAW, Gray, D.
WO/2021/183701MICROBIAL CONSORTIA FOR THE TREATMENT OF DISEASEFEDERATION BIO INC.
WO/2021/183702GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND  THEIR USE FOR TREATING GPX4-MEDIATED DISEASESEUBULUS BIOTHERAPEUTICS INC.
WO/2021/183716COMPOSITIONS FOR COLORING HAIR INCLUDING ULTRA-EFFICIENT HIGH  AQUEOUS, MULTI-LAMELLAR EMULSION SYSTEMS, AND METHODS OF MAKING THE SAMECOMBE INCORPORATED
WO/2021/183725USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT  METASTASISASCLEA CORP.
WO/2021/188349METHODS OF TREATING MITOCHONDRIAL DISORDERSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183735PULMONARY AGENT DELIVERY METHODS AND COMPOSITIONS FOR  PRACTICING THE SAMETHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/183740METHODS OF TREATING DIARRHEA OR INFLAMMATORY CONDITIONS OF THE  GUTABBOTT LABORATORIES
WO/2021/183752DAPTOMYCIN FORMULATIONS CONTAINING A COMBINATION OF SORBITOL  AND MANNITOLBAXTER INTERNATIONAL INC.
WO/2021/183760METHODS OF MODULATING T-CELL ACTIVATION USING ESTROGEN  RECEPTOR BETA (ERΒ) AGONISTSOHIO STATE INNOVATION FOUNDATION
WO/2021/183764METHODS OF MODULATING T-CELL ACTIVATION USING CARBORANES AND  CARBORANE ANALOGSOHIO STATE INNOVATION FOUNDATION
WO/2021/183776NK CELLS AND USES THEREOF FOR TREATMENT OF MICROBIAL  INFECTIONSRESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/183779GENE THERAPY FOR NMNAT1-ASSOCIATED RETINAL DEGENERATIONMASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/183780LICHENASE-COVID-19 BASED VACCINEIBIO, INC.
WO/2021/183781METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERSSELECTA BIOSCIENCES, INC.
WO/2021/183790METHOD FOR TREATMENT OF COVID-19-ASSOCIATED CONDITIONSRIGEL PHARMACEUTICALS, INC.
WO/2021/183791WNT/CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOFCITY OF HOPE
WO/2021/183796CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF3+2 PHARMA
WO/2021/183814METABOLITES RELEASED FROM APOPTOTIC CELLS ACT AS NOVEL TISSUE  MESSENGERSUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/183819SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR  TREATING RENAL DISEASES OR CONDITIONSACCELERON PHARMA INC.
WO/2021/183830METHODS FOR TREATING FIBROSIS USING PKM2 ACTIVATORSPRODA BIOTECH L.L.C.
WO/2021/183832INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND METHODS OF USE  THEREOFAMBRX, INC.
WO/2021/183850COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACIDTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183851HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOFOSIRIS THERAPEUTICS, INC.
WO/2021/183863METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS  INFECTIONCONSTANT THERAPEUTICS LLC
WO/2021/202084TREATING PULMONARY INFLAMMATORY DISEASE ASSOCIATED WITH  COVID-19 BY ADMINISTERING RESINIFERATOXINSORRENTO THERAPEUTICS, INC.
WO/2021/183873SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-DG, CHECKPOINT  INHIBITORS AND RADIATION THERAPYTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/183884COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACIDTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183908GPX4 COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATMENT USING  SAMETHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/183910GENERATION OF AUTOIMMUNE INHIBITORY T CELLS BY FIBROBLAST  MEDIATED EDUCATIONFIGENE, LLC
WO/2021/183913FENTANYL HAPTENS, FENTANYL HAPTEN CONJUGATES, AND METHODS FOR  MAKING AND USINGREGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/183918METHODS OF TREATING ILLNESSES CAUSED BY CORONAVIRUS, SWINE FLU  AND AVIAN FLUCMTX BIOTECH INC.
WO/2021/183928ASSESSING AND TREATING ACUTE DECOMPENSATED HEART FAILUREMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/183931TARGETED NANOBUBBLE THERAPYCASE WESTERN RESERVE UNIVERSITY
WO/2021/183934A COMBINATION THERAPY WITH NIROGACESTAT AND A BCMA-DIRECTED  THERAPY AND USES THEREOFSPRINGWORKS THERAPEUTICS, INC.
WO/2021/188387COMBINATION THERAPY FOR ACUTE MYELOID LEUKEMIACELGENE CORPORATION
WO/2021/183937SUBSTITUTED ISOXAZOLES AS SELECTIVE NAV1.7 INHIBITORS FOR PAIN  TREATMENT AND METHOD OF PAIN TREATMENTBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/183942INHIBITORS OF HSP70 PROTEINSARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/188388USE OF CANNABIDIOL IN TREATING ANTI-DEPRESSANT-INDUCED FEMALE  SEXUAL DYSFUNCTIONVELLA BIOSCIENCE, INC.
WO/2021/188390COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL  MUSCULAR DYSTROPHYAVIDITY BIOSCIENCES, INC.
WO/2021/183983A METHOD FOR CONTROLLING CLOSTRIDIUM INFECTION IN ANIMALSKEMIN INDUSTRIES, INC.
WO/2021/188409TREATMENT OF CYTOKINE RELEASE SYNDROME WITH GM-CSF ANTAGONISTSKINIKSA PHARMACEUTICALS, LTD.
WO/2021/188415ANDROGEN RECEPTOR MODULATORSTRUSTEES OF DARTMOUTH COLLEGE
WO/2021/183995COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF VIRAL  DISORDERSFURST-MCNESS COMPANY
WO/2021/230973COMPOUNDS FOR THE TREATMENT OF SARSGHOSH, Arun K.
WO/2021/184008PROBIOTIC COMPOSITIONS FOR IMPROVING HUMAN HEALTH AND ATHLETIC  PERFORMANCEFITBIOMICS INC.
WO/2021/184009KIR 7.1 GENE THERAPY VECTORS AND METHODS OF USING THE SAMEWISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/184010NOVEL NANO-FORMULATION OF CANNABIDIOL (CBD) AND OTHER  CANNABINOIDS FOR TREATMENT OF OCULAR DISORDERSMILANE, Michael
WO/2021/188448STABILIZATION OF COMPOUNDS AS CYCLODEXTRIN COMPLEXESUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/188450NLRP3 MODULATORSZOMAGEN BIOSCIENCES LTD
WO/2021/184014STABLE REACTIVE COMPOSITIONS FOR BIOCONJUGATION, PROBES, AND  PROTEIN LABELINGARIZONA BOARD OF REGETNS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/184017EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERSCODIAK BIOSCIENCES, INC.
WO/2021/184022TARGETED DELIVERY OF EXTRACELLULAR VESICLESCODIAK BIOSCIENCES, INC.
WO/2021/188467COMPOSITIONS AND METHODS OF TREATING GLIOMATHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146740SOLUTION AND METHOD FOR REDUCING THE VIRULENCE OF MICROBESCHANGARIS, David, G.
WO/2021/188473DELTA OPIOID RECEPTOR ANTAGONISTS REPROGRAM IMMUNOSUPPRESSIVE  MICROENVIRONMENT TO BOOST IMMUNOTHERAPYH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/188500MULTI-OMIC ANALYSIS IN MONODISPERSE DROPLETSFLUENT BIOSCIENCES INC.
WO/2021/188504INJECTABLE FORMULATION OF POLY(LACTIC-CO-GLYCOLIC (PLGA))  MICROSPHERES ENCAPSULATING SILTUXIMABFLOW PHARMA, INC.
WO/2021/188517CONTINUOUS MELT-COATING OF ACTIVE PHARMACEUTICAL INGREDIENTS  USING SURFACTANTS FOR DISSOLUTION ENHANCEMENTRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/188518PERSISTANT TOPICAL ANTIMICROBIAL COMPOSITIONS AND METHODS OF  USING THE SAMEBLUEWILLOW BIOLOGICS, INC.
WO/2021/188520METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING  THE OCCURRENCE OF VIRAL INFECTIONGLOBAL BIOLIFE INC.
WO/2021/188537SELECTIVE SMALL MOLECULE DEGRADERS OF CEREBLONDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/1885635-HT3 RECEPTOR MODULATOR, THE CRYSTALLINE FORM, METHODS OF  MAKING, AND USE THEREOFCHENGDU SCIMOUNT PHARMATECH CO., LTD.
WO/2021/188564METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUNDFIRST WAVE BIO, INC.
WO/2021/188575DIETARY SUPPLEMENT COMPRISING ALDEHYDE FUNCTIONAL  MONOTERPENOIDSCOE, William, B.
WO/2021/188578SCREENING METHODS TO IDENTIFY SMALL MOLECULE COMPOUNDS THAT  PROMOTE OR INHIBIT THE GROWTH OF CIRCULATING TUMOR CELLS, AND USES THEREOFUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/188580RAPID DIAGNOSTIC TESTDETECT, INC.
WO/2021/188586METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE  MONOSACCHARIDES AND ANALOGS THEREOFBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/188592RADIONUCLIDE TRACERS OF  1-AMINO-3,4-DIFLUOROCYCLOPENTANE-1-CARBOXYLIC ACID, DERIVATIVES, AND USES  THEREOFEMORY UNIVERSITY
WO/2021/188599NOVEL ANTIGEN BINDING DOMAINS AND SYNTHETIC ANTIGEN RECEPTORS  INCORPORATING THE SAMEUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/194804HAIR CARE FORMULATIONROHM AND HAAS COMPANY
WO/2021/194805HAIR CLEANSERROHM AND HAAS COMPANY
WO/2021/194806SKIN CLEANSING FORMULATIONDOW GLOBAL TECHNOLOGIES LLC
WO/2021/188606OXAZOLIDINONE COMPOUND AND METHODS OF USE THEREOF AS AN  ANTIBACTERIAL AGENTMERCK SHARP & DOHME CORP.
WO/2021/194807HAIR CLEANSING FORMULATIONROHM AND HAAS COMPANY
WO/2021/194809HAIR OIL FORMULATIONDOW GLOBAL TECHNOLOGIES LLC
WO/2021/206877INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATIONCOCRYSTAL PHARMA, INC.
WO/2021/188616DESIGNER EXTRACELLULAR VESICLES FOR TREATING EXCITOTOXICITYOHIO STATE INNOVATION FOUNDATION
WO/2021/188618BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE  CATABOLISM OF LEUCINESYNLOGIC OPERATING COMPANY, INC.
WO/2021/188619HETEROCLITIC CANCER VACCINESMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/188630COMBINATION TUMOR TREATMENTBOSTON SCIENTIFIC SCIMED, INC.
WO/2021/188631ANTI-IL4 RECEPTOR ANTIBODIES FOR VETERINARY USEKINDRED BIOSCIENCES, INC.
WO/2021/188659HELICAL STAPLED PEPTIDES AND USES THEREOFFOG PHARMACEUTICALS, INC.
WO/2021/188667TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER  PBB3DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/188681COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND  APPLICATIONS THEREOFCELLULAR BIOMEDICINE GROUP HK LIMITED
WO/2021/188688FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASEMETACRINE, INC.
WO/2021/188690FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASEMETACRINE, INC.
WO/2021/188692CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONISTMETACRINE, INC.
WO/2021/188695FORMULATIONS OF A FARNESOID X RECEPTOR AGONISTMETACRINE, INC.
WO/2021/188696STAT DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/202103METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTIONPHOENIX BIOTECHNOLOGY, INC.
WO/2021/188709TREATING SARS-COV-2 INFECTED SUBJECTS WITH SMALL MOLECULE  COMPOUNDSANIVIVE LIFESCIENCES, INC.
WO/2021/188742EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR  PROLONGED DRUG RELEASEBLAESI, Aron, H.
WO/2021/188745METHOD AND APPARATUS FOR 3D-MICRO-PATTERNINGBLAESI, Aron, H.
WO/2021/188753OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTSCARA THERAPEUTICS, INC.
WO/2021/188761MODIFIED ARRESTIN-1 TO ENHANCE PHOTORECEPTOR SURVIVAL IN  RETINAL DISEASEUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/188770ANTI-CERAMIDE ANTIBODIESMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/188772COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN  ASSOCIATED WITH MALIGNANT GROWTH DISORDERDUKE UNIVERSITY
WO/2021/188773SOFTGEL CAPSULESR.P. SCHERER TECHNOLOGIES, LLC
WO/2021/188802MOLECULAR TRANSPORT SYSTEM TO THE CENTRAL NERVOUS SYSTEMBROWN, Kathlynn C.
WO/2021/188809INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL  TARTRATEHUANG, Cai Gu
WO/2021/188812CRYSTALLINE NORPSILOCIN COMPOUNDSCAAMTECH, INC.
WO/2021/188815INHALATIONAL THERAPY FOR COVID-19MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/188818VACCINE CONSTRUCTS AND COMPOSITIONS AND METHODS OF USE THEREOFTHE UNITED STATES OF AMERICA AS represented by THE SECRETARY  OF THE NAVY
WO/2021/188828METHODS FOR TREATING CANCER BY INHIBITING CARM1DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/188831ANTIBODY GENE EDITING IN B LYMPHOCYTES AND CO-EXPRESSION OF  CARGO PROTEINTHE ROCKEFELLER UNIVERSITY
WO/2021/188835MULTIVALENT CHEMOKINE RECEPTOR BINDING COMPLEXESCITY OF HOPE
WO/2021/188836UPREGULATION OF CATHELICIDIN GENE EXPRESSION AS AN ADJUVANT TO  OTHER TREATMENTS FOR DISEASESBARRON, Annelise E.
WO/2021/188837PROPHYLAXIS AND TREATMENT OF PATHOGENIC CORONAVIRUS INFECTIONSTHE JOHNS HOPKINS UNIVERSITY
WO/2021/188841GENE SILENCING AGENTS FOR TARGETING CORONAVIRUS GENES AND USES  THEREOFQIANGXIN INSTITUTE OF TECHNOLOGY
WO/2021/188844INJECTABLE BOTULINUM TOXIN METHODS FOR TREATING HEADACHESREVANCE THERAPEUTICS, INC.
WO/2021/188849METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND  FIBROTIC PULMONARY DISORDERSUNIVERSITY OF HOUSTON SYSTEM
WO/2021/188855SYMBIOTIC PRODRUGS FOR THE TREATMENT OF CANCER AND OTHER  DISEASESBOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
WO/2021/188865CANNABINOID MEDICAL CARRIERNEW YORK MEDICAL COLLEGE
WO/2021/188866RIBONUCLEASES FOR TREATING VIRAL INFECTIONSORGENESIS INC.
WO/2021/188870PSILOCYBIN AND PSILOCIN CONTAINING COMPOSITIONS AND METHODS OF  USING AND MAKING THE SAMEORTHOGONAL THINKER, INC.
WO/2021/188871SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4TRUSTEES OF BOSTON UNIVERSITY
WO/2021/188880BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES  THEREOFAMATHUS THERAPEUTICS, INC.
WO/2021/188882SULFATED GLYCOSAMINOGLYCAN BIOMATERIALS AS PROTEOGLYCAN MIMICSGLYCOLOGIX, LLC
WO/2021/188883METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASE  USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/188886ANTIMICROBIAL COMPOSITIONS AND METHODSCREDO SCIENCE, LLC
WO/2021/188887COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL  CANCERSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/236222COMPOSITIONS AND METHODS FOR PREVENTING POST-ERCP PANCREATITISTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/188899CARDIOSPHERE-DERIVED CELL (CDC) THERAPY FOR THE TREATMENT OF  VIRAL INFECTIONSCEDARS-SINAI MEDICAL CENTER
WO/2021/188906NOVEL MRNA-BASED COVID-19 MULTI-VALENT VACCINE AND METHODS OF  SCALED PRODUCTION OF THE SAMENATURE'S TOOLBOX, INC.
WO/2021/188907PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES  THEREOFAMATHUS THERAPEUTICS, INC.
WO/2021/188910NRTIS, NRTI METABOLITES, AND NRTI ANALOGS FOR MACULAR  DEGENERATION AND VIRAL INFECTIONSUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/188911CYCLIC SULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES  THEREOFAMATHUS THERAPEUTICS, INC.
WO/2021/188915METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS  INFECTIONTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/188948MDM2 DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/1889493-DIARYLMETHYLENES AND USES THEREOFATUX ISKAY LLC
WO/2021/194890HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A  RESPIRATORY VIRUSATOSSA THERAPEUTICS, INC.
WO/2021/188966SARS-COV-2 SPIKE PROTEIN BINDING PEPTIDESMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/188969CORONAVIRUS VACCINES AND METHODS OF USEBIONTECH US INC.
WO/2021/236225METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIESTAKEDA VACCINES, INC.
WO/2021/188977ION SELECTIVE MEMBRANES FOR ORGANIC ELECTROCHEMICAL PROCESSESUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/188978PHOTOREACTIVE AND CLEAVABLE PROBES FOR TAGGING BIOMOLECULESACADEMIA SINICA
WO/2021/188983CANNABINOID COMPOSITIONSTHE QUEEN'S MEDICAL CENTER
WO/2021/188991HAPTENIZED CORONAVIRUS SPIKE PROTEINSBIOVAXYS INC.
WO/2021/194906NEURONAL DIENCEPHALON STEM CELLS AND EXOSOMES THEREOF FOR THE  TREATMENT AND PREVENTION OF DISEASESFLORICA THERAPEUTICS, INC.
WO/2021/189004CAR PEPTIDE FOR IMPROVED CORONAVIRUS SURVIVALVASCULAR BIOSCIENCES
WO/2021/189006METHODS OF USING ACTIVIN RECEPTOR TYPE IIA VARIANTSKEROS THERAPEUTICS, INC.
WO/2021/189010METHODS OF USING ACTIVIN RECEPTOR TYPE IIB VARIANTSKEROS THERAPEUTICS, INC.
WO/2021/189013METHODS AND COMPOSITIONS FOR TREATING ACUTE LUNG INJURY AND  ACUTE RESPIRATORY DISTRESS SYNDROMECALCIMEDICA, INC.
WO/2021/189017STABLE POLYMORPHIC COMPOSITIONS OF BREQUINAR SODIUM AND  METHODS OF USE AND MANUFACTURE THEREOFCLEAR CREEK BIO, INC.
WO/2021/189018METHODS OF TREATING VIRAL INFECTIONS USING INHIBITORS OF  NUCLEOTIDE SYNTHESIS PATHWAYSCLEAR CREEK BIO, INC.
WO/2021/189019ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOFKEROS THERAPEUTICS, INC.
WO/2021/194918METHODS OF TREATING PULMONARY INJURY WITH CGRP INHIBITORSBIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
WO/2021/189032CORONAVIRUS: EARLY DETECTION AND TREATMENTYU, Ruey, J.
WO/2021/194919COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS  (TTFIELDS)THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/194927COMPOSITION OF ANTIVIRAL AGENT FOR USE IN PROPHYLACTIC OR  POST-EXPOSURE TREATMENT OF INFECTIOUS OR RESPIRATORY DISEASESTLC BIOPHARMACEUTICALS, INC.
WO/2021/194929METHODS, SYSTEMS AND APPARATUS FOR REDUCING PATHOGEN LOADS IN  CIRCULATING BODY FLUIDSMI2 HOLDINGS LLC
WO/2021/189036TAF1 INHIBITORSH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/194938UNIVERSAL NANOSPONGE FOR TREATING RESPIRATORY VIRAL INFECTIONTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/194940SARS-COV-2-SPECIFIC T CELLS AND METHODS OF TREATMENT USING  THEMCHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/194946COMBINATION THERAPY WITH A MUTANT IDH INHIBITORELI LILLY AND COMPANY
WO/2021/194948COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR CONDITIONSEYEGATE PHARMACEUTICALS, INC.
WO/2021/236227METHODS FOR TREATING PLASMA PROTEIN IMBALANCES OR DEPLETIONOHIO STATE INNOVATION FOUNDATION
WO/2021/194950COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR AND A BCL-2  INHIBITORELI LILLY AND COMPANY
WO/2021/194953METHOD FOR TREATING IDH1 INHIBITOR-RESISTANT SUBJECTSELI LILLY AND COMPANY
WO/2021/194954SUBSTITUTED AZOLE DIONE COMPOUNDS WITH ANTIVIRAL ACTIVITYSTEMLINE THERAPEUTICS, INC.
WO/2021/194959TREATMENT OF EYE DISORDERS WITH URIDINE PHOSPHATE DERIVATIVESGLIAGUARD, INC.
WO/2021/202144METHODS FOR TREATMENT OF VIRAL INFECTIONSELYSIUM HEALTH INC.
WO/2021/189046COMPOSITIONS AND METHODS FOR TREATMENT OF SARS-COV-2UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/194970METHODS OF PREVENTING AND TREATING COVID-19 INFECTIONHAZAN, Sabine
WO/2021/194975METHOD FOR TREATING DIABETESOLATEC THERAPEUTICS LLC
WO/2021/194982POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/194983COMPOSITIONS AND TREATMENTS FOR ISCHEMIC INJURIESUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/189051ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERSUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/194991USE OF LOSMAPIMOD FOR TREATMENT OF COVID-19FULCRUM THERAPEUTICS, INC.
WO/2021/194992RECOMBINANT VIRUSES, INSECT CELLS AND THEIR USES IN VIRAL  DETECTION AND VACCINATIONACADEMIA SINICA
WO/2021/189056SARS-CORONAVIRUS 2 (SARS-COV-2) SUBUNIT VACCINE CANDIDATESKANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/194994SPRAYABLE FILM FORMING COMPOSITIONS FOR IMPROVING THE  PERFORMANCE OF TOPICAL PREPARATIONSELC MANAGEMENT LLC
WO/2021/195011IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF VIRAL  RESPIRATORY INFECTIONINTRINSIC MEDICINE, INC.
WO/2021/195016COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY  CONTACT LENS MEDIATED DRUG DELIVERYEYEGATE PHARMACEUTICALS, INC.
WO/2021/195017IODINE COMPOUNDS FOR TREATING RESPIRATORY PATHOGENSIOCURE, INC.
WO/2021/195020METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING FIBROSIS  RESULTING FROM A CORONAVIRUS INFECTIONG3 PHARMACEUTICALS, INC.
WO/2021/202156MATTIFYING NAIL COMPOSITIONSL'OREAL
WO/2021/195024ADJUVANT COMPOUNDS, SALT FORMS, AND FORMULATIONSADJUVANCE TECHNOLOGIES, INC.
WO/2021/195036TNFAIP3 AS A BIOMARKER FOR AUTOIMMUNE DISEASESTHE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/195039METHODS OF TREATING OR PREVENTING A VIRAL INFECTION USING  BACTERIOPHAGESCHEN, Shu-Chih
WO/2021/195064CELL ACTIVATABLE IRON CHELATORSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/195069CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES AND ASSOCIATED  IMMUNOMODULATORY CELLS FOR TREATING ASPERGILLOSISATARA BIOTHERAPEUTICS, INC.
WO/2021/195108T CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOFCUE BIOPHARMA, INC.
WO/2021/195113COMPOSITIONS AND METHODS FOR TARGETING CORONAVIRUS USING LIPID  VESICLES INCLUDING EXOSOMESBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/195119METHODS OF REDUCING THE RISK OF, SEVERITY OF, AND TREATING  CORONAVIRUS INFECTIONSCORCEPT THERAPEUTICS INCORPORATED
WO/2021/195124STRESS TEST AND TREATMENT OF CHRONIC KIDNEY DISEASERENIBUS THERAPEUTICS, INC.
WO/2021/195126ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONSBURNET, Michael, W.
WO/2021/195128EIF4A INHIBITOR COMBINATIONSEFFECTOR THERAPEUTICS, INC.
WO/2021/195131FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOFFUSION PHARMACEUTICALS INC.
WO/2021/195137CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USING SAMELOYOLA UNIVERSITY OF CHICAGO
WO/2021/195163OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOROCULAR THERAPEUTIX, INC.
WO/2021/202183QTY FC FUSION WATER SOLUBLE GPCR PROTEINSMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/195173SOLID CANNABINOID FORMULATION FOR ORAL ADMINISTRATIONMOLECULAR INFUSIONS, LLC
WO/2021/195176PROCESSES AND AGENTS FOR GLAUCOMAAUFBAU MEDICAL INNOVATIONS LIMITED
WO/2021/195182ANTIPERSPIRANT AND DEODORANT COMPOSITIONS FOR INCREASED SKIN  LUBRICITYTHE PROCTER & GAMBLE COMPANY
WO/2021/195185METHOD OF TREATING CORONAVIRUS INFECTION BY ADMINISTRATION OF  ETHYL MERCURY OR THIOL DERIVATIVE THEREOFBEECH TREE LABS, INC.
WO/2021/195198FAP-TARGETED RADIOPHARMACEUTICALS AND IMAGING AGENTS, AND USES  RELATED THERETOTRUSTEES OF TUFTS COLLEGE
WO/2021/195205TREATMENT OF LOWER RESPIRATORY TRACT INFECTION WITH  TRADIPITANTVANDA PHARMACEUTICALS INC.
WO/2021/195209MORPHINAN ISOMERS AND THEIR STRUCTURAL MODIFICATIONS AS NMDAR  ANTAGONISTS AND NEUROPLASTOGENSUNIVERSITY OF PADOVA
WO/2021/195236BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF  TREATING MICROBIAL CO-INFECTIONSMICROBION CORPORATION
WO/2021/195254PROTEIN KINASE C MODULATORSYOUNG THERAPEUTICS, LLC
WO/2021/195256PHARMACEUTICAL PREPARATIONAERIE PHARMACEUTICALS, INC.
WO/2021/195260LPXC INHIBITOR AND METHODS OF MAKINGFORGE THERAPEUTICS, INC.
WO/2021/195265METHODS FOR TREATING DISEASES ASSOCIATED WITH RESPIRATORY  VIRUSESAMPIO PHARMACEUTICALS, INC.
WO/2021/202208TARGETED DEGRADATION OF THE ONCOGENIC MICRORNA 17-92 CLUSTER  BY STRUCTURE-TARGETING LIGANDSTHE SCRIPPS RESEARCH INSTITUTE
WO/2021/195286COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING  CORONAVIRUSESSVENSKA VACCINFABRIKEN PRODUKTION AB
WO/2021/195295BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOFFLAGSHIP PIONEERING, INC.
WO/2021/195297USE OF AGENTS FOR TREATMENT OF RESPIRATORY CONDITIONSSAGE THERAPEUTICS, INC.
WO/2021/195300INHALED INTERFERONS FOR VIRAL RESPIRATORY INFECTIONSTHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/195301USE OF GABA<sb>A</sb> MODULATORS FOR TREATMENT OF  RESPIRATORY CONDITIONSSAGE THERAPEUTICS, INC.
WO/2021/195308USE OF PHYCOBILIPROTEIN (PBP) TO INHIBIT OR TREAT SARS-COV-2  INFECTIONBACK OF THE YARDS ALGAE SCIENCES LLC
WO/2021/195319PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION  AND- METHODS FOR MAKING AND USING SAMEPLX OPCO INC.
WO/2021/195325ANTI-CORONAVIRUS COMPOSITIONS, ASSAYS, AND METHODS RELATED  THERETOTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/195326HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY  SYNDROME CORONAVIRUS 2 (SARS-COV-2)VANDERBILT UNIVERSITY
WO/2021/195344COMPOSITIONS AND METHODS FOR DIABETES TREATMENTTHE GENERAL HOSPITAL CORPORATION
WO/2021/195346LIPOXYGENASE INHIBITORSSRI INTERNATIONAL
WO/2021/202232CELL IMMUNOTHERAPY FOR THE TREATMENT OF CANCERBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/195367HAIR CARE COMPOSITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/195372LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL  DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITYNUTRIVERT LLC
WO/2021/195390METHOD FOR TREATING CANCERTHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/195395BETA-ARRESTIN COMPOSITIONS AND ASSOCIATED METHODSDUKE UNIVERSITY
WO/2021/195401TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONSBIOHAVEN THERAPEUTICS LTD.
WO/2021/195406NEW THERAPEUTIC USES OF COMPOUNDSPROXIMAGEN, LLC
WO/2021/195410RECOMBINANT MULTIVALENT INFLUENZA VIRUSESWISCONSIN ALUMNI RESEARCH FOUNDATION (WARF)
WO/2021/195411T-CELL MODULATORY MULTIMERIC POLYPEPTIDES WITH CONJUGATION  SITES AND METHODS OF USE THEREOFCUE BIOPHARMA, INC.
WO/2021/202245VIRAL TREATMENT REGIMENSEGACEUTICAL CORPORATION
WO/2021/195425ISOTOPICALLY-LABELLED TRAPIDIL DERIVATIVESSINOPIA BIOSCIENCES, INC.
WO/2021/195426HYPOIMMUNOGENIC NEURAL CELLS FOR THE TREATMENT OF NEUROLOGICAL  DISORDERS AND CONDITIONSSANA BIOTECHNOLOGY, INC.
WO/2021/1954272-BROMO-LYSERGIC ACID DIETHYLAMIDE FOR SUBSTANCE ABUSECH TAC, LLC
WO/2021/195431INHALED XENON THERAPY IN NEURODEGENERATIVE DISEASETHE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/195435TREATMENT OF RESPIRATORY DISORDERSTERNS, INC.
WO/2021/195439ENTERIC NITRERGIC NEURONS AND METHODS OF USING THE SAMETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247124COMPOSITION, SYSTEM AND METHOD FOR A PIG CONTRACEPTIVECORONA FEED ADDITIVES, L.L.C.
WO/2021/195442COMPOSITIONS AND METHODS FOR TREATING CLONAL HEMATOPOIESISPRESIDENT AND FELLOWS HARVARD COLLEGE
WO/2021/195445HYDROPHOBIC SILK FIBROIN COMPOSITIONS AND METHODS OF MAKING  THE SAMETRUSTEES OF TUFTS COLLEGE
WO/2021/195452USE OF OLIGOCHITOSANS AND DERIVATIVES THEREOF FOR NEUTRALIZING  VIRAL AGENTSMOHAPATRA, Subhra
WO/2021/202254FACTOR XI ACTIVATION INHIBITORSMERCK SHARP & DOHME CORP.
WO/2021/206930COMPOSITIONS AND METHODS FOR TREATING ONE OR MORE AILMENTS  WITH A NASAL RINSE COMPRISING N-ACETYLCYSTEINEPACIFIC SINUS SOLUTIONS LLC
WO/2021/221836COMPOSITION OF SCALABLE THYROINTEGRIN ANTAGONISTS WITH  IMPROVED BLOOD BRAIN BARRIER PENETRATION AND RETENTION IN BRAIN TUMORSNANOPHARMACEUTICALS, LLC
WO/2021/195465TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND RELATED  CONDITIONS WITH ANTAGONISTS OF E-SELECTINMAGNANI, John L.
WO/2021/195467RNAi AGENTS FOR INHIBITING EXPRESSION OF PNPLA3,  PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USEARROWHEAD PHARMACEUTICALS, INC.
WO/2021/195469COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHYAVIDITY BIOSCIENCES, INC.
WO/2021/195475PROCESS, COMPOSITIONS, AND CRYSTALLINE FORMS OF SUBSTITUTED  PYRIDINONE-PYRIDINYL COMPOUNDSACLARIS THERAPEUTICS, INC.
WO/2021/195477KETONE ESTER AS A THERAPEUTIC TREATMENT OF COVID-19, LONG  COVID, AND RELATED VIRAL INFECTIONSKETONEAID, INC.
WO/2021/195493DEVICES, SYSTEMS, AND METHODS FOR TREATING SEPSIS AND/OR VIRAL  INFECTIONADVANCED COOLING THERAPY, INC.
WO/2021/195496NOVEL ANUCLEATED CELLS AND USES THEREOFPLATELET BIOGENESIS, INC.
WO/2021/195507METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONSACLARIS THERAPEUTICS, INC.
WO/2021/195510DUAL-ACTING SIRNA BASED MODULATION OF  <i>C9ORF72</i>UNIVERSITY OF MASSACHUSETTS
WO/2021/195521METHODS OF TREATING CORONAVIRUS INFECTIONSACER THERAPEUTICS INC.
WO/2021/195522COMPOSITIONS AND METHODS RELATING TO PIGMENTATIONALASTIN SKINCARE, INC.
WO/2021/202286COMPOSITIONS AND METHODS FOR TREATING AUTONOMIC DYSREFLEXIADIGNIFY THERAPEUTICS, LLC
WO/2021/195540CANNABINOID BASED COMPOSITION FOR MITIGATION OF VIRAL EFFECTSRADIENT TECHNOLOGIES INNOVATIONS INC.
WO/2021/195544NOVEL ANUCLEATED CELLS FOR THE TREATMENT OF DISEASESPLATELET BIOGENESIS, INC.
WO/2021/202305METHOD FOR PREVENTING OR TREATING LUNG INFECTION AND LUNG  INFLAMMATIONOLATEC THERAPEUTICS LLC
WO/2021/195553LYTIC DOMAIN FUSION CONSTRUCTS, CHECKPOINT INHIBITORS, AND  METHODS OF MAKING AND USING SAMEESPERANCE PHARMACEUTICALS, INC
WO/2021/195559METHODS FOR GENERATING IMMUNE RESPONSES AGAINST CANCER  ANTIGENS USING MICROCHANNEL DELIVERY DEVICESAQUAVIT PHARMACEUTICALS, INC.
WO/2021/195562ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF  IMMUNE CONDITIONSACLARIS THERAPEUTICS, INC.
WO/2021/195573TREATMENT OF SOLID CANCEROUS TUMORS BY ORAL ADMINISTRATION OF  A HALOGENATED XANTHENEPROVECTUS PHARMATECH, INC.
WO/2021/195577COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS,  ENHANCING DRUG POTENCY AND TREATING VIRAL INFECTIONS, AND METHODS FOR MAKING  AND USING SAMEPERSEPHONE BIOSCIENCES, INC.
WO/2021/195580PREVENTION AND TREATMENT OF CORONAVIRUS-ASSOCIATED DISEASES  USING AN APELIN PEPTIDE AND FORMULATIONS THEREOFCHAN, John
WO/2021/195581AEROSOLIZED FORMULATIONS OF AN APELIN PEPTIDE AND USES THEREOFCHAN, John
WO/2021/195582METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT  USING MEDICAL ICE SLURRYSTEFATER, James Anthony, III
WO/2021/195589METHOD FOR TREATING THERAPY-RESISTANT MUC4+ CANCERCONSEJO NACIONAL DE INVESTIGACIONES CIENTíFICAS Y TéCNICAS
WO/2021/195590ORAL CARE COMPOSITIONS AND METHODS OF USECOLGATE-PALMOLIVE COMPANY
WO/2021/195594COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING  INFECTIONSSAN DIEGO STATE UNIVERSITY (SDSU) FOUNDATION, DBA SAN DIEGO  STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/195598DEGRADER-ANTIBODY CONJUGATES AND METHODS OF USING SAMEANGIEX, INC.
WO/2021/195602ALZHEIMER'S DIAGNOSTIC METHODTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/202317NOVEL METHODS OF USING NITRIC OXIDE DONOR COMPOUNDS FOR  TREATMENT OF COVID-19 AND OTHER INFECTIOUS DISEASESCOEURATIVE, INC.
WO/2021/202320METHODS FOR TREATING INFLAMMATORY AND FIBROTIC DISEASES AND  DISORDERSYALE UNIVERSITY
WO/2021/202321PREVENTATIVE TREATMENT OF MIGRAINEBIOHAVEN PHARMACEUTICAL IRELAND DAC
WO/2021/236231COPPER ION COMPOSITIONS AND METHODS OF TREATMENT FOR  CONDITIONS CAUSED BY CORONAVIRUS AND INFLUENZACDA RESEARCH GROUP, INC.
WO/2021/195605VACCINE FORMULATION TO PROTECT AGAINST PERTUSSISWEST VIRGINIA UNIVERSITY
WO/2021/202329TRANSDERMAL DELIVERY OF DEXTROMETHORPHANSHINKEI THERAPEUTICS LLC
WO/2021/202332AQUEOUS FORMULATIONS CONTAINING POVIDONE IODINE FOR EFFECTIVE  TREATMENT AND PREVENTION OF VIRUS INFECTIONSIVIEW THERAPEUTICS, INC.
WO/2021/195613HIGH-EFFICIENCY GOLD RECOVERY WITH CUCURBIT[6]URILNORTHWESTERN UNIVERSITY
WO/2021/202354IL-2/IL-15 COMPOSITIONS AND METHODS OF USE THEREOFPROVIVA THERAPEUTICS (HONG KONG) LIMITED
WO/2021/195619FEED MITIGANT COMPOSITIONS FOR INACTIVATING SWINE VIRUSES AND  RELATED METHODSRALCO NUTRITION, INC.
WO/2021/202361ENGINEERED BACTERIA FOR USE IN VACCINE COMPOSITIONSNORTH CAROLINA STATE UNIVERSITY
WO/2021/202363COMBINED ANIMAL-DERIVED AND SYNTHETICALLY PRODUCED PANCREATIC  ENZYME REPLACEMENT THERAPYWALL, Jai
WO/2021/202376METHOD FOR BLOCKING UPTAKE OF PROSTATE-SPECIFIC MEMBRANE  ANTIGEN (PSMA)-TARGETED RADIONUCLIDES BY EXOCRINE ORGANSTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/202381METHODS AND COMPOSITIONS FOR MODULATING LIPID STORAGE IN  ADIPOSE TISSUEMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/195627METHOD OF TREATMENT FOR ANOREXIA NERVOSA, BULIMIA AND RELATED  CLINICAL SYNDROMESHOMEOSTASIS THERAPEUTICS, LIMITED
WO/2021/202399METHODS OF TREATING CORONAVIRUS INFECTIONS USING  ANGIOTENSIN-CONVERTING ENZYME 2 INHIBITORSKUMUDA, INC.
WO/2021/202400PERSONAL CARE COMPOSITIONSCOLGATE-PALMOLIVE COMPANY
WO/2021/202413SYSTEMS, METHODS, AND COMPOSITIONS FOR INFECTIONSOJAI ENERGETICS PBC
WO/2021/202414MULTIANALYTE TEST FOR IMMUNE RESPONSE TO SARS-COV-2 VIRUS  LEADING TO COVID-19RUSH UNIVERSITY MEDICAL CENTER
WO/2021/202419USE OF BUPROPION AND DEXTROMETHORPHAN COMBINATIONS FOR  TREATING NEUROLOGICAL DISORDERSANTECIP BIOVENTURES II LLC
WO/2021/195636MICROBIOME-BASED THERAPEUTICSCORNELL UNIVERSITY
WO/2021/202421METHODS FOR INTEGRATING DNA INTO GENES WITH GAIN-OF-FUNCTION  OR LOSS-OF-FUNCTION MUTATIONSBLUEALLELE, LLC
WO/2021/202429METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19ESRAIL MEDICAL CORP.
WO/2021/202437METHODS AND PHARMACEUTICAL COMPOSITIONS OF THROMBOXANE A2  RECEPTOR ANTAGONIST FOR THE TREATMENT OF COVID-19OGLETREE, Martin
WO/2021/202449NANOPARTICLE-LOADED SILICIFIED CELLS, METHODS OF MAKING, AND  METHODS OF USEUNM RAINFOREST INNOVATIONS
WO/2021/202456SYNTHETIC SOLUBLE RECEPTOR MIMICS AND METHODS OF USE FOR  TREATMENT OF COVID-19THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/202459COMPOSITIONS AND METHODS RELATING TO EXOSOMES DERIVED FROM  HUMAN DERMAL PAPILLA CELLSNORTH CAROLINA STATE UNIVERSITY
WO/2021/202478PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORSIGIA PHARMACEUTICALS, INC.
WO/2021/202481COMPOSITIONS AND METHODS FOR INHIBITING TYPE 1 COLLAGEN  PRODUCTIONFLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/202493CERAMIDE CONTAINING CAPSULES, CERAMIDE COMPOSITIONS, AND  COSMETIC COMPOSITIONS THEREOFL'OREAL
WO/2021/206955MACROCYCLIC COMPOUNDS AS KINASES INHIBITORS AND USES THEREOFANGEX PHARMACEUTICAL, INC.
WO/2021/202523ALDOSE REDUCTASE INHIBITORS FOR THE TREATMENT OF ACUTE  RESPIRATORY DISTRESS SYNDROME, ACUTE LUNG INFLAMMATION/INJURY, CARDIAC INJURY  AND ANTI-VIRAL THERAPYAPPLIED THERAPEUTICS, INC.
WO/2021/202530CASPASE INHIBITORS TO ENHANCE INJURY REPAIR AND TO TREAT  BACTERIAL AND VIRAL INFECTIONSTHE JOHNS HOPKINS UNIVERSITY
WO/2021/202533HIGH-STRENGTH COLLAGEN COMPOSITIONS AND METHODS OF USEGENIPHYS, INC.
WO/2021/202535METHODS FOR TREATING, AMELIORATING, OR PREVENTING VIRAL  INFECTIONSTHOMAS JEFFERSON UNIVERSITY
WO/2021/202540HSP70 INHIBITORS AND METHODS OF USING SAMETHE WISTAR INSTITUTE
WO/2021/202546EARLY DRUG INTERVENTIONS TO REDUCE COVID-19 RELATED  RESPIRATORY DISTRESS, NEED FOR VENTILATOR ASSISTANCE AND DEATHCYCLERION THERAPEUTICS, INC.
WO/2021/202553CXCR5 ANTAGONISTS AND METHODS OF TREATING DISEASES OR  DISORDERS USING SAMEYALE UNIVERSITY
WO/2021/202563METHODS OF TREATING CORONAVIRUS INFECTIONCYTODYN INC.
WO/2021/206965ANTIBODY FORMULATIONTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/202570USE OF STEM CELLS FOR TREATMENT OF EXCESSIVE INFLAMMATIONCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/202577STERILIZATION OF SELF-ASSEMBLING PEPTIDES BY IRRADIATION3-D MATRIX, LTD.
WO/2021/202592MONOCLONAL ANTIBODIES FOR INTRACELLULAR DELIVERY OF PAYLOADSOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/202599ADENO-ASSOCIATED VIRUS BASED COMPOSITIONS AND RELATED METHODS  FOR INDUCING HUMORAL IMMUNITYVALIANT BIOSCIENCES, LLC
WO/2021/202608SERUM METABOLITES AS BIOMARKERS FOR CARNITINE TREATMENT OF  SEPSISPUSKARICH, Michael A.
WO/2021/211294BASIC CHEMOTHERAPEUTIC INTRATUMOUR INJECTION FORMULATIONUS NANO FOOD & DRUG INC
WO/2021/202630RECOMBINANT BACTERIA PRODUCING CHEMICALS INHIBITORY TO  SALMONELLA INVASIONCORNELL UNIVERSITY
WO/2021/202632COMPOSITIONS AND METHODS FOR INHIBITING VIBRIO INFECTIONCORNELL UNIVERSITY
WO/2021/202642IMMUNOTHERANOSTIC AGENT TARGETING MESENCHYMAL STEM  CELL-DERIVED CANCER CELLS AND MESENCHYMAL STEM CELL ASSOCIATED DISEASETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/202644THERAPEUTIC COMPOSITIONSWINTERMUTE BIOMEDICAL, INC.
WO/2021/202650CYSTEAMINE PRECURSOR COMPOUNDS FOR THE TREATMENT OF  BETACORONAVIRUS INFECTIONSTHIOGENESIS THERAPEUTICS, INC.
WO/2021/202652TYROSINE KINASE 2 INHIBITORS, PREPARATION METHODS AND  MEDICINAL USES THEREOFETERNITY BIOSCIENCE INC.
WO/2021/202656HAIR CARE COMPOSITIONS COMPRISING POLYOL, C2-6 MONOALCOHOL AND  CATIONIC SURFACTANTL'OREAL
WO/2021/202680KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPAAKER BIOMARINE ANTARCTIC AS
WO/2021/202690VIRUS TREATMENT METHODS, AND RELATED PHARMACEUTICAL  COMPOSITIONS, VACCINE COMPOSITIONS, SANITIZING COMPOSITIONS, AND DRUG  DISCOVERY METHODSCASHMAN, Daniel Patrick
WO/2021/202708METHODS FOR TREATING VIRAL INFECTIONS WITH NAFAMOSTATENSYSCE BIOSCIENCES, INC.
WO/2021/202720USE OF TRITERPENOID NRF2 INHIBITORSFRONTHERA U.S. PHARMACEUTICALS LLC
WO/2021/202726ANTI-CD33 ANTIBODIES AND USES THEREOFFRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/202731COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL  DISEASE USING CCR9 INHIBITOR AND ANTI-IL-23 BLOCKING ANTIBODIESCHEMOCENTRYX, INC.
WO/2021/202734UNIVERSAL INFLUENZA VACCINE USING NUCLEOSIDE-MODIFIELD MRNATHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/202735THE USE OF DIFFUSION ENHANCING COMPOUNDS FOR TREATMENT OF  VIRAL AND BACTERIAL INDUCED RESPIRATORY DISEASEDIFFUSION PHARMACEUTICALS LLC
WO/2021/202745TREATMENT OF COVID-19 WITH A SINE COMPOUNDKARYOPHARM THERAPEUTICS INC.
WO/2021/202765SARS-COV-2 VACCINES FOR POPULATION-SCALE IMMUNITYTHE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/202767ENTERIC AEROBIZATION THERAPYLPOXY THERAPEUTICS, INC
WO/2021/202772MULTILAMELLAR RNA NANOPARTICLE VACCINE AGAINST SARS-COV-2UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/202780METHODS AND COMPOSITIONS FOR TREATING CANCERENGINE BIOSCIENCES PTE. LTD.
WO/2021/202798ANTIGEN BINDING PROTEINS TO CLASS 5 ETEC ADHESINSTHE UNITED STATES OF AMERICA as represented by THE SECRETARY  OF THE NAVY
WO/2021/202801AUGMENTING ANTIGEN-NEGATIVE CELL DEATH IN ANTIGEN-TARGETED  IMMUNOTHERAPIESFRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/202802CONJUGATES FOR SELECTIVE RESPONSIVENESS TO VICINAL DIOLSPROTOMER TECHNOLOGIES INC.
WO/2021/202806COMPOSITIONS COMPRISING NON-VIABLE FECAL MICROBIOTA AND  METHODS OF USE THEREOFFINCH THERAPEUTICS HOLDINGS LLC
WO/2021/159128METHODS AND KIT FOR DETECTION OF ANALYTESALLEN, Randy Leiman
WO/2021/202817DUAL AAV-MYO7A VECTORS WITH IMPROVED SAFETY FOR THE TREATMENT  OF USH1BUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/202822COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED DISEASES AND  PREMATURE AGING DISORDERSSIRTSEI PHARMACEUTICALS, INC.
WO/2021/202823THERAPEUTIC TREATMENT FOR THE CORONAVIRUS DISEASE COVID-19MOLLICK, Peter J.
WO/2021/202825METHODS OF TREATING RELAPSING MULTIPLE SCLEROSIS USING AN  INHIBITOR OF BRUTON'S TYROSINE KINASEGENENTECH, INC.
WO/2021/202826MATERIALS AND METHODS FOR IMMUNOSUPPRESSIVE TUMOR  MICROENVIRONMENT-TARGETED CANCER THERAPYUNIVERSITY OF CINCINNATI
WO/2021/202830HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOFTARVEDA THERAPEUTICS, INC.
WO/2021/202836FACTOR B INHIBITORS AND USES THEREOFTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/202861METHOD OF CHARACTERISATIONINVIVOSCRIBE, INC.
WO/2021/202863HUMAN ROR-1 ANTIBODY AND ANTI-ROR-1-CAR-T CELLSPROMAB BIOTECHNOLOGIES, INC.
WO/2021/211303ANTIVIRAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR USE  AGAINST VIRUSESCONTRAFECT CORPORATION
WO/2021/202874FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONSBP ASSET V, INC.
WO/2021/202875COSMETIC COMPOSITIONSTWINMEDIX LLC
WO/2021/202885TNFα SIGNALING TRIGGERS TUMOR-PROMOTING INFLAMMATION THAT CAN  BE TARGETED TO THERAPYBAYLOR COLLEGE OF MEDICINE
WO/2021/202886METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATESBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/202893DETECTING ADAPTIVE IMMUNITY TO CORONAVIRUSNONIGENEX, INC.
WO/2021/202898METHODS OF MAKING PLURIPOTENT STEM CELLS AND USES THEREOFNATIONAL JEWISH HEALTH
WO/2021/202904ENGINEERED ANTIBODIES THAT BIND LAGSSORRENTO THERAPEUTICS, INC.
WO/2021/202906METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEAAPNIMED, INC. (DELAWARE)
WO/2021/202908CD5L-BINDING ANTIBODIES AND USES FOR THE SAMETHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/202912COMPOSITIONS FOR TREATMENT OF VIRAL RESPIRATORY INFECTIONS AND  METHODS OF USE THEREOFWASHINGTON UNIVERSITY
WO/2021/202917A NONINVASIVE MULTIPARAMETER APPROACH FOR EARLY IDENTIFICATION  OF THERAPEUTIC BENEFIT FROM IMMUNE CHECKPOINT INHIBITION FOR LUNG CANCERTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/202919TOCILIZUMAB FOR THE TREATMENT OF VIRAL INFECTIONSTHE UNIVERSITY OF CHICAGO
WO/2021/202921IMIDAZOQUINOLINE-TYPE COMPOUNDS AND USES THEREOFALTIMMUNE UK LIMITED
WO/2021/202923IMMUNOMODULATOR FOR THE PREVENTION AND TREATMENT OF  CORONOVIRUS INFECTION AND OTHER CONDITIONSNEKTAR THERAPEUTICS
WO/2021/202928PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDEBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/202936PYRAZOLYLPROPANAMIDE COMPOUNDS AND USES THEREOF FOR TREATMENT  OF PROSTATE CANCERUNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/202943TREATMENT OF PHENYLKETONURIA WITH AAV AND THERAPEUTIC  FORMULATIONSBIOMARIN PHARMACEUTICAL, INC.
WO/2021/202945NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOFCORNELL UNIVERSITY
WO/2021/202947METHOD FOR TREATING LUNG DISEASE WITH CELL-FREE AMNIOTIC FLUIDUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/202949COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIAINOVIO PHARMACEUTICALS, INC.
WO/2021/202952COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR  INHIBITING SARS-COV-2LINHARDT, Robert, John
WO/2021/202957USE OF ARGINASE FOR TREATMENT OF CORONAVIRUS INFECTIONAEGLEA BIOTHERAPEUTICS, INC.
WO/2021/202961METHODS OF TREATING IMMUNOTHERAPY RESISTANT METASTATIC  MELANOMAUNITED STATES AS REPRESENTED BY DEPT OF VETERANS AFFAIRS
WO/2021/202971COVID-19 VACCINE BASED ON THE MYXOMA VIRUS PLATFORMARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/207020CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERYTIBA BIOTECH LLC
WO/2021/202975IMPLANTABLE CELL MACROENCAPSULATION DEVICE AND METHOD OF  MANUFACTURE AND USETHE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/202977PYRROLOPYRIMIDINE AMINES AS COMPLEMENT INHIBITORSBIOCRYST PHARMACEUTICALS, INC.
WO/2021/202981CO-ADMINISTRATION OF MIRDAMETINIB AND LIFIRAFENIB FOR USE IN  TREATING CANCERSBEIGENE, LTD.
WO/2021/202984ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTSMERSANA THERAPEUTICS, INC.
WO/2021/207024PREPARATION OF A 1,3,5-TRIAZINYL BENZIMIDAZOLEMEI PHARMA, INC.
WO/2021/202988COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSETURTLE BEAR HOLDINGS, LLC
WO/2021/202990METHODS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONSTEPPER, Mark, Allan
WO/2021/203001METHOD OF TREATING PATIENTS INFECTED WITH A VIRAL INFECTION  WITH AN INHIBITOR OF SMALL UBIQUITIN LIKE MODIFIER ACTIVATING ENZYMEMILLENNIUM PHARMACEUTICALS, INC.
WO/2021/203013METHODS OF TREATING IMMUNE MEDIATED PULMONARY INJURYVIELA BIO, INC.
WO/2021/203017BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR PREVENTION OF  SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) INFECTIONASCENDO BIOTECHNOLOGY, INC.
WO/2021/203024ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOFVISTERRA, INC.
WO/2021/203033METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO  TREAT OBESITY-RELATED CONDITIONSARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/203038DELIVERY OF GINSENOSIDES TO THE RESPIRATORY SYSTEM VIA  ELECTRONIC BREATH ACTUATED DROPLET DELIVERY DEVICEPNEUMA RESPIRATORY, INC.
WO/2021/203042A UNIVERSAL ADOPTIVE IMMUNOTHERAPY APPROACH TO TREAT COVID-19  AND FUTURE EMERGING INFECTIOUS DISEASESLINEAGE CELL THERAPEUTICS, INC.
WO/2021/203048NOVEL 2-PYRIMIDONE ANALOGS AS POTENT ANTIVIRAL AGENTS AGAINST  ALPHAVIRUSESSOUTHERN RESEARCH INSTITUTE
WO/2021/203051AEROSOLIZED HYALURONIDASE AND/OR 4-METHYLUMBELLIFERONE  COMPOSITIONS AND METHODS OF USING SAME TO TREAT RESPIRATORY DISEASES OR  DISORDERSSTANDARD OF CARE CORPORATION
WO/2021/203055VIRAL ENTRY INHIBITORS AND RNA POLYMERASE INHIBITORSSELVA THERAPEUTICS, INC.
WO/2021/203061STEM CELL IMMUNOMODULATORY THERAPY FOR COVID-19 INFECTIONUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/203062REDUCING OR INHIBITING OCULAR DAMAGE BY HYALURONIDASE  ADMINISTRATIONMED PROGRESS, LLC
WO/2021/207047COMPOSITIONS AND METHODS FOR THE TREATMENT OF  INFECTION-INDUCED CARDIOMYOPATHYDUKE UNIVERSITY
WO/2021/207051METHODS OF TREATING ACUTE RESPIRATORY DISORDERSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/207052ARGININE METHYLTRANSFERASE 5 (PRMT5) DEGRADERS AND USES  THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/207054METHODS OF REDUCING PLASMA LEVEL OF MACROPHAGE MIGRATORY  INHIBITORY FACTOR IN PATIENTS WITH IBUDILASTMEDICINOVA, INC.
WO/2021/207060METHODS OF TREATMENT OF CORONAVIRUS-INDUCED INFLAMMATION  CONDITIONSTHE GENERAL HOSPITAL CORPORATION
WO/2021/252054COMPOSITIONS AND USES IN METHOD FOR POST-OPERATIVE OCULAR CAREOCULAR SCIENCE, INC.
WO/2021/203093RAPID POINT OF CARE ASSAY FOR THE DETECTION OF THE  ASYMPTOMATIC CARRIER STATE OF COVID-19LOOMIS, Lawrence
WO/2021/207077ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR IDS GENE TRANSFER AND  METHODS OF USE THEREOFHOMOLOGY MEDICINES, INC.
WO/2021/207082METHOD FOR TREATING IMPLANTABLE DEVICE INFECTIONSADAPTIVE PHAGE THERAPEUTICS, INC.
WO/2021/207086TEM-1-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOFFUSION PHARMACEUTICALS INC.
WO/2021/203100METHODS OF TREATING CORONAVIRUSVERU INC.
WO/2021/203101HYPOCHLOROUS ACID SOLUTIONS AND METHODS OF USEPHASE ONE HEALTH, LLC
WO/2021/207099CORONAVIRUS THERAPEUTICS AND TREATMENT METHODSHAMILTON, Douglas, A.
WO/2021/203103ACE2 RECEPTOR POLYMORPHISMS AND VARYING SUSCEPTIBILITY TO  SARS-COV-2, METHODS FOR DIAGNOSIS AND TREATMENTSESHAGIRI, Somasekar
WO/2021/203104INFECTIOUS DISEASE ANTIGENS AND VACCINESGRITSTONE BIO, INC.
WO/2021/216276RAPID, POINT OF CARE DETECTION OF NEUTRALIZING ANTIBODIES  AGAINST A VIRUSMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/207121HYPOIMMUNOGENIC CELLS AND METHODS AND COMPOSITIONS FOR THEIR  PRODUCTIONRXCELL INC.
WO/2021/207126COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONSTHE TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/207130HYALURONATE COMPOSITIONS AND SOFT TISSUE FILLERSAMC GROUP LLC
WO/2021/207137CRYSTALLINE 5-METHOXY-<i>N,N</i>-DIALLYLTRYPTAMINE  COMPOUNDSCAAMTECH, INC.
WO/2021/207141METHODS OF USING NEUROKININ-1 RECEPTOR (NK-1R) ANTAGONISTS TO  TREAT β-CORONAVIRUS INFECTION INCLUDING SARS-COV-2 INFECTION AND/OR COVID-19  DISEASETHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/207149SYSTEM AND METHOD FOR AEROSOL PARTICLE PRODUCTION OF SUBMICRON  AND NANO STRUCTURED MATERIALSTHE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/207152CROSS-REACTIVE CORONAVIRUS ANTIBODIES AND USES THEREOFVANDERBILT UNIVERSITY
WO/2021/207155AIRWAY EPITHELIAL ALKALINE THERAPY TO TREAT VIRAL RESPIRATORY  INFECTIONTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/207164COMPOSITIONS AND USES OF LOCALLY APPLIED SYNTHETIC AMINO ACID  POLYMERS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONSAMICROBE, INC.
WO/2021/207168METHODS FOR USING EXTRACELLULAR MICROVESICLES WITH  SYNCYTIOTROPHOBLAST MARKERS TO DIAGNOSE PREECLAMPSIATHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/207176GENISTEIN TREATMENT OF INFLAMMATORY PULMONARY INJURYHUMANETICS CORPORATION
WO/2021/211325CRISPR-INHIBITION FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHYBOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON  BEHALF OF THE UNIVERSITY OF NEVADA, RENO
WO/2021/207178SILVER NANOPARTICLES FOR USE IN INHIBITING AND TREATING  CORONAVIRUS INFECTIONAGARWAL, Ankit
WO/2021/207180NUTRITIONAL FORMULATIONS FOR MODULATING RESPIRATORY-INDUCED  CYTOKINESABBOTT LABORATORIES
WO/2021/207197BISPECIFIC APTAMER COMPOSITIONS FOR THE TREATMENT OF RETINAL  DISORDERSDRIVE THERAPEUTICS L.L.C.
WO/2021/207206ANTI-OBESITY PEPTIDES AND USES THEREOFARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/207213METHODS TO PREVENT SARS-COV-2 INFECTION AND TREAT COVID-19UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/207217COMPOSITIONS AND METHODS FOR TREATING VIRUSESUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/207218TREATMENT OF NIDOVIRALES INFECTION WITH ERITORANEISAI R&D MANAGEMENT CO., LTD.
WO/2021/207230METHODS OF TREATING CYTOKINE RELEASE SYNDROME USING A PI3K  INHIBITORVERASTEM, INC.
WO/2021/207247SPERMIDINE-SUPPLEMENTED FOOD PRODUCTSKALIN HEALTH LLC
WO/2021/207249VACCINE PLATFORM FOR THE INDUCTION OF SYSTEMIC IMMUNE  RESPONSESTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/207253PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAMAXSOME THERAPEUTICS, INC.
WO/2021/207271ORGANOSELENIDE GLUTATHIONE PEROXIDASE MIMETICS FOR THE  TREATMENT OF INFLAMMATORY PULMONARY DISORDERSEBVIA INC.
WO/2021/207273MANUFACTURING OF SYNTHETIC EXOSOMES FOR CNS AND NON-CNS  DELIVERY OF THERAPEUTICSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/207281VACCINES, ADJUVANTS, AND METHODS OF GENERATING AN IMMUNE  RESPONSEEISAI R&D MANAGEMENT CO., LTD.
WO/2021/207290ENGINEERED IMMUNE CELLSSYNTHEKINE, INC.
WO/2021/221863RAPID TESTING MECHANISM AND METHOD FOR RESPIRATORY VIRAL  PATHOGENSHEEGER, Brandon
WO/2021/207291COMPOUNDS AND USES THEREOFFOGHORN THERAPEUTICS INC.
WO/2021/207295TREATING ARDS USING A POLY-OXYGENATED ALUMINUM HYDROXIDEHEMOTEK LLC
WO/2021/207300METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING AND  PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH VIRAL  INFECTIONSHISTA RX LLC
WO/2021/207303IMMUNE STIMULATION AGAINST CORONAVIRUS INFECTIONSALSATECH, INC.
WO/2021/207305COMPOSITIONS AND METHODS USING INTERFERON FOR TREATING VIRAL  RESPIRATORY INFECTIONSNOSTRUM PHARMACEUTICALS, LLC
WO/2021/207306RECOMBINANT BACTERIA FOR USE AS A VACCINE TO PREVENT COVID19  INFECTIONSYNLOGIC OPERATING COMPANY, INC.
WO/2021/207307COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND/OR TREATMENT  OF VIRAL INFECTIONS OR CONDITIONS ASSOCIATED THEREWITHNOSTRUM PHARMACEUTICALS, LLC
WO/2021/207312METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RETINAL  NERVE DAMAGEG3 PHARMACEUTICALS, INC.
WO/2021/207325NATURAL EXTRACT AND THEIR COMPONENTS FOR USE IN MITIGATING  ACUTE RESPIRATORY DISTRESS SYNDROMESYTHEON LIMITED
WO/2021/207329MULTI-DRUG FORMULATIONS FOR SUBCUTANEOUS BIODEGRADABLE  RESERVOIR DEVICERESEARCH TRIANGLE INSTITUTE
WO/2021/207336ORAL FORMULATIONS FOR SUSTAINED RELEASE AND GASTROINTESTINAL  RETENTIONVERTé THERAPEUTICS, LLC
WO/2021/207343MALT1 INHIBITORS AND USES THEREOFRHEOS MEDICINES, INC.
WO/2021/207348METHOD OF TREATING AND PREVENTING OCULAR DISEASE WITH HSV-2  DELTA GDALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/207349PREVENTION AND TREATMENT OF VIRIAL INFECTIONSHABBOUSHE, Joseph
WO/2021/207359COMPOSITIONS AND METHODS FOR THE PREVENTION OF STRESS-INDUCED  FEAR, DEPRESSIVE-LIKE AND ANXIETY- LIKE BEHAVIORTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/207367RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONSHOFSETH BIOCARE ASA
WO/2021/207380THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST  INJURYTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/207384METHODS OF TREATING AND/OR PREVENTING VIRAL INFECTIONS AND/OR  DISEASES CAUSED BY VIRUSES IN A SUBJECT IN NEED THEREOFJIAO, Lixia
WO/2021/207386METHODS, COMPOSITIONS, AND DOSING REGIMENS FOR TREATMENT OF  SARS-COV-2 INFECTIONSBIOCRYST PHARMACEUTICALS, INC.
WO/2021/207387USE OF BROMODOMAIN INHIBITORS FOR TREATMENT OF HUNTINGTON'S  DISEASERUMI SCIENTIFIC HOLDINGS, INC.
WO/2021/207388COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL  INFECTIONS AND OTHER RESPIRATORY DISORDERSFIRSTSTRING RESEARCH, INC.
WO/2021/207394SYNTHESIS AND APPLICATIONS OF POLYMERS OF PENTADECYL  CAPROLACTONEREGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/207396GALECTIN-1 IMMUNOMODULATION AND MYOGENIC IMPROVEMENTS IN  MUSCLE DISEASES AND AUTOIMMUINE DISORDERSBRIGHAM YOUNG UNIVERSITY
WO/2021/207399HYDROLYSABLE TANNINS FOR USE IN MITIGATING ACUTE RESPIRATORY  DISTRESS SYNDROMESYTHEON LIMITED
WO/2021/211343ZIKA VIRUS MRNA VACCINESMODERNATX, INC.
WO/2021/207420AN INNOVATIVE DNA VACCINE FOR SARS-COV, SARS-COV-2, AND  MERS-COVTHE JOHNS HOPKINS UNIVERSITY
WO/2021/207436RHEOLOGICAL SOLID COMPOSITION FOR USE IN SHAVINGTHE PROCTER & GAMBLE COMPANY
WO/2021/207437STRUCTURED RHEOLOGICAL SOLID COMPOSITIONSTHE PROCTER & GAMBLE COMPANY
WO/2021/207438ORAL CARE PRODUCT COMPRISING A RHEOLOGICAL SOLID COMPOSITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/207439RHEOLOGICAL SOLID COMPOSITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/207440RHEOLOGICAL SOLID COMPOSITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/207442RHEOLOGICAL SOLID ORAL COMPOSITIONTHE PROCTER & GAMBLE COMPANY
WO/2021/207443METHODS OF TREATING SARS-COV-2 INFECTIONSEAGLE PHARMACEUTICALS, INC.
WO/2021/207444METHODS OF TREATING SEVERE ACUTE RESPIRATORY SYNDROMEEAGLE PHARMACEUTICALS, INC.
WO/2021/207445METHODS OF TREATING CORONAVIRUS INFECTIONSEAGLE PHARMACEUTICALS, INC.
WO/2021/207446METHODS OF TREATING VIRAL INFECTIONSEAGLE PHARMACEUTICALS, INC.
WO/2021/207451STRUCTURED RHEOLOGICAL SOLID PERSONAL CARE COMPOSITIONSTHE PROCTER & GAMBLE COMPANY
WO/2021/207469NOVEL INHIBITORS OF HISTONE ACETYLTRANSFERASE P300/CBP FOR  CANCER THERAPYBAYLOR COLLEGE OF MEDICINE
WO/2021/207478COMPOSITIONS AND METHODS FOR TREATING HOT FLASHESTHE PROCTER & GAMBLE COMPANY
WO/2021/207483MICRONEEDLE ARRAY DELIVERY OF ADENOVIRUS VECTORED VACCINES  WITH AND WITHOUT ADJUVANTSUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/207486TREATMENTSAERIE PHARMACEUTICALS, INC.
WO/2021/207487METHODS OF TREATING CONDITIONS CHARACTERIZED BY INSULIN  DEFICIENCY IN ANIMALSHOFFMAN TECHNOLOGIES LLC
WO/2021/207489METHODS AND PHARMACEUTICAL COMPOSITIONS TO TREAT PULMONARY  INFLAMMATION IN INFECTED PATIENTSRTU PHARMACEUTICALS, LLC
WO/2021/207500TGFβ THERAPY FOR OCULAR AND NEURODEGENERATIVE DISEASESPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/207514COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG  DISEASEARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/221879COMPOSITIONS AND METHODS FOR USING TRANSPLANTED MICROGLIA AS A  VEHICLE FOR WIDESPREAD DELIVERY OF CELLS AND OTHER BIOLOGIC AGENTS TO THE  BRAINALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/211358LSD DOSE IDENTIFICATIONUNIVERSITÄTSSPITAL BASEL
WO/2021/207566CAROTENOID SOLUTIONS AND USES THEREOFL.E.A.F. HOLDINGS GROUP LLC
WO/2021/207577PROCESS FOR PRODUCING TCA CYCLE INTERMEDIATE CONJUGATES AND  POLYMORPHS OF A TCA CYCLE INTERMEDIATE CONJUGATEIMBRIA PHARMACEUTICALS, INC.
WO/2021/211365MULTIMODAL AUTOMATED DISINFECTING SYSTEMGMA INTERNATIONAL SERVICES, INC.
WO/2021/207592USE OF VIRAL VECTORS FOR CORONAVIRUS VACCINE PRODUCTION4MVAC LLC
WO/2021/207595RECOMBINANT VACCINES AND METHODS OF USE THEREOFVANDERBILT UNIVERSITY
WO/2021/207597COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOFADAGIO THERAPEUTICS, INC.
WO/2021/207598COMBINATION TREATMENT WITH AN AGONIST OF P53 AND A SECOND  THERAPEUTIC AGENTAPREA THERAPEUTICS, INC.
WO/2021/207601CROSS-LINKED COMPOSITIONS AND THEIR USEVERTELLUS HOLDINGS LLC
WO/2021/207606METHODS FOR TREATMENT OF CORONAVIRUS INFECTIONSUNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/211382COMPOUNDS AND METHODS FOR MODIFYING IAGEEDIFICE HEALTH, INC.
WO/2021/207630OXIDIZED TUMOR CELL LYSATES ENCAPSULATED IN LIPOSOMAL  SPHERICAL NUCLEIC ACIDS AS POTENT CANCER IMMUNOTHERAPEUTICSNORTHWESTERN UNIVERSITY
WO/2021/207632SMALL MOLECULE THERAPEUTICS FOR THE TREATMENT OF VIRAL  INFECTIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/207634BIOMARKERS RELATED TO PARKINSON'S DISEASE AND METHODS OF USING  THE SAMESENDA BIOSCIENCES, INC.
WO/2021/207635PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY  REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS  THEREOFTHE GEORGE WASHINGTON UNIVERSITY
WO/2021/207644COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONSBIOVISTA, INC.
WO/2021/207653USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19IDERA PHARMACEUTICALS, INC.
WO/2021/207662USE OF IL-22FC FOR THE TREATMENT OR PREVENTION OF PNEUMONIA,  ACUTE RESPIRATORY DISTRESS SYNDROME, OR CYTOKINE RELEASE SYNDROMEGENENTECH, INC.
WO/2021/207671TREATING AUTOIMMUNE DISEASES WITH GENETICALLY MODIFIED CELLSWALLKILL BIOPHARMA, INC.
WO/2021/207676METHODS OF SYNTHESIZING CAROTENOIDSL.E.A.F. HOLDINGS GROUP LLC
WO/2021/207678KAPPA OPIOID RECEPTOR ANTAGONISTS FOR TREATING PAIN-RELATED  SLEEP DISORDERSARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/207679POLYPEPTIDE COMPOSITIONS AND USES THEREOFLIBERTY BIOSECURITY, LLC
WO/2021/207681TARGETED REDUCTION OF ACTIVATED IMMUNE CELLSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/207687POLYPEPTIDE COMPOSITIONS AND USES THEREOFLIBERTY BIOSECURITY LLC
WO/2021/207689METHODS AND USES RELATED TO CELL THERAPY ENGINEERED WITH A  CHIMERIC ANTIGEN RECEPTOR TARGETING B-CELL MATURATION ANTIGENJUNO THERAPEUTICS, INC.
WO/2021/207690TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENSL.E.A.F. HOLDINGS GROUP LLC
WO/2021/207691PHTHALOCYANINE DYE COMPOUNDS, CONJUGATES AND METHODS OF USE  THEREOFRAKUTEN MEDICAL, INC.
WO/2021/207697TREATMENT OF ACUTE LUNG INJURYCANTEX PHARMACEUTICALS, INC.
WO/2021/207701CHARGE VARIANT LINKERSSEAGEN INC.
WO/2021/207704APPARATUS FOR DECARBOXYLATION OF CANNABIS EXTRACTSJENNY'S ROSE, LLC
WO/2021/207706METHODS AND COMPOSITIONS FOR INACTIVATING  INTERLEUKIN-2-INDUCIBLE T-CELL KINASE (ITK)THE RESEARCH FOUNDATION FOR THE STATE UNIVERSTIY OF NEW YORK
WO/2021/207716METHODS AND COMPOSITION FOR TREATMENT OF COVID-19 ILLNESS  REQUIRING HOSPITALIZATIONOHIO STATE INNOVATION FOUNDATION
WO/2021/211386TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATIONFIGENE, LLC
WO/2021/207717SYSTEMS, DEVICES, AND METHODS FOR DELIVERING A SUBSTANCE  WITHIN A TARGET TISSUETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/211393HAIR COLOR MODIFICATION ADDITIVE AND RELATED METHODSPWAI, LLC
WO/2021/211406TMPRSS2-TARGETED COMPOSITIONS AND METHODS FOR TREATING  COVID-19MADDON ADVISORS LLC
WO/2021/207723METHODS OF TREATING DIABETIC KIDNEY DISEASECHINOOK THERAPEUTICS, INC.
WO/2021/207725LIPOCALIN-2 ASSAY FOR INTESTINAL ADAPTATIONTHE JOHNS HOPKINS UNIVERSITY
WO/2021/211414BISPECIFIC ANTIBODY COMPOSITIONS AND METHODS FOR TREATING  COVID-19MADDON ADVISORS LLC
WO/2021/211416ACE2- AND TMPRSS2-TARGETED COMPOSITIONS AND METHODS FOR  TREATING COVID-19MADDON ADVISORS LLC
WO/2021/211418METHODS FOR TREATING ANEMIA USING AN ACTRIIB LIGAND TRAP AND  FEDRATINIBCELGENE CORPORATION
WO/2021/207727COMBINATORIAL TARGETED THERAPY METHODSPOSTSURGICAL THERAPEUTICS, INC.
WO/2021/211441MODIFIED SUGAR POLYMERS WITH LOW ANTICOAGULANT ACTIVITY AND  THERAPEUTIC ACTIVITYTHE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
WO/2021/207729COMPOSITIONS AND METHODS FOR MODULATING ACE2 RECEPTORMUBARAK, Kamal Khan
WO/2021/207730VACCINES FOR CORONAVIRUS AND METHODS OF USING THE SAMETHE WISTAR INSTITUTE OF ANATOMY & BIOLOGY
WO/2021/211460CELL-RECEPTOR TARGETED EXOSOMESCITY OF HOPE
WO/2021/207737LONG-ACTING APOMORPHINE FORMULATIONS AND INJECTORS FOR  THERAPEUTIC DELIVERY OF THE SAMESCIENTURE, INC.
WO/2021/207738HYDROXYUREAMETHYL-ACYLFULVENE FOR TREATING BRAIN CANCER OR CNS  CANCERLANTERN PHARMA INC.
WO/2021/211468ANHYDROUS SILKY COSMETIC PRODUCTAKI, INC.
WO/2021/207742NANOPARTICLES FOR USE IN PHOTODYNAMIC THERAPIES AND METHODS OF  MAKING, EVALUATING AND USING THE SAMEMI2 HOLDINGS LLC
WO/2021/211487COMPOSITIONS AND METHODS OF TREATING COVID-19 WITH HEPARIN OR  OTHER NEGATIVELY CHARGED MOLECULESSIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/211489(S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMINE  FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERSSUNOVION PHARMACEUTICALS INC.
WO/2021/211504NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITSGLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
WO/2021/211540DIAGNOSIS AND TREATMENT OF ADDICTIONTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/221902MULTI-CHROME COSMETIC HAIR COMPOSITIONHOLECKO, Hana
WO/2021/211552COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND TREATING VIRAL  INFECTIONSUT-BATTELLE, LLC
WO/2021/211558TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEM COMPRISING  HYDROXYCHLOROQUINE AND/OR CHLOROQUINEGLANIS PHARMACEUTICAL INC.
WO/2021/211572ANTISENSE THERAPEUTICS FOR THE TREATMENT OF CORONAVIRUSOREGON STATE UNIVERSITY
WO/2021/211575COMPOSITIONS COMPRISING PROPOFOL, KETAMINE, AND NON-OPIOID  ANALGESIC, AND METHODS OF USETHE REGENTS OF THE UNIVEFISITY OF CALIFORNIA
WO/2021/211614AAV-BASED GENE THERAPIES FOR TREATMENT OF AUTOIMMUNE DISEASESUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/211620METHOD AND SYSTEM FOR DETECTING AND TREATING EXPOSURE TO AN  INFECTIOUS PATHOGENSUN GENOMICS, INC.
WO/2021/211625QUINOLINE COMPOUNDS FOR TREATING LUNG, LIVER, AND KIDNEY  DISEASES, DISORDERS, OR CONDITIONSALDEYRA THERAPEUTICS, INC.
WO/2021/211628COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF CANCERPOSEIDA THERAPEUTICS, INC.
WO/2021/211629METHODS OF MAKING AND USING A VACCINE AGAINST CORONAVIRUSMASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/216325COMPOSITIONS AND METHODS FOR TREATING METABOLIC AND  CARDIOVASCULAR DISEASESUNIVERSITY OF ROCHESTER
WO/2021/211660METHOD OF PREVENTING OR TREATING VIRAL INFECTIONSVECTOR VITALE IP LLC
WO/2021/211670POROUS NANOCOMPOSITE MEDICAL IMPLANT DEVICELYNTHERA CORPORATION
WO/2021/211688SARS-2 SPIKE PROTEIN DESIGNS, COMPOSITIONS AND METHODS FOR  THEIR USEDUKE UNIVERSITY
WO/2021/211691YEAST LYSATE COVID-19 VACCINEIMMUNITYBIO, INC.
WO/2021/211698TREATING OR PREVENTING TRAVELERS DIARRHEASCALED MICROBIOMICS, LLC
WO/2021/211700COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL  DISORDERSTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/231018PLANT-BASED PHYTONUTRIENT COMPOSITION FOR REGULATION OF SIGNAL  TRANSDUCTION CASCADES IN THE BODY AND RELATED METHODSBRILLIANT LAB LLC
WO/2021/211704SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED  ON VESICULAR STOMATITIS VIRUS VECTORSWASHINGTON UNIVERSITY
WO/2021/225760COPPER-CONTAINING THERAGNOSTIC COMPOUNDS AND METHODS OF USECORNELL UNIVERSITY
WO/2021/211705TREATMENT OF SARCOPENIA USING NT-3 GENE THERAPYRESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/257169MDMA RESPONSE PREDICTIONUNIVERSITÄTSSPITAL BASEL
WO/2021/211713TREATMENT OF CHARCOT-MARIE-TOOTH AXONAL TYPE 2D USING NT-3  GENE THERAPYRESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/211738METHODS AND COMPOSITIONS FOR ANTIVIRAL TREATMENTSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/211740PRODUCTS AND METHODS FOR DETECTION OF VIRAL NUCLEIC ACIDSPECTRUM SOLUTIONS L.L.C.
WO/2021/211742USE OF GCN2 INHIBITORS IN TREATING MITOCHONDRIAL MYOPATHIES  AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTIONTHE GENERAL HOSPITAL CORPORATION
WO/2021/211745PIRFENIDONE FOR CORONAVIRUS TREATMENTEXCALIBUR PHARMACEUTICALS, INC.
WO/2021/211746METHODS FOR TREATING POLYMICROBIAL INFECTIONSCAP DIAGNOSTICS, LLC, DBA PATHNOSTICS
WO/2021/211748PAN-CORONAVIRUS VACCINE COMPOSITIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/211749MULTI-EPITOPE PAN-CORONAVIRUS VACCINE COMPOSITIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/211757METHOD FOR TREATING <i>ARENAVIRIDAE</i> INFECTIONSOYAGEN, INC.
WO/2021/211759METHOD FOR TREATING POXVIRIDAE INFECTIONSOYAGEN, INC.
WO/2021/211760LARGE SEQUENCE PAN-CORONAVIRUS VACCINE COMPOSITIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/211761TARGETING ABCB5 IN GLIOBLASTOMA MULTIFORMECHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/211772IMPROVED IMMUNE RESPONSE AND DECREASED IMMUNOPARALYSIS WITH  IMMUNOMODULATING TREATMENTCYTOSORBENTS CORPORATION
WO/2021/211782METHODS OF TREATING ACUTE LUNG INJURY AND ACUTE RESPIRATORY  DISTRESS SYNDROMETELIOS PHARMA, INC.
WO/2021/211792TREATMENT OF CORONAVIRUS INFECTIONS WITH AURANOFINGEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/211795LARAZOTIDE DERIVATIVES COMPRISING D-AMINO ACIDS9 METERS BIOPHARMA, INC.
WO/2021/211796STABLE DIGLYCERIDE EMULSIONS AND METHODS FOR TREATING ORGAN  INJURYTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/211808COMPOSITIONS AND METHODS TO REDUCE THE INFECTIVITY OF A VIRUSATOSSA THERAPEUTICS, INC.
WO/2021/211819INHIBITION OF BAX-MEDIATED CELL DEATH BY ELTROMBOPAGALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/211839MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED  PRODUCTS AND METHODSESCIENT PHARMACEUTICALS, INC.
WO/2021/211841CONTROL OF REPLICATION AND TRANSCRIPTION OF SELF-REPLICATING  RNA IN RESPONSE TO SMALL MOLECULESMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/211847SYNTHETIC PEPTIDES FOR MODULATING THE METABOTROPIC GLUTAMATE  RECEPTOR 5LACTOCORE, INC.
WO/2021/211848ENGINEERED CELLS SECRETING THERAPEUTIC ENZYMESCARTESIAN THERAPEUTICS, INC.
WO/2021/211850INHALABLE FORMULATION OF A SOLUTION CONTAINING OLODATEROLANOVENT PHARMACEUTICAL(U.S.)., LLC
WO/2021/211854INHALABLE FORMULATION OF A SOLUTION CONTAINING TIOTROPIUM  BROMIDEHUANG, Cai Gu
WO/2021/211857IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS  INHIBITORSALKERMES PHARMA IRELAND LIMITED
WO/2021/211858INHALABLE FORMULATION OF A SOLUTION CONTAINING TIOTROPIUM  BROMIDE AND OLODATEROLANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/211860IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS  INHIBITORSALKERMES PHARMA IRELAND LIMITED
WO/2021/225767METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2THE SCRIPPS RESEARCH INSTITUTE
WO/2021/211882METHODS FOR PREPARING TYROSINE RECEPTOR KINASE INHIBITORSPYRAMID BIOSCIENCES, INC.
WO/2021/211885MATRIX BOUND VESICLES (MBV) FOR TREATMENT OF ACUTE RESPIRATORY  DISTRESS SYNDROMEUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/211890COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE  THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERSADIMABIO LLC
WO/2021/211894TARGETED RNA EDITING USING ENGINEERED ADENOSINE DEAMINASE  ACTING ON TRNA (ADAT) SYSTEMSSHAPE THERAPEUTICS INC.
WO/2021/211898MULTI-COMPONENT PACKAGED DOSAGE FORM AND METHODAPRECIA PHARMACEUTICALS LLC
WO/2021/211903TWIN BASE LINKERS FOR VIRUS INACTIVATIONNORTHEASTERN UNIVERSITY
WO/2021/211909USE OF DIRECT THROMBIN INHIBITORS IN THE TREATMENT OF  NEURODEGENERATIVE DISEASESGRAMMAS, Paula
WO/2021/211915POLYCANNABINOIDS, COMPOUNDS, COMPOSITIONS AND METHODS OF USEUNIVERSITY OF CONNECTICUT
WO/2021/211916TREPROSTINIL FOR USE IN THE TREATMENT OF INTERSITIAL LUNG  DISEASEUNITED THERAPEUTICS CORPORATION
WO/2021/211919ECLITASERTIB FOR USE IN TREATING CONDITIONS INVOLVING SYSTEMIC  HYPERINFLAMMATORY RESPONSEGENZYME CORPORATION
WO/2021/211921METHODS OF REDUCING OR PREVENTING CLOSTRIDIOIDES DIFFICILE  COLONIZATIONBIOVECTOR, INC.
WO/2021/211923COMPOSITIONS AND METHODS FOR TREATING DISEASEPULMOQUINE THERAPEUTICS, INC.
WO/2021/211942PRECISION DELIVERY OF MULTI-SCALE PAYLOADS TO TISSUE-SPECIFIC  TARGETS IN PLANTSMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/211961REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS,  METHODS OF PRODUCTION, AND METHODS OF USE THEREOFCROWN SCIENTIFIC, L.L.C.
WO/2021/211974HSD17B13 INHIBITORS AND USES THEREOFINIPHARM, INC.
WO/2021/211984DIELS-ALDER CONJUGATION METHODSREGENERON PHARMACEUTICALS, INC.
WO/2021/211990LIPID COMPOSITIONS AND METHODS OF PREPARATION THEREOFWAKE FOREST UNIVERSITY
WO/2021/212000SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILESEVELO BIOSCIENCES, INC.
WO/2021/212013BIOACTIVE PEPTIDES AND METHODS OF USE THEREOFOP-T LLC
WO/2021/212019METHODS OF FORMING PARTICLES BY CONTINUOUS DROPLET FORMATION  AND DEHYDRATIONELEKTROFI, INC.
WO/2021/212022AEROSOLIZED FORMULATIONS OF HIV PROTEASE INHIBITORS FOR THE  TREATMENT OF AIRWAY REFLUXTHE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/216372SUBCUTANEOUS ABSORPTION AND BIOAVAILABILITY OF ANTIBODIESELI LILLY AND COMPANY
WO/2021/212032SOLID FORMS OF AN N-TERMINAL DOMAIN ANDROGEN RECEPTOR  INHIBITOR AND USES THEREOFESSA PHARMA, INC.
WO/2021/212037IMMUNE CELL REDIRECTING COMPOSITIONS AND THERAPEUTIC USES  THEREOFEMORY UNIVERSITY
WO/2021/212039INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOFPARDES BIOSCIENCES, INC.
WO/2021/212044METHODS AND COMPOSITIONS FOR IMPROVING SC-BETA CELLS OR  ENHANCING THEIR UTILITYWASHINGTON UNIVERSITY
WO/2021/212048BITTER BLOCKERS AND RELATED METHODS OF USECONAGEN INC.
WO/2021/216378METHODS AND MATERIALS FOR TREATMENT OF FIBROSISTHE SCHEPENS EYE RESEARCH INSTITUTE, INC.
WO/2021/212054METHODS AND COMPOSITIONS FOR TREATING SUBJECTS WITH METABOLIC  DISORDERS AND CORONAVIRUS INFECTIONSCIRIUS THERAPEUTICS, INC.
WO/2021/212055DEFIBROTIDE TREATMENT FOR THE PREVENTION OF ORGAN REJECTION  AND INJURYJAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/212073HIGH-POTENCY VITAMIN C AND SUGAR ALCOHOL TOPICAL FORMULATIONSBAEK CLINICAL INC.
WO/2021/212075STABILIZING VITAMIN C APPLICATION FORMULATIONSBAEK CLINICAL INC.
WO/2021/212079HIGH-POTENCY VITAMIN C CHEMICAL PEELING SOLUTIONSBAEK CLINICAL INC.
WO/2021/212080ANHYDROUS AZELAIC ACID TOPICAL FORMULATIONSBAEK CLINICAL INC.
WO/2021/216385METHODS FOR THE PROPHYLAXIS AND TREATMENT OF COVID AND  COVID-19TRAN, Lloyd, Hung Loi
WO/2021/216394TOOTHPASTE COMPOSITIONS COMPRISING SILICA AND SURFACE ACTIVE  POLYMERTHE PROCTER & GAMBLE COMPANY
WO/2021/216399PULMONARY AMINOSTEROL COMPOSITIONS AND METHODS OF USING THE  SAME TO TREAT MICROBIAL INFECTIONSENTERIN, INC.
WO/2021/216403COMPOSITIONS AND METHODS FOR TREATING CORNEAL ENDOTHELIUMD&D BIOPHARMACEUTICALS, INC.
WO/2021/216418COMBINATION THERAPY USING AN IL-20 ANTAGONIST AND AN IMMUNE  CHECKPOINT INHIBITORLBL BIOTECHNOLOGY INC.
WO/2021/212097CONTROLLED RELEASE HYALURONIC ACID COMPOSITIONSPURCELL, Brendan Patrick
WO/2021/212100METHODS, COMPOSITIONS AND USES THEREOF FOR REVERSING  SACROPENIATHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/212101COMPOSITIONS FOR TREATING AND/OR PREVENTING CORONAVIRUS  INFECTIONSVYRIAD, INC.
WO/2021/216441AAK1 INHIBITORS FOR USE IN TREATING VIRAL INFECTIONSLEXICON PHARMACEUTICALS, INC.
WO/2021/257173ANTIBIOTIC ADJUVANT COMPOUNDSUNIVERSITY OF NOTRE DAME DU LAC
WO/2021/212108METHOD OF STABLE FORMULATION OF MICROBIAL AND MICROBE DERIVED  PRODUCTS AND USE OF SAMEADVANCED BIOLOGICAL MARKETING, INC.
WO/2021/216450OPIOID ANTAGONIST FORMULATIONSEMERGENT PRODUCT DEVELOPMENTGAITHERSBURG INC.
WO/2021/2164544-(3-(PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIMIDIN-5-YL)PIPERAZINE  FOR USE IN THE THE TREATMENT OF COV-229E OR COV-OC43 CORONAVIRUSES INFECTIONSLEXICON PHARMACEUTICALS, INC.
WO/2021/212111COMPOSITIONS AND METHODS FOR TREATING LEUKEMIAAUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/216461SMALL MOLECULES FOR TREATING AGE-RELATED RETINAL DISEASESUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/212114WOUND PREVENTION AND/OR TREATMENT AND RELATED COMPOUNDS,  MATRICES, COMPOSITIONS, METHODS AND SYSTEMSCALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/216467A NANO-ENABLED VACCINATION APPROACH FOR CORONAVIRUS DISEASE  (COVID-19) AND OTHER VIRAL DISEASESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/216468HUMAN TIGIT SPECIFIC SINGLE DOMAIN ANTIBODIES AND METHODS OF  USEASKGENE PHARMA INC.
WO/2021/212122ENGINEERED PROBIOTICS FOR TREATMENT AND IMMUNITY AGAINST  VIRUSESUNIVERSITY OF CINCINNATI
WO/2021/216475COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL  AGENTSPOVIVA CORP.
WO/2021/216480NOVEL ANHYDROUS COMPOSITIONS COMPRISED OF MARINE OILSOMEZA, LLC
WO/2021/216489METHODS FOR TREATING MILD TRAUMATIC BRAIN INJURY, POST  TRAUMATIC STRESS DISORDER AND MILD TRAUMATIC BRAIN INJURYLOBE SCIENCES LTD.
WO/2021/216494COMPOSITIONS AND METHODS FOR TREATMENT OF GASTROINTESTINAL  BLEEDINGINTACT THERAPEUTICS, INC.
WO/2021/216496PROCESS FOR THE PREPARATION OF 1,3-BIS(ALLYLAMINO)PROPANETRICIDA, INC.
WO/2021/216530TREATMENT OF VIRAL INFECTIONS, OF ORGAN INJURY, AND OF RELATED  CONDITIONS USING A HIF PROLYL HYDROXYLASE INHIBITOR OR A HIF-ALPHA STABILIZERAKEBIA THERAPEUTICS, INC.
WO/2021/216537ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOFAB STUDIO INC.
WO/2021/216541BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF  THEIR MANUFACTURE AND USEBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/216545ORAL SOLID MELOXICAM FORMULATIONS FOR THE TREATMENT OF ACUTE  PAINMYLAN SPECIALTY L.P.
WO/2021/216547PULMONARY ADMINISTRATION OF ACE2 POLYPEPTIDESSORRENTO THERAPEUTICS, INC.
WO/2021/216548METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED MACULAR  DEGENERATIONUNIVERSITY OF MASSACHUSETTS
WO/2021/216562ZINC FOR TREATING COVID-19FINZI, Eric
WO/2021/262298ELECTROPHILIC COMPOUNDS AND ELECTROPHILIC PRODRUGS FOR  TREATING ANEURYSMUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/216569ENGINEERING BROADLY REACTIVE CORONAVIRUS VACCINES AND RELATED  DESIGNS AND USESGREFFEX, INC.
WO/2021/216572LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND  USES THEREOFMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/216575RECOMBINANT ROTAVIRUS EXPRESSION SYSTEM AND RECOMBINANT  ROTAVIRUSESTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/216577LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOFBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/216581METHOD OF TREATING AND PREVENTING CORONAVIRUS DISEASE 19  (COVID-19) USING A SELENIUM ADMINISTRATIONGHOWEBA, Mohamed Samir Elsayed
WO/2021/216584USE OF SURFACTANT PROTEIN D TO TREAT VIRAL INFECTIONSAIRWAY THERAPEUTICS, INC.
WO/2021/216586USE OF HUMAN AMYLIN ANALOG POLYPEPTIDES FOR PROVIDING SUPERIOR  GLYCEMIC CONTROL TO TYPE 1 DIABETICSINTARCIA THERAPEUTICS, INC.
WO/2021/216592LOX ENZYME INHIBITING METHODS AND COMPOSITIONSANOVIA BIOSCIENCES, INC.
WO/2021/216615HIGHLY-NETWORKED CORONAVIRUS IMMUNOGEN COMPOSITIONTHE GENERAL HOSPITAL CORPORATION
WO/2021/216618COMPOSITIONS AND METHODS COMPRISING CLOSTRIDIUM BUTYRICUM FOR  THE TREATMENT OF CANCERCITY OF HOPE
WO/2021/216620METHODS FOR TREATING BLADDER CANCERBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/216625OPTIMIZED PROTEIN FUSIONS AND LINKERSINTEGRATED DNA TECHNOLOGIES, INC.
WO/2021/216640COMPOSITION, ARTICLE AND METHOD FOR AFFECTING A MAMMALCOOLHOUSE SOURCING LLC
WO/2021/216659MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND USES THEREOFLUNG THERAPEUTICS, INC.
WO/2021/216674IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING  PLATFORMSUNIVERSITY OF MASSACHUSETTS
WO/2021/216678RENIN-ANGIOTENSIN SYSTEM (RAS) MODULATORS FOR TREATMENT OF  VIRAL INFECTIONS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAMETROCAR PHARMA INC.
WO/2021/216686TREATING AND CURING COVID-19 INFECTION UTILIZING A LASERARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/216687PEPTIDES FOR THE TREATMENT OF COVID-19RUSH UNIVERSITY MEDICAL CENTER
WO/2021/216691METHODS OF DETECTING AND TREATING CANCERS CHARACTERIZED BY  LOSS OF MIR15 AND MIR16 EXPRESSIONCROCE, Carlo, M.
WO/2021/216696TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND OTHER  DISORDERS INVOLVING CYTOKINE STORM USING BTK INHIBITORSPRINCIPIA BIOPHARMA INC.
WO/2021/216698COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAINDUKE UNIVERSITY
WO/2021/216699COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF  VIRAL INFECTIONSNED BIOSYSTEMS, INC.
WO/2021/216701COMPOSITIONS FOR TREATMENT OF VASCULAR DISEASEHOUSTON GENE THERAPEUTICS LLC
WO/2021/216710USE OF SALMETEROL AS AN ANTI-CORONAVIRAL AGENTTHE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/216722STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE  PHOSPHORAMIDATESATEA PHARMACEUTICALS, INC.
WO/2021/216729CELLULAR VACCINE PLATFORM AND METHODS OF USEINTIMA BIOSCIENCE, INC.
WO/2021/216731POLYSPECIFIC BINDING MOLECULES AND THEIR USE IN CELL THERAPYINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
WO/2021/216749METHOD FOR TREATING VIRAL AND BACTERIAL INFECTION THROUGH  INHALATION THERAPYHOAG, George, Edward
WO/2021/216754USE OF P38 MAPK INHIBITORS FOR PREVENTION AND TREATMENT OF  AGING AND AGING-RELATED DISORDERS AND FOR BOOSTING AN IMMUNE SYSTEMSPRING DISCOVERY, INC.
WO/2021/216755COMPOSITIONS AND METHODS FOR INTRANASAL TREATMENT WITH DOUBLE  STRANDED RNATHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/216759QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSECOHEN, Noam
WO/2021/216785BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOFFLAGSHIP PIONEERING, INC.
WO/2021/216786BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOFFLAGSHIP PIONEERING, INC.
WO/2021/216789SYSTEM, DEVICE, AND METHOD FOR SINGLE-CELL ENCAPSULATION AND  CULTUREUNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/216801PEGYLATED INTERFERON TAU AND COMPOSITIONS AND METHODS THEREOFSOUTHLAKE PHARMACEUTICALS, INC.
WO/2021/221983INTERFERON TAU AS ANTIVIRAL THERAPYSOUTHLAKE PHARMACEUTICALS, INC.
WO/2021/216807BIODEGRADABLE COPOLYMERS AND NANOFIBROUS SCAFFOLD THEREOFTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/216810LONG-ACTING ANTI-IL31 ANTIBODIES FOR VETERINARY USEKINDRED BIOSCIENCES, INC.
WO/2021/216812GALACTOKINASE INHIBITORSUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/216814BTK INHIBITORS TO TREAT PULMONARY DISTRESS IN COVID-19  PATIENTSDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/216816COMPOSITIONS COMPRISING EXTRACELLULAR MATERIAL WITH ANTIVIRAL  ACTIVITY AND USES THEREOFFETTECH, LLC
WO/2021/216832CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIESREMD BIOTHERAPEUTICS, INC.
WO/2021/216841COMPOSITIONS AND METHODS FOR MODULATING TRP CHANNEL ACTIVITYDUKE UNIVERSITY
WO/2021/225794METHODS FOR ORGANOIDS PRODUCTIONCITY OF HOPE
WO/2021/257179VAGINAL GELNATIONAL MEDICAL SUPPLY, LLC
WO/2021/216866METHODS FOR TREATING DISEASES BY TARGETING ONCOGENIC LIPIDSTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/216869NASAL SPRAY COMPOSITIONSCIVOLETTO, Joseph
WO/2021/221995MODIFIED NUCLEIC ACIDS ENCODING ASPARTOACYLASE (ASPA) AND  VECTOR FOR GENE THERAPYPFIZER INC.
WO/2021/216896TREATMENT OF CONDITIONS ASSOCIATED WITH THYROID HORMONESCOTT, Linzy O.
WO/2021/216903METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS  ASSOCIATED WITH INFECTIOUS DISEASEPETTINE, Kenneth Allen
WO/2021/216909TREATMENT OF VIRAL CONJUNCTIVITISOKOGEN, INC.
WO/2021/216916FORMULATION, DOSAGE REGIMEN, AND MANUFACTURING PROCESS FOR  HETERODIMERIC FC-FUSED PROTEINSDRAGONFLY THERAPEUTICS, INC.
WO/2021/225796MDMA TREATMENT TO ENHANCE ACUTE EMOTIONAL EFFECTS PROFILE OF  LSD, PSILOCYBIN OR OTHER PSYCHEDELICSUNIVERSITÄTSSPITAL BASEL
WO/2021/216925TRANSDERMAL ACTIVE AGENT DELIVERY DEVICES HAVING CORONAVIRUS  VACCINE COATED MICROPROTRUSIONSZOSANO PHARMA CORPORATION
WO/2021/216928LONG-ACTING BUPIVACAINE MICROSPHERE FORMULATIONSSCIENTURE, INC.
WO/2021/216934CLEARANCE OF SENESCENT CELLS BY ACTIVATION OF iNKT CELLSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/216936COMPOSITION FOR TREATING BLOOD CANCER USING  4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND USES THEREOFSOUTHERN RESEARCH INSTITUTE
WO/2021/222006POLYETHYLENE GLYCOL-FUNCTIONALIZED TRIGLYCERIDE POLYOL  POLYMERSKANSAS SOYBEAN COMMISSION
WO/2021/216944METHODS OF INCREASING MICROVASCULAR BLOOD FLOWABBOTT LABORATORIES
WO/2021/222009CLOBAZAM TRANSDERMAL DELIVERY SYSTEM AND USES THEREOFTAHO PHARMACEUTICALS LTD.
WO/2021/216973NURR1 RECEPTOR MODULATORS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/216975AAV NATIVE-NEURO PLATFORM AND USE FOR NEURONAL DISEASE GENE  THERAPYAAV GENE THERAPEUTICS, INC.
WO/2021/216980TARGETING THE PALMOTYLATION/DEPALMOTYLATION CYCLE TO TREAT  INFLAMMATORY DISEASESCORNELL UNIVERSITY
WO/2021/216993METHODS OF DETERMINING GENE EDITING EFFICIENCIES IN CELLSPACT PHARMA, INC.
WO/2021/216998MODIFIED NUCLEOTIDES AND USES THEREOFSINGULAR GENOMICS SYSTEMS, INC.
WO/2021/217006(S)-2-AMINO-6-((3-AMINOPROPYL)AMINO)HEXANOIC ACID (APL) FOR  USE IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH), LIVER  INFLAMMATION, HEPATOCELLULAR BALLOONING, LIVER FIBROSIS AND STEATOSISTEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/217010SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONSKALOCYTE, INC.
WO/2021/217018MICROPARTICLE-ASSISTED TREG THERAPY FOR TREATMENT OF TISSUE  INJURY AND FIBROSISUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/217019RAS INHIBITORS AND USES THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/217024ANTI-CD19 ANTIBODIES AND USES THEREOFMILLENNIUM PHARMACEUTICALS, INC.
WO/2021/217028COMPOSITIONS AND METHODS FOR <i>IN VIVO</i> LUNG  AND BLOOD SNO REPLETIONUNIVERSITY HOSPITALS - CLEVELAND MEDICAL CENTER
WO/2021/217036GPER PROTEOLYTIC TARGETING CHIMERASSALEM, Aliasger K.
WO/2021/262306DEVICES AND METHODS FOR THE TREATMENT OF SKIN DEPIGMENTATIONTEVIDO BIODEVICES, INC.
WO/2021/217043METHODS OF TREATING ACUTE LUNG INJURY USING EBSELENSOUND PHARMACEUTICALS INC.
WO/2021/217053PLASMA KALLIKREIN INHIBITORS FOR THE TREATMENT OF ARDS AND  RELATED CONDITIONSREZOLUTE, INC.
WO/2021/217063COMPOSITIONS AND METHODS FOR TREATING LUNG INJURYUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/217072USE OF IGF-2 FOR TREATMENT OF EPILEPTIC SEIZURESNEW YORK UNIVERSITY
WO/2021/217082POLYMER WITH CATIONIC AND HYDROPHOBIC SIDE CHAINSGENEDIT INC.
WO/2021/217084USE OF NITRO-FATTY ACIDS AND ANALOGUES THEREOF FOR THE  PREVENTION AND/OR TREATMENT OF ACUTE LUNG INJURY AND/OR SARS-COV-2 INFECTIONIMARA INC.
WO/2021/217086COMPOSITIONS AND METHODS COMPRISING DENDRIMERS AND THERAPEUTIC  AGENTSTHE JOHNS HOPKINS UNIVERSITY
WO/2021/217098TREATMENT OF VIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROMEABT HOLDING COMPANY
WO/2021/222045NOVEL PHARMACEUTICAL FORMULATION FOR C-MET INHIBITORAPOLLOMICS INC.
WO/2021/217109METHODS AND COMPOSITIONS FOR ENHANCING IMMUNOGENICITY OF  VACCINEZHANG, Kang
WO/2021/217111PH RESPONSIVE BLOCK COPOLYMER COMPOSITIONS AND MICELLES THAT  INHIBIT MCT 1 AND RELATED PROTEINSTHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/217117TARGETED THERAPY FOR THE TREATMENT & PREVENTION OF  LIFE-THREATENING COMPLICATIONS OF INFECTIONMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/222079SOLID COMPOSITIONS CONTAINING AMINE, PROTONATED AMINE OR  QUATERNARY AMMONIUM COMPOUNDSSTEPAN COMPANY
WO/2021/217122COMPOSITION, KIT AND METHOD FOR DIAGNOSIS AND TREATMENT OF  PROSTATE CANCERRADIOMEDIX, INC.
WO/2021/217131DENDRIMER COMPOSITIONS AND METHODS FOR TREATMENT OF SEVERE  ACUTE RESPIRATORY DISTRESS SYNDROMEASHVATTHA THERAPEUTICS, INC.
WO/2021/262311SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 AGONIST AND LIPOSOMAL  FORMULATIONS THEREOFTHE PENN STATE RESEARCH FOUNDATION
WO/2021/222094CODON OPTIMIZED GLA GENES AND USES THEREOF4D MOLECULAR THERAPEUTICS INC.
WO/2021/217143AMINOPIPERIDINE AMIDES, DERIVATIVES, COMPOSITIONS, AND USES  RELATED TO CXCR4 MODULATIONEMORY UNIVERSITY
WO/2021/217145COMPOSITIONS AND METHODS FOR REGULATION OF CELL ACTIVITY VIA  MODULATION OF BETA-CYTOKINE ACTIVITYTHE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/222129METHOD OF TREATING AN INFLAMMATORY DISORDERTHE UNIVERSITY OF MIAMI
WO/2021/242461NUTRIENT COMPOSITION ABLE TO INHIBIT QUORUM SENSINGBRILLIANT LAB LLC
WO/2021/222138COMPOUNDS FOR MUTANT RAS PROTEIN DEGRADATIONDEVELOPMENT CENTER FOR BIOTECHNOLOGY
WO/2021/222145METHODS OF TREATING AGITATION ASSOCIATED WITH ALZHEIMER'S  DISEASEAVANIR PHARMACEUTICALS INC.
WO/2021/222147HETEROCYCLIC GCN2 MODULATORSHIBERCELL, INC.
WO/2021/222156COMPOUNDS AND COMPOSITIONS FOR TREATING HEMATOLOGIC  MALIGNANCIESTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/222163PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURE USING  THERMALLY CONDUCTIVE EXCIPIENTSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/222165ALDOSE REDUCTASE INHIBITORS FOR TREATING SORBITOL  DEHYDROGENASE DEFICIENCYAPPLIED THERAPEUTICS, INC.
WO/2021/222174BCL-2 INHIBITORS AND THEIR USE AS PHARMACEUTICALSPRELUDE THERAPEUTICS INCORPORATED
WO/2021/222178ADJUNCT THERAPY FOR SUPPRESSING IMMUNE RESPONSE AGAINST GENE  THERAPYTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/222189METHOD FOR INCREASING SERUM ADIPONECTIN FOR TREATMENT AND  REDUCTION OF THE RISK OF CARDIOVASCULAR, VASCULAR, AND RELATED DISEASESFIRST FRUITS BUSINESS MINISTRY, LLC
WO/2021/222196METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTSPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/222227CHIMERIC ANTIGEN RECEPTORS TARGETING CD127 AND USE THEREOFMEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/222228A LIVE ATTENUATED MEASLES VIRUS VECTORED VACCINE FOR  SARS-COV-2OHIO STATE INNOVATION FOUNDATION
WO/2021/222230LOCAL ADMINISTRATION OF NICOTINIC ACETYLCHOLINE RECEPTOR  AGONISTS FOR THE INHIBITION OF CORONAVIRUS INFECTIONSOYSTER POINT PHARMA, INC.
WO/2021/222231PPARγ AGONISTS FOR TREATMENT OF KIDNEY DISEASETHE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/222232COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN  SYNDROMETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/222239PRECISION DOSING REGIMENCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/222240DRUG COMBINATIONS FOR INHIBITING INFECTIVITY OF INFLUENZA AND  CORONA VIRUSESSYSTAMEDIC INC.
WO/2021/222242METHODS FOR GENERATION OF MOUSE AND HUMAN URETERIC BUD  ORGANOIDS AND COLLECTING DUCT ORGANOIDSUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/222243STRUCTURALLY-STABILIZED AND HDMX-SELECTIVE P53 PEPTIDES AND  USES THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/222249COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND  OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITYTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/222257BACTERIOPHAGE COMPOSITIONS FOR TREATING  <i>PSEUDOMONAS</i> INFECTIONARMATA PHARMACEUTICALS, INC.
WO/2021/222262NATURALLY BASED PRESERVATIVES FOR PERSONAL CARE APPLICATIONSCARGILL, INCORPORATED
WO/2021/222268CRISPR/CAS9 THERAPIES FOR CORRECTING DUCHENNE MUSCULAR  DYSTROPHY BY TARGETED GENOMIC INTEGRATIONDUKE UNIVERSITY
WO/2021/222270PERSONAL CARE COMPOSITIONSCOLGATE-PALMOLIVE COMPANY
WO/2021/222288COMPOSITIONS AND METHODS FOR ENHANCING RECOMBINANT  BIOSYNTHESIS OF CANNABINOIDSWILLOW BIOSCIENCES, INC.
WO/2021/222291PHARMACEUTICAL COMPOSITION COMPRISING CHLORINE DIOXIDE FOR THE  TREATMENT OF COVID-19RADINOR, LLC
WO/2021/222295BINDING AGENTS AND USES THEREOF FOR CENTRAL NERVOUS SYSTEM  DELIVERYARUNA BIO, INC.
WO/2021/222297METHODS FOR GENERATING THYMIC CELLS IN VITROTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/222298MECHANICAL AND BIOCHEMICAL ACTIVATION AND CONTROL OF SKELETAL  STEM CELLS FOR CARTILAGE REGENERATIONTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/222308SSAO INHIBITORS FOR THE TREATMENT OF DISEASEMETACRINE, INC.
WO/2021/222309DETECTION AND MODIFICATION OF GUT MICROBIAL POPULATIONIXCELA, INC.
WO/2021/222322ACTRII PROTEINS AND USE IN TREATING POST-CAPILLARY PULMONARY  HYPERTENSIONACCELERON PHARMA INC.
WO/2021/222330COMBINATION OF BCMA-DIRECTED T CELL THERAPY AND AN  IMMUNOMODULATORY COMPOUNDJUNO THERAPEUTICS, INC.
WO/2021/222342METHODS OF USE OF T-TYPE CALCIUM CHANNEL MODULATORSPRAXIS PRECISION MEDICINES, INC.
WO/2021/222347PHARMACEUTICAL FORMULATIONAMGEN INC.
WO/2021/222355PHARMACEUTICAL FORMULATIONAMGEN INC.
WO/2021/222366IRAK INHIBITORS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/222368SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-VIRAL AND  ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITYIRENIX MEDICAL, INC.
WO/2021/222369MODIFIED RELEASE PHARMACEUTICAL FORMULATION COMPRISING  HYDROXYPROPYL CELLULOSEHERCULES LLC
WO/2021/222370A SERINE PROTEASE INHIBITOR FOR TREATING CORONAVIRUS INFECTIONCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/222385GLUCOCORTICOID RECEPTOR (GR) MODULATORS FOR TREATING A  SARS-COV-2 VIRUSAVM BIOTECHNOLOGY, LLC
WO/2021/222389MESENCHYMAL STEM CELL THERAPIESFACTOR BIOSCIENCE INC.
WO/2021/222424HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS FOR  TREATING AGING-RELATED CONDITIONSBIOAGE LABS, INC.
WO/2021/222453FAST-ACTING TOPICAL ANESTHETIC FORMULATIONSACHELON, INC.
WO/2021/222483METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORSGLOBAL BLOOD THERAPEUTICS, INC.
WO/2021/222485MINT FLAVOR COMPOSITIONSTHE PROCTER & GAMBLE COMPANY
WO/2021/225851METHODS OF TREATING CANCER USING A COMBINATION OF A PD-1  ANTAGONIST, A CHEMORADIATION THERAPY AND A PARP INHIBITORMERCK SHARP & DOHME CORP.
WO/2021/222513HAIR TREATMENT COMPOSITIONSL'OREAL
WO/2021/222519ENCAPSULATED COMPOSITIONS AND USE OF OCTENYLSUCCINIC ANHYDRIDE  STARCH AS EMULSIFYING AGENTKANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/222525BRIMONIDINE COMPOSITIONS AND METHODS OF USEEYE THERAPIES, LLC
WO/2021/222534COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF  CORONAVIRUS INFECTIONSARJIL BIOTECH HOLDING COMPANY LIMITED
WO/2021/222535METHOD FOR TREATING RESPIRATORY VIRAL INFECTIONS COMPRISING  ADMINISTRATION OF FATTY ACID COMPOSITIONSIRAZU BIO
WO/2021/222541METAL COMPOSITIONS AND METHODS OF USE THEREOFTHE UNIVERSITY OF MASSACHUSETTS
WO/2021/222545NALOXONE NANOPARTICLE COMPOSITIONS AND METHODS THEREOFTHE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/222549COMPLEMENT FACTOR B (CFB) IRNA COMPOSITIONS AND METHODS OF USE  THEREOFALNYLAM PHARMACEUTICALS, INC.
WO/2021/222552METHODS OF TREATING CYTOKINE-RELATED ADVERSE EVENTSCELGENE CORPORATION
WO/2021/222565NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF CYTOKINE  STORM SYNDROME (CSS) AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)ONCOUR PHARMA, INC.
WO/2021/231094DOXYCYCLINE OR MINOCYCLINE INJECTION FOR SCLEROTHERAPY OF  LOWER EYELID FESTOONS AND MALAR EDEMAFREUND, Robert
WO/2021/222575FLUORESCENT DYE IN TERNARY COMPLEXDAXOR CORP.
WO/2021/222577N-ACETYLSEROTONIN DERIVATIVES AS TRKB ACTIVATORS AND USES  THEREOFEMORY UNIVERSITY
WO/2021/222589COMBINATION TREATMENT OF RHAMNOLIPID AND NICLOSAMIDELEIGHTON, Anton
WO/2021/222593PD-L1 BINDING PEPTIDESUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/222616METHODS OF TREATING MULTIPLE MYELOMATENEOBIO, INC.
WO/2021/222618METHODS AND SYSTEMS FOR ASSESSING FIBROTIC DISEASE WITH DEEP  LEARNINGCEDARS-SINAI MEDICAL CENTER
WO/2021/222623COMPOSITIONS AND METHODS FOR INHIBITING VIRAL RECOGNITION  SITESWASHINGTON UNIVERSITY
WO/2021/222639RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USETHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/222654COMPOSITIONS AND METHODS FOR TREATMENT OF INHERITED MACULAR  DEGENERATIONSALIOGEN THERAPEUTICS, INC.
WO/2021/222660OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR  TREATING VIRAL INFECTIONSKALEIDO BIOSCIENCES, INC.
WO/2021/222682APPLICATION OF AAV44.9 VECTOR IN GENE THERAPY FOR THE INNER  EARTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/222696LIVE SELF-DESTRUCTING BACTERIAL ADJUVANTS TO ENHANCE INDUCTION  OF IMMUNITYUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/222700COMPOSITIONS AND METHODS FOR TREATING CANCER WITH  ANDROGRAPHOLIDE AND MELATONIN COMBINATION THERAPYUNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/222702CRYSTALLINE FORMS, COMPOSITIONS CONTAINING THEM, AND METHODS  OF THEIR USEFLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/222717METHODS OF GENERATING VACCINES AGAINST NOVEL CORONAVIRUS,  NAMED SARS-COV-2 COMPRISING VARIABLE EPITOPE LIBRARIES (VELS) AS IMMUNOGENSPRIMEX CLINICAL LABORATORIES
WO/2021/222727COMPOSITIONS AND METHODS OF USE THEREOFSYNEDGEN, INC.
WO/2021/222733OVERCOMING IMMUNE SUPPRESSION WITH TGF-β RESISTANT NK CELLSRESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/222738COMPOUNDS FOR ESTROGEN RECEPTOR POSITIVE CANCERSTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/222739ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID  DISPERSION OF NILOTINIBNANOCOPOEIA, LLC
WO/2021/222740CLOFAZIMINE COMPOSITION AND METHOD FOR THE TREATMENT OR  PROPHYLAXIS OF VIRAL INFECTIONSMANNKIND CORPORATION
WO/2021/222759ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF  CANCERBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/222764WATER-IN-OIL EMULSIONS CONTAINING SURFACTANT, SILICONE GUM  AND/OR LATEX, AND SILOXYSILICATE RESINL'OREAL
WO/2021/225892ANTIBODY-DRUG CONJUGATES (ADCS) COMPRISING AN ANTI-TROP-2  ANTIBODY, COMPOSITIONS COMPRISING SUCH ADCS, AS WELL AS METHODS OF MAKING AND  USING THE SAMELEVENA (SUZHOU) BIOPHARMA CO., LTD.
WO/2021/222773COMPOSITIONS COMPRISING N-ACETYL METHYL GABA AND RELATED  METHODSMBI DISTRIBUTING
WO/2021/222781COMPOSITIONS AND METHODS FOR TREATING CYTOKINE STORMSTOBIA, Annette M.
WO/2021/222783ANTI-TM4SF1 ANTIBODY DRUG CONJUGATES AND METHODS OF USING SAMEANGIEX, INC.
WO/2021/222789INHIBITORS OF ALPHA 2 BETA 1 INTEGRIN AND METHODS OF USE  THEREOFTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/222793MULTISPECIFIC ANTI-FLT3 CHIMERIC ANTIGEN RECEPTORSTHE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/222807FATTY ACYL AND FATTY ETHER CONJUGATES OF REMDESIVIR AND ITS  ACTIVE METABOLITES AS ANTIVIRALSAJK PHARMACEUTICAL LLC
WO/2021/222817COMPOSITIONS AND METHODS FOR SOLIDIFIED FERMENTED ANIMAL FEEDPACKERLAND WHEY PRODUCTS D/B/A FERMENTED NUTRITION
WO/2021/222835COMPOSITIONS AND METHODS COMPRISING STABLE REDUCED GLUTATHIONEPURSER, Danny, C.
WO/2021/225908TRIPLE COMBINATION THERAPY FOR ENHANCING CANCER CELL KILLING  IN CANCERS WITH LOW IMMUNOGENICITYBEYONDSPRING PHARMACEUTICALS, INC.
WO/2021/222851COMBINATIONS OF VIRAL PROTEINS, PEPTIDE SEQUENCES, EPITOPES,  AND METHODS AND USES THEREOFLA JOLLA INSTITUTE FOR IMMUNOLOGY
WO/2021/222852METHODS OF TREATMENT COMPRISING STABLE REDUCED GLUTATHIONEPURSER, Danny C.
WO/2021/222855NEOANTIGEN-INFORMED TUMOR-INFILTRATING LYMPHOCYTE CANCER  IMMUNOTHERAPYTHE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
WO/2021/222861ANTIBODIES SPECIFIC TO ABCB5 AND USES THEREOFCHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/222865METHODS FOR TREATING MYELIN ASSOCIATED DISEASES AND  MITOCHONDRIA ASSOCIATED DISEASESLARIMAR THERAPEUTICS, INC.
WO/2021/222875METHODS OF USING ALK2 INHIBITORSKEROS THERAPEUTICS, INC.
WO/2021/225912TREATMENT OF RESPIRATORY DISEASES WITH AMINO ACID COMPOUNDSPLIANT THERAPEUTICS, INC.
WO/2021/225918SEMI-SOLID CHEWABLE COMPOSITIONS AND METHODS OF MAKING AND  USING THEREOFSEATTLE GUMMY COMPANY
WO/2021/225926COMBINATION CANCER THERAPY USING N2-QUINOLINE OR ISOQUINOLINE  SUBSTITUTED PURINE DERIVATIVESWU, Zhanggui
WO/2021/225932FURAN SURFACTANT COMPOSITIONS AND METHODSSIRONIX RENEWABLES, INC.
WO/2021/225937COMPOSITIONS COMPRISING GELSOLIN FOR TREATING FRAILTYBIOAEGIS THERAPEUTICS INC.
WO/2021/222884AQUEOUS ANTI MICROBIAL COMPOSITION USEFUL AS A THERAPEUTIC  MATERIALTYGRUS LLC
WO/2021/222885TRANSDERMAL DRUG DELIVERY DEVICES HAVING PSILOCYBIN, LYSERGIC  ACID DIETHYLAMIDE OR 3,4-METHYLENEDIOXYMETHAMPHETAMINE COATED  MICROPROTRUSIONSZOSANO PHARMA CORPORATION
WO/2021/222886COMPOSITIONS AND METHODS TO TREAT POLYCYSTIC KIDNEY DISEASEBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/225950DOSING METHODS FOR TREATMENT OF CARDIOVASCULAR CONDITIONSIMBRIA PHARMACEUTICALS, INC.
WO/2021/222890CORONAVIRUS ASSAYS, DIAGNOSTIC METHODS, TREATMENT METHODS, AND  COMPOSITIONS RELATED THERETOEMORY UNIVERSITY
WO/2021/222903COMPOSITIONS COMPRISING ANTI-VEGF AND NANOPARTICLES AND  METHODS OF USING THE SAME FOR THE TREATMENT OF ABNORMAL OR EXCESSIVE  ANGIOGENESISPHAM, Randal Tanh Hoang
WO/2021/225973NALOXONE PHARMACEUTICAL FORMULATIONS FOR INTRANASAL (IN)  DELIVERYAMPHASTAR PHARMACEUTICALS, INC.
WO/2021/225974EPINEPHRINE PHARMACEUTICAL FORMULATIONS FOR INTRANASAL  DELIVERYAMPHASTAR PHARMACEUTICALS, INC.
WO/2021/225976SAFE USE OF BILE ACIDS AND THEIR SALTS AS ENHANCERS FOR NASAL  DELIVERY OF PHARMACEUTICALSAMPHASTAR PHARMACEUTICALS, INC.
WO/2021/225982SOS1 ALLOSTERIC SITE TARGETINGCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/225983SYSTEM AND METHOD TO USE SUCTION TO ENHANCE PERMEABILIZATION  AND TRANSFECTION OF CELLSRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/225987TOPICAL FORMULATIONS COMPRISING DUTASTERIDE FOR TREATING  DERMATOLOGICAL DISORDERS INCLUDING MALE PATTERN BALDNESSXYON HEALTH INC.
WO/2021/225996METHODS AND COMPOUNDS FOR PREVENTING AND ARRESTING COVID-19  MORBIDITY AND MORTALITY, VIA INHIBITION OF INTERLEUKIN-6, TNF-ALPHA, AND  OTHER CYTOKINES, AND VIA REDUCTION OF C-REACTIVE PROTEINSBIOVED PHARMACEUTICALS, INC.
WO/2021/226015NEUROQUIESCENCE - A TREATMENT FOR NEURODEVELOPMENTAL AND  NEURODEGENERATIVE BIOELECTRICAL DYSREGULATION AND DEMYELINATIONZUCCO SASSI YONEZAWA SIVIGLIA, Debora
WO/2021/226022PHOTOCHEMICAL SYNTHESIS OF MARMYCIN ANALOGUES THROUGH A NEW  PHOTOCHEMICAL REACTION INVOLVING CARBONYL COMPOUNDSBOWLING GREEN STATE UNIVERSITY
WO/2021/226024METHOD FOR TREATING SYMPTOMS OF VIRAL INFECTIONSWAINER, Irving, W.
WO/2021/226033HYALURONIC ACID DRUG CONJUGATESPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/226037TREATMENT OF VIRAL INFECTIONSSULFAGENIX, INC.
WO/2021/257193TRIAMCINOLONE ACETONIDE-LOADED LIPOSOMES TOPICAL OPHTHALMIC  FORMULATIONS AS PRIMARY THERAPY FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL  VEIN OCCLUSIONOPKO PHARMACEUTICALS, LLC
WO/2021/226039MODULAR THERAPEUTICS HAVING ANTI-RNA ACTIVITY AND METHODS  THEREOFSANATIO BIOSCIENCE CORP.
WO/2021/226042BIOMARKERS FOR ASSESSING LIVER DISEASEUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/226044PRODUCTION OF NMN AND ITS DERIVATIVES VIA MICROBIAL PROCESSESCONAGEN INC.
WO/2021/226054DROPLET ENCAPSULATION OF A CELL AND CONTROLLED RELEASE  PARTICLETHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/226060FORMULATIONS OF HYALURONIC ACID AND AMNIOTIC OR GESTATIONAL  FLUID, AND USES OF THE SAMEGENESIS BIOLOGICS, INC.
WO/2021/226076POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND  METHOD FOR DETECTION OF BACTERIAL INFECTIONTHE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/226088VACCINE ADJUVANTSVIROVAX LLC
WO/2021/226092SYNTHETIC LIPID-LIKE MATERIALS FOR BRAIN DELIVERYTRUSTEES OF TUFTS COLLEGE
WO/2021/226099TOPICAL ANTI-INFLAMMATORY CANNABINOID COMPOSITIONSAGRONOMED MANAGEMENT, LLC
WO/2021/226107COMPOSITIONS AND METHODS OF TREATING POMPE DISEASEAVIDITY BIOSCIENCES, INC.
WO/2021/226108PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING SECRETOMESACCELERATED BIOSCIENCES CORP.
WO/2021/226111IMMUNOTHROMBOSIS IN COVID-19 ACUTE RESPIRATORY DISTRESS  SYNDROMEUNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/226129SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3  AND METHODS OF USE THEREOFNEURALEXO, INC.
WO/2021/226135HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON  MYELOID CELLS 2 AGONISTS AND METHODS OF USEAMGEN INC.
WO/2021/226136ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSEANGARUS THERAPEUTICS, INC.
WO/2021/226137COMPOSITIONS, DEVICES AND METHODS FOR INDUCING IMMUNE  RESPONSES TO INFECTIOUS AGENTSSIGILON THERAPEUTICS, INC.
WO/2021/226148METHODS FOR TREATING PANCREATIC CANCER AND OTHER SOLID TUMORSDRUGCENDR AUSTRALIA PTY LTD.
WO/2021/226153ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/226154ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/226155ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACIDTHE PROCTER & GAMBLE COMPANY
WO/2021/226156ORAL CARE COMPOSITIONS COMPRISING MONODENTATE AND POLYDENTATE  LIGANDTHE PROCTER & GAMBLE COMPANY
WO/2021/226157REMINERALIZING ORAL CARE COMPOSITIONS COMPRISING TINTHE PROCTER & GAMBLE COMPANY
WO/2021/226158REMINERALIZING ORAL CARE COMPOSITIONS COMPRISING TINTHE PROCTER & GAMBLE COMPANY
WO/2021/226159ORAL CARE COMPOSITIONS COMPRISING TINTHE PROCTER & GAMBLE COMPANY
WO/2021/226161PROCESS FOR THE PREPARATION OF VERDIPERSTATBIOHAVEN THERAPEUTICS LTD.
WO/2021/226162EP4 ANTAGONISTS AND THEIR USE IN THE TREATMENT OF  PROLIFERATIVE DISEASESARRYS THERAPEUTICS, INC.
WO/2021/226193PROTEINS BINDING NKG2D, CD16 AND CLEC12ADRAGONFLY THERAPEUTICS, INC.
WO/2021/226244VASOACTIVE INTESTINAL PEPTIDE FUSION PROTEINS FOR THE  TREATMENT OF COVID-19PHASEBIO PHARMACEUTICALS, INC.
WO/2021/226256NICLOSAMIDE FORMULATIONS AND METHODS OF USENEUROBO PHARMACEUTICALS, INC.
WO/2021/226258FORMULATIONS OF PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR  MODULATORSCORCEPT THERAPEUTICS INCORPORATED
WO/2021/226263COMBINATIONSRECURIUM IP HOLDINGS, LLC
WO/2021/226269HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTSNUVALENT, INC.
WO/2021/226278AN ULTRASENSITIVE RAPID AND PORTABLE CASE13D-BASED DIAGNOSTIC  ASSAYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/236335PHARMACEUTICAL COMPOSITIONGLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
WO/2021/226329PURIFICATION AND SANITIZATION USING DIRECTED ENERGYARGOSY HOLDINGS, LLC
WO/2021/226330AGENTS TO PREVENT TISSUE DAMAGE FROM CLOSTRIDIUM DIFFICILE  INFECTIONS BY INHIBITION OF THE GUT-DAMAGING BACTERIAL TOXINS TCDA AND TCDBALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/226336COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN STRUCTURE  DETERMINATIONTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/226343DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HEPATITIS B VIRUSTHE WISTAR INSTITUTE OF ANATOMY ANDBIOLOGY
WO/2021/226358REDUCTION OF VIRAL DISEASE TRANSMISSION BY AVIAN ANTIBODIESCAMAS INCORPORATED
WO/2021/226368LIPOSOME FORMULATIONS FOR TREATMENT OF CANCERS AND DRUG  RESISTANCE OF CANCERSNANOTECH PHARMA INC.
WO/2021/226370TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE  ANIONIC SURFACTANTSARCUTIS BIOTHERAPEUTICS, INC.
WO/2021/226384METHODS OF TREATMENT FOR DISEASE FROM CORONAVIRUS EXPOSUREENSEMLBLE GROUP HOLDINGS
WO/2021/226390PROGESTOGEN FORMULATIONS AND USES THEREOFSHENZHEN EVERGREEN THERAPEUTICS CO., LTD.
WO/2021/226391USE OF GHRELIN OR GHRELIN VARIANT FOR INCREASING DOSE  INTENSITY OF CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH CANCEROXEIA BIOPHARMACEUTICALS, INC.
WO/2021/226402PROGESTOGEN FORMULATIONS FOR USE IN MODULATING A CYTOKINE  STORM MEDIATORSHENZHEN EVERGREEN THERAPEUTICS CO., LTD.
WO/2021/226404USE OF IL-6 ANTIBODIES AND VEGF TRAPS, AND FUSION CONSTRUCTS  AND CONJUGATES THEREOFKODIAK SCIENCES INC.
WO/2021/226405COVID-19 ANTIBODIES AND USES THEREOFINTERNATIONAL AIDS VACCINE INITIATIVE INC.
WO/2021/226412METHODS AND COMPOSITIONS FOR TREATING AN RNA VIRUS INDUCED  DISEASEGOLDEN BIOTECHNOLOGY CORPORATION
WO/2021/226416NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONSPSILERA INC.
WO/2021/226432METHODS OF DETECTING AND TREATING LUNG DAMAGE IN  RESPIRATORY-RELATED VIRAL INFECTIONSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/226436OPTIMIZED NUCLEOTIDE SEQUENCES ENCODING SARS-COV-2 ANTIGENSTRANSLATE BIO, INC.
WO/2021/226440ELASTASE-SUBSTRATE, PEPTIDE LINKER IMMUNOCONJUGATES, AND USES  THEREOFBOLT BIOTHERAPEUTICS, INC.
WO/2021/231208METHODS OF TREATING COVID-19 USING BARDOXOLONE METHYL OR  ANALOGS THEREOFREATA PHARMACEUTICALS, INC.
WO/2021/226454LINKER COMPOUNDSMPEG LA, L.L.C.
WO/2021/226455METHODS AND COMPOSITIONS FOR REDUCING JOINT INFLAMMATION USING  MESENCHYMAL STEM CELLSPRIMEGEN BIOTECH, LLC
WO/2021/231211COMPLEMENT COMPONENT C1S INHIBITORS FOR TREATING A  NEUROLOGICAL DISEASE, AND RELATED COMPOSITIONS, SYSTEMS AND METHODS OF USING  SAMEGENENTECH, INC.
WO/2021/226458AKT3 MODULATORSGEORGIAMUNE LLC
WO/2021/226465GLUCOCORTICOID RECEPTOR MODULATORSTRUSTEES OF DARTMOUTH COLLEGE
WO/2021/226476COCRYSTAL ANTIOXIDANTS OF PROTOCATECHUIC ACID WITH L-THEANINE  FOR THE TREATMENT OF OXIDATIVE STRESS AND INFLAMMATORY CONDITIONSTHEAPRIN PHARMACEUTICALS INC.
WO/2021/226477AKT3 MODULATORSGEORGIAMUNE LLC
WO/2021/226478DHODH INHIBITOR FOR THE TREATMENT OF COVID-19PTC THERAPEUTICS, INC.
WO/2021/226485ANTISENSE THERAPEUTICS FOR BETACORONAVIRUS TREATMENTOREGON STATE UNIVERSITY
WO/2021/242504METHODS FOR TREATING DEPRESSIONJANSSEN PHARMACEUTICALS, INC.
WO/2021/226510AKT3 MODULATORS AND METHODS OF USE THEREOFGEORGIAMUNE LLC
WO/2021/226520PEPTIDE COMPOSITIONS FOR THE TREATMENT OF PATHOGENIC  INFECTIONSKIROMIC BIOPHARMA, INC.
WO/2021/226532TRANSLATION BLOCKERS REPURPOSED FOR COVID-19 THERAPYTHE GENERAL HOSPITAL CORPORATION
WO/2021/226533CHIMERIC INFLUENZA VACCINESACADEMIA SINICA
WO/2021/226536CANNABINOID POUCHESTRINIDAD CONSULTING, LLC
WO/2021/226542POUCHESTRINIDAD CONSULTING, LLC
WO/2021/226546PROTEASE INHIBITORS FOR TREATMENT OR PREVENTION OF CORONAVIRUS  DISEASETHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/226561COVID-19 THERAPEUTICS AND METHODS OF TREATMENTBOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/231250TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES  COMPRISING GDC-9545 AND A CDK4/6 INHIBITORGENENTECH, INC.
WO/2021/226572PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND  VACCINATIONRESEARCH DEVELOPMENT FOUNDATION
WO/2021/231272ADMINISTRATION OF GUT-SELECTIVE JAK3 INHIBITORTHERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/231278COMBINATION THERAPY WITH MODIFIED PBMCS AND AN IMMUNOCONJUGATEF. HOFFMANN-LA ROCHE AG
WO/2021/226583ANTIVIRAL COMPOSITIONS AND METHODSWAYNE STATE UNIVERSITY
WO/2021/226584SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES BY ADP-RIBOSYL CYCLASESUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/231304MEASUREMENT OF AFUCOSYLATED IGG FC GLYCANS AND RELATED  COVID-19 TREATMENT METHODSCHAN ZUCKERBERG BIOHUB, INC.
WO/2021/231309METHODS FOR THE USE OF A B7-H3 ANTIBODY-DRUG CONJUGATE ALONE  OR IN COMBINATIONMACROGENICS, INC.
WO/2021/226592METHOD FOR TREATING PANCREATIC CANCERLANTERN PHARMA INC.
WO/2021/231314METHODS OF TREATING COVID-19 USING TETRACYCLINE COMPOUNDSPARATEK PHARMACEUTICALS INC.
WO/2021/231316IL-2 FUSION POLYPEPTIDE COMPOSITIONS AND METHODS OF MAKING AND  USING THE SAMEALKERMES PHARMA IRELAND LIMITED
WO/2021/231319IL-2 FUSION POLYPEPTIDE COMPOSITIONS AND METHODS OF MAKING AND  USING THE SAMEALKERMES PHARMA IRELAND LIMITED
WO/2021/231327METHODS FOR DE-CLOAKING CANCER FROM THE IMMUNE SYSTEMMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/226597CIRCULAR RNA COMPOSITIONS AND METHODSORNA THERAPEUTICS, INC.
WO/2021/226600TREATMENT OF METABOLIC DISORDERS THROUGH THE TARGETING OF A  NOVEL CIRCULATING HORMONE COMPLEXPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/226602PLACENTA-DERIVED ADHERENT (PDA) STEM CELL FOR THE TREATMENT OF  ADULTS WITH SARS-COV-2 RELATED ACUTE RESPIRATORY FAILURE AND ARDS (COVID-19)CELULARITY INC.
WO/2021/231335NOVEL INTERMEDIATES AND SYNTHESIS FOR ENDOCHIN-LIKE QUINOLONE  COMPOUNDSOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/231343SURFACTANT PROTEIN C MIMICS DISPLAYING PATHOGEN- OR  ALLERGEN-BINDING MOIETIESBARRON, Annelise E.
WO/2021/231346DOSING AND ADMINISTRATION OF ACTIVATABLE ANTI-CTLA-4 ANTIBODYBRISTOL-MYERS SQUIBB COMPANY
WO/2021/231350COMPOSITIONS OF POLYMERIC MICRODEVICES AND THEIR USE IN CANCER  IMMUNOTHERAPYMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/231361PHARMACEUTICAL FORMULATION CONTAINING ACTIVE METABOLITES OF  REMDESIVIR FOR INHALATIONANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/231383ORAL DELIVERY OF NANOPARTICLES FOR KIDNEY DISEASEUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/231397THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTIONTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/231405METHODS FOR TREATING GLIOBLASTOMABOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/231410METHOD OF TREATING CANCER WITH TELOTRISAT OR A PRODRUG THEREOFTERSERA THERAPEUTICS LLC
WO/2021/231413A TREATMENT APPROACH INVOLVING KIF18A INHIBITION FOR  CHROMOSOMALLY UNSTABLE TUMORSUNIVERSITY OF VERMONT
WO/2021/231421THIOL-CONTAINING COMPOUNDS FOR USE IN TREATING CORONAVIRUSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247208TOPICAL OPHTHALMOLOGICAL COMPOSITIONS AND METHODS FOR TREATING  ABNORMAL ANGIOGENESISADS THERAPEUTICS LLC
WO/2021/231431METHODS OF TREATING PROSTATE CANCERARVINAS OPERATIONS, INC.
WO/2021/231436THERAPEUTIC METHODS FOR TREATING COVID-19 INFECTIONSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/231441COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES AGAINST  CLASS I FUSION PROTEIN VIRUSESUNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/231443COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/231463VIRAL CLEARANCE BY LOW PH HOLDREGENERON PHARMACEUTICALS, INC.
WO/2021/231470USE OF COMPLEMENT FACTOR D INHIBITORS ALONE OR IN COMBINATION  WITH ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIAALEXION PHARMACEUTICALS, INC.
WO/2021/231474METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONPMV PHARMACEUTICALS, INC.
WO/2021/231486CANCER TREATMENT BY SENESCENCE INDUCTION FOLLOWED BY A  SENOLYTICUNITY BIOTECHNOLOGY, INC.
WO/2021/231499COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONSREVIR, INC.
WO/2021/231505VECTORS AND METHODS FOR IN VIVO TRANSDUCTIONABINTUS BIO, INC.
WO/2021/231509SHAMPOO COMPOSITION COMPRISING DECYL GLUCOSIDE AND A CATIONIC  GUARTHE PROCTER & GAMBLE COMPANY
WO/2021/231510SHAMPOO COMPOSITION COMPRISING ALKYL GLUCOSIDETHE PROCTER & GAMBLE COMPANY
WO/2021/231518NUCLEIC ACID LIGAND CONJUGATES AND USE THEREOF FOR DELIVERY TO  CELLSTHE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/231528COMPOSITIONS AND METHODS FOR TREATING CANCERRUSH UNIVERSITY MEDICAL CENTER
WO/2021/231539ALLEVIATION OF LIVER INJURY BY ACTIVATING THE SIGNALING  PATHWAY MEDIATED BY FARNESOID X RECEPTORCHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/231541POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOADNUTCRACKER THERAPEUTICS, INC.
WO/2021/231546SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF  NEUROMUSCULAR DISEASESEDGEWISE THERAPEUTICS, INC.
WO/2021/236389TREATMENT OF KNOWN AND UNKNOWN VIRAL INFECTION WITH LIPID  AGENTSBOND, Jason R.
WO/2021/231560ENGINEERING CORONAVIRUS SPIKE PROTEINS AS VACCINE ANTIGENS,  THEIR DESIGN AND USESGREFFEX, INC.
WO/2021/231563GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER  EARSPIRAL THERAPEUTICS INC.
WO/2021/231566THE USE OF CHOLINE SUPPLEMENTATION AS THERAPY FOR  APOE4-RELATED DISORDERSMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/231568METHODS OF TREATING CANCER USING A COMBINATION OF ANTI-CD30  ANTIBODY-DRUG CONJUGATESSEAGEN INC.
WO/2021/231570CYSTEAMINE FOR THE TREATMENT OF SARS-COV-2 INFECTIONTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/231581METHODS OF TREATING OR PREVENTING VIRAL INFECTION WITH  FLUORINATED α <sb>V</sb> INTEGRIN ANTAGONISTSSCIFLUOR LIFE SCIENCES, INC.
WO/2021/231611METHODS FOR TREATING CANCER USING SPL-108 POLYPEPTIDE BASED ON  TP53 MUTATIONAL STATUSSPLASH PHARMACEUTICALS, INC.
WO/2021/231615SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF  NEUROMUSCULAR DISEASESEDGEWISE THERAPEUTICS, INC.
WO/2021/231630SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF  NEUROMUSCULAR DISEASESEDGEWISE THERAPEUTICS, INC.
WO/2021/231639USE OF A MULTIMERIC ANTI-DR5 BINDING MOLECULE IN COMBINATION  WITH A CANCER THERAPY FOR TREATING CANCERIGM BIOSCIENCES, INC.
WO/2021/231644COMBINATION TREATMENT OF LIVER DISORDERSTERNS PHARMACEUTICALS, INC.
WO/2021/231646COMBINATION TREATMENT OF LIVER DISORDERSTERNS PHARMACEUTICALS, INC.
WO/2021/231648CANCER THERAPEUTICS COMPRISING CHEMOKINE OR ITS ANALOGGIGAGEN, INC.
WO/2021/231652USING THE P62 PLASMID TO TREAT OR REDUCE THE SEVERITY OF  CORONAVIRUS INFECTIONSCURELAB ONCOLOGY, INC.
WO/2021/231658SHEAR-THINNING COSMETIC COMPOSITIONELC MANAGEMENT LLC
WO/2021/231659NEUTRALIZING ANTIBODY TESTING AND TREATMENTSAPPHIRE BIOTECH, INC.
WO/2021/231660TREATMENT OF DYSLEXIA USING BOTULINUM TOXIN <u>  </u>PENLAND FOUNDATION
WO/2021/231665NOVEL ENCAPSULATED COSMETIC COMPOSITIONS AND USES THEREOFELC MANAGEMENT LLC
WO/2021/231666TREATMENT OF ASTHMA USING BOTULINUM TOXINPENLAND FOUNDATION
WO/2021/231668TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING  BOTULINUM TOXINPENLAND FOUNDATION
WO/2021/231669TREATMENT OF CARDIAC ARRHYTHMIA USING BOTULINUM TOXINPENLAND FOUNDATION
WO/2021/231671TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING BOTULINUM  TOXINPENLAND FOUNDATION
WO/2021/231672TREATMENT OF CIRRHOSIS USING BOTULINUM TOXINPENLAND FOUNDATION
WO/2021/231676EXTENDED TIME ACTION ACYLATED INSULIN COMPOUNDSELI LILLY AND COMPANY
WO/2021/231678REDUCING PROMININ2-MEDIATED RESISTANCE TO FERROPTOTIC CELL  DEATHUNIVERSITY OF MASSACHUSETTS
WO/2021/231689PHAGE-MEDIATED DELIVERY OF GENES TO GUT MICROBIOMECHAN ZUCKERBERG BIOHUB, INC.
WO/2021/236410ANTIFIBROTIC COMPOUNDS AND RELATED METHODSFLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/231697PEG LIPIDOID COMPOUNDSTRANSLATE BIO, INC.
WO/2021/236415SAFE POTENT SINGLE VECTOR PLATFORM VACCINE AGAINST COVID-19THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/231701CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS AND METHODS OF  MANUFACTURING SUCH COMPOUNDSSAVAGE, Paul B.
WO/2021/231702COMPOSITIONS AND METHODS FOR TREATING WOUNDSRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/231712HYPOIMMUNOGENIC CELLS AND USES THEREOF IN IMMUNE RESPONSESRXCELL INC.
WO/2021/231721TETRAHYDROCURCUMINOID-METAL COMPLEXES, MANUFACTURING METHODS  THEREOF, AND USES THEREOFPROBIOTICSMART, LLC
WO/2021/231727TOPICAL DUTASTERIDE EMULSIONS FOR TREATING ENDOCRINE  THERAPY-INDUCED ALOPECIAVARSONA THERAPEUTICS, INC.
WO/2021/231729ADJUVANTED STABILIZED STEM HEMAGGLUTININ NANOPARTICLES AND  METHODS OF USING THE SAME TO INDUCE BROADLY NEUTRALIZING ANTIBODIES AGAINST  INFLUENZASANOFI
WO/2021/231730COMPOSITIONS AND METHODS FOR TREATING GM1 GANGLIOSIDOSIS AND  OTHER DISORDERSLYSOGENE
WO/2021/2317502'-FUCOSYLLACTOSE FOR THE PREVENTION AND TREATMENT OF  CORONAVIRUS-INDUCED INFLAMMATIONGLYCOSYN LLC
WO/2021/231762COMBINATION THERAPY FOR THE TREATMENT OF TNBC WITH A PI3K  PATHWAY INHIBITOR THAT TARGETS PI3KDELTA AND PI3KGAMMA TNBCTHE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/231773COMPOSITIONS OF PROTEIN COMPLEXES AND METHODS OF USE THEREOFGOOD THERAPEUTICS, INC.
WO/2021/231778CORONAVIRUS PROTEASE DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/231782PERK INHIBITORS FOR TREATING VIRAL INFECTIONSHIBERCELL, INC.
WO/2021/231784PERK INHIBITING IMIDAZOLOPYRAZINE COMPOUNDSHIBERCELL, INC.
WO/2021/231788PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS TO TREAT VIRAL  INFECTIONSHIBERCELL, INC.
WO/2021/231792PHARMACEUTICAL FORMULATIONS AND USES THEREOFALDEYRA THERAPEUTICS, INC.
WO/2021/231795METHODS AND COMPOSITIONS FOR TREATING A TUMORRAKUTEN MEDICAL, INC.
WO/2021/231798ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSISDISC MEDICINE, INC.
WO/2021/231800ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING ANEMIA OF  CHRONIC DISEASEDISC MEDICINE, INC.
WO/2021/231802METHODS OF TREATING SJÖGREN'S SYNDROMEVANDERBILT UNIVERSITY
WO/2021/231804METHODS AND COMPOSITIONS FOR SUPPRESSING INFLAMMATION INDUCED  BY GUT MICROBESPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/231807NOVEL ANUCLEATED CELLS AS A SOURCE FOR TREATMENT OF PLATELET  RICH PLASMA DEPENDENT DISORDERSPLATELET BIOGENESIS, INC.
WO/2021/231810CANNABIDIOL AS A THERAPEUTIC MODALITY FOR COVID-19AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/236430C-TERMINAL FRAGMENT OF TETANUS TOXIN (HC) FOR TREATMENT OF  DEPRESSIONHOWARD UNIVERSITY
WO/2021/231814COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF  VASCULAR MALFORMATIONSTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/231830METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF  ABCA4KORRO BIO, INC.
WO/2021/231847OLEOGEL AND OLEOPASTE COMPOSITIONS AND USES THEREOFMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/231851METHODS AND COMPOSITIONS FOR TREATING ANEMIA USING ACTRIIB  LIGAND TRAPS AND MTOR INHIBITORSCELGENE CORPORATION
WO/2021/231854LNP COMPOSITIONS COMPRISING AN MRNA THERAPEUTIC AND AN  EFFECTOR MOLECULEMODERNATX, INC.
WO/2021/236440ATHLETIC PERFORMANCE ENHANCEMENT COMPOSITION USING MENTHOLADVANCED FOOD CONCEPTS, INC.
WO/2021/231860SOLID DOSAGE FORM FOR TRANSMUCOSAL DRUG DELIVERYPRIMO PHARMATECH LLC
WO/2021/231863COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/231866CARBON NANOTUBES AND COMPLEXES THEREOF FOR TREATING AND  DETECTING OCULAR TUMORSTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/231869USE OF TLR4 MODULATOR IN THE TREATMENT OF COCCIDIOSISZIVO BIOSCIENCE, INC.
WO/2021/231872COMPOSITIONS AND METHODS FOR INCREASING EFFICACY OF A DRUGHEALION BIO, INC.
WO/2021/231877ADMINISTRATION OF SUMO-ACTIVATING ENZYME INHIBITOR AND  ANTI-CD38 ANTIBODIESMILLENNIUM PHARMACEUTICALS, INC.
WO/2021/231885COMPOSITIONS AND METHODS FOR PROMOTING HAIR CELL REGENERATIONDECIBEL THERAPEUTICS, INC.
WO/2021/231893COMPOUNDS FOR INHIBITING LY6K AND METHODS OF USING SAMETHE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF  MILITARY MEDICINE, INC.
WO/2021/231901LIPID NANOPARTICLE FORMULATIONS FOR MRNA DELIVERYTRANSLATE BIO, INC.
WO/2021/231904DETECTION AND INDICATION OF COVID-19, OTHER VIRUSES AND  PATHOGENS AND VACCINE ASSOCIATED EFFICACYDIOMICS CORPORATION
WO/2021/231905KETAMINE TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSISTHE UNIVERSITY OF KANSAS
WO/2021/231908COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPYFRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/231922AGONISTIC TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY  POLYPEPTIDESTHE GENERAL HOSPITAL CORPORATION
WO/2021/231923COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A  SARS-COV-2 INFECTIONMETACLIPSE THERAPEUTICS CORPORATION
WO/2021/231925VACCINES FOR RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS  OF USING THE SAMEINOVIO PHARMACEUTICALS, INC.
WO/2021/231927ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON  LIGANDTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/231928A METHOD FOR TREATING CANCER WITH AN ORAL DOSAGE FORM OF AN  FGFR4 INHIBITOREISAI R&D MANAGEMENT CO., LTD.
WO/2021/242545AGENTS AND METHODS FOR TREATING TAUOPATHIESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/231929RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTIONMODERNATX, INC.
WO/2021/231930IMMUNE BOOSTER SUPPLEMENT TREATMENT KIT AND METHODS OF USEALTERED LABS LLC
WO/2021/231931METHODS OF TREATING SARS-COV-2 INFECTIONSTYME, INC.
WO/2021/231933ANTI-EPILEPTIC PHARMACEUTICAL COMPOSITIONS AND USE THEREOFNEUCYTE PHARMACEUTICALS
WO/2021/231941TLR7/8 ANTAGONISTS FOR THE TREATMENT OF CORONAVIRUS INFECTIONSMERCK HEALTHCARE KGAA
WO/2021/231942TOLL-LIKE RECEPTOR (TLR) AGONIST NANOPARTICLES AND USES  THEREOFTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/231945ASSAYS FOR ASSESSING ANTI-SEIZURE ACTIVITY OF CHEMICAL  COMPOUNDSNEUCYTE PHARMACEUTICALS
WO/2021/231946COMPOSITIONS AND METHODS FOR HARDENINGSPI PHARMA, INC.
WO/2021/231950APPARATUS FOR CANNABINOL GENERATION AND METHODS OF USING THE  SAMEAZDT HOLDINGS, LLC
WO/2021/231954METHODS FOR IMMUNOTHERAPYPRECISION BIOSCIENCES, INC.
WO/2021/231959METHODS FOR IMMUNOTHERAPYPRECISION BIOSCIENCES, INC.
WO/2021/231960METHODS OF TREATING LEFT VENTRICLE HYPERTROPHYAMGEN INC.
WO/2021/231963RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION, AND METHODS OF  USING THE SAME FOR TREATING COVID-19MODERNATX, INC.
WO/2021/231971SELECTIVE TARGETING OF THE TREML1/MD2 INTERACTION BY SMALL  PEPTIDE OR PROTEIN AND ITS USE FOR VACCINE ADJUVANTSASCENDO BIOTECHNOLOGY, INC.
WO/2021/231975HUMANIZED CD38 AND ICAM1 ANTIBODIES AND USES THEREOFVIRTUOSO BINCO, INC.
WO/2021/231982SMC1A ANTIBODIES AND USES THEREOFCITY OF HOPE
WO/2021/231988MITOCHONDRIAL-DERIVED PEPTIDES AND ANALOGS THEREOF FOR USE AS  A THERAPY FOR AGE-RELATED DISEASES INCLUDING CANCERUNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/236474NOVEL PROCESSES FOR PREPARING CONJUGATES OF THE IL-2 PROTEINMERCK SHARP & DOHME CORP.
WO/2021/242547BELVARAFENIB FOR USE IN CANCER TREATMENTHANMI PHARM. CO., LTD.
WO/2021/236489BIOMASS DERIVED DIKETONES AS EFFICIENT VISIBLE LIGHT  PHOTOINITIATORSBOWLING GREEN STATE UNIVERSITY
WO/2021/236491BENZOYLHYDRAZIDE-DERIVED HDAC DEGRADERS AS THERAPEUTICS FOR  TREATING CANCER AND OTHER HUMAN DISEASESUNIVERSITY OF FLORIDA RESEARCH FOUNDATION
WO/2021/236496ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITISBOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/236498TREATMENT OF KRAS-VARIANT CANCERS WITH SEROTONIN UPTAKE  INHIBITORSYALE UNIVERSITY
WO/2021/236508KITS AND METHODS FOR DETERMINING COPY NUMBER OF MOUSE TCR GENECELLULAR BIOMEDICINE GROUP HK LIMITED
WO/2021/236513VACCINE COMPOSITIONS COMPRISING ENDOGENOUS GAG POLYPEPTIDESVNV NEWCO INC.
WO/2021/236518LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF SEPSIS AND  SYMPTOMS THEREOFIRR, INC.
WO/2021/232013BIOACTIVE TISSUE DERIVED NANOCOMPOSITE HYDROGELS FOR PERMANENT  ARTERIAL EMBOLIZATION AND ENHANCED VASCULAR HEALINGMAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/236522USES OF ORNITHINE PHENYLACETATE FOR TREATING HYPERAMMONEMIAOCERA THERAPEUTICS, INC.
WO/2021/236526COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIABIOASIS TECHNOLOGIES, INC.
WO/2021/232015PLATELET DERIVED EXTRACELLULAR VESICLESCELLPHIRE, INC.
WO/2021/232019STING AGONIST COMBINATION TREATMENTS WITH IMMUNE CHECKPOINT  INHIBITORSIMMUNESENSOR THERAPEUTICS, INC.
WO/2021/236543TREATMENT FOR AMYLOIDOSISRECURIUM IP HOLDINGS, LLC
WO/2021/236550SYNTHETIC MODIFIED VACCINIA ANKARA (SMVA) BASED CORONAVIRUS  VACCINESCITY OF HOPE
WO/2021/236570PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR AND ITS  ACTIVE METABOLITES FOR DRY POWDER INHALATIONANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/236579DELIVERY OF AMNIOTIC MEMBRANE COMPONENTS TO OCULAR EPITHELIA  FOR WOUND HEALINGARLINGTON VISION, LLC
WO/2021/236581GRANULES FOR 3D PRINTING TECHNOLOGYBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/236599CONJUGATED OLIGONUCLEOTIDES AND USES THEREOFIONIS PHARMACEUTICALS, INC.
WO/2021/236606TREATMENT OF ADJUSTMENT DISORDERSVISTAGEN THERAPEUTICS, INC.
WO/2021/236607SKIN CARE PRODUCT WITH PROTEIN MATRIXEIGHTH DAY LABS, LLC
WO/2021/236614TARGETED ANTIVIRAL DRUGSNORTHWESTERN UNIVERSITY
WO/2021/236626MUCORETENTIVE ANTIVIRAL TECHNOLOGIESN-FOLD LLC
WO/2021/236629UNIVERSAL MULTI-FUNCTIONAL GSH-RESPONSIVE SILICA NANOPARTICLES  FOR DELIVERY OF BIOMOLECULES INTO CELLSWISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/236636MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE  AGAINST GRAM-POSITIVE BACTERIACONTRAFECT CORPORATION
WO/2021/236654ANTI-CANCER SPIROCYCLIC-GUANIDINE COMPOUNDS AND USES THEREOFTHE JOHNS HOPKINS UNIVERSITY
WO/2021/236671LOW-DOSE CARBACHOL COMPOSITIONS AND METHODS FOR TREATMENT OF  NIGHT VISION DISTURBANCEVYLUMA INC.
WO/2021/236672COMPOSITIONS AND METHODS FOR PREVENTION OF CORONAVIRUS  INFECTIONUNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/236685METHODS FOR THE TREATMENT OF PANCREATITIS AND PREVENTION OF  PANCREATIC CANCERBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/236689ORTHOGONALLY LINKED MULTIMERIC OLIGONUCLEOTIDESMPEG LA, L.L.C.
WO/2021/236711CALCINEURIN INHIBITOR TO IMPROVE CD3+CELL SURVIVAL TO THEREBY  FACILITATE ENGRAFTMENT OF DONOR CD34+ CELLS IN A RECIPIENTMEDEOR THERAPEUTICS, INC.
WO/2021/236718ANTI-FIBROTIC COMPOSITION AND RELATED METHODSFRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/236748CANNABIDIOL AND ACTIVE DELIVERY SYSTEMSELEMENTIS SPECIALTIES, INC.
WO/2021/236751SELENIUM-BASED COMPOSITIONS AND THERAPEUTIC METHODSHESS PHARMACEUTICALS, INC.
WO/2021/236782TOPICAL COMPOSITIONS AND METHODS FOR TREATING PAINMIG USA, LLC
WO/2021/236789METHOD OF TREATING OBESITY-INDUCED GLUCOSE INTOLERANCE AND  LIVER FIBROSISTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/236808USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC  DISEASESARJIL BIOTECH HOLDING COMPANY LIMITED
WO/2021/236811USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC  DISEASESARJIL BIOTECH HOLDING COMPANY LIMITED
WO/2021/236820METHODS AND COMPOSITIONS FOR TREATING ACUTE KIDNEY INJURYCALCIMEDICA, INC.
WO/2021/236841CONJUGATE POLYPEPTIDES AND VACCINES FOR INDUCING IMMUNE  RESPONSESTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/236845METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIESTAKEDA VACCINES, INC.
WO/2021/236852METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTIONSSANA BIOTECHNOLOGY, INC.
WO/2021/236855CIRCULAR RNA COMPOSITIONS AND METHODSORNA THERAPEUTICS, INC.
WO/2021/236859SYNTHESIS OF FLUORINATED NUCLEOTIDESMERCK SHARP & DOHME CORP.
WO/2021/236879METHOD FOR TREATING LYSOSOMAL STORAGE DISEASES WITH HISTATIN  PEPTIDESTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/236885PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS  AND METHODS OF USEDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/236890COMPOSITIONS AND METHODS FOR ACTIVATING SIGNALING THROUGH THE  CB2 CANNABINOID RECEPTOR FOR TREATING AND PREVENTING LYSOSOMAL STORAGE  DISEASES AND DISORDERSWYLDER NATION FOUNDATION
WO/2021/236891GUT-TARGETED PHOSPHODIESTERASE INHIBITORSAUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/236922ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODSWAYNE STATE UNIVERSITY
WO/2021/236930IMMUNOGENIC COMPOSITIONS AND USES THEREOFFLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/236935COMPOSITIONS AND METHODS FOR TREATING LUNG INJURIES ASSOCIATED  WITH VIRAL INFECTIONSQX THERAPEUTICS INC.
WO/2021/236938COMPOSITIONS AND METHODS RELATING TO AGING SKINALASTIN SKINCARE, INC.
WO/2021/236944PHARMACEUTICAL COMPOSITIONS COMPRISING BICTEGRAVIRGILEAD SCIENCES, INC.
WO/2021/236952COMPOSITIONS AND METHODS FOR PRODUCING HUMAN POLYCLONAL  ANTIBODIESFLAGSHIP PIONEERING, INC.
WO/2021/236958COMPOSITIONS AND METHODS OF TREATMENT WITH GLUTATHIONEAURO PHARMACEUTICALS, INC.
WO/2021/236980CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USESFLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/236985METHODS OF TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH  ACTIVATORS OF TIE-2AERPIO PHARMACEUTICALS, INC.
WO/2021/237022COMPOSITIONS AND METHODS FOR TREATING BREAST CANCERTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/237039COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF  GONADOTROPIN-RELEASING HORMONE (GNRH) ANTAGONISTSVERU INC.
WO/2021/237048MICRONEEDLE DEVICE FOR CONTROL OF THYROID HORMONE LEVELSEQUILIBRATE THERAPEUTICS, LLC
WO/2021/237061METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASETRUSTEES OF BOSTON UNIVERSITY
WO/2021/242630MAGNETO-ENDOSOMALYTIC THERAPY FOR CANCERUNIVERSITY OF WASHINGTON
WO/2021/237084METHYLENE BLUE STABILIZED MRNA COMPOSITIONSMODERNATX, INC.
WO/2021/237096DURABLE IMPLANTS AND MICROPARTICLES FOR LONG-TERM OCULAR  THERAPYGRAYBUG VISION, INC.
WO/2021/237100METHODS OF TARGETING EXTRACELLULAR VESICLES TO LUNGCODIAK BIOSCIENCES, INC.
WO/2021/237109COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONSTRAILHEAD BIOSYSTEMS INC.
WO/2021/237124SARS-COV-2 SPIKE PROTEIN PSEUDOTYPED VSV-DELTA G PARTICLES AND  USES THEREOFICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/242642COMPOSITION FOR TREATING PAIN WHILE MINIMIZING THE RISK OF  OPIOID ADDICTIONTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/237143TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)DURECT CORPORATION
WO/2021/237145COMPOSITION FOR SUNSCREEN COSMETICSFE:I BEAUTY TECH, INC.
WO/2021/237146TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)DURECT CORPORATION
WO/2021/237155COMPOSITION FOR COSMETICSFE:I BEAUTY TECH, INC.
WO/2021/237159METHODS AND COMPOSITIONS TO TREAT VASCULAR LEAKYALE UNIVERSITY
WO/2021/237174COMPOSITIONS AND DEVICES FOR VACCINE RELEASE AND USES THEREOFVAXESS TECHNOLOGIES, INC.
WO/2021/242649TISSUE-MIMICKING MATERIAL FOR A MULTI-MODALITY IMAGING PHANTOMENDRA LIFE SCIENCES INC.
WO/2021/242650THROMBOMODULIN DOMAIN 1 FOR TREATING EYE DISEASES ASSOCIATED  WITH PATHOLOGICAL OCULAR ANGIOGENESISWU, Hua-Lin
WO/2021/237193USE OF NAD+ PRECURSORS, STING INHIBITORS, AND FXR AGONISTS FOR  INHIBITING SARS-COV-2 (COVID-19)-INDUCED CYTOKINE RELEASEGEORGETOWN UNIVERSITY
WO/2021/247262ADHESIVE MATERIAL WITH TRIGGERABLE ON-DEMAND DETACHMENTMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/242683INHIBITION OF ARENAVIRUSES BY COMBINATIONS OF APPROVED  THERAPEUTIC DRUGSUNIVERSITY OF WASHINGTON
WO/2021/237209METAL-ORGANIC FRAMEWORKS DELIVER SMALL MOLECULES AND  BIOMACROMOLECULES FOR CANCER IMMUNOTHERAPYTHE UNIVERSITY OF CHICAGO
WO/2021/237213ANTI-MYOCILIN OLF ANTIBODIES AND METHODS OF USE THEREOFGEORGIA TECH RESEARCH CORPORATION
WO/2021/242711ADJUVANTED CONJUGATE OPIOID VACCINEUNIVERSITY OF HOUSTON SYSTEM
WO/2021/242724A NO MALODOR HAIR PERM FORMULATION AND METHOD OF USECALI-CURL, LLC
WO/2021/257252COMPOSITION FOR TREATING VIRAL INFECTIONSHOFLEITNER, Peter
WO/2021/242751COMPOSITIONS AND METHODS FOR TREATING SARS-COV-2HU, Mickey
WO/2021/242752METHODS OF CONTROLLING ACUTE INFLAMMATORY RESPONSEENDOCYTE, INC.
WO/2021/242753MITOCHONDRIAL TARGETING COMPOUNDS FOR THE TREATMENT OF  ASSOCIATED DISEASESTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/242757MONOCOLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS  USING SAMETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/242758IMPROVED NITRO-FATTY ACID ORAL DOSE REGIMENSIMARA INC.
WO/2021/242760METHODS OF TREATING VIRAL INFECTION USING PROTEASE INHIBITORSLOWELL THERAPEUTICS, INC.
WO/2021/247293METHODS AND PHARMACEUTICAL PREPARATIONS FOR ELEVATING KETONE  UTILIZATIONGLYKON TECHNOLOGIES GROUP, LLC
WO/2021/242788METHODS AND COMPOSITIONS FOR TREATING RETINAL DISEASES AND  CONDITIONSLINEAGE CELL THERAPEUTICS, INC.
WO/2021/242798SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES  THEREOFSYNLOGIC OPERATING COMPANY, INC.
WO/2021/242808CANNABINOID COMPOSITIONS AND DOSAGE FORMS FOR INTRANASAL OR  INHALATIONAL DELIVERYRHODES TECHNOLOGIES
WO/2021/242821COMPOSITIONS AND METHODS FOR TREATING MORPHINE, HEROIN, AND  ALCOHOL DEPENDENCEBEHNAM, Babak
WO/2021/242826COMPOSITIONS AND METHODS FOR TRANSDIFFERENTIATING CELLSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/242838COMPOSITIONS COMPRISING PERSONAL CARE PRODUCTS AND RELATED  METHODSONE FUN COMPANY, INC.
WO/2021/242848ANTI-GD2 SADA CONJUGATES AND USES THEREOFMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/242849ANTIBACTERIAL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS  USING SAMETHE ROCKEFELLER UNIVERSITY
WO/2021/242850COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING  SARS-COV-2 INFECTIONTHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/242859COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID  LEUKEMIAS TO CHEMOTHERAPYDUKE UNIVERSITY
WO/2021/242883SYNTHETIC OLIGONUCLEOTIDES HAVING REGIONS OF BLOCK AND CLUSTER  MODIFICATIONSUNIVERSITY OF MASSACHUSETTS
WO/2021/242896NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL  ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGINGUNM RAINFOREST INNOVATIONS
WO/2021/242905CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR  MODULATOR RELACORILANT AND CYP2C8 SUBSTRATESCORCEPT THERAPEUTICS INCORPORATED
WO/2021/242912CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR  MODULATOR RELACORILANT AND PACLITAXEL, A DUAL SUBSTRATE OF CYP2C8 AND CYP3A4CORCEPT THERAPEUTICS INCORPORATED
WO/2021/242916CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR  MODULATOR RELACORILANT AND CYP2C9 SUBSTRATESCORCEPT THERAPEUTICS INCORPORATED
WO/2021/242917TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY  DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONSGEORGETOWN UNIVERSITY
WO/2021/242923TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES  THEREOFAXIAL THERAPEUTICS, INC.
WO/2021/242935ANTIGEN PRESENTING POLYPEPTIDE COMPLEXES AND METHODS OF USE  THEREOFCUE BIOPHARMA, INC.
WO/2021/242937ANTIGEN PRESENTING POLYPEPTIDE COMPLEXES AND METHODS OF USE  THEREOFCUE BIOPHARMA, INC.
WO/2021/242942PROCESS FOR REDUCING HAIR DAMAGE UPON EXPOSURE TO HEATDOW GLOBAL TECHNOLOGIES LLC
WO/2021/242945GLUCOSYL ESTERS FOR INFECTION SCREENINGBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/242970METHODS FOR IMPROVED ENDOVASCULAR THROMBECTOMY USING  3,3'-DIINDOLYLMETHANEBOULDER BIOSCIENCE LLC
WO/2021/242976FUNCTIONAL SKIN COATING POLYMERTHE JOHNS HOPKINS UNIVERSITY
WO/2021/242988AIRWAY MEDICAMENTSTRENCH THERAPEUTICS, INC.
WO/2021/243007COMPOSITIONS AND METHODS FOR TREATING ACUTE RESPIRATORY  DISTRESS SYNDROME (ARDS) AND INFLAMMATORY DISORDERS CAUSED BY CORONAVIRUSESPHOR-MED, INC.
WO/2021/247360PARENTERAL NUTRITION FORMULATIONBAXTER INTERNATIONAL INC.
WO/2021/243015ANTIBACTERIAL COMPOUNDSTHE PENN STATE RESEARCH FOUNDATION
WO/2021/243023METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF  SERPINA1KORRO BIO, INC.
WO/2021/243028BISPECIFIC MOLECULES FOR SELECTIVELY MODULATING T CELLSDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/243031COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL ARTERY  DISEASEINOZYME PHARMA, INC.
WO/2021/247367COMPOUNDS AND COMPOSITIONS FOR TREATING, AMELIORATING, AND/OR  PREVENTING SARS-COV-2 INFECTION AND/OR COMPLICATIONS THEREOFYALE UNIVERSITY
WO/2021/243041PRINTING DROPLETS CONTAINING BIOLOGICAL MATERIALTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/243054COMPOSITIONS AND METHODS FOR INHIBITING VASCULAR SMOOTH MUSCLE  CELL PROLIFERATIONINOZYME PHARMA, INC.
WO/2021/243055PHOTOCURABLE RESIN FOR HIGH-RESOLUTION 3-D PRINTINGUNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/243081COMPOSITIONS AND METHODS FOR TREATING COVID-19 INFECTIONSAPIQUEST USA, INC
WO/2021/243093METHODS AND COMPOSITIONS FOR TREATING AND RECOVERING FORM  VIRAL INFECTIONSIMMUNOFLEX THERAPEUTICS INC.
WO/2021/243118INHIBITORS OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME  VIRUSUNIVERSITY OF CONNECTICUT
WO/2021/243123METHODS OF TREATING HER2 POSITIVE CANCER WITH TUCATINIB IN  COMBINATION WITH TRASTUZUMAB AND AN OXALIPLATIN-BASED CHEMOTHERAPYSEAGEN INC.
WO/2021/243136METHODS AND COMPOSITIONS FOR TREATING, PREVENTING THE ONSET  AND/OR SLOWING PROGRESSION OF OSTEOARTHRITISNEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED,  MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY
WO/2021/243148METHODS AND COMPOSITIONS FOR TREATING ALCOHOLIC LIVER DISEASEVANDERBILT UNIVERSITY
WO/2021/243157REMDESIVIR TREATMENT METHODSGILEAD SCIENCES, INC.
WO/2021/243162USE OF RIGOSERTIB TO TREAT RNA VIRUS INFECTIONSICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/247396COMPOUNDS AND METHODS FOR REDUCTION OF CANCER CELL BURDEN AND  PROTECTION OF NORMAL HEMATOPOIESISMAGNANI, John L.
WO/2021/243171METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONESAMO PHARMA LTD
WO/2021/243182DEVICES COMPRISING HYALURONIC ACID AND SILK FIBROINUNIVERSITY OF MONTANA
WO/2021/243183FORMULATIONS AND METHODS FOR TREATING ACUTE RESPIRATORY  DISTRESS SYNDROME, ASTHMA, OR ALLERGIC RHINITISUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/243186PRALSETINIB PHARMACEUTICAL COMPOSITIONSBLUEPRINT MEDICINES CORPORATION
WO/2021/243188POWDERIZED CANNABIS OILHEMP SYNERGISTICS
WO/2021/247412MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINENEW YORK UNIVERSITY
WO/2021/243201TOPICAL COMPOSITIONS FOR TREATING PERIPHERAL NEUROPATHIC PAINTHE UNIVERSITY OF MISSISSIPPI
WO/2021/243207USE OF MRNAS ENCODING OX40L, IL-23 AND IL-36GAMMA FOR TREATING  CANCERMODERNATX, INC.
WO/2021/243210METHOD OF REDUCING ENVIRONMENTAL METHYLMERCURY AND LIMITING  ITS UPTAKE INTO PLANTS AND ORGANISMSALBEMARLE CORPORATION
WO/2021/243226METHODS FOR THE TREATMENT OF INFANTILE SPASMS USING MEDIUM  CHAIN TRIGLYCERIDESCERECIN INC.
WO/2021/247423ABCG2 EFFLUX PUMP-CANCER ANTIGEN MULTI-SPECIFIC ANTIBODIES AND  COMPOSITIONS, REAGENTS, KITS AND METHODS RELATED THERETOKENJOCKETY BIOTECHNOLOGY, INC.
WO/2021/243256RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR DUAL CELL  AGGREGATES AND METHODS OF USE THEREOFFUJIFILM CELLULAR DYNAMICS, INC.
WO/2021/243259HAIR GROWTH COMPOSITIONSWALLER, Edmund
WO/2021/243270DEVICES, SYSTEMS, AND METHODS FOR FACILITATING TISSUE DELIVERY  OF DRUGGEORGIA TECH RESEARCH CORPORATION
WO/2021/243273BACTERIAL EFFLUX PUMP INHIBITORSTAXIS PHARMACEUTICALS, INC.
WO/2021/247430COMBINATION THERAPIES COMPRISING A HYPOMETHYLATION AGENT FOR  TREATING CANCERALX ONCOLOGY INC.
WO/2021/243280METHODS OF TREATING CANCER IN PATIENTS WITH AN ANOMALOUS KRAS  GENE OR DELETIONS WITHIN CHROMOSOME 9SYROS PHARMACEUTICALS, INC.
WO/2021/243284ANTIBODY FORMULATIONS AND USES THEREOFAMGEN INC.
WO/2021/243295IDENTIFICATION OF HLA-RESTRICTED PRAME PEPTIDE EPITOPES,  PRAME-SPECIFIC T CELLS SUITABLE FOR "OFF-THE-SHELF" TREATMENT OF  CANCER EXPRESSING PRAMECHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/243298METHODS OF TREATING IGA NEPHROPATHY WITH AN APRIL BINDING  ANTIBODYCHINOOK THERAPEUTICS, INC.
WO/2021/243309PARENTERAL DELIVERY OF AVIZAFONESOLLIEVO PHARMACEUTICALS, INC
WO/2021/247447ANTIVIRAL COMPOSITIONSKLELE, Luke
WO/2021/247454METHODS AND TREATMENT INVOLVING ANTIBODIES TO IL-18AVALO THERAPEUTICS, INC.
WO/2021/243319BIARYLSULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF,  AND THEIR USE FOR TREATING FIBROTIC LUNG DISEASENOVOMEDIX, LLC
WO/2021/247463FORMULATION OF MONODISPERSE KINETICALLY FROZEN POLYMER  MICELLES VIA EQUILIBRATION-NANOPRECIPITATIONPURDUE RESEARCH FOUNDATION
WO/2021/247473METHODS OF TREATMENT USING ICAM-MODULATING AGENTSAVM BIOTECHNOLOGY, LLC
WO/2021/247476MATERIALS AND METHODS FOR VIRAL PURIFICATIONJANSSEN BIOTECH, INC.
WO/2021/247480ENGINEERED MICROORGANISMS FOR DIAGNOSTIC IMAGINGSANARX BIOTHERAPEUTICS, INC.
WO/2021/247487RECOMBINANT FUSION PROTEINS TARGETING P-SELECTIN, AND METHODS  OF USE THEREOF FOR TREATING DISEASES AND DISORDERSMEDICAL UNIVERSITY OF SOUTH CAROLINA
WO/2021/247495LOW-pH SKIN CARE COMPOSITION AND METHODS OF USING THE SAMETHE PROCTER & GAMBLE COMPANY
WO/2021/247496METHOD OF IMPROVING PENETRATION OF A VITAMIN B3 COMPOUND INTO  SKINTHE PROCTER & GAMBLE COMPANY
WO/2021/247499USE OF A COMBINATION OF COLCHICINE AND A CXCR-2 INHIBITOR FOR  THE TREATMENT OR PREVENTION OF FAMILIAL MEDITERRANEAN FEVER (FMF) AND  FLARE-UPS THEREOFARISTEA THERAPEUTICS, INC.
WO/2021/247512METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHYMERCK PATENT GMBH
WO/2021/243328METHODS OF USING HSV-2 SINGLE CYCLE VIRUS DELTA-GD AND HSV-2  RECOMBINANT GLYCOPROTEIN DALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/257273TLR7/8 ANTAGONISTS AND USES THEREOFMERCK PATENT GMBH
WO/2021/247535LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING  GLUCOSE-6-PHOSPHATASE AND USES THEREOFMODERNATX, INC.
WO/2021/247537METAL DI-AMINO ACID CHELATES OR METAL TRI-AMINO ACID CHELATESBALCHEM CORPORATION
WO/2021/247542PHARMACEUTICAL COMPOSITIONS COMPRISING INSOLUBLE ACTIVE  INGREDIENTSADVENT THERAPEUTICS, INC.
WO/2021/247567CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING  SAMEWASHINGTON UNIVERSITY
WO/2021/247571VAGINAL MICROBIOTA COMPOSITIONSFERRING B.V.
WO/2021/247594DIHOMO-GAMMA LINOLENIC ACID (DGLA) IS A NOVEL SENOLYTICBUCK INSTITUTE FOR RESEARCH ON AGING
WO/2021/247606NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS  UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORSKSQ THERAPEUTICS, INC.
WO/2021/247620USE OF 2-HOBA TO TREAT ATHEROSCLEROSISVANDERBILT UNIVERSITY
WO/2021/247632SYSTEMS AND METHODS FOR TREATING CANCERARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/247652FORMULATIONS AND METHODS FOR TREATING DIARRHEAUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/247690RHO KINASE INHIBITOR RELEASING IMPLANTS AND RELATED METHODS OF  USEGLAUKOS CORPORATION
WO/2021/247703MAMMALIAN MILK OLIGOSACCHARIDES PREVENT VIRAL INFECTION OF  HUMAN EPITHELIUMTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247714COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING  COMPLEX AND HORMONE THERAPY AGENTGALERA LABS, LLC
WO/2021/247718ANTAGONISTIC BIPARATOPIC ANTIBODIES THAT SPECIFICALLY BIND  FIBROBLAST GROWTH FACTOR RECEPTOR 2 AND METHODS OF USING SAMETHE BROAD INSTITUTE, INC.
WO/2021/247724FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENTFAETH THERAPEUTICS, INC.
WO/2021/247743AUTOLOGOUS DENDRITIC CELL VACCINE KIT AND USESAIVITA BIOMEDICAL, INC.
WO/2021/247756RECOMBINANT HUMAN CC10 PROTEIN FOR TREATMENT OF INFLUENZA,  EBOLA, AND CORONAVIRUSAPC RESEARCH ASSETS LLC
WO/2021/2477581,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME  FOR USE IN THE PREVENTION AND TREATMENT OF CANCERARTEMIFLOW GMBH
WO/2021/247776BIOLOGICALLY ACTIVE COMPOSITIONS AND METHODS OF USINGMEDIWEL LABS, LLC
WO/2021/247798BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1  AND USES THEREOFMERCK PATENT GMBH
WO/2021/247805HUMANIZED ANTIBODIES DIRECTED AGAINST KCNK9THE JOHNS HOPKINS UNIVERSITY
WO/2021/252254NOVEL PREVENTIVE AND THERAPEUTIC TREATMENT FOR COVID 19 AND  ANY OTHER DISEASE CAUSED BY SARS COV 2AMCYTE PHARMA, INC
WO/2021/247809PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF USE  THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSMERCK SHARP & DOHME CORP.
WO/2021/247821MONOCLONAL ANTIBODIES AGAINST HUMAN SIGLEC-9 AND USE THEREOF  FOR IMMUNOTHERAPYTHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/247824PROFRAGRANCE CONJUGATESINTERNATIONAL FLAVORS & FRAGRANCES INC.
WO/2021/247836METHODS FOR TARGETING SHP-2 TO OVERCOME RESISTANCEBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/247838FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONENT AND A  NON-ODOROUS FRAGRANCE MODULATORCOTY INC.
WO/2021/247841PURINES AND METHODS OF THEIR USEYUMANITY THERAPEUTICS, INC.
WO/2021/247862BICYCLIC HETEROARENES AND METHODS OF THEIR USEYUMANITY THERAPEUTICS, INC.
WO/2021/247880SPIRO-LACTAM COMPOUNDS AND METHODS OF TREATING VIRAL  INFECTIONSAPTINYX INC.
WO/2021/247889INHIBITION OF BMI1 ELIMINATES CANCER STEM CELLS AND ACTIVATES  ANTITUMOR IMMUNITYTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247890ZONAL AND TARGETED METHODS AND USES FOR TREATING A MIGRAINE  DISORDERMIOTOX, LLC
WO/2021/247895METHODS AND ANTIBODIES IN TREATMENT OF FOCAL SEGMENTAL  GLOMERULOSCLEROSIS (FSGS)THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247897DEUTERATED IRAK DEGRADERS AND USES THEREOFKYMERA THERAPEUTICS, INC.
WO/2021/247899CRYSTALLINE FORMS OF IRAK DEGRADERSKYMERA THERAPEUTICS, INC.
WO/2021/247900COMPOUNDS AND METHODS FOR THE TREATMENT OF EYE DISORDERSOCCURX PTY. LTD.
WO/2021/247901COMPOUNDS AND METHODS FOR THE TREATMENT OF EYE DISORDERSOCCURX PTY. LTD.
WO/2021/247921BENZOTHIAZOLE COMPOUNDS AND USES THEREOFYUMANITY THERAPEUTICS, INC.
WO/2021/247923PERSONALIZED METHODS OF TREATING CANCERFAETH THERAPEUTICS, INC.
WO/2021/247933EXTRACTION TECHNIQUES TO PRESERVE CANNABINOID AND TERPENOID  PROFILESCREDO SCIENCE, LLC
WO/2021/247934FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONISTCURASEN THERAPEUTICS, INC.
WO/2021/247963(S)-ALPHA-FLUOROMETHYLTYROSINE AS DECARBOXYLASE INHIBITORS FOR  USE IN THE TREATMENT OF HYPOTENSIONSENDA BIOSCIENCES, INC.
WO/2021/247977METHODS OF TREATING PROSTATE CANCERCELGENE QUANTICEL RESEARCH, INC.
WO/2021/247978ANTIBACTERIAL SYNTHETIC-BIOINFORMATIC NATURAL PRODUCTS AND  USES THEREOFTHE ROCKEFELLER UNIVERSITY
WO/2021/248001SERUM BIOMARKERS FOR PREDICTING AND PREVENTING HEMORRHAGIC  STROKETEXAS TECH UNIVERSITY SYSTEM
WO/2021/248008ARYLAMIDE COMPOUNDS FOR TREATMENT AND PREVENTION OF VIRAL  INFECTIONSINNOVATION PHARMACEUTICALS INC.
WO/2021/248022METHODS OF TREATING A CORONAVIRUS INFECTIONTHE GENERAL HOSPITAL CORPORATION
WO/2021/248033CADHERIN-11 INHIBITOR FORMULATION AND ITS USES IN  IMMUNOTHERAPYGEORGETOWN UNIVERSITY
WO/2021/248052COMPOSITIONS AND METHODS FOR TREATING NEOPLASIATHE BROAD INSTITUTE, INC.
WO/2021/252290COMPOSITIONS AND METHODS FOR TREATING NOVEL CORONAVIRUS  SARS-COV-2-MEDIATED INFLAMMATORY CONDITIONSGRI BIO, INC.
WO/2021/248061NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORSCARISMA THERAPEUTICS INC.
WO/2021/248081ACVR1 (ALK2) RECEPTOR INHIBITION TO TREAT NEUROLOGICAL  DISEASESTHE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST  ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE
WO/2021/248086LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUSTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/248093DACLATASVIR FOR USE IN TREATING LUNG AND PROSTATE CANCERHENRY FORD HEALTH SYSTEM
WO/2021/252307RIPK1 INHIBITORS AND METHODS OF USEMERCK SHARP & DOHME CORP.
WO/2021/252314METHODS OF TREATING FEMALE HEALTH CONDITIONS RELATED TO SEX  HORMONESELIEM THERAPEUTICS, INC.
WO/2021/252316GRANULAR COMPOSITION OF AN ERK INHIBITOR AND USES THEREOFMERCK SHARP & DOHME CORP.
WO/2021/248109DYNAMICALLY CROSSLINKED INJECTABLE HYDROGELS WITH CHEMICALLY  STABILIZED MULTILAMELLAR VESICLESTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY  OFFICE OF THE GENERAL COUNSEL
WO/2021/248111MATERIALS AND METHODS FOR INHIBITING A VIRAL INFECTION,  INCLUDING A CORONAVIRUS INFECTIONQUORUM INNOVATIONS, LLC
WO/2021/252347THERAPEUTICS FOR TREATMENT OF COVID-19 SYMPTOMSTHE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/252358ANTI-CD171 CHIMERIC ANTIGEN RECEPTORSSEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH  INSTITUTE)
WO/2021/248122COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAMEAPPLIED MATERIALS, INC.
WO/2021/252371USE OF ATOVAQUONE AND PROGUANIL FOR TREATMENT OF  GASTROINTESTINAL DISEASES AND INFLAMMATIONELEVAID THERAPEUTICS, INC.
WO/2021/252373TREATMENT OF CYSTINOSISNACUITY PHARMACEUTICALS, INC.
WO/2021/257314METHOD OF TREATING DIFFICULT TO ACCESS TUMORS WITH  PHOTOACTIVATED CANCER THERAPYIMMUNOLIGHT, LLC
WO/2021/252378PREVENTION OR TREATMENT OF COVID-19NACUITY PHARMACEUTICALS, INC.
WO/2021/252382THERAPEUTIC CARBON NANOMATERIAL H2S OXIDANTS FOR BIOLOGICAL  POLYSULFIDE SYNTHESISTHE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/248133ANTI-TRANSFERRIN EXTRACELLULAR VESICLESCODIAK BIOSCIENCES, INC.
WO/2021/248134COMPOSITIONS AND METHODS FOR TREATING LONG COVIDAIM IMMUNO TECH INC.
WO/2021/252421METHODS OF TREATING VISUAL DISORDERS USING DAILY LOW DOSING OF  A RETINOID COMPOUNDRETINAGENIX HOLDINGS LLC
WO/2021/252426COLORED COSMETIC SOLID DISPERSIONSSUN CHEMICAL CORPORATION
WO/2021/252432COMPOSITIONS AND METHODS FOR DELIVERING POLYNUCLEOTIDESNEONC TECHNOLOGIES, INC.
WO/2021/252448IMAGING COMPOUNDS SELECTIVE FOR NAV1.7MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/252449STERILIZED FORMULATIONSHARM REDUCTION THERAPEUTICS, INC.
WO/2021/252450PHAGE DISPLAY VACCINE FOR COVID-19 USING A NOVEL PEPTIDE  SEQUENCEADAPTIVE PHAGE THERAPEUTICS, INC.
WO/2021/252459USE OF CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS TO  DEACTIVATE CORONAVIRUSSAVAGE, Paul B.
WO/2021/252484COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND  METHODS OF USE AND MAKING THEREOFDISRUPTION LABS INC.
WO/2021/252496ENGINEERED ADENOVIRUS VECTORS AND USES THEREOFLOWENTHAL, Richard
WO/2021/252505ARYLACETAMIDE ANALOGS OF  PIPERAZINE-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINESUNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE
WO/2021/252507THERMOGEL SUSTAINED-RELEASE MICROPARTICLE-BASED DELIVERY TO A  PARANASAL AND/OR NASAL CAVITYUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/252513USES OF HYALURONAN CONJUGATEAIHOL CORPORATION
WO/2021/252517ENGINEERED T CELL RECEPTORS AND METHODS OF USEBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/252519MATERIALS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF  CANCERUNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/262437USE OF IL13 FOR PREVENTION AND TREATMENT OF COVID-19DESAI, Ketan
WO/2021/252577PHARMACEUTICAL FORMULATION CONTAINING UMECLIDINIUM BROMIDE AND  VILANTEROL TRIFENATATEANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/252581DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A  BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING β-GLUCAN AS A VACCINE  ADJUVANTMEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/252583SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF  MACROMOLECULAR DRUG DELIVERY PLATFORMTHE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/252586PHARMACEUTICAL FORMULATION CONTAINING GLYCOPYRROLATE AND  INDACATEROL MALEATEANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/262439REDUCED GLYCOL FATTY ALCOHOL ETHOXYLATES AND REDUCED GLYCOL  SULFATE ETHOXY LATED|SURFACTANTSTHE PROCTER & GAMBLE COMPANY
WO/2021/252604CORONAVIRUS DISEASE 2019 (COVID-19) COMBINATION VACCINETHE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/252612UNDENATURED TYPE II COLLAGEN AS A SUPPLEMENT FOR IMPROVED  ENDURANCE, LIPID METABOLISM, AND OXIDATIVE STRESSLONZA CONSUMER HEALTH INC.
WO/2021/252618METHODS AND MATCHA GREEN TEA CONTAINING COMPOSITIONS FOR  PREVENTING AND TREATING TOOTH EROSIONUNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/252626METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH FENOTEROL HYDROBROMIDE, A β2- ADRENERGIC RECEPTOR AGONIST, AND  DERIVATIVES THEREOFTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252628METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH TRICHOSTATIN A, A HISTONE DEACETYLASE (HDAC) INHIBITOR, AND DERIVATIVES  THEREOFTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252630METHODS FOR TREATING OR PREVENTING CHRONIC KIDNEY DISEASEARTHROSI THERAPEUTICS, INC.
WO/2021/252632PHYSIOLOGICALLY ACCEPTABLE COMPOSITIONS CONTAINING  MICROORGANISMS OR MICROBIAL PRODUCTSFLAGSHIP PIONEERING, INC.
WO/2021/252634DEUTERATED PROTEASE INHIBITORSKANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/252636METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH FINGOLIMOD, A SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR, AND  DERIVATIVES THEREOFTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252647METHODS OF IMPROVING RETINA-ASSOCIATED DISEASE OUTCOME USING  CCR3-INHIBITORSALKAHEST INC.
WO/2021/252650HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCERICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/252654CELL/GENE THERAPIES TARGETING MAGE-A4 PEPTIDEINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
WO/2021/252659MANUFACTURE, FORMULATION AND DOSING OF APRAGLUTIDEVECTIVBIO AG
WO/2021/252661ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOFDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/252664GRANZYME B DIRECTED IMAGING AND THERAPYCYTOSITE BIOPHARMA INC.
WO/2021/252669CRF1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF CONGENITAL  ADRENAL HYPERPLASIANEUROCRINE BIOSCIENCES, INC.
WO/2021/252685BLOOD IRRADIATION DEVICE AND METHODS FOR TREATING VIRAL  INFECTIONS USING SAMEASCEPI MEDICAL GROUP, LLC
WO/2021/257353PLASMA KALLIKREIN INHIBITORSMERCK SHARP & DOHME CORP.
WO/2021/252708STABILIZED TRIOXACARCIN ANTIBODY DRUG CONJUGATES AND USES  THEREOFPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/252709COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING,  AMELIORATING, AND/OR PREVENTING SIGMA RECEPTOR RELATED DISEASES AND/OR  DISORDERSRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/252717METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH BERBERINE, A BERBERIDACEAEN ALKALOID, AND DERIVATIVES THEREOFTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252718TLR7 INHIBITOR IN COMBINATION WITH PREDNISOLONE OR  HYDROXYCHLOROQUINE FOR TREATING CUTANEOUS LUPUS ERYTHEMATOSUSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/252719METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH S-METHYL-L-THIOCITRULLINE, A SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE  (NNOS) INHIBITOR, AND DERIVATIVES THEREOFTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252741OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS  OF USE THEREOFAUSPEX PHARMACEUTICALS, INC.
WO/2021/252760SWINE ORIGIN PROBIOTICS THAT PROMOTE HEALTH AND GROWTH  PERFORMANCE IN PIGSTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
WO/2021/252769PH-RESPONSIVE LIPIDOID NANOPARTICLES FOR INTRACELLULAR MRNA  DELIVERYTRUSTEES OF TUFTS COLLEGE
WO/2021/252776COMBINATION THERAPIESMEI PHARMA, INC.
WO/2021/252786EFFECTIVE TEETH WHITENING COMPOSITION UTILIZING BROMELAIN  ENZYMESAMARILLO JUNIOR COLLEGE DISTRICT
WO/2021/2527933D LASER SINTERING PROCESSES FOR IMPROVED DRUG DELIVERYBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/252803NANOLIPOPROTEIN-POLYPEPTIDE CONJUGATES AND COMPOSITIONS,  SYSTEMS, AND METHODS USING SAMEGENENTECH, INC.
WO/2021/252821ENHANCED IMMUNOGENIC DNA/RNA COMPOSITIONS AND METHODSMBF THERAPEUTICS INC.
WO/2021/252838COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS  USING <i>FOURNIERELLA MASSILIENSIS</i>EVELO BIOSCIENCES, INC.
WO/2021/252844SYSTEMS, DEVICES, COMPOSITIONS, AND METHODS FOR TREATING  DIABETESABVANCE THERAPEUTICS INC.
WO/2021/252861COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS  USING <i>MEGASPHAERA SP</i>EVELO BIOSCIENCES, INC.
WO/2021/252874XPO1 INHIBITORS FOR USE IN TREATING CANCERKARYOPHARM THERAPEUTICS INC.
WO/2021/252877COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS  USING OSCILLOSPIRACEAE MICROBIAL EXTRACELLULAR VESICLESEVELO BIOSCIENCES, INC.
WO/2021/252881ENGINEERED PROBES FOR SIALOGLYCAN BINDINGVANDERBILT UNIVERSITY
WO/2021/257398COMPOSITIONS AND METHODS FOR OVERCOMING  MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETINGMAGNANI, John L.
WO/2021/252889NANOSPHERE SIZE CONTROL BY VARYING THE RATIO OF COPOLYMER  BLENDSRUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/252895COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF  NEUROLOGICAL DISORDERSYUMANITY THERAPEUTICS, INC.
WO/2021/252896METHODS AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTIOUS  DISEASETHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/252900BIOMARKERS FOR RESPONSE TO EXPORTIN-1 INHIBITORS IN MULTIPLE  MYELOMA PATIENTSKARYOPHARM THERAPEUTICS INC.
WO/2021/252904RIBONUCLEOPROTEIN APPROACH TO BOOST THE STING SIGNALING FOR  CANCER IMMUNOTHERAPYMASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/252905BIOMARKERS FOR RESPONSE TO EXPORTIN-1 INHIBITORS IN DIFFUSE  LARGE B-CELL LYMPHOMA PATIENTSKARYOPHARM THERAPEUTICS INC.
WO/2021/252910C-TYPE NATRIURETIC PEPTIDES AND METHODS THEREOF IN TREATING  ACUTE LUNG INJURYPHARMAIN CORPORATION
WO/2021/252915GASDERMIN D (GSDMD) SUCCINATION FOR THE TREATMENT OF  INFLAMMATORY DISEASEUNIVERSITY OF MASSACHUSETTS
WO/2021/252924ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY TO THE NERVOUS  SYSTEMPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/252931C-TYPE NATRIURETIC PEPTIDES AND METHODS THEREOF IN TREATING  CANCERPHARMAIN CORPORATION
WO/2021/252936REJUVENATION OF AGED TISSUES AND ORGANS BY INHIBITION OF THE  PGE2 DEGRADING ENZYME, 15-PGDHTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/252950T-TYPE CALCIUM CHANNEL ENHANCER FOR TREATING TAF1 ASSOCIATED  NEUROLOGICAL DEFECTSARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/252951METHODS OF TREATMENT FOR GASTROINTESTINAL MOTILITY DISORDERSVANDERBILT UNIVERSITY
WO/2021/252954INACTIVATION OF GENOME ENVELOPED WITHIN CORONAVIRUS SPHERICAL  OR PLEOMORPHIC PARTICLES OR SHELLS TO FORM A VACCINESCHOSSAU, Tom M.
WO/2021/252957CANNABINOID COMPLEXES AND METHODS OF MAKING AND USING THEMTEST KITCHENS, INC.
WO/2021/252959SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL  FIBRILLATIONHUYABIO INTERNATIONAL, LLC
WO/2021/252962METHODS AND COMPOSITIONS FOR DELIVERING BIOACTIVE COMPOSITIONS  TO OCULAR TISSUE USING MICRONEEDLE DEVICESAQUAVIT PHARMACEUTICALS, INC,
WO/2021/257409COMPOSITIONS AND METHODS FOR TREATING LATE-ONSET POMPE DISEASEGENZYME CORPORATION
WO/2021/252970GENETIC MODIFICATIONPETER BIOTHERAPEUTICS, INC.
WO/2021/252986TLR7/8-MEDIATED TISSUE REPAIR BY REGULATORY T CELLSTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/2574182-OXO-OXAZOLIDINE-5-CARBOXAMIDES AS NAV1.8 INHIBITORSMERCK SHARP & DOHME CORP.
WO/2021/2574205-OXOPYRROLIDINE-3-CARBOXAMIDES AS NAV1.8 INHIBITORSMERCK SHARP & DOHME CORP.
WO/2021/257456TREATMENT OF ATRIAL DYSFUNCTIONMYOKARDIA, INC.
WO/2021/257461COMBINATION ANTIBACTERIAL COMPOSITION AND METHOD FOR  ANTIBACTERIAL THERAPYMYLAN LABORATORIES LIMITED
WO/2021/257466COMBINATION ANTIBACTERIAL COMPOSITION AND METHOD FOR  ANTIBACTERIAL THERAPYTHE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/253007DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2  GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATIONEMORY UNIVERSITY
WO/2021/253008PARTIALLY DESULFATED HEPARIN FOR TREATING CORONAVIRAL  INFECTIONSIHP THERAPEUTICS INC.
WO/2021/257479DERMAL PATCHES AND GLASS SWABS FOR APPLICATION OF TOPICAL  IMMUNOSENSITIZERSSQUAREX, LLC
WO/2021/257500METHODS AND COMPOSITIONS FOR TREATING MILD TRAUMATIC BRAIN  INJURY, POST-TRAUMATIC STRESS DISORDER AND MILD TRAUMATIC BRAIN INJURY WITH  POST TRAUMATIC STRESS DISORDERLOBE SCIENCES LTD.
WO/2021/257503METHODS AND COMPOSITIONS FOR TREATING TRIPLE-NEGATIVE BREAST  CANCERGENENTECH, INC.
WO/2021/257510MEASLES VIRUS VACCINE EXPRESSING SARS-COV-2 PROTEIN(S)UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/257523USE OF ARGINASE FOR TREATMENT OF INFLUENZA INFECTIONSAEGLEA BIOTHERAPEUTICS, INC.
WO/2021/257532ALK2 INHIBITORS FOR THE TREATMENT OF ANEMIAINCYTE CORPORATION
WO/2021/257533MICROPARTICLES FOR CONTROLLED RELEASE OF EXTRACELLULAR  VESICLES AND METHODS FOR FABRICATING THE SAMETHE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/257544SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMAICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/257562COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE  (HMB) AND CHEMOTHERAPY AGENTSMETABOLIC TECHNOLOGIES, LLC
WO/2021/257569ANTI-VIRAL COMPOUNDS AND METHODS OF USEMETRO INTERNATIONAL BIOTECH, LLC
WO/2021/257574TRI-SWITCH TECHNOLOGY FOR MULTI-DIMENSIONAL CONTROL OF CELL  THERAPYKIROMIC BIOPHARMA INC.
WO/2021/257587MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE  THEREOFG1 THERAPEUTICS, INC.
WO/2021/257595ADENO-ASSOCIATED VIRUS VECTOR DELIVERY FOR MUSCULAR  DYSTROPHIESRESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/262484COMBINATION THERAPY FOR TREATMENT OF CANCERPMV PHARMACEUTICALS, INC.
WO/2021/257605COMPOSITIONS AND METHODS RELATING TO ANTIVIRAL THERAPEUTICSNORTH CAROLINA STATE UNIVERSITY
WO/2021/257607TREATMENT FOR HUMAN CORONAVIRUS INFECTIONTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
WO/2021/257626EXCIPIENTS PROVIDING STABILIZATION AND ENHANCED WATER  SOLUBILIZATION AND THEIR USESNANOSYNTHONS LLC
WO/2021/257655ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILUREACCELERON PHARMA INC.
WO/2021/262498METHODS AND MATERIALS FOR TREATING NON-MALIGNANT DISORDERS OR  DISEASES WITH CORD BLOODUNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/257660SMALL MOLECULE COVALENT ACTIVATORS OF UCP1DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/257670COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONSAMPLYX PHARMACEUTICALS, INC.
WO/2021/257673METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR  DYSTROPHYSTEALTH BIOTHERAPEUTICS INC.
WO/2021/257696ISOFORM-SPECIFIC ALDEHYDE DEHYDROGENASE INHIBITORSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/257697COMPOUNDS AND METHODS FOR BLOCKING APOPTOSIS AND INDUCING  AUTOPHAGYPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/257706RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND  IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOFBOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
WO/2021/257723COMPOSITION AND METHOD FOR NEW THERAPEUTIC AGENTS INCLUDING  GUANIDINIUM-PRESENTING DENDRIMERS AND BRANCHED STRUCTURESTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/257736METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED  RESISTANCE TO RAS INHIBITORSREVOLUTION MEDICINES, INC.
WO/2021/257754SMALL MOLECULE VE-PTP INHIBITORSRIPKA, Amy
WO/2021/257784INJECTABLE MELOXICAM FORMULATIONSVERTé THERAPEUTICS, LLC
WO/2021/257788METHODS FOR MANUFACTURING ADASFLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/257799MESHED UMBILICAL CORD TISSUE GRAFTSMIMEDX GROUP, INC.
WO/2021/257800MODULATION OF DRUG-DRUG INTERACTIONS OF VADADUSTATAKEBIA THERAPEUTICS, INC.
WO/2021/257802COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATIONTHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/257803ADAS COMPRISING BACTERIAL SECRETION SYSTEMSFLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/257804THYROMIMETICSAUTOBAHN THERAPEUTICS, INC.
WO/2021/257806IODIDE FOR TREATMENT OF NONTHYROIDAL ILLNESS SYNDROMEFRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/257812PLURIPOTENT STEM CELL-DERIVED HEART ORGANOIDBOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/257816MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF  PATHOGEN-INDUCED LUNG INJURYLUNG THERAPEUTICS, INC.
WO/2021/257832PHARMACEUTICAL GRANULATIONS OF WATER-SOLUBLE ACTIVE  PHARMACEUTICAL INGREDIENTSXWPHARMA LTD.
WO/2021/257841CHIMERIC RSV AND CORONAVIRUS PROTEINS, IMMUNOGENIC  COMPOSITIONS, AND METHODS OF USEMEISSA VACCINES, INC.
WO/2021/257842SMARCA4 INHIBITION FOR THE TREATMENT OF CANCEREPIZYME, INC.
WO/2021/257843NON-PORCINE FORMULATIONS AND METHODS THEREOFAZURRX BIOPHARMA, INC.
WO/2021/257880USE OF ALDH MODULATORS OR GASDERMIN D INHIBITORS FOR  PREVENTION AND TREATMENT OF AGING AND AGING-RELATED DISORDERS AND FOR  BOOSTING AN IMMUNE SYSTEMSPRING DISCOVERY, INC.
WO/2021/257884VACCINES, VACCINE PRIMING, AND ANTIGEN DOSE SPARINGADJUVANCE TECHNOLOGIES, INC.
WO/2021/257886CONTROLLED RELEASE GRANULATIONS OF WATER-SOLUBLE ACTIVE  PHARMACEUTICAL INGREDIENTSXWPHARMA LTD.
WO/2021/257887USE OF INHIBITORS OF THE ACTIVATOR PROTEIN 1 (AP-1) FOR  PREVENTING ADHESIONSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/257888TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS  THERAPEUTIC TARGETS FOR COVID-19UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/257894ANTI-BST2 ANTIBODIES TARGETING BST2 LONG ISOFORMBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/257899METHODS FOR TREATING HEMOPHILIA A AND POPULATION  PHARMACOKINETICS TOOLS FOR DETERMINING TREATMENTS AND USES THEREOFBIOVERATIV THERAPEUTICS INC.
WO/2021/257913COMPOSITIONS FOR SOLUBILIZING WATER-INSOLUBLE ACTIVE  INGREDIENTSCHAVAN, Neha
WO/2021/257916UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASESARCTURUS THERAPEUTICS, INC.
WO/2021/257917UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASESARCTURUS THERAPEUTICS, INC.
WO/2021/257924METHODS AND COMPOSITIONS FOR CATEGORIZING AND/OR TREATING CHIN  RETRUSION IN A SUBJECT IN NEED THEREOFALLERGAN, INC.
WO/2021/262536METHOD OF MAKING AND USING A SKIN MOISTURIZING FORMULATIONROHM AND HAAS COMPANY
WO/2021/257935NANOPARTICLE-ENCAPSULATED CANNABINOIDS AND METHODS FOR MAKING  AND USING SAMELUCAS, Naomie
WO/2021/257936CANNABINOID SYRUP AND METHODS FOR MAKING AND USING SAMELUCAS, Naomie
WO/2021/257937CHEMICALLY CROSS-LINKED ELASTOMERS FORMED BY MICHAEL ADDITION  AND COMPOSITIONS COMPRISING SUCH ELASTOMERSNANOMETICS LLC (D.B.A. PHD BIOSCIENCES)
WO/2021/257938MARKERS FOR USE IN METHODS FOR TREATING CANCERS WITH ANTIBODY  DRUG CONJUGATES (ADC)AGENSYS, INC,
WO/2021/257940TREATMENT OF VIRAL INFECTIONS WITH ESTROGEN RECEPTOR  MODULATORS AND ANTI-INFLAMMATORY AGENTSTHE CLEVELAND CLINIC FOUNDATION
WO/2021/257947ACTIVIN A ANTIBODY FORMULATIONS AND METHODS OF USE THEREOFREGENERON PHARMACEUTICALS, INC.
WO/2021/257953READY-TO-USE PROBIOTIC COMPOSITIONS AND USES THEREOFHEALTHY COW CORPORATION
WO/2021/257956ADMINISTRATION OF RESINIFERATOXIN FOR TREATMENT OF BLADDER  PAIN OR BLADDER CANCERSORRENTO THERAPEUTICS, INC.
WO/2021/257969ORAL DELIVERY OF NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) AND  OTHER NUTRITIONAL SUPPLEMENTSKONIVER, Craig
WO/2021/258008COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL  INFECTIONIMMUNACOR LLC
WO/2021/258013OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING  OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOFAKAGERA MEDICINES, INC.
WO/2021/258030SILK-HYALURONIC ACID COMPOSITIONS FOR TISSUE FILLING, TISSUE  SPACING, AND TISSUE BULKINGEVOLVED BY NATURE, INC.
WO/2021/262561TREATING RHEUMATOID ARTHRITISBRISTOL-MYERS SQUIBB COMPANY
WO/2021/262562METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING  A COMBINATION OF A PD-1 ANTAGONIST, A HIF-2 ALPHA INHIBITOR, AND LENVATINIB  OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOFMERCK SHARP & DOHME CORP.
WO/2021/262563METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING  A COMBINATION OF A HIF-2 ALPHA INHIBITOR AND LENVATINIBMERCK SHARP & DOHME CORP.
WO/2021/262567ANTHOCYANIN AND QUERCETIN BASED FORMULATIONS FOR IMPROVED  RESPIRATORY HEALTHZESTT WELLNESS LIMITED
WO/2021/262579COMPOSITIONS AND METHODS RELATING TO COMBINATORIAL HYALURONIC  ACID CONJUGATESPRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/258042POLYMERIC BILE ACID ESTER NANOPARTICLES COMPRISING AN  IMMUNOMODULATOR AGENT TO INDUCE ANTIGEN-SPECIFIC TOLERANCEYALE UNIVERSITY
WO/2021/262591PROTEIN TAG TO INDUCE LIGAND DEPENDENT DEGRADATION OF  PROTEIN/PROTEIN-FUSIONSDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/262596METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTIONPMV PHARMACEUTICALS, INC.
WO/2021/262604ADMINISTRATION OF CEBP-BETA ANTAGONIST AND METHODS OF USESAPIENCE THERAPEUTICS, INC.
WO/2021/262607ORONASAL CANNABINOID FORMULATIONS AND USES THEREOFJUPITER WELLNESS, INC.
WO/2021/258055SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN  THE TREATMENT OF NON-HUMAN ANIMALSKIMBERLY-CLARK WORLDWIDE, INC.
WO/2021/258056SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN  THE TREATMENT OF NON-HUMAN ANIMALSKIMBERLY-CLARK WORLDWIDE, INC.
WO/2021/262608COMBINATION VERAPAMIL AND MOMETASONE THERAPY FOR THE TREATMENT  OF CHRONIC RHINOSINUSITISMASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/262617TREATMENT OF SYSTEMIC IMMUNE ACTIVATION SYNDROMESTRANQUIS THERAPEUTICS, INC.
WO/2021/262619GENERATION OF PERINATAL-LIKE MESENCHYMAL STEM CELLS FROM HUMAN  INDUCED PLURIPOTENT STEM CELLSMA, Zhen
WO/2021/262622PROBIOTIC SKIN FORMULATIONSCROWN LABORATORIES, INC.
WO/2021/262627METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE  DERIVATIVESCHEMOCENTRYX, INC.
WO/2021/262628POLY HETEROCYCLIC CONJUGATES AND THEIR PHARMACEUTICAL USESSHIH, Chuan
WO/2021/262645REDOX-RESPONSIVE NANOPARTICLE COMPOSITIONS FOR OCULAR DELIVERY  OF THERAPEUTICSOHIO STATE INNOVATION FOUNDATION
WO/2021/262648PREPARATION OF A PHARMACEUTICAL COMPOSITION OF OLODATEROL AND  BUDESONIDEANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/262659FLAVIVIRUS SIGNAL PEPTIDES, VACCINE CONSTRUCTS, AND METHODS  THEREFORUNIVERSITY OF CONNECTICUT
WO/2021/262675PREPARATION OF A PHARMACEUTICAL COMPOSITION OF OLODATEROL,  TIOTROPIUM BROMIDE AND BUDESONIDEANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/262695METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIAGENZYME CORPORATION
WO/2021/262715PHARMACEUTICAL FORMULATION CONTAINING ACTIVE METABOLITES OF  REMDESIVIR OR ITS ANALOG FOR INHALATIONANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/262718ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL  HYPERTENSION (PAH)ACCELERON PHARMA INC.
WO/2021/262743PROCESS FOR SYNTHESIZING TARGETING MOLECULESBRISTOL-MYERS SQUIBB COMPANY
WO/2021/262745PROCESS FOR SYNTHESIZING CATIONIC LIPIDSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/262746PROCESS FOR SYNTHESIZING LIPIDSBRISTOL-MYERS SQUIBB COMPANY
WO/2021/262749COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING VIRAL  INFECTIONRESEARCH CANCER INSTITUTE OF AMERICA
WO/2021/262773COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF CAS  NUCLEASESOBSIDIAN THERAPEUTICS, INC.
WO/2021/262787COSMETIC COMPOSITIONS COMPRISING BIODEGRADABLE POLYMERSL'ORéAL
WO/2021/262791HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT  SERINE 413MERCK SHARP & DOHME CORP.
WO/2021/262799ANTI-VIRAL COMPOUNDS AND METHODS OF USING SAMEFLAGSHIP PIONEERING, INC.
WO/2021/262803COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC SHOCKVIRTECH BIO, INC
WO/2021/262810CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS  OF TREATMENT THEREWITHCELGENE CORPORATION
WO/2021/262812CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS  OF TREATMENT THEREWITHCELGENE CORPORATION
WO/2021/262813DR5 RADIOIMMUNOTHERAPY IN THE TREATMENT OF SOLID CANCERSACTINIUM PHARMACEUTICALS, INC.
WO/2021/262814IMIQUIMOD COCRYSTALSCELISTA PHARMACEUTICALS LLC
WO/2021/262815CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS  OF TREATMENT THEREWITHCELGENE CORPORATION
WO/2021/262850ANTIVIRAL THERAPY WITH IMIQUIMOD AND COCRYSTALS THEREOFCELISTA PHARMACEUTICALS LLC
WO/2021/262869COMBINATION THERAPY COMPRISING ANTI-CD137 ANTIBODIESADAGENE PTE. LTD.
WO/2021/262874USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER  THERAPYSERVIER PHARMACEUTICALS , LLC
WO/2021/262878NOVEL MOLECULE FOR MODULATION OF INNATE IMMUNE RESPONSES  CONTROLLED BY STING PROTEINOREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/262879EXTRACELLULAR VESICLES WITH IMMUNE MODULATORSCHAMELEON BIOSCIENCES, INC.
WO/2021/262881USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER  THERAPYSERVIER PHARMACEUTICALS, LLC
WO/2021/262892COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG  DELIVERY SYSTEMTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/262903METHOD AND COMPOUND FOR THE TREATMENT AND ELIMINATION OF AN  IMMUNODEFICIENCY CONDITIONSEIFU, Lydia
WO/2021/262910TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATESREGENERON PHARMACEUTICALS, INC.
WO/2021/262912DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC  SURFACTANTSTHE PROCTER & GAMBLE COMPANY
WO/2021/262914COMPOSITIONS AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE  DISORDERBIOHAVEN THERAPEUTICS LTD.
WO/2021/262916PHARMACEUTICAL FORMULATIONS OF GRISEOFULVIN FOR LONG-TERM  OCULAR DELIVERYPURDUE RESEARCH FOUNDATION
WO/2021/262917TOPICAL PHARMACEUTICAL COMPOSITIONSDERMAVANT SCIENCES GMBH
WO/2021/262956TOPICAL GEL FORMULATIONS AND THEIR USE IN TREATING SKIN  CONDITIONSROIVANT SCIENCES GMBH
WO/2021/262962METHODS FOR TREATING CANCER WITH COMBINATION THERAPIESCELGENE CORPORATION
WO/2021/262963METHODS FOR THE REMOVAL OF FREE FACTOR VIII FROM PREPARATIONS  OF LENTIVIRAL VECTORS MODIFIED TO EXPRESS SAID PROTEINBIOVERATIV THERAPEUTICS INC.
WO/2021/262985CYTOKINE CONJUGATESAMUNIX PHARMACEUTICALS, INC.
WO/2021/262992GEMCABENE FOR TREATMENT OF CYTOKINE STORMS AND VIRAL-INDUCED  INFLAMMATIONNEUROBO PHARMACEUTICALS, INC.
WO/2021/262998COMPOUNDS FOR SENSING REACTIVE OXYGEN SPECIES AND METHODS FOR  USING THE SAMEWAKE FOREST UNIVERSITY HEALTH SCIENCES
WO/2021/263026IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND  ANTI-EGFR ANTIBODIESSYNTHORX, INC.
WO/2021/263040STABLE PEPTIBODY FORMULATIONSSHIRE-NPS PHARMACEUTICALS, INC.
WO/2021/263056DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT  OF AMYOTROPHIC LATERAL SCLEROSISALEXION PHARMACEUTICALS, INC.
WO/2021/263072METHODS OF TREATING DISEASEDANA-FARBER CANCER INSTITUTE, INC.
WO/2021/263074ANTIMICROBIAL COMPOUNDS AND COMPOSITIONSPREVENIAL, LLC
WO/2021/263081BREAST CANCER VACCINENATIONAL BREAST CANCER COALITION
WO/2021/263085COMBINATION THERAPY FOR THE TREATMENT OF SOLID AND  HEMATOLOGICAL CANCERSARCH ONCOLOGY, INC.
WO/2021/263097METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSISTHE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/263128ACE2-FC FUSION PROTEINS AND METHODS OF USEGLIKNIK INC.
WO/2021/263129KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USEICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/263131COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE  AGAINST CORONAVIRUSELICIO THERAPEUTICS, INC.
WO/2021/263132RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITYAPRECIA PHARMACEUTICALS LLC
WO/2021/263139METHODS OF TREATING CORONAVIRUS INFECTION USING HSP90  INHIBITORSDUKE UNIVERSITY
WO/2021/263152mRNA TRANSFECTION OF IMMUNE CELLSCARISMA THERAPEUTICS INC.
WO/2021/263171SELECTIVE HISTONE DEACETYLASE 6 INHIBITORSTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOS
WO/2021/263173USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING  NEUROLOGICAL CONDITIONS, NEURODEGENERATIVE DISEASES, AND ADDICTIONDURECT CORPORATION
WO/2021/263177USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AUTOIMMUNE  CONDITIONSDURECT CORPORATION
WO/2021/263178STABLE <i>CANNABINOID</i> COMPOSITIONSCBDMD, INC.
WO/2021/263179TARGETING THE HUMAN CCR5 LOCUS AS A SAFE HARBOR FOR THE  EXPRESSION OF THERAPEUTIC PROTEINSTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/263180USE OF OXYGENATED CHOLESTEROL SULFATES FOR CANCERS AND  NON-CANCEROUS TRANSFORMATIONS RELATED TO EPSTEIN-BARR VIRUSDURECT CORPORATION
WO/2021/263185USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST  ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETESDURECT CORPORATION
WO/2021/263186USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING  INFLAMMATORY CONDITIONSDURECT CORPORATION
WO/2021/263189ENDOTHELIAL CELLS FOR MITIGATION OF CHEMOTHERAPY-INDUCED  TOXICITYANGIOCRINE BIOSCIENCE, INC.
WO/2021/263197STABLE SUSTAINED RELEASE THERAPEUTIC COMPOSITIONS IN APROTIC  POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAMEXERIS PHARMACEUTICALS, INC.
WO/2021/263205COMBINATION THERAPY WITH DEOXYURIDINE TRIPHOSPHATASE  INHIBITORSCV6 THERAPEUTICS (NI) LIMITED
WO/2021/263206COMPOSITIONS AND METHODS FOR THE TREATMENT OF COVID-19PROTHIONE, LLC
WO/2021/263221BINDING MODULATORNOVATHER, INC.
WO/2021/263227ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER  METASTASISMINERVA BIOTECHNOLOGIES CORPORATION
WO/2021/263241METHODS FOR DERIVING DOPAMINERGIC NEURONS FROM PLURIPOTENT  STEM CELLSMINERVA BIOTECHNOLOGIES CORPORATION
WO/2021/222913MICRO DOSING OF VIRAL VACCINESKOZIOL, Jeffrey E.
WO/2021/237228METHOD AND COMPOUND FOR THE TREATMENT OF COVID-19TESFAZION, Amanuel
WO/2021/258086GALLIUM IN THE TREATENT OF CORONAVIRUS DISEASEBERNSTEIN, Lawrence
WO/2021/263250METHOD OF TREATING SEVERE FORMS OF PULMONARY HYPERTENSIONREVERSPAH LLC
WO/2021/146749TOLL-LIKE RECEPTOR AGONIST FORMULATIONS AND METHODS OF USETHE UNIVERSITY OF CHICAGO
WO/2021/155390ANTIMICROBIAL COMPOSITIONSSHAMAN NATURALS, LLC.
WO/2021/155398LIP COMPOSITIONMARY KAY INC.
WO/2021/168474TOPICAL COSMETIC COMPOSITIONSMARY KAY INC.
WO/2021/179003ORAL CARE COMPOSITION CONTAINING CETYLPYRIDINIUM  TETRACHLOROZINCATECOLGATE-PALMOLIVE COMPANY
WO/2021/179014TOOTHPASTES CONTAINING CALCIUM CARBONATE, XANTHAN GUM AND  POLYACRYLIC ACID POLYMERCOLGATE-PALMOLIVE COMPANY
WO/2021/189077METHODS FOR TREATING ACNECHEMISTRYRX
WO/2021/189080METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZATHE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/195661ANTI-VIRAL COMPOUNDS AND METHODS FOR ADMINISTRATION THEREOFGREGG, John, M.H.
WO/2021/195672DETECTION AND TREATMENT OF INTESTINAL FIBROSISTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/203127SULFATE-FREE PERSONAL CARE COMPOSITIONS AND METHODS FOR  PREVENTING AND TREATING POLLUTION DAMAGE TO SKINCOLGATE-PALMOLIVE COMPANY
WO/2021/203128PERSONAL CARE COMPOSITIONS COMPRISING CANNABIDIOL AND LICORICECOLGATE-PALMOLIVE COMPANY
WO/2021/203132IMPROVING, MAINTAINING, PROTECTING AND REPAIRING TISSUE  INTEGRITY, BARRIER FUNCTION AND IMMUNITY USING A COMPOSITION COMPRISING A  SOURCE OF ZINC IONSCOLGATE-PALMOLIVE COMPANY
WO/2021/203136METHODS FOR TREATING HYPERPIGMENTATION AND COMPOSITIONS FOR  SAMECHEMISTRYRX
WO/2021/203141FULL-LENGTH CILP AS A BIOMARKER FOR CARDIAC FIBROSISTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/207759MODIFIED KISSPEPTIN RECEPTOR AGONISTS FOR FATTY LIVER DISEASERUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/207767METHODS OF TREATMENT USING ANTIFOLATES AND PHARMACEUTICAL  FORMULATIONS COMPRISING ANTIFOLATESEMPHASCIENCE, INC.
WO/2021/207770HUMANIZED ANTIBODY TARGETING THE TUMOR ASSOCIATED ANTIGEN  IL13Ra2NORTHWESTERN UNIVERSITY
WO/2021/217176TOPICAL COSMETIC COMPOSITIONSMARY KAY INC.
WO/2021/217178CALIBRATION AND QUALITY CONTROL REAGENTS FOR USE WITH  IMMUNOASSAYS FOR ANTIBODIESSIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/217179COMPOSITIONS, KITS, AND METHODS FOR ANTI-MICROBIAL SEROLOGY  ASSAYS USING ANTI-HUMAN IMMUNOGLOBULIN ANTIBODYSIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/217186TOPICAL COSMETIC COMPOSITIONSMARY KAY INC.
WO/2021/222927VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN  RECEPTORSBAYLOR COLLEGE OF MEDICINE
WO/2021/222928TREATMENT AND PREVENTION OF CANCER USING VIRUS-SPECIFIC IMMUNE  CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORSBAYLOR COLLEGE OF MEDICINE
WO/2021/222929TREATMENT AND PREVENTION OF ALLOREACTIVITY USING  VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORSBAYLOR COLLEGE OF MEDICINE
WO/2021/222933COSMETIC COMPOSITIONS AND METHODS COMPRISING PLUMERIA ALBA  FLOWER EXTRACTMARY KAY INC.
WO/2021/222939ANTIBIOTIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS OF  USETHE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
WO/2021/222943IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR TARGETING  CANCER FIBROBLASTSFIGENE, LLC
WO/2021/222944ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND  METHODS OF USE THEREOFBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/226629HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON  MYELOID CELLS 2 AGONISTS AND METHODS OF USEAMGEN INC.
WO/2021/226632COSMETIC COMPOSITION COMPRISING GLUCONOLACTONE AND GLYCOLIC  ACIDMARY KAY INC.
WO/2021/226637METHOD OF TREATING A PATIENT INFECTED WITH A CORONAVIRUS WITH  NEZULCITINIBTHERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/232040BRIGHTENING BOOSTER TECHNOLOGY AND BRIGHTENING AMPULEMARY KAY INC.
WO/2021/232041N-ACETYLCYSTEINE AND GLYCINE FOR TREATMENT OF COVID-19 AND  POST COVID-19 SYMPTOMSBAYLOR COLLEGE OF MEDICINE
WO/2021/232048SARS-COV-2-SPECIFIC T CELLSBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/232052MICROENCAPSULATED DELIVERY SYSTEM FOR RELEASE OF  ANTI-INFLAMMATORY AGENTS INTO THE LUNGTEXAS BIOMEDICAL RESEARCH INSTITUTE
WO/2021/232054COMPOSITIONS FOR TREATING HAIR LOSSCHEMISTRYRX
WO/2021/232055METHODS FOR TREATING HAIR LOSS AND COMPOSITIONS FOR SAMECHEMISTRYRX
WO/2021/232057METHODS FOR BREAST CANCER TREATMENT AND PREDICTION OF  THERAPEUTIC RESPONSEINSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI ISUNYER  (IDIBAPS)
WO/2021/232062FIBROBLAST BASED THERAPY FOR TREATMENT OF PARKINSON'S DISEASEFIGENE, LLC
WO/2021/232064TREATMENT OF OVARIAN FAILURE USING REGENERATIVE CELLSFIGENE, LLC
WO/2021/232066VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS  TREATMENT AND PREVENTIONBAYLOR COLLEGE OF MEDICINE
WO/2021/232067STATS3 INHIBITION FOR TREATMENT AND PREVENTION OF HUMAN  CORONAVIRUS INFECTIONGLG PHARMA, LLC
WO/2021/237239ACTIVE LOW MOLECULAR WEIGHT VARIANT OF ANGIOTENSIN CONVERTING  ENZYME 2 (ACE2) FOR THE TREATMENT OF DISEASES AND CONDITIONS OF THE EYENORTHWESTERN UNIVERSITY
WO/2021/243350MULTI-CAVITY CUSTOMIZABLE DOSAGE FORMSJOHNSON & JOHNSON CONSUMER INC.
WO/2021/243359TOPICAL COMPOSITIONS AND METHODSMARY KAY INC.
WO/2021/243376FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMSFIGENE, LLC
WO/2021/243380AUGMENTATION OF FIBROBLAST CELL THERAPY EFFICACY BY MICROBIOME  MANIPULATIONFIGENE, LLC
WO/2021/248158FIBROBLASTS AS A REGENERATIVE CELLULAR SOURCE FOR THE  TREATMENT OF BLINDNESSFIGENE, LLC
WO/2021/248160METHODS OF TREATMENT OF A CYTOKINE STORMLOMA LINDA UNIVERSITY HEALTH
WO/2021/248164LARGE SCALE PURIFICATION OF CASTANOSPERMINEFLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/253049NANOEMULSION SYSTEM FOR TRANSDERMAL DELIVERY OF PHARMACEUTICAL  COMPOSITIONS AND OTHER ACTIVE AGENTSDE MENEZES, Sergio, Bezerra
WO/2021/253053TOPICAL COMPOSITIONS AND METHODSMARY KAY INC.
WO/2021/258099COSMETIC COMPOSITIONMARY KAY INC.
WO/2021/263270ANTIMICROBIAL MOISTURE AVOIDANCE POWERS AND SUBSTANCESATACAMA, LLC
WO/2021/263282EDIBLE CELL BASED VACCINESTRUSTEES OF TUFTS COLLEGE
WO/2021/263285LARGE-SCALE PRODUCTION OF EXOSOMES FROM PRIMED MESENCHYMAL  STROMAL CELLS FOR CLINICAL USEBOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/042137NATURAL ESSENTIAL OIL COMPOSITION FOR RELAXING NERVES,  SLEEPING WELL AND PREVENTING COLD AND FLUSUNSTAR JOINT STOCK COMPANY
WO/2021/151122THERAPEUTIC COMPOSITIONS COMPRISING SODIUM DIACETATE FOR  CANCER PAIN AND METABOLIC ABNORMALITIESTHAI MINH PHARMACEUTIAL JOINT STOCK COMPANY
WO/2021/163736PROBIOTIC-CONTAINING NATURAL COMPOSITION FOR CLEANING THE  BODY, WHICH IS CAPABLE OF DEODORIZING, DECOMPOSING ORGANIC MATTERS ADHERED TO  THE BODY AND THE BODY CLEANING PRODUCTS MADE FROM THIS COMPOSITIONPHU, Nguyen
WO/2021/232070ORGANIC SOL-GEL NANO-COMPOSITION FROM PANAX NOTOGINSENG,  RUTIN, GINKGO BILOBA EFFECTIVE IN ENHANCING CEREBRAL AND CARDIOVASCULAR  PROTECTION AND METHOD OF PRODUCING THEREOFVAN, Nguyen Anh
WO/2021/232071SOLID LIPID NANO-COMPOSITION CONTAINING BERBERINE AND  CINNAMONALDEHYDE EFFECTIVE IN TREATING DIABETES, DYSLIPIDEMIA, AND METHOD OF  PREPARING THE SAMEVAN, Nguyen Anh
WO/2021/203146PAIN-RELIEVING AND ANTI-INFLAMMATORY PREPARATION FOR  PREVENTING AND TREATING THROMBOSISSUNSTAR JOINT STOCK COMPANY

 




https://blog.sciencenet.cn/blog-681765-1365034.html

上一篇：2021年无线通信（H04W）类各专利局的PCT申请数量分布——中国占53%，美国占14%，韩国占10%，华为、高通领先
下一篇：2021年物理测量领域的PCT专利申请状况——中国占23%，美国占18%，日本占22%，欧洲占18%
收藏 IP: 61.158.184.*| 热度|

0

该博文允许注册用户评论 请点击登录 评论 (0 个评论)

数据加载中...
扫一扫，分享此博文

全部作者的精选博文

全部作者的其他最新博文

全部精选博文导读

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-5-21 23:26

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部